data_2jp2_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2jp2 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 6.4 m . . . . . 0 CA--C 1.536 0.428 0 N-CA-C 112.494 0.553 . . . . 0.0 112.494 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 10.0 m-85 -66.89 112.93 4.56 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 120.685 0.279 . . . . 0.0 110.489 176.009 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.527 HG13 HG23 ' A' ' 16' ' ' VAL . 34.0 pt -92.01 -26.82 4.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.357 178.188 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.527 HG23 HG13 ' A' ' 15' ' ' ILE . 92.1 t -135.35 137.72 49.53 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.194 179.466 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.452 ' NH1' ' HG2' ' A' ' 42' ' ' ARG . 18.9 tpp180 -132.74 123.33 26.03 Favored 'General case' 0 N--CA 1.463 0.21 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 175.508 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 30.2 m -124.09 176.6 5.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 C-N-CA 122.659 0.383 . . . . 0.0 110.375 179.072 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 22.4 pttp -132.48 125.51 30.83 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 179.43 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -165.91 177.71 6.95 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 -179.3 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 60.2 t -100.24 118.14 46.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 110.177 -0.305 . . . . 0.0 110.177 176.059 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 17.8 m -66.71 109.0 1.15 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.354 0 CA-C-O 121.352 0.596 . . . . 0.0 111.237 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 25.1 mmt -106.65 166.52 10.51 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.129 179.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.512 HG23 ' CE1' ' A' ' 33' ' ' PHE . 11.0 t -160.84 150.63 17.39 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.934 -0.575 . . . . 0.0 109.708 177.769 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 20.7 ttt180 -120.31 100.64 7.29 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 174.071 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -69.38 84.31 0.4 Allowed 'General case' 0 C--O 1.235 0.299 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.481 179.449 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 15.4 t70 64.44 -81.63 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.139 -175.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 41.2 m -149.43 17.8 0.93 Allowed 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 120.81 0.338 . . . . 0.0 110.432 178.228 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 38.6 t -64.66 89.58 0.07 Allowed 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.829 -179.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 76.32 -63.72 2.91 Favored Glycine 0 C--N 1.332 0.353 0 CA-C-N 116.093 -0.503 . . . . 0.0 112.351 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 158.51 -140.28 6.84 Favored Glycine 0 N--CA 1.449 -0.475 0 N-CA-C 111.027 -0.829 . . . . 0.0 111.027 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . 0.497 ' HH2' ' HG2' ' A' ' 99' ' ' LYS . 97.9 m95 -79.02 93.9 5.2 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 176.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.512 ' CE1' HG23 ' A' ' 24' ' ' THR . 21.3 p90 -103.65 143.17 26.11 Favored Pre-proline 0 C--O 1.236 0.353 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.505 -178.311 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -69.08 103.37 1.04 Allowed 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.286 1.991 . . . . 0.0 111.266 176.19 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -57.04 -49.44 75.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.476 -179.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -157.45 171.2 20.8 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 179.36 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 78.52 -75.41 1.97 Allowed Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 121.053 -0.594 . . . . 0.0 111.777 -179.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 70.91 -73.95 0.64 Allowed Glycine 0 C--N 1.332 0.354 0 C-N-CA 121.562 -0.351 . . . . 0.0 112.25 -179.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -70.86 76.96 0.54 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 121.5 -0.381 . . . . 0.0 112.289 178.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 38.1 mm 66.87 142.84 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 C-N-CA 123.442 0.697 . . . . 0.0 111.31 178.455 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 18.2 m -132.96 133.85 43.74 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.057 0.455 . . . . 0.0 110.44 178.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.452 ' HG2' ' NH1' ' A' ' 17' ' ' ARG . 37.8 ttt85 -86.51 83.44 7.64 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.551 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 28.8 t -100.97 155.53 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.567 -172.414 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -162.78 -178.19 36.41 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.623 -0.799 . . . . 0.0 112.702 177.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 59.8 t -128.98 128.63 67.52 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 179.008 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . 0.516 ' SG ' ' HB3' ' A' ' 60' ' ' LEU . 13.7 p -119.45 126.44 51.32 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 176.479 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -82.06 98.39 8.62 Favored 'General case' 0 C--O 1.234 0.237 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 179.392 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.493 HG21 ' HE1' ' A' ' 76' ' ' TYR . 33.0 m -86.53 -168.95 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.21 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 22.1 ptp . . . . . 0 C--N 1.328 -0.351 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 177.497 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.248 0 N-CA-C 110.714 -0.954 . . . . 0.0 110.714 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -135.96 148.7 48.59 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 117.337 0.568 . . . . 0.0 110.518 -177.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.664 HD21 ' HB2' ' A' ' 62' ' ' HIS . 2.3 tt -133.37 113.0 12.07 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 179.171 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.544 ' HB ' ' HB2' ' A' ' 75' ' ' CYS . 46.2 mt -79.96 98.31 3.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 108.396 -0.965 . . . . 0.0 108.396 174.605 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . 0.664 ' HB2' HD21 ' A' ' 60' ' ' LEU . 23.8 t-80 -120.93 141.22 50.86 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 -173.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -156.3 126.93 1.88 Allowed Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.322 -0.942 . . . . 0.0 113.132 -177.439 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -90.5 164.04 14.4 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 172.273 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.554 ' HB3' HG11 ' A' ' 72' ' ' VAL . 16.5 ptm180 -81.41 164.1 22.32 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.176 -0.675 . . . . 0.0 109.176 172.633 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 54.7 tp60 -78.05 68.3 4.07 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-O 121.38 0.61 . . . . 0.0 109.43 179.304 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.795 ' HE3' ' HA ' ' A' ' 67' ' ' LYS . 0.5 OUTLIER -171.58 49.7 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.223 -0.899 . . . . 0.0 109.017 -177.145 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.436 ' HB2' ' O ' ' A' ' 67' ' ' LYS . 4.3 m-20 71.8 -179.05 0.22 Allowed 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 115.257 -0.883 . . . . 0.0 111.149 -177.502 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 5.1 mptp? -65.92 93.62 0.2 Allowed 'General case' 0 C--O 1.233 0.215 0 CA-C-N 115.897 -0.592 . . . . 0.0 112.594 -175.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 58.1 tp -136.22 105.14 5.88 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 167.403 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 44.1 t -62.56 108.34 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.673 -177.035 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.554 HG11 ' HB3' ' A' ' 65' ' ' ARG . 33.7 m -107.75 -9.84 10.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.77 179.112 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -144.67 127.11 15.93 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 179.338 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -146.74 115.27 6.74 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 177.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' CYS . . . . . 0.544 ' HB2' ' HB ' ' A' ' 61' ' ' ILE . 39.8 m -137.73 85.42 2.11 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.079 0.466 . . . . 0.0 109.986 177.545 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.493 ' HE1' HG21 ' A' ' 48' ' ' VAL . 86.3 t80 -75.28 135.38 40.94 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.548 176.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.419 HG11 ' HG ' ' A' ' 81' ' ' LEU . 25.6 m -134.19 149.56 30.32 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 177.602 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.456 ' HD3' ' N ' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -108.83 -35.09 6.47 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.183 -174.346 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 59.9 tttm -165.83 23.34 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 121.491 0.663 . . . . 0.0 109.625 -177.591 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -146.63 125.18 12.44 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.227 -170.223 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.419 ' HG ' HG11 ' A' ' 77' ' ' VAL . 5.3 mt -160.81 122.55 3.05 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.014 177.042 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 48.4 t -124.29 98.64 5.52 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 177.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.632 ' HB3' ' NE2' ' A' ' 91' ' ' HIS . 84.1 m-85 -90.58 161.68 15.34 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.407 177.234 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.446 ' HB ' ' CE1' ' A' ' 92' ' ' HIS . 60.7 m -158.89 115.66 2.72 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 174.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.51 ' HZ2' ' CG ' ' A' ' 114' ' ' ASP . 36.2 ttpt -89.11 107.54 19.1 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 178.457 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -73.71 -41.68 62.26 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.387 -175.001 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -136.61 153.47 75.97 Favored Pre-proline 0 C--N 1.325 -0.472 0 CA-C-N 115.203 -0.908 . . . . 0.0 108.647 179.017 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_exo -52.89 -23.51 21.26 Favored 'Trans proline' 0 N--CA 1.476 0.449 0 C-N-CA 122.491 2.127 . . . . 0.0 112.695 -179.166 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 14.6 t -107.54 8.93 29.55 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.576 -177.277 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.409 ' HE1' ' HB3' ' A' ' 92' ' ' HIS . 4.6 t80 -148.38 111.68 4.95 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-O 120.975 0.417 . . . . 0.0 110.953 -178.083 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' HIS . . . . . 0.632 ' NE2' ' HB3' ' A' ' 83' ' ' TYR . 3.1 t-160 -111.52 133.28 53.91 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 177.613 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . 0.446 ' CE1' ' HB ' ' A' ' 84' ' ' THR . 33.0 p80 -134.52 165.22 25.69 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.852 0.358 . . . . 0.0 111.346 -177.345 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 47.4 p90 -147.66 143.87 27.97 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.351 -179.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 48.6 tttm -112.99 122.94 49.14 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.153 179.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 27.7 m -110.21 32.88 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.325 0 CA-C-O 121.265 0.555 . . . . 0.0 109.937 -177.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 23.8 t70 71.92 -57.42 0.62 Allowed 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 114.859 -1.064 . . . . 0.0 109.81 -173.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -73.9 97.1 2.72 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 172.497 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 12.2 mpt_? 60.56 176.38 0.1 Allowed 'General case' 0 C--O 1.243 0.748 0 CA-C-O 122.186 0.993 . . . . 0.0 112.077 -176.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.497 ' HG2' ' HH2' ' A' ' 32' ' ' TRP . 38.1 ttpt -126.51 106.95 9.81 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 114.34 -1.3 . . . . 0.0 108.2 176.274 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . 0.499 ' CD2' ' SG ' ' A' ' 75' ' ' CYS . 4.7 m-85 -89.76 173.87 8.03 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 -175.816 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -177.66 -175.44 44.87 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.833 -0.699 . . . . 0.0 111.972 177.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.427 ' O ' HD13 ' A' ' 102' ' ' LEU . 1.3 pp -152.0 150.33 29.87 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.099 0.476 . . . . 0.0 110.898 177.012 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 25.2 m -101.0 116.18 32.24 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.806 176.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 40.5 m-85 -63.59 147.42 51.52 Favored 'General case' 0 C--O 1.237 0.413 0 O-C-N 123.369 0.418 . . . . 0.0 110.422 178.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 19.0 pt20 -114.25 -10.8 12.68 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.473 -0.331 . . . . 0.0 110.974 -178.244 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 20.4 m -155.12 151.7 23.5 Favored Pre-proline 0 C--N 1.33 -0.251 0 N-CA-C 110.089 -0.337 . . . . 0.0 110.089 174.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -60.16 -19.2 55.7 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.344 2.029 . . . . 0.0 111.65 176.361 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -66.08 -60.43 2.83 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.519 177.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -65.19 -31.98 73.43 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.79 179.035 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -57.61 -61.53 2.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.003 0.43 . . . . 0.0 110.726 175.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . 0.427 ' O ' ' HD2' ' A' ' 111' ' ' ARG . 5.4 tmm_? -62.57 -38.23 89.28 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.235 -177.496 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -63.5 -43.48 97.11 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.095 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 75.4 t80 -67.06 -47.33 71.64 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.081 -178.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.51 ' CG ' ' HZ2' ' A' ' 85' ' ' LYS . 59.5 m-20 -57.5 -39.48 76.57 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.526 178.095 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . 0.419 HH11 ' HD2' ' A' ' 115' ' ' ARG . 0.6 OUTLIER -62.12 -49.86 74.22 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.112 178.359 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -61.25 -42.4 99.77 Favored Glycine 0 C--N 1.333 0.367 0 CA-C-N 115.599 -0.728 . . . . 0.0 112.063 179.631 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 55.4 t -60.91 -46.67 96.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.927 0.394 . . . . 0.0 110.699 177.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 25.6 tpt180 -59.88 -49.78 76.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.221 -177.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.68 ' HZ1' ' HB3' ' A' ' 119' ' ' LYS . 4.3 mmmp? -64.28 -41.18 97.02 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.942 178.691 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -58.08 -55.99 27.78 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.538 -179.591 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.426 ' O ' HG23 ' A' ' 125' ' ' ILE . 46.2 mm -58.27 -42.59 84.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.326 178.687 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -53.28 -59.08 5.01 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.472 -179.355 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 50.0 m-20 -74.16 -24.67 59.42 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.271 -176.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 9.9 tt -68.89 -38.83 79.9 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.36 178.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.426 HG23 ' O ' ' A' ' 121' ' ' ILE . 13.8 tt -91.17 -37.83 9.77 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 CA-C-N 116.625 -0.261 . . . . 0.0 111.342 -176.496 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 . . . . . 0 C--O 1.25 1.093 0 CA-C-O 118.422 -0.799 . . . . 0.0 110.218 -177.04 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 39.2 t . . . . . 0 C--O 1.238 0.46 0 CA-C-O 120.522 0.201 . . . . 0.0 111.442 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -64.2 140.75 58.9 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 120.912 0.386 . . . . 0.0 111.303 -177.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 61.2 mt -126.71 -64.92 0.98 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.203 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.427 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.548 ' HB ' ' HB ' ' A' ' 45' ' ' VAL . 60.2 t -99.07 106.29 18.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.095 -178.193 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.417 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 62.2 mtm180 -120.42 90.15 3.27 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.044 0.45 . . . . 0.0 110.212 179.421 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.403 HG12 ' HB2' ' A' ' 109' ' ' ASP . 86.6 t -107.89 135.87 45.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.887 -176.545 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -85.46 106.16 16.6 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 174.239 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -144.84 -172.15 3.77 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.114 -177.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.567 ' HB ' ' HB ' ' A' ' 103' ' ' THR . 23.6 t -101.53 121.54 52.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.615 0.245 . . . . 0.0 110.473 -179.193 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.486 HG13 ' HG ' ' A' ' 73' ' ' LEU . 60.8 t -97.71 98.28 7.18 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 CA-C-O 121.035 0.445 . . . . 0.0 110.461 176.134 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' MET . . . . . 0.44 ' HB3' ' HB3' ' A' ' 32' ' ' TRP . 24.9 mmt -74.47 106.38 6.04 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 174.06 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.452 HG21 ' CE1' ' A' ' 33' ' ' PHE . 10.0 t -76.69 -46.4 25.72 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 111.583 0.216 . . . . 0.0 111.583 -173.204 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.505 ' HB2' ' CE3' ' A' ' 32' ' ' TRP . 23.4 ttt180 57.84 135.13 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 121.317 0.58 . . . . 0.0 110.396 -172.041 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -81.08 64.85 5.98 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 177.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 32.5 t70 58.96 -74.73 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 114.536 -1.211 . . . . 0.0 110.932 -172.5 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 26.4 t -121.76 99.06 6.25 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 177.242 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 10.8 m -126.04 159.71 32.04 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.712 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -69.3 76.55 0.35 Allowed Glycine 0 C--N 1.332 0.34 0 N-CA-C 111.582 -0.607 . . . . 0.0 111.582 176.583 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 106.72 -158.67 15.16 Favored Glycine 0 C--O 1.237 0.334 0 N-CA-C 111.264 -0.735 . . . . 0.0 111.264 -175.035 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . 0.505 ' CE3' ' HB2' ' A' ' 25' ' ' ARG . 53.7 m95 -127.42 126.16 41.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.656 0.265 . . . . 0.0 110.424 -179.593 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.472 ' HA ' ' HD3' ' A' ' 34' ' ' PRO . 6.4 p90 -114.44 137.71 22.75 Favored Pre-proline 0 C--O 1.238 0.45 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.139 -179.851 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.557 ' HB2' ' HA2' ' A' ' 38' ' ' GLY . 7.3 Cg_exo -74.05 154.07 47.18 Favored 'Trans proline' 0 N--CA 1.462 -0.367 0 C-N-CA 122.785 2.323 . . . . 0.0 111.358 175.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . 0.411 ' H ' ' HG3' ' A' ' 35' ' ' GLN . 0.0 OUTLIER -75.51 -163.39 0.25 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.303 175.166 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -45.99 -34.55 4.09 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 -173.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -66.73 -30.1 75.74 Favored Glycine 0 CA--C 1.519 0.336 0 C-N-CA 121.242 -0.504 . . . . 0.0 113.074 -175.581 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.557 ' HA2' ' HB2' ' A' ' 34' ' ' PRO . . . 58.37 13.53 16.44 Favored Glycine 0 CA--C 1.522 0.476 0 C-N-CA 121.506 -0.378 . . . . 0.0 113.248 179.497 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.475 ' HA2' HG22 ' A' ' 21' ' ' VAL . . . 154.81 -43.12 0.58 Allowed Glycine 0 N--CA 1.449 -0.451 0 N-CA-C 111.612 -0.595 . . . . 0.0 111.612 -176.884 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.435 ' O ' HG13 ' A' ' 40' ' ' ILE . 32.4 pt -89.88 111.06 22.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 121.221 0.534 . . . . 0.0 110.532 179.263 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 21.1 m -146.41 131.15 17.96 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.73 177.581 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.567 ' HB3' ' HB2' ' A' ' 64' ' ' GLU . 35.4 ttt180 -90.31 103.27 15.97 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 176.304 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.614 HG21 HD21 ' A' ' 102' ' ' LEU . 25.5 t -81.2 94.51 2.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.164 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -90.27 81.89 1.37 Allowed Glycine 0 N--CA 1.452 -0.276 0 CA-C-N 115.978 -0.556 . . . . 0.0 112.639 -177.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.548 ' HB ' ' HB ' ' A' ' 16' ' ' VAL . 61.0 t -76.44 108.72 9.55 Favored 'Isoleucine or valine' 0 C--O 1.24 0.569 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 176.506 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . 0.624 ' SG ' ' HB3' ' A' ' 60' ' ' LEU . 11.8 p -115.65 136.86 52.64 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.997 -177.738 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -91.52 92.31 8.46 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 176.397 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 23.1 m -83.76 111.63 20.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 121.396 0.617 . . . . 0.0 110.667 -176.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 22.7 ptp . . . . . 0 C--O 1.234 0.261 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.392 -179.956 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.387 0 N-CA-C 111.188 -0.765 . . . . 0.0 111.188 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -117.84 106.91 13.49 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.934 0.397 . . . . 0.0 110.286 179.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.624 ' HB3' ' SG ' ' A' ' 46' ' ' CYS . 2.5 tt -88.66 105.16 17.5 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 179.7 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 58.6 mt -73.41 87.96 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 174.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 8.5 t-80 -91.55 100.33 13.09 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.177 -175.318 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.473 ' HA3' ' HB2' ' A' ' 73' ' ' LEU . . . -87.1 95.09 2.04 Favored Glycine 0 N--CA 1.449 -0.496 0 CA-C-N 115.762 -0.654 . . . . 0.0 112.324 -178.819 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.567 ' HB2' ' HB3' ' A' ' 42' ' ' ARG . 34.6 mt-10 -83.07 137.49 34.08 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 177.007 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.52 ' NH1' ' HB2' ' A' ' 67' ' ' LYS . 6.3 tmm_? -114.04 126.18 54.83 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 178.411 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.422 ' O ' ' HD2' ' A' ' 65' ' ' ARG . 1.0 OUTLIER -67.84 -160.95 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.488 0 O-C-N 123.564 0.54 . . . . 0.0 112.073 -174.262 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.52 ' HB2' ' NH1' ' A' ' 65' ' ' ARG . 34.5 mmtp 65.4 -82.89 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 -173.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -74.22 -30.81 62.35 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.615 176.47 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.458 ' HA ' ' O ' ' A' ' 65' ' ' ARG . 22.8 tptm 60.27 81.89 0.17 Allowed 'General case' 0 C--O 1.233 0.217 0 CA-C-N 115.084 -0.962 . . . . 0.0 110.074 -176.721 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -150.1 168.7 23.16 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.472 -177.741 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 21.6 t -83.15 109.69 17.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.893 -176.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.432 HG21 HD21 ' A' ' 73' ' ' LEU . 18.0 m -102.05 -35.91 4.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 CA-C-O 120.888 0.375 . . . . 0.0 111.053 177.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.486 ' HG ' HG13 ' A' ' 22' ' ' VAL . 4.5 mm? -116.24 117.11 29.1 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.229 178.741 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -118.96 104.2 10.29 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 176.205 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' CYS . . . . . 0.401 ' SG ' ' CE2' ' A' ' 100' ' ' PHE . 61.1 m -135.22 83.48 2.02 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.346 0.593 . . . . 0.0 110.632 -179.329 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 80.0 t80 -69.41 105.98 2.78 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.468 -0.787 . . . . 0.0 108.997 172.477 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 39.6 t -100.69 132.71 45.84 Favored 'Isoleucine or valine' 0 C--O 1.237 0.395 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 -175.053 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.414 ' C ' ' H ' ' A' ' 80' ' ' ASP . 30.4 ttp180 -135.46 100.17 4.43 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.403 -174.33 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.685 ' H ' HD21 ' A' ' 124' ' ' LEU . 66.4 mmtt 72.05 -29.74 0.2 Allowed 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.339 0.655 . . . . 0.0 112.748 178.444 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . 0.414 ' H ' ' C ' ' A' ' 78' ' ' ARG . 11.6 p-10 -88.38 23.01 2.31 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 120.973 0.416 . . . . 0.0 110.753 -177.058 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.588 HD23 HG12 ' A' ' 121' ' ' ILE . 1.0 OUTLIER -71.3 89.85 0.91 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.828 -179.249 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 49.0 t -123.0 99.9 7.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.121 0.486 . . . . 0.0 110.593 179.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.705 ' HB3' ' NE2' ' A' ' 91' ' ' HIS . 4.2 m-85 -87.1 115.47 24.51 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.47 175.738 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 31.2 m -98.61 119.71 37.8 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.176 -0.465 . . . . 0.0 109.869 173.387 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.441 ' HZ3' ' CG ' ' A' ' 114' ' ' ASP . 24.2 ttmm -86.6 103.94 15.57 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 176.646 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -82.56 -19.9 37.62 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 121.064 0.459 . . . . 0.0 110.237 -178.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . 0.831 ' HB3' ' HB3' ' A' ' 90' ' ' PHE . 12.3 t-20 -156.58 144.69 14.3 Favored Pre-proline 0 C--N 1.326 -0.453 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 178.761 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.443 ' HD2' ' ND2' ' A' ' 87' ' ' ASN . 33.9 Cg_exo -34.47 -50.8 0.65 Allowed 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 123.374 2.716 . . . . 0.0 113.718 179.309 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.558 ' HA ' ' HD2' ' A' ' 104' ' ' PHE . 19.5 p -102.37 -0.72 32.18 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 112.144 0.424 . . . . 0.0 112.144 -176.872 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.831 ' HB3' ' HB3' ' A' ' 87' ' ' ASN . 62.0 t80 -115.78 99.3 7.21 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-O 121.402 0.62 . . . . 0.0 110.07 176.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' HIS . . . . . 0.705 ' NE2' ' HB3' ' A' ' 83' ' ' TYR . 0.8 OUTLIER -103.15 149.9 24.18 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 177.493 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 25.5 p80 -149.91 159.56 44.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 118.206 0.457 . . . . 0.0 110.74 176.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . 0.644 ' HZ3' ' HB2' ' A' ' 102' ' ' LEU . 28.5 p90 -137.29 146.72 45.01 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.323 -0.399 . . . . 0.0 109.979 178.632 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.697 ' HZ2' ' HB3' ' A' ' 94' ' ' LYS . 5.7 ttpm? -114.63 99.47 7.55 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.704 -178.708 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.46 HG11 ' HD1' ' A' ' 93' ' ' TRP . 16.7 m -85.18 113.58 23.87 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 176.023 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 57.08 -86.89 0.02 OUTLIER 'General case' 0 C--O 1.235 0.311 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.405 -173.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -126.22 -16.66 5.42 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.457 -177.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.98 134.2 33.51 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.836 0.351 . . . . 0.0 110.86 -177.395 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 3.6 mppt? -109.98 123.24 49.29 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.029 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . 0.401 ' CE2' ' SG ' ' A' ' 75' ' ' CYS . 44.3 m-85 -122.05 141.71 51.1 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 176.211 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -116.73 125.33 6.52 Favored Glycine 0 CA--C 1.516 0.144 0 C-N-CA 121.377 -0.439 . . . . 0.0 113.227 -174.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.644 ' HB2' ' HZ3' ' A' ' 93' ' ' TRP . 0.4 OUTLIER -94.4 104.28 16.25 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 175.675 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' THR . . . . . 0.567 ' HB ' ' HB ' ' A' ' 21' ' ' VAL . 33.3 m -92.54 119.5 32.07 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 177.161 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.558 ' HD2' ' HA ' ' A' ' 89' ' ' THR . 36.7 m-85 -73.82 148.22 42.64 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.438 -175.04 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -88.81 -52.56 5.05 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.605 -176.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' SER . . . . . 0.407 ' HB3' ' HD2' ' A' ' 107' ' ' PRO . 19.7 m -134.01 159.11 73.67 Favored Pre-proline 0 C--N 1.326 -0.413 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.142 -177.826 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . 0.407 ' HD2' ' HB3' ' A' ' 106' ' ' SER . 12.9 Cg_endo -55.59 -29.85 71.96 Favored 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 122.526 2.15 . . . . 0.0 112.17 -179.46 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -61.8 -62.04 2.08 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.77 179.371 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.403 ' HB2' HG12 ' A' ' 18' ' ' VAL . 3.3 p-10 -66.83 -29.09 68.92 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.838 -179.455 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -57.82 -60.82 3.12 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.922 0.392 . . . . 0.0 110.697 176.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 69.7 mtp180 -64.12 -42.37 96.89 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.54 -0.754 . . . . 0.0 110.802 -178.431 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -61.54 -41.46 97.38 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.938 -179.359 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 35.4 t80 -75.42 -37.02 60.67 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.213 -177.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.441 ' CG ' ' HZ3' ' A' ' 85' ' ' LYS . 35.3 m-20 -58.82 -53.83 53.92 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 120.884 0.373 . . . . 0.0 110.336 177.29 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? -66.01 -37.92 87.15 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.501 179.05 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -62.77 -49.98 68.07 Favored Glycine 0 C--N 1.331 0.274 0 CA-C-N 116.053 -0.522 . . . . 0.0 112.501 -179.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.51 ' O ' HG13 ' A' ' 121' ' ' ILE . 9.1 p -69.66 -35.45 65.9 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.201 0 N-CA-C 110.123 -0.325 . . . . 0.0 110.123 -178.598 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . 0.519 ' O ' ' HG3' ' A' ' 122' ' ' GLU . 69.8 ttt180 -57.46 -51.16 70.59 Favored 'General case' 0 C--O 1.23 0.073 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 176.091 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 64.3 tttp -56.82 -43.93 81.53 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.422 177.453 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.58 -43.18 97.61 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.154 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.588 HG12 HD23 ' A' ' 81' ' ' LEU . 80.2 mt -62.18 -51.53 71.3 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.195 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.414 179.536 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . 0.519 ' HG3' ' O ' ' A' ' 118' ' ' ARG . 42.8 mt-10 -61.23 -44.52 97.13 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 115.729 -0.668 . . . . 0.0 110.616 -177.363 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -60.67 -42.21 96.62 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.527 178.323 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.685 HD21 ' H ' ' A' ' 79' ' ' LYS . 41.0 tp -66.65 -47.72 71.66 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.134 -177.715 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.477 HG12 ' O ' ' A' ' 121' ' ' ILE . 17.7 pt -74.53 -65.05 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 C-N-CA 120.964 -0.294 . . . . 0.0 111.42 -176.791 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.455 ' N ' HG13 ' A' ' 125' ' ' ILE . 71.7 mm-40 . . . . . 0 C--O 1.25 1.129 0 CA-C-O 119.035 -0.507 . . . . 0.0 110.069 -172.498 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.538 0.503 0 CA-C-O 121.057 0.456 . . . . 0.0 111.277 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -76.89 137.88 39.4 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.046 177.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.683 HD13 ' HB2' ' A' ' 47' ' ' LYS . 1.8 mp -88.35 -53.48 9.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 173.723 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 14.5 p -166.03 146.07 1.66 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.311 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.38 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.494 ' HG2' ' HA3' ' A' ' 44' ' ' GLY . 24.0 mtm180 -118.09 109.06 15.97 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.492 173.04 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 34.8 m -109.23 162.81 6.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.824 -177.058 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.48 ' HE3' HG12 ' A' ' 40' ' ' ILE . 83.9 tttt -84.41 130.13 34.8 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.414 177.172 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -153.92 -167.27 2.61 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 175.378 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.559 ' HB ' ' HB ' ' A' ' 103' ' ' THR . 64.8 t -124.51 114.85 42.63 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 175.15 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.482 HG23 ' HG2' ' A' ' 35' ' ' GLN . 9.3 m -73.08 110.45 6.32 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 CA-C-O 121.367 0.603 . . . . 0.0 111.67 -178.102 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' MET . . . . . 0.534 ' SD ' HG12 ' A' ' 21' ' ' VAL . 38.3 mmm -104.42 146.02 29.45 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.628 -0.714 . . . . 0.0 109.554 -178.521 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.482 ' HB ' ' NE2' ' A' ' 35' ' ' GLN . 10.7 t -135.32 -6.12 2.3 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 111.766 0.284 . . . . 0.0 111.766 179.26 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 31.6 ttp180 53.25 46.93 25.46 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 122.891 0.477 . . . . 0.0 111.324 -178.26 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.487 ' O ' ' HB3' ' A' ' 27' ' ' ASP . 4.4 p-10 45.88 26.65 0.4 Allowed 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 124.038 0.935 . . . . 0.0 113.361 174.102 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.487 ' HB3' ' O ' ' A' ' 26' ' ' ASP . 8.3 t70 74.99 -40.23 0.43 Allowed 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 122.785 0.434 . . . . 0.0 111.518 178.633 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 17.2 m -96.91 -91.57 0.24 Allowed 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 116.945 -0.116 . . . . 0.0 111.278 -176.017 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 11.0 p -176.72 27.73 0.0 OUTLIER 'General case' 0 C--O 1.236 0.391 0 N-CA-C 112.253 0.464 . . . . 0.0 112.253 -174.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -76.34 -28.83 59.23 Favored Glycine 0 CA--C 1.519 0.342 0 C-N-CA 120.772 -0.727 . . . . 0.0 111.924 179.066 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 158.34 151.3 6.03 Favored Glycine 0 CA--C 1.519 0.318 0 C-N-CA 121.386 -0.435 . . . . 0.0 112.265 178.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 83.9 m95 -76.95 102.04 6.24 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 110.165 -0.309 . . . . 0.0 110.165 179.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -114.83 153.55 46.94 Favored Pre-proline 0 C--O 1.237 0.422 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.145 177.48 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_exo -67.05 130.67 23.39 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.791 2.328 . . . . 0.0 111.473 175.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . 0.482 ' HG2' HG23 ' A' ' 22' ' ' VAL . 7.9 pt20 -92.02 85.92 5.67 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 121.32 0.581 . . . . 0.0 110.837 -178.132 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 71.66 -34.13 0.29 Allowed 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.929 0.892 . . . . 0.0 113.312 176.459 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.438 ' HA2' ' HD2' ' A' ' 65' ' ' ARG . . . -63.77 -50.02 64.3 Favored Glycine 0 C--N 1.333 0.405 0 C-N-CA 121.163 -0.541 . . . . 0.0 112.347 -179.729 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 82.45 -146.0 24.46 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.99 -0.624 . . . . 0.0 111.672 -178.312 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -65.17 -23.6 69.89 Favored Glycine 0 CA--C 1.518 0.243 0 C-N-CA 121.429 -0.415 . . . . 0.0 112.83 -178.601 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.48 HG12 ' HE3' ' A' ' 19' ' ' LYS . 57.8 mt -113.52 104.3 16.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.961 0.41 . . . . 0.0 110.344 179.28 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.413 ' HB3' HG11 ' A' ' 22' ' ' VAL . 19.1 m -131.1 107.71 9.24 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 173.697 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.598 ' HB3' ' HG3' ' A' ' 64' ' ' GLU . 47.0 ttt180 -77.08 91.72 3.7 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.223 0.535 . . . . 0.0 109.901 -177.422 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 78.8 t -79.74 119.89 30.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.197 -179.459 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.494 ' HA3' ' HG2' ' A' ' 17' ' ' ARG . . . -116.91 123.28 5.75 Favored Glycine 0 N--CA 1.445 -0.705 0 CA-C-N 115.897 -0.592 . . . . 0.0 112.76 -177.396 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.451 HG12 ' HB ' ' A' ' 15' ' ' ILE . 7.6 p -99.51 123.29 52.15 Favored 'Isoleucine or valine' 0 C--O 1.24 0.591 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 175.086 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . 0.814 ' SG ' ' HB3' ' A' ' 60' ' ' LEU . 8.8 p -126.37 141.87 51.74 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.507 178.853 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.683 ' HB2' HD13 ' A' ' 15' ' ' ILE . 83.3 tttt -88.21 102.19 14.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.843 -176.199 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.564 HG13 ' OH ' ' A' ' 76' ' ' TYR . 95.4 t -74.67 96.14 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 121.06 0.457 . . . . 0.0 110.631 -177.139 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.238 0.478 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.286 178.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.238 0 N-CA-C 111.827 -0.509 . . . . 0.0 111.827 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -141.09 144.49 34.93 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.751 0.31 . . . . 0.0 110.501 -179.008 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.814 ' HB3' ' SG ' ' A' ' 46' ' ' CYS . 1.6 tt -104.51 109.47 21.36 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 172.559 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.656 ' HB ' ' HB3' ' A' ' 75' ' ' CYS . 44.5 mm -81.66 89.52 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 108.415 -0.958 . . . . 0.0 108.415 174.354 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 12.3 t-80 -93.01 144.35 25.33 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.509 -0.768 . . . . 0.0 110.617 -173.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.496 ' HA3' ' HB3' ' A' ' 73' ' ' LEU . . . -131.43 87.21 0.29 Allowed Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 121.164 -0.541 . . . . 0.0 111.986 179.085 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.598 ' HG3' ' HB3' ' A' ' 42' ' ' ARG . 6.0 pt-20 -88.08 135.13 33.56 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 173.483 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.438 ' HD2' ' HA2' ' A' ' 37' ' ' GLY . 21.7 mtm180 -54.78 -67.05 0.3 Allowed 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 120.868 0.366 . . . . 0.0 111.676 -172.08 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 39.6 mt-30 -118.36 -43.69 2.71 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.054 0.454 . . . . 0.0 110.61 -175.179 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 32.3 ttpt -173.16 94.24 0.11 Allowed 'General case' 0 C--O 1.236 0.352 0 CA-C-N 115.593 -0.73 . . . . 0.0 109.128 -178.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 12.5 t70 52.11 -143.7 0.66 Allowed 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 -175.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 86.0 tttt 71.04 -65.39 0.34 Allowed 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 123.513 0.725 . . . . 0.0 112.028 175.133 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.8 tt -129.01 114.49 16.47 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-O 120.711 0.291 . . . . 0.0 110.279 -175.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 48.3 t -89.18 113.88 26.41 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.623 176.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 18.5 m -105.57 -12.5 9.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 111.762 0.282 . . . . 0.0 111.762 -177.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.496 ' HB3' ' HA3' ' A' ' 63' ' ' GLY . 3.3 tm? -142.98 120.32 11.6 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 -179.617 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -127.71 98.51 5.21 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 178.79 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' CYS . . . . . 0.656 ' HB3' ' HB ' ' A' ' 61' ' ' ILE . 41.9 t -124.08 67.0 1.05 Allowed 'General case' 0 C--O 1.235 0.305 0 CA-C-O 121.668 0.747 . . . . 0.0 110.475 -177.708 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.564 ' OH ' HG13 ' A' ' 48' ' ' VAL . 31.8 t80 -62.64 101.14 0.23 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 114.94 -1.027 . . . . 0.0 109.089 173.64 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.592 HG22 HD12 ' A' ' 81' ' ' LEU . 29.2 m -84.08 111.39 19.92 Favored 'Isoleucine or valine' 0 C--O 1.239 0.539 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 -178.737 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.495 ' NH1' ' O ' ' A' ' 76' ' ' TYR . 9.8 mpt_? -77.56 66.05 3.2 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.98 -177.327 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 50.9 mtpt 72.71 -33.85 0.28 Allowed 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.773 0.829 . . . . 0.0 112.002 -178.476 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -75.92 108.25 8.67 Favored 'General case' 0 C--O 1.233 0.189 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 173.206 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.592 HD12 HG22 ' A' ' 77' ' ' VAL . 6.6 tt -134.58 113.8 12.13 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 -177.519 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 49.2 t -124.28 90.61 1.64 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 CA-C-O 120.701 0.286 . . . . 0.0 110.989 -179.075 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.712 ' HB3' ' NE2' ' A' ' 91' ' ' HIS . 4.1 m-85 -88.26 152.93 21.61 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 120.922 0.392 . . . . 0.0 110.205 174.012 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 61.8 m -155.55 118.2 4.23 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 123.535 0.734 . . . . 0.0 109.097 178.044 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.481 ' HA ' ' HA ' ' A' ' 91' ' ' HIS . 3.1 pptp? -90.81 131.89 36.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.888 0.375 . . . . 0.0 110.249 179.33 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -96.32 -31.08 13.07 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.249 0.547 . . . . 0.0 109.697 176.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . 0.538 ' HB2' ' HB3' ' A' ' 90' ' ' PHE . 43.9 m-80 -143.3 158.93 57.01 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 115.251 -0.886 . . . . 0.0 109.282 179.134 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.435 ' O ' ' HB2' ' A' ' 110' ' ' ALA . 52.3 Cg_exo -55.91 -28.23 67.18 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.227 1.951 . . . . 0.0 111.642 175.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.442 ' HA ' ' HB2' ' A' ' 104' ' ' PHE . 12.6 p -109.3 16.41 22.41 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 115.74 -0.663 . . . . 0.0 111.601 -178.724 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.538 ' HB3' ' HB2' ' A' ' 87' ' ' ASN . 58.7 t80 -150.67 107.11 3.49 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-O 120.803 0.335 . . . . 0.0 110.734 -178.789 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' HIS . . . . . 0.712 ' NE2' ' HB3' ' A' ' 83' ' ' TYR . 2.2 t60 -120.16 141.92 49.43 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 177.913 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . 0.445 ' HA ' ' HA2' ' A' ' 101' ' ' GLY . 21.5 p80 -138.12 152.62 48.91 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.485 0.183 . . . . 0.0 110.516 -179.275 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . 0.601 ' HZ3' HD23 ' A' ' 102' ' ' LEU . 47.3 p90 -127.13 145.54 50.71 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 121.228 0.537 . . . . 0.0 111.245 -179.214 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 36.3 ttmt -91.59 133.42 35.56 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.285 -176.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 9.3 m -134.38 82.04 0.56 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.316 0 CA-C-O 121.558 0.694 . . . . 0.0 110.783 177.138 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 20.0 t70 59.67 -84.73 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 114.861 -1.063 . . . . 0.0 111.846 178.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -99.29 -48.39 4.83 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 120.741 0.305 . . . . 0.0 110.826 -176.481 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 9.0 mpt_? -87.76 176.15 7.53 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-O 121.168 0.508 . . . . 0.0 110.878 -178.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.404 ' HE3' ' HB2' ' A' ' 99' ' ' LYS . 39.1 ttmt -154.27 104.21 2.58 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 -178.225 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . 0.425 ' HB2' ' CE2' ' A' ' 93' ' ' TRP . 3.6 m-85 -92.97 179.12 5.54 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 -176.814 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . 0.445 ' HA2' ' HA ' ' A' ' 92' ' ' HIS . . . -168.3 177.57 42.32 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.621 -0.8 . . . . 0.0 112.196 178.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.601 HD23 ' HZ3' ' A' ' 93' ' ' TRP . 2.3 pt? -142.36 133.04 25.41 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 177.163 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' THR . . . . . 0.559 ' HB ' ' HB ' ' A' ' 21' ' ' VAL . 24.8 m -93.63 127.4 39.3 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.56 177.081 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.442 ' HB2' ' HA ' ' A' ' 89' ' ' THR . 73.6 m-85 -86.59 157.3 19.75 Favored 'General case' 0 C--O 1.237 0.41 0 O-C-N 123.305 0.378 . . . . 0.0 110.171 -179.859 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 21.1 mp0 -102.96 -33.74 9.19 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.327 -177.53 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 8.4 m -137.84 144.77 45.56 Favored Pre-proline 0 CA--C 1.532 0.25 0 CA-C-O 120.437 0.16 . . . . 0.0 110.78 -178.387 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_exo -53.17 -21.9 18.09 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 122.64 2.227 . . . . 0.0 112.491 176.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -64.06 -65.81 0.63 Allowed 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.56 176.362 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -62.48 -36.78 83.58 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.569 179.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . 0.435 ' HB2' ' O ' ' A' ' 88' ' ' PRO . . . -55.84 -67.09 0.32 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.403 177.705 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 83.8 mtm180 -62.29 -34.27 76.25 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.139 -175.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -62.43 -43.35 99.02 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-O 120.949 0.404 . . . . 0.0 110.361 177.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.473 ' O ' HG22 ' A' ' 117' ' ' VAL . 52.8 t80 -69.28 -43.5 73.74 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.02 -179.841 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -55.78 -46.17 78.01 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 121.015 0.436 . . . . 0.0 110.628 177.411 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . 0.426 ' HA ' ' HD2' ' A' ' 115' ' ' ARG . 24.2 tpt180 -65.97 -34.79 78.91 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 116.137 -0.483 . . . . 0.0 109.76 178.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -62.28 -38.7 96.66 Favored Glycine 0 C--N 1.333 0.366 0 N-CA-C 111.471 -0.652 . . . . 0.0 111.471 174.451 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.487 ' O ' HG13 ' A' ' 121' ' ' ILE . 96.8 t -62.21 -45.87 97.76 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.142 0 N-CA-C 109.73 -0.471 . . . . 0.0 109.73 176.373 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . 0.528 ' O ' ' HG2' ' A' ' 122' ' ' GLU . 8.5 tpm_? -53.2 -52.44 58.87 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.467 176.621 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 7.4 tmtt? -60.26 -47.72 84.8 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.032 -178.389 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -57.6 -48.17 80.12 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.941 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.487 HG13 ' O ' ' A' ' 117' ' ' VAL . 75.0 mt -56.9 -42.51 78.59 Favored 'Isoleucine or valine' 0 C--O 1.232 0.177 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.44 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . 0.528 ' HG2' ' O ' ' A' ' 118' ' ' ARG . 15.6 mm-40 -57.05 -57.06 14.21 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-O 121.038 0.447 . . . . 0.0 110.621 177.621 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -71.46 -12.74 61.55 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.651 -177.337 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 62.7 tp -87.61 -68.24 0.77 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.761 0.315 . . . . 0.0 110.929 178.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.421 ' O ' ' HB3' ' A' ' 126' ' ' GLU . 34.8 pt -89.79 -18.6 7.66 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 N-CA-C 112.241 0.46 . . . . 0.0 112.241 -172.369 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.421 ' HB3' ' O ' ' A' ' 125' ' ' ILE . 36.5 tt0 . . . . . 0 C--O 1.252 1.192 0 O-C-N 123.441 0.463 . . . . 0.0 110.23 -178.203 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 37.4 t . . . . . 0 C--O 1.231 0.098 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.434 ' CG ' ' HB3' ' A' ' 46' ' ' CYS . 46.5 m-85 64.14 101.73 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 115.8 -0.637 . . . . 0.0 111.803 178.463 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.637 HG21 HG22 ' A' ' 16' ' ' VAL . 11.5 tt -82.14 -31.75 10.46 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 CA-C-N 115.624 -0.717 . . . . 0.0 110.56 -178.859 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.637 HG22 HG21 ' A' ' 15' ' ' ILE . 76.5 t -117.23 113.98 44.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.249 179.505 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.488 ' NH2' HH12 ' A' ' 42' ' ' ARG . 22.3 mtp180 -136.21 86.54 2.23 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 175.885 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.403 ' HB ' ' CZ ' ' A' ' 113' ' ' PHE . 44.2 t -130.61 153.89 39.77 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.391 -176.578 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 23.3 pttm -65.28 154.85 37.02 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.466 178.32 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -179.61 174.04 1.0 Allowed 'General case' 0 C--O 1.233 0.211 0 O-C-N 123.466 0.479 . . . . 0.0 110.532 175.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 61.8 t -123.89 143.98 35.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 171.124 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 29.6 m -115.02 131.0 68.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-O 121.097 0.475 . . . . 0.0 111.465 -175.401 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 25.2 mmt -100.23 113.42 26.09 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.057 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.403 HG22 ' O ' ' A' ' 33' ' ' PHE . 11.8 t -82.62 152.64 25.81 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 178.005 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.46 ' HD2' ' CZ2' ' A' ' 32' ' ' TRP . 36.1 ttt85 -122.05 114.11 20.48 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 -172.154 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -72.31 93.54 1.51 Allowed 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 107.602 -1.259 . . . . 0.0 107.602 165.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -54.65 149.74 10.46 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 115.603 -0.726 . . . . 0.0 112.879 -169.179 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 51.9 m 72.89 -36.46 0.36 Allowed 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 114.612 -1.176 . . . . 0.0 112.306 179.005 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 29.4 t -78.54 -44.53 24.06 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 175.436 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 149.64 -67.2 0.36 Allowed Glycine 0 N--CA 1.452 -0.291 0 N-CA-C 111.559 -0.616 . . . . 0.0 111.559 178.182 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.436 ' HA3' ' HA ' ' A' ' 25' ' ' ARG . . . 71.34 -126.07 12.65 Favored Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 121.449 -0.405 . . . . 0.0 112.884 178.565 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . 0.535 ' HH2' ' HG2' ' A' ' 99' ' ' LYS . 24.6 m95 58.96 38.03 24.41 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 123.041 0.537 . . . . 0.0 109.957 -175.039 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.403 ' O ' HG22 ' A' ' 24' ' ' THR . 21.1 p90 -112.26 148.93 40.17 Favored Pre-proline 0 CA--C 1.532 0.252 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.574 -177.261 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -68.21 109.58 2.02 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 122.706 2.271 . . . . 0.0 111.85 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 28.9 pt20 -59.4 132.27 53.49 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.375 -177.321 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 60.81 20.9 11.04 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.756 177.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 99.43 -15.62 59.85 Favored Glycine 0 C--N 1.333 0.379 0 CA-C-N 116.023 -0.535 . . . . 0.0 112.33 -179.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 100.18 -115.62 5.35 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 121.577 -0.344 . . . . 0.0 112.398 179.381 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.81 150.0 26.41 Favored Glycine 0 N--CA 1.451 -0.305 0 N-CA-C 111.774 -0.53 . . . . 0.0 111.774 -177.352 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 6.0 tp -55.88 115.73 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 CA-C-O 121.133 0.492 . . . . 0.0 110.689 179.511 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.408 ' HA ' ' HA ' ' A' ' 65' ' ' ARG . 20.0 m -116.95 175.23 5.68 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.361 -177.81 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.488 HH12 ' NH2' ' A' ' 17' ' ' ARG . 49.6 ttp180 -138.58 137.43 36.98 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.414 -0.588 . . . . 0.0 109.414 177.284 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.607 HG22 HD12 ' A' ' 102' ' ' LEU . 61.7 t -97.49 118.81 44.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 176.88 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.436 ' HA2' ' O ' ' A' ' 16' ' ' VAL . . . -116.59 94.92 0.66 Allowed Glycine 0 N--CA 1.452 -0.263 0 CA-C-N 116.013 -0.54 . . . . 0.0 112.109 -179.259 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.488 ' HB ' ' HB ' ' A' ' 16' ' ' VAL . 60.8 t -92.04 116.24 32.77 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 N-CA-C 110.235 -0.283 . . . . 0.0 110.235 178.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . 0.528 ' SG ' ' HB3' ' A' ' 60' ' ' LEU . 24.2 p -118.45 131.39 56.27 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.694 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 60.2 tttp -74.33 102.22 4.31 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 175.411 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.429 HG22 ' CE1' ' A' ' 76' ' ' TYR . 26.9 m -73.24 124.95 31.34 Favored 'Isoleucine or valine' 0 C--O 1.24 0.602 0 CA-C-O 121.202 0.525 . . . . 0.0 110.219 179.559 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 25.9 mmt . . . . . 0 C--N 1.328 -0.366 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.599 -176.501 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.227 -0.3 0 CA-C-O 120.847 0.137 . . . . 0.0 113.3 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.411 ' HA ' ' O ' ' A' ' 46' ' ' CYS . 45.1 m-85 -131.76 122.14 25.35 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 122.867 0.467 . . . . 0.0 109.98 177.88 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.528 ' HB3' ' SG ' ' A' ' 46' ' ' CYS . 0.9 OUTLIER -80.1 112.34 17.31 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 175.582 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.545 ' HB ' ' HB2' ' A' ' 75' ' ' CYS . 50.5 mm -76.27 82.08 0.68 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.322 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 174.303 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 63.1 t-80 -99.59 164.29 12.13 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.198 -0.91 . . . . 0.0 109.751 -176.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 175.48 149.98 7.68 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.816 -0.707 . . . . 0.0 111.651 176.419 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.438 ' CD ' HH21 ' A' ' 42' ' ' ARG . 0.1 OUTLIER -142.06 171.01 14.64 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.96 0.41 . . . . 0.0 110.888 -178.586 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.408 ' HA ' ' HA ' ' A' ' 41' ' ' SER . 38.3 ttm180 -83.98 119.16 24.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.36 177.709 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 -61.77 87.99 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 121.255 0.55 . . . . 0.0 111.518 -173.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 40.0 ttpt 178.2 -30.59 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 114.587 -1.188 . . . . 0.0 108.563 178.343 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.428 ' C ' ' H ' ' A' ' 70' ' ' LEU . 19.4 t70 -156.65 170.75 21.68 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.021 -0.99 . . . . 0.0 108.875 177.455 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 93.0 mttt -74.64 16.97 0.23 Allowed 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 120.652 0.263 . . . . 0.0 111.175 178.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.428 ' H ' ' C ' ' A' ' 68' ' ' ASP . 5.7 tt -58.03 97.94 0.03 OUTLIER 'General case' 0 C--O 1.233 0.219 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 174.88 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 27.5 m -69.9 130.87 34.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.257 0.551 . . . . 0.0 111.978 -175.352 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 33.1 m -109.69 -14.49 10.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.056 175.211 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 60.1 mt -132.13 134.39 45.38 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.488 178.593 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -159.39 92.42 1.06 Allowed 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 174.792 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' CYS . . . . . 0.545 ' HB2' ' HB ' ' A' ' 61' ' ' ILE . 66.9 m -136.36 105.67 6.05 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.756 179.102 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.434 ' HE2' ' HD3' ' A' ' 78' ' ' ARG . 50.9 t80 -76.01 101.22 5.16 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.098 -178.291 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 83.6 t -103.41 99.41 8.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.006 0.431 . . . . 0.0 110.071 -178.186 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.434 ' HD3' ' HE2' ' A' ' 76' ' ' TYR . 18.6 ptt180 -108.38 -20.53 13.09 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.883 -178.397 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 1.8 tmtp? -123.92 79.03 1.68 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.829 -174.33 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 32.7 m-20 62.73 168.34 0.13 Allowed 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 115.124 -0.944 . . . . 0.0 112.102 176.061 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.496 HD22 ' N ' ' A' ' 82' ' ' VAL . 5.6 tt -146.66 135.45 22.27 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 -177.883 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.496 ' N ' HD22 ' A' ' 81' ' ' LEU . 48.3 t -77.97 -77.25 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 O-C-N 122.978 0.174 . . . . 0.0 111.247 -176.731 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.49 ' CD2' HG23 ' A' ' 117' ' ' VAL . 0.0 OUTLIER 64.66 136.52 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 121.469 0.652 . . . . 0.0 111.399 -177.421 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.515 ' HB ' ' CE1' ' A' ' 92' ' ' HIS . 90.0 m -154.31 117.9 4.62 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.357 -179.399 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.481 ' HZ2' ' CG ' ' A' ' 114' ' ' ASP . 36.9 ttpt -95.69 103.99 15.89 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.912 0.387 . . . . 0.0 110.215 -178.111 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -85.15 -29.73 24.54 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.085 178.336 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . 0.589 ' HB2' ' HB3' ' A' ' 90' ' ' PHE . 18.6 m120 -143.93 153.56 57.41 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.264 178.88 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -63.57 -4.72 7.34 Favored 'Trans proline' 0 N--CA 1.478 0.562 0 C-N-CA 122.735 2.29 . . . . 0.0 112.748 -179.417 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 8.3 t -126.46 16.08 7.66 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 121.355 0.598 . . . . 0.0 110.123 178.267 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.589 ' HB3' ' HB2' ' A' ' 87' ' ' ASN . 64.1 t80 -152.09 101.23 2.7 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.203 -175.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' HIS . . . . . 0.481 ' CE1' ' HB2' ' A' ' 85' ' ' LYS . 2.1 t-160 -125.55 106.81 10.04 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 -179.225 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . 0.549 ' ND1' ' HD2' ' A' ' 99' ' ' LYS . 35.1 p80 -103.49 150.03 24.28 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 120.739 0.304 . . . . 0.0 111.671 -173.769 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . 0.541 ' HZ3' ' HB2' ' A' ' 102' ' ' LEU . 24.9 p90 -132.74 130.98 40.69 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.335 176.199 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.511 ' HA ' ' HA ' ' A' ' 99' ' ' LYS . 65.0 tttp -94.7 139.01 31.81 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.198 -0.455 . . . . 0.0 109.926 172.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.405 HG21 ' H ' ' A' ' 97' ' ' ASN . 29.2 m -117.28 -162.56 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.662 177.288 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -56.35 -24.87 46.99 Favored 'General case' 0 CA--C 1.532 0.27 0 O-C-N 123.094 0.246 . . . . 0.0 111.631 -176.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.405 ' H ' HG21 ' A' ' 95' ' ' VAL . 0.9 OUTLIER -114.8 -94.38 0.48 Allowed 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 120.491 0.186 . . . . 0.0 111.457 176.793 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 29.8 mmt180 -93.33 -174.33 3.49 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 121.321 0.581 . . . . 0.0 111.866 -170.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.549 ' HD2' ' ND1' ' A' ' 92' ' ' HIS . 38.2 ttpt -125.7 110.22 13.51 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.128 -0.942 . . . . 0.0 109.551 -178.561 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 17.9 m-85 -97.15 162.28 13.43 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 109.819 -0.438 . . . . 0.0 109.819 -176.524 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . 0.49 ' HA2' ' HA ' ' A' ' 92' ' ' HIS . . . -128.78 140.58 11.84 Favored Glycine 0 C--N 1.333 0.415 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.94 -177.592 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.607 HD12 HG22 ' A' ' 43' ' ' VAL . 4.8 tt -109.66 133.84 52.65 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 177.599 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' THR . . . . . 0.518 ' N ' HD23 ' A' ' 102' ' ' LEU . 88.1 m -106.66 114.43 28.54 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.808 179.722 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.419 ' CE2' ' HB2' ' A' ' 91' ' ' HIS . 22.5 m-85 -79.76 148.56 31.43 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 175.418 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 59.3 tt0 -105.5 -33.02 8.25 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.876 0.37 . . . . 0.0 110.601 -178.006 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 32.6 t -124.64 147.52 56.1 Favored Pre-proline 0 C--N 1.329 -0.297 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -60.34 -25.62 80.73 Favored 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 121.878 1.719 . . . . 0.0 110.417 172.126 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -69.6 -58.33 4.08 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.786 178.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -65.83 -32.89 74.67 Favored 'General case' 0 N--CA 1.463 0.206 0 C-N-CA 121.013 -0.275 . . . . 0.0 110.271 -179.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -55.06 -60.13 3.8 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.745 174.077 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 16.2 ttm180 -61.1 -30.69 70.51 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.469 -178.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -62.31 -42.87 99.73 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.434 175.556 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.403 ' CZ ' ' HB ' ' A' ' 18' ' ' VAL . 39.7 m-85 -66.59 -43.27 85.38 Favored 'General case' 0 C--O 1.23 0.079 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.49 177.308 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.481 ' CG ' ' HZ2' ' A' ' 85' ' ' LYS . 17.2 m-20 -55.01 -51.32 66.63 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 120.885 0.374 . . . . 0.0 110.447 178.503 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 3.1 mmp_? -60.48 -46.01 91.65 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.582 178.448 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -60.25 -51.4 59.02 Favored Glycine 0 C--N 1.333 0.367 0 CA-C-N 115.46 -0.791 . . . . 0.0 112.633 -177.519 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.49 HG23 ' CD2' ' A' ' 83' ' ' TYR . 11.4 p -68.53 -32.78 56.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.416 0.15 . . . . 0.0 110.621 -178.281 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 8.1 mmm180 -56.18 -57.05 13.83 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 174.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -63.73 -32.34 73.8 Favored 'General case' 0 C--O 1.224 -0.24 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.388 179.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -62.64 -50.32 71.69 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-O 120.564 0.221 . . . . 0.0 111.235 179.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 69.4 mt -66.47 -39.38 83.86 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 CA-C-O 121.063 0.459 . . . . 0.0 110.338 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 -67.32 -34.28 77.03 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.313 177.163 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -79.84 -17.03 54.25 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 121.284 0.564 . . . . 0.0 110.0 178.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.402 ' HG ' ' CE1' ' A' ' 59' ' ' PHE . 11.7 mt -71.09 -58.92 3.09 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.581 170.378 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 11.1 tp -68.71 -23.99 28.39 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.054 -176.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 . . . . . 0 C--O 1.251 1.136 0 CA-C-O 118.116 -0.945 . . . . 0.0 110.175 176.691 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 19.9 m . . . . . 0 C--O 1.235 0.305 0 CA-C-O 120.558 0.218 . . . . 0.0 111.062 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 61.9 m-85 -62.63 112.81 2.66 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 120.819 0.343 . . . . 0.0 110.523 177.122 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.507 HG23 HG22 ' A' ' 16' ' ' VAL . 63.0 mt -70.53 -48.78 57.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 174.897 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.507 HG22 HG23 ' A' ' 15' ' ' ILE . 87.4 t -144.33 104.65 0.82 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.355 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.481 178.718 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.549 ' HA ' ' HA2' ' A' ' 44' ' ' GLY . 27.2 ptt180 -101.6 112.88 25.58 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 169.491 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 7.4 p -143.91 157.37 15.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.14 0.495 . . . . 0.0 111.529 -172.241 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.82 ' HB3' ' HZ3' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -70.01 124.58 24.43 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.326 177.833 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -151.0 -168.6 3.15 Favored 'General case' 0 C--O 1.235 0.33 0 O-C-N 123.243 0.34 . . . . 0.0 110.313 179.394 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.434 ' HB ' ' HB ' ' A' ' 103' ' ' THR . 45.9 t -123.97 138.68 52.83 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 N-CA-C 110.22 -0.289 . . . . 0.0 110.22 176.502 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 17.6 m -106.3 135.4 44.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.532 177.367 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 24.9 mmt -123.47 146.19 48.24 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 178.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.436 HG22 ' H ' ' A' ' 26' ' ' ASP . 6.4 t -129.0 -6.31 4.97 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.597 -0.441 . . . . 0.0 111.616 177.122 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.445 ' HB2' ' CE3' ' A' ' 32' ' ' TRP . 65.2 ttt180 54.07 24.46 4.79 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 121.295 0.569 . . . . 0.0 111.037 178.749 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.436 ' H ' HG22 ' A' ' 24' ' ' THR . 36.4 t70 54.23 45.32 27.58 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.007 -177.228 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 52.8 m-20 73.04 -68.51 0.22 Allowed 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 114.68 -1.145 . . . . 0.0 110.639 -178.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 68.9 m -152.8 87.92 1.31 Allowed 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 176.399 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.415 ' HG ' ' HB3' ' A' ' 26' ' ' ASP . 53.3 m -140.53 -160.42 1.07 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.774 179.81 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -61.96 -90.17 0.02 OUTLIER Glycine 0 CA--C 1.52 0.401 0 C-N-CA 121.246 -0.502 . . . . 0.0 113.311 -177.547 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -97.1 176.97 32.23 Favored Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 121.432 -0.413 . . . . 0.0 112.995 -173.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . 0.47 ' CH2' ' HB3' ' A' ' 99' ' ' LYS . 37.3 m95 -97.03 113.82 25.39 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 -179.648 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 2.8 p90 -104.25 145.85 31.45 Favored Pre-proline 0 C--N 1.329 -0.298 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 179.179 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.529 ' HB2' ' HA3' ' A' ' 38' ' ' GLY . 88.9 Cg_endo -84.1 120.46 2.6 Favored 'Trans proline' 0 CA--C 1.534 0.521 0 C-N-CA 122.583 2.189 . . . . 0.0 112.068 178.67 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 5.0 pm0 -107.93 144.61 34.95 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.166 179.312 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 57.94 97.33 0.02 OUTLIER 'General case' 0 C--O 1.238 0.453 0 CA-C-O 121.441 0.638 . . . . 0.0 111.534 179.072 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 76.04 -72.33 1.86 Allowed Glycine 0 N--CA 1.45 -0.404 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.466 -176.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.529 ' HA3' ' HB2' ' A' ' 34' ' ' PRO . . . 58.66 65.8 3.24 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 121.354 -0.45 . . . . 0.0 112.759 177.527 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 156.37 -43.72 0.53 Allowed Glycine 0 N--CA 1.453 -0.176 0 N-CA-C 111.646 -0.581 . . . . 0.0 111.646 -179.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.475 ' O ' HG12 ' A' ' 40' ' ' ILE . 11.9 tt -121.91 22.19 4.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 121.539 0.685 . . . . 0.0 109.696 178.857 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 21.3 m -60.61 122.36 14.51 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.29 -177.108 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.423 ' HB2' ' HA ' ' A' ' 66' ' ' GLN . 29.0 ttt85 -82.95 92.71 7.39 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.45 -175.562 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 41.1 t -95.47 150.62 4.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.076 -179.322 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.549 ' HA2' ' HA ' ' A' ' 17' ' ' ARG . . . -154.22 116.61 0.74 Allowed Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 121.178 -0.534 . . . . 0.0 112.335 -179.544 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 6.7 p -87.56 117.85 32.29 Favored 'Isoleucine or valine' 0 C--O 1.237 0.415 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 176.356 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . 0.757 ' SG ' ' HB3' ' A' ' 60' ' ' LEU . 13.9 p -113.69 146.54 39.67 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.068 -178.718 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.408 ' HB2' HD11 ' A' ' 15' ' ' ILE . 47.9 tttp -92.48 101.68 14.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.772 179.088 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 22.2 m -85.19 157.05 3.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.689 0.281 . . . . 0.0 110.512 -179.018 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 22.6 ptp . . . . . 0 C--N 1.328 -0.327 0 CA-C-O 120.798 0.333 . . . . 0.0 110.629 -178.85 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.211 0 N-CA-C 111.394 -0.682 . . . . 0.0 111.394 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -141.86 162.49 35.35 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.9 0.35 . . . . 0.0 110.411 -178.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.757 ' HB3' ' SG ' ' A' ' 46' ' ' CYS . 3.3 tt -137.07 121.67 18.45 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.411 ' O ' ' HA ' ' A' ' 74' ' ' GLU . 41.3 mt -83.03 84.29 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 175.066 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . 0.5 ' HB2' HD22 ' A' ' 60' ' ' LEU . 53.9 t60 -96.99 141.89 29.6 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.25 -0.432 . . . . 0.0 109.865 -177.433 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -154.84 127.54 2.11 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 121.036 -0.602 . . . . 0.0 112.043 -179.398 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -115.0 -179.63 3.68 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 176.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.601 ' HD2' HD12 ' A' ' 70' ' ' LEU . 69.8 mtt180 -65.83 -65.41 0.68 Allowed 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 120.549 -0.46 . . . . 0.0 110.274 178.51 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.438 ' HG3' ' HG3' ' A' ' 67' ' ' LYS . 17.1 pt20 175.53 -23.63 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.284 0 O-C-N 123.407 0.442 . . . . 0.0 111.161 -177.817 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.438 ' HG3' ' HG3' ' A' ' 66' ' ' GLN . 98.5 mttt -144.31 129.34 18.54 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.737 -178.83 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 37.5 t70 71.24 163.33 0.26 Allowed 'General case' 0 CA--C 1.533 0.318 0 O-C-N 123.763 0.665 . . . . 0.0 112.207 169.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 43.6 mtmt -55.47 99.13 0.03 OUTLIER 'General case' 0 C--O 1.234 0.243 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.684 -176.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.601 HD12 ' HD2' ' A' ' 65' ' ' ARG . 3.8 tt -162.51 86.28 0.58 Allowed 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 173.685 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 45.4 t -75.66 117.0 19.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.393 -179.535 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 22.1 m -98.54 -21.89 5.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.335 -177.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -150.51 129.72 12.77 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 -177.236 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.603 ' HG3' HD21 ' A' ' 60' ' ' LEU . 37.0 tt0 -153.81 113.11 3.76 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.986 0.422 . . . . 0.0 110.162 178.606 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' CYS . . . . . 0.548 ' SG ' ' CE2' ' A' ' 100' ' ' PHE . 57.4 m -130.48 118.51 21.24 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 -178.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.422 ' HD1' ' HG ' ' A' ' 60' ' ' LEU . 29.5 t80 -85.32 121.73 28.47 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.01 -173.325 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.505 HG12 ' O ' ' A' ' 80' ' ' ASP . 96.3 t -100.67 97.57 5.9 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 -177.243 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 20.7 ptt-85 -115.92 68.39 0.72 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.226 0.536 . . . . 0.0 110.51 -172.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt 67.53 25.42 8.4 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.011 -177.165 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . 0.505 ' O ' HG12 ' A' ' 77' ' ' VAL . 5.6 p-10 -149.05 -175.26 4.89 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 174.56 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 7.0 tt 66.72 98.22 0.05 Allowed 'General case' 0 CA--C 1.534 0.327 0 CA-C-O 121.193 0.521 . . . . 0.0 110.177 177.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 58.9 t -112.06 133.42 57.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.612 -178.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -68.92 124.38 23.56 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.615 177.388 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 35.9 m -95.86 114.66 26.41 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 174.165 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.406 ' HG2' ' NE2' ' A' ' 91' ' ' HIS . 5.7 tmtp? -75.81 98.9 4.28 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 116.144 -0.48 . . . . 0.0 109.73 178.875 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -91.21 -46.66 7.95 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.237 0.541 . . . . 0.0 110.183 -179.002 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . 0.753 ' HB2' ' HB3' ' A' ' 90' ' ' PHE . 40.4 m-80 -131.54 153.27 81.51 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.261 178.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -50.62 -31.5 32.18 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.706 2.271 . . . . 0.0 112.683 -179.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.539 ' HA ' ' HD2' ' A' ' 104' ' ' PHE . 16.5 p -115.22 18.11 16.32 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.722 -178.182 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.753 ' HB3' ' HB2' ' A' ' 87' ' ' ASN . 74.1 t80 -145.18 115.25 7.44 Favored 'General case' 0 C--O 1.24 0.585 0 CA-C-O 121.366 0.603 . . . . 0.0 111.985 -176.803 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' HIS . . . . . 0.406 ' NE2' ' HG2' ' A' ' 85' ' ' LYS . 31.5 m80 -103.88 157.06 17.35 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.152 -0.931 . . . . 0.0 109.277 171.455 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 19.5 p80 -154.42 149.73 27.13 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 110.191 -0.299 . . . . 0.0 110.191 172.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 38.5 p90 -137.66 140.42 40.81 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 110.016 -0.364 . . . . 0.0 110.016 178.417 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -109.85 112.74 24.96 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.101 -173.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 23.4 m -138.9 144.12 30.34 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 174.192 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 58.12 25.9 13.02 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 120.725 0.298 . . . . 0.0 110.712 -178.074 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 68.09 1.47 2.8 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.755 -177.464 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 64.3 mtt-85 -89.31 134.39 34.08 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 109.489 -0.559 . . . . 0.0 109.489 178.131 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.47 ' HB3' ' CH2' ' A' ' 32' ' ' TRP . 12.3 mptt -94.33 97.48 10.24 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.984 0.421 . . . . 0.0 110.491 -178.03 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . 0.548 ' CE2' ' SG ' ' A' ' 75' ' ' CYS . 2.3 m-85 -81.65 141.11 33.95 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 174.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -138.59 157.6 24.68 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 121.224 -0.513 . . . . 0.0 112.103 178.613 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 6.4 tt -143.56 121.31 11.9 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 108.912 -0.774 . . . . 0.0 108.912 178.289 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' THR . . . . . 0.454 ' HG1' ' HD1' ' A' ' 90' ' ' PHE . 26.8 m -109.11 136.34 48.78 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.438 -178.519 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.539 ' HD2' ' HA ' ' A' ' 89' ' ' THR . 41.1 m-85 -86.0 139.61 31.03 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.213 -0.448 . . . . 0.0 109.983 178.471 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 8.3 tp-100 -93.44 -42.83 9.05 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.36 -175.487 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -130.49 147.72 67.08 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.518 -176.748 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -53.88 -25.07 33.82 Favored 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 122.299 1.999 . . . . 0.0 111.908 179.039 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -62.26 -57.54 11.05 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.026 176.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -70.35 -29.64 66.38 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.634 -179.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . 0.426 ' O ' ' HB2' ' A' ' 114' ' ' ASP . . . -56.89 -58.16 9.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.251 174.544 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . 0.557 ' HA ' ' HE ' ' A' ' 111' ' ' ARG . 1.3 tpm_? -59.47 -50.49 73.74 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.954 -179.628 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -60.89 -57.19 13.71 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.63 -174.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.504 ' O ' HG22 ' A' ' 117' ' ' VAL . 38.6 t80 -67.4 -36.47 81.37 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.666 -174.87 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.426 ' HB2' ' O ' ' A' ' 110' ' ' ALA . 8.2 t70 -59.98 -49.25 78.39 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 121.168 0.509 . . . . 0.0 109.753 177.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 41.9 ttt180 -51.74 -45.24 63.59 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 115.117 -0.947 . . . . 0.0 109.923 174.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -60.35 -39.4 96.09 Favored Glycine 0 CA--C 1.519 0.297 0 CA-C-N 115.651 -0.704 . . . . 0.0 112.19 176.12 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.504 HG22 ' O ' ' A' ' 113' ' ' PHE . 75.7 t -66.08 -54.58 25.38 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.163 0 C-N-CA 122.382 0.273 . . . . 0.0 111.112 -179.48 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 19.6 ptp180 -60.3 -38.02 82.33 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 116.578 -0.283 . . . . 0.0 110.606 -177.503 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 16.1 mmmt -68.85 -39.22 80.04 Favored 'General case' 0 C--N 1.334 -0.078 0 CA-C-N 116.613 -0.267 . . . . 0.0 110.646 175.151 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.5 -44.26 96.18 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.884 0.373 . . . . 0.0 110.223 177.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 48.1 mm -62.9 -45.0 99.97 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.313 178.409 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -57.44 -51.02 71.14 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.661 178.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -74.51 -17.31 60.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.247 -178.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 45.1 tp -74.89 -47.7 28.66 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 177.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 75.1 mt -70.18 -40.35 78.04 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.303 178.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.249 1.066 0 N-CA-C 109.084 -0.709 . . . . 0.0 109.084 -179.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 19.7 m . . . . . 0 CA--C 1.537 0.478 0 N-CA-C 112.438 0.532 . . . . 0.0 112.438 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.408 ' HD2' ' HB3' ' A' ' 17' ' ' ARG . 3.3 m-85 -70.32 123.63 22.18 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 110.123 -0.325 . . . . 0.0 110.123 176.166 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 7.1 tp -88.45 -41.45 14.18 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 175.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 69.9 t -131.96 128.58 59.74 Favored 'Isoleucine or valine' 0 C--O 1.232 0.178 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 177.074 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.408 ' HB3' ' HD2' ' A' ' 14' ' ' TYR . 6.5 ptm180 -147.12 145.14 29.48 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.055 0.455 . . . . 0.0 111.468 -178.451 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 60.0 t -133.09 154.65 39.91 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 CA-C-N 115.411 -0.813 . . . . 0.0 108.993 177.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 2.2 tmmm? -98.41 117.17 32.23 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 175.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.489 ' HB3' ' O ' ' A' ' 103' ' ' THR . . . -158.55 -170.39 3.06 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-N 116.678 -0.237 . . . . 0.0 110.929 -178.339 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.728 HG22 ' HA2' ' A' ' 39' ' ' GLY . 60.8 t -99.91 114.2 37.61 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.123 -177.524 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.475 HG22 HG21 ' A' ' 72' ' ' VAL . 19.0 m -80.64 106.87 12.37 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 CA-C-O 121.098 0.475 . . . . 0.0 110.71 176.666 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 45.1 mtt -100.95 167.12 10.46 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.665 179.141 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.477 HG22 ' CE1' ' A' ' 33' ' ' PHE . 10.9 t -141.73 166.9 23.45 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.705 -0.68 . . . . 0.0 109.767 178.531 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.414 ' NH2' ' HA2' ' A' ' 30' ' ' GLY . 19.2 ttt180 -129.98 109.61 11.01 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 177.828 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -56.49 88.36 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.821 -173.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.461 ' HA ' ' HG2' ' A' ' 98' ' ' ARG . 34.1 t70 52.0 -84.78 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 123.522 0.729 . . . . 0.0 112.156 -179.403 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 32.9 t -125.02 16.88 8.52 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 120.865 0.364 . . . . 0.0 110.738 -175.553 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 33.1 t -67.96 138.17 55.73 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.304 179.29 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.414 ' HA2' ' NH2' ' A' ' 25' ' ' ARG . . . -83.35 65.1 4.19 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 121.07 -0.586 . . . . 0.0 112.155 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -177.32 167.2 38.2 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.884 -0.674 . . . . 0.0 112.889 179.472 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . 0.496 ' HH2' ' HB3' ' A' ' 99' ' ' LYS . 94.7 m95 -125.85 125.61 43.13 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 122.637 0.375 . . . . 0.0 110.038 178.132 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.477 ' CE1' HG22 ' A' ' 24' ' ' THR . 5.7 p90 -137.47 144.37 44.87 Favored Pre-proline 0 C--O 1.234 0.284 0 CA-C-N 116.631 -0.259 . . . . 0.0 111.244 -176.035 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -60.82 132.35 42.07 Favored 'Trans proline' 0 C--N 1.353 0.803 0 C-N-CA 122.594 2.196 . . . . 0.0 111.271 173.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . 0.433 ' H ' ' HG2' ' A' ' 35' ' ' GLN . 10.1 pt20 -86.91 -36.61 18.27 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.042 -0.526 . . . . 0.0 112.23 -174.442 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 20.1 tp10 -166.16 -55.28 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 120.658 0.266 . . . . 0.0 110.845 -177.312 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -53.97 -41.26 67.76 Favored Glycine 0 C--N 1.332 0.36 0 CA-C-N 116.03 -0.532 . . . . 0.0 113.522 -175.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 67.02 -138.1 34.43 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.994 -0.622 . . . . 0.0 111.954 -177.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.728 ' HA2' HG22 ' A' ' 21' ' ' VAL . . . -62.25 -34.37 88.96 Favored Glycine 0 CA--C 1.521 0.445 0 C-N-CA 121.61 -0.329 . . . . 0.0 113.675 -175.356 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.524 ' N ' HD13 ' A' ' 40' ' ' ILE . 3.1 mp -107.95 108.67 25.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 N-CA-C 110.24 -0.281 . . . . 0.0 110.24 -177.106 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 23.3 m -144.15 118.2 9.45 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.471 0.177 . . . . 0.0 110.551 172.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.439 ' CZ ' ' HD3' ' A' ' 65' ' ' ARG . 96.1 mtt180 -71.77 90.82 1.1 Allowed 'General case' 0 CA--C 1.521 -0.157 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 171.563 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.4 p -104.1 139.53 24.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.893 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -175.99 176.09 47.52 Favored Glycine 0 N--CA 1.443 -0.87 0 C-N-CA 120.463 -0.875 . . . . 0.0 112.703 178.234 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 59.4 t -107.84 129.09 62.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 178.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . 0.749 ' SG ' ' HB3' ' A' ' 60' ' ' LEU . 10.4 p -112.73 117.64 32.77 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.635 176.106 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 36.5 ttmt -76.02 83.21 2.9 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 179.3 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 27.1 m -75.35 135.14 27.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.375 -178.481 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 63.0 mtt . . . . . 0 C--N 1.327 -0.37 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.263 -179.752 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.37 0 N-CA-C 111.064 -0.814 . . . . 0.0 111.064 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 -119.64 112.16 18.96 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.887 0.375 . . . . 0.0 110.499 -178.283 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.749 ' HB3' ' SG ' ' A' ' 46' ' ' CYS . 2.6 tt -101.76 110.88 22.96 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 179.698 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.401 ' O ' ' HA ' ' A' ' 74' ' ' GLU . 62.5 mt -78.26 100.22 3.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 173.634 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 3.2 t-80 -112.22 145.95 39.01 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 -173.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -146.51 119.59 1.18 Allowed Glycine 0 C--O 1.236 0.242 0 N-CA-C 110.716 -0.954 . . . . 0.0 110.716 -178.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -156.69 -175.71 5.58 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.916 0.865 . . . . 0.0 113.235 -167.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.439 ' HD3' ' CZ ' ' A' ' 42' ' ' ARG . 44.4 ttt-85 61.39 89.22 0.08 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 113.395 -1.73 . . . . 0.0 114.219 160.825 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.55 -42.58 0.61 Allowed 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 106.505 -1.665 . . . . 0.0 106.505 162.296 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.556 ' HE2' HD22 ' A' ' 70' ' ' LEU . 37.7 ttpt -90.23 163.19 14.89 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 163.226 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -51.09 94.45 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 -173.299 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 58.3 mtmt 49.77 84.75 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.311 -0.859 . . . . 0.0 112.209 177.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.556 HD22 ' HE2' ' A' ' 67' ' ' LYS . 61.9 tp -136.56 121.04 18.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.866 -179.222 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 54.1 t -79.29 113.37 18.54 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 N-CA-C 109.943 -0.391 . . . . 0.0 109.943 178.059 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.475 HG21 HG22 ' A' ' 22' ' ' VAL . 33.6 m -108.64 -2.5 10.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.602 -175.526 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -169.03 138.64 2.18 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 179.127 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.401 ' HA ' ' O ' ' A' ' 61' ' ' ILE . 0.2 OUTLIER -165.35 145.49 6.9 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 121.082 0.468 . . . . 0.0 111.31 176.752 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' CYS . . . . . 0.583 ' SG ' HG11 ' A' ' 95' ' ' VAL . 50.4 t -166.11 118.83 1.08 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.635 179.542 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 86.5 t80 -94.73 137.83 33.33 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.521 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 35.4 m -132.49 139.11 50.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 109.354 -0.609 . . . . 0.0 109.354 177.066 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 35.0 ttm-85 -107.67 -25.24 11.4 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.007 -175.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 39.4 tptt -170.05 -30.46 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 120.81 0.338 . . . . 0.0 110.496 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -97.03 124.49 41.03 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.993 179.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.465 HD13 ' N ' ' A' ' 82' ' ' VAL . 3.3 tm? -175.85 139.52 0.4 Allowed 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 177.172 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.465 ' N ' HD13 ' A' ' 81' ' ' LEU . 66.0 t -130.48 122.31 52.79 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 CA-C-N 116.602 -0.272 . . . . 0.0 110.554 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.611 ' HB3' ' NE2' ' A' ' 91' ' ' HIS . 96.1 m-85 -91.79 153.83 19.34 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-O 120.968 0.413 . . . . 0.0 110.06 173.8 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 91.4 m -156.0 117.5 3.92 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 174.727 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.407 ' HZ3' ' CG ' ' A' ' 114' ' ' ASP . 20.2 ptmt -101.31 125.13 47.9 Favored 'General case' 0 C--N 1.328 -0.366 0 O-C-N 122.034 -0.416 . . . . 0.0 110.546 178.685 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -80.6 -34.01 35.5 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.63 -0.713 . . . . 0.0 110.363 -178.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -136.99 155.4 76.28 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.084 179.134 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_exo -48.73 -41.91 37.45 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.469 2.113 . . . . 0.0 111.959 176.178 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 13.4 p -97.25 18.16 15.68 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 115.716 -0.675 . . . . 0.0 112.051 -178.485 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 21.5 t80 -147.47 98.32 2.97 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-O 121.148 0.499 . . . . 0.0 110.865 177.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' HIS . . . . . 0.611 ' NE2' ' HB3' ' A' ' 83' ' ' TYR . 3.4 t-160 -109.47 125.15 52.15 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 -179.604 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 25.8 p80 -125.6 167.03 15.64 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.971 0.415 . . . . 0.0 110.926 -178.499 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 26.8 p90 -139.63 177.9 7.61 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.282 176.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 62.6 pttt -154.28 147.29 24.57 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.817 0.341 . . . . 0.0 111.052 -174.435 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.583 HG11 ' SG ' ' A' ' 75' ' ' CYS . 35.7 m -132.72 143.94 38.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 173.737 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 66.01 -72.17 0.08 Allowed 'General case' 0 N--CA 1.465 0.321 0 O-C-N 123.56 0.538 . . . . 0.0 110.719 -176.192 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -165.34 -26.78 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.874 -178.626 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.461 ' HG2' ' HA ' ' A' ' 27' ' ' ASP . 99.8 mtt180 -81.81 149.51 28.32 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 120.832 0.348 . . . . 0.0 111.027 -178.299 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.496 ' HB3' ' HH2' ' A' ' 32' ' ' TRP . 0.0 OUTLIER -114.22 142.66 45.98 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.261 -173.141 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 2.9 p90 -150.05 138.88 20.9 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 173.056 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -142.69 -170.1 12.62 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.205 -0.998 . . . . 0.0 114.605 -169.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.459 HD13 ' HB2' ' A' ' 20' ' ' ALA . 34.3 tp -134.17 124.26 25.74 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 114.995 -0.603 . . . . 0.0 110.868 -173.189 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' THR . . . . . 0.543 ' HB ' ' HB ' ' A' ' 21' ' ' VAL . 22.5 m -98.5 124.92 43.51 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 175.563 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 57.0 m-85 -87.76 161.77 17.4 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.863 -175.136 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 23.8 pt20 -96.29 -27.99 14.72 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.655 -177.499 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 49.1 m -149.56 154.43 38.09 Favored Pre-proline 0 CA--C 1.532 0.264 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.544 178.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -58.73 -24.43 71.19 Favored 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 122.555 2.17 . . . . 0.0 112.064 178.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -62.21 -56.09 22.14 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.916 178.542 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -71.73 -28.73 63.87 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.759 179.206 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -58.97 -60.66 3.5 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.127 0.489 . . . . 0.0 110.392 174.456 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 67.5 mtp85 -62.43 -32.62 73.51 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.913 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -62.59 -38.59 90.72 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.311 176.167 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 52.6 t80 -73.68 -34.48 64.91 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.169 179.099 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.417 ' HA ' HG22 ' A' ' 117' ' ' VAL . 63.9 m-20 -61.71 -38.64 88.61 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 121.337 0.589 . . . . 0.0 109.534 173.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 17.0 mmm180 -62.39 -42.05 99.13 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.684 172.071 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -60.17 -46.4 94.3 Favored Glycine 0 N--CA 1.45 -0.412 0 CA-C-N 115.336 -0.847 . . . . 0.0 112.519 178.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.425 ' O ' HG13 ' A' ' 121' ' ' ILE . 21.3 m -70.51 -34.82 59.06 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.366 0 CA-C-N 116.737 0.268 . . . . 0.0 110.634 -178.878 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -61.88 -48.91 78.38 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 176.839 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 7.9 tmtm? -62.03 -45.9 91.51 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 114.775 -1.102 . . . . 0.0 109.801 -179.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -61.42 -52.11 65.96 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.818 -179.687 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.425 HG13 ' O ' ' A' ' 117' ' ' VAL . 68.4 mt -57.66 -41.12 78.62 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.123 -178.136 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . 0.546 ' O ' ' HG3' ' A' ' 126' ' ' GLU . 37.0 tt0 -63.37 -58.34 7.41 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 121.018 0.437 . . . . 0.0 110.394 177.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -60.76 -22.55 64.18 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.449 -179.506 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 9.4 tt -84.47 -39.82 18.44 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.418 179.346 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.497 HG21 ' O ' ' A' ' 122' ' ' GLU . 10.8 tp -72.11 -25.87 24.25 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 CA-C-N 116.732 -0.213 . . . . 0.0 110.434 -176.04 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.546 ' HG3' ' O ' ' A' ' 122' ' ' GLU . 46.8 mt-10 . . . . . 0 C--O 1.25 1.098 0 CA-C-O 118.728 -0.653 . . . . 0.0 110.336 175.18 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.787 ' HB2' ' SG ' ' A' ' 46' ' ' CYS . 58.3 m . . . . . 0 CA--C 1.532 0.27 0 CA-C-O 119.931 -0.08 . . . . 0.0 110.92 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 31.8 m-85 42.88 91.34 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 122.74 0.416 . . . . 0.0 111.87 -175.263 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.624 HD12 ' HB2' ' A' ' 47' ' ' LYS . 63.0 mt -61.18 -51.15 76.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 121.147 0.499 . . . . 0.0 109.916 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.517 HG23 HG22 ' A' ' 15' ' ' ILE . 92.0 t -140.1 119.33 12.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.882 178.701 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.57 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 27.8 ttp180 -128.05 86.7 2.5 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-O 121.264 0.554 . . . . 0.0 109.776 173.122 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 35.0 m -117.68 173.03 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-N 115.329 -0.85 . . . . 0.0 110.474 -177.205 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 26.1 ttpp -92.06 134.91 34.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.91 0.386 . . . . 0.0 110.914 179.638 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -160.11 -164.21 1.25 Allowed 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 178.304 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 25.0 t -122.44 109.16 23.34 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 177.538 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.685 HG22 ' NE2' ' A' ' 35' ' ' GLN . 19.7 m -84.16 133.18 29.8 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 CA-C-O 120.989 0.423 . . . . 0.0 111.031 -178.233 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 24.5 mmt -117.09 152.42 34.73 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.108 -176.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.424 HG21 ' CE1' ' A' ' 33' ' ' PHE . 9.8 t -132.66 140.26 48.08 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-O 121.134 0.492 . . . . 0.0 110.955 176.427 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.44 ' HE ' ' HA ' ' A' ' 28' ' ' SER . 21.1 tpt180 -90.21 77.78 6.66 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 174.71 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.539 ' HB2' ' HE1' ' A' ' 33' ' ' PHE . 35.7 t70 -56.3 94.74 0.01 OUTLIER 'General case' 0 C--O 1.236 0.371 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 179.478 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 16.0 t70 63.47 -74.78 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.941 -173.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.44 ' HA ' ' HE ' ' A' ' 25' ' ' ARG . 8.0 t -167.27 -44.26 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 175.324 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 18.5 t -61.88 -12.34 17.31 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.53 -178.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -62.1 -26.58 67.68 Favored Glycine 0 CA--C 1.523 0.574 0 C-N-CA 121.153 -0.546 . . . . 0.0 112.478 175.569 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 56.79 28.54 57.34 Favored Glycine 0 C--N 1.338 0.663 0 C-N-CA 121.739 -0.267 . . . . 0.0 113.537 177.298 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . 0.575 ' HH2' ' HG2' ' A' ' 99' ' ' LYS . 62.4 m95 63.03 96.76 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 123.174 0.59 . . . . 0.0 110.678 -177.789 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.539 ' HE1' ' HB2' ' A' ' 26' ' ' ASP . 2.9 p90 -132.04 150.84 77.23 Favored Pre-proline 0 C--O 1.236 0.376 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.928 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.482 ' HB2' ' HA2' ' A' ' 38' ' ' GLY . 77.1 Cg_endo -79.35 109.2 2.46 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.527 2.151 . . . . 0.0 112.084 179.15 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . 0.685 ' NE2' HG22 ' A' ' 22' ' ' VAL . 0.2 OUTLIER -75.57 125.95 30.04 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 176.861 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 65.07 -75.1 0.05 OUTLIER 'General case' 0 C--O 1.236 0.377 0 C-N-CA 123.133 0.573 . . . . 0.0 111.317 -178.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -76.25 74.33 1.69 Allowed Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 121.575 -0.345 . . . . 0.0 112.782 -177.242 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.482 ' HA2' ' HB2' ' A' ' 34' ' ' PRO . . . -75.56 66.74 2.32 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 121.209 -0.52 . . . . 0.0 112.114 177.156 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 129.02 -32.0 3.37 Favored Glycine 0 N--CA 1.453 -0.173 0 C-N-CA 121.415 -0.421 . . . . 0.0 112.07 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 67.4 mt -120.4 100.75 9.76 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 CA-C-O 120.823 0.344 . . . . 0.0 110.501 179.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 16.5 m -132.49 151.42 51.91 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 175.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 6.5 tpt180 -113.9 116.12 28.77 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 174.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.57 ' O ' ' HA ' ' A' ' 17' ' ' ARG . 24.2 t -95.46 103.16 14.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.273 -178.047 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -106.16 89.43 0.61 Allowed Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 121.334 -0.46 . . . . 0.0 112.491 179.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 85.0 t -84.86 120.8 36.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 120.856 0.36 . . . . 0.0 110.067 177.015 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . 0.787 ' SG ' ' HB2' ' A' ' 13' ' ' SER . 45.0 t -117.8 165.2 13.93 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.921 -178.666 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.624 ' HB2' HD12 ' A' ' 15' ' ' ILE . 83.8 tttt -118.65 116.05 25.78 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.368 -179.65 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.442 HG22 ' CE2' ' A' ' 76' ' ' TYR . 36.0 m -110.55 150.96 12.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.094 0.473 . . . . 0.0 111.286 -175.414 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 4.0 mpp? . . . . . 0 C--N 1.328 -0.346 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.416 178.36 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.436 0 N-CA-C 111.934 -0.466 . . . . 0.0 111.934 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -133.17 158.09 43.71 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.87 -0.418 . . . . 0.0 109.87 178.574 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.424 HD23 ' HB2' ' A' ' 62' ' ' HIS . 1.9 tt -132.23 113.61 13.47 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 -179.774 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.512 ' HB ' ' HB2' ' A' ' 75' ' ' CYS . 58.0 mt -82.24 97.23 3.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 174.666 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . 0.424 ' HB2' HD23 ' A' ' 60' ' ' LEU . 26.6 t-80 -111.24 91.67 3.75 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.737 -172.446 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -89.98 114.79 4.43 Favored Glycine 0 C--O 1.236 0.275 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.625 177.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -143.49 -161.15 1.21 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.655 0.227 . . . . 0.0 111.526 -174.334 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 1.4 mmp_? 63.98 32.1 13.27 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 115.764 -0.653 . . . . 0.0 112.687 170.547 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.469 ' N ' HE21 ' A' ' 66' ' ' GLN . 0.0 OUTLIER -72.73 -67.51 0.55 Allowed 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.771 -0.372 . . . . 0.0 110.498 176.614 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 64.6 tttm -132.51 130.02 39.87 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 178.396 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 59.71 -80.93 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 -174.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 23.2 pttm -178.66 128.41 0.11 Allowed 'General case' 0 C--O 1.232 0.176 0 C-N-CA 123.149 0.58 . . . . 0.0 109.775 169.114 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -174.46 157.93 2.74 Favored 'General case' 0 C--O 1.24 0.571 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.03 177.634 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 25.0 t -95.41 117.51 39.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 O-C-N 123.297 0.373 . . . . 0.0 110.24 -179.286 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 33.6 m -92.48 -24.9 5.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 120.864 0.364 . . . . 0.0 111.062 -179.101 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -145.85 109.35 4.73 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 -176.287 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -116.9 116.61 27.75 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 178.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' CYS . . . . . 0.512 ' HB2' ' HB ' ' A' ' 61' ' ' ILE . 63.0 m -137.48 90.85 2.55 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 121.151 0.501 . . . . 0.0 110.526 179.448 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.442 ' CE2' HG22 ' A' ' 48' ' ' VAL . 56.6 t80 -70.98 105.26 3.23 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 173.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 15.6 m -103.62 97.55 5.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 121.81 0.814 . . . . 0.0 110.366 -174.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 28.6 ptt180 -83.06 80.37 9.07 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.396 -177.246 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.736 ' HA ' HD11 ' A' ' 124' ' ' LEU . 11.0 tmtt? 76.1 -37.5 0.31 Allowed 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.995 177.735 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -68.82 108.33 3.4 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 122.363 0.265 . . . . 0.0 110.715 -179.425 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.403 HD22 ' HA ' ' A' ' 81' ' ' LEU . 12.2 mt -152.02 163.21 39.77 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.213 0.53 . . . . 0.0 110.832 179.577 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 58.3 t -131.84 -65.7 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.721 176.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.433 ' HB3' ' NE2' ' A' ' 91' ' ' HIS . 21.0 m-85 56.73 103.61 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.431 -176.729 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 53.0 m -134.12 112.52 11.2 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.736 178.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.557 ' HA ' ' HA ' ' A' ' 91' ' ' HIS . 0.2 OUTLIER -82.16 91.1 6.65 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.454 0.645 . . . . 0.0 109.68 177.16 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -66.24 -32.01 73.18 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.046 -178.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . 0.727 ' HB2' ' HB3' ' A' ' 90' ' ' PHE . 15.6 m120 -129.09 155.35 79.96 Favored Pre-proline 0 C--N 1.326 -0.414 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 175.458 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_exo -44.26 -44.01 13.05 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.648 2.232 . . . . 0.0 112.915 179.41 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.546 ' O ' ' HA ' ' A' ' 103' ' ' THR . 37.3 p -108.67 16.98 22.43 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 -177.411 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.727 ' HB3' ' HB2' ' A' ' 87' ' ' ASN . 73.4 t80 -131.0 104.04 6.88 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 120.894 0.378 . . . . 0.0 110.509 -178.543 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' HIS . . . . . 0.557 ' HA ' ' HA ' ' A' ' 85' ' ' LYS . 1.5 t60 -114.9 124.27 51.28 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 -179.121 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . 0.463 ' HA ' ' HA2' ' A' ' 101' ' ' GLY . 23.5 p80 -126.78 159.54 33.5 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 120.953 0.406 . . . . 0.0 111.766 -176.394 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 49.1 p90 -155.39 147.53 23.62 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.282 -179.462 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.53 ' HB3' ' HZ3' ' A' ' 94' ' ' LYS . 5.7 ttpm? -112.85 127.53 56.2 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 177.426 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 19.1 m -146.69 146.94 18.34 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 O-C-N 123.253 0.346 . . . . 0.0 110.473 -179.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 33.6 t70 63.82 -73.33 0.05 OUTLIER 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.373 0.669 . . . . 0.0 111.773 178.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -146.43 -57.22 0.28 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.657 0.265 . . . . 0.0 110.65 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -78.8 176.19 9.78 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-O 121.538 0.685 . . . . 0.0 111.249 -178.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.575 ' HG2' ' HH2' ' A' ' 32' ' ' TRP . 37.2 ttpt -128.97 115.33 17.65 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.136 -179.268 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . 0.445 ' CE2' ' SG ' ' A' ' 75' ' ' CYS . 41.2 m-85 -101.21 168.38 9.6 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.528 -0.306 . . . . 0.0 110.605 -174.037 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . 0.463 ' HA2' ' HA ' ' A' ' 92' ' ' HIS . . . -151.08 170.87 30.79 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 121.136 -0.554 . . . . 0.0 112.161 -177.798 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.409 HD23 ' N ' ' A' ' 103' ' ' THR . 2.5 tt -143.52 128.77 18.8 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 -178.212 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' THR . . . . . 0.546 ' HA ' ' O ' ' A' ' 89' ' ' THR . 84.2 m -110.89 122.48 47.96 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.189 176.035 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.421 ' HD2' ' HA ' ' A' ' 89' ' ' THR . 50.9 m-85 -89.28 162.21 15.98 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.699 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 19.0 pt20 -113.5 -48.17 2.96 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 111.396 0.147 . . . . 0.0 111.396 -176.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 17.2 m -117.34 143.93 32.93 Favored Pre-proline 0 C--N 1.328 -0.34 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 -177.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_exo -47.7 -29.98 11.91 Favored 'Trans proline' 0 C--N 1.354 0.829 0 C-N-CA 122.593 2.196 . . . . 0.0 112.314 177.584 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -58.06 -70.75 0.13 Allowed 'General case' 0 C--O 1.233 0.204 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.98 177.024 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -60.45 -37.35 80.69 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.062 -178.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . 0.409 ' HA ' ' CG ' ' A' ' 104' ' ' PHE . . . -54.01 -69.56 0.12 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.261 178.711 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 78.4 mtt180 -70.94 -22.81 62.18 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.536 -173.307 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -65.67 -48.89 70.56 Favored 'General case' 0 C--O 1.238 0.471 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 174.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 57.1 t80 -69.59 -47.16 64.48 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.075 -179.464 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.409 ' O ' ' HG2' ' A' ' 118' ' ' ARG . 4.8 m-20 -51.93 -58.72 5.66 Favored 'General case' 0 N--CA 1.465 0.294 0 O-C-N 123.191 0.307 . . . . 0.0 110.75 178.638 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 27.3 mtp180 -60.71 -38.43 85.04 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-O 120.699 0.285 . . . . 0.0 110.892 -179.007 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . 0.495 ' O ' ' HG3' ' A' ' 119' ' ' LYS . . . -62.04 -56.64 21.22 Favored Glycine 0 CA--C 1.52 0.386 0 C-N-CA 121.183 -0.532 . . . . 0.0 112.575 179.231 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.546 ' O ' HG12 ' A' ' 121' ' ' ILE . 12.1 p -64.59 -30.91 51.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.571 0.224 . . . . 0.0 110.408 -178.529 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . 0.409 ' HD2' ' HA ' ' A' ' 118' ' ' ARG . 7.9 mmm180 -62.77 -50.75 69.82 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.653 177.688 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.495 ' HG3' ' O ' ' A' ' 116' ' ' GLY . 0.0 OUTLIER -62.01 -33.98 75.35 Favored 'General case' 0 N--CA 1.462 0.151 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 178.753 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -62.51 -36.53 82.86 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.449 175.423 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.546 HG12 ' O ' ' A' ' 117' ' ' VAL . 40.3 mm -64.09 -44.65 97.71 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.076 0 CA-C-N 116.248 -0.433 . . . . 0.0 109.879 175.904 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -58.55 -39.19 79.55 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.71 176.175 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 87.9 m-20 -66.05 -37.08 84.95 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 121.252 0.549 . . . . 0.0 110.239 176.439 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.736 HD11 ' HA ' ' A' ' 79' ' ' LYS . 49.4 tp -70.5 -57.73 4.46 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.335 -0.848 . . . . 0.0 111.469 -176.294 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.487 HG13 ' O ' ' A' ' 121' ' ' ILE . 2.9 pp -75.02 -29.47 22.16 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.05 -177.594 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.46 ' N ' HD13 ' A' ' 125' ' ' ILE . 39.5 tt0 . . . . . 0 C--O 1.248 1.008 0 CA-C-O 118.15 -0.929 . . . . 0.0 111.094 176.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 60.5 m . . . . . 0 CA--C 1.533 0.307 0 N-CA-C 111.938 0.347 . . . . 0.0 111.938 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 13.3 m-85 -73.45 123.19 23.4 Favored 'General case' 0 C--O 1.235 0.305 0 O-C-N 122.096 -0.378 . . . . 0.0 110.841 176.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.434 HG21 HG12 ' A' ' 16' ' ' VAL . 13.6 tt -85.12 -27.15 6.57 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 174.137 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.434 HG12 HG21 ' A' ' 15' ' ' ILE . 9.2 p -159.15 144.97 6.95 Favored 'Isoleucine or valine' 0 C--O 1.231 0.13 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.906 176.279 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 55.8 ttp180 -160.04 109.35 1.78 Allowed 'General case' 0 C--O 1.235 0.315 0 CA-C-O 121.026 0.441 . . . . 0.0 110.433 176.024 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 34.6 m -113.01 -170.32 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.089 -179.219 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.51 ' HB2' HG21 ' A' ' 40' ' ' ILE . 57.4 pttt -126.26 113.59 17.17 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.069 0.461 . . . . 0.0 110.392 178.511 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -143.52 178.14 7.98 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.351 -177.483 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.519 ' HB ' ' HB ' ' A' ' 103' ' ' THR . 27.5 t -83.37 135.17 25.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.442 0.163 . . . . 0.0 110.564 179.825 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.55 HG22 ' HG2' ' A' ' 35' ' ' GLN . 11.6 m -95.24 95.26 4.87 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 CA-C-O 121.473 0.654 . . . . 0.0 110.847 177.087 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 23.6 mmt -86.77 160.01 18.94 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.699 -178.262 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 11.7 t -160.24 150.71 18.53 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.867 174.168 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.409 ' HD2' ' O ' ' A' ' 29' ' ' SER . 47.6 ttp180 -114.1 89.74 3.17 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 107.594 -1.261 . . . . 0.0 107.594 171.835 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -43.47 96.99 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.33 0 O-C-N 124.482 1.114 . . . . 0.0 112.364 -169.357 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 18.7 t70 58.22 -78.92 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 115.15 -0.932 . . . . 0.0 111.088 -179.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 21.1 m -141.95 105.7 4.71 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 176.329 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.409 ' O ' ' HD2' ' A' ' 25' ' ' ARG . 36.4 t -141.84 171.1 14.52 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.14 -176.481 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -100.02 38.87 2.93 Favored Glycine 0 CA--C 1.518 0.268 0 C-N-CA 121.293 -0.479 . . . . 0.0 112.93 -176.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 171.92 163.71 26.29 Favored Glycine 0 C--N 1.33 0.243 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.649 177.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 86.2 m95 -103.6 113.73 27.47 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 176.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -117.6 144.76 34.86 Favored Pre-proline 0 C--N 1.327 -0.402 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.288 -177.007 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo -71.11 137.73 32.16 Favored 'Trans proline' 0 C--N 1.351 0.676 0 C-N-CA 122.846 2.364 . . . . 0.0 111.46 175.038 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . 0.55 ' HG2' HG22 ' A' ' 22' ' ' VAL . 7.1 pt20 -87.91 -147.53 0.15 Allowed 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.07 179.261 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 44.5 mm-40 -46.66 -42.73 16.87 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 111.832 0.308 . . . . 0.0 111.832 179.528 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -80.8 68.58 3.37 Favored Glycine 0 CA--C 1.519 0.328 0 C-N-CA 121.184 -0.532 . . . . 0.0 112.544 -179.392 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -77.33 132.07 11.74 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 121.204 -0.522 . . . . 0.0 112.392 179.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 85.05 -57.96 4.98 Favored Glycine 0 CA--C 1.518 0.264 0 C-N-CA 121.283 -0.484 . . . . 0.0 112.885 176.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.51 HG21 ' HB2' ' A' ' 19' ' ' LYS . 65.5 mt -142.23 140.76 29.12 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 C-N-CA 122.341 0.256 . . . . 0.0 110.458 -177.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.439 ' O ' ' HA ' ' A' ' 19' ' ' LYS . 53.0 m -150.71 133.96 16.2 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 174.344 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 55.4 ttp180 -81.47 90.63 6.23 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 109.808 -0.441 . . . . 0.0 109.808 -178.375 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.459 ' HA ' ' HA2' ' A' ' 63' ' ' GLY . 31.4 t -111.96 143.3 22.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.443 -175.721 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -160.96 -177.43 34.06 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.994 -0.622 . . . . 0.0 112.718 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 50.5 t -118.04 130.45 72.89 Favored 'Isoleucine or valine' 0 C--O 1.241 0.614 0 CA-C-O 120.721 0.296 . . . . 0.0 110.263 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . 0.675 ' SG ' ' HB3' ' A' ' 60' ' ' LEU . 12.4 p -119.67 122.49 41.6 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.452 173.361 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 33.3 ttpt -78.72 102.03 7.86 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 121.053 0.454 . . . . 0.0 110.145 179.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 51.3 t -75.86 110.74 11.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.372 -179.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 22.9 ptp . . . . . 0 C--N 1.326 -0.415 0 CA-C-N 116.288 -0.415 . . . . 0.0 109.979 178.505 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.467 0 N-CA-C 112.618 -0.193 . . . . 0.0 112.618 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -130.32 125.56 35.01 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 -176.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.675 ' HB3' ' SG ' ' A' ' 46' ' ' CYS . 2.3 tt -95.81 118.29 32.18 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 -179.531 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 49.5 mm -84.27 93.95 3.48 Favored 'Isoleucine or valine' 0 C--O 1.235 0.292 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 172.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . 0.599 ' HB2' HD21 ' A' ' 60' ' ' LEU . 38.5 t-80 -108.48 131.91 54.33 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.941 -171.798 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.459 ' HA2' ' HA ' ' A' ' 43' ' ' VAL . . . -128.24 133.06 7.58 Favored Glycine 0 N--CA 1.449 -0.481 0 N-CA-C 110.89 -0.884 . . . . 0.0 110.89 177.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -146.89 178.17 8.55 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.78 0.324 . . . . 0.0 111.329 -172.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 5.1 mmt180 68.1 169.37 0.27 Allowed 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 115.303 -0.862 . . . . 0.0 111.868 174.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 65.33 165.63 0.17 Allowed 'General case' 0 C--O 1.235 0.323 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.297 -173.216 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 24.9 tptp 71.24 -59.82 0.53 Allowed 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 122.946 0.498 . . . . 0.0 109.665 -174.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -165.24 -84.97 0.02 OUTLIER 'General case' 0 C--O 1.234 0.28 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.235 173.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.592 ' HZ1' ' HB2' ' A' ' 69' ' ' LYS . 4.3 ttmp? -165.85 96.0 0.62 Allowed 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 -179.262 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.4 pp -173.23 178.92 2.32 Favored 'General case' 0 C--O 1.239 0.514 0 CA-C-O 120.633 0.254 . . . . 0.0 110.474 -173.01 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.462 HG23 ' O ' ' A' ' 71' ' ' VAL . 27.4 m -103.41 104.1 16.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.889 177.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.419 HG23 ' HB3' ' A' ' 41' ' ' SER . 34.7 m -68.46 -31.37 50.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.41 -178.572 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 40.4 mt -141.06 94.22 2.68 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.362 178.042 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -98.51 94.92 6.96 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 170.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' CYS . . . . . 0.486 ' SG ' ' CE2' ' A' ' 100' ' ' PHE . 57.9 m -139.43 89.4 2.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.363 0.601 . . . . 0.0 111.011 -172.386 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.485 ' HA ' ' HA ' ' A' ' 60' ' ' LEU . 29.9 t80 -74.27 116.13 14.57 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.173 178.072 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.59 HG11 HD12 ' A' ' 81' ' ' LEU . 95.8 t -80.19 105.93 10.56 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 CA-C-O 121.144 0.497 . . . . 0.0 109.818 179.719 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.575 ' HD2' ' O ' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -80.79 61.86 4.6 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.276 -179.906 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.566 ' HG3' HD22 ' A' ' 124' ' ' LEU . 45.4 tttp 74.86 124.19 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 115.172 -0.922 . . . . 0.0 111.394 -176.479 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 76.7 m-20 70.6 119.39 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 115.113 -0.949 . . . . 0.0 112.915 174.15 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.59 HD12 HG11 ' A' ' 77' ' ' VAL . 0.0 OUTLIER -143.52 134.26 25.17 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 167.47 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 19.8 t -65.61 -52.02 55.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.888 -169.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.575 ' HH ' HD11 ' A' ' 102' ' ' LEU . 0.9 OUTLIER 57.87 51.59 8.93 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 121.292 0.568 . . . . 0.0 109.987 -177.626 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 33.7 m -60.52 114.18 2.83 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.786 -179.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.456 ' HB3' ' CD2' ' A' ' 91' ' ' HIS . 0.0 OUTLIER -99.71 102.25 13.66 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.972 0.415 . . . . 0.0 110.334 176.112 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -75.46 -37.15 60.48 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 175.367 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . 0.442 ' HB2' ' HB3' ' A' ' 90' ' ' PHE . 77.0 m-20 -127.67 151.46 75.33 Favored Pre-proline 0 C--N 1.326 -0.423 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 174.095 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.484 ' O ' ' HB3' ' A' ' 110' ' ' ALA . 88.7 Cg_exo -48.22 -33.82 22.71 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.313 2.009 . . . . 0.0 112.374 178.387 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.448 ' O ' ' HA ' ' A' ' 103' ' ' THR . 14.7 p -97.68 -15.65 20.3 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 115.889 -0.596 . . . . 0.0 112.138 -178.519 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.442 ' HB3' ' HB2' ' A' ' 87' ' ' ASN . 86.8 t80 -107.31 102.47 11.77 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-O 121.087 0.47 . . . . 0.0 110.854 -176.653 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' HIS . . . . . 0.456 ' CD2' ' HB3' ' A' ' 85' ' ' LYS . 56.5 m80 -112.82 147.3 37.24 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.155 177.201 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . 0.542 ' HA ' ' HA3' ' A' ' 101' ' ' GLY . 15.4 p80 -153.95 152.84 31.04 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 174.789 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . 0.444 ' HD1' HG13 ' A' ' 95' ' ' VAL . 47.8 p90 -137.13 145.28 43.63 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-O 121.283 0.563 . . . . 0.0 111.291 177.867 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 1.1 tmtm? -102.04 119.52 38.93 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.013 -0.994 . . . . 0.0 109.286 176.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.444 HG13 ' HD1' ' A' ' 93' ' ' TRP . 19.3 m -125.45 125.64 69.22 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 173.417 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 59.56 -79.4 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.77 -175.518 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 44.1 t30 -142.29 -35.21 0.43 Allowed 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 112.063 0.394 . . . . 0.0 112.063 -177.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.507 ' N ' ' HD2' ' A' ' 98' ' ' ARG . 2.3 mpt_? -84.46 148.29 26.64 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.899 0.381 . . . . 0.0 111.212 -174.659 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 3.5 mppt? -119.92 124.49 46.14 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.759 -176.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . 0.486 ' CE2' ' SG ' ' A' ' 75' ' ' CYS . 0.7 OUTLIER -144.31 150.44 37.85 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.485 176.095 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . 0.542 ' HA3' ' HA ' ' A' ' 92' ' ' HIS . . . -157.71 -165.61 15.64 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 121.021 -0.609 . . . . 0.0 112.82 -175.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.575 HD11 ' HH ' ' A' ' 83' ' ' TYR . 94.9 mt -128.42 147.32 50.65 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.998 0.428 . . . . 0.0 110.887 -174.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' THR . . . . . 0.519 ' HB ' ' HB ' ' A' ' 21' ' ' VAL . 63.2 m -123.79 107.67 11.67 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 172.74 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.448 ' HB3' ' OD2' ' A' ' 109' ' ' ASP . 99.4 m-85 -78.28 167.97 20.54 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.645 -0.707 . . . . 0.0 112.019 -172.122 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 -92.06 -41.76 10.33 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.03 -175.618 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 16.7 m -137.54 156.13 75.01 Favored Pre-proline 0 C--O 1.234 0.285 0 CA-C-N 116.621 -0.263 . . . . 0.0 110.883 -175.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -54.2 -32.65 71.61 Favored 'Trans proline' 0 C--N 1.351 0.676 0 C-N-CA 122.656 2.237 . . . . 0.0 112.234 177.392 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -56.43 -66.32 0.46 Allowed 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.401 179.05 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.448 ' OD2' ' HB3' ' A' ' 104' ' ' PHE . 1.6 p-10 -63.63 -35.73 81.47 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.086 -178.415 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . 0.484 ' HB3' ' O ' ' A' ' 88' ' ' PRO . . . -58.64 -61.51 2.55 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 121.174 0.511 . . . . 0.0 111.263 177.444 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 82.5 mtp180 -65.39 -26.32 67.94 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.738 -177.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -68.71 -43.06 76.79 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.748 177.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -71.98 -37.27 69.91 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 -178.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -55.73 -51.96 65.53 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 121.917 0.865 . . . . 0.0 109.409 172.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 35.2 ttt180 -56.16 -37.1 69.07 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 114.347 -1.297 . . . . 0.0 110.676 174.004 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -61.69 -52.57 49.88 Favored Glycine 0 C--N 1.332 0.315 0 CA-C-N 115.853 -0.612 . . . . 0.0 112.446 178.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.408 HG13 ' HD2' ' A' ' 83' ' ' TYR . 11.3 p -67.09 -28.72 43.71 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.151 0 CA-C-O 121.001 0.429 . . . . 0.0 109.961 179.233 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . 0.406 HH11 ' HD3' ' A' ' 118' ' ' ARG . 0.0 OUTLIER -58.88 -55.33 36.55 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 176.932 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 59.8 tttm -66.68 -35.29 79.79 Favored 'General case' 0 C--O 1.227 -0.095 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.315 179.356 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -56.6 -58.26 8.84 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 121.132 0.492 . . . . 0.0 110.539 178.441 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.49 HD11 HD13 ' A' ' 81' ' ' LEU . 47.5 mm -63.2 -29.67 47.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.2 178.516 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . 0.812 ' HA ' ' HA ' ' A' ' 126' ' ' GLU . 42.3 tt0 -64.37 -46.31 83.95 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.42 176.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -63.19 -34.23 77.18 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 121.197 0.522 . . . . 0.0 109.643 177.628 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.566 HD22 ' HG3' ' A' ' 79' ' ' LYS . 63.0 tp -64.63 -63.52 1.11 Allowed 'General case' 0 C--O 1.235 0.332 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.047 177.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.482 ' O ' HG12 ' A' ' 125' ' ' ILE . 12.3 tt -163.5 26.14 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.722 0 CA-C-O 121.128 0.489 . . . . 0.0 110.924 -175.789 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.812 ' HA ' ' HA ' ' A' ' 122' ' ' GLU . 35.4 tt0 . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.413 -0.803 . . . . 0.0 111.151 -178.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 20.2 m . . . . . 0 CA--C 1.534 0.351 0 CA-C-O 121.274 0.559 . . . . 0.0 110.633 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -53.53 135.5 39.98 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.668 176.213 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.738 HD11 ' HB2' ' A' ' 47' ' ' LYS . 38.6 pt -91.84 -27.94 4.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 170.805 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.552 HG21 HG13 ' A' ' 15' ' ' ILE . 67.1 t -137.4 137.92 45.49 Favored 'Isoleucine or valine' 0 C--O 1.232 0.142 0 CA-C-N 114.965 -1.016 . . . . 0.0 108.994 177.682 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 32.2 ptt180 -147.22 134.37 20.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.835 0.35 . . . . 0.0 110.289 178.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 29.1 m -133.67 174.31 13.36 Favored 'Isoleucine or valine' 0 C--O 1.237 0.415 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.523 -177.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -129.84 121.16 26.19 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 179.207 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -169.84 -174.27 1.78 Allowed 'General case' 0 C--O 1.232 0.182 0 CA-C-O 120.776 0.322 . . . . 0.0 111.249 -176.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.423 HG11 ' O ' ' A' ' 38' ' ' GLY . 87.6 t -92.25 142.49 13.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.022 178.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.432 HG12 HG21 ' A' ' 43' ' ' VAL . 27.4 m -117.42 134.23 61.69 Favored 'Isoleucine or valine' 0 C--O 1.237 0.411 0 CA-C-O 121.308 0.575 . . . . 0.0 111.476 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' MET . . . . . 0.638 ' SD ' ' HG3' ' A' ' 34' ' ' PRO . 24.7 mmt -119.04 169.52 9.83 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.058 -0.974 . . . . 0.0 109.052 178.385 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 8.9 t -153.64 157.25 39.35 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 174.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 41.1 ttp180 -128.41 111.17 13.03 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 178.434 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.575 ' H ' ' HE1' ' A' ' 33' ' ' PHE . 38.1 t70 -61.52 97.93 0.08 Allowed 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 179.17 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.539 ' HB3' ' NH1' ' A' ' 98' ' ' ARG . 1.6 p30 46.59 -75.99 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.293 1.037 . . . . 0.0 111.994 -169.208 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.447 ' N ' ' O ' ' A' ' 26' ' ' ASP . 69.3 m -141.13 152.04 44.4 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 110.092 -0.336 . . . . 0.0 110.092 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 21.1 m 67.16 167.8 0.24 Allowed 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.435 -179.147 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 115.07 -6.44 21.72 Favored Glycine 0 N--CA 1.453 -0.212 0 N-CA-C 111.684 -0.566 . . . . 0.0 111.684 -177.197 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 59.07 27.05 61.91 Favored Glycine 0 C--N 1.334 0.432 0 C-N-CA 121.653 -0.308 . . . . 0.0 112.986 179.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . 0.55 ' CH2' ' HB3' ' A' ' 99' ' ' LYS . 89.2 m95 57.91 98.12 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 121.439 0.638 . . . . 0.0 110.873 -176.516 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.575 ' HE1' ' H ' ' A' ' 26' ' ' ASP . 40.1 p90 -103.16 138.22 19.48 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.906 -175.183 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.638 ' HG3' ' SD ' ' A' ' 23' ' ' MET . 5.1 Cg_exo -79.23 115.43 3.48 Favored 'Trans proline' 0 N--CA 1.457 -0.665 0 C-N-CA 122.452 2.101 . . . . 0.0 110.865 172.593 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -65.88 -162.71 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.836 176.04 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -46.54 -39.14 10.41 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 112.724 0.638 . . . . 0.0 112.724 -176.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -72.63 -115.29 0.06 OUTLIER Glycine 0 CA--C 1.519 0.285 0 N-CA-C 111.591 -0.604 . . . . 0.0 111.591 176.347 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.423 ' O ' HG11 ' A' ' 21' ' ' VAL . . . 82.45 -67.09 3.77 Favored Glycine 0 C--N 1.329 0.193 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.104 174.455 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -66.81 80.22 0.13 Allowed Glycine 0 CA--C 1.519 0.291 0 C-N-CA 121.507 -0.378 . . . . 0.0 112.601 -178.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.453 ' O ' ' HG2' ' A' ' 66' ' ' GLN . 50.8 mm 63.64 82.15 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 CA-C-O 121.556 0.693 . . . . 0.0 111.155 178.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 49.1 m -99.98 148.33 24.63 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.114 178.201 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.415 HH21 ' CD ' ' A' ' 64' ' ' GLU . 7.4 tmm_? -98.83 99.89 11.02 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 -177.718 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.432 HG21 HG12 ' A' ' 22' ' ' VAL . 50.2 t -120.93 155.16 24.5 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.931 -171.22 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -173.3 -163.5 27.06 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 121.143 -0.551 . . . . 0.0 112.239 176.413 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 61.6 t -130.34 139.73 50.63 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 CA-C-O 120.868 0.366 . . . . 0.0 110.79 -177.119 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 47.2 t -119.96 131.78 55.3 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 173.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.738 ' HB2' HD11 ' A' ' 15' ' ' ILE . 84.9 tttt -83.39 118.72 23.91 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.795 0.331 . . . . 0.0 111.021 -174.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 49.1 t -78.85 126.37 38.81 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.227 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' MET . . . . . 0.703 ' HA ' ' HE1' ' A' ' 49' ' ' MET . 16.0 mmt . . . . . 0 C--N 1.328 -0.363 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.085 -177.272 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.179 0 N-CA-C 112.011 -0.435 . . . . 0.0 112.011 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -140.18 117.55 11.38 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.986 0.422 . . . . 0.0 110.877 -179.04 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.539 ' HG ' ' HD1' ' A' ' 76' ' ' TYR . 0.5 OUTLIER -87.31 102.85 14.9 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 175.29 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.755 ' HB ' ' HB3' ' A' ' 75' ' ' CYS . 63.5 mt -76.89 116.16 19.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 172.195 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 5.6 t-80 -127.55 141.44 51.64 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 -172.264 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -136.66 115.02 1.22 Allowed Glycine 0 C--N 1.333 0.383 0 C-N-CA 120.914 -0.66 . . . . 0.0 113.335 -174.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.415 ' CD ' HH21 ' A' ' 42' ' ' ARG . 41.7 tt0 -81.02 144.14 32.0 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 122.81 0.444 . . . . 0.0 110.606 178.352 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.459 ' HG2' HG12 ' A' ' 72' ' ' VAL . 0.2 OUTLIER -51.59 -56.07 15.6 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 115.682 -0.69 . . . . 0.0 112.208 -173.875 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.453 ' HG2' ' O ' ' A' ' 40' ' ' ILE . 0.0 OUTLIER -172.52 -77.15 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 -175.526 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 57.6 tttp -117.24 -46.15 2.71 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.39 178.076 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -69.16 132.1 46.01 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.101 174.13 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 23.5 mtpp -74.23 97.12 2.9 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.486 -177.56 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 51.0 tp -146.56 135.56 22.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.936 -179.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 26.8 t -81.44 95.18 2.75 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.937 -176.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.459 HG12 ' HG2' ' A' ' 65' ' ' ARG . 15.8 m -93.24 -37.72 8.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.058 179.362 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -125.06 143.03 51.12 Favored 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 109.819 -0.438 . . . . 0.0 109.819 176.188 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -159.82 165.12 32.96 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.301 173.154 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' CYS . . . . . 0.755 ' HB3' ' HB ' ' A' ' 61' ' ' ILE . 31.6 t -164.76 103.21 0.8 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.74 -0.663 . . . . 0.0 109.659 -177.153 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.539 ' HD1' ' HG ' ' A' ' 60' ' ' LEU . 57.0 t80 -81.99 99.79 9.32 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.017 -179.142 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.473 HG12 ' O ' ' A' ' 80' ' ' ASP . 95.6 t -90.74 98.16 8.03 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 N-CA-C 109.049 -0.722 . . . . 0.0 109.049 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 16.9 tpt180 -75.37 -42.82 53.16 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 -178.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.605 ' HA ' HD12 ' A' ' 124' ' ' LEU . 24.1 ttpp -173.61 29.75 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.226 174.419 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . 0.473 ' O ' HG12 ' A' ' 77' ' ' VAL . 23.1 t70 -144.22 129.69 18.97 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 178.249 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.5 HD22 ' CD1' ' A' ' 83' ' ' TYR . 8.4 tt -156.09 128.39 7.62 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 -173.413 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 61.6 t -132.64 101.27 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.255 -179.248 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.538 ' HB3' ' NE2' ' A' ' 91' ' ' HIS . 8.1 m-85 -96.34 156.65 16.25 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.023 0.439 . . . . 0.0 110.416 172.531 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 86.0 m -157.82 135.85 10.82 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 176.204 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.444 ' HB3' ' CG ' ' A' ' 91' ' ' HIS . 19.1 ptmt -128.81 141.51 51.28 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.218 0.532 . . . . 0.0 111.397 -179.286 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -100.46 -39.31 8.01 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.581 177.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -126.62 151.31 72.97 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 115.415 -0.811 . . . . 0.0 108.919 178.244 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -46.0 -36.81 16.54 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 122.503 2.135 . . . . 0.0 112.173 178.079 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 17.9 p -83.91 -42.01 16.78 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 115.573 -0.739 . . . . 0.0 111.48 178.071 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 68.1 t80 -85.43 92.11 8.4 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-O 120.947 0.403 . . . . 0.0 110.359 -177.615 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' HIS . . . . . 0.538 ' NE2' ' HB3' ' A' ' 83' ' ' TYR . 4.7 t-160 -121.79 118.75 29.78 Favored 'General case' 0 N--CA 1.462 0.17 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 176.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 25.4 p80 -120.03 175.47 5.9 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.654 0.264 . . . . 0.0 110.482 -177.008 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . 0.477 ' HZ3' ' HB2' ' A' ' 102' ' ' LEU . 36.5 p90 -146.36 155.1 42.37 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.02 175.578 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 28.9 ttpt -120.28 122.34 40.65 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.784 -179.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.516 ' O ' ' N ' ' A' ' 97' ' ' ASN . 28.5 m -93.09 142.78 12.68 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 N-CA-C 106.294 -1.743 . . . . 0.0 106.294 160.689 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -60.35 77.66 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.066 0.46 . . . . 0.0 110.692 -177.026 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.561 ' O ' ' HD2' ' A' ' 98' ' ' ARG . 0.2 OUTLIER 169.82 -51.52 0.01 OUTLIER 'General case' 0 C--O 1.234 0.28 0 CA-C-N 115.085 -0.961 . . . . 0.0 109.856 -176.059 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.561 ' HD2' ' O ' ' A' ' 97' ' ' ASN . 0.6 OUTLIER -141.81 155.39 45.58 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.929 -175.304 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.55 ' HB3' ' CH2' ' A' ' 32' ' ' TRP . 89.2 mttt -112.88 116.3 29.81 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.047 173.629 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 27.2 m-85 -103.24 135.46 44.84 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 178.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -112.31 146.37 18.13 Favored Glycine 0 N--CA 1.453 -0.218 0 C-N-CA 121.155 -0.545 . . . . 0.0 112.83 -176.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.477 ' HB2' ' HZ3' ' A' ' 93' ' ' TRP . 2.8 tt -124.71 116.68 22.73 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 176.674 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' THR . . . . . 0.42 ' HB ' ' HB ' ' A' ' 21' ' ' VAL . 35.1 m -104.83 103.07 12.6 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.162 178.337 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.4 ' HB3' ' OD2' ' A' ' 109' ' ' ASP . 74.2 m-85 -65.37 163.28 15.93 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.22 -178.551 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 18.9 pt20 -102.56 -26.59 13.17 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.301 -176.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 19.4 m -147.41 150.17 36.61 Favored Pre-proline 0 CA--C 1.534 0.354 0 CA-C-O 120.439 0.162 . . . . 0.0 110.723 179.374 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -51.56 -27.46 25.41 Favored 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 122.97 2.447 . . . . 0.0 112.732 177.435 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -61.04 -63.0 1.44 Allowed 'General case' 0 C--O 1.237 0.436 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.001 178.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.4 ' OD2' ' HB3' ' A' ' 104' ' ' PHE . 1.5 p-10 -64.4 -34.67 78.71 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.86 179.845 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -57.99 -60.74 3.26 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.056 0.455 . . . . 0.0 110.822 176.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 61.5 ttt180 -61.22 -36.65 80.51 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.507 -176.615 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -62.63 -45.18 94.05 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-N 115.58 -0.737 . . . . 0.0 110.61 178.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 38.9 t80 -76.27 -26.38 55.89 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.469 -178.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 46.6 m-20 -59.67 -56.01 27.29 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 173.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 90.5 mtt180 -64.62 -27.66 69.09 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.154 174.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . 0.465 ' HA2' ' NZ ' ' A' ' 119' ' ' LYS . . . -59.7 -58.8 12.38 Favored Glycine 0 N--CA 1.45 -0.417 0 CA-C-N 115.834 -0.621 . . . . 0.0 112.065 176.589 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.496 ' O ' HG13 ' A' ' 121' ' ' ILE . 9.0 p -65.66 -33.92 66.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 110.404 -0.221 . . . . 0.0 110.404 -179.302 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 43.6 ttm180 -59.78 -54.06 50.66 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.619 -0.264 . . . . 0.0 110.605 177.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.465 ' NZ ' ' HA2' ' A' ' 116' ' ' GLY . 25.0 pttm -69.33 -24.11 63.87 Favored 'General case' 0 CA--C 1.528 0.128 0 CA-C-O 120.841 0.353 . . . . 0.0 110.261 -179.739 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -67.2 -43.4 82.18 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.119 174.24 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.496 HG13 ' O ' ' A' ' 117' ' ' VAL . 79.7 mt -62.63 -41.63 92.94 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.168 0 CA-C-N 116.314 -0.403 . . . . 0.0 109.916 177.018 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -58.4 -43.83 88.73 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.132 174.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 40.7 t0 -75.51 -19.82 59.12 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.539 -177.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.605 HD12 ' HA ' ' A' ' 79' ' ' LYS . 55.2 tp -88.35 -39.1 14.59 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.647 -178.779 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 61.1 mt -112.23 -39.84 3.49 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 N-CA-C 111.801 0.297 . . . . 0.0 111.801 -172.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.323 -0.846 . . . . 0.0 110.226 -174.714 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 16.8 m . . . . . 0 N--CA 1.453 -0.285 0 CA-C-O 120.926 0.393 . . . . 0.0 110.925 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.442 ' HA ' ' HB3' ' A' ' 46' ' ' CYS . 67.5 m-85 -141.85 153.28 44.35 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.704 175.742 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.477 HG23 HG23 ' A' ' 16' ' ' VAL . 52.2 mt -108.35 -63.67 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.714 0.292 . . . . 0.0 110.371 178.106 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.477 HG23 HG23 ' A' ' 15' ' ' ILE . 60.0 t -114.94 113.08 42.6 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.517 -178.604 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 36.8 mtp180 -110.47 99.41 8.41 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.671 175.005 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 16.8 m -128.8 162.27 36.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.759 0.314 . . . . 0.0 110.769 -179.175 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.47 ' HE2' ' HA ' ' A' ' 40' ' ' ILE . 46.3 tttm -97.19 137.74 35.76 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.918 -176.792 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -159.04 -175.74 5.45 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-N 115.958 -0.564 . . . . 0.0 109.768 177.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.418 HG21 ' HA2' ' A' ' 39' ' ' GLY . 38.4 t -107.72 100.78 11.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.583 -0.281 . . . . 0.0 110.476 177.452 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.607 HG21 ' NE2' ' A' ' 35' ' ' GLN . 13.6 m -65.39 127.12 25.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.611 177.511 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 19.6 mmt -122.9 149.74 43.83 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.206 -175.131 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.431 HG23 ' CE1' ' A' ' 33' ' ' PHE . 12.7 t -122.31 171.75 8.81 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.051 175.373 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.479 ' HG3' ' H ' ' A' ' 27' ' ' ASP . 14.4 tpt180 -120.1 144.28 47.7 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.656 -178.367 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -79.93 11.91 3.04 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.862 179.64 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.479 ' H ' ' HG3' ' A' ' 25' ' ' ARG . 19.2 t70 63.85 156.73 0.07 Allowed 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.857 -173.779 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 47.8 t 56.58 -116.28 0.97 Allowed 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 -173.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 50.8 m -155.3 100.76 2.17 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 118.056 0.389 . . . . 0.0 111.525 177.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -131.35 -35.22 0.38 Allowed Glycine 0 C--N 1.329 0.183 0 N-CA-C 111.33 -0.708 . . . . 0.0 111.33 171.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 153.72 132.01 1.64 Allowed Glycine 0 CA--C 1.519 0.315 0 N-CA-C 112.117 -0.393 . . . . 0.0 112.117 176.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . 0.422 ' HZ3' ' HA ' ' A' ' 100' ' ' PHE . 69.1 m95 -67.88 138.18 55.84 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 176.689 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.431 ' CE1' HG23 ' A' ' 24' ' ' THR . 4.6 p90 -145.62 152.55 49.38 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 116.85 -0.159 . . . . 0.0 110.737 -175.375 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -82.67 117.15 2.64 Favored 'Trans proline' 0 N--CA 1.461 -0.424 0 C-N-CA 122.446 2.097 . . . . 0.0 112.042 176.182 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . 0.607 ' NE2' HG21 ' A' ' 22' ' ' VAL . 4.3 pm0 -53.32 -38.7 63.42 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.315 176.397 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -161.96 160.22 27.48 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.069 178.242 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 76.51 -72.53 1.95 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 121.361 -0.447 . . . . 0.0 111.992 178.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 69.43 29.6 71.61 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 121.143 -0.551 . . . . 0.0 112.692 179.282 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.418 ' HA2' HG21 ' A' ' 21' ' ' VAL . . . -177.28 -72.09 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.216 179.629 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.536 ' N ' HD13 ' A' ' 40' ' ' ILE . 3.0 mp -92.11 103.72 14.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.694 0.283 . . . . 0.0 110.618 -176.837 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.583 ' HA ' ' O ' ' A' ' 65' ' ' ARG . 30.0 m -146.62 127.41 14.38 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.236 -0.438 . . . . 0.0 109.821 172.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.448 ' O ' ' HG3' ' A' ' 42' ' ' ARG . 14.1 ptt180 -92.01 116.67 29.12 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 121.201 0.524 . . . . 0.0 110.092 179.424 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 40.4 t -95.29 128.92 46.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.626 178.417 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -123.25 108.99 1.27 Allowed Glycine 0 N--CA 1.448 -0.562 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.774 -178.402 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 7.6 p -92.14 130.98 40.45 Favored 'Isoleucine or valine' 0 C--O 1.238 0.496 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 175.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . 0.679 ' SG ' ' HB3' ' A' ' 60' ' ' LEU . 15.3 p -131.97 130.18 41.15 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.839 -178.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -92.35 86.54 5.73 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 175.324 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 30.8 m -80.25 159.5 4.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.399 -178.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 25.2 ptm . . . . . 0 C--N 1.324 -0.508 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.778 179.946 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.331 0 N-CA-C 111.006 -0.838 . . . . 0.0 111.006 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.543 ' HB2' ' HB ' ' A' ' 77' ' ' VAL . 83.8 m-85 -107.02 98.41 8.07 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 117.015 0.408 . . . . 0.0 110.353 -177.059 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.709 HD22 ' HB2' ' A' ' 62' ' ' HIS . 0.9 OUTLIER -78.35 106.04 10.01 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 179.633 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.484 HG12 HG21 ' A' ' 77' ' ' VAL . 50.8 mm -84.25 96.26 4.38 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 173.781 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . 0.709 ' HB2' HD22 ' A' ' 60' ' ' LEU . 21.0 t-80 -119.21 150.87 39.35 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.313 -175.618 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -141.83 123.93 2.35 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 121.297 -0.478 . . . . 0.0 112.099 -178.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -99.37 149.89 22.71 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 177.521 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.583 ' O ' ' HA ' ' A' ' 41' ' ' SER . 3.1 tmm_? -58.24 -73.22 0.08 Allowed 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 109.09 -0.708 . . . . 0.0 109.09 176.012 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.495 ' HB2' ' O ' ' A' ' 65' ' ' ARG . 6.6 tp-100 169.38 132.3 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 123.111 0.564 . . . . 0.0 109.564 175.591 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt 68.04 -67.98 0.18 Allowed 'General case' 0 N--CA 1.465 0.302 0 O-C-N 123.794 0.684 . . . . 0.0 110.842 -179.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -74.21 128.47 35.61 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 110.109 -0.33 . . . . 0.0 110.109 177.187 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 12.5 mptt -67.2 78.21 0.14 Allowed 'General case' 0 C--O 1.236 0.385 0 CA-C-O 121.061 0.458 . . . . 0.0 110.42 -179.535 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 58.0 tp -116.37 116.84 28.44 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.113 -179.051 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 48.8 t -72.59 101.5 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.414 -179.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 27.3 m -96.84 -14.43 7.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.782 177.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.451 HD23 ' N ' ' A' ' 74' ' ' GLU . 2.2 tt -157.43 130.41 7.63 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 177.664 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.451 ' N ' HD23 ' A' ' 73' ' ' LEU . 4.1 tm-20 -145.59 127.02 14.98 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 177.675 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' CYS . . . . . 0.406 ' HB2' ' HE2' ' A' ' 100' ' ' PHE . 48.5 t -160.72 91.03 0.88 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.463 0.649 . . . . 0.0 109.856 177.468 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.474 ' HD1' ' HG ' ' A' ' 60' ' ' LEU . 82.3 t80 -67.4 118.32 10.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.454 -0.793 . . . . 0.0 110.79 179.638 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.761 HG23 HD12 ' A' ' 81' ' ' LEU . 62.0 t -77.34 94.5 1.35 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.356 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 176.111 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.421 ' O ' ' HB2' ' A' ' 79' ' ' LYS . 15.1 ptt180 -78.83 35.76 0.25 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.717 179.052 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.676 ' HA ' HD12 ' A' ' 124' ' ' LEU . 59.5 mttp 67.91 13.64 9.21 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 123.16 0.584 . . . . 0.0 110.721 -169.027 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -135.19 96.73 3.55 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 115.989 -0.55 . . . . 0.0 109.898 178.177 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.761 HD12 HG23 ' A' ' 77' ' ' VAL . 7.1 tt -177.89 137.6 0.19 Allowed 'General case' 0 C--O 1.233 0.212 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 179.697 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.512 ' N ' HD21 ' A' ' 81' ' ' LEU . 40.6 t -126.19 122.52 61.71 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 CA-C-O 120.507 0.194 . . . . 0.0 111.075 -176.482 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.448 ' CG ' HG21 ' A' ' 117' ' ' VAL . 7.4 m-85 -84.52 172.8 11.34 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-O 121.284 0.564 . . . . 0.0 111.231 176.738 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 87.0 m -153.99 101.82 2.45 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.89 177.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -79.85 93.53 5.66 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 174.604 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -83.9 -59.22 2.48 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.536 -175.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . 0.461 ' HB2' ' HB3' ' A' ' 90' ' ' PHE . 10.5 m120 -113.11 155.44 44.33 Favored Pre-proline 0 C--N 1.327 -0.385 0 N-CA-C 109.171 -0.678 . . . . 0.0 109.171 -179.196 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_exo -53.59 -19.18 13.31 Favored 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 122.658 2.238 . . . . 0.0 113.034 -179.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.427 ' HA ' ' HD2' ' A' ' 104' ' ' PHE . 15.3 t -121.05 -1.31 9.84 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 120.836 0.35 . . . . 0.0 111.448 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.461 ' HB3' ' HB2' ' A' ' 87' ' ' ASN . 78.0 t80 -120.84 114.67 21.94 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-O 121.007 0.432 . . . . 0.0 110.544 -176.254 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 2.0 t-160 -133.0 112.91 12.23 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 -176.066 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . 0.575 ' HA ' ' HA3' ' A' ' 101' ' ' GLY . 11.6 p80 -125.73 -178.42 4.26 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 -178.461 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 49.4 p90 -146.02 164.83 30.86 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.201 173.468 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 14.4 tmtt? -146.32 130.14 17.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.222 -177.097 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 30.8 m -136.49 147.11 27.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.738 -0.665 . . . . 0.0 109.388 176.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 18.7 t70 59.93 -89.86 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.447 0 O-C-N 123.235 0.334 . . . . 0.0 110.414 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 59.1 t30 -148.21 10.62 0.89 Allowed 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 121.685 0.755 . . . . 0.0 109.415 175.111 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 73.3 mtp180 -109.49 131.87 54.66 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.296 -176.283 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.547 ' HD3' ' N ' ' A' ' 99' ' ' LYS . 0.0 OUTLIER -127.66 127.54 43.93 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.567 -178.062 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . 0.422 ' HA ' ' HZ3' ' A' ' 32' ' ' TRP . 4.9 p90 -156.01 164.06 38.93 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.527 -0.761 . . . . 0.0 109.004 177.295 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . 0.575 ' HA3' ' HA ' ' A' ' 92' ' ' HIS . . . -173.94 -135.35 2.01 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.401 -0.904 . . . . 0.0 112.703 -175.611 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 2.2 pp -159.69 175.28 13.36 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 121.339 0.59 . . . . 0.0 111.746 -178.195 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 91.2 m -130.02 140.49 50.87 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.114 176.249 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.427 ' HD2' ' HA ' ' A' ' 89' ' ' THR . 23.7 m-85 -83.18 166.38 18.67 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.324 0.583 . . . . 0.0 111.389 -174.407 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 21.6 tt0 -123.19 -57.31 1.69 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.822 175.34 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 18.8 m -118.66 149.46 46.38 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.345 -176.023 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -53.2 -20.77 15.26 Favored 'Trans proline' 0 C--N 1.352 0.744 0 C-N-CA 122.587 2.191 . . . . 0.0 112.476 179.016 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -62.37 -66.6 0.52 Allowed 'General case' 0 C--O 1.235 0.329 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.523 175.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -63.19 -39.23 94.06 Favored 'General case' 0 C--O 1.231 0.101 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.764 -179.604 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . 0.424 ' HA ' ' CD1' ' A' ' 104' ' ' PHE . . . -52.61 -58.99 5.04 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-O 121.387 0.613 . . . . 0.0 111.174 177.008 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 69.7 ttt180 -66.59 -29.26 69.27 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.466 -178.141 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -64.95 -48.34 74.4 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.194 179.685 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 58.4 m-85 -67.27 -46.8 72.57 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 116.698 -0.228 . . . . 0.0 110.577 179.072 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -53.18 -64.99 0.64 Allowed 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 121.235 0.54 . . . . 0.0 110.773 178.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 41.8 ttm180 -57.3 -38.16 73.57 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 114.938 -1.028 . . . . 0.0 110.799 177.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -56.76 -58.2 15.67 Favored Glycine 0 C--N 1.331 0.252 0 CA-C-N 115.955 -0.566 . . . . 0.0 112.484 -177.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.448 HG21 ' CG ' ' A' ' 83' ' ' TYR . 7.6 p -69.03 -36.88 75.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.532 0.206 . . . . 0.0 110.803 -178.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 25.1 ttt180 -60.72 -42.77 97.92 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.738 -0.468 . . . . 0.0 109.738 -179.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 7.4 mmtt -74.96 -30.05 61.1 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.659 178.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -62.71 -47.92 81.51 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 176.387 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 72.2 mt -66.32 -40.57 87.11 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.037 177.128 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -55.74 -48.31 75.47 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.397 178.64 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -74.94 -35.18 62.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.037 -178.408 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.676 HD12 ' HA ' ' A' ' 79' ' ' LYS . 6.3 tt -62.02 -50.23 72.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.28 -178.164 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 60.8 mt -83.12 -40.32 16.17 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.865 -177.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 . . . . . 0 C--O 1.251 1.142 0 CA-C-O 118.311 -0.852 . . . . 0.0 110.544 -177.281 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 20.8 m . . . . . 0 N--CA 1.465 0.316 0 N-CA-C 111.8 0.296 . . . . 0.0 111.8 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.422 ' HA ' ' HA ' ' A' ' 46' ' ' CYS . 35.8 m-85 -66.14 135.2 54.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.857 0.36 . . . . 0.0 111.878 -179.564 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 50.3 mm -92.36 -40.94 12.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 171.315 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 7.4 p -155.49 136.74 5.27 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 CA-C-N 115.179 -0.919 . . . . 0.0 109.974 178.356 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 22.4 ptt180 -149.52 114.29 5.35 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.818 0.342 . . . . 0.0 110.232 178.053 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 15.0 m -150.09 -170.82 0.17 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.325 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.057 -178.045 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.674 ' HZ1' ' HB3' ' A' ' 19' ' ' LYS . 5.9 ttpm? -87.57 132.69 33.97 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.592 179.343 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.485 ' O ' ' HB2' ' A' ' 41' ' ' SER . . . -157.45 -178.22 7.18 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.178 -0.465 . . . . 0.0 109.846 176.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.569 ' HB ' ' HB ' ' A' ' 103' ' ' THR . 38.2 t -112.53 107.77 23.82 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 CA-C-N 116.647 -0.252 . . . . 0.0 110.841 -179.625 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 11.9 m -73.94 96.48 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 CA-C-O 121.368 0.604 . . . . 0.0 110.279 175.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 91.9 mmm -82.92 119.41 24.38 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.772 -176.486 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.446 HG21 ' CE1' ' A' ' 33' ' ' PHE . 10.0 t -93.9 171.16 9.04 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.055 176.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 14.4 ttp180 -133.46 21.47 3.98 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 178.483 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.421 ' HB3' ' CB ' ' A' ' 29' ' ' SER . 35.6 t70 50.68 36.81 14.98 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 114.778 -1.101 . . . . 0.0 110.536 179.748 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 34.1 t70 61.98 83.21 0.16 Allowed 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.542 -179.528 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 24.2 p 50.1 27.35 2.49 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 115.277 -0.874 . . . . 0.0 112.894 178.009 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.421 ' CB ' ' HB3' ' A' ' 26' ' ' ASP . 32.4 t -70.17 -36.16 74.5 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-O 120.653 0.263 . . . . 0.0 110.981 -178.891 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 150.79 -91.77 0.14 Allowed Glycine 0 C--N 1.332 0.351 0 C-N-CA 120.918 -0.658 . . . . 0.0 112.535 178.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -81.99 163.26 43.42 Favored Glycine 0 CA--C 1.518 0.279 0 C-N-CA 121.199 -0.524 . . . . 0.0 112.683 -178.775 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . 0.453 ' HZ2' ' HE2' ' A' ' 99' ' ' LYS . 74.6 m95 -93.57 147.8 22.67 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-O 120.732 0.301 . . . . 0.0 110.803 -179.337 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.446 ' CE1' HG21 ' A' ' 24' ' ' THR . 6.8 p90 -156.34 150.34 19.58 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.896 176.827 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_exo -63.27 139.8 73.81 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.589 2.193 . . . . 0.0 111.893 176.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 22.1 pt20 -105.64 131.73 52.66 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.604 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 16.0 tp10 64.36 -73.06 0.06 Allowed 'General case' 0 CA--C 1.533 0.312 0 O-C-N 123.851 0.719 . . . . 0.0 111.063 -179.581 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.452 ' HA3' ' OE1' ' A' ' 66' ' ' GLN . . . -148.65 109.74 0.46 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 121.173 -0.536 . . . . 0.0 111.912 179.726 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.434 ' O ' HG22 ' A' ' 21' ' ' VAL . . . -89.88 5.29 83.42 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 121.393 -0.432 . . . . 0.0 112.539 -178.42 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -81.62 -41.34 9.95 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.945 -0.645 . . . . 0.0 111.802 178.27 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.515 HD13 ' HG3' ' A' ' 19' ' ' LYS . 3.7 tp -143.54 91.95 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 CA-C-O 121.426 0.632 . . . . 0.0 110.756 -179.753 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.485 ' HB2' ' O ' ' A' ' 20' ' ' ALA . 21.4 m -106.32 119.33 38.98 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 173.188 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.609 ' HB3' ' O ' ' A' ' 64' ' ' GLU . 8.2 tpt85 -77.24 90.3 3.72 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 121.453 0.644 . . . . 0.0 109.419 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 38.8 t -94.87 117.88 39.68 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 CA-C-N 115.241 -0.89 . . . . 0.0 110.345 -177.361 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -129.17 118.3 2.65 Favored Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 121.174 -0.536 . . . . 0.0 111.995 179.655 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 61.4 t -96.04 110.22 24.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 176.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . 0.473 ' SG ' ' HB3' ' A' ' 60' ' ' LEU . 12.3 p -107.96 147.42 31.08 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.583 -179.468 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 10.3 tmtt? -102.03 95.16 6.17 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 176.611 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.568 HG21 ' HE1' ' A' ' 76' ' ' TYR . 35.4 m -71.86 141.94 16.0 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.432 -173.859 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 22.2 mmt . . . . . 0 C--N 1.327 -0.403 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.403 179.391 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.366 0 N-CA-C 111.945 -0.462 . . . . 0.0 111.945 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.43 ' HB2' ' HB ' ' A' ' 77' ' ' VAL . 83.2 m-85 -117.15 161.42 19.47 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.473 ' HB3' ' SG ' ' A' ' 46' ' ' CYS . 2.0 tt -147.07 112.56 5.61 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 176.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.486 ' HB ' ' HB2' ' A' ' 75' ' ' CYS . 59.5 mt -84.78 103.69 12.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 174.206 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 12.5 t-80 -117.25 104.51 11.25 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.038 -169.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -100.6 121.83 7.38 Favored Glycine 0 C--N 1.333 0.415 0 N-CA-C 111.3 -0.72 . . . . 0.0 111.3 177.493 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.609 ' O ' ' HB3' ' A' ' 42' ' ' ARG . 16.1 pt-20 -150.3 -166.82 2.65 Favored 'General case' 0 C--O 1.24 0.588 0 CA-C-O 121.205 0.526 . . . . 0.0 112.37 -170.707 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 29.4 ttt180 74.68 -30.97 0.21 Allowed 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.974 1.31 . . . . 0.0 112.778 170.487 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.706 ' HA ' HE21 ' A' ' 66' ' ' GLN . 0.0 OUTLIER -59.09 131.69 51.8 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 110.232 -0.284 . . . . 0.0 110.232 177.697 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 85.2 tttt 66.07 76.4 0.31 Allowed 'General case' 0 C--O 1.235 0.332 0 O-C-N 123.7 0.625 . . . . 0.0 109.823 -178.553 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 69.65 -86.78 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.005 -0.998 . . . . 0.0 110.99 -176.397 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 28.9 tptp -175.48 98.47 0.07 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.012 0.434 . . . . 0.0 110.467 -176.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -157.89 166.95 31.33 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 172.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 6.2 t -99.13 109.31 24.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-O 120.797 0.332 . . . . 0.0 110.523 -176.698 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 33.9 m -94.48 -6.65 10.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.223 -177.41 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -148.51 117.29 6.67 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 -178.241 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -127.92 124.63 37.82 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.094 177.409 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' CYS . . . . . 0.552 ' SG ' ' CD2' ' A' ' 100' ' ' PHE . 24.6 m -145.96 89.15 1.86 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.407 176.915 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.568 ' HE1' HG21 ' A' ' 48' ' ' VAL . 87.1 t80 -71.9 136.75 47.02 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.554 -0.535 . . . . 0.0 109.554 173.478 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.43 ' HB ' ' HB2' ' A' ' 59' ' ' PHE . 58.3 t -125.31 96.0 3.5 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 CA-C-O 120.943 0.401 . . . . 0.0 110.372 -175.772 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 43.4 ttp180 -84.4 69.07 10.46 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.215 0.531 . . . . 0.0 110.023 179.422 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.594 ' HB3' ' HZ1' ' A' ' 79' ' ' LYS . 8.2 mtpm? 52.92 21.13 1.88 Allowed 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 115.254 -0.885 . . . . 0.0 112.345 179.17 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -125.19 114.08 18.51 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 172.181 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.454 HD13 ' HD2' ' A' ' 83' ' ' TYR . 2.8 tm? -152.97 138.23 17.47 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.601 -170.114 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.458 ' HB ' ' HB3' ' A' ' 94' ' ' LYS . 48.6 t -132.45 88.92 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.8 173.618 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.503 ' HD1' ' HD2' ' A' ' 91' ' ' HIS . 0.3 OUTLIER -85.51 146.58 26.85 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 174.829 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.446 ' HB ' ' CE1' ' A' ' 92' ' ' HIS . 38.3 m -140.69 121.74 14.66 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 177.901 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -83.51 96.0 8.47 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 176.181 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -66.85 -42.63 85.38 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.167 0.508 . . . . 0.0 109.813 179.105 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . 0.67 ' HB2' ' HD2' ' A' ' 88' ' ' PRO . 9.8 p30 -161.41 164.27 18.67 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-N 115.145 -0.934 . . . . 0.0 108.835 177.442 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.67 ' HD2' ' HB2' ' A' ' 87' ' ' ASN . 9.6 Cg_endo -50.26 -22.55 8.52 Favored 'Trans proline' 0 C--N 1.352 0.75 0 C-N-CA 123.264 2.643 . . . . 0.0 114.091 -175.861 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 10.8 p -116.9 15.23 15.22 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 112.409 0.522 . . . . 0.0 112.409 -176.01 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.423 ' HB3' ' ND2' ' A' ' 87' ' ' ASN . 45.4 t80 -152.1 111.62 3.95 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-O 121.152 0.501 . . . . 0.0 111.383 178.924 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' HIS . . . . . 0.503 ' HD2' ' HD1' ' A' ' 83' ' ' TYR . 2.3 m80 -106.81 155.06 20.12 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 169.409 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . 0.446 ' CE1' ' HB ' ' A' ' 84' ' ' THR . 20.6 p80 -146.23 146.98 30.98 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 171.327 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . 0.544 ' CE2' ' HB2' ' A' ' 100' ' ' PHE . 28.4 p90 -123.52 146.21 48.27 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.173 0.511 . . . . 0.0 111.072 -178.778 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.477 ' HE3' ' HA ' ' A' ' 97' ' ' ASN . 3.0 tmtm? -110.25 101.18 9.95 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.051 -0.977 . . . . 0.0 108.83 -178.05 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 28.2 m -137.55 145.82 28.64 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 -179.609 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 27.9 t70 55.26 27.86 10.4 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 121.778 0.799 . . . . 0.0 109.978 -177.524 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.477 ' HA ' ' HE3' ' A' ' 94' ' ' LYS . 64.6 t30 74.88 -15.44 0.65 Allowed 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 114.66 -1.155 . . . . 0.0 111.633 -179.116 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 33.7 ttm180 -89.98 156.41 18.44 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.701 0.286 . . . . 0.0 110.462 -177.155 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.453 ' HE2' ' HZ2' ' A' ' 32' ' ' TRP . 62.0 mtpt -116.14 133.53 55.92 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.219 -178.62 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . 0.552 ' CD2' ' SG ' ' A' ' 75' ' ' CYS . 31.0 m-85 -128.81 139.51 52.14 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 175.577 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -110.8 163.56 12.28 Favored Glycine 0 N--CA 1.453 -0.183 0 C-N-CA 121.291 -0.48 . . . . 0.0 112.417 -178.315 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.407 ' HB2' ' HZ3' ' A' ' 93' ' ' TRP . 31.3 tp -146.91 112.8 5.74 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 110.145 -0.317 . . . . 0.0 110.145 -178.723 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' THR . . . . . 0.569 ' HB ' ' HB ' ' A' ' 21' ' ' VAL . 84.1 m -92.79 134.17 35.32 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 176.312 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.456 ' HE2' ' HD1' ' A' ' 91' ' ' HIS . 46.9 m-85 -90.97 137.98 31.95 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.243 -178.816 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . 0.533 ' OE1' ' HG2' ' A' ' 19' ' ' LYS . 52.7 mt-30 -102.78 -26.39 13.17 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.637 -173.727 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 49.4 m -148.47 159.72 38.16 Favored Pre-proline 0 CA--C 1.536 0.409 0 CA-C-O 120.434 0.159 . . . . 0.0 110.652 -179.667 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . 0.554 ' O ' ' HD3' ' A' ' 111' ' ' ARG . 57.0 Cg_exo -53.48 -34.54 72.44 Favored 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 122.657 2.238 . . . . 0.0 112.413 178.273 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -56.81 -61.27 2.55 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.986 -179.069 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -67.17 -38.41 85.39 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.901 -179.149 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -54.85 -53.05 60.38 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.236 179.231 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . 0.554 ' HD3' ' O ' ' A' ' 107' ' ' PRO . 5.2 mpt_? -71.62 -37.42 70.91 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.555 -178.051 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -59.4 -55.9 28.81 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.638 -179.523 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.439 ' O ' HG23 ' A' ' 117' ' ' VAL . 37.8 m-85 -63.86 -50.24 69.58 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.901 179.718 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.607 ' O ' ' HG2' ' A' ' 118' ' ' ARG . 22.3 t70 -53.01 -67.92 0.21 Allowed 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 121.155 0.502 . . . . 0.0 110.649 -178.934 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 53.1 ttt180 -51.91 -46.31 64.55 Favored 'General case' 0 C--O 1.242 0.691 0 CA-C-N 114.972 -1.013 . . . . 0.0 111.166 -178.107 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -59.52 -42.63 97.75 Favored Glycine 0 C--N 1.334 0.451 0 CA-C-N 115.869 -0.605 . . . . 0.0 112.148 179.133 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.457 ' O ' HG13 ' A' ' 121' ' ' ILE . 41.2 t -66.8 -36.03 76.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 C-N-CA 122.156 0.182 . . . . 0.0 110.698 179.683 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . 0.607 ' HG2' ' O ' ' A' ' 114' ' ' ASP . 8.9 mmm180 -58.53 -56.54 20.8 Favored 'General case' 0 C--O 1.241 0.628 0 CA-C-O 121.277 0.561 . . . . 0.0 109.646 178.164 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 9.8 mmpt? -61.24 -38.97 88.59 Favored 'General case' 0 C--O 1.239 0.507 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.191 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -59.28 -53.93 52.64 Favored 'General case' 0 C--O 1.226 -0.184 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.872 179.654 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.457 HG13 ' O ' ' A' ' 117' ' ' VAL . 73.8 mt -55.09 -45.04 76.9 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 O-C-N 123.236 0.335 . . . . 0.0 110.493 -179.097 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . 0.416 ' O ' ' HB2' ' A' ' 126' ' ' GLU . 50.5 mt-10 -55.3 -55.93 25.88 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.07 178.632 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -69.02 -24.8 64.25 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 121.258 0.552 . . . . 0.0 110.971 -179.145 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.537 ' HG ' ' HA ' ' A' ' 79' ' ' LYS . 9.2 tt -74.14 -46.75 40.52 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.54 -0.754 . . . . 0.0 111.956 -174.901 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.438 HG22 ' O ' ' A' ' 121' ' ' ILE . 18.9 tt -106.57 -33.03 2.66 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 N-CA-C 112.38 0.511 . . . . 0.0 112.38 -173.165 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.416 ' HB2' ' O ' ' A' ' 122' ' ' GLU . 44.1 mt-10 . . . . . 0 C--O 1.248 0.988 0 CA-C-O 118.484 -0.769 . . . . 0.0 110.182 -179.157 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.693 ' HB2' ' SG ' ' A' ' 46' ' ' CYS . 20.3 m . . . . . 0 CA--C 1.535 0.369 0 N-CA-C 111.868 0.322 . . . . 0.0 111.868 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.47 ' CE2' ' HA3' ' A' ' 44' ' ' GLY . 4.1 m-30 -66.4 85.1 0.1 Allowed 'General case' 0 C--O 1.234 0.282 0 CA-C-O 120.85 0.357 . . . . 0.0 110.917 175.555 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.443 HD13 ' HB3' ' A' ' 47' ' ' LYS . 55.0 mt -70.16 -59.0 3.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 175.634 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 62.0 t -110.0 113.62 44.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 177.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.473 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 0.0 OUTLIER -136.63 130.86 32.88 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.772 0.32 . . . . 0.0 110.177 178.171 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 35.1 m -131.83 171.68 17.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.037 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.465 ' HB2' HD12 ' A' ' 40' ' ' ILE . 57.0 pttt -110.44 109.34 19.68 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 177.495 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -157.01 158.26 36.22 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.724 -177.318 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 50.0 t -81.39 111.85 18.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.642 0.258 . . . . 0.0 110.763 -178.579 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.495 HG21 ' NE2' ' A' ' 35' ' ' GLN . 17.1 m -75.26 128.62 37.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.362 176.126 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 87.1 mmm -122.34 166.66 14.33 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 -177.135 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 9.1 t -143.93 164.51 30.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.445 0.64 . . . . 0.0 111.08 178.477 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.527 ' HB3' ' HB2' ' A' ' 99' ' ' LYS . 73.2 ttt180 -150.04 140.02 21.96 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 -179.846 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.534 ' HA ' ' HG2' ' A' ' 98' ' ' ARG . 26.0 t0 -79.15 37.39 0.32 Allowed 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 121.348 0.594 . . . . 0.0 110.322 -177.869 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.462 ' HA ' ' HG3' ' A' ' 99' ' ' LYS . 22.0 t70 63.49 -63.36 0.13 Allowed 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 123.891 0.876 . . . . 0.0 109.715 -171.018 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 22.3 p -68.93 170.8 9.06 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.861 168.719 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 15.7 m 64.78 96.06 0.05 OUTLIER 'General case' 0 CA--C 1.536 0.431 0 CA-C-O 120.984 0.421 . . . . 0.0 111.142 178.346 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -80.59 22.91 4.43 Favored Glycine 0 CA--C 1.519 0.301 0 C-N-CA 121.494 -0.384 . . . . 0.0 113.557 -175.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -80.48 -27.02 53.05 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.949 -0.643 . . . . 0.0 112.458 179.022 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . 0.515 ' CH2' ' HB3' ' A' ' 99' ' ' LYS . 83.4 m95 58.15 101.79 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 121.452 0.644 . . . . 0.0 110.841 -176.312 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 31.1 p90 -101.16 135.51 19.9 Favored Pre-proline 0 CA--C 1.532 0.254 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.915 -174.266 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.529 ' HB2' ' HA3' ' A' ' 38' ' ' GLY . 73.7 Cg_endo -79.05 111.41 2.93 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.694 2.262 . . . . 0.0 112.133 178.756 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . 0.495 ' NE2' HG21 ' A' ' 22' ' ' VAL . 4.7 pm0 -75.69 168.3 20.28 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.36 -179.392 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 62.07 -77.84 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 115.395 -0.821 . . . . 0.0 110.794 177.311 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -148.52 -7.72 0.21 Allowed Glycine 0 CA--C 1.518 0.264 0 C-N-CA 121.252 -0.499 . . . . 0.0 112.558 -179.687 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.529 ' HA3' ' HB2' ' A' ' 34' ' ' PRO . . . 58.08 83.07 0.05 OUTLIER Glycine 0 C--N 1.334 0.462 0 C-N-CA 121.38 -0.438 . . . . 0.0 113.113 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -157.35 174.23 34.84 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 121.039 -0.601 . . . . 0.0 112.007 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.465 HD12 ' HB2' ' A' ' 19' ' ' LYS . 9.2 tt -58.55 129.24 20.38 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 CA-C-O 121.074 0.464 . . . . 0.0 110.081 178.66 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 43.7 t -121.61 146.02 47.4 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.317 0.58 . . . . 0.0 111.705 -170.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.632 ' HB3' ' HB2' ' A' ' 64' ' ' GLU . 19.8 ttt180 -77.61 83.23 4.0 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 114.971 -1.013 . . . . 0.0 108.457 171.752 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.473 ' O ' ' HA ' ' A' ' 17' ' ' ARG . 45.7 t -73.1 92.46 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.466 -175.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.47 ' HA3' ' CE2' ' A' ' 14' ' ' TYR . . . -93.24 95.67 2.01 Favored Glycine 0 N--CA 1.448 -0.565 0 CA-C-N 115.864 -0.607 . . . . 0.0 112.63 -179.467 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 61.4 t -82.14 93.24 2.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-O 121.407 0.623 . . . . 0.0 109.409 176.625 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . 0.693 ' SG ' ' HB2' ' A' ' 13' ' ' SER . 43.0 t -91.45 114.3 26.8 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.547 -177.926 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.443 ' HB3' HD13 ' A' ' 15' ' ' ILE . 40.0 ttmt -75.91 92.6 3.12 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 175.055 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.464 HG23 ' CE1' ' A' ' 76' ' ' TYR . 28.3 m -86.65 170.2 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.571 -174.022 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 26.0 ptm . . . . . 0 C--N 1.326 -0.452 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.233 -179.616 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.193 0 N-CA-C 112.324 -0.31 . . . . 0.0 112.324 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -132.36 139.17 48.02 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.124 0.488 . . . . 0.0 110.583 -179.089 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 3.1 tt -119.82 112.13 18.85 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 176.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.446 ' HB ' ' HB3' ' A' ' 75' ' ' CYS . 44.5 mm -75.94 92.73 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 175.842 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 16.9 t-80 -104.19 93.54 4.89 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.469 -175.725 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -102.21 112.71 4.39 Favored Glycine 0 CA--C 1.518 0.277 0 C-N-CA 121.235 -0.507 . . . . 0.0 112.7 -175.622 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.632 ' HB2' ' HB3' ' A' ' 42' ' ' ARG . 43.5 mm-40 -93.43 162.35 14.01 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.708 0.289 . . . . 0.0 110.82 178.043 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 15.1 ttm180 -82.47 151.78 26.38 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 167.77 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 28.4 mm-40 -59.39 88.03 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 120.884 0.373 . . . . 0.0 110.735 -179.586 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 87.1 tttt 173.76 -21.39 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.173 -0.921 . . . . 0.0 108.981 -176.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 71.24 49.59 0.32 Allowed 'General case' 0 C--O 1.237 0.415 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.384 176.064 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.44 ' O ' ' HB2' ' A' ' 70' ' ' LEU . 11.9 tmtt? -176.0 60.19 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.132 -179.155 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.486 ' O ' ' HA ' ' A' ' 64' ' ' GLU . 54.3 tp 174.2 105.29 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.041 177.757 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 4.0 m -70.73 96.0 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 CA-C-O 121.21 0.529 . . . . 0.0 110.593 174.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 28.6 m -86.99 -9.06 11.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.915 179.649 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.45 ' HB2' HG22 ' A' ' 22' ' ' VAL . 1.5 tm? -159.72 121.1 3.21 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 177.793 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -129.09 122.27 29.57 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 179.328 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' CYS . . . . . 0.446 ' HB3' ' HB ' ' A' ' 61' ' ' ILE . 42.6 t -149.21 87.97 1.56 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.204 0.526 . . . . 0.0 110.572 178.877 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.464 ' CE1' HG23 ' A' ' 48' ' ' VAL . 67.0 t80 -77.26 123.04 25.91 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.146 175.065 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.502 HG11 HD13 ' A' ' 81' ' ' LEU . 17.3 m -133.62 111.64 16.05 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 CA-C-O 121.173 0.511 . . . . 0.0 110.092 177.03 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 16.0 ptm180 -81.25 -17.39 49.64 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.796 -178.222 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.413 ' HA ' HD22 ' A' ' 124' ' ' LEU . 85.6 tttt -172.15 152.69 2.9 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.373 -177.429 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 26.8 t70 71.6 105.25 0.07 Allowed 'General case' 0 N--CA 1.468 0.461 0 O-C-N 123.704 0.627 . . . . 0.0 112.235 173.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.505 HD23 ' N ' ' A' ' 82' ' ' VAL . 4.7 tt -179.37 129.21 0.1 Allowed 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 177.131 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.505 ' N ' HD23 ' A' ' 81' ' ' LEU . 75.6 t -128.02 129.95 69.7 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 N-CA-C 110.33 -0.248 . . . . 0.0 110.33 177.832 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.419 ' CE2' HG23 ' A' ' 117' ' ' VAL . 6.7 m-85 -83.24 159.56 21.94 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.24 0.543 . . . . 0.0 111.024 178.114 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 87.8 m -150.05 135.79 18.43 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.361 177.674 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.552 ' HD2' ' H ' ' A' ' 85' ' ' LYS . 0.0 OUTLIER -105.59 126.51 52.23 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.795 0.331 . . . . 0.0 110.43 -178.617 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.402 ' C ' HD21 ' A' ' 87' ' ' ASN . . . -98.51 -46.08 5.87 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.334 0.588 . . . . 0.0 109.485 175.793 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . 0.794 ' HB2' ' HB3' ' A' ' 90' ' ' PHE . 0.9 OUTLIER -125.17 152.03 70.23 Favored Pre-proline 0 C--N 1.327 -0.411 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 174.387 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -54.32 -25.88 41.07 Favored 'Trans proline' 0 CA--C 1.533 0.47 0 C-N-CA 122.44 2.094 . . . . 0.0 112.431 177.552 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.411 ' HA ' ' HD2' ' A' ' 104' ' ' PHE . 14.3 p -112.82 11.99 19.42 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.746 178.919 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.794 ' HB3' ' HB2' ' A' ' 87' ' ' ASN . 35.4 t80 -136.71 96.89 3.41 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-O 121.266 0.555 . . . . 0.0 109.642 178.111 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -97.36 163.08 13.04 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 176.632 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 28.6 p80 -166.63 169.97 13.07 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.909 0.385 . . . . 0.0 111.233 178.031 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . 0.52 ' CE2' ' HB2' ' A' ' 100' ' ' PHE . 38.8 p90 -149.69 134.94 18.17 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.36 174.539 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 7.7 tmtm? -102.36 116.68 33.14 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.817 -179.482 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.444 HG21 ' H ' ' A' ' 97' ' ' ASN . 34.9 m -105.72 -170.6 0.32 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.398 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.261 179.596 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -54.62 -25.87 29.33 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 122.877 0.471 . . . . 0.0 111.754 -176.707 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.465 ' O ' ' HB2' ' A' ' 98' ' ' ARG . 4.9 p-10 -155.11 131.3 10.26 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.179 -0.464 . . . . 0.0 109.972 177.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.534 ' HG2' ' HA ' ' A' ' 26' ' ' ASP . 57.7 mtt180 73.04 162.09 0.26 Allowed 'General case' 0 C--O 1.236 0.354 0 CA-C-O 122.071 0.939 . . . . 0.0 112.237 -173.766 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.527 ' HB2' ' HB3' ' A' ' 25' ' ' ARG . 63.5 mttp -122.35 124.54 43.95 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 114.221 -1.354 . . . . 0.0 108.055 174.623 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . 0.52 ' HB2' ' CE2' ' A' ' 93' ' ' TRP . 1.7 m-85 -101.11 128.87 46.98 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 -177.311 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -111.04 164.17 12.18 Favored Glycine 0 N--CA 1.454 -0.114 0 C-N-CA 121.431 -0.414 . . . . 0.0 112.694 -176.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 7.0 tt -150.24 104.37 3.25 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 -179.65 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 36.6 m -91.84 115.52 28.13 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.013 178.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.411 ' HD2' ' HA ' ' A' ' 89' ' ' THR . 82.1 m-85 -67.35 160.1 27.99 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.616 -175.439 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 8.2 tp-100 -92.6 -42.0 9.91 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.382 -178.518 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 49.5 m -143.65 153.95 58.89 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.402 -179.03 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -52.35 -27.96 33.11 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 122.627 2.218 . . . . 0.0 112.344 177.258 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -60.41 -62.18 2.05 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.159 177.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 -66.02 -29.22 69.55 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.589 179.573 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . 0.401 ' HA ' ' CD1' ' A' ' 104' ' ' PHE . . . -57.8 -57.51 12.45 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.585 175.767 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 62.0 mtp180 -60.94 -49.28 78.07 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.904 -179.317 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -60.75 -49.68 76.51 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.498 -176.174 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 66.0 t80 -71.62 -38.03 70.83 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.707 -177.191 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -55.87 -61.87 2.08 Favored 'General case' 0 C--O 1.24 0.557 0 CA-C-O 121.847 0.832 . . . . 0.0 110.241 178.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 40.7 ttm180 -60.98 -45.88 92.99 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 114.643 -1.162 . . . . 0.0 110.571 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -62.19 -41.45 99.71 Favored Glycine 0 N--CA 1.451 -0.304 0 CA-C-N 115.506 -0.77 . . . . 0.0 112.975 -177.065 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.513 ' O ' HG12 ' A' ' 121' ' ' ILE . 8.1 p -73.98 -33.27 35.9 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-N 116.78 0.29 . . . . 0.0 110.306 -177.228 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 27.5 tpt180 -57.28 -50.32 73.29 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 172.035 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 3.9 tmmm? -57.85 -38.76 76.25 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.725 176.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -65.53 -40.93 93.5 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.254 179.562 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.513 HG12 ' O ' ' A' ' 117' ' ' VAL . 46.0 mm -62.9 -40.76 90.1 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 178.216 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -62.42 -43.87 97.79 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.58 174.518 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -65.75 -23.85 66.82 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.006 179.638 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.413 HD22 ' HA ' ' A' ' 79' ' ' LYS . 5.4 tt -77.98 -52.6 8.56 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.452 179.054 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 61.6 mt -94.62 -47.21 13.38 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 -171.209 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 13.5 tp10 . . . . . 0 C--O 1.243 0.746 0 CA-C-O 118.516 -0.754 . . . . 0.0 110.343 -174.966 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 28.6 m . . . . . 0 CA--C 1.535 0.369 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 76.9 m-85 -67.88 110.25 3.76 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-O 120.829 0.347 . . . . 0.0 110.603 178.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 48.8 mm -83.6 -55.77 6.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.934 -0.575 . . . . 0.0 109.877 178.459 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 61.8 t -122.91 134.3 66.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.376 -178.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 32.8 mtm180 -134.7 94.77 3.23 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 175.04 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 13.6 p -118.02 142.37 32.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.842 0.353 . . . . 0.0 110.882 -177.166 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 64.2 tttm -72.15 131.28 42.58 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.05 -179.42 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -161.7 -164.31 1.09 Allowed 'General case' 0 C--O 1.239 0.52 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.302 179.447 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 61.7 t -124.21 105.7 15.77 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 CA-C-N 116.741 -0.208 . . . . 0.0 110.525 177.303 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.434 HG22 HG21 ' A' ' 72' ' ' VAL . 28.6 m -72.89 116.78 15.53 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 CA-C-O 121.475 0.655 . . . . 0.0 110.761 178.476 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 25.8 mmt -92.22 110.3 21.68 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.22 178.455 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.635 ' O ' ' HG3' ' A' ' 25' ' ' ARG . 7.4 t -83.23 2.53 35.35 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.578 -179.646 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.746 HH11 ' HG3' ' A' ' 25' ' ' ARG . 0.4 OUTLIER 53.37 172.88 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.956 0 N-CA-C 115.397 1.628 . . . . 0.0 115.397 166.449 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.541 ' HB2' ' CE2' ' A' ' 33' ' ' PHE . 36.6 t70 -143.03 6.76 1.57 Allowed 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 114.047 -1.433 . . . . 0.0 109.91 -178.936 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 65.4 m-20 66.24 -86.23 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.404 -178.219 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 22.9 t -151.1 99.95 2.73 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.334 -174.428 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.458 ' HB3' ' OD2' ' A' ' 26' ' ' ASP . 30.5 t 174.9 -54.46 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 177.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -111.26 -41.42 1.16 Allowed Glycine 0 N--CA 1.451 -0.307 0 N-CA-C 110.434 -1.067 . . . . 0.0 110.434 170.575 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 128.07 -109.97 1.09 Allowed Glycine 0 C--N 1.333 0.374 0 C-N-CA 121.578 -0.344 . . . . 0.0 112.675 175.122 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . 0.709 ' CE3' ' HB3' ' A' ' 25' ' ' ARG . 65.1 m95 -128.75 114.49 16.65 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 -178.797 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.541 ' CE2' ' HB2' ' A' ' 26' ' ' ASP . 8.5 p90 -120.47 151.41 53.8 Favored Pre-proline 0 C--O 1.239 0.503 0 CA-C-O 120.495 0.188 . . . . 0.0 110.966 178.47 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.433 ' HB2' ' HA3' ' A' ' 38' ' ' GLY . 73.5 Cg_endo -89.44 -154.35 0.05 OUTLIER 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 123.331 2.687 . . . . 0.0 111.739 175.171 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -156.62 147.44 21.82 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-O 120.532 0.206 . . . . 0.0 111.08 -176.779 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.464 ' HB3' ' HD3' ' A' ' 67' ' ' LYS . 12.3 mm-40 54.71 25.77 6.83 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 115.883 -0.598 . . . . 0.0 112.0 175.433 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 115.8 -42.48 1.89 Allowed Glycine 0 N--CA 1.453 -0.207 0 N-CA-C 111.497 -0.641 . . . . 0.0 111.497 -179.057 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.433 ' HA3' ' HB2' ' A' ' 34' ' ' PRO . . . 59.98 67.66 2.05 Favored Glycine 0 C--N 1.331 0.3 0 C-N-CA 121.353 -0.451 . . . . 0.0 112.76 179.198 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -153.78 -46.02 0.02 OUTLIER Glycine 0 N--CA 1.455 -0.1 0 N-CA-C 111.6 -0.6 . . . . 0.0 111.6 177.71 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.544 ' O ' HG21 ' A' ' 40' ' ' ILE . 2.6 mp -97.24 63.45 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 CA-C-O 121.634 0.73 . . . . 0.0 109.379 178.862 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.479 ' HB2' HE22 ' A' ' 66' ' ' GLN . 25.6 t -117.56 109.51 16.8 Favored 'General case' 0 C--N 1.33 -0.242 0 O-C-N 121.978 -0.451 . . . . 0.0 110.23 -178.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 60.4 mtp180 -89.62 110.98 21.81 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-O 120.895 0.379 . . . . 0.0 110.206 179.547 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.548 HG23 HD21 ' A' ' 102' ' ' LEU . 46.4 t -72.4 103.04 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.932 177.774 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -92.52 86.02 1.2 Allowed Glycine 0 N--CA 1.449 -0.483 0 CA-C-N 115.793 -0.639 . . . . 0.0 112.389 -178.798 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 51.4 t -71.5 100.72 0.9 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.411 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 176.564 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . 0.632 ' SG ' ' HB3' ' A' ' 60' ' ' LEU . 11.5 p -107.97 138.28 44.5 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.627 -178.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -95.71 119.37 34.09 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.8 -0.445 . . . . 0.0 109.8 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 33.5 m -92.69 148.38 4.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.802 -177.579 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 85.8 mtp . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.796 -178.524 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.567 0 N-CA-C 111.991 -0.443 . . . . 0.0 111.991 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.495 ' HE1' ' HB2' ' A' ' 124' ' ' LEU . 85.7 m-85 -134.03 155.5 49.89 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.995 0.426 . . . . 0.0 110.517 -178.064 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.632 ' HB3' ' SG ' ' A' ' 46' ' ' CYS . 3.8 tt -121.91 107.91 12.82 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 174.364 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.465 ' O ' ' HA ' ' A' ' 74' ' ' GLU . 49.1 mt -70.66 83.86 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 178.643 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . 0.559 ' HB2' HD23 ' A' ' 60' ' ' LEU . 11.9 t60 -103.35 93.02 4.75 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.482 -174.624 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -88.3 121.94 6.14 Favored Glycine 0 N--CA 1.447 -0.568 0 N-CA-C 111.057 -0.817 . . . . 0.0 111.057 174.695 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.7 pp20? -124.63 -175.58 3.31 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 116.857 0.329 . . . . 0.0 110.759 -179.448 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.519 ' O ' ' HB2' ' A' ' 66' ' ' GLN . 0.1 OUTLIER 79.3 147.31 0.09 Allowed 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.064 -0.971 . . . . 0.0 111.409 173.843 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.519 ' HB2' ' O ' ' A' ' 65' ' ' ARG . 5.4 tp-100 172.31 -57.09 0.01 OUTLIER 'General case' 0 C--O 1.231 0.12 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.612 172.199 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.464 ' HD3' ' HB3' ' A' ' 36' ' ' GLU . 7.2 ptmm? -156.07 -37.43 0.08 Allowed 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.903 -172.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -118.41 9.93 12.56 Favored 'General case' 0 N--CA 1.47 0.544 0 O-C-N 122.399 -0.188 . . . . 0.0 111.106 -178.268 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 20.0 ttmm 49.43 90.2 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 121.493 0.663 . . . . 0.0 109.732 -167.165 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.469 HD23 ' N ' ' A' ' 70' ' ' LEU . 2.0 pt? -142.03 160.18 40.73 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 -176.377 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 16.0 t -80.47 93.81 2.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 123.605 0.565 . . . . 0.0 109.567 178.611 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.434 HG21 HG22 ' A' ' 22' ' ' VAL . 30.6 m -79.26 -20.67 12.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.819 -177.575 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.449 HD12 ' N ' ' A' ' 74' ' ' GLU . 2.6 tm? -153.89 133.43 12.86 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 178.86 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.465 ' HA ' ' O ' ' A' ' 61' ' ' ILE . 13.2 pt-20 -151.49 129.6 11.87 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 176.31 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 61.0 m -146.93 117.7 7.6 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.057 -0.52 . . . . 0.0 109.779 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 42.3 t80 -90.96 144.26 25.86 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 -179.787 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 12.2 p -157.17 145.61 10.76 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 N-CA-C 110.3 -0.259 . . . . 0.0 110.3 179.6 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.97 -161.19 0.65 Allowed 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.101 179.663 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.516 ' O ' ' HB2' ' A' ' 80' ' ' ASP . 23.0 ttmm -66.48 77.2 0.11 Allowed 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.934 176.907 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . 0.516 ' HB2' ' O ' ' A' ' 79' ' ' LYS . 25.6 t70 169.13 95.91 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.461 0.705 . . . . 0.0 109.585 174.489 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.464 HD21 ' H ' ' A' ' 82' ' ' VAL . 1.1 tt -137.06 138.83 40.84 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 -178.321 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.464 ' H ' HD21 ' A' ' 81' ' ' LEU . 26.0 m -124.43 127.53 73.12 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 CA-C-O 120.941 0.401 . . . . 0.0 110.933 179.041 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.636 ' HB3' ' NE2' ' A' ' 91' ' ' HIS . 11.7 m-85 -111.53 139.88 46.6 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.909 174.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.462 ' HB ' ' CE1' ' A' ' 92' ' ' HIS . 36.6 m -132.84 114.7 14.38 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.505 -179.472 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.423 ' HZ3' ' CB ' ' A' ' 85' ' ' LYS . 2.6 ttmp? -85.34 99.61 11.27 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 177.269 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -83.08 -13.99 54.64 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.283 0.563 . . . . 0.0 110.518 -176.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . 0.746 ' HB3' ' HB3' ' A' ' 90' ' ' PHE . 27.8 t-20 -160.47 140.33 8.29 Favored Pre-proline 0 C--N 1.324 -0.513 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 -178.128 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_endo -46.94 -22.95 2.26 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 122.948 2.432 . . . . 0.0 113.614 178.073 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.456 HG22 ' OD1' ' A' ' 87' ' ' ASN . 12.6 t -116.51 14.7 15.6 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 120.767 0.318 . . . . 0.0 111.62 -179.872 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.746 ' HB3' ' HB3' ' A' ' 87' ' ' ASN . 79.6 t80 -146.39 114.98 6.79 Favored 'General case' 0 C--O 1.239 0.518 0 CA-C-O 121.218 0.532 . . . . 0.0 110.7 -178.262 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' HIS . . . . . 0.636 ' NE2' ' HB3' ' A' ' 83' ' ' TYR . 1.8 t-160 -121.49 123.11 41.25 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 -179.147 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . 0.462 ' CE1' ' HB ' ' A' ' 84' ' ' THR . 34.6 p80 -120.4 168.27 11.48 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.686 0.279 . . . . 0.0 110.857 -179.668 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 45.1 p90 -154.22 137.87 16.07 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.112 -177.653 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 56.6 tttp -95.71 107.81 20.06 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 174.466 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 35.5 m -136.41 151.04 27.85 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 CA-C-O 121.032 0.444 . . . . 0.0 111.15 -179.37 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 33.1 t70 59.87 -78.07 0.02 OUTLIER 'General case' 0 C--O 1.236 0.368 0 CA-C-N 114.882 -1.054 . . . . 0.0 112.459 173.291 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -134.96 -22.87 1.57 Allowed 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 112.796 0.665 . . . . 0.0 112.796 -174.373 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 7.9 tpt180 -146.02 175.55 10.37 Favored 'General case' 0 N--CA 1.465 0.316 0 O-C-N 121.884 -0.51 . . . . 0.0 111.026 -172.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 38.1 ttmt -101.43 108.42 20.02 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.822 -0.627 . . . . 0.0 109.623 -179.693 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -103.14 166.9 10.16 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 -179.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -159.59 178.57 35.65 Favored Glycine 0 CA--C 1.51 -0.239 0 C-N-CA 119.945 -1.121 . . . . 0.0 112.974 -177.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.548 HD21 HG23 ' A' ' 43' ' ' VAL . 3.9 pp -148.94 154.47 39.45 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-O 120.857 0.36 . . . . 0.0 110.771 177.697 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 90.0 m -105.42 128.38 53.49 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.755 175.41 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.427 ' CE2' ' HB2' ' A' ' 91' ' ' HIS . 61.2 m-85 -74.19 169.58 17.29 Favored 'General case' 0 C--O 1.238 0.489 0 CA-C-O 121.182 0.515 . . . . 0.0 111.224 -178.264 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 28.2 tt0 -106.94 -38.15 6.13 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.122 -179.363 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 24.8 m -151.83 157.21 34.49 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.94 178.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -56.55 -22.61 43.95 Favored 'Trans proline' 0 C--N 1.352 0.743 0 C-N-CA 122.348 2.032 . . . . 0.0 111.99 177.041 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -60.58 -63.32 1.34 Allowed 'General case' 0 C--O 1.233 0.213 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.716 175.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -66.23 -29.08 69.25 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.732 178.656 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -59.65 -52.5 65.24 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.975 0.416 . . . . 0.0 110.694 175.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 60.8 ttp85 -68.39 -44.31 75.39 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.337 -179.488 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -59.18 -42.1 90.02 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.01 -178.681 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 74.9 t80 -73.69 -39.11 64.63 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.424 -179.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.413 ' O ' HG11 ' A' ' 117' ' ' VAL . 37.4 t70 -62.69 -65.78 0.64 Allowed 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 121.326 0.584 . . . . 0.0 110.47 179.178 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 1.5 tmt_? -56.69 -39.8 74.47 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.166 -0.925 . . . . 0.0 110.017 177.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -59.19 -51.03 61.61 Favored Glycine 0 C--N 1.333 0.416 0 C-N-CA 121.101 -0.571 . . . . 0.0 112.501 179.62 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.508 ' O ' HG12 ' A' ' 121' ' ' ILE . 8.6 p -68.88 -30.26 46.29 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 N-CA-C 110.209 -0.293 . . . . 0.0 110.209 -178.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 3.2 mpt_? -62.53 -46.57 87.78 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.379 177.434 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 53.7 tptt -65.79 -40.92 92.42 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.111 177.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -57.49 -45.92 84.34 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.457 177.395 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.508 HG12 ' O ' ' A' ' 117' ' ' VAL . 40.1 mm -64.43 -38.71 83.28 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.337 177.823 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -57.89 -50.65 72.6 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.531 -179.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 44.1 m-20 -71.2 -29.42 65.13 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.847 178.697 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.495 ' HB2' ' HE1' ' A' ' 59' ' ' PHE . 65.6 tp -65.71 -54.38 28.13 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.229 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.476 HG21 ' O ' ' A' ' 121' ' ' ILE . 10.7 tp -83.05 -37.18 13.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.19 -174.05 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 . . . . . 0 C--O 1.251 1.163 0 O-C-N 123.59 0.556 . . . . 0.0 109.945 -176.606 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 15.8 m . . . . . 0 CA--C 1.532 0.283 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.601 ' HB3' ' HD2' ' A' ' 17' ' ' ARG . 59.6 m-85 -63.31 93.1 0.06 Allowed 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 120.835 0.35 . . . . 0.0 110.933 179.088 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 7.5 tp -83.41 -45.66 18.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.308 -178.301 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 92.1 t -125.3 121.46 60.62 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 CA-C-O 120.848 0.356 . . . . 0.0 110.64 -177.788 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.601 ' HD2' ' HB3' ' A' ' 14' ' ' TYR . 0.0 OUTLIER -125.51 103.8 8.08 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.81 178.94 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 27.2 m -119.89 176.47 3.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 177.547 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 21.5 pttm -128.33 129.97 47.07 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.822 0.344 . . . . 0.0 110.752 -177.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.427 ' HB2' HD21 ' A' ' 102' ' ' LEU . . . -159.02 -178.86 7.54 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.833 179.699 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 40.3 t -93.54 99.78 10.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 120.866 0.365 . . . . 0.0 110.707 -176.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.474 HG13 ' HG ' ' A' ' 73' ' ' LEU . 57.2 t -81.79 106.42 12.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.626 -179.678 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 23.1 mmt -86.04 150.72 24.26 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.258 177.598 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 5.2 t -123.08 151.49 41.96 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.055 -0.521 . . . . 0.0 109.951 177.539 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 59.1 ttt180 -123.18 104.7 9.34 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.145 -0.48 . . . . 0.0 109.82 -178.61 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -81.2 56.14 2.76 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-O 121.27 0.557 . . . . 0.0 109.681 -179.044 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 65.4 m-20 57.58 22.88 8.65 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.131 -0.94 . . . . 0.0 110.563 -177.374 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.9 m -67.32 156.38 36.58 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 115.179 -0.919 . . . . 0.0 110.782 179.574 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 23.9 m -62.19 -43.73 98.19 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-O 120.961 0.41 . . . . 0.0 110.461 177.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -164.01 10.27 0.08 OUTLIER Glycine 0 C--N 1.333 0.371 0 CA-C-N 115.839 -0.619 . . . . 0.0 112.38 177.22 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -83.11 80.22 1.84 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 121.203 -0.522 . . . . 0.0 112.492 -178.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 84.9 m95 -72.98 99.64 2.77 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 174.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.475 ' HA ' ' HD3' ' A' ' 34' ' ' PRO . 26.0 p90 -98.07 141.04 22.32 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.949 -174.471 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.558 ' HB2' ' HA2' ' A' ' 38' ' ' GLY . 9.1 Cg_exo -72.15 136.34 26.74 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.894 2.396 . . . . 0.0 111.593 178.625 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . 0.434 ' O ' ' N ' ' A' ' 37' ' ' GLY . 2.9 pp0? -93.38 145.13 24.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.208 -179.419 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 44.8 mm-40 41.5 -82.76 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 113.788 1.032 . . . . 0.0 113.788 173.274 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.434 ' N ' ' O ' ' A' ' 35' ' ' GLN . . . -58.8 -30.8 66.6 Favored Glycine 0 C--N 1.333 0.392 0 C-N-CA 121.45 -0.405 . . . . 0.0 112.959 -174.705 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.558 ' HA2' ' HB2' ' A' ' 34' ' ' PRO . . . 67.21 12.06 60.02 Favored Glycine 0 C--N 1.33 0.249 0 C-N-CA 121.046 -0.597 . . . . 0.0 112.261 -179.054 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -167.72 -123.02 0.64 Allowed Glycine 0 N--CA 1.446 -0.67 0 N-CA-C 111.586 -0.606 . . . . 0.0 111.586 -177.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 34.0 pt -64.23 135.98 27.12 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 CA-C-O 121.343 0.592 . . . . 0.0 111.815 -177.171 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 39.6 m -144.0 132.84 22.59 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.022 175.284 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.464 ' HD3' ' HB3' ' A' ' 17' ' ' ARG . 5.7 tmm_? -76.3 103.45 6.33 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 -179.017 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.452 HG12 HD12 ' A' ' 102' ' ' LEU . 4.0 p -91.79 110.2 22.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.58 0.705 . . . . 0.0 109.89 177.323 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.436 ' N ' HH11 ' A' ' 42' ' ' ARG . . . -107.43 103.67 1.99 Allowed Glycine 0 N--CA 1.448 -0.536 0 CA-C-N 115.395 -0.821 . . . . 0.0 111.505 -179.495 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 7.5 p -86.13 125.18 40.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 178.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . 0.776 ' SG ' ' HB3' ' A' ' 60' ' ' LEU . 7.0 p -126.54 128.5 46.97 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.603 -178.063 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 3.2 ttmp? -81.58 98.85 8.53 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 177.162 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 46.0 t -73.87 85.49 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 177.694 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 13.5 tpt . . . . . 0 C--O 1.237 0.431 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.499 -178.676 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.347 0 N-CA-C 112.234 -0.346 . . . . 0.0 112.234 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.466 ' O ' HG21 ' A' ' 77' ' ' VAL . 84.8 m-85 -127.83 125.78 40.41 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 178.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.776 ' HB3' ' SG ' ' A' ' 46' ' ' CYS . 1.6 tt -93.99 108.2 20.04 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 179.86 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 48.3 mm -80.65 91.41 1.81 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.261 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 174.418 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . 0.649 ' HB2' HD22 ' A' ' 60' ' ' LEU . 28.5 t60 -108.45 106.64 16.85 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.83 -173.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.42 ' HA2' ' O ' ' A' ' 42' ' ' ARG . . . -114.8 138.57 14.91 Favored Glycine 0 C--O 1.235 0.209 0 N-CA-C 111.725 -0.55 . . . . 0.0 111.725 178.422 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.408 ' HB2' ' O ' ' A' ' 70' ' ' LEU . 14.4 pt-20 -120.35 160.18 23.55 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 120.881 0.372 . . . . 0.0 110.801 -179.803 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.443 ' HB2' HG12 ' A' ' 72' ' ' VAL . 2.0 tmt_? -82.75 122.66 28.46 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 177.428 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 9.5 mm100 -58.67 97.45 0.03 OUTLIER 'General case' 0 C--O 1.234 0.269 0 CA-C-O 121.105 0.479 . . . . 0.0 112.007 -174.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 29.5 mtpp -140.27 -72.05 0.37 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.193 -0.912 . . . . 0.0 108.739 173.152 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -160.25 -46.89 0.05 OUTLIER 'General case' 0 C--O 1.235 0.327 0 CA-C-N 114.67 -1.15 . . . . 0.0 108.93 -178.617 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 56.1 tttm -170.36 99.12 0.26 Allowed 'General case' 0 C--O 1.236 0.39 0 CA-C-N 115.099 -0.955 . . . . 0.0 109.569 177.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.408 ' O ' ' HB2' ' A' ' 64' ' ' GLU . 4.1 tt -157.21 107.77 2.28 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 -178.744 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 43.8 t -78.58 125.18 37.9 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.004 -177.377 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.443 HG12 ' HB2' ' A' ' 65' ' ' ARG . 27.7 m -123.02 -28.96 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.584 179.735 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.474 ' HG ' HG13 ' A' ' 22' ' ' VAL . 2.6 tm? -123.66 117.02 24.05 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 -177.446 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -131.78 107.0 8.47 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 176.742 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 52.5 t -135.13 79.5 1.79 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.349 0.595 . . . . 0.0 109.953 179.676 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.533 ' HA ' ' HA ' ' A' ' 60' ' ' LEU . 57.2 t80 -72.74 105.07 4.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.98 175.472 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.466 HG21 ' O ' ' A' ' 59' ' ' PHE . 34.8 m -81.11 114.54 22.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 178.601 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.64 ' H ' ' HD2' ' A' ' 78' ' ' ARG . 0.3 OUTLIER -82.66 61.67 5.89 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 -173.819 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 36.3 mtmm 68.68 -2.87 1.54 Allowed 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.206 -172.385 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . 0.417 ' H ' ' C ' ' A' ' 78' ' ' ARG . 21.9 t70 -92.36 85.77 5.49 Favored 'General case' 0 N--CA 1.462 0.148 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 174.035 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.692 HD21 HD11 ' A' ' 121' ' ' ILE . 2.4 tt -131.25 106.82 8.56 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.976 -173.854 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 59.5 t -124.05 92.38 2.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.252 176.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -81.49 101.54 9.98 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.04 178.672 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 22.5 m -90.93 127.22 36.31 Favored 'General case' 0 C--N 1.323 -0.543 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 178.602 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 24.7 pttm -93.32 111.25 22.85 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.111 0.481 . . . . 0.0 110.857 -177.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -90.07 -44.16 10.01 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.271 0.558 . . . . 0.0 109.503 175.676 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . 0.591 ' HB2' ' HB3' ' A' ' 90' ' ' PHE . 93.0 m-20 -138.63 153.98 72.81 Favored Pre-proline 0 C--N 1.328 -0.363 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 177.132 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -55.26 -27.41 56.94 Favored 'Trans proline' 0 CA--C 1.533 0.471 0 C-N-CA 122.22 1.947 . . . . 0.0 112.034 176.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 10.8 p -105.91 8.47 32.61 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.836 178.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.591 ' HB3' ' HB2' ' A' ' 87' ' ' ASN . 25.6 t80 -140.81 102.97 4.4 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-O 121.076 0.465 . . . . 0.0 110.405 -179.784 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' HIS . . . . . 0.609 ' HD1' ' HE2' ' A' ' 104' ' ' PHE . 14.2 m80 -107.7 132.51 53.27 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.513 174.321 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . 0.41 ' HA ' ' O ' ' A' ' 100' ' ' PHE . 8.2 p80 -126.95 129.56 48.37 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.74 0.305 . . . . 0.0 110.204 178.138 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . 0.612 ' HZ3' ' HB2' ' A' ' 102' ' ' LEU . 34.8 p90 -110.01 149.77 29.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.079 179.3 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 14.3 tmtt? -112.57 122.1 46.72 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.059 -178.038 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.432 HG12 ' HD1' ' A' ' 93' ' ' TRP . 21.1 m -124.88 127.33 72.47 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.071 176.863 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 42.3 m-20 59.6 -80.18 0.02 OUTLIER 'General case' 0 C--O 1.235 0.297 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.953 -179.108 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -133.74 -28.48 1.41 Allowed 'General case' 0 C--O 1.234 0.243 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.609 -176.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 62.5 mtt180 -103.44 156.46 17.74 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 121.482 0.658 . . . . 0.0 112.495 -171.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.84 137.34 52.83 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 114.64 -1.164 . . . . 0.0 109.846 -179.89 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . 0.41 ' O ' ' HA ' ' A' ' 92' ' ' HIS . 36.6 m-85 -122.98 137.13 55.04 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 176.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -115.76 101.59 1.03 Allowed Glycine 0 C--N 1.333 0.409 0 C-N-CA 120.968 -0.634 . . . . 0.0 113.216 -171.116 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.612 ' HB2' ' HZ3' ' A' ' 93' ' ' TRP . 3.7 tt -74.42 104.25 5.09 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.211 -0.662 . . . . 0.0 109.211 177.047 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 17.5 m -96.67 114.97 26.66 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.142 179.773 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.609 ' HE2' ' HD1' ' A' ' 91' ' ' HIS . 74.5 m-85 -72.27 167.31 20.67 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.296 -175.368 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -112.71 -31.66 6.67 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.71 -175.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 5.7 m -138.51 150.07 64.92 Favored Pre-proline 0 C--N 1.329 -0.31 0 N-CA-C 110.187 -0.301 . . . . 0.0 110.187 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -52.96 -29.02 42.17 Favored 'Trans proline' 0 C--N 1.352 0.718 0 C-N-CA 122.309 2.006 . . . . 0.0 111.86 176.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -59.44 -65.59 0.65 Allowed 'General case' 0 C--O 1.236 0.384 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.858 177.227 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -64.92 -31.59 72.9 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.949 -179.344 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . 0.424 ' HA ' ' CG ' ' A' ' 104' ' ' PHE . . . -58.52 -60.85 3.15 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.092 177.395 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 20.0 mtm180 -66.54 -32.54 73.96 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.748 -177.628 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -63.51 -56.67 14.24 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.037 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 39.1 t80 -71.03 -28.89 64.72 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.337 -177.214 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -54.84 -63.43 1.16 Allowed 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 121.808 0.813 . . . . 0.0 109.588 173.17 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 52.4 ttt180 -56.51 -37.21 70.1 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.306 -1.315 . . . . 0.0 110.835 177.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -63.94 -53.89 34.39 Favored Glycine 0 C--O 1.237 0.304 0 CA-C-N 115.837 -0.62 . . . . 0.0 112.909 -179.164 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.435 ' O ' HG12 ' A' ' 121' ' ' ILE . 11.9 p -67.71 -33.67 63.23 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 -178.292 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . 0.5 ' O ' ' HG3' ' A' ' 122' ' ' GLU . 54.2 ttt180 -55.54 -50.96 68.63 Favored 'General case' 0 C--O 1.231 0.089 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 173.223 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.62 ' HE2' ' HA ' ' A' ' 119' ' ' LYS . 0.6 OUTLIER -56.47 -46.39 80.42 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.065 178.786 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -56.85 -42.5 79.8 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.949 178.769 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.692 HD11 HD21 ' A' ' 81' ' ' LEU . 42.6 mm -61.59 -39.59 83.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.925 176.682 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . 0.516 ' HA ' ' HA ' ' A' ' 126' ' ' GLU . 41.2 mt-10 -66.23 -37.73 86.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.652 179.676 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -65.26 -36.6 84.61 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-O 121.222 0.534 . . . . 0.0 109.988 174.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 59.3 tp -71.46 -55.35 8.07 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.675 -176.714 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.42 HG13 ' O ' ' A' ' 125' ' ' ILE . 11.3 tp -145.47 10.18 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 N-CA-C 111.655 0.243 . . . . 0.0 111.655 -171.937 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.516 ' HA ' ' HA ' ' A' ' 122' ' ' GLU . 34.0 tt0 . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.429 -0.796 . . . . 0.0 110.753 -175.291 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 16.5 m . . . . . 0 CA--C 1.536 0.429 0 N-CA-C 111.857 0.317 . . . . 0.0 111.857 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 24.7 m-85 -65.14 123.4 19.42 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-O 120.695 0.283 . . . . 0.0 110.561 178.191 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 13.0 tt -102.73 -34.1 3.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 173.411 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.4 ' HB ' ' HB ' ' A' ' 45' ' ' VAL . 97.8 t -139.3 130.12 33.03 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.764 177.808 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 11.6 ptm180 -142.41 91.13 2.29 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.199 0.523 . . . . 0.0 110.277 176.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 35.1 m -107.5 161.08 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.928 -177.629 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 47.3 mtmt -93.83 130.58 39.8 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.392 178.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -163.25 158.59 21.72 Favored 'General case' 0 C--N 1.331 -0.223 0 O-C-N 123.254 0.346 . . . . 0.0 110.29 179.219 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 58.4 t -90.77 105.66 16.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 178.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.586 HG23 ' NE2' ' A' ' 35' ' ' GLN . 15.8 m -81.23 115.18 23.37 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 CA-C-O 121.406 0.622 . . . . 0.0 111.673 -176.541 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 24.0 mmt -99.66 162.78 12.81 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.973 179.589 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 9.9 t -136.64 158.19 45.02 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.943 0.402 . . . . 0.0 110.854 -179.13 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 20.5 ttt180 -136.36 100.26 4.33 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 -179.651 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.539 ' H ' ' HE1' ' A' ' 33' ' ' PHE . 27.4 t70 -63.03 104.43 0.56 Allowed 'General case' 0 C--O 1.234 0.267 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.541 -172.078 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.627 ' HA ' ' HG2' ' A' ' 98' ' ' ARG . 23.8 t70 60.23 -76.85 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.677 176.862 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 37.4 p -145.01 22.94 1.55 Allowed 'General case' 0 C--O 1.236 0.345 0 N-CA-C 111.484 0.179 . . . . 0.0 111.484 -178.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 49.1 m -51.6 143.05 13.1 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.994 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -81.58 61.89 4.57 Favored Glycine 0 CA--C 1.52 0.354 0 C-N-CA 121.431 -0.414 . . . . 0.0 112.629 -177.386 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 158.67 -168.91 34.98 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 121.279 -0.486 . . . . 0.0 111.942 179.195 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . 0.579 ' HH2' ' HG2' ' A' ' 99' ' ' LYS . 88.2 m95 -128.26 116.45 19.88 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 177.871 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.539 ' HE1' ' H ' ' A' ' 26' ' ' ASP . 37.7 p90 -110.78 148.29 38.25 Favored Pre-proline 0 C--O 1.235 0.308 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.894 -175.833 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -77.88 157.55 31.14 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.73 2.287 . . . . 0.0 111.549 176.484 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . 0.586 ' NE2' HG23 ' A' ' 22' ' ' VAL . 2.5 pp0? -136.11 -152.89 0.47 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.059 -0.518 . . . . 0.0 109.923 -178.728 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.434 ' H ' ' HB2' ' A' ' 35' ' ' GLN . 22.5 tp10 -52.74 -22.15 4.92 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 120.918 0.389 . . . . 0.0 111.49 -177.163 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -112.32 46.13 1.22 Allowed Glycine 0 CA--C 1.518 0.26 0 N-CA-C 111.578 -0.609 . . . . 0.0 111.578 175.304 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -71.95 -19.45 78.3 Favored Glycine 0 C--N 1.331 0.292 0 C-N-CA 121.357 -0.449 . . . . 0.0 112.664 -179.507 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -97.29 -151.04 27.39 Favored Glycine 0 C--O 1.237 0.301 0 C-N-CA 121.35 -0.452 . . . . 0.0 112.097 178.286 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 50.6 mm -65.72 99.18 0.29 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.38 0 CA-C-O 121.154 0.502 . . . . 0.0 110.284 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 36.8 m -105.66 -175.8 2.9 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.475 179.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.588 HH22 ' N ' ' A' ' 68' ' ' ASP . 28.3 ttm180 -130.53 134.94 47.44 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.764 -178.022 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.756 HG23 HD23 ' A' ' 102' ' ' LEU . 24.3 t -100.05 94.44 3.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 171.216 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -98.37 91.94 1.18 Allowed Glycine 0 N--CA 1.449 -0.474 0 CA-C-N 115.827 -0.624 . . . . 0.0 113.098 -173.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.4 ' HB ' ' HB ' ' A' ' 16' ' ' VAL . 51.4 t -76.3 109.94 10.94 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 175.236 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . 0.689 ' SG ' ' HB3' ' A' ' 60' ' ' LEU . 9.1 p -121.88 137.33 54.82 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.431 -178.446 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.566 ' HA ' ' O ' ' A' ' 58' ' ' GLY . 42.1 mtmt -84.97 118.38 24.52 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.981 0.42 . . . . 0.0 111.033 -179.797 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 42.7 t -90.91 118.24 35.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.185 173.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 67.1 mtm . . . . . 0 C--N 1.329 -0.312 0 CA-C-O 121.018 0.437 . . . . 0.0 110.529 -178.597 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.566 ' O ' ' HA ' ' A' ' 47' ' ' LYS . . . . . . . . 0 N--CA 1.452 -0.263 0 N-CA-C 112.079 -0.408 . . . . 0.0 112.079 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 32.6 m-85 -103.0 97.07 7.24 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.268 0.556 . . . . 0.0 110.5 -177.592 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.699 ' HA ' ' HA ' ' A' ' 76' ' ' TYR . 2.7 tt -81.69 110.0 16.63 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 178.53 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 60.8 mt -75.33 86.4 0.66 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.314 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 174.106 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 12.3 t-80 -90.08 101.19 13.91 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.254 -0.884 . . . . 0.0 109.946 -176.337 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -91.27 114.55 4.52 Favored Glycine 0 N--CA 1.449 -0.435 0 CA-C-N 115.937 -0.574 . . . . 0.0 112.204 -177.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -119.51 -170.27 1.91 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.025 0.44 . . . . 0.0 110.934 179.589 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 23.0 mmt85 -83.58 -174.73 5.45 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.451 169.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 28.7 pt20 -55.59 -35.17 65.51 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.168 177.127 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -115.51 147.89 40.13 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.278 -178.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.588 ' N ' HH22 ' A' ' 42' ' ' ARG . 1.8 m-20 -67.85 105.59 2.02 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.1 -178.424 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -176.17 -39.21 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.348 0 O-C-N 123.168 0.293 . . . . 0.0 111.591 -179.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 61.5 tp -122.03 115.54 22.69 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.622 0.249 . . . . 0.0 111.282 -175.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 35.4 t -88.82 110.47 21.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.891 176.771 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 35.9 m -91.3 -36.68 8.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.259 -177.696 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -133.42 151.49 51.82 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 122.491 0.317 . . . . 0.0 110.234 178.742 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.528 ' HG2' HD23 ' A' ' 60' ' ' LEU . 2.9 tm-20 -146.94 115.75 6.82 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 175.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 50.0 t -141.15 83.7 1.89 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.21 0.529 . . . . 0.0 110.616 -178.364 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.699 ' HA ' ' HA ' ' A' ' 60' ' ' LEU . 78.4 t80 -68.87 122.65 19.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.587 175.768 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.455 HG11 ' HB2' ' A' ' 80' ' ' ASP . 17.2 m -133.21 122.71 45.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.006 0.431 . . . . 0.0 110.281 178.031 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 11.5 ptm180 -110.04 -27.77 9.03 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.2 0.524 . . . . 0.0 110.211 179.164 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -155.05 22.25 0.43 Allowed 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 173.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . 0.455 ' HB2' HG11 ' A' ' 77' ' ' VAL . 0.7 OUTLIER -114.7 9.55 16.45 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 114.414 -1.266 . . . . 0.0 109.816 -172.557 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.803 HD21 HD12 ' A' ' 121' ' ' ILE . 3.5 tt -79.17 104.42 9.79 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.171 -172.316 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 48.4 t -127.97 96.78 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 CA-C-N 116.567 -0.288 . . . . 0.0 110.667 177.201 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.503 ' HD2' ' CD2' ' A' ' 91' ' ' HIS . 4.5 m-85 -91.71 172.46 8.47 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-O 121.396 0.617 . . . . 0.0 111.076 178.306 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 50.1 m -154.42 110.75 3.26 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.056 -0.974 . . . . 0.0 109.314 -179.629 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.599 ' HB3' ' HZ1' ' A' ' 85' ' ' LYS . 5.2 ttpm? -77.3 107.05 9.43 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 177.346 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -85.28 -59.65 2.26 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.214 0.53 . . . . 0.0 110.138 -179.614 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 -130.19 158.63 73.59 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.353 -179.177 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -56.13 -13.69 10.05 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 122.6 2.2 . . . . 0.0 113.189 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 12.7 t -125.21 5.8 7.81 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-O 120.452 0.168 . . . . 0.0 111.304 179.509 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 17.8 t80 -135.36 114.28 12.05 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 -179.57 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' HIS . . . . . 0.503 ' CD2' ' HD2' ' A' ' 83' ' ' TYR . 2.3 t-160 -130.24 129.91 43.94 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 -176.897 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 20.7 p80 -138.78 174.98 9.96 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.527 0.203 . . . . 0.0 111.066 -174.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . 0.465 ' HB3' ' CD1' ' A' ' 83' ' ' TYR . 34.2 p90 -142.8 171.72 13.67 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 176.427 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -137.24 150.34 47.78 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.037 0.446 . . . . 0.0 110.815 -178.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 24.6 m -122.85 -140.27 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 173.4 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -59.39 83.72 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 118.083 0.401 . . . . 0.0 110.918 176.548 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 52.8 t30 68.99 -63.58 0.36 Allowed 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.232 1.013 . . . . 0.0 112.147 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.627 ' HG2' ' HA ' ' A' ' 27' ' ' ASP . 60.0 mtt-85 -55.03 136.07 48.28 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 121.251 0.548 . . . . 0.0 110.745 -176.611 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.777 ' HZ1' ' HB2' ' A' ' 99' ' ' LYS . 4.5 ttmp? -127.18 132.84 50.4 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.472 -0.786 . . . . 0.0 110.308 -169.058 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 1.1 p90 -147.2 158.22 43.87 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 -179.174 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . 0.422 ' HA2' ' CZ3' ' A' ' 93' ' ' TRP . . . -164.23 -153.21 7.29 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.384 -0.912 . . . . 0.0 113.338 -174.572 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.756 HD23 HG23 ' A' ' 43' ' ' VAL . 4.1 pp -144.48 168.21 20.67 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.099 0.476 . . . . 0.0 110.977 -174.63 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 15.3 m -128.59 119.73 25.32 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.533 178.091 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 47.5 m-85 -66.27 160.05 25.27 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.089 178.091 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 29.8 pt20 -129.54 -27.08 2.42 Favored 'General case' 0 C--N 1.328 -0.37 0 N-CA-C 111.535 0.198 . . . . 0.0 111.535 -177.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 32.1 m -135.13 150.21 72.29 Favored Pre-proline 0 C--N 1.329 -0.299 0 N-CA-C 110.282 -0.266 . . . . 0.0 110.282 179.449 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . 0.58 ' O ' ' HG2' ' A' ' 111' ' ' ARG . 82.2 Cg_exo -49.59 -35.2 36.79 Favored 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 122.683 2.256 . . . . 0.0 112.254 177.13 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -57.84 -63.52 1.22 Allowed 'General case' 0 C--O 1.235 0.314 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.574 -179.57 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -62.28 -34.37 76.44 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.736 -179.003 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -55.29 -66.59 0.39 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.117 177.151 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . 0.58 ' HG2' ' O ' ' A' ' 107' ' ' PRO . 44.7 ptt85 -59.58 -47.21 86.47 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.237 -176.794 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -63.15 -49.84 72.76 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.74 -172.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.48 ' O ' HG23 ' A' ' 117' ' ' VAL . 63.2 t80 -75.6 -43.45 48.05 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.803 -175.655 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -55.47 -59.71 4.43 Favored 'General case' 0 C--O 1.24 0.556 0 CA-C-O 121.566 0.698 . . . . 0.0 109.957 179.688 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 22.8 ttm180 -59.4 -37.23 77.47 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 114.895 -1.048 . . . . 0.0 109.93 177.041 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -58.35 -39.38 92.63 Favored Glycine 0 N--CA 1.45 -0.419 0 CA-C-N 115.861 -0.609 . . . . 0.0 112.362 178.257 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.48 HG23 ' O ' ' A' ' 113' ' ' PHE . 72.6 t -71.3 -49.8 45.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.607 0.241 . . . . 0.0 110.809 -179.727 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 44.2 mtm105 -59.78 -44.87 93.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.875 0.369 . . . . 0.0 110.785 179.503 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 45.3 tptt -65.97 -36.01 82.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.447 177.54 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -62.42 -43.84 97.86 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.309 176.481 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.803 HD12 HD21 ' A' ' 81' ' ' LEU . 32.4 mm -60.68 -42.81 93.34 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.108 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.278 177.617 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . 0.44 ' O ' ' HG3' ' A' ' 126' ' ' GLU . 34.7 tt0 -56.35 -57.32 12.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.165 177.837 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 74.0 m-20 -69.7 -18.91 63.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.601 -177.583 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 6.0 tt -77.27 -45.44 26.34 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 178.057 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 13.9 tt -78.98 -28.05 13.68 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.354 -175.46 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.44 ' HG3' ' O ' ' A' ' 122' ' ' GLU . 50.1 mt-10 . . . . . 0 C--O 1.255 1.39 0 CA-C-O 118.384 -0.817 . . . . 0.0 110.264 178.372 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 33.3 t . . . . . 0 C--O 1.234 0.254 0 CA-C-O 120.518 0.199 . . . . 0.0 111.189 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 61.8 m-85 -63.36 89.57 0.04 OUTLIER 'General case' 0 C--O 1.233 0.232 0 CA-C-O 121.065 0.46 . . . . 0.0 110.446 177.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 62.5 mt -73.96 -32.08 32.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.62 -179.057 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 60.4 t -123.62 100.3 7.63 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.18 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.902 -178.708 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 86.6 mtm180 -112.74 93.58 4.49 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 172.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 30.9 m -120.12 174.47 5.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.993 0.425 . . . . 0.0 111.644 -175.69 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.659 ' HD2' HD11 ' A' ' 40' ' ' ILE . 9.4 mtmp? -110.74 114.96 28.72 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.71 -178.1 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -148.54 179.97 7.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.222 179.748 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 42.6 t -109.15 109.89 30.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 110.251 -0.278 . . . . 0.0 110.251 179.69 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 15.8 m -70.46 95.9 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 CA-C-O 121.522 0.677 . . . . 0.0 111.415 -178.728 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' MET . . . . . 0.616 ' H ' ' HA ' ' A' ' 102' ' ' LEU . 21.2 mmt -89.96 115.16 27.04 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.036 -179.781 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.485 HG22 ' CE1' ' A' ' 33' ' ' PHE . 9.6 t -112.67 162.93 15.15 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.341 0.591 . . . . 0.0 110.393 179.67 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.411 ' O ' ' N ' ' A' ' 27' ' ' ASP . 5.4 tpm_? -133.12 98.17 4.2 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 176.557 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.569 ' H ' ' HE1' ' A' ' 33' ' ' PHE . 30.8 t70 -60.7 80.46 0.01 OUTLIER 'General case' 0 C--O 1.233 0.211 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.137 -178.151 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.411 ' N ' ' O ' ' A' ' 25' ' ' ARG . 0.8 OUTLIER 57.04 173.07 0.04 OUTLIER 'General case' 0 C--O 1.235 0.314 0 CA-C-N 115.037 -0.983 . . . . 0.0 111.208 -174.658 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 40.0 m 59.66 -167.83 0.16 Allowed 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 120.873 0.368 . . . . 0.0 110.91 -178.217 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 68.1 m -149.64 132.0 15.61 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 172.274 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 146.95 65.7 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.297 0 N-CA-C 111.601 -0.6 . . . . 0.0 111.601 -178.67 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 118.84 98.84 1.86 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 121.235 -0.507 . . . . 0.0 112.195 -179.525 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . 0.527 ' HH2' ' HG2' ' A' ' 99' ' ' LYS . 77.7 m95 -81.9 120.2 24.9 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 176.694 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.569 ' HE1' ' H ' ' A' ' 26' ' ' ASP . 14.2 p90 -115.09 132.5 23.0 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.438 -0.347 . . . . 0.0 110.505 -176.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.537 ' HB2' ' HA3' ' A' ' 38' ' ' GLY . 71.4 Cg_endo -74.69 112.86 3.65 Favored 'Trans proline' 0 N--CA 1.458 -0.57 0 C-N-CA 121.939 1.76 . . . . 0.0 110.657 175.158 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -54.81 129.03 35.66 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.455 -175.424 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 63.19 16.0 9.03 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.62 -179.554 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 107.34 -26.27 19.07 Favored Glycine 0 C--N 1.33 0.245 0 C-N-CA 121.494 -0.384 . . . . 0.0 112.643 177.666 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.537 ' HA3' ' HB2' ' A' ' 34' ' ' PRO . . . 72.41 -71.61 1.02 Allowed Glycine 0 CA--C 1.519 0.289 0 C-N-CA 121.221 -0.514 . . . . 0.0 112.572 -179.835 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 62.04 -96.68 0.14 Allowed Glycine 0 C--N 1.333 0.394 0 N-CA-C 112.121 -0.392 . . . . 0.0 112.121 -179.292 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.659 HD11 ' HD2' ' A' ' 19' ' ' LYS . 12.5 tt -141.78 80.53 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 122.056 0.932 . . . . 0.0 109.475 178.23 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 9.3 m -77.09 141.92 40.02 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.67 -173.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.739 ' HB3' ' HB2' ' A' ' 64' ' ' GLU . 41.3 ttm180 -92.98 97.53 10.78 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 178.125 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 48.1 t -76.22 107.47 7.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.097 -0.501 . . . . 0.0 109.961 -178.591 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -106.78 112.08 3.7 Favored Glycine 0 N--CA 1.448 -0.511 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.824 179.446 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 62.0 t -106.4 111.52 35.68 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 177.613 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . 0.766 ' SG ' ' HB3' ' A' ' 60' ' ' LEU . 8.0 p -104.92 143.1 33.62 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.548 178.352 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 40.9 ttmt -94.89 92.9 7.14 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 121.026 0.441 . . . . 0.0 109.972 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 42.6 t -77.11 88.0 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.769 178.718 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 61.0 mtm . . . . . 0 C--N 1.328 -0.369 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.256 -179.954 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.366 0 N-CA-C 111.662 -0.575 . . . . 0.0 111.662 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -133.24 119.76 20.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.928 0.394 . . . . 0.0 110.413 -179.54 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.766 ' HB3' ' SG ' ' A' ' 46' ' ' CYS . 1.2 tt -96.2 110.21 22.54 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 179.003 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 57.3 mt -84.85 90.84 2.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 174.54 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -103.46 116.16 31.88 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.082 -175.106 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -91.42 96.05 2.14 Favored Glycine 0 N--CA 1.449 -0.493 0 CA-C-N 115.964 -0.562 . . . . 0.0 112.111 -179.025 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.739 ' HB2' ' HB3' ' A' ' 42' ' ' ARG . 5.2 mm-40 -73.77 145.21 45.24 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 177.365 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.44 ' HD2' HD23 ' A' ' 70' ' ' LEU . 18.6 ttt180 -76.58 8.33 3.66 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.241 -178.591 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.426 ' NE2' ' HB2' ' A' ' 42' ' ' ARG . 6.7 tp-100 71.9 -68.67 0.21 Allowed 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 123.521 0.728 . . . . 0.0 110.263 -178.864 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -88.27 118.19 27.7 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 177.571 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 32.5 t70 73.61 146.58 0.08 Allowed 'General case' 0 N--CA 1.469 0.518 0 O-C-N 124.003 0.814 . . . . 0.0 111.269 -178.786 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -74.39 79.47 1.89 Allowed 'General case' 0 C--O 1.236 0.369 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.2 -179.33 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.44 HD23 ' HD2' ' A' ' 65' ' ' ARG . 6.2 tt -130.9 131.85 44.76 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 179.762 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.438 ' N ' HD21 ' A' ' 70' ' ' LEU . 23.6 t -89.73 117.67 33.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.042 -175.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 32.8 m -98.29 -23.0 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-O 120.713 0.292 . . . . 0.0 110.806 176.792 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.408 HD21 ' N ' ' A' ' 74' ' ' GLU . 9.3 tt -145.54 139.52 26.8 Favored 'General case' 0 N--CA 1.462 0.166 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 -179.179 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.408 ' N ' HD21 ' A' ' 73' ' ' LEU . 1.7 tm-20 -142.5 109.51 5.53 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 -179.129 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' CYS . . . . . 0.46 ' SG ' ' NE1' ' A' ' 93' ' ' TRP . 35.0 t -140.12 82.56 1.87 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.384 0.611 . . . . 0.0 110.984 -179.288 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.412 ' HD1' ' HG ' ' A' ' 60' ' ' LEU . 82.5 t80 -75.13 121.99 22.91 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.812 174.662 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.503 HG13 ' HB2' ' A' ' 81' ' ' LEU . 92.8 t -124.85 112.02 30.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 -177.218 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.412 ' HD3' ' OH ' ' A' ' 76' ' ' TYR . 46.5 ttp180 -120.4 1.24 10.69 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-O 121.253 0.549 . . . . 0.0 110.58 -179.692 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 19.3 ptmt -141.01 86.86 2.06 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 115.965 -0.562 . . . . 0.0 111.141 -176.002 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . 0.443 ' H ' HD11 ' A' ' 124' ' ' LEU . 18.2 t70 64.5 148.4 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 115.649 -0.705 . . . . 0.0 112.154 178.108 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.503 ' HB2' HG13 ' A' ' 77' ' ' VAL . 51.5 tp -149.46 137.78 20.71 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.846 -0.615 . . . . 0.0 109.961 178.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 60.3 t -77.28 -65.13 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.363 178.338 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.44 ' HD2' ' HB ' ' A' ' 117' ' ' VAL . 4.5 t80 37.99 79.89 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 124.111 0.964 . . . . 0.0 111.729 -178.767 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 97.1 m -112.64 136.5 52.13 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.261 -0.881 . . . . 0.0 109.913 179.714 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.455 ' HA ' ' HA ' ' A' ' 91' ' ' HIS . 18.0 ptmt -85.37 108.77 17.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.043 0.449 . . . . 0.0 109.846 176.569 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -74.85 -27.55 60.31 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.446 0.641 . . . . 0.0 109.846 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . 0.479 ' HB2' ' HB3' ' A' ' 90' ' ' PHE . 16.5 m120 -141.62 156.43 66.4 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-N 115.059 -0.973 . . . . 0.0 108.709 177.923 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -58.56 -13.29 16.72 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.581 2.187 . . . . 0.0 112.561 180.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.412 ' HA ' ' HD2' ' A' ' 104' ' ' PHE . 23.6 p -124.55 14.3 8.79 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.608 -178.885 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.479 ' HB3' ' HB2' ' A' ' 87' ' ' ASN . 42.6 t80 -145.19 123.17 12.04 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-O 120.706 0.289 . . . . 0.0 110.833 -177.539 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' HIS . . . . . 0.473 ' HD1' ' HZ ' ' A' ' 104' ' ' PHE . 0.3 OUTLIER -126.01 136.29 52.79 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 -179.134 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . 0.55 ' HA ' ' HA3' ' A' ' 101' ' ' GLY . 11.7 p80 -141.53 158.59 43.66 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 120.643 0.259 . . . . 0.0 110.905 -177.148 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . 0.509 ' CZ3' ' HA2' ' A' ' 101' ' ' GLY . 39.3 p90 -136.45 158.89 43.36 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.848 0.356 . . . . 0.0 110.375 176.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt -122.48 113.96 20.04 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.669 179.577 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.417 HG22 ' SG ' ' A' ' 75' ' ' CYS . 28.0 m -141.34 162.63 21.38 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 N-CA-C 110.021 -0.363 . . . . 0.0 110.021 178.084 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 26.0 t70 63.56 -76.1 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.393 0 O-C-N 123.694 0.621 . . . . 0.0 110.957 179.699 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -155.92 -9.86 0.11 Allowed 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.781 177.269 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 42.0 ttm180 -122.15 155.59 35.43 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.261 0.553 . . . . 0.0 112.032 -165.553 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.527 ' HG2' ' HH2' ' A' ' 32' ' ' TRP . 37.4 ttpt -108.63 107.25 17.66 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.053 -0.976 . . . . 0.0 109.436 178.312 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . 0.45 ' HA ' ' HZ3' ' A' ' 32' ' ' TRP . 3.6 p90 -138.55 155.19 48.59 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.662 -0.245 . . . . 0.0 110.667 -179.419 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . 0.55 ' HA3' ' HA ' ' A' ' 92' ' ' HIS . . . -163.09 -141.5 3.14 Favored Glycine 0 C--N 1.332 0.346 0 C-N-CA 121.116 -0.564 . . . . 0.0 112.702 -177.177 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.616 ' HA ' ' H ' ' A' ' 23' ' ' MET . 0.0 OUTLIER -157.51 156.02 31.3 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 121.032 0.444 . . . . 0.0 111.035 -178.699 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 36.2 m -101.52 132.53 47.1 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.752 175.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.473 ' HZ ' ' HD1' ' A' ' 91' ' ' HIS . 19.6 m-85 -67.41 160.27 27.74 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.412 -179.874 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -117.08 -52.46 2.51 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.205 178.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 25.4 m -129.75 153.2 80.79 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.251 -177.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_exo -49.11 -31.44 21.3 Favored 'Trans proline' 0 C--N 1.353 0.8 0 C-N-CA 122.669 2.246 . . . . 0.0 112.66 178.569 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -59.47 -62.22 2.04 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.249 179.376 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -65.67 -38.03 88.15 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.591 -179.429 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -52.81 -60.74 2.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.028 0.442 . . . . 0.0 110.781 176.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 72.4 mtp180 -64.08 -27.52 69.16 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.634 -179.368 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -65.23 -39.27 92.51 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.547 176.191 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 46.2 m-85 -71.03 -43.84 67.05 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.589 177.667 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.418 ' O ' HG12 ' A' ' 117' ' ' VAL . 49.9 m-20 -61.59 -55.55 29.49 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 120.814 0.34 . . . . 0.0 110.623 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 80.2 mtt-85 -66.39 -28.72 68.86 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-O 121.02 0.438 . . . . 0.0 110.154 176.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -59.35 -50.98 61.93 Favored Glycine 0 N--CA 1.447 -0.579 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.86 176.139 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.44 ' HB ' ' HD2' ' A' ' 83' ' ' TYR . 11.9 p -69.27 -32.75 54.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 116.694 0.247 . . . . 0.0 110.584 -179.74 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . 0.456 ' O ' ' HG3' ' A' ' 122' ' ' GLU . 3.4 mmp_? -53.04 -64.63 0.76 Allowed 'General case' 0 C--O 1.238 0.476 0 CA-C-O 121.231 0.539 . . . . 0.0 109.995 174.17 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 81.4 tttt -66.86 -33.63 76.01 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 115.476 -0.783 . . . . 0.0 110.728 -176.107 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -61.03 -50.84 71.72 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.458 178.21 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.538 ' O ' HG22 ' A' ' 125' ' ' ILE . 31.8 mm -60.08 -40.68 84.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.109 178.947 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . 0.485 ' O ' ' HB2' ' A' ' 126' ' ' GLU . 43.5 mt-10 -54.8 -56.46 19.18 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 110.284 -0.265 . . . . 0.0 110.284 176.385 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 49.4 m-20 -65.26 -27.23 68.5 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.668 -0.242 . . . . 0.0 111.425 -178.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.443 HD11 ' H ' ' A' ' 80' ' ' ASP . 3.2 tm? -76.51 -56.68 4.4 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.179 -176.126 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.538 HG22 ' O ' ' A' ' 121' ' ' ILE . 11.2 tp -94.12 -34.02 5.43 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 -170.349 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.485 ' HB2' ' O ' ' A' ' 122' ' ' GLU . 32.1 mm-40 . . . . . 0 C--O 1.251 1.142 0 CA-C-O 118.637 -0.697 . . . . 0.0 110.862 -174.535 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 15.6 m . . . . . 0 CA--C 1.535 0.383 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.631 ' HB3' ' HD2' ' A' ' 17' ' ' ARG . 58.7 m-85 -91.57 106.42 18.47 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 120.806 0.336 . . . . 0.0 111.12 -177.487 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.485 HG23 HG21 ' A' ' 16' ' ' VAL . 52.1 mt -71.66 -57.23 7.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.931 -176.851 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.485 HG21 HG23 ' A' ' 15' ' ' ILE . 61.0 t -129.0 132.05 67.63 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 CA-C-O 120.709 0.29 . . . . 0.0 110.963 -177.06 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.631 ' HD2' ' HB3' ' A' ' 14' ' ' TYR . 0.0 OUTLIER -128.06 115.62 18.75 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 174.949 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 27.6 m -124.11 166.01 19.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.732 0.301 . . . . 0.0 110.804 -179.598 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -87.51 137.08 32.65 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.623 -178.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -169.77 -165.1 0.47 Allowed 'General case' 0 C--O 1.237 0.437 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 178.377 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 7.3 p -140.44 126.97 21.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.031 0.443 . . . . 0.0 110.549 173.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.438 HG22 ' HB2' ' A' ' 73' ' ' LEU . 30.9 m -81.25 131.15 34.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.747 175.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 89.2 mmm -114.63 130.52 56.8 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.643 -0.502 . . . . 0.0 109.643 -176.471 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.402 HG22 ' HD1' ' A' ' 33' ' ' PHE . 9.5 t -103.16 162.01 13.32 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.086 0.469 . . . . 0.0 111.202 -178.518 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 19.8 ttt180 -120.38 21.26 11.72 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.18 -0.918 . . . . 0.0 108.6 178.239 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.404 ' O ' ' HB3' ' A' ' 27' ' ' ASP . 36.0 t70 49.17 38.39 13.09 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 114.423 -1.262 . . . . 0.0 111.192 177.899 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.404 ' HB3' ' O ' ' A' ' 26' ' ' ASP . 27.6 t70 73.27 -54.86 0.69 Allowed 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 115.242 -0.89 . . . . 0.0 112.758 177.207 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 22.1 m -136.62 18.59 3.09 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 112.611 0.597 . . . . 0.0 112.611 -174.025 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 65.7 m -86.14 -170.69 3.21 Favored 'General case' 0 C--N 1.327 -0.372 0 O-C-N 122.297 -0.252 . . . . 0.0 110.321 177.327 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -111.49 -44.14 0.93 Allowed Glycine 0 C--N 1.334 0.436 0 C-N-CA 121.294 -0.479 . . . . 0.0 112.368 -179.677 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -77.54 170.84 55.12 Favored Glycine 0 C--N 1.33 0.235 0 C-N-CA 121.192 -0.528 . . . . 0.0 112.692 -178.651 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . 0.4 ' HZ2' ' HZ1' ' A' ' 99' ' ' LYS . 91.0 m95 -117.41 120.37 37.96 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 179.665 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.402 ' HD1' HG22 ' A' ' 24' ' ' THR . 1.4 m-85 -101.79 156.36 35.29 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.657 -170.896 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.437 ' HB3' ' HA2' ' A' ' 38' ' ' GLY . 51.3 Cg_exo -56.44 -11.82 7.12 Favored 'Trans proline' 0 C--N 1.355 0.918 0 C-N-CA 123.352 2.701 . . . . 0.0 112.992 178.496 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . 0.539 HE22 ' HB ' ' A' ' 72' ' ' VAL . 0.2 OUTLIER 72.61 -71.08 0.14 Allowed 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 123.327 0.651 . . . . 0.0 110.554 174.256 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -161.74 -55.1 0.05 OUTLIER 'General case' 0 C--O 1.234 0.24 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 -179.779 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -62.76 -39.66 98.23 Favored Glycine 0 C--N 1.331 0.278 0 CA-C-N 115.596 -0.729 . . . . 0.0 112.553 -179.524 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.437 ' HA2' ' HB3' ' A' ' 34' ' ' PRO . . . 57.57 19.4 34.4 Favored Glycine 0 C--N 1.334 0.431 0 C-N-CA 121.544 -0.36 . . . . 0.0 113.551 177.16 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 140.2 -29.31 2.42 Favored Glycine 0 C--O 1.235 0.187 0 N-CA-C 111.203 -0.759 . . . . 0.0 111.203 -178.189 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.546 HD11 ' N ' ' A' ' 40' ' ' ILE . 2.8 mp -100.63 93.94 3.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 175.842 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 49.1 m -151.75 130.48 12.37 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 174.151 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 34.9 ttp180 -101.31 102.42 13.27 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 177.019 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 4.5 p -81.01 106.84 12.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 121.476 0.655 . . . . 0.0 109.976 179.52 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -102.8 112.37 4.25 Favored Glycine 0 N--CA 1.446 -0.669 0 CA-C-N 115.334 -0.848 . . . . 0.0 112.018 -179.511 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 7.0 p -86.45 109.22 18.6 Favored 'Isoleucine or valine' 0 C--O 1.239 0.5 0 CA-C-O 121.393 0.615 . . . . 0.0 109.967 176.162 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . 0.742 ' SG ' ' HB3' ' A' ' 60' ' ' LEU . 12.1 p -105.87 145.43 31.25 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.005 178.358 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 12.0 tmtt? -100.78 105.75 17.1 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 179.335 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.437 HG22 ' HE1' ' A' ' 76' ' ' TYR . 60.8 t -66.87 125.64 24.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.307 -179.129 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 66.1 mtt . . . . . 0 C--N 1.327 -0.4 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.193 179.253 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.384 0 N-CA-C 111.261 -0.735 . . . . 0.0 111.261 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -129.44 154.51 46.89 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 177.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.742 ' HB3' ' SG ' ' A' ' 46' ' ' CYS . 3.0 tt -128.42 119.06 24.22 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 178.882 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 57.2 mt -80.23 86.74 1.41 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.371 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 175.442 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . 0.44 ' HB3' ' HE2' ' A' ' 14' ' ' TYR . 21.7 t60 -98.84 107.69 20.19 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.981 -176.605 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -97.07 99.16 2.24 Favored Glycine 0 C--O 1.239 0.409 0 CA-C-N 115.81 -0.632 . . . . 0.0 112.488 -178.378 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -73.03 152.13 41.43 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 175.674 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 71.0 ttt-85 -67.38 -31.95 72.54 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 174.474 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -168.13 -60.92 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.233 178.377 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 53.7 tttm -173.93 124.12 0.34 Allowed 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 117.804 0.275 . . . . 0.0 111.611 175.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 57.69 14.62 2.5 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.636 0.774 . . . . 0.0 112.005 174.002 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -106.77 -69.65 0.83 Allowed 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 111.831 0.308 . . . . 0.0 111.831 -167.322 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 48.5 tp -149.34 138.04 21.05 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.426 -175.078 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 21.4 t -88.52 102.0 12.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 176.075 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.539 ' HB ' HE22 ' A' ' 35' ' ' GLN . 28.3 m -88.17 -20.86 7.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.625 0.25 . . . . 0.0 111.355 -176.04 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.534 HD11 ' N ' ' A' ' 74' ' ' GLU . 2.9 tm? -149.65 140.74 22.99 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 179.373 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.534 ' N ' HD11 ' A' ' 73' ' ' LEU . 34.0 tt0 -159.07 119.86 3.24 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 -177.863 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 66.2 m -142.27 137.86 30.96 Favored 'General case' 0 C--O 1.232 0.161 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 -176.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.437 ' HE1' HG22 ' A' ' 48' ' ' VAL . 85.7 t80 -99.82 138.89 36.27 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 110.215 -0.291 . . . . 0.0 110.215 -176.25 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.688 HG12 HG13 ' A' ' 95' ' ' VAL . 20.3 m -135.19 141.16 43.51 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 -178.717 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 36.4 mtm180 -110.32 -73.06 0.7 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.941 0.401 . . . . 0.0 110.068 -178.121 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -152.85 19.63 0.6 Allowed 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 175.675 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -112.61 17.48 19.13 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 114.229 -1.35 . . . . 0.0 110.276 -176.145 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.568 HD22 ' HB2' ' A' ' 83' ' ' TYR . 1.6 tt -73.37 92.54 1.84 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.278 -176.736 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 3.6 p -81.17 85.25 1.52 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 CA-C-O 121.509 0.671 . . . . 0.0 110.009 174.757 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.6 ' HD2' HG23 ' A' ' 117' ' ' VAL . 0.6 OUTLIER -92.23 102.7 15.22 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.003 -177.011 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 99.9 m -114.46 133.12 55.99 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.295 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.52 ' HA ' ' HA ' ' A' ' 91' ' ' HIS . 4.9 ptpp? -94.96 111.8 23.56 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 175.528 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -70.94 -35.04 72.05 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.364 0.602 . . . . 0.0 109.494 175.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . 0.524 ' HB2' ' HB3' ' A' ' 90' ' ' PHE . 92.5 m-20 -134.48 155.18 79.9 Favored Pre-proline 0 C--N 1.332 -0.18 0 CA-C-N 114.99 -1.005 . . . . 0.0 108.529 176.339 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -54.3 -23.23 29.47 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.546 2.164 . . . . 0.0 112.753 178.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 14.9 t -112.45 2.31 16.32 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.335 -178.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.524 ' HB3' ' HB2' ' A' ' 87' ' ' ASN . 72.1 t80 -131.73 109.74 10.38 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-O 120.929 0.395 . . . . 0.0 110.681 -177.761 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' HIS . . . . . 0.52 ' HA ' ' HA ' ' A' ' 85' ' ' LYS . 0.1 OUTLIER -107.03 159.68 16.11 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 177.65 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 17.2 p80 -155.73 160.82 40.64 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.612 0.244 . . . . 0.0 110.543 178.311 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 34.6 p90 -149.5 166.29 29.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.741 -178.664 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -131.63 106.08 7.94 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 174.264 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.688 HG13 HG12 ' A' ' 77' ' ' VAL . 29.8 m -136.56 172.54 15.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.139 -0.482 . . . . 0.0 109.822 179.544 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 42.9 m-20 59.09 -77.25 0.02 OUTLIER 'General case' 0 C--O 1.234 0.24 0 O-C-N 123.663 0.602 . . . . 0.0 110.427 -174.135 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 30.4 p-10 -163.26 9.12 0.05 Allowed 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 179.641 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 3.7 tpt180 -149.29 167.28 26.5 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 118.329 0.513 . . . . 0.0 111.627 -175.384 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.4 ' HZ1' ' HZ2' ' A' ' 32' ' ' TRP . 58.5 tttm -103.74 118.18 36.1 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.316 -176.882 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 33.8 m-85 -115.37 170.76 8.16 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.152 -0.476 . . . . 0.0 109.935 -178.591 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -142.39 164.86 26.88 Favored Glycine 0 C--N 1.332 0.35 0 C-N-CA 120.968 -0.634 . . . . 0.0 112.862 -177.657 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 8.3 tt -150.25 132.42 15.39 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 -179.586 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 45.5 m -112.76 134.54 54.23 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.868 0.366 . . . . 0.0 110.316 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 63.8 m-85 -86.78 -178.23 6.29 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.179 -179.003 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 24.6 tt0 -124.54 -70.55 0.75 Allowed 'General case' 0 C--O 1.236 0.346 0 CA-C-O 120.907 0.384 . . . . 0.0 111.122 -178.15 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 48.8 m -108.81 158.49 33.98 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.435 -175.127 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -54.8 -28.72 59.16 Favored 'Trans proline' 0 C--N 1.352 0.731 0 C-N-CA 122.539 2.159 . . . . 0.0 111.96 179.108 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -59.65 -68.39 0.29 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.736 178.513 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -61.62 -44.72 96.47 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.066 -178.475 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -56.23 -63.94 1.02 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.48 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 7.1 tpt180 -61.05 -39.51 90.09 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.635 -175.034 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -65.55 -39.48 91.76 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.075 -179.271 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 21.1 t80 -70.24 -42.87 71.64 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 -178.384 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 45.0 m-20 -58.53 -44.32 89.53 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-O 121.37 0.605 . . . . 0.0 109.991 175.489 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 45.2 ttm180 -63.75 -39.67 94.84 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.289 -0.869 . . . . 0.0 109.84 178.265 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -67.55 -44.7 81.91 Favored Glycine 0 N--CA 1.449 -0.468 0 CA-C-N 115.235 -0.893 . . . . 0.0 112.622 -178.063 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.6 HG23 ' HD2' ' A' ' 83' ' ' TYR . 13.0 p -68.5 -35.75 71.78 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.105 0 CA-C-N 116.744 0.272 . . . . 0.0 110.398 -179.237 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 67.1 ttt180 -58.95 -52.53 65.34 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 174.004 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 54.3 tptt -58.08 -32.01 67.64 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.063 178.519 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -68.79 -36.68 78.57 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.476 176.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.528 HG13 ' O ' ' A' ' 117' ' ' VAL . 77.5 mt -60.86 -47.98 90.94 Favored 'Isoleucine or valine' 0 C--O 1.232 0.173 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 176.814 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -58.91 -57.83 11.33 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-O 120.907 0.384 . . . . 0.0 110.382 174.167 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -63.03 -29.21 70.64 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.774 -0.648 . . . . 0.0 112.54 -171.658 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 49.6 tp -93.47 -44.41 8.26 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 111.789 0.292 . . . . 0.0 111.789 -177.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.501 HD12 HG22 ' A' ' 121' ' ' ILE . 59.3 mt -99.85 -44.52 11.62 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 N-CA-C 112.705 0.631 . . . . 0.0 112.705 -170.457 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 . . . . . 0 C--O 1.249 1.028 0 CA-C-O 119.104 -0.474 . . . . 0.0 111.32 -170.314 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 19.2 m . . . . . 0 C--O 1.237 0.42 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.575 ' HA ' ' HA ' ' A' ' 46' ' ' CYS . 45.4 m-85 -68.74 125.12 25.56 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 120.623 0.249 . . . . 0.0 110.663 175.696 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 62.4 mt -67.47 -47.66 79.9 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 177.166 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 9.8 p -166.19 139.37 0.92 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.334 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.216 178.494 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.673 HH12 ' NH1' ' A' ' 65' ' ' ARG . 50.0 mtt180 -109.23 100.99 10.05 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 176.317 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 30.1 t -92.52 148.48 4.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.989 -174.702 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -83.75 120.92 26.61 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.445 179.739 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -164.88 -171.04 2.13 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.108 -0.496 . . . . 0.0 109.76 -179.624 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.442 ' HB ' ' HB ' ' A' ' 103' ' ' THR . 84.7 t -121.44 115.88 47.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.651 0.263 . . . . 0.0 110.576 178.774 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.518 HG23 HE22 ' A' ' 35' ' ' GLN . 16.4 m -83.95 125.98 40.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.767 0.318 . . . . 0.0 110.524 177.795 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 22.5 mmt -112.27 150.31 31.13 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.795 -176.658 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 11.9 t -129.61 155.39 45.91 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.112 -0.495 . . . . 0.0 109.932 176.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 25.9 tpt180 -140.56 141.02 35.27 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 178.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -70.69 111.31 6.06 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 174.435 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 22.7 t70 61.96 -83.19 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.556 0 O-C-N 123.53 0.519 . . . . 0.0 111.887 179.034 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 68.3 m -154.4 -172.06 4.08 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 122.389 0.276 . . . . 0.0 110.882 -176.766 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 12.7 t 85.09 151.73 0.08 Allowed 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.165 0.986 . . . . 0.0 111.47 179.587 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -77.8 80.62 1.32 Allowed Glycine 0 C--N 1.334 0.454 0 CA-C-N 115.605 -0.725 . . . . 0.0 112.581 -176.692 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -152.68 55.51 0.44 Allowed Glycine 0 CA--C 1.51 -0.258 0 N-CA-C 110.595 -1.002 . . . . 0.0 110.595 176.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 80.6 m95 -70.79 119.53 15.07 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.158 -0.521 . . . . 0.0 111.219 -173.782 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 46.9 p90 -107.11 126.7 29.52 Favored Pre-proline 0 CA--C 1.534 0.35 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.678 -177.732 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -73.1 99.19 1.07 Allowed 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 122.75 2.3 . . . . 0.0 111.696 178.791 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . 0.545 HE21 HG23 ' A' ' 72' ' ' VAL . 5.0 pm0 -57.2 -48.78 77.93 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 115.648 -0.705 . . . . 0.0 112.703 -175.592 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.575 ' CB ' HG11 ' A' ' 72' ' ' VAL . 16.3 tp10 -134.8 -83.47 0.42 Allowed 'General case' 0 N--CA 1.467 0.406 0 O-C-N 122.254 -0.279 . . . . 0.0 110.919 -174.647 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -72.92 68.02 1.34 Allowed Glycine 0 C--N 1.336 0.568 0 C-N-CA 121.408 -0.425 . . . . 0.0 112.672 179.578 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -80.59 -35.35 25.91 Favored Glycine 0 C--N 1.331 0.267 0 C-N-CA 121.395 -0.431 . . . . 0.0 112.415 -179.085 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -79.45 -29.08 50.62 Favored Glycine 0 C--O 1.236 0.227 0 N-CA-C 111.454 -0.658 . . . . 0.0 111.454 177.741 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.406 HG12 ' NE2' ' A' ' 66' ' ' GLN . 8.6 tt -174.85 139.16 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 179.037 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 23.3 t -145.11 -178.51 6.09 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 177.628 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 60.1 mtt180 -130.89 106.9 8.73 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.098 0.475 . . . . 0.0 110.211 -177.222 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 40.9 t -81.6 103.39 8.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.127 -179.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -90.73 105.06 3.22 Favored Glycine 0 N--CA 1.446 -0.698 0 CA-C-N 115.959 -0.564 . . . . 0.0 112.352 -179.228 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 54.4 t -88.02 103.12 13.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 176.071 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . 0.614 ' SG ' ' HB3' ' A' ' 60' ' ' LEU . 5.3 p -108.49 145.55 34.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.258 -179.112 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 35.9 ttmt -98.31 100.96 12.29 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 175.093 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 30.1 m -86.87 128.58 39.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 121.096 0.474 . . . . 0.0 111.602 -172.468 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 25.1 ptm . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.553 178.877 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.387 0 N-CA-C 111.505 -0.638 . . . . 0.0 111.505 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.644 ' HB2' ' HB ' ' A' ' 77' ' ' VAL . 76.9 m-85 -134.96 163.78 29.08 Favored 'General case' 0 C--N 1.327 -0.409 0 O-C-N 122.559 -0.377 . . . . 0.0 110.299 -177.285 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.614 ' HB3' ' SG ' ' A' ' 46' ' ' CYS . 2.8 tt -150.29 118.63 6.41 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 177.843 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.447 ' O ' ' HA ' ' A' ' 74' ' ' GLU . 44.5 mm -82.63 91.53 2.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 175.537 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 12.6 t-80 -102.66 98.07 8.17 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.645 -174.445 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.499 ' O ' ' HB2' ' A' ' 64' ' ' GLU . . . -104.73 116.78 5.42 Favored Glycine 0 CA--C 1.522 0.48 0 CA-C-N 116.096 -0.502 . . . . 0.0 114.319 -171.727 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.675 ' HB2' HG21 ' A' ' 72' ' ' VAL . 7.7 tp10 165.08 -99.23 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 124.799 1.24 . . . . 0.0 109.103 164.228 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.673 ' NH1' HH12 ' A' ' 17' ' ' ARG . 8.6 tpt180 59.35 -1.03 0.15 Allowed 'General case' 0 CA--C 1.545 0.777 0 N-CA-C 113.436 0.902 . . . . 0.0 113.436 171.665 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.406 ' NE2' HG12 ' A' ' 40' ' ' ILE . 6.6 tp-100 -52.15 -59.04 4.84 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 -171.713 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 51.7 tttp -91.33 5.45 49.19 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-O 120.983 0.421 . . . . 0.0 110.397 -178.692 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 31.8 t0 64.84 149.2 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.568 -175.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 4.3 mppt? 55.84 26.23 9.4 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 121.003 0.43 . . . . 0.0 110.7 -169.681 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.547 HD23 ' HG2' ' A' ' 64' ' ' GLU . 0.9 OUTLIER -129.12 128.2 43.0 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.298 -0.631 . . . . 0.0 109.298 -179.056 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.609 ' HA ' ' HB3' ' A' ' 64' ' ' GLU . 51.4 t -137.66 140.67 40.93 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 179.18 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.675 HG21 ' HB2' ' A' ' 64' ' ' GLU . 27.5 m -130.35 -41.17 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 177.529 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.3 tt -124.36 133.79 53.33 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.389 -0.596 . . . . 0.0 109.389 -175.534 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.447 ' HA ' ' O ' ' A' ' 61' ' ' ILE . 11.0 pt-20 -146.98 130.3 16.62 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.067 0.461 . . . . 0.0 109.803 173.444 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 47.7 t -130.03 109.34 10.78 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 -179.321 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 24.9 t80 -74.7 129.55 37.9 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.046 -0.525 . . . . 0.0 109.914 -177.083 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.644 ' HB ' ' HB2' ' A' ' 59' ' ' PHE . 63.1 t -105.45 85.32 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.496 0.665 . . . . 0.0 109.216 -177.894 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.436 ' O ' ' HB3' ' A' ' 79' ' ' LYS . 6.9 ptm180 -97.29 67.01 2.11 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.195 -0.911 . . . . 0.0 109.631 -179.633 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.474 ' HA ' HD22 ' A' ' 124' ' ' LEU . 7.3 tmtm? 77.39 -49.08 0.52 Allowed 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.478 -175.365 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . 0.413 ' OD1' ' HG3' ' A' ' 78' ' ' ARG . 5.0 p-10 -81.91 128.97 34.6 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-O 121.058 0.456 . . . . 0.0 110.623 -178.595 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.627 HD12 HD11 ' A' ' 121' ' ' ILE . 3.3 tm? -177.48 135.53 0.19 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.269 -0.878 . . . . 0.0 108.684 -178.263 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 3.7 p -145.71 106.09 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 CA-C-O 121.019 0.438 . . . . 0.0 111.3 -179.054 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.704 ' HB3' ' NE2' ' A' ' 91' ' ' HIS . 3.2 m-85 -88.84 150.97 22.64 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.217 176.299 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 81.5 m -150.47 120.23 7.05 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.883 177.566 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.471 ' HZ2' ' HB3' ' A' ' 85' ' ' LYS . 8.0 ttpm? -90.64 110.72 21.87 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 177.707 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -78.62 -50.16 11.98 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.069 -179.374 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . 0.584 ' HB2' ' HB3' ' A' ' 90' ' ' PHE . 91.7 m-20 -120.11 153.41 55.39 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.004 179.706 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_endo -48.39 -33.63 23.24 Favored 'Trans proline' 0 CA--C 1.534 0.518 0 C-N-CA 122.99 2.46 . . . . 0.0 112.881 -176.295 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 15.2 t -112.36 13.87 20.34 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.419 -176.661 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.584 ' HB3' ' HB2' ' A' ' 87' ' ' ASN . 91.3 t80 -139.02 119.85 14.27 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-O 121.187 0.518 . . . . 0.0 111.493 -178.192 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' HIS . . . . . 0.704 ' NE2' ' HB3' ' A' ' 83' ' ' TYR . 1.2 t60 -116.24 157.8 24.34 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.384 -0.825 . . . . 0.0 108.915 178.5 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 25.0 p80 -155.05 157.58 37.8 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 175.304 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . 0.43 ' HZ3' ' HB2' ' A' ' 102' ' ' LEU . 36.4 p90 -144.03 174.21 11.05 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 176.687 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 61.5 pttt -144.01 155.57 44.06 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 179.559 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.625 HG22 ' H ' ' A' ' 96' ' ' ASP . 7.9 m -133.55 -63.73 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.913 176.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . 0.625 ' H ' HG22 ' A' ' 95' ' ' VAL . 20.3 m-20 -115.32 71.8 0.78 Allowed 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 -179.388 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 18.0 m120 74.02 -39.54 0.43 Allowed 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 115.346 -0.843 . . . . 0.0 112.155 178.788 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 63.7 ttt180 -87.18 148.8 25.02 Favored 'General case' 0 C--O 1.242 0.702 0 CA-C-O 121.033 0.444 . . . . 0.0 111.372 -176.083 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 61.9 mttp -100.71 143.57 30.72 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 114.956 -1.02 . . . . 0.0 110.834 178.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -118.94 143.85 46.78 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 172.061 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -113.09 163.04 12.17 Favored Glycine 0 C--N 1.331 0.285 0 C-N-CA 120.834 -0.698 . . . . 0.0 113.892 -170.722 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.43 ' HB2' ' HZ3' ' A' ' 93' ' ' TRP . 57.3 tp -150.7 106.92 3.46 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 122.793 0.437 . . . . 0.0 110.181 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' THR . . . . . 0.442 ' HB ' ' HB ' ' A' ' 21' ' ' VAL . 52.1 m -89.31 125.04 34.95 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.323 178.044 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.545 ' CZ ' ' HB2' ' A' ' 91' ' ' HIS . 23.8 m-85 -78.76 161.04 27.12 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.462 179.465 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 65.3 tt0 -109.17 -42.04 4.51 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.712 179.469 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 13.6 m -140.88 151.63 63.23 Favored Pre-proline 0 CA--C 1.533 0.327 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.254 -179.072 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_exo -50.41 -30.26 26.58 Favored 'Trans proline' 0 C--N 1.352 0.752 0 C-N-CA 122.975 2.45 . . . . 0.0 113.207 -179.289 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -62.87 -64.11 1.01 Allowed 'General case' 0 C--O 1.235 0.291 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.98 179.844 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -62.99 -33.95 76.51 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.354 179.236 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . 0.438 ' HB2' ' NH2' ' A' ' 111' ' ' ARG . . . -54.8 -63.89 1.01 Allowed 'General case' 0 C--O 1.235 0.325 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.092 177.688 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . 0.438 ' NH2' ' HB2' ' A' ' 110' ' ' ALA . 0.0 OUTLIER -65.65 -24.43 67.02 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.788 179.765 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -61.93 -40.51 95.75 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 175.124 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 47.4 m-85 -70.89 -48.23 54.84 Favored 'General case' 0 N--CA 1.461 0.1 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.587 176.083 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -53.54 -66.19 0.43 Allowed 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 121.39 0.614 . . . . 0.0 110.441 178.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 16.5 mtp180 -63.68 -36.56 84.25 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.889 -178.014 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -60.26 -53.78 42.77 Favored Glycine 0 C--N 1.332 0.344 0 CA-C-N 116.097 -0.501 . . . . 0.0 112.588 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 10.7 p -66.27 -36.47 77.46 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.121 0 CA-C-N 116.672 0.236 . . . . 0.0 110.505 -178.071 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 95.8 mtt180 -60.95 -42.59 98.52 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.475 -0.329 . . . . 0.0 111.104 177.777 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 30.8 mmtp -76.29 -27.52 56.66 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 120.68 0.276 . . . . 0.0 110.948 178.223 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -63.35 -48.69 76.91 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 174.732 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.627 HD11 HD12 ' A' ' 81' ' ' LEU . 46.9 mm -66.8 -36.08 76.33 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.187 176.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -54.65 -56.67 16.67 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.253 178.265 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 -70.15 -29.5 66.43 Favored 'General case' 0 C--O 1.225 -0.188 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.94 179.386 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.474 HD22 ' HA ' ' A' ' 79' ' ' LYS . 6.7 tt -59.59 -43.76 93.58 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 177.241 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 66.7 mt -77.7 -30.88 16.95 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.495 178.595 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.428 -0.796 . . . . 0.0 109.808 179.101 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 15.1 m . . . . . 0 N--CA 1.465 0.279 0 CA-C-O 120.798 0.333 . . . . 0.0 111.538 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 67.8 m-85 -88.05 147.9 24.75 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.96 0.41 . . . . 0.0 111.515 -176.649 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 48.9 mm -105.81 -37.88 4.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 168.036 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 59.4 t -136.29 142.98 37.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 114.964 -1.016 . . . . 0.0 108.684 175.327 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.484 HH21 ' CD ' ' A' ' 64' ' ' GLU . 63.1 ttt180 -149.24 84.02 1.44 Allowed 'General case' 0 C--O 1.235 0.304 0 CA-C-O 121.22 0.533 . . . . 0.0 109.931 179.223 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 60.1 t -107.37 141.78 21.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.034 -177.752 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.664 ' HD3' ' H ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -82.83 127.51 33.54 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.943 -0.392 . . . . 0.0 109.943 176.909 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -150.48 171.92 16.29 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.64 178.597 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.539 ' HB ' ' HB ' ' A' ' 103' ' ' THR . 49.0 t -84.99 96.89 5.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.977 0.417 . . . . 0.0 110.783 -176.398 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 57.8 t -79.35 113.67 19.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.562 179.761 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 22.5 mmt -99.34 156.55 16.94 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.024 -0.534 . . . . 0.0 109.923 178.27 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.496 HG22 ' CE1' ' A' ' 33' ' ' PHE . 8.8 t -130.39 142.12 50.53 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.026 0.441 . . . . 0.0 110.536 179.466 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.42 ' HB2' ' CZ3' ' A' ' 32' ' ' TRP . 0.0 OUTLIER -94.06 101.33 13.36 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 173.778 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.476 ' HB2' ' CE1' ' A' ' 33' ' ' PHE . 32.1 t70 -52.4 120.82 5.99 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 178.085 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -39.26 108.68 0.09 Allowed 'General case' 0 N--CA 1.466 0.339 0 O-C-N 124.228 0.955 . . . . 0.0 111.487 -176.231 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 40.6 p 46.02 82.31 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.39 0 O-C-N 123.836 0.71 . . . . 0.0 111.36 -176.377 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 6.9 t -131.15 -69.38 0.63 Allowed 'General case' 0 C--O 1.234 0.27 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.812 -175.535 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 174.12 -62.02 0.12 Allowed Glycine 0 C--N 1.333 0.364 0 C-N-CA 121.177 -0.535 . . . . 0.0 112.005 -179.26 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -128.46 -139.28 4.73 Favored Glycine 0 C--O 1.236 0.245 0 C-N-CA 121.226 -0.511 . . . . 0.0 112.556 -179.213 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . 0.508 ' HH2' ' HG2' ' A' ' 99' ' ' LYS . 67.8 m95 -125.1 149.4 47.88 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 179.252 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.496 ' CE1' HG22 ' A' ' 24' ' ' THR . 2.0 p90 -149.07 152.86 37.25 Favored Pre-proline 0 C--O 1.236 0.366 0 N-CA-C 110.318 -0.253 . . . . 0.0 110.318 177.726 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -63.03 125.69 16.41 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 122.297 1.998 . . . . 0.0 111.785 176.008 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . 0.649 ' HG2' HD21 ' A' ' 73' ' ' LEU . 2.0 pp0? -69.06 -168.67 0.15 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.263 174.739 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -55.59 -14.72 2.28 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 -173.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -67.59 -40.84 90.57 Favored Glycine 0 CA--C 1.521 0.414 0 N-CA-C 111.599 -0.6 . . . . 0.0 111.599 173.703 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 86.43 -33.95 3.57 Favored Glycine 0 C--N 1.333 0.411 0 N-CA-C 112.17 -0.372 . . . . 0.0 112.17 178.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.456 ' O ' ' HA ' ' A' ' 21' ' ' VAL . . . -162.78 -105.06 0.19 Allowed Glycine 0 N--CA 1.443 -0.859 0 N-CA-C 111.195 -0.762 . . . . 0.0 111.195 176.663 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.424 HG21 ' HB2' ' A' ' 19' ' ' LYS . 1.8 mp -60.9 131.88 26.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 120.973 0.416 . . . . 0.0 110.334 -179.904 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 41.6 m -145.82 152.89 40.25 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.333 178.322 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.763 ' HB2' ' HB2' ' A' ' 64' ' ' GLU . 13.1 mmt180 -72.99 105.13 4.34 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 110.379 -0.23 . . . . 0.0 110.379 -179.655 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 56.4 t -83.47 89.89 2.39 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 174.13 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -88.09 104.13 3.0 Favored Glycine 0 N--CA 1.444 -0.794 0 CA-C-N 115.515 -0.766 . . . . 0.0 112.669 -177.79 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 53.5 t -80.58 88.35 1.57 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.522 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 174.774 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . 0.676 ' HB3' ' HB3' ' A' ' 60' ' ' LEU . 42.6 t -85.58 146.73 26.75 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.392 179.204 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 79.6 tttt -142.73 96.88 3.01 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 -174.394 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 26.9 m -98.97 132.74 43.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.652 -176.82 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.248 0 CA-C-O 120.838 0.351 . . . . 0.0 111.116 -177.065 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.422 0 N-CA-C 110.937 -0.865 . . . . 0.0 110.937 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.439 ' HB2' HG21 ' A' ' 77' ' ' VAL . 69.5 m-85 -104.08 122.31 45.03 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.906 0.384 . . . . 0.0 110.316 -174.65 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.676 ' HB3' ' HB3' ' A' ' 46' ' ' CYS . 3.6 tt -103.9 107.3 18.12 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 179.416 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 61.4 mt -71.49 91.97 0.43 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.327 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 174.707 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 12.4 t-80 -97.3 100.39 11.85 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.074 -173.111 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.43 ' HA3' ' HB2' ' A' ' 73' ' ' LEU . . . -99.35 112.96 4.59 Favored Glycine 0 C--N 1.33 0.22 0 C-N-CA 121.399 -0.429 . . . . 0.0 112.271 -177.373 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.763 ' HB2' ' HB2' ' A' ' 42' ' ' ARG . 22.1 mt-10 -107.05 138.2 43.67 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 122.226 0.21 . . . . 0.0 110.607 -178.545 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 26.6 ttt85 -67.63 130.85 44.3 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 173.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 6.8 tp60 -58.56 154.93 13.2 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.368 -176.521 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt 72.86 -69.84 0.18 Allowed 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 123.422 0.689 . . . . 0.0 111.35 177.471 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -69.23 -36.23 77.0 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 120.706 0.289 . . . . 0.0 110.543 -176.541 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 50.4 mtmt 61.93 85.28 0.12 Allowed 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.57 -0.741 . . . . 0.0 112.06 176.285 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -150.26 154.91 38.74 Favored 'General case' 0 C--O 1.24 0.565 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 173.468 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 10.5 t -72.5 92.61 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 CA-C-O 120.958 0.408 . . . . 0.0 111.517 -171.662 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 9.5 m -88.22 -37.47 10.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.452 176.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.649 HD21 ' HG2' ' A' ' 35' ' ' GLN . 4.2 mm? -117.35 137.88 52.16 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 176.784 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.554 ' HG3' HD21 ' A' ' 60' ' ' LEU . 35.0 tt0 -150.21 114.56 5.17 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 177.868 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' CYS . . . . . 0.509 ' SG ' ' CE2' ' A' ' 100' ' ' PHE . 36.5 m -138.07 101.4 4.41 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.959 0.409 . . . . 0.0 110.156 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 75.5 t80 -84.62 112.31 20.33 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.12 -0.491 . . . . 0.0 109.924 179.791 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.457 HG22 HD23 ' A' ' 81' ' ' LEU . 16.4 m -97.54 100.33 10.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 121.863 0.84 . . . . 0.0 109.267 177.803 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 19.5 ptt180 -70.92 -45.68 63.81 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 114.631 -1.168 . . . . 0.0 112.092 -172.117 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 35.8 ttpt -160.99 29.73 0.14 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.569 0.7 . . . . 0.0 109.792 -175.02 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . 0.426 ' O ' ' HB ' ' A' ' 77' ' ' VAL . 7.3 p-10 -149.66 140.98 23.19 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.08 -178.802 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.457 HD23 HG22 ' A' ' 77' ' ' VAL . 12.8 mt -155.36 101.38 2.2 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.967 179.057 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.471 HG22 ' N ' ' A' ' 83' ' ' TYR . 27.6 m -74.3 -53.06 18.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 174.468 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.471 ' N ' HG22 ' A' ' 82' ' ' VAL . 4.5 t80 30.46 82.86 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.431 1.092 . . . . 0.0 112.015 177.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 36.0 m -112.41 133.48 54.47 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.998 -179.079 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.507 ' HA ' ' HA ' ' A' ' 91' ' ' HIS . 17.7 ptmt -93.46 101.72 13.93 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.315 0.579 . . . . 0.0 110.224 178.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -72.34 -49.49 33.94 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.975 -178.501 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . 0.551 ' HB2' ' HB3' ' A' ' 90' ' ' PHE . 0.8 OUTLIER -104.83 153.27 39.44 Favored Pre-proline 0 C--N 1.327 -0.387 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 174.753 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_exo -48.24 -31.91 18.13 Favored 'Trans proline' 0 CA--C 1.534 0.499 0 C-N-CA 122.621 2.214 . . . . 0.0 112.765 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.471 ' HA ' ' HD2' ' A' ' 104' ' ' PHE . 20.5 p -120.09 16.35 12.43 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 112.328 0.492 . . . . 0.0 112.328 -178.321 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.551 ' HB3' ' HB2' ' A' ' 87' ' ' ASN . 5.5 t80 -129.88 105.84 8.27 Favored 'General case' 0 C--O 1.239 0.5 0 CA-C-O 120.93 0.395 . . . . 0.0 110.094 178.665 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' HIS . . . . . 0.507 ' HA ' ' HA ' ' A' ' 85' ' ' LYS . 0.1 OUTLIER -102.73 133.18 48.19 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 177.763 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 30.2 p80 -129.1 155.05 46.07 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.935 0.398 . . . . 0.0 110.812 -178.003 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . 0.403 ' CE2' ' HB2' ' A' ' 100' ' ' PHE . 43.8 p90 -144.91 158.49 43.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.174 178.517 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 22.5 ptmt -144.02 148.98 35.98 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 177.784 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.691 HG23 ' H ' ' A' ' 96' ' ' ASP . 4.4 m -127.64 -66.87 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 C-N-CA 121.2 -0.2 . . . . 0.0 111.173 -179.3 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . 0.691 ' H ' HG23 ' A' ' 95' ' ' VAL . 10.9 m-20 -120.87 80.1 1.59 Allowed 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 177.157 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 52.4 t-20 74.35 -52.96 0.68 Allowed 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 114.79 -1.095 . . . . 0.0 111.429 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -68.87 139.42 55.17 Favored 'General case' 0 C--O 1.244 0.806 0 CA-C-O 121.003 0.43 . . . . 0.0 110.239 -175.813 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.508 ' HG2' ' HH2' ' A' ' 32' ' ' TRP . 39.7 ttmt -121.49 135.49 55.03 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.503 -178.711 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . 0.509 ' CE2' ' SG ' ' A' ' 75' ' ' CYS . 20.4 m-85 -124.0 164.31 19.61 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 -178.797 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -139.64 159.74 25.92 Favored Glycine 0 C--N 1.331 0.298 0 C-N-CA 120.764 -0.732 . . . . 0.0 113.461 -174.47 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.4 ' HB2' ' HZ3' ' A' ' 93' ' ' TRP . 5.6 tt -139.54 114.77 9.72 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 -179.496 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' THR . . . . . 0.539 ' HB ' ' HB ' ' A' ' 21' ' ' VAL . 48.5 m -93.3 119.65 32.69 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.087 176.873 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.471 ' HD2' ' HA ' ' A' ' 89' ' ' THR . 33.3 m-85 -70.02 158.4 35.74 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.224 179.599 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 45.6 mt-30 -108.13 -46.31 3.77 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.771 -178.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 14.7 m -135.07 156.49 78.26 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.408 -176.21 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -51.52 -30.49 35.82 Favored 'Trans proline' 0 C--N 1.35 0.619 0 C-N-CA 122.652 2.235 . . . . 0.0 112.49 177.036 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -60.57 -61.02 2.89 Favored 'General case' 0 C--O 1.239 0.516 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.384 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -65.52 -43.74 89.11 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.433 -0.348 . . . . 0.0 110.599 -178.724 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -51.95 -54.74 26.06 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 121.086 0.47 . . . . 0.0 111.027 177.36 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 34.7 ttt180 -61.59 -39.21 90.4 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.01 -177.633 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -61.99 -43.39 98.94 Favored 'General case' 0 C--O 1.231 0.109 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.304 179.685 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 49.1 m-85 -69.64 -39.86 76.87 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.617 -0.265 . . . . 0.0 110.965 -179.133 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.462 ' CG ' ' HZ3' ' A' ' 85' ' ' LYS . 45.6 m-20 -60.15 -57.88 10.91 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-O 121.31 0.576 . . . . 0.0 110.752 178.45 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 37.3 mmt180 -66.87 -31.27 71.76 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.171 -179.497 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -64.21 -48.86 70.53 Favored Glycine 0 N--CA 1.449 -0.441 0 CA-C-N 115.635 -0.711 . . . . 0.0 112.199 179.195 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.483 ' O ' HG12 ' A' ' 121' ' ' ILE . 11.5 p -66.89 -37.88 80.3 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.086 0 N-CA-C 110.26 -0.274 . . . . 0.0 110.26 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 8.1 tpt180 -56.69 -49.45 75.1 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-O 120.853 0.359 . . . . 0.0 110.169 176.054 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 60.0 tptt -58.61 -44.42 89.9 Favored 'General case' 0 C--O 1.241 0.647 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.382 177.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -57.94 -47.23 83.51 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.56 178.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.483 HG12 ' O ' ' A' ' 117' ' ' VAL . 43.0 mm -59.21 -46.63 92.05 Favored 'Isoleucine or valine' 0 C--O 1.232 0.14 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.469 179.422 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 62.6 mm-40 -51.7 -58.16 7.16 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.945 179.699 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -73.75 -33.22 64.21 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.569 -174.755 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 60.2 tp -64.98 -41.82 95.08 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.911 0.386 . . . . 0.0 110.449 -179.082 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 47.9 mm -78.99 -55.96 8.4 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.901 -178.106 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 . . . . . 0 C--O 1.253 1.243 0 CA-C-O 119.356 -0.354 . . . . 0.0 111.266 -176.827 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 57.8 m . . . . . 0 N--CA 1.469 0.484 0 N-CA-C 111.867 0.321 . . . . 0.0 111.867 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.418 ' HA ' ' HB3' ' A' ' 46' ' ' CYS . 59.5 m-85 -76.54 93.29 3.54 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 121.111 0.481 . . . . 0.0 110.504 177.922 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.55 HG22 HG22 ' A' ' 16' ' ' VAL . 44.0 mm -69.19 -56.59 11.31 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 CA-C-N 115.437 -0.802 . . . . 0.0 111.465 -173.809 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.55 HG22 HG22 ' A' ' 15' ' ' ILE . 57.8 t -131.84 131.15 61.96 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 CA-C-O 120.574 0.226 . . . . 0.0 111.128 -175.507 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.572 ' HG3' ' HA2' ' A' ' 44' ' ' GLY . 0.5 OUTLIER -110.89 98.27 7.45 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 171.895 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 44.9 t -76.39 154.85 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.464 -177.263 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 58.7 tttp -98.88 131.33 45.06 Favored 'General case' 0 N--CA 1.462 0.129 0 CA-C-O 120.826 0.346 . . . . 0.0 110.374 178.12 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.5 ' O ' ' HB2' ' A' ' 41' ' ' SER . . . -171.19 -166.95 0.5 Allowed 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 175.479 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 61.7 t -117.93 120.19 63.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 167.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.506 HG13 ' HG ' ' A' ' 73' ' ' LEU . 49.6 t -71.7 94.15 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 121.148 0.499 . . . . 0.0 109.985 179.65 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' MET . . . . . 0.445 ' HB3' ' HB3' ' A' ' 32' ' ' TRP . 21.4 mmt -86.44 110.7 19.91 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.582 -178.473 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 1.1 m -100.78 120.77 40.6 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.427 -0.806 . . . . 0.0 108.961 172.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.79 114.86 11.4 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 179.361 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -58.03 91.18 0.01 OUTLIER 'General case' 0 C--O 1.233 0.222 0 O-C-N 123.345 0.403 . . . . 0.0 110.44 -176.485 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 28.3 t70 55.54 -87.7 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.788 -176.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 60.4 m -157.99 26.97 0.26 Allowed 'General case' 0 C--O 1.235 0.315 0 CA-C-O 121.093 0.473 . . . . 0.0 109.993 177.532 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 34.8 t -143.18 159.52 42.14 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.032 -179.358 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 82.38 -53.57 4.8 Favored Glycine 0 C--N 1.329 0.187 0 C-N-CA 121.235 -0.507 . . . . 0.0 112.22 179.207 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 131.29 -161.43 23.59 Favored Glycine 0 C--N 1.331 0.304 0 N-CA-C 111.976 -0.449 . . . . 0.0 111.976 177.457 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . 0.445 ' HB3' ' HB3' ' A' ' 23' ' ' MET . 84.2 m95 -84.69 104.83 15.01 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 109.36 -0.608 . . . . 0.0 109.36 176.347 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -103.71 147.84 34.87 Favored Pre-proline 0 C--O 1.237 0.423 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 -175.522 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -59.96 132.21 43.56 Favored 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 122.472 2.114 . . . . 0.0 111.355 179.152 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 8.0 tp-100 -39.73 -47.16 2.01 Favored 'General case' 0 N--CA 1.468 0.439 0 O-C-N 123.764 0.665 . . . . 0.0 112.055 -175.782 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -176.07 -34.91 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 178.454 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -108.86 167.9 13.23 Favored Glycine 0 N--CA 1.453 -0.209 0 CA-C-N 115.14 -0.936 . . . . 0.0 110.776 171.466 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -132.49 150.41 19.68 Favored Glycine 0 C--O 1.234 0.151 0 C-N-CA 120.95 -0.643 . . . . 0.0 112.473 -178.194 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 81.06 -58.59 4.82 Favored Glycine 0 C--N 1.331 0.293 0 C-N-CA 121.46 -0.4 . . . . 0.0 112.585 178.407 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.493 HD11 ' N ' ' A' ' 40' ' ' ILE . 3.5 mp -101.85 107.29 21.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.783 0.325 . . . . 0.0 110.599 -178.784 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.5 ' HB2' ' O ' ' A' ' 20' ' ' ALA . 36.6 m -141.9 113.84 8.01 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 171.316 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.491 ' HB2' ' O ' ' A' ' 64' ' ' GLU . 5.7 mpt_? -88.79 133.48 34.23 Favored 'General case' 0 CA--C 1.519 -0.218 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 175.642 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.756 HG21 HD22 ' A' ' 102' ' ' LEU . 75.5 t -106.2 100.01 9.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.006 177.328 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.572 ' HA2' ' HG3' ' A' ' 17' ' ' ARG . . . -71.26 84.63 0.41 Allowed Glycine 0 N--CA 1.448 -0.546 0 CA-C-N 115.673 -0.694 . . . . 0.0 112.693 -179.202 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 54.8 t -75.69 107.96 7.22 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 176.479 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . 0.688 ' SG ' ' HB3' ' A' ' 60' ' ' LEU . 6.1 p -125.51 125.71 43.71 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.064 -0.517 . . . . 0.0 111.079 -177.336 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 57.8 tttm -87.6 89.08 7.86 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 175.833 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 31.0 t -77.12 125.57 37.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.23 -174.091 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 97.6 mmm . . . . . 0 C--N 1.326 -0.45 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 174.763 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.516 0 N-CA-C 111.29 -0.724 . . . . 0.0 111.29 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 71.7 m-85 -91.06 104.55 17.12 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.061 0.457 . . . . 0.0 109.813 -176.613 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.688 ' HB3' ' SG ' ' A' ' 46' ' ' CYS . 1.9 tt -93.35 106.71 18.64 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.806 -0.633 . . . . 0.0 109.499 -178.204 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 49.8 mm -78.58 85.91 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 173.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . 0.405 ' HA ' ' HA ' ' A' ' 74' ' ' GLU . 15.4 t-80 -90.94 168.11 11.92 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.593 -176.548 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -151.09 112.96 0.56 Allowed Glycine 0 C--O 1.236 0.258 0 C-N-CA 120.948 -0.644 . . . . 0.0 112.111 -178.309 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.491 ' O ' ' HB2' ' A' ' 42' ' ' ARG . 0.0 OUTLIER -145.95 -167.29 2.68 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 122.385 0.274 . . . . 0.0 110.739 -176.101 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.43 ' HB3' ' HD3' ' A' ' 42' ' ' ARG . 0.0 OUTLIER 57.41 34.95 25.39 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-O 120.928 0.394 . . . . 0.0 110.205 175.181 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 84.0 mm-40 -63.88 -11.58 28.98 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 115.67 -0.695 . . . . 0.0 112.571 -172.447 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 34.7 ttpt -174.5 -63.28 0.01 OUTLIER 'General case' 0 C--O 1.234 0.261 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 173.311 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -105.43 -85.05 0.49 Allowed 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 170.595 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.69 ' HZ1' ' HB3' ' A' ' 69' ' ' LYS . 6.3 ttpm? -140.72 108.17 5.56 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 178.565 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 48.2 tp -163.73 124.54 2.26 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 110.418 -0.216 . . . . 0.0 110.418 -173.375 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 83.9 t -98.58 135.23 34.28 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 O-C-N 123.697 0.623 . . . . 0.0 109.443 173.052 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 35.4 m -134.92 -41.17 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 N-CA-C 112.127 0.418 . . . . 0.0 112.127 -177.195 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.528 HD11 ' N ' ' A' ' 74' ' ' GLU . 3.0 tm? -119.91 143.3 48.03 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.821 0.343 . . . . 0.0 110.781 -170.847 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.528 ' N ' HD11 ' A' ' 73' ' ' LEU . 9.5 pt-20 -158.45 112.17 2.44 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.915 173.555 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 42.0 t -126.0 97.81 5.26 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 179.512 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.409 ' HB2' ' HG ' ' A' ' 60' ' ' LEU . 69.2 t80 -88.36 134.82 33.72 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.99 -176.336 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 35.1 m -141.42 145.28 24.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 176.31 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 24.5 ttp180 -130.67 -24.44 2.46 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.134 0.493 . . . . 0.0 110.428 177.2 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.516 ' HD3' ' N ' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -160.9 29.21 0.15 Allowed 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 174.948 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -127.92 170.31 12.98 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 115.123 -0.944 . . . . 0.0 110.709 -167.45 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.624 HD11 ' CD1' ' A' ' 93' ' ' TRP . 10.2 tt 72.92 151.8 0.12 Allowed 'General case' 0 N--CA 1.469 0.514 0 O-C-N 123.996 0.81 . . . . 0.0 112.163 167.854 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.502 ' N ' HD23 ' A' ' 81' ' ' LEU . 8.7 p -139.63 141.02 35.74 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.68 177.221 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 14.6 m-85 -94.5 166.35 12.09 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 121.176 0.513 . . . . 0.0 111.079 -177.633 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 88.7 m -152.08 109.81 3.64 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.015 176.548 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.471 ' O ' ' HD2' ' A' ' 85' ' ' LYS . 0.0 OUTLIER -108.81 138.57 44.93 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.941 0.401 . . . . 0.0 110.663 -179.316 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -108.18 -45.72 3.88 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.956 -0.566 . . . . 0.0 109.846 178.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 -133.94 158.86 74.42 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.324 -179.749 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -60.43 -19.97 61.36 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.175 1.917 . . . . 0.0 111.917 177.648 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 34.8 p -100.43 2.72 42.49 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.724 -179.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 70.6 t80 -147.05 101.39 3.41 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-O 121.128 0.49 . . . . 0.0 109.921 -178.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 3.3 t-160 -131.08 110.22 11.04 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 -177.689 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . 0.646 ' HA ' ' HA3' ' A' ' 101' ' ' GLY . 16.9 p80 -120.54 -178.19 3.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.744 0.307 . . . . 0.0 110.646 -176.883 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . 0.624 ' CD1' HD11 ' A' ' 81' ' ' LEU . 41.4 p90 -148.77 -171.36 3.85 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.57 174.292 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -151.73 147.28 26.5 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.913 0.387 . . . . 0.0 111.029 -177.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.429 HG23 ' O ' ' A' ' 95' ' ' VAL . 19.0 m -123.97 107.51 18.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 172.887 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 21.9 t70 67.53 -68.02 0.17 Allowed 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.903 -174.82 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 45.7 t-20 -144.25 -43.04 0.26 Allowed 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 178.766 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 88.2 mtm180 -58.41 124.2 18.74 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.037 -179.538 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.48 ' HD3' ' N ' ' A' ' 99' ' ' LYS . 0.0 OUTLIER -116.42 129.32 56.16 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.245 -175.107 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . 0.4 ' HA ' ' HZ3' ' A' ' 32' ' ' TRP . 1.8 p90 -148.22 155.3 41.2 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.384 -0.825 . . . . 0.0 109.356 177.421 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . 0.646 ' HA3' ' HA ' ' A' ' 92' ' ' HIS . . . -175.83 -157.57 17.4 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.565 -0.826 . . . . 0.0 113.148 -176.915 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.756 HD22 HG21 ' A' ' 43' ' ' VAL . 9.2 mp -114.56 146.6 40.56 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 121.362 0.601 . . . . 0.0 111.683 -174.354 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 91.4 m -123.69 111.51 16.28 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 166.649 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 48.7 m-85 -89.77 149.42 22.72 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.737 -170.398 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 19.3 mp0 -103.08 -43.14 5.57 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 170.708 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -82.2 141.61 46.59 Favored Pre-proline 0 CA--C 1.535 0.388 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.496 178.7 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -86.38 -38.48 0.09 OUTLIER 'Trans proline' 0 C--N 1.353 0.776 0 C-N-CA 122.676 2.251 . . . . 0.0 114.217 -174.052 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -64.89 -60.08 3.47 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 120.879 0.371 . . . . 0.0 111.639 -172.767 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 22.4 p-10 -66.43 -26.51 67.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.476 -178.696 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -60.68 -52.79 63.62 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 121.217 0.532 . . . . 0.0 110.313 172.706 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 4.2 tmm_? -63.81 -32.72 74.33 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.746 178.242 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -65.68 -39.27 91.11 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.749 177.214 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.468 ' O ' HG23 ' A' ' 117' ' ' VAL . 73.2 t80 -66.91 -52.99 36.48 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.122 179.079 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.442 ' O ' ' HG3' ' A' ' 118' ' ' ARG . 13.7 t70 -54.09 -56.9 13.71 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 121.522 0.677 . . . . 0.0 110.178 179.42 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 15.2 tpt180 -53.27 -47.74 68.87 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-N 114.628 -1.169 . . . . 0.0 110.605 176.825 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -59.76 -38.69 94.29 Favored Glycine 0 N--CA 1.451 -0.327 0 CA-C-N 115.505 -0.77 . . . . 0.0 112.15 -179.695 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.468 HG23 ' O ' ' A' ' 113' ' ' PHE . 48.3 t -62.09 -46.98 95.25 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 CA-C-O 120.736 0.303 . . . . 0.0 110.315 177.406 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . 0.442 ' HG3' ' O ' ' A' ' 114' ' ' ASP . 81.5 mtt180 -54.85 -54.7 39.05 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.125 179.582 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.633 ' HB3' ' HZ2' ' A' ' 119' ' ' LYS . 0.0 OUTLIER -68.2 -29.59 68.47 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.764 -177.258 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -65.19 -58.05 6.96 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.829 0.347 . . . . 0.0 110.342 179.547 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 49.3 mm -59.63 -43.07 90.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.388 179.663 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 13.5 tp10 -58.52 -50.14 74.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.571 -179.303 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -72.7 -29.81 63.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.911 -176.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 6.1 tt -69.09 -53.31 20.98 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.753 179.733 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 47.9 mm -72.32 -52.47 23.87 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.547 -174.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 . . . . . 0 C--O 1.25 1.107 0 CA-C-O 119.011 -0.519 . . . . 0.0 110.145 -175.288 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.902 0 N-CA-C 111.447 -0.661 . . . . 0.0 111.447 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.8 t -61.79 -45.82 92.22 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 173.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' MET . . . . . 0.435 ' N ' ' SD ' ' A' ' 3' ' ' MET . 1.8 mpt? -99.68 146.27 26.69 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 168.677 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 53.3 m 59.6 93.05 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 O-C-N 123.44 0.463 . . . . 0.0 110.341 -176.245 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -93.8 104.61 16.68 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.049 0.452 . . . . 0.0 111.295 -176.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -94.63 -165.69 1.35 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.692 -0.685 . . . . 0.0 109.25 172.085 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.632 HG21 ' HB2' ' A' ' 13' ' ' SER . 24.7 m 69.66 8.93 6.99 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-O 121.158 0.504 . . . . 0.0 111.419 178.556 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.682 ' HB2' ' HD3' ' A' ' 9' ' ' PRO . 89.3 m-70 -127.94 -63.63 0.02 OUTLIER Pre-proline 0 CA--C 1.541 0.599 0 CA-C-N 116.53 -0.305 . . . . 0.0 111.123 178.575 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.682 ' HD3' ' HB2' ' A' ' 8' ' ' HIS . 84.9 Cg_endo -80.71 -52.34 0.05 OUTLIER 'Trans proline' 0 C--N 1.363 1.325 0 C-N-CA 121.534 1.489 . . . . 0.0 112.272 -177.147 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -79.85 -1.79 40.62 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.461 179.308 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.564 ' O ' ' HA ' ' A' ' 7' ' ' THR . 35.5 m-20 66.24 -79.2 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.74 -179.305 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 12.8 t70 64.33 -74.7 0.05 OUTLIER 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 123.102 0.561 . . . . 0.0 112.344 175.023 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.632 ' HB2' HG21 ' A' ' 7' ' ' THR . 6.4 m -83.85 11.5 7.51 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 112.494 0.553 . . . . 0.0 112.494 -170.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 10.0 m-85 -66.89 112.93 4.56 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 120.685 0.279 . . . . 0.0 110.489 176.009 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.527 HG13 HG23 ' A' ' 16' ' ' VAL . 34.0 pt -92.01 -26.82 4.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.357 178.188 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.527 HG23 HG13 ' A' ' 15' ' ' ILE . 92.1 t -135.35 137.72 49.53 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.194 179.466 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.452 ' NH1' ' HG2' ' A' ' 42' ' ' ARG . 18.9 tpp180 -132.74 123.33 26.03 Favored 'General case' 0 N--CA 1.463 0.21 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 175.508 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 30.2 m -124.09 176.6 5.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 C-N-CA 122.659 0.383 . . . . 0.0 110.375 179.072 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 22.4 pttp -132.48 125.51 30.83 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 179.43 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -165.91 177.71 6.95 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 -179.3 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 60.2 t -100.24 118.14 46.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 110.177 -0.305 . . . . 0.0 110.177 176.059 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 17.8 m -66.71 109.0 1.15 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.354 0 CA-C-O 121.352 0.596 . . . . 0.0 111.237 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 25.1 mmt -106.65 166.52 10.51 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.129 179.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.512 HG23 ' CE1' ' A' ' 33' ' ' PHE . 11.0 t -160.84 150.63 17.39 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.934 -0.575 . . . . 0.0 109.708 177.769 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 20.7 ttt180 -120.31 100.64 7.29 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 174.071 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -69.38 84.31 0.4 Allowed 'General case' 0 C--O 1.235 0.299 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.481 179.449 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 15.4 t70 64.44 -81.63 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.139 -175.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 41.2 m -149.43 17.8 0.93 Allowed 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 120.81 0.338 . . . . 0.0 110.432 178.228 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 38.6 t -64.66 89.58 0.07 Allowed 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.829 -179.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 76.32 -63.72 2.91 Favored Glycine 0 C--N 1.332 0.353 0 CA-C-N 116.093 -0.503 . . . . 0.0 112.351 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 158.51 -140.28 6.84 Favored Glycine 0 N--CA 1.449 -0.475 0 N-CA-C 111.027 -0.829 . . . . 0.0 111.027 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . 0.497 ' HH2' ' HG2' ' A' ' 99' ' ' LYS . 97.9 m95 -79.02 93.9 5.2 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 176.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.512 ' CE1' HG23 ' A' ' 24' ' ' THR . 21.3 p90 -103.65 143.17 26.11 Favored Pre-proline 0 C--O 1.236 0.353 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.505 -178.311 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -69.08 103.37 1.04 Allowed 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.286 1.991 . . . . 0.0 111.266 176.19 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -57.04 -49.44 75.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.476 -179.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -157.45 171.2 20.8 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 179.36 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 78.52 -75.41 1.97 Allowed Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 121.053 -0.594 . . . . 0.0 111.777 -179.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 70.91 -73.95 0.64 Allowed Glycine 0 C--N 1.332 0.354 0 C-N-CA 121.562 -0.351 . . . . 0.0 112.25 -179.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -70.86 76.96 0.54 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 121.5 -0.381 . . . . 0.0 112.289 178.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 38.1 mm 66.87 142.84 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 C-N-CA 123.442 0.697 . . . . 0.0 111.31 178.455 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 18.2 m -132.96 133.85 43.74 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.057 0.455 . . . . 0.0 110.44 178.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.452 ' HG2' ' NH1' ' A' ' 17' ' ' ARG . 37.8 ttt85 -86.51 83.44 7.64 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.551 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 28.8 t -100.97 155.53 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.567 -172.414 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -162.78 -178.19 36.41 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.623 -0.799 . . . . 0.0 112.702 177.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 59.8 t -128.98 128.63 67.52 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 179.008 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . 0.516 ' SG ' ' HB3' ' A' ' 60' ' ' LEU . 13.7 p -119.45 126.44 51.32 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 176.479 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -82.06 98.39 8.62 Favored 'General case' 0 C--O 1.234 0.237 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 179.392 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.493 HG21 ' HE1' ' A' ' 76' ' ' TYR . 33.0 m -86.53 -168.95 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.21 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 22.1 ptp -169.27 169.68 9.02 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 177.497 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -82.34 131.23 56.45 Favored Pre-proline 0 C--N 1.327 -0.373 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 176.273 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -56.3 -13.45 9.94 Favored 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 123.306 2.671 . . . . 0.0 113.298 -173.242 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -57.21 -36.79 71.3 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.419 178.208 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 73.44 81.52 0.4 Allowed Glycine 0 C--N 1.333 0.4 0 CA-C-N 115.849 -0.614 . . . . 0.0 112.327 179.043 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 19.5 m120 -134.04 23.04 3.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.891 0.376 . . . . 0.0 110.544 -179.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 84.31 -49.68 4.27 Favored Glycine 0 C--N 1.331 0.284 0 C-N-CA 121.326 -0.464 . . . . 0.0 112.249 179.389 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 30.9 ttp-105 -51.86 128.43 23.94 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 122.616 0.366 . . . . 0.0 110.778 177.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 15.4 m -119.96 161.86 20.18 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.841 -177.101 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -121.83 -173.41 14.45 Favored Glycine 0 N--CA 1.452 -0.248 0 N-CA-C 110.714 -0.954 . . . . 0.0 110.714 176.18 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -135.96 148.7 48.59 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 117.337 0.568 . . . . 0.0 110.518 -177.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.664 HD21 ' HB2' ' A' ' 62' ' ' HIS . 2.3 tt -133.37 113.0 12.07 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 179.171 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.544 ' HB ' ' HB2' ' A' ' 75' ' ' CYS . 46.2 mt -79.96 98.31 3.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 108.396 -0.965 . . . . 0.0 108.396 174.605 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . 0.664 ' HB2' HD21 ' A' ' 60' ' ' LEU . 23.8 t-80 -120.93 141.22 50.86 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 -173.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -156.3 126.93 1.88 Allowed Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.322 -0.942 . . . . 0.0 113.132 -177.439 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -90.5 164.04 14.4 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 172.273 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.554 ' HB3' HG11 ' A' ' 72' ' ' VAL . 16.5 ptm180 -81.41 164.1 22.32 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.176 -0.675 . . . . 0.0 109.176 172.633 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 54.7 tp60 -78.05 68.3 4.07 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-O 121.38 0.61 . . . . 0.0 109.43 179.304 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.795 ' HE3' ' HA ' ' A' ' 67' ' ' LYS . 0.5 OUTLIER -171.58 49.7 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.223 -0.899 . . . . 0.0 109.017 -177.145 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.436 ' HB2' ' O ' ' A' ' 67' ' ' LYS . 4.3 m-20 71.8 -179.05 0.22 Allowed 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 115.257 -0.883 . . . . 0.0 111.149 -177.502 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.454 ' HZ1' ' CG ' ' A' ' 11' ' ' ASP . 5.1 mptp? -65.92 93.62 0.2 Allowed 'General case' 0 C--O 1.233 0.215 0 CA-C-N 115.897 -0.592 . . . . 0.0 112.594 -175.463 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 58.1 tp -136.22 105.14 5.88 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 167.403 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 44.1 t -62.56 108.34 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.673 -177.035 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.554 HG11 ' HB3' ' A' ' 65' ' ' ARG . 33.7 m -107.75 -9.84 10.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.77 179.112 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -144.67 127.11 15.93 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 179.338 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -146.74 115.27 6.74 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 177.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . 0.544 ' HB2' ' HB ' ' A' ' 61' ' ' ILE . 39.8 m -137.73 85.42 2.11 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.079 0.466 . . . . 0.0 109.986 177.545 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.493 ' HE1' HG21 ' A' ' 48' ' ' VAL . 86.3 t80 -75.28 135.38 40.94 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.548 176.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.419 HG11 ' HG ' ' A' ' 81' ' ' LEU . 25.6 m -134.19 149.56 30.32 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 177.602 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.456 ' HD3' ' N ' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -108.83 -35.09 6.47 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.183 -174.346 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 59.9 tttm -165.83 23.34 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 121.491 0.663 . . . . 0.0 109.625 -177.591 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -146.63 125.18 12.44 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.227 -170.223 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.419 ' HG ' HG11 ' A' ' 77' ' ' VAL . 5.3 mt -160.81 122.55 3.05 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.014 177.042 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 48.4 t -124.29 98.64 5.52 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 177.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.632 ' HB3' ' NE2' ' A' ' 91' ' ' HIS . 84.1 m-85 -90.58 161.68 15.34 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.407 177.234 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.446 ' HB ' ' CE1' ' A' ' 92' ' ' HIS . 60.7 m -158.89 115.66 2.72 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 174.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.51 ' HZ2' ' CG ' ' A' ' 114' ' ' ASP . 36.2 ttpt -89.11 107.54 19.1 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 178.457 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -73.71 -41.68 62.26 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.387 -175.001 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -136.61 153.47 75.97 Favored Pre-proline 0 C--N 1.325 -0.472 0 CA-C-N 115.203 -0.908 . . . . 0.0 108.647 179.017 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_exo -52.89 -23.51 21.26 Favored 'Trans proline' 0 N--CA 1.476 0.449 0 C-N-CA 122.491 2.127 . . . . 0.0 112.695 -179.166 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 14.6 t -107.54 8.93 29.55 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.576 -177.277 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.409 ' HE1' ' HB3' ' A' ' 92' ' ' HIS . 4.6 t80 -148.38 111.68 4.95 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-O 120.975 0.417 . . . . 0.0 110.953 -178.083 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . 0.632 ' NE2' ' HB3' ' A' ' 83' ' ' TYR . 3.1 t-160 -111.52 133.28 53.91 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 177.613 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . 0.446 ' CE1' ' HB ' ' A' ' 84' ' ' THR . 33.0 p80 -134.52 165.22 25.69 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.852 0.358 . . . . 0.0 111.346 -177.345 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 47.4 p90 -147.66 143.87 27.97 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.351 -179.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 48.6 tttm -112.99 122.94 49.14 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.153 179.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 27.7 m -110.21 32.88 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.325 0 CA-C-O 121.265 0.555 . . . . 0.0 109.937 -177.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 23.8 t70 71.92 -57.42 0.62 Allowed 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 114.859 -1.064 . . . . 0.0 109.81 -173.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -73.9 97.1 2.72 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 172.497 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 12.2 mpt_? 60.56 176.38 0.1 Allowed 'General case' 0 C--O 1.243 0.748 0 CA-C-O 122.186 0.993 . . . . 0.0 112.077 -176.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.497 ' HG2' ' HH2' ' A' ' 32' ' ' TRP . 38.1 ttpt -126.51 106.95 9.81 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 114.34 -1.3 . . . . 0.0 108.2 176.274 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . 0.499 ' CD2' ' SG ' ' A' ' 75' ' ' CYS . 4.7 m-85 -89.76 173.87 8.03 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 -175.816 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -177.66 -175.44 44.87 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.833 -0.699 . . . . 0.0 111.972 177.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.427 ' O ' HD13 ' A' ' 102' ' ' LEU . 1.3 pp -152.0 150.33 29.87 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.099 0.476 . . . . 0.0 110.898 177.012 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 25.2 m -101.0 116.18 32.24 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.806 176.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 40.5 m-85 -63.59 147.42 51.52 Favored 'General case' 0 C--O 1.237 0.413 0 O-C-N 123.369 0.418 . . . . 0.0 110.422 178.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 19.0 pt20 -114.25 -10.8 12.68 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.473 -0.331 . . . . 0.0 110.974 -178.244 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 20.4 m -155.12 151.7 23.5 Favored Pre-proline 0 C--N 1.33 -0.251 0 N-CA-C 110.089 -0.337 . . . . 0.0 110.089 174.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -60.16 -19.2 55.7 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.344 2.029 . . . . 0.0 111.65 176.361 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -66.08 -60.43 2.83 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.519 177.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -65.19 -31.98 73.43 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.79 179.035 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -57.61 -61.53 2.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.003 0.43 . . . . 0.0 110.726 175.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.427 ' O ' ' HD2' ' A' ' 111' ' ' ARG . 5.4 tmm_? -62.57 -38.23 89.28 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.235 -177.496 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -63.5 -43.48 97.11 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.095 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 75.4 t80 -67.06 -47.33 71.64 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.081 -178.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.51 ' CG ' ' HZ2' ' A' ' 85' ' ' LYS . 59.5 m-20 -57.5 -39.48 76.57 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.526 178.095 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . 0.419 HH11 ' HD2' ' A' ' 115' ' ' ARG . 0.6 OUTLIER -62.12 -49.86 74.22 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.112 178.359 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -61.25 -42.4 99.77 Favored Glycine 0 C--N 1.333 0.367 0 CA-C-N 115.599 -0.728 . . . . 0.0 112.063 179.631 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 55.4 t -60.91 -46.67 96.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.927 0.394 . . . . 0.0 110.699 177.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 25.6 tpt180 -59.88 -49.78 76.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.221 -177.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.68 ' HZ1' ' HB3' ' A' ' 119' ' ' LYS . 4.3 mmmp? -64.28 -41.18 97.02 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.942 178.691 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -58.08 -55.99 27.78 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.538 -179.591 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.426 ' O ' HG23 ' A' ' 125' ' ' ILE . 46.2 mm -58.27 -42.59 84.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.326 178.687 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -53.28 -59.08 5.01 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.472 -179.355 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 50.0 m-20 -74.16 -24.67 59.42 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.271 -176.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 9.9 tt -68.89 -38.83 79.9 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.36 178.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.426 HG23 ' O ' ' A' ' 121' ' ' ILE . 13.8 tt -91.17 -37.83 9.77 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 CA-C-N 116.625 -0.261 . . . . 0.0 111.342 -176.496 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 . . . . . 0 C--O 1.25 1.093 0 CA-C-O 118.422 -0.799 . . . . 0.0 110.218 -177.04 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.892 0 N-CA-C 112.005 -0.438 . . . . 0.0 112.005 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.403 ' O ' ' HB2' ' A' ' 3' ' ' MET . 20.1 m 66.3 155.31 0.09 Allowed 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 122.875 0.47 . . . . 0.0 111.113 -178.521 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' MET . . . . . 0.403 ' HB2' ' O ' ' A' ' 2' ' ' SER . 1.5 mpt? 73.23 -52.08 0.7 Allowed 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.461 0.704 . . . . 0.0 111.225 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 56.4 p -120.47 89.38 3.12 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 110.307 -0.257 . . . . 0.0 110.307 176.006 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 17.8 mp0 -67.42 -57.02 7.32 Favored 'General case' 0 C--O 1.232 0.178 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 175.149 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -90.41 168.99 11.44 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.502 171.587 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.495 HG22 ' HA ' ' A' ' 11' ' ' ASP . 5.2 t -166.04 178.83 6.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.852 0.358 . . . . 0.0 111.368 -176.596 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.445 ' HB3' ' HD3' ' A' ' 9' ' ' PRO . 80.2 t60 176.43 -42.31 0.0 OUTLIER Pre-proline 0 CA--C 1.544 0.714 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.009 -171.192 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.445 ' HD3' ' HB3' ' A' ' 8' ' ' HIS . 45.6 Cg_endo -100.82 15.5 0.39 Allowed 'Trans proline' 0 C--N 1.363 1.296 0 C-N-CA 123.009 2.473 . . . . 0.0 113.698 174.768 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -143.46 -72.41 0.29 Allowed 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 -174.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.495 ' HA ' HG22 ' A' ' 7' ' ' THR . 0.9 OUTLIER 74.1 94.43 0.07 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.135 -0.939 . . . . 0.0 113.384 165.049 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -131.23 21.37 4.83 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.145 -0.934 . . . . 0.0 108.581 171.162 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 39.2 t -128.86 -24.01 3.01 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-N 115.281 -0.872 . . . . 0.0 111.442 -175.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.491 ' HE1' HG21 ' A' ' 7' ' ' THR . 5.2 m-85 -64.2 140.75 58.9 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 120.912 0.386 . . . . 0.0 111.303 -177.905 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 61.2 mt -126.71 -64.92 0.98 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.203 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.427 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.548 ' HB ' ' HB ' ' A' ' 45' ' ' VAL . 60.2 t -99.07 106.29 18.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.095 -178.193 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.417 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 62.2 mtm180 -120.42 90.15 3.27 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.044 0.45 . . . . 0.0 110.212 179.421 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.403 HG12 ' HB2' ' A' ' 109' ' ' ASP . 86.6 t -107.89 135.87 45.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.887 -176.545 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -85.46 106.16 16.6 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 174.239 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -144.84 -172.15 3.77 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.114 -177.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.567 ' HB ' ' HB ' ' A' ' 103' ' ' THR . 23.6 t -101.53 121.54 52.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.615 0.245 . . . . 0.0 110.473 -179.193 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.486 HG13 ' HG ' ' A' ' 73' ' ' LEU . 60.8 t -97.71 98.28 7.18 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 CA-C-O 121.035 0.445 . . . . 0.0 110.461 176.134 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' MET . . . . . 0.44 ' HB3' ' HB3' ' A' ' 32' ' ' TRP . 24.9 mmt -74.47 106.38 6.04 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 174.06 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.452 HG21 ' CE1' ' A' ' 33' ' ' PHE . 10.0 t -76.69 -46.4 25.72 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 111.583 0.216 . . . . 0.0 111.583 -173.204 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.505 ' HB2' ' CE3' ' A' ' 32' ' ' TRP . 23.4 ttt180 57.84 135.13 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 121.317 0.58 . . . . 0.0 110.396 -172.041 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -81.08 64.85 5.98 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 177.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 32.5 t70 58.96 -74.73 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 114.536 -1.211 . . . . 0.0 110.932 -172.5 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 26.4 t -121.76 99.06 6.25 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 177.242 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 10.8 m -126.04 159.71 32.04 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.712 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -69.3 76.55 0.35 Allowed Glycine 0 C--N 1.332 0.34 0 N-CA-C 111.582 -0.607 . . . . 0.0 111.582 176.583 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 106.72 -158.67 15.16 Favored Glycine 0 C--O 1.237 0.334 0 N-CA-C 111.264 -0.735 . . . . 0.0 111.264 -175.035 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . 0.505 ' CE3' ' HB2' ' A' ' 25' ' ' ARG . 53.7 m95 -127.42 126.16 41.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.656 0.265 . . . . 0.0 110.424 -179.593 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.472 ' HA ' ' HD3' ' A' ' 34' ' ' PRO . 6.4 p90 -114.44 137.71 22.75 Favored Pre-proline 0 C--O 1.238 0.45 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.139 -179.851 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.557 ' HB2' ' HA2' ' A' ' 38' ' ' GLY . 7.3 Cg_exo -74.05 154.07 47.18 Favored 'Trans proline' 0 N--CA 1.462 -0.367 0 C-N-CA 122.785 2.323 . . . . 0.0 111.358 175.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.411 ' H ' ' HG3' ' A' ' 35' ' ' GLN . 0.0 OUTLIER -75.51 -163.39 0.25 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.303 175.166 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -45.99 -34.55 4.09 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 -173.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -66.73 -30.1 75.74 Favored Glycine 0 CA--C 1.519 0.336 0 C-N-CA 121.242 -0.504 . . . . 0.0 113.074 -175.581 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.557 ' HA2' ' HB2' ' A' ' 34' ' ' PRO . . . 58.37 13.53 16.44 Favored Glycine 0 CA--C 1.522 0.476 0 C-N-CA 121.506 -0.378 . . . . 0.0 113.248 179.497 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.475 ' HA2' HG22 ' A' ' 21' ' ' VAL . . . 154.81 -43.12 0.58 Allowed Glycine 0 N--CA 1.449 -0.451 0 N-CA-C 111.612 -0.595 . . . . 0.0 111.612 -176.884 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.435 ' O ' HG13 ' A' ' 40' ' ' ILE . 32.4 pt -89.88 111.06 22.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 121.221 0.534 . . . . 0.0 110.532 179.263 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 21.1 m -146.41 131.15 17.96 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.73 177.581 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.567 ' HB3' ' HB2' ' A' ' 64' ' ' GLU . 35.4 ttt180 -90.31 103.27 15.97 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 176.304 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.614 HG21 HD21 ' A' ' 102' ' ' LEU . 25.5 t -81.2 94.51 2.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.164 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -90.27 81.89 1.37 Allowed Glycine 0 N--CA 1.452 -0.276 0 CA-C-N 115.978 -0.556 . . . . 0.0 112.639 -177.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.548 ' HB ' ' HB ' ' A' ' 16' ' ' VAL . 61.0 t -76.44 108.72 9.55 Favored 'Isoleucine or valine' 0 C--O 1.24 0.569 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 176.506 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . 0.624 ' SG ' ' HB3' ' A' ' 60' ' ' LEU . 11.8 p -115.65 136.86 52.64 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.997 -177.738 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -91.52 92.31 8.46 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 176.397 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 23.1 m -83.76 111.63 20.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 121.396 0.617 . . . . 0.0 110.667 -176.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 22.7 ptp -98.85 124.91 44.06 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.392 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 7.8 p80 -70.23 132.82 87.8 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.09 178.421 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -56.58 138.99 86.84 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 122.859 2.373 . . . . 0.0 112.434 -175.387 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 66.26 16.03 10.29 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 115.736 -0.666 . . . . 0.0 111.172 178.208 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -65.46 148.47 51.26 Favored Glycine 0 C--N 1.333 0.411 0 CA-C-N 115.884 -0.598 . . . . 0.0 112.461 179.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 29.3 p-10 -79.06 -21.04 47.39 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.668 0.27 . . . . 0.0 111.043 -177.426 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 162.66 161.22 11.93 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.291 178.246 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 91.3 mtt-85 67.23 168.77 0.25 Allowed 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 123.513 0.725 . . . . 0.0 111.066 -177.076 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 22.7 m -153.55 161.66 42.0 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.542 -177.525 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -87.11 160.01 31.72 Favored Glycine 0 N--CA 1.45 -0.387 0 N-CA-C 111.188 -0.765 . . . . 0.0 111.188 177.008 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -117.84 106.91 13.49 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.934 0.397 . . . . 0.0 110.286 179.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.624 ' HB3' ' SG ' ' A' ' 46' ' ' CYS . 2.5 tt -88.66 105.16 17.5 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 179.7 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 58.6 mt -73.41 87.96 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 174.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 8.5 t-80 -91.55 100.33 13.09 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.177 -175.318 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.473 ' HA3' ' HB2' ' A' ' 73' ' ' LEU . . . -87.1 95.09 2.04 Favored Glycine 0 N--CA 1.449 -0.496 0 CA-C-N 115.762 -0.654 . . . . 0.0 112.324 -178.819 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.567 ' HB2' ' HB3' ' A' ' 42' ' ' ARG . 34.6 mt-10 -83.07 137.49 34.08 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 177.007 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.52 ' NH1' ' HB2' ' A' ' 67' ' ' LYS . 6.3 tmm_? -114.04 126.18 54.83 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 178.411 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.422 ' O ' ' HD2' ' A' ' 65' ' ' ARG . 1.0 OUTLIER -67.84 -160.95 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.488 0 O-C-N 123.564 0.54 . . . . 0.0 112.073 -174.262 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.52 ' HB2' ' NH1' ' A' ' 65' ' ' ARG . 34.5 mmtp 65.4 -82.89 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 -173.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -74.22 -30.81 62.35 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.615 176.47 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.458 ' HA ' ' O ' ' A' ' 65' ' ' ARG . 22.8 tptm 60.27 81.89 0.17 Allowed 'General case' 0 C--O 1.233 0.217 0 CA-C-N 115.084 -0.962 . . . . 0.0 110.074 -176.721 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -150.1 168.7 23.16 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.472 -177.741 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 21.6 t -83.15 109.69 17.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.893 -176.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.432 HG21 HD21 ' A' ' 73' ' ' LEU . 18.0 m -102.05 -35.91 4.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 CA-C-O 120.888 0.375 . . . . 0.0 111.053 177.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.486 ' HG ' HG13 ' A' ' 22' ' ' VAL . 4.5 mm? -116.24 117.11 29.1 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.229 178.741 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -118.96 104.2 10.29 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 176.205 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . 0.401 ' SG ' ' CE2' ' A' ' 100' ' ' PHE . 61.1 m -135.22 83.48 2.02 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.346 0.593 . . . . 0.0 110.632 -179.329 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 80.0 t80 -69.41 105.98 2.78 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.468 -0.787 . . . . 0.0 108.997 172.477 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 39.6 t -100.69 132.71 45.84 Favored 'Isoleucine or valine' 0 C--O 1.237 0.395 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 -175.053 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.414 ' C ' ' H ' ' A' ' 80' ' ' ASP . 30.4 ttp180 -135.46 100.17 4.43 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.403 -174.33 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.685 ' H ' HD21 ' A' ' 124' ' ' LEU . 66.4 mmtt 72.05 -29.74 0.2 Allowed 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.339 0.655 . . . . 0.0 112.748 178.444 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.414 ' H ' ' C ' ' A' ' 78' ' ' ARG . 11.6 p-10 -88.38 23.01 2.31 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 120.973 0.416 . . . . 0.0 110.753 -177.058 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.588 HD23 HG12 ' A' ' 121' ' ' ILE . 1.0 OUTLIER -71.3 89.85 0.91 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.828 -179.249 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 49.0 t -123.0 99.9 7.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.121 0.486 . . . . 0.0 110.593 179.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.705 ' HB3' ' NE2' ' A' ' 91' ' ' HIS . 4.2 m-85 -87.1 115.47 24.51 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.47 175.738 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 31.2 m -98.61 119.71 37.8 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.176 -0.465 . . . . 0.0 109.869 173.387 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.441 ' HZ3' ' CG ' ' A' ' 114' ' ' ASP . 24.2 ttmm -86.6 103.94 15.57 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 176.646 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -82.56 -19.9 37.62 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 121.064 0.459 . . . . 0.0 110.237 -178.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . 0.831 ' HB3' ' HB3' ' A' ' 90' ' ' PHE . 12.3 t-20 -156.58 144.69 14.3 Favored Pre-proline 0 C--N 1.326 -0.453 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 178.761 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.443 ' HD2' ' ND2' ' A' ' 87' ' ' ASN . 33.9 Cg_exo -34.47 -50.8 0.65 Allowed 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 123.374 2.716 . . . . 0.0 113.718 179.309 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.558 ' HA ' ' HD2' ' A' ' 104' ' ' PHE . 19.5 p -102.37 -0.72 32.18 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 112.144 0.424 . . . . 0.0 112.144 -176.872 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.831 ' HB3' ' HB3' ' A' ' 87' ' ' ASN . 62.0 t80 -115.78 99.3 7.21 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-O 121.402 0.62 . . . . 0.0 110.07 176.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . 0.705 ' NE2' ' HB3' ' A' ' 83' ' ' TYR . 0.8 OUTLIER -103.15 149.9 24.18 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 177.493 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 25.5 p80 -149.91 159.56 44.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 118.206 0.457 . . . . 0.0 110.74 176.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . 0.644 ' HZ3' ' HB2' ' A' ' 102' ' ' LEU . 28.5 p90 -137.29 146.72 45.01 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.323 -0.399 . . . . 0.0 109.979 178.632 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.697 ' HZ2' ' HB3' ' A' ' 94' ' ' LYS . 5.7 ttpm? -114.63 99.47 7.55 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.704 -178.708 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.46 HG11 ' HD1' ' A' ' 93' ' ' TRP . 16.7 m -85.18 113.58 23.87 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 176.023 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 57.08 -86.89 0.02 OUTLIER 'General case' 0 C--O 1.235 0.311 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.405 -173.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -126.22 -16.66 5.42 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.457 -177.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.98 134.2 33.51 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.836 0.351 . . . . 0.0 110.86 -177.395 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 3.6 mppt? -109.98 123.24 49.29 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.029 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . 0.401 ' CE2' ' SG ' ' A' ' 75' ' ' CYS . 44.3 m-85 -122.05 141.71 51.1 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 176.211 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -116.73 125.33 6.52 Favored Glycine 0 CA--C 1.516 0.144 0 C-N-CA 121.377 -0.439 . . . . 0.0 113.227 -174.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.644 ' HB2' ' HZ3' ' A' ' 93' ' ' TRP . 0.4 OUTLIER -94.4 104.28 16.25 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 175.675 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.567 ' HB ' ' HB ' ' A' ' 21' ' ' VAL . 33.3 m -92.54 119.5 32.07 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 177.161 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.558 ' HD2' ' HA ' ' A' ' 89' ' ' THR . 36.7 m-85 -73.82 148.22 42.64 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.438 -175.04 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -88.81 -52.56 5.05 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.605 -176.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' SER . . . . . 0.407 ' HB3' ' HD2' ' A' ' 107' ' ' PRO . 19.7 m -134.01 159.11 73.67 Favored Pre-proline 0 C--N 1.326 -0.413 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.142 -177.826 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.407 ' HD2' ' HB3' ' A' ' 106' ' ' SER . 12.9 Cg_endo -55.59 -29.85 71.96 Favored 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 122.526 2.15 . . . . 0.0 112.17 -179.46 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -61.8 -62.04 2.08 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.77 179.371 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.403 ' HB2' HG12 ' A' ' 18' ' ' VAL . 3.3 p-10 -66.83 -29.09 68.92 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.838 -179.455 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -57.82 -60.82 3.12 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.922 0.392 . . . . 0.0 110.697 176.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 69.7 mtp180 -64.12 -42.37 96.89 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.54 -0.754 . . . . 0.0 110.802 -178.431 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -61.54 -41.46 97.38 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.938 -179.359 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 35.4 t80 -75.42 -37.02 60.67 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.213 -177.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.441 ' CG ' ' HZ3' ' A' ' 85' ' ' LYS . 35.3 m-20 -58.82 -53.83 53.92 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 120.884 0.373 . . . . 0.0 110.336 177.29 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? -66.01 -37.92 87.15 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.501 179.05 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -62.77 -49.98 68.07 Favored Glycine 0 C--N 1.331 0.274 0 CA-C-N 116.053 -0.522 . . . . 0.0 112.501 -179.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.51 ' O ' HG13 ' A' ' 121' ' ' ILE . 9.1 p -69.66 -35.45 65.9 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.201 0 N-CA-C 110.123 -0.325 . . . . 0.0 110.123 -178.598 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.519 ' O ' ' HG3' ' A' ' 122' ' ' GLU . 69.8 ttt180 -57.46 -51.16 70.59 Favored 'General case' 0 C--O 1.23 0.073 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 176.091 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 64.3 tttp -56.82 -43.93 81.53 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.422 177.453 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.58 -43.18 97.61 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.154 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.588 HG12 HD23 ' A' ' 81' ' ' LEU . 80.2 mt -62.18 -51.53 71.3 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.195 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.414 179.536 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.519 ' HG3' ' O ' ' A' ' 118' ' ' ARG . 42.8 mt-10 -61.23 -44.52 97.13 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 115.729 -0.668 . . . . 0.0 110.616 -177.363 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -60.67 -42.21 96.62 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.527 178.323 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.685 HD21 ' H ' ' A' ' 79' ' ' LYS . 41.0 tp -66.65 -47.72 71.66 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.134 -177.715 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.477 HG12 ' O ' ' A' ' 121' ' ' ILE . 17.7 pt -74.53 -65.05 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 C-N-CA 120.964 -0.294 . . . . 0.0 111.42 -176.791 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.455 ' N ' HG13 ' A' ' 125' ' ' ILE . 71.7 mm-40 . . . . . 0 C--O 1.25 1.129 0 CA-C-O 119.035 -0.507 . . . . 0.0 110.069 -172.498 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.74 0 N-CA-C 112.019 -0.432 . . . . 0.0 112.019 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 49.1 m -83.81 85.2 7.33 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.126 0.489 . . . . 0.0 110.639 179.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 26.1 ptm -71.69 -24.0 61.75 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.131 176.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.436 ' O ' ' HB2' ' A' ' 5' ' ' GLU . 7.7 t -129.12 -174.32 3.24 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 115.452 -0.795 . . . . 0.0 108.938 177.054 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.436 ' HB2' ' O ' ' A' ' 4' ' ' THR . 2.1 mp0 66.51 18.37 10.8 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 110.04 -0.355 . . . . 0.0 110.04 -170.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 59.34 -174.01 0.1 Allowed 'General case' 0 C--O 1.235 0.322 0 CA-C-N 115.399 -0.818 . . . . 0.0 111.365 -177.439 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 57.0 m -152.19 123.57 7.75 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.93 -177.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.675 ' CD2' ' HD2' ' A' ' 9' ' ' PRO . 31.8 t-80 -65.46 149.3 97.34 Favored Pre-proline 0 CA--C 1.539 0.53 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 175.09 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.675 ' HD2' ' CD2' ' A' ' 8' ' ' HIS . 26.8 Cg_exo -36.33 -38.16 0.3 Allowed 'Trans proline' 0 C--N 1.366 1.453 0 C-N-CA 122.967 2.445 . . . . 0.0 112.238 176.094 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -134.94 116.01 14.22 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 163.369 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -116.72 23.01 12.28 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 -177.37 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -106.18 -40.55 5.61 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.292 -175.195 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -92.48 21.31 5.44 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 121.057 0.456 . . . . 0.0 111.277 -173.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -76.89 137.88 39.4 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.046 177.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.683 HD13 ' HB2' ' A' ' 47' ' ' LYS . 1.8 mp -88.35 -53.48 9.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 173.723 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 14.5 p -166.03 146.07 1.66 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.311 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.38 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.494 ' HG2' ' HA3' ' A' ' 44' ' ' GLY . 24.0 mtm180 -118.09 109.06 15.97 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.492 173.04 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 34.8 m -109.23 162.81 6.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.824 -177.058 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.48 ' HE3' HG12 ' A' ' 40' ' ' ILE . 83.9 tttt -84.41 130.13 34.8 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.414 177.172 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -153.92 -167.27 2.61 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 175.378 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.559 ' HB ' ' HB ' ' A' ' 103' ' ' THR . 64.8 t -124.51 114.85 42.63 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 175.15 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.482 HG23 ' HG2' ' A' ' 35' ' ' GLN . 9.3 m -73.08 110.45 6.32 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 CA-C-O 121.367 0.603 . . . . 0.0 111.67 -178.102 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' MET . . . . . 0.534 ' SD ' HG12 ' A' ' 21' ' ' VAL . 38.3 mmm -104.42 146.02 29.45 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.628 -0.714 . . . . 0.0 109.554 -178.521 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.482 ' HB ' ' NE2' ' A' ' 35' ' ' GLN . 10.7 t -135.32 -6.12 2.3 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 111.766 0.284 . . . . 0.0 111.766 179.26 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 31.6 ttp180 53.25 46.93 25.46 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 122.891 0.477 . . . . 0.0 111.324 -178.26 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.487 ' O ' ' HB3' ' A' ' 27' ' ' ASP . 4.4 p-10 45.88 26.65 0.4 Allowed 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 124.038 0.935 . . . . 0.0 113.361 174.102 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.487 ' HB3' ' O ' ' A' ' 26' ' ' ASP . 8.3 t70 74.99 -40.23 0.43 Allowed 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 122.785 0.434 . . . . 0.0 111.518 178.633 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 17.2 m -96.91 -91.57 0.24 Allowed 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 116.945 -0.116 . . . . 0.0 111.278 -176.017 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 11.0 p -176.72 27.73 0.0 OUTLIER 'General case' 0 C--O 1.236 0.391 0 N-CA-C 112.253 0.464 . . . . 0.0 112.253 -174.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -76.34 -28.83 59.23 Favored Glycine 0 CA--C 1.519 0.342 0 C-N-CA 120.772 -0.727 . . . . 0.0 111.924 179.066 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 158.34 151.3 6.03 Favored Glycine 0 CA--C 1.519 0.318 0 C-N-CA 121.386 -0.435 . . . . 0.0 112.265 178.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 83.9 m95 -76.95 102.04 6.24 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 110.165 -0.309 . . . . 0.0 110.165 179.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -114.83 153.55 46.94 Favored Pre-proline 0 C--O 1.237 0.422 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.145 177.48 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_exo -67.05 130.67 23.39 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.791 2.328 . . . . 0.0 111.473 175.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.482 ' HG2' HG23 ' A' ' 22' ' ' VAL . 7.9 pt20 -92.02 85.92 5.67 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 121.32 0.581 . . . . 0.0 110.837 -178.132 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 71.66 -34.13 0.29 Allowed 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.929 0.892 . . . . 0.0 113.312 176.459 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.438 ' HA2' ' HD2' ' A' ' 65' ' ' ARG . . . -63.77 -50.02 64.3 Favored Glycine 0 C--N 1.333 0.405 0 C-N-CA 121.163 -0.541 . . . . 0.0 112.347 -179.729 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 82.45 -146.0 24.46 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.99 -0.624 . . . . 0.0 111.672 -178.312 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -65.17 -23.6 69.89 Favored Glycine 0 CA--C 1.518 0.243 0 C-N-CA 121.429 -0.415 . . . . 0.0 112.83 -178.601 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.48 HG12 ' HE3' ' A' ' 19' ' ' LYS . 57.8 mt -113.52 104.3 16.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.961 0.41 . . . . 0.0 110.344 179.28 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.413 ' HB3' HG11 ' A' ' 22' ' ' VAL . 19.1 m -131.1 107.71 9.24 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 173.697 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.598 ' HB3' ' HG3' ' A' ' 64' ' ' GLU . 47.0 ttt180 -77.08 91.72 3.7 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.223 0.535 . . . . 0.0 109.901 -177.422 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 78.8 t -79.74 119.89 30.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.197 -179.459 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.494 ' HA3' ' HG2' ' A' ' 17' ' ' ARG . . . -116.91 123.28 5.75 Favored Glycine 0 N--CA 1.445 -0.705 0 CA-C-N 115.897 -0.592 . . . . 0.0 112.76 -177.396 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.451 HG12 ' HB ' ' A' ' 15' ' ' ILE . 7.6 p -99.51 123.29 52.15 Favored 'Isoleucine or valine' 0 C--O 1.24 0.591 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 175.086 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . 0.814 ' SG ' ' HB3' ' A' ' 60' ' ' LEU . 8.8 p -126.37 141.87 51.74 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.507 178.853 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.683 ' HB2' HD13 ' A' ' 15' ' ' ILE . 83.3 tttt -88.21 102.19 14.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.843 -176.199 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.564 HG13 ' OH ' ' A' ' 76' ' ' TYR . 95.4 t -74.67 96.14 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 121.06 0.457 . . . . 0.0 110.631 -177.139 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -86.44 164.65 16.87 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.286 178.566 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 24.8 p80 -150.68 161.81 29.13 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-N 116.244 -0.435 . . . . 0.0 109.96 -175.246 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -53.94 144.4 56.46 Favored 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 122.438 2.092 . . . . 0.0 111.354 174.135 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -52.17 105.49 0.12 Allowed 'General case' 0 C--O 1.234 0.27 0 CA-C-O 120.847 0.356 . . . . 0.0 110.895 -177.416 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -151.51 -86.29 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.263 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.924 -179.01 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -71.42 -77.22 0.09 Allowed 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.811 0.339 . . . . 0.0 110.999 -179.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 132.38 156.59 8.3 Favored Glycine 0 C--N 1.331 0.273 0 N-CA-C 111.572 -0.611 . . . . 0.0 111.572 -178.4 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 31.0 mmt180 60.26 90.01 0.06 Allowed 'General case' 0 C--O 1.234 0.281 0 CA-C-O 121.27 0.557 . . . . 0.0 110.582 -176.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.401 ' OG ' ' HE2' ' A' ' 47' ' ' LYS . 19.3 p -59.89 143.73 50.64 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.215 -0.902 . . . . 0.0 111.472 -178.814 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -81.89 -166.7 37.96 Favored Glycine 0 C--N 1.333 0.369 0 C-N-CA 121.039 -0.601 . . . . 0.0 111.827 179.487 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -141.09 144.49 34.93 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.751 0.31 . . . . 0.0 110.501 -179.008 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.814 ' HB3' ' SG ' ' A' ' 46' ' ' CYS . 1.6 tt -104.51 109.47 21.36 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 172.559 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.656 ' HB ' ' HB3' ' A' ' 75' ' ' CYS . 44.5 mm -81.66 89.52 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 108.415 -0.958 . . . . 0.0 108.415 174.354 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 12.3 t-80 -93.01 144.35 25.33 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.509 -0.768 . . . . 0.0 110.617 -173.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.496 ' HA3' ' HB3' ' A' ' 73' ' ' LEU . . . -131.43 87.21 0.29 Allowed Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 121.164 -0.541 . . . . 0.0 111.986 179.085 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.598 ' HG3' ' HB3' ' A' ' 42' ' ' ARG . 6.0 pt-20 -88.08 135.13 33.56 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 173.483 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.438 ' HD2' ' HA2' ' A' ' 37' ' ' GLY . 21.7 mtm180 -54.78 -67.05 0.3 Allowed 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 120.868 0.366 . . . . 0.0 111.676 -172.08 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 39.6 mt-30 -118.36 -43.69 2.71 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.054 0.454 . . . . 0.0 110.61 -175.179 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 32.3 ttpt -173.16 94.24 0.11 Allowed 'General case' 0 C--O 1.236 0.352 0 CA-C-N 115.593 -0.73 . . . . 0.0 109.128 -178.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 12.5 t70 52.11 -143.7 0.66 Allowed 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 -175.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 86.0 tttt 71.04 -65.39 0.34 Allowed 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 123.513 0.725 . . . . 0.0 112.028 175.133 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.8 tt -129.01 114.49 16.47 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-O 120.711 0.291 . . . . 0.0 110.279 -175.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 48.3 t -89.18 113.88 26.41 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.623 176.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 18.5 m -105.57 -12.5 9.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 111.762 0.282 . . . . 0.0 111.762 -177.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.496 ' HB3' ' HA3' ' A' ' 63' ' ' GLY . 3.3 tm? -142.98 120.32 11.6 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 -179.617 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -127.71 98.51 5.21 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 178.79 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . 0.656 ' HB3' ' HB ' ' A' ' 61' ' ' ILE . 41.9 t -124.08 67.0 1.05 Allowed 'General case' 0 C--O 1.235 0.305 0 CA-C-O 121.668 0.747 . . . . 0.0 110.475 -177.708 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.564 ' OH ' HG13 ' A' ' 48' ' ' VAL . 31.8 t80 -62.64 101.14 0.23 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 114.94 -1.027 . . . . 0.0 109.089 173.64 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.592 HG22 HD12 ' A' ' 81' ' ' LEU . 29.2 m -84.08 111.39 19.92 Favored 'Isoleucine or valine' 0 C--O 1.239 0.539 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 -178.737 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.495 ' NH1' ' O ' ' A' ' 76' ' ' TYR . 9.8 mpt_? -77.56 66.05 3.2 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.98 -177.327 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 50.9 mtpt 72.71 -33.85 0.28 Allowed 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.773 0.829 . . . . 0.0 112.002 -178.476 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -75.92 108.25 8.67 Favored 'General case' 0 C--O 1.233 0.189 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 173.206 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.592 HD12 HG22 ' A' ' 77' ' ' VAL . 6.6 tt -134.58 113.8 12.13 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 -177.519 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 49.2 t -124.28 90.61 1.64 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 CA-C-O 120.701 0.286 . . . . 0.0 110.989 -179.075 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.712 ' HB3' ' NE2' ' A' ' 91' ' ' HIS . 4.1 m-85 -88.26 152.93 21.61 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 120.922 0.392 . . . . 0.0 110.205 174.012 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 61.8 m -155.55 118.2 4.23 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 123.535 0.734 . . . . 0.0 109.097 178.044 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.481 ' HA ' ' HA ' ' A' ' 91' ' ' HIS . 3.1 pptp? -90.81 131.89 36.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.888 0.375 . . . . 0.0 110.249 179.33 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -96.32 -31.08 13.07 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.249 0.547 . . . . 0.0 109.697 176.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . 0.538 ' HB2' ' HB3' ' A' ' 90' ' ' PHE . 43.9 m-80 -143.3 158.93 57.01 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 115.251 -0.886 . . . . 0.0 109.282 179.134 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.435 ' O ' ' HB2' ' A' ' 110' ' ' ALA . 52.3 Cg_exo -55.91 -28.23 67.18 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.227 1.951 . . . . 0.0 111.642 175.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.442 ' HA ' ' HB2' ' A' ' 104' ' ' PHE . 12.6 p -109.3 16.41 22.41 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 115.74 -0.663 . . . . 0.0 111.601 -178.724 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.538 ' HB3' ' HB2' ' A' ' 87' ' ' ASN . 58.7 t80 -150.67 107.11 3.49 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-O 120.803 0.335 . . . . 0.0 110.734 -178.789 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . 0.712 ' NE2' ' HB3' ' A' ' 83' ' ' TYR . 2.2 t60 -120.16 141.92 49.43 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 177.913 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . 0.445 ' HA ' ' HA2' ' A' ' 101' ' ' GLY . 21.5 p80 -138.12 152.62 48.91 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.485 0.183 . . . . 0.0 110.516 -179.275 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . 0.601 ' HZ3' HD23 ' A' ' 102' ' ' LEU . 47.3 p90 -127.13 145.54 50.71 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 121.228 0.537 . . . . 0.0 111.245 -179.214 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 36.3 ttmt -91.59 133.42 35.56 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.285 -176.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 9.3 m -134.38 82.04 0.56 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.316 0 CA-C-O 121.558 0.694 . . . . 0.0 110.783 177.138 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 20.0 t70 59.67 -84.73 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 114.861 -1.063 . . . . 0.0 111.846 178.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -99.29 -48.39 4.83 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 120.741 0.305 . . . . 0.0 110.826 -176.481 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 9.0 mpt_? -87.76 176.15 7.53 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-O 121.168 0.508 . . . . 0.0 110.878 -178.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.404 ' HE3' ' HB2' ' A' ' 99' ' ' LYS . 39.1 ttmt -154.27 104.21 2.58 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 -178.225 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . 0.425 ' HB2' ' CE2' ' A' ' 93' ' ' TRP . 3.6 m-85 -92.97 179.12 5.54 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 -176.814 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.445 ' HA2' ' HA ' ' A' ' 92' ' ' HIS . . . -168.3 177.57 42.32 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.621 -0.8 . . . . 0.0 112.196 178.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.601 HD23 ' HZ3' ' A' ' 93' ' ' TRP . 2.3 pt? -142.36 133.04 25.41 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 177.163 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.559 ' HB ' ' HB ' ' A' ' 21' ' ' VAL . 24.8 m -93.63 127.4 39.3 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.56 177.081 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.442 ' HB2' ' HA ' ' A' ' 89' ' ' THR . 73.6 m-85 -86.59 157.3 19.75 Favored 'General case' 0 C--O 1.237 0.41 0 O-C-N 123.305 0.378 . . . . 0.0 110.171 -179.859 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 21.1 mp0 -102.96 -33.74 9.19 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.327 -177.53 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 8.4 m -137.84 144.77 45.56 Favored Pre-proline 0 CA--C 1.532 0.25 0 CA-C-O 120.437 0.16 . . . . 0.0 110.78 -178.387 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_exo -53.17 -21.9 18.09 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 122.64 2.227 . . . . 0.0 112.491 176.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -64.06 -65.81 0.63 Allowed 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.56 176.362 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -62.48 -36.78 83.58 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.569 179.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . 0.435 ' HB2' ' O ' ' A' ' 88' ' ' PRO . . . -55.84 -67.09 0.32 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.403 177.705 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 83.8 mtm180 -62.29 -34.27 76.25 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.139 -175.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -62.43 -43.35 99.02 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-O 120.949 0.404 . . . . 0.0 110.361 177.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.473 ' O ' HG22 ' A' ' 117' ' ' VAL . 52.8 t80 -69.28 -43.5 73.74 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.02 -179.841 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -55.78 -46.17 78.01 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 121.015 0.436 . . . . 0.0 110.628 177.411 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . 0.426 ' HA ' ' HD2' ' A' ' 115' ' ' ARG . 24.2 tpt180 -65.97 -34.79 78.91 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 116.137 -0.483 . . . . 0.0 109.76 178.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -62.28 -38.7 96.66 Favored Glycine 0 C--N 1.333 0.366 0 N-CA-C 111.471 -0.652 . . . . 0.0 111.471 174.451 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.487 ' O ' HG13 ' A' ' 121' ' ' ILE . 96.8 t -62.21 -45.87 97.76 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.142 0 N-CA-C 109.73 -0.471 . . . . 0.0 109.73 176.373 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.528 ' O ' ' HG2' ' A' ' 122' ' ' GLU . 8.5 tpm_? -53.2 -52.44 58.87 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.467 176.621 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 7.4 tmtt? -60.26 -47.72 84.8 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.032 -178.389 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -57.6 -48.17 80.12 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.941 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.487 HG13 ' O ' ' A' ' 117' ' ' VAL . 75.0 mt -56.9 -42.51 78.59 Favored 'Isoleucine or valine' 0 C--O 1.232 0.177 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.44 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.528 ' HG2' ' O ' ' A' ' 118' ' ' ARG . 15.6 mm-40 -57.05 -57.06 14.21 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-O 121.038 0.447 . . . . 0.0 110.621 177.621 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -71.46 -12.74 61.55 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.651 -177.337 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 62.7 tp -87.61 -68.24 0.77 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.761 0.315 . . . . 0.0 110.929 178.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.421 ' O ' ' HB3' ' A' ' 126' ' ' GLU . 34.8 pt -89.79 -18.6 7.66 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 N-CA-C 112.241 0.46 . . . . 0.0 112.241 -172.369 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.421 ' HB3' ' O ' ' A' ' 125' ' ' ILE . 36.5 tt0 . . . . . 0 C--O 1.252 1.192 0 O-C-N 123.441 0.463 . . . . 0.0 110.23 -178.203 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.741 0 N-CA-C 112.102 -0.399 . . . . 0.0 112.102 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 17.5 m -70.09 -7.43 41.33 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 122.547 0.339 . . . . 0.0 111.751 -177.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' MET . . . . . 0.49 ' O ' HG23 ' A' ' 4' ' ' THR . 25.2 ttt -62.46 -70.01 0.23 Allowed 'General case' 0 CA--C 1.529 0.166 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 175.037 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.49 HG23 ' O ' ' A' ' 3' ' ' MET . 0.8 OUTLIER -167.98 88.51 0.26 Allowed 'General case' 0 C--O 1.236 0.379 0 CA-C-N 114.996 -1.002 . . . . 0.0 108.383 175.97 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -72.29 122.82 21.77 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.023 0.44 . . . . 0.0 111.016 -174.375 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -157.92 143.15 16.8 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-N 115.45 -0.795 . . . . 0.0 109.452 178.244 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.467 ' O ' ' HE2' ' A' ' 69' ' ' LYS . 35.5 p -108.7 -173.45 2.28 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.731 -176.007 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 85.9 m-70 -62.48 157.09 58.69 Favored Pre-proline 0 N--CA 1.464 0.257 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 175.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_exo -43.36 -44.44 10.39 Favored 'Trans proline' 0 C--N 1.357 1.015 0 C-N-CA 122.561 2.174 . . . . 0.0 111.202 175.328 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -132.77 109.28 9.55 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 169.305 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -104.26 82.15 1.91 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.836 0.35 . . . . 0.0 110.665 -173.523 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -64.34 -55.54 20.51 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.995 178.447 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 37.4 t -164.6 -58.3 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.914 -176.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.434 ' CG ' ' HB3' ' A' ' 46' ' ' CYS . 46.5 m-85 64.14 101.73 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 115.8 -0.637 . . . . 0.0 111.803 178.463 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.637 HG21 HG22 ' A' ' 16' ' ' VAL . 11.5 tt -82.14 -31.75 10.46 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 CA-C-N 115.624 -0.717 . . . . 0.0 110.56 -178.859 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.637 HG22 HG21 ' A' ' 15' ' ' ILE . 76.5 t -117.23 113.98 44.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.249 179.505 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.488 ' NH2' HH12 ' A' ' 42' ' ' ARG . 22.3 mtp180 -136.21 86.54 2.23 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 175.885 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.403 ' HB ' ' CZ ' ' A' ' 113' ' ' PHE . 44.2 t -130.61 153.89 39.77 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.391 -176.578 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 23.3 pttm -65.28 154.85 37.02 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.466 178.32 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -179.61 174.04 1.0 Allowed 'General case' 0 C--O 1.233 0.211 0 O-C-N 123.466 0.479 . . . . 0.0 110.532 175.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 61.8 t -123.89 143.98 35.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 171.124 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 29.6 m -115.02 131.0 68.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-O 121.097 0.475 . . . . 0.0 111.465 -175.401 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 25.2 mmt -100.23 113.42 26.09 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.057 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.403 HG22 ' O ' ' A' ' 33' ' ' PHE . 11.8 t -82.62 152.64 25.81 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 178.005 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.46 ' HD2' ' CZ2' ' A' ' 32' ' ' TRP . 36.1 ttt85 -122.05 114.11 20.48 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 -172.154 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -72.31 93.54 1.51 Allowed 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 107.602 -1.259 . . . . 0.0 107.602 165.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -54.65 149.74 10.46 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 115.603 -0.726 . . . . 0.0 112.879 -169.179 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 51.9 m 72.89 -36.46 0.36 Allowed 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 114.612 -1.176 . . . . 0.0 112.306 179.005 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 29.4 t -78.54 -44.53 24.06 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 175.436 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 149.64 -67.2 0.36 Allowed Glycine 0 N--CA 1.452 -0.291 0 N-CA-C 111.559 -0.616 . . . . 0.0 111.559 178.182 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.436 ' HA3' ' HA ' ' A' ' 25' ' ' ARG . . . 71.34 -126.07 12.65 Favored Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 121.449 -0.405 . . . . 0.0 112.884 178.565 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . 0.535 ' HH2' ' HG2' ' A' ' 99' ' ' LYS . 24.6 m95 58.96 38.03 24.41 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 123.041 0.537 . . . . 0.0 109.957 -175.039 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.403 ' O ' HG22 ' A' ' 24' ' ' THR . 21.1 p90 -112.26 148.93 40.17 Favored Pre-proline 0 CA--C 1.532 0.252 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.574 -177.261 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -68.21 109.58 2.02 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 122.706 2.271 . . . . 0.0 111.85 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 28.9 pt20 -59.4 132.27 53.49 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.375 -177.321 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 60.81 20.9 11.04 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.756 177.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 99.43 -15.62 59.85 Favored Glycine 0 C--N 1.333 0.379 0 CA-C-N 116.023 -0.535 . . . . 0.0 112.33 -179.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 100.18 -115.62 5.35 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 121.577 -0.344 . . . . 0.0 112.398 179.381 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.81 150.0 26.41 Favored Glycine 0 N--CA 1.451 -0.305 0 N-CA-C 111.774 -0.53 . . . . 0.0 111.774 -177.352 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 6.0 tp -55.88 115.73 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 CA-C-O 121.133 0.492 . . . . 0.0 110.689 179.511 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.408 ' HA ' ' HA ' ' A' ' 65' ' ' ARG . 20.0 m -116.95 175.23 5.68 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.361 -177.81 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.488 HH12 ' NH2' ' A' ' 17' ' ' ARG . 49.6 ttp180 -138.58 137.43 36.98 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.414 -0.588 . . . . 0.0 109.414 177.284 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.607 HG22 HD12 ' A' ' 102' ' ' LEU . 61.7 t -97.49 118.81 44.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 176.88 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.436 ' HA2' ' O ' ' A' ' 16' ' ' VAL . . . -116.59 94.92 0.66 Allowed Glycine 0 N--CA 1.452 -0.263 0 CA-C-N 116.013 -0.54 . . . . 0.0 112.109 -179.259 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.488 ' HB ' ' HB ' ' A' ' 16' ' ' VAL . 60.8 t -92.04 116.24 32.77 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 N-CA-C 110.235 -0.283 . . . . 0.0 110.235 178.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . 0.528 ' SG ' ' HB3' ' A' ' 60' ' ' LEU . 24.2 p -118.45 131.39 56.27 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.694 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.662 ' HE3' ' HB2' ' A' ' 57' ' ' SER . 60.2 tttp -74.33 102.22 4.31 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 175.411 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.429 HG22 ' CE1' ' A' ' 76' ' ' TYR . 26.9 m -73.24 124.95 31.34 Favored 'Isoleucine or valine' 0 C--O 1.24 0.602 0 CA-C-O 121.202 0.525 . . . . 0.0 110.219 179.559 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 25.9 mmt -88.09 -179.4 6.18 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.599 -176.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 1.8 p80 -129.11 125.95 22.92 Favored Pre-proline 0 C--N 1.323 -0.578 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.766 -177.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_endo -57.3 -47.28 23.0 Favored 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 122.564 2.176 . . . . 0.0 111.335 179.543 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -162.2 138.65 7.85 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.388 173.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 132.83 96.8 0.63 Allowed Glycine 0 N--CA 1.448 -0.533 0 N-CA-C 110.953 -0.859 . . . . 0.0 110.953 -177.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -53.62 146.46 13.13 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-O 120.711 0.291 . . . . 0.0 110.916 -178.012 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 152.76 -153.47 24.89 Favored Glycine 0 N--CA 1.448 -0.54 0 N-CA-C 111.629 -0.588 . . . . 0.0 111.629 -178.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.491 HH11 ' HA ' ' A' ' 125' ' ' ILE . 67.6 mtm180 -105.54 125.95 51.57 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 110.348 -0.242 . . . . 0.0 110.348 -178.333 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.662 ' HB2' ' HE3' ' A' ' 47' ' ' LYS . 14.8 m -80.23 132.21 35.82 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 178.541 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -92.44 -173.24 41.61 Favored Glycine 0 C--O 1.227 -0.3 0 C-N-CA 121.06 -0.591 . . . . 0.0 113.3 -168.261 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.411 ' HA ' ' O ' ' A' ' 46' ' ' CYS . 45.1 m-85 -131.76 122.14 25.35 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 122.867 0.467 . . . . 0.0 109.98 177.88 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.528 ' HB3' ' SG ' ' A' ' 46' ' ' CYS . 0.9 OUTLIER -80.1 112.34 17.31 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 175.582 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.545 ' HB ' ' HB2' ' A' ' 75' ' ' CYS . 50.5 mm -76.27 82.08 0.68 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.322 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 174.303 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 63.1 t-80 -99.59 164.29 12.13 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.198 -0.91 . . . . 0.0 109.751 -176.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 175.48 149.98 7.68 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.816 -0.707 . . . . 0.0 111.651 176.419 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.438 ' CD ' HH21 ' A' ' 42' ' ' ARG . 0.1 OUTLIER -142.06 171.01 14.64 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.96 0.41 . . . . 0.0 110.888 -178.586 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.408 ' HA ' ' HA ' ' A' ' 41' ' ' SER . 38.3 ttm180 -83.98 119.16 24.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.36 177.709 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 -61.77 87.99 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 121.255 0.55 . . . . 0.0 111.518 -173.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 40.0 ttpt 178.2 -30.59 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 114.587 -1.188 . . . . 0.0 108.563 178.343 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.428 ' C ' ' H ' ' A' ' 70' ' ' LEU . 19.4 t70 -156.65 170.75 21.68 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.021 -0.99 . . . . 0.0 108.875 177.455 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.467 ' HE2' ' O ' ' A' ' 7' ' ' THR . 93.0 mttt -74.64 16.97 0.23 Allowed 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 120.652 0.263 . . . . 0.0 111.175 178.733 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.428 ' H ' ' C ' ' A' ' 68' ' ' ASP . 5.7 tt -58.03 97.94 0.03 OUTLIER 'General case' 0 C--O 1.233 0.219 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 174.88 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 27.5 m -69.9 130.87 34.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.257 0.551 . . . . 0.0 111.978 -175.352 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 33.1 m -109.69 -14.49 10.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.056 175.211 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 60.1 mt -132.13 134.39 45.38 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.488 178.593 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -159.39 92.42 1.06 Allowed 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 174.792 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . 0.545 ' HB2' ' HB ' ' A' ' 61' ' ' ILE . 66.9 m -136.36 105.67 6.05 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.756 179.102 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.434 ' HE2' ' HD3' ' A' ' 78' ' ' ARG . 50.9 t80 -76.01 101.22 5.16 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.098 -178.291 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 83.6 t -103.41 99.41 8.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.006 0.431 . . . . 0.0 110.071 -178.186 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.434 ' HD3' ' HE2' ' A' ' 76' ' ' TYR . 18.6 ptt180 -108.38 -20.53 13.09 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.883 -178.397 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 1.8 tmtp? -123.92 79.03 1.68 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.829 -174.33 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 32.7 m-20 62.73 168.34 0.13 Allowed 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 115.124 -0.944 . . . . 0.0 112.102 176.061 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.496 HD22 ' N ' ' A' ' 82' ' ' VAL . 5.6 tt -146.66 135.45 22.27 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 -177.883 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.496 ' N ' HD22 ' A' ' 81' ' ' LEU . 48.3 t -77.97 -77.25 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 O-C-N 122.978 0.174 . . . . 0.0 111.247 -176.731 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.49 ' CD2' HG23 ' A' ' 117' ' ' VAL . 0.0 OUTLIER 64.66 136.52 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 121.469 0.652 . . . . 0.0 111.399 -177.421 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.515 ' HB ' ' CE1' ' A' ' 92' ' ' HIS . 90.0 m -154.31 117.9 4.62 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.357 -179.399 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.481 ' HZ2' ' CG ' ' A' ' 114' ' ' ASP . 36.9 ttpt -95.69 103.99 15.89 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.912 0.387 . . . . 0.0 110.215 -178.111 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -85.15 -29.73 24.54 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.085 178.336 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . 0.589 ' HB2' ' HB3' ' A' ' 90' ' ' PHE . 18.6 m120 -143.93 153.56 57.41 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.264 178.88 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -63.57 -4.72 7.34 Favored 'Trans proline' 0 N--CA 1.478 0.562 0 C-N-CA 122.735 2.29 . . . . 0.0 112.748 -179.417 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 8.3 t -126.46 16.08 7.66 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 121.355 0.598 . . . . 0.0 110.123 178.267 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.589 ' HB3' ' HB2' ' A' ' 87' ' ' ASN . 64.1 t80 -152.09 101.23 2.7 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.203 -175.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . 0.481 ' CE1' ' HB2' ' A' ' 85' ' ' LYS . 2.1 t-160 -125.55 106.81 10.04 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 -179.225 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . 0.549 ' ND1' ' HD2' ' A' ' 99' ' ' LYS . 35.1 p80 -103.49 150.03 24.28 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 120.739 0.304 . . . . 0.0 111.671 -173.769 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . 0.541 ' HZ3' ' HB2' ' A' ' 102' ' ' LEU . 24.9 p90 -132.74 130.98 40.69 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.335 176.199 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.511 ' HA ' ' HA ' ' A' ' 99' ' ' LYS . 65.0 tttp -94.7 139.01 31.81 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.198 -0.455 . . . . 0.0 109.926 172.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.405 HG21 ' H ' ' A' ' 97' ' ' ASN . 29.2 m -117.28 -162.56 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.662 177.288 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -56.35 -24.87 46.99 Favored 'General case' 0 CA--C 1.532 0.27 0 O-C-N 123.094 0.246 . . . . 0.0 111.631 -176.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.405 ' H ' HG21 ' A' ' 95' ' ' VAL . 0.9 OUTLIER -114.8 -94.38 0.48 Allowed 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 120.491 0.186 . . . . 0.0 111.457 176.793 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 29.8 mmt180 -93.33 -174.33 3.49 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 121.321 0.581 . . . . 0.0 111.866 -170.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.549 ' HD2' ' ND1' ' A' ' 92' ' ' HIS . 38.2 ttpt -125.7 110.22 13.51 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.128 -0.942 . . . . 0.0 109.551 -178.561 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 17.9 m-85 -97.15 162.28 13.43 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 109.819 -0.438 . . . . 0.0 109.819 -176.524 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.49 ' HA2' ' HA ' ' A' ' 92' ' ' HIS . . . -128.78 140.58 11.84 Favored Glycine 0 C--N 1.333 0.415 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.94 -177.592 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.607 HD12 HG22 ' A' ' 43' ' ' VAL . 4.8 tt -109.66 133.84 52.65 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 177.599 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.518 ' N ' HD23 ' A' ' 102' ' ' LEU . 88.1 m -106.66 114.43 28.54 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.808 179.722 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.419 ' CE2' ' HB2' ' A' ' 91' ' ' HIS . 22.5 m-85 -79.76 148.56 31.43 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 175.418 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 59.3 tt0 -105.5 -33.02 8.25 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.876 0.37 . . . . 0.0 110.601 -178.006 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 32.6 t -124.64 147.52 56.1 Favored Pre-proline 0 C--N 1.329 -0.297 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -60.34 -25.62 80.73 Favored 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 121.878 1.719 . . . . 0.0 110.417 172.126 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -69.6 -58.33 4.08 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.786 178.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -65.83 -32.89 74.67 Favored 'General case' 0 N--CA 1.463 0.206 0 C-N-CA 121.013 -0.275 . . . . 0.0 110.271 -179.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -55.06 -60.13 3.8 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.745 174.077 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 16.2 ttm180 -61.1 -30.69 70.51 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.469 -178.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -62.31 -42.87 99.73 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.434 175.556 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.403 ' CZ ' ' HB ' ' A' ' 18' ' ' VAL . 39.7 m-85 -66.59 -43.27 85.38 Favored 'General case' 0 C--O 1.23 0.079 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.49 177.308 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.481 ' CG ' ' HZ2' ' A' ' 85' ' ' LYS . 17.2 m-20 -55.01 -51.32 66.63 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 120.885 0.374 . . . . 0.0 110.447 178.503 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 3.1 mmp_? -60.48 -46.01 91.65 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.582 178.448 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -60.25 -51.4 59.02 Favored Glycine 0 C--N 1.333 0.367 0 CA-C-N 115.46 -0.791 . . . . 0.0 112.633 -177.519 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.49 HG23 ' CD2' ' A' ' 83' ' ' TYR . 11.4 p -68.53 -32.78 56.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.416 0.15 . . . . 0.0 110.621 -178.281 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 8.1 mmm180 -56.18 -57.05 13.83 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 174.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -63.73 -32.34 73.8 Favored 'General case' 0 C--O 1.224 -0.24 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.388 179.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -62.64 -50.32 71.69 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-O 120.564 0.221 . . . . 0.0 111.235 179.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 69.4 mt -66.47 -39.38 83.86 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 CA-C-O 121.063 0.459 . . . . 0.0 110.338 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 -67.32 -34.28 77.03 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.313 177.163 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -79.84 -17.03 54.25 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 121.284 0.564 . . . . 0.0 110.0 178.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.434 ' O ' ' HD2' ' A' ' 56' ' ' ARG . 11.7 mt -71.09 -58.92 3.09 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.581 170.378 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.491 ' HA ' HH11 ' A' ' 56' ' ' ARG . 11.1 tp -68.71 -23.99 28.39 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.054 -176.839 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 . . . . . 0 C--O 1.251 1.136 0 CA-C-O 118.116 -0.945 . . . . 0.0 110.175 176.691 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.935 0 N-CA-C 112.344 -0.302 . . . . 0.0 112.344 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 56.6 m -151.87 173.57 14.63 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 110.102 -0.333 . . . . 0.0 110.102 -179.459 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 69.3 mtm -92.42 146.26 23.82 Favored 'General case' 0 C--O 1.238 0.474 0 N-CA-C 109.651 -0.499 . . . . 0.0 109.651 174.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 77.6 p -73.39 165.74 24.49 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.454 -176.216 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.41 ' O ' ' HG3' ' A' ' 5' ' ' GLU . 7.5 pt-20 -150.09 96.61 2.45 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-O 121.359 0.6 . . . . 0.0 110.147 175.841 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -87.57 171.47 10.47 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.304 179.538 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 25.3 p -81.35 175.55 10.48 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.772 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 31.0 m-70 -62.4 146.29 93.46 Favored Pre-proline 0 C--O 1.235 0.297 0 N-CA-C 110.043 -0.354 . . . . 0.0 110.043 178.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -53.83 -28.99 50.69 Favored 'Trans proline' 0 C--N 1.354 0.842 0 C-N-CA 122.797 2.331 . . . . 0.0 112.128 -176.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.806 ' HB3' ' HB2' ' A' ' 13' ' ' SER . 13.4 m-20 -130.26 44.22 3.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.555 178.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -51.57 -39.13 57.24 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 114.857 -1.065 . . . . 0.0 112.26 -175.377 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -100.2 -3.21 32.08 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 111.486 0.18 . . . . 0.0 111.486 -178.433 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.806 ' HB2' ' HB3' ' A' ' 10' ' ' ASP . 19.9 m -92.74 -0.36 57.29 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 120.558 0.218 . . . . 0.0 111.062 -178.424 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 61.9 m-85 -62.63 112.81 2.66 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 120.819 0.343 . . . . 0.0 110.523 177.122 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.507 HG23 HG22 ' A' ' 16' ' ' VAL . 63.0 mt -70.53 -48.78 57.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 174.897 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.507 HG22 HG23 ' A' ' 15' ' ' ILE . 87.4 t -144.33 104.65 0.82 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.355 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.481 178.718 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.549 ' HA ' ' HA2' ' A' ' 44' ' ' GLY . 27.2 ptt180 -101.6 112.88 25.58 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 169.491 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 7.4 p -143.91 157.37 15.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.14 0.495 . . . . 0.0 111.529 -172.241 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.82 ' HB3' ' HZ3' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -70.01 124.58 24.43 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.326 177.833 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -151.0 -168.6 3.15 Favored 'General case' 0 C--O 1.235 0.33 0 O-C-N 123.243 0.34 . . . . 0.0 110.313 179.394 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.434 ' HB ' ' HB ' ' A' ' 103' ' ' THR . 45.9 t -123.97 138.68 52.83 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 N-CA-C 110.22 -0.289 . . . . 0.0 110.22 176.502 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 17.6 m -106.3 135.4 44.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.532 177.367 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 24.9 mmt -123.47 146.19 48.24 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 178.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.436 HG22 ' H ' ' A' ' 26' ' ' ASP . 6.4 t -129.0 -6.31 4.97 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.597 -0.441 . . . . 0.0 111.616 177.122 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.445 ' HB2' ' CE3' ' A' ' 32' ' ' TRP . 65.2 ttt180 54.07 24.46 4.79 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 121.295 0.569 . . . . 0.0 111.037 178.749 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.436 ' H ' HG22 ' A' ' 24' ' ' THR . 36.4 t70 54.23 45.32 27.58 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.007 -177.228 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 52.8 m-20 73.04 -68.51 0.22 Allowed 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 114.68 -1.145 . . . . 0.0 110.639 -178.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 68.9 m -152.8 87.92 1.31 Allowed 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 176.399 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.415 ' HG ' ' HB3' ' A' ' 26' ' ' ASP . 53.3 m -140.53 -160.42 1.07 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.774 179.81 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -61.96 -90.17 0.02 OUTLIER Glycine 0 CA--C 1.52 0.401 0 C-N-CA 121.246 -0.502 . . . . 0.0 113.311 -177.547 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -97.1 176.97 32.23 Favored Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 121.432 -0.413 . . . . 0.0 112.995 -173.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . 0.47 ' CH2' ' HB3' ' A' ' 99' ' ' LYS . 37.3 m95 -97.03 113.82 25.39 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 -179.648 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 2.8 p90 -104.25 145.85 31.45 Favored Pre-proline 0 C--N 1.329 -0.298 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 179.179 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.529 ' HB2' ' HA3' ' A' ' 38' ' ' GLY . 88.9 Cg_endo -84.1 120.46 2.6 Favored 'Trans proline' 0 CA--C 1.534 0.521 0 C-N-CA 122.583 2.189 . . . . 0.0 112.068 178.67 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 5.0 pm0 -107.93 144.61 34.95 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.166 179.312 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 57.94 97.33 0.02 OUTLIER 'General case' 0 C--O 1.238 0.453 0 CA-C-O 121.441 0.638 . . . . 0.0 111.534 179.072 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 76.04 -72.33 1.86 Allowed Glycine 0 N--CA 1.45 -0.404 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.466 -176.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.529 ' HA3' ' HB2' ' A' ' 34' ' ' PRO . . . 58.66 65.8 3.24 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 121.354 -0.45 . . . . 0.0 112.759 177.527 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 156.37 -43.72 0.53 Allowed Glycine 0 N--CA 1.453 -0.176 0 N-CA-C 111.646 -0.581 . . . . 0.0 111.646 -179.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.475 ' O ' HG12 ' A' ' 40' ' ' ILE . 11.9 tt -121.91 22.19 4.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 121.539 0.685 . . . . 0.0 109.696 178.857 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 21.3 m -60.61 122.36 14.51 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.29 -177.108 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.423 ' HB2' ' HA ' ' A' ' 66' ' ' GLN . 29.0 ttt85 -82.95 92.71 7.39 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.45 -175.562 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 41.1 t -95.47 150.62 4.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.076 -179.322 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.549 ' HA2' ' HA ' ' A' ' 17' ' ' ARG . . . -154.22 116.61 0.74 Allowed Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 121.178 -0.534 . . . . 0.0 112.335 -179.544 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 6.7 p -87.56 117.85 32.29 Favored 'Isoleucine or valine' 0 C--O 1.237 0.415 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 176.356 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . 0.757 ' SG ' ' HB3' ' A' ' 60' ' ' LEU . 13.9 p -113.69 146.54 39.67 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.068 -178.718 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.408 ' HB2' HD11 ' A' ' 15' ' ' ILE . 47.9 tttp -92.48 101.68 14.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.772 179.088 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 22.2 m -85.19 157.05 3.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.689 0.281 . . . . 0.0 110.512 -179.018 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 22.6 ptp -151.24 153.39 34.79 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.798 0.333 . . . . 0.0 110.629 -178.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . 0.43 ' NE2' ' HA3' ' A' ' 53' ' ' GLY . 0.4 OUTLIER -70.2 143.52 91.22 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.076 179.152 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -69.64 -15.38 37.49 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 122.598 2.199 . . . . 0.0 111.958 179.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 15.0 tp10 -131.11 93.74 3.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.748 179.527 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.43 ' HA3' ' NE2' ' A' ' 50' ' ' HIS . . . 165.56 -175.96 41.18 Favored Glycine 0 N--CA 1.452 -0.258 0 N-CA-C 111.801 -0.519 . . . . 0.0 111.801 -179.341 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 -136.62 -74.03 0.43 Allowed 'General case' 0 C--O 1.236 0.365 0 CA-C-O 120.787 0.327 . . . . 0.0 111.666 -175.176 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.403 ' O ' ' HG3' ' A' ' 56' ' ' ARG . . . -100.49 52.49 0.95 Allowed Glycine 0 C--N 1.33 0.2 0 CA-C-N 116.289 -0.414 . . . . 0.0 113.844 -170.342 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.403 ' HG3' ' O ' ' A' ' 55' ' ' GLY . 53.4 mtt180 -160.85 136.07 7.77 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 122.678 0.391 . . . . 0.0 110.024 172.244 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 49.8 m -156.21 161.49 40.27 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 116.466 -0.333 . . . . 0.0 110.639 -177.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -121.52 -158.88 10.51 Favored Glycine 0 C--N 1.33 0.242 0 N-CA-C 111.394 -0.682 . . . . 0.0 111.394 179.428 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -141.86 162.49 35.35 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.9 0.35 . . . . 0.0 110.411 -178.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.757 ' HB3' ' SG ' ' A' ' 46' ' ' CYS . 3.3 tt -137.07 121.67 18.45 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.411 ' O ' ' HA ' ' A' ' 74' ' ' GLU . 41.3 mt -83.03 84.29 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 175.066 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . 0.5 ' HB2' HD22 ' A' ' 60' ' ' LEU . 53.9 t60 -96.99 141.89 29.6 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.25 -0.432 . . . . 0.0 109.865 -177.433 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -154.84 127.54 2.11 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 121.036 -0.602 . . . . 0.0 112.043 -179.398 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -115.0 -179.63 3.68 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 176.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.601 ' HD2' HD12 ' A' ' 70' ' ' LEU . 69.8 mtt180 -65.83 -65.41 0.68 Allowed 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 120.549 -0.46 . . . . 0.0 110.274 178.51 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.438 ' HG3' ' HG3' ' A' ' 67' ' ' LYS . 17.1 pt20 175.53 -23.63 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.284 0 O-C-N 123.407 0.442 . . . . 0.0 111.161 -177.817 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.438 ' HG3' ' HG3' ' A' ' 66' ' ' GLN . 98.5 mttt -144.31 129.34 18.54 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.737 -178.83 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 37.5 t70 71.24 163.33 0.26 Allowed 'General case' 0 CA--C 1.533 0.318 0 O-C-N 123.763 0.665 . . . . 0.0 112.207 169.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 43.6 mtmt -55.47 99.13 0.03 OUTLIER 'General case' 0 C--O 1.234 0.243 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.684 -176.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.601 HD12 ' HD2' ' A' ' 65' ' ' ARG . 3.8 tt -162.51 86.28 0.58 Allowed 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 173.685 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 45.4 t -75.66 117.0 19.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.393 -179.535 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 22.1 m -98.54 -21.89 5.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.335 -177.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -150.51 129.72 12.77 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 -177.236 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.603 ' HG3' HD21 ' A' ' 60' ' ' LEU . 37.0 tt0 -153.81 113.11 3.76 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.986 0.422 . . . . 0.0 110.162 178.606 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . 0.548 ' SG ' ' CE2' ' A' ' 100' ' ' PHE . 57.4 m -130.48 118.51 21.24 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 -178.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.422 ' HD1' ' HG ' ' A' ' 60' ' ' LEU . 29.5 t80 -85.32 121.73 28.47 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.01 -173.325 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.505 HG12 ' O ' ' A' ' 80' ' ' ASP . 96.3 t -100.67 97.57 5.9 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 -177.243 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 20.7 ptt-85 -115.92 68.39 0.72 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.226 0.536 . . . . 0.0 110.51 -172.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt 67.53 25.42 8.4 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.011 -177.165 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.505 ' O ' HG12 ' A' ' 77' ' ' VAL . 5.6 p-10 -149.05 -175.26 4.89 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 174.56 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 7.0 tt 66.72 98.22 0.05 Allowed 'General case' 0 CA--C 1.534 0.327 0 CA-C-O 121.193 0.521 . . . . 0.0 110.177 177.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 58.9 t -112.06 133.42 57.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.612 -178.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -68.92 124.38 23.56 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.615 177.388 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 35.9 m -95.86 114.66 26.41 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 174.165 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.406 ' HG2' ' NE2' ' A' ' 91' ' ' HIS . 5.7 tmtp? -75.81 98.9 4.28 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 116.144 -0.48 . . . . 0.0 109.73 178.875 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -91.21 -46.66 7.95 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.237 0.541 . . . . 0.0 110.183 -179.002 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . 0.753 ' HB2' ' HB3' ' A' ' 90' ' ' PHE . 40.4 m-80 -131.54 153.27 81.51 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.261 178.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -50.62 -31.5 32.18 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.706 2.271 . . . . 0.0 112.683 -179.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.539 ' HA ' ' HD2' ' A' ' 104' ' ' PHE . 16.5 p -115.22 18.11 16.32 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.722 -178.182 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.753 ' HB3' ' HB2' ' A' ' 87' ' ' ASN . 74.1 t80 -145.18 115.25 7.44 Favored 'General case' 0 C--O 1.24 0.585 0 CA-C-O 121.366 0.603 . . . . 0.0 111.985 -176.803 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . 0.406 ' NE2' ' HG2' ' A' ' 85' ' ' LYS . 31.5 m80 -103.88 157.06 17.35 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.152 -0.931 . . . . 0.0 109.277 171.455 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 19.5 p80 -154.42 149.73 27.13 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 110.191 -0.299 . . . . 0.0 110.191 172.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 38.5 p90 -137.66 140.42 40.81 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 110.016 -0.364 . . . . 0.0 110.016 178.417 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -109.85 112.74 24.96 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.101 -173.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 23.4 m -138.9 144.12 30.34 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 174.192 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 58.12 25.9 13.02 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 120.725 0.298 . . . . 0.0 110.712 -178.074 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 68.09 1.47 2.8 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.755 -177.464 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 64.3 mtt-85 -89.31 134.39 34.08 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 109.489 -0.559 . . . . 0.0 109.489 178.131 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.47 ' HB3' ' CH2' ' A' ' 32' ' ' TRP . 12.3 mptt -94.33 97.48 10.24 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.984 0.421 . . . . 0.0 110.491 -178.03 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . 0.548 ' CE2' ' SG ' ' A' ' 75' ' ' CYS . 2.3 m-85 -81.65 141.11 33.95 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 174.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -138.59 157.6 24.68 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 121.224 -0.513 . . . . 0.0 112.103 178.613 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 6.4 tt -143.56 121.31 11.9 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 108.912 -0.774 . . . . 0.0 108.912 178.289 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.454 ' HG1' ' HD1' ' A' ' 90' ' ' PHE . 26.8 m -109.11 136.34 48.78 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.438 -178.519 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.539 ' HD2' ' HA ' ' A' ' 89' ' ' THR . 41.1 m-85 -86.0 139.61 31.03 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.213 -0.448 . . . . 0.0 109.983 178.471 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 8.3 tp-100 -93.44 -42.83 9.05 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.36 -175.487 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -130.49 147.72 67.08 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.518 -176.748 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -53.88 -25.07 33.82 Favored 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 122.299 1.999 . . . . 0.0 111.908 179.039 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -62.26 -57.54 11.05 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.026 176.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -70.35 -29.64 66.38 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.634 -179.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . 0.426 ' O ' ' HB2' ' A' ' 114' ' ' ASP . . . -56.89 -58.16 9.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.251 174.544 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.557 ' HA ' ' HE ' ' A' ' 111' ' ' ARG . 1.3 tpm_? -59.47 -50.49 73.74 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.954 -179.628 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -60.89 -57.19 13.71 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.63 -174.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.504 ' O ' HG22 ' A' ' 117' ' ' VAL . 38.6 t80 -67.4 -36.47 81.37 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.666 -174.87 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.426 ' HB2' ' O ' ' A' ' 110' ' ' ALA . 8.2 t70 -59.98 -49.25 78.39 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 121.168 0.509 . . . . 0.0 109.753 177.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 41.9 ttt180 -51.74 -45.24 63.59 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 115.117 -0.947 . . . . 0.0 109.923 174.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -60.35 -39.4 96.09 Favored Glycine 0 CA--C 1.519 0.297 0 CA-C-N 115.651 -0.704 . . . . 0.0 112.19 176.12 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.504 HG22 ' O ' ' A' ' 113' ' ' PHE . 75.7 t -66.08 -54.58 25.38 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.163 0 C-N-CA 122.382 0.273 . . . . 0.0 111.112 -179.48 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 19.6 ptp180 -60.3 -38.02 82.33 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 116.578 -0.283 . . . . 0.0 110.606 -177.503 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 16.1 mmmt -68.85 -39.22 80.04 Favored 'General case' 0 C--N 1.334 -0.078 0 CA-C-N 116.613 -0.267 . . . . 0.0 110.646 175.151 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.5 -44.26 96.18 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.884 0.373 . . . . 0.0 110.223 177.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 48.1 mm -62.9 -45.0 99.97 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.313 178.409 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -57.44 -51.02 71.14 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.661 178.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -74.51 -17.31 60.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.247 -178.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 45.1 tp -74.89 -47.7 28.66 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 177.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 75.1 mt -70.18 -40.35 78.04 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.303 178.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.249 1.066 0 N-CA-C 109.084 -0.709 . . . . 0.0 109.084 -179.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.728 0 N-CA-C 112.18 -0.368 . . . . 0.0 112.18 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.9 p -75.51 -13.83 60.39 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.217 0.532 . . . . 0.0 110.662 178.216 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 21.2 ptp -152.54 174.58 13.74 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 115.463 -0.79 . . . . 0.0 109.851 -178.535 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 6.2 t -135.24 136.83 42.02 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.048 0.451 . . . . 0.0 110.667 179.071 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -120.69 21.2 11.58 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 176.56 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -75.3 -84.09 0.05 Allowed 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 115.062 -0.972 . . . . 0.0 111.231 -175.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.6 m 55.5 66.54 1.19 Allowed 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.609 -178.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 1.2 t60 171.36 -65.54 0.0 OUTLIER Pre-proline 0 CA--C 1.542 0.65 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.265 -175.315 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -59.02 104.95 0.21 Allowed 'Trans proline' 0 C--N 1.356 0.941 0 C-N-CA 121.747 1.631 . . . . 0.0 112.119 -174.086 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 36.3 t70 62.69 41.96 8.7 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.03 -178.45 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 63.67 -88.0 0.03 OUTLIER 'General case' 0 C--O 1.235 0.328 0 CA-C-N 114.755 -1.111 . . . . 0.0 111.665 173.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 17.9 t70 69.25 -63.44 0.37 Allowed 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 123.574 0.749 . . . . 0.0 112.222 -175.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 19.7 m -87.29 1.24 53.82 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 112.438 0.532 . . . . 0.0 112.438 -172.603 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.408 ' HD2' ' HB3' ' A' ' 17' ' ' ARG . 3.3 m-85 -70.32 123.63 22.18 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 110.123 -0.325 . . . . 0.0 110.123 176.166 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 7.1 tp -88.45 -41.45 14.18 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 175.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 69.9 t -131.96 128.58 59.74 Favored 'Isoleucine or valine' 0 C--O 1.232 0.178 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 177.074 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.408 ' HB3' ' HD2' ' A' ' 14' ' ' TYR . 6.5 ptm180 -147.12 145.14 29.48 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.055 0.455 . . . . 0.0 111.468 -178.451 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 60.0 t -133.09 154.65 39.91 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 CA-C-N 115.411 -0.813 . . . . 0.0 108.993 177.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 2.2 tmmm? -98.41 117.17 32.23 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 175.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.489 ' HB3' ' O ' ' A' ' 103' ' ' THR . . . -158.55 -170.39 3.06 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-N 116.678 -0.237 . . . . 0.0 110.929 -178.339 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.728 HG22 ' HA2' ' A' ' 39' ' ' GLY . 60.8 t -99.91 114.2 37.61 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.123 -177.524 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.475 HG22 HG21 ' A' ' 72' ' ' VAL . 19.0 m -80.64 106.87 12.37 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 CA-C-O 121.098 0.475 . . . . 0.0 110.71 176.666 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 45.1 mtt -100.95 167.12 10.46 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.665 179.141 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.477 HG22 ' CE1' ' A' ' 33' ' ' PHE . 10.9 t -141.73 166.9 23.45 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.705 -0.68 . . . . 0.0 109.767 178.531 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.414 ' NH2' ' HA2' ' A' ' 30' ' ' GLY . 19.2 ttt180 -129.98 109.61 11.01 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 177.828 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -56.49 88.36 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.821 -173.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.461 ' HA ' ' HG2' ' A' ' 98' ' ' ARG . 34.1 t70 52.0 -84.78 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 123.522 0.729 . . . . 0.0 112.156 -179.403 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 32.9 t -125.02 16.88 8.52 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 120.865 0.364 . . . . 0.0 110.738 -175.553 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 33.1 t -67.96 138.17 55.73 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.304 179.29 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.414 ' HA2' ' NH2' ' A' ' 25' ' ' ARG . . . -83.35 65.1 4.19 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 121.07 -0.586 . . . . 0.0 112.155 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -177.32 167.2 38.2 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.884 -0.674 . . . . 0.0 112.889 179.472 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . 0.496 ' HH2' ' HB3' ' A' ' 99' ' ' LYS . 94.7 m95 -125.85 125.61 43.13 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 122.637 0.375 . . . . 0.0 110.038 178.132 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.477 ' CE1' HG22 ' A' ' 24' ' ' THR . 5.7 p90 -137.47 144.37 44.87 Favored Pre-proline 0 C--O 1.234 0.284 0 CA-C-N 116.631 -0.259 . . . . 0.0 111.244 -176.035 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -60.82 132.35 42.07 Favored 'Trans proline' 0 C--N 1.353 0.803 0 C-N-CA 122.594 2.196 . . . . 0.0 111.271 173.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.433 ' H ' ' HG2' ' A' ' 35' ' ' GLN . 10.1 pt20 -86.91 -36.61 18.27 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.042 -0.526 . . . . 0.0 112.23 -174.442 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 20.1 tp10 -166.16 -55.28 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 120.658 0.266 . . . . 0.0 110.845 -177.312 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -53.97 -41.26 67.76 Favored Glycine 0 C--N 1.332 0.36 0 CA-C-N 116.03 -0.532 . . . . 0.0 113.522 -175.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 67.02 -138.1 34.43 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.994 -0.622 . . . . 0.0 111.954 -177.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.728 ' HA2' HG22 ' A' ' 21' ' ' VAL . . . -62.25 -34.37 88.96 Favored Glycine 0 CA--C 1.521 0.445 0 C-N-CA 121.61 -0.329 . . . . 0.0 113.675 -175.356 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.524 ' N ' HD13 ' A' ' 40' ' ' ILE . 3.1 mp -107.95 108.67 25.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 N-CA-C 110.24 -0.281 . . . . 0.0 110.24 -177.106 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 23.3 m -144.15 118.2 9.45 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.471 0.177 . . . . 0.0 110.551 172.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.439 ' CZ ' ' HD3' ' A' ' 65' ' ' ARG . 96.1 mtt180 -71.77 90.82 1.1 Allowed 'General case' 0 CA--C 1.521 -0.157 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 171.563 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.4 p -104.1 139.53 24.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.893 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -175.99 176.09 47.52 Favored Glycine 0 N--CA 1.443 -0.87 0 C-N-CA 120.463 -0.875 . . . . 0.0 112.703 178.234 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 59.4 t -107.84 129.09 62.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 178.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . 0.749 ' SG ' ' HB3' ' A' ' 60' ' ' LEU . 10.4 p -112.73 117.64 32.77 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.635 176.106 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 36.5 ttmt -76.02 83.21 2.9 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 179.3 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 27.1 m -75.35 135.14 27.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.375 -178.481 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 63.0 mtt -92.05 173.48 7.82 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.263 -179.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 26.2 p80 -142.58 149.91 52.33 Favored Pre-proline 0 C--N 1.325 -0.473 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.174 -176.33 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_endo -61.93 149.4 90.35 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 122.167 1.911 . . . . 0.0 110.644 173.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 11.8 mm-40 61.33 94.22 0.04 OUTLIER 'General case' 0 C--O 1.233 0.229 0 N-CA-C 109.935 -0.395 . . . . 0.0 109.935 -175.1 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -76.06 35.05 1.27 Allowed Glycine 0 CA--C 1.519 0.341 0 CA-C-N 116.251 -0.432 . . . . 0.0 113.464 -175.071 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 77.8 m-20 -86.37 76.7 9.61 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 177.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 162.83 -96.52 0.14 Allowed Glycine 0 N--CA 1.451 -0.348 0 CA-C-N 114.833 -1.076 . . . . 0.0 110.77 -177.532 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 22.5 ttm-85 -173.09 -86.99 0.01 OUTLIER 'General case' 0 C--O 1.233 0.206 0 N-CA-C 110.497 -0.186 . . . . 0.0 110.497 175.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 58.3 m -164.27 172.58 13.38 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 122.545 0.338 . . . . 0.0 110.189 -177.525 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -118.34 153.66 16.94 Favored Glycine 0 N--CA 1.45 -0.37 0 N-CA-C 111.064 -0.814 . . . . 0.0 111.064 175.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 -119.64 112.16 18.96 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.887 0.375 . . . . 0.0 110.499 -178.283 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.749 ' HB3' ' SG ' ' A' ' 46' ' ' CYS . 2.6 tt -101.76 110.88 22.96 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 179.698 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.401 ' O ' ' HA ' ' A' ' 74' ' ' GLU . 62.5 mt -78.26 100.22 3.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 173.634 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 3.2 t-80 -112.22 145.95 39.01 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 -173.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -146.51 119.59 1.18 Allowed Glycine 0 C--O 1.236 0.242 0 N-CA-C 110.716 -0.954 . . . . 0.0 110.716 -178.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -156.69 -175.71 5.58 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.916 0.865 . . . . 0.0 113.235 -167.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.439 ' HD3' ' CZ ' ' A' ' 42' ' ' ARG . 44.4 ttt-85 61.39 89.22 0.08 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 113.395 -1.73 . . . . 0.0 114.219 160.825 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.55 -42.58 0.61 Allowed 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 106.505 -1.665 . . . . 0.0 106.505 162.296 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.556 ' HE2' HD22 ' A' ' 70' ' ' LEU . 37.7 ttpt -90.23 163.19 14.89 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 163.226 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -51.09 94.45 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 -173.299 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 58.3 mtmt 49.77 84.75 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.311 -0.859 . . . . 0.0 112.209 177.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.556 HD22 ' HE2' ' A' ' 67' ' ' LYS . 61.9 tp -136.56 121.04 18.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.866 -179.222 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 54.1 t -79.29 113.37 18.54 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 N-CA-C 109.943 -0.391 . . . . 0.0 109.943 178.059 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.475 HG21 HG22 ' A' ' 22' ' ' VAL . 33.6 m -108.64 -2.5 10.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.602 -175.526 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -169.03 138.64 2.18 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 179.127 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.401 ' HA ' ' O ' ' A' ' 61' ' ' ILE . 0.2 OUTLIER -165.35 145.49 6.9 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 121.082 0.468 . . . . 0.0 111.31 176.752 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . 0.583 ' SG ' HG11 ' A' ' 95' ' ' VAL . 50.4 t -166.11 118.83 1.08 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.635 179.542 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 86.5 t80 -94.73 137.83 33.33 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.521 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 35.4 m -132.49 139.11 50.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 109.354 -0.609 . . . . 0.0 109.354 177.066 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 35.0 ttm-85 -107.67 -25.24 11.4 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.007 -175.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 39.4 tptt -170.05 -30.46 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 120.81 0.338 . . . . 0.0 110.496 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -97.03 124.49 41.03 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.993 179.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.465 HD13 ' N ' ' A' ' 82' ' ' VAL . 3.3 tm? -175.85 139.52 0.4 Allowed 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 177.172 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.465 ' N ' HD13 ' A' ' 81' ' ' LEU . 66.0 t -130.48 122.31 52.79 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 CA-C-N 116.602 -0.272 . . . . 0.0 110.554 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.611 ' HB3' ' NE2' ' A' ' 91' ' ' HIS . 96.1 m-85 -91.79 153.83 19.34 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-O 120.968 0.413 . . . . 0.0 110.06 173.8 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 91.4 m -156.0 117.5 3.92 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 174.727 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.407 ' HZ3' ' CG ' ' A' ' 114' ' ' ASP . 20.2 ptmt -101.31 125.13 47.9 Favored 'General case' 0 C--N 1.328 -0.366 0 O-C-N 122.034 -0.416 . . . . 0.0 110.546 178.685 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -80.6 -34.01 35.5 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.63 -0.713 . . . . 0.0 110.363 -178.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -136.99 155.4 76.28 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.084 179.134 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_exo -48.73 -41.91 37.45 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.469 2.113 . . . . 0.0 111.959 176.178 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 13.4 p -97.25 18.16 15.68 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 115.716 -0.675 . . . . 0.0 112.051 -178.485 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 21.5 t80 -147.47 98.32 2.97 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-O 121.148 0.499 . . . . 0.0 110.865 177.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . 0.611 ' NE2' ' HB3' ' A' ' 83' ' ' TYR . 3.4 t-160 -109.47 125.15 52.15 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 -179.604 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 25.8 p80 -125.6 167.03 15.64 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.971 0.415 . . . . 0.0 110.926 -178.499 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 26.8 p90 -139.63 177.9 7.61 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.282 176.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 62.6 pttt -154.28 147.29 24.57 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.817 0.341 . . . . 0.0 111.052 -174.435 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.583 HG11 ' SG ' ' A' ' 75' ' ' CYS . 35.7 m -132.72 143.94 38.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 173.737 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 66.01 -72.17 0.08 Allowed 'General case' 0 N--CA 1.465 0.321 0 O-C-N 123.56 0.538 . . . . 0.0 110.719 -176.192 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -165.34 -26.78 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.874 -178.626 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.461 ' HG2' ' HA ' ' A' ' 27' ' ' ASP . 99.8 mtt180 -81.81 149.51 28.32 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 120.832 0.348 . . . . 0.0 111.027 -178.299 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.496 ' HB3' ' HH2' ' A' ' 32' ' ' TRP . 0.0 OUTLIER -114.22 142.66 45.98 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.261 -173.141 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 2.9 p90 -150.05 138.88 20.9 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 173.056 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -142.69 -170.1 12.62 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.205 -0.998 . . . . 0.0 114.605 -169.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.459 HD13 ' HB2' ' A' ' 20' ' ' ALA . 34.3 tp -134.17 124.26 25.74 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 114.995 -0.603 . . . . 0.0 110.868 -173.189 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.543 ' HB ' ' HB ' ' A' ' 21' ' ' VAL . 22.5 m -98.5 124.92 43.51 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 175.563 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 57.0 m-85 -87.76 161.77 17.4 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.863 -175.136 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 23.8 pt20 -96.29 -27.99 14.72 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.655 -177.499 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 49.1 m -149.56 154.43 38.09 Favored Pre-proline 0 CA--C 1.532 0.264 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.544 178.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -58.73 -24.43 71.19 Favored 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 122.555 2.17 . . . . 0.0 112.064 178.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -62.21 -56.09 22.14 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.916 178.542 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -71.73 -28.73 63.87 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.759 179.206 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -58.97 -60.66 3.5 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.127 0.489 . . . . 0.0 110.392 174.456 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 67.5 mtp85 -62.43 -32.62 73.51 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.913 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -62.59 -38.59 90.72 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.311 176.167 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 52.6 t80 -73.68 -34.48 64.91 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.169 179.099 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.417 ' HA ' HG22 ' A' ' 117' ' ' VAL . 63.9 m-20 -61.71 -38.64 88.61 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 121.337 0.589 . . . . 0.0 109.534 173.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 17.0 mmm180 -62.39 -42.05 99.13 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.684 172.071 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -60.17 -46.4 94.3 Favored Glycine 0 N--CA 1.45 -0.412 0 CA-C-N 115.336 -0.847 . . . . 0.0 112.519 178.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.425 ' O ' HG13 ' A' ' 121' ' ' ILE . 21.3 m -70.51 -34.82 59.06 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.366 0 CA-C-N 116.737 0.268 . . . . 0.0 110.634 -178.878 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -61.88 -48.91 78.38 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 176.839 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 7.9 tmtm? -62.03 -45.9 91.51 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 114.775 -1.102 . . . . 0.0 109.801 -179.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -61.42 -52.11 65.96 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.818 -179.687 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.425 HG13 ' O ' ' A' ' 117' ' ' VAL . 68.4 mt -57.66 -41.12 78.62 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.123 -178.136 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.546 ' O ' ' HG3' ' A' ' 126' ' ' GLU . 37.0 tt0 -63.37 -58.34 7.41 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 121.018 0.437 . . . . 0.0 110.394 177.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -60.76 -22.55 64.18 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.449 -179.506 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 9.4 tt -84.47 -39.82 18.44 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.418 179.346 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.497 HG21 ' O ' ' A' ' 122' ' ' GLU . 10.8 tp -72.11 -25.87 24.25 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 CA-C-N 116.732 -0.213 . . . . 0.0 110.434 -176.04 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.546 ' HG3' ' O ' ' A' ' 122' ' ' GLU . 46.8 mt-10 . . . . . 0 C--O 1.25 1.098 0 CA-C-O 118.728 -0.653 . . . . 0.0 110.336 175.18 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.767 0 N-CA-C 111.929 -0.469 . . . . 0.0 111.929 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 32.2 t -69.03 126.94 31.38 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-O 120.727 0.299 . . . . 0.0 110.742 -179.641 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 34.7 tpp -71.82 112.68 8.13 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.474 178.342 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 43.5 m 69.64 92.06 0.09 Allowed 'General case' 0 CA--C 1.531 0.248 0 O-C-N 123.686 0.616 . . . . 0.0 111.565 178.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -100.1 -52.15 3.49 Favored 'General case' 0 C--O 1.233 0.229 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 173.336 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 19.3 mm-40 -87.08 -161.26 0.67 Allowed 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 115.232 -0.894 . . . . 0.0 108.902 174.407 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 21.5 m 72.78 76.12 0.15 Allowed 'General case' 0 C--O 1.234 0.27 0 CA-C-O 121.369 0.604 . . . . 0.0 111.349 177.029 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.595 ' HB3' ' HD2' ' A' ' 9' ' ' PRO . 33.4 m170 -89.79 170.16 11.08 Favored Pre-proline 0 CA--C 1.535 0.386 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.488 173.356 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.595 ' HD2' ' HB3' ' A' ' 8' ' ' HIS . 35.7 Cg_exo -37.29 -48.14 1.71 Allowed 'Trans proline' 0 C--N 1.364 1.346 0 C-N-CA 123.215 2.61 . . . . 0.0 113.068 179.179 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -124.66 89.94 3.16 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 172.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.461 ' HB2' ' H ' ' A' ' 8' ' ' HIS . 14.2 t70 -106.52 -14.17 15.13 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.227 -175.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -75.28 -20.36 59.18 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.29 -174.438 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.787 ' HB2' ' SG ' ' A' ' 46' ' ' CYS . 58.3 m -93.97 -90.03 0.21 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.729 -0.214 . . . . 0.0 110.92 178.772 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.448 ' CE2' ' HA ' ' A' ' 11' ' ' ASP . 31.8 m-85 42.88 91.34 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 122.74 0.416 . . . . 0.0 111.87 -175.263 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.624 HD12 ' HB2' ' A' ' 47' ' ' LYS . 63.0 mt -61.18 -51.15 76.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 121.147 0.499 . . . . 0.0 109.916 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.517 HG23 HG22 ' A' ' 15' ' ' ILE . 92.0 t -140.1 119.33 12.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.882 178.701 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.57 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 27.8 ttp180 -128.05 86.7 2.5 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-O 121.264 0.554 . . . . 0.0 109.776 173.122 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 35.0 m -117.68 173.03 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-N 115.329 -0.85 . . . . 0.0 110.474 -177.205 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 26.1 ttpp -92.06 134.91 34.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.91 0.386 . . . . 0.0 110.914 179.638 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -160.11 -164.21 1.25 Allowed 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 178.304 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 25.0 t -122.44 109.16 23.34 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 177.538 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.685 HG22 ' NE2' ' A' ' 35' ' ' GLN . 19.7 m -84.16 133.18 29.8 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 CA-C-O 120.989 0.423 . . . . 0.0 111.031 -178.233 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 24.5 mmt -117.09 152.42 34.73 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.108 -176.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.424 HG21 ' CE1' ' A' ' 33' ' ' PHE . 9.8 t -132.66 140.26 48.08 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-O 121.134 0.492 . . . . 0.0 110.955 176.427 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.44 ' HE ' ' HA ' ' A' ' 28' ' ' SER . 21.1 tpt180 -90.21 77.78 6.66 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 174.71 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.539 ' HB2' ' HE1' ' A' ' 33' ' ' PHE . 35.7 t70 -56.3 94.74 0.01 OUTLIER 'General case' 0 C--O 1.236 0.371 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 179.478 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 16.0 t70 63.47 -74.78 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.941 -173.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.44 ' HA ' ' HE ' ' A' ' 25' ' ' ARG . 8.0 t -167.27 -44.26 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 175.324 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 18.5 t -61.88 -12.34 17.31 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.53 -178.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -62.1 -26.58 67.68 Favored Glycine 0 CA--C 1.523 0.574 0 C-N-CA 121.153 -0.546 . . . . 0.0 112.478 175.569 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 56.79 28.54 57.34 Favored Glycine 0 C--N 1.338 0.663 0 C-N-CA 121.739 -0.267 . . . . 0.0 113.537 177.298 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . 0.575 ' HH2' ' HG2' ' A' ' 99' ' ' LYS . 62.4 m95 63.03 96.76 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 123.174 0.59 . . . . 0.0 110.678 -177.789 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.539 ' HE1' ' HB2' ' A' ' 26' ' ' ASP . 2.9 p90 -132.04 150.84 77.23 Favored Pre-proline 0 C--O 1.236 0.376 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.928 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.482 ' HB2' ' HA2' ' A' ' 38' ' ' GLY . 77.1 Cg_endo -79.35 109.2 2.46 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.527 2.151 . . . . 0.0 112.084 179.15 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.685 ' NE2' HG22 ' A' ' 22' ' ' VAL . 0.2 OUTLIER -75.57 125.95 30.04 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 176.861 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 65.07 -75.1 0.05 OUTLIER 'General case' 0 C--O 1.236 0.377 0 C-N-CA 123.133 0.573 . . . . 0.0 111.317 -178.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -76.25 74.33 1.69 Allowed Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 121.575 -0.345 . . . . 0.0 112.782 -177.242 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.482 ' HA2' ' HB2' ' A' ' 34' ' ' PRO . . . -75.56 66.74 2.32 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 121.209 -0.52 . . . . 0.0 112.114 177.156 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 129.02 -32.0 3.37 Favored Glycine 0 N--CA 1.453 -0.173 0 C-N-CA 121.415 -0.421 . . . . 0.0 112.07 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 67.4 mt -120.4 100.75 9.76 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 CA-C-O 120.823 0.344 . . . . 0.0 110.501 179.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 16.5 m -132.49 151.42 51.91 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 175.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 6.5 tpt180 -113.9 116.12 28.77 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 174.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.57 ' O ' ' HA ' ' A' ' 17' ' ' ARG . 24.2 t -95.46 103.16 14.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.273 -178.047 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -106.16 89.43 0.61 Allowed Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 121.334 -0.46 . . . . 0.0 112.491 179.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 85.0 t -84.86 120.8 36.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 120.856 0.36 . . . . 0.0 110.067 177.015 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . 0.787 ' SG ' ' HB2' ' A' ' 13' ' ' SER . 45.0 t -117.8 165.2 13.93 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.921 -178.666 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.624 ' HB2' HD12 ' A' ' 15' ' ' ILE . 83.8 tttt -118.65 116.05 25.78 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.368 -179.65 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.442 HG22 ' CE2' ' A' ' 76' ' ' TYR . 36.0 m -110.55 150.96 12.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.094 0.473 . . . . 0.0 111.286 -175.414 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 4.0 mpp? -93.51 -171.44 2.63 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.416 178.36 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 28.8 p80 -137.1 157.66 74.09 Favored Pre-proline 0 C--O 1.237 0.41 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.725 -177.249 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -64.86 -153.06 0.02 OUTLIER 'Trans proline' 0 C--N 1.353 0.787 0 C-N-CA 122.925 2.417 . . . . 0.0 111.285 172.558 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 67.8 mm-40 -56.58 118.76 5.15 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 120.651 0.262 . . . . 0.0 110.435 178.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -170.17 -179.91 42.0 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 121.211 -0.519 . . . . 0.0 111.932 -177.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -83.89 -40.76 18.2 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.695 0.283 . . . . 0.0 110.838 -177.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 167.13 -140.93 6.57 Favored Glycine 0 N--CA 1.453 -0.221 0 C-N-CA 121.078 -0.582 . . . . 0.0 111.89 -178.552 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 3.6 mpt_? 69.32 100.32 0.06 Allowed 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 121.206 0.527 . . . . 0.0 111.016 -177.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 23.4 p -75.58 124.76 27.75 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.48 179.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -86.46 161.31 33.82 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.893 -0.67 . . . . 0.0 111.934 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -133.17 158.09 43.71 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.87 -0.418 . . . . 0.0 109.87 178.574 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.424 HD23 ' HB2' ' A' ' 62' ' ' HIS . 1.9 tt -132.23 113.61 13.47 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 -179.774 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.512 ' HB ' ' HB2' ' A' ' 75' ' ' CYS . 58.0 mt -82.24 97.23 3.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 174.666 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . 0.424 ' HB2' HD23 ' A' ' 60' ' ' LEU . 26.6 t-80 -111.24 91.67 3.75 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.737 -172.446 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -89.98 114.79 4.43 Favored Glycine 0 C--O 1.236 0.275 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.625 177.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -143.49 -161.15 1.21 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.655 0.227 . . . . 0.0 111.526 -174.334 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 1.4 mmp_? 63.98 32.1 13.27 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 115.764 -0.653 . . . . 0.0 112.687 170.547 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.469 ' N ' HE21 ' A' ' 66' ' ' GLN . 0.0 OUTLIER -72.73 -67.51 0.55 Allowed 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.771 -0.372 . . . . 0.0 110.498 176.614 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 64.6 tttm -132.51 130.02 39.87 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 178.396 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 59.71 -80.93 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 -174.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 23.2 pttm -178.66 128.41 0.11 Allowed 'General case' 0 C--O 1.232 0.176 0 C-N-CA 123.149 0.58 . . . . 0.0 109.775 169.114 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -174.46 157.93 2.74 Favored 'General case' 0 C--O 1.24 0.571 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.03 177.634 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 25.0 t -95.41 117.51 39.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 O-C-N 123.297 0.373 . . . . 0.0 110.24 -179.286 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 33.6 m -92.48 -24.9 5.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 120.864 0.364 . . . . 0.0 111.062 -179.101 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -145.85 109.35 4.73 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 -176.287 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -116.9 116.61 27.75 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 178.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . 0.512 ' HB2' ' HB ' ' A' ' 61' ' ' ILE . 63.0 m -137.48 90.85 2.55 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 121.151 0.501 . . . . 0.0 110.526 179.448 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.442 ' CE2' HG22 ' A' ' 48' ' ' VAL . 56.6 t80 -70.98 105.26 3.23 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 173.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 15.6 m -103.62 97.55 5.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 121.81 0.814 . . . . 0.0 110.366 -174.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 28.6 ptt180 -83.06 80.37 9.07 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.396 -177.246 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.736 ' HA ' HD11 ' A' ' 124' ' ' LEU . 11.0 tmtt? 76.1 -37.5 0.31 Allowed 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.995 177.735 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -68.82 108.33 3.4 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 122.363 0.265 . . . . 0.0 110.715 -179.425 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.403 HD22 ' HA ' ' A' ' 81' ' ' LEU . 12.2 mt -152.02 163.21 39.77 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.213 0.53 . . . . 0.0 110.832 179.577 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 58.3 t -131.84 -65.7 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.721 176.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.433 ' HB3' ' NE2' ' A' ' 91' ' ' HIS . 21.0 m-85 56.73 103.61 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.431 -176.729 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 53.0 m -134.12 112.52 11.2 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.736 178.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.557 ' HA ' ' HA ' ' A' ' 91' ' ' HIS . 0.2 OUTLIER -82.16 91.1 6.65 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.454 0.645 . . . . 0.0 109.68 177.16 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -66.24 -32.01 73.18 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.046 -178.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . 0.727 ' HB2' ' HB3' ' A' ' 90' ' ' PHE . 15.6 m120 -129.09 155.35 79.96 Favored Pre-proline 0 C--N 1.326 -0.414 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 175.458 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_exo -44.26 -44.01 13.05 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.648 2.232 . . . . 0.0 112.915 179.41 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.546 ' O ' ' HA ' ' A' ' 103' ' ' THR . 37.3 p -108.67 16.98 22.43 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 -177.411 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.727 ' HB3' ' HB2' ' A' ' 87' ' ' ASN . 73.4 t80 -131.0 104.04 6.88 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 120.894 0.378 . . . . 0.0 110.509 -178.543 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . 0.557 ' HA ' ' HA ' ' A' ' 85' ' ' LYS . 1.5 t60 -114.9 124.27 51.28 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 -179.121 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . 0.463 ' HA ' ' HA2' ' A' ' 101' ' ' GLY . 23.5 p80 -126.78 159.54 33.5 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 120.953 0.406 . . . . 0.0 111.766 -176.394 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 49.1 p90 -155.39 147.53 23.62 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.282 -179.462 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.53 ' HB3' ' HZ3' ' A' ' 94' ' ' LYS . 5.7 ttpm? -112.85 127.53 56.2 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 177.426 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 19.1 m -146.69 146.94 18.34 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 O-C-N 123.253 0.346 . . . . 0.0 110.473 -179.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 33.6 t70 63.82 -73.33 0.05 OUTLIER 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.373 0.669 . . . . 0.0 111.773 178.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -146.43 -57.22 0.28 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.657 0.265 . . . . 0.0 110.65 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -78.8 176.19 9.78 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-O 121.538 0.685 . . . . 0.0 111.249 -178.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.575 ' HG2' ' HH2' ' A' ' 32' ' ' TRP . 37.2 ttpt -128.97 115.33 17.65 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.136 -179.268 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . 0.445 ' CE2' ' SG ' ' A' ' 75' ' ' CYS . 41.2 m-85 -101.21 168.38 9.6 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.528 -0.306 . . . . 0.0 110.605 -174.037 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.463 ' HA2' ' HA ' ' A' ' 92' ' ' HIS . . . -151.08 170.87 30.79 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 121.136 -0.554 . . . . 0.0 112.161 -177.798 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.409 HD23 ' N ' ' A' ' 103' ' ' THR . 2.5 tt -143.52 128.77 18.8 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 -178.212 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.546 ' HA ' ' O ' ' A' ' 89' ' ' THR . 84.2 m -110.89 122.48 47.96 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.189 176.035 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.421 ' HD2' ' HA ' ' A' ' 89' ' ' THR . 50.9 m-85 -89.28 162.21 15.98 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.699 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 19.0 pt20 -113.5 -48.17 2.96 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 111.396 0.147 . . . . 0.0 111.396 -176.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 17.2 m -117.34 143.93 32.93 Favored Pre-proline 0 C--N 1.328 -0.34 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 -177.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_exo -47.7 -29.98 11.91 Favored 'Trans proline' 0 C--N 1.354 0.829 0 C-N-CA 122.593 2.196 . . . . 0.0 112.314 177.584 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -58.06 -70.75 0.13 Allowed 'General case' 0 C--O 1.233 0.204 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.98 177.024 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -60.45 -37.35 80.69 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.062 -178.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . 0.409 ' HA ' ' CG ' ' A' ' 104' ' ' PHE . . . -54.01 -69.56 0.12 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.261 178.711 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 78.4 mtt180 -70.94 -22.81 62.18 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.536 -173.307 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -65.67 -48.89 70.56 Favored 'General case' 0 C--O 1.238 0.471 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 174.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 57.1 t80 -69.59 -47.16 64.48 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.075 -179.464 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.409 ' O ' ' HG2' ' A' ' 118' ' ' ARG . 4.8 m-20 -51.93 -58.72 5.66 Favored 'General case' 0 N--CA 1.465 0.294 0 O-C-N 123.191 0.307 . . . . 0.0 110.75 178.638 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 27.3 mtp180 -60.71 -38.43 85.04 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-O 120.699 0.285 . . . . 0.0 110.892 -179.007 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.495 ' O ' ' HG3' ' A' ' 119' ' ' LYS . . . -62.04 -56.64 21.22 Favored Glycine 0 CA--C 1.52 0.386 0 C-N-CA 121.183 -0.532 . . . . 0.0 112.575 179.231 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.546 ' O ' HG12 ' A' ' 121' ' ' ILE . 12.1 p -64.59 -30.91 51.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.571 0.224 . . . . 0.0 110.408 -178.529 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.409 ' HD2' ' HA ' ' A' ' 118' ' ' ARG . 7.9 mmm180 -62.77 -50.75 69.82 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.653 177.688 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.495 ' HG3' ' O ' ' A' ' 116' ' ' GLY . 0.0 OUTLIER -62.01 -33.98 75.35 Favored 'General case' 0 N--CA 1.462 0.151 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 178.753 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -62.51 -36.53 82.86 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.449 175.423 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.546 HG12 ' O ' ' A' ' 117' ' ' VAL . 40.3 mm -64.09 -44.65 97.71 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.076 0 CA-C-N 116.248 -0.433 . . . . 0.0 109.879 175.904 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -58.55 -39.19 79.55 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.71 176.175 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 87.9 m-20 -66.05 -37.08 84.95 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 121.252 0.549 . . . . 0.0 110.239 176.439 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.736 HD11 ' HA ' ' A' ' 79' ' ' LYS . 49.4 tp -70.5 -57.73 4.46 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.335 -0.848 . . . . 0.0 111.469 -176.294 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.487 HG13 ' O ' ' A' ' 121' ' ' ILE . 2.9 pp -75.02 -29.47 22.16 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.05 -177.594 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.46 ' N ' HD13 ' A' ' 125' ' ' ILE . 39.5 tt0 . . . . . 0 C--O 1.248 1.008 0 CA-C-O 118.15 -0.929 . . . . 0.0 111.094 176.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.729 0 N-CA-C 112.185 -0.366 . . . . 0.0 112.185 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 23.8 p -66.19 113.44 4.55 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 177.303 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' MET . . . . . 0.466 ' HE3' HG13 ' A' ' 48' ' ' VAL . 52.2 ttp -144.99 128.26 16.79 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.976 0.417 . . . . 0.0 111.554 -173.583 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 12.0 t -166.52 137.42 3.4 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 176.006 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -158.32 -85.89 0.04 OUTLIER 'General case' 0 C--O 1.234 0.237 0 CA-C-O 120.613 0.244 . . . . 0.0 111.056 -174.107 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -90.01 -50.25 6.13 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 121.101 0.477 . . . . 0.0 109.974 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.408 ' O ' ' HB2' ' A' ' 8' ' ' HIS . 15.2 t -63.08 157.64 21.66 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.774 178.171 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.655 ' HB2' ' HD3' ' A' ' 9' ' ' PRO . 32.1 m170 103.09 -68.74 0.0 OUTLIER Pre-proline 0 N--CA 1.482 1.145 0 C-N-CA 125.391 1.476 . . . . 0.0 113.235 176.726 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.655 ' HD3' ' HB2' ' A' ' 8' ' ' HIS . 80.7 Cg_exo -48.96 -44.59 31.89 Favored 'Trans proline' 0 C--N 1.37 1.693 0 C-N-CA 121.867 1.711 . . . . 0.0 112.066 -177.217 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -83.29 -85.8 0.12 Allowed 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 172.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -175.12 -50.02 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 168.196 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 33.1 t70 65.15 -71.16 0.08 Allowed 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 112.959 0.725 . . . . 0.0 112.959 172.568 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 60.5 m -130.53 26.86 5.04 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 111.938 0.347 . . . . 0.0 111.938 -175.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.645 ' HE2' ' HA ' ' A' ' 8' ' ' HIS . 13.3 m-85 -73.45 123.19 23.4 Favored 'General case' 0 C--O 1.235 0.305 0 O-C-N 122.096 -0.378 . . . . 0.0 110.841 176.591 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.434 HG21 HG12 ' A' ' 16' ' ' VAL . 13.6 tt -85.12 -27.15 6.57 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 174.137 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.434 HG12 HG21 ' A' ' 15' ' ' ILE . 9.2 p -159.15 144.97 6.95 Favored 'Isoleucine or valine' 0 C--O 1.231 0.13 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.906 176.279 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 55.8 ttp180 -160.04 109.35 1.78 Allowed 'General case' 0 C--O 1.235 0.315 0 CA-C-O 121.026 0.441 . . . . 0.0 110.433 176.024 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 34.6 m -113.01 -170.32 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.089 -179.219 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.51 ' HB2' HG21 ' A' ' 40' ' ' ILE . 57.4 pttt -126.26 113.59 17.17 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.069 0.461 . . . . 0.0 110.392 178.511 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -143.52 178.14 7.98 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.351 -177.483 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.519 ' HB ' ' HB ' ' A' ' 103' ' ' THR . 27.5 t -83.37 135.17 25.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.442 0.163 . . . . 0.0 110.564 179.825 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.55 HG22 ' HG2' ' A' ' 35' ' ' GLN . 11.6 m -95.24 95.26 4.87 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 CA-C-O 121.473 0.654 . . . . 0.0 110.847 177.087 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 23.6 mmt -86.77 160.01 18.94 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.699 -178.262 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 11.7 t -160.24 150.71 18.53 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.867 174.168 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.409 ' HD2' ' O ' ' A' ' 29' ' ' SER . 47.6 ttp180 -114.1 89.74 3.17 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 107.594 -1.261 . . . . 0.0 107.594 171.835 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -43.47 96.99 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.33 0 O-C-N 124.482 1.114 . . . . 0.0 112.364 -169.357 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 18.7 t70 58.22 -78.92 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 115.15 -0.932 . . . . 0.0 111.088 -179.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 21.1 m -141.95 105.7 4.71 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 176.329 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.409 ' O ' ' HD2' ' A' ' 25' ' ' ARG . 36.4 t -141.84 171.1 14.52 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.14 -176.481 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -100.02 38.87 2.93 Favored Glycine 0 CA--C 1.518 0.268 0 C-N-CA 121.293 -0.479 . . . . 0.0 112.93 -176.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 171.92 163.71 26.29 Favored Glycine 0 C--N 1.33 0.243 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.649 177.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 86.2 m95 -103.6 113.73 27.47 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 176.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -117.6 144.76 34.86 Favored Pre-proline 0 C--N 1.327 -0.402 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.288 -177.007 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo -71.11 137.73 32.16 Favored 'Trans proline' 0 C--N 1.351 0.676 0 C-N-CA 122.846 2.364 . . . . 0.0 111.46 175.038 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.55 ' HG2' HG22 ' A' ' 22' ' ' VAL . 7.1 pt20 -87.91 -147.53 0.15 Allowed 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.07 179.261 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 44.5 mm-40 -46.66 -42.73 16.87 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 111.832 0.308 . . . . 0.0 111.832 179.528 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -80.8 68.58 3.37 Favored Glycine 0 CA--C 1.519 0.328 0 C-N-CA 121.184 -0.532 . . . . 0.0 112.544 -179.392 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -77.33 132.07 11.74 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 121.204 -0.522 . . . . 0.0 112.392 179.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 85.05 -57.96 4.98 Favored Glycine 0 CA--C 1.518 0.264 0 C-N-CA 121.283 -0.484 . . . . 0.0 112.885 176.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.51 HG21 ' HB2' ' A' ' 19' ' ' LYS . 65.5 mt -142.23 140.76 29.12 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 C-N-CA 122.341 0.256 . . . . 0.0 110.458 -177.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.439 ' O ' ' HA ' ' A' ' 19' ' ' LYS . 53.0 m -150.71 133.96 16.2 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 174.344 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 55.4 ttp180 -81.47 90.63 6.23 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 109.808 -0.441 . . . . 0.0 109.808 -178.375 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.459 ' HA ' ' HA2' ' A' ' 63' ' ' GLY . 31.4 t -111.96 143.3 22.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.443 -175.721 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -160.96 -177.43 34.06 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.994 -0.622 . . . . 0.0 112.718 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 50.5 t -118.04 130.45 72.89 Favored 'Isoleucine or valine' 0 C--O 1.241 0.614 0 CA-C-O 120.721 0.296 . . . . 0.0 110.263 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . 0.675 ' SG ' ' HB3' ' A' ' 60' ' ' LEU . 12.4 p -119.67 122.49 41.6 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.452 173.361 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 33.3 ttpt -78.72 102.03 7.86 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 121.053 0.454 . . . . 0.0 110.145 179.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.517 ' O ' ' HB3' ' A' ' 57' ' ' SER . 51.3 t -75.86 110.74 11.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.372 -179.691 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 22.9 ptp -107.7 135.63 48.81 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.288 -0.415 . . . . 0.0 109.979 178.505 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 19.3 p80 -58.73 127.04 82.03 Favored Pre-proline 0 CA--C 1.532 0.267 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.908 177.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -58.45 -56.94 1.24 Allowed 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 122.351 2.034 . . . . 0.0 110.965 176.23 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 10.4 mp0 -114.41 -60.07 1.93 Allowed 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 170.533 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 176.04 47.78 0.06 OUTLIER Glycine 0 C--N 1.33 0.231 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.314 178.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 24.6 p-10 -64.73 -42.8 94.94 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 111.994 0.368 . . . . 0.0 111.994 -174.264 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -168.36 -171.68 34.48 Favored Glycine 0 C--O 1.236 0.248 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.898 -178.056 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -64.84 105.37 0.99 Allowed 'General case' 0 C--O 1.234 0.276 0 CA-C-O 120.859 0.361 . . . . 0.0 111.038 -179.147 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.517 ' HB3' ' O ' ' A' ' 48' ' ' VAL . 22.7 m -68.31 151.91 46.21 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.341 177.214 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -165.37 -147.14 5.04 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.618 -177.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -130.32 125.56 35.01 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 -176.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.675 ' HB3' ' SG ' ' A' ' 46' ' ' CYS . 2.3 tt -95.81 118.29 32.18 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 -179.531 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 49.5 mm -84.27 93.95 3.48 Favored 'Isoleucine or valine' 0 C--O 1.235 0.292 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 172.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . 0.599 ' HB2' HD21 ' A' ' 60' ' ' LEU . 38.5 t-80 -108.48 131.91 54.33 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.941 -171.798 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.459 ' HA2' ' HA ' ' A' ' 43' ' ' VAL . . . -128.24 133.06 7.58 Favored Glycine 0 N--CA 1.449 -0.481 0 N-CA-C 110.89 -0.884 . . . . 0.0 110.89 177.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -146.89 178.17 8.55 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.78 0.324 . . . . 0.0 111.329 -172.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 5.1 mmt180 68.1 169.37 0.27 Allowed 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 115.303 -0.862 . . . . 0.0 111.868 174.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 65.33 165.63 0.17 Allowed 'General case' 0 C--O 1.235 0.323 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.297 -173.216 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 24.9 tptp 71.24 -59.82 0.53 Allowed 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 122.946 0.498 . . . . 0.0 109.665 -174.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -165.24 -84.97 0.02 OUTLIER 'General case' 0 C--O 1.234 0.28 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.235 173.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.592 ' HZ1' ' HB2' ' A' ' 69' ' ' LYS . 4.3 ttmp? -165.85 96.0 0.62 Allowed 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 -179.262 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.4 pp -173.23 178.92 2.32 Favored 'General case' 0 C--O 1.239 0.514 0 CA-C-O 120.633 0.254 . . . . 0.0 110.474 -173.01 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.462 HG23 ' O ' ' A' ' 71' ' ' VAL . 27.4 m -103.41 104.1 16.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.889 177.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.419 HG23 ' HB3' ' A' ' 41' ' ' SER . 34.7 m -68.46 -31.37 50.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.41 -178.572 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 40.4 mt -141.06 94.22 2.68 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.362 178.042 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -98.51 94.92 6.96 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 170.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . 0.486 ' SG ' ' CE2' ' A' ' 100' ' ' PHE . 57.9 m -139.43 89.4 2.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.363 0.601 . . . . 0.0 111.011 -172.386 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.485 ' HA ' ' HA ' ' A' ' 60' ' ' LEU . 29.9 t80 -74.27 116.13 14.57 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.173 178.072 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.59 HG11 HD12 ' A' ' 81' ' ' LEU . 95.8 t -80.19 105.93 10.56 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 CA-C-O 121.144 0.497 . . . . 0.0 109.818 179.719 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.575 ' HD2' ' O ' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -80.79 61.86 4.6 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.276 -179.906 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.566 ' HG3' HD22 ' A' ' 124' ' ' LEU . 45.4 tttp 74.86 124.19 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 115.172 -0.922 . . . . 0.0 111.394 -176.479 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 76.7 m-20 70.6 119.39 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 115.113 -0.949 . . . . 0.0 112.915 174.15 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.59 HD12 HG11 ' A' ' 77' ' ' VAL . 0.0 OUTLIER -143.52 134.26 25.17 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 167.47 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 19.8 t -65.61 -52.02 55.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.888 -169.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.575 ' HH ' HD11 ' A' ' 102' ' ' LEU . 0.9 OUTLIER 57.87 51.59 8.93 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 121.292 0.568 . . . . 0.0 109.987 -177.626 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 33.7 m -60.52 114.18 2.83 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.786 -179.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.456 ' HB3' ' CD2' ' A' ' 91' ' ' HIS . 0.0 OUTLIER -99.71 102.25 13.66 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.972 0.415 . . . . 0.0 110.334 176.112 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -75.46 -37.15 60.48 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 175.367 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . 0.442 ' HB2' ' HB3' ' A' ' 90' ' ' PHE . 77.0 m-20 -127.67 151.46 75.33 Favored Pre-proline 0 C--N 1.326 -0.423 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 174.095 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.484 ' O ' ' HB3' ' A' ' 110' ' ' ALA . 88.7 Cg_exo -48.22 -33.82 22.71 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.313 2.009 . . . . 0.0 112.374 178.387 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.448 ' O ' ' HA ' ' A' ' 103' ' ' THR . 14.7 p -97.68 -15.65 20.3 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 115.889 -0.596 . . . . 0.0 112.138 -178.519 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.442 ' HB3' ' HB2' ' A' ' 87' ' ' ASN . 86.8 t80 -107.31 102.47 11.77 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-O 121.087 0.47 . . . . 0.0 110.854 -176.653 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . 0.456 ' CD2' ' HB3' ' A' ' 85' ' ' LYS . 56.5 m80 -112.82 147.3 37.24 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.155 177.201 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . 0.542 ' HA ' ' HA3' ' A' ' 101' ' ' GLY . 15.4 p80 -153.95 152.84 31.04 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 174.789 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . 0.444 ' HD1' HG13 ' A' ' 95' ' ' VAL . 47.8 p90 -137.13 145.28 43.63 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-O 121.283 0.563 . . . . 0.0 111.291 177.867 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 1.1 tmtm? -102.04 119.52 38.93 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.013 -0.994 . . . . 0.0 109.286 176.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.444 HG13 ' HD1' ' A' ' 93' ' ' TRP . 19.3 m -125.45 125.64 69.22 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 173.417 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 59.56 -79.4 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.77 -175.518 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 44.1 t30 -142.29 -35.21 0.43 Allowed 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 112.063 0.394 . . . . 0.0 112.063 -177.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.507 ' N ' ' HD2' ' A' ' 98' ' ' ARG . 2.3 mpt_? -84.46 148.29 26.64 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.899 0.381 . . . . 0.0 111.212 -174.659 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 3.5 mppt? -119.92 124.49 46.14 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.759 -176.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . 0.486 ' CE2' ' SG ' ' A' ' 75' ' ' CYS . 0.7 OUTLIER -144.31 150.44 37.85 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.485 176.095 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.542 ' HA3' ' HA ' ' A' ' 92' ' ' HIS . . . -157.71 -165.61 15.64 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 121.021 -0.609 . . . . 0.0 112.82 -175.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.575 HD11 ' HH ' ' A' ' 83' ' ' TYR . 94.9 mt -128.42 147.32 50.65 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.998 0.428 . . . . 0.0 110.887 -174.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.519 ' HB ' ' HB ' ' A' ' 21' ' ' VAL . 63.2 m -123.79 107.67 11.67 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 172.74 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.448 ' HB3' ' OD2' ' A' ' 109' ' ' ASP . 99.4 m-85 -78.28 167.97 20.54 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.645 -0.707 . . . . 0.0 112.019 -172.122 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 -92.06 -41.76 10.33 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.03 -175.618 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 16.7 m -137.54 156.13 75.01 Favored Pre-proline 0 C--O 1.234 0.285 0 CA-C-N 116.621 -0.263 . . . . 0.0 110.883 -175.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -54.2 -32.65 71.61 Favored 'Trans proline' 0 C--N 1.351 0.676 0 C-N-CA 122.656 2.237 . . . . 0.0 112.234 177.392 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -56.43 -66.32 0.46 Allowed 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.401 179.05 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.448 ' OD2' ' HB3' ' A' ' 104' ' ' PHE . 1.6 p-10 -63.63 -35.73 81.47 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.086 -178.415 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . 0.484 ' HB3' ' O ' ' A' ' 88' ' ' PRO . . . -58.64 -61.51 2.55 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 121.174 0.511 . . . . 0.0 111.263 177.444 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 82.5 mtp180 -65.39 -26.32 67.94 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.738 -177.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -68.71 -43.06 76.79 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.748 177.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -71.98 -37.27 69.91 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 -178.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -55.73 -51.96 65.53 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 121.917 0.865 . . . . 0.0 109.409 172.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 35.2 ttt180 -56.16 -37.1 69.07 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 114.347 -1.297 . . . . 0.0 110.676 174.004 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -61.69 -52.57 49.88 Favored Glycine 0 C--N 1.332 0.315 0 CA-C-N 115.853 -0.612 . . . . 0.0 112.446 178.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.408 HG13 ' HD2' ' A' ' 83' ' ' TYR . 11.3 p -67.09 -28.72 43.71 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.151 0 CA-C-O 121.001 0.429 . . . . 0.0 109.961 179.233 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.406 HH11 ' HD3' ' A' ' 118' ' ' ARG . 0.0 OUTLIER -58.88 -55.33 36.55 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 176.932 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 59.8 tttm -66.68 -35.29 79.79 Favored 'General case' 0 C--O 1.227 -0.095 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.315 179.356 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -56.6 -58.26 8.84 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 121.132 0.492 . . . . 0.0 110.539 178.441 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.49 HD11 HD13 ' A' ' 81' ' ' LEU . 47.5 mm -63.2 -29.67 47.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.2 178.516 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.812 ' HA ' ' HA ' ' A' ' 126' ' ' GLU . 42.3 tt0 -64.37 -46.31 83.95 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.42 176.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -63.19 -34.23 77.18 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 121.197 0.522 . . . . 0.0 109.643 177.628 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.566 HD22 ' HG3' ' A' ' 79' ' ' LYS . 63.0 tp -64.63 -63.52 1.11 Allowed 'General case' 0 C--O 1.235 0.332 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.047 177.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.482 ' O ' HG12 ' A' ' 125' ' ' ILE . 12.3 tt -163.5 26.14 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.722 0 CA-C-O 121.128 0.489 . . . . 0.0 110.924 -175.789 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.812 ' HA ' ' HA ' ' A' ' 122' ' ' GLU . 35.4 tt0 . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.413 -0.803 . . . . 0.0 111.151 -178.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.731 0 N-CA-C 111.858 -0.497 . . . . 0.0 111.858 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.3 m -72.28 76.27 1.0 Allowed 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 120.909 0.385 . . . . 0.0 110.259 178.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 26.3 ptm -127.09 25.46 6.22 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.145 -176.065 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 32.1 p -87.6 17.8 4.39 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-O 120.852 0.358 . . . . 0.0 110.973 179.628 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 30.3 mm-40 -55.4 146.6 19.28 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.949 177.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 30.2 mm-40 -61.71 146.78 48.19 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 173.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.0 p -151.86 160.05 43.66 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 121.102 0.477 . . . . 0.0 112.0 -169.09 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.423 ' NE2' HG23 ' A' ' 71' ' ' VAL . 84.5 t60 -176.48 -54.07 0.0 OUTLIER Pre-proline 0 CA--C 1.534 0.351 0 CA-C-N 114.666 -1.152 . . . . 0.0 108.468 177.797 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -71.91 -43.12 1.32 Allowed 'Trans proline' 0 C--N 1.36 1.141 0 C-N-CA 121.65 1.567 . . . . 0.0 110.577 168.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -85.68 62.61 7.57 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 121.723 0.773 . . . . 0.0 108.972 173.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.712 ' HB2' ' HE1' ' A' ' 14' ' ' TYR . 20.9 p-10 -81.76 65.18 6.78 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.038 -0.983 . . . . 0.0 111.683 -173.337 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -106.77 -0.61 23.34 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.686 173.351 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 20.2 m -73.2 5.54 3.44 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.633 175.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.712 ' HE1' ' HB2' ' A' ' 11' ' ' ASP . 3.3 m-85 -53.53 135.5 39.98 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.668 176.213 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.738 HD11 ' HB2' ' A' ' 47' ' ' LYS . 38.6 pt -91.84 -27.94 4.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 170.805 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.552 HG21 HG13 ' A' ' 15' ' ' ILE . 67.1 t -137.4 137.92 45.49 Favored 'Isoleucine or valine' 0 C--O 1.232 0.142 0 CA-C-N 114.965 -1.016 . . . . 0.0 108.994 177.682 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 32.2 ptt180 -147.22 134.37 20.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.835 0.35 . . . . 0.0 110.289 178.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 29.1 m -133.67 174.31 13.36 Favored 'Isoleucine or valine' 0 C--O 1.237 0.415 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.523 -177.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -129.84 121.16 26.19 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 179.207 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -169.84 -174.27 1.78 Allowed 'General case' 0 C--O 1.232 0.182 0 CA-C-O 120.776 0.322 . . . . 0.0 111.249 -176.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.423 HG11 ' O ' ' A' ' 38' ' ' GLY . 87.6 t -92.25 142.49 13.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.022 178.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.432 HG12 HG21 ' A' ' 43' ' ' VAL . 27.4 m -117.42 134.23 61.69 Favored 'Isoleucine or valine' 0 C--O 1.237 0.411 0 CA-C-O 121.308 0.575 . . . . 0.0 111.476 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' MET . . . . . 0.638 ' SD ' ' HG3' ' A' ' 34' ' ' PRO . 24.7 mmt -119.04 169.52 9.83 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.058 -0.974 . . . . 0.0 109.052 178.385 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 8.9 t -153.64 157.25 39.35 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 174.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 41.1 ttp180 -128.41 111.17 13.03 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 178.434 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.575 ' H ' ' HE1' ' A' ' 33' ' ' PHE . 38.1 t70 -61.52 97.93 0.08 Allowed 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 179.17 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.539 ' HB3' ' NH1' ' A' ' 98' ' ' ARG . 1.6 p30 46.59 -75.99 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.293 1.037 . . . . 0.0 111.994 -169.208 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.447 ' N ' ' O ' ' A' ' 26' ' ' ASP . 69.3 m -141.13 152.04 44.4 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 110.092 -0.336 . . . . 0.0 110.092 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 21.1 m 67.16 167.8 0.24 Allowed 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.435 -179.147 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 115.07 -6.44 21.72 Favored Glycine 0 N--CA 1.453 -0.212 0 N-CA-C 111.684 -0.566 . . . . 0.0 111.684 -177.197 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 59.07 27.05 61.91 Favored Glycine 0 C--N 1.334 0.432 0 C-N-CA 121.653 -0.308 . . . . 0.0 112.986 179.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . 0.55 ' CH2' ' HB3' ' A' ' 99' ' ' LYS . 89.2 m95 57.91 98.12 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 121.439 0.638 . . . . 0.0 110.873 -176.516 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.575 ' HE1' ' H ' ' A' ' 26' ' ' ASP . 40.1 p90 -103.16 138.22 19.48 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.906 -175.183 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.638 ' HG3' ' SD ' ' A' ' 23' ' ' MET . 5.1 Cg_exo -79.23 115.43 3.48 Favored 'Trans proline' 0 N--CA 1.457 -0.665 0 C-N-CA 122.452 2.101 . . . . 0.0 110.865 172.593 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -65.88 -162.71 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.836 176.04 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -46.54 -39.14 10.41 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 112.724 0.638 . . . . 0.0 112.724 -176.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -72.63 -115.29 0.06 OUTLIER Glycine 0 CA--C 1.519 0.285 0 N-CA-C 111.591 -0.604 . . . . 0.0 111.591 176.347 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.423 ' O ' HG11 ' A' ' 21' ' ' VAL . . . 82.45 -67.09 3.77 Favored Glycine 0 C--N 1.329 0.193 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.104 174.455 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -66.81 80.22 0.13 Allowed Glycine 0 CA--C 1.519 0.291 0 C-N-CA 121.507 -0.378 . . . . 0.0 112.601 -178.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.453 ' O ' ' HG2' ' A' ' 66' ' ' GLN . 50.8 mm 63.64 82.15 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 CA-C-O 121.556 0.693 . . . . 0.0 111.155 178.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 49.1 m -99.98 148.33 24.63 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.114 178.201 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.415 HH21 ' CD ' ' A' ' 64' ' ' GLU . 7.4 tmm_? -98.83 99.89 11.02 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 -177.718 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.432 HG21 HG12 ' A' ' 22' ' ' VAL . 50.2 t -120.93 155.16 24.5 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.931 -171.22 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -173.3 -163.5 27.06 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 121.143 -0.551 . . . . 0.0 112.239 176.413 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 61.6 t -130.34 139.73 50.63 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 CA-C-O 120.868 0.366 . . . . 0.0 110.79 -177.119 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 47.2 t -119.96 131.78 55.3 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 173.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.738 ' HB2' HD11 ' A' ' 15' ' ' ILE . 84.9 tttt -83.39 118.72 23.91 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.795 0.331 . . . . 0.0 111.021 -174.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 49.1 t -78.85 126.37 38.81 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.227 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' MET . . . . . 0.703 ' HA ' ' HE1' ' A' ' 49' ' ' MET . 16.0 mmt -84.13 115.91 22.63 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.085 -177.272 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 53.1 m170 -102.36 117.53 60.88 Favored Pre-proline 0 C--N 1.327 -0.382 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 176.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_exo -64.39 91.9 0.18 Allowed 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 122.711 2.274 . . . . 0.0 112.087 -178.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 63.01 -177.12 0.15 Allowed 'General case' 0 C--O 1.238 0.458 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.323 177.25 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 98.61 155.52 29.25 Favored Glycine 0 C--O 1.236 0.243 0 CA-C-N 116.072 -0.513 . . . . 0.0 112.428 178.21 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -83.76 2.1 39.61 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.82 0.343 . . . . 0.0 110.543 -179.417 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -72.6 -4.36 61.04 Favored Glycine 0 C--N 1.334 0.433 0 CA-C-N 116.041 -0.527 . . . . 0.0 112.909 179.36 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.612 ' HG3' ' H ' ' A' ' 57' ' ' SER . 11.0 tpt85 68.1 -167.42 0.19 Allowed 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 122.577 0.351 . . . . 0.0 110.15 175.801 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.612 ' H ' ' HG3' ' A' ' 56' ' ' ARG . 16.5 m -105.14 148.29 27.03 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.527 0.203 . . . . 0.0 110.559 -178.4 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -95.52 173.42 31.09 Favored Glycine 0 C--N 1.332 0.355 0 C-N-CA 121.194 -0.527 . . . . 0.0 112.011 -179.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -140.18 117.55 11.38 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.986 0.422 . . . . 0.0 110.877 -179.04 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.539 ' HG ' ' HD1' ' A' ' 76' ' ' TYR . 0.5 OUTLIER -87.31 102.85 14.9 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 175.29 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.755 ' HB ' ' HB3' ' A' ' 75' ' ' CYS . 63.5 mt -76.89 116.16 19.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 172.195 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 5.6 t-80 -127.55 141.44 51.64 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 -172.264 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -136.66 115.02 1.22 Allowed Glycine 0 C--N 1.333 0.383 0 C-N-CA 120.914 -0.66 . . . . 0.0 113.335 -174.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.415 ' CD ' HH21 ' A' ' 42' ' ' ARG . 41.7 tt0 -81.02 144.14 32.0 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 122.81 0.444 . . . . 0.0 110.606 178.352 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.459 ' HG2' HG12 ' A' ' 72' ' ' VAL . 0.2 OUTLIER -51.59 -56.07 15.6 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 115.682 -0.69 . . . . 0.0 112.208 -173.875 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.453 ' HG2' ' O ' ' A' ' 40' ' ' ILE . 0.0 OUTLIER -172.52 -77.15 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 -175.526 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 57.6 tttp -117.24 -46.15 2.71 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.39 178.076 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -69.16 132.1 46.01 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.101 174.13 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 23.5 mtpp -74.23 97.12 2.9 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.486 -177.56 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 51.0 tp -146.56 135.56 22.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.936 -179.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.423 HG23 ' NE2' ' A' ' 8' ' ' HIS . 26.8 t -81.44 95.18 2.75 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.937 -176.73 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.459 HG12 ' HG2' ' A' ' 65' ' ' ARG . 15.8 m -93.24 -37.72 8.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.058 179.362 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -125.06 143.03 51.12 Favored 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 109.819 -0.438 . . . . 0.0 109.819 176.188 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -159.82 165.12 32.96 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.301 173.154 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . 0.755 ' HB3' ' HB ' ' A' ' 61' ' ' ILE . 31.6 t -164.76 103.21 0.8 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.74 -0.663 . . . . 0.0 109.659 -177.153 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.539 ' HD1' ' HG ' ' A' ' 60' ' ' LEU . 57.0 t80 -81.99 99.79 9.32 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.017 -179.142 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.473 HG12 ' O ' ' A' ' 80' ' ' ASP . 95.6 t -90.74 98.16 8.03 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 N-CA-C 109.049 -0.722 . . . . 0.0 109.049 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 16.9 tpt180 -75.37 -42.82 53.16 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 -178.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.605 ' HA ' HD12 ' A' ' 124' ' ' LEU . 24.1 ttpp -173.61 29.75 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.226 174.419 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.473 ' O ' HG12 ' A' ' 77' ' ' VAL . 23.1 t70 -144.22 129.69 18.97 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 178.249 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.5 HD22 ' CD1' ' A' ' 83' ' ' TYR . 8.4 tt -156.09 128.39 7.62 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 -173.413 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 61.6 t -132.64 101.27 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.255 -179.248 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.538 ' HB3' ' NE2' ' A' ' 91' ' ' HIS . 8.1 m-85 -96.34 156.65 16.25 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.023 0.439 . . . . 0.0 110.416 172.531 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 86.0 m -157.82 135.85 10.82 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 176.204 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.444 ' HB3' ' CG ' ' A' ' 91' ' ' HIS . 19.1 ptmt -128.81 141.51 51.28 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.218 0.532 . . . . 0.0 111.397 -179.286 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -100.46 -39.31 8.01 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.581 177.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -126.62 151.31 72.97 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 115.415 -0.811 . . . . 0.0 108.919 178.244 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -46.0 -36.81 16.54 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 122.503 2.135 . . . . 0.0 112.173 178.079 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 17.9 p -83.91 -42.01 16.78 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 115.573 -0.739 . . . . 0.0 111.48 178.071 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 68.1 t80 -85.43 92.11 8.4 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-O 120.947 0.403 . . . . 0.0 110.359 -177.615 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . 0.538 ' NE2' ' HB3' ' A' ' 83' ' ' TYR . 4.7 t-160 -121.79 118.75 29.78 Favored 'General case' 0 N--CA 1.462 0.17 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 176.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 25.4 p80 -120.03 175.47 5.9 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.654 0.264 . . . . 0.0 110.482 -177.008 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . 0.477 ' HZ3' ' HB2' ' A' ' 102' ' ' LEU . 36.5 p90 -146.36 155.1 42.37 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.02 175.578 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 28.9 ttpt -120.28 122.34 40.65 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.784 -179.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.516 ' O ' ' N ' ' A' ' 97' ' ' ASN . 28.5 m -93.09 142.78 12.68 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 N-CA-C 106.294 -1.743 . . . . 0.0 106.294 160.689 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -60.35 77.66 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.066 0.46 . . . . 0.0 110.692 -177.026 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.561 ' O ' ' HD2' ' A' ' 98' ' ' ARG . 0.2 OUTLIER 169.82 -51.52 0.01 OUTLIER 'General case' 0 C--O 1.234 0.28 0 CA-C-N 115.085 -0.961 . . . . 0.0 109.856 -176.059 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.561 ' HD2' ' O ' ' A' ' 97' ' ' ASN . 0.6 OUTLIER -141.81 155.39 45.58 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.929 -175.304 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.55 ' HB3' ' CH2' ' A' ' 32' ' ' TRP . 89.2 mttt -112.88 116.3 29.81 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.047 173.629 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 27.2 m-85 -103.24 135.46 44.84 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 178.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -112.31 146.37 18.13 Favored Glycine 0 N--CA 1.453 -0.218 0 C-N-CA 121.155 -0.545 . . . . 0.0 112.83 -176.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.477 ' HB2' ' HZ3' ' A' ' 93' ' ' TRP . 2.8 tt -124.71 116.68 22.73 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 176.674 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.42 ' HB ' ' HB ' ' A' ' 21' ' ' VAL . 35.1 m -104.83 103.07 12.6 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.162 178.337 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.4 ' HB3' ' OD2' ' A' ' 109' ' ' ASP . 74.2 m-85 -65.37 163.28 15.93 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.22 -178.551 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 18.9 pt20 -102.56 -26.59 13.17 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.301 -176.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 19.4 m -147.41 150.17 36.61 Favored Pre-proline 0 CA--C 1.534 0.354 0 CA-C-O 120.439 0.162 . . . . 0.0 110.723 179.374 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -51.56 -27.46 25.41 Favored 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 122.97 2.447 . . . . 0.0 112.732 177.435 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -61.04 -63.0 1.44 Allowed 'General case' 0 C--O 1.237 0.436 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.001 178.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.4 ' OD2' ' HB3' ' A' ' 104' ' ' PHE . 1.5 p-10 -64.4 -34.67 78.71 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.86 179.845 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -57.99 -60.74 3.26 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.056 0.455 . . . . 0.0 110.822 176.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 61.5 ttt180 -61.22 -36.65 80.51 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.507 -176.615 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -62.63 -45.18 94.05 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-N 115.58 -0.737 . . . . 0.0 110.61 178.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 38.9 t80 -76.27 -26.38 55.89 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.469 -178.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 46.6 m-20 -59.67 -56.01 27.29 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 173.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 90.5 mtt180 -64.62 -27.66 69.09 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.154 174.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.465 ' HA2' ' NZ ' ' A' ' 119' ' ' LYS . . . -59.7 -58.8 12.38 Favored Glycine 0 N--CA 1.45 -0.417 0 CA-C-N 115.834 -0.621 . . . . 0.0 112.065 176.589 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.496 ' O ' HG13 ' A' ' 121' ' ' ILE . 9.0 p -65.66 -33.92 66.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 110.404 -0.221 . . . . 0.0 110.404 -179.302 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 43.6 ttm180 -59.78 -54.06 50.66 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.619 -0.264 . . . . 0.0 110.605 177.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.465 ' NZ ' ' HA2' ' A' ' 116' ' ' GLY . 25.0 pttm -69.33 -24.11 63.87 Favored 'General case' 0 CA--C 1.528 0.128 0 CA-C-O 120.841 0.353 . . . . 0.0 110.261 -179.739 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -67.2 -43.4 82.18 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.119 174.24 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.496 HG13 ' O ' ' A' ' 117' ' ' VAL . 79.7 mt -62.63 -41.63 92.94 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.168 0 CA-C-N 116.314 -0.403 . . . . 0.0 109.916 177.018 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -58.4 -43.83 88.73 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.132 174.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 40.7 t0 -75.51 -19.82 59.12 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.539 -177.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.605 HD12 ' HA ' ' A' ' 79' ' ' LYS . 55.2 tp -88.35 -39.1 14.59 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.647 -178.779 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 61.1 mt -112.23 -39.84 3.49 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 N-CA-C 111.801 0.297 . . . . 0.0 111.801 -172.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.323 -0.846 . . . . 0.0 110.226 -174.714 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.656 0 N-CA-C 111.812 -0.515 . . . . 0.0 111.812 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 42.7 t -141.96 170.05 16.43 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 179.442 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 23.8 ptm -144.73 115.25 7.65 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.103 -0.499 . . . . 0.0 109.68 178.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 25.7 m -67.47 133.54 49.7 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.954 -177.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -60.95 167.42 2.89 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.374 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -60.82 178.3 0.24 Allowed 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 120.951 0.405 . . . . 0.0 111.753 -179.129 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.448 ' O ' ' HB3' ' A' ' 8' ' ' HIS . 62.7 p 59.86 -172.25 0.12 Allowed 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 123.944 0.898 . . . . 0.0 112.206 178.821 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.448 ' HB3' ' O ' ' A' ' 7' ' ' THR . 20.9 t-80 105.75 -69.56 0.0 OUTLIER Pre-proline 0 N--CA 1.482 1.14 0 C-N-CA 125.813 1.645 . . . . 0.0 112.005 -177.2 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.478 ' HA ' ' HG2' ' A' ' 69' ' ' LYS . 26.5 Cg_endo -60.41 -29.56 89.0 Favored 'Trans proline' 0 C--N 1.365 1.412 0 C-N-CA 121.402 1.402 . . . . 0.0 111.615 -177.376 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -79.04 -32.69 45.04 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.425 176.464 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.42 ' HA ' ' HE2' ' A' ' 14' ' ' TYR . 11.0 t70 53.87 93.92 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.361 -178.823 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -140.3 -66.85 0.44 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.816 178.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 16.8 m -79.29 90.89 4.97 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.925 -176.389 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.442 ' HA ' ' HB3' ' A' ' 46' ' ' CYS . 67.5 m-85 -141.85 153.28 44.35 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.704 175.742 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.477 HG23 HG23 ' A' ' 16' ' ' VAL . 52.2 mt -108.35 -63.67 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.714 0.292 . . . . 0.0 110.371 178.106 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.477 HG23 HG23 ' A' ' 15' ' ' ILE . 60.0 t -114.94 113.08 42.6 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.517 -178.604 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 36.8 mtp180 -110.47 99.41 8.41 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.671 175.005 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 16.8 m -128.8 162.27 36.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.759 0.314 . . . . 0.0 110.769 -179.175 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.47 ' HE2' ' HA ' ' A' ' 40' ' ' ILE . 46.3 tttm -97.19 137.74 35.76 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.918 -176.792 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -159.04 -175.74 5.45 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-N 115.958 -0.564 . . . . 0.0 109.768 177.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.418 HG21 ' HA2' ' A' ' 39' ' ' GLY . 38.4 t -107.72 100.78 11.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.583 -0.281 . . . . 0.0 110.476 177.452 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.607 HG21 ' NE2' ' A' ' 35' ' ' GLN . 13.6 m -65.39 127.12 25.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.611 177.511 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 19.6 mmt -122.9 149.74 43.83 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.206 -175.131 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.431 HG23 ' CE1' ' A' ' 33' ' ' PHE . 12.7 t -122.31 171.75 8.81 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.051 175.373 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.479 ' HG3' ' H ' ' A' ' 27' ' ' ASP . 14.4 tpt180 -120.1 144.28 47.7 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.656 -178.367 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -79.93 11.91 3.04 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.862 179.64 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.479 ' H ' ' HG3' ' A' ' 25' ' ' ARG . 19.2 t70 63.85 156.73 0.07 Allowed 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.857 -173.779 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 47.8 t 56.58 -116.28 0.97 Allowed 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 -173.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 50.8 m -155.3 100.76 2.17 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 118.056 0.389 . . . . 0.0 111.525 177.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -131.35 -35.22 0.38 Allowed Glycine 0 C--N 1.329 0.183 0 N-CA-C 111.33 -0.708 . . . . 0.0 111.33 171.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 153.72 132.01 1.64 Allowed Glycine 0 CA--C 1.519 0.315 0 N-CA-C 112.117 -0.393 . . . . 0.0 112.117 176.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . 0.422 ' HZ3' ' HA ' ' A' ' 100' ' ' PHE . 69.1 m95 -67.88 138.18 55.84 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 176.689 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.431 ' CE1' HG23 ' A' ' 24' ' ' THR . 4.6 p90 -145.62 152.55 49.38 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 116.85 -0.159 . . . . 0.0 110.737 -175.375 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -82.67 117.15 2.64 Favored 'Trans proline' 0 N--CA 1.461 -0.424 0 C-N-CA 122.446 2.097 . . . . 0.0 112.042 176.182 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.607 ' NE2' HG21 ' A' ' 22' ' ' VAL . 4.3 pm0 -53.32 -38.7 63.42 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.315 176.397 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -161.96 160.22 27.48 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.069 178.242 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 76.51 -72.53 1.95 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 121.361 -0.447 . . . . 0.0 111.992 178.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 69.43 29.6 71.61 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 121.143 -0.551 . . . . 0.0 112.692 179.282 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.418 ' HA2' HG21 ' A' ' 21' ' ' VAL . . . -177.28 -72.09 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.216 179.629 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.536 ' N ' HD13 ' A' ' 40' ' ' ILE . 3.0 mp -92.11 103.72 14.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.694 0.283 . . . . 0.0 110.618 -176.837 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.583 ' HA ' ' O ' ' A' ' 65' ' ' ARG . 30.0 m -146.62 127.41 14.38 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.236 -0.438 . . . . 0.0 109.821 172.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.448 ' O ' ' HG3' ' A' ' 42' ' ' ARG . 14.1 ptt180 -92.01 116.67 29.12 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 121.201 0.524 . . . . 0.0 110.092 179.424 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 40.4 t -95.29 128.92 46.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.626 178.417 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -123.25 108.99 1.27 Allowed Glycine 0 N--CA 1.448 -0.562 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.774 -178.402 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 7.6 p -92.14 130.98 40.45 Favored 'Isoleucine or valine' 0 C--O 1.238 0.496 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 175.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . 0.679 ' SG ' ' HB3' ' A' ' 60' ' ' LEU . 15.3 p -131.97 130.18 41.15 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.839 -178.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -92.35 86.54 5.73 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 175.324 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 30.8 m -80.25 159.5 4.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.399 -178.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 25.2 ptm -150.68 156.58 41.61 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.778 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . 0.434 ' NE2' ' HD2' ' A' ' 56' ' ' ARG . 11.3 m-70 -84.29 140.38 39.22 Favored Pre-proline 0 C--N 1.322 -0.612 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 176.869 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 8.6 Cg_exo -73.14 33.65 0.32 Allowed 'Trans proline' 0 CA--C 1.536 0.61 0 C-N-CA 123.089 2.526 . . . . 0.0 112.531 -179.159 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.429 ' H ' ' C ' ' A' ' 50' ' ' HIS . 36.4 mt-10 -109.58 166.25 11.04 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 179.264 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -63.55 -25.54 68.87 Favored Glycine 0 C--N 1.331 0.256 0 N-CA-C 111.295 -0.722 . . . . 0.0 111.295 174.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 -59.58 -31.58 69.57 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 115.306 -0.447 . . . . 0.0 110.853 176.586 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 73.43 -79.11 0.81 Allowed Glycine 0 C--N 1.332 0.357 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.817 -176.111 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.434 ' HD2' ' NE2' ' A' ' 50' ' ' HIS . 1.2 tmt_? 57.58 90.13 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 123.037 0.535 . . . . 0.0 110.49 -179.493 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 42.8 p -77.96 143.88 37.24 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.489 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -145.25 135.76 6.17 Favored Glycine 0 N--CA 1.451 -0.331 0 N-CA-C 111.006 -0.838 . . . . 0.0 111.006 175.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.543 ' HB2' ' HB ' ' A' ' 77' ' ' VAL . 83.8 m-85 -107.02 98.41 8.07 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 117.015 0.408 . . . . 0.0 110.353 -177.059 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.709 HD22 ' HB2' ' A' ' 62' ' ' HIS . 0.9 OUTLIER -78.35 106.04 10.01 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 179.633 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.484 HG12 HG21 ' A' ' 77' ' ' VAL . 50.8 mm -84.25 96.26 4.38 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 173.781 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . 0.709 ' HB2' HD22 ' A' ' 60' ' ' LEU . 21.0 t-80 -119.21 150.87 39.35 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.313 -175.618 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -141.83 123.93 2.35 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 121.297 -0.478 . . . . 0.0 112.099 -178.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -99.37 149.89 22.71 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 177.521 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.583 ' O ' ' HA ' ' A' ' 41' ' ' SER . 3.1 tmm_? -58.24 -73.22 0.08 Allowed 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 109.09 -0.708 . . . . 0.0 109.09 176.012 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.495 ' HB2' ' O ' ' A' ' 65' ' ' ARG . 6.6 tp-100 169.38 132.3 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 123.111 0.564 . . . . 0.0 109.564 175.591 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt 68.04 -67.98 0.18 Allowed 'General case' 0 N--CA 1.465 0.302 0 O-C-N 123.794 0.684 . . . . 0.0 110.842 -179.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -74.21 128.47 35.61 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 110.109 -0.33 . . . . 0.0 110.109 177.187 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.478 ' HG2' ' HA ' ' A' ' 9' ' ' PRO . 12.5 mptt -67.2 78.21 0.14 Allowed 'General case' 0 C--O 1.236 0.385 0 CA-C-O 121.061 0.458 . . . . 0.0 110.42 -179.535 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 58.0 tp -116.37 116.84 28.44 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.113 -179.051 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 48.8 t -72.59 101.5 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.414 -179.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 27.3 m -96.84 -14.43 7.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.782 177.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.451 HD23 ' N ' ' A' ' 74' ' ' GLU . 2.2 tt -157.43 130.41 7.63 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 177.664 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.451 ' N ' HD23 ' A' ' 73' ' ' LEU . 4.1 tm-20 -145.59 127.02 14.98 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 177.675 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . 0.406 ' HB2' ' HE2' ' A' ' 100' ' ' PHE . 48.5 t -160.72 91.03 0.88 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.463 0.649 . . . . 0.0 109.856 177.468 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.474 ' HD1' ' HG ' ' A' ' 60' ' ' LEU . 82.3 t80 -67.4 118.32 10.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.454 -0.793 . . . . 0.0 110.79 179.638 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.761 HG23 HD12 ' A' ' 81' ' ' LEU . 62.0 t -77.34 94.5 1.35 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.356 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 176.111 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.421 ' O ' ' HB2' ' A' ' 79' ' ' LYS . 15.1 ptt180 -78.83 35.76 0.25 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.717 179.052 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.676 ' HA ' HD12 ' A' ' 124' ' ' LEU . 59.5 mttp 67.91 13.64 9.21 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 123.16 0.584 . . . . 0.0 110.721 -169.027 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -135.19 96.73 3.55 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 115.989 -0.55 . . . . 0.0 109.898 178.177 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.761 HD12 HG23 ' A' ' 77' ' ' VAL . 7.1 tt -177.89 137.6 0.19 Allowed 'General case' 0 C--O 1.233 0.212 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 179.697 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.512 ' N ' HD21 ' A' ' 81' ' ' LEU . 40.6 t -126.19 122.52 61.71 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 CA-C-O 120.507 0.194 . . . . 0.0 111.075 -176.482 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.448 ' CG ' HG21 ' A' ' 117' ' ' VAL . 7.4 m-85 -84.52 172.8 11.34 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-O 121.284 0.564 . . . . 0.0 111.231 176.738 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 87.0 m -153.99 101.82 2.45 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.89 177.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -79.85 93.53 5.66 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 174.604 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -83.9 -59.22 2.48 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.536 -175.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . 0.461 ' HB2' ' HB3' ' A' ' 90' ' ' PHE . 10.5 m120 -113.11 155.44 44.33 Favored Pre-proline 0 C--N 1.327 -0.385 0 N-CA-C 109.171 -0.678 . . . . 0.0 109.171 -179.196 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_exo -53.59 -19.18 13.31 Favored 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 122.658 2.238 . . . . 0.0 113.034 -179.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.427 ' HA ' ' HD2' ' A' ' 104' ' ' PHE . 15.3 t -121.05 -1.31 9.84 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 120.836 0.35 . . . . 0.0 111.448 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.461 ' HB3' ' HB2' ' A' ' 87' ' ' ASN . 78.0 t80 -120.84 114.67 21.94 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-O 121.007 0.432 . . . . 0.0 110.544 -176.254 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 2.0 t-160 -133.0 112.91 12.23 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 -176.066 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . 0.575 ' HA ' ' HA3' ' A' ' 101' ' ' GLY . 11.6 p80 -125.73 -178.42 4.26 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 -178.461 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 49.4 p90 -146.02 164.83 30.86 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.201 173.468 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 14.4 tmtt? -146.32 130.14 17.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.222 -177.097 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 30.8 m -136.49 147.11 27.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.738 -0.665 . . . . 0.0 109.388 176.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 18.7 t70 59.93 -89.86 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.447 0 O-C-N 123.235 0.334 . . . . 0.0 110.414 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 59.1 t30 -148.21 10.62 0.89 Allowed 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 121.685 0.755 . . . . 0.0 109.415 175.111 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 73.3 mtp180 -109.49 131.87 54.66 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.296 -176.283 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.547 ' HD3' ' N ' ' A' ' 99' ' ' LYS . 0.0 OUTLIER -127.66 127.54 43.93 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.567 -178.062 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . 0.422 ' HA ' ' HZ3' ' A' ' 32' ' ' TRP . 4.9 p90 -156.01 164.06 38.93 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.527 -0.761 . . . . 0.0 109.004 177.295 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.575 ' HA3' ' HA ' ' A' ' 92' ' ' HIS . . . -173.94 -135.35 2.01 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.401 -0.904 . . . . 0.0 112.703 -175.611 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 2.2 pp -159.69 175.28 13.36 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 121.339 0.59 . . . . 0.0 111.746 -178.195 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 91.2 m -130.02 140.49 50.87 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.114 176.249 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.427 ' HD2' ' HA ' ' A' ' 89' ' ' THR . 23.7 m-85 -83.18 166.38 18.67 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.324 0.583 . . . . 0.0 111.389 -174.407 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 21.6 tt0 -123.19 -57.31 1.69 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.822 175.34 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 18.8 m -118.66 149.46 46.38 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.345 -176.023 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -53.2 -20.77 15.26 Favored 'Trans proline' 0 C--N 1.352 0.744 0 C-N-CA 122.587 2.191 . . . . 0.0 112.476 179.016 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -62.37 -66.6 0.52 Allowed 'General case' 0 C--O 1.235 0.329 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.523 175.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -63.19 -39.23 94.06 Favored 'General case' 0 C--O 1.231 0.101 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.764 -179.604 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . 0.424 ' HA ' ' CD1' ' A' ' 104' ' ' PHE . . . -52.61 -58.99 5.04 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-O 121.387 0.613 . . . . 0.0 111.174 177.008 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 69.7 ttt180 -66.59 -29.26 69.27 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.466 -178.141 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -64.95 -48.34 74.4 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.194 179.685 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 58.4 m-85 -67.27 -46.8 72.57 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 116.698 -0.228 . . . . 0.0 110.577 179.072 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -53.18 -64.99 0.64 Allowed 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 121.235 0.54 . . . . 0.0 110.773 178.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 41.8 ttm180 -57.3 -38.16 73.57 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 114.938 -1.028 . . . . 0.0 110.799 177.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -56.76 -58.2 15.67 Favored Glycine 0 C--N 1.331 0.252 0 CA-C-N 115.955 -0.566 . . . . 0.0 112.484 -177.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.448 HG21 ' CG ' ' A' ' 83' ' ' TYR . 7.6 p -69.03 -36.88 75.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.532 0.206 . . . . 0.0 110.803 -178.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 25.1 ttt180 -60.72 -42.77 97.92 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.738 -0.468 . . . . 0.0 109.738 -179.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 7.4 mmtt -74.96 -30.05 61.1 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.659 178.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -62.71 -47.92 81.51 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 176.387 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 72.2 mt -66.32 -40.57 87.11 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.037 177.128 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -55.74 -48.31 75.47 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.397 178.64 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -74.94 -35.18 62.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.037 -178.408 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.676 HD12 ' HA ' ' A' ' 79' ' ' LYS . 6.3 tt -62.02 -50.23 72.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.28 -178.164 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 60.8 mt -83.12 -40.32 16.17 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.865 -177.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 . . . . . 0 C--O 1.251 1.142 0 CA-C-O 118.311 -0.852 . . . . 0.0 110.544 -177.281 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.747 0 N-CA-C 112.068 -0.413 . . . . 0.0 112.068 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 22.6 p -91.14 51.7 1.99 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.593 0.235 . . . . 0.0 110.886 -178.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' MET . . . . . 0.409 ' HB3' ' HG2' ' A' ' 5' ' ' GLU . 3.5 mpp? -54.96 -49.41 71.45 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.971 0.415 . . . . 0.0 109.986 178.251 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 3.5 m 56.38 38.14 29.45 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.665 176.537 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.409 ' HG2' ' HB3' ' A' ' 3' ' ' MET . 20.7 mm-40 -74.36 76.03 1.88 Allowed 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.641 -175.093 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -111.74 -63.33 1.43 Allowed 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 168.366 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.9 t 21.92 78.75 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.607 0 O-C-N 124.726 1.266 . . . . 0.0 113.691 171.21 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 64.4 t60 -73.03 149.13 89.58 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-N 115.661 -0.699 . . . . 0.0 109.857 178.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_exo -46.47 102.56 0.04 OUTLIER 'Trans proline' 0 C--N 1.355 0.886 0 C-N-CA 122.283 1.988 . . . . 0.0 111.462 172.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 63.33 68.29 0.62 Allowed 'General case' 0 C--O 1.233 0.205 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.48 -171.529 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -52.68 -31.2 36.12 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 114.828 -1.078 . . . . 0.0 111.848 -175.335 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -70.75 -1.38 11.31 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.082 -0.508 . . . . 0.0 112.348 -177.158 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 20.8 m -89.4 -3.22 58.52 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 111.8 0.296 . . . . 0.0 111.8 -174.624 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.422 ' HA ' ' HA ' ' A' ' 46' ' ' CYS . 35.8 m-85 -66.14 135.2 54.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.857 0.36 . . . . 0.0 111.878 -179.564 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 50.3 mm -92.36 -40.94 12.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 171.315 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 7.4 p -155.49 136.74 5.27 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 CA-C-N 115.179 -0.919 . . . . 0.0 109.974 178.356 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 22.4 ptt180 -149.52 114.29 5.35 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.818 0.342 . . . . 0.0 110.232 178.053 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 15.0 m -150.09 -170.82 0.17 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.325 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.057 -178.045 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.674 ' HZ1' ' HB3' ' A' ' 19' ' ' LYS . 5.9 ttpm? -87.57 132.69 33.97 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.592 179.343 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.485 ' O ' ' HB2' ' A' ' 41' ' ' SER . . . -157.45 -178.22 7.18 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.178 -0.465 . . . . 0.0 109.846 176.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.569 ' HB ' ' HB ' ' A' ' 103' ' ' THR . 38.2 t -112.53 107.77 23.82 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 CA-C-N 116.647 -0.252 . . . . 0.0 110.841 -179.625 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 11.9 m -73.94 96.48 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 CA-C-O 121.368 0.604 . . . . 0.0 110.279 175.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 91.9 mmm -82.92 119.41 24.38 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.772 -176.486 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.446 HG21 ' CE1' ' A' ' 33' ' ' PHE . 10.0 t -93.9 171.16 9.04 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.055 176.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 14.4 ttp180 -133.46 21.47 3.98 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 178.483 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.421 ' HB3' ' CB ' ' A' ' 29' ' ' SER . 35.6 t70 50.68 36.81 14.98 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 114.778 -1.101 . . . . 0.0 110.536 179.748 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 34.1 t70 61.98 83.21 0.16 Allowed 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.542 -179.528 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 24.2 p 50.1 27.35 2.49 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 115.277 -0.874 . . . . 0.0 112.894 178.009 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.421 ' CB ' ' HB3' ' A' ' 26' ' ' ASP . 32.4 t -70.17 -36.16 74.5 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-O 120.653 0.263 . . . . 0.0 110.981 -178.891 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 150.79 -91.77 0.14 Allowed Glycine 0 C--N 1.332 0.351 0 C-N-CA 120.918 -0.658 . . . . 0.0 112.535 178.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -81.99 163.26 43.42 Favored Glycine 0 CA--C 1.518 0.279 0 C-N-CA 121.199 -0.524 . . . . 0.0 112.683 -178.775 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . 0.453 ' HZ2' ' HE2' ' A' ' 99' ' ' LYS . 74.6 m95 -93.57 147.8 22.67 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-O 120.732 0.301 . . . . 0.0 110.803 -179.337 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.446 ' CE1' HG21 ' A' ' 24' ' ' THR . 6.8 p90 -156.34 150.34 19.58 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.896 176.827 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_exo -63.27 139.8 73.81 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.589 2.193 . . . . 0.0 111.893 176.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 22.1 pt20 -105.64 131.73 52.66 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.604 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 16.0 tp10 64.36 -73.06 0.06 Allowed 'General case' 0 CA--C 1.533 0.312 0 O-C-N 123.851 0.719 . . . . 0.0 111.063 -179.581 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.452 ' HA3' ' OE1' ' A' ' 66' ' ' GLN . . . -148.65 109.74 0.46 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 121.173 -0.536 . . . . 0.0 111.912 179.726 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.434 ' O ' HG22 ' A' ' 21' ' ' VAL . . . -89.88 5.29 83.42 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 121.393 -0.432 . . . . 0.0 112.539 -178.42 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -81.62 -41.34 9.95 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.945 -0.645 . . . . 0.0 111.802 178.27 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.515 HD13 ' HG3' ' A' ' 19' ' ' LYS . 3.7 tp -143.54 91.95 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 CA-C-O 121.426 0.632 . . . . 0.0 110.756 -179.753 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.485 ' HB2' ' O ' ' A' ' 20' ' ' ALA . 21.4 m -106.32 119.33 38.98 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 173.188 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.609 ' HB3' ' O ' ' A' ' 64' ' ' GLU . 8.2 tpt85 -77.24 90.3 3.72 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 121.453 0.644 . . . . 0.0 109.419 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 38.8 t -94.87 117.88 39.68 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 CA-C-N 115.241 -0.89 . . . . 0.0 110.345 -177.361 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -129.17 118.3 2.65 Favored Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 121.174 -0.536 . . . . 0.0 111.995 179.655 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 61.4 t -96.04 110.22 24.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 176.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . 0.473 ' SG ' ' HB3' ' A' ' 60' ' ' LEU . 12.3 p -107.96 147.42 31.08 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.583 -179.468 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 10.3 tmtt? -102.03 95.16 6.17 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 176.611 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.568 HG21 ' HE1' ' A' ' 76' ' ' TYR . 35.4 m -71.86 141.94 16.0 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.432 -173.859 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 22.2 mmt -95.89 178.77 5.32 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.403 179.391 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 1.8 p80 -126.81 118.49 22.49 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 120.518 0.199 . . . . 0.0 110.739 -178.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_exo -65.37 -39.23 23.14 Favored 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 122.452 2.102 . . . . 0.0 110.703 174.13 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -163.62 139.27 6.51 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 176.228 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 109.27 117.63 4.01 Favored Glycine 0 CA--C 1.517 0.179 0 N-CA-C 111.475 -0.65 . . . . 0.0 111.475 -176.089 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 27.1 p-10 -59.74 -39.2 83.97 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 111.914 0.338 . . . . 0.0 111.914 -174.767 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -96.99 18.83 56.85 Favored Glycine 0 CA--C 1.519 0.316 0 C-N-CA 121.224 -0.512 . . . . 0.0 113.442 -174.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 29.5 mmt180 -93.53 -9.8 37.0 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.942 0.371 . . . . 0.0 110.925 179.245 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 14.6 p -98.03 141.83 30.5 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.355 178.145 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 174.13 -145.67 8.25 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 121.058 -0.592 . . . . 0.0 111.945 -179.345 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.43 ' HB2' ' HB ' ' A' ' 77' ' ' VAL . 83.2 m-85 -117.15 161.42 19.47 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.473 ' HB3' ' SG ' ' A' ' 46' ' ' CYS . 2.0 tt -147.07 112.56 5.61 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 176.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.486 ' HB ' ' HB2' ' A' ' 75' ' ' CYS . 59.5 mt -84.78 103.69 12.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 174.206 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 12.5 t-80 -117.25 104.51 11.25 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.038 -169.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -100.6 121.83 7.38 Favored Glycine 0 C--N 1.333 0.415 0 N-CA-C 111.3 -0.72 . . . . 0.0 111.3 177.493 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.609 ' O ' ' HB3' ' A' ' 42' ' ' ARG . 16.1 pt-20 -150.3 -166.82 2.65 Favored 'General case' 0 C--O 1.24 0.588 0 CA-C-O 121.205 0.526 . . . . 0.0 112.37 -170.707 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 29.4 ttt180 74.68 -30.97 0.21 Allowed 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.974 1.31 . . . . 0.0 112.778 170.487 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.706 ' HA ' HE21 ' A' ' 66' ' ' GLN . 0.0 OUTLIER -59.09 131.69 51.8 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 110.232 -0.284 . . . . 0.0 110.232 177.697 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 85.2 tttt 66.07 76.4 0.31 Allowed 'General case' 0 C--O 1.235 0.332 0 O-C-N 123.7 0.625 . . . . 0.0 109.823 -178.553 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 69.65 -86.78 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.005 -0.998 . . . . 0.0 110.99 -176.397 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 28.9 tptp -175.48 98.47 0.07 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.012 0.434 . . . . 0.0 110.467 -176.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -157.89 166.95 31.33 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 172.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 6.2 t -99.13 109.31 24.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-O 120.797 0.332 . . . . 0.0 110.523 -176.698 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 33.9 m -94.48 -6.65 10.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.223 -177.41 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -148.51 117.29 6.67 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 -178.241 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -127.92 124.63 37.82 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.094 177.409 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . 0.552 ' SG ' ' CD2' ' A' ' 100' ' ' PHE . 24.6 m -145.96 89.15 1.86 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.407 176.915 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.568 ' HE1' HG21 ' A' ' 48' ' ' VAL . 87.1 t80 -71.9 136.75 47.02 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.554 -0.535 . . . . 0.0 109.554 173.478 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.43 ' HB ' ' HB2' ' A' ' 59' ' ' PHE . 58.3 t -125.31 96.0 3.5 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 CA-C-O 120.943 0.401 . . . . 0.0 110.372 -175.772 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 43.4 ttp180 -84.4 69.07 10.46 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.215 0.531 . . . . 0.0 110.023 179.422 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.594 ' HB3' ' HZ1' ' A' ' 79' ' ' LYS . 8.2 mtpm? 52.92 21.13 1.88 Allowed 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 115.254 -0.885 . . . . 0.0 112.345 179.17 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -125.19 114.08 18.51 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 172.181 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.454 HD13 ' HD2' ' A' ' 83' ' ' TYR . 2.8 tm? -152.97 138.23 17.47 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.601 -170.114 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.458 ' HB ' ' HB3' ' A' ' 94' ' ' LYS . 48.6 t -132.45 88.92 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.8 173.618 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.503 ' HD1' ' HD2' ' A' ' 91' ' ' HIS . 0.3 OUTLIER -85.51 146.58 26.85 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 174.829 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.446 ' HB ' ' CE1' ' A' ' 92' ' ' HIS . 38.3 m -140.69 121.74 14.66 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 177.901 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -83.51 96.0 8.47 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 176.181 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -66.85 -42.63 85.38 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.167 0.508 . . . . 0.0 109.813 179.105 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . 0.67 ' HB2' ' HD2' ' A' ' 88' ' ' PRO . 9.8 p30 -161.41 164.27 18.67 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-N 115.145 -0.934 . . . . 0.0 108.835 177.442 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.67 ' HD2' ' HB2' ' A' ' 87' ' ' ASN . 9.6 Cg_endo -50.26 -22.55 8.52 Favored 'Trans proline' 0 C--N 1.352 0.75 0 C-N-CA 123.264 2.643 . . . . 0.0 114.091 -175.861 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 10.8 p -116.9 15.23 15.22 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 112.409 0.522 . . . . 0.0 112.409 -176.01 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.423 ' HB3' ' ND2' ' A' ' 87' ' ' ASN . 45.4 t80 -152.1 111.62 3.95 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-O 121.152 0.501 . . . . 0.0 111.383 178.924 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . 0.503 ' HD2' ' HD1' ' A' ' 83' ' ' TYR . 2.3 m80 -106.81 155.06 20.12 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 169.409 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . 0.446 ' CE1' ' HB ' ' A' ' 84' ' ' THR . 20.6 p80 -146.23 146.98 30.98 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 171.327 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . 0.544 ' CE2' ' HB2' ' A' ' 100' ' ' PHE . 28.4 p90 -123.52 146.21 48.27 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.173 0.511 . . . . 0.0 111.072 -178.778 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.477 ' HE3' ' HA ' ' A' ' 97' ' ' ASN . 3.0 tmtm? -110.25 101.18 9.95 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.051 -0.977 . . . . 0.0 108.83 -178.05 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 28.2 m -137.55 145.82 28.64 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 -179.609 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 27.9 t70 55.26 27.86 10.4 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 121.778 0.799 . . . . 0.0 109.978 -177.524 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.477 ' HA ' ' HE3' ' A' ' 94' ' ' LYS . 64.6 t30 74.88 -15.44 0.65 Allowed 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 114.66 -1.155 . . . . 0.0 111.633 -179.116 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 33.7 ttm180 -89.98 156.41 18.44 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.701 0.286 . . . . 0.0 110.462 -177.155 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.453 ' HE2' ' HZ2' ' A' ' 32' ' ' TRP . 62.0 mtpt -116.14 133.53 55.92 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.219 -178.62 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . 0.552 ' CD2' ' SG ' ' A' ' 75' ' ' CYS . 31.0 m-85 -128.81 139.51 52.14 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 175.577 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -110.8 163.56 12.28 Favored Glycine 0 N--CA 1.453 -0.183 0 C-N-CA 121.291 -0.48 . . . . 0.0 112.417 -178.315 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.407 ' HB2' ' HZ3' ' A' ' 93' ' ' TRP . 31.3 tp -146.91 112.8 5.74 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 110.145 -0.317 . . . . 0.0 110.145 -178.723 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.569 ' HB ' ' HB ' ' A' ' 21' ' ' VAL . 84.1 m -92.79 134.17 35.32 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 176.312 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.456 ' HE2' ' HD1' ' A' ' 91' ' ' HIS . 46.9 m-85 -90.97 137.98 31.95 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.243 -178.816 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.533 ' OE1' ' HG2' ' A' ' 19' ' ' LYS . 52.7 mt-30 -102.78 -26.39 13.17 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.637 -173.727 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 49.4 m -148.47 159.72 38.16 Favored Pre-proline 0 CA--C 1.536 0.409 0 CA-C-O 120.434 0.159 . . . . 0.0 110.652 -179.667 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.554 ' O ' ' HD3' ' A' ' 111' ' ' ARG . 57.0 Cg_exo -53.48 -34.54 72.44 Favored 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 122.657 2.238 . . . . 0.0 112.413 178.273 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -56.81 -61.27 2.55 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.986 -179.069 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -67.17 -38.41 85.39 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.901 -179.149 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -54.85 -53.05 60.38 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.236 179.231 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.554 ' HD3' ' O ' ' A' ' 107' ' ' PRO . 5.2 mpt_? -71.62 -37.42 70.91 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.555 -178.051 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -59.4 -55.9 28.81 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.638 -179.523 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.439 ' O ' HG23 ' A' ' 117' ' ' VAL . 37.8 m-85 -63.86 -50.24 69.58 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.901 179.718 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.607 ' O ' ' HG2' ' A' ' 118' ' ' ARG . 22.3 t70 -53.01 -67.92 0.21 Allowed 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 121.155 0.502 . . . . 0.0 110.649 -178.934 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 53.1 ttt180 -51.91 -46.31 64.55 Favored 'General case' 0 C--O 1.242 0.691 0 CA-C-N 114.972 -1.013 . . . . 0.0 111.166 -178.107 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -59.52 -42.63 97.75 Favored Glycine 0 C--N 1.334 0.451 0 CA-C-N 115.869 -0.605 . . . . 0.0 112.148 179.133 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.457 ' O ' HG13 ' A' ' 121' ' ' ILE . 41.2 t -66.8 -36.03 76.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 C-N-CA 122.156 0.182 . . . . 0.0 110.698 179.683 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.607 ' HG2' ' O ' ' A' ' 114' ' ' ASP . 8.9 mmm180 -58.53 -56.54 20.8 Favored 'General case' 0 C--O 1.241 0.628 0 CA-C-O 121.277 0.561 . . . . 0.0 109.646 178.164 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 9.8 mmpt? -61.24 -38.97 88.59 Favored 'General case' 0 C--O 1.239 0.507 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.191 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -59.28 -53.93 52.64 Favored 'General case' 0 C--O 1.226 -0.184 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.872 179.654 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.457 HG13 ' O ' ' A' ' 117' ' ' VAL . 73.8 mt -55.09 -45.04 76.9 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 O-C-N 123.236 0.335 . . . . 0.0 110.493 -179.097 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.416 ' O ' ' HB2' ' A' ' 126' ' ' GLU . 50.5 mt-10 -55.3 -55.93 25.88 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.07 178.632 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -69.02 -24.8 64.25 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 121.258 0.552 . . . . 0.0 110.971 -179.145 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.537 ' HG ' ' HA ' ' A' ' 79' ' ' LYS . 9.2 tt -74.14 -46.75 40.52 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.54 -0.754 . . . . 0.0 111.956 -174.901 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.438 HG22 ' O ' ' A' ' 121' ' ' ILE . 18.9 tt -106.57 -33.03 2.66 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 N-CA-C 112.38 0.511 . . . . 0.0 112.38 -173.165 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.416 ' HB2' ' O ' ' A' ' 122' ' ' GLU . 44.1 mt-10 . . . . . 0 C--O 1.248 0.988 0 CA-C-O 118.484 -0.769 . . . . 0.0 110.182 -179.157 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.798 0 N-CA-C 112.11 -0.396 . . . . 0.0 112.11 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.5 t -98.68 -25.19 14.77 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 121.187 0.518 . . . . 0.0 110.323 -179.327 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 24.3 mmt -112.88 114.0 26.32 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.789 -178.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 15.3 t -92.87 145.41 24.41 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.72 0.295 . . . . 0.0 110.377 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -70.1 99.22 1.44 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.88 0.371 . . . . 0.0 110.647 178.518 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 19.0 tt0 -112.6 -69.52 0.86 Allowed 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 175.516 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.544 HG22 ' HB3' ' A' ' 68' ' ' ASP . 82.5 p 47.08 -152.15 0.08 Allowed 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 112.751 0.649 . . . . 0.0 112.751 168.182 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.454 ' HB3' ' HD2' ' A' ' 9' ' ' PRO . 16.6 m80 -130.49 164.54 40.66 Favored Pre-proline 0 CA--C 1.534 0.348 0 O-C-N 122.185 -0.322 . . . . 0.0 110.406 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.454 ' HD2' ' HB3' ' A' ' 8' ' ' HIS . 63.5 Cg_exo -41.72 -53.89 3.1 Favored 'Trans proline' 0 C--N 1.356 0.964 0 C-N-CA 123.567 2.845 . . . . 0.0 114.548 -172.041 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -91.0 22.71 3.53 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 112.108 0.41 . . . . 0.0 112.108 -174.44 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -60.23 -33.17 71.9 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 121.351 0.596 . . . . 0.0 110.409 177.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -62.44 -31.66 72.4 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.507 -0.77 . . . . 0.0 111.173 -177.036 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.693 ' HB2' ' SG ' ' A' ' 46' ' ' CYS . 20.3 m -87.25 14.28 8.1 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.868 -173.394 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.47 ' CE2' ' HA3' ' A' ' 44' ' ' GLY . 4.1 m-30 -66.4 85.1 0.1 Allowed 'General case' 0 C--O 1.234 0.282 0 CA-C-O 120.85 0.357 . . . . 0.0 110.917 175.555 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.443 HD13 ' HB3' ' A' ' 47' ' ' LYS . 55.0 mt -70.16 -59.0 3.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 175.634 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 62.0 t -110.0 113.62 44.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 177.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.473 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 0.0 OUTLIER -136.63 130.86 32.88 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.772 0.32 . . . . 0.0 110.177 178.171 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 35.1 m -131.83 171.68 17.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.037 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.465 ' HB2' HD12 ' A' ' 40' ' ' ILE . 57.0 pttt -110.44 109.34 19.68 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 177.495 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -157.01 158.26 36.22 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.724 -177.318 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 50.0 t -81.39 111.85 18.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.642 0.258 . . . . 0.0 110.763 -178.579 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.495 HG21 ' NE2' ' A' ' 35' ' ' GLN . 17.1 m -75.26 128.62 37.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.362 176.126 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 87.1 mmm -122.34 166.66 14.33 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 -177.135 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 9.1 t -143.93 164.51 30.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.445 0.64 . . . . 0.0 111.08 178.477 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.527 ' HB3' ' HB2' ' A' ' 99' ' ' LYS . 73.2 ttt180 -150.04 140.02 21.96 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 -179.846 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.534 ' HA ' ' HG2' ' A' ' 98' ' ' ARG . 26.0 t0 -79.15 37.39 0.32 Allowed 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 121.348 0.594 . . . . 0.0 110.322 -177.869 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.462 ' HA ' ' HG3' ' A' ' 99' ' ' LYS . 22.0 t70 63.49 -63.36 0.13 Allowed 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 123.891 0.876 . . . . 0.0 109.715 -171.018 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 22.3 p -68.93 170.8 9.06 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.861 168.719 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 15.7 m 64.78 96.06 0.05 OUTLIER 'General case' 0 CA--C 1.536 0.431 0 CA-C-O 120.984 0.421 . . . . 0.0 111.142 178.346 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -80.59 22.91 4.43 Favored Glycine 0 CA--C 1.519 0.301 0 C-N-CA 121.494 -0.384 . . . . 0.0 113.557 -175.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -80.48 -27.02 53.05 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.949 -0.643 . . . . 0.0 112.458 179.022 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . 0.515 ' CH2' ' HB3' ' A' ' 99' ' ' LYS . 83.4 m95 58.15 101.79 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 121.452 0.644 . . . . 0.0 110.841 -176.312 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 31.1 p90 -101.16 135.51 19.9 Favored Pre-proline 0 CA--C 1.532 0.254 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.915 -174.266 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.529 ' HB2' ' HA3' ' A' ' 38' ' ' GLY . 73.7 Cg_endo -79.05 111.41 2.93 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.694 2.262 . . . . 0.0 112.133 178.756 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.495 ' NE2' HG21 ' A' ' 22' ' ' VAL . 4.7 pm0 -75.69 168.3 20.28 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.36 -179.392 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 62.07 -77.84 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 115.395 -0.821 . . . . 0.0 110.794 177.311 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -148.52 -7.72 0.21 Allowed Glycine 0 CA--C 1.518 0.264 0 C-N-CA 121.252 -0.499 . . . . 0.0 112.558 -179.687 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.529 ' HA3' ' HB2' ' A' ' 34' ' ' PRO . . . 58.08 83.07 0.05 OUTLIER Glycine 0 C--N 1.334 0.462 0 C-N-CA 121.38 -0.438 . . . . 0.0 113.113 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -157.35 174.23 34.84 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 121.039 -0.601 . . . . 0.0 112.007 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.465 HD12 ' HB2' ' A' ' 19' ' ' LYS . 9.2 tt -58.55 129.24 20.38 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 CA-C-O 121.074 0.464 . . . . 0.0 110.081 178.66 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 43.7 t -121.61 146.02 47.4 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.317 0.58 . . . . 0.0 111.705 -170.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.632 ' HB3' ' HB2' ' A' ' 64' ' ' GLU . 19.8 ttt180 -77.61 83.23 4.0 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 114.971 -1.013 . . . . 0.0 108.457 171.752 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.473 ' O ' ' HA ' ' A' ' 17' ' ' ARG . 45.7 t -73.1 92.46 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.466 -175.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.47 ' HA3' ' CE2' ' A' ' 14' ' ' TYR . . . -93.24 95.67 2.01 Favored Glycine 0 N--CA 1.448 -0.565 0 CA-C-N 115.864 -0.607 . . . . 0.0 112.63 -179.467 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 61.4 t -82.14 93.24 2.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-O 121.407 0.623 . . . . 0.0 109.409 176.625 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . 0.693 ' SG ' ' HB2' ' A' ' 13' ' ' SER . 43.0 t -91.45 114.3 26.8 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.547 -177.926 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.443 ' HB3' HD13 ' A' ' 15' ' ' ILE . 40.0 ttmt -75.91 92.6 3.12 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 175.055 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.464 HG23 ' CE1' ' A' ' 76' ' ' TYR . 28.3 m -86.65 170.2 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.571 -174.022 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 26.0 ptm -126.25 -178.13 4.21 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.233 -179.616 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 8.6 p80 -134.22 159.71 71.28 Favored Pre-proline 0 C--N 1.326 -0.442 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 178.384 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.406 ' O ' ' HB2' ' A' ' 52' ' ' GLU . 90.9 Cg_exo -46.1 137.09 13.84 Favored 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 122.797 2.331 . . . . 0.0 112.414 178.596 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.406 ' HB2' ' O ' ' A' ' 51' ' ' PRO . 47.1 mt-10 74.13 -54.52 0.68 Allowed 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 123.575 0.75 . . . . 0.0 110.913 -176.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 77.77 95.49 0.23 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 121.255 -0.498 . . . . 0.0 112.392 177.455 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 32.1 p30 -69.45 -27.0 64.86 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.921 0.391 . . . . 0.0 110.763 179.145 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 140.98 -42.15 1.21 Allowed Glycine 0 C--N 1.331 0.286 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.974 177.462 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 7.3 mmm180 -80.64 103.31 10.4 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 120.836 0.35 . . . . 0.0 110.264 -177.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 20.9 m -81.09 141.36 34.39 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.616 -177.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -88.68 -174.24 47.02 Favored Glycine 0 C--N 1.331 0.259 0 CA-C-N 116.214 -0.448 . . . . 0.0 112.324 -178.3 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -132.36 139.17 48.02 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.124 0.488 . . . . 0.0 110.583 -179.089 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 3.1 tt -119.82 112.13 18.85 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 176.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.446 ' HB ' ' HB3' ' A' ' 75' ' ' CYS . 44.5 mm -75.94 92.73 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 175.842 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 16.9 t-80 -104.19 93.54 4.89 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.469 -175.725 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -102.21 112.71 4.39 Favored Glycine 0 CA--C 1.518 0.277 0 C-N-CA 121.235 -0.507 . . . . 0.0 112.7 -175.622 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.632 ' HB2' ' HB3' ' A' ' 42' ' ' ARG . 43.5 mm-40 -93.43 162.35 14.01 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.708 0.289 . . . . 0.0 110.82 178.043 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 15.1 ttm180 -82.47 151.78 26.38 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 167.77 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 28.4 mm-40 -59.39 88.03 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 120.884 0.373 . . . . 0.0 110.735 -179.586 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 87.1 tttt 173.76 -21.39 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.173 -0.921 . . . . 0.0 108.981 -176.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.544 ' HB3' HG22 ' A' ' 7' ' ' THR . 28.1 m-20 71.24 49.59 0.32 Allowed 'General case' 0 C--O 1.237 0.415 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.384 176.064 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.44 ' O ' ' HB2' ' A' ' 70' ' ' LEU . 11.9 tmtt? -176.0 60.19 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.132 -179.155 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.486 ' O ' ' HA ' ' A' ' 64' ' ' GLU . 54.3 tp 174.2 105.29 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.041 177.757 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 4.0 m -70.73 96.0 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 CA-C-O 121.21 0.529 . . . . 0.0 110.593 174.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 28.6 m -86.99 -9.06 11.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.915 179.649 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.45 ' HB2' HG22 ' A' ' 22' ' ' VAL . 1.5 tm? -159.72 121.1 3.21 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 177.793 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -129.09 122.27 29.57 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 179.328 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . 0.446 ' HB3' ' HB ' ' A' ' 61' ' ' ILE . 42.6 t -149.21 87.97 1.56 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.204 0.526 . . . . 0.0 110.572 178.877 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.464 ' CE1' HG23 ' A' ' 48' ' ' VAL . 67.0 t80 -77.26 123.04 25.91 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.146 175.065 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.502 HG11 HD13 ' A' ' 81' ' ' LEU . 17.3 m -133.62 111.64 16.05 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 CA-C-O 121.173 0.511 . . . . 0.0 110.092 177.03 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 16.0 ptm180 -81.25 -17.39 49.64 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.796 -178.222 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.413 ' HA ' HD22 ' A' ' 124' ' ' LEU . 85.6 tttt -172.15 152.69 2.9 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.373 -177.429 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 26.8 t70 71.6 105.25 0.07 Allowed 'General case' 0 N--CA 1.468 0.461 0 O-C-N 123.704 0.627 . . . . 0.0 112.235 173.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.505 HD23 ' N ' ' A' ' 82' ' ' VAL . 4.7 tt -179.37 129.21 0.1 Allowed 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 177.131 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.505 ' N ' HD23 ' A' ' 81' ' ' LEU . 75.6 t -128.02 129.95 69.7 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 N-CA-C 110.33 -0.248 . . . . 0.0 110.33 177.832 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.419 ' CE2' HG23 ' A' ' 117' ' ' VAL . 6.7 m-85 -83.24 159.56 21.94 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.24 0.543 . . . . 0.0 111.024 178.114 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 87.8 m -150.05 135.79 18.43 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.361 177.674 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.552 ' HD2' ' H ' ' A' ' 85' ' ' LYS . 0.0 OUTLIER -105.59 126.51 52.23 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.795 0.331 . . . . 0.0 110.43 -178.617 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.402 ' C ' HD21 ' A' ' 87' ' ' ASN . . . -98.51 -46.08 5.87 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.334 0.588 . . . . 0.0 109.485 175.793 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . 0.794 ' HB2' ' HB3' ' A' ' 90' ' ' PHE . 0.9 OUTLIER -125.17 152.03 70.23 Favored Pre-proline 0 C--N 1.327 -0.411 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 174.387 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -54.32 -25.88 41.07 Favored 'Trans proline' 0 CA--C 1.533 0.47 0 C-N-CA 122.44 2.094 . . . . 0.0 112.431 177.552 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.411 ' HA ' ' HD2' ' A' ' 104' ' ' PHE . 14.3 p -112.82 11.99 19.42 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.746 178.919 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.794 ' HB3' ' HB2' ' A' ' 87' ' ' ASN . 35.4 t80 -136.71 96.89 3.41 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-O 121.266 0.555 . . . . 0.0 109.642 178.111 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -97.36 163.08 13.04 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 176.632 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 28.6 p80 -166.63 169.97 13.07 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.909 0.385 . . . . 0.0 111.233 178.031 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . 0.52 ' CE2' ' HB2' ' A' ' 100' ' ' PHE . 38.8 p90 -149.69 134.94 18.17 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.36 174.539 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 7.7 tmtm? -102.36 116.68 33.14 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.817 -179.482 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.444 HG21 ' H ' ' A' ' 97' ' ' ASN . 34.9 m -105.72 -170.6 0.32 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.398 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.261 179.596 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -54.62 -25.87 29.33 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 122.877 0.471 . . . . 0.0 111.754 -176.707 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.465 ' O ' ' HB2' ' A' ' 98' ' ' ARG . 4.9 p-10 -155.11 131.3 10.26 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.179 -0.464 . . . . 0.0 109.972 177.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.534 ' HG2' ' HA ' ' A' ' 26' ' ' ASP . 57.7 mtt180 73.04 162.09 0.26 Allowed 'General case' 0 C--O 1.236 0.354 0 CA-C-O 122.071 0.939 . . . . 0.0 112.237 -173.766 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.527 ' HB2' ' HB3' ' A' ' 25' ' ' ARG . 63.5 mttp -122.35 124.54 43.95 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 114.221 -1.354 . . . . 0.0 108.055 174.623 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . 0.52 ' HB2' ' CE2' ' A' ' 93' ' ' TRP . 1.7 m-85 -101.11 128.87 46.98 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 -177.311 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -111.04 164.17 12.18 Favored Glycine 0 N--CA 1.454 -0.114 0 C-N-CA 121.431 -0.414 . . . . 0.0 112.694 -176.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 7.0 tt -150.24 104.37 3.25 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 -179.65 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 36.6 m -91.84 115.52 28.13 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.013 178.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.411 ' HD2' ' HA ' ' A' ' 89' ' ' THR . 82.1 m-85 -67.35 160.1 27.99 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.616 -175.439 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 8.2 tp-100 -92.6 -42.0 9.91 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.382 -178.518 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 49.5 m -143.65 153.95 58.89 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.402 -179.03 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -52.35 -27.96 33.11 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 122.627 2.218 . . . . 0.0 112.344 177.258 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -60.41 -62.18 2.05 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.159 177.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 -66.02 -29.22 69.55 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.589 179.573 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . 0.401 ' HA ' ' CD1' ' A' ' 104' ' ' PHE . . . -57.8 -57.51 12.45 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.585 175.767 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 62.0 mtp180 -60.94 -49.28 78.07 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.904 -179.317 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -60.75 -49.68 76.51 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.498 -176.174 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 66.0 t80 -71.62 -38.03 70.83 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.707 -177.191 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -55.87 -61.87 2.08 Favored 'General case' 0 C--O 1.24 0.557 0 CA-C-O 121.847 0.832 . . . . 0.0 110.241 178.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 40.7 ttm180 -60.98 -45.88 92.99 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 114.643 -1.162 . . . . 0.0 110.571 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -62.19 -41.45 99.71 Favored Glycine 0 N--CA 1.451 -0.304 0 CA-C-N 115.506 -0.77 . . . . 0.0 112.975 -177.065 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.513 ' O ' HG12 ' A' ' 121' ' ' ILE . 8.1 p -73.98 -33.27 35.9 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-N 116.78 0.29 . . . . 0.0 110.306 -177.228 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 27.5 tpt180 -57.28 -50.32 73.29 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 172.035 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 3.9 tmmm? -57.85 -38.76 76.25 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.725 176.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -65.53 -40.93 93.5 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.254 179.562 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.513 HG12 ' O ' ' A' ' 117' ' ' VAL . 46.0 mm -62.9 -40.76 90.1 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 178.216 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -62.42 -43.87 97.79 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.58 174.518 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -65.75 -23.85 66.82 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.006 179.638 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.413 HD22 ' HA ' ' A' ' 79' ' ' LYS . 5.4 tt -77.98 -52.6 8.56 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.452 179.054 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 61.6 mt -94.62 -47.21 13.38 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 -171.209 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 13.5 tp10 . . . . . 0 C--O 1.243 0.746 0 CA-C-O 118.516 -0.754 . . . . 0.0 110.343 -174.966 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.754 0 N-CA-C 111.863 -0.495 . . . . 0.0 111.863 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 25.5 t -73.04 85.2 1.3 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.185 0.516 . . . . 0.0 110.042 179.452 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 66.4 mtt -71.18 81.94 0.72 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.559 177.024 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 10.2 t -90.51 -13.3 34.95 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.36 -0.837 . . . . 0.0 111.644 -174.504 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -88.71 -64.8 1.09 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.394 0.616 . . . . 0.0 109.583 -179.3 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -135.22 153.84 51.8 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 108.617 -0.882 . . . . 0.0 108.617 177.04 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.54 HG21 ' HB2' ' A' ' 64' ' ' GLU . 34.2 p -90.08 -12.18 39.2 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.369 0.604 . . . . 0.0 110.498 178.598 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -130.7 125.63 21.52 Favored Pre-proline 0 C--N 1.328 -0.369 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 170.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -54.45 -25.7 41.28 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.381 2.054 . . . . 0.0 111.786 -179.48 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -86.77 -57.86 2.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.331 -0.85 . . . . 0.0 109.927 175.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.413 ' HA ' ' CE2' ' A' ' 14' ' ' TYR . 21.7 t70 63.9 0.21 0.9 Allowed 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 115.35 -0.841 . . . . 0.0 112.317 174.933 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -84.32 -32.22 24.43 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.284 0.564 . . . . 0.0 110.653 -177.341 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 28.6 m -74.1 -4.17 34.02 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.139 -0.937 . . . . 0.0 112.65 -171.068 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.413 ' CE2' ' HA ' ' A' ' 11' ' ' ASP . 76.9 m-85 -67.88 110.25 3.76 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-O 120.829 0.347 . . . . 0.0 110.603 178.823 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 48.8 mm -83.6 -55.77 6.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.934 -0.575 . . . . 0.0 109.877 178.459 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 61.8 t -122.91 134.3 66.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.376 -178.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 32.8 mtm180 -134.7 94.77 3.23 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 175.04 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 13.6 p -118.02 142.37 32.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.842 0.353 . . . . 0.0 110.882 -177.166 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 64.2 tttm -72.15 131.28 42.58 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.05 -179.42 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -161.7 -164.31 1.09 Allowed 'General case' 0 C--O 1.239 0.52 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.302 179.447 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 61.7 t -124.21 105.7 15.77 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 CA-C-N 116.741 -0.208 . . . . 0.0 110.525 177.303 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.434 HG22 HG21 ' A' ' 72' ' ' VAL . 28.6 m -72.89 116.78 15.53 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 CA-C-O 121.475 0.655 . . . . 0.0 110.761 178.476 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 25.8 mmt -92.22 110.3 21.68 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.22 178.455 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.635 ' O ' ' HG3' ' A' ' 25' ' ' ARG . 7.4 t -83.23 2.53 35.35 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.578 -179.646 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.746 HH11 ' HG3' ' A' ' 25' ' ' ARG . 0.4 OUTLIER 53.37 172.88 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.956 0 N-CA-C 115.397 1.628 . . . . 0.0 115.397 166.449 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.541 ' HB2' ' CE2' ' A' ' 33' ' ' PHE . 36.6 t70 -143.03 6.76 1.57 Allowed 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 114.047 -1.433 . . . . 0.0 109.91 -178.936 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 65.4 m-20 66.24 -86.23 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.404 -178.219 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 22.9 t -151.1 99.95 2.73 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.334 -174.428 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.458 ' HB3' ' OD2' ' A' ' 26' ' ' ASP . 30.5 t 174.9 -54.46 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 177.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -111.26 -41.42 1.16 Allowed Glycine 0 N--CA 1.451 -0.307 0 N-CA-C 110.434 -1.067 . . . . 0.0 110.434 170.575 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 128.07 -109.97 1.09 Allowed Glycine 0 C--N 1.333 0.374 0 C-N-CA 121.578 -0.344 . . . . 0.0 112.675 175.122 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . 0.709 ' CE3' ' HB3' ' A' ' 25' ' ' ARG . 65.1 m95 -128.75 114.49 16.65 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 -178.797 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.541 ' CE2' ' HB2' ' A' ' 26' ' ' ASP . 8.5 p90 -120.47 151.41 53.8 Favored Pre-proline 0 C--O 1.239 0.503 0 CA-C-O 120.495 0.188 . . . . 0.0 110.966 178.47 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.433 ' HB2' ' HA3' ' A' ' 38' ' ' GLY . 73.5 Cg_endo -89.44 -154.35 0.05 OUTLIER 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 123.331 2.687 . . . . 0.0 111.739 175.171 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -156.62 147.44 21.82 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-O 120.532 0.206 . . . . 0.0 111.08 -176.779 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.464 ' HB3' ' HD3' ' A' ' 67' ' ' LYS . 12.3 mm-40 54.71 25.77 6.83 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 115.883 -0.598 . . . . 0.0 112.0 175.433 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 115.8 -42.48 1.89 Allowed Glycine 0 N--CA 1.453 -0.207 0 N-CA-C 111.497 -0.641 . . . . 0.0 111.497 -179.057 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.433 ' HA3' ' HB2' ' A' ' 34' ' ' PRO . . . 59.98 67.66 2.05 Favored Glycine 0 C--N 1.331 0.3 0 C-N-CA 121.353 -0.451 . . . . 0.0 112.76 179.198 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -153.78 -46.02 0.02 OUTLIER Glycine 0 N--CA 1.455 -0.1 0 N-CA-C 111.6 -0.6 . . . . 0.0 111.6 177.71 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.544 ' O ' HG21 ' A' ' 40' ' ' ILE . 2.6 mp -97.24 63.45 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 CA-C-O 121.634 0.73 . . . . 0.0 109.379 178.862 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.479 ' HB2' HE22 ' A' ' 66' ' ' GLN . 25.6 t -117.56 109.51 16.8 Favored 'General case' 0 C--N 1.33 -0.242 0 O-C-N 121.978 -0.451 . . . . 0.0 110.23 -178.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 60.4 mtp180 -89.62 110.98 21.81 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-O 120.895 0.379 . . . . 0.0 110.206 179.547 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.548 HG23 HD21 ' A' ' 102' ' ' LEU . 46.4 t -72.4 103.04 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.932 177.774 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -92.52 86.02 1.2 Allowed Glycine 0 N--CA 1.449 -0.483 0 CA-C-N 115.793 -0.639 . . . . 0.0 112.389 -178.798 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 51.4 t -71.5 100.72 0.9 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.411 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 176.564 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . 0.632 ' SG ' ' HB3' ' A' ' 60' ' ' LEU . 11.5 p -107.97 138.28 44.5 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.627 -178.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -95.71 119.37 34.09 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.8 -0.445 . . . . 0.0 109.8 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 33.5 m -92.69 148.38 4.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.802 -177.579 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 85.8 mtp -94.0 159.57 15.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.796 -178.524 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . 0.558 ' HB2' ' HA2' ' A' ' 55' ' ' GLY . 5.0 p80 -75.3 137.37 71.76 Favored Pre-proline 0 CA--C 1.536 0.435 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.296 -177.587 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -82.6 45.19 1.85 Allowed 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 123.626 2.884 . . . . 0.0 112.809 -179.014 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 66.92 -77.79 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 112.935 0.717 . . . . 0.0 112.935 175.13 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -53.99 -91.67 0.01 OUTLIER Glycine 0 C--N 1.339 0.724 0 O-C-N 123.506 0.504 . . . . 0.0 114.056 -169.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -69.43 -15.51 63.3 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.821 0.343 . . . . 0.0 110.176 179.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.558 ' HA2' ' HB2' ' A' ' 50' ' ' HIS . . . 60.83 -129.26 46.43 Favored Glycine 0 N--CA 1.445 -0.716 0 CA-C-N 115.728 -0.669 . . . . 0.0 112.69 175.951 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 2.5 mpt_? 60.83 85.13 0.12 Allowed 'General case' 0 C--O 1.234 0.261 0 CA-C-O 121.218 0.532 . . . . 0.0 111.16 -178.33 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 33.0 p -79.02 -179.28 6.57 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.694 174.563 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 177.17 -143.1 6.08 Favored Glycine 0 N--CA 1.448 -0.567 0 C-N-CA 120.714 -0.755 . . . . 0.0 111.991 -179.126 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.495 ' HE1' ' HB2' ' A' ' 124' ' ' LEU . 85.7 m-85 -134.03 155.5 49.89 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.995 0.426 . . . . 0.0 110.517 -178.064 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.632 ' HB3' ' SG ' ' A' ' 46' ' ' CYS . 3.8 tt -121.91 107.91 12.82 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 174.364 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.465 ' O ' ' HA ' ' A' ' 74' ' ' GLU . 49.1 mt -70.66 83.86 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 178.643 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . 0.559 ' HB2' HD23 ' A' ' 60' ' ' LEU . 11.9 t60 -103.35 93.02 4.75 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.482 -174.624 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -88.3 121.94 6.14 Favored Glycine 0 N--CA 1.447 -0.568 0 N-CA-C 111.057 -0.817 . . . . 0.0 111.057 174.695 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.54 ' HB2' HG21 ' A' ' 7' ' ' THR . 1.7 pp20? -124.63 -175.58 3.31 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 116.857 0.329 . . . . 0.0 110.759 -179.448 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.519 ' O ' ' HB2' ' A' ' 66' ' ' GLN . 0.1 OUTLIER 79.3 147.31 0.09 Allowed 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.064 -0.971 . . . . 0.0 111.409 173.843 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.519 ' HB2' ' O ' ' A' ' 65' ' ' ARG . 5.4 tp-100 172.31 -57.09 0.01 OUTLIER 'General case' 0 C--O 1.231 0.12 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.612 172.199 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.464 ' HD3' ' HB3' ' A' ' 36' ' ' GLU . 7.2 ptmm? -156.07 -37.43 0.08 Allowed 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.903 -172.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -118.41 9.93 12.56 Favored 'General case' 0 N--CA 1.47 0.544 0 O-C-N 122.399 -0.188 . . . . 0.0 111.106 -178.268 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 20.0 ttmm 49.43 90.2 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 121.493 0.663 . . . . 0.0 109.732 -167.165 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.469 HD23 ' N ' ' A' ' 70' ' ' LEU . 2.0 pt? -142.03 160.18 40.73 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 -176.377 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 16.0 t -80.47 93.81 2.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 123.605 0.565 . . . . 0.0 109.567 178.611 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.434 HG21 HG22 ' A' ' 22' ' ' VAL . 30.6 m -79.26 -20.67 12.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.819 -177.575 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.449 HD12 ' N ' ' A' ' 74' ' ' GLU . 2.6 tm? -153.89 133.43 12.86 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 178.86 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.465 ' HA ' ' O ' ' A' ' 61' ' ' ILE . 13.2 pt-20 -151.49 129.6 11.87 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 176.31 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 61.0 m -146.93 117.7 7.6 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.057 -0.52 . . . . 0.0 109.779 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 42.3 t80 -90.96 144.26 25.86 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 -179.787 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 12.2 p -157.17 145.61 10.76 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 N-CA-C 110.3 -0.259 . . . . 0.0 110.3 179.6 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.97 -161.19 0.65 Allowed 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.101 179.663 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.516 ' O ' ' HB2' ' A' ' 80' ' ' ASP . 23.0 ttmm -66.48 77.2 0.11 Allowed 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.934 176.907 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.516 ' HB2' ' O ' ' A' ' 79' ' ' LYS . 25.6 t70 169.13 95.91 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.461 0.705 . . . . 0.0 109.585 174.489 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.464 HD21 ' H ' ' A' ' 82' ' ' VAL . 1.1 tt -137.06 138.83 40.84 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 -178.321 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.464 ' H ' HD21 ' A' ' 81' ' ' LEU . 26.0 m -124.43 127.53 73.12 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 CA-C-O 120.941 0.401 . . . . 0.0 110.933 179.041 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.636 ' HB3' ' NE2' ' A' ' 91' ' ' HIS . 11.7 m-85 -111.53 139.88 46.6 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.909 174.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.462 ' HB ' ' CE1' ' A' ' 92' ' ' HIS . 36.6 m -132.84 114.7 14.38 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.505 -179.472 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.423 ' HZ3' ' CB ' ' A' ' 85' ' ' LYS . 2.6 ttmp? -85.34 99.61 11.27 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 177.269 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -83.08 -13.99 54.64 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.283 0.563 . . . . 0.0 110.518 -176.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . 0.746 ' HB3' ' HB3' ' A' ' 90' ' ' PHE . 27.8 t-20 -160.47 140.33 8.29 Favored Pre-proline 0 C--N 1.324 -0.513 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 -178.128 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_endo -46.94 -22.95 2.26 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 122.948 2.432 . . . . 0.0 113.614 178.073 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.456 HG22 ' OD1' ' A' ' 87' ' ' ASN . 12.6 t -116.51 14.7 15.6 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 120.767 0.318 . . . . 0.0 111.62 -179.872 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.746 ' HB3' ' HB3' ' A' ' 87' ' ' ASN . 79.6 t80 -146.39 114.98 6.79 Favored 'General case' 0 C--O 1.239 0.518 0 CA-C-O 121.218 0.532 . . . . 0.0 110.7 -178.262 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . 0.636 ' NE2' ' HB3' ' A' ' 83' ' ' TYR . 1.8 t-160 -121.49 123.11 41.25 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 -179.147 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . 0.462 ' CE1' ' HB ' ' A' ' 84' ' ' THR . 34.6 p80 -120.4 168.27 11.48 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.686 0.279 . . . . 0.0 110.857 -179.668 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 45.1 p90 -154.22 137.87 16.07 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.112 -177.653 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 56.6 tttp -95.71 107.81 20.06 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 174.466 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 35.5 m -136.41 151.04 27.85 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 CA-C-O 121.032 0.444 . . . . 0.0 111.15 -179.37 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 33.1 t70 59.87 -78.07 0.02 OUTLIER 'General case' 0 C--O 1.236 0.368 0 CA-C-N 114.882 -1.054 . . . . 0.0 112.459 173.291 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -134.96 -22.87 1.57 Allowed 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 112.796 0.665 . . . . 0.0 112.796 -174.373 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 7.9 tpt180 -146.02 175.55 10.37 Favored 'General case' 0 N--CA 1.465 0.316 0 O-C-N 121.884 -0.51 . . . . 0.0 111.026 -172.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 38.1 ttmt -101.43 108.42 20.02 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.822 -0.627 . . . . 0.0 109.623 -179.693 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -103.14 166.9 10.16 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 -179.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -159.59 178.57 35.65 Favored Glycine 0 CA--C 1.51 -0.239 0 C-N-CA 119.945 -1.121 . . . . 0.0 112.974 -177.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.548 HD21 HG23 ' A' ' 43' ' ' VAL . 3.9 pp -148.94 154.47 39.45 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-O 120.857 0.36 . . . . 0.0 110.771 177.697 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 90.0 m -105.42 128.38 53.49 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.755 175.41 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.427 ' CE2' ' HB2' ' A' ' 91' ' ' HIS . 61.2 m-85 -74.19 169.58 17.29 Favored 'General case' 0 C--O 1.238 0.489 0 CA-C-O 121.182 0.515 . . . . 0.0 111.224 -178.264 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 28.2 tt0 -106.94 -38.15 6.13 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.122 -179.363 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 24.8 m -151.83 157.21 34.49 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.94 178.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -56.55 -22.61 43.95 Favored 'Trans proline' 0 C--N 1.352 0.743 0 C-N-CA 122.348 2.032 . . . . 0.0 111.99 177.041 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -60.58 -63.32 1.34 Allowed 'General case' 0 C--O 1.233 0.213 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.716 175.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -66.23 -29.08 69.25 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.732 178.656 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -59.65 -52.5 65.24 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.975 0.416 . . . . 0.0 110.694 175.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 60.8 ttp85 -68.39 -44.31 75.39 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.337 -179.488 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -59.18 -42.1 90.02 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.01 -178.681 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 74.9 t80 -73.69 -39.11 64.63 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.424 -179.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.413 ' O ' HG11 ' A' ' 117' ' ' VAL . 37.4 t70 -62.69 -65.78 0.64 Allowed 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 121.326 0.584 . . . . 0.0 110.47 179.178 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 1.5 tmt_? -56.69 -39.8 74.47 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.166 -0.925 . . . . 0.0 110.017 177.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -59.19 -51.03 61.61 Favored Glycine 0 C--N 1.333 0.416 0 C-N-CA 121.101 -0.571 . . . . 0.0 112.501 179.62 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.508 ' O ' HG12 ' A' ' 121' ' ' ILE . 8.6 p -68.88 -30.26 46.29 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 N-CA-C 110.209 -0.293 . . . . 0.0 110.209 -178.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 3.2 mpt_? -62.53 -46.57 87.78 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.379 177.434 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 53.7 tptt -65.79 -40.92 92.42 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.111 177.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -57.49 -45.92 84.34 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.457 177.395 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.508 HG12 ' O ' ' A' ' 117' ' ' VAL . 40.1 mm -64.43 -38.71 83.28 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.337 177.823 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -57.89 -50.65 72.6 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.531 -179.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 44.1 m-20 -71.2 -29.42 65.13 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.847 178.697 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.495 ' HB2' ' HE1' ' A' ' 59' ' ' PHE . 65.6 tp -65.71 -54.38 28.13 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.229 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.476 HG21 ' O ' ' A' ' 121' ' ' ILE . 10.7 tp -83.05 -37.18 13.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.19 -174.05 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 . . . . . 0 C--O 1.251 1.163 0 O-C-N 123.59 0.556 . . . . 0.0 109.945 -176.606 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.827 0 N-CA-C 111.867 -0.493 . . . . 0.0 111.867 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 10.9 t -94.36 36.76 1.13 Allowed 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 178.665 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 65.2 mtt 68.52 -168.1 0.19 Allowed 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.34 -176.5 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 63.5 m -146.21 97.41 2.94 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 120.814 0.34 . . . . 0.0 111.145 -178.037 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -139.98 176.9 8.36 Favored 'General case' 0 C--O 1.238 0.453 0 N-CA-C 109.419 -0.585 . . . . 0.0 109.419 173.635 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -82.24 166.92 19.15 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 110.032 -0.359 . . . . 0.0 110.032 177.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 4.4 m -116.13 20.85 14.11 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.74 0.781 . . . . 0.0 109.513 -179.702 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.544 ' HB3' ' HD2' ' A' ' 9' ' ' PRO . 25.7 m170 -74.43 170.74 13.61 Favored Pre-proline 0 CA--C 1.535 0.389 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.411 -178.706 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.544 ' HD2' ' HB3' ' A' ' 8' ' ' HIS . 88.3 Cg_exo -43.91 126.23 5.83 Favored 'Trans proline' 0 C--N 1.355 0.873 0 C-N-CA 122.608 2.205 . . . . 0.0 112.677 175.35 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.472 ' HB3' ' HB2' ' A' ' 13' ' ' SER . 3.9 m-20 64.87 38.03 6.81 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 121.348 0.594 . . . . 0.0 110.597 -178.385 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.505 ' HA ' ' CD2' ' A' ' 14' ' ' TYR . 10.2 p-10 -55.69 -28.8 57.57 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.822 176.322 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -76.93 -24.81 52.42 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.231 179.479 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.472 ' HB2' ' HB3' ' A' ' 10' ' ' ASP . 15.8 m -88.96 -8.67 53.7 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 116.041 -0.527 . . . . 0.0 112.278 -171.603 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.601 ' HB3' ' HD2' ' A' ' 17' ' ' ARG . 59.6 m-85 -63.31 93.1 0.06 Allowed 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 120.835 0.35 . . . . 0.0 110.933 179.088 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 7.5 tp -83.41 -45.66 18.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.308 -178.301 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 92.1 t -125.3 121.46 60.62 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 CA-C-O 120.848 0.356 . . . . 0.0 110.64 -177.788 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.601 ' HD2' ' HB3' ' A' ' 14' ' ' TYR . 0.0 OUTLIER -125.51 103.8 8.08 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.81 178.94 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 27.2 m -119.89 176.47 3.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 177.547 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 21.5 pttm -128.33 129.97 47.07 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.822 0.344 . . . . 0.0 110.752 -177.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.427 ' HB2' HD21 ' A' ' 102' ' ' LEU . . . -159.02 -178.86 7.54 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.833 179.699 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 40.3 t -93.54 99.78 10.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 120.866 0.365 . . . . 0.0 110.707 -176.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.474 HG13 ' HG ' ' A' ' 73' ' ' LEU . 57.2 t -81.79 106.42 12.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.626 -179.678 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 23.1 mmt -86.04 150.72 24.26 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.258 177.598 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 5.2 t -123.08 151.49 41.96 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.055 -0.521 . . . . 0.0 109.951 177.539 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 59.1 ttt180 -123.18 104.7 9.34 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.145 -0.48 . . . . 0.0 109.82 -178.61 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -81.2 56.14 2.76 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-O 121.27 0.557 . . . . 0.0 109.681 -179.044 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 65.4 m-20 57.58 22.88 8.65 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.131 -0.94 . . . . 0.0 110.563 -177.374 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.9 m -67.32 156.38 36.58 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 115.179 -0.919 . . . . 0.0 110.782 179.574 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 23.9 m -62.19 -43.73 98.19 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-O 120.961 0.41 . . . . 0.0 110.461 177.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -164.01 10.27 0.08 OUTLIER Glycine 0 C--N 1.333 0.371 0 CA-C-N 115.839 -0.619 . . . . 0.0 112.38 177.22 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -83.11 80.22 1.84 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 121.203 -0.522 . . . . 0.0 112.492 -178.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 84.9 m95 -72.98 99.64 2.77 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 174.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.475 ' HA ' ' HD3' ' A' ' 34' ' ' PRO . 26.0 p90 -98.07 141.04 22.32 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.949 -174.471 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.558 ' HB2' ' HA2' ' A' ' 38' ' ' GLY . 9.1 Cg_exo -72.15 136.34 26.74 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.894 2.396 . . . . 0.0 111.593 178.625 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.434 ' O ' ' N ' ' A' ' 37' ' ' GLY . 2.9 pp0? -93.38 145.13 24.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.208 -179.419 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 44.8 mm-40 41.5 -82.76 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 113.788 1.032 . . . . 0.0 113.788 173.274 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.434 ' N ' ' O ' ' A' ' 35' ' ' GLN . . . -58.8 -30.8 66.6 Favored Glycine 0 C--N 1.333 0.392 0 C-N-CA 121.45 -0.405 . . . . 0.0 112.959 -174.705 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.558 ' HA2' ' HB2' ' A' ' 34' ' ' PRO . . . 67.21 12.06 60.02 Favored Glycine 0 C--N 1.33 0.249 0 C-N-CA 121.046 -0.597 . . . . 0.0 112.261 -179.054 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -167.72 -123.02 0.64 Allowed Glycine 0 N--CA 1.446 -0.67 0 N-CA-C 111.586 -0.606 . . . . 0.0 111.586 -177.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 34.0 pt -64.23 135.98 27.12 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 CA-C-O 121.343 0.592 . . . . 0.0 111.815 -177.171 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 39.6 m -144.0 132.84 22.59 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.022 175.284 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.464 ' HD3' ' HB3' ' A' ' 17' ' ' ARG . 5.7 tmm_? -76.3 103.45 6.33 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 -179.017 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.452 HG12 HD12 ' A' ' 102' ' ' LEU . 4.0 p -91.79 110.2 22.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.58 0.705 . . . . 0.0 109.89 177.323 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.436 ' N ' HH11 ' A' ' 42' ' ' ARG . . . -107.43 103.67 1.99 Allowed Glycine 0 N--CA 1.448 -0.536 0 CA-C-N 115.395 -0.821 . . . . 0.0 111.505 -179.495 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 7.5 p -86.13 125.18 40.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 178.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . 0.776 ' SG ' ' HB3' ' A' ' 60' ' ' LEU . 7.0 p -126.54 128.5 46.97 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.603 -178.063 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 3.2 ttmp? -81.58 98.85 8.53 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 177.162 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 46.0 t -73.87 85.49 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 177.694 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 13.5 tpt -89.58 147.81 23.72 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.499 -178.676 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . 0.407 ' CD2' ' HB3' ' A' ' 57' ' ' SER . 0.3 OUTLIER -117.84 159.61 41.91 Favored Pre-proline 0 C--N 1.321 -0.673 0 CA-C-N 115.364 -0.835 . . . . 0.0 109.563 -178.472 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_exo -73.4 43.36 0.75 Allowed 'Trans proline' 0 CA--C 1.537 0.649 0 C-N-CA 122.767 2.311 . . . . 0.0 112.208 176.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 57.48 19.99 5.71 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 123.353 0.661 . . . . 0.0 111.811 177.684 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -117.26 -153.17 9.7 Favored Glycine 0 C--N 1.331 0.266 0 C-N-CA 121.278 -0.487 . . . . 0.0 112.697 -178.107 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 63.1 t30 -64.77 -13.0 53.59 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 123.196 0.598 . . . . 0.0 111.42 -175.641 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.449 ' HA2' ' NH1' ' A' ' 56' ' ' ARG . . . -58.29 143.49 43.8 Favored Glycine 0 CA--C 1.521 0.466 0 C-N-CA 121.189 -0.529 . . . . 0.0 112.403 177.782 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.449 ' NH1' ' HA2' ' A' ' 55' ' ' GLY . 0.1 OUTLIER -69.33 140.66 54.34 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 120.712 0.292 . . . . 0.0 110.712 -179.527 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.407 ' HB3' ' CD2' ' A' ' 50' ' ' HIS . 20.2 p -125.28 132.36 52.92 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.452 179.675 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 173.39 -161.61 32.48 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 121.017 -0.611 . . . . 0.0 112.234 179.709 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.466 ' O ' HG21 ' A' ' 77' ' ' VAL . 84.8 m-85 -127.83 125.78 40.41 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 178.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.776 ' HB3' ' SG ' ' A' ' 46' ' ' CYS . 1.6 tt -93.99 108.2 20.04 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 179.86 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 48.3 mm -80.65 91.41 1.81 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.261 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 174.418 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . 0.649 ' HB2' HD22 ' A' ' 60' ' ' LEU . 28.5 t60 -108.45 106.64 16.85 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.83 -173.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.42 ' HA2' ' O ' ' A' ' 42' ' ' ARG . . . -114.8 138.57 14.91 Favored Glycine 0 C--O 1.235 0.209 0 N-CA-C 111.725 -0.55 . . . . 0.0 111.725 178.422 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.408 ' HB2' ' O ' ' A' ' 70' ' ' LEU . 14.4 pt-20 -120.35 160.18 23.55 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 120.881 0.372 . . . . 0.0 110.801 -179.803 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.443 ' HB2' HG12 ' A' ' 72' ' ' VAL . 2.0 tmt_? -82.75 122.66 28.46 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 177.428 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 9.5 mm100 -58.67 97.45 0.03 OUTLIER 'General case' 0 C--O 1.234 0.269 0 CA-C-O 121.105 0.479 . . . . 0.0 112.007 -174.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 29.5 mtpp -140.27 -72.05 0.37 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.193 -0.912 . . . . 0.0 108.739 173.152 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -160.25 -46.89 0.05 OUTLIER 'General case' 0 C--O 1.235 0.327 0 CA-C-N 114.67 -1.15 . . . . 0.0 108.93 -178.617 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.402 ' HE2' ' NE2' ' A' ' 8' ' ' HIS . 56.1 tttm -170.36 99.12 0.26 Allowed 'General case' 0 C--O 1.236 0.39 0 CA-C-N 115.099 -0.955 . . . . 0.0 109.569 177.835 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.408 ' O ' ' HB2' ' A' ' 64' ' ' GLU . 4.1 tt -157.21 107.77 2.28 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 -178.744 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 43.8 t -78.58 125.18 37.9 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.004 -177.377 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.443 HG12 ' HB2' ' A' ' 65' ' ' ARG . 27.7 m -123.02 -28.96 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.584 179.735 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.474 ' HG ' HG13 ' A' ' 22' ' ' VAL . 2.6 tm? -123.66 117.02 24.05 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 -177.446 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -131.78 107.0 8.47 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 176.742 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 52.5 t -135.13 79.5 1.79 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.349 0.595 . . . . 0.0 109.953 179.676 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.533 ' HA ' ' HA ' ' A' ' 60' ' ' LEU . 57.2 t80 -72.74 105.07 4.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.98 175.472 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.466 HG21 ' O ' ' A' ' 59' ' ' PHE . 34.8 m -81.11 114.54 22.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 178.601 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.64 ' H ' ' HD2' ' A' ' 78' ' ' ARG . 0.3 OUTLIER -82.66 61.67 5.89 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 -173.819 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 36.3 mtmm 68.68 -2.87 1.54 Allowed 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.206 -172.385 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.417 ' H ' ' C ' ' A' ' 78' ' ' ARG . 21.9 t70 -92.36 85.77 5.49 Favored 'General case' 0 N--CA 1.462 0.148 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 174.035 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.692 HD21 HD11 ' A' ' 121' ' ' ILE . 2.4 tt -131.25 106.82 8.56 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.976 -173.854 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 59.5 t -124.05 92.38 2.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.252 176.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -81.49 101.54 9.98 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.04 178.672 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 22.5 m -90.93 127.22 36.31 Favored 'General case' 0 C--N 1.323 -0.543 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 178.602 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 24.7 pttm -93.32 111.25 22.85 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.111 0.481 . . . . 0.0 110.857 -177.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -90.07 -44.16 10.01 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.271 0.558 . . . . 0.0 109.503 175.676 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . 0.591 ' HB2' ' HB3' ' A' ' 90' ' ' PHE . 93.0 m-20 -138.63 153.98 72.81 Favored Pre-proline 0 C--N 1.328 -0.363 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 177.132 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -55.26 -27.41 56.94 Favored 'Trans proline' 0 CA--C 1.533 0.471 0 C-N-CA 122.22 1.947 . . . . 0.0 112.034 176.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 10.8 p -105.91 8.47 32.61 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.836 178.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.591 ' HB3' ' HB2' ' A' ' 87' ' ' ASN . 25.6 t80 -140.81 102.97 4.4 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-O 121.076 0.465 . . . . 0.0 110.405 -179.784 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . 0.609 ' HD1' ' HE2' ' A' ' 104' ' ' PHE . 14.2 m80 -107.7 132.51 53.27 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.513 174.321 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . 0.41 ' HA ' ' O ' ' A' ' 100' ' ' PHE . 8.2 p80 -126.95 129.56 48.37 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.74 0.305 . . . . 0.0 110.204 178.138 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . 0.612 ' HZ3' ' HB2' ' A' ' 102' ' ' LEU . 34.8 p90 -110.01 149.77 29.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.079 179.3 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 14.3 tmtt? -112.57 122.1 46.72 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.059 -178.038 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.432 HG12 ' HD1' ' A' ' 93' ' ' TRP . 21.1 m -124.88 127.33 72.47 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.071 176.863 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 42.3 m-20 59.6 -80.18 0.02 OUTLIER 'General case' 0 C--O 1.235 0.297 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.953 -179.108 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -133.74 -28.48 1.41 Allowed 'General case' 0 C--O 1.234 0.243 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.609 -176.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 62.5 mtt180 -103.44 156.46 17.74 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 121.482 0.658 . . . . 0.0 112.495 -171.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.84 137.34 52.83 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 114.64 -1.164 . . . . 0.0 109.846 -179.89 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . 0.41 ' O ' ' HA ' ' A' ' 92' ' ' HIS . 36.6 m-85 -122.98 137.13 55.04 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 176.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -115.76 101.59 1.03 Allowed Glycine 0 C--N 1.333 0.409 0 C-N-CA 120.968 -0.634 . . . . 0.0 113.216 -171.116 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.612 ' HB2' ' HZ3' ' A' ' 93' ' ' TRP . 3.7 tt -74.42 104.25 5.09 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.211 -0.662 . . . . 0.0 109.211 177.047 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 17.5 m -96.67 114.97 26.66 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.142 179.773 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.609 ' HE2' ' HD1' ' A' ' 91' ' ' HIS . 74.5 m-85 -72.27 167.31 20.67 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.296 -175.368 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -112.71 -31.66 6.67 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.71 -175.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 5.7 m -138.51 150.07 64.92 Favored Pre-proline 0 C--N 1.329 -0.31 0 N-CA-C 110.187 -0.301 . . . . 0.0 110.187 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -52.96 -29.02 42.17 Favored 'Trans proline' 0 C--N 1.352 0.718 0 C-N-CA 122.309 2.006 . . . . 0.0 111.86 176.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -59.44 -65.59 0.65 Allowed 'General case' 0 C--O 1.236 0.384 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.858 177.227 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -64.92 -31.59 72.9 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.949 -179.344 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . 0.424 ' HA ' ' CG ' ' A' ' 104' ' ' PHE . . . -58.52 -60.85 3.15 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.092 177.395 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 20.0 mtm180 -66.54 -32.54 73.96 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.748 -177.628 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -63.51 -56.67 14.24 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.037 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 39.1 t80 -71.03 -28.89 64.72 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.337 -177.214 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -54.84 -63.43 1.16 Allowed 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 121.808 0.813 . . . . 0.0 109.588 173.17 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 52.4 ttt180 -56.51 -37.21 70.1 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.306 -1.315 . . . . 0.0 110.835 177.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -63.94 -53.89 34.39 Favored Glycine 0 C--O 1.237 0.304 0 CA-C-N 115.837 -0.62 . . . . 0.0 112.909 -179.164 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.435 ' O ' HG12 ' A' ' 121' ' ' ILE . 11.9 p -67.71 -33.67 63.23 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 -178.292 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.5 ' O ' ' HG3' ' A' ' 122' ' ' GLU . 54.2 ttt180 -55.54 -50.96 68.63 Favored 'General case' 0 C--O 1.231 0.089 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 173.223 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.62 ' HE2' ' HA ' ' A' ' 119' ' ' LYS . 0.6 OUTLIER -56.47 -46.39 80.42 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.065 178.786 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -56.85 -42.5 79.8 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.949 178.769 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.692 HD11 HD21 ' A' ' 81' ' ' LEU . 42.6 mm -61.59 -39.59 83.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.925 176.682 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.516 ' HA ' ' HA ' ' A' ' 126' ' ' GLU . 41.2 mt-10 -66.23 -37.73 86.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.652 179.676 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -65.26 -36.6 84.61 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-O 121.222 0.534 . . . . 0.0 109.988 174.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 59.3 tp -71.46 -55.35 8.07 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.675 -176.714 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.42 HG13 ' O ' ' A' ' 125' ' ' ILE . 11.3 tp -145.47 10.18 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 N-CA-C 111.655 0.243 . . . . 0.0 111.655 -171.937 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.516 ' HA ' ' HA ' ' A' ' 122' ' ' GLU . 34.0 tt0 . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.429 -0.796 . . . . 0.0 110.753 -175.291 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.949 0 N-CA-C 111.722 -0.551 . . . . 0.0 111.722 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 42.1 t -60.47 -40.81 92.57 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 175.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 95.7 mmm -100.99 160.85 14.03 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.413 174.256 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 41.7 p -74.37 173.25 10.53 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.538 178.676 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -66.37 84.11 0.1 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.39 0.614 . . . . 0.0 110.698 176.697 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -84.62 -44.07 13.83 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 114.941 -1.027 . . . . 0.0 108.561 174.289 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.747 HG22 ' H ' ' A' ' 8' ' ' HIS . 1.7 m 63.54 -162.22 0.28 Allowed 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 114.155 -1.384 . . . . 0.0 110.458 175.283 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.747 ' H ' HG22 ' A' ' 7' ' ' THR . 68.5 t60 94.1 -74.66 0.0 OUTLIER Pre-proline 0 CA--C 1.548 0.883 0 C-N-CA 124.937 1.295 . . . . 0.0 111.008 -173.818 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.524 ' HD3' ' HB3' ' A' ' 8' ' ' HIS . 65.7 Cg_endo -89.66 -4.51 5.53 Favored 'Trans proline' 0 C--N 1.367 1.536 0 CA-C-N 121.483 1.565 . . . . 0.0 111.541 173.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.49 ' HB3' ' HA ' ' A' ' 7' ' ' THR . 30.2 t70 -87.55 -51.5 5.87 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.904 178.725 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.421 ' O ' ' HB2' ' A' ' 14' ' ' TYR . 28.4 t70 75.47 -23.69 0.23 Allowed 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 113.609 0.966 . . . . 0.0 113.609 170.313 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -59.1 -31.96 69.38 Favored 'General case' 0 N--CA 1.469 0.514 0 O-C-N 122.08 -0.387 . . . . 0.0 111.591 -175.285 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 16.5 m -73.84 -15.86 61.15 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 111.857 0.317 . . . . 0.0 111.857 -178.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.421 ' HB2' ' O ' ' A' ' 11' ' ' ASP . 24.7 m-85 -65.14 123.4 19.42 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-O 120.695 0.283 . . . . 0.0 110.561 178.191 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 13.0 tt -102.73 -34.1 3.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 173.411 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.4 ' HB ' ' HB ' ' A' ' 45' ' ' VAL . 97.8 t -139.3 130.12 33.03 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.764 177.808 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 11.6 ptm180 -142.41 91.13 2.29 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.199 0.523 . . . . 0.0 110.277 176.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 35.1 m -107.5 161.08 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.928 -177.629 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 47.3 mtmt -93.83 130.58 39.8 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.392 178.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -163.25 158.59 21.72 Favored 'General case' 0 C--N 1.331 -0.223 0 O-C-N 123.254 0.346 . . . . 0.0 110.29 179.219 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 58.4 t -90.77 105.66 16.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 178.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.586 HG23 ' NE2' ' A' ' 35' ' ' GLN . 15.8 m -81.23 115.18 23.37 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 CA-C-O 121.406 0.622 . . . . 0.0 111.673 -176.541 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 24.0 mmt -99.66 162.78 12.81 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.973 179.589 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 9.9 t -136.64 158.19 45.02 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.943 0.402 . . . . 0.0 110.854 -179.13 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 20.5 ttt180 -136.36 100.26 4.33 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 -179.651 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.539 ' H ' ' HE1' ' A' ' 33' ' ' PHE . 27.4 t70 -63.03 104.43 0.56 Allowed 'General case' 0 C--O 1.234 0.267 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.541 -172.078 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.627 ' HA ' ' HG2' ' A' ' 98' ' ' ARG . 23.8 t70 60.23 -76.85 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.677 176.862 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 37.4 p -145.01 22.94 1.55 Allowed 'General case' 0 C--O 1.236 0.345 0 N-CA-C 111.484 0.179 . . . . 0.0 111.484 -178.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 49.1 m -51.6 143.05 13.1 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.994 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -81.58 61.89 4.57 Favored Glycine 0 CA--C 1.52 0.354 0 C-N-CA 121.431 -0.414 . . . . 0.0 112.629 -177.386 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 158.67 -168.91 34.98 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 121.279 -0.486 . . . . 0.0 111.942 179.195 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . 0.579 ' HH2' ' HG2' ' A' ' 99' ' ' LYS . 88.2 m95 -128.26 116.45 19.88 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 177.871 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.539 ' HE1' ' H ' ' A' ' 26' ' ' ASP . 37.7 p90 -110.78 148.29 38.25 Favored Pre-proline 0 C--O 1.235 0.308 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.894 -175.833 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -77.88 157.55 31.14 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.73 2.287 . . . . 0.0 111.549 176.484 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.586 ' NE2' HG23 ' A' ' 22' ' ' VAL . 2.5 pp0? -136.11 -152.89 0.47 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.059 -0.518 . . . . 0.0 109.923 -178.728 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.434 ' H ' ' HB2' ' A' ' 35' ' ' GLN . 22.5 tp10 -52.74 -22.15 4.92 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 120.918 0.389 . . . . 0.0 111.49 -177.163 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -112.32 46.13 1.22 Allowed Glycine 0 CA--C 1.518 0.26 0 N-CA-C 111.578 -0.609 . . . . 0.0 111.578 175.304 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -71.95 -19.45 78.3 Favored Glycine 0 C--N 1.331 0.292 0 C-N-CA 121.357 -0.449 . . . . 0.0 112.664 -179.507 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -97.29 -151.04 27.39 Favored Glycine 0 C--O 1.237 0.301 0 C-N-CA 121.35 -0.452 . . . . 0.0 112.097 178.286 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 50.6 mm -65.72 99.18 0.29 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.38 0 CA-C-O 121.154 0.502 . . . . 0.0 110.284 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 36.8 m -105.66 -175.8 2.9 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.475 179.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.588 HH22 ' N ' ' A' ' 68' ' ' ASP . 28.3 ttm180 -130.53 134.94 47.44 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.764 -178.022 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.756 HG23 HD23 ' A' ' 102' ' ' LEU . 24.3 t -100.05 94.44 3.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 171.216 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -98.37 91.94 1.18 Allowed Glycine 0 N--CA 1.449 -0.474 0 CA-C-N 115.827 -0.624 . . . . 0.0 113.098 -173.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.4 ' HB ' ' HB ' ' A' ' 16' ' ' VAL . 51.4 t -76.3 109.94 10.94 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 175.236 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . 0.689 ' SG ' ' HB3' ' A' ' 60' ' ' LEU . 9.1 p -121.88 137.33 54.82 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.431 -178.446 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.586 ' HB3' ' HB2' ' A' ' 57' ' ' SER . 42.1 mtmt -84.97 118.38 24.52 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.981 0.42 . . . . 0.0 111.033 -179.797 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.42 ' O ' ' HB3' ' A' ' 57' ' ' SER . 42.7 t -90.91 118.24 35.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.185 173.946 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 67.1 mtm -87.38 151.01 23.44 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.018 0.437 . . . . 0.0 110.529 -178.597 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 53.7 m-70 -131.38 157.95 76.67 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.127 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -51.75 132.58 42.11 Favored 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 122.342 2.028 . . . . 0.0 111.947 178.191 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 71.97 77.8 0.16 Allowed 'General case' 0 CA--C 1.536 0.427 0 O-C-N 123.719 0.637 . . . . 0.0 110.247 -179.591 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 125.01 119.58 2.39 Favored Glycine 0 C--N 1.333 0.38 0 CA-C-N 116.055 -0.521 . . . . 0.0 112.159 -178.54 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -126.91 -4.86 6.31 Favored 'General case' 0 N--CA 1.466 0.357 0 O-C-N 122.649 -0.324 . . . . 0.0 111.044 179.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -84.6 -76.17 1.2 Allowed Glycine 0 C--N 1.331 0.273 0 C-N-CA 120.997 -0.621 . . . . 0.0 111.91 179.361 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 3.6 tmm_? -80.93 96.89 7.2 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 177.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.586 ' HB2' ' HB3' ' A' ' 47' ' ' LYS . 14.7 m -108.81 174.35 5.91 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.805 -176.559 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.566 ' O ' ' HA ' ' A' ' 47' ' ' LYS . . . -73.8 147.19 37.98 Favored Glycine 0 C--N 1.332 0.324 0 C-N-CA 121.366 -0.445 . . . . 0.0 112.079 179.153 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 32.6 m-85 -103.0 97.07 7.24 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.268 0.556 . . . . 0.0 110.5 -177.592 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.699 ' HA ' ' HA ' ' A' ' 76' ' ' TYR . 2.7 tt -81.69 110.0 16.63 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 178.53 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 60.8 mt -75.33 86.4 0.66 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.314 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 174.106 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 12.3 t-80 -90.08 101.19 13.91 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.254 -0.884 . . . . 0.0 109.946 -176.337 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -91.27 114.55 4.52 Favored Glycine 0 N--CA 1.449 -0.435 0 CA-C-N 115.937 -0.574 . . . . 0.0 112.204 -177.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -119.51 -170.27 1.91 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.025 0.44 . . . . 0.0 110.934 179.589 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 23.0 mmt85 -83.58 -174.73 5.45 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.451 169.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 28.7 pt20 -55.59 -35.17 65.51 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.168 177.127 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -115.51 147.89 40.13 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.278 -178.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.588 ' N ' HH22 ' A' ' 42' ' ' ARG . 1.8 m-20 -67.85 105.59 2.02 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.1 -178.424 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -176.17 -39.21 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.348 0 O-C-N 123.168 0.293 . . . . 0.0 111.591 -179.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 61.5 tp -122.03 115.54 22.69 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.622 0.249 . . . . 0.0 111.282 -175.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 35.4 t -88.82 110.47 21.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.891 176.771 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 35.9 m -91.3 -36.68 8.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.259 -177.696 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -133.42 151.49 51.82 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 122.491 0.317 . . . . 0.0 110.234 178.742 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.528 ' HG2' HD23 ' A' ' 60' ' ' LEU . 2.9 tm-20 -146.94 115.75 6.82 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 175.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 50.0 t -141.15 83.7 1.89 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.21 0.529 . . . . 0.0 110.616 -178.364 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.699 ' HA ' ' HA ' ' A' ' 60' ' ' LEU . 78.4 t80 -68.87 122.65 19.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.587 175.768 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.455 HG11 ' HB2' ' A' ' 80' ' ' ASP . 17.2 m -133.21 122.71 45.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.006 0.431 . . . . 0.0 110.281 178.031 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 11.5 ptm180 -110.04 -27.77 9.03 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.2 0.524 . . . . 0.0 110.211 179.164 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -155.05 22.25 0.43 Allowed 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 173.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.455 ' HB2' HG11 ' A' ' 77' ' ' VAL . 0.7 OUTLIER -114.7 9.55 16.45 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 114.414 -1.266 . . . . 0.0 109.816 -172.557 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.803 HD21 HD12 ' A' ' 121' ' ' ILE . 3.5 tt -79.17 104.42 9.79 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.171 -172.316 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 48.4 t -127.97 96.78 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 CA-C-N 116.567 -0.288 . . . . 0.0 110.667 177.201 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.503 ' HD2' ' CD2' ' A' ' 91' ' ' HIS . 4.5 m-85 -91.71 172.46 8.47 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-O 121.396 0.617 . . . . 0.0 111.076 178.306 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 50.1 m -154.42 110.75 3.26 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.056 -0.974 . . . . 0.0 109.314 -179.629 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.599 ' HB3' ' HZ1' ' A' ' 85' ' ' LYS . 5.2 ttpm? -77.3 107.05 9.43 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 177.346 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -85.28 -59.65 2.26 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.214 0.53 . . . . 0.0 110.138 -179.614 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 -130.19 158.63 73.59 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.353 -179.177 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -56.13 -13.69 10.05 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 122.6 2.2 . . . . 0.0 113.189 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 12.7 t -125.21 5.8 7.81 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-O 120.452 0.168 . . . . 0.0 111.304 179.509 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 17.8 t80 -135.36 114.28 12.05 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 -179.57 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . 0.503 ' CD2' ' HD2' ' A' ' 83' ' ' TYR . 2.3 t-160 -130.24 129.91 43.94 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 -176.897 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 20.7 p80 -138.78 174.98 9.96 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.527 0.203 . . . . 0.0 111.066 -174.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . 0.465 ' HB3' ' CD1' ' A' ' 83' ' ' TYR . 34.2 p90 -142.8 171.72 13.67 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 176.427 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -137.24 150.34 47.78 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.037 0.446 . . . . 0.0 110.815 -178.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 24.6 m -122.85 -140.27 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 173.4 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -59.39 83.72 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 118.083 0.401 . . . . 0.0 110.918 176.548 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 52.8 t30 68.99 -63.58 0.36 Allowed 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.232 1.013 . . . . 0.0 112.147 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.627 ' HG2' ' HA ' ' A' ' 27' ' ' ASP . 60.0 mtt-85 -55.03 136.07 48.28 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 121.251 0.548 . . . . 0.0 110.745 -176.611 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.777 ' HZ1' ' HB2' ' A' ' 99' ' ' LYS . 4.5 ttmp? -127.18 132.84 50.4 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.472 -0.786 . . . . 0.0 110.308 -169.058 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 1.1 p90 -147.2 158.22 43.87 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 -179.174 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.422 ' HA2' ' CZ3' ' A' ' 93' ' ' TRP . . . -164.23 -153.21 7.29 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.384 -0.912 . . . . 0.0 113.338 -174.572 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.756 HD23 HG23 ' A' ' 43' ' ' VAL . 4.1 pp -144.48 168.21 20.67 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.099 0.476 . . . . 0.0 110.977 -174.63 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 15.3 m -128.59 119.73 25.32 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.533 178.091 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 47.5 m-85 -66.27 160.05 25.27 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.089 178.091 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 29.8 pt20 -129.54 -27.08 2.42 Favored 'General case' 0 C--N 1.328 -0.37 0 N-CA-C 111.535 0.198 . . . . 0.0 111.535 -177.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 32.1 m -135.13 150.21 72.29 Favored Pre-proline 0 C--N 1.329 -0.299 0 N-CA-C 110.282 -0.266 . . . . 0.0 110.282 179.449 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.58 ' O ' ' HG2' ' A' ' 111' ' ' ARG . 82.2 Cg_exo -49.59 -35.2 36.79 Favored 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 122.683 2.256 . . . . 0.0 112.254 177.13 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -57.84 -63.52 1.22 Allowed 'General case' 0 C--O 1.235 0.314 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.574 -179.57 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -62.28 -34.37 76.44 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.736 -179.003 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -55.29 -66.59 0.39 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.117 177.151 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.58 ' HG2' ' O ' ' A' ' 107' ' ' PRO . 44.7 ptt85 -59.58 -47.21 86.47 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.237 -176.794 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -63.15 -49.84 72.76 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.74 -172.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.48 ' O ' HG23 ' A' ' 117' ' ' VAL . 63.2 t80 -75.6 -43.45 48.05 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.803 -175.655 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -55.47 -59.71 4.43 Favored 'General case' 0 C--O 1.24 0.556 0 CA-C-O 121.566 0.698 . . . . 0.0 109.957 179.688 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 22.8 ttm180 -59.4 -37.23 77.47 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 114.895 -1.048 . . . . 0.0 109.93 177.041 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -58.35 -39.38 92.63 Favored Glycine 0 N--CA 1.45 -0.419 0 CA-C-N 115.861 -0.609 . . . . 0.0 112.362 178.257 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.48 HG23 ' O ' ' A' ' 113' ' ' PHE . 72.6 t -71.3 -49.8 45.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.607 0.241 . . . . 0.0 110.809 -179.727 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 44.2 mtm105 -59.78 -44.87 93.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.875 0.369 . . . . 0.0 110.785 179.503 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 45.3 tptt -65.97 -36.01 82.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.447 177.54 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -62.42 -43.84 97.86 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.309 176.481 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.803 HD12 HD21 ' A' ' 81' ' ' LEU . 32.4 mm -60.68 -42.81 93.34 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.108 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.278 177.617 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.44 ' O ' ' HG3' ' A' ' 126' ' ' GLU . 34.7 tt0 -56.35 -57.32 12.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.165 177.837 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 74.0 m-20 -69.7 -18.91 63.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.601 -177.583 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 6.0 tt -77.27 -45.44 26.34 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 178.057 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 13.9 tt -78.98 -28.05 13.68 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.354 -175.46 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.44 ' HG3' ' O ' ' A' ' 122' ' ' GLU . 50.1 mt-10 . . . . . 0 C--O 1.255 1.39 0 CA-C-O 118.384 -0.817 . . . . 0.0 110.264 178.372 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.708 0 N-CA-C 112.351 -0.3 . . . . 0.0 112.351 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 45.9 t -169.5 -49.54 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 -179.253 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 27.4 ttt -160.58 112.4 1.93 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.215 -0.902 . . . . 0.0 108.848 179.234 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 16.3 p -58.24 -63.95 1.09 Allowed 'General case' 0 C--O 1.236 0.392 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.754 -174.184 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -87.3 135.37 33.34 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 178.069 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -70.03 -53.9 15.54 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.856 0.687 . . . . 0.0 112.856 -166.818 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 91.7 m -137.01 -71.59 0.44 Allowed 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 121.308 -0.157 . . . . 0.0 111.217 -174.194 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 18.3 m80 -158.98 156.84 27.44 Favored Pre-proline 0 CA--C 1.533 0.311 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 -178.048 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_exo -50.87 -31.86 35.29 Favored 'Trans proline' 0 C--N 1.355 0.885 0 C-N-CA 123.301 2.667 . . . . 0.0 113.996 -171.295 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.681 ' HB3' ' HB3' ' A' ' 13' ' ' SER . 29.2 m-20 -109.5 35.86 3.16 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.811 0.338 . . . . 0.0 110.566 -177.138 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -53.99 -32.61 54.65 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.824 -177.671 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -85.62 -19.66 30.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.864 0.364 . . . . 0.0 110.984 -179.305 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.681 ' HB3' ' HB3' ' A' ' 10' ' ' ASP . 33.3 t -90.21 -12.58 37.65 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.189 -172.691 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 61.8 m-85 -63.36 89.57 0.04 OUTLIER 'General case' 0 C--O 1.233 0.232 0 CA-C-O 121.065 0.46 . . . . 0.0 110.446 177.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 62.5 mt -73.96 -32.08 32.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.62 -179.057 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 60.4 t -123.62 100.3 7.63 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.18 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.902 -178.708 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 86.6 mtm180 -112.74 93.58 4.49 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 172.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 30.9 m -120.12 174.47 5.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.993 0.425 . . . . 0.0 111.644 -175.69 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.659 ' HD2' HD11 ' A' ' 40' ' ' ILE . 9.4 mtmp? -110.74 114.96 28.72 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.71 -178.1 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -148.54 179.97 7.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.222 179.748 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 42.6 t -109.15 109.89 30.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 110.251 -0.278 . . . . 0.0 110.251 179.69 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 15.8 m -70.46 95.9 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 CA-C-O 121.522 0.677 . . . . 0.0 111.415 -178.728 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' MET . . . . . 0.616 ' H ' ' HA ' ' A' ' 102' ' ' LEU . 21.2 mmt -89.96 115.16 27.04 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.036 -179.781 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.485 HG22 ' CE1' ' A' ' 33' ' ' PHE . 9.6 t -112.67 162.93 15.15 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.341 0.591 . . . . 0.0 110.393 179.67 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.411 ' O ' ' N ' ' A' ' 27' ' ' ASP . 5.4 tpm_? -133.12 98.17 4.2 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 176.557 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.569 ' H ' ' HE1' ' A' ' 33' ' ' PHE . 30.8 t70 -60.7 80.46 0.01 OUTLIER 'General case' 0 C--O 1.233 0.211 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.137 -178.151 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.411 ' N ' ' O ' ' A' ' 25' ' ' ARG . 0.8 OUTLIER 57.04 173.07 0.04 OUTLIER 'General case' 0 C--O 1.235 0.314 0 CA-C-N 115.037 -0.983 . . . . 0.0 111.208 -174.658 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 40.0 m 59.66 -167.83 0.16 Allowed 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 120.873 0.368 . . . . 0.0 110.91 -178.217 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 68.1 m -149.64 132.0 15.61 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 172.274 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 146.95 65.7 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.297 0 N-CA-C 111.601 -0.6 . . . . 0.0 111.601 -178.67 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 118.84 98.84 1.86 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 121.235 -0.507 . . . . 0.0 112.195 -179.525 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . 0.527 ' HH2' ' HG2' ' A' ' 99' ' ' LYS . 77.7 m95 -81.9 120.2 24.9 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 176.694 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.569 ' HE1' ' H ' ' A' ' 26' ' ' ASP . 14.2 p90 -115.09 132.5 23.0 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.438 -0.347 . . . . 0.0 110.505 -176.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.537 ' HB2' ' HA3' ' A' ' 38' ' ' GLY . 71.4 Cg_endo -74.69 112.86 3.65 Favored 'Trans proline' 0 N--CA 1.458 -0.57 0 C-N-CA 121.939 1.76 . . . . 0.0 110.657 175.158 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -54.81 129.03 35.66 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.455 -175.424 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 63.19 16.0 9.03 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.62 -179.554 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 107.34 -26.27 19.07 Favored Glycine 0 C--N 1.33 0.245 0 C-N-CA 121.494 -0.384 . . . . 0.0 112.643 177.666 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.537 ' HA3' ' HB2' ' A' ' 34' ' ' PRO . . . 72.41 -71.61 1.02 Allowed Glycine 0 CA--C 1.519 0.289 0 C-N-CA 121.221 -0.514 . . . . 0.0 112.572 -179.835 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 62.04 -96.68 0.14 Allowed Glycine 0 C--N 1.333 0.394 0 N-CA-C 112.121 -0.392 . . . . 0.0 112.121 -179.292 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.659 HD11 ' HD2' ' A' ' 19' ' ' LYS . 12.5 tt -141.78 80.53 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 122.056 0.932 . . . . 0.0 109.475 178.23 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 9.3 m -77.09 141.92 40.02 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.67 -173.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.739 ' HB3' ' HB2' ' A' ' 64' ' ' GLU . 41.3 ttm180 -92.98 97.53 10.78 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 178.125 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 48.1 t -76.22 107.47 7.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.097 -0.501 . . . . 0.0 109.961 -178.591 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -106.78 112.08 3.7 Favored Glycine 0 N--CA 1.448 -0.511 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.824 179.446 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 62.0 t -106.4 111.52 35.68 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 177.613 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . 0.766 ' SG ' ' HB3' ' A' ' 60' ' ' LEU . 8.0 p -104.92 143.1 33.62 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.548 178.352 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 40.9 ttmt -94.89 92.9 7.14 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 121.026 0.441 . . . . 0.0 109.972 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 42.6 t -77.11 88.0 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.769 178.718 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 61.0 mtm -65.3 140.26 58.67 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.256 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 14.7 m-70 -67.13 126.81 93.08 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.405 -179.656 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -59.31 -23.08 68.35 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 122.511 2.14 . . . . 0.0 111.272 175.315 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.5 ' HB3' HD21 ' A' ' 54' ' ' ASN . 7.8 mp0 -59.36 -34.89 72.94 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.418 175.68 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 65.73 11.31 53.53 Favored Glycine 0 CA--C 1.524 0.599 0 CA-C-N 115.954 -0.566 . . . . 0.0 114.374 174.289 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.5 HD21 ' HB3' ' A' ' 52' ' ' GLU . 11.5 p30 -83.13 -26.26 31.14 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 117.368 0.584 . . . . 0.0 110.776 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 158.47 171.28 24.14 Favored Glycine 0 C--O 1.237 0.287 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.887 -177.725 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 32.6 ttm180 68.1 147.61 0.05 Allowed 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 123.474 0.71 . . . . 0.0 111.301 -177.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 23.9 m -134.52 129.64 35.41 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.503 175.756 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -77.84 155.94 43.48 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.999 -0.619 . . . . 0.0 111.662 177.39 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -133.24 119.76 20.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.928 0.394 . . . . 0.0 110.413 -179.54 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.766 ' HB3' ' SG ' ' A' ' 46' ' ' CYS . 1.2 tt -96.2 110.21 22.54 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 179.003 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 57.3 mt -84.85 90.84 2.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 174.54 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -103.46 116.16 31.88 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.082 -175.106 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -91.42 96.05 2.14 Favored Glycine 0 N--CA 1.449 -0.493 0 CA-C-N 115.964 -0.562 . . . . 0.0 112.111 -179.025 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.739 ' HB2' ' HB3' ' A' ' 42' ' ' ARG . 5.2 mm-40 -73.77 145.21 45.24 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 177.365 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.44 ' HD2' HD23 ' A' ' 70' ' ' LEU . 18.6 ttt180 -76.58 8.33 3.66 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.241 -178.591 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.426 ' NE2' ' HB2' ' A' ' 42' ' ' ARG . 6.7 tp-100 71.9 -68.67 0.21 Allowed 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 123.521 0.728 . . . . 0.0 110.263 -178.864 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -88.27 118.19 27.7 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 177.571 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 32.5 t70 73.61 146.58 0.08 Allowed 'General case' 0 N--CA 1.469 0.518 0 O-C-N 124.003 0.814 . . . . 0.0 111.269 -178.786 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -74.39 79.47 1.89 Allowed 'General case' 0 C--O 1.236 0.369 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.2 -179.33 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.44 HD23 ' HD2' ' A' ' 65' ' ' ARG . 6.2 tt -130.9 131.85 44.76 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 179.762 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.438 ' N ' HD21 ' A' ' 70' ' ' LEU . 23.6 t -89.73 117.67 33.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.042 -175.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 32.8 m -98.29 -23.0 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-O 120.713 0.292 . . . . 0.0 110.806 176.792 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.408 HD21 ' N ' ' A' ' 74' ' ' GLU . 9.3 tt -145.54 139.52 26.8 Favored 'General case' 0 N--CA 1.462 0.166 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 -179.179 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.408 ' N ' HD21 ' A' ' 73' ' ' LEU . 1.7 tm-20 -142.5 109.51 5.53 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 -179.129 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . 0.46 ' SG ' ' NE1' ' A' ' 93' ' ' TRP . 35.0 t -140.12 82.56 1.87 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.384 0.611 . . . . 0.0 110.984 -179.288 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.412 ' HD1' ' HG ' ' A' ' 60' ' ' LEU . 82.5 t80 -75.13 121.99 22.91 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.812 174.662 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.503 HG13 ' HB2' ' A' ' 81' ' ' LEU . 92.8 t -124.85 112.02 30.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 -177.218 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.412 ' HD3' ' OH ' ' A' ' 76' ' ' TYR . 46.5 ttp180 -120.4 1.24 10.69 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-O 121.253 0.549 . . . . 0.0 110.58 -179.692 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 19.3 ptmt -141.01 86.86 2.06 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 115.965 -0.562 . . . . 0.0 111.141 -176.002 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.443 ' H ' HD11 ' A' ' 124' ' ' LEU . 18.2 t70 64.5 148.4 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 115.649 -0.705 . . . . 0.0 112.154 178.108 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.503 ' HB2' HG13 ' A' ' 77' ' ' VAL . 51.5 tp -149.46 137.78 20.71 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.846 -0.615 . . . . 0.0 109.961 178.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 60.3 t -77.28 -65.13 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.363 178.338 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.44 ' HD2' ' HB ' ' A' ' 117' ' ' VAL . 4.5 t80 37.99 79.89 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 124.111 0.964 . . . . 0.0 111.729 -178.767 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 97.1 m -112.64 136.5 52.13 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.261 -0.881 . . . . 0.0 109.913 179.714 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.455 ' HA ' ' HA ' ' A' ' 91' ' ' HIS . 18.0 ptmt -85.37 108.77 17.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.043 0.449 . . . . 0.0 109.846 176.569 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -74.85 -27.55 60.31 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.446 0.641 . . . . 0.0 109.846 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . 0.479 ' HB2' ' HB3' ' A' ' 90' ' ' PHE . 16.5 m120 -141.62 156.43 66.4 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-N 115.059 -0.973 . . . . 0.0 108.709 177.923 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -58.56 -13.29 16.72 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.581 2.187 . . . . 0.0 112.561 180.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.412 ' HA ' ' HD2' ' A' ' 104' ' ' PHE . 23.6 p -124.55 14.3 8.79 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.608 -178.885 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.479 ' HB3' ' HB2' ' A' ' 87' ' ' ASN . 42.6 t80 -145.19 123.17 12.04 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-O 120.706 0.289 . . . . 0.0 110.833 -177.539 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . 0.473 ' HD1' ' HZ ' ' A' ' 104' ' ' PHE . 0.3 OUTLIER -126.01 136.29 52.79 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 -179.134 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . 0.55 ' HA ' ' HA3' ' A' ' 101' ' ' GLY . 11.7 p80 -141.53 158.59 43.66 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 120.643 0.259 . . . . 0.0 110.905 -177.148 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . 0.509 ' CZ3' ' HA2' ' A' ' 101' ' ' GLY . 39.3 p90 -136.45 158.89 43.36 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.848 0.356 . . . . 0.0 110.375 176.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt -122.48 113.96 20.04 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.669 179.577 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.417 HG22 ' SG ' ' A' ' 75' ' ' CYS . 28.0 m -141.34 162.63 21.38 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 N-CA-C 110.021 -0.363 . . . . 0.0 110.021 178.084 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 26.0 t70 63.56 -76.1 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.393 0 O-C-N 123.694 0.621 . . . . 0.0 110.957 179.699 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -155.92 -9.86 0.11 Allowed 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.781 177.269 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 42.0 ttm180 -122.15 155.59 35.43 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.261 0.553 . . . . 0.0 112.032 -165.553 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.527 ' HG2' ' HH2' ' A' ' 32' ' ' TRP . 37.4 ttpt -108.63 107.25 17.66 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.053 -0.976 . . . . 0.0 109.436 178.312 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . 0.45 ' HA ' ' HZ3' ' A' ' 32' ' ' TRP . 3.6 p90 -138.55 155.19 48.59 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.662 -0.245 . . . . 0.0 110.667 -179.419 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.55 ' HA3' ' HA ' ' A' ' 92' ' ' HIS . . . -163.09 -141.5 3.14 Favored Glycine 0 C--N 1.332 0.346 0 C-N-CA 121.116 -0.564 . . . . 0.0 112.702 -177.177 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.616 ' HA ' ' H ' ' A' ' 23' ' ' MET . 0.0 OUTLIER -157.51 156.02 31.3 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 121.032 0.444 . . . . 0.0 111.035 -178.699 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 36.2 m -101.52 132.53 47.1 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.752 175.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.473 ' HZ ' ' HD1' ' A' ' 91' ' ' HIS . 19.6 m-85 -67.41 160.27 27.74 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.412 -179.874 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -117.08 -52.46 2.51 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.205 178.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 25.4 m -129.75 153.2 80.79 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.251 -177.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_exo -49.11 -31.44 21.3 Favored 'Trans proline' 0 C--N 1.353 0.8 0 C-N-CA 122.669 2.246 . . . . 0.0 112.66 178.569 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -59.47 -62.22 2.04 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.249 179.376 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -65.67 -38.03 88.15 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.591 -179.429 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -52.81 -60.74 2.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.028 0.442 . . . . 0.0 110.781 176.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 72.4 mtp180 -64.08 -27.52 69.16 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.634 -179.368 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -65.23 -39.27 92.51 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.547 176.191 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 46.2 m-85 -71.03 -43.84 67.05 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.589 177.667 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.418 ' O ' HG12 ' A' ' 117' ' ' VAL . 49.9 m-20 -61.59 -55.55 29.49 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 120.814 0.34 . . . . 0.0 110.623 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 80.2 mtt-85 -66.39 -28.72 68.86 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-O 121.02 0.438 . . . . 0.0 110.154 176.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -59.35 -50.98 61.93 Favored Glycine 0 N--CA 1.447 -0.579 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.86 176.139 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.44 ' HB ' ' HD2' ' A' ' 83' ' ' TYR . 11.9 p -69.27 -32.75 54.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 116.694 0.247 . . . . 0.0 110.584 -179.74 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.456 ' O ' ' HG3' ' A' ' 122' ' ' GLU . 3.4 mmp_? -53.04 -64.63 0.76 Allowed 'General case' 0 C--O 1.238 0.476 0 CA-C-O 121.231 0.539 . . . . 0.0 109.995 174.17 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 81.4 tttt -66.86 -33.63 76.01 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 115.476 -0.783 . . . . 0.0 110.728 -176.107 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -61.03 -50.84 71.72 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.458 178.21 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.538 ' O ' HG22 ' A' ' 125' ' ' ILE . 31.8 mm -60.08 -40.68 84.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.109 178.947 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.485 ' O ' ' HB2' ' A' ' 126' ' ' GLU . 43.5 mt-10 -54.8 -56.46 19.18 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 110.284 -0.265 . . . . 0.0 110.284 176.385 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 49.4 m-20 -65.26 -27.23 68.5 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.668 -0.242 . . . . 0.0 111.425 -178.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.443 HD11 ' H ' ' A' ' 80' ' ' ASP . 3.2 tm? -76.51 -56.68 4.4 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.179 -176.126 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.538 HG22 ' O ' ' A' ' 121' ' ' ILE . 11.2 tp -94.12 -34.02 5.43 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 -170.349 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.485 ' HB2' ' O ' ' A' ' 122' ' ' GLU . 32.1 mm-40 . . . . . 0 C--O 1.251 1.142 0 CA-C-O 118.637 -0.697 . . . . 0.0 110.862 -174.535 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.837 0 N-CA-C 112.014 -0.434 . . . . 0.0 112.014 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 13.5 p -69.04 97.29 0.86 Allowed 'General case' 0 CA--C 1.533 0.3 0 CA-C-O 120.769 0.319 . . . . 0.0 111.365 -178.454 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 65.5 mtt -100.6 -8.45 22.96 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.653 179.498 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 7.5 p -72.12 120.78 18.2 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.6 -177.693 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -160.4 106.41 1.51 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.436 -0.802 . . . . 0.0 108.963 176.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -164.38 -58.39 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.825 -172.626 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.705 ' HB ' ' HE1' ' A' ' 14' ' ' TYR . 11.3 p 53.67 106.42 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 114.978 -1.01 . . . . 0.0 112.234 179.769 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.592 ' HB3' ' HD3' ' A' ' 9' ' ' PRO . 76.2 t60 178.24 -54.19 0.0 OUTLIER Pre-proline 0 N--CA 1.47 0.534 0 CA-C-N 115.033 -0.985 . . . . 0.0 108.925 -174.558 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.592 ' HD3' ' HB3' ' A' ' 8' ' ' HIS . 98.4 Cg_endo -87.03 5.16 5.89 Favored 'Trans proline' 0 C--N 1.361 1.189 0 C-N-CA 122.273 1.982 . . . . 0.0 110.122 169.445 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -150.84 107.74 3.55 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 114.101 -1.409 . . . . 0.0 107.806 -178.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.61 ' HB2' ' HB2' ' A' ' 14' ' ' TYR . 7.7 p-10 -83.6 40.6 0.74 Allowed 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 111.658 0.244 . . . . 0.0 111.658 -171.041 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -43.52 -42.39 4.92 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 112.86 0.689 . . . . 0.0 112.86 -175.391 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 15.6 m -124.4 18.14 8.95 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 -174.108 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.705 ' HE1' ' HB ' ' A' ' 7' ' ' THR . 58.7 m-85 -91.57 106.42 18.47 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 120.806 0.336 . . . . 0.0 111.12 -177.487 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.485 HG23 HG21 ' A' ' 16' ' ' VAL . 52.1 mt -71.66 -57.23 7.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.931 -176.851 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.485 HG21 HG23 ' A' ' 15' ' ' ILE . 61.0 t -129.0 132.05 67.63 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 CA-C-O 120.709 0.29 . . . . 0.0 110.963 -177.06 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.631 ' HD2' ' HB3' ' A' ' 14' ' ' TYR . 0.0 OUTLIER -128.06 115.62 18.75 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 174.949 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 27.6 m -124.11 166.01 19.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.732 0.301 . . . . 0.0 110.804 -179.598 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -87.51 137.08 32.65 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.623 -178.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -169.77 -165.1 0.47 Allowed 'General case' 0 C--O 1.237 0.437 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 178.377 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 7.3 p -140.44 126.97 21.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.031 0.443 . . . . 0.0 110.549 173.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.438 HG22 ' HB2' ' A' ' 73' ' ' LEU . 30.9 m -81.25 131.15 34.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.747 175.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 89.2 mmm -114.63 130.52 56.8 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.643 -0.502 . . . . 0.0 109.643 -176.471 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.402 HG22 ' HD1' ' A' ' 33' ' ' PHE . 9.5 t -103.16 162.01 13.32 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.086 0.469 . . . . 0.0 111.202 -178.518 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 19.8 ttt180 -120.38 21.26 11.72 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.18 -0.918 . . . . 0.0 108.6 178.239 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.404 ' O ' ' HB3' ' A' ' 27' ' ' ASP . 36.0 t70 49.17 38.39 13.09 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 114.423 -1.262 . . . . 0.0 111.192 177.899 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.404 ' HB3' ' O ' ' A' ' 26' ' ' ASP . 27.6 t70 73.27 -54.86 0.69 Allowed 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 115.242 -0.89 . . . . 0.0 112.758 177.207 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 22.1 m -136.62 18.59 3.09 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 112.611 0.597 . . . . 0.0 112.611 -174.025 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 65.7 m -86.14 -170.69 3.21 Favored 'General case' 0 C--N 1.327 -0.372 0 O-C-N 122.297 -0.252 . . . . 0.0 110.321 177.327 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -111.49 -44.14 0.93 Allowed Glycine 0 C--N 1.334 0.436 0 C-N-CA 121.294 -0.479 . . . . 0.0 112.368 -179.677 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -77.54 170.84 55.12 Favored Glycine 0 C--N 1.33 0.235 0 C-N-CA 121.192 -0.528 . . . . 0.0 112.692 -178.651 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . 0.4 ' HZ2' ' HZ1' ' A' ' 99' ' ' LYS . 91.0 m95 -117.41 120.37 37.96 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 179.665 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.402 ' HD1' HG22 ' A' ' 24' ' ' THR . 1.4 m-85 -101.79 156.36 35.29 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.657 -170.896 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.437 ' HB3' ' HA2' ' A' ' 38' ' ' GLY . 51.3 Cg_exo -56.44 -11.82 7.12 Favored 'Trans proline' 0 C--N 1.355 0.918 0 C-N-CA 123.352 2.701 . . . . 0.0 112.992 178.496 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.539 HE22 ' HB ' ' A' ' 72' ' ' VAL . 0.2 OUTLIER 72.61 -71.08 0.14 Allowed 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 123.327 0.651 . . . . 0.0 110.554 174.256 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -161.74 -55.1 0.05 OUTLIER 'General case' 0 C--O 1.234 0.24 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 -179.779 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -62.76 -39.66 98.23 Favored Glycine 0 C--N 1.331 0.278 0 CA-C-N 115.596 -0.729 . . . . 0.0 112.553 -179.524 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.437 ' HA2' ' HB3' ' A' ' 34' ' ' PRO . . . 57.57 19.4 34.4 Favored Glycine 0 C--N 1.334 0.431 0 C-N-CA 121.544 -0.36 . . . . 0.0 113.551 177.16 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 140.2 -29.31 2.42 Favored Glycine 0 C--O 1.235 0.187 0 N-CA-C 111.203 -0.759 . . . . 0.0 111.203 -178.189 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.546 HD11 ' N ' ' A' ' 40' ' ' ILE . 2.8 mp -100.63 93.94 3.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 175.842 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 49.1 m -151.75 130.48 12.37 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 174.151 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 34.9 ttp180 -101.31 102.42 13.27 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 177.019 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 4.5 p -81.01 106.84 12.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 121.476 0.655 . . . . 0.0 109.976 179.52 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -102.8 112.37 4.25 Favored Glycine 0 N--CA 1.446 -0.669 0 CA-C-N 115.334 -0.848 . . . . 0.0 112.018 -179.511 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 7.0 p -86.45 109.22 18.6 Favored 'Isoleucine or valine' 0 C--O 1.239 0.5 0 CA-C-O 121.393 0.615 . . . . 0.0 109.967 176.162 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . 0.742 ' SG ' ' HB3' ' A' ' 60' ' ' LEU . 12.1 p -105.87 145.43 31.25 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.005 178.358 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 12.0 tmtt? -100.78 105.75 17.1 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 179.335 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.437 HG22 ' HE1' ' A' ' 76' ' ' TYR . 60.8 t -66.87 125.64 24.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.307 -179.129 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 66.1 mtt -87.17 147.38 25.63 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.193 179.253 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . 0.482 ' HB3' ' HB3' ' A' ' 57' ' ' SER . 28.8 p80 -85.77 133.97 40.52 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.52 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -79.13 175.06 11.29 Favored 'Trans proline' 0 C--O 1.239 0.547 0 C-N-CA 122.239 1.96 . . . . 0.0 110.608 170.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -65.7 135.4 54.91 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-O 120.975 0.417 . . . . 0.0 110.162 178.366 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 129.04 -150.46 18.82 Favored Glycine 0 N--CA 1.453 -0.225 0 N-CA-C 111.098 -0.801 . . . . 0.0 111.098 -176.204 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -58.31 -63.71 1.17 Allowed 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.891 0.377 . . . . 0.0 111.048 -179.641 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 149.34 158.39 8.08 Favored Glycine 0 N--CA 1.45 -0.377 0 CA-C-N 115.921 -0.581 . . . . 0.0 112.04 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 31.3 ttt180 -163.98 29.12 0.08 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.694 0.759 . . . . 0.0 109.028 179.42 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.482 ' HB3' ' HB3' ' A' ' 50' ' ' HIS . 25.3 p -89.29 154.46 20.08 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.318 -0.856 . . . . 0.0 111.261 -176.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 166.99 -142.42 7.58 Favored Glycine 0 N--CA 1.45 -0.384 0 N-CA-C 111.261 -0.735 . . . . 0.0 111.261 179.775 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -129.44 154.51 46.89 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 177.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.742 ' HB3' ' SG ' ' A' ' 46' ' ' CYS . 3.0 tt -128.42 119.06 24.22 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 178.882 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 57.2 mt -80.23 86.74 1.41 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.371 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 175.442 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . 0.44 ' HB3' ' HE2' ' A' ' 14' ' ' TYR . 21.7 t60 -98.84 107.69 20.19 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.981 -176.605 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -97.07 99.16 2.24 Favored Glycine 0 C--O 1.239 0.409 0 CA-C-N 115.81 -0.632 . . . . 0.0 112.488 -178.378 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.444 ' HG2' ' CE1' ' A' ' 8' ' ' HIS . 43.8 mt-10 -73.03 152.13 41.43 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 175.674 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 71.0 ttt-85 -67.38 -31.95 72.54 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 174.474 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -168.13 -60.92 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.233 178.377 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 53.7 tttm -173.93 124.12 0.34 Allowed 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 117.804 0.275 . . . . 0.0 111.611 175.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 57.69 14.62 2.5 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.636 0.774 . . . . 0.0 112.005 174.002 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -106.77 -69.65 0.83 Allowed 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 111.831 0.308 . . . . 0.0 111.831 -167.322 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 48.5 tp -149.34 138.04 21.05 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.426 -175.078 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 21.4 t -88.52 102.0 12.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 176.075 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.539 ' HB ' HE22 ' A' ' 35' ' ' GLN . 28.3 m -88.17 -20.86 7.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.625 0.25 . . . . 0.0 111.355 -176.04 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.534 HD11 ' N ' ' A' ' 74' ' ' GLU . 2.9 tm? -149.65 140.74 22.99 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 179.373 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.534 ' N ' HD11 ' A' ' 73' ' ' LEU . 34.0 tt0 -159.07 119.86 3.24 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 -177.863 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 66.2 m -142.27 137.86 30.96 Favored 'General case' 0 C--O 1.232 0.161 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 -176.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.437 ' HE1' HG22 ' A' ' 48' ' ' VAL . 85.7 t80 -99.82 138.89 36.27 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 110.215 -0.291 . . . . 0.0 110.215 -176.25 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.688 HG12 HG13 ' A' ' 95' ' ' VAL . 20.3 m -135.19 141.16 43.51 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 -178.717 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 36.4 mtm180 -110.32 -73.06 0.7 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.941 0.401 . . . . 0.0 110.068 -178.121 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -152.85 19.63 0.6 Allowed 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 175.675 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -112.61 17.48 19.13 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 114.229 -1.35 . . . . 0.0 110.276 -176.145 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.568 HD22 ' HB2' ' A' ' 83' ' ' TYR . 1.6 tt -73.37 92.54 1.84 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.278 -176.736 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 3.6 p -81.17 85.25 1.52 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 CA-C-O 121.509 0.671 . . . . 0.0 110.009 174.757 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.6 ' HD2' HG23 ' A' ' 117' ' ' VAL . 0.6 OUTLIER -92.23 102.7 15.22 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.003 -177.011 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 99.9 m -114.46 133.12 55.99 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.295 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.52 ' HA ' ' HA ' ' A' ' 91' ' ' HIS . 4.9 ptpp? -94.96 111.8 23.56 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 175.528 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -70.94 -35.04 72.05 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.364 0.602 . . . . 0.0 109.494 175.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . 0.524 ' HB2' ' HB3' ' A' ' 90' ' ' PHE . 92.5 m-20 -134.48 155.18 79.9 Favored Pre-proline 0 C--N 1.332 -0.18 0 CA-C-N 114.99 -1.005 . . . . 0.0 108.529 176.339 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -54.3 -23.23 29.47 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.546 2.164 . . . . 0.0 112.753 178.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 14.9 t -112.45 2.31 16.32 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.335 -178.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.524 ' HB3' ' HB2' ' A' ' 87' ' ' ASN . 72.1 t80 -131.73 109.74 10.38 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-O 120.929 0.395 . . . . 0.0 110.681 -177.761 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . 0.52 ' HA ' ' HA ' ' A' ' 85' ' ' LYS . 0.1 OUTLIER -107.03 159.68 16.11 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 177.65 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 17.2 p80 -155.73 160.82 40.64 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.612 0.244 . . . . 0.0 110.543 178.311 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 34.6 p90 -149.5 166.29 29.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.741 -178.664 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -131.63 106.08 7.94 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 174.264 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.688 HG13 HG12 ' A' ' 77' ' ' VAL . 29.8 m -136.56 172.54 15.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.139 -0.482 . . . . 0.0 109.822 179.544 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 42.9 m-20 59.09 -77.25 0.02 OUTLIER 'General case' 0 C--O 1.234 0.24 0 O-C-N 123.663 0.602 . . . . 0.0 110.427 -174.135 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 30.4 p-10 -163.26 9.12 0.05 Allowed 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 179.641 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 3.7 tpt180 -149.29 167.28 26.5 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 118.329 0.513 . . . . 0.0 111.627 -175.384 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.4 ' HZ1' ' HZ2' ' A' ' 32' ' ' TRP . 58.5 tttm -103.74 118.18 36.1 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.316 -176.882 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 33.8 m-85 -115.37 170.76 8.16 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.152 -0.476 . . . . 0.0 109.935 -178.591 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -142.39 164.86 26.88 Favored Glycine 0 C--N 1.332 0.35 0 C-N-CA 120.968 -0.634 . . . . 0.0 112.862 -177.657 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 8.3 tt -150.25 132.42 15.39 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 -179.586 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 45.5 m -112.76 134.54 54.23 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.868 0.366 . . . . 0.0 110.316 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 63.8 m-85 -86.78 -178.23 6.29 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.179 -179.003 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 24.6 tt0 -124.54 -70.55 0.75 Allowed 'General case' 0 C--O 1.236 0.346 0 CA-C-O 120.907 0.384 . . . . 0.0 111.122 -178.15 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 48.8 m -108.81 158.49 33.98 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.435 -175.127 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -54.8 -28.72 59.16 Favored 'Trans proline' 0 C--N 1.352 0.731 0 C-N-CA 122.539 2.159 . . . . 0.0 111.96 179.108 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -59.65 -68.39 0.29 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.736 178.513 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -61.62 -44.72 96.47 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.066 -178.475 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -56.23 -63.94 1.02 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.48 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 7.1 tpt180 -61.05 -39.51 90.09 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.635 -175.034 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -65.55 -39.48 91.76 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.075 -179.271 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 21.1 t80 -70.24 -42.87 71.64 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 -178.384 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 45.0 m-20 -58.53 -44.32 89.53 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-O 121.37 0.605 . . . . 0.0 109.991 175.489 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 45.2 ttm180 -63.75 -39.67 94.84 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.289 -0.869 . . . . 0.0 109.84 178.265 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -67.55 -44.7 81.91 Favored Glycine 0 N--CA 1.449 -0.468 0 CA-C-N 115.235 -0.893 . . . . 0.0 112.622 -178.063 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.6 HG23 ' HD2' ' A' ' 83' ' ' TYR . 13.0 p -68.5 -35.75 71.78 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.105 0 CA-C-N 116.744 0.272 . . . . 0.0 110.398 -179.237 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 67.1 ttt180 -58.95 -52.53 65.34 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 174.004 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 54.3 tptt -58.08 -32.01 67.64 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.063 178.519 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -68.79 -36.68 78.57 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.476 176.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.528 HG13 ' O ' ' A' ' 117' ' ' VAL . 77.5 mt -60.86 -47.98 90.94 Favored 'Isoleucine or valine' 0 C--O 1.232 0.173 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 176.814 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -58.91 -57.83 11.33 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-O 120.907 0.384 . . . . 0.0 110.382 174.167 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -63.03 -29.21 70.64 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.774 -0.648 . . . . 0.0 112.54 -171.658 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 49.6 tp -93.47 -44.41 8.26 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 111.789 0.292 . . . . 0.0 111.789 -177.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.501 HD12 HG22 ' A' ' 121' ' ' ILE . 59.3 mt -99.85 -44.52 11.62 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 N-CA-C 112.705 0.631 . . . . 0.0 112.705 -170.457 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 . . . . . 0 C--O 1.249 1.028 0 CA-C-O 119.104 -0.474 . . . . 0.0 111.32 -170.314 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.641 0 N-CA-C 111.709 -0.556 . . . . 0.0 111.709 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 10.9 p -76.15 95.74 3.74 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.708 0.29 . . . . 0.0 110.319 178.545 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 27.1 ttt -62.46 -37.34 85.55 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.465 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 31.0 m -132.31 94.05 3.37 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.364 -179.138 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -114.63 -29.56 6.77 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 108.552 -0.906 . . . . 0.0 108.552 167.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -77.21 121.26 23.41 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 114.665 -1.152 . . . . 0.0 110.158 176.244 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 49.0 m -64.35 -31.27 72.41 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.019 0.437 . . . . 0.0 110.975 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.411 ' CD2' HH11 ' A' ' 65' ' ' ARG . 52.8 m-70 -132.99 150.38 75.47 Favored Pre-proline 0 C--N 1.329 -0.288 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 179.356 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -53.93 -42.82 63.53 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 122.342 2.028 . . . . 0.0 111.716 178.815 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.493 ' HB3' ' HB2' ' A' ' 13' ' ' SER . 5.1 m-20 -105.2 32.61 4.12 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.049 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.426 ' HA ' ' CE1' ' A' ' 14' ' ' TYR . 24.6 t70 -54.96 -36.67 65.58 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.619 -175.721 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -83.44 -19.57 35.65 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.103 -178.548 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.493 ' HB2' ' HB3' ' A' ' 10' ' ' ASP . 19.2 m -92.08 9.59 32.77 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-N 115.993 -0.549 . . . . 0.0 112.056 -172.569 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.575 ' HA ' ' HA ' ' A' ' 46' ' ' CYS . 45.4 m-85 -68.74 125.12 25.56 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 120.623 0.249 . . . . 0.0 110.663 175.696 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 62.4 mt -67.47 -47.66 79.9 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 177.166 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 9.8 p -166.19 139.37 0.92 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.334 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.216 178.494 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.673 HH12 ' NH1' ' A' ' 65' ' ' ARG . 50.0 mtt180 -109.23 100.99 10.05 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 176.317 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 30.1 t -92.52 148.48 4.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.989 -174.702 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -83.75 120.92 26.61 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.445 179.739 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -164.88 -171.04 2.13 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.108 -0.496 . . . . 0.0 109.76 -179.624 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.442 ' HB ' ' HB ' ' A' ' 103' ' ' THR . 84.7 t -121.44 115.88 47.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.651 0.263 . . . . 0.0 110.576 178.774 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.518 HG23 HE22 ' A' ' 35' ' ' GLN . 16.4 m -83.95 125.98 40.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.767 0.318 . . . . 0.0 110.524 177.795 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 22.5 mmt -112.27 150.31 31.13 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.795 -176.658 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 11.9 t -129.61 155.39 45.91 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.112 -0.495 . . . . 0.0 109.932 176.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 25.9 tpt180 -140.56 141.02 35.27 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 178.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -70.69 111.31 6.06 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 174.435 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 22.7 t70 61.96 -83.19 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.556 0 O-C-N 123.53 0.519 . . . . 0.0 111.887 179.034 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 68.3 m -154.4 -172.06 4.08 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 122.389 0.276 . . . . 0.0 110.882 -176.766 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 12.7 t 85.09 151.73 0.08 Allowed 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.165 0.986 . . . . 0.0 111.47 179.587 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -77.8 80.62 1.32 Allowed Glycine 0 C--N 1.334 0.454 0 CA-C-N 115.605 -0.725 . . . . 0.0 112.581 -176.692 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -152.68 55.51 0.44 Allowed Glycine 0 CA--C 1.51 -0.258 0 N-CA-C 110.595 -1.002 . . . . 0.0 110.595 176.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 80.6 m95 -70.79 119.53 15.07 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.158 -0.521 . . . . 0.0 111.219 -173.782 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 46.9 p90 -107.11 126.7 29.52 Favored Pre-proline 0 CA--C 1.534 0.35 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.678 -177.732 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -73.1 99.19 1.07 Allowed 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 122.75 2.3 . . . . 0.0 111.696 178.791 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.545 HE21 HG23 ' A' ' 72' ' ' VAL . 5.0 pm0 -57.2 -48.78 77.93 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 115.648 -0.705 . . . . 0.0 112.703 -175.592 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.575 ' CB ' HG11 ' A' ' 72' ' ' VAL . 16.3 tp10 -134.8 -83.47 0.42 Allowed 'General case' 0 N--CA 1.467 0.406 0 O-C-N 122.254 -0.279 . . . . 0.0 110.919 -174.647 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -72.92 68.02 1.34 Allowed Glycine 0 C--N 1.336 0.568 0 C-N-CA 121.408 -0.425 . . . . 0.0 112.672 179.578 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -80.59 -35.35 25.91 Favored Glycine 0 C--N 1.331 0.267 0 C-N-CA 121.395 -0.431 . . . . 0.0 112.415 -179.085 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -79.45 -29.08 50.62 Favored Glycine 0 C--O 1.236 0.227 0 N-CA-C 111.454 -0.658 . . . . 0.0 111.454 177.741 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.406 HG12 ' NE2' ' A' ' 66' ' ' GLN . 8.6 tt -174.85 139.16 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 179.037 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 23.3 t -145.11 -178.51 6.09 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 177.628 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 60.1 mtt180 -130.89 106.9 8.73 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.098 0.475 . . . . 0.0 110.211 -177.222 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 40.9 t -81.6 103.39 8.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.127 -179.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -90.73 105.06 3.22 Favored Glycine 0 N--CA 1.446 -0.698 0 CA-C-N 115.959 -0.564 . . . . 0.0 112.352 -179.228 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 54.4 t -88.02 103.12 13.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 176.071 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . 0.614 ' SG ' ' HB3' ' A' ' 60' ' ' LEU . 5.3 p -108.49 145.55 34.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.258 -179.112 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 35.9 ttmt -98.31 100.96 12.29 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 175.093 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 30.1 m -86.87 128.58 39.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 121.096 0.474 . . . . 0.0 111.602 -172.468 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 25.1 ptm -84.59 140.49 31.35 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.553 178.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 23.5 m-70 -101.98 156.74 34.85 Favored Pre-proline 0 C--N 1.331 -0.217 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.115 -177.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_exo -71.27 61.85 2.64 Favored 'Trans proline' 0 CA--C 1.535 0.566 0 C-N-CA 122.843 2.362 . . . . 0.0 111.085 171.468 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 68.76 157.45 0.14 Allowed 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.913 -176.31 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 158.06 -26.36 0.43 Allowed Glycine 0 C--N 1.332 0.306 0 C-N-CA 121.331 -0.461 . . . . 0.0 112.235 -179.772 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -162.28 -53.25 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 121.096 0.474 . . . . 0.0 110.332 -178.138 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 140.11 -54.33 0.66 Allowed Glycine 0 CA--C 1.51 -0.24 0 N-CA-C 110.87 -0.892 . . . . 0.0 110.87 -179.183 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 39.0 ttm180 -73.78 139.27 45.08 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.762 0.315 . . . . 0.0 110.172 175.702 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 49.6 m -77.1 152.4 35.01 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.551 179.365 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -85.57 -161.72 35.09 Favored Glycine 0 N--CA 1.45 -0.387 0 N-CA-C 111.505 -0.638 . . . . 0.0 111.505 178.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.644 ' HB2' ' HB ' ' A' ' 77' ' ' VAL . 76.9 m-85 -134.96 163.78 29.08 Favored 'General case' 0 C--N 1.327 -0.409 0 O-C-N 122.559 -0.377 . . . . 0.0 110.299 -177.285 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.614 ' HB3' ' SG ' ' A' ' 46' ' ' CYS . 2.8 tt -150.29 118.63 6.41 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 177.843 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.447 ' O ' ' HA ' ' A' ' 74' ' ' GLU . 44.5 mm -82.63 91.53 2.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 175.537 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 12.6 t-80 -102.66 98.07 8.17 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.645 -174.445 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.499 ' O ' ' HB2' ' A' ' 64' ' ' GLU . . . -104.73 116.78 5.42 Favored Glycine 0 CA--C 1.522 0.48 0 CA-C-N 116.096 -0.502 . . . . 0.0 114.319 -171.727 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.675 ' HB2' HG21 ' A' ' 72' ' ' VAL . 7.7 tp10 165.08 -99.23 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 124.799 1.24 . . . . 0.0 109.103 164.228 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.673 ' NH1' HH12 ' A' ' 17' ' ' ARG . 8.6 tpt180 59.35 -1.03 0.15 Allowed 'General case' 0 CA--C 1.545 0.777 0 N-CA-C 113.436 0.902 . . . . 0.0 113.436 171.665 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.406 ' NE2' HG12 ' A' ' 40' ' ' ILE . 6.6 tp-100 -52.15 -59.04 4.84 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 -171.713 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 51.7 tttp -91.33 5.45 49.19 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-O 120.983 0.421 . . . . 0.0 110.397 -178.692 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 31.8 t0 64.84 149.2 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.568 -175.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 4.3 mppt? 55.84 26.23 9.4 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 121.003 0.43 . . . . 0.0 110.7 -169.681 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.547 HD23 ' HG2' ' A' ' 64' ' ' GLU . 0.9 OUTLIER -129.12 128.2 43.0 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.298 -0.631 . . . . 0.0 109.298 -179.056 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.609 ' HA ' ' HB3' ' A' ' 64' ' ' GLU . 51.4 t -137.66 140.67 40.93 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 179.18 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.675 HG21 ' HB2' ' A' ' 64' ' ' GLU . 27.5 m -130.35 -41.17 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 177.529 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.3 tt -124.36 133.79 53.33 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.389 -0.596 . . . . 0.0 109.389 -175.534 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.447 ' HA ' ' O ' ' A' ' 61' ' ' ILE . 11.0 pt-20 -146.98 130.3 16.62 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.067 0.461 . . . . 0.0 109.803 173.444 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 47.7 t -130.03 109.34 10.78 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 -179.321 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 24.9 t80 -74.7 129.55 37.9 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.046 -0.525 . . . . 0.0 109.914 -177.083 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.644 ' HB ' ' HB2' ' A' ' 59' ' ' PHE . 63.1 t -105.45 85.32 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.496 0.665 . . . . 0.0 109.216 -177.894 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.436 ' O ' ' HB3' ' A' ' 79' ' ' LYS . 6.9 ptm180 -97.29 67.01 2.11 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.195 -0.911 . . . . 0.0 109.631 -179.633 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.474 ' HA ' HD22 ' A' ' 124' ' ' LEU . 7.3 tmtm? 77.39 -49.08 0.52 Allowed 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.478 -175.365 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.413 ' OD1' ' HG3' ' A' ' 78' ' ' ARG . 5.0 p-10 -81.91 128.97 34.6 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-O 121.058 0.456 . . . . 0.0 110.623 -178.595 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.627 HD12 HD11 ' A' ' 121' ' ' ILE . 3.3 tm? -177.48 135.53 0.19 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.269 -0.878 . . . . 0.0 108.684 -178.263 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 3.7 p -145.71 106.09 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 CA-C-O 121.019 0.438 . . . . 0.0 111.3 -179.054 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.704 ' HB3' ' NE2' ' A' ' 91' ' ' HIS . 3.2 m-85 -88.84 150.97 22.64 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.217 176.299 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 81.5 m -150.47 120.23 7.05 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.883 177.566 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.471 ' HZ2' ' HB3' ' A' ' 85' ' ' LYS . 8.0 ttpm? -90.64 110.72 21.87 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 177.707 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -78.62 -50.16 11.98 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.069 -179.374 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . 0.584 ' HB2' ' HB3' ' A' ' 90' ' ' PHE . 91.7 m-20 -120.11 153.41 55.39 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.004 179.706 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_endo -48.39 -33.63 23.24 Favored 'Trans proline' 0 CA--C 1.534 0.518 0 C-N-CA 122.99 2.46 . . . . 0.0 112.881 -176.295 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 15.2 t -112.36 13.87 20.34 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.419 -176.661 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.584 ' HB3' ' HB2' ' A' ' 87' ' ' ASN . 91.3 t80 -139.02 119.85 14.27 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-O 121.187 0.518 . . . . 0.0 111.493 -178.192 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . 0.704 ' NE2' ' HB3' ' A' ' 83' ' ' TYR . 1.2 t60 -116.24 157.8 24.34 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.384 -0.825 . . . . 0.0 108.915 178.5 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 25.0 p80 -155.05 157.58 37.8 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 175.304 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . 0.43 ' HZ3' ' HB2' ' A' ' 102' ' ' LEU . 36.4 p90 -144.03 174.21 11.05 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 176.687 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 61.5 pttt -144.01 155.57 44.06 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 179.559 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.625 HG22 ' H ' ' A' ' 96' ' ' ASP . 7.9 m -133.55 -63.73 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.913 176.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.625 ' H ' HG22 ' A' ' 95' ' ' VAL . 20.3 m-20 -115.32 71.8 0.78 Allowed 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 -179.388 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 18.0 m120 74.02 -39.54 0.43 Allowed 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 115.346 -0.843 . . . . 0.0 112.155 178.788 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 63.7 ttt180 -87.18 148.8 25.02 Favored 'General case' 0 C--O 1.242 0.702 0 CA-C-O 121.033 0.444 . . . . 0.0 111.372 -176.083 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 61.9 mttp -100.71 143.57 30.72 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 114.956 -1.02 . . . . 0.0 110.834 178.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -118.94 143.85 46.78 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 172.061 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -113.09 163.04 12.17 Favored Glycine 0 C--N 1.331 0.285 0 C-N-CA 120.834 -0.698 . . . . 0.0 113.892 -170.722 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.43 ' HB2' ' HZ3' ' A' ' 93' ' ' TRP . 57.3 tp -150.7 106.92 3.46 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 122.793 0.437 . . . . 0.0 110.181 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.442 ' HB ' ' HB ' ' A' ' 21' ' ' VAL . 52.1 m -89.31 125.04 34.95 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.323 178.044 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.545 ' CZ ' ' HB2' ' A' ' 91' ' ' HIS . 23.8 m-85 -78.76 161.04 27.12 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.462 179.465 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 65.3 tt0 -109.17 -42.04 4.51 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.712 179.469 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 13.6 m -140.88 151.63 63.23 Favored Pre-proline 0 CA--C 1.533 0.327 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.254 -179.072 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_exo -50.41 -30.26 26.58 Favored 'Trans proline' 0 C--N 1.352 0.752 0 C-N-CA 122.975 2.45 . . . . 0.0 113.207 -179.289 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -62.87 -64.11 1.01 Allowed 'General case' 0 C--O 1.235 0.291 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.98 179.844 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -62.99 -33.95 76.51 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.354 179.236 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . 0.438 ' HB2' ' NH2' ' A' ' 111' ' ' ARG . . . -54.8 -63.89 1.01 Allowed 'General case' 0 C--O 1.235 0.325 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.092 177.688 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.438 ' NH2' ' HB2' ' A' ' 110' ' ' ALA . 0.0 OUTLIER -65.65 -24.43 67.02 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.788 179.765 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -61.93 -40.51 95.75 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 175.124 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 47.4 m-85 -70.89 -48.23 54.84 Favored 'General case' 0 N--CA 1.461 0.1 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.587 176.083 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -53.54 -66.19 0.43 Allowed 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 121.39 0.614 . . . . 0.0 110.441 178.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 16.5 mtp180 -63.68 -36.56 84.25 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.889 -178.014 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -60.26 -53.78 42.77 Favored Glycine 0 C--N 1.332 0.344 0 CA-C-N 116.097 -0.501 . . . . 0.0 112.588 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 10.7 p -66.27 -36.47 77.46 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.121 0 CA-C-N 116.672 0.236 . . . . 0.0 110.505 -178.071 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 95.8 mtt180 -60.95 -42.59 98.52 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.475 -0.329 . . . . 0.0 111.104 177.777 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 30.8 mmtp -76.29 -27.52 56.66 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 120.68 0.276 . . . . 0.0 110.948 178.223 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -63.35 -48.69 76.91 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 174.732 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.627 HD11 HD12 ' A' ' 81' ' ' LEU . 46.9 mm -66.8 -36.08 76.33 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.187 176.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -54.65 -56.67 16.67 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.253 178.265 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 -70.15 -29.5 66.43 Favored 'General case' 0 C--O 1.225 -0.188 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.94 179.386 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.474 HD22 ' HA ' ' A' ' 79' ' ' LYS . 6.7 tt -59.59 -43.76 93.58 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 177.241 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 66.7 mt -77.7 -30.88 16.95 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.495 178.595 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.428 -0.796 . . . . 0.0 109.808 179.101 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.716 0 N-CA-C 112.087 -0.405 . . . . 0.0 112.087 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 26.1 m -67.06 94.36 0.33 Allowed 'General case' 0 CA--C 1.532 0.266 0 CA-C-O 120.968 0.413 . . . . 0.0 110.913 -179.083 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 16.1 tpt -152.83 43.03 0.63 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.791 0.805 . . . . 0.0 109.002 177.758 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 18.2 p -99.61 113.17 25.44 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.538 -176.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -121.98 174.07 7.13 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 173.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 14.6 tm-20 71.57 -73.88 0.09 Allowed 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 -178.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.486 ' HB ' ' HB2' ' A' ' 12' ' ' ASP . 40.1 p 45.99 98.69 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 113.933 1.086 . . . . 0.0 113.933 171.656 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.414 ' HB2' ' HD3' ' A' ' 9' ' ' PRO . 25.0 m170 -151.95 -54.85 0.02 OUTLIER Pre-proline 0 CA--C 1.536 0.416 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 -179.047 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.414 ' HD3' ' HB2' ' A' ' 8' ' ' HIS . 92.2 Cg_endo -79.7 40.76 1.0 Allowed 'Trans proline' 0 C--N 1.36 1.177 0 C-N-CA 122.215 1.943 . . . . 0.0 110.714 169.855 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -168.75 -30.76 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 -174.133 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 80.21 102.75 0.06 Allowed 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 113.436 -1.711 . . . . 0.0 113.165 165.809 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.486 ' HB2' ' HB ' ' A' ' 7' ' ' THR . 3.7 m-20 -149.42 -23.79 0.28 Allowed 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.8 167.184 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 15.1 m -89.27 -8.12 54.05 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 120.798 0.333 . . . . 0.0 111.538 -176.767 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 67.8 m-85 -88.05 147.9 24.75 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.96 0.41 . . . . 0.0 111.515 -176.649 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 48.9 mm -105.81 -37.88 4.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 168.036 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 59.4 t -136.29 142.98 37.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 114.964 -1.016 . . . . 0.0 108.684 175.327 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.484 HH21 ' CD ' ' A' ' 64' ' ' GLU . 63.1 ttt180 -149.24 84.02 1.44 Allowed 'General case' 0 C--O 1.235 0.304 0 CA-C-O 121.22 0.533 . . . . 0.0 109.931 179.223 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 60.1 t -107.37 141.78 21.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.034 -177.752 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.664 ' HD3' ' H ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -82.83 127.51 33.54 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.943 -0.392 . . . . 0.0 109.943 176.909 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -150.48 171.92 16.29 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.64 178.597 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.539 ' HB ' ' HB ' ' A' ' 103' ' ' THR . 49.0 t -84.99 96.89 5.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.977 0.417 . . . . 0.0 110.783 -176.398 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 57.8 t -79.35 113.67 19.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.562 179.761 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 22.5 mmt -99.34 156.55 16.94 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.024 -0.534 . . . . 0.0 109.923 178.27 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.496 HG22 ' CE1' ' A' ' 33' ' ' PHE . 8.8 t -130.39 142.12 50.53 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.026 0.441 . . . . 0.0 110.536 179.466 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.42 ' HB2' ' CZ3' ' A' ' 32' ' ' TRP . 0.0 OUTLIER -94.06 101.33 13.36 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 173.778 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.476 ' HB2' ' CE1' ' A' ' 33' ' ' PHE . 32.1 t70 -52.4 120.82 5.99 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 178.085 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -39.26 108.68 0.09 Allowed 'General case' 0 N--CA 1.466 0.339 0 O-C-N 124.228 0.955 . . . . 0.0 111.487 -176.231 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 40.6 p 46.02 82.31 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.39 0 O-C-N 123.836 0.71 . . . . 0.0 111.36 -176.377 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 6.9 t -131.15 -69.38 0.63 Allowed 'General case' 0 C--O 1.234 0.27 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.812 -175.535 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 174.12 -62.02 0.12 Allowed Glycine 0 C--N 1.333 0.364 0 C-N-CA 121.177 -0.535 . . . . 0.0 112.005 -179.26 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -128.46 -139.28 4.73 Favored Glycine 0 C--O 1.236 0.245 0 C-N-CA 121.226 -0.511 . . . . 0.0 112.556 -179.213 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . 0.508 ' HH2' ' HG2' ' A' ' 99' ' ' LYS . 67.8 m95 -125.1 149.4 47.88 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 179.252 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.496 ' CE1' HG22 ' A' ' 24' ' ' THR . 2.0 p90 -149.07 152.86 37.25 Favored Pre-proline 0 C--O 1.236 0.366 0 N-CA-C 110.318 -0.253 . . . . 0.0 110.318 177.726 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -63.03 125.69 16.41 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 122.297 1.998 . . . . 0.0 111.785 176.008 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.649 ' HG2' HD21 ' A' ' 73' ' ' LEU . 2.0 pp0? -69.06 -168.67 0.15 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.263 174.739 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -55.59 -14.72 2.28 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 -173.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -67.59 -40.84 90.57 Favored Glycine 0 CA--C 1.521 0.414 0 N-CA-C 111.599 -0.6 . . . . 0.0 111.599 173.703 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 86.43 -33.95 3.57 Favored Glycine 0 C--N 1.333 0.411 0 N-CA-C 112.17 -0.372 . . . . 0.0 112.17 178.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.456 ' O ' ' HA ' ' A' ' 21' ' ' VAL . . . -162.78 -105.06 0.19 Allowed Glycine 0 N--CA 1.443 -0.859 0 N-CA-C 111.195 -0.762 . . . . 0.0 111.195 176.663 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.424 HG21 ' HB2' ' A' ' 19' ' ' LYS . 1.8 mp -60.9 131.88 26.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 120.973 0.416 . . . . 0.0 110.334 -179.904 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 41.6 m -145.82 152.89 40.25 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.333 178.322 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.763 ' HB2' ' HB2' ' A' ' 64' ' ' GLU . 13.1 mmt180 -72.99 105.13 4.34 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 110.379 -0.23 . . . . 0.0 110.379 -179.655 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 56.4 t -83.47 89.89 2.39 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 174.13 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -88.09 104.13 3.0 Favored Glycine 0 N--CA 1.444 -0.794 0 CA-C-N 115.515 -0.766 . . . . 0.0 112.669 -177.79 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 53.5 t -80.58 88.35 1.57 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.522 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 174.774 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . 0.676 ' HB3' ' HB3' ' A' ' 60' ' ' LEU . 42.6 t -85.58 146.73 26.75 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.392 179.204 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 79.6 tttt -142.73 96.88 3.01 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 -174.394 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 26.9 m -98.97 132.74 43.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.652 -176.82 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.7 151.83 40.6 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.838 0.351 . . . . 0.0 111.116 -177.065 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 13.6 m170 -93.84 121.61 63.99 Favored Pre-proline 0 C--O 1.233 0.234 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 176.652 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -49.48 -54.19 5.85 Favored 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 123.139 2.559 . . . . 0.0 113.278 -175.145 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -155.99 125.71 6.4 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 121.015 0.436 . . . . 0.0 109.891 -178.527 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 149.63 -159.81 28.22 Favored Glycine 0 C--N 1.329 0.185 0 N-CA-C 110.941 -0.864 . . . . 0.0 110.941 -178.019 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 51.4 t30 -95.71 130.04 42.74 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 117.342 0.571 . . . . 0.0 109.577 175.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 121.97 144.58 6.85 Favored Glycine 0 N--CA 1.449 -0.44 0 N-CA-C 111.541 -0.624 . . . . 0.0 111.541 -177.188 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 52.6 ttm-85 -86.92 -56.07 3.56 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.086 0.469 . . . . 0.0 110.265 -178.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 24.3 m -156.24 133.87 10.96 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.613 -176.731 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -78.64 147.16 30.71 Favored Glycine 0 N--CA 1.45 -0.422 0 N-CA-C 110.937 -0.865 . . . . 0.0 110.937 174.299 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.439 ' HB2' HG21 ' A' ' 77' ' ' VAL . 69.5 m-85 -104.08 122.31 45.03 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.906 0.384 . . . . 0.0 110.316 -174.65 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.676 ' HB3' ' HB3' ' A' ' 46' ' ' CYS . 3.6 tt -103.9 107.3 18.12 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 179.416 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 61.4 mt -71.49 91.97 0.43 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.327 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 174.707 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 12.4 t-80 -97.3 100.39 11.85 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.074 -173.111 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.43 ' HA3' ' HB2' ' A' ' 73' ' ' LEU . . . -99.35 112.96 4.59 Favored Glycine 0 C--N 1.33 0.22 0 C-N-CA 121.399 -0.429 . . . . 0.0 112.271 -177.373 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.763 ' HB2' ' HB2' ' A' ' 42' ' ' ARG . 22.1 mt-10 -107.05 138.2 43.67 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 122.226 0.21 . . . . 0.0 110.607 -178.545 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 26.6 ttt85 -67.63 130.85 44.3 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 173.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 6.8 tp60 -58.56 154.93 13.2 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.368 -176.521 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt 72.86 -69.84 0.18 Allowed 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 123.422 0.689 . . . . 0.0 111.35 177.471 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -69.23 -36.23 77.0 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 120.706 0.289 . . . . 0.0 110.543 -176.541 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 50.4 mtmt 61.93 85.28 0.12 Allowed 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.57 -0.741 . . . . 0.0 112.06 176.285 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -150.26 154.91 38.74 Favored 'General case' 0 C--O 1.24 0.565 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 173.468 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 10.5 t -72.5 92.61 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 CA-C-O 120.958 0.408 . . . . 0.0 111.517 -171.662 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 9.5 m -88.22 -37.47 10.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.452 176.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.649 HD21 ' HG2' ' A' ' 35' ' ' GLN . 4.2 mm? -117.35 137.88 52.16 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 176.784 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.554 ' HG3' HD21 ' A' ' 60' ' ' LEU . 35.0 tt0 -150.21 114.56 5.17 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 177.868 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . 0.509 ' SG ' ' CE2' ' A' ' 100' ' ' PHE . 36.5 m -138.07 101.4 4.41 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.959 0.409 . . . . 0.0 110.156 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 75.5 t80 -84.62 112.31 20.33 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.12 -0.491 . . . . 0.0 109.924 179.791 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.457 HG22 HD23 ' A' ' 81' ' ' LEU . 16.4 m -97.54 100.33 10.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 121.863 0.84 . . . . 0.0 109.267 177.803 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 19.5 ptt180 -70.92 -45.68 63.81 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 114.631 -1.168 . . . . 0.0 112.092 -172.117 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 35.8 ttpt -160.99 29.73 0.14 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.569 0.7 . . . . 0.0 109.792 -175.02 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.426 ' O ' ' HB ' ' A' ' 77' ' ' VAL . 7.3 p-10 -149.66 140.98 23.19 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.08 -178.802 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.457 HD23 HG22 ' A' ' 77' ' ' VAL . 12.8 mt -155.36 101.38 2.2 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.967 179.057 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.471 HG22 ' N ' ' A' ' 83' ' ' TYR . 27.6 m -74.3 -53.06 18.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 174.468 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.471 ' N ' HG22 ' A' ' 82' ' ' VAL . 4.5 t80 30.46 82.86 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.431 1.092 . . . . 0.0 112.015 177.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 36.0 m -112.41 133.48 54.47 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.998 -179.079 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.507 ' HA ' ' HA ' ' A' ' 91' ' ' HIS . 17.7 ptmt -93.46 101.72 13.93 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.315 0.579 . . . . 0.0 110.224 178.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -72.34 -49.49 33.94 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.975 -178.501 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . 0.551 ' HB2' ' HB3' ' A' ' 90' ' ' PHE . 0.8 OUTLIER -104.83 153.27 39.44 Favored Pre-proline 0 C--N 1.327 -0.387 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 174.753 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_exo -48.24 -31.91 18.13 Favored 'Trans proline' 0 CA--C 1.534 0.499 0 C-N-CA 122.621 2.214 . . . . 0.0 112.765 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.471 ' HA ' ' HD2' ' A' ' 104' ' ' PHE . 20.5 p -120.09 16.35 12.43 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 112.328 0.492 . . . . 0.0 112.328 -178.321 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.551 ' HB3' ' HB2' ' A' ' 87' ' ' ASN . 5.5 t80 -129.88 105.84 8.27 Favored 'General case' 0 C--O 1.239 0.5 0 CA-C-O 120.93 0.395 . . . . 0.0 110.094 178.665 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . 0.507 ' HA ' ' HA ' ' A' ' 85' ' ' LYS . 0.1 OUTLIER -102.73 133.18 48.19 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 177.763 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 30.2 p80 -129.1 155.05 46.07 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.935 0.398 . . . . 0.0 110.812 -178.003 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . 0.403 ' CE2' ' HB2' ' A' ' 100' ' ' PHE . 43.8 p90 -144.91 158.49 43.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.174 178.517 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 22.5 ptmt -144.02 148.98 35.98 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 177.784 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.691 HG23 ' H ' ' A' ' 96' ' ' ASP . 4.4 m -127.64 -66.87 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 C-N-CA 121.2 -0.2 . . . . 0.0 111.173 -179.3 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.691 ' H ' HG23 ' A' ' 95' ' ' VAL . 10.9 m-20 -120.87 80.1 1.59 Allowed 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 177.157 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 52.4 t-20 74.35 -52.96 0.68 Allowed 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 114.79 -1.095 . . . . 0.0 111.429 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -68.87 139.42 55.17 Favored 'General case' 0 C--O 1.244 0.806 0 CA-C-O 121.003 0.43 . . . . 0.0 110.239 -175.813 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.508 ' HG2' ' HH2' ' A' ' 32' ' ' TRP . 39.7 ttmt -121.49 135.49 55.03 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.503 -178.711 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . 0.509 ' CE2' ' SG ' ' A' ' 75' ' ' CYS . 20.4 m-85 -124.0 164.31 19.61 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 -178.797 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -139.64 159.74 25.92 Favored Glycine 0 C--N 1.331 0.298 0 C-N-CA 120.764 -0.732 . . . . 0.0 113.461 -174.47 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.4 ' HB2' ' HZ3' ' A' ' 93' ' ' TRP . 5.6 tt -139.54 114.77 9.72 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 -179.496 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.539 ' HB ' ' HB ' ' A' ' 21' ' ' VAL . 48.5 m -93.3 119.65 32.69 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.087 176.873 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.471 ' HD2' ' HA ' ' A' ' 89' ' ' THR . 33.3 m-85 -70.02 158.4 35.74 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.224 179.599 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 45.6 mt-30 -108.13 -46.31 3.77 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.771 -178.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 14.7 m -135.07 156.49 78.26 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.408 -176.21 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -51.52 -30.49 35.82 Favored 'Trans proline' 0 C--N 1.35 0.619 0 C-N-CA 122.652 2.235 . . . . 0.0 112.49 177.036 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -60.57 -61.02 2.89 Favored 'General case' 0 C--O 1.239 0.516 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.384 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -65.52 -43.74 89.11 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.433 -0.348 . . . . 0.0 110.599 -178.724 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -51.95 -54.74 26.06 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 121.086 0.47 . . . . 0.0 111.027 177.36 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 34.7 ttt180 -61.59 -39.21 90.4 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.01 -177.633 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -61.99 -43.39 98.94 Favored 'General case' 0 C--O 1.231 0.109 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.304 179.685 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 49.1 m-85 -69.64 -39.86 76.87 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.617 -0.265 . . . . 0.0 110.965 -179.133 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.462 ' CG ' ' HZ3' ' A' ' 85' ' ' LYS . 45.6 m-20 -60.15 -57.88 10.91 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-O 121.31 0.576 . . . . 0.0 110.752 178.45 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 37.3 mmt180 -66.87 -31.27 71.76 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.171 -179.497 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -64.21 -48.86 70.53 Favored Glycine 0 N--CA 1.449 -0.441 0 CA-C-N 115.635 -0.711 . . . . 0.0 112.199 179.195 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.483 ' O ' HG12 ' A' ' 121' ' ' ILE . 11.5 p -66.89 -37.88 80.3 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.086 0 N-CA-C 110.26 -0.274 . . . . 0.0 110.26 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 8.1 tpt180 -56.69 -49.45 75.1 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-O 120.853 0.359 . . . . 0.0 110.169 176.054 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 60.0 tptt -58.61 -44.42 89.9 Favored 'General case' 0 C--O 1.241 0.647 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.382 177.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -57.94 -47.23 83.51 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.56 178.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.483 HG12 ' O ' ' A' ' 117' ' ' VAL . 43.0 mm -59.21 -46.63 92.05 Favored 'Isoleucine or valine' 0 C--O 1.232 0.14 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.469 179.422 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 62.6 mm-40 -51.7 -58.16 7.16 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.945 179.699 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -73.75 -33.22 64.21 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.569 -174.755 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 60.2 tp -64.98 -41.82 95.08 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.911 0.386 . . . . 0.0 110.449 -179.082 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 47.9 mm -78.99 -55.96 8.4 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.901 -178.106 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 . . . . . 0 C--O 1.253 1.243 0 CA-C-O 119.356 -0.354 . . . . 0.0 111.266 -176.827 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.794 0 N-CA-C 112.031 -0.428 . . . . 0.0 112.031 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 24.2 p -89.31 28.37 1.26 Allowed 'General case' 0 C--O 1.237 0.446 0 CA-C-O 121.336 0.588 . . . . 0.0 110.801 179.365 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 49.1 ttp -92.78 159.15 15.53 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.215 176.404 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 23.5 m 74.0 127.19 0.04 OUTLIER 'General case' 0 C--O 1.235 0.312 0 O-C-N 123.535 0.522 . . . . 0.0 109.935 -177.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -110.02 152.53 25.8 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.016 0.436 . . . . 0.0 111.407 -174.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.423 ' HB3' ' HB2' ' A' ' 11' ' ' ASP . 1.5 mp0 -108.02 145.57 33.76 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 161.459 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.421 ' O ' ' HG3' ' A' ' 64' ' ' GLU . 0.5 OUTLIER -79.41 -30.19 42.27 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.599 0.714 . . . . 0.0 109.085 -176.003 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.482 ' HD2' ' H ' ' A' ' 10' ' ' ASP . 5.9 t60 -119.35 136.42 24.54 Favored Pre-proline 0 C--N 1.328 -0.362 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 177.301 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -56.13 -6.4 1.31 Allowed 'Trans proline' 0 C--N 1.353 0.787 0 C-N-CA 122.79 2.327 . . . . 0.0 112.775 179.352 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.482 ' H ' ' HD2' ' A' ' 8' ' ' HIS . 27.2 t70 -141.55 46.1 1.7 Allowed 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 173.329 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.423 ' HB2' ' HB3' ' A' ' 6' ' ' GLU . 7.7 t70 -52.38 104.61 0.09 Allowed 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 115.073 -0.967 . . . . 0.0 110.889 -174.953 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -96.66 -54.68 3.15 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.102 -0.499 . . . . 0.0 112.223 -175.783 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 57.8 m -143.55 37.0 1.33 Allowed 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 111.867 0.321 . . . . 0.0 111.867 -175.553 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.418 ' HA ' ' HB3' ' A' ' 46' ' ' CYS . 59.5 m-85 -76.54 93.29 3.54 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 121.111 0.481 . . . . 0.0 110.504 177.922 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.55 HG22 HG22 ' A' ' 16' ' ' VAL . 44.0 mm -69.19 -56.59 11.31 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 CA-C-N 115.437 -0.802 . . . . 0.0 111.465 -173.809 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.55 HG22 HG22 ' A' ' 15' ' ' ILE . 57.8 t -131.84 131.15 61.96 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 CA-C-O 120.574 0.226 . . . . 0.0 111.128 -175.507 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.572 ' HG3' ' HA2' ' A' ' 44' ' ' GLY . 0.5 OUTLIER -110.89 98.27 7.45 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 171.895 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 44.9 t -76.39 154.85 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.464 -177.263 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 58.7 tttp -98.88 131.33 45.06 Favored 'General case' 0 N--CA 1.462 0.129 0 CA-C-O 120.826 0.346 . . . . 0.0 110.374 178.12 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.5 ' O ' ' HB2' ' A' ' 41' ' ' SER . . . -171.19 -166.95 0.5 Allowed 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 175.479 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 61.7 t -117.93 120.19 63.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 167.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.506 HG13 ' HG ' ' A' ' 73' ' ' LEU . 49.6 t -71.7 94.15 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 121.148 0.499 . . . . 0.0 109.985 179.65 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' MET . . . . . 0.445 ' HB3' ' HB3' ' A' ' 32' ' ' TRP . 21.4 mmt -86.44 110.7 19.91 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.582 -178.473 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 1.1 m -100.78 120.77 40.6 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.427 -0.806 . . . . 0.0 108.961 172.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.79 114.86 11.4 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 179.361 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -58.03 91.18 0.01 OUTLIER 'General case' 0 C--O 1.233 0.222 0 O-C-N 123.345 0.403 . . . . 0.0 110.44 -176.485 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 28.3 t70 55.54 -87.7 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.788 -176.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 60.4 m -157.99 26.97 0.26 Allowed 'General case' 0 C--O 1.235 0.315 0 CA-C-O 121.093 0.473 . . . . 0.0 109.993 177.532 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 34.8 t -143.18 159.52 42.14 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.032 -179.358 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 82.38 -53.57 4.8 Favored Glycine 0 C--N 1.329 0.187 0 C-N-CA 121.235 -0.507 . . . . 0.0 112.22 179.207 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 131.29 -161.43 23.59 Favored Glycine 0 C--N 1.331 0.304 0 N-CA-C 111.976 -0.449 . . . . 0.0 111.976 177.457 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . 0.445 ' HB3' ' HB3' ' A' ' 23' ' ' MET . 84.2 m95 -84.69 104.83 15.01 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 109.36 -0.608 . . . . 0.0 109.36 176.347 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -103.71 147.84 34.87 Favored Pre-proline 0 C--O 1.237 0.423 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 -175.522 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -59.96 132.21 43.56 Favored 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 122.472 2.114 . . . . 0.0 111.355 179.152 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 8.0 tp-100 -39.73 -47.16 2.01 Favored 'General case' 0 N--CA 1.468 0.439 0 O-C-N 123.764 0.665 . . . . 0.0 112.055 -175.782 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -176.07 -34.91 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 178.454 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -108.86 167.9 13.23 Favored Glycine 0 N--CA 1.453 -0.209 0 CA-C-N 115.14 -0.936 . . . . 0.0 110.776 171.466 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -132.49 150.41 19.68 Favored Glycine 0 C--O 1.234 0.151 0 C-N-CA 120.95 -0.643 . . . . 0.0 112.473 -178.194 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 81.06 -58.59 4.82 Favored Glycine 0 C--N 1.331 0.293 0 C-N-CA 121.46 -0.4 . . . . 0.0 112.585 178.407 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.493 HD11 ' N ' ' A' ' 40' ' ' ILE . 3.5 mp -101.85 107.29 21.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.783 0.325 . . . . 0.0 110.599 -178.784 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.5 ' HB2' ' O ' ' A' ' 20' ' ' ALA . 36.6 m -141.9 113.84 8.01 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 171.316 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.491 ' HB2' ' O ' ' A' ' 64' ' ' GLU . 5.7 mpt_? -88.79 133.48 34.23 Favored 'General case' 0 CA--C 1.519 -0.218 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 175.642 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.756 HG21 HD22 ' A' ' 102' ' ' LEU . 75.5 t -106.2 100.01 9.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.006 177.328 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.572 ' HA2' ' HG3' ' A' ' 17' ' ' ARG . . . -71.26 84.63 0.41 Allowed Glycine 0 N--CA 1.448 -0.546 0 CA-C-N 115.673 -0.694 . . . . 0.0 112.693 -179.202 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 54.8 t -75.69 107.96 7.22 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 176.479 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . 0.688 ' SG ' ' HB3' ' A' ' 60' ' ' LEU . 6.1 p -125.51 125.71 43.71 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.064 -0.517 . . . . 0.0 111.079 -177.336 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 57.8 tttm -87.6 89.08 7.86 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 175.833 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 31.0 t -77.12 125.57 37.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.23 -174.091 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 97.6 mmm -81.59 109.1 15.71 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 174.763 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 7.5 p80 -68.47 154.33 94.51 Favored Pre-proline 0 C--N 1.325 -0.482 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.424 -179.198 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -54.13 135.45 64.42 Favored 'Trans proline' 0 C--N 1.352 0.724 0 C-N-CA 122.587 2.191 . . . . 0.0 111.569 178.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 61.48 40.22 14.07 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.702 -176.026 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -50.16 105.64 0.18 Allowed Glycine 0 C--N 1.333 0.382 0 CA-C-N 115.507 -0.77 . . . . 0.0 112.526 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 30.3 p-10 -79.15 -16.61 56.4 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.914 0.388 . . . . 0.0 111.173 -177.19 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 150.71 -24.65 1.05 Allowed Glycine 0 N--CA 1.453 -0.221 0 N-CA-C 111.546 -0.622 . . . . 0.0 111.546 -178.508 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.527 ' NE ' ' HA ' ' A' ' 56' ' ' ARG . 0.6 OUTLIER -87.05 171.68 10.54 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 177.571 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.49 ' H ' ' HG3' ' A' ' 56' ' ' ARG . 24.9 m -145.13 166.26 25.93 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.749 0.309 . . . . 0.0 110.554 177.849 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -107.09 120.36 6.17 Favored Glycine 0 N--CA 1.448 -0.516 0 N-CA-C 111.29 -0.724 . . . . 0.0 111.29 176.697 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 71.7 m-85 -91.06 104.55 17.12 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.061 0.457 . . . . 0.0 109.813 -176.613 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.688 ' HB3' ' SG ' ' A' ' 46' ' ' CYS . 1.9 tt -93.35 106.71 18.64 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.806 -0.633 . . . . 0.0 109.499 -178.204 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 49.8 mm -78.58 85.91 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 173.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . 0.405 ' HA ' ' HA ' ' A' ' 74' ' ' GLU . 15.4 t-80 -90.94 168.11 11.92 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.593 -176.548 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -151.09 112.96 0.56 Allowed Glycine 0 C--O 1.236 0.258 0 C-N-CA 120.948 -0.644 . . . . 0.0 112.111 -178.309 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.491 ' O ' ' HB2' ' A' ' 42' ' ' ARG . 0.0 OUTLIER -145.95 -167.29 2.68 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 122.385 0.274 . . . . 0.0 110.739 -176.101 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.43 ' HB3' ' HD3' ' A' ' 42' ' ' ARG . 0.0 OUTLIER 57.41 34.95 25.39 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-O 120.928 0.394 . . . . 0.0 110.205 175.181 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 84.0 mm-40 -63.88 -11.58 28.98 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 115.67 -0.695 . . . . 0.0 112.571 -172.447 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 34.7 ttpt -174.5 -63.28 0.01 OUTLIER 'General case' 0 C--O 1.234 0.261 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 173.311 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -105.43 -85.05 0.49 Allowed 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 170.595 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.69 ' HZ1' ' HB3' ' A' ' 69' ' ' LYS . 6.3 ttpm? -140.72 108.17 5.56 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 178.565 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 48.2 tp -163.73 124.54 2.26 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 110.418 -0.216 . . . . 0.0 110.418 -173.375 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 83.9 t -98.58 135.23 34.28 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 O-C-N 123.697 0.623 . . . . 0.0 109.443 173.052 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 35.4 m -134.92 -41.17 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 N-CA-C 112.127 0.418 . . . . 0.0 112.127 -177.195 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.528 HD11 ' N ' ' A' ' 74' ' ' GLU . 3.0 tm? -119.91 143.3 48.03 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.821 0.343 . . . . 0.0 110.781 -170.847 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.528 ' N ' HD11 ' A' ' 73' ' ' LEU . 9.5 pt-20 -158.45 112.17 2.44 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.915 173.555 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 42.0 t -126.0 97.81 5.26 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 179.512 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.409 ' HB2' ' HG ' ' A' ' 60' ' ' LEU . 69.2 t80 -88.36 134.82 33.72 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.99 -176.336 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 35.1 m -141.42 145.28 24.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 176.31 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 24.5 ttp180 -130.67 -24.44 2.46 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.134 0.493 . . . . 0.0 110.428 177.2 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.516 ' HD3' ' N ' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -160.9 29.21 0.15 Allowed 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 174.948 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -127.92 170.31 12.98 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 115.123 -0.944 . . . . 0.0 110.709 -167.45 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.624 HD11 ' CD1' ' A' ' 93' ' ' TRP . 10.2 tt 72.92 151.8 0.12 Allowed 'General case' 0 N--CA 1.469 0.514 0 O-C-N 123.996 0.81 . . . . 0.0 112.163 167.854 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.502 ' N ' HD23 ' A' ' 81' ' ' LEU . 8.7 p -139.63 141.02 35.74 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.68 177.221 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 14.6 m-85 -94.5 166.35 12.09 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 121.176 0.513 . . . . 0.0 111.079 -177.633 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 88.7 m -152.08 109.81 3.64 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.015 176.548 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.471 ' O ' ' HD2' ' A' ' 85' ' ' LYS . 0.0 OUTLIER -108.81 138.57 44.93 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.941 0.401 . . . . 0.0 110.663 -179.316 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -108.18 -45.72 3.88 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.956 -0.566 . . . . 0.0 109.846 178.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 -133.94 158.86 74.42 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.324 -179.749 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -60.43 -19.97 61.36 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.175 1.917 . . . . 0.0 111.917 177.648 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 34.8 p -100.43 2.72 42.49 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.724 -179.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 70.6 t80 -147.05 101.39 3.41 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-O 121.128 0.49 . . . . 0.0 109.921 -178.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 3.3 t-160 -131.08 110.22 11.04 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 -177.689 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . 0.646 ' HA ' ' HA3' ' A' ' 101' ' ' GLY . 16.9 p80 -120.54 -178.19 3.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.744 0.307 . . . . 0.0 110.646 -176.883 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . 0.624 ' CD1' HD11 ' A' ' 81' ' ' LEU . 41.4 p90 -148.77 -171.36 3.85 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.57 174.292 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -151.73 147.28 26.5 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.913 0.387 . . . . 0.0 111.029 -177.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.429 HG23 ' O ' ' A' ' 95' ' ' VAL . 19.0 m -123.97 107.51 18.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 172.887 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 21.9 t70 67.53 -68.02 0.17 Allowed 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.903 -174.82 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 45.7 t-20 -144.25 -43.04 0.26 Allowed 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 178.766 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 88.2 mtm180 -58.41 124.2 18.74 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.037 -179.538 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.48 ' HD3' ' N ' ' A' ' 99' ' ' LYS . 0.0 OUTLIER -116.42 129.32 56.16 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.245 -175.107 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . 0.4 ' HA ' ' HZ3' ' A' ' 32' ' ' TRP . 1.8 p90 -148.22 155.3 41.2 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.384 -0.825 . . . . 0.0 109.356 177.421 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.646 ' HA3' ' HA ' ' A' ' 92' ' ' HIS . . . -175.83 -157.57 17.4 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.565 -0.826 . . . . 0.0 113.148 -176.915 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.756 HD22 HG21 ' A' ' 43' ' ' VAL . 9.2 mp -114.56 146.6 40.56 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 121.362 0.601 . . . . 0.0 111.683 -174.354 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 91.4 m -123.69 111.51 16.28 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 166.649 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 48.7 m-85 -89.77 149.42 22.72 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.737 -170.398 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 19.3 mp0 -103.08 -43.14 5.57 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 170.708 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -82.2 141.61 46.59 Favored Pre-proline 0 CA--C 1.535 0.388 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.496 178.7 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -86.38 -38.48 0.09 OUTLIER 'Trans proline' 0 C--N 1.353 0.776 0 C-N-CA 122.676 2.251 . . . . 0.0 114.217 -174.052 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -64.89 -60.08 3.47 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 120.879 0.371 . . . . 0.0 111.639 -172.767 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 22.4 p-10 -66.43 -26.51 67.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.476 -178.696 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -60.68 -52.79 63.62 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 121.217 0.532 . . . . 0.0 110.313 172.706 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 4.2 tmm_? -63.81 -32.72 74.33 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.746 178.242 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -65.68 -39.27 91.11 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.749 177.214 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.468 ' O ' HG23 ' A' ' 117' ' ' VAL . 73.2 t80 -66.91 -52.99 36.48 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.122 179.079 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.442 ' O ' ' HG3' ' A' ' 118' ' ' ARG . 13.7 t70 -54.09 -56.9 13.71 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 121.522 0.677 . . . . 0.0 110.178 179.42 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 15.2 tpt180 -53.27 -47.74 68.87 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-N 114.628 -1.169 . . . . 0.0 110.605 176.825 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -59.76 -38.69 94.29 Favored Glycine 0 N--CA 1.451 -0.327 0 CA-C-N 115.505 -0.77 . . . . 0.0 112.15 -179.695 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.468 HG23 ' O ' ' A' ' 113' ' ' PHE . 48.3 t -62.09 -46.98 95.25 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 CA-C-O 120.736 0.303 . . . . 0.0 110.315 177.406 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.442 ' HG3' ' O ' ' A' ' 114' ' ' ASP . 81.5 mtt180 -54.85 -54.7 39.05 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.125 179.582 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.633 ' HB3' ' HZ2' ' A' ' 119' ' ' LYS . 0.0 OUTLIER -68.2 -29.59 68.47 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.764 -177.258 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -65.19 -58.05 6.96 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.829 0.347 . . . . 0.0 110.342 179.547 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 49.3 mm -59.63 -43.07 90.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.388 179.663 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 13.5 tp10 -58.52 -50.14 74.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.571 -179.303 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -72.7 -29.81 63.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.911 -176.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 6.1 tt -69.09 -53.31 20.98 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.753 179.733 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 47.9 mm -72.32 -52.47 23.87 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.547 -174.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 . . . . . 0 C--O 1.25 1.107 0 CA-C-O 119.011 -0.519 . . . . 0.0 110.145 -175.288 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 6.4 m . . . . . 0 CA--C 1.536 0.428 0 N-CA-C 112.494 0.553 . . . . 0.0 112.494 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 10.0 m-85 -66.89 112.93 4.56 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 120.685 0.279 . . . . 0.0 110.489 176.009 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.538 HG13 HG23 ' A' ' 16' ' ' VAL . 34.0 pt -92.01 -26.82 4.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.357 178.188 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.538 HG23 HG13 ' A' ' 15' ' ' ILE . 92.1 t -135.35 137.72 49.53 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.194 179.466 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.462 ' NH1' ' HG2' ' A' ' 42' ' ' ARG . 18.9 tpp180 -132.74 123.33 26.03 Favored 'General case' 0 N--CA 1.463 0.21 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 175.508 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 30.2 m -124.09 176.6 5.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 C-N-CA 122.659 0.383 . . . . 0.0 110.375 179.072 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 22.4 pttp -132.48 125.51 30.83 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 179.43 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -165.91 177.71 6.95 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 -179.3 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 60.2 t -100.24 118.14 46.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 110.177 -0.305 . . . . 0.0 110.177 176.059 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 17.8 m -66.71 109.0 1.15 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.354 0 CA-C-O 121.352 0.596 . . . . 0.0 111.237 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 25.1 mmt -106.65 166.52 10.51 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.129 179.626 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.521 HG23 ' CE1' ' A' ' 33' ' ' PHE . 11.0 t -160.84 150.63 17.39 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.934 -0.575 . . . . 0.0 109.708 177.769 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 20.7 ttt180 -120.31 100.64 7.29 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 174.071 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -69.38 84.31 0.4 Allowed 'General case' 0 C--O 1.235 0.299 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.481 179.449 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 15.4 t70 64.44 -81.63 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.139 -175.673 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 41.2 m -149.43 17.8 0.93 Allowed 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 120.81 0.338 . . . . 0.0 110.432 178.228 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 38.6 t -64.66 89.58 0.07 Allowed 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.829 -179.483 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 76.32 -63.72 2.91 Favored Glycine 0 C--N 1.332 0.353 0 CA-C-N 116.093 -0.503 . . . . 0.0 112.351 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 158.51 -140.28 6.84 Favored Glycine 0 N--CA 1.449 -0.475 0 N-CA-C 111.027 -0.829 . . . . 0.0 111.027 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' TRP . . . . . 0.492 ' HH2' ' HG2' ' A' ' 99' ' ' LYS . 97.9 m95 -79.02 93.9 5.2 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 176.977 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.521 ' CE1' HG23 ' A' ' 24' ' ' THR . 21.3 p90 -103.65 143.17 26.11 Favored Pre-proline 0 C--O 1.236 0.353 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.505 -178.311 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -69.08 103.37 1.04 Allowed 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.286 1.991 . . . . 0.0 111.266 176.19 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' GLN . . . . . 0.427 ' H ' ' HG2' ' A' ' 35' ' ' GLN . 3.7 pt20 -57.04 -49.44 75.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.476 -179.625 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -157.45 171.2 20.8 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 179.36 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 78.52 -75.41 1.97 Allowed Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 121.053 -0.594 . . . . 0.0 111.777 -179.483 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 70.91 -73.95 0.64 Allowed Glycine 0 C--N 1.332 0.354 0 C-N-CA 121.562 -0.351 . . . . 0.0 112.25 -179.622 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -70.86 76.96 0.54 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 121.5 -0.381 . . . . 0.0 112.289 178.964 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 38.1 mm 66.87 142.84 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 C-N-CA 123.442 0.697 . . . . 0.0 111.31 178.455 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 18.2 m -132.96 133.85 43.74 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.057 0.455 . . . . 0.0 110.44 178.83 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.462 ' HG2' ' NH1' ' A' ' 17' ' ' ARG . 37.8 ttt85 -86.51 83.44 7.64 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.551 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 28.8 t -100.97 155.53 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.567 -172.414 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -162.78 -178.19 36.41 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.623 -0.799 . . . . 0.0 112.702 177.951 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 59.8 t -128.98 128.63 67.52 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 179.008 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' CYS . . . . . 0.526 ' SG ' ' HB3' ' A' ' 60' ' ' LEU . 13.7 p -119.45 126.44 51.32 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 176.479 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -82.06 98.39 8.62 Favored 'General case' 0 C--O 1.234 0.237 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 179.392 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.5 HG21 ' HE1' ' A' ' 76' ' ' TYR . 33.0 m -86.53 -168.95 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.21 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 22.1 ptp . . . . . 0 C--N 1.328 -0.351 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 177.497 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.248 0 N-CA-C 110.714 -0.954 . . . . 0.0 110.714 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -135.96 148.7 48.59 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 117.337 0.568 . . . . 0.0 110.518 -177.747 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.67 HD22 ' HB2' ' A' ' 62' ' ' HIS . 2.3 tt -133.37 113.0 12.07 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 179.171 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.558 ' HB ' ' HB2' ' A' ' 75' ' ' CYS . 46.2 mt -79.96 98.31 3.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 108.396 -0.965 . . . . 0.0 108.396 174.605 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' HIS . . . . . 0.67 ' HB2' HD22 ' A' ' 60' ' ' LEU . 23.8 t-80 -120.93 141.22 50.86 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 -173.919 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -156.3 126.93 1.88 Allowed Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.322 -0.942 . . . . 0.0 113.132 -177.439 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -90.5 164.04 14.4 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 172.273 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.576 ' HB3' HG11 ' A' ' 72' ' ' VAL . 16.5 ptm180 -81.41 164.1 22.32 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.176 -0.675 . . . . 0.0 109.176 172.633 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 54.7 tp60 -78.05 68.3 4.07 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-O 121.38 0.61 . . . . 0.0 109.43 179.304 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.817 ' HA ' ' HE3' ' A' ' 67' ' ' LYS . 0.5 OUTLIER -171.58 49.7 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.223 -0.899 . . . . 0.0 109.017 -177.145 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.437 ' HB2' ' O ' ' A' ' 67' ' ' LYS . 4.3 m-20 71.8 -179.05 0.22 Allowed 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 115.257 -0.883 . . . . 0.0 111.149 -177.502 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 5.1 mptp? -65.92 93.62 0.2 Allowed 'General case' 0 C--O 1.233 0.215 0 CA-C-N 115.897 -0.592 . . . . 0.0 112.594 -175.463 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 58.1 tp -136.22 105.14 5.88 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 167.403 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 44.1 t -62.56 108.34 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.673 -177.035 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.576 HG11 ' HB3' ' A' ' 65' ' ' ARG . 33.7 m -107.75 -9.84 10.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.77 179.112 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -144.67 127.11 15.93 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 179.338 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -146.74 115.27 6.74 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 177.931 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' CYS . . . . . 0.558 ' HB2' ' HB ' ' A' ' 61' ' ' ILE . 39.8 m -137.73 85.42 2.11 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.079 0.466 . . . . 0.0 109.986 177.545 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.5 ' HE1' HG21 ' A' ' 48' ' ' VAL . 86.3 t80 -75.28 135.38 40.94 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.548 176.837 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.437 HG11 ' HG ' ' A' ' 81' ' ' LEU . 25.6 m -134.19 149.56 30.32 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 177.602 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.444 ' N ' ' HD3' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -108.83 -35.09 6.47 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.183 -174.346 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 59.9 tttm -165.83 23.34 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 121.491 0.663 . . . . 0.0 109.625 -177.591 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -146.63 125.18 12.44 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.227 -170.223 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.437 ' HG ' HG11 ' A' ' 77' ' ' VAL . 5.3 mt -160.81 122.55 3.05 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.014 177.042 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 48.4 t -124.29 98.64 5.52 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 177.882 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.644 ' HB3' ' NE2' ' A' ' 91' ' ' HIS . 84.1 m-85 -90.58 161.68 15.34 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.407 177.234 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 60.7 m -158.89 115.66 2.72 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 174.908 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.448 ' HA ' ' HA ' ' A' ' 91' ' ' HIS . 36.2 ttpt -89.11 107.54 19.1 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 178.457 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -73.71 -41.68 62.26 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.387 -175.001 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -136.61 153.47 75.97 Favored Pre-proline 0 C--N 1.325 -0.472 0 CA-C-N 115.203 -0.908 . . . . 0.0 108.647 179.017 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_exo -52.89 -23.51 21.26 Favored 'Trans proline' 0 N--CA 1.476 0.449 0 C-N-CA 122.491 2.127 . . . . 0.0 112.695 -179.166 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 14.6 t -107.54 8.93 29.55 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.576 -177.277 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.42 ' HE1' ' HB3' ' A' ' 92' ' ' HIS . 4.6 t80 -148.38 111.68 4.95 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-O 120.975 0.417 . . . . 0.0 110.953 -178.083 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' HIS . . . . . 0.644 ' NE2' ' HB3' ' A' ' 83' ' ' TYR . 3.1 t-160 -111.52 133.28 53.91 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 177.613 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' HIS . . . . . 0.439 ' HB2' ' O ' ' A' ' 100' ' ' PHE . 21.6 p-80 -134.52 165.22 25.69 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.852 0.358 . . . . 0.0 111.346 -177.345 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 47.4 p90 -147.66 143.87 27.97 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.351 -179.679 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 48.6 tttm -112.99 122.94 49.14 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.153 179.574 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 27.7 m -110.21 32.88 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.325 0 CA-C-O 121.265 0.555 . . . . 0.0 109.937 -177.538 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 23.8 t70 71.92 -57.42 0.62 Allowed 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 114.859 -1.064 . . . . 0.0 109.81 -173.593 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -73.9 97.1 2.72 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 172.497 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 12.2 mpt_? 60.56 176.38 0.1 Allowed 'General case' 0 C--O 1.243 0.748 0 CA-C-O 122.186 0.993 . . . . 0.0 112.077 -176.972 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.492 ' HG2' ' HH2' ' A' ' 32' ' ' TRP . 38.1 ttpt -126.51 106.95 9.81 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 114.34 -1.3 . . . . 0.0 108.2 176.274 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' PHE . . . . . 0.491 ' CD2' ' SG ' ' A' ' 75' ' ' CYS . 4.7 m-85 -89.76 173.87 8.03 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 -175.816 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -177.66 -175.44 44.87 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.833 -0.699 . . . . 0.0 111.972 177.747 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.449 ' O ' HD12 ' A' ' 102' ' ' LEU . 1.3 pp -152.0 150.33 29.87 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.099 0.476 . . . . 0.0 110.898 177.012 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 25.2 m -101.0 116.18 32.24 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.806 176.968 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 40.5 m-85 -63.59 147.42 51.52 Favored 'General case' 0 C--O 1.237 0.413 0 O-C-N 123.369 0.418 . . . . 0.0 110.422 178.551 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 19.0 pt20 -114.25 -10.8 12.68 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.473 -0.331 . . . . 0.0 110.974 -178.244 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 20.4 m -155.12 151.7 23.5 Favored Pre-proline 0 C--N 1.33 -0.251 0 N-CA-C 110.089 -0.337 . . . . 0.0 110.089 174.667 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -60.16 -19.2 55.7 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.344 2.029 . . . . 0.0 111.65 176.361 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -66.08 -60.43 2.83 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.519 177.381 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -65.19 -31.98 73.43 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.79 179.035 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -57.61 -61.53 2.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.003 0.43 . . . . 0.0 110.726 175.943 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' ARG . . . . . 0.428 ' HD2' ' O ' ' A' ' 111' ' ' ARG . 5.4 tmm_? -62.57 -38.23 89.28 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.235 -177.496 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -63.5 -43.48 97.11 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.095 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.405 ' O ' HG23 ' A' ' 117' ' ' VAL . 75.4 t80 -67.06 -47.33 71.64 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.081 -178.899 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 59.5 m-20 -57.5 -39.48 76.57 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.526 178.095 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -62.12 -49.86 74.22 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.112 178.359 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -61.25 -42.4 99.77 Favored Glycine 0 C--N 1.333 0.367 0 CA-C-N 115.599 -0.728 . . . . 0.0 112.063 179.631 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.405 HG23 ' O ' ' A' ' 113' ' ' PHE . 55.4 t -60.91 -46.67 96.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.927 0.394 . . . . 0.0 110.699 177.883 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 25.6 tpt180 -59.88 -49.78 76.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.221 -177.549 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 4.3 mmmp? -64.28 -41.18 97.02 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.942 178.691 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -58.08 -55.99 27.78 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.538 -179.591 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.457 ' O ' HG22 ' A' ' 125' ' ' ILE . 46.2 mm -58.27 -42.59 84.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.326 178.687 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -53.28 -59.08 5.01 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.472 -179.355 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 50.0 m-20 -74.16 -24.67 59.42 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.271 -176.918 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 9.9 tt -68.89 -38.83 79.9 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.36 178.511 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.457 HG22 ' O ' ' A' ' 121' ' ' ILE . 13.8 tt -91.17 -37.83 9.77 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 CA-C-N 116.625 -0.261 . . . . 0.0 111.342 -176.496 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 . . . . . 0 C--O 1.25 1.093 0 CA-C-O 118.422 -0.799 . . . . 0.0 110.218 -177.04 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 39.2 t . . . . . 0 C--O 1.238 0.46 0 CA-C-O 120.522 0.201 . . . . 0.0 111.442 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -64.2 140.75 58.9 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 120.912 0.386 . . . . 0.0 111.303 -177.905 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 61.2 mt -126.71 -64.92 0.98 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.203 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.427 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.566 ' HB ' ' HB ' ' A' ' 45' ' ' VAL . 60.2 t -99.07 106.29 18.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.095 -178.193 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.421 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 62.2 mtm180 -120.42 90.15 3.27 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.044 0.45 . . . . 0.0 110.212 179.421 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.418 HG11 ' HB2' ' A' ' 109' ' ' ASP . 86.6 t -107.89 135.87 45.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.887 -176.545 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -85.46 106.16 16.6 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 174.239 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -144.84 -172.15 3.77 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.114 -177.812 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.587 ' HB ' ' HB ' ' A' ' 103' ' ' THR . 23.6 t -101.53 121.54 52.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.615 0.245 . . . . 0.0 110.473 -179.193 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.502 HG11 ' HG ' ' A' ' 73' ' ' LEU . 60.8 t -97.71 98.28 7.18 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 CA-C-O 121.035 0.445 . . . . 0.0 110.461 176.134 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' MET . . . . . 0.444 ' HB3' ' HB3' ' A' ' 32' ' ' TRP . 24.9 mmt -74.47 106.38 6.04 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 174.06 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.462 HG23 ' CE1' ' A' ' 33' ' ' PHE . 10.0 t -76.69 -46.4 25.72 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 111.583 0.216 . . . . 0.0 111.583 -173.204 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.514 ' HB2' ' CE3' ' A' ' 32' ' ' TRP . 23.4 ttt180 57.84 135.13 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 121.317 0.58 . . . . 0.0 110.396 -172.041 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -81.08 64.85 5.98 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 177.512 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 32.5 t70 58.96 -74.73 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 114.536 -1.211 . . . . 0.0 110.932 -172.5 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 26.4 t -121.76 99.06 6.25 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 177.242 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 10.8 m -126.04 159.71 32.04 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.712 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -69.3 76.55 0.35 Allowed Glycine 0 C--N 1.332 0.34 0 N-CA-C 111.582 -0.607 . . . . 0.0 111.582 176.583 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 106.72 -158.67 15.16 Favored Glycine 0 C--O 1.237 0.334 0 N-CA-C 111.264 -0.735 . . . . 0.0 111.264 -175.035 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' TRP . . . . . 0.514 ' CE3' ' HB2' ' A' ' 25' ' ' ARG . 53.7 m95 -127.42 126.16 41.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.656 0.265 . . . . 0.0 110.424 -179.593 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.479 ' HA ' ' HD3' ' A' ' 34' ' ' PRO . 6.4 p90 -114.44 137.71 22.75 Favored Pre-proline 0 C--O 1.238 0.45 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.139 -179.851 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.581 ' HB2' ' HA2' ' A' ' 38' ' ' GLY . 7.3 Cg_exo -74.05 154.07 47.18 Favored 'Trans proline' 0 N--CA 1.462 -0.367 0 C-N-CA 122.785 2.323 . . . . 0.0 111.358 175.897 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' GLN . . . . . 0.403 ' NE2' ' HB ' ' A' ' 22' ' ' VAL . 0.0 OUTLIER -75.51 -163.39 0.25 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.303 175.166 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -45.99 -34.55 4.09 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 -173.982 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -66.73 -30.1 75.74 Favored Glycine 0 CA--C 1.519 0.336 0 C-N-CA 121.242 -0.504 . . . . 0.0 113.074 -175.581 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.581 ' HA2' ' HB2' ' A' ' 34' ' ' PRO . . . 58.37 13.53 16.44 Favored Glycine 0 CA--C 1.522 0.476 0 C-N-CA 121.506 -0.378 . . . . 0.0 113.248 179.497 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.482 ' HA2' HG22 ' A' ' 21' ' ' VAL . . . 154.81 -43.12 0.58 Allowed Glycine 0 N--CA 1.449 -0.451 0 N-CA-C 111.612 -0.595 . . . . 0.0 111.612 -176.884 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.455 ' O ' HG13 ' A' ' 40' ' ' ILE . 32.4 pt -89.88 111.06 22.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 121.221 0.534 . . . . 0.0 110.532 179.263 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 21.1 m -146.41 131.15 17.96 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.73 177.581 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.586 ' HB3' ' HB2' ' A' ' 64' ' ' GLU . 35.4 ttt180 -90.31 103.27 15.97 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 176.304 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.642 HG21 HD21 ' A' ' 102' ' ' LEU . 25.5 t -81.2 94.51 2.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.164 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -90.27 81.89 1.37 Allowed Glycine 0 N--CA 1.452 -0.276 0 CA-C-N 115.978 -0.556 . . . . 0.0 112.639 -177.766 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.566 ' HB ' ' HB ' ' A' ' 16' ' ' VAL . 61.0 t -76.44 108.72 9.55 Favored 'Isoleucine or valine' 0 C--O 1.24 0.569 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 176.506 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' CYS . . . . . 0.633 ' SG ' ' HB3' ' A' ' 60' ' ' LEU . 11.8 p -115.65 136.86 52.64 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.997 -177.738 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -91.52 92.31 8.46 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 176.397 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 23.1 m -83.76 111.63 20.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 121.396 0.617 . . . . 0.0 110.667 -176.837 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 22.7 ptp . . . . . 0 C--O 1.234 0.261 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.392 -179.956 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.387 0 N-CA-C 111.188 -0.765 . . . . 0.0 111.188 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -117.84 106.91 13.49 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.934 0.397 . . . . 0.0 110.286 179.625 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.633 ' HB3' ' SG ' ' A' ' 46' ' ' CYS . 2.5 tt -88.66 105.16 17.5 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 179.7 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.422 ' HB ' ' HB2' ' A' ' 75' ' ' CYS . 58.6 mt -73.41 87.96 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 174.719 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 8.5 t-80 -91.55 100.33 13.09 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.177 -175.318 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.489 ' HA3' ' HB2' ' A' ' 73' ' ' LEU . . . -87.1 95.09 2.04 Favored Glycine 0 N--CA 1.449 -0.496 0 CA-C-N 115.762 -0.654 . . . . 0.0 112.324 -178.819 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.586 ' HB2' ' HB3' ' A' ' 42' ' ' ARG . 34.6 mt-10 -83.07 137.49 34.08 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 177.007 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.53 ' NH1' ' HB2' ' A' ' 67' ' ' LYS . 6.3 tmm_? -114.04 126.18 54.83 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 178.411 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.433 ' O ' ' HD2' ' A' ' 65' ' ' ARG . 1.0 OUTLIER -67.84 -160.95 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.488 0 O-C-N 123.564 0.54 . . . . 0.0 112.073 -174.262 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.53 ' HB2' ' NH1' ' A' ' 65' ' ' ARG . 34.5 mmtp 65.4 -82.89 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 -173.998 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.434 ' HB2' HD12 ' A' ' 70' ' ' LEU . 5.9 m-20 -74.22 -30.81 62.35 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.615 176.47 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.44 ' HA ' ' O ' ' A' ' 65' ' ' ARG . 22.8 tptm 60.27 81.89 0.17 Allowed 'General case' 0 C--O 1.233 0.217 0 CA-C-N 115.084 -0.962 . . . . 0.0 110.074 -176.721 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.434 HD12 ' HB2' ' A' ' 68' ' ' ASP . 0.0 OUTLIER -150.1 168.7 23.16 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.472 -177.741 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 21.6 t -83.15 109.69 17.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.893 -176.711 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.435 HG23 HD23 ' A' ' 73' ' ' LEU . 18.0 m -102.05 -35.91 4.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 CA-C-O 120.888 0.375 . . . . 0.0 111.053 177.968 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.502 ' HG ' HG11 ' A' ' 22' ' ' VAL . 4.5 mm? -116.24 117.11 29.1 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.229 178.741 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -118.96 104.2 10.29 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 176.205 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' CYS . . . . . 0.422 ' HB2' ' HB ' ' A' ' 61' ' ' ILE . 61.1 m -135.22 83.48 2.02 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.346 0.593 . . . . 0.0 110.632 -179.329 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.4 ' HA ' ' HA ' ' A' ' 60' ' ' LEU . 80.0 t80 -69.41 105.98 2.78 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.468 -0.787 . . . . 0.0 108.997 172.477 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 39.6 t -100.69 132.71 45.84 Favored 'Isoleucine or valine' 0 C--O 1.237 0.395 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 -175.053 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 30.4 ttp180 -135.46 100.17 4.43 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.403 -174.33 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.751 ' H ' HD21 ' A' ' 124' ' ' LEU . 66.4 mmtt 72.05 -29.74 0.2 Allowed 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.339 0.655 . . . . 0.0 112.748 178.444 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -88.38 23.01 2.31 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 120.973 0.416 . . . . 0.0 110.753 -177.058 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.604 HD22 HG12 ' A' ' 121' ' ' ILE . 1.0 OUTLIER -71.3 89.85 0.91 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.828 -179.249 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 49.0 t -123.0 99.9 7.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.121 0.486 . . . . 0.0 110.593 179.734 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.716 ' HB3' ' NE2' ' A' ' 91' ' ' HIS . 4.2 m-85 -87.1 115.47 24.51 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.47 175.738 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 31.2 m -98.61 119.71 37.8 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.176 -0.465 . . . . 0.0 109.869 173.387 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 24.2 ttmm -86.6 103.94 15.57 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 176.646 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -82.56 -19.9 37.62 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 121.064 0.459 . . . . 0.0 110.237 -178.869 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ASN . . . . . 0.856 ' HB3' ' HB3' ' A' ' 90' ' ' PHE . 12.3 t-20 -156.58 144.69 14.3 Favored Pre-proline 0 C--N 1.326 -0.453 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 178.761 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.446 ' HD2' ' ND2' ' A' ' 87' ' ' ASN . 33.9 Cg_exo -34.47 -50.8 0.65 Allowed 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 123.374 2.716 . . . . 0.0 113.718 179.309 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.562 ' HA ' ' HD2' ' A' ' 104' ' ' PHE . 19.5 p -102.37 -0.72 32.18 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 112.144 0.424 . . . . 0.0 112.144 -176.872 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.856 ' HB3' ' HB3' ' A' ' 87' ' ' ASN . 62.0 t80 -115.78 99.3 7.21 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-O 121.402 0.62 . . . . 0.0 110.07 176.922 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' HIS . . . . . 0.716 ' NE2' ' HB3' ' A' ' 83' ' ' TYR . 0.8 OUTLIER -103.15 149.9 24.18 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 177.493 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 25.5 p80 -149.91 159.56 44.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 118.206 0.457 . . . . 0.0 110.74 176.858 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' TRP . . . . . 0.645 ' HZ3' ' HB2' ' A' ' 102' ' ' LEU . 28.5 p90 -137.29 146.72 45.01 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.323 -0.399 . . . . 0.0 109.979 178.632 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.525 ' NZ ' ' HB3' ' A' ' 94' ' ' LYS . 5.7 ttpm? -114.63 99.47 7.55 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.704 -178.708 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.479 HG13 ' HD1' ' A' ' 93' ' ' TRP . 16.7 m -85.18 113.58 23.87 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 176.023 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 57.08 -86.89 0.02 OUTLIER 'General case' 0 C--O 1.235 0.311 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.405 -173.795 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -126.22 -16.66 5.42 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.457 -177.865 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.98 134.2 33.51 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.836 0.351 . . . . 0.0 110.86 -177.395 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 3.6 mppt? -109.98 123.24 49.29 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.029 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' PHE . . . . . 0.401 ' CE2' ' SG ' ' A' ' 75' ' ' CYS . 44.3 m-85 -122.05 141.71 51.1 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 176.211 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -116.73 125.33 6.52 Favored Glycine 0 CA--C 1.516 0.144 0 C-N-CA 121.377 -0.439 . . . . 0.0 113.227 -174.668 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.645 ' HB2' ' HZ3' ' A' ' 93' ' ' TRP . 0.4 OUTLIER -94.4 104.28 16.25 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 175.675 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.587 ' HB ' ' HB ' ' A' ' 21' ' ' VAL . 33.3 m -92.54 119.5 32.07 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 177.161 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.562 ' HD2' ' HA ' ' A' ' 89' ' ' THR . 36.7 m-85 -73.82 148.22 42.64 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.438 -175.04 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 49.8 tt0 -88.81 -52.56 5.05 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.605 -176.599 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 19.7 m -134.01 159.11 73.67 Favored Pre-proline 0 C--N 1.326 -0.413 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.142 -177.826 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_endo -55.59 -29.85 71.96 Favored 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 122.526 2.15 . . . . 0.0 112.17 -179.46 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -61.8 -62.04 2.08 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.77 179.371 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.418 ' HB2' HG11 ' A' ' 18' ' ' VAL . 3.3 p-10 -66.83 -29.09 68.92 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.838 -179.455 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -57.82 -60.82 3.12 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.922 0.392 . . . . 0.0 110.697 176.832 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 69.7 mtp180 -64.12 -42.37 96.89 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.54 -0.754 . . . . 0.0 110.802 -178.431 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -61.54 -41.46 97.38 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.938 -179.359 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 35.4 t80 -75.42 -37.02 60.67 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.213 -177.857 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 35.3 m-20 -58.82 -53.83 53.92 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 120.884 0.373 . . . . 0.0 110.336 177.29 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? -66.01 -37.92 87.15 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.501 179.05 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -62.77 -49.98 68.07 Favored Glycine 0 C--N 1.331 0.274 0 CA-C-N 116.053 -0.522 . . . . 0.0 112.501 -179.765 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.515 ' O ' HG13 ' A' ' 121' ' ' ILE . 9.1 p -69.66 -35.45 65.9 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.201 0 N-CA-C 110.123 -0.325 . . . . 0.0 110.123 -178.598 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.52 ' O ' ' HG3' ' A' ' 122' ' ' GLU . 69.8 ttt180 -57.46 -51.16 70.59 Favored 'General case' 0 C--O 1.23 0.073 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 176.091 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 64.3 tttp -56.82 -43.93 81.53 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.422 177.453 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.58 -43.18 97.61 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.154 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.604 HG12 HD22 ' A' ' 81' ' ' LEU . 80.2 mt -62.18 -51.53 71.3 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.195 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.414 179.536 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.52 ' HG3' ' O ' ' A' ' 118' ' ' ARG . 42.8 mt-10 -61.23 -44.52 97.13 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 115.729 -0.668 . . . . 0.0 110.616 -177.363 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -60.67 -42.21 96.62 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.527 178.323 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.751 HD21 ' H ' ' A' ' 79' ' ' LYS . 41.0 tp -66.65 -47.72 71.66 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.134 -177.715 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.481 HG12 ' O ' ' A' ' 121' ' ' ILE . 17.7 pt -74.53 -65.05 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 C-N-CA 120.964 -0.294 . . . . 0.0 111.42 -176.791 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.479 ' H ' HG13 ' A' ' 125' ' ' ILE . 71.7 mm-40 . . . . . 0 C--O 1.25 1.129 0 CA-C-O 119.035 -0.507 . . . . 0.0 110.069 -172.498 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.538 0.503 0 CA-C-O 121.057 0.456 . . . . 0.0 111.277 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -76.89 137.88 39.4 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.046 177.499 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.715 HD11 ' HB2' ' A' ' 47' ' ' LYS . 1.8 mp -88.35 -53.48 9.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 173.723 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 14.5 p -166.03 146.07 1.66 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.311 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.38 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.541 ' HG2' ' HA3' ' A' ' 44' ' ' GLY . 24.0 mtm180 -118.09 109.06 15.97 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.492 173.04 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 34.8 m -109.23 162.81 6.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.824 -177.058 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.5 ' HE3' HG12 ' A' ' 40' ' ' ILE . 83.9 tttt -84.41 130.13 34.8 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.414 177.172 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -153.92 -167.27 2.61 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 175.378 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.57 ' HB ' ' HB ' ' A' ' 103' ' ' THR . 64.8 t -124.51 114.85 42.63 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 175.15 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.507 HG23 ' HG2' ' A' ' 35' ' ' GLN . 9.3 m -73.08 110.45 6.32 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 CA-C-O 121.367 0.603 . . . . 0.0 111.67 -178.102 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' MET . . . . . 0.556 ' SD ' HG12 ' A' ' 21' ' ' VAL . 38.3 mmm -104.42 146.02 29.45 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.628 -0.714 . . . . 0.0 109.554 -178.521 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 10.7 t -135.32 -6.12 2.3 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 111.766 0.284 . . . . 0.0 111.766 179.26 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 31.6 ttp180 53.25 46.93 25.46 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 122.891 0.477 . . . . 0.0 111.324 -178.26 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.496 ' O ' ' HB3' ' A' ' 27' ' ' ASP . 4.4 p-10 45.88 26.65 0.4 Allowed 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 124.038 0.935 . . . . 0.0 113.361 174.102 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.496 ' HB3' ' O ' ' A' ' 26' ' ' ASP . 8.3 t70 74.99 -40.23 0.43 Allowed 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 122.785 0.434 . . . . 0.0 111.518 178.633 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 17.2 m -96.91 -91.57 0.24 Allowed 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 116.945 -0.116 . . . . 0.0 111.278 -176.017 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 11.0 p -176.72 27.73 0.0 OUTLIER 'General case' 0 C--O 1.236 0.391 0 N-CA-C 112.253 0.464 . . . . 0.0 112.253 -174.966 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -76.34 -28.83 59.23 Favored Glycine 0 CA--C 1.519 0.342 0 C-N-CA 120.772 -0.727 . . . . 0.0 111.924 179.066 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 158.34 151.3 6.03 Favored Glycine 0 CA--C 1.519 0.318 0 C-N-CA 121.386 -0.435 . . . . 0.0 112.265 178.593 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 83.9 m95 -76.95 102.04 6.24 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 110.165 -0.309 . . . . 0.0 110.165 179.508 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.411 ' H ' ' HD1' ' A' ' 33' ' ' PHE . 0.2 OUTLIER -114.83 153.55 46.94 Favored Pre-proline 0 C--O 1.237 0.422 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.145 177.48 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_exo -67.05 130.67 23.39 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.791 2.328 . . . . 0.0 111.473 175.816 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' GLN . . . . . 0.507 ' HG2' HG23 ' A' ' 22' ' ' VAL . 14.1 pt20 -92.02 85.92 5.67 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 121.32 0.581 . . . . 0.0 110.837 -178.132 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 71.66 -34.13 0.29 Allowed 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.929 0.892 . . . . 0.0 113.312 176.459 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.446 ' HA2' ' HD2' ' A' ' 65' ' ' ARG . . . -63.77 -50.02 64.3 Favored Glycine 0 C--N 1.333 0.405 0 C-N-CA 121.163 -0.541 . . . . 0.0 112.347 -179.729 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 82.45 -146.0 24.46 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.99 -0.624 . . . . 0.0 111.672 -178.312 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -65.17 -23.6 69.89 Favored Glycine 0 CA--C 1.518 0.243 0 C-N-CA 121.429 -0.415 . . . . 0.0 112.83 -178.601 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.5 HG12 ' HE3' ' A' ' 19' ' ' LYS . 57.8 mt -113.52 104.3 16.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.961 0.41 . . . . 0.0 110.344 179.28 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.454 ' HB3' HG13 ' A' ' 22' ' ' VAL . 19.1 m -131.1 107.71 9.24 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 173.697 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.615 ' HB3' ' HG3' ' A' ' 64' ' ' GLU . 47.0 ttt180 -77.08 91.72 3.7 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.223 0.535 . . . . 0.0 109.901 -177.422 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 78.8 t -79.74 119.89 30.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.197 -179.459 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.541 ' HA3' ' HG2' ' A' ' 17' ' ' ARG . . . -116.91 123.28 5.75 Favored Glycine 0 N--CA 1.445 -0.705 0 CA-C-N 115.897 -0.592 . . . . 0.0 112.76 -177.396 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.456 HG13 ' HB ' ' A' ' 15' ' ' ILE . 7.6 p -99.51 123.29 52.15 Favored 'Isoleucine or valine' 0 C--O 1.24 0.591 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 175.086 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' CYS . . . . . 0.825 ' SG ' ' HB3' ' A' ' 60' ' ' LEU . 8.8 p -126.37 141.87 51.74 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.507 178.853 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.715 ' HB2' HD11 ' A' ' 15' ' ' ILE . 83.3 tttt -88.21 102.19 14.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.843 -176.199 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.574 HG11 ' OH ' ' A' ' 76' ' ' TYR . 95.4 t -74.67 96.14 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 121.06 0.457 . . . . 0.0 110.631 -177.139 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.238 0.478 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.286 178.566 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.238 0 N-CA-C 111.827 -0.509 . . . . 0.0 111.827 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -141.09 144.49 34.93 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.751 0.31 . . . . 0.0 110.501 -179.008 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.825 ' HB3' ' SG ' ' A' ' 46' ' ' CYS . 1.6 tt -104.51 109.47 21.36 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 172.559 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.659 ' HB ' ' HB3' ' A' ' 75' ' ' CYS . 44.5 mm -81.66 89.52 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 108.415 -0.958 . . . . 0.0 108.415 174.354 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 12.3 t-80 -93.01 144.35 25.33 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.509 -0.768 . . . . 0.0 110.617 -173.997 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.513 ' HA3' ' HB3' ' A' ' 73' ' ' LEU . . . -131.43 87.21 0.29 Allowed Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 121.164 -0.541 . . . . 0.0 111.986 179.085 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.615 ' HG3' ' HB3' ' A' ' 42' ' ' ARG . 6.0 pt-20 -88.08 135.13 33.56 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 173.483 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.446 ' HD2' ' HA2' ' A' ' 37' ' ' GLY . 21.7 mtm180 -54.78 -67.05 0.3 Allowed 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 120.868 0.366 . . . . 0.0 111.676 -172.08 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 39.6 mt-30 -118.36 -43.69 2.71 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.054 0.454 . . . . 0.0 110.61 -175.179 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 32.3 ttpt -173.16 94.24 0.11 Allowed 'General case' 0 C--O 1.236 0.352 0 CA-C-N 115.593 -0.73 . . . . 0.0 109.128 -178.956 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 12.5 t70 52.11 -143.7 0.66 Allowed 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 -175.83 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 86.0 tttt 71.04 -65.39 0.34 Allowed 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 123.513 0.725 . . . . 0.0 112.028 175.133 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.8 tt -129.01 114.49 16.47 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-O 120.711 0.291 . . . . 0.0 110.279 -175.863 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 48.3 t -89.18 113.88 26.41 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.623 176.903 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 18.5 m -105.57 -12.5 9.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 111.762 0.282 . . . . 0.0 111.762 -177.73 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.513 ' HB3' ' HA3' ' A' ' 63' ' ' GLY . 3.3 tm? -142.98 120.32 11.6 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 -179.617 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -127.71 98.51 5.21 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 178.79 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' CYS . . . . . 0.659 ' HB3' ' HB ' ' A' ' 61' ' ' ILE . 41.9 t -124.08 67.0 1.05 Allowed 'General case' 0 C--O 1.235 0.305 0 CA-C-O 121.668 0.747 . . . . 0.0 110.475 -177.708 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.574 ' OH ' HG11 ' A' ' 48' ' ' VAL . 31.8 t80 -62.64 101.14 0.23 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 114.94 -1.027 . . . . 0.0 109.089 173.64 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.609 HG21 HD12 ' A' ' 81' ' ' LEU . 29.2 m -84.08 111.39 19.92 Favored 'Isoleucine or valine' 0 C--O 1.239 0.539 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 -178.737 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.495 ' NH1' ' O ' ' A' ' 76' ' ' TYR . 9.8 mpt_? -77.56 66.05 3.2 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.98 -177.327 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 50.9 mtpt 72.71 -33.85 0.28 Allowed 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.773 0.829 . . . . 0.0 112.002 -178.476 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -75.92 108.25 8.67 Favored 'General case' 0 C--O 1.233 0.189 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 173.206 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.609 HD12 HG21 ' A' ' 77' ' ' VAL . 6.6 tt -134.58 113.8 12.13 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 -177.519 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 49.2 t -124.28 90.61 1.64 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 CA-C-O 120.701 0.286 . . . . 0.0 110.989 -179.075 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.715 ' HB3' ' NE2' ' A' ' 91' ' ' HIS . 4.1 m-85 -88.26 152.93 21.61 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 120.922 0.392 . . . . 0.0 110.205 174.012 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 61.8 m -155.55 118.2 4.23 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 123.535 0.734 . . . . 0.0 109.097 178.044 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.507 ' HA ' ' HA ' ' A' ' 91' ' ' HIS . 3.1 pptp? -90.81 131.89 36.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.888 0.375 . . . . 0.0 110.249 179.33 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.42 ' HB3' ' HD1' ' A' ' 90' ' ' PHE . . . -96.32 -31.08 13.07 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.249 0.547 . . . . 0.0 109.697 176.437 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ASN . . . . . 0.558 ' HB2' ' HB3' ' A' ' 90' ' ' PHE . 43.9 m-80 -143.3 158.93 57.01 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 115.251 -0.886 . . . . 0.0 109.282 179.134 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.422 ' O ' ' HB1' ' A' ' 110' ' ' ALA . 52.3 Cg_exo -55.91 -28.23 67.18 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.227 1.951 . . . . 0.0 111.642 175.96 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.438 ' HA ' ' HB2' ' A' ' 104' ' ' PHE . 12.6 p -109.3 16.41 22.41 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 115.74 -0.663 . . . . 0.0 111.601 -178.724 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.558 ' HB3' ' HB2' ' A' ' 87' ' ' ASN . 58.7 t80 -150.67 107.11 3.49 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-O 120.803 0.335 . . . . 0.0 110.734 -178.789 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' HIS . . . . . 0.715 ' NE2' ' HB3' ' A' ' 83' ' ' TYR . 2.2 t60 -120.16 141.92 49.43 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 177.913 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' HIS . . . . . 0.473 ' HA ' ' HA2' ' A' ' 101' ' ' GLY . 21.5 p80 -138.12 152.62 48.91 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.485 0.183 . . . . 0.0 110.516 -179.275 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' TRP . . . . . 0.617 ' HZ3' HD22 ' A' ' 102' ' ' LEU . 47.3 p90 -127.13 145.54 50.71 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 121.228 0.537 . . . . 0.0 111.245 -179.214 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 36.3 ttmt -91.59 133.42 35.56 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.285 -176.551 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.402 HG21 ' CE2' ' A' ' 100' ' ' PHE . 9.3 m -134.38 82.04 0.56 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.316 0 CA-C-O 121.558 0.694 . . . . 0.0 110.783 177.138 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 20.0 t70 59.67 -84.73 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 114.861 -1.063 . . . . 0.0 111.846 178.482 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -99.29 -48.39 4.83 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 120.741 0.305 . . . . 0.0 110.826 -176.481 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 9.0 mpt_? -87.76 176.15 7.53 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-O 121.168 0.508 . . . . 0.0 110.878 -178.927 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.414 ' HE3' ' HB2' ' A' ' 99' ' ' LYS . 39.1 ttmt -154.27 104.21 2.58 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 -178.225 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' PHE . . . . . 0.432 ' HB2' ' CE2' ' A' ' 93' ' ' TRP . 3.6 m-85 -92.97 179.12 5.54 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 -176.814 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.473 ' HA2' ' HA ' ' A' ' 92' ' ' HIS . . . -168.3 177.57 42.32 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.621 -0.8 . . . . 0.0 112.196 178.955 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.617 HD22 ' HZ3' ' A' ' 93' ' ' TRP . 2.3 pt? -142.36 133.04 25.41 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 177.163 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.57 ' HB ' ' HB ' ' A' ' 21' ' ' VAL . 24.8 m -93.63 127.4 39.3 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.56 177.081 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.455 ' HE2' ' HB2' ' A' ' 91' ' ' HIS . 73.6 m-85 -86.59 157.3 19.75 Favored 'General case' 0 C--O 1.237 0.41 0 O-C-N 123.305 0.378 . . . . 0.0 110.171 -179.859 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 21.1 mp0 -102.96 -33.74 9.19 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.327 -177.53 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 8.4 m -137.84 144.77 45.56 Favored Pre-proline 0 CA--C 1.532 0.25 0 CA-C-O 120.437 0.16 . . . . 0.0 110.78 -178.387 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_exo -53.17 -21.9 18.09 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 122.64 2.227 . . . . 0.0 112.491 176.898 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -64.06 -65.81 0.63 Allowed 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.56 176.362 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -62.48 -36.78 83.58 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.569 179.778 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.422 ' HB1' ' O ' ' A' ' 88' ' ' PRO . . . -55.84 -67.09 0.32 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.403 177.705 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 83.8 mtm180 -62.29 -34.27 76.25 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.139 -175.817 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -62.43 -43.35 99.02 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-O 120.949 0.404 . . . . 0.0 110.361 177.851 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.482 ' O ' HG23 ' A' ' 117' ' ' VAL . 52.8 t80 -69.28 -43.5 73.74 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.02 -179.841 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -55.78 -46.17 78.01 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 121.015 0.436 . . . . 0.0 110.628 177.411 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 24.2 tpt180 -65.97 -34.79 78.91 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 116.137 -0.483 . . . . 0.0 109.76 178.982 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -62.28 -38.7 96.66 Favored Glycine 0 C--N 1.333 0.366 0 N-CA-C 111.471 -0.652 . . . . 0.0 111.471 174.451 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.487 ' O ' HG13 ' A' ' 121' ' ' ILE . 96.8 t -62.21 -45.87 97.76 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.142 0 N-CA-C 109.73 -0.471 . . . . 0.0 109.73 176.373 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.539 ' O ' ' HG2' ' A' ' 122' ' ' GLU . 8.5 tpm_? -53.2 -52.44 58.87 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.467 176.621 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 7.4 tmtt? -60.26 -47.72 84.8 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.032 -178.389 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -57.6 -48.17 80.12 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.941 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.487 HG13 ' O ' ' A' ' 117' ' ' VAL . 75.0 mt -56.9 -42.51 78.59 Favored 'Isoleucine or valine' 0 C--O 1.232 0.177 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.44 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.539 ' HG2' ' O ' ' A' ' 118' ' ' ARG . 15.6 mm-40 -57.05 -57.06 14.21 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-O 121.038 0.447 . . . . 0.0 110.621 177.621 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -71.46 -12.74 61.55 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.651 -177.337 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 62.7 tp -87.61 -68.24 0.77 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.761 0.315 . . . . 0.0 110.929 178.679 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.44 HG12 ' O ' ' A' ' 121' ' ' ILE . 34.8 pt -89.79 -18.6 7.66 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 N-CA-C 112.241 0.46 . . . . 0.0 112.241 -172.369 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.43 ' HB3' ' O ' ' A' ' 125' ' ' ILE . 36.5 tt0 . . . . . 0 C--O 1.252 1.192 0 O-C-N 123.441 0.463 . . . . 0.0 110.23 -178.203 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 37.4 t . . . . . 0 C--O 1.231 0.098 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.448 ' CG ' ' HB3' ' A' ' 46' ' ' CYS . 46.5 m-85 64.14 101.73 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 115.8 -0.637 . . . . 0.0 111.803 178.463 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.641 HG23 HG23 ' A' ' 16' ' ' VAL . 11.5 tt -82.14 -31.75 10.46 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 CA-C-N 115.624 -0.717 . . . . 0.0 110.56 -178.859 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.641 HG23 HG23 ' A' ' 15' ' ' ILE . 76.5 t -117.23 113.98 44.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.249 179.505 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.503 ' NH2' HH12 ' A' ' 42' ' ' ARG . 22.3 mtp180 -136.21 86.54 2.23 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 175.885 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.411 ' HB ' ' CZ ' ' A' ' 113' ' ' PHE . 44.2 t -130.61 153.89 39.77 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.391 -176.578 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 23.3 pttm -65.28 154.85 37.02 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.466 178.32 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.411 ' HB3' HG23 ' A' ' 43' ' ' VAL . . . -179.61 174.04 1.0 Allowed 'General case' 0 C--O 1.233 0.211 0 O-C-N 123.466 0.479 . . . . 0.0 110.532 175.528 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 61.8 t -123.89 143.98 35.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 171.124 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.415 HG11 HD11 ' A' ' 73' ' ' LEU . 29.6 m -115.02 131.0 68.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-O 121.097 0.475 . . . . 0.0 111.465 -175.401 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 25.2 mmt -100.23 113.42 26.09 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.057 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.407 HG22 ' O ' ' A' ' 33' ' ' PHE . 11.8 t -82.62 152.64 25.81 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 178.005 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.473 ' HD2' ' CZ2' ' A' ' 32' ' ' TRP . 36.1 ttt85 -122.05 114.11 20.48 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 -172.154 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -72.31 93.54 1.51 Allowed 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 107.602 -1.259 . . . . 0.0 107.602 165.901 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -54.65 149.74 10.46 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 115.603 -0.726 . . . . 0.0 112.879 -169.179 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 51.9 m 72.89 -36.46 0.36 Allowed 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 114.612 -1.176 . . . . 0.0 112.306 179.005 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 29.4 t -78.54 -44.53 24.06 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 175.436 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 149.64 -67.2 0.36 Allowed Glycine 0 N--CA 1.452 -0.291 0 N-CA-C 111.559 -0.616 . . . . 0.0 111.559 178.182 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.453 ' HA3' ' HA ' ' A' ' 25' ' ' ARG . . . 71.34 -126.07 12.65 Favored Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 121.449 -0.405 . . . . 0.0 112.884 178.565 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' TRP . . . . . 0.53 ' HH2' ' HG2' ' A' ' 99' ' ' LYS . 24.6 m95 58.96 38.03 24.41 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 123.041 0.537 . . . . 0.0 109.957 -175.039 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.407 ' O ' HG22 ' A' ' 24' ' ' THR . 21.1 p90 -112.26 148.93 40.17 Favored Pre-proline 0 CA--C 1.532 0.252 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.574 -177.261 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -68.21 109.58 2.02 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 122.706 2.271 . . . . 0.0 111.85 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -59.4 132.27 53.49 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.375 -177.321 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 60.81 20.9 11.04 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.756 177.994 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 99.43 -15.62 59.85 Favored Glycine 0 C--N 1.333 0.379 0 CA-C-N 116.023 -0.535 . . . . 0.0 112.33 -179.723 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 100.18 -115.62 5.35 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 121.577 -0.344 . . . . 0.0 112.398 179.381 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.81 150.0 26.41 Favored Glycine 0 N--CA 1.451 -0.305 0 N-CA-C 111.774 -0.53 . . . . 0.0 111.774 -177.352 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 6.0 tp -55.88 115.73 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 CA-C-O 121.133 0.492 . . . . 0.0 110.689 179.511 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.416 ' HA ' ' HA ' ' A' ' 65' ' ' ARG . 20.0 m -116.95 175.23 5.68 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.361 -177.81 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.503 HH12 ' NH2' ' A' ' 17' ' ' ARG . 49.6 ttp180 -138.58 137.43 36.98 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.414 -0.588 . . . . 0.0 109.414 177.284 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.632 HG21 HD11 ' A' ' 102' ' ' LEU . 61.7 t -97.49 118.81 44.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 176.88 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.437 ' HA2' ' O ' ' A' ' 16' ' ' VAL . . . -116.59 94.92 0.66 Allowed Glycine 0 N--CA 1.452 -0.263 0 CA-C-N 116.013 -0.54 . . . . 0.0 112.109 -179.259 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.498 ' HB ' ' HB ' ' A' ' 16' ' ' VAL . 60.8 t -92.04 116.24 32.77 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 N-CA-C 110.235 -0.283 . . . . 0.0 110.235 178.94 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' CYS . . . . . 0.537 ' SG ' ' HB3' ' A' ' 60' ' ' LEU . 24.2 p -118.45 131.39 56.27 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.694 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 60.2 tttp -74.33 102.22 4.31 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 175.411 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.442 HG21 ' CE1' ' A' ' 76' ' ' TYR . 26.9 m -73.24 124.95 31.34 Favored 'Isoleucine or valine' 0 C--O 1.24 0.602 0 CA-C-O 121.202 0.525 . . . . 0.0 110.219 179.559 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 25.9 mmt . . . . . 0 C--N 1.328 -0.366 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.599 -176.501 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.227 -0.3 0 CA-C-O 120.847 0.137 . . . . 0.0 113.3 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.412 ' HA ' ' O ' ' A' ' 46' ' ' CYS . 45.1 m-85 -131.76 122.14 25.35 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 122.867 0.467 . . . . 0.0 109.98 177.88 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.537 ' HB3' ' SG ' ' A' ' 46' ' ' CYS . 0.9 OUTLIER -80.1 112.34 17.31 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 175.582 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.568 ' HB ' ' HB2' ' A' ' 75' ' ' CYS . 50.5 mm -76.27 82.08 0.68 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.322 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 174.303 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' HIS . . . . . 0.406 ' HB2' HD22 ' A' ' 60' ' ' LEU . 63.1 t-80 -99.59 164.29 12.13 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.198 -0.91 . . . . 0.0 109.751 -176.922 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 175.48 149.98 7.68 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.816 -0.707 . . . . 0.0 111.651 176.419 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.448 ' CD ' HH21 ' A' ' 42' ' ' ARG . 0.1 OUTLIER -142.06 171.01 14.64 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.96 0.41 . . . . 0.0 110.888 -178.586 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.416 ' HA ' ' HA ' ' A' ' 41' ' ' SER . 38.3 ttm180 -83.98 119.16 24.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.36 177.709 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 -61.77 87.99 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 121.255 0.55 . . . . 0.0 111.518 -173.922 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 40.0 ttpt 178.2 -30.59 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 114.587 -1.188 . . . . 0.0 108.563 178.343 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -156.65 170.75 21.68 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.021 -0.99 . . . . 0.0 108.875 177.455 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 93.0 mttt -74.64 16.97 0.23 Allowed 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 120.652 0.263 . . . . 0.0 111.175 178.733 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 5.7 tt -58.03 97.94 0.03 OUTLIER 'General case' 0 C--O 1.233 0.219 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 174.88 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 27.5 m -69.9 130.87 34.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.257 0.551 . . . . 0.0 111.978 -175.352 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 33.1 m -109.69 -14.49 10.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.056 175.211 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.415 HD11 HG11 ' A' ' 22' ' ' VAL . 60.1 mt -132.13 134.39 45.38 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.488 178.593 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -159.39 92.42 1.06 Allowed 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 174.792 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' CYS . . . . . 0.568 ' HB2' ' HB ' ' A' ' 61' ' ' ILE . 66.9 m -136.36 105.67 6.05 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.756 179.102 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.442 ' CE1' HG21 ' A' ' 48' ' ' VAL . 50.9 t80 -76.01 101.22 5.16 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.098 -178.291 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 83.6 t -103.41 99.41 8.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.006 0.431 . . . . 0.0 110.071 -178.186 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.433 ' HD3' ' HE2' ' A' ' 76' ' ' TYR . 18.6 ptt180 -108.38 -20.53 13.09 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.883 -178.397 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 1.8 tmtp? -123.92 79.03 1.68 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.829 -174.33 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 32.7 m-20 62.73 168.34 0.13 Allowed 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 115.124 -0.944 . . . . 0.0 112.102 176.061 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.511 HD23 ' N ' ' A' ' 82' ' ' VAL . 5.6 tt -146.66 135.45 22.27 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 -177.883 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.511 ' N ' HD23 ' A' ' 81' ' ' LEU . 48.3 t -77.97 -77.25 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 O-C-N 122.978 0.174 . . . . 0.0 111.247 -176.731 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.502 ' CD2' HG21 ' A' ' 117' ' ' VAL . 0.0 OUTLIER 64.66 136.52 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 121.469 0.652 . . . . 0.0 111.399 -177.421 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.516 ' HB ' ' CE1' ' A' ' 92' ' ' HIS . 90.0 m -154.31 117.9 4.62 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.357 -179.399 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.488 ' HB2' ' CE1' ' A' ' 91' ' ' HIS . 36.9 ttpt -95.69 103.99 15.89 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.912 0.387 . . . . 0.0 110.215 -178.111 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -85.15 -29.73 24.54 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.085 178.336 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ASN . . . . . 0.609 ' HB2' ' HB3' ' A' ' 90' ' ' PHE . 18.6 m120 -143.93 153.56 57.41 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.264 178.88 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -63.57 -4.72 7.34 Favored 'Trans proline' 0 N--CA 1.478 0.562 0 C-N-CA 122.735 2.29 . . . . 0.0 112.748 -179.417 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 8.3 t -126.46 16.08 7.66 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 121.355 0.598 . . . . 0.0 110.123 178.267 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.609 ' HB3' ' HB2' ' A' ' 87' ' ' ASN . 64.1 t80 -152.09 101.23 2.7 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.203 -175.938 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' HIS . . . . . 0.488 ' CE1' ' HB2' ' A' ' 85' ' ' LYS . 2.1 t-160 -125.55 106.81 10.04 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 -179.225 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' HIS . . . . . 0.553 ' ND1' ' HD2' ' A' ' 99' ' ' LYS . 35.1 p80 -103.49 150.03 24.28 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 120.739 0.304 . . . . 0.0 111.671 -173.769 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' TRP . . . . . 0.541 ' HZ3' ' HB2' ' A' ' 102' ' ' LEU . 24.9 p90 -132.74 130.98 40.69 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.335 176.199 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.532 ' HA ' ' HA ' ' A' ' 99' ' ' LYS . 65.0 tttp -94.7 139.01 31.81 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.198 -0.455 . . . . 0.0 109.926 172.949 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.461 HG23 ' H ' ' A' ' 97' ' ' ASN . 29.2 m -117.28 -162.56 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.662 177.288 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -56.35 -24.87 46.99 Favored 'General case' 0 CA--C 1.532 0.27 0 O-C-N 123.094 0.246 . . . . 0.0 111.631 -176.526 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.461 ' H ' HG23 ' A' ' 95' ' ' VAL . 4.0 m-20 -114.8 -94.38 0.48 Allowed 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 120.491 0.186 . . . . 0.0 111.457 176.793 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 29.8 mmt180 -93.33 -174.33 3.49 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 121.321 0.581 . . . . 0.0 111.866 -170.637 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.553 ' HD2' ' ND1' ' A' ' 92' ' ' HIS . 38.2 ttpt -125.7 110.22 13.51 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.128 -0.942 . . . . 0.0 109.551 -178.561 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 17.9 m-85 -97.15 162.28 13.43 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 109.819 -0.438 . . . . 0.0 109.819 -176.524 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.503 ' HA2' ' HA ' ' A' ' 92' ' ' HIS . . . -128.78 140.58 11.84 Favored Glycine 0 C--N 1.333 0.415 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.94 -177.592 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.632 HD11 HG21 ' A' ' 43' ' ' VAL . 4.8 tt -109.66 133.84 52.65 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 177.599 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.548 ' N ' HD23 ' A' ' 102' ' ' LEU . 88.1 m -106.66 114.43 28.54 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.808 179.722 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.432 ' CE2' ' HB2' ' A' ' 91' ' ' HIS . 22.5 m-85 -79.76 148.56 31.43 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 175.418 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 59.3 tt0 -105.5 -33.02 8.25 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.876 0.37 . . . . 0.0 110.601 -178.006 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 32.6 t -124.64 147.52 56.1 Favored Pre-proline 0 C--N 1.329 -0.297 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -60.34 -25.62 80.73 Favored 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 121.878 1.719 . . . . 0.0 110.417 172.126 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -69.6 -58.33 4.08 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.786 178.624 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -65.83 -32.89 74.67 Favored 'General case' 0 N--CA 1.463 0.206 0 C-N-CA 121.013 -0.275 . . . . 0.0 110.271 -179.77 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -55.06 -60.13 3.8 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.745 174.077 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' ARG . . . . . 0.408 HH11 ' HD3' ' A' ' 111' ' ' ARG . 16.2 ttm180 -61.1 -30.69 70.51 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.469 -178.715 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -62.31 -42.87 99.73 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.434 175.556 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.411 ' CZ ' ' HB ' ' A' ' 18' ' ' VAL . 39.7 m-85 -66.59 -43.27 85.38 Favored 'General case' 0 C--O 1.23 0.079 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.49 177.308 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -55.01 -51.32 66.63 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 120.885 0.374 . . . . 0.0 110.447 178.503 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' ARG . . . . . 0.414 HH11 ' HD3' ' A' ' 115' ' ' ARG . 3.1 mmp_? -60.48 -46.01 91.65 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.582 178.448 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -60.25 -51.4 59.02 Favored Glycine 0 C--N 1.333 0.367 0 CA-C-N 115.46 -0.791 . . . . 0.0 112.633 -177.519 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.502 HG21 ' CD2' ' A' ' 83' ' ' TYR . 11.4 p -68.53 -32.78 56.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.416 0.15 . . . . 0.0 110.621 -178.281 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 8.1 mmm180 -56.18 -57.05 13.83 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 174.94 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -63.73 -32.34 73.8 Favored 'General case' 0 C--O 1.224 -0.24 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.388 179.643 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -62.64 -50.32 71.69 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-O 120.564 0.221 . . . . 0.0 111.235 179.827 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.401 ' O ' ' HB2' ' A' ' 124' ' ' LEU . 69.4 mt -66.47 -39.38 83.86 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 CA-C-O 121.063 0.459 . . . . 0.0 110.338 -179.817 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 -67.32 -34.28 77.03 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.313 177.163 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -79.84 -17.03 54.25 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 121.284 0.564 . . . . 0.0 110.0 178.573 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.407 ' HG ' ' CE1' ' A' ' 59' ' ' PHE . 11.7 mt -71.09 -58.92 3.09 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.581 170.378 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 11.1 tp -68.71 -23.99 28.39 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.054 -176.839 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 . . . . . 0 C--O 1.251 1.136 0 CA-C-O 118.116 -0.945 . . . . 0.0 110.175 176.691 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 19.9 m . . . . . 0 C--O 1.235 0.305 0 CA-C-O 120.558 0.218 . . . . 0.0 111.062 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 61.9 m-85 -62.63 112.81 2.66 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 120.819 0.343 . . . . 0.0 110.523 177.122 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.526 HG22 HG23 ' A' ' 16' ' ' VAL . 63.0 mt -70.53 -48.78 57.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 174.897 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.526 HG23 HG22 ' A' ' 15' ' ' ILE . 87.4 t -144.33 104.65 0.82 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.355 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.481 178.718 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.577 ' HA ' ' HA2' ' A' ' 44' ' ' GLY . 27.2 ptt180 -101.6 112.88 25.58 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 169.491 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 7.4 p -143.91 157.37 15.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.14 0.495 . . . . 0.0 111.529 -172.241 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.546 ' NZ ' ' HB3' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -70.01 124.58 24.43 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.326 177.833 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -151.0 -168.6 3.15 Favored 'General case' 0 C--O 1.235 0.33 0 O-C-N 123.243 0.34 . . . . 0.0 110.313 179.394 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.454 ' HB ' ' HB ' ' A' ' 103' ' ' THR . 45.9 t -123.97 138.68 52.83 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 N-CA-C 110.22 -0.289 . . . . 0.0 110.22 176.502 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 17.6 m -106.3 135.4 44.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.532 177.367 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 24.9 mmt -123.47 146.19 48.24 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 178.931 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.527 HG23 ' H ' ' A' ' 26' ' ' ASP . 6.4 t -129.0 -6.31 4.97 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.597 -0.441 . . . . 0.0 111.616 177.122 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.457 ' HB2' ' CE3' ' A' ' 32' ' ' TRP . 65.2 ttt180 54.07 24.46 4.79 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 121.295 0.569 . . . . 0.0 111.037 178.749 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.527 ' H ' HG23 ' A' ' 24' ' ' THR . 36.4 t70 54.23 45.32 27.58 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.007 -177.228 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 52.8 m-20 73.04 -68.51 0.22 Allowed 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 114.68 -1.145 . . . . 0.0 110.639 -178.84 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 68.9 m -152.8 87.92 1.31 Allowed 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 176.399 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 53.3 m -140.53 -160.42 1.07 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.774 179.81 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -61.96 -90.17 0.02 OUTLIER Glycine 0 CA--C 1.52 0.401 0 C-N-CA 121.246 -0.502 . . . . 0.0 113.311 -177.547 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -97.1 176.97 32.23 Favored Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 121.432 -0.413 . . . . 0.0 112.995 -173.718 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' TRP . . . . . 0.481 ' CH2' ' HB3' ' A' ' 99' ' ' LYS . 37.3 m95 -97.03 113.82 25.39 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 -179.648 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 2.8 p90 -104.25 145.85 31.45 Favored Pre-proline 0 C--N 1.329 -0.298 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 179.179 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.557 ' HB2' ' HA3' ' A' ' 38' ' ' GLY . 88.9 Cg_endo -84.1 120.46 2.6 Favored 'Trans proline' 0 CA--C 1.534 0.521 0 C-N-CA 122.583 2.189 . . . . 0.0 112.068 178.67 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 5.0 pm0 -107.93 144.61 34.95 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.166 179.312 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 57.94 97.33 0.02 OUTLIER 'General case' 0 C--O 1.238 0.453 0 CA-C-O 121.441 0.638 . . . . 0.0 111.534 179.072 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 76.04 -72.33 1.86 Allowed Glycine 0 N--CA 1.45 -0.404 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.466 -176.728 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.557 ' HA3' ' HB2' ' A' ' 34' ' ' PRO . . . 58.66 65.8 3.24 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 121.354 -0.45 . . . . 0.0 112.759 177.527 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 156.37 -43.72 0.53 Allowed Glycine 0 N--CA 1.453 -0.176 0 N-CA-C 111.646 -0.581 . . . . 0.0 111.646 -179.741 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.495 ' O ' HG12 ' A' ' 40' ' ' ILE . 11.9 tt -121.91 22.19 4.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 121.539 0.685 . . . . 0.0 109.696 178.857 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 21.3 m -60.61 122.36 14.51 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.29 -177.108 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.446 ' HB2' ' HA ' ' A' ' 66' ' ' GLN . 29.0 ttt85 -82.95 92.71 7.39 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.45 -175.562 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 41.1 t -95.47 150.62 4.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.076 -179.322 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.577 ' HA2' ' HA ' ' A' ' 17' ' ' ARG . . . -154.22 116.61 0.74 Allowed Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 121.178 -0.534 . . . . 0.0 112.335 -179.544 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 6.7 p -87.56 117.85 32.29 Favored 'Isoleucine or valine' 0 C--O 1.237 0.415 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 176.356 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' CYS . . . . . 0.769 ' SG ' ' HB3' ' A' ' 60' ' ' LEU . 13.9 p -113.69 146.54 39.67 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.068 -178.718 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.405 ' HB2' HD11 ' A' ' 15' ' ' ILE . 47.9 tttp -92.48 101.68 14.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.772 179.088 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 22.2 m -85.19 157.05 3.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.689 0.281 . . . . 0.0 110.512 -179.018 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 22.6 ptp . . . . . 0 C--N 1.328 -0.327 0 CA-C-O 120.798 0.333 . . . . 0.0 110.629 -178.85 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.211 0 N-CA-C 111.394 -0.682 . . . . 0.0 111.394 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -141.86 162.49 35.35 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.9 0.35 . . . . 0.0 110.411 -178.745 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.769 ' HB3' ' SG ' ' A' ' 46' ' ' CYS . 3.3 tt -137.07 121.67 18.45 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.413 ' O ' ' HA ' ' A' ' 74' ' ' GLU . 41.3 mt -83.03 84.29 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 175.066 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' HIS . . . . . 0.515 ' HB2' HD22 ' A' ' 60' ' ' LEU . 57.9 t-80 -96.99 141.89 29.6 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.25 -0.432 . . . . 0.0 109.865 -177.433 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -154.84 127.54 2.11 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 121.036 -0.602 . . . . 0.0 112.043 -179.398 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -115.0 -179.63 3.68 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 176.963 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.598 ' HD2' HD13 ' A' ' 70' ' ' LEU . 69.8 mtt180 -65.83 -65.41 0.68 Allowed 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 120.549 -0.46 . . . . 0.0 110.274 178.51 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.451 ' HG3' ' HG3' ' A' ' 67' ' ' LYS . 10.0 pt20 175.53 -23.63 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.284 0 O-C-N 123.407 0.442 . . . . 0.0 111.161 -177.817 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.451 ' HG3' ' HG3' ' A' ' 66' ' ' GLN . 98.5 mttt -144.31 129.34 18.54 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.737 -178.83 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 37.5 t70 71.24 163.33 0.26 Allowed 'General case' 0 CA--C 1.533 0.318 0 O-C-N 123.763 0.665 . . . . 0.0 112.207 169.764 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 43.6 mtmt -55.47 99.13 0.03 OUTLIER 'General case' 0 C--O 1.234 0.243 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.684 -176.989 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.598 HD13 ' HD2' ' A' ' 65' ' ' ARG . 3.8 tt -162.51 86.28 0.58 Allowed 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 173.685 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 45.4 t -75.66 117.0 19.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.393 -179.535 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 22.1 m -98.54 -21.89 5.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.335 -177.736 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.409 HD13 ' N ' ' A' ' 74' ' ' GLU . 2.9 tm? -150.51 129.72 12.77 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 -177.236 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.626 ' HG3' HD21 ' A' ' 60' ' ' LEU . 37.0 tt0 -153.81 113.11 3.76 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.986 0.422 . . . . 0.0 110.162 178.606 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' CYS . . . . . 0.548 ' SG ' ' CE2' ' A' ' 100' ' ' PHE . 57.4 m -130.48 118.51 21.24 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 -178.939 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.416 ' HD1' ' HG ' ' A' ' 60' ' ' LEU . 29.5 t80 -85.32 121.73 28.47 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.01 -173.325 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.521 HG13 ' O ' ' A' ' 80' ' ' ASP . 96.3 t -100.67 97.57 5.9 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 -177.243 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 20.7 ptt-85 -115.92 68.39 0.72 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.226 0.536 . . . . 0.0 110.51 -172.775 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt 67.53 25.42 8.4 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.011 -177.165 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ASP . . . . . 0.521 ' O ' HG13 ' A' ' 77' ' ' VAL . 5.6 p-10 -149.05 -175.26 4.89 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 174.56 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 7.0 tt 66.72 98.22 0.05 Allowed 'General case' 0 CA--C 1.534 0.327 0 CA-C-O 121.193 0.521 . . . . 0.0 110.177 177.624 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 58.9 t -112.06 133.42 57.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.612 -178.998 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -68.92 124.38 23.56 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.615 177.388 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 35.9 m -95.86 114.66 26.41 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 174.165 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.413 ' HG2' ' NE2' ' A' ' 91' ' ' HIS . 5.7 tmtp? -75.81 98.9 4.28 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 116.144 -0.48 . . . . 0.0 109.73 178.875 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -91.21 -46.66 7.95 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.237 0.541 . . . . 0.0 110.183 -179.002 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ASN . . . . . 0.773 ' HB2' ' HB3' ' A' ' 90' ' ' PHE . 40.4 m-80 -131.54 153.27 81.51 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.261 178.931 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -50.62 -31.5 32.18 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.706 2.271 . . . . 0.0 112.683 -179.549 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.546 ' HA ' ' HD2' ' A' ' 104' ' ' PHE . 16.5 p -115.22 18.11 16.32 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.722 -178.182 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.773 ' HB3' ' HB2' ' A' ' 87' ' ' ASN . 74.1 t80 -145.18 115.25 7.44 Favored 'General case' 0 C--O 1.24 0.585 0 CA-C-O 121.366 0.603 . . . . 0.0 111.985 -176.803 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' HIS . . . . . 0.413 ' NE2' ' HG2' ' A' ' 85' ' ' LYS . 31.5 m80 -103.88 157.06 17.35 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.152 -0.931 . . . . 0.0 109.277 171.455 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 19.5 p80 -154.42 149.73 27.13 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 110.191 -0.299 . . . . 0.0 110.191 172.708 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 38.5 p90 -137.66 140.42 40.81 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 110.016 -0.364 . . . . 0.0 110.016 178.417 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -109.85 112.74 24.96 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.101 -173.733 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 23.4 m -138.9 144.12 30.34 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 174.192 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 58.12 25.9 13.02 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 120.725 0.298 . . . . 0.0 110.712 -178.074 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 68.09 1.47 2.8 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.755 -177.464 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 64.3 mtt-85 -89.31 134.39 34.08 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 109.489 -0.559 . . . . 0.0 109.489 178.131 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.481 ' HB3' ' CH2' ' A' ' 32' ' ' TRP . 12.3 mptt -94.33 97.48 10.24 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.984 0.421 . . . . 0.0 110.491 -178.03 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' PHE . . . . . 0.548 ' CE2' ' SG ' ' A' ' 75' ' ' CYS . 2.3 m-85 -81.65 141.11 33.95 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 174.963 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -138.59 157.6 24.68 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 121.224 -0.513 . . . . 0.0 112.103 178.613 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 6.4 tt -143.56 121.31 11.9 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 108.912 -0.774 . . . . 0.0 108.912 178.289 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.454 ' HB ' ' HB ' ' A' ' 21' ' ' VAL . 26.8 m -109.11 136.34 48.78 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.438 -178.519 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.546 ' HD2' ' HA ' ' A' ' 89' ' ' THR . 41.1 m-85 -86.0 139.61 31.03 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.213 -0.448 . . . . 0.0 109.983 178.471 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 60.4 tp60 -93.44 -42.83 9.05 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.36 -175.487 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -130.49 147.72 67.08 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.518 -176.748 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -53.88 -25.07 33.82 Favored 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 122.299 1.999 . . . . 0.0 111.908 179.039 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -62.26 -57.54 11.05 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.026 176.981 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -70.35 -29.64 66.38 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.634 -179.65 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.441 ' O ' ' HB2' ' A' ' 114' ' ' ASP . . . -56.89 -58.16 9.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.251 174.544 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' ARG . . . . . 0.582 ' HE ' ' HA ' ' A' ' 111' ' ' ARG . 1.3 tpm_? -59.47 -50.49 73.74 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.954 -179.628 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -60.89 -57.19 13.71 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.63 -174.756 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.512 ' O ' HG23 ' A' ' 117' ' ' VAL . 38.6 t80 -67.4 -36.47 81.37 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.666 -174.87 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.441 ' HB2' ' O ' ' A' ' 110' ' ' ALA . 8.2 t70 -59.98 -49.25 78.39 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 121.168 0.509 . . . . 0.0 109.753 177.921 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 41.9 ttt180 -51.74 -45.24 63.59 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 115.117 -0.947 . . . . 0.0 109.923 174.807 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -60.35 -39.4 96.09 Favored Glycine 0 CA--C 1.519 0.297 0 CA-C-N 115.651 -0.704 . . . . 0.0 112.19 176.12 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.512 HG23 ' O ' ' A' ' 113' ' ' PHE . 75.7 t -66.08 -54.58 25.38 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.163 0 C-N-CA 122.382 0.273 . . . . 0.0 111.112 -179.48 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 19.6 ptp180 -60.3 -38.02 82.33 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 116.578 -0.283 . . . . 0.0 110.606 -177.503 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.403 ' HD2' ' HA ' ' A' ' 119' ' ' LYS . 16.1 mmmt -68.85 -39.22 80.04 Favored 'General case' 0 C--N 1.334 -0.078 0 CA-C-N 116.613 -0.267 . . . . 0.0 110.646 175.151 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.5 -44.26 96.18 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.884 0.373 . . . . 0.0 110.223 177.834 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.408 HG12 ' O ' ' A' ' 117' ' ' VAL . 48.1 mm -62.9 -45.0 99.97 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.313 178.409 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -57.44 -51.02 71.14 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.661 178.612 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -74.51 -17.31 60.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.247 -178.821 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 45.1 tp -74.89 -47.7 28.66 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 177.0 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 75.1 mt -70.18 -40.35 78.04 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.303 178.682 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.249 1.066 0 N-CA-C 109.084 -0.709 . . . . 0.0 109.084 -179.636 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 19.7 m . . . . . 0 CA--C 1.537 0.478 0 N-CA-C 112.438 0.532 . . . . 0.0 112.438 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.423 ' HD2' ' HB3' ' A' ' 17' ' ' ARG . 3.3 m-85 -70.32 123.63 22.18 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 110.123 -0.325 . . . . 0.0 110.123 176.166 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 7.1 tp -88.45 -41.45 14.18 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 175.864 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 69.9 t -131.96 128.58 59.74 Favored 'Isoleucine or valine' 0 C--O 1.232 0.178 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 177.074 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.423 ' HB3' ' HD2' ' A' ' 14' ' ' TYR . 6.5 ptm180 -147.12 145.14 29.48 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.055 0.455 . . . . 0.0 111.468 -178.451 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 60.0 t -133.09 154.65 39.91 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 CA-C-N 115.411 -0.813 . . . . 0.0 108.993 177.769 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 2.2 tmmm? -98.41 117.17 32.23 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 175.522 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.499 ' HB1' ' O ' ' A' ' 103' ' ' THR . . . -158.55 -170.39 3.06 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-N 116.678 -0.237 . . . . 0.0 110.929 -178.339 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.733 HG22 ' HA2' ' A' ' 39' ' ' GLY . 60.8 t -99.91 114.2 37.61 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.123 -177.524 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.482 HG21 HG23 ' A' ' 72' ' ' VAL . 19.0 m -80.64 106.87 12.37 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 CA-C-O 121.098 0.475 . . . . 0.0 110.71 176.666 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 45.1 mtt -100.95 167.12 10.46 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.665 179.141 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.487 HG23 ' CE1' ' A' ' 33' ' ' PHE . 10.9 t -141.73 166.9 23.45 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.705 -0.68 . . . . 0.0 109.767 178.531 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.42 ' NH2' ' HA2' ' A' ' 30' ' ' GLY . 19.2 ttt180 -129.98 109.61 11.01 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 177.828 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -56.49 88.36 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.821 -173.578 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.464 ' HA ' ' HG2' ' A' ' 98' ' ' ARG . 34.1 t70 52.0 -84.78 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 123.522 0.729 . . . . 0.0 112.156 -179.403 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 32.9 t -125.02 16.88 8.52 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 120.865 0.364 . . . . 0.0 110.738 -175.553 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 33.1 t -67.96 138.17 55.73 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.304 179.29 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.42 ' HA2' ' NH2' ' A' ' 25' ' ' ARG . . . -83.35 65.1 4.19 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 121.07 -0.586 . . . . 0.0 112.155 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -177.32 167.2 38.2 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.884 -0.674 . . . . 0.0 112.889 179.472 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' TRP . . . . . 0.511 ' HH2' ' HB3' ' A' ' 99' ' ' LYS . 94.7 m95 -125.85 125.61 43.13 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 122.637 0.375 . . . . 0.0 110.038 178.132 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.487 ' CE1' HG23 ' A' ' 24' ' ' THR . 5.7 p90 -137.47 144.37 44.87 Favored Pre-proline 0 C--O 1.234 0.284 0 CA-C-N 116.631 -0.259 . . . . 0.0 111.244 -176.035 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -60.82 132.35 42.07 Favored 'Trans proline' 0 C--N 1.353 0.803 0 C-N-CA 122.594 2.196 . . . . 0.0 111.271 173.747 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' GLN . . . . . 0.419 ' H ' ' HG2' ' A' ' 35' ' ' GLN . 3.5 pt20 -86.91 -36.61 18.27 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.042 -0.526 . . . . 0.0 112.23 -174.442 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 20.1 tp10 -166.16 -55.28 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 120.658 0.266 . . . . 0.0 110.845 -177.312 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -53.97 -41.26 67.76 Favored Glycine 0 C--N 1.332 0.36 0 CA-C-N 116.03 -0.532 . . . . 0.0 113.522 -175.999 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 67.02 -138.1 34.43 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.994 -0.622 . . . . 0.0 111.954 -177.872 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.733 ' HA2' HG22 ' A' ' 21' ' ' VAL . . . -62.25 -34.37 88.96 Favored Glycine 0 CA--C 1.521 0.445 0 C-N-CA 121.61 -0.329 . . . . 0.0 113.675 -175.356 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.541 ' N ' HD12 ' A' ' 40' ' ' ILE . 3.1 mp -107.95 108.67 25.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 N-CA-C 110.24 -0.281 . . . . 0.0 110.24 -177.106 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 23.3 m -144.15 118.2 9.45 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.471 0.177 . . . . 0.0 110.551 172.558 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.446 ' CZ ' ' HD3' ' A' ' 65' ' ' ARG . 96.1 mtt180 -71.77 90.82 1.1 Allowed 'General case' 0 CA--C 1.521 -0.157 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 171.563 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.401 ' HA ' ' HA2' ' A' ' 63' ' ' GLY . 7.4 p -104.1 139.53 24.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.893 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -175.99 176.09 47.52 Favored Glycine 0 N--CA 1.443 -0.87 0 C-N-CA 120.463 -0.875 . . . . 0.0 112.703 178.234 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 59.4 t -107.84 129.09 62.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 178.786 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' CYS . . . . . 0.761 ' SG ' ' HB3' ' A' ' 60' ' ' LEU . 10.4 p -112.73 117.64 32.77 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.635 176.106 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 36.5 ttmt -76.02 83.21 2.9 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 179.3 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 27.1 m -75.35 135.14 27.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.375 -178.481 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 63.0 mtt . . . . . 0 C--N 1.327 -0.37 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.263 -179.752 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.37 0 N-CA-C 111.064 -0.814 . . . . 0.0 111.064 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 -119.64 112.16 18.96 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.887 0.375 . . . . 0.0 110.499 -178.283 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.761 ' HB3' ' SG ' ' A' ' 46' ' ' CYS . 2.6 tt -101.76 110.88 22.96 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 179.698 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.416 ' O ' ' HA ' ' A' ' 74' ' ' GLU . 62.5 mt -78.26 100.22 3.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 173.634 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 3.2 t-80 -112.22 145.95 39.01 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 -173.99 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.401 ' HA2' ' HA ' ' A' ' 43' ' ' VAL . . . -146.51 119.59 1.18 Allowed Glycine 0 C--O 1.236 0.242 0 N-CA-C 110.716 -0.954 . . . . 0.0 110.716 -178.578 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -156.69 -175.71 5.58 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.916 0.865 . . . . 0.0 113.235 -167.913 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.446 ' HD3' ' CZ ' ' A' ' 42' ' ' ARG . 44.4 ttt-85 61.39 89.22 0.08 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 113.395 -1.73 . . . . 0.0 114.219 160.825 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.55 -42.58 0.61 Allowed 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 106.505 -1.665 . . . . 0.0 106.505 162.296 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.58 ' HE2' HD22 ' A' ' 70' ' ' LEU . 37.7 ttpt -90.23 163.19 14.89 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 163.226 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -51.09 94.45 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 -173.299 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 58.3 mtmt 49.77 84.75 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.311 -0.859 . . . . 0.0 112.209 177.637 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.58 HD22 ' HE2' ' A' ' 67' ' ' LYS . 61.9 tp -136.56 121.04 18.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.866 -179.222 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 54.1 t -79.29 113.37 18.54 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 N-CA-C 109.943 -0.391 . . . . 0.0 109.943 178.059 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.482 HG23 HG21 ' A' ' 22' ' ' VAL . 33.6 m -108.64 -2.5 10.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.602 -175.526 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -169.03 138.64 2.18 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 179.127 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.416 ' HA ' ' O ' ' A' ' 61' ' ' ILE . 0.2 OUTLIER -165.35 145.49 6.9 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 121.082 0.468 . . . . 0.0 111.31 176.752 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 75' ' ' CYS . . . . . 0.597 ' SG ' HG11 ' A' ' 95' ' ' VAL . 50.4 t -166.11 118.83 1.08 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.635 179.542 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 86.5 t80 -94.73 137.83 33.33 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.521 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 35.4 m -132.49 139.11 50.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 109.354 -0.609 . . . . 0.0 109.354 177.066 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 35.0 ttm-85 -107.67 -25.24 11.4 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.007 -175.897 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 39.4 tptt -170.05 -30.46 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 120.81 0.338 . . . . 0.0 110.496 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -97.03 124.49 41.03 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.993 179.636 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.473 HD13 ' N ' ' A' ' 82' ' ' VAL . 3.3 tm? -175.85 139.52 0.4 Allowed 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 177.172 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.473 ' N ' HD13 ' A' ' 81' ' ' LEU . 66.0 t -130.48 122.31 52.79 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 CA-C-N 116.602 -0.272 . . . . 0.0 110.554 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.622 ' HB3' ' NE2' ' A' ' 91' ' ' HIS . 96.1 m-85 -91.79 153.83 19.34 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-O 120.968 0.413 . . . . 0.0 110.06 173.8 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 91.4 m -156.0 117.5 3.92 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 174.727 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 20.2 ptmt -101.31 125.13 47.9 Favored 'General case' 0 C--N 1.328 -0.366 0 O-C-N 122.034 -0.416 . . . . 0.0 110.546 178.685 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -80.6 -34.01 35.5 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.63 -0.713 . . . . 0.0 110.363 -178.9 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -136.99 155.4 76.28 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.084 179.134 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_exo -48.73 -41.91 37.45 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.469 2.113 . . . . 0.0 111.959 176.178 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 13.4 p -97.25 18.16 15.68 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 115.716 -0.675 . . . . 0.0 112.051 -178.485 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 21.5 t80 -147.47 98.32 2.97 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-O 121.148 0.499 . . . . 0.0 110.865 177.838 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' HIS . . . . . 0.622 ' NE2' ' HB3' ' A' ' 83' ' ' TYR . 3.4 t-160 -109.47 125.15 52.15 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 -179.604 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 25.8 p80 -125.6 167.03 15.64 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.971 0.415 . . . . 0.0 110.926 -178.499 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 26.8 p90 -139.63 177.9 7.61 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.282 176.666 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 62.6 pttt -154.28 147.29 24.57 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.817 0.341 . . . . 0.0 111.052 -174.435 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.597 HG11 ' SG ' ' A' ' 75' ' ' CYS . 35.7 m -132.72 143.94 38.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 173.737 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 66.01 -72.17 0.08 Allowed 'General case' 0 N--CA 1.465 0.321 0 O-C-N 123.56 0.538 . . . . 0.0 110.719 -176.192 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -165.34 -26.78 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.874 -178.626 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.464 ' HG2' ' HA ' ' A' ' 27' ' ' ASP . 99.8 mtt180 -81.81 149.51 28.32 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 120.832 0.348 . . . . 0.0 111.027 -178.299 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.511 ' HB3' ' HH2' ' A' ' 32' ' ' TRP . 0.0 OUTLIER -114.22 142.66 45.98 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.261 -173.141 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 2.9 p90 -150.05 138.88 20.9 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 173.056 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -142.69 -170.1 12.62 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.205 -0.998 . . . . 0.0 114.605 -169.867 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.499 HD11 ' HB3' ' A' ' 20' ' ' ALA . 34.3 tp -134.17 124.26 25.74 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 114.995 -0.603 . . . . 0.0 110.868 -173.189 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.556 ' HB ' ' HB ' ' A' ' 21' ' ' VAL . 22.5 m -98.5 124.92 43.51 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 175.563 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 57.0 m-85 -87.76 161.77 17.4 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.863 -175.136 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -96.29 -27.99 14.72 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.655 -177.499 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 49.1 m -149.56 154.43 38.09 Favored Pre-proline 0 CA--C 1.532 0.264 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.544 178.955 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -58.73 -24.43 71.19 Favored 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 122.555 2.17 . . . . 0.0 112.064 178.731 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -62.21 -56.09 22.14 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.916 178.542 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -71.73 -28.73 63.87 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.759 179.206 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -58.97 -60.66 3.5 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.127 0.489 . . . . 0.0 110.392 174.456 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 67.5 mtp85 -62.43 -32.62 73.51 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.913 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -62.59 -38.59 90.72 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.311 176.167 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 52.6 t80 -73.68 -34.48 64.91 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.169 179.099 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.4 ' HA ' HG22 ' A' ' 117' ' ' VAL . 63.9 m-20 -61.71 -38.64 88.61 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 121.337 0.589 . . . . 0.0 109.534 173.987 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 17.0 mmm180 -62.39 -42.05 99.13 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.684 172.071 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -60.17 -46.4 94.3 Favored Glycine 0 N--CA 1.45 -0.412 0 CA-C-N 115.336 -0.847 . . . . 0.0 112.519 178.86 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.421 ' O ' HG13 ' A' ' 121' ' ' ILE . 21.3 m -70.51 -34.82 59.06 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.366 0 CA-C-N 116.737 0.268 . . . . 0.0 110.634 -178.878 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -61.88 -48.91 78.38 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 176.839 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 7.9 tmtm? -62.03 -45.9 91.51 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 114.775 -1.102 . . . . 0.0 109.801 -179.713 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -61.42 -52.11 65.96 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.818 -179.687 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.421 HG13 ' O ' ' A' ' 117' ' ' VAL . 68.4 mt -57.66 -41.12 78.62 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.123 -178.136 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.559 ' O ' ' HG3' ' A' ' 126' ' ' GLU . 37.0 tt0 -63.37 -58.34 7.41 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 121.018 0.437 . . . . 0.0 110.394 177.997 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -60.76 -22.55 64.18 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.449 -179.506 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 9.4 tt -84.47 -39.82 18.44 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.418 179.346 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.514 HG22 ' O ' ' A' ' 122' ' ' GLU . 10.8 tp -72.11 -25.87 24.25 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 CA-C-N 116.732 -0.213 . . . . 0.0 110.434 -176.04 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.559 ' HG3' ' O ' ' A' ' 122' ' ' GLU . 46.8 mt-10 . . . . . 0 C--O 1.25 1.098 0 CA-C-O 118.728 -0.653 . . . . 0.0 110.336 175.18 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.815 ' HB2' ' SG ' ' A' ' 46' ' ' CYS . 58.3 m . . . . . 0 CA--C 1.532 0.27 0 CA-C-O 119.931 -0.08 . . . . 0.0 110.92 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 31.8 m-85 42.88 91.34 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 122.74 0.416 . . . . 0.0 111.87 -175.263 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.646 HD11 ' HB2' ' A' ' 47' ' ' LYS . 63.0 mt -61.18 -51.15 76.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 121.147 0.499 . . . . 0.0 109.916 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.537 HG23 HG22 ' A' ' 15' ' ' ILE . 92.0 t -140.1 119.33 12.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.882 178.701 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.571 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 27.8 ttp180 -128.05 86.7 2.5 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-O 121.264 0.554 . . . . 0.0 109.776 173.122 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 35.0 m -117.68 173.03 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-N 115.329 -0.85 . . . . 0.0 110.474 -177.205 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 26.1 ttpp -92.06 134.91 34.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.91 0.386 . . . . 0.0 110.914 179.638 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -160.11 -164.21 1.25 Allowed 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 178.304 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 25.0 t -122.44 109.16 23.34 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 177.538 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.553 HG23 ' OE1' ' A' ' 35' ' ' GLN . 19.7 m -84.16 133.18 29.8 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 CA-C-O 120.989 0.423 . . . . 0.0 111.031 -178.233 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 24.5 mmt -117.09 152.42 34.73 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.108 -176.945 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.432 HG23 ' CE1' ' A' ' 33' ' ' PHE . 9.8 t -132.66 140.26 48.08 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-O 121.134 0.492 . . . . 0.0 110.955 176.427 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.456 ' HE ' ' HA ' ' A' ' 28' ' ' SER . 21.1 tpt180 -90.21 77.78 6.66 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 174.71 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.565 ' HB2' ' HE1' ' A' ' 33' ' ' PHE . 35.7 t70 -56.3 94.74 0.01 OUTLIER 'General case' 0 C--O 1.236 0.371 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 179.478 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 16.0 t70 63.47 -74.78 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.941 -173.911 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.456 ' HA ' ' HE ' ' A' ' 25' ' ' ARG . 8.0 t -167.27 -44.26 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 175.324 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 18.5 t -61.88 -12.34 17.31 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.53 -178.785 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -62.1 -26.58 67.68 Favored Glycine 0 CA--C 1.523 0.574 0 C-N-CA 121.153 -0.546 . . . . 0.0 112.478 175.569 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 56.79 28.54 57.34 Favored Glycine 0 C--N 1.338 0.663 0 C-N-CA 121.739 -0.267 . . . . 0.0 113.537 177.298 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' TRP . . . . . 0.582 ' HH2' ' HG2' ' A' ' 99' ' ' LYS . 62.4 m95 63.03 96.76 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 123.174 0.59 . . . . 0.0 110.678 -177.789 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.565 ' HE1' ' HB2' ' A' ' 26' ' ' ASP . 2.9 p90 -132.04 150.84 77.23 Favored Pre-proline 0 C--O 1.236 0.376 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.928 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.51 ' HB2' ' HA2' ' A' ' 38' ' ' GLY . 77.1 Cg_endo -79.35 109.2 2.46 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.527 2.151 . . . . 0.0 112.084 179.15 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' GLN . . . . . 0.553 ' OE1' HG23 ' A' ' 22' ' ' VAL . 0.2 OUTLIER -75.57 125.95 30.04 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 176.861 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 65.07 -75.1 0.05 OUTLIER 'General case' 0 C--O 1.236 0.377 0 C-N-CA 123.133 0.573 . . . . 0.0 111.317 -178.892 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -76.25 74.33 1.69 Allowed Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 121.575 -0.345 . . . . 0.0 112.782 -177.242 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.51 ' HA2' ' HB2' ' A' ' 34' ' ' PRO . . . -75.56 66.74 2.32 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 121.209 -0.52 . . . . 0.0 112.114 177.156 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 129.02 -32.0 3.37 Favored Glycine 0 N--CA 1.453 -0.173 0 C-N-CA 121.415 -0.421 . . . . 0.0 112.07 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 67.4 mt -120.4 100.75 9.76 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 CA-C-O 120.823 0.344 . . . . 0.0 110.501 179.647 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 16.5 m -132.49 151.42 51.91 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 175.842 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.407 HH11 ' HD3' ' A' ' 42' ' ' ARG . 6.5 tpt180 -113.9 116.12 28.77 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 174.868 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.571 ' O ' ' HA ' ' A' ' 17' ' ' ARG . 24.2 t -95.46 103.16 14.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.273 -178.047 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -106.16 89.43 0.61 Allowed Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 121.334 -0.46 . . . . 0.0 112.491 179.787 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 85.0 t -84.86 120.8 36.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 120.856 0.36 . . . . 0.0 110.067 177.015 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' CYS . . . . . 0.815 ' SG ' ' HB2' ' A' ' 13' ' ' SER . 45.0 t -117.8 165.2 13.93 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.921 -178.666 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.646 ' HB2' HD11 ' A' ' 15' ' ' ILE . 83.8 tttt -118.65 116.05 25.78 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.368 -179.65 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.451 HG21 ' CE2' ' A' ' 76' ' ' TYR . 36.0 m -110.55 150.96 12.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.094 0.473 . . . . 0.0 111.286 -175.414 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 4.0 mpp? . . . . . 0 C--N 1.328 -0.346 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.416 178.36 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.436 0 N-CA-C 111.934 -0.466 . . . . 0.0 111.934 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -133.17 158.09 43.71 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.87 -0.418 . . . . 0.0 109.87 178.574 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.434 HD22 ' HB2' ' A' ' 62' ' ' HIS . 1.9 tt -132.23 113.61 13.47 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 -179.774 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.537 ' HB ' ' HB2' ' A' ' 75' ' ' CYS . 58.0 mt -82.24 97.23 3.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 174.666 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' HIS . . . . . 0.434 ' HB2' HD22 ' A' ' 60' ' ' LEU . 26.6 t-80 -111.24 91.67 3.75 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.737 -172.446 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -89.98 114.79 4.43 Favored Glycine 0 C--O 1.236 0.275 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.625 177.894 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -143.49 -161.15 1.21 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.655 0.227 . . . . 0.0 111.526 -174.334 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 1.4 mmp_? 63.98 32.1 13.27 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 115.764 -0.653 . . . . 0.0 112.687 170.547 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.507 HE21 ' N ' ' A' ' 66' ' ' GLN . 0.0 OUTLIER -72.73 -67.51 0.55 Allowed 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.771 -0.372 . . . . 0.0 110.498 176.614 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 64.6 tttm -132.51 130.02 39.87 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 178.396 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 59.71 -80.93 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 -174.94 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 23.2 pttm -178.66 128.41 0.11 Allowed 'General case' 0 C--O 1.232 0.176 0 C-N-CA 123.149 0.58 . . . . 0.0 109.775 169.114 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -174.46 157.93 2.74 Favored 'General case' 0 C--O 1.24 0.571 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.03 177.634 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 25.0 t -95.41 117.51 39.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 O-C-N 123.297 0.373 . . . . 0.0 110.24 -179.286 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 33.6 m -92.48 -24.9 5.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 120.864 0.364 . . . . 0.0 111.062 -179.101 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -145.85 109.35 4.73 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 -176.287 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -116.9 116.61 27.75 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 178.792 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' CYS . . . . . 0.537 ' HB2' ' HB ' ' A' ' 61' ' ' ILE . 63.0 m -137.48 90.85 2.55 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 121.151 0.501 . . . . 0.0 110.526 179.448 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.451 ' CE2' HG21 ' A' ' 48' ' ' VAL . 56.6 t80 -70.98 105.26 3.23 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 173.963 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 15.6 m -103.62 97.55 5.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 121.81 0.814 . . . . 0.0 110.366 -174.759 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 28.6 ptt180 -83.06 80.37 9.07 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.396 -177.246 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.771 ' HA ' HD11 ' A' ' 124' ' ' LEU . 11.0 tmtt? 76.1 -37.5 0.31 Allowed 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.995 177.735 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -68.82 108.33 3.4 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 122.363 0.265 . . . . 0.0 110.715 -179.425 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.404 HD23 ' HA ' ' A' ' 81' ' ' LEU . 12.2 mt -152.02 163.21 39.77 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.213 0.53 . . . . 0.0 110.832 179.577 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 58.3 t -131.84 -65.7 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.721 176.792 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.431 ' HB3' ' NE2' ' A' ' 91' ' ' HIS . 21.0 m-85 56.73 103.61 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.431 -176.729 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 53.0 m -134.12 112.52 11.2 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.736 178.799 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.558 ' HA ' ' HA ' ' A' ' 91' ' ' HIS . 0.2 OUTLIER -82.16 91.1 6.65 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.454 0.645 . . . . 0.0 109.68 177.16 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -66.24 -32.01 73.18 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.046 -178.928 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ASN . . . . . 0.747 ' HB2' ' HB3' ' A' ' 90' ' ' PHE . 15.6 m120 -129.09 155.35 79.96 Favored Pre-proline 0 C--N 1.326 -0.414 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 175.458 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_exo -44.26 -44.01 13.05 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.648 2.232 . . . . 0.0 112.915 179.41 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.548 ' O ' ' HA ' ' A' ' 103' ' ' THR . 37.3 p -108.67 16.98 22.43 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 -177.411 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.747 ' HB3' ' HB2' ' A' ' 87' ' ' ASN . 73.4 t80 -131.0 104.04 6.88 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 120.894 0.378 . . . . 0.0 110.509 -178.543 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' HIS . . . . . 0.558 ' HA ' ' HA ' ' A' ' 85' ' ' LYS . 1.5 t60 -114.9 124.27 51.28 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 -179.121 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' HIS . . . . . 0.475 ' HA ' ' HA2' ' A' ' 101' ' ' GLY . 23.5 p80 -126.78 159.54 33.5 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 120.953 0.406 . . . . 0.0 111.766 -176.394 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 49.1 p90 -155.39 147.53 23.62 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.282 -179.462 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.42 ' NZ ' ' HB3' ' A' ' 94' ' ' LYS . 5.7 ttpm? -112.85 127.53 56.2 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 177.426 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 19.1 m -146.69 146.94 18.34 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 O-C-N 123.253 0.346 . . . . 0.0 110.473 -179.659 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 33.6 t70 63.82 -73.33 0.05 OUTLIER 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.373 0.669 . . . . 0.0 111.773 178.645 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -146.43 -57.22 0.28 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.657 0.265 . . . . 0.0 110.65 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -78.8 176.19 9.78 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-O 121.538 0.685 . . . . 0.0 111.249 -178.906 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.582 ' HG2' ' HH2' ' A' ' 32' ' ' TRP . 37.2 ttpt -128.97 115.33 17.65 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.136 -179.268 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 41.2 m-85 -101.21 168.38 9.6 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.528 -0.306 . . . . 0.0 110.605 -174.037 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.475 ' HA2' ' HA ' ' A' ' 92' ' ' HIS . . . -151.08 170.87 30.79 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 121.136 -0.554 . . . . 0.0 112.161 -177.798 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.436 HD23 ' N ' ' A' ' 103' ' ' THR . 2.5 tt -143.52 128.77 18.8 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 -178.212 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.548 ' HA ' ' O ' ' A' ' 89' ' ' THR . 84.2 m -110.89 122.48 47.96 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.189 176.035 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.423 ' HD2' ' HA ' ' A' ' 89' ' ' THR . 50.9 m-85 -89.28 162.21 15.98 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.699 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 19.0 pt20 -113.5 -48.17 2.96 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 111.396 0.147 . . . . 0.0 111.396 -176.705 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 17.2 m -117.34 143.93 32.93 Favored Pre-proline 0 C--N 1.328 -0.34 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 -177.75 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_exo -47.7 -29.98 11.91 Favored 'Trans proline' 0 C--N 1.354 0.829 0 C-N-CA 122.593 2.196 . . . . 0.0 112.314 177.584 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -58.06 -70.75 0.13 Allowed 'General case' 0 C--O 1.233 0.204 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.98 177.024 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -60.45 -37.35 80.69 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.062 -178.779 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.408 ' HA ' ' CG ' ' A' ' 104' ' ' PHE . . . -54.01 -69.56 0.12 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.261 178.711 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 78.4 mtt180 -70.94 -22.81 62.18 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.536 -173.307 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -65.67 -48.89 70.56 Favored 'General case' 0 C--O 1.238 0.471 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 174.764 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 57.1 t80 -69.59 -47.16 64.48 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.075 -179.464 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.418 ' O ' ' HG2' ' A' ' 118' ' ' ARG . 4.8 m-20 -51.93 -58.72 5.66 Favored 'General case' 0 N--CA 1.465 0.294 0 O-C-N 123.191 0.307 . . . . 0.0 110.75 178.638 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 27.3 mtp180 -60.71 -38.43 85.04 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-O 120.699 0.285 . . . . 0.0 110.892 -179.007 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' GLY . . . . . 0.507 ' O ' ' HG3' ' A' ' 119' ' ' LYS . . . -62.04 -56.64 21.22 Favored Glycine 0 CA--C 1.52 0.386 0 C-N-CA 121.183 -0.532 . . . . 0.0 112.575 179.231 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.56 ' O ' HG12 ' A' ' 121' ' ' ILE . 12.1 p -64.59 -30.91 51.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.571 0.224 . . . . 0.0 110.408 -178.529 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.418 ' HG2' ' O ' ' A' ' 114' ' ' ASP . 7.9 mmm180 -62.77 -50.75 69.82 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.653 177.688 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.507 ' HG3' ' O ' ' A' ' 116' ' ' GLY . 0.0 OUTLIER -62.01 -33.98 75.35 Favored 'General case' 0 N--CA 1.462 0.151 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 178.753 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -62.51 -36.53 82.86 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.449 175.423 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.56 HG12 ' O ' ' A' ' 117' ' ' VAL . 40.3 mm -64.09 -44.65 97.71 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.076 0 CA-C-N 116.248 -0.433 . . . . 0.0 109.879 175.904 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -58.55 -39.19 79.55 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.71 176.175 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 87.9 m-20 -66.05 -37.08 84.95 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 121.252 0.549 . . . . 0.0 110.239 176.439 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.771 HD11 ' HA ' ' A' ' 79' ' ' LYS . 49.4 tp -70.5 -57.73 4.46 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.335 -0.848 . . . . 0.0 111.469 -176.294 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.505 HG13 ' O ' ' A' ' 121' ' ' ILE . 2.9 pp -75.02 -29.47 22.16 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.05 -177.594 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.467 ' N ' HD12 ' A' ' 125' ' ' ILE . 39.5 tt0 . . . . . 0 C--O 1.248 1.008 0 CA-C-O 118.15 -0.929 . . . . 0.0 111.094 176.751 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 60.5 m . . . . . 0 CA--C 1.533 0.307 0 N-CA-C 111.938 0.347 . . . . 0.0 111.938 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 13.3 m-85 -73.45 123.19 23.4 Favored 'General case' 0 C--O 1.235 0.305 0 O-C-N 122.096 -0.378 . . . . 0.0 110.841 176.591 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.447 HG23 HG12 ' A' ' 16' ' ' VAL . 13.6 tt -85.12 -27.15 6.57 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 174.137 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.447 HG12 HG23 ' A' ' 15' ' ' ILE . 9.2 p -159.15 144.97 6.95 Favored 'Isoleucine or valine' 0 C--O 1.231 0.13 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.906 176.279 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 55.8 ttp180 -160.04 109.35 1.78 Allowed 'General case' 0 C--O 1.235 0.315 0 CA-C-O 121.026 0.441 . . . . 0.0 110.433 176.024 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 34.6 m -113.01 -170.32 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.089 -179.219 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.521 ' HB2' HG23 ' A' ' 40' ' ' ILE . 57.4 pttt -126.26 113.59 17.17 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.069 0.461 . . . . 0.0 110.392 178.511 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -143.52 178.14 7.98 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.351 -177.483 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.53 ' HB ' ' HB ' ' A' ' 103' ' ' THR . 27.5 t -83.37 135.17 25.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.442 0.163 . . . . 0.0 110.564 179.825 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.585 HG23 ' HG2' ' A' ' 35' ' ' GLN . 11.6 m -95.24 95.26 4.87 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 CA-C-O 121.473 0.654 . . . . 0.0 110.847 177.087 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 23.6 mmt -86.77 160.01 18.94 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.699 -178.262 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.431 ' HA ' ' HA ' ' A' ' 100' ' ' PHE . 11.7 t -160.24 150.71 18.53 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.867 174.168 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.407 ' HD2' ' O ' ' A' ' 29' ' ' SER . 47.6 ttp180 -114.1 89.74 3.17 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 107.594 -1.261 . . . . 0.0 107.594 171.835 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -43.47 96.99 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.33 0 O-C-N 124.482 1.114 . . . . 0.0 112.364 -169.357 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 18.7 t70 58.22 -78.92 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 115.15 -0.932 . . . . 0.0 111.088 -179.582 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 21.1 m -141.95 105.7 4.71 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 176.329 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.407 ' O ' ' HD2' ' A' ' 25' ' ' ARG . 36.4 t -141.84 171.1 14.52 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.14 -176.481 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -100.02 38.87 2.93 Favored Glycine 0 CA--C 1.518 0.268 0 C-N-CA 121.293 -0.479 . . . . 0.0 112.93 -176.755 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 171.92 163.71 26.29 Favored Glycine 0 C--N 1.33 0.243 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.649 177.856 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' TRP . . . . . 0.401 ' CH2' ' HB3' ' A' ' 99' ' ' LYS . 86.2 m95 -103.6 113.73 27.47 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 176.646 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.462 ' HA ' ' HD3' ' A' ' 34' ' ' PRO . 0.5 OUTLIER -117.6 144.76 34.86 Favored Pre-proline 0 C--N 1.327 -0.402 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.288 -177.007 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.462 ' HD3' ' HA ' ' A' ' 33' ' ' PHE . 11.6 Cg_exo -71.11 137.73 32.16 Favored 'Trans proline' 0 C--N 1.351 0.676 0 C-N-CA 122.846 2.364 . . . . 0.0 111.46 175.038 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' GLN . . . . . 0.585 ' HG2' HG23 ' A' ' 22' ' ' VAL . 12.6 pt20 -87.91 -147.53 0.15 Allowed 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.07 179.261 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 44.5 mm-40 -46.66 -42.73 16.87 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 111.832 0.308 . . . . 0.0 111.832 179.528 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -80.8 68.58 3.37 Favored Glycine 0 CA--C 1.519 0.328 0 C-N-CA 121.184 -0.532 . . . . 0.0 112.544 -179.392 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -77.33 132.07 11.74 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 121.204 -0.522 . . . . 0.0 112.392 179.705 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 85.05 -57.96 4.98 Favored Glycine 0 CA--C 1.518 0.264 0 C-N-CA 121.283 -0.484 . . . . 0.0 112.885 176.653 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.521 HG23 ' HB2' ' A' ' 19' ' ' LYS . 65.5 mt -142.23 140.76 29.12 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 C-N-CA 122.341 0.256 . . . . 0.0 110.458 -177.935 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.454 ' O ' ' HA ' ' A' ' 19' ' ' LYS . 53.0 m -150.71 133.96 16.2 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 174.344 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 55.4 ttp180 -81.47 90.63 6.23 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 109.808 -0.441 . . . . 0.0 109.808 -178.375 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.481 ' HA ' ' HA2' ' A' ' 63' ' ' GLY . 31.4 t -111.96 143.3 22.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.443 -175.721 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -160.96 -177.43 34.06 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.994 -0.622 . . . . 0.0 112.718 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.405 ' O ' HG22 ' A' ' 15' ' ' ILE . 50.5 t -118.04 130.45 72.89 Favored 'Isoleucine or valine' 0 C--O 1.241 0.614 0 CA-C-O 120.721 0.296 . . . . 0.0 110.263 179.859 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' CYS . . . . . 0.684 ' SG ' ' HB3' ' A' ' 60' ' ' LEU . 12.4 p -119.67 122.49 41.6 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.452 173.361 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 33.3 ttpt -78.72 102.03 7.86 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 121.053 0.454 . . . . 0.0 110.145 179.808 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 51.3 t -75.86 110.74 11.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.372 -179.691 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 22.9 ptp . . . . . 0 C--N 1.326 -0.415 0 CA-C-N 116.288 -0.415 . . . . 0.0 109.979 178.505 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.594 ' N ' ' HH ' ' A' ' 76' ' ' TYR . . . . . . . . 0 N--CA 1.449 -0.467 0 N-CA-C 112.618 -0.193 . . . . 0.0 112.618 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -130.32 125.56 35.01 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 -176.953 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.684 ' HB3' ' SG ' ' A' ' 46' ' ' CYS . 2.3 tt -95.81 118.29 32.18 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 -179.531 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 49.5 mm -84.27 93.95 3.48 Favored 'Isoleucine or valine' 0 C--O 1.235 0.292 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 172.767 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' HIS . . . . . 0.607 ' HB2' HD22 ' A' ' 60' ' ' LEU . 38.5 t-80 -108.48 131.91 54.33 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.941 -171.798 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.481 ' HA2' ' HA ' ' A' ' 43' ' ' VAL . . . -128.24 133.06 7.58 Favored Glycine 0 N--CA 1.449 -0.481 0 N-CA-C 110.89 -0.884 . . . . 0.0 110.89 177.941 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -146.89 178.17 8.55 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.78 0.324 . . . . 0.0 111.329 -172.705 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 5.1 mmt180 68.1 169.37 0.27 Allowed 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 115.303 -0.862 . . . . 0.0 111.868 174.912 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 26.8 mp0 65.33 165.63 0.17 Allowed 'General case' 0 C--O 1.235 0.323 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.297 -173.216 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 24.9 tptp 71.24 -59.82 0.53 Allowed 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 122.946 0.498 . . . . 0.0 109.665 -174.754 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -165.24 -84.97 0.02 OUTLIER 'General case' 0 C--O 1.234 0.28 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.235 173.691 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 4.3 ttmp? -165.85 96.0 0.62 Allowed 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 -179.262 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.4 pp -173.23 178.92 2.32 Favored 'General case' 0 C--O 1.239 0.514 0 CA-C-O 120.633 0.254 . . . . 0.0 110.474 -173.01 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.475 ' O ' HG23 ' A' ' 71' ' ' VAL . 27.4 m -103.41 104.1 16.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.889 177.91 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.438 HG21 ' HB3' ' A' ' 41' ' ' SER . 34.7 m -68.46 -31.37 50.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.41 -178.572 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 40.4 mt -141.06 94.22 2.68 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.362 178.042 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -98.51 94.92 6.96 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 170.793 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' CYS . . . . . 0.469 ' SG ' ' CE2' ' A' ' 100' ' ' PHE . 57.9 m -139.43 89.4 2.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.363 0.601 . . . . 0.0 111.011 -172.386 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.594 ' HH ' ' N ' ' A' ' 58' ' ' GLY . 29.9 t80 -74.27 116.13 14.57 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.173 178.072 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.605 HG11 HD12 ' A' ' 81' ' ' LEU . 95.8 t -80.19 105.93 10.56 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 CA-C-O 121.144 0.497 . . . . 0.0 109.818 179.719 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.592 ' HD2' ' O ' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -80.79 61.86 4.6 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.276 -179.906 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.58 ' HG3' HD21 ' A' ' 124' ' ' LEU . 45.4 tttp 74.86 124.19 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 115.172 -0.922 . . . . 0.0 111.394 -176.479 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 76.7 m-20 70.6 119.39 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 115.113 -0.949 . . . . 0.0 112.915 174.15 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.605 HD12 HG11 ' A' ' 77' ' ' VAL . 0.0 OUTLIER -143.52 134.26 25.17 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 167.47 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 19.8 t -65.61 -52.02 55.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.888 -169.82 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.465 ' HD2' HG11 ' A' ' 117' ' ' VAL . 0.9 OUTLIER 57.87 51.59 8.93 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 121.292 0.568 . . . . 0.0 109.987 -177.626 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 33.7 m -60.52 114.18 2.83 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.786 -179.74 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.45 ' HB3' ' CD2' ' A' ' 91' ' ' HIS . 0.0 OUTLIER -99.71 102.25 13.66 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.972 0.415 . . . . 0.0 110.334 176.112 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -75.46 -37.15 60.48 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 175.367 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ASN . . . . . 0.458 ' HB2' ' HB3' ' A' ' 90' ' ' PHE . 77.0 m-20 -127.67 151.46 75.33 Favored Pre-proline 0 C--N 1.326 -0.423 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 174.095 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.499 ' O ' ' HB1' ' A' ' 110' ' ' ALA . 88.7 Cg_exo -48.22 -33.82 22.71 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.313 2.009 . . . . 0.0 112.374 178.387 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.448 ' O ' ' HA ' ' A' ' 103' ' ' THR . 14.7 p -97.68 -15.65 20.3 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 115.889 -0.596 . . . . 0.0 112.138 -178.519 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.458 ' HB3' ' HB2' ' A' ' 87' ' ' ASN . 86.8 t80 -107.31 102.47 11.77 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-O 121.087 0.47 . . . . 0.0 110.854 -176.653 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' HIS . . . . . 0.45 ' CD2' ' HB3' ' A' ' 85' ' ' LYS . 56.5 m80 -112.82 147.3 37.24 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.155 177.201 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' HIS . . . . . 0.579 ' HA ' ' HA3' ' A' ' 101' ' ' GLY . 15.4 p80 -153.95 152.84 31.04 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 174.789 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' TRP . . . . . 0.448 ' HD1' HG13 ' A' ' 95' ' ' VAL . 47.8 p90 -137.13 145.28 43.63 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-O 121.283 0.563 . . . . 0.0 111.291 177.867 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 1.1 tmtm? -102.04 119.52 38.93 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.013 -0.994 . . . . 0.0 109.286 176.917 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.448 HG13 ' HD1' ' A' ' 93' ' ' TRP . 19.3 m -125.45 125.64 69.22 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 173.417 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 59.56 -79.4 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.77 -175.518 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 44.1 t30 -142.29 -35.21 0.43 Allowed 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 112.063 0.394 . . . . 0.0 112.063 -177.967 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.518 ' HD2' ' N ' ' A' ' 98' ' ' ARG . 2.3 mpt_? -84.46 148.29 26.64 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.899 0.381 . . . . 0.0 111.212 -174.659 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.401 ' HB3' ' CH2' ' A' ' 32' ' ' TRP . 3.5 mppt? -119.92 124.49 46.14 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.759 -176.97 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' PHE . . . . . 0.469 ' CE2' ' SG ' ' A' ' 75' ' ' CYS . 0.7 OUTLIER -144.31 150.44 37.85 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.485 176.095 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.579 ' HA3' ' HA ' ' A' ' 92' ' ' HIS . . . -157.71 -165.61 15.64 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 121.021 -0.609 . . . . 0.0 112.82 -175.973 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 94.9 mt -128.42 147.32 50.65 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.998 0.428 . . . . 0.0 110.887 -174.969 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.53 ' HB ' ' HB ' ' A' ' 21' ' ' VAL . 63.2 m -123.79 107.67 11.67 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 172.74 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.451 ' HB3' ' OD2' ' A' ' 109' ' ' ASP . 99.4 m-85 -78.28 167.97 20.54 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.645 -0.707 . . . . 0.0 112.019 -172.122 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 -92.06 -41.76 10.33 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.03 -175.618 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 16.7 m -137.54 156.13 75.01 Favored Pre-proline 0 C--O 1.234 0.285 0 CA-C-N 116.621 -0.263 . . . . 0.0 110.883 -175.606 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -54.2 -32.65 71.61 Favored 'Trans proline' 0 C--N 1.351 0.676 0 C-N-CA 122.656 2.237 . . . . 0.0 112.234 177.392 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -56.43 -66.32 0.46 Allowed 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.401 179.05 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.451 ' OD2' ' HB3' ' A' ' 104' ' ' PHE . 1.6 p-10 -63.63 -35.73 81.47 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.086 -178.415 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.499 ' HB1' ' O ' ' A' ' 88' ' ' PRO . . . -58.64 -61.51 2.55 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 121.174 0.511 . . . . 0.0 111.263 177.444 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 82.5 mtp180 -65.39 -26.32 67.94 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.738 -177.733 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -68.71 -43.06 76.79 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.748 177.873 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -71.98 -37.27 69.91 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 -178.727 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.416 ' O ' HG12 ' A' ' 117' ' ' VAL . 24.0 t70 -55.73 -51.96 65.53 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 121.917 0.865 . . . . 0.0 109.409 172.819 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 35.2 ttt180 -56.16 -37.1 69.07 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 114.347 -1.297 . . . . 0.0 110.676 174.004 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -61.69 -52.57 49.88 Favored Glycine 0 C--N 1.332 0.315 0 CA-C-N 115.853 -0.612 . . . . 0.0 112.446 178.942 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.465 HG11 ' HD2' ' A' ' 83' ' ' TYR . 11.3 p -67.09 -28.72 43.71 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.151 0 CA-C-O 121.001 0.429 . . . . 0.0 109.961 179.233 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.418 HH11 ' HD3' ' A' ' 118' ' ' ARG . 0.0 OUTLIER -58.88 -55.33 36.55 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 176.932 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 59.8 tttm -66.68 -35.29 79.79 Favored 'General case' 0 C--O 1.227 -0.095 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.315 179.356 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -56.6 -58.26 8.84 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 121.132 0.492 . . . . 0.0 110.539 178.441 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.503 HD11 HD13 ' A' ' 81' ' ' LEU . 47.5 mm -63.2 -29.67 47.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.2 178.516 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.824 ' HA ' ' HA ' ' A' ' 126' ' ' GLU . 42.3 tt0 -64.37 -46.31 83.95 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.42 176.912 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -63.19 -34.23 77.18 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 121.197 0.522 . . . . 0.0 109.643 177.628 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.58 HD21 ' HG3' ' A' ' 79' ' ' LYS . 63.0 tp -64.63 -63.52 1.11 Allowed 'General case' 0 C--O 1.235 0.332 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.047 177.95 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.501 ' O ' HG12 ' A' ' 125' ' ' ILE . 12.3 tt -163.5 26.14 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.722 0 CA-C-O 121.128 0.489 . . . . 0.0 110.924 -175.789 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.824 ' HA ' ' HA ' ' A' ' 122' ' ' GLU . 35.4 tt0 . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.413 -0.803 . . . . 0.0 111.151 -178.736 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 20.2 m . . . . . 0 CA--C 1.534 0.351 0 CA-C-O 121.274 0.559 . . . . 0.0 110.633 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -53.53 135.5 39.98 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.668 176.213 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.756 HD13 ' HB2' ' A' ' 47' ' ' LYS . 38.6 pt -91.84 -27.94 4.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 170.805 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.559 HG23 HG13 ' A' ' 15' ' ' ILE . 67.1 t -137.4 137.92 45.49 Favored 'Isoleucine or valine' 0 C--O 1.232 0.142 0 CA-C-N 114.965 -1.016 . . . . 0.0 108.994 177.682 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 32.2 ptt180 -147.22 134.37 20.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.835 0.35 . . . . 0.0 110.289 178.866 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 29.1 m -133.67 174.31 13.36 Favored 'Isoleucine or valine' 0 C--O 1.237 0.415 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.523 -177.878 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -129.84 121.16 26.19 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 179.207 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -169.84 -174.27 1.78 Allowed 'General case' 0 C--O 1.232 0.182 0 CA-C-O 120.776 0.322 . . . . 0.0 111.249 -176.799 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.449 ' HB ' ' HB ' ' A' ' 103' ' ' THR . 87.6 t -92.25 142.49 13.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.022 178.98 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.442 HG11 HG21 ' A' ' 43' ' ' VAL . 27.4 m -117.42 134.23 61.69 Favored 'Isoleucine or valine' 0 C--O 1.237 0.411 0 CA-C-O 121.308 0.575 . . . . 0.0 111.476 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' MET . . . . . 0.626 ' SD ' ' HG3' ' A' ' 34' ' ' PRO . 24.7 mmt -119.04 169.52 9.83 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.058 -0.974 . . . . 0.0 109.052 178.385 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 8.9 t -153.64 157.25 39.35 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 174.909 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 41.1 ttp180 -128.41 111.17 13.03 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 178.434 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.613 ' H ' ' HE1' ' A' ' 33' ' ' PHE . 38.1 t70 -61.52 97.93 0.08 Allowed 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 179.17 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.543 ' HB3' ' NH1' ' A' ' 98' ' ' ARG . 1.6 p30 46.59 -75.99 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.293 1.037 . . . . 0.0 111.994 -169.208 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.447 ' N ' ' O ' ' A' ' 26' ' ' ASP . 69.3 m -141.13 152.04 44.4 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 110.092 -0.336 . . . . 0.0 110.092 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 21.1 m 67.16 167.8 0.24 Allowed 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.435 -179.147 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 115.07 -6.44 21.72 Favored Glycine 0 N--CA 1.453 -0.212 0 N-CA-C 111.684 -0.566 . . . . 0.0 111.684 -177.197 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 59.07 27.05 61.91 Favored Glycine 0 C--N 1.334 0.432 0 C-N-CA 121.653 -0.308 . . . . 0.0 112.986 179.754 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' TRP . . . . . 0.569 ' CH2' ' HB3' ' A' ' 99' ' ' LYS . 89.2 m95 57.91 98.12 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 121.439 0.638 . . . . 0.0 110.873 -176.516 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.613 ' HE1' ' H ' ' A' ' 26' ' ' ASP . 40.1 p90 -103.16 138.22 19.48 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.906 -175.183 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.626 ' HG3' ' SD ' ' A' ' 23' ' ' MET . 5.1 Cg_exo -79.23 115.43 3.48 Favored 'Trans proline' 0 N--CA 1.457 -0.665 0 C-N-CA 122.452 2.101 . . . . 0.0 110.865 172.593 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -65.88 -162.71 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.836 176.04 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -46.54 -39.14 10.41 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 112.724 0.638 . . . . 0.0 112.724 -176.8 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -72.63 -115.29 0.06 OUTLIER Glycine 0 CA--C 1.519 0.285 0 N-CA-C 111.591 -0.604 . . . . 0.0 111.591 176.347 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.44 ' O ' HG13 ' A' ' 21' ' ' VAL . . . 82.45 -67.09 3.77 Favored Glycine 0 C--N 1.329 0.193 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.104 174.455 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -66.81 80.22 0.13 Allowed Glycine 0 CA--C 1.519 0.291 0 C-N-CA 121.507 -0.378 . . . . 0.0 112.601 -178.966 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.448 ' O ' ' HG2' ' A' ' 66' ' ' GLN . 50.8 mm 63.64 82.15 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 CA-C-O 121.556 0.693 . . . . 0.0 111.155 178.954 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 49.1 m -99.98 148.33 24.63 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.114 178.201 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.428 HH21 ' CD ' ' A' ' 64' ' ' GLU . 7.4 tmm_? -98.83 99.89 11.02 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 -177.718 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.442 HG21 HG11 ' A' ' 22' ' ' VAL . 50.2 t -120.93 155.16 24.5 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.931 -171.22 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -173.3 -163.5 27.06 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 121.143 -0.551 . . . . 0.0 112.239 176.413 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 61.6 t -130.34 139.73 50.63 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 CA-C-O 120.868 0.366 . . . . 0.0 110.79 -177.119 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 47.2 t -119.96 131.78 55.3 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 173.871 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.756 ' HB2' HD13 ' A' ' 15' ' ' ILE . 84.9 tttt -83.39 118.72 23.91 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.795 0.331 . . . . 0.0 111.021 -174.97 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 49.1 t -78.85 126.37 38.81 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.227 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 16.0 mmt . . . . . 0 C--N 1.328 -0.363 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.085 -177.272 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.179 0 N-CA-C 112.011 -0.435 . . . . 0.0 112.011 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -140.18 117.55 11.38 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.986 0.422 . . . . 0.0 110.877 -179.04 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.548 ' HG ' ' HD1' ' A' ' 76' ' ' TYR . 0.5 OUTLIER -87.31 102.85 14.9 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 175.29 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.78 ' HB ' ' HB3' ' A' ' 75' ' ' CYS . 63.5 mt -76.89 116.16 19.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 172.195 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 5.6 t-80 -127.55 141.44 51.64 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 -172.264 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -136.66 115.02 1.22 Allowed Glycine 0 C--N 1.333 0.383 0 C-N-CA 120.914 -0.66 . . . . 0.0 113.335 -174.959 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.428 ' CD ' HH21 ' A' ' 42' ' ' ARG . 41.7 tt0 -81.02 144.14 32.0 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 122.81 0.444 . . . . 0.0 110.606 178.352 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.486 ' HG2' HG11 ' A' ' 72' ' ' VAL . 0.2 OUTLIER -51.59 -56.07 15.6 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 115.682 -0.69 . . . . 0.0 112.208 -173.875 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.448 ' HG2' ' O ' ' A' ' 40' ' ' ILE . 0.0 OUTLIER -172.52 -77.15 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 -175.526 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 57.6 tttp -117.24 -46.15 2.71 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.39 178.076 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -69.16 132.1 46.01 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.101 174.13 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 23.5 mtpp -74.23 97.12 2.9 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.486 -177.56 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 51.0 tp -146.56 135.56 22.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.936 -179.73 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 26.8 t -81.44 95.18 2.75 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.937 -176.73 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.486 HG11 ' HG2' ' A' ' 65' ' ' ARG . 15.8 m -93.24 -37.72 8.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.058 179.362 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -125.06 143.03 51.12 Favored 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 109.819 -0.438 . . . . 0.0 109.819 176.188 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -159.82 165.12 32.96 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.301 173.154 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' CYS . . . . . 0.78 ' HB3' ' HB ' ' A' ' 61' ' ' ILE . 31.6 t -164.76 103.21 0.8 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.74 -0.663 . . . . 0.0 109.659 -177.153 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.548 ' HD1' ' HG ' ' A' ' 60' ' ' LEU . 57.0 t80 -81.99 99.79 9.32 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.017 -179.142 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.485 HG13 ' O ' ' A' ' 80' ' ' ASP . 95.6 t -90.74 98.16 8.03 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 N-CA-C 109.049 -0.722 . . . . 0.0 109.049 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 16.9 tpt180 -75.37 -42.82 53.16 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 -178.796 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.616 ' HA ' HD11 ' A' ' 124' ' ' LEU . 24.1 ttpp -173.61 29.75 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.226 174.419 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ASP . . . . . 0.485 ' O ' HG13 ' A' ' 77' ' ' VAL . 23.1 t70 -144.22 129.69 18.97 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 178.249 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.6 HD21 ' CD1' ' A' ' 83' ' ' TYR . 8.4 tt -156.09 128.39 7.62 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 -173.413 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 61.6 t -132.64 101.27 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.255 -179.248 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.6 ' CD1' HD21 ' A' ' 81' ' ' LEU . 8.1 m-85 -96.34 156.65 16.25 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.023 0.439 . . . . 0.0 110.416 172.531 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 86.0 m -157.82 135.85 10.82 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 176.204 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.458 ' HB3' ' CG ' ' A' ' 91' ' ' HIS . 19.1 ptmt -128.81 141.51 51.28 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.218 0.532 . . . . 0.0 111.397 -179.286 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -100.46 -39.31 8.01 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.581 177.556 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -126.62 151.31 72.97 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 115.415 -0.811 . . . . 0.0 108.919 178.244 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -46.0 -36.81 16.54 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 122.503 2.135 . . . . 0.0 112.173 178.079 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 17.9 p -83.91 -42.01 16.78 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 115.573 -0.739 . . . . 0.0 111.48 178.071 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 68.1 t80 -85.43 92.11 8.4 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-O 120.947 0.403 . . . . 0.0 110.359 -177.615 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' HIS . . . . . 0.543 ' NE2' ' HB3' ' A' ' 83' ' ' TYR . 4.7 t-160 -121.79 118.75 29.78 Favored 'General case' 0 N--CA 1.462 0.17 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 176.897 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 25.4 p80 -120.03 175.47 5.9 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.654 0.264 . . . . 0.0 110.482 -177.008 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' TRP . . . . . 0.485 ' HZ3' ' HB2' ' A' ' 102' ' ' LEU . 36.5 p90 -146.36 155.1 42.37 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.02 175.578 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 28.9 ttpt -120.28 122.34 40.65 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.784 -179.71 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.516 ' O ' ' N ' ' A' ' 97' ' ' ASN . 28.5 m -93.09 142.78 12.68 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 N-CA-C 106.294 -1.743 . . . . 0.0 106.294 160.689 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -60.35 77.66 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.066 0.46 . . . . 0.0 110.692 -177.026 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.566 ' O ' ' HD2' ' A' ' 98' ' ' ARG . 0.2 OUTLIER 169.82 -51.52 0.01 OUTLIER 'General case' 0 C--O 1.234 0.28 0 CA-C-N 115.085 -0.961 . . . . 0.0 109.856 -176.059 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.566 ' HD2' ' O ' ' A' ' 97' ' ' ASN . 0.6 OUTLIER -141.81 155.39 45.58 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.929 -175.304 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.569 ' HB3' ' CH2' ' A' ' 32' ' ' TRP . 89.2 mttt -112.88 116.3 29.81 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.047 173.629 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 27.2 m-85 -103.24 135.46 44.84 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 178.695 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -112.31 146.37 18.13 Favored Glycine 0 N--CA 1.453 -0.218 0 C-N-CA 121.155 -0.545 . . . . 0.0 112.83 -176.785 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.485 ' HB2' ' HZ3' ' A' ' 93' ' ' TRP . 2.8 tt -124.71 116.68 22.73 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 176.674 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.449 ' HB ' ' HB ' ' A' ' 21' ' ' VAL . 35.1 m -104.83 103.07 12.6 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.162 178.337 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.402 ' HB3' ' OD2' ' A' ' 109' ' ' ASP . 74.2 m-85 -65.37 163.28 15.93 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.22 -178.551 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 18.9 pt20 -102.56 -26.59 13.17 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.301 -176.95 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 19.4 m -147.41 150.17 36.61 Favored Pre-proline 0 CA--C 1.534 0.354 0 CA-C-O 120.439 0.162 . . . . 0.0 110.723 179.374 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -51.56 -27.46 25.41 Favored 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 122.97 2.447 . . . . 0.0 112.732 177.435 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -61.04 -63.0 1.44 Allowed 'General case' 0 C--O 1.237 0.436 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.001 178.718 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.402 ' OD2' ' HB3' ' A' ' 104' ' ' PHE . 1.5 p-10 -64.4 -34.67 78.71 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.86 179.845 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -57.99 -60.74 3.26 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.056 0.455 . . . . 0.0 110.822 176.643 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 61.5 ttt180 -61.22 -36.65 80.51 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.507 -176.615 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -62.63 -45.18 94.05 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-N 115.58 -0.737 . . . . 0.0 110.61 178.896 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 38.9 t80 -76.27 -26.38 55.89 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.469 -178.718 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 46.6 m-20 -59.67 -56.01 27.29 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 173.619 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 90.5 mtt180 -64.62 -27.66 69.09 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.154 174.818 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' GLY . . . . . 0.477 ' HA2' ' NZ ' ' A' ' 119' ' ' LYS . . . -59.7 -58.8 12.38 Favored Glycine 0 N--CA 1.45 -0.417 0 CA-C-N 115.834 -0.621 . . . . 0.0 112.065 176.589 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.497 ' O ' HG13 ' A' ' 121' ' ' ILE . 9.0 p -65.66 -33.92 66.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 110.404 -0.221 . . . . 0.0 110.404 -179.302 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 43.6 ttm180 -59.78 -54.06 50.66 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.619 -0.264 . . . . 0.0 110.605 177.78 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.477 ' NZ ' ' HA2' ' A' ' 116' ' ' GLY . 25.0 pttm -69.33 -24.11 63.87 Favored 'General case' 0 CA--C 1.528 0.128 0 CA-C-O 120.841 0.353 . . . . 0.0 110.261 -179.739 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -67.2 -43.4 82.18 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.119 174.24 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.497 HG13 ' O ' ' A' ' 117' ' ' VAL . 79.7 mt -62.63 -41.63 92.94 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.168 0 CA-C-N 116.314 -0.403 . . . . 0.0 109.916 177.018 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -58.4 -43.83 88.73 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.132 174.707 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 40.7 t0 -75.51 -19.82 59.12 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.539 -177.76 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.616 HD11 ' HA ' ' A' ' 79' ' ' LYS . 55.2 tp -88.35 -39.1 14.59 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.647 -178.779 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 61.1 mt -112.23 -39.84 3.49 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 N-CA-C 111.801 0.297 . . . . 0.0 111.801 -172.939 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.323 -0.846 . . . . 0.0 110.226 -174.714 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 16.8 m . . . . . 0 N--CA 1.453 -0.285 0 CA-C-O 120.926 0.393 . . . . 0.0 110.925 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.482 ' HA ' ' HB3' ' A' ' 46' ' ' CYS . 67.5 m-85 -141.85 153.28 44.35 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.704 175.742 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.483 HG22 HG23 ' A' ' 16' ' ' VAL . 52.2 mt -108.35 -63.67 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.714 0.292 . . . . 0.0 110.371 178.106 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.483 HG23 HG22 ' A' ' 15' ' ' ILE . 60.0 t -114.94 113.08 42.6 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.517 -178.604 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 36.8 mtp180 -110.47 99.41 8.41 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.671 175.005 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 16.8 m -128.8 162.27 36.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.759 0.314 . . . . 0.0 110.769 -179.175 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.493 ' HE2' ' HA ' ' A' ' 40' ' ' ILE . 46.3 tttm -97.19 137.74 35.76 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.918 -176.792 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -159.04 -175.74 5.45 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-N 115.958 -0.564 . . . . 0.0 109.768 177.899 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.42 HG22 ' HA2' ' A' ' 39' ' ' GLY . 38.4 t -107.72 100.78 11.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.583 -0.281 . . . . 0.0 110.476 177.452 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.628 HG23 ' NE2' ' A' ' 35' ' ' GLN . 13.6 m -65.39 127.12 25.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.611 177.511 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 19.6 mmt -122.9 149.74 43.83 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.206 -175.131 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.443 HG23 ' CE1' ' A' ' 33' ' ' PHE . 12.7 t -122.31 171.75 8.81 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.051 175.373 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.531 ' HG3' ' H ' ' A' ' 27' ' ' ASP . 14.4 tpt180 -120.1 144.28 47.7 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.656 -178.367 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -79.93 11.91 3.04 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.862 179.64 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.531 ' H ' ' HG3' ' A' ' 25' ' ' ARG . 19.2 t70 63.85 156.73 0.07 Allowed 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.857 -173.779 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 47.8 t 56.58 -116.28 0.97 Allowed 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 -173.774 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 50.8 m -155.3 100.76 2.17 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 118.056 0.389 . . . . 0.0 111.525 177.702 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -131.35 -35.22 0.38 Allowed Glycine 0 C--N 1.329 0.183 0 N-CA-C 111.33 -0.708 . . . . 0.0 111.33 171.864 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.427 ' H ' ' NH1' ' A' ' 25' ' ' ARG . . . 153.72 132.01 1.64 Allowed Glycine 0 CA--C 1.519 0.315 0 N-CA-C 112.117 -0.393 . . . . 0.0 112.117 176.952 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' TRP . . . . . 0.411 ' HZ3' ' HA ' ' A' ' 100' ' ' PHE . 69.1 m95 -67.88 138.18 55.84 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 176.689 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.443 ' CE1' HG23 ' A' ' 24' ' ' THR . 4.6 p90 -145.62 152.55 49.38 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 116.85 -0.159 . . . . 0.0 110.737 -175.375 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -82.67 117.15 2.64 Favored 'Trans proline' 0 N--CA 1.461 -0.424 0 C-N-CA 122.446 2.097 . . . . 0.0 112.042 176.182 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' GLN . . . . . 0.628 ' NE2' HG23 ' A' ' 22' ' ' VAL . 4.3 pm0 -53.32 -38.7 63.42 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.315 176.397 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -161.96 160.22 27.48 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.069 178.242 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 76.51 -72.53 1.95 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 121.361 -0.447 . . . . 0.0 111.992 178.856 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 69.43 29.6 71.61 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 121.143 -0.551 . . . . 0.0 112.692 179.282 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.42 ' HA2' HG22 ' A' ' 21' ' ' VAL . . . -177.28 -72.09 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.216 179.629 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.546 ' N ' HD12 ' A' ' 40' ' ' ILE . 3.0 mp -92.11 103.72 14.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.694 0.283 . . . . 0.0 110.618 -176.837 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.589 ' HA ' ' O ' ' A' ' 65' ' ' ARG . 30.0 m -146.62 127.41 14.38 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.236 -0.438 . . . . 0.0 109.821 172.894 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.459 ' O ' ' HG3' ' A' ' 42' ' ' ARG . 14.1 ptt180 -92.01 116.67 29.12 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 121.201 0.524 . . . . 0.0 110.092 179.424 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 40.4 t -95.29 128.92 46.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.626 178.417 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -123.25 108.99 1.27 Allowed Glycine 0 N--CA 1.448 -0.562 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.774 -178.402 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 7.6 p -92.14 130.98 40.45 Favored 'Isoleucine or valine' 0 C--O 1.238 0.496 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 175.668 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' CYS . . . . . 0.69 ' SG ' ' HB3' ' A' ' 60' ' ' LEU . 15.3 p -131.97 130.18 41.15 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.839 -178.909 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -92.35 86.54 5.73 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 175.324 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 30.8 m -80.25 159.5 4.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.399 -178.915 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 25.2 ptm . . . . . 0 C--N 1.324 -0.508 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.778 179.946 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.331 0 N-CA-C 111.006 -0.838 . . . . 0.0 111.006 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.551 ' HB2' ' HB ' ' A' ' 77' ' ' VAL . 83.8 m-85 -107.02 98.41 8.07 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 117.015 0.408 . . . . 0.0 110.353 -177.059 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.718 HD22 ' HB2' ' A' ' 62' ' ' HIS . 0.9 OUTLIER -78.35 106.04 10.01 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 179.633 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.528 HG12 HG23 ' A' ' 77' ' ' VAL . 50.8 mm -84.25 96.26 4.38 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 173.781 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' HIS . . . . . 0.718 ' HB2' HD22 ' A' ' 60' ' ' LEU . 21.0 t-80 -119.21 150.87 39.35 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.313 -175.618 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -141.83 123.93 2.35 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 121.297 -0.478 . . . . 0.0 112.099 -178.855 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -99.37 149.89 22.71 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 177.521 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.589 ' O ' ' HA ' ' A' ' 41' ' ' SER . 3.1 tmm_? -58.24 -73.22 0.08 Allowed 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 109.09 -0.708 . . . . 0.0 109.09 176.012 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.507 ' HB2' ' O ' ' A' ' 65' ' ' ARG . 6.6 tp-100 169.38 132.3 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 123.111 0.564 . . . . 0.0 109.564 175.591 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt 68.04 -67.98 0.18 Allowed 'General case' 0 N--CA 1.465 0.302 0 O-C-N 123.794 0.684 . . . . 0.0 110.842 -179.51 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -74.21 128.47 35.61 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 110.109 -0.33 . . . . 0.0 110.109 177.187 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 12.5 mptt -67.2 78.21 0.14 Allowed 'General case' 0 C--O 1.236 0.385 0 CA-C-O 121.061 0.458 . . . . 0.0 110.42 -179.535 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 58.0 tp -116.37 116.84 28.44 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.113 -179.051 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 48.8 t -72.59 101.5 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.414 -179.757 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 27.3 m -96.84 -14.43 7.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.782 177.609 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.462 HD23 ' N ' ' A' ' 74' ' ' GLU . 2.2 tt -157.43 130.41 7.63 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 177.664 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.462 ' N ' HD23 ' A' ' 73' ' ' LEU . 4.1 tm-20 -145.59 127.02 14.98 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 177.675 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' CYS . . . . . 0.428 ' HB2' ' HE2' ' A' ' 100' ' ' PHE . 48.5 t -160.72 91.03 0.88 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.463 0.649 . . . . 0.0 109.856 177.468 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.495 ' HD1' ' HG ' ' A' ' 60' ' ' LEU . 82.3 t80 -67.4 118.32 10.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.454 -0.793 . . . . 0.0 110.79 179.638 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.794 HG22 HD13 ' A' ' 81' ' ' LEU . 62.0 t -77.34 94.5 1.35 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.356 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 176.111 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.426 ' HG3' ' HB3' ' A' ' 80' ' ' ASP . 15.1 ptt180 -78.83 35.76 0.25 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.717 179.052 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.695 ' HA ' HD11 ' A' ' 124' ' ' LEU . 59.5 mttp 67.91 13.64 9.21 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 123.16 0.584 . . . . 0.0 110.721 -169.027 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ASP . . . . . 0.426 ' HB3' ' HG3' ' A' ' 78' ' ' ARG . 15.0 t70 -135.19 96.73 3.55 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 115.989 -0.55 . . . . 0.0 109.898 178.177 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.794 HD13 HG22 ' A' ' 77' ' ' VAL . 7.1 tt -177.89 137.6 0.19 Allowed 'General case' 0 C--O 1.233 0.212 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 179.697 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.526 ' N ' HD23 ' A' ' 81' ' ' LEU . 40.6 t -126.19 122.52 61.71 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 CA-C-O 120.507 0.194 . . . . 0.0 111.075 -176.482 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.46 ' CG ' HG21 ' A' ' 117' ' ' VAL . 7.4 m-85 -84.52 172.8 11.34 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-O 121.284 0.564 . . . . 0.0 111.231 176.738 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 87.0 m -153.99 101.82 2.45 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.89 177.956 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -79.85 93.53 5.66 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 174.604 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -83.9 -59.22 2.48 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.536 -175.78 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ASN . . . . . 0.468 ' HB2' ' HB3' ' A' ' 90' ' ' PHE . 10.5 m120 -113.11 155.44 44.33 Favored Pre-proline 0 C--N 1.327 -0.385 0 N-CA-C 109.171 -0.678 . . . . 0.0 109.171 -179.196 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_exo -53.59 -19.18 13.31 Favored 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 122.658 2.238 . . . . 0.0 113.034 -179.644 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.44 ' HA ' ' HD2' ' A' ' 104' ' ' PHE . 15.3 t -121.05 -1.31 9.84 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 120.836 0.35 . . . . 0.0 111.448 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.468 ' HB3' ' HB2' ' A' ' 87' ' ' ASN . 78.0 t80 -120.84 114.67 21.94 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-O 121.007 0.432 . . . . 0.0 110.544 -176.254 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 2.0 t-160 -133.0 112.91 12.23 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 -176.066 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' HIS . . . . . 0.601 ' HA ' ' HA3' ' A' ' 101' ' ' GLY . 11.6 p80 -125.73 -178.42 4.26 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 -178.461 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' TRP . . . . . 0.405 ' CZ3' ' HA2' ' A' ' 101' ' ' GLY . 49.4 p90 -146.02 164.83 30.86 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.201 173.468 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 14.4 tmtt? -146.32 130.14 17.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.222 -177.097 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 30.8 m -136.49 147.11 27.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.738 -0.665 . . . . 0.0 109.388 176.976 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 18.7 t70 59.93 -89.86 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.447 0 O-C-N 123.235 0.334 . . . . 0.0 110.414 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 59.1 t30 -148.21 10.62 0.89 Allowed 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 121.685 0.755 . . . . 0.0 109.415 175.111 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 73.3 mtp180 -109.49 131.87 54.66 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.296 -176.283 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.546 ' HD3' ' N ' ' A' ' 99' ' ' LYS . 0.0 OUTLIER -127.66 127.54 43.93 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.567 -178.062 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 100' ' ' PHE . . . . . 0.428 ' HE2' ' HB2' ' A' ' 75' ' ' CYS . 4.9 p90 -156.01 164.06 38.93 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.527 -0.761 . . . . 0.0 109.004 177.295 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.601 ' HA3' ' HA ' ' A' ' 92' ' ' HIS . . . -173.94 -135.35 2.01 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.401 -0.904 . . . . 0.0 112.703 -175.611 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 2.2 pp -159.69 175.28 13.36 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 121.339 0.59 . . . . 0.0 111.746 -178.195 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 91.2 m -130.02 140.49 50.87 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.114 176.249 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.44 ' HD2' ' HA ' ' A' ' 89' ' ' THR . 23.7 m-85 -83.18 166.38 18.67 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.324 0.583 . . . . 0.0 111.389 -174.407 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 21.6 tt0 -123.19 -57.31 1.69 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.822 175.34 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 18.8 m -118.66 149.46 46.38 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.345 -176.023 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -53.2 -20.77 15.26 Favored 'Trans proline' 0 C--N 1.352 0.744 0 C-N-CA 122.587 2.191 . . . . 0.0 112.476 179.016 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -62.37 -66.6 0.52 Allowed 'General case' 0 C--O 1.235 0.329 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.523 175.839 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -63.19 -39.23 94.06 Favored 'General case' 0 C--O 1.231 0.101 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.764 -179.604 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.427 ' HA ' ' CD1' ' A' ' 104' ' ' PHE . . . -52.61 -58.99 5.04 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-O 121.387 0.613 . . . . 0.0 111.174 177.008 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 69.7 ttt180 -66.59 -29.26 69.27 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.466 -178.141 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -64.95 -48.34 74.4 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.194 179.685 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.403 ' O ' HG12 ' A' ' 117' ' ' VAL . 58.4 m-85 -67.27 -46.8 72.57 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 116.698 -0.228 . . . . 0.0 110.577 179.072 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -53.18 -64.99 0.64 Allowed 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 121.235 0.54 . . . . 0.0 110.773 178.863 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' ARG . . . . . 0.402 ' O ' ' HB2' ' A' ' 119' ' ' LYS . 41.8 ttm180 -57.3 -38.16 73.57 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 114.938 -1.028 . . . . 0.0 110.799 177.809 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -56.76 -58.2 15.67 Favored Glycine 0 C--N 1.331 0.252 0 CA-C-N 115.955 -0.566 . . . . 0.0 112.484 -177.954 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.46 HG21 ' CG ' ' A' ' 83' ' ' TYR . 7.6 p -69.03 -36.88 75.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.532 0.206 . . . . 0.0 110.803 -178.938 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 25.1 ttt180 -60.72 -42.77 97.92 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.738 -0.468 . . . . 0.0 109.738 -179.787 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.402 ' HB2' ' O ' ' A' ' 115' ' ' ARG . 7.4 mmtt -74.96 -30.05 61.1 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.659 178.508 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -62.71 -47.92 81.51 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 176.387 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 72.2 mt -66.32 -40.57 87.11 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.037 177.128 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -55.74 -48.31 75.47 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.397 178.64 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -74.94 -35.18 62.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.037 -178.408 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.695 HD11 ' HA ' ' A' ' 79' ' ' LYS . 6.3 tt -62.02 -50.23 72.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.28 -178.164 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 60.8 mt -83.12 -40.32 16.17 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.865 -177.889 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 . . . . . 0 C--O 1.251 1.142 0 CA-C-O 118.311 -0.852 . . . . 0.0 110.544 -177.281 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 20.8 m . . . . . 0 N--CA 1.465 0.316 0 N-CA-C 111.8 0.296 . . . . 0.0 111.8 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.436 ' HA ' ' HA ' ' A' ' 46' ' ' CYS . 35.8 m-85 -66.14 135.2 54.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.857 0.36 . . . . 0.0 111.878 -179.564 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 50.3 mm -92.36 -40.94 12.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 171.315 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 7.4 p -155.49 136.74 5.27 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 CA-C-N 115.179 -0.919 . . . . 0.0 109.974 178.356 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 22.4 ptt180 -149.52 114.29 5.35 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.818 0.342 . . . . 0.0 110.232 178.053 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 15.0 m -150.09 -170.82 0.17 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.325 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.057 -178.045 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.544 ' HG2' ' OE1' ' A' ' 105' ' ' GLN . 5.9 ttpm? -87.57 132.69 33.97 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.592 179.343 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.477 ' O ' ' HB2' ' A' ' 41' ' ' SER . . . -157.45 -178.22 7.18 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.178 -0.465 . . . . 0.0 109.846 176.968 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.588 ' HB ' ' HB ' ' A' ' 103' ' ' THR . 38.2 t -112.53 107.77 23.82 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 CA-C-N 116.647 -0.252 . . . . 0.0 110.841 -179.625 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 11.9 m -73.94 96.48 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 CA-C-O 121.368 0.604 . . . . 0.0 110.279 175.817 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 91.9 mmm -82.92 119.41 24.38 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.772 -176.486 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.46 HG23 ' CE1' ' A' ' 33' ' ' PHE . 10.0 t -93.9 171.16 9.04 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.055 176.965 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 14.4 ttp180 -133.46 21.47 3.98 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 178.483 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.426 ' HB3' ' CB ' ' A' ' 29' ' ' SER . 35.6 t70 50.68 36.81 14.98 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 114.778 -1.101 . . . . 0.0 110.536 179.748 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 34.1 t70 61.98 83.21 0.16 Allowed 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.542 -179.528 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 24.2 p 50.1 27.35 2.49 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 115.277 -0.874 . . . . 0.0 112.894 178.009 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.426 ' CB ' ' HB3' ' A' ' 26' ' ' ASP . 32.4 t -70.17 -36.16 74.5 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-O 120.653 0.263 . . . . 0.0 110.981 -178.891 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 150.79 -91.77 0.14 Allowed Glycine 0 C--N 1.332 0.351 0 C-N-CA 120.918 -0.658 . . . . 0.0 112.535 178.813 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -81.99 163.26 43.42 Favored Glycine 0 CA--C 1.518 0.279 0 C-N-CA 121.199 -0.524 . . . . 0.0 112.683 -178.775 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' TRP . . . . . 0.467 ' HH2' ' HB3' ' A' ' 99' ' ' LYS . 74.6 m95 -93.57 147.8 22.67 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-O 120.732 0.301 . . . . 0.0 110.803 -179.337 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.46 ' CE1' HG23 ' A' ' 24' ' ' THR . 6.8 p90 -156.34 150.34 19.58 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.896 176.827 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_exo -63.27 139.8 73.81 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.589 2.193 . . . . 0.0 111.893 176.978 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -105.64 131.73 52.66 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.604 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 16.0 tp10 64.36 -73.06 0.06 Allowed 'General case' 0 CA--C 1.533 0.312 0 O-C-N 123.851 0.719 . . . . 0.0 111.063 -179.581 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.848 ' HA3' HE21 ' A' ' 66' ' ' GLN . . . -148.65 109.74 0.46 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 121.173 -0.536 . . . . 0.0 111.912 179.726 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.446 ' O ' HG22 ' A' ' 21' ' ' VAL . . . -89.88 5.29 83.42 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 121.393 -0.432 . . . . 0.0 112.539 -178.42 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -81.62 -41.34 9.95 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.945 -0.645 . . . . 0.0 111.802 178.27 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.523 HD12 ' HG3' ' A' ' 19' ' ' LYS . 3.7 tp -143.54 91.95 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 CA-C-O 121.426 0.632 . . . . 0.0 110.756 -179.753 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.477 ' HB2' ' O ' ' A' ' 20' ' ' ALA . 21.4 m -106.32 119.33 38.98 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 173.188 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.611 ' HB3' ' O ' ' A' ' 64' ' ' GLU . 8.2 tpt85 -77.24 90.3 3.72 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 121.453 0.644 . . . . 0.0 109.419 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 38.8 t -94.87 117.88 39.68 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 CA-C-N 115.241 -0.89 . . . . 0.0 110.345 -177.361 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -129.17 118.3 2.65 Favored Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 121.174 -0.536 . . . . 0.0 111.995 179.655 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 61.4 t -96.04 110.22 24.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 176.864 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' CYS . . . . . 0.483 ' SG ' ' HB3' ' A' ' 60' ' ' LEU . 12.3 p -107.96 147.42 31.08 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.583 -179.468 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 10.3 tmtt? -102.03 95.16 6.17 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 176.611 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.574 HG21 ' HE1' ' A' ' 76' ' ' TYR . 35.4 m -71.86 141.94 16.0 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.432 -173.859 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 22.2 mmt . . . . . 0 C--N 1.327 -0.403 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.403 179.391 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.366 0 N-CA-C 111.945 -0.462 . . . . 0.0 111.945 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.446 ' HB2' ' HB ' ' A' ' 77' ' ' VAL . 83.2 m-85 -117.15 161.42 19.47 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.483 ' HB3' ' SG ' ' A' ' 46' ' ' CYS . 2.0 tt -147.07 112.56 5.61 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 176.983 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.499 ' HB ' ' HB2' ' A' ' 75' ' ' CYS . 59.5 mt -84.78 103.69 12.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 174.206 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 12.5 t-80 -117.25 104.51 11.25 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.038 -169.722 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -100.6 121.83 7.38 Favored Glycine 0 C--N 1.333 0.415 0 N-CA-C 111.3 -0.72 . . . . 0.0 111.3 177.493 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.611 ' O ' ' HB3' ' A' ' 42' ' ' ARG . 16.1 pt-20 -150.3 -166.82 2.65 Favored 'General case' 0 C--O 1.24 0.588 0 CA-C-O 121.205 0.526 . . . . 0.0 112.37 -170.707 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.425 ' HB3' ' HB3' ' A' ' 42' ' ' ARG . 29.4 ttt180 74.68 -30.97 0.21 Allowed 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.974 1.31 . . . . 0.0 112.778 170.487 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.848 HE21 ' HA3' ' A' ' 37' ' ' GLY . 7.1 tp60 -59.09 131.69 51.8 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 110.232 -0.284 . . . . 0.0 110.232 177.697 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 85.2 tttt 66.07 76.4 0.31 Allowed 'General case' 0 C--O 1.235 0.332 0 O-C-N 123.7 0.625 . . . . 0.0 109.823 -178.553 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 69.65 -86.78 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.005 -0.998 . . . . 0.0 110.99 -176.397 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 28.9 tptp -175.48 98.47 0.07 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.012 0.434 . . . . 0.0 110.467 -176.806 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -157.89 166.95 31.33 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 172.802 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 6.2 t -99.13 109.31 24.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-O 120.797 0.332 . . . . 0.0 110.523 -176.698 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 33.9 m -94.48 -6.65 10.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.223 -177.41 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -148.51 117.29 6.67 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 -178.241 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -127.92 124.63 37.82 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.094 177.409 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' CYS . . . . . 0.543 ' SG ' ' CD2' ' A' ' 100' ' ' PHE . 24.6 m -145.96 89.15 1.86 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.407 176.915 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.574 ' HE1' HG21 ' A' ' 48' ' ' VAL . 87.1 t80 -71.9 136.75 47.02 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.554 -0.535 . . . . 0.0 109.554 173.478 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.446 ' HB ' ' HB2' ' A' ' 59' ' ' PHE . 58.3 t -125.31 96.0 3.5 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 CA-C-O 120.943 0.401 . . . . 0.0 110.372 -175.772 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 43.4 ttp180 -84.4 69.07 10.46 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.215 0.531 . . . . 0.0 110.023 179.422 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.541 ' HA ' ' HG ' ' A' ' 124' ' ' LEU . 8.2 mtpm? 52.92 21.13 1.88 Allowed 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 115.254 -0.885 . . . . 0.0 112.345 179.17 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -125.19 114.08 18.51 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 172.181 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.478 HD12 HG12 ' A' ' 121' ' ' ILE . 2.8 tm? -152.97 138.23 17.47 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.601 -170.114 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.474 ' HB ' ' HB3' ' A' ' 94' ' ' LYS . 48.6 t -132.45 88.92 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.8 173.618 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.495 ' HD1' ' HD2' ' A' ' 91' ' ' HIS . 0.3 OUTLIER -85.51 146.58 26.85 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 174.829 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.445 ' HB ' ' CE1' ' A' ' 92' ' ' HIS . 38.3 m -140.69 121.74 14.66 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 177.901 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.429 ' HE3' ' HA ' ' A' ' 88' ' ' PRO . 86.5 tttt -83.51 96.0 8.47 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 176.181 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -66.85 -42.63 85.38 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.167 0.508 . . . . 0.0 109.813 179.105 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ASN . . . . . 0.679 ' HB2' ' HD2' ' A' ' 88' ' ' PRO . 9.8 p30 -161.41 164.27 18.67 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-N 115.145 -0.934 . . . . 0.0 108.835 177.442 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.679 ' HD2' ' HB2' ' A' ' 87' ' ' ASN . 9.6 Cg_endo -50.26 -22.55 8.52 Favored 'Trans proline' 0 C--N 1.352 0.75 0 C-N-CA 123.264 2.643 . . . . 0.0 114.091 -175.861 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 10.8 p -116.9 15.23 15.22 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 112.409 0.522 . . . . 0.0 112.409 -176.01 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.435 ' HB3' ' ND2' ' A' ' 87' ' ' ASN . 45.4 t80 -152.1 111.62 3.95 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-O 121.152 0.501 . . . . 0.0 111.383 178.924 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' HIS . . . . . 0.498 ' HD1' ' HE2' ' A' ' 104' ' ' PHE . 2.3 m80 -106.81 155.06 20.12 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 169.409 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' HIS . . . . . 0.445 ' CE1' ' HB ' ' A' ' 84' ' ' THR . 20.6 p80 -146.23 146.98 30.98 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 171.327 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' TRP . . . . . 0.559 ' CE2' ' HB2' ' A' ' 100' ' ' PHE . 28.4 p90 -123.52 146.21 48.27 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.173 0.511 . . . . 0.0 111.072 -178.778 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.474 ' HB3' ' HB ' ' A' ' 82' ' ' VAL . 3.0 tmtm? -110.25 101.18 9.95 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.051 -0.977 . . . . 0.0 108.83 -178.05 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 28.2 m -137.55 145.82 28.64 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 -179.609 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 27.9 t70 55.26 27.86 10.4 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 121.778 0.799 . . . . 0.0 109.978 -177.524 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.47 ' HA ' ' HE3' ' A' ' 94' ' ' LYS . 64.6 t30 74.88 -15.44 0.65 Allowed 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 114.66 -1.155 . . . . 0.0 111.633 -179.116 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 33.7 ttm180 -89.98 156.41 18.44 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.701 0.286 . . . . 0.0 110.462 -177.155 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.467 ' HB3' ' HH2' ' A' ' 32' ' ' TRP . 62.0 mtpt -116.14 133.53 55.92 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.219 -178.62 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' PHE . . . . . 0.559 ' HB2' ' CE2' ' A' ' 93' ' ' TRP . 31.0 m-85 -128.81 139.51 52.14 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 175.577 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -110.8 163.56 12.28 Favored Glycine 0 N--CA 1.453 -0.183 0 C-N-CA 121.291 -0.48 . . . . 0.0 112.417 -178.315 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.418 ' HB2' ' HZ3' ' A' ' 93' ' ' TRP . 31.3 tp -146.91 112.8 5.74 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 110.145 -0.317 . . . . 0.0 110.145 -178.723 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.588 ' HB ' ' HB ' ' A' ' 21' ' ' VAL . 84.1 m -92.79 134.17 35.32 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 176.312 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.498 ' HE2' ' HD1' ' A' ' 91' ' ' HIS . 46.9 m-85 -90.97 137.98 31.95 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.243 -178.816 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' GLN . . . . . 0.544 ' OE1' ' HG2' ' A' ' 19' ' ' LYS . 52.7 mt-30 -102.78 -26.39 13.17 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.637 -173.727 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 49.4 m -148.47 159.72 38.16 Favored Pre-proline 0 CA--C 1.536 0.409 0 CA-C-O 120.434 0.159 . . . . 0.0 110.652 -179.667 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.565 ' O ' ' HD3' ' A' ' 111' ' ' ARG . 57.0 Cg_exo -53.48 -34.54 72.44 Favored 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 122.657 2.238 . . . . 0.0 112.413 178.273 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -56.81 -61.27 2.55 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.986 -179.069 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -67.17 -38.41 85.39 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.901 -179.149 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -54.85 -53.05 60.38 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.236 179.231 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' ARG . . . . . 0.565 ' HD3' ' O ' ' A' ' 107' ' ' PRO . 5.2 mpt_? -71.62 -37.42 70.91 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.555 -178.051 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -59.4 -55.9 28.81 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.638 -179.523 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.461 ' O ' HG23 ' A' ' 117' ' ' VAL . 37.8 m-85 -63.86 -50.24 69.58 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.901 179.718 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.613 ' O ' ' HG2' ' A' ' 118' ' ' ARG . 22.3 t70 -53.01 -67.92 0.21 Allowed 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 121.155 0.502 . . . . 0.0 110.649 -178.934 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 53.1 ttt180 -51.91 -46.31 64.55 Favored 'General case' 0 C--O 1.242 0.691 0 CA-C-N 114.972 -1.013 . . . . 0.0 111.166 -178.107 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -59.52 -42.63 97.75 Favored Glycine 0 C--N 1.334 0.451 0 CA-C-N 115.869 -0.605 . . . . 0.0 112.148 179.133 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.461 HG23 ' O ' ' A' ' 113' ' ' PHE . 41.2 t -66.8 -36.03 76.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 C-N-CA 122.156 0.182 . . . . 0.0 110.698 179.683 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.613 ' HG2' ' O ' ' A' ' 114' ' ' ASP . 8.9 mmm180 -58.53 -56.54 20.8 Favored 'General case' 0 C--O 1.241 0.628 0 CA-C-O 121.277 0.561 . . . . 0.0 109.646 178.164 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 9.8 mmpt? -61.24 -38.97 88.59 Favored 'General case' 0 C--O 1.239 0.507 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.191 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -59.28 -53.93 52.64 Favored 'General case' 0 C--O 1.226 -0.184 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.872 179.654 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.478 HG12 HD12 ' A' ' 81' ' ' LEU . 73.8 mt -55.09 -45.04 76.9 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 O-C-N 123.236 0.335 . . . . 0.0 110.493 -179.097 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.411 ' O ' ' HB2' ' A' ' 126' ' ' GLU . 50.5 mt-10 -55.3 -55.93 25.88 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.07 178.632 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -69.02 -24.8 64.25 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 121.258 0.552 . . . . 0.0 110.971 -179.145 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.541 ' HG ' ' HA ' ' A' ' 79' ' ' LYS . 9.2 tt -74.14 -46.75 40.52 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.54 -0.754 . . . . 0.0 111.956 -174.901 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.448 HG22 ' O ' ' A' ' 121' ' ' ILE . 18.9 tt -106.57 -33.03 2.66 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 N-CA-C 112.38 0.511 . . . . 0.0 112.38 -173.165 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.411 ' HB2' ' O ' ' A' ' 122' ' ' GLU . 44.1 mt-10 . . . . . 0 C--O 1.248 0.988 0 CA-C-O 118.484 -0.769 . . . . 0.0 110.182 -179.157 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.72 ' HB2' ' SG ' ' A' ' 46' ' ' CYS . 20.3 m . . . . . 0 CA--C 1.535 0.369 0 N-CA-C 111.868 0.322 . . . . 0.0 111.868 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.492 ' CE2' ' HA3' ' A' ' 44' ' ' GLY . 4.1 m-30 -66.4 85.1 0.1 Allowed 'General case' 0 C--O 1.234 0.282 0 CA-C-O 120.85 0.357 . . . . 0.0 110.917 175.555 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.489 HD12 ' HB3' ' A' ' 47' ' ' LYS . 55.0 mt -70.16 -59.0 3.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 175.634 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 62.0 t -110.0 113.62 44.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 177.945 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.483 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 0.0 OUTLIER -136.63 130.86 32.88 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.772 0.32 . . . . 0.0 110.177 178.171 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 35.1 m -131.83 171.68 17.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.037 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.477 ' HB2' HD11 ' A' ' 40' ' ' ILE . 57.0 pttt -110.44 109.34 19.68 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 177.495 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -157.01 158.26 36.22 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.724 -177.318 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 50.0 t -81.39 111.85 18.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.642 0.258 . . . . 0.0 110.763 -178.579 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.51 HG23 ' NE2' ' A' ' 35' ' ' GLN . 17.1 m -75.26 128.62 37.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.362 176.126 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 87.1 mmm -122.34 166.66 14.33 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 -177.135 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 9.1 t -143.93 164.51 30.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.445 0.64 . . . . 0.0 111.08 178.477 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.538 ' HB3' ' HB2' ' A' ' 99' ' ' LYS . 73.2 ttt180 -150.04 140.02 21.96 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 -179.846 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.554 ' HA ' ' HG2' ' A' ' 98' ' ' ARG . 26.0 t0 -79.15 37.39 0.32 Allowed 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 121.348 0.594 . . . . 0.0 110.322 -177.869 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.476 ' HA ' ' HG3' ' A' ' 99' ' ' LYS . 22.0 t70 63.49 -63.36 0.13 Allowed 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 123.891 0.876 . . . . 0.0 109.715 -171.018 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 22.3 p -68.93 170.8 9.06 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.861 168.719 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 15.7 m 64.78 96.06 0.05 OUTLIER 'General case' 0 CA--C 1.536 0.431 0 CA-C-O 120.984 0.421 . . . . 0.0 111.142 178.346 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -80.59 22.91 4.43 Favored Glycine 0 CA--C 1.519 0.301 0 C-N-CA 121.494 -0.384 . . . . 0.0 113.557 -175.857 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -80.48 -27.02 53.05 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.949 -0.643 . . . . 0.0 112.458 179.022 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' TRP . . . . . 0.535 ' CH2' ' HB3' ' A' ' 99' ' ' LYS . 83.4 m95 58.15 101.79 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 121.452 0.644 . . . . 0.0 110.841 -176.312 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 31.1 p90 -101.16 135.51 19.9 Favored Pre-proline 0 CA--C 1.532 0.254 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.915 -174.266 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.568 ' HB2' ' HA3' ' A' ' 38' ' ' GLY . 73.7 Cg_endo -79.05 111.41 2.93 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.694 2.262 . . . . 0.0 112.133 178.756 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' GLN . . . . . 0.51 ' NE2' HG23 ' A' ' 22' ' ' VAL . 4.7 pm0 -75.69 168.3 20.28 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.36 -179.392 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 62.07 -77.84 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 115.395 -0.821 . . . . 0.0 110.794 177.311 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -148.52 -7.72 0.21 Allowed Glycine 0 CA--C 1.518 0.264 0 C-N-CA 121.252 -0.499 . . . . 0.0 112.558 -179.687 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.568 ' HA3' ' HB2' ' A' ' 34' ' ' PRO . . . 58.08 83.07 0.05 OUTLIER Glycine 0 C--N 1.334 0.462 0 C-N-CA 121.38 -0.438 . . . . 0.0 113.113 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -157.35 174.23 34.84 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 121.039 -0.601 . . . . 0.0 112.007 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.477 HD11 ' HB2' ' A' ' 19' ' ' LYS . 9.2 tt -58.55 129.24 20.38 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 CA-C-O 121.074 0.464 . . . . 0.0 110.081 178.66 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 43.7 t -121.61 146.02 47.4 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.317 0.58 . . . . 0.0 111.705 -170.98 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.649 ' HB3' ' HB2' ' A' ' 64' ' ' GLU . 19.8 ttt180 -77.61 83.23 4.0 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 114.971 -1.013 . . . . 0.0 108.457 171.752 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.483 ' O ' ' HA ' ' A' ' 17' ' ' ARG . 45.7 t -73.1 92.46 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.466 -175.997 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.492 ' HA3' ' CE2' ' A' ' 14' ' ' TYR . . . -93.24 95.67 2.01 Favored Glycine 0 N--CA 1.448 -0.565 0 CA-C-N 115.864 -0.607 . . . . 0.0 112.63 -179.467 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 61.4 t -82.14 93.24 2.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-O 121.407 0.623 . . . . 0.0 109.409 176.625 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' CYS . . . . . 0.72 ' SG ' ' HB2' ' A' ' 13' ' ' SER . 43.0 t -91.45 114.3 26.8 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.547 -177.926 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.489 ' HB3' HD12 ' A' ' 15' ' ' ILE . 40.0 ttmt -75.91 92.6 3.12 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 175.055 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.478 HG21 ' CE1' ' A' ' 76' ' ' TYR . 28.3 m -86.65 170.2 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.571 -174.022 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 26.0 ptm . . . . . 0 C--N 1.326 -0.452 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.233 -179.616 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.193 0 N-CA-C 112.324 -0.31 . . . . 0.0 112.324 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -132.36 139.17 48.02 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.124 0.488 . . . . 0.0 110.583 -179.089 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 3.1 tt -119.82 112.13 18.85 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 176.979 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.472 ' HB ' ' HB3' ' A' ' 75' ' ' CYS . 44.5 mm -75.94 92.73 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 175.842 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 16.9 t-80 -104.19 93.54 4.89 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.469 -175.725 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -102.21 112.71 4.39 Favored Glycine 0 CA--C 1.518 0.277 0 C-N-CA 121.235 -0.507 . . . . 0.0 112.7 -175.622 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.649 ' HB2' ' HB3' ' A' ' 42' ' ' ARG . 43.5 mm-40 -93.43 162.35 14.01 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.708 0.289 . . . . 0.0 110.82 178.043 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.415 HH11 ' HD3' ' A' ' 65' ' ' ARG . 15.1 ttm180 -82.47 151.78 26.38 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 167.77 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 28.4 mm-40 -59.39 88.03 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 120.884 0.373 . . . . 0.0 110.735 -179.586 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 87.1 tttt 173.76 -21.39 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.173 -0.921 . . . . 0.0 108.981 -176.915 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 71.24 49.59 0.32 Allowed 'General case' 0 C--O 1.237 0.415 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.384 176.064 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.444 ' O ' ' HB2' ' A' ' 70' ' ' LEU . 11.9 tmtt? -176.0 60.19 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.132 -179.155 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.483 ' O ' ' HA ' ' A' ' 64' ' ' GLU . 54.3 tp 174.2 105.29 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.041 177.757 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 4.0 m -70.73 96.0 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 CA-C-O 121.21 0.529 . . . . 0.0 110.593 174.975 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 28.6 m -86.99 -9.06 11.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.915 179.649 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.463 ' HB2' HG21 ' A' ' 22' ' ' VAL . 1.5 tm? -159.72 121.1 3.21 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 177.793 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -129.09 122.27 29.57 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 179.328 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' CYS . . . . . 0.472 ' HB3' ' HB ' ' A' ' 61' ' ' ILE . 42.6 t -149.21 87.97 1.56 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.204 0.526 . . . . 0.0 110.572 178.877 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.478 ' CE1' HG21 ' A' ' 48' ' ' VAL . 67.0 t80 -77.26 123.04 25.91 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.146 175.065 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.528 HG11 HD12 ' A' ' 81' ' ' LEU . 17.3 m -133.62 111.64 16.05 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 CA-C-O 121.173 0.511 . . . . 0.0 110.092 177.03 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 16.0 ptm180 -81.25 -17.39 49.64 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.796 -178.222 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.438 ' HA ' HD21 ' A' ' 124' ' ' LEU . 85.6 tttt -172.15 152.69 2.9 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.373 -177.429 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 26.8 t70 71.6 105.25 0.07 Allowed 'General case' 0 N--CA 1.468 0.461 0 O-C-N 123.704 0.627 . . . . 0.0 112.235 173.917 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.535 HD23 ' N ' ' A' ' 82' ' ' VAL . 4.7 tt -179.37 129.21 0.1 Allowed 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 177.131 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.535 ' N ' HD23 ' A' ' 81' ' ' LEU . 75.6 t -128.02 129.95 69.7 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 N-CA-C 110.33 -0.248 . . . . 0.0 110.33 177.832 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.439 ' CE2' HG21 ' A' ' 117' ' ' VAL . 6.7 m-85 -83.24 159.56 21.94 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.24 0.543 . . . . 0.0 111.024 178.114 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 87.8 m -150.05 135.79 18.43 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.361 177.674 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.613 ' H ' ' HD2' ' A' ' 85' ' ' LYS . 0.0 OUTLIER -105.59 126.51 52.23 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.795 0.331 . . . . 0.0 110.43 -178.617 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -98.51 -46.08 5.87 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.334 0.588 . . . . 0.0 109.485 175.793 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ASN . . . . . 0.819 ' HB2' ' HB3' ' A' ' 90' ' ' PHE . 5.1 m-20 -125.17 152.03 70.23 Favored Pre-proline 0 C--N 1.327 -0.411 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 174.387 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -54.32 -25.88 41.07 Favored 'Trans proline' 0 CA--C 1.533 0.47 0 C-N-CA 122.44 2.094 . . . . 0.0 112.431 177.552 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.423 ' HA ' ' HD2' ' A' ' 104' ' ' PHE . 14.3 p -112.82 11.99 19.42 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.746 178.919 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.819 ' HB3' ' HB2' ' A' ' 87' ' ' ASN . 35.4 t80 -136.71 96.89 3.41 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-O 121.266 0.555 . . . . 0.0 109.642 178.111 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' HIS . . . . . 0.401 ' NE2' ' HB3' ' A' ' 83' ' ' TYR . 0.4 OUTLIER -97.36 163.08 13.04 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 176.632 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 28.6 p80 -166.63 169.97 13.07 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.909 0.385 . . . . 0.0 111.233 178.031 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' TRP . . . . . 0.54 ' CE2' ' HB2' ' A' ' 100' ' ' PHE . 38.8 p90 -149.69 134.94 18.17 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.36 174.539 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 7.7 tmtm? -102.36 116.68 33.14 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.817 -179.482 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.519 HG23 ' H ' ' A' ' 97' ' ' ASN . 34.9 m -105.72 -170.6 0.32 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.398 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.261 179.596 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -54.62 -25.87 29.33 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 122.877 0.471 . . . . 0.0 111.754 -176.707 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.519 ' H ' HG23 ' A' ' 95' ' ' VAL . 4.9 p-10 -155.11 131.3 10.26 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.179 -0.464 . . . . 0.0 109.972 177.975 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.554 ' HG2' ' HA ' ' A' ' 26' ' ' ASP . 57.7 mtt180 73.04 162.09 0.26 Allowed 'General case' 0 C--O 1.236 0.354 0 CA-C-O 122.071 0.939 . . . . 0.0 112.237 -173.766 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.538 ' HB2' ' HB3' ' A' ' 25' ' ' ARG . 63.5 mttp -122.35 124.54 43.95 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 114.221 -1.354 . . . . 0.0 108.055 174.623 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' PHE . . . . . 0.54 ' HB2' ' CE2' ' A' ' 93' ' ' TRP . 1.7 m-85 -101.11 128.87 46.98 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 -177.311 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -111.04 164.17 12.18 Favored Glycine 0 N--CA 1.454 -0.114 0 C-N-CA 121.431 -0.414 . . . . 0.0 112.694 -176.743 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 7.0 tt -150.24 104.37 3.25 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 -179.65 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 36.6 m -91.84 115.52 28.13 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.013 178.97 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.423 ' HD2' ' HA ' ' A' ' 89' ' ' THR . 82.1 m-85 -67.35 160.1 27.99 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.616 -175.439 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 60.4 tp60 -92.6 -42.0 9.91 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.382 -178.518 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 49.5 m -143.65 153.95 58.89 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.402 -179.03 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -52.35 -27.96 33.11 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 122.627 2.218 . . . . 0.0 112.344 177.258 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -60.41 -62.18 2.05 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.159 177.952 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 -66.02 -29.22 69.55 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.589 179.573 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.407 ' HA ' ' CD1' ' A' ' 104' ' ' PHE . . . -57.8 -57.51 12.45 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.585 175.767 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 62.0 mtp180 -60.94 -49.28 78.07 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.904 -179.317 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -60.75 -49.68 76.51 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.498 -176.174 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 66.0 t80 -71.62 -38.03 70.83 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.707 -177.191 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -55.87 -61.87 2.08 Favored 'General case' 0 C--O 1.24 0.557 0 CA-C-O 121.847 0.832 . . . . 0.0 110.241 178.843 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 40.7 ttm180 -60.98 -45.88 92.99 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 114.643 -1.162 . . . . 0.0 110.571 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -62.19 -41.45 99.71 Favored Glycine 0 N--CA 1.451 -0.304 0 CA-C-N 115.506 -0.77 . . . . 0.0 112.975 -177.065 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.523 ' O ' HG12 ' A' ' 121' ' ' ILE . 8.1 p -73.98 -33.27 35.9 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-N 116.78 0.29 . . . . 0.0 110.306 -177.228 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 27.5 tpt180 -57.28 -50.32 73.29 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 172.035 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 3.9 tmmm? -57.85 -38.76 76.25 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.725 176.89 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -65.53 -40.93 93.5 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.254 179.562 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.523 HG12 ' O ' ' A' ' 117' ' ' VAL . 46.0 mm -62.9 -40.76 90.1 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 178.216 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -62.42 -43.87 97.79 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.58 174.518 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -65.75 -23.85 66.82 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.006 179.638 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.438 HD21 ' HA ' ' A' ' 79' ' ' LYS . 5.4 tt -77.98 -52.6 8.56 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.452 179.054 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 61.6 mt -94.62 -47.21 13.38 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 -171.209 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 13.5 tp10 . . . . . 0 C--O 1.243 0.746 0 CA-C-O 118.516 -0.754 . . . . 0.0 110.343 -174.966 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 28.6 m . . . . . 0 CA--C 1.535 0.369 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 76.9 m-85 -67.88 110.25 3.76 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-O 120.829 0.347 . . . . 0.0 110.603 178.823 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 48.8 mm -83.6 -55.77 6.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.934 -0.575 . . . . 0.0 109.877 178.459 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 61.8 t -122.91 134.3 66.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.376 -178.869 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 32.8 mtm180 -134.7 94.77 3.23 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 175.04 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 13.6 p -118.02 142.37 32.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.842 0.353 . . . . 0.0 110.882 -177.166 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 64.2 tttm -72.15 131.28 42.58 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.05 -179.42 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -161.7 -164.31 1.09 Allowed 'General case' 0 C--O 1.239 0.52 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.302 179.447 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.403 ' HB ' ' HB ' ' A' ' 103' ' ' THR . 61.7 t -124.21 105.7 15.77 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 CA-C-N 116.741 -0.208 . . . . 0.0 110.525 177.303 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.446 HG21 HG23 ' A' ' 72' ' ' VAL . 28.6 m -72.89 116.78 15.53 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 CA-C-O 121.475 0.655 . . . . 0.0 110.761 178.476 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 25.8 mmt -92.22 110.3 21.68 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.22 178.455 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.652 ' O ' ' HG3' ' A' ' 25' ' ' ARG . 7.4 t -83.23 2.53 35.35 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.578 -179.646 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.775 ' HG3' HH11 ' A' ' 25' ' ' ARG . 0.4 OUTLIER 53.37 172.88 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.956 0 N-CA-C 115.397 1.628 . . . . 0.0 115.397 166.449 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.545 ' HB2' ' CE2' ' A' ' 33' ' ' PHE . 36.6 t70 -143.03 6.76 1.57 Allowed 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 114.047 -1.433 . . . . 0.0 109.91 -178.936 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 65.4 m-20 66.24 -86.23 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.404 -178.219 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 22.9 t -151.1 99.95 2.73 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.334 -174.428 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.468 ' HB3' ' OD2' ' A' ' 26' ' ' ASP . 30.5 t 174.9 -54.46 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 177.983 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -111.26 -41.42 1.16 Allowed Glycine 0 N--CA 1.451 -0.307 0 N-CA-C 110.434 -1.067 . . . . 0.0 110.434 170.575 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 128.07 -109.97 1.09 Allowed Glycine 0 C--N 1.333 0.374 0 C-N-CA 121.578 -0.344 . . . . 0.0 112.675 175.122 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' TRP . . . . . 0.731 ' CE3' ' HB3' ' A' ' 25' ' ' ARG . 65.1 m95 -128.75 114.49 16.65 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 -178.797 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.545 ' CE2' ' HB2' ' A' ' 26' ' ' ASP . 8.5 p90 -120.47 151.41 53.8 Favored Pre-proline 0 C--O 1.239 0.503 0 CA-C-O 120.495 0.188 . . . . 0.0 110.966 178.47 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.475 ' HB2' ' HA3' ' A' ' 38' ' ' GLY . 73.5 Cg_endo -89.44 -154.35 0.05 OUTLIER 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 123.331 2.687 . . . . 0.0 111.739 175.171 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -156.62 147.44 21.82 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-O 120.532 0.206 . . . . 0.0 111.08 -176.779 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.478 ' HB3' ' HD3' ' A' ' 67' ' ' LYS . 12.3 mm-40 54.71 25.77 6.83 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 115.883 -0.598 . . . . 0.0 112.0 175.433 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 115.8 -42.48 1.89 Allowed Glycine 0 N--CA 1.453 -0.207 0 N-CA-C 111.497 -0.641 . . . . 0.0 111.497 -179.057 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.475 ' HA3' ' HB2' ' A' ' 34' ' ' PRO . . . 59.98 67.66 2.05 Favored Glycine 0 C--N 1.331 0.3 0 C-N-CA 121.353 -0.451 . . . . 0.0 112.76 179.198 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -153.78 -46.02 0.02 OUTLIER Glycine 0 N--CA 1.455 -0.1 0 N-CA-C 111.6 -0.6 . . . . 0.0 111.6 177.71 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.563 HG22 ' O ' ' A' ' 40' ' ' ILE . 2.6 mp -97.24 63.45 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 CA-C-O 121.634 0.73 . . . . 0.0 109.379 178.862 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.54 ' HB2' HE22 ' A' ' 66' ' ' GLN . 25.6 t -117.56 109.51 16.8 Favored 'General case' 0 C--N 1.33 -0.242 0 O-C-N 121.978 -0.451 . . . . 0.0 110.23 -178.97 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 60.4 mtp180 -89.62 110.98 21.81 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-O 120.895 0.379 . . . . 0.0 110.206 179.547 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.575 HG21 HD22 ' A' ' 102' ' ' LEU . 46.4 t -72.4 103.04 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.932 177.774 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -92.52 86.02 1.2 Allowed Glycine 0 N--CA 1.449 -0.483 0 CA-C-N 115.793 -0.639 . . . . 0.0 112.389 -178.798 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 51.4 t -71.5 100.72 0.9 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.411 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 176.564 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' CYS . . . . . 0.641 ' SG ' ' HB3' ' A' ' 60' ' ' LEU . 11.5 p -107.97 138.28 44.5 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.627 -178.982 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -95.71 119.37 34.09 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.8 -0.445 . . . . 0.0 109.8 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 33.5 m -92.69 148.38 4.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.802 -177.579 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 85.8 mtp . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.796 -178.524 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.567 0 N-CA-C 111.991 -0.443 . . . . 0.0 111.991 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.499 ' HE1' ' HB2' ' A' ' 124' ' ' LEU . 85.7 m-85 -134.03 155.5 49.89 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.995 0.426 . . . . 0.0 110.517 -178.064 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.641 ' HB3' ' SG ' ' A' ' 46' ' ' CYS . 3.8 tt -121.91 107.91 12.82 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 174.364 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.463 ' O ' ' HA ' ' A' ' 74' ' ' GLU . 49.1 mt -70.66 83.86 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 178.643 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' HIS . . . . . 0.577 ' HB2' HD22 ' A' ' 60' ' ' LEU . 52.6 t-80 -103.35 93.02 4.75 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.482 -174.624 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -88.3 121.94 6.14 Favored Glycine 0 N--CA 1.447 -0.568 0 N-CA-C 111.057 -0.817 . . . . 0.0 111.057 174.695 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.7 pp20? -124.63 -175.58 3.31 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 116.857 0.329 . . . . 0.0 110.759 -179.448 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.524 ' O ' ' HB2' ' A' ' 66' ' ' GLN . 0.1 OUTLIER 79.3 147.31 0.09 Allowed 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.064 -0.971 . . . . 0.0 111.409 173.843 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.54 HE22 ' HB2' ' A' ' 41' ' ' SER . 5.4 tp-100 172.31 -57.09 0.01 OUTLIER 'General case' 0 C--O 1.231 0.12 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.612 172.199 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.478 ' HD3' ' HB3' ' A' ' 36' ' ' GLU . 7.2 ptmm? -156.07 -37.43 0.08 Allowed 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.903 -172.958 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -118.41 9.93 12.56 Favored 'General case' 0 N--CA 1.47 0.544 0 O-C-N 122.399 -0.188 . . . . 0.0 111.106 -178.268 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 20.0 ttmm 49.43 90.2 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 121.493 0.663 . . . . 0.0 109.732 -167.165 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.49 ' H ' HD23 ' A' ' 70' ' ' LEU . 2.0 pt? -142.03 160.18 40.73 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 -176.377 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 16.0 t -80.47 93.81 2.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 123.605 0.565 . . . . 0.0 109.567 178.611 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.446 HG23 HG21 ' A' ' 22' ' ' VAL . 30.6 m -79.26 -20.67 12.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.819 -177.575 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.474 HD13 ' N ' ' A' ' 74' ' ' GLU . 2.6 tm? -153.89 133.43 12.86 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 178.86 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.474 ' N ' HD13 ' A' ' 73' ' ' LEU . 13.2 pt-20 -151.49 129.6 11.87 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 176.31 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 61.0 m -146.93 117.7 7.6 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.057 -0.52 . . . . 0.0 109.779 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 42.3 t80 -90.96 144.26 25.86 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 -179.787 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 12.2 p -157.17 145.61 10.76 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 N-CA-C 110.3 -0.259 . . . . 0.0 110.3 179.6 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.404 ' HB3' ' H ' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -86.97 -161.19 0.65 Allowed 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.101 179.663 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.528 ' O ' ' HB2' ' A' ' 80' ' ' ASP . 23.0 ttmm -66.48 77.2 0.11 Allowed 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.934 176.907 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' ASP . . . . . 0.528 ' HB2' ' O ' ' A' ' 79' ' ' LYS . 25.6 t70 169.13 95.91 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.461 0.705 . . . . 0.0 109.585 174.489 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.478 HD23 ' H ' ' A' ' 82' ' ' VAL . 1.1 tt -137.06 138.83 40.84 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 -178.321 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.478 ' H ' HD23 ' A' ' 81' ' ' LEU . 26.0 m -124.43 127.53 73.12 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 CA-C-O 120.941 0.401 . . . . 0.0 110.933 179.041 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.642 ' HB3' ' NE2' ' A' ' 91' ' ' HIS . 11.7 m-85 -111.53 139.88 46.6 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.909 174.955 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.468 ' HB ' ' CE1' ' A' ' 92' ' ' HIS . 36.6 m -132.84 114.7 14.38 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.505 -179.472 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 2.6 ttmp? -85.34 99.61 11.27 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 177.269 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -83.08 -13.99 54.64 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.283 0.563 . . . . 0.0 110.518 -176.895 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ASN . . . . . 0.766 ' HB3' ' HB3' ' A' ' 90' ' ' PHE . 27.8 t-20 -160.47 140.33 8.29 Favored Pre-proline 0 C--N 1.324 -0.513 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 -178.128 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_endo -46.94 -22.95 2.26 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 122.948 2.432 . . . . 0.0 113.614 178.073 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.471 HG22 ' OD1' ' A' ' 87' ' ' ASN . 12.6 t -116.51 14.7 15.6 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 120.767 0.318 . . . . 0.0 111.62 -179.872 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.766 ' HB3' ' HB3' ' A' ' 87' ' ' ASN . 79.6 t80 -146.39 114.98 6.79 Favored 'General case' 0 C--O 1.239 0.518 0 CA-C-O 121.218 0.532 . . . . 0.0 110.7 -178.262 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' HIS . . . . . 0.642 ' NE2' ' HB3' ' A' ' 83' ' ' TYR . 1.8 t-160 -121.49 123.11 41.25 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 -179.147 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' HIS . . . . . 0.468 ' CE1' ' HB ' ' A' ' 84' ' ' THR . 34.6 p80 -120.4 168.27 11.48 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.686 0.279 . . . . 0.0 110.857 -179.668 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 45.1 p90 -154.22 137.87 16.07 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.112 -177.653 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 56.6 tttp -95.71 107.81 20.06 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 174.466 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 35.5 m -136.41 151.04 27.85 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 CA-C-O 121.032 0.444 . . . . 0.0 111.15 -179.37 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 33.1 t70 59.87 -78.07 0.02 OUTLIER 'General case' 0 C--O 1.236 0.368 0 CA-C-N 114.882 -1.054 . . . . 0.0 112.459 173.291 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -134.96 -22.87 1.57 Allowed 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 112.796 0.665 . . . . 0.0 112.796 -174.373 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 7.9 tpt180 -146.02 175.55 10.37 Favored 'General case' 0 N--CA 1.465 0.316 0 O-C-N 121.884 -0.51 . . . . 0.0 111.026 -172.837 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 38.1 ttmt -101.43 108.42 20.02 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.822 -0.627 . . . . 0.0 109.623 -179.693 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -103.14 166.9 10.16 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 -179.751 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.413 ' HA2' ' HA ' ' A' ' 92' ' ' HIS . . . -159.59 178.57 35.65 Favored Glycine 0 CA--C 1.51 -0.239 0 C-N-CA 119.945 -1.121 . . . . 0.0 112.974 -177.982 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.575 HD22 HG21 ' A' ' 43' ' ' VAL . 3.9 pp -148.94 154.47 39.45 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-O 120.857 0.36 . . . . 0.0 110.771 177.697 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.403 ' HB ' ' HB ' ' A' ' 21' ' ' VAL . 90.0 m -105.42 128.38 53.49 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.755 175.41 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.436 ' CE2' ' HB2' ' A' ' 91' ' ' HIS . 61.2 m-85 -74.19 169.58 17.29 Favored 'General case' 0 C--O 1.238 0.489 0 CA-C-O 121.182 0.515 . . . . 0.0 111.224 -178.264 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 28.2 tt0 -106.94 -38.15 6.13 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.122 -179.363 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 24.8 m -151.83 157.21 34.49 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.94 178.799 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.483 ' HA ' ' HB3' ' A' ' 110' ' ' ALA . 12.2 Cg_endo -56.55 -22.61 43.95 Favored 'Trans proline' 0 C--N 1.352 0.743 0 C-N-CA 122.348 2.032 . . . . 0.0 111.99 177.041 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -60.58 -63.32 1.34 Allowed 'General case' 0 C--O 1.233 0.213 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.716 175.775 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -66.23 -29.08 69.25 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.732 178.656 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.483 ' HB3' ' HA ' ' A' ' 107' ' ' PRO . . . -59.65 -52.5 65.24 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.975 0.416 . . . . 0.0 110.694 175.788 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 60.8 ttp85 -68.39 -44.31 75.39 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.337 -179.488 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -59.18 -42.1 90.02 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.01 -178.681 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 74.9 t80 -73.69 -39.11 64.63 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.424 -179.846 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.419 ' O ' HG12 ' A' ' 117' ' ' VAL . 37.4 t70 -62.69 -65.78 0.64 Allowed 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 121.326 0.584 . . . . 0.0 110.47 179.178 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 1.5 tmt_? -56.69 -39.8 74.47 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.166 -0.925 . . . . 0.0 110.017 177.991 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -59.19 -51.03 61.61 Favored Glycine 0 C--N 1.333 0.416 0 C-N-CA 121.101 -0.571 . . . . 0.0 112.501 179.62 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.526 ' O ' HG12 ' A' ' 121' ' ' ILE . 8.6 p -68.88 -30.26 46.29 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 N-CA-C 110.209 -0.293 . . . . 0.0 110.209 -178.971 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 3.2 mpt_? -62.53 -46.57 87.78 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.379 177.434 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 53.7 tptt -65.79 -40.92 92.42 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.111 177.889 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -57.49 -45.92 84.34 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.457 177.395 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.526 HG12 ' O ' ' A' ' 117' ' ' VAL . 40.1 mm -64.43 -38.71 83.28 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.337 177.823 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -57.89 -50.65 72.6 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.531 -179.799 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 44.1 m-20 -71.2 -29.42 65.13 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.847 178.697 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.499 ' HB2' ' HE1' ' A' ' 59' ' ' PHE . 65.6 tp -65.71 -54.38 28.13 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.229 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.492 HG22 ' O ' ' A' ' 121' ' ' ILE . 10.7 tp -83.05 -37.18 13.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.19 -174.05 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 . . . . . 0 C--O 1.251 1.163 0 O-C-N 123.59 0.556 . . . . 0.0 109.945 -176.606 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 15.8 m . . . . . 0 CA--C 1.532 0.283 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.622 ' HB3' ' HD2' ' A' ' 17' ' ' ARG . 59.6 m-85 -63.31 93.1 0.06 Allowed 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 120.835 0.35 . . . . 0.0 110.933 179.088 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.4 HG23 HG23 ' A' ' 16' ' ' VAL . 7.5 tp -83.41 -45.66 18.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.308 -178.301 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.4 HG23 HG23 ' A' ' 15' ' ' ILE . 92.1 t -125.3 121.46 60.62 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 CA-C-O 120.848 0.356 . . . . 0.0 110.64 -177.788 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.622 ' HD2' ' HB3' ' A' ' 14' ' ' TYR . 0.0 OUTLIER -125.51 103.8 8.08 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.81 178.94 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 27.2 m -119.89 176.47 3.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 177.547 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 21.5 pttm -128.33 129.97 47.07 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.822 0.344 . . . . 0.0 110.752 -177.888 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.441 ' HB3' HD21 ' A' ' 102' ' ' LEU . . . -159.02 -178.86 7.54 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.833 179.699 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 40.3 t -93.54 99.78 10.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 120.866 0.365 . . . . 0.0 110.707 -176.86 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.488 HG11 ' HG ' ' A' ' 73' ' ' LEU . 57.2 t -81.79 106.42 12.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.626 -179.678 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 23.1 mmt -86.04 150.72 24.26 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.258 177.598 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 5.2 t -123.08 151.49 41.96 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.055 -0.521 . . . . 0.0 109.951 177.539 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 59.1 ttt180 -123.18 104.7 9.34 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.145 -0.48 . . . . 0.0 109.82 -178.61 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -81.2 56.14 2.76 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-O 121.27 0.557 . . . . 0.0 109.681 -179.044 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 65.4 m-20 57.58 22.88 8.65 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.131 -0.94 . . . . 0.0 110.563 -177.374 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.9 m -67.32 156.38 36.58 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 115.179 -0.919 . . . . 0.0 110.782 179.574 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 23.9 m -62.19 -43.73 98.19 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-O 120.961 0.41 . . . . 0.0 110.461 177.903 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -164.01 10.27 0.08 OUTLIER Glycine 0 C--N 1.333 0.371 0 CA-C-N 115.839 -0.619 . . . . 0.0 112.38 177.22 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -83.11 80.22 1.84 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 121.203 -0.522 . . . . 0.0 112.492 -178.96 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 84.9 m95 -72.98 99.64 2.77 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 174.814 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.488 ' HA ' ' HD3' ' A' ' 34' ' ' PRO . 26.0 p90 -98.07 141.04 22.32 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.949 -174.471 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.593 ' HB2' ' HA2' ' A' ' 38' ' ' GLY . 9.1 Cg_exo -72.15 136.34 26.74 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.894 2.396 . . . . 0.0 111.593 178.625 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' GLN . . . . . 0.434 ' O ' ' N ' ' A' ' 37' ' ' GLY . 2.9 pp0? -93.38 145.13 24.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.208 -179.419 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 44.8 mm-40 41.5 -82.76 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 113.788 1.032 . . . . 0.0 113.788 173.274 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.434 ' N ' ' O ' ' A' ' 35' ' ' GLN . . . -58.8 -30.8 66.6 Favored Glycine 0 C--N 1.333 0.392 0 C-N-CA 121.45 -0.405 . . . . 0.0 112.959 -174.705 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.593 ' HA2' ' HB2' ' A' ' 34' ' ' PRO . . . 67.21 12.06 60.02 Favored Glycine 0 C--N 1.33 0.249 0 C-N-CA 121.046 -0.597 . . . . 0.0 112.261 -179.054 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -167.72 -123.02 0.64 Allowed Glycine 0 N--CA 1.446 -0.67 0 N-CA-C 111.586 -0.606 . . . . 0.0 111.586 -177.831 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 34.0 pt -64.23 135.98 27.12 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 CA-C-O 121.343 0.592 . . . . 0.0 111.815 -177.171 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 39.6 m -144.0 132.84 22.59 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.022 175.284 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.479 ' HD3' ' HB3' ' A' ' 17' ' ' ARG . 5.7 tmm_? -76.3 103.45 6.33 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 -179.017 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.476 HG11 HD11 ' A' ' 102' ' ' LEU . 4.0 p -91.79 110.2 22.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.58 0.705 . . . . 0.0 109.89 177.323 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.451 ' N ' HH11 ' A' ' 42' ' ' ARG . . . -107.43 103.67 1.99 Allowed Glycine 0 N--CA 1.448 -0.536 0 CA-C-N 115.395 -0.821 . . . . 0.0 111.505 -179.495 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 7.5 p -86.13 125.18 40.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 178.899 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' CYS . . . . . 0.789 ' SG ' ' HB3' ' A' ' 60' ' ' LEU . 7.0 p -126.54 128.5 46.97 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.603 -178.063 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 3.2 ttmp? -81.58 98.85 8.53 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 177.162 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 46.0 t -73.87 85.49 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 177.694 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 13.5 tpt . . . . . 0 C--O 1.237 0.431 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.499 -178.676 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.347 0 N-CA-C 112.234 -0.346 . . . . 0.0 112.234 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.474 ' O ' HG22 ' A' ' 77' ' ' VAL . 84.8 m-85 -127.83 125.78 40.41 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 178.963 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.789 ' HB3' ' SG ' ' A' ' 46' ' ' CYS . 1.6 tt -93.99 108.2 20.04 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 179.86 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 48.3 mm -80.65 91.41 1.81 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.261 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 174.418 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' HIS . . . . . 0.672 ' HB2' HD22 ' A' ' 60' ' ' LEU . 54.2 t-80 -108.45 106.64 16.85 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.83 -173.908 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.427 ' HA2' ' O ' ' A' ' 42' ' ' ARG . . . -114.8 138.57 14.91 Favored Glycine 0 C--O 1.235 0.209 0 N-CA-C 111.725 -0.55 . . . . 0.0 111.725 178.422 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.419 ' HB2' ' O ' ' A' ' 70' ' ' LEU . 14.4 pt-20 -120.35 160.18 23.55 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 120.881 0.372 . . . . 0.0 110.801 -179.803 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.475 ' HB2' HG11 ' A' ' 72' ' ' VAL . 2.0 tmt_? -82.75 122.66 28.46 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 177.428 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 9.5 mm100 -58.67 97.45 0.03 OUTLIER 'General case' 0 C--O 1.234 0.269 0 CA-C-O 121.105 0.479 . . . . 0.0 112.007 -174.842 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 29.5 mtpp -140.27 -72.05 0.37 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.193 -0.912 . . . . 0.0 108.739 173.152 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -160.25 -46.89 0.05 OUTLIER 'General case' 0 C--O 1.235 0.327 0 CA-C-N 114.67 -1.15 . . . . 0.0 108.93 -178.617 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 56.1 tttm -170.36 99.12 0.26 Allowed 'General case' 0 C--O 1.236 0.39 0 CA-C-N 115.099 -0.955 . . . . 0.0 109.569 177.835 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.419 ' O ' ' HB2' ' A' ' 64' ' ' GLU . 4.1 tt -157.21 107.77 2.28 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 -178.744 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 43.8 t -78.58 125.18 37.9 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.004 -177.377 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.475 HG11 ' HB2' ' A' ' 65' ' ' ARG . 27.7 m -123.02 -28.96 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.584 179.735 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.488 ' HG ' HG11 ' A' ' 22' ' ' VAL . 2.6 tm? -123.66 117.02 24.05 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 -177.446 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -131.78 107.0 8.47 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 176.742 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 52.5 t -135.13 79.5 1.79 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.349 0.595 . . . . 0.0 109.953 179.676 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.549 ' HA ' ' HA ' ' A' ' 60' ' ' LEU . 57.2 t80 -72.74 105.07 4.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.98 175.472 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.474 HG22 ' O ' ' A' ' 59' ' ' PHE . 34.8 m -81.11 114.54 22.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 178.601 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.723 ' HD2' ' H ' ' A' ' 78' ' ' ARG . 0.3 OUTLIER -82.66 61.67 5.89 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 -173.819 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 36.3 mtmm 68.68 -2.87 1.54 Allowed 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.206 -172.385 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -92.36 85.77 5.49 Favored 'General case' 0 N--CA 1.462 0.148 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 174.035 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.721 HD22 HD11 ' A' ' 121' ' ' ILE . 2.4 tt -131.25 106.82 8.56 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.976 -173.854 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 59.5 t -124.05 92.38 2.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.252 176.86 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.407 ' CD1' ' HB3' ' A' ' 93' ' ' TRP . 0.2 OUTLIER -81.49 101.54 9.98 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.04 178.672 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 22.5 m -90.93 127.22 36.31 Favored 'General case' 0 C--N 1.323 -0.543 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 178.602 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 24.7 pttm -93.32 111.25 22.85 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.111 0.481 . . . . 0.0 110.857 -177.844 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -90.07 -44.16 10.01 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.271 0.558 . . . . 0.0 109.503 175.676 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ASN . . . . . 0.612 ' HB2' ' HB3' ' A' ' 90' ' ' PHE . 93.0 m-20 -138.63 153.98 72.81 Favored Pre-proline 0 C--N 1.328 -0.363 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 177.132 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -55.26 -27.41 56.94 Favored 'Trans proline' 0 CA--C 1.533 0.471 0 C-N-CA 122.22 1.947 . . . . 0.0 112.034 176.951 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 10.8 p -105.91 8.47 32.61 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.836 178.842 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.612 ' HB3' ' HB2' ' A' ' 87' ' ' ASN . 25.6 t80 -140.81 102.97 4.4 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-O 121.076 0.465 . . . . 0.0 110.405 -179.784 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 14.2 m80 -107.7 132.51 53.27 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.513 174.321 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' HIS . . . . . 0.424 ' HA ' ' O ' ' A' ' 100' ' ' PHE . 8.2 p80 -126.95 129.56 48.37 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.74 0.305 . . . . 0.0 110.204 178.138 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' TRP . . . . . 0.62 ' HZ3' ' HB2' ' A' ' 102' ' ' LEU . 34.8 p90 -110.01 149.77 29.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.079 179.3 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 14.3 tmtt? -112.57 122.1 46.72 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.059 -178.038 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.439 HG13 ' HD1' ' A' ' 93' ' ' TRP . 21.1 m -124.88 127.33 72.47 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.071 176.863 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 42.3 m-20 59.6 -80.18 0.02 OUTLIER 'General case' 0 C--O 1.235 0.297 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.953 -179.108 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -133.74 -28.48 1.41 Allowed 'General case' 0 C--O 1.234 0.243 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.609 -176.65 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 62.5 mtt180 -103.44 156.46 17.74 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 121.482 0.658 . . . . 0.0 112.495 -171.998 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.84 137.34 52.83 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 114.64 -1.164 . . . . 0.0 109.846 -179.89 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' PHE . . . . . 0.424 ' O ' ' HA ' ' A' ' 92' ' ' HIS . 36.6 m-85 -122.98 137.13 55.04 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 176.998 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -115.76 101.59 1.03 Allowed Glycine 0 C--N 1.333 0.409 0 C-N-CA 120.968 -0.634 . . . . 0.0 113.216 -171.116 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.62 ' HB2' ' HZ3' ' A' ' 93' ' ' TRP . 3.7 tt -74.42 104.25 5.09 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.211 -0.662 . . . . 0.0 109.211 177.047 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.401 ' HG1' ' HD2' ' A' ' 90' ' ' PHE . 17.5 m -96.67 114.97 26.66 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.142 179.773 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.422 ' CG ' ' HA ' ' A' ' 110' ' ' ALA . 74.5 m-85 -72.27 167.31 20.67 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.296 -175.368 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -112.71 -31.66 6.67 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.71 -175.89 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 5.7 m -138.51 150.07 64.92 Favored Pre-proline 0 C--N 1.329 -0.31 0 N-CA-C 110.187 -0.301 . . . . 0.0 110.187 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -52.96 -29.02 42.17 Favored 'Trans proline' 0 C--N 1.352 0.718 0 C-N-CA 122.309 2.006 . . . . 0.0 111.86 176.781 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -59.44 -65.59 0.65 Allowed 'General case' 0 C--O 1.236 0.384 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.858 177.227 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -64.92 -31.59 72.9 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.949 -179.344 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.422 ' HA ' ' CG ' ' A' ' 104' ' ' PHE . . . -58.52 -60.85 3.15 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.092 177.395 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 20.0 mtm180 -66.54 -32.54 73.96 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.748 -177.628 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -63.51 -56.67 14.24 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.037 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.405 ' HB3' ' CE1' ' A' ' 104' ' ' PHE . 39.1 t80 -71.03 -28.89 64.72 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.337 -177.214 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -54.84 -63.43 1.16 Allowed 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 121.808 0.813 . . . . 0.0 109.588 173.17 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 52.4 ttt180 -56.51 -37.21 70.1 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.306 -1.315 . . . . 0.0 110.835 177.883 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -63.94 -53.89 34.39 Favored Glycine 0 C--O 1.237 0.304 0 CA-C-N 115.837 -0.62 . . . . 0.0 112.909 -179.164 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.449 ' O ' HG12 ' A' ' 121' ' ' ILE . 11.9 p -67.71 -33.67 63.23 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 -178.292 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.503 ' O ' ' HG3' ' A' ' 122' ' ' GLU . 54.2 ttt180 -55.54 -50.96 68.63 Favored 'General case' 0 C--O 1.231 0.089 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 173.223 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.643 ' HE2' ' HA ' ' A' ' 119' ' ' LYS . 0.6 OUTLIER -56.47 -46.39 80.42 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.065 178.786 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -56.85 -42.5 79.8 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.949 178.769 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.721 HD11 HD22 ' A' ' 81' ' ' LEU . 42.6 mm -61.59 -39.59 83.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.925 176.682 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.53 ' HA ' ' HA ' ' A' ' 126' ' ' GLU . 41.2 mt-10 -66.23 -37.73 86.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.652 179.676 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -65.26 -36.6 84.61 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-O 121.222 0.534 . . . . 0.0 109.988 174.975 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 59.3 tp -71.46 -55.35 8.07 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.675 -176.714 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.42 ' O ' HG13 ' A' ' 125' ' ' ILE . 11.3 tp -145.47 10.18 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 N-CA-C 111.655 0.243 . . . . 0.0 111.655 -171.937 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.53 ' HA ' ' HA ' ' A' ' 122' ' ' GLU . 34.0 tt0 . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.429 -0.796 . . . . 0.0 110.753 -175.291 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 16.5 m . . . . . 0 CA--C 1.536 0.429 0 N-CA-C 111.857 0.317 . . . . 0.0 111.857 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.425 ' HE2' ' HA3' ' A' ' 44' ' ' GLY . 24.7 m-85 -65.14 123.4 19.42 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-O 120.695 0.283 . . . . 0.0 110.561 178.191 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 13.0 tt -102.73 -34.1 3.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 173.411 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.414 ' HB ' ' HB ' ' A' ' 45' ' ' VAL . 97.8 t -139.3 130.12 33.03 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.764 177.808 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 11.6 ptm180 -142.41 91.13 2.29 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.199 0.523 . . . . 0.0 110.277 176.96 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 35.1 m -107.5 161.08 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.928 -177.629 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 47.3 mtmt -93.83 130.58 39.8 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.392 178.764 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -163.25 158.59 21.72 Favored 'General case' 0 C--N 1.331 -0.223 0 O-C-N 123.254 0.346 . . . . 0.0 110.29 179.219 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 58.4 t -90.77 105.66 16.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 178.939 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.599 HG23 ' NE2' ' A' ' 35' ' ' GLN . 15.8 m -81.23 115.18 23.37 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 CA-C-O 121.406 0.622 . . . . 0.0 111.673 -176.541 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 24.0 mmt -99.66 162.78 12.81 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.973 179.589 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 9.9 t -136.64 158.19 45.02 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.943 0.402 . . . . 0.0 110.854 -179.13 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 20.5 ttt180 -136.36 100.26 4.33 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 -179.651 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.587 ' H ' ' HE1' ' A' ' 33' ' ' PHE . 27.4 t70 -63.03 104.43 0.56 Allowed 'General case' 0 C--O 1.234 0.267 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.541 -172.078 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.639 ' HA ' ' HG2' ' A' ' 98' ' ' ARG . 23.8 t70 60.23 -76.85 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.677 176.862 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 37.4 p -145.01 22.94 1.55 Allowed 'General case' 0 C--O 1.236 0.345 0 N-CA-C 111.484 0.179 . . . . 0.0 111.484 -178.694 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 49.1 m -51.6 143.05 13.1 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.994 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -81.58 61.89 4.57 Favored Glycine 0 CA--C 1.52 0.354 0 C-N-CA 121.431 -0.414 . . . . 0.0 112.629 -177.386 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 158.67 -168.91 34.98 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 121.279 -0.486 . . . . 0.0 111.942 179.195 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' TRP . . . . . 0.571 ' HH2' ' HG2' ' A' ' 99' ' ' LYS . 88.2 m95 -128.26 116.45 19.88 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 177.871 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.587 ' HE1' ' H ' ' A' ' 26' ' ' ASP . 37.7 p90 -110.78 148.29 38.25 Favored Pre-proline 0 C--O 1.235 0.308 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.894 -175.833 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -77.88 157.55 31.14 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.73 2.287 . . . . 0.0 111.549 176.484 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' GLN . . . . . 0.599 ' NE2' HG23 ' A' ' 22' ' ' VAL . 2.5 pp0? -136.11 -152.89 0.47 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.059 -0.518 . . . . 0.0 109.923 -178.728 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 22.5 tp10 -52.74 -22.15 4.92 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 120.918 0.389 . . . . 0.0 111.49 -177.163 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -112.32 46.13 1.22 Allowed Glycine 0 CA--C 1.518 0.26 0 N-CA-C 111.578 -0.609 . . . . 0.0 111.578 175.304 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -71.95 -19.45 78.3 Favored Glycine 0 C--N 1.331 0.292 0 C-N-CA 121.357 -0.449 . . . . 0.0 112.664 -179.507 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -97.29 -151.04 27.39 Favored Glycine 0 C--O 1.237 0.301 0 C-N-CA 121.35 -0.452 . . . . 0.0 112.097 178.286 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 50.6 mm -65.72 99.18 0.29 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.38 0 CA-C-O 121.154 0.502 . . . . 0.0 110.284 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 36.8 m -105.66 -175.8 2.9 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.475 179.818 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.608 HH22 ' N ' ' A' ' 68' ' ' ASP . 28.3 ttm180 -130.53 134.94 47.44 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.764 -178.022 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.808 HG21 HD22 ' A' ' 102' ' ' LEU . 24.3 t -100.05 94.44 3.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 171.216 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.425 ' HA3' ' HE2' ' A' ' 14' ' ' TYR . . . -98.37 91.94 1.18 Allowed Glycine 0 N--CA 1.449 -0.474 0 CA-C-N 115.827 -0.624 . . . . 0.0 113.098 -173.969 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.414 ' HB ' ' HB ' ' A' ' 16' ' ' VAL . 51.4 t -76.3 109.94 10.94 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 175.236 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' CYS . . . . . 0.699 ' SG ' ' HB3' ' A' ' 60' ' ' LEU . 9.1 p -121.88 137.33 54.82 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.431 -178.446 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.574 ' HA ' ' O ' ' A' ' 58' ' ' GLY . 42.1 mtmt -84.97 118.38 24.52 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.981 0.42 . . . . 0.0 111.033 -179.797 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 42.7 t -90.91 118.24 35.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.185 173.946 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 67.1 mtm . . . . . 0 C--N 1.329 -0.312 0 CA-C-O 121.018 0.437 . . . . 0.0 110.529 -178.597 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.574 ' O ' ' HA ' ' A' ' 47' ' ' LYS . . . . . . . . 0 N--CA 1.452 -0.263 0 N-CA-C 112.079 -0.408 . . . . 0.0 112.079 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 32.6 m-85 -103.0 97.07 7.24 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.268 0.556 . . . . 0.0 110.5 -177.592 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.719 ' HA ' ' HA ' ' A' ' 76' ' ' TYR . 2.7 tt -81.69 110.0 16.63 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 178.53 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 60.8 mt -75.33 86.4 0.66 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.314 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 174.106 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 12.3 t-80 -90.08 101.19 13.91 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.254 -0.884 . . . . 0.0 109.946 -176.337 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -91.27 114.55 4.52 Favored Glycine 0 N--CA 1.449 -0.435 0 CA-C-N 115.937 -0.574 . . . . 0.0 112.204 -177.853 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -119.51 -170.27 1.91 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.025 0.44 . . . . 0.0 110.934 179.589 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 23.0 mmt85 -83.58 -174.73 5.45 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.451 169.717 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 28.7 pt20 -55.59 -35.17 65.51 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.168 177.127 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -115.51 147.89 40.13 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.278 -178.886 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.608 ' N ' HH22 ' A' ' 42' ' ' ARG . 1.8 m-20 -67.85 105.59 2.02 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.1 -178.424 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -176.17 -39.21 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.348 0 O-C-N 123.168 0.293 . . . . 0.0 111.591 -179.85 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 61.5 tp -122.03 115.54 22.69 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.622 0.249 . . . . 0.0 111.282 -175.839 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 35.4 t -88.82 110.47 21.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.891 176.771 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 35.9 m -91.3 -36.68 8.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.259 -177.696 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -133.42 151.49 51.82 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 122.491 0.317 . . . . 0.0 110.234 178.742 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.542 ' HG2' HD21 ' A' ' 60' ' ' LEU . 2.9 tm-20 -146.94 115.75 6.82 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 175.982 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 50.0 t -141.15 83.7 1.89 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.21 0.529 . . . . 0.0 110.616 -178.364 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.719 ' HA ' ' HA ' ' A' ' 60' ' ' LEU . 78.4 t80 -68.87 122.65 19.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.587 175.768 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.475 HG12 ' HB2' ' A' ' 80' ' ' ASP . 17.2 m -133.21 122.71 45.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.006 0.431 . . . . 0.0 110.281 178.031 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 11.5 ptm180 -110.04 -27.77 9.03 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.2 0.524 . . . . 0.0 110.211 179.164 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -155.05 22.25 0.43 Allowed 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 173.963 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' ASP . . . . . 0.475 ' HB2' HG12 ' A' ' 77' ' ' VAL . 0.7 OUTLIER -114.7 9.55 16.45 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 114.414 -1.266 . . . . 0.0 109.816 -172.557 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.828 HD22 HD11 ' A' ' 121' ' ' ILE . 3.5 tt -79.17 104.42 9.79 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.171 -172.316 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 48.4 t -127.97 96.78 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 CA-C-N 116.567 -0.288 . . . . 0.0 110.667 177.201 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.506 ' HD2' ' CD2' ' A' ' 91' ' ' HIS . 4.5 m-85 -91.71 172.46 8.47 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-O 121.396 0.617 . . . . 0.0 111.076 178.306 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 50.1 m -154.42 110.75 3.26 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.056 -0.974 . . . . 0.0 109.314 -179.629 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.474 ' NZ ' ' HB3' ' A' ' 85' ' ' LYS . 5.2 ttpm? -77.3 107.05 9.43 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 177.346 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -85.28 -59.65 2.26 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.214 0.53 . . . . 0.0 110.138 -179.614 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 -130.19 158.63 73.59 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.353 -179.177 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -56.13 -13.69 10.05 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 122.6 2.2 . . . . 0.0 113.189 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 12.7 t -125.21 5.8 7.81 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-O 120.452 0.168 . . . . 0.0 111.304 179.509 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 17.8 t80 -135.36 114.28 12.05 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 -179.57 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' HIS . . . . . 0.506 ' CD2' ' HD2' ' A' ' 83' ' ' TYR . 2.3 t-160 -130.24 129.91 43.94 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 -176.897 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 53.6 p-80 -138.78 174.98 9.96 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.527 0.203 . . . . 0.0 111.066 -174.832 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' TRP . . . . . 0.48 ' HB3' ' CD1' ' A' ' 83' ' ' TYR . 34.2 p90 -142.8 171.72 13.67 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 176.427 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -137.24 150.34 47.78 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.037 0.446 . . . . 0.0 110.815 -178.988 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 24.6 m -122.85 -140.27 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 173.4 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -59.39 83.72 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 118.083 0.401 . . . . 0.0 110.918 176.548 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 52.8 t30 68.99 -63.58 0.36 Allowed 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.232 1.013 . . . . 0.0 112.147 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.639 ' HG2' ' HA ' ' A' ' 27' ' ' ASP . 60.0 mtt-85 -55.03 136.07 48.28 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 121.251 0.548 . . . . 0.0 110.745 -176.611 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.571 ' HG2' ' HH2' ' A' ' 32' ' ' TRP . 4.5 ttmp? -127.18 132.84 50.4 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.472 -0.786 . . . . 0.0 110.308 -169.058 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 1.1 p90 -147.2 158.22 43.87 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 -179.174 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.427 ' HA2' ' CZ3' ' A' ' 93' ' ' TRP . . . -164.23 -153.21 7.29 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.384 -0.912 . . . . 0.0 113.338 -174.572 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.808 HD22 HG21 ' A' ' 43' ' ' VAL . 4.1 pp -144.48 168.21 20.67 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.099 0.476 . . . . 0.0 110.977 -174.63 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 15.3 m -128.59 119.73 25.32 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.533 178.091 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 47.5 m-85 -66.27 160.05 25.27 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.089 178.091 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 29.8 pt20 -129.54 -27.08 2.42 Favored 'General case' 0 C--N 1.328 -0.37 0 N-CA-C 111.535 0.198 . . . . 0.0 111.535 -177.849 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 32.1 m -135.13 150.21 72.29 Favored Pre-proline 0 C--N 1.329 -0.299 0 N-CA-C 110.282 -0.266 . . . . 0.0 110.282 179.449 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.579 ' O ' ' HG2' ' A' ' 111' ' ' ARG . 82.2 Cg_exo -49.59 -35.2 36.79 Favored 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 122.683 2.256 . . . . 0.0 112.254 177.13 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -57.84 -63.52 1.22 Allowed 'General case' 0 C--O 1.235 0.314 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.574 -179.57 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -62.28 -34.37 76.44 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.736 -179.003 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -55.29 -66.59 0.39 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.117 177.151 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' ARG . . . . . 0.579 ' HG2' ' O ' ' A' ' 107' ' ' PRO . 44.7 ptt85 -59.58 -47.21 86.47 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.237 -176.794 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -63.15 -49.84 72.76 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.74 -172.971 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.493 ' O ' HG23 ' A' ' 117' ' ' VAL . 63.2 t80 -75.6 -43.45 48.05 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.803 -175.655 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -55.47 -59.71 4.43 Favored 'General case' 0 C--O 1.24 0.556 0 CA-C-O 121.566 0.698 . . . . 0.0 109.957 179.688 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 22.8 ttm180 -59.4 -37.23 77.47 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 114.895 -1.048 . . . . 0.0 109.93 177.041 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -58.35 -39.38 92.63 Favored Glycine 0 N--CA 1.45 -0.419 0 CA-C-N 115.861 -0.609 . . . . 0.0 112.362 178.257 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.493 HG23 ' O ' ' A' ' 113' ' ' PHE . 72.6 t -71.3 -49.8 45.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.607 0.241 . . . . 0.0 110.809 -179.727 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.403 HH11 ' HD2' ' A' ' 118' ' ' ARG . 44.2 mtm105 -59.78 -44.87 93.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.875 0.369 . . . . 0.0 110.785 179.503 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 45.3 tptt -65.97 -36.01 82.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.447 177.54 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -62.42 -43.84 97.86 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.309 176.481 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.828 HD11 HD22 ' A' ' 81' ' ' LEU . 32.4 mm -60.68 -42.81 93.34 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.108 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.278 177.617 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.441 ' O ' ' HG3' ' A' ' 126' ' ' GLU . 34.7 tt0 -56.35 -57.32 12.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.165 177.837 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 74.0 m-20 -69.7 -18.91 63.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.601 -177.583 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 6.0 tt -77.27 -45.44 26.34 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 178.057 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 13.9 tt -78.98 -28.05 13.68 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.354 -175.46 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.441 ' HG3' ' O ' ' A' ' 122' ' ' GLU . 50.1 mt-10 . . . . . 0 C--O 1.255 1.39 0 CA-C-O 118.384 -0.817 . . . . 0.0 110.264 178.372 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 33.3 t . . . . . 0 C--O 1.234 0.254 0 CA-C-O 120.518 0.199 . . . . 0.0 111.189 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 61.8 m-85 -63.36 89.57 0.04 OUTLIER 'General case' 0 C--O 1.233 0.232 0 CA-C-O 121.065 0.46 . . . . 0.0 110.446 177.903 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 62.5 mt -73.96 -32.08 32.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.62 -179.057 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 60.4 t -123.62 100.3 7.63 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.18 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.902 -178.708 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 86.6 mtm180 -112.74 93.58 4.49 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 172.822 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 30.9 m -120.12 174.47 5.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.993 0.425 . . . . 0.0 111.644 -175.69 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.687 ' HD2' HD11 ' A' ' 40' ' ' ILE . 9.4 mtmp? -110.74 114.96 28.72 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.71 -178.1 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -148.54 179.97 7.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.222 179.748 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 42.6 t -109.15 109.89 30.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 110.251 -0.278 . . . . 0.0 110.251 179.69 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 15.8 m -70.46 95.9 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 CA-C-O 121.522 0.677 . . . . 0.0 111.415 -178.728 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' MET . . . . . 0.659 ' H ' ' HA ' ' A' ' 102' ' ' LEU . 21.2 mmt -89.96 115.16 27.04 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.036 -179.781 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.495 HG23 ' CE1' ' A' ' 33' ' ' PHE . 9.6 t -112.67 162.93 15.15 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.341 0.591 . . . . 0.0 110.393 179.67 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.411 ' O ' ' N ' ' A' ' 27' ' ' ASP . 5.4 tpm_? -133.12 98.17 4.2 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 176.557 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.62 ' H ' ' HE1' ' A' ' 33' ' ' PHE . 30.8 t70 -60.7 80.46 0.01 OUTLIER 'General case' 0 C--O 1.233 0.211 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.137 -178.151 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.411 ' N ' ' O ' ' A' ' 25' ' ' ARG . 0.8 OUTLIER 57.04 173.07 0.04 OUTLIER 'General case' 0 C--O 1.235 0.314 0 CA-C-N 115.037 -0.983 . . . . 0.0 111.208 -174.658 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 40.0 m 59.66 -167.83 0.16 Allowed 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 120.873 0.368 . . . . 0.0 110.91 -178.217 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 68.1 m -149.64 132.0 15.61 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 172.274 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 146.95 65.7 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.297 0 N-CA-C 111.601 -0.6 . . . . 0.0 111.601 -178.67 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 118.84 98.84 1.86 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 121.235 -0.507 . . . . 0.0 112.195 -179.525 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' TRP . . . . . 0.539 ' HH2' ' HG2' ' A' ' 99' ' ' LYS . 77.7 m95 -81.9 120.2 24.9 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 176.694 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.62 ' HE1' ' H ' ' A' ' 26' ' ' ASP . 14.2 p90 -115.09 132.5 23.0 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.438 -0.347 . . . . 0.0 110.505 -176.992 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.559 ' HB2' ' HA3' ' A' ' 38' ' ' GLY . 71.4 Cg_endo -74.69 112.86 3.65 Favored 'Trans proline' 0 N--CA 1.458 -0.57 0 C-N-CA 121.939 1.76 . . . . 0.0 110.657 175.158 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -54.81 129.03 35.66 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.455 -175.424 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 63.19 16.0 9.03 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.62 -179.554 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 107.34 -26.27 19.07 Favored Glycine 0 C--N 1.33 0.245 0 C-N-CA 121.494 -0.384 . . . . 0.0 112.643 177.666 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.559 ' HA3' ' HB2' ' A' ' 34' ' ' PRO . . . 72.41 -71.61 1.02 Allowed Glycine 0 CA--C 1.519 0.289 0 C-N-CA 121.221 -0.514 . . . . 0.0 112.572 -179.835 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 62.04 -96.68 0.14 Allowed Glycine 0 C--N 1.333 0.394 0 N-CA-C 112.121 -0.392 . . . . 0.0 112.121 -179.292 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.687 HD11 ' HD2' ' A' ' 19' ' ' LYS . 12.5 tt -141.78 80.53 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 122.056 0.932 . . . . 0.0 109.475 178.23 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 9.3 m -77.09 141.92 40.02 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.67 -173.846 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.755 ' HB3' ' HB2' ' A' ' 64' ' ' GLU . 41.3 ttm180 -92.98 97.53 10.78 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 178.125 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 48.1 t -76.22 107.47 7.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.097 -0.501 . . . . 0.0 109.961 -178.591 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -106.78 112.08 3.7 Favored Glycine 0 N--CA 1.448 -0.511 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.824 179.446 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 62.0 t -106.4 111.52 35.68 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 177.613 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' CYS . . . . . 0.779 ' SG ' ' HB3' ' A' ' 60' ' ' LEU . 8.0 p -104.92 143.1 33.62 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.548 178.352 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 40.9 ttmt -94.89 92.9 7.14 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 121.026 0.441 . . . . 0.0 109.972 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 42.6 t -77.11 88.0 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.769 178.718 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 61.0 mtm . . . . . 0 C--N 1.328 -0.369 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.256 -179.954 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.366 0 N-CA-C 111.662 -0.575 . . . . 0.0 111.662 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -133.24 119.76 20.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.928 0.394 . . . . 0.0 110.413 -179.54 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.779 ' HB3' ' SG ' ' A' ' 46' ' ' CYS . 1.2 tt -96.2 110.21 22.54 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 179.003 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 57.3 mt -84.85 90.84 2.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 174.54 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -103.46 116.16 31.88 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.082 -175.106 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -91.42 96.05 2.14 Favored Glycine 0 N--CA 1.449 -0.493 0 CA-C-N 115.964 -0.562 . . . . 0.0 112.111 -179.025 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.755 ' HB2' ' HB3' ' A' ' 42' ' ' ARG . 5.2 mm-40 -73.77 145.21 45.24 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 177.365 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.46 ' HD2' HD22 ' A' ' 70' ' ' LEU . 18.6 ttt180 -76.58 8.33 3.66 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.241 -178.591 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.424 ' NE2' ' HB2' ' A' ' 42' ' ' ARG . 6.7 tp-100 71.9 -68.67 0.21 Allowed 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 123.521 0.728 . . . . 0.0 110.263 -178.864 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.409 ' O ' ' HB3' ' A' ' 68' ' ' ASP . 88.0 tttt -88.27 118.19 27.7 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 177.571 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.409 ' HB3' ' O ' ' A' ' 67' ' ' LYS . 32.5 t70 73.61 146.58 0.08 Allowed 'General case' 0 N--CA 1.469 0.518 0 O-C-N 124.003 0.814 . . . . 0.0 111.269 -178.786 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -74.39 79.47 1.89 Allowed 'General case' 0 C--O 1.236 0.369 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.2 -179.33 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.46 HD22 ' HD2' ' A' ' 65' ' ' ARG . 6.2 tt -130.9 131.85 44.76 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 179.762 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.455 ' N ' HD23 ' A' ' 70' ' ' LEU . 23.6 t -89.73 117.67 33.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.042 -175.976 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 32.8 m -98.29 -23.0 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-O 120.713 0.292 . . . . 0.0 110.806 176.792 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.414 HD23 ' N ' ' A' ' 74' ' ' GLU . 9.3 tt -145.54 139.52 26.8 Favored 'General case' 0 N--CA 1.462 0.166 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 -179.179 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.414 ' N ' HD23 ' A' ' 73' ' ' LEU . 1.7 tm-20 -142.5 109.51 5.53 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 -179.129 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' CYS . . . . . 0.424 ' SG ' HG21 ' A' ' 95' ' ' VAL . 35.0 t -140.12 82.56 1.87 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.384 0.611 . . . . 0.0 110.984 -179.288 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.422 ' HA ' ' HA ' ' A' ' 60' ' ' LEU . 82.5 t80 -75.13 121.99 22.91 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.812 174.662 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.511 HG11 ' HB2' ' A' ' 81' ' ' LEU . 92.8 t -124.85 112.02 30.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 -177.218 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.415 ' HD3' ' OH ' ' A' ' 76' ' ' TYR . 46.5 ttp180 -120.4 1.24 10.69 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-O 121.253 0.549 . . . . 0.0 110.58 -179.692 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 19.3 ptmt -141.01 86.86 2.06 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 115.965 -0.562 . . . . 0.0 111.141 -176.002 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' ASP . . . . . 0.534 ' H ' HD11 ' A' ' 124' ' ' LEU . 18.2 t70 64.5 148.4 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 115.649 -0.705 . . . . 0.0 112.154 178.108 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.511 ' HB2' HG11 ' A' ' 77' ' ' VAL . 51.5 tp -149.46 137.78 20.71 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.846 -0.615 . . . . 0.0 109.961 178.999 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 60.3 t -77.28 -65.13 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.363 178.338 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.438 ' HD2' ' HB ' ' A' ' 117' ' ' VAL . 4.5 t80 37.99 79.89 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 124.111 0.964 . . . . 0.0 111.729 -178.767 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 97.1 m -112.64 136.5 52.13 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.261 -0.881 . . . . 0.0 109.913 179.714 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.464 ' HA ' ' HA ' ' A' ' 91' ' ' HIS . 18.0 ptmt -85.37 108.77 17.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.043 0.449 . . . . 0.0 109.846 176.569 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -74.85 -27.55 60.31 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.446 0.641 . . . . 0.0 109.846 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' ASN . . . . . 0.502 ' HB2' ' HB3' ' A' ' 90' ' ' PHE . 16.5 m120 -141.62 156.43 66.4 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-N 115.059 -0.973 . . . . 0.0 108.709 177.923 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -58.56 -13.29 16.72 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.581 2.187 . . . . 0.0 112.561 180.0 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.435 ' HA ' ' HD2' ' A' ' 104' ' ' PHE . 23.6 p -124.55 14.3 8.79 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.608 -178.885 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.502 ' HB3' ' HB2' ' A' ' 87' ' ' ASN . 42.6 t80 -145.19 123.17 12.04 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-O 120.706 0.289 . . . . 0.0 110.833 -177.539 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' HIS . . . . . 0.471 ' HB2' ' CZ ' ' A' ' 104' ' ' PHE . 0.3 OUTLIER -126.01 136.29 52.79 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 -179.134 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 92' ' ' HIS . . . . . 0.569 ' HA ' ' HA3' ' A' ' 101' ' ' GLY . 11.7 p80 -141.53 158.59 43.66 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 120.643 0.259 . . . . 0.0 110.905 -177.148 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' TRP . . . . . 0.517 ' CZ3' ' HA2' ' A' ' 101' ' ' GLY . 39.3 p90 -136.45 158.89 43.36 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.848 0.356 . . . . 0.0 110.375 176.976 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt -122.48 113.96 20.04 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.669 179.577 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.424 HG21 ' SG ' ' A' ' 75' ' ' CYS . 28.0 m -141.34 162.63 21.38 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 N-CA-C 110.021 -0.363 . . . . 0.0 110.021 178.084 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 26.0 t70 63.56 -76.1 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.393 0 O-C-N 123.694 0.621 . . . . 0.0 110.957 179.699 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -155.92 -9.86 0.11 Allowed 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.781 177.269 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 42.0 ttm180 -122.15 155.59 35.43 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.261 0.553 . . . . 0.0 112.032 -165.553 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.539 ' HG2' ' HH2' ' A' ' 32' ' ' TRP . 37.4 ttpt -108.63 107.25 17.66 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.053 -0.976 . . . . 0.0 109.436 178.312 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' PHE . . . . . 0.456 ' HA ' ' HZ3' ' A' ' 32' ' ' TRP . 3.6 p90 -138.55 155.19 48.59 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.662 -0.245 . . . . 0.0 110.667 -179.419 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.569 ' HA3' ' HA ' ' A' ' 92' ' ' HIS . . . -163.09 -141.5 3.14 Favored Glycine 0 C--N 1.332 0.346 0 C-N-CA 121.116 -0.564 . . . . 0.0 112.702 -177.177 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.659 ' HA ' ' H ' ' A' ' 23' ' ' MET . 0.0 OUTLIER -157.51 156.02 31.3 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 121.032 0.444 . . . . 0.0 111.035 -178.699 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 36.2 m -101.52 132.53 47.1 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.752 175.967 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.471 ' CZ ' ' HB2' ' A' ' 91' ' ' HIS . 19.6 m-85 -67.41 160.27 27.74 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.412 -179.874 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 -117.08 -52.46 2.51 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.205 178.948 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 25.4 m -129.75 153.2 80.79 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.251 -177.868 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_exo -49.11 -31.44 21.3 Favored 'Trans proline' 0 C--N 1.353 0.8 0 C-N-CA 122.669 2.246 . . . . 0.0 112.66 178.569 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -59.47 -62.22 2.04 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.249 179.376 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -65.67 -38.03 88.15 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.591 -179.429 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -52.81 -60.74 2.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.028 0.442 . . . . 0.0 110.781 176.761 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 72.4 mtp180 -64.08 -27.52 69.16 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.634 -179.368 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -65.23 -39.27 92.51 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.547 176.191 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 46.2 m-85 -71.03 -43.84 67.05 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.589 177.667 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.425 ' O ' HG12 ' A' ' 117' ' ' VAL . 49.9 m-20 -61.59 -55.55 29.49 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 120.814 0.34 . . . . 0.0 110.623 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 80.2 mtt-85 -66.39 -28.72 68.86 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-O 121.02 0.438 . . . . 0.0 110.154 176.84 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -59.35 -50.98 61.93 Favored Glycine 0 N--CA 1.447 -0.579 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.86 176.139 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.438 ' HB ' ' HD2' ' A' ' 83' ' ' TYR . 11.9 p -69.27 -32.75 54.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 116.694 0.247 . . . . 0.0 110.584 -179.74 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.454 ' O ' ' HG3' ' A' ' 122' ' ' GLU . 3.4 mmp_? -53.04 -64.63 0.76 Allowed 'General case' 0 C--O 1.238 0.476 0 CA-C-O 121.231 0.539 . . . . 0.0 109.995 174.17 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 81.4 tttt -66.86 -33.63 76.01 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 115.476 -0.783 . . . . 0.0 110.728 -176.107 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -61.03 -50.84 71.72 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.458 178.21 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.552 ' O ' HG22 ' A' ' 125' ' ' ILE . 31.8 mm -60.08 -40.68 84.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.109 178.947 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.484 ' O ' ' HB2' ' A' ' 126' ' ' GLU . 43.5 mt-10 -54.8 -56.46 19.18 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 110.284 -0.265 . . . . 0.0 110.284 176.385 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 49.4 m-20 -65.26 -27.23 68.5 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.668 -0.242 . . . . 0.0 111.425 -178.981 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.534 HD11 ' H ' ' A' ' 80' ' ' ASP . 3.2 tm? -76.51 -56.68 4.4 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.179 -176.126 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.552 HG22 ' O ' ' A' ' 121' ' ' ILE . 11.2 tp -94.12 -34.02 5.43 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 -170.349 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.484 ' HB2' ' O ' ' A' ' 122' ' ' GLU . 32.1 mm-40 . . . . . 0 C--O 1.251 1.142 0 CA-C-O 118.637 -0.697 . . . . 0.0 110.862 -174.535 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 15.6 m . . . . . 0 CA--C 1.535 0.383 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.659 ' HB3' ' HD2' ' A' ' 17' ' ' ARG . 58.7 m-85 -91.57 106.42 18.47 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 120.806 0.336 . . . . 0.0 111.12 -177.487 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.515 HG22 HG23 ' A' ' 16' ' ' VAL . 52.1 mt -71.66 -57.23 7.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.931 -176.851 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.515 HG23 HG22 ' A' ' 15' ' ' ILE . 61.0 t -129.0 132.05 67.63 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 CA-C-O 120.709 0.29 . . . . 0.0 110.963 -177.06 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.659 ' HD2' ' HB3' ' A' ' 14' ' ' TYR . 0.0 OUTLIER -128.06 115.62 18.75 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 174.949 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 27.6 m -124.11 166.01 19.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.732 0.301 . . . . 0.0 110.804 -179.598 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -87.51 137.08 32.65 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.623 -178.989 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -169.77 -165.1 0.47 Allowed 'General case' 0 C--O 1.237 0.437 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 178.377 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 7.3 p -140.44 126.97 21.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.031 0.443 . . . . 0.0 110.549 173.934 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.458 HG21 ' HB2' ' A' ' 73' ' ' LEU . 30.9 m -81.25 131.15 34.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.747 175.981 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 89.2 mmm -114.63 130.52 56.8 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.643 -0.502 . . . . 0.0 109.643 -176.471 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.447 HG23 ' HD1' ' A' ' 33' ' ' PHE . 9.5 t -103.16 162.01 13.32 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.086 0.469 . . . . 0.0 111.202 -178.518 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 19.8 ttt180 -120.38 21.26 11.72 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.18 -0.918 . . . . 0.0 108.6 178.239 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.412 ' O ' ' HB3' ' A' ' 27' ' ' ASP . 36.0 t70 49.17 38.39 13.09 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 114.423 -1.262 . . . . 0.0 111.192 177.899 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.412 ' HB3' ' O ' ' A' ' 26' ' ' ASP . 27.6 t70 73.27 -54.86 0.69 Allowed 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 115.242 -0.89 . . . . 0.0 112.758 177.207 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 22.1 m -136.62 18.59 3.09 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 112.611 0.597 . . . . 0.0 112.611 -174.025 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 65.7 m -86.14 -170.69 3.21 Favored 'General case' 0 C--N 1.327 -0.372 0 O-C-N 122.297 -0.252 . . . . 0.0 110.321 177.327 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -111.49 -44.14 0.93 Allowed Glycine 0 C--N 1.334 0.436 0 C-N-CA 121.294 -0.479 . . . . 0.0 112.368 -179.677 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -77.54 170.84 55.12 Favored Glycine 0 C--N 1.33 0.235 0 C-N-CA 121.192 -0.528 . . . . 0.0 112.692 -178.651 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 91.0 m95 -117.41 120.37 37.96 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 179.665 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.447 ' HD1' HG23 ' A' ' 24' ' ' THR . 1.4 m-85 -101.79 156.36 35.29 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.657 -170.896 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.455 ' HB3' ' HA2' ' A' ' 38' ' ' GLY . 51.3 Cg_exo -56.44 -11.82 7.12 Favored 'Trans proline' 0 C--N 1.355 0.918 0 C-N-CA 123.352 2.701 . . . . 0.0 112.992 178.496 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER 72.61 -71.08 0.14 Allowed 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 123.327 0.651 . . . . 0.0 110.554 174.256 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -161.74 -55.1 0.05 OUTLIER 'General case' 0 C--O 1.234 0.24 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 -179.779 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -62.76 -39.66 98.23 Favored Glycine 0 C--N 1.331 0.278 0 CA-C-N 115.596 -0.729 . . . . 0.0 112.553 -179.524 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.455 ' HA2' ' HB3' ' A' ' 34' ' ' PRO . . . 57.57 19.4 34.4 Favored Glycine 0 C--N 1.334 0.431 0 C-N-CA 121.544 -0.36 . . . . 0.0 113.551 177.16 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 140.2 -29.31 2.42 Favored Glycine 0 C--O 1.235 0.187 0 N-CA-C 111.203 -0.759 . . . . 0.0 111.203 -178.189 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.57 ' N ' HD12 ' A' ' 40' ' ' ILE . 2.8 mp -100.63 93.94 3.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 175.842 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 49.1 m -151.75 130.48 12.37 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 174.151 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 34.9 ttp180 -101.31 102.42 13.27 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 177.019 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 4.5 p -81.01 106.84 12.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 121.476 0.655 . . . . 0.0 109.976 179.52 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -102.8 112.37 4.25 Favored Glycine 0 N--CA 1.446 -0.669 0 CA-C-N 115.334 -0.848 . . . . 0.0 112.018 -179.511 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 7.0 p -86.45 109.22 18.6 Favored 'Isoleucine or valine' 0 C--O 1.239 0.5 0 CA-C-O 121.393 0.615 . . . . 0.0 109.967 176.162 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' CYS . . . . . 0.754 ' SG ' ' HB3' ' A' ' 60' ' ' LEU . 12.1 p -105.87 145.43 31.25 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.005 178.358 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 12.0 tmtt? -100.78 105.75 17.1 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 179.335 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.435 HG21 ' HE1' ' A' ' 76' ' ' TYR . 60.8 t -66.87 125.64 24.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.307 -179.129 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 66.1 mtt . . . . . 0 C--N 1.327 -0.4 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.193 179.253 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.384 0 N-CA-C 111.261 -0.735 . . . . 0.0 111.261 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -129.44 154.51 46.89 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 177.956 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.754 ' HB3' ' SG ' ' A' ' 46' ' ' CYS . 3.0 tt -128.42 119.06 24.22 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 178.882 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 57.2 mt -80.23 86.74 1.41 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.371 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 175.442 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' HIS . . . . . 0.444 ' HB3' ' HE2' ' A' ' 14' ' ' TYR . 21.7 t60 -98.84 107.69 20.19 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.981 -176.605 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -97.07 99.16 2.24 Favored Glycine 0 C--O 1.239 0.409 0 CA-C-N 115.81 -0.632 . . . . 0.0 112.488 -178.378 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -73.03 152.13 41.43 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 175.674 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.4 ' O ' HG22 ' A' ' 40' ' ' ILE . 71.0 ttt-85 -67.38 -31.95 72.54 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 174.474 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -168.13 -60.92 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.233 178.377 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 53.7 tttm -173.93 124.12 0.34 Allowed 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 117.804 0.275 . . . . 0.0 111.611 175.883 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 57.69 14.62 2.5 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.636 0.774 . . . . 0.0 112.005 174.002 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -106.77 -69.65 0.83 Allowed 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 111.831 0.308 . . . . 0.0 111.831 -167.322 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 48.5 tp -149.34 138.04 21.05 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.426 -175.078 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 21.4 t -88.52 102.0 12.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 176.075 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 28.3 m -88.17 -20.86 7.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.625 0.25 . . . . 0.0 111.355 -176.04 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.552 HD13 ' N ' ' A' ' 74' ' ' GLU . 2.9 tm? -149.65 140.74 22.99 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 179.373 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.552 ' N ' HD13 ' A' ' 73' ' ' LEU . 34.0 tt0 -159.07 119.86 3.24 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 -177.863 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 66.2 m -142.27 137.86 30.96 Favored 'General case' 0 C--O 1.232 0.161 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 -176.964 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.435 ' HE1' HG21 ' A' ' 48' ' ' VAL . 85.7 t80 -99.82 138.89 36.27 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 110.215 -0.291 . . . . 0.0 110.215 -176.25 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.72 HG12 HG11 ' A' ' 95' ' ' VAL . 20.3 m -135.19 141.16 43.51 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 -178.717 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 36.4 mtm180 -110.32 -73.06 0.7 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.941 0.401 . . . . 0.0 110.068 -178.121 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -152.85 19.63 0.6 Allowed 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 175.675 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -112.61 17.48 19.13 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 114.229 -1.35 . . . . 0.0 110.276 -176.145 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.574 HD22 ' HB2' ' A' ' 83' ' ' TYR . 1.6 tt -73.37 92.54 1.84 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.278 -176.736 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 3.6 p -81.17 85.25 1.52 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 CA-C-O 121.509 0.671 . . . . 0.0 110.009 174.757 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.614 ' HD2' HG21 ' A' ' 117' ' ' VAL . 0.6 OUTLIER -92.23 102.7 15.22 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.003 -177.011 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 99.9 m -114.46 133.12 55.99 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.295 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.534 ' HA ' ' HA ' ' A' ' 91' ' ' HIS . 4.9 ptpp? -94.96 111.8 23.56 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 175.528 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -70.94 -35.04 72.05 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.364 0.602 . . . . 0.0 109.494 175.874 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' ASN . . . . . 0.541 ' HB2' ' HB3' ' A' ' 90' ' ' PHE . 92.5 m-20 -134.48 155.18 79.9 Favored Pre-proline 0 C--N 1.332 -0.18 0 CA-C-N 114.99 -1.005 . . . . 0.0 108.529 176.339 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -54.3 -23.23 29.47 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.546 2.164 . . . . 0.0 112.753 178.958 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 14.9 t -112.45 2.31 16.32 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.335 -178.99 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.541 ' HB3' ' HB2' ' A' ' 87' ' ' ASN . 72.1 t80 -131.73 109.74 10.38 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-O 120.929 0.395 . . . . 0.0 110.681 -177.761 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' HIS . . . . . 0.534 ' HA ' ' HA ' ' A' ' 85' ' ' LYS . 0.1 OUTLIER -107.03 159.68 16.11 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 177.65 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 92' ' ' HIS . . . . . 0.413 ' HA ' ' HA2' ' A' ' 101' ' ' GLY . 17.2 p80 -155.73 160.82 40.64 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.612 0.244 . . . . 0.0 110.543 178.311 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 34.6 p90 -149.5 166.29 29.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.741 -178.664 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -131.63 106.08 7.94 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 174.264 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.72 HG11 HG12 ' A' ' 77' ' ' VAL . 29.8 m -136.56 172.54 15.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.139 -0.482 . . . . 0.0 109.822 179.544 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 42.9 m-20 59.09 -77.25 0.02 OUTLIER 'General case' 0 C--O 1.234 0.24 0 O-C-N 123.663 0.602 . . . . 0.0 110.427 -174.135 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 30.4 p-10 -163.26 9.12 0.05 Allowed 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 179.641 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 3.7 tpt180 -149.29 167.28 26.5 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 118.329 0.513 . . . . 0.0 111.627 -175.384 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 58.5 tttm -103.74 118.18 36.1 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.316 -176.882 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 33.8 m-85 -115.37 170.76 8.16 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.152 -0.476 . . . . 0.0 109.935 -178.591 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.413 ' HA2' ' HA ' ' A' ' 92' ' ' HIS . . . -142.39 164.86 26.88 Favored Glycine 0 C--N 1.332 0.35 0 C-N-CA 120.968 -0.634 . . . . 0.0 112.862 -177.657 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 8.3 tt -150.25 132.42 15.39 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 -179.586 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 45.5 m -112.76 134.54 54.23 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.868 0.366 . . . . 0.0 110.316 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 63.8 m-85 -86.78 -178.23 6.29 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.179 -179.003 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 24.6 tt0 -124.54 -70.55 0.75 Allowed 'General case' 0 C--O 1.236 0.346 0 CA-C-O 120.907 0.384 . . . . 0.0 111.122 -178.15 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 48.8 m -108.81 158.49 33.98 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.435 -175.127 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -54.8 -28.72 59.16 Favored 'Trans proline' 0 C--N 1.352 0.731 0 C-N-CA 122.539 2.159 . . . . 0.0 111.96 179.108 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -59.65 -68.39 0.29 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.736 178.513 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -61.62 -44.72 96.47 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.066 -178.475 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -56.23 -63.94 1.02 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.48 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 7.1 tpt180 -61.05 -39.51 90.09 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.635 -175.034 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -65.55 -39.48 91.76 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.075 -179.271 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 21.1 t80 -70.24 -42.87 71.64 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 -178.384 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 45.0 m-20 -58.53 -44.32 89.53 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-O 121.37 0.605 . . . . 0.0 109.991 175.489 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' ARG . . . . . 0.41 HH11 ' HD2' ' A' ' 115' ' ' ARG . 45.2 ttm180 -63.75 -39.67 94.84 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.289 -0.869 . . . . 0.0 109.84 178.265 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -67.55 -44.7 81.91 Favored Glycine 0 N--CA 1.449 -0.468 0 CA-C-N 115.235 -0.893 . . . . 0.0 112.622 -178.063 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.614 HG21 ' HD2' ' A' ' 83' ' ' TYR . 13.0 p -68.5 -35.75 71.78 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.105 0 CA-C-N 116.744 0.272 . . . . 0.0 110.398 -179.237 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 67.1 ttt180 -58.95 -52.53 65.34 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 174.004 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 54.3 tptt -58.08 -32.01 67.64 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.063 178.519 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -68.79 -36.68 78.57 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.476 176.937 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.536 HG13 ' O ' ' A' ' 117' ' ' VAL . 77.5 mt -60.86 -47.98 90.94 Favored 'Isoleucine or valine' 0 C--O 1.232 0.173 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 176.814 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -58.91 -57.83 11.33 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-O 120.907 0.384 . . . . 0.0 110.382 174.167 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -63.03 -29.21 70.64 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.774 -0.648 . . . . 0.0 112.54 -171.658 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 49.6 tp -93.47 -44.41 8.26 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 111.789 0.292 . . . . 0.0 111.789 -177.922 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.523 HD12 HG23 ' A' ' 121' ' ' ILE . 59.3 mt -99.85 -44.52 11.62 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 N-CA-C 112.705 0.631 . . . . 0.0 112.705 -170.457 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 . . . . . 0 C--O 1.249 1.028 0 CA-C-O 119.104 -0.474 . . . . 0.0 111.32 -170.314 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 19.2 m . . . . . 0 C--O 1.237 0.42 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.581 ' HA ' ' HA ' ' A' ' 46' ' ' CYS . 45.4 m-85 -68.74 125.12 25.56 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 120.623 0.249 . . . . 0.0 110.663 175.696 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 62.4 mt -67.47 -47.66 79.9 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 177.166 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 9.8 p -166.19 139.37 0.92 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.334 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.216 178.494 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.687 HH12 ' NH1' ' A' ' 65' ' ' ARG . 50.0 mtt180 -109.23 100.99 10.05 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 176.317 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 30.1 t -92.52 148.48 4.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.989 -174.702 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -83.75 120.92 26.61 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.445 179.739 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -164.88 -171.04 2.13 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.108 -0.496 . . . . 0.0 109.76 -179.624 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.461 ' HB ' ' HB ' ' A' ' 103' ' ' THR . 84.7 t -121.44 115.88 47.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.651 0.263 . . . . 0.0 110.576 178.774 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.571 HG23 HE22 ' A' ' 35' ' ' GLN . 16.4 m -83.95 125.98 40.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.767 0.318 . . . . 0.0 110.524 177.795 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 22.5 mmt -112.27 150.31 31.13 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.795 -176.658 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 11.9 t -129.61 155.39 45.91 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.112 -0.495 . . . . 0.0 109.932 176.997 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 25.9 tpt180 -140.56 141.02 35.27 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 178.888 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -70.69 111.31 6.06 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 174.435 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 22.7 t70 61.96 -83.19 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.556 0 O-C-N 123.53 0.519 . . . . 0.0 111.887 179.034 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 68.3 m -154.4 -172.06 4.08 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 122.389 0.276 . . . . 0.0 110.882 -176.766 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 12.7 t 85.09 151.73 0.08 Allowed 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.165 0.986 . . . . 0.0 111.47 179.587 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -77.8 80.62 1.32 Allowed Glycine 0 C--N 1.334 0.454 0 CA-C-N 115.605 -0.725 . . . . 0.0 112.581 -176.692 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -152.68 55.51 0.44 Allowed Glycine 0 CA--C 1.51 -0.258 0 N-CA-C 110.595 -1.002 . . . . 0.0 110.595 176.921 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 80.6 m95 -70.79 119.53 15.07 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.158 -0.521 . . . . 0.0 111.219 -173.782 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 46.9 p90 -107.11 126.7 29.52 Favored Pre-proline 0 CA--C 1.534 0.35 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.678 -177.732 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -73.1 99.19 1.07 Allowed 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 122.75 2.3 . . . . 0.0 111.696 178.791 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' GLN . . . . . 0.571 HE22 HG23 ' A' ' 22' ' ' VAL . 5.0 pm0 -57.2 -48.78 77.93 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 115.648 -0.705 . . . . 0.0 112.703 -175.592 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.587 ' CB ' HG11 ' A' ' 72' ' ' VAL . 16.3 tp10 -134.8 -83.47 0.42 Allowed 'General case' 0 N--CA 1.467 0.406 0 O-C-N 122.254 -0.279 . . . . 0.0 110.919 -174.647 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -72.92 68.02 1.34 Allowed Glycine 0 C--N 1.336 0.568 0 C-N-CA 121.408 -0.425 . . . . 0.0 112.672 179.578 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -80.59 -35.35 25.91 Favored Glycine 0 C--N 1.331 0.267 0 C-N-CA 121.395 -0.431 . . . . 0.0 112.415 -179.085 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -79.45 -29.08 50.62 Favored Glycine 0 C--O 1.236 0.227 0 N-CA-C 111.454 -0.658 . . . . 0.0 111.454 177.741 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.415 HG12 HE22 ' A' ' 66' ' ' GLN . 8.6 tt -174.85 139.16 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 179.037 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 23.3 t -145.11 -178.51 6.09 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 177.628 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 60.1 mtt180 -130.89 106.9 8.73 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.098 0.475 . . . . 0.0 110.211 -177.222 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 40.9 t -81.6 103.39 8.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.127 -179.77 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -90.73 105.06 3.22 Favored Glycine 0 N--CA 1.446 -0.698 0 CA-C-N 115.959 -0.564 . . . . 0.0 112.352 -179.228 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 54.4 t -88.02 103.12 13.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 176.071 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' CYS . . . . . 0.624 ' SG ' ' HB3' ' A' ' 60' ' ' LEU . 5.3 p -108.49 145.55 34.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.258 -179.112 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 35.9 ttmt -98.31 100.96 12.29 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 175.093 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 30.1 m -86.87 128.58 39.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 121.096 0.474 . . . . 0.0 111.602 -172.468 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 25.1 ptm . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.553 178.877 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.387 0 N-CA-C 111.505 -0.638 . . . . 0.0 111.505 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.658 ' HB2' ' HB ' ' A' ' 77' ' ' VAL . 76.9 m-85 -134.96 163.78 29.08 Favored 'General case' 0 C--N 1.327 -0.409 0 O-C-N 122.559 -0.377 . . . . 0.0 110.299 -177.285 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.624 ' HB3' ' SG ' ' A' ' 46' ' ' CYS . 2.8 tt -150.29 118.63 6.41 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 177.843 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.449 ' O ' ' HA ' ' A' ' 74' ' ' GLU . 44.5 mm -82.63 91.53 2.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 175.537 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 12.6 t-80 -102.66 98.07 8.17 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.645 -174.445 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.513 ' O ' ' HB2' ' A' ' 64' ' ' GLU . . . -104.73 116.78 5.42 Favored Glycine 0 CA--C 1.522 0.48 0 CA-C-N 116.096 -0.502 . . . . 0.0 114.319 -171.727 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.681 ' HB2' HG22 ' A' ' 72' ' ' VAL . 7.7 tp10 165.08 -99.23 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 124.799 1.24 . . . . 0.0 109.103 164.228 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.687 ' NH1' HH12 ' A' ' 17' ' ' ARG . 8.6 tpt180 59.35 -1.03 0.15 Allowed 'General case' 0 CA--C 1.545 0.777 0 N-CA-C 113.436 0.902 . . . . 0.0 113.436 171.665 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.415 HE22 HG12 ' A' ' 40' ' ' ILE . 6.6 tp-100 -52.15 -59.04 4.84 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 -171.713 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 51.7 tttp -91.33 5.45 49.19 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-O 120.983 0.421 . . . . 0.0 110.397 -178.692 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 31.8 t0 64.84 149.2 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.568 -175.872 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 4.3 mppt? 55.84 26.23 9.4 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 121.003 0.43 . . . . 0.0 110.7 -169.681 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.574 HD22 ' HG2' ' A' ' 64' ' ' GLU . 0.9 OUTLIER -129.12 128.2 43.0 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.298 -0.631 . . . . 0.0 109.298 -179.056 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.625 ' HA ' ' HB3' ' A' ' 64' ' ' GLU . 51.4 t -137.66 140.67 40.93 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 179.18 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.681 HG22 ' HB2' ' A' ' 64' ' ' GLU . 27.5 m -130.35 -41.17 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 177.529 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.3 tt -124.36 133.79 53.33 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.389 -0.596 . . . . 0.0 109.389 -175.534 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.449 ' HA ' ' O ' ' A' ' 61' ' ' ILE . 11.0 pt-20 -146.98 130.3 16.62 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.067 0.461 . . . . 0.0 109.803 173.444 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' CYS . . . . . 0.54 ' HG ' ' HE1' ' A' ' 93' ' ' TRP . 47.7 t -130.03 109.34 10.78 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 -179.321 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 24.9 t80 -74.7 129.55 37.9 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.046 -0.525 . . . . 0.0 109.914 -177.083 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.658 ' HB ' ' HB2' ' A' ' 59' ' ' PHE . 63.1 t -105.45 85.32 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.496 0.665 . . . . 0.0 109.216 -177.894 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.446 ' O ' ' HB3' ' A' ' 79' ' ' LYS . 6.9 ptm180 -97.29 67.01 2.11 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.195 -0.911 . . . . 0.0 109.631 -179.633 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.49 ' HA ' HD21 ' A' ' 124' ' ' LEU . 7.3 tmtm? 77.39 -49.08 0.52 Allowed 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.478 -175.365 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' ASP . . . . . 0.43 ' OD1' ' HG3' ' A' ' 78' ' ' ARG . 5.0 p-10 -81.91 128.97 34.6 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-O 121.058 0.456 . . . . 0.0 110.623 -178.595 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.624 HD12 HD11 ' A' ' 121' ' ' ILE . 3.3 tm? -177.48 135.53 0.19 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.269 -0.878 . . . . 0.0 108.684 -178.263 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 3.7 p -145.71 106.09 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 CA-C-O 121.019 0.438 . . . . 0.0 111.3 -179.054 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.706 ' HB3' ' NE2' ' A' ' 91' ' ' HIS . 3.2 m-85 -88.84 150.97 22.64 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.217 176.299 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 81.5 m -150.47 120.23 7.05 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.883 177.566 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.453 ' HA ' ' HA ' ' A' ' 91' ' ' HIS . 8.0 ttpm? -90.64 110.72 21.87 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 177.707 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -78.62 -50.16 11.98 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.069 -179.374 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' ASN . . . . . 0.603 ' HB2' ' HB3' ' A' ' 90' ' ' PHE . 91.7 m-20 -120.11 153.41 55.39 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.004 179.706 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_endo -48.39 -33.63 23.24 Favored 'Trans proline' 0 CA--C 1.534 0.518 0 C-N-CA 122.99 2.46 . . . . 0.0 112.881 -176.295 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 15.2 t -112.36 13.87 20.34 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.419 -176.661 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.603 ' HB3' ' HB2' ' A' ' 87' ' ' ASN . 91.3 t80 -139.02 119.85 14.27 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-O 121.187 0.518 . . . . 0.0 111.493 -178.192 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' HIS . . . . . 0.706 ' NE2' ' HB3' ' A' ' 83' ' ' TYR . 1.2 t60 -116.24 157.8 24.34 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.384 -0.825 . . . . 0.0 108.915 178.5 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 25.0 p80 -155.05 157.58 37.8 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 175.304 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' TRP . . . . . 0.54 ' HE1' ' HG ' ' A' ' 75' ' ' CYS . 36.4 p90 -144.03 174.21 11.05 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 176.687 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 61.5 pttt -144.01 155.57 44.06 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 179.559 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.629 HG23 ' H ' ' A' ' 96' ' ' ASP . 7.9 m -133.55 -63.73 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.913 176.977 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.629 ' H ' HG23 ' A' ' 95' ' ' VAL . 20.3 m-20 -115.32 71.8 0.78 Allowed 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 -179.388 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 18.0 m120 74.02 -39.54 0.43 Allowed 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 115.346 -0.843 . . . . 0.0 112.155 178.788 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 63.7 ttt180 -87.18 148.8 25.02 Favored 'General case' 0 C--O 1.242 0.702 0 CA-C-O 121.033 0.444 . . . . 0.0 111.372 -176.083 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 61.9 mttp -100.71 143.57 30.72 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 114.956 -1.02 . . . . 0.0 110.834 178.957 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' PHE . . . . . 0.408 ' HB2' ' CE2' ' A' ' 93' ' ' TRP . 6.8 m-85 -118.94 143.85 46.78 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 172.061 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -113.09 163.04 12.17 Favored Glycine 0 C--N 1.331 0.285 0 C-N-CA 120.834 -0.698 . . . . 0.0 113.892 -170.722 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.44 ' HB2' ' HZ3' ' A' ' 93' ' ' TRP . 57.3 tp -150.7 106.92 3.46 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 122.793 0.437 . . . . 0.0 110.181 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.461 ' HB ' ' HB ' ' A' ' 21' ' ' VAL . 52.1 m -89.31 125.04 34.95 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.323 178.044 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.55 ' CZ ' ' HB2' ' A' ' 91' ' ' HIS . 23.8 m-85 -78.76 161.04 27.12 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.462 179.465 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 65.3 tt0 -109.17 -42.04 4.51 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.712 179.469 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 13.6 m -140.88 151.63 63.23 Favored Pre-proline 0 CA--C 1.533 0.327 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.254 -179.072 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_exo -50.41 -30.26 26.58 Favored 'Trans proline' 0 C--N 1.352 0.752 0 C-N-CA 122.975 2.45 . . . . 0.0 113.207 -179.289 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -62.87 -64.11 1.01 Allowed 'General case' 0 C--O 1.235 0.291 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.98 179.844 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -62.99 -33.95 76.51 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.354 179.236 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.48 ' HB1' ' NH2' ' A' ' 111' ' ' ARG . . . -54.8 -63.89 1.01 Allowed 'General case' 0 C--O 1.235 0.325 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.092 177.688 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 111' ' ' ARG . . . . . 0.48 ' NH2' ' HB1' ' A' ' 110' ' ' ALA . 0.0 OUTLIER -65.65 -24.43 67.02 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.788 179.765 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -61.93 -40.51 95.75 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 175.124 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.41 ' O ' HG12 ' A' ' 117' ' ' VAL . 47.4 m-85 -70.89 -48.23 54.84 Favored 'General case' 0 N--CA 1.461 0.1 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.587 176.083 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -53.54 -66.19 0.43 Allowed 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 121.39 0.614 . . . . 0.0 110.441 178.934 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 16.5 mtp180 -63.68 -36.56 84.25 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.889 -178.014 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -60.26 -53.78 42.77 Favored Glycine 0 C--N 1.332 0.344 0 CA-C-N 116.097 -0.501 . . . . 0.0 112.588 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.41 HG12 ' O ' ' A' ' 113' ' ' PHE . 10.7 p -66.27 -36.47 77.46 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.121 0 CA-C-N 116.672 0.236 . . . . 0.0 110.505 -178.071 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 95.8 mtt180 -60.95 -42.59 98.52 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.475 -0.329 . . . . 0.0 111.104 177.777 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 30.8 mmtp -76.29 -27.52 56.66 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 120.68 0.276 . . . . 0.0 110.948 178.223 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -63.35 -48.69 76.91 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 174.732 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.624 HD11 HD12 ' A' ' 81' ' ' LEU . 46.9 mm -66.8 -36.08 76.33 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.187 176.996 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -54.65 -56.67 16.67 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.253 178.265 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 -70.15 -29.5 66.43 Favored 'General case' 0 C--O 1.225 -0.188 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.94 179.386 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.49 HD21 ' HA ' ' A' ' 79' ' ' LYS . 6.7 tt -59.59 -43.76 93.58 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 177.241 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 66.7 mt -77.7 -30.88 16.95 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.495 178.595 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.428 -0.796 . . . . 0.0 109.808 179.101 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 15.1 m . . . . . 0 N--CA 1.465 0.279 0 CA-C-O 120.798 0.333 . . . . 0.0 111.538 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 67.8 m-85 -88.05 147.9 24.75 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.96 0.41 . . . . 0.0 111.515 -176.649 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 48.9 mm -105.81 -37.88 4.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 168.036 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 59.4 t -136.29 142.98 37.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 114.964 -1.016 . . . . 0.0 108.684 175.327 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.496 HH21 ' CD ' ' A' ' 64' ' ' GLU . 63.1 ttt180 -149.24 84.02 1.44 Allowed 'General case' 0 C--O 1.235 0.304 0 CA-C-O 121.22 0.533 . . . . 0.0 109.931 179.223 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 60.1 t -107.37 141.78 21.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.034 -177.752 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.742 ' HD3' ' H ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -82.83 127.51 33.54 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.943 -0.392 . . . . 0.0 109.943 176.909 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -150.48 171.92 16.29 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.64 178.597 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.56 ' HB ' ' HB ' ' A' ' 103' ' ' THR . 49.0 t -84.99 96.89 5.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.977 0.417 . . . . 0.0 110.783 -176.398 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 57.8 t -79.35 113.67 19.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.562 179.761 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 22.5 mmt -99.34 156.55 16.94 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.024 -0.534 . . . . 0.0 109.923 178.27 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.503 HG23 ' CE1' ' A' ' 33' ' ' PHE . 8.8 t -130.39 142.12 50.53 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.026 0.441 . . . . 0.0 110.536 179.466 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.428 ' HB2' ' CZ3' ' A' ' 32' ' ' TRP . 0.0 OUTLIER -94.06 101.33 13.36 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 173.778 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.487 ' HB2' ' CE1' ' A' ' 33' ' ' PHE . 32.1 t70 -52.4 120.82 5.99 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 178.085 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -39.26 108.68 0.09 Allowed 'General case' 0 N--CA 1.466 0.339 0 O-C-N 124.228 0.955 . . . . 0.0 111.487 -176.231 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 40.6 p 46.02 82.31 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.39 0 O-C-N 123.836 0.71 . . . . 0.0 111.36 -176.377 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 6.9 t -131.15 -69.38 0.63 Allowed 'General case' 0 C--O 1.234 0.27 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.812 -175.535 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 174.12 -62.02 0.12 Allowed Glycine 0 C--N 1.333 0.364 0 C-N-CA 121.177 -0.535 . . . . 0.0 112.005 -179.26 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -128.46 -139.28 4.73 Favored Glycine 0 C--O 1.236 0.245 0 C-N-CA 121.226 -0.511 . . . . 0.0 112.556 -179.213 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' TRP . . . . . 0.496 ' HH2' ' HG2' ' A' ' 99' ' ' LYS . 67.8 m95 -125.1 149.4 47.88 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 179.252 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.503 ' CE1' HG23 ' A' ' 24' ' ' THR . 2.0 p90 -149.07 152.86 37.25 Favored Pre-proline 0 C--O 1.236 0.366 0 N-CA-C 110.318 -0.253 . . . . 0.0 110.318 177.726 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -63.03 125.69 16.41 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 122.297 1.998 . . . . 0.0 111.785 176.008 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' GLN . . . . . 0.638 ' HG2' HD21 ' A' ' 73' ' ' LEU . 2.0 pp0? -69.06 -168.67 0.15 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.263 174.739 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -55.59 -14.72 2.28 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 -173.871 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -67.59 -40.84 90.57 Favored Glycine 0 CA--C 1.521 0.414 0 N-CA-C 111.599 -0.6 . . . . 0.0 111.599 173.703 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 86.43 -33.95 3.57 Favored Glycine 0 C--N 1.333 0.411 0 N-CA-C 112.17 -0.372 . . . . 0.0 112.17 178.888 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.457 ' O ' ' HA ' ' A' ' 21' ' ' VAL . . . -162.78 -105.06 0.19 Allowed Glycine 0 N--CA 1.443 -0.859 0 N-CA-C 111.195 -0.762 . . . . 0.0 111.195 176.663 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.425 HG23 ' HB2' ' A' ' 19' ' ' LYS . 1.8 mp -60.9 131.88 26.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 120.973 0.416 . . . . 0.0 110.334 -179.904 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 41.6 m -145.82 152.89 40.25 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.333 178.322 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.757 ' HB2' ' HB2' ' A' ' 64' ' ' GLU . 13.1 mmt180 -72.99 105.13 4.34 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 110.379 -0.23 . . . . 0.0 110.379 -179.655 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 56.4 t -83.47 89.89 2.39 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 174.13 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -88.09 104.13 3.0 Favored Glycine 0 N--CA 1.444 -0.794 0 CA-C-N 115.515 -0.766 . . . . 0.0 112.669 -177.79 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 53.5 t -80.58 88.35 1.57 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.522 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 174.774 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' CYS . . . . . 0.683 ' HB3' ' HB3' ' A' ' 60' ' ' LEU . 42.6 t -85.58 146.73 26.75 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.392 179.204 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 79.6 tttt -142.73 96.88 3.01 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 -174.394 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 26.9 m -98.97 132.74 43.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.652 -176.82 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.248 0 CA-C-O 120.838 0.351 . . . . 0.0 111.116 -177.065 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.422 0 N-CA-C 110.937 -0.865 . . . . 0.0 110.937 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.446 ' HB2' HG23 ' A' ' 77' ' ' VAL . 69.5 m-85 -104.08 122.31 45.03 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.906 0.384 . . . . 0.0 110.316 -174.65 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.683 ' HB3' ' HB3' ' A' ' 46' ' ' CYS . 3.6 tt -103.9 107.3 18.12 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 179.416 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 61.4 mt -71.49 91.97 0.43 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.327 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 174.707 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 12.4 t-80 -97.3 100.39 11.85 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.074 -173.111 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.437 ' HA3' ' HB2' ' A' ' 73' ' ' LEU . . . -99.35 112.96 4.59 Favored Glycine 0 C--N 1.33 0.22 0 C-N-CA 121.399 -0.429 . . . . 0.0 112.271 -177.373 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.757 ' HB2' ' HB2' ' A' ' 42' ' ' ARG . 22.1 mt-10 -107.05 138.2 43.67 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 122.226 0.21 . . . . 0.0 110.607 -178.545 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 26.6 ttt85 -67.63 130.85 44.3 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 173.768 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 6.8 tp60 -58.56 154.93 13.2 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.368 -176.521 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt 72.86 -69.84 0.18 Allowed 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 123.422 0.689 . . . . 0.0 111.35 177.471 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -69.23 -36.23 77.0 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 120.706 0.289 . . . . 0.0 110.543 -176.541 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 50.4 mtmt 61.93 85.28 0.12 Allowed 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.57 -0.741 . . . . 0.0 112.06 176.285 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -150.26 154.91 38.74 Favored 'General case' 0 C--O 1.24 0.565 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 173.468 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 10.5 t -72.5 92.61 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 CA-C-O 120.958 0.408 . . . . 0.0 111.517 -171.662 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 9.5 m -88.22 -37.47 10.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.452 176.91 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.638 HD21 ' HG2' ' A' ' 35' ' ' GLN . 4.2 mm? -117.35 137.88 52.16 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 176.784 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.584 ' HG3' HD21 ' A' ' 60' ' ' LEU . 35.0 tt0 -150.21 114.56 5.17 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 177.868 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' CYS . . . . . 0.507 ' SG ' ' CE2' ' A' ' 100' ' ' PHE . 36.5 m -138.07 101.4 4.41 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.959 0.409 . . . . 0.0 110.156 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 75.5 t80 -84.62 112.31 20.33 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.12 -0.491 . . . . 0.0 109.924 179.791 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.466 HG21 HD21 ' A' ' 81' ' ' LEU . 16.4 m -97.54 100.33 10.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 121.863 0.84 . . . . 0.0 109.267 177.803 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.452 ' HG2' ' H ' ' A' ' 78' ' ' ARG . 19.5 ptt180 -70.92 -45.68 63.81 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 114.631 -1.168 . . . . 0.0 112.092 -172.117 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 35.8 ttpt -160.99 29.73 0.14 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.569 0.7 . . . . 0.0 109.792 -175.02 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' ASP . . . . . 0.421 ' O ' ' HB ' ' A' ' 77' ' ' VAL . 7.3 p-10 -149.66 140.98 23.19 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.08 -178.802 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.466 HD21 HG21 ' A' ' 77' ' ' VAL . 12.8 mt -155.36 101.38 2.2 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.967 179.057 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.467 HG23 ' N ' ' A' ' 83' ' ' TYR . 27.6 m -74.3 -53.06 18.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 174.468 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.467 ' N ' HG23 ' A' ' 82' ' ' VAL . 4.5 t80 30.46 82.86 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.431 1.092 . . . . 0.0 112.015 177.992 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 36.0 m -112.41 133.48 54.47 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.998 -179.079 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.525 ' HA ' ' HA ' ' A' ' 91' ' ' HIS . 17.7 ptmt -93.46 101.72 13.93 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.315 0.579 . . . . 0.0 110.224 178.973 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -72.34 -49.49 33.94 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.975 -178.501 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' ASN . . . . . 0.572 ' HB2' ' HB3' ' A' ' 90' ' ' PHE . 3.8 m-20 -104.83 153.27 39.44 Favored Pre-proline 0 C--N 1.327 -0.387 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 174.753 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_exo -48.24 -31.91 18.13 Favored 'Trans proline' 0 CA--C 1.534 0.499 0 C-N-CA 122.621 2.214 . . . . 0.0 112.765 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.484 ' HA ' ' HD2' ' A' ' 104' ' ' PHE . 20.5 p -120.09 16.35 12.43 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 112.328 0.492 . . . . 0.0 112.328 -178.321 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.572 ' HB3' ' HB2' ' A' ' 87' ' ' ASN . 5.5 t80 -129.88 105.84 8.27 Favored 'General case' 0 C--O 1.239 0.5 0 CA-C-O 120.93 0.395 . . . . 0.0 110.094 178.665 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' HIS . . . . . 0.525 ' HA ' ' HA ' ' A' ' 85' ' ' LYS . 0.1 OUTLIER -102.73 133.18 48.19 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 177.763 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 30.2 p80 -129.1 155.05 46.07 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.935 0.398 . . . . 0.0 110.812 -178.003 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' TRP . . . . . 0.412 ' CE2' ' HB2' ' A' ' 100' ' ' PHE . 43.8 p90 -144.91 158.49 43.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.174 178.517 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 22.5 ptmt -144.02 148.98 35.98 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 177.784 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.701 HG23 ' H ' ' A' ' 96' ' ' ASP . 4.4 m -127.64 -66.87 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 C-N-CA 121.2 -0.2 . . . . 0.0 111.173 -179.3 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.701 ' H ' HG23 ' A' ' 95' ' ' VAL . 10.9 m-20 -120.87 80.1 1.59 Allowed 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 177.157 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 52.4 t-20 74.35 -52.96 0.68 Allowed 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 114.79 -1.095 . . . . 0.0 111.429 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -68.87 139.42 55.17 Favored 'General case' 0 C--O 1.244 0.806 0 CA-C-O 121.003 0.43 . . . . 0.0 110.239 -175.813 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.496 ' HG2' ' HH2' ' A' ' 32' ' ' TRP . 39.7 ttmt -121.49 135.49 55.03 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.503 -178.711 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' PHE . . . . . 0.507 ' CE2' ' SG ' ' A' ' 75' ' ' CYS . 20.4 m-85 -124.0 164.31 19.61 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 -178.797 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -139.64 159.74 25.92 Favored Glycine 0 C--N 1.331 0.298 0 C-N-CA 120.764 -0.732 . . . . 0.0 113.461 -174.47 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.41 ' HB2' ' HZ3' ' A' ' 93' ' ' TRP . 5.6 tt -139.54 114.77 9.72 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 -179.496 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.56 ' HB ' ' HB ' ' A' ' 21' ' ' VAL . 48.5 m -93.3 119.65 32.69 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.087 176.873 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.484 ' HD2' ' HA ' ' A' ' 89' ' ' THR . 33.3 m-85 -70.02 158.4 35.74 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.224 179.599 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 50.0 mt-30 -108.13 -46.31 3.77 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.771 -178.924 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 14.7 m -135.07 156.49 78.26 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.408 -176.21 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -51.52 -30.49 35.82 Favored 'Trans proline' 0 C--N 1.35 0.619 0 C-N-CA 122.652 2.235 . . . . 0.0 112.49 177.036 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -60.57 -61.02 2.89 Favored 'General case' 0 C--O 1.239 0.516 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.384 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -65.52 -43.74 89.11 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.433 -0.348 . . . . 0.0 110.599 -178.724 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -51.95 -54.74 26.06 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 121.086 0.47 . . . . 0.0 111.027 177.36 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 34.7 ttt180 -61.59 -39.21 90.4 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.01 -177.633 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -61.99 -43.39 98.94 Favored 'General case' 0 C--O 1.231 0.109 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.304 179.685 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 49.1 m-85 -69.64 -39.86 76.87 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.617 -0.265 . . . . 0.0 110.965 -179.133 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 45.6 m-20 -60.15 -57.88 10.91 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-O 121.31 0.576 . . . . 0.0 110.752 178.45 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 37.3 mmt180 -66.87 -31.27 71.76 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.171 -179.497 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -64.21 -48.86 70.53 Favored Glycine 0 N--CA 1.449 -0.441 0 CA-C-N 115.635 -0.711 . . . . 0.0 112.199 179.195 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.5 ' O ' HG12 ' A' ' 121' ' ' ILE . 11.5 p -66.89 -37.88 80.3 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.086 0 N-CA-C 110.26 -0.274 . . . . 0.0 110.26 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 8.1 tpt180 -56.69 -49.45 75.1 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-O 120.853 0.359 . . . . 0.0 110.169 176.054 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 60.0 tptt -58.61 -44.42 89.9 Favored 'General case' 0 C--O 1.241 0.647 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.382 177.947 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -57.94 -47.23 83.51 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.56 178.946 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.5 HG12 ' O ' ' A' ' 117' ' ' VAL . 43.0 mm -59.21 -46.63 92.05 Favored 'Isoleucine or valine' 0 C--O 1.232 0.14 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.469 179.422 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 62.6 mm-40 -51.7 -58.16 7.16 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.945 179.699 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -73.75 -33.22 64.21 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.569 -174.755 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 60.2 tp -64.98 -41.82 95.08 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.911 0.386 . . . . 0.0 110.449 -179.082 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 47.9 mm -78.99 -55.96 8.4 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.901 -178.106 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 . . . . . 0 C--O 1.253 1.243 0 CA-C-O 119.356 -0.354 . . . . 0.0 111.266 -176.827 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 57.8 m . . . . . 0 N--CA 1.469 0.484 0 N-CA-C 111.867 0.321 . . . . 0.0 111.867 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.442 ' HA ' ' HB3' ' A' ' 46' ' ' CYS . 59.5 m-85 -76.54 93.29 3.54 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 121.111 0.481 . . . . 0.0 110.504 177.922 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.566 HG22 HG23 ' A' ' 16' ' ' VAL . 44.0 mm -69.19 -56.59 11.31 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 CA-C-N 115.437 -0.802 . . . . 0.0 111.465 -173.809 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.566 HG23 HG22 ' A' ' 15' ' ' ILE . 57.8 t -131.84 131.15 61.96 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 CA-C-O 120.574 0.226 . . . . 0.0 111.128 -175.507 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.586 ' HG3' ' HA2' ' A' ' 44' ' ' GLY . 0.5 OUTLIER -110.89 98.27 7.45 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 171.895 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 44.9 t -76.39 154.85 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.464 -177.263 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 58.7 tttp -98.88 131.33 45.06 Favored 'General case' 0 N--CA 1.462 0.129 0 CA-C-O 120.826 0.346 . . . . 0.0 110.374 178.12 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.495 ' O ' ' HB2' ' A' ' 41' ' ' SER . . . -171.19 -166.95 0.5 Allowed 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 175.479 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 61.7 t -117.93 120.19 63.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 167.994 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.528 HG11 ' HG ' ' A' ' 73' ' ' LEU . 49.6 t -71.7 94.15 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 121.148 0.499 . . . . 0.0 109.985 179.65 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' MET . . . . . 0.467 ' HB3' ' HB3' ' A' ' 32' ' ' TRP . 21.4 mmt -86.44 110.7 19.91 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.582 -178.473 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 1.1 m -100.78 120.77 40.6 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.427 -0.806 . . . . 0.0 108.961 172.976 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.79 114.86 11.4 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 179.361 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -58.03 91.18 0.01 OUTLIER 'General case' 0 C--O 1.233 0.222 0 O-C-N 123.345 0.403 . . . . 0.0 110.44 -176.485 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 28.3 t70 55.54 -87.7 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.788 -176.858 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 60.4 m -157.99 26.97 0.26 Allowed 'General case' 0 C--O 1.235 0.315 0 CA-C-O 121.093 0.473 . . . . 0.0 109.993 177.532 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 34.8 t -143.18 159.52 42.14 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.032 -179.358 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 82.38 -53.57 4.8 Favored Glycine 0 C--N 1.329 0.187 0 C-N-CA 121.235 -0.507 . . . . 0.0 112.22 179.207 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 131.29 -161.43 23.59 Favored Glycine 0 C--N 1.331 0.304 0 N-CA-C 111.976 -0.449 . . . . 0.0 111.976 177.457 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' TRP . . . . . 0.467 ' HB3' ' HB3' ' A' ' 23' ' ' MET . 84.2 m95 -84.69 104.83 15.01 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 109.36 -0.608 . . . . 0.0 109.36 176.347 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -103.71 147.84 34.87 Favored Pre-proline 0 C--O 1.237 0.423 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 -175.522 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -59.96 132.21 43.56 Favored 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 122.472 2.114 . . . . 0.0 111.355 179.152 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 50.8 tp60 -39.73 -47.16 2.01 Favored 'General case' 0 N--CA 1.468 0.439 0 O-C-N 123.764 0.665 . . . . 0.0 112.055 -175.782 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -176.07 -34.91 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 178.454 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -108.86 167.9 13.23 Favored Glycine 0 N--CA 1.453 -0.209 0 CA-C-N 115.14 -0.936 . . . . 0.0 110.776 171.466 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -132.49 150.41 19.68 Favored Glycine 0 C--O 1.234 0.151 0 C-N-CA 120.95 -0.643 . . . . 0.0 112.473 -178.194 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 81.06 -58.59 4.82 Favored Glycine 0 C--N 1.331 0.293 0 C-N-CA 121.46 -0.4 . . . . 0.0 112.585 178.407 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.496 ' N ' HD12 ' A' ' 40' ' ' ILE . 3.5 mp -101.85 107.29 21.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.783 0.325 . . . . 0.0 110.599 -178.784 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.495 ' HB2' ' O ' ' A' ' 20' ' ' ALA . 36.6 m -141.9 113.84 8.01 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 171.316 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.502 ' HB2' ' O ' ' A' ' 64' ' ' GLU . 5.7 mpt_? -88.79 133.48 34.23 Favored 'General case' 0 CA--C 1.519 -0.218 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 175.642 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.787 HG21 HD21 ' A' ' 102' ' ' LEU . 75.5 t -106.2 100.01 9.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.006 177.328 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.586 ' HA2' ' HG3' ' A' ' 17' ' ' ARG . . . -71.26 84.63 0.41 Allowed Glycine 0 N--CA 1.448 -0.546 0 CA-C-N 115.673 -0.694 . . . . 0.0 112.693 -179.202 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 54.8 t -75.69 107.96 7.22 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 176.479 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' CYS . . . . . 0.699 ' SG ' ' HB3' ' A' ' 60' ' ' LEU . 6.1 p -125.51 125.71 43.71 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.064 -0.517 . . . . 0.0 111.079 -177.336 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 57.8 tttm -87.6 89.08 7.86 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 175.833 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 31.0 t -77.12 125.57 37.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.23 -174.091 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 97.6 mmm . . . . . 0 C--N 1.326 -0.45 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 174.763 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.516 0 N-CA-C 111.29 -0.724 . . . . 0.0 111.29 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 71.7 m-85 -91.06 104.55 17.12 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.061 0.457 . . . . 0.0 109.813 -176.613 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.699 ' HB3' ' SG ' ' A' ' 46' ' ' CYS . 1.9 tt -93.35 106.71 18.64 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.806 -0.633 . . . . 0.0 109.499 -178.204 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 49.8 mm -78.58 85.91 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 173.853 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' HIS . . . . . 0.409 ' HA ' ' HA ' ' A' ' 74' ' ' GLU . 15.4 t-80 -90.94 168.11 11.92 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.593 -176.548 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -151.09 112.96 0.56 Allowed Glycine 0 C--O 1.236 0.258 0 C-N-CA 120.948 -0.644 . . . . 0.0 112.111 -178.309 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.502 ' O ' ' HB2' ' A' ' 42' ' ' ARG . 0.0 OUTLIER -145.95 -167.29 2.68 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 122.385 0.274 . . . . 0.0 110.739 -176.101 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.43 ' HB3' ' HD3' ' A' ' 42' ' ' ARG . 0.0 OUTLIER 57.41 34.95 25.39 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-O 120.928 0.394 . . . . 0.0 110.205 175.181 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 84.0 mm-40 -63.88 -11.58 28.98 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 115.67 -0.695 . . . . 0.0 112.571 -172.447 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 34.7 ttpt -174.5 -63.28 0.01 OUTLIER 'General case' 0 C--O 1.234 0.261 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 173.311 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -105.43 -85.05 0.49 Allowed 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 170.595 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.484 ' HB3' ' NZ ' ' A' ' 69' ' ' LYS . 6.3 ttpm? -140.72 108.17 5.56 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 178.565 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 48.2 tp -163.73 124.54 2.26 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 110.418 -0.216 . . . . 0.0 110.418 -173.375 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 83.9 t -98.58 135.23 34.28 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 O-C-N 123.697 0.623 . . . . 0.0 109.443 173.052 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 35.4 m -134.92 -41.17 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 N-CA-C 112.127 0.418 . . . . 0.0 112.127 -177.195 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.54 HD13 ' N ' ' A' ' 74' ' ' GLU . 3.0 tm? -119.91 143.3 48.03 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.821 0.343 . . . . 0.0 110.781 -170.847 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.54 ' N ' HD13 ' A' ' 73' ' ' LEU . 9.5 pt-20 -158.45 112.17 2.44 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.915 173.555 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 42.0 t -126.0 97.81 5.26 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 179.512 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.414 ' HB2' ' HG ' ' A' ' 60' ' ' LEU . 69.2 t80 -88.36 134.82 33.72 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.99 -176.336 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 35.1 m -141.42 145.28 24.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 176.31 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 24.5 ttp180 -130.67 -24.44 2.46 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.134 0.493 . . . . 0.0 110.428 177.2 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.521 ' N ' ' HD3' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -160.9 29.21 0.15 Allowed 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 174.948 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -127.92 170.31 12.98 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 115.123 -0.944 . . . . 0.0 110.709 -167.45 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.639 HD11 ' CD1' ' A' ' 93' ' ' TRP . 10.2 tt 72.92 151.8 0.12 Allowed 'General case' 0 N--CA 1.469 0.514 0 O-C-N 123.996 0.81 . . . . 0.0 112.163 167.854 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.511 ' N ' HD23 ' A' ' 81' ' ' LEU . 8.7 p -139.63 141.02 35.74 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.68 177.221 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 14.6 m-85 -94.5 166.35 12.09 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 121.176 0.513 . . . . 0.0 111.079 -177.633 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 88.7 m -152.08 109.81 3.64 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.015 176.548 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.479 ' O ' ' HD2' ' A' ' 85' ' ' LYS . 0.0 OUTLIER -108.81 138.57 44.93 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.941 0.401 . . . . 0.0 110.663 -179.316 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -108.18 -45.72 3.88 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.956 -0.566 . . . . 0.0 109.846 178.92 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 -133.94 158.86 74.42 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.324 -179.749 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -60.43 -19.97 61.36 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.175 1.917 . . . . 0.0 111.917 177.648 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 34.8 p -100.43 2.72 42.49 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.724 -179.84 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 70.6 t80 -147.05 101.39 3.41 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-O 121.128 0.49 . . . . 0.0 109.921 -178.965 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 3.3 t-160 -131.08 110.22 11.04 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 -177.689 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' HIS . . . . . 0.671 ' HA ' ' HA3' ' A' ' 101' ' ' GLY . 16.9 p80 -120.54 -178.19 3.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.744 0.307 . . . . 0.0 110.646 -176.883 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' TRP . . . . . 0.639 ' CD1' HD11 ' A' ' 81' ' ' LEU . 41.4 p90 -148.77 -171.36 3.85 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.57 174.292 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -151.73 147.28 26.5 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.913 0.387 . . . . 0.0 111.029 -177.93 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.451 HG23 ' O ' ' A' ' 95' ' ' VAL . 19.0 m -123.97 107.51 18.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 172.887 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 21.9 t70 67.53 -68.02 0.17 Allowed 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.903 -174.82 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 45.7 t-20 -144.25 -43.04 0.26 Allowed 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 178.766 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 88.2 mtm180 -58.41 124.2 18.74 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.037 -179.538 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.481 ' HD3' ' N ' ' A' ' 99' ' ' LYS . 0.0 OUTLIER -116.42 129.32 56.16 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.245 -175.107 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -148.22 155.3 41.2 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.384 -0.825 . . . . 0.0 109.356 177.421 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.671 ' HA3' ' HA ' ' A' ' 92' ' ' HIS . . . -175.83 -157.57 17.4 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.565 -0.826 . . . . 0.0 113.148 -176.915 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.787 HD21 HG21 ' A' ' 43' ' ' VAL . 9.2 mp -114.56 146.6 40.56 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 121.362 0.601 . . . . 0.0 111.683 -174.354 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 91.4 m -123.69 111.51 16.28 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 166.649 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 48.7 m-85 -89.77 149.42 22.72 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.737 -170.398 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 19.3 mp0 -103.08 -43.14 5.57 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 170.708 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -82.2 141.61 46.59 Favored Pre-proline 0 CA--C 1.535 0.388 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.496 178.7 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -86.38 -38.48 0.09 OUTLIER 'Trans proline' 0 C--N 1.353 0.776 0 C-N-CA 122.676 2.251 . . . . 0.0 114.217 -174.052 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -64.89 -60.08 3.47 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 120.879 0.371 . . . . 0.0 111.639 -172.767 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 22.4 p-10 -66.43 -26.51 67.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.476 -178.696 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -60.68 -52.79 63.62 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 121.217 0.532 . . . . 0.0 110.313 172.706 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 4.2 tmm_? -63.81 -32.72 74.33 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.746 178.242 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -65.68 -39.27 91.11 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.749 177.214 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.484 ' O ' HG23 ' A' ' 117' ' ' VAL . 73.2 t80 -66.91 -52.99 36.48 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.122 179.079 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.452 ' O ' ' HG3' ' A' ' 118' ' ' ARG . 13.7 t70 -54.09 -56.9 13.71 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 121.522 0.677 . . . . 0.0 110.178 179.42 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 15.2 tpt180 -53.27 -47.74 68.87 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-N 114.628 -1.169 . . . . 0.0 110.605 176.825 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -59.76 -38.69 94.29 Favored Glycine 0 N--CA 1.451 -0.327 0 CA-C-N 115.505 -0.77 . . . . 0.0 112.15 -179.695 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.484 HG23 ' O ' ' A' ' 113' ' ' PHE . 48.3 t -62.09 -46.98 95.25 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 CA-C-O 120.736 0.303 . . . . 0.0 110.315 177.406 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.452 ' HG3' ' O ' ' A' ' 114' ' ' ASP . 81.5 mtt180 -54.85 -54.7 39.05 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.125 179.582 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.498 ' HB3' ' HZ2' ' A' ' 119' ' ' LYS . 0.0 OUTLIER -68.2 -29.59 68.47 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.764 -177.258 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -65.19 -58.05 6.96 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.829 0.347 . . . . 0.0 110.342 179.547 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 49.3 mm -59.63 -43.07 90.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.388 179.663 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 13.5 tp10 -58.52 -50.14 74.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.571 -179.303 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -72.7 -29.81 63.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.911 -176.902 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 6.1 tt -69.09 -53.31 20.98 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.753 179.733 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 47.9 mm -72.32 -52.47 23.87 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.547 -174.96 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 . . . . . 0 C--O 1.25 1.107 0 CA-C-O 119.011 -0.519 . . . . 0.0 110.145 -175.288 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.902 0 N-CA-C 111.447 -0.661 . . . . 0.0 111.447 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.8 t -61.79 -45.82 92.22 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 173.611 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' MET . . . . . 0.435 ' N ' ' SD ' ' A' ' 3' ' ' MET . 1.8 mpt? -99.68 146.27 26.69 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 168.677 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 53.3 m 59.6 93.05 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 O-C-N 123.44 0.463 . . . . 0.0 110.341 -176.245 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -93.8 104.61 16.68 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.049 0.452 . . . . 0.0 111.295 -176.525 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -94.63 -165.69 1.35 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.692 -0.685 . . . . 0.0 109.25 172.085 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.657 HG23 ' HB2' ' A' ' 13' ' ' SER . 24.7 m 69.66 8.93 6.99 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-O 121.158 0.504 . . . . 0.0 111.419 178.556 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.718 ' HB2' ' HD3' ' A' ' 9' ' ' PRO . 89.3 m-70 -127.94 -63.63 0.02 OUTLIER Pre-proline 0 CA--C 1.541 0.599 0 CA-C-N 116.53 -0.305 . . . . 0.0 111.123 178.575 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.718 ' HD3' ' HB2' ' A' ' 8' ' ' HIS . 84.9 Cg_endo -80.71 -52.34 0.05 OUTLIER 'Trans proline' 0 C--N 1.363 1.325 0 C-N-CA 121.534 1.489 . . . . 0.0 112.272 -177.147 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -79.85 -1.79 40.62 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.461 179.308 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.575 ' O ' ' HA ' ' A' ' 7' ' ' THR . 35.5 m-20 66.24 -79.2 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.74 -179.305 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 12.8 t70 64.33 -74.7 0.05 OUTLIER 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 123.102 0.561 . . . . 0.0 112.344 175.023 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.657 ' HB2' HG23 ' A' ' 7' ' ' THR . 6.4 m -83.85 11.5 7.51 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 112.494 0.553 . . . . 0.0 112.494 -170.936 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 10.0 m-85 -66.89 112.93 4.56 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 120.685 0.279 . . . . 0.0 110.489 176.009 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.538 HG13 HG23 ' A' ' 16' ' ' VAL . 34.0 pt -92.01 -26.82 4.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.357 178.188 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.538 HG23 HG13 ' A' ' 15' ' ' ILE . 92.1 t -135.35 137.72 49.53 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.194 179.466 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.462 ' NH1' ' HG2' ' A' ' 42' ' ' ARG . 18.9 tpp180 -132.74 123.33 26.03 Favored 'General case' 0 N--CA 1.463 0.21 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 175.508 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 30.2 m -124.09 176.6 5.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 C-N-CA 122.659 0.383 . . . . 0.0 110.375 179.072 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 22.4 pttp -132.48 125.51 30.83 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 179.43 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -165.91 177.71 6.95 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 -179.3 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 60.2 t -100.24 118.14 46.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 110.177 -0.305 . . . . 0.0 110.177 176.059 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 17.8 m -66.71 109.0 1.15 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.354 0 CA-C-O 121.352 0.596 . . . . 0.0 111.237 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 25.1 mmt -106.65 166.52 10.51 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.129 179.626 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.521 HG23 ' CE1' ' A' ' 33' ' ' PHE . 11.0 t -160.84 150.63 17.39 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.934 -0.575 . . . . 0.0 109.708 177.769 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 20.7 ttt180 -120.31 100.64 7.29 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 174.071 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -69.38 84.31 0.4 Allowed 'General case' 0 C--O 1.235 0.299 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.481 179.449 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 15.4 t70 64.44 -81.63 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.139 -175.673 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 41.2 m -149.43 17.8 0.93 Allowed 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 120.81 0.338 . . . . 0.0 110.432 178.228 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 38.6 t -64.66 89.58 0.07 Allowed 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.829 -179.483 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 76.32 -63.72 2.91 Favored Glycine 0 C--N 1.332 0.353 0 CA-C-N 116.093 -0.503 . . . . 0.0 112.351 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 158.51 -140.28 6.84 Favored Glycine 0 N--CA 1.449 -0.475 0 N-CA-C 111.027 -0.829 . . . . 0.0 111.027 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' TRP . . . . . 0.492 ' HH2' ' HG2' ' A' ' 99' ' ' LYS . 97.9 m95 -79.02 93.9 5.2 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 176.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.521 ' CE1' HG23 ' A' ' 24' ' ' THR . 21.3 p90 -103.65 143.17 26.11 Favored Pre-proline 0 C--O 1.236 0.353 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.505 -178.311 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -69.08 103.37 1.04 Allowed 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.286 1.991 . . . . 0.0 111.266 176.19 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.427 ' H ' ' HG2' ' A' ' 35' ' ' GLN . 3.7 pt20 -57.04 -49.44 75.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.476 -179.625 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -157.45 171.2 20.8 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 179.36 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 78.52 -75.41 1.97 Allowed Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 121.053 -0.594 . . . . 0.0 111.777 -179.483 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 70.91 -73.95 0.64 Allowed Glycine 0 C--N 1.332 0.354 0 C-N-CA 121.562 -0.351 . . . . 0.0 112.25 -179.622 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -70.86 76.96 0.54 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 121.5 -0.381 . . . . 0.0 112.289 178.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 38.1 mm 66.87 142.84 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 C-N-CA 123.442 0.697 . . . . 0.0 111.31 178.455 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 18.2 m -132.96 133.85 43.74 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.057 0.455 . . . . 0.0 110.44 178.83 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.462 ' HG2' ' NH1' ' A' ' 17' ' ' ARG . 37.8 ttt85 -86.51 83.44 7.64 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.551 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 28.8 t -100.97 155.53 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.567 -172.414 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -162.78 -178.19 36.41 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.623 -0.799 . . . . 0.0 112.702 177.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 59.8 t -128.98 128.63 67.52 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 179.008 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' CYS . . . . . 0.526 ' SG ' ' HB3' ' A' ' 60' ' ' LEU . 13.7 p -119.45 126.44 51.32 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 176.479 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -82.06 98.39 8.62 Favored 'General case' 0 C--O 1.234 0.237 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 179.392 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.5 HG21 ' HE1' ' A' ' 76' ' ' TYR . 33.0 m -86.53 -168.95 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.21 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 22.1 ptp -169.27 169.68 9.02 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 177.497 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' HIS . . . . . 0.401 ' HA ' ' HD3' ' A' ' 51' ' ' PRO . 4.2 p-80 -82.34 131.23 56.45 Favored Pre-proline 0 C--N 1.327 -0.373 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 176.273 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 50' ' ' HIS . 51.5 Cg_exo -56.3 -13.45 9.94 Favored 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 123.306 2.671 . . . . 0.0 113.298 -173.242 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -57.21 -36.79 71.3 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.419 178.208 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 73.44 81.52 0.4 Allowed Glycine 0 C--N 1.333 0.4 0 CA-C-N 115.849 -0.614 . . . . 0.0 112.327 179.043 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 44.6 m-80 -134.04 23.04 3.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.891 0.376 . . . . 0.0 110.544 -179.727 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 84.31 -49.68 4.27 Favored Glycine 0 C--N 1.331 0.284 0 C-N-CA 121.326 -0.464 . . . . 0.0 112.249 179.389 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 30.9 ttp-105 -51.86 128.43 23.94 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 122.616 0.366 . . . . 0.0 110.778 177.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 15.4 m -119.96 161.86 20.18 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.841 -177.101 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -121.83 -173.41 14.45 Favored Glycine 0 N--CA 1.452 -0.248 0 N-CA-C 110.714 -0.954 . . . . 0.0 110.714 176.18 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -135.96 148.7 48.59 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 117.337 0.568 . . . . 0.0 110.518 -177.747 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.67 HD22 ' HB2' ' A' ' 62' ' ' HIS . 2.3 tt -133.37 113.0 12.07 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 179.171 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.558 ' HB ' ' HB2' ' A' ' 75' ' ' CYS . 46.2 mt -79.96 98.31 3.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 108.396 -0.965 . . . . 0.0 108.396 174.605 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' HIS . . . . . 0.67 ' HB2' HD22 ' A' ' 60' ' ' LEU . 23.8 t-80 -120.93 141.22 50.86 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 -173.919 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -156.3 126.93 1.88 Allowed Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.322 -0.942 . . . . 0.0 113.132 -177.439 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -90.5 164.04 14.4 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 172.273 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.576 ' HB3' HG11 ' A' ' 72' ' ' VAL . 16.5 ptm180 -81.41 164.1 22.32 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.176 -0.675 . . . . 0.0 109.176 172.633 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 54.7 tp60 -78.05 68.3 4.07 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-O 121.38 0.61 . . . . 0.0 109.43 179.304 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.817 ' HA ' ' HE3' ' A' ' 67' ' ' LYS . 0.5 OUTLIER -171.58 49.7 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.223 -0.899 . . . . 0.0 109.017 -177.145 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.437 ' HB2' ' O ' ' A' ' 67' ' ' LYS . 4.3 m-20 71.8 -179.05 0.22 Allowed 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 115.257 -0.883 . . . . 0.0 111.149 -177.502 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 5.1 mptp? -65.92 93.62 0.2 Allowed 'General case' 0 C--O 1.233 0.215 0 CA-C-N 115.897 -0.592 . . . . 0.0 112.594 -175.463 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 58.1 tp -136.22 105.14 5.88 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 167.403 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 44.1 t -62.56 108.34 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.673 -177.035 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.576 HG11 ' HB3' ' A' ' 65' ' ' ARG . 33.7 m -107.75 -9.84 10.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.77 179.112 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -144.67 127.11 15.93 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 179.338 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -146.74 115.27 6.74 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 177.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' CYS . . . . . 0.558 ' HB2' ' HB ' ' A' ' 61' ' ' ILE . 39.8 m -137.73 85.42 2.11 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.079 0.466 . . . . 0.0 109.986 177.545 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.5 ' HE1' HG21 ' A' ' 48' ' ' VAL . 86.3 t80 -75.28 135.38 40.94 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.548 176.837 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.437 HG11 ' HG ' ' A' ' 81' ' ' LEU . 25.6 m -134.19 149.56 30.32 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 177.602 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.444 ' N ' ' HD3' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -108.83 -35.09 6.47 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.183 -174.346 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 59.9 tttm -165.83 23.34 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 121.491 0.663 . . . . 0.0 109.625 -177.591 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -146.63 125.18 12.44 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.227 -170.223 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.437 ' HG ' HG11 ' A' ' 77' ' ' VAL . 5.3 mt -160.81 122.55 3.05 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.014 177.042 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 48.4 t -124.29 98.64 5.52 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 177.882 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.644 ' HB3' ' NE2' ' A' ' 91' ' ' HIS . 84.1 m-85 -90.58 161.68 15.34 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.407 177.234 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 60.7 m -158.89 115.66 2.72 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 174.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.448 ' HA ' ' HA ' ' A' ' 91' ' ' HIS . 36.2 ttpt -89.11 107.54 19.1 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 178.457 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -73.71 -41.68 62.26 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.387 -175.001 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -136.61 153.47 75.97 Favored Pre-proline 0 C--N 1.325 -0.472 0 CA-C-N 115.203 -0.908 . . . . 0.0 108.647 179.017 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_exo -52.89 -23.51 21.26 Favored 'Trans proline' 0 N--CA 1.476 0.449 0 C-N-CA 122.491 2.127 . . . . 0.0 112.695 -179.166 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 14.6 t -107.54 8.93 29.55 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.576 -177.277 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.42 ' HE1' ' HB3' ' A' ' 92' ' ' HIS . 4.6 t80 -148.38 111.68 4.95 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-O 120.975 0.417 . . . . 0.0 110.953 -178.083 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' HIS . . . . . 0.644 ' NE2' ' HB3' ' A' ' 83' ' ' TYR . 3.1 t-160 -111.52 133.28 53.91 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 177.613 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' HIS . . . . . 0.439 ' HB2' ' O ' ' A' ' 100' ' ' PHE . 21.6 p-80 -134.52 165.22 25.69 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.852 0.358 . . . . 0.0 111.346 -177.345 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 47.4 p90 -147.66 143.87 27.97 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.351 -179.679 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 48.6 tttm -112.99 122.94 49.14 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.153 179.574 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 27.7 m -110.21 32.88 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.325 0 CA-C-O 121.265 0.555 . . . . 0.0 109.937 -177.538 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 23.8 t70 71.92 -57.42 0.62 Allowed 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 114.859 -1.064 . . . . 0.0 109.81 -173.593 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -73.9 97.1 2.72 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 172.497 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 12.2 mpt_? 60.56 176.38 0.1 Allowed 'General case' 0 C--O 1.243 0.748 0 CA-C-O 122.186 0.993 . . . . 0.0 112.077 -176.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.492 ' HG2' ' HH2' ' A' ' 32' ' ' TRP . 38.1 ttpt -126.51 106.95 9.81 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 114.34 -1.3 . . . . 0.0 108.2 176.274 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.491 ' CD2' ' SG ' ' A' ' 75' ' ' CYS . 4.7 m-85 -89.76 173.87 8.03 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 -175.816 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -177.66 -175.44 44.87 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.833 -0.699 . . . . 0.0 111.972 177.747 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.449 ' O ' HD12 ' A' ' 102' ' ' LEU . 1.3 pp -152.0 150.33 29.87 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.099 0.476 . . . . 0.0 110.898 177.012 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 25.2 m -101.0 116.18 32.24 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.806 176.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 40.5 m-85 -63.59 147.42 51.52 Favored 'General case' 0 C--O 1.237 0.413 0 O-C-N 123.369 0.418 . . . . 0.0 110.422 178.551 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 19.0 pt20 -114.25 -10.8 12.68 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.473 -0.331 . . . . 0.0 110.974 -178.244 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 20.4 m -155.12 151.7 23.5 Favored Pre-proline 0 C--N 1.33 -0.251 0 N-CA-C 110.089 -0.337 . . . . 0.0 110.089 174.667 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -60.16 -19.2 55.7 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.344 2.029 . . . . 0.0 111.65 176.361 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -66.08 -60.43 2.83 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.519 177.381 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -65.19 -31.98 73.43 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.79 179.035 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -57.61 -61.53 2.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.003 0.43 . . . . 0.0 110.726 175.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.428 ' HD2' ' O ' ' A' ' 111' ' ' ARG . 5.4 tmm_? -62.57 -38.23 89.28 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.235 -177.496 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -63.5 -43.48 97.11 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.095 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.405 ' O ' HG23 ' A' ' 117' ' ' VAL . 75.4 t80 -67.06 -47.33 71.64 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.081 -178.899 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 59.5 m-20 -57.5 -39.48 76.57 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.526 178.095 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -62.12 -49.86 74.22 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.112 178.359 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -61.25 -42.4 99.77 Favored Glycine 0 C--N 1.333 0.367 0 CA-C-N 115.599 -0.728 . . . . 0.0 112.063 179.631 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.405 HG23 ' O ' ' A' ' 113' ' ' PHE . 55.4 t -60.91 -46.67 96.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.927 0.394 . . . . 0.0 110.699 177.883 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 25.6 tpt180 -59.88 -49.78 76.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.221 -177.549 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 4.3 mmmp? -64.28 -41.18 97.02 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.942 178.691 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -58.08 -55.99 27.78 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.538 -179.591 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.457 ' O ' HG22 ' A' ' 125' ' ' ILE . 46.2 mm -58.27 -42.59 84.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.326 178.687 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -53.28 -59.08 5.01 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.472 -179.355 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 50.0 m-20 -74.16 -24.67 59.42 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.271 -176.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 9.9 tt -68.89 -38.83 79.9 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.36 178.511 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.457 HG22 ' O ' ' A' ' 121' ' ' ILE . 13.8 tt -91.17 -37.83 9.77 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 CA-C-N 116.625 -0.261 . . . . 0.0 111.342 -176.496 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 . . . . . 0 C--O 1.25 1.093 0 CA-C-O 118.422 -0.799 . . . . 0.0 110.218 -177.04 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.892 0 N-CA-C 112.005 -0.438 . . . . 0.0 112.005 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.403 ' O ' ' HB2' ' A' ' 3' ' ' MET . 20.1 m 66.3 155.31 0.09 Allowed 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 122.875 0.47 . . . . 0.0 111.113 -178.521 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' MET . . . . . 0.403 ' HB2' ' O ' ' A' ' 2' ' ' SER . 1.5 mpt? 73.23 -52.08 0.7 Allowed 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.461 0.704 . . . . 0.0 111.225 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 56.4 p -120.47 89.38 3.12 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 110.307 -0.257 . . . . 0.0 110.307 176.006 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 17.8 mp0 -67.42 -57.02 7.32 Favored 'General case' 0 C--O 1.232 0.178 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 175.149 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -90.41 168.99 11.44 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.502 171.587 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.539 HG21 ' HA ' ' A' ' 11' ' ' ASP . 5.2 t -166.04 178.83 6.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.852 0.358 . . . . 0.0 111.368 -176.596 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.448 ' HB3' ' HD3' ' A' ' 9' ' ' PRO . 80.2 t60 176.43 -42.31 0.0 OUTLIER Pre-proline 0 CA--C 1.544 0.714 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.009 -171.192 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.448 ' HD3' ' HB3' ' A' ' 8' ' ' HIS . 45.6 Cg_endo -100.82 15.5 0.39 Allowed 'Trans proline' 0 C--N 1.363 1.296 0 C-N-CA 123.009 2.473 . . . . 0.0 113.698 174.768 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -143.46 -72.41 0.29 Allowed 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 -174.831 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.539 ' HA ' HG21 ' A' ' 7' ' ' THR . 0.9 OUTLIER 74.1 94.43 0.07 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.135 -0.939 . . . . 0.0 113.384 165.049 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -131.23 21.37 4.83 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.145 -0.934 . . . . 0.0 108.581 171.162 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 39.2 t -128.86 -24.01 3.01 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-N 115.281 -0.872 . . . . 0.0 111.442 -175.69 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.514 ' HE1' HG23 ' A' ' 7' ' ' THR . 5.2 m-85 -64.2 140.75 58.9 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 120.912 0.386 . . . . 0.0 111.303 -177.905 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 61.2 mt -126.71 -64.92 0.98 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.203 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.427 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.566 ' HB ' ' HB ' ' A' ' 45' ' ' VAL . 60.2 t -99.07 106.29 18.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.095 -178.193 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.421 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 62.2 mtm180 -120.42 90.15 3.27 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.044 0.45 . . . . 0.0 110.212 179.421 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.418 HG11 ' HB2' ' A' ' 109' ' ' ASP . 86.6 t -107.89 135.87 45.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.887 -176.545 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -85.46 106.16 16.6 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 174.239 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -144.84 -172.15 3.77 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.114 -177.812 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.587 ' HB ' ' HB ' ' A' ' 103' ' ' THR . 23.6 t -101.53 121.54 52.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.615 0.245 . . . . 0.0 110.473 -179.193 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.502 HG11 ' HG ' ' A' ' 73' ' ' LEU . 60.8 t -97.71 98.28 7.18 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 CA-C-O 121.035 0.445 . . . . 0.0 110.461 176.134 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' MET . . . . . 0.444 ' HB3' ' HB3' ' A' ' 32' ' ' TRP . 24.9 mmt -74.47 106.38 6.04 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 174.06 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.462 HG23 ' CE1' ' A' ' 33' ' ' PHE . 10.0 t -76.69 -46.4 25.72 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 111.583 0.216 . . . . 0.0 111.583 -173.204 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.514 ' HB2' ' CE3' ' A' ' 32' ' ' TRP . 23.4 ttt180 57.84 135.13 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 121.317 0.58 . . . . 0.0 110.396 -172.041 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -81.08 64.85 5.98 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 177.512 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 32.5 t70 58.96 -74.73 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 114.536 -1.211 . . . . 0.0 110.932 -172.5 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 26.4 t -121.76 99.06 6.25 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 177.242 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 10.8 m -126.04 159.71 32.04 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.712 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -69.3 76.55 0.35 Allowed Glycine 0 C--N 1.332 0.34 0 N-CA-C 111.582 -0.607 . . . . 0.0 111.582 176.583 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 106.72 -158.67 15.16 Favored Glycine 0 C--O 1.237 0.334 0 N-CA-C 111.264 -0.735 . . . . 0.0 111.264 -175.035 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' TRP . . . . . 0.514 ' CE3' ' HB2' ' A' ' 25' ' ' ARG . 53.7 m95 -127.42 126.16 41.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.656 0.265 . . . . 0.0 110.424 -179.593 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.479 ' HA ' ' HD3' ' A' ' 34' ' ' PRO . 6.4 p90 -114.44 137.71 22.75 Favored Pre-proline 0 C--O 1.238 0.45 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.139 -179.851 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.581 ' HB2' ' HA2' ' A' ' 38' ' ' GLY . 7.3 Cg_exo -74.05 154.07 47.18 Favored 'Trans proline' 0 N--CA 1.462 -0.367 0 C-N-CA 122.785 2.323 . . . . 0.0 111.358 175.897 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.403 ' NE2' ' HB ' ' A' ' 22' ' ' VAL . 0.0 OUTLIER -75.51 -163.39 0.25 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.303 175.166 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -45.99 -34.55 4.09 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 -173.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -66.73 -30.1 75.74 Favored Glycine 0 CA--C 1.519 0.336 0 C-N-CA 121.242 -0.504 . . . . 0.0 113.074 -175.581 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.581 ' HA2' ' HB2' ' A' ' 34' ' ' PRO . . . 58.37 13.53 16.44 Favored Glycine 0 CA--C 1.522 0.476 0 C-N-CA 121.506 -0.378 . . . . 0.0 113.248 179.497 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.482 ' HA2' HG22 ' A' ' 21' ' ' VAL . . . 154.81 -43.12 0.58 Allowed Glycine 0 N--CA 1.449 -0.451 0 N-CA-C 111.612 -0.595 . . . . 0.0 111.612 -176.884 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.455 ' O ' HG13 ' A' ' 40' ' ' ILE . 32.4 pt -89.88 111.06 22.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 121.221 0.534 . . . . 0.0 110.532 179.263 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 21.1 m -146.41 131.15 17.96 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.73 177.581 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.586 ' HB3' ' HB2' ' A' ' 64' ' ' GLU . 35.4 ttt180 -90.31 103.27 15.97 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 176.304 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.642 HG21 HD21 ' A' ' 102' ' ' LEU . 25.5 t -81.2 94.51 2.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.164 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -90.27 81.89 1.37 Allowed Glycine 0 N--CA 1.452 -0.276 0 CA-C-N 115.978 -0.556 . . . . 0.0 112.639 -177.766 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.566 ' HB ' ' HB ' ' A' ' 16' ' ' VAL . 61.0 t -76.44 108.72 9.55 Favored 'Isoleucine or valine' 0 C--O 1.24 0.569 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 176.506 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' CYS . . . . . 0.633 ' SG ' ' HB3' ' A' ' 60' ' ' LEU . 11.8 p -115.65 136.86 52.64 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.997 -177.738 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -91.52 92.31 8.46 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 176.397 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 23.1 m -83.76 111.63 20.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 121.396 0.617 . . . . 0.0 110.667 -176.837 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 22.7 ptp -98.85 124.91 44.06 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.392 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 34.7 p-80 -70.23 132.82 87.8 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.09 178.421 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -56.58 138.99 86.84 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 122.859 2.373 . . . . 0.0 112.434 -175.387 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 66.26 16.03 10.29 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 115.736 -0.666 . . . . 0.0 111.172 178.208 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -65.46 148.47 51.26 Favored Glycine 0 C--N 1.333 0.411 0 CA-C-N 115.884 -0.598 . . . . 0.0 112.461 179.726 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 29.3 p-10 -79.06 -21.04 47.39 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.668 0.27 . . . . 0.0 111.043 -177.426 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 162.66 161.22 11.93 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.291 178.246 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 91.3 mtt-85 67.23 168.77 0.25 Allowed 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 123.513 0.725 . . . . 0.0 111.066 -177.076 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 22.7 m -153.55 161.66 42.0 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.542 -177.525 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -87.11 160.01 31.72 Favored Glycine 0 N--CA 1.45 -0.387 0 N-CA-C 111.188 -0.765 . . . . 0.0 111.188 177.008 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -117.84 106.91 13.49 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.934 0.397 . . . . 0.0 110.286 179.625 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.633 ' HB3' ' SG ' ' A' ' 46' ' ' CYS . 2.5 tt -88.66 105.16 17.5 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 179.7 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.422 ' HB ' ' HB2' ' A' ' 75' ' ' CYS . 58.6 mt -73.41 87.96 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 174.719 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 8.5 t-80 -91.55 100.33 13.09 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.177 -175.318 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.489 ' HA3' ' HB2' ' A' ' 73' ' ' LEU . . . -87.1 95.09 2.04 Favored Glycine 0 N--CA 1.449 -0.496 0 CA-C-N 115.762 -0.654 . . . . 0.0 112.324 -178.819 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.586 ' HB2' ' HB3' ' A' ' 42' ' ' ARG . 34.6 mt-10 -83.07 137.49 34.08 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 177.007 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.53 ' NH1' ' HB2' ' A' ' 67' ' ' LYS . 6.3 tmm_? -114.04 126.18 54.83 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 178.411 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.433 ' O ' ' HD2' ' A' ' 65' ' ' ARG . 1.0 OUTLIER -67.84 -160.95 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.488 0 O-C-N 123.564 0.54 . . . . 0.0 112.073 -174.262 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.53 ' HB2' ' NH1' ' A' ' 65' ' ' ARG . 34.5 mmtp 65.4 -82.89 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 -173.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.434 ' HB2' HD12 ' A' ' 70' ' ' LEU . 5.9 m-20 -74.22 -30.81 62.35 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.615 176.47 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.44 ' HA ' ' O ' ' A' ' 65' ' ' ARG . 22.8 tptm 60.27 81.89 0.17 Allowed 'General case' 0 C--O 1.233 0.217 0 CA-C-N 115.084 -0.962 . . . . 0.0 110.074 -176.721 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.434 HD12 ' HB2' ' A' ' 68' ' ' ASP . 0.0 OUTLIER -150.1 168.7 23.16 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.472 -177.741 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 21.6 t -83.15 109.69 17.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.893 -176.711 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.435 HG23 HD23 ' A' ' 73' ' ' LEU . 18.0 m -102.05 -35.91 4.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 CA-C-O 120.888 0.375 . . . . 0.0 111.053 177.968 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.502 ' HG ' HG11 ' A' ' 22' ' ' VAL . 4.5 mm? -116.24 117.11 29.1 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.229 178.741 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -118.96 104.2 10.29 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 176.205 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' CYS . . . . . 0.422 ' HB2' ' HB ' ' A' ' 61' ' ' ILE . 61.1 m -135.22 83.48 2.02 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.346 0.593 . . . . 0.0 110.632 -179.329 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.4 ' HA ' ' HA ' ' A' ' 60' ' ' LEU . 80.0 t80 -69.41 105.98 2.78 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.468 -0.787 . . . . 0.0 108.997 172.477 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 39.6 t -100.69 132.71 45.84 Favored 'Isoleucine or valine' 0 C--O 1.237 0.395 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 -175.053 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 30.4 ttp180 -135.46 100.17 4.43 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.403 -174.33 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.751 ' H ' HD21 ' A' ' 124' ' ' LEU . 66.4 mmtt 72.05 -29.74 0.2 Allowed 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.339 0.655 . . . . 0.0 112.748 178.444 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -88.38 23.01 2.31 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 120.973 0.416 . . . . 0.0 110.753 -177.058 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.604 HD22 HG12 ' A' ' 121' ' ' ILE . 1.0 OUTLIER -71.3 89.85 0.91 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.828 -179.249 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 49.0 t -123.0 99.9 7.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.121 0.486 . . . . 0.0 110.593 179.734 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.716 ' HB3' ' NE2' ' A' ' 91' ' ' HIS . 4.2 m-85 -87.1 115.47 24.51 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.47 175.738 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 31.2 m -98.61 119.71 37.8 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.176 -0.465 . . . . 0.0 109.869 173.387 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 24.2 ttmm -86.6 103.94 15.57 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 176.646 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -82.56 -19.9 37.62 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 121.064 0.459 . . . . 0.0 110.237 -178.869 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ASN . . . . . 0.856 ' HB3' ' HB3' ' A' ' 90' ' ' PHE . 12.3 t-20 -156.58 144.69 14.3 Favored Pre-proline 0 C--N 1.326 -0.453 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 178.761 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.446 ' HD2' ' ND2' ' A' ' 87' ' ' ASN . 33.9 Cg_exo -34.47 -50.8 0.65 Allowed 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 123.374 2.716 . . . . 0.0 113.718 179.309 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.562 ' HA ' ' HD2' ' A' ' 104' ' ' PHE . 19.5 p -102.37 -0.72 32.18 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 112.144 0.424 . . . . 0.0 112.144 -176.872 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.856 ' HB3' ' HB3' ' A' ' 87' ' ' ASN . 62.0 t80 -115.78 99.3 7.21 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-O 121.402 0.62 . . . . 0.0 110.07 176.922 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' HIS . . . . . 0.716 ' NE2' ' HB3' ' A' ' 83' ' ' TYR . 0.8 OUTLIER -103.15 149.9 24.18 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 177.493 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 25.5 p80 -149.91 159.56 44.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 118.206 0.457 . . . . 0.0 110.74 176.858 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' TRP . . . . . 0.645 ' HZ3' ' HB2' ' A' ' 102' ' ' LEU . 28.5 p90 -137.29 146.72 45.01 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.323 -0.399 . . . . 0.0 109.979 178.632 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.525 ' NZ ' ' HB3' ' A' ' 94' ' ' LYS . 5.7 ttpm? -114.63 99.47 7.55 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.704 -178.708 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.479 HG13 ' HD1' ' A' ' 93' ' ' TRP . 16.7 m -85.18 113.58 23.87 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 176.023 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 57.08 -86.89 0.02 OUTLIER 'General case' 0 C--O 1.235 0.311 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.405 -173.795 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -126.22 -16.66 5.42 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.457 -177.865 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.98 134.2 33.51 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.836 0.351 . . . . 0.0 110.86 -177.395 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 3.6 mppt? -109.98 123.24 49.29 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.029 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.401 ' CE2' ' SG ' ' A' ' 75' ' ' CYS . 44.3 m-85 -122.05 141.71 51.1 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 176.211 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -116.73 125.33 6.52 Favored Glycine 0 CA--C 1.516 0.144 0 C-N-CA 121.377 -0.439 . . . . 0.0 113.227 -174.668 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.645 ' HB2' ' HZ3' ' A' ' 93' ' ' TRP . 0.4 OUTLIER -94.4 104.28 16.25 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 175.675 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.587 ' HB ' ' HB ' ' A' ' 21' ' ' VAL . 33.3 m -92.54 119.5 32.07 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 177.161 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.562 ' HD2' ' HA ' ' A' ' 89' ' ' THR . 36.7 m-85 -73.82 148.22 42.64 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.438 -175.04 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 49.8 tt0 -88.81 -52.56 5.05 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.605 -176.599 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 19.7 m -134.01 159.11 73.67 Favored Pre-proline 0 C--N 1.326 -0.413 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.142 -177.826 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_endo -55.59 -29.85 71.96 Favored 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 122.526 2.15 . . . . 0.0 112.17 -179.46 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -61.8 -62.04 2.08 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.77 179.371 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.418 ' HB2' HG11 ' A' ' 18' ' ' VAL . 3.3 p-10 -66.83 -29.09 68.92 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.838 -179.455 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -57.82 -60.82 3.12 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.922 0.392 . . . . 0.0 110.697 176.832 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 69.7 mtp180 -64.12 -42.37 96.89 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.54 -0.754 . . . . 0.0 110.802 -178.431 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -61.54 -41.46 97.38 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.938 -179.359 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 35.4 t80 -75.42 -37.02 60.67 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.213 -177.857 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 35.3 m-20 -58.82 -53.83 53.92 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 120.884 0.373 . . . . 0.0 110.336 177.29 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? -66.01 -37.92 87.15 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.501 179.05 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -62.77 -49.98 68.07 Favored Glycine 0 C--N 1.331 0.274 0 CA-C-N 116.053 -0.522 . . . . 0.0 112.501 -179.765 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.515 ' O ' HG13 ' A' ' 121' ' ' ILE . 9.1 p -69.66 -35.45 65.9 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.201 0 N-CA-C 110.123 -0.325 . . . . 0.0 110.123 -178.598 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.52 ' O ' ' HG3' ' A' ' 122' ' ' GLU . 69.8 ttt180 -57.46 -51.16 70.59 Favored 'General case' 0 C--O 1.23 0.073 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 176.091 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 64.3 tttp -56.82 -43.93 81.53 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.422 177.453 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.58 -43.18 97.61 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.154 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.604 HG12 HD22 ' A' ' 81' ' ' LEU . 80.2 mt -62.18 -51.53 71.3 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.195 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.414 179.536 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.52 ' HG3' ' O ' ' A' ' 118' ' ' ARG . 42.8 mt-10 -61.23 -44.52 97.13 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 115.729 -0.668 . . . . 0.0 110.616 -177.363 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -60.67 -42.21 96.62 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.527 178.323 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.751 HD21 ' H ' ' A' ' 79' ' ' LYS . 41.0 tp -66.65 -47.72 71.66 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.134 -177.715 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.481 HG12 ' O ' ' A' ' 121' ' ' ILE . 17.7 pt -74.53 -65.05 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 C-N-CA 120.964 -0.294 . . . . 0.0 111.42 -176.791 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.479 ' H ' HG13 ' A' ' 125' ' ' ILE . 71.7 mm-40 . . . . . 0 C--O 1.25 1.129 0 CA-C-O 119.035 -0.507 . . . . 0.0 110.069 -172.498 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.74 0 N-CA-C 112.019 -0.432 . . . . 0.0 112.019 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 49.1 m -83.81 85.2 7.33 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.126 0.489 . . . . 0.0 110.639 179.739 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 26.1 ptm -71.69 -24.0 61.75 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.131 176.766 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.441 ' O ' ' HB2' ' A' ' 5' ' ' GLU . 7.7 t -129.12 -174.32 3.24 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 115.452 -0.795 . . . . 0.0 108.938 177.054 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.441 ' HB2' ' O ' ' A' ' 4' ' ' THR . 2.1 mp0 66.51 18.37 10.8 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 110.04 -0.355 . . . . 0.0 110.04 -170.978 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 59.34 -174.01 0.1 Allowed 'General case' 0 C--O 1.235 0.322 0 CA-C-N 115.399 -0.818 . . . . 0.0 111.365 -177.439 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 57.0 m -152.19 123.57 7.75 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.93 -177.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.694 ' CD2' ' HD2' ' A' ' 9' ' ' PRO . 31.8 t-80 -65.46 149.3 97.34 Favored Pre-proline 0 CA--C 1.539 0.53 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 175.09 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.694 ' HD2' ' CD2' ' A' ' 8' ' ' HIS . 26.8 Cg_exo -36.33 -38.16 0.3 Allowed 'Trans proline' 0 C--N 1.366 1.453 0 C-N-CA 122.967 2.445 . . . . 0.0 112.238 176.094 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -134.94 116.01 14.22 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 163.369 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -116.72 23.01 12.28 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 -177.37 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -106.18 -40.55 5.61 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.292 -175.195 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -92.48 21.31 5.44 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 121.057 0.456 . . . . 0.0 111.277 -173.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -76.89 137.88 39.4 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.046 177.499 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.715 HD11 ' HB2' ' A' ' 47' ' ' LYS . 1.8 mp -88.35 -53.48 9.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 173.723 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 14.5 p -166.03 146.07 1.66 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.311 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.38 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.541 ' HG2' ' HA3' ' A' ' 44' ' ' GLY . 24.0 mtm180 -118.09 109.06 15.97 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.492 173.04 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 34.8 m -109.23 162.81 6.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.824 -177.058 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.5 ' HE3' HG12 ' A' ' 40' ' ' ILE . 83.9 tttt -84.41 130.13 34.8 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.414 177.172 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -153.92 -167.27 2.61 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 175.378 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.57 ' HB ' ' HB ' ' A' ' 103' ' ' THR . 64.8 t -124.51 114.85 42.63 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 175.15 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.507 HG23 ' HG2' ' A' ' 35' ' ' GLN . 9.3 m -73.08 110.45 6.32 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 CA-C-O 121.367 0.603 . . . . 0.0 111.67 -178.102 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' MET . . . . . 0.556 ' SD ' HG12 ' A' ' 21' ' ' VAL . 38.3 mmm -104.42 146.02 29.45 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.628 -0.714 . . . . 0.0 109.554 -178.521 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 10.7 t -135.32 -6.12 2.3 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 111.766 0.284 . . . . 0.0 111.766 179.26 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 31.6 ttp180 53.25 46.93 25.46 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 122.891 0.477 . . . . 0.0 111.324 -178.26 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.496 ' O ' ' HB3' ' A' ' 27' ' ' ASP . 4.4 p-10 45.88 26.65 0.4 Allowed 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 124.038 0.935 . . . . 0.0 113.361 174.102 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.496 ' HB3' ' O ' ' A' ' 26' ' ' ASP . 8.3 t70 74.99 -40.23 0.43 Allowed 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 122.785 0.434 . . . . 0.0 111.518 178.633 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 17.2 m -96.91 -91.57 0.24 Allowed 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 116.945 -0.116 . . . . 0.0 111.278 -176.017 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 11.0 p -176.72 27.73 0.0 OUTLIER 'General case' 0 C--O 1.236 0.391 0 N-CA-C 112.253 0.464 . . . . 0.0 112.253 -174.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -76.34 -28.83 59.23 Favored Glycine 0 CA--C 1.519 0.342 0 C-N-CA 120.772 -0.727 . . . . 0.0 111.924 179.066 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 158.34 151.3 6.03 Favored Glycine 0 CA--C 1.519 0.318 0 C-N-CA 121.386 -0.435 . . . . 0.0 112.265 178.593 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 83.9 m95 -76.95 102.04 6.24 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 110.165 -0.309 . . . . 0.0 110.165 179.508 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.411 ' H ' ' HD1' ' A' ' 33' ' ' PHE . 0.2 OUTLIER -114.83 153.55 46.94 Favored Pre-proline 0 C--O 1.237 0.422 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.145 177.48 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_exo -67.05 130.67 23.39 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.791 2.328 . . . . 0.0 111.473 175.816 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.507 ' HG2' HG23 ' A' ' 22' ' ' VAL . 14.1 pt20 -92.02 85.92 5.67 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 121.32 0.581 . . . . 0.0 110.837 -178.132 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 71.66 -34.13 0.29 Allowed 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.929 0.892 . . . . 0.0 113.312 176.459 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.446 ' HA2' ' HD2' ' A' ' 65' ' ' ARG . . . -63.77 -50.02 64.3 Favored Glycine 0 C--N 1.333 0.405 0 C-N-CA 121.163 -0.541 . . . . 0.0 112.347 -179.729 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 82.45 -146.0 24.46 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.99 -0.624 . . . . 0.0 111.672 -178.312 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -65.17 -23.6 69.89 Favored Glycine 0 CA--C 1.518 0.243 0 C-N-CA 121.429 -0.415 . . . . 0.0 112.83 -178.601 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.5 HG12 ' HE3' ' A' ' 19' ' ' LYS . 57.8 mt -113.52 104.3 16.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.961 0.41 . . . . 0.0 110.344 179.28 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.454 ' HB3' HG13 ' A' ' 22' ' ' VAL . 19.1 m -131.1 107.71 9.24 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 173.697 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.615 ' HB3' ' HG3' ' A' ' 64' ' ' GLU . 47.0 ttt180 -77.08 91.72 3.7 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.223 0.535 . . . . 0.0 109.901 -177.422 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 78.8 t -79.74 119.89 30.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.197 -179.459 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.541 ' HA3' ' HG2' ' A' ' 17' ' ' ARG . . . -116.91 123.28 5.75 Favored Glycine 0 N--CA 1.445 -0.705 0 CA-C-N 115.897 -0.592 . . . . 0.0 112.76 -177.396 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.456 HG13 ' HB ' ' A' ' 15' ' ' ILE . 7.6 p -99.51 123.29 52.15 Favored 'Isoleucine or valine' 0 C--O 1.24 0.591 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 175.086 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' CYS . . . . . 0.825 ' SG ' ' HB3' ' A' ' 60' ' ' LEU . 8.8 p -126.37 141.87 51.74 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.507 178.853 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.715 ' HB2' HD11 ' A' ' 15' ' ' ILE . 83.3 tttt -88.21 102.19 14.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.843 -176.199 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.574 HG11 ' OH ' ' A' ' 76' ' ' TYR . 95.4 t -74.67 96.14 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 121.06 0.457 . . . . 0.0 110.631 -177.139 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -86.44 164.65 16.87 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.286 178.566 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 24.8 p80 -150.68 161.81 29.13 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-N 116.244 -0.435 . . . . 0.0 109.96 -175.246 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -53.94 144.4 56.46 Favored 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 122.438 2.092 . . . . 0.0 111.354 174.135 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -52.17 105.49 0.12 Allowed 'General case' 0 C--O 1.234 0.27 0 CA-C-O 120.847 0.356 . . . . 0.0 110.895 -177.416 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -151.51 -86.29 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.263 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.924 -179.01 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -71.42 -77.22 0.09 Allowed 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.811 0.339 . . . . 0.0 110.999 -179.437 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 132.38 156.59 8.3 Favored Glycine 0 C--N 1.331 0.273 0 N-CA-C 111.572 -0.611 . . . . 0.0 111.572 -178.4 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 31.0 mmt180 60.26 90.01 0.06 Allowed 'General case' 0 C--O 1.234 0.281 0 CA-C-O 121.27 0.557 . . . . 0.0 110.582 -176.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.42 ' OG ' ' HE2' ' A' ' 47' ' ' LYS . 19.3 p -59.89 143.73 50.64 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.215 -0.902 . . . . 0.0 111.472 -178.814 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -81.89 -166.7 37.96 Favored Glycine 0 C--N 1.333 0.369 0 C-N-CA 121.039 -0.601 . . . . 0.0 111.827 179.487 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -141.09 144.49 34.93 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.751 0.31 . . . . 0.0 110.501 -179.008 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.825 ' HB3' ' SG ' ' A' ' 46' ' ' CYS . 1.6 tt -104.51 109.47 21.36 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 172.559 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.659 ' HB ' ' HB3' ' A' ' 75' ' ' CYS . 44.5 mm -81.66 89.52 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 108.415 -0.958 . . . . 0.0 108.415 174.354 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 12.3 t-80 -93.01 144.35 25.33 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.509 -0.768 . . . . 0.0 110.617 -173.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.513 ' HA3' ' HB3' ' A' ' 73' ' ' LEU . . . -131.43 87.21 0.29 Allowed Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 121.164 -0.541 . . . . 0.0 111.986 179.085 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.615 ' HG3' ' HB3' ' A' ' 42' ' ' ARG . 6.0 pt-20 -88.08 135.13 33.56 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 173.483 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.446 ' HD2' ' HA2' ' A' ' 37' ' ' GLY . 21.7 mtm180 -54.78 -67.05 0.3 Allowed 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 120.868 0.366 . . . . 0.0 111.676 -172.08 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 39.6 mt-30 -118.36 -43.69 2.71 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.054 0.454 . . . . 0.0 110.61 -175.179 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 32.3 ttpt -173.16 94.24 0.11 Allowed 'General case' 0 C--O 1.236 0.352 0 CA-C-N 115.593 -0.73 . . . . 0.0 109.128 -178.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 12.5 t70 52.11 -143.7 0.66 Allowed 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 -175.83 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 86.0 tttt 71.04 -65.39 0.34 Allowed 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 123.513 0.725 . . . . 0.0 112.028 175.133 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.8 tt -129.01 114.49 16.47 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-O 120.711 0.291 . . . . 0.0 110.279 -175.863 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 48.3 t -89.18 113.88 26.41 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.623 176.903 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 18.5 m -105.57 -12.5 9.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 111.762 0.282 . . . . 0.0 111.762 -177.73 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.513 ' HB3' ' HA3' ' A' ' 63' ' ' GLY . 3.3 tm? -142.98 120.32 11.6 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 -179.617 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -127.71 98.51 5.21 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 178.79 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' CYS . . . . . 0.659 ' HB3' ' HB ' ' A' ' 61' ' ' ILE . 41.9 t -124.08 67.0 1.05 Allowed 'General case' 0 C--O 1.235 0.305 0 CA-C-O 121.668 0.747 . . . . 0.0 110.475 -177.708 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.574 ' OH ' HG11 ' A' ' 48' ' ' VAL . 31.8 t80 -62.64 101.14 0.23 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 114.94 -1.027 . . . . 0.0 109.089 173.64 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.609 HG21 HD12 ' A' ' 81' ' ' LEU . 29.2 m -84.08 111.39 19.92 Favored 'Isoleucine or valine' 0 C--O 1.239 0.539 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 -178.737 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.495 ' NH1' ' O ' ' A' ' 76' ' ' TYR . 9.8 mpt_? -77.56 66.05 3.2 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.98 -177.327 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 50.9 mtpt 72.71 -33.85 0.28 Allowed 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.773 0.829 . . . . 0.0 112.002 -178.476 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -75.92 108.25 8.67 Favored 'General case' 0 C--O 1.233 0.189 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 173.206 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.609 HD12 HG21 ' A' ' 77' ' ' VAL . 6.6 tt -134.58 113.8 12.13 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 -177.519 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 49.2 t -124.28 90.61 1.64 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 CA-C-O 120.701 0.286 . . . . 0.0 110.989 -179.075 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.715 ' HB3' ' NE2' ' A' ' 91' ' ' HIS . 4.1 m-85 -88.26 152.93 21.61 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 120.922 0.392 . . . . 0.0 110.205 174.012 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 61.8 m -155.55 118.2 4.23 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 123.535 0.734 . . . . 0.0 109.097 178.044 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.507 ' HA ' ' HA ' ' A' ' 91' ' ' HIS . 3.1 pptp? -90.81 131.89 36.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.888 0.375 . . . . 0.0 110.249 179.33 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.42 ' HB3' ' HD1' ' A' ' 90' ' ' PHE . . . -96.32 -31.08 13.07 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.249 0.547 . . . . 0.0 109.697 176.437 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ASN . . . . . 0.558 ' HB2' ' HB3' ' A' ' 90' ' ' PHE . 43.9 m-80 -143.3 158.93 57.01 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 115.251 -0.886 . . . . 0.0 109.282 179.134 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.422 ' O ' ' HB1' ' A' ' 110' ' ' ALA . 52.3 Cg_exo -55.91 -28.23 67.18 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.227 1.951 . . . . 0.0 111.642 175.96 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.438 ' HA ' ' HB2' ' A' ' 104' ' ' PHE . 12.6 p -109.3 16.41 22.41 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 115.74 -0.663 . . . . 0.0 111.601 -178.724 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.558 ' HB3' ' HB2' ' A' ' 87' ' ' ASN . 58.7 t80 -150.67 107.11 3.49 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-O 120.803 0.335 . . . . 0.0 110.734 -178.789 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' HIS . . . . . 0.715 ' NE2' ' HB3' ' A' ' 83' ' ' TYR . 2.2 t60 -120.16 141.92 49.43 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 177.913 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' HIS . . . . . 0.473 ' HA ' ' HA2' ' A' ' 101' ' ' GLY . 21.5 p80 -138.12 152.62 48.91 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.485 0.183 . . . . 0.0 110.516 -179.275 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' TRP . . . . . 0.617 ' HZ3' HD22 ' A' ' 102' ' ' LEU . 47.3 p90 -127.13 145.54 50.71 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 121.228 0.537 . . . . 0.0 111.245 -179.214 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 36.3 ttmt -91.59 133.42 35.56 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.285 -176.551 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.402 HG21 ' CE2' ' A' ' 100' ' ' PHE . 9.3 m -134.38 82.04 0.56 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.316 0 CA-C-O 121.558 0.694 . . . . 0.0 110.783 177.138 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 20.0 t70 59.67 -84.73 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 114.861 -1.063 . . . . 0.0 111.846 178.482 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -99.29 -48.39 4.83 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 120.741 0.305 . . . . 0.0 110.826 -176.481 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 9.0 mpt_? -87.76 176.15 7.53 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-O 121.168 0.508 . . . . 0.0 110.878 -178.927 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.414 ' HE3' ' HB2' ' A' ' 99' ' ' LYS . 39.1 ttmt -154.27 104.21 2.58 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 -178.225 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.432 ' HB2' ' CE2' ' A' ' 93' ' ' TRP . 3.6 m-85 -92.97 179.12 5.54 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 -176.814 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.473 ' HA2' ' HA ' ' A' ' 92' ' ' HIS . . . -168.3 177.57 42.32 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.621 -0.8 . . . . 0.0 112.196 178.955 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.617 HD22 ' HZ3' ' A' ' 93' ' ' TRP . 2.3 pt? -142.36 133.04 25.41 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 177.163 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.57 ' HB ' ' HB ' ' A' ' 21' ' ' VAL . 24.8 m -93.63 127.4 39.3 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.56 177.081 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.455 ' HE2' ' HB2' ' A' ' 91' ' ' HIS . 73.6 m-85 -86.59 157.3 19.75 Favored 'General case' 0 C--O 1.237 0.41 0 O-C-N 123.305 0.378 . . . . 0.0 110.171 -179.859 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 21.1 mp0 -102.96 -33.74 9.19 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.327 -177.53 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 8.4 m -137.84 144.77 45.56 Favored Pre-proline 0 CA--C 1.532 0.25 0 CA-C-O 120.437 0.16 . . . . 0.0 110.78 -178.387 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_exo -53.17 -21.9 18.09 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 122.64 2.227 . . . . 0.0 112.491 176.898 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -64.06 -65.81 0.63 Allowed 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.56 176.362 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -62.48 -36.78 83.58 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.569 179.778 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.422 ' HB1' ' O ' ' A' ' 88' ' ' PRO . . . -55.84 -67.09 0.32 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.403 177.705 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 83.8 mtm180 -62.29 -34.27 76.25 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.139 -175.817 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -62.43 -43.35 99.02 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-O 120.949 0.404 . . . . 0.0 110.361 177.851 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.482 ' O ' HG23 ' A' ' 117' ' ' VAL . 52.8 t80 -69.28 -43.5 73.74 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.02 -179.841 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -55.78 -46.17 78.01 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 121.015 0.436 . . . . 0.0 110.628 177.411 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 24.2 tpt180 -65.97 -34.79 78.91 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 116.137 -0.483 . . . . 0.0 109.76 178.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -62.28 -38.7 96.66 Favored Glycine 0 C--N 1.333 0.366 0 N-CA-C 111.471 -0.652 . . . . 0.0 111.471 174.451 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.487 ' O ' HG13 ' A' ' 121' ' ' ILE . 96.8 t -62.21 -45.87 97.76 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.142 0 N-CA-C 109.73 -0.471 . . . . 0.0 109.73 176.373 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.539 ' O ' ' HG2' ' A' ' 122' ' ' GLU . 8.5 tpm_? -53.2 -52.44 58.87 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.467 176.621 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 7.4 tmtt? -60.26 -47.72 84.8 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.032 -178.389 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -57.6 -48.17 80.12 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.941 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.487 HG13 ' O ' ' A' ' 117' ' ' VAL . 75.0 mt -56.9 -42.51 78.59 Favored 'Isoleucine or valine' 0 C--O 1.232 0.177 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.44 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.539 ' HG2' ' O ' ' A' ' 118' ' ' ARG . 15.6 mm-40 -57.05 -57.06 14.21 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-O 121.038 0.447 . . . . 0.0 110.621 177.621 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -71.46 -12.74 61.55 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.651 -177.337 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 62.7 tp -87.61 -68.24 0.77 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.761 0.315 . . . . 0.0 110.929 178.679 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.44 HG12 ' O ' ' A' ' 121' ' ' ILE . 34.8 pt -89.79 -18.6 7.66 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 N-CA-C 112.241 0.46 . . . . 0.0 112.241 -172.369 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.43 ' HB3' ' O ' ' A' ' 125' ' ' ILE . 36.5 tt0 . . . . . 0 C--O 1.252 1.192 0 O-C-N 123.441 0.463 . . . . 0.0 110.23 -178.203 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.741 0 N-CA-C 112.102 -0.399 . . . . 0.0 112.102 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 17.5 m -70.09 -7.43 41.33 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 122.547 0.339 . . . . 0.0 111.751 -177.592 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' MET . . . . . 0.514 ' O ' HG23 ' A' ' 4' ' ' THR . 25.2 ttt -62.46 -70.01 0.23 Allowed 'General case' 0 CA--C 1.529 0.166 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 175.037 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.514 HG23 ' O ' ' A' ' 3' ' ' MET . 0.8 OUTLIER -167.98 88.51 0.26 Allowed 'General case' 0 C--O 1.236 0.379 0 CA-C-N 114.996 -1.002 . . . . 0.0 108.383 175.97 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -72.29 122.82 21.77 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.023 0.44 . . . . 0.0 111.016 -174.375 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -157.92 143.15 16.8 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-N 115.45 -0.795 . . . . 0.0 109.452 178.244 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.465 ' O ' ' HE2' ' A' ' 69' ' ' LYS . 35.5 p -108.7 -173.45 2.28 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.731 -176.007 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 85.9 m-70 -62.48 157.09 58.69 Favored Pre-proline 0 N--CA 1.464 0.257 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 175.884 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_exo -43.36 -44.44 10.39 Favored 'Trans proline' 0 C--N 1.357 1.015 0 C-N-CA 122.561 2.174 . . . . 0.0 111.202 175.328 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -132.77 109.28 9.55 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 169.305 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -104.26 82.15 1.91 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.836 0.35 . . . . 0.0 110.665 -173.523 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -64.34 -55.54 20.51 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.995 178.447 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 37.4 t -164.6 -58.3 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.914 -176.922 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.448 ' CG ' ' HB3' ' A' ' 46' ' ' CYS . 46.5 m-85 64.14 101.73 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 115.8 -0.637 . . . . 0.0 111.803 178.463 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.641 HG23 HG23 ' A' ' 16' ' ' VAL . 11.5 tt -82.14 -31.75 10.46 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 CA-C-N 115.624 -0.717 . . . . 0.0 110.56 -178.859 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.641 HG23 HG23 ' A' ' 15' ' ' ILE . 76.5 t -117.23 113.98 44.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.249 179.505 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.503 ' NH2' HH12 ' A' ' 42' ' ' ARG . 22.3 mtp180 -136.21 86.54 2.23 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 175.885 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.411 ' HB ' ' CZ ' ' A' ' 113' ' ' PHE . 44.2 t -130.61 153.89 39.77 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.391 -176.578 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 23.3 pttm -65.28 154.85 37.02 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.466 178.32 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.411 ' HB3' HG23 ' A' ' 43' ' ' VAL . . . -179.61 174.04 1.0 Allowed 'General case' 0 C--O 1.233 0.211 0 O-C-N 123.466 0.479 . . . . 0.0 110.532 175.528 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 61.8 t -123.89 143.98 35.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 171.124 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.415 HG11 HD11 ' A' ' 73' ' ' LEU . 29.6 m -115.02 131.0 68.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-O 121.097 0.475 . . . . 0.0 111.465 -175.401 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 25.2 mmt -100.23 113.42 26.09 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.057 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.407 HG22 ' O ' ' A' ' 33' ' ' PHE . 11.8 t -82.62 152.64 25.81 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 178.005 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.473 ' HD2' ' CZ2' ' A' ' 32' ' ' TRP . 36.1 ttt85 -122.05 114.11 20.48 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 -172.154 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -72.31 93.54 1.51 Allowed 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 107.602 -1.259 . . . . 0.0 107.602 165.901 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -54.65 149.74 10.46 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 115.603 -0.726 . . . . 0.0 112.879 -169.179 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 51.9 m 72.89 -36.46 0.36 Allowed 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 114.612 -1.176 . . . . 0.0 112.306 179.005 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 29.4 t -78.54 -44.53 24.06 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 175.436 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 149.64 -67.2 0.36 Allowed Glycine 0 N--CA 1.452 -0.291 0 N-CA-C 111.559 -0.616 . . . . 0.0 111.559 178.182 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.453 ' HA3' ' HA ' ' A' ' 25' ' ' ARG . . . 71.34 -126.07 12.65 Favored Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 121.449 -0.405 . . . . 0.0 112.884 178.565 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' TRP . . . . . 0.53 ' HH2' ' HG2' ' A' ' 99' ' ' LYS . 24.6 m95 58.96 38.03 24.41 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 123.041 0.537 . . . . 0.0 109.957 -175.039 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.407 ' O ' HG22 ' A' ' 24' ' ' THR . 21.1 p90 -112.26 148.93 40.17 Favored Pre-proline 0 CA--C 1.532 0.252 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.574 -177.261 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -68.21 109.58 2.02 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 122.706 2.271 . . . . 0.0 111.85 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -59.4 132.27 53.49 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.375 -177.321 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 60.81 20.9 11.04 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.756 177.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 99.43 -15.62 59.85 Favored Glycine 0 C--N 1.333 0.379 0 CA-C-N 116.023 -0.535 . . . . 0.0 112.33 -179.723 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 100.18 -115.62 5.35 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 121.577 -0.344 . . . . 0.0 112.398 179.381 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.81 150.0 26.41 Favored Glycine 0 N--CA 1.451 -0.305 0 N-CA-C 111.774 -0.53 . . . . 0.0 111.774 -177.352 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 6.0 tp -55.88 115.73 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 CA-C-O 121.133 0.492 . . . . 0.0 110.689 179.511 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.416 ' HA ' ' HA ' ' A' ' 65' ' ' ARG . 20.0 m -116.95 175.23 5.68 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.361 -177.81 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.503 HH12 ' NH2' ' A' ' 17' ' ' ARG . 49.6 ttp180 -138.58 137.43 36.98 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.414 -0.588 . . . . 0.0 109.414 177.284 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.632 HG21 HD11 ' A' ' 102' ' ' LEU . 61.7 t -97.49 118.81 44.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 176.88 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.437 ' HA2' ' O ' ' A' ' 16' ' ' VAL . . . -116.59 94.92 0.66 Allowed Glycine 0 N--CA 1.452 -0.263 0 CA-C-N 116.013 -0.54 . . . . 0.0 112.109 -179.259 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.498 ' HB ' ' HB ' ' A' ' 16' ' ' VAL . 60.8 t -92.04 116.24 32.77 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 N-CA-C 110.235 -0.283 . . . . 0.0 110.235 178.94 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' CYS . . . . . 0.537 ' SG ' ' HB3' ' A' ' 60' ' ' LEU . 24.2 p -118.45 131.39 56.27 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.694 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.677 ' HE3' ' HB2' ' A' ' 57' ' ' SER . 60.2 tttp -74.33 102.22 4.31 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 175.411 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.442 HG21 ' CE1' ' A' ' 76' ' ' TYR . 26.9 m -73.24 124.95 31.34 Favored 'Isoleucine or valine' 0 C--O 1.24 0.602 0 CA-C-O 121.202 0.525 . . . . 0.0 110.219 179.559 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 25.9 mmt -88.09 -179.4 6.18 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.599 -176.501 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 1.8 p80 -129.11 125.95 22.92 Favored Pre-proline 0 C--N 1.323 -0.578 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.766 -177.816 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_endo -57.3 -47.28 23.0 Favored 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 122.564 2.176 . . . . 0.0 111.335 179.543 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -162.2 138.65 7.85 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.388 173.862 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 132.83 96.8 0.63 Allowed Glycine 0 N--CA 1.448 -0.533 0 N-CA-C 110.953 -0.859 . . . . 0.0 110.953 -177.633 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -53.62 146.46 13.13 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-O 120.711 0.291 . . . . 0.0 110.916 -178.012 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 152.76 -153.47 24.89 Favored Glycine 0 N--CA 1.448 -0.54 0 N-CA-C 111.629 -0.588 . . . . 0.0 111.629 -178.685 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.517 HH11 ' HA ' ' A' ' 125' ' ' ILE . 67.6 mtm180 -105.54 125.95 51.57 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 110.348 -0.242 . . . . 0.0 110.348 -178.333 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.677 ' HB2' ' HE3' ' A' ' 47' ' ' LYS . 14.8 m -80.23 132.21 35.82 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 178.541 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -92.44 -173.24 41.61 Favored Glycine 0 C--O 1.227 -0.3 0 C-N-CA 121.06 -0.591 . . . . 0.0 113.3 -168.261 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.412 ' HA ' ' O ' ' A' ' 46' ' ' CYS . 45.1 m-85 -131.76 122.14 25.35 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 122.867 0.467 . . . . 0.0 109.98 177.88 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.537 ' HB3' ' SG ' ' A' ' 46' ' ' CYS . 0.9 OUTLIER -80.1 112.34 17.31 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 175.582 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.568 ' HB ' ' HB2' ' A' ' 75' ' ' CYS . 50.5 mm -76.27 82.08 0.68 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.322 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 174.303 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' HIS . . . . . 0.406 ' HB2' HD22 ' A' ' 60' ' ' LEU . 63.1 t-80 -99.59 164.29 12.13 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.198 -0.91 . . . . 0.0 109.751 -176.922 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 175.48 149.98 7.68 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.816 -0.707 . . . . 0.0 111.651 176.419 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.448 ' CD ' HH21 ' A' ' 42' ' ' ARG . 0.1 OUTLIER -142.06 171.01 14.64 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.96 0.41 . . . . 0.0 110.888 -178.586 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.416 ' HA ' ' HA ' ' A' ' 41' ' ' SER . 38.3 ttm180 -83.98 119.16 24.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.36 177.709 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 -61.77 87.99 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 121.255 0.55 . . . . 0.0 111.518 -173.922 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 40.0 ttpt 178.2 -30.59 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 114.587 -1.188 . . . . 0.0 108.563 178.343 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -156.65 170.75 21.68 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.021 -0.99 . . . . 0.0 108.875 177.455 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.465 ' HE2' ' O ' ' A' ' 7' ' ' THR . 93.0 mttt -74.64 16.97 0.23 Allowed 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 120.652 0.263 . . . . 0.0 111.175 178.733 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 5.7 tt -58.03 97.94 0.03 OUTLIER 'General case' 0 C--O 1.233 0.219 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 174.88 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 27.5 m -69.9 130.87 34.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.257 0.551 . . . . 0.0 111.978 -175.352 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 33.1 m -109.69 -14.49 10.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.056 175.211 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.415 HD11 HG11 ' A' ' 22' ' ' VAL . 60.1 mt -132.13 134.39 45.38 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.488 178.593 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -159.39 92.42 1.06 Allowed 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 174.792 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' CYS . . . . . 0.568 ' HB2' ' HB ' ' A' ' 61' ' ' ILE . 66.9 m -136.36 105.67 6.05 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.756 179.102 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.442 ' CE1' HG21 ' A' ' 48' ' ' VAL . 50.9 t80 -76.01 101.22 5.16 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.098 -178.291 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 83.6 t -103.41 99.41 8.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.006 0.431 . . . . 0.0 110.071 -178.186 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.433 ' HD3' ' HE2' ' A' ' 76' ' ' TYR . 18.6 ptt180 -108.38 -20.53 13.09 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.883 -178.397 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 1.8 tmtp? -123.92 79.03 1.68 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.829 -174.33 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 32.7 m-20 62.73 168.34 0.13 Allowed 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 115.124 -0.944 . . . . 0.0 112.102 176.061 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.511 HD23 ' N ' ' A' ' 82' ' ' VAL . 5.6 tt -146.66 135.45 22.27 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 -177.883 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.511 ' N ' HD23 ' A' ' 81' ' ' LEU . 48.3 t -77.97 -77.25 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 O-C-N 122.978 0.174 . . . . 0.0 111.247 -176.731 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.502 ' CD2' HG21 ' A' ' 117' ' ' VAL . 0.0 OUTLIER 64.66 136.52 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 121.469 0.652 . . . . 0.0 111.399 -177.421 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.516 ' HB ' ' CE1' ' A' ' 92' ' ' HIS . 90.0 m -154.31 117.9 4.62 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.357 -179.399 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.488 ' HB2' ' CE1' ' A' ' 91' ' ' HIS . 36.9 ttpt -95.69 103.99 15.89 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.912 0.387 . . . . 0.0 110.215 -178.111 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -85.15 -29.73 24.54 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.085 178.336 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ASN . . . . . 0.609 ' HB2' ' HB3' ' A' ' 90' ' ' PHE . 18.6 m120 -143.93 153.56 57.41 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.264 178.88 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -63.57 -4.72 7.34 Favored 'Trans proline' 0 N--CA 1.478 0.562 0 C-N-CA 122.735 2.29 . . . . 0.0 112.748 -179.417 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 8.3 t -126.46 16.08 7.66 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 121.355 0.598 . . . . 0.0 110.123 178.267 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.609 ' HB3' ' HB2' ' A' ' 87' ' ' ASN . 64.1 t80 -152.09 101.23 2.7 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.203 -175.938 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' HIS . . . . . 0.488 ' CE1' ' HB2' ' A' ' 85' ' ' LYS . 2.1 t-160 -125.55 106.81 10.04 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 -179.225 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' HIS . . . . . 0.553 ' ND1' ' HD2' ' A' ' 99' ' ' LYS . 35.1 p80 -103.49 150.03 24.28 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 120.739 0.304 . . . . 0.0 111.671 -173.769 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' TRP . . . . . 0.541 ' HZ3' ' HB2' ' A' ' 102' ' ' LEU . 24.9 p90 -132.74 130.98 40.69 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.335 176.199 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.532 ' HA ' ' HA ' ' A' ' 99' ' ' LYS . 65.0 tttp -94.7 139.01 31.81 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.198 -0.455 . . . . 0.0 109.926 172.949 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.461 HG23 ' H ' ' A' ' 97' ' ' ASN . 29.2 m -117.28 -162.56 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.662 177.288 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -56.35 -24.87 46.99 Favored 'General case' 0 CA--C 1.532 0.27 0 O-C-N 123.094 0.246 . . . . 0.0 111.631 -176.526 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.461 ' H ' HG23 ' A' ' 95' ' ' VAL . 4.0 m-20 -114.8 -94.38 0.48 Allowed 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 120.491 0.186 . . . . 0.0 111.457 176.793 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 29.8 mmt180 -93.33 -174.33 3.49 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 121.321 0.581 . . . . 0.0 111.866 -170.637 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.553 ' HD2' ' ND1' ' A' ' 92' ' ' HIS . 38.2 ttpt -125.7 110.22 13.51 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.128 -0.942 . . . . 0.0 109.551 -178.561 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 17.9 m-85 -97.15 162.28 13.43 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 109.819 -0.438 . . . . 0.0 109.819 -176.524 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.503 ' HA2' ' HA ' ' A' ' 92' ' ' HIS . . . -128.78 140.58 11.84 Favored Glycine 0 C--N 1.333 0.415 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.94 -177.592 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.632 HD11 HG21 ' A' ' 43' ' ' VAL . 4.8 tt -109.66 133.84 52.65 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 177.599 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.548 ' N ' HD23 ' A' ' 102' ' ' LEU . 88.1 m -106.66 114.43 28.54 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.808 179.722 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.432 ' CE2' ' HB2' ' A' ' 91' ' ' HIS . 22.5 m-85 -79.76 148.56 31.43 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 175.418 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 59.3 tt0 -105.5 -33.02 8.25 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.876 0.37 . . . . 0.0 110.601 -178.006 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 32.6 t -124.64 147.52 56.1 Favored Pre-proline 0 C--N 1.329 -0.297 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -60.34 -25.62 80.73 Favored 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 121.878 1.719 . . . . 0.0 110.417 172.126 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -69.6 -58.33 4.08 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.786 178.624 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -65.83 -32.89 74.67 Favored 'General case' 0 N--CA 1.463 0.206 0 C-N-CA 121.013 -0.275 . . . . 0.0 110.271 -179.77 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -55.06 -60.13 3.8 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.745 174.077 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.408 HH11 ' HD3' ' A' ' 111' ' ' ARG . 16.2 ttm180 -61.1 -30.69 70.51 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.469 -178.715 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -62.31 -42.87 99.73 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.434 175.556 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.411 ' CZ ' ' HB ' ' A' ' 18' ' ' VAL . 39.7 m-85 -66.59 -43.27 85.38 Favored 'General case' 0 C--O 1.23 0.079 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.49 177.308 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -55.01 -51.32 66.63 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 120.885 0.374 . . . . 0.0 110.447 178.503 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' ARG . . . . . 0.414 HH11 ' HD3' ' A' ' 115' ' ' ARG . 3.1 mmp_? -60.48 -46.01 91.65 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.582 178.448 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -60.25 -51.4 59.02 Favored Glycine 0 C--N 1.333 0.367 0 CA-C-N 115.46 -0.791 . . . . 0.0 112.633 -177.519 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.502 HG21 ' CD2' ' A' ' 83' ' ' TYR . 11.4 p -68.53 -32.78 56.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.416 0.15 . . . . 0.0 110.621 -178.281 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 8.1 mmm180 -56.18 -57.05 13.83 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 174.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -63.73 -32.34 73.8 Favored 'General case' 0 C--O 1.224 -0.24 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.388 179.643 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -62.64 -50.32 71.69 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-O 120.564 0.221 . . . . 0.0 111.235 179.827 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.401 ' O ' ' HB2' ' A' ' 124' ' ' LEU . 69.4 mt -66.47 -39.38 83.86 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 CA-C-O 121.063 0.459 . . . . 0.0 110.338 -179.817 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 -67.32 -34.28 77.03 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.313 177.163 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -79.84 -17.03 54.25 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 121.284 0.564 . . . . 0.0 110.0 178.573 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.435 ' O ' ' HD2' ' A' ' 56' ' ' ARG . 11.7 mt -71.09 -58.92 3.09 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.581 170.378 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.517 ' HA ' HH11 ' A' ' 56' ' ' ARG . 11.1 tp -68.71 -23.99 28.39 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.054 -176.839 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 . . . . . 0 C--O 1.251 1.136 0 CA-C-O 118.116 -0.945 . . . . 0.0 110.175 176.691 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.935 0 N-CA-C 112.344 -0.302 . . . . 0.0 112.344 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 56.6 m -151.87 173.57 14.63 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 110.102 -0.333 . . . . 0.0 110.102 -179.459 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 69.3 mtm -92.42 146.26 23.82 Favored 'General case' 0 C--O 1.238 0.474 0 N-CA-C 109.651 -0.499 . . . . 0.0 109.651 174.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 77.6 p -73.39 165.74 24.49 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.454 -176.216 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.411 ' O ' ' HG3' ' A' ' 5' ' ' GLU . 7.5 pt-20 -150.09 96.61 2.45 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-O 121.359 0.6 . . . . 0.0 110.147 175.841 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -87.57 171.47 10.47 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.304 179.538 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 25.3 p -81.35 175.55 10.48 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.772 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 31.0 m-70 -62.4 146.29 93.46 Favored Pre-proline 0 C--O 1.235 0.297 0 N-CA-C 110.043 -0.354 . . . . 0.0 110.043 178.572 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -53.83 -28.99 50.69 Favored 'Trans proline' 0 C--N 1.354 0.842 0 C-N-CA 122.797 2.331 . . . . 0.0 112.128 -176.797 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.804 ' HB3' ' HB2' ' A' ' 13' ' ' SER . 13.4 m-20 -130.26 44.22 3.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.555 178.975 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -51.57 -39.13 57.24 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 114.857 -1.065 . . . . 0.0 112.26 -175.377 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -100.2 -3.21 32.08 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 111.486 0.18 . . . . 0.0 111.486 -178.433 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.804 ' HB2' ' HB3' ' A' ' 10' ' ' ASP . 19.9 m -92.74 -0.36 57.29 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 120.558 0.218 . . . . 0.0 111.062 -178.424 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 61.9 m-85 -62.63 112.81 2.66 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 120.819 0.343 . . . . 0.0 110.523 177.122 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.526 HG22 HG23 ' A' ' 16' ' ' VAL . 63.0 mt -70.53 -48.78 57.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 174.897 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.526 HG23 HG22 ' A' ' 15' ' ' ILE . 87.4 t -144.33 104.65 0.82 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.355 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.481 178.718 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.577 ' HA ' ' HA2' ' A' ' 44' ' ' GLY . 27.2 ptt180 -101.6 112.88 25.58 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 169.491 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 7.4 p -143.91 157.37 15.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.14 0.495 . . . . 0.0 111.529 -172.241 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.546 ' NZ ' ' HB3' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -70.01 124.58 24.43 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.326 177.833 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -151.0 -168.6 3.15 Favored 'General case' 0 C--O 1.235 0.33 0 O-C-N 123.243 0.34 . . . . 0.0 110.313 179.394 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.454 ' HB ' ' HB ' ' A' ' 103' ' ' THR . 45.9 t -123.97 138.68 52.83 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 N-CA-C 110.22 -0.289 . . . . 0.0 110.22 176.502 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 17.6 m -106.3 135.4 44.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.532 177.367 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 24.9 mmt -123.47 146.19 48.24 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 178.931 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.527 HG23 ' H ' ' A' ' 26' ' ' ASP . 6.4 t -129.0 -6.31 4.97 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.597 -0.441 . . . . 0.0 111.616 177.122 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.457 ' HB2' ' CE3' ' A' ' 32' ' ' TRP . 65.2 ttt180 54.07 24.46 4.79 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 121.295 0.569 . . . . 0.0 111.037 178.749 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.527 ' H ' HG23 ' A' ' 24' ' ' THR . 36.4 t70 54.23 45.32 27.58 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.007 -177.228 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 52.8 m-20 73.04 -68.51 0.22 Allowed 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 114.68 -1.145 . . . . 0.0 110.639 -178.84 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 68.9 m -152.8 87.92 1.31 Allowed 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 176.399 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 53.3 m -140.53 -160.42 1.07 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.774 179.81 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -61.96 -90.17 0.02 OUTLIER Glycine 0 CA--C 1.52 0.401 0 C-N-CA 121.246 -0.502 . . . . 0.0 113.311 -177.547 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -97.1 176.97 32.23 Favored Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 121.432 -0.413 . . . . 0.0 112.995 -173.718 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' TRP . . . . . 0.481 ' CH2' ' HB3' ' A' ' 99' ' ' LYS . 37.3 m95 -97.03 113.82 25.39 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 -179.648 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 2.8 p90 -104.25 145.85 31.45 Favored Pre-proline 0 C--N 1.329 -0.298 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 179.179 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.557 ' HB2' ' HA3' ' A' ' 38' ' ' GLY . 88.9 Cg_endo -84.1 120.46 2.6 Favored 'Trans proline' 0 CA--C 1.534 0.521 0 C-N-CA 122.583 2.189 . . . . 0.0 112.068 178.67 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 5.0 pm0 -107.93 144.61 34.95 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.166 179.312 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 57.94 97.33 0.02 OUTLIER 'General case' 0 C--O 1.238 0.453 0 CA-C-O 121.441 0.638 . . . . 0.0 111.534 179.072 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 76.04 -72.33 1.86 Allowed Glycine 0 N--CA 1.45 -0.404 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.466 -176.728 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.557 ' HA3' ' HB2' ' A' ' 34' ' ' PRO . . . 58.66 65.8 3.24 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 121.354 -0.45 . . . . 0.0 112.759 177.527 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 156.37 -43.72 0.53 Allowed Glycine 0 N--CA 1.453 -0.176 0 N-CA-C 111.646 -0.581 . . . . 0.0 111.646 -179.741 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.495 ' O ' HG12 ' A' ' 40' ' ' ILE . 11.9 tt -121.91 22.19 4.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 121.539 0.685 . . . . 0.0 109.696 178.857 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 21.3 m -60.61 122.36 14.51 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.29 -177.108 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.446 ' HB2' ' HA ' ' A' ' 66' ' ' GLN . 29.0 ttt85 -82.95 92.71 7.39 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.45 -175.562 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 41.1 t -95.47 150.62 4.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.076 -179.322 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.577 ' HA2' ' HA ' ' A' ' 17' ' ' ARG . . . -154.22 116.61 0.74 Allowed Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 121.178 -0.534 . . . . 0.0 112.335 -179.544 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 6.7 p -87.56 117.85 32.29 Favored 'Isoleucine or valine' 0 C--O 1.237 0.415 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 176.356 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' CYS . . . . . 0.769 ' SG ' ' HB3' ' A' ' 60' ' ' LEU . 13.9 p -113.69 146.54 39.67 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.068 -178.718 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.405 ' HB2' HD11 ' A' ' 15' ' ' ILE . 47.9 tttp -92.48 101.68 14.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.772 179.088 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 22.2 m -85.19 157.05 3.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.689 0.281 . . . . 0.0 110.512 -179.018 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 22.6 ptp -151.24 153.39 34.79 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.798 0.333 . . . . 0.0 110.629 -178.85 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' HIS . . . . . 0.428 ' NE2' ' HA3' ' A' ' 53' ' ' GLY . 0.4 OUTLIER -70.2 143.52 91.22 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.076 179.152 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -69.64 -15.38 37.49 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 122.598 2.199 . . . . 0.0 111.958 179.545 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 15.0 tp10 -131.11 93.74 3.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.748 179.527 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.428 ' HA3' ' NE2' ' A' ' 50' ' ' HIS . . . 165.56 -175.96 41.18 Favored Glycine 0 N--CA 1.452 -0.258 0 N-CA-C 111.801 -0.519 . . . . 0.0 111.801 -179.341 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 -136.62 -74.03 0.43 Allowed 'General case' 0 C--O 1.236 0.365 0 CA-C-O 120.787 0.327 . . . . 0.0 111.666 -175.176 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.41 ' O ' ' HG3' ' A' ' 56' ' ' ARG . . . -100.49 52.49 0.95 Allowed Glycine 0 C--N 1.33 0.2 0 CA-C-N 116.289 -0.414 . . . . 0.0 113.844 -170.342 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.41 ' HG3' ' O ' ' A' ' 55' ' ' GLY . 53.4 mtt180 -160.85 136.07 7.77 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 122.678 0.391 . . . . 0.0 110.024 172.244 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 49.8 m -156.21 161.49 40.27 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 116.466 -0.333 . . . . 0.0 110.639 -177.687 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -121.52 -158.88 10.51 Favored Glycine 0 C--N 1.33 0.242 0 N-CA-C 111.394 -0.682 . . . . 0.0 111.394 179.428 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -141.86 162.49 35.35 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.9 0.35 . . . . 0.0 110.411 -178.745 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.769 ' HB3' ' SG ' ' A' ' 46' ' ' CYS . 3.3 tt -137.07 121.67 18.45 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.413 ' O ' ' HA ' ' A' ' 74' ' ' GLU . 41.3 mt -83.03 84.29 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 175.066 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' HIS . . . . . 0.515 ' HB2' HD22 ' A' ' 60' ' ' LEU . 53.9 t60 -96.99 141.89 29.6 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.25 -0.432 . . . . 0.0 109.865 -177.433 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -154.84 127.54 2.11 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 121.036 -0.602 . . . . 0.0 112.043 -179.398 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -115.0 -179.63 3.68 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 176.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.598 ' HD2' HD13 ' A' ' 70' ' ' LEU . 69.8 mtt180 -65.83 -65.41 0.68 Allowed 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 120.549 -0.46 . . . . 0.0 110.274 178.51 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.451 ' HG3' ' HG3' ' A' ' 67' ' ' LYS . 10.0 pt20 175.53 -23.63 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.284 0 O-C-N 123.407 0.442 . . . . 0.0 111.161 -177.817 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.451 ' HG3' ' HG3' ' A' ' 66' ' ' GLN . 98.5 mttt -144.31 129.34 18.54 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.737 -178.83 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 37.5 t70 71.24 163.33 0.26 Allowed 'General case' 0 CA--C 1.533 0.318 0 O-C-N 123.763 0.665 . . . . 0.0 112.207 169.764 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 43.6 mtmt -55.47 99.13 0.03 OUTLIER 'General case' 0 C--O 1.234 0.243 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.684 -176.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.598 HD13 ' HD2' ' A' ' 65' ' ' ARG . 3.8 tt -162.51 86.28 0.58 Allowed 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 173.685 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 45.4 t -75.66 117.0 19.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.393 -179.535 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 22.1 m -98.54 -21.89 5.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.335 -177.736 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.409 HD13 ' N ' ' A' ' 74' ' ' GLU . 2.9 tm? -150.51 129.72 12.77 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 -177.236 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.626 ' HG3' HD21 ' A' ' 60' ' ' LEU . 37.0 tt0 -153.81 113.11 3.76 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.986 0.422 . . . . 0.0 110.162 178.606 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' CYS . . . . . 0.548 ' SG ' ' CE2' ' A' ' 100' ' ' PHE . 57.4 m -130.48 118.51 21.24 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 -178.939 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.416 ' HD1' ' HG ' ' A' ' 60' ' ' LEU . 29.5 t80 -85.32 121.73 28.47 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.01 -173.325 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.521 HG13 ' O ' ' A' ' 80' ' ' ASP . 96.3 t -100.67 97.57 5.9 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 -177.243 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 20.7 ptt-85 -115.92 68.39 0.72 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.226 0.536 . . . . 0.0 110.51 -172.775 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt 67.53 25.42 8.4 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.011 -177.165 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.521 ' O ' HG13 ' A' ' 77' ' ' VAL . 5.6 p-10 -149.05 -175.26 4.89 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 174.56 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 7.0 tt 66.72 98.22 0.05 Allowed 'General case' 0 CA--C 1.534 0.327 0 CA-C-O 121.193 0.521 . . . . 0.0 110.177 177.624 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 58.9 t -112.06 133.42 57.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.612 -178.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -68.92 124.38 23.56 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.615 177.388 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 35.9 m -95.86 114.66 26.41 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 174.165 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.413 ' HG2' ' NE2' ' A' ' 91' ' ' HIS . 5.7 tmtp? -75.81 98.9 4.28 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 116.144 -0.48 . . . . 0.0 109.73 178.875 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -91.21 -46.66 7.95 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.237 0.541 . . . . 0.0 110.183 -179.002 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ASN . . . . . 0.773 ' HB2' ' HB3' ' A' ' 90' ' ' PHE . 40.4 m-80 -131.54 153.27 81.51 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.261 178.931 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -50.62 -31.5 32.18 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.706 2.271 . . . . 0.0 112.683 -179.549 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.546 ' HA ' ' HD2' ' A' ' 104' ' ' PHE . 16.5 p -115.22 18.11 16.32 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.722 -178.182 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.773 ' HB3' ' HB2' ' A' ' 87' ' ' ASN . 74.1 t80 -145.18 115.25 7.44 Favored 'General case' 0 C--O 1.24 0.585 0 CA-C-O 121.366 0.603 . . . . 0.0 111.985 -176.803 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' HIS . . . . . 0.413 ' NE2' ' HG2' ' A' ' 85' ' ' LYS . 31.5 m80 -103.88 157.06 17.35 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.152 -0.931 . . . . 0.0 109.277 171.455 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 19.5 p80 -154.42 149.73 27.13 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 110.191 -0.299 . . . . 0.0 110.191 172.708 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 38.5 p90 -137.66 140.42 40.81 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 110.016 -0.364 . . . . 0.0 110.016 178.417 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -109.85 112.74 24.96 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.101 -173.733 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 23.4 m -138.9 144.12 30.34 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 174.192 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 58.12 25.9 13.02 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 120.725 0.298 . . . . 0.0 110.712 -178.074 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 68.09 1.47 2.8 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.755 -177.464 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 64.3 mtt-85 -89.31 134.39 34.08 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 109.489 -0.559 . . . . 0.0 109.489 178.131 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.481 ' HB3' ' CH2' ' A' ' 32' ' ' TRP . 12.3 mptt -94.33 97.48 10.24 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.984 0.421 . . . . 0.0 110.491 -178.03 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.548 ' CE2' ' SG ' ' A' ' 75' ' ' CYS . 2.3 m-85 -81.65 141.11 33.95 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 174.963 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -138.59 157.6 24.68 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 121.224 -0.513 . . . . 0.0 112.103 178.613 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 6.4 tt -143.56 121.31 11.9 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 108.912 -0.774 . . . . 0.0 108.912 178.289 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.454 ' HB ' ' HB ' ' A' ' 21' ' ' VAL . 26.8 m -109.11 136.34 48.78 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.438 -178.519 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.546 ' HD2' ' HA ' ' A' ' 89' ' ' THR . 41.1 m-85 -86.0 139.61 31.03 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.213 -0.448 . . . . 0.0 109.983 178.471 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 60.4 tp60 -93.44 -42.83 9.05 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.36 -175.487 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -130.49 147.72 67.08 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.518 -176.748 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -53.88 -25.07 33.82 Favored 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 122.299 1.999 . . . . 0.0 111.908 179.039 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -62.26 -57.54 11.05 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.026 176.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -70.35 -29.64 66.38 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.634 -179.65 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.441 ' O ' ' HB2' ' A' ' 114' ' ' ASP . . . -56.89 -58.16 9.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.251 174.544 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.582 ' HE ' ' HA ' ' A' ' 111' ' ' ARG . 1.3 tpm_? -59.47 -50.49 73.74 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.954 -179.628 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -60.89 -57.19 13.71 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.63 -174.756 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.512 ' O ' HG23 ' A' ' 117' ' ' VAL . 38.6 t80 -67.4 -36.47 81.37 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.666 -174.87 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.441 ' HB2' ' O ' ' A' ' 110' ' ' ALA . 8.2 t70 -59.98 -49.25 78.39 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 121.168 0.509 . . . . 0.0 109.753 177.921 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 41.9 ttt180 -51.74 -45.24 63.59 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 115.117 -0.947 . . . . 0.0 109.923 174.807 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -60.35 -39.4 96.09 Favored Glycine 0 CA--C 1.519 0.297 0 CA-C-N 115.651 -0.704 . . . . 0.0 112.19 176.12 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.512 HG23 ' O ' ' A' ' 113' ' ' PHE . 75.7 t -66.08 -54.58 25.38 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.163 0 C-N-CA 122.382 0.273 . . . . 0.0 111.112 -179.48 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 19.6 ptp180 -60.3 -38.02 82.33 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 116.578 -0.283 . . . . 0.0 110.606 -177.503 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.403 ' HD2' ' HA ' ' A' ' 119' ' ' LYS . 16.1 mmmt -68.85 -39.22 80.04 Favored 'General case' 0 C--N 1.334 -0.078 0 CA-C-N 116.613 -0.267 . . . . 0.0 110.646 175.151 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.5 -44.26 96.18 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.884 0.373 . . . . 0.0 110.223 177.834 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.408 HG12 ' O ' ' A' ' 117' ' ' VAL . 48.1 mm -62.9 -45.0 99.97 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.313 178.409 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -57.44 -51.02 71.14 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.661 178.612 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -74.51 -17.31 60.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.247 -178.821 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 45.1 tp -74.89 -47.7 28.66 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 177.0 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 75.1 mt -70.18 -40.35 78.04 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.303 178.682 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.249 1.066 0 N-CA-C 109.084 -0.709 . . . . 0.0 109.084 -179.636 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.728 0 N-CA-C 112.18 -0.368 . . . . 0.0 112.18 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.9 p -75.51 -13.83 60.39 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.217 0.532 . . . . 0.0 110.662 178.216 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 21.2 ptp -152.54 174.58 13.74 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 115.463 -0.79 . . . . 0.0 109.851 -178.535 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 6.2 t -135.24 136.83 42.02 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.048 0.451 . . . . 0.0 110.667 179.071 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -120.69 21.2 11.58 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 176.56 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -75.3 -84.09 0.05 Allowed 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 115.062 -0.972 . . . . 0.0 111.231 -175.741 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.6 m 55.5 66.54 1.19 Allowed 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.609 -178.57 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 1.2 t60 171.36 -65.54 0.0 OUTLIER Pre-proline 0 CA--C 1.542 0.65 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.265 -175.315 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -59.02 104.95 0.21 Allowed 'Trans proline' 0 C--N 1.356 0.941 0 C-N-CA 121.747 1.631 . . . . 0.0 112.119 -174.086 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 36.3 t70 62.69 41.96 8.7 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.03 -178.45 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 63.67 -88.0 0.03 OUTLIER 'General case' 0 C--O 1.235 0.328 0 CA-C-N 114.755 -1.111 . . . . 0.0 111.665 173.614 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 17.9 t70 69.25 -63.44 0.37 Allowed 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 123.574 0.749 . . . . 0.0 112.222 -175.634 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 19.7 m -87.29 1.24 53.82 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 112.438 0.532 . . . . 0.0 112.438 -172.603 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.423 ' HD2' ' HB3' ' A' ' 17' ' ' ARG . 3.3 m-85 -70.32 123.63 22.18 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 110.123 -0.325 . . . . 0.0 110.123 176.166 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 7.1 tp -88.45 -41.45 14.18 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 175.864 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 69.9 t -131.96 128.58 59.74 Favored 'Isoleucine or valine' 0 C--O 1.232 0.178 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 177.074 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.423 ' HB3' ' HD2' ' A' ' 14' ' ' TYR . 6.5 ptm180 -147.12 145.14 29.48 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.055 0.455 . . . . 0.0 111.468 -178.451 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 60.0 t -133.09 154.65 39.91 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 CA-C-N 115.411 -0.813 . . . . 0.0 108.993 177.769 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 2.2 tmmm? -98.41 117.17 32.23 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 175.522 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.499 ' HB1' ' O ' ' A' ' 103' ' ' THR . . . -158.55 -170.39 3.06 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-N 116.678 -0.237 . . . . 0.0 110.929 -178.339 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.733 HG22 ' HA2' ' A' ' 39' ' ' GLY . 60.8 t -99.91 114.2 37.61 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.123 -177.524 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.482 HG21 HG23 ' A' ' 72' ' ' VAL . 19.0 m -80.64 106.87 12.37 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 CA-C-O 121.098 0.475 . . . . 0.0 110.71 176.666 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 45.1 mtt -100.95 167.12 10.46 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.665 179.141 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.487 HG23 ' CE1' ' A' ' 33' ' ' PHE . 10.9 t -141.73 166.9 23.45 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.705 -0.68 . . . . 0.0 109.767 178.531 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.42 ' NH2' ' HA2' ' A' ' 30' ' ' GLY . 19.2 ttt180 -129.98 109.61 11.01 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 177.828 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -56.49 88.36 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.821 -173.578 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.464 ' HA ' ' HG2' ' A' ' 98' ' ' ARG . 34.1 t70 52.0 -84.78 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 123.522 0.729 . . . . 0.0 112.156 -179.403 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 32.9 t -125.02 16.88 8.52 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 120.865 0.364 . . . . 0.0 110.738 -175.553 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 33.1 t -67.96 138.17 55.73 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.304 179.29 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.42 ' HA2' ' NH2' ' A' ' 25' ' ' ARG . . . -83.35 65.1 4.19 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 121.07 -0.586 . . . . 0.0 112.155 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -177.32 167.2 38.2 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.884 -0.674 . . . . 0.0 112.889 179.472 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' TRP . . . . . 0.511 ' HH2' ' HB3' ' A' ' 99' ' ' LYS . 94.7 m95 -125.85 125.61 43.13 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 122.637 0.375 . . . . 0.0 110.038 178.132 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.487 ' CE1' HG23 ' A' ' 24' ' ' THR . 5.7 p90 -137.47 144.37 44.87 Favored Pre-proline 0 C--O 1.234 0.284 0 CA-C-N 116.631 -0.259 . . . . 0.0 111.244 -176.035 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -60.82 132.35 42.07 Favored 'Trans proline' 0 C--N 1.353 0.803 0 C-N-CA 122.594 2.196 . . . . 0.0 111.271 173.747 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.419 ' H ' ' HG2' ' A' ' 35' ' ' GLN . 3.5 pt20 -86.91 -36.61 18.27 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.042 -0.526 . . . . 0.0 112.23 -174.442 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 20.1 tp10 -166.16 -55.28 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 120.658 0.266 . . . . 0.0 110.845 -177.312 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -53.97 -41.26 67.76 Favored Glycine 0 C--N 1.332 0.36 0 CA-C-N 116.03 -0.532 . . . . 0.0 113.522 -175.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 67.02 -138.1 34.43 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.994 -0.622 . . . . 0.0 111.954 -177.872 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.733 ' HA2' HG22 ' A' ' 21' ' ' VAL . . . -62.25 -34.37 88.96 Favored Glycine 0 CA--C 1.521 0.445 0 C-N-CA 121.61 -0.329 . . . . 0.0 113.675 -175.356 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.541 ' N ' HD12 ' A' ' 40' ' ' ILE . 3.1 mp -107.95 108.67 25.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 N-CA-C 110.24 -0.281 . . . . 0.0 110.24 -177.106 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 23.3 m -144.15 118.2 9.45 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.471 0.177 . . . . 0.0 110.551 172.558 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.446 ' CZ ' ' HD3' ' A' ' 65' ' ' ARG . 96.1 mtt180 -71.77 90.82 1.1 Allowed 'General case' 0 CA--C 1.521 -0.157 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 171.563 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.401 ' HA ' ' HA2' ' A' ' 63' ' ' GLY . 7.4 p -104.1 139.53 24.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.893 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -175.99 176.09 47.52 Favored Glycine 0 N--CA 1.443 -0.87 0 C-N-CA 120.463 -0.875 . . . . 0.0 112.703 178.234 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 59.4 t -107.84 129.09 62.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 178.786 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' CYS . . . . . 0.761 ' SG ' ' HB3' ' A' ' 60' ' ' LEU . 10.4 p -112.73 117.64 32.77 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.635 176.106 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 36.5 ttmt -76.02 83.21 2.9 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 179.3 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 27.1 m -75.35 135.14 27.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.375 -178.481 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 63.0 mtt -92.05 173.48 7.82 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.263 -179.752 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 26.2 p80 -142.58 149.91 52.33 Favored Pre-proline 0 C--N 1.325 -0.473 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.174 -176.33 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_endo -61.93 149.4 90.35 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 122.167 1.911 . . . . 0.0 110.644 173.6 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 11.8 mm-40 61.33 94.22 0.04 OUTLIER 'General case' 0 C--O 1.233 0.229 0 N-CA-C 109.935 -0.395 . . . . 0.0 109.935 -175.1 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -76.06 35.05 1.27 Allowed Glycine 0 CA--C 1.519 0.341 0 CA-C-N 116.251 -0.432 . . . . 0.0 113.464 -175.071 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 77.8 m-20 -86.37 76.7 9.61 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 177.609 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 162.83 -96.52 0.14 Allowed Glycine 0 N--CA 1.451 -0.348 0 CA-C-N 114.833 -1.076 . . . . 0.0 110.77 -177.532 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 22.5 ttm-85 -173.09 -86.99 0.01 OUTLIER 'General case' 0 C--O 1.233 0.206 0 N-CA-C 110.497 -0.186 . . . . 0.0 110.497 175.751 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 58.3 m -164.27 172.58 13.38 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 122.545 0.338 . . . . 0.0 110.189 -177.525 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -118.34 153.66 16.94 Favored Glycine 0 N--CA 1.45 -0.37 0 N-CA-C 111.064 -0.814 . . . . 0.0 111.064 175.861 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 -119.64 112.16 18.96 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.887 0.375 . . . . 0.0 110.499 -178.283 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.761 ' HB3' ' SG ' ' A' ' 46' ' ' CYS . 2.6 tt -101.76 110.88 22.96 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 179.698 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.416 ' O ' ' HA ' ' A' ' 74' ' ' GLU . 62.5 mt -78.26 100.22 3.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 173.634 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 3.2 t-80 -112.22 145.95 39.01 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 -173.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.401 ' HA2' ' HA ' ' A' ' 43' ' ' VAL . . . -146.51 119.59 1.18 Allowed Glycine 0 C--O 1.236 0.242 0 N-CA-C 110.716 -0.954 . . . . 0.0 110.716 -178.578 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -156.69 -175.71 5.58 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.916 0.865 . . . . 0.0 113.235 -167.913 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.446 ' HD3' ' CZ ' ' A' ' 42' ' ' ARG . 44.4 ttt-85 61.39 89.22 0.08 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 113.395 -1.73 . . . . 0.0 114.219 160.825 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.55 -42.58 0.61 Allowed 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 106.505 -1.665 . . . . 0.0 106.505 162.296 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.58 ' HE2' HD22 ' A' ' 70' ' ' LEU . 37.7 ttpt -90.23 163.19 14.89 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 163.226 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -51.09 94.45 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 -173.299 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 58.3 mtmt 49.77 84.75 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.311 -0.859 . . . . 0.0 112.209 177.637 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.58 HD22 ' HE2' ' A' ' 67' ' ' LYS . 61.9 tp -136.56 121.04 18.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.866 -179.222 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 54.1 t -79.29 113.37 18.54 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 N-CA-C 109.943 -0.391 . . . . 0.0 109.943 178.059 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.482 HG23 HG21 ' A' ' 22' ' ' VAL . 33.6 m -108.64 -2.5 10.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.602 -175.526 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -169.03 138.64 2.18 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 179.127 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.416 ' HA ' ' O ' ' A' ' 61' ' ' ILE . 0.2 OUTLIER -165.35 145.49 6.9 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 121.082 0.468 . . . . 0.0 111.31 176.752 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 75' ' ' CYS . . . . . 0.597 ' SG ' HG11 ' A' ' 95' ' ' VAL . 50.4 t -166.11 118.83 1.08 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.635 179.542 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 86.5 t80 -94.73 137.83 33.33 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.521 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 35.4 m -132.49 139.11 50.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 109.354 -0.609 . . . . 0.0 109.354 177.066 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 35.0 ttm-85 -107.67 -25.24 11.4 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.007 -175.897 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 39.4 tptt -170.05 -30.46 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 120.81 0.338 . . . . 0.0 110.496 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -97.03 124.49 41.03 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.993 179.636 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.473 HD13 ' N ' ' A' ' 82' ' ' VAL . 3.3 tm? -175.85 139.52 0.4 Allowed 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 177.172 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.473 ' N ' HD13 ' A' ' 81' ' ' LEU . 66.0 t -130.48 122.31 52.79 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 CA-C-N 116.602 -0.272 . . . . 0.0 110.554 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.622 ' HB3' ' NE2' ' A' ' 91' ' ' HIS . 96.1 m-85 -91.79 153.83 19.34 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-O 120.968 0.413 . . . . 0.0 110.06 173.8 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 91.4 m -156.0 117.5 3.92 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 174.727 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 20.2 ptmt -101.31 125.13 47.9 Favored 'General case' 0 C--N 1.328 -0.366 0 O-C-N 122.034 -0.416 . . . . 0.0 110.546 178.685 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -80.6 -34.01 35.5 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.63 -0.713 . . . . 0.0 110.363 -178.9 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -136.99 155.4 76.28 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.084 179.134 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_exo -48.73 -41.91 37.45 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.469 2.113 . . . . 0.0 111.959 176.178 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 13.4 p -97.25 18.16 15.68 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 115.716 -0.675 . . . . 0.0 112.051 -178.485 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 21.5 t80 -147.47 98.32 2.97 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-O 121.148 0.499 . . . . 0.0 110.865 177.838 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' HIS . . . . . 0.622 ' NE2' ' HB3' ' A' ' 83' ' ' TYR . 3.4 t-160 -109.47 125.15 52.15 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 -179.604 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 25.8 p80 -125.6 167.03 15.64 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.971 0.415 . . . . 0.0 110.926 -178.499 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 26.8 p90 -139.63 177.9 7.61 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.282 176.666 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 62.6 pttt -154.28 147.29 24.57 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.817 0.341 . . . . 0.0 111.052 -174.435 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.597 HG11 ' SG ' ' A' ' 75' ' ' CYS . 35.7 m -132.72 143.94 38.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 173.737 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 66.01 -72.17 0.08 Allowed 'General case' 0 N--CA 1.465 0.321 0 O-C-N 123.56 0.538 . . . . 0.0 110.719 -176.192 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -165.34 -26.78 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.874 -178.626 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.464 ' HG2' ' HA ' ' A' ' 27' ' ' ASP . 99.8 mtt180 -81.81 149.51 28.32 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 120.832 0.348 . . . . 0.0 111.027 -178.299 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.511 ' HB3' ' HH2' ' A' ' 32' ' ' TRP . 0.0 OUTLIER -114.22 142.66 45.98 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.261 -173.141 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 2.9 p90 -150.05 138.88 20.9 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 173.056 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -142.69 -170.1 12.62 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.205 -0.998 . . . . 0.0 114.605 -169.867 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.499 HD11 ' HB3' ' A' ' 20' ' ' ALA . 34.3 tp -134.17 124.26 25.74 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 114.995 -0.603 . . . . 0.0 110.868 -173.189 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.556 ' HB ' ' HB ' ' A' ' 21' ' ' VAL . 22.5 m -98.5 124.92 43.51 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 175.563 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 57.0 m-85 -87.76 161.77 17.4 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.863 -175.136 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -96.29 -27.99 14.72 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.655 -177.499 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 49.1 m -149.56 154.43 38.09 Favored Pre-proline 0 CA--C 1.532 0.264 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.544 178.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -58.73 -24.43 71.19 Favored 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 122.555 2.17 . . . . 0.0 112.064 178.731 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -62.21 -56.09 22.14 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.916 178.542 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -71.73 -28.73 63.87 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.759 179.206 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -58.97 -60.66 3.5 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.127 0.489 . . . . 0.0 110.392 174.456 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 67.5 mtp85 -62.43 -32.62 73.51 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.913 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -62.59 -38.59 90.72 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.311 176.167 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 52.6 t80 -73.68 -34.48 64.91 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.169 179.099 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.4 ' HA ' HG22 ' A' ' 117' ' ' VAL . 63.9 m-20 -61.71 -38.64 88.61 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 121.337 0.589 . . . . 0.0 109.534 173.987 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 17.0 mmm180 -62.39 -42.05 99.13 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.684 172.071 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -60.17 -46.4 94.3 Favored Glycine 0 N--CA 1.45 -0.412 0 CA-C-N 115.336 -0.847 . . . . 0.0 112.519 178.86 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.421 ' O ' HG13 ' A' ' 121' ' ' ILE . 21.3 m -70.51 -34.82 59.06 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.366 0 CA-C-N 116.737 0.268 . . . . 0.0 110.634 -178.878 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -61.88 -48.91 78.38 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 176.839 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 7.9 tmtm? -62.03 -45.9 91.51 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 114.775 -1.102 . . . . 0.0 109.801 -179.713 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -61.42 -52.11 65.96 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.818 -179.687 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.421 HG13 ' O ' ' A' ' 117' ' ' VAL . 68.4 mt -57.66 -41.12 78.62 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.123 -178.136 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.559 ' O ' ' HG3' ' A' ' 126' ' ' GLU . 37.0 tt0 -63.37 -58.34 7.41 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 121.018 0.437 . . . . 0.0 110.394 177.997 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -60.76 -22.55 64.18 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.449 -179.506 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 9.4 tt -84.47 -39.82 18.44 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.418 179.346 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.514 HG22 ' O ' ' A' ' 122' ' ' GLU . 10.8 tp -72.11 -25.87 24.25 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 CA-C-N 116.732 -0.213 . . . . 0.0 110.434 -176.04 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.559 ' HG3' ' O ' ' A' ' 122' ' ' GLU . 46.8 mt-10 . . . . . 0 C--O 1.25 1.098 0 CA-C-O 118.728 -0.653 . . . . 0.0 110.336 175.18 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.767 0 N-CA-C 111.929 -0.469 . . . . 0.0 111.929 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 32.2 t -69.03 126.94 31.38 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-O 120.727 0.299 . . . . 0.0 110.742 -179.641 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 34.7 tpp -71.82 112.68 8.13 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.474 178.342 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 43.5 m 69.64 92.06 0.09 Allowed 'General case' 0 CA--C 1.531 0.248 0 O-C-N 123.686 0.616 . . . . 0.0 111.565 178.686 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -100.1 -52.15 3.49 Favored 'General case' 0 C--O 1.233 0.229 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 173.336 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 19.3 mm-40 -87.08 -161.26 0.67 Allowed 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 115.232 -0.894 . . . . 0.0 108.902 174.407 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 21.5 m 72.78 76.12 0.15 Allowed 'General case' 0 C--O 1.234 0.27 0 CA-C-O 121.369 0.604 . . . . 0.0 111.349 177.029 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.613 ' HB3' ' HD2' ' A' ' 9' ' ' PRO . 33.4 m170 -89.79 170.16 11.08 Favored Pre-proline 0 CA--C 1.535 0.386 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.488 173.356 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.613 ' HD2' ' HB3' ' A' ' 8' ' ' HIS . 35.7 Cg_exo -37.29 -48.14 1.71 Allowed 'Trans proline' 0 C--N 1.364 1.346 0 C-N-CA 123.215 2.61 . . . . 0.0 113.068 179.179 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -124.66 89.94 3.16 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 172.621 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.462 ' HB2' ' H ' ' A' ' 8' ' ' HIS . 14.2 t70 -106.52 -14.17 15.13 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.227 -175.943 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -75.28 -20.36 59.18 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.29 -174.438 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.815 ' HB2' ' SG ' ' A' ' 46' ' ' CYS . 58.3 m -93.97 -90.03 0.21 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.729 -0.214 . . . . 0.0 110.92 178.772 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.46 ' CE2' ' HA ' ' A' ' 11' ' ' ASP . 31.8 m-85 42.88 91.34 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 122.74 0.416 . . . . 0.0 111.87 -175.263 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.646 HD11 ' HB2' ' A' ' 47' ' ' LYS . 63.0 mt -61.18 -51.15 76.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 121.147 0.499 . . . . 0.0 109.916 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.537 HG23 HG22 ' A' ' 15' ' ' ILE . 92.0 t -140.1 119.33 12.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.882 178.701 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.571 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 27.8 ttp180 -128.05 86.7 2.5 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-O 121.264 0.554 . . . . 0.0 109.776 173.122 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 35.0 m -117.68 173.03 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-N 115.329 -0.85 . . . . 0.0 110.474 -177.205 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 26.1 ttpp -92.06 134.91 34.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.91 0.386 . . . . 0.0 110.914 179.638 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -160.11 -164.21 1.25 Allowed 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 178.304 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 25.0 t -122.44 109.16 23.34 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 177.538 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.553 HG23 ' OE1' ' A' ' 35' ' ' GLN . 19.7 m -84.16 133.18 29.8 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 CA-C-O 120.989 0.423 . . . . 0.0 111.031 -178.233 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 24.5 mmt -117.09 152.42 34.73 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.108 -176.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.432 HG23 ' CE1' ' A' ' 33' ' ' PHE . 9.8 t -132.66 140.26 48.08 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-O 121.134 0.492 . . . . 0.0 110.955 176.427 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.456 ' HE ' ' HA ' ' A' ' 28' ' ' SER . 21.1 tpt180 -90.21 77.78 6.66 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 174.71 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.565 ' HB2' ' HE1' ' A' ' 33' ' ' PHE . 35.7 t70 -56.3 94.74 0.01 OUTLIER 'General case' 0 C--O 1.236 0.371 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 179.478 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 16.0 t70 63.47 -74.78 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.941 -173.911 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.456 ' HA ' ' HE ' ' A' ' 25' ' ' ARG . 8.0 t -167.27 -44.26 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 175.324 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 18.5 t -61.88 -12.34 17.31 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.53 -178.785 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -62.1 -26.58 67.68 Favored Glycine 0 CA--C 1.523 0.574 0 C-N-CA 121.153 -0.546 . . . . 0.0 112.478 175.569 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 56.79 28.54 57.34 Favored Glycine 0 C--N 1.338 0.663 0 C-N-CA 121.739 -0.267 . . . . 0.0 113.537 177.298 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' TRP . . . . . 0.582 ' HH2' ' HG2' ' A' ' 99' ' ' LYS . 62.4 m95 63.03 96.76 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 123.174 0.59 . . . . 0.0 110.678 -177.789 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.565 ' HE1' ' HB2' ' A' ' 26' ' ' ASP . 2.9 p90 -132.04 150.84 77.23 Favored Pre-proline 0 C--O 1.236 0.376 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.928 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.51 ' HB2' ' HA2' ' A' ' 38' ' ' GLY . 77.1 Cg_endo -79.35 109.2 2.46 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.527 2.151 . . . . 0.0 112.084 179.15 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.553 ' OE1' HG23 ' A' ' 22' ' ' VAL . 0.2 OUTLIER -75.57 125.95 30.04 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 176.861 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 65.07 -75.1 0.05 OUTLIER 'General case' 0 C--O 1.236 0.377 0 C-N-CA 123.133 0.573 . . . . 0.0 111.317 -178.892 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -76.25 74.33 1.69 Allowed Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 121.575 -0.345 . . . . 0.0 112.782 -177.242 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.51 ' HA2' ' HB2' ' A' ' 34' ' ' PRO . . . -75.56 66.74 2.32 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 121.209 -0.52 . . . . 0.0 112.114 177.156 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 129.02 -32.0 3.37 Favored Glycine 0 N--CA 1.453 -0.173 0 C-N-CA 121.415 -0.421 . . . . 0.0 112.07 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 67.4 mt -120.4 100.75 9.76 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 CA-C-O 120.823 0.344 . . . . 0.0 110.501 179.647 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 16.5 m -132.49 151.42 51.91 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 175.842 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.407 HH11 ' HD3' ' A' ' 42' ' ' ARG . 6.5 tpt180 -113.9 116.12 28.77 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 174.868 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.571 ' O ' ' HA ' ' A' ' 17' ' ' ARG . 24.2 t -95.46 103.16 14.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.273 -178.047 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -106.16 89.43 0.61 Allowed Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 121.334 -0.46 . . . . 0.0 112.491 179.787 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 85.0 t -84.86 120.8 36.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 120.856 0.36 . . . . 0.0 110.067 177.015 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' CYS . . . . . 0.815 ' SG ' ' HB2' ' A' ' 13' ' ' SER . 45.0 t -117.8 165.2 13.93 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.921 -178.666 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.646 ' HB2' HD11 ' A' ' 15' ' ' ILE . 83.8 tttt -118.65 116.05 25.78 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.368 -179.65 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.451 HG21 ' CE2' ' A' ' 76' ' ' TYR . 36.0 m -110.55 150.96 12.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.094 0.473 . . . . 0.0 111.286 -175.414 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 4.0 mpp? -93.51 -171.44 2.63 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.416 178.36 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 28.8 p80 -137.1 157.66 74.09 Favored Pre-proline 0 C--O 1.237 0.41 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.725 -177.249 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -64.86 -153.06 0.02 OUTLIER 'Trans proline' 0 C--N 1.353 0.787 0 C-N-CA 122.925 2.417 . . . . 0.0 111.285 172.558 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 67.8 mm-40 -56.58 118.76 5.15 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 120.651 0.262 . . . . 0.0 110.435 178.85 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -170.17 -179.91 42.0 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 121.211 -0.519 . . . . 0.0 111.932 -177.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -83.89 -40.76 18.2 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.695 0.283 . . . . 0.0 110.838 -177.662 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.402 ' O ' ' HB2' ' A' ' 56' ' ' ARG . . . 167.13 -140.93 6.57 Favored Glycine 0 N--CA 1.453 -0.221 0 C-N-CA 121.078 -0.582 . . . . 0.0 111.89 -178.552 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.402 ' HB2' ' O ' ' A' ' 55' ' ' GLY . 3.6 mpt_? 69.32 100.32 0.06 Allowed 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 121.206 0.527 . . . . 0.0 111.016 -177.631 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 23.4 p -75.58 124.76 27.75 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.48 179.837 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -86.46 161.31 33.82 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.893 -0.67 . . . . 0.0 111.934 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -133.17 158.09 43.71 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.87 -0.418 . . . . 0.0 109.87 178.574 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.434 HD22 ' HB2' ' A' ' 62' ' ' HIS . 1.9 tt -132.23 113.61 13.47 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 -179.774 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.537 ' HB ' ' HB2' ' A' ' 75' ' ' CYS . 58.0 mt -82.24 97.23 3.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 174.666 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' HIS . . . . . 0.434 ' HB2' HD22 ' A' ' 60' ' ' LEU . 26.6 t-80 -111.24 91.67 3.75 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.737 -172.446 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -89.98 114.79 4.43 Favored Glycine 0 C--O 1.236 0.275 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.625 177.894 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -143.49 -161.15 1.21 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.655 0.227 . . . . 0.0 111.526 -174.334 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 1.4 mmp_? 63.98 32.1 13.27 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 115.764 -0.653 . . . . 0.0 112.687 170.547 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.507 HE21 ' N ' ' A' ' 66' ' ' GLN . 0.0 OUTLIER -72.73 -67.51 0.55 Allowed 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.771 -0.372 . . . . 0.0 110.498 176.614 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 64.6 tttm -132.51 130.02 39.87 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 178.396 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 59.71 -80.93 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 -174.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 23.2 pttm -178.66 128.41 0.11 Allowed 'General case' 0 C--O 1.232 0.176 0 C-N-CA 123.149 0.58 . . . . 0.0 109.775 169.114 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -174.46 157.93 2.74 Favored 'General case' 0 C--O 1.24 0.571 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.03 177.634 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 25.0 t -95.41 117.51 39.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 O-C-N 123.297 0.373 . . . . 0.0 110.24 -179.286 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 33.6 m -92.48 -24.9 5.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 120.864 0.364 . . . . 0.0 111.062 -179.101 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -145.85 109.35 4.73 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 -176.287 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -116.9 116.61 27.75 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 178.792 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' CYS . . . . . 0.537 ' HB2' ' HB ' ' A' ' 61' ' ' ILE . 63.0 m -137.48 90.85 2.55 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 121.151 0.501 . . . . 0.0 110.526 179.448 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.451 ' CE2' HG21 ' A' ' 48' ' ' VAL . 56.6 t80 -70.98 105.26 3.23 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 173.963 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 15.6 m -103.62 97.55 5.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 121.81 0.814 . . . . 0.0 110.366 -174.759 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 28.6 ptt180 -83.06 80.37 9.07 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.396 -177.246 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.771 ' HA ' HD11 ' A' ' 124' ' ' LEU . 11.0 tmtt? 76.1 -37.5 0.31 Allowed 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.995 177.735 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -68.82 108.33 3.4 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 122.363 0.265 . . . . 0.0 110.715 -179.425 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.404 HD23 ' HA ' ' A' ' 81' ' ' LEU . 12.2 mt -152.02 163.21 39.77 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.213 0.53 . . . . 0.0 110.832 179.577 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 58.3 t -131.84 -65.7 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.721 176.792 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.431 ' HB3' ' NE2' ' A' ' 91' ' ' HIS . 21.0 m-85 56.73 103.61 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.431 -176.729 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 53.0 m -134.12 112.52 11.2 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.736 178.799 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.558 ' HA ' ' HA ' ' A' ' 91' ' ' HIS . 0.2 OUTLIER -82.16 91.1 6.65 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.454 0.645 . . . . 0.0 109.68 177.16 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -66.24 -32.01 73.18 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.046 -178.928 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ASN . . . . . 0.747 ' HB2' ' HB3' ' A' ' 90' ' ' PHE . 15.6 m120 -129.09 155.35 79.96 Favored Pre-proline 0 C--N 1.326 -0.414 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 175.458 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_exo -44.26 -44.01 13.05 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.648 2.232 . . . . 0.0 112.915 179.41 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.548 ' O ' ' HA ' ' A' ' 103' ' ' THR . 37.3 p -108.67 16.98 22.43 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 -177.411 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.747 ' HB3' ' HB2' ' A' ' 87' ' ' ASN . 73.4 t80 -131.0 104.04 6.88 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 120.894 0.378 . . . . 0.0 110.509 -178.543 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' HIS . . . . . 0.558 ' HA ' ' HA ' ' A' ' 85' ' ' LYS . 1.5 t60 -114.9 124.27 51.28 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 -179.121 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' HIS . . . . . 0.475 ' HA ' ' HA2' ' A' ' 101' ' ' GLY . 23.5 p80 -126.78 159.54 33.5 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 120.953 0.406 . . . . 0.0 111.766 -176.394 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 49.1 p90 -155.39 147.53 23.62 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.282 -179.462 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.42 ' NZ ' ' HB3' ' A' ' 94' ' ' LYS . 5.7 ttpm? -112.85 127.53 56.2 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 177.426 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 19.1 m -146.69 146.94 18.34 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 O-C-N 123.253 0.346 . . . . 0.0 110.473 -179.659 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 33.6 t70 63.82 -73.33 0.05 OUTLIER 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.373 0.669 . . . . 0.0 111.773 178.645 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -146.43 -57.22 0.28 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.657 0.265 . . . . 0.0 110.65 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -78.8 176.19 9.78 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-O 121.538 0.685 . . . . 0.0 111.249 -178.906 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.582 ' HG2' ' HH2' ' A' ' 32' ' ' TRP . 37.2 ttpt -128.97 115.33 17.65 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.136 -179.268 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 41.2 m-85 -101.21 168.38 9.6 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.528 -0.306 . . . . 0.0 110.605 -174.037 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.475 ' HA2' ' HA ' ' A' ' 92' ' ' HIS . . . -151.08 170.87 30.79 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 121.136 -0.554 . . . . 0.0 112.161 -177.798 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.436 HD23 ' N ' ' A' ' 103' ' ' THR . 2.5 tt -143.52 128.77 18.8 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 -178.212 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.548 ' HA ' ' O ' ' A' ' 89' ' ' THR . 84.2 m -110.89 122.48 47.96 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.189 176.035 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.423 ' HD2' ' HA ' ' A' ' 89' ' ' THR . 50.9 m-85 -89.28 162.21 15.98 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.699 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 19.0 pt20 -113.5 -48.17 2.96 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 111.396 0.147 . . . . 0.0 111.396 -176.705 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 17.2 m -117.34 143.93 32.93 Favored Pre-proline 0 C--N 1.328 -0.34 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 -177.75 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_exo -47.7 -29.98 11.91 Favored 'Trans proline' 0 C--N 1.354 0.829 0 C-N-CA 122.593 2.196 . . . . 0.0 112.314 177.584 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -58.06 -70.75 0.13 Allowed 'General case' 0 C--O 1.233 0.204 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.98 177.024 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -60.45 -37.35 80.69 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.062 -178.779 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.408 ' HA ' ' CG ' ' A' ' 104' ' ' PHE . . . -54.01 -69.56 0.12 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.261 178.711 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 78.4 mtt180 -70.94 -22.81 62.18 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.536 -173.307 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -65.67 -48.89 70.56 Favored 'General case' 0 C--O 1.238 0.471 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 174.764 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 57.1 t80 -69.59 -47.16 64.48 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.075 -179.464 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.418 ' O ' ' HG2' ' A' ' 118' ' ' ARG . 4.8 m-20 -51.93 -58.72 5.66 Favored 'General case' 0 N--CA 1.465 0.294 0 O-C-N 123.191 0.307 . . . . 0.0 110.75 178.638 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 27.3 mtp180 -60.71 -38.43 85.04 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-O 120.699 0.285 . . . . 0.0 110.892 -179.007 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.507 ' O ' ' HG3' ' A' ' 119' ' ' LYS . . . -62.04 -56.64 21.22 Favored Glycine 0 CA--C 1.52 0.386 0 C-N-CA 121.183 -0.532 . . . . 0.0 112.575 179.231 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.56 ' O ' HG12 ' A' ' 121' ' ' ILE . 12.1 p -64.59 -30.91 51.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.571 0.224 . . . . 0.0 110.408 -178.529 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.418 ' HG2' ' O ' ' A' ' 114' ' ' ASP . 7.9 mmm180 -62.77 -50.75 69.82 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.653 177.688 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.507 ' HG3' ' O ' ' A' ' 116' ' ' GLY . 0.0 OUTLIER -62.01 -33.98 75.35 Favored 'General case' 0 N--CA 1.462 0.151 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 178.753 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -62.51 -36.53 82.86 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.449 175.423 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.56 HG12 ' O ' ' A' ' 117' ' ' VAL . 40.3 mm -64.09 -44.65 97.71 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.076 0 CA-C-N 116.248 -0.433 . . . . 0.0 109.879 175.904 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -58.55 -39.19 79.55 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.71 176.175 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 87.9 m-20 -66.05 -37.08 84.95 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 121.252 0.549 . . . . 0.0 110.239 176.439 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.771 HD11 ' HA ' ' A' ' 79' ' ' LYS . 49.4 tp -70.5 -57.73 4.46 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.335 -0.848 . . . . 0.0 111.469 -176.294 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.505 HG13 ' O ' ' A' ' 121' ' ' ILE . 2.9 pp -75.02 -29.47 22.16 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.05 -177.594 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.467 ' N ' HD12 ' A' ' 125' ' ' ILE . 39.5 tt0 . . . . . 0 C--O 1.248 1.008 0 CA-C-O 118.15 -0.929 . . . . 0.0 111.094 176.751 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.729 0 N-CA-C 112.185 -0.366 . . . . 0.0 112.185 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 23.8 p -66.19 113.44 4.55 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 177.303 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 52.2 ttp -144.99 128.26 16.79 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.976 0.417 . . . . 0.0 111.554 -173.583 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 12.0 t -166.52 137.42 3.4 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 176.006 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -158.32 -85.89 0.04 OUTLIER 'General case' 0 C--O 1.234 0.237 0 CA-C-O 120.613 0.244 . . . . 0.0 111.056 -174.107 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -90.01 -50.25 6.13 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 121.101 0.477 . . . . 0.0 109.974 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 15.2 t -63.08 157.64 21.66 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.774 178.171 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.686 ' HB2' ' HD3' ' A' ' 9' ' ' PRO . 32.1 m170 103.09 -68.74 0.0 OUTLIER Pre-proline 0 N--CA 1.482 1.145 0 C-N-CA 125.391 1.476 . . . . 0.0 113.235 176.726 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.686 ' HD3' ' HB2' ' A' ' 8' ' ' HIS . 80.7 Cg_exo -48.96 -44.59 31.89 Favored 'Trans proline' 0 C--N 1.37 1.693 0 C-N-CA 121.867 1.711 . . . . 0.0 112.066 -177.217 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -83.29 -85.8 0.12 Allowed 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 172.764 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -175.12 -50.02 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 168.196 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 33.1 t70 65.15 -71.16 0.08 Allowed 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 112.959 0.725 . . . . 0.0 112.959 172.568 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 60.5 m -130.53 26.86 5.04 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 111.938 0.347 . . . . 0.0 111.938 -175.703 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.648 ' HE2' ' HA ' ' A' ' 8' ' ' HIS . 13.3 m-85 -73.45 123.19 23.4 Favored 'General case' 0 C--O 1.235 0.305 0 O-C-N 122.096 -0.378 . . . . 0.0 110.841 176.591 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.447 HG23 HG12 ' A' ' 16' ' ' VAL . 13.6 tt -85.12 -27.15 6.57 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 174.137 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.447 HG12 HG23 ' A' ' 15' ' ' ILE . 9.2 p -159.15 144.97 6.95 Favored 'Isoleucine or valine' 0 C--O 1.231 0.13 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.906 176.279 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 55.8 ttp180 -160.04 109.35 1.78 Allowed 'General case' 0 C--O 1.235 0.315 0 CA-C-O 121.026 0.441 . . . . 0.0 110.433 176.024 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 34.6 m -113.01 -170.32 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.089 -179.219 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.521 ' HB2' HG23 ' A' ' 40' ' ' ILE . 57.4 pttt -126.26 113.59 17.17 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.069 0.461 . . . . 0.0 110.392 178.511 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -143.52 178.14 7.98 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.351 -177.483 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.53 ' HB ' ' HB ' ' A' ' 103' ' ' THR . 27.5 t -83.37 135.17 25.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.442 0.163 . . . . 0.0 110.564 179.825 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.585 HG23 ' HG2' ' A' ' 35' ' ' GLN . 11.6 m -95.24 95.26 4.87 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 CA-C-O 121.473 0.654 . . . . 0.0 110.847 177.087 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 23.6 mmt -86.77 160.01 18.94 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.699 -178.262 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.431 ' HA ' ' HA ' ' A' ' 100' ' ' PHE . 11.7 t -160.24 150.71 18.53 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.867 174.168 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.407 ' HD2' ' O ' ' A' ' 29' ' ' SER . 47.6 ttp180 -114.1 89.74 3.17 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 107.594 -1.261 . . . . 0.0 107.594 171.835 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -43.47 96.99 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.33 0 O-C-N 124.482 1.114 . . . . 0.0 112.364 -169.357 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 18.7 t70 58.22 -78.92 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 115.15 -0.932 . . . . 0.0 111.088 -179.582 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 21.1 m -141.95 105.7 4.71 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 176.329 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.407 ' O ' ' HD2' ' A' ' 25' ' ' ARG . 36.4 t -141.84 171.1 14.52 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.14 -176.481 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -100.02 38.87 2.93 Favored Glycine 0 CA--C 1.518 0.268 0 C-N-CA 121.293 -0.479 . . . . 0.0 112.93 -176.755 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 171.92 163.71 26.29 Favored Glycine 0 C--N 1.33 0.243 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.649 177.856 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' TRP . . . . . 0.401 ' CH2' ' HB3' ' A' ' 99' ' ' LYS . 86.2 m95 -103.6 113.73 27.47 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 176.646 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.462 ' HA ' ' HD3' ' A' ' 34' ' ' PRO . 0.5 OUTLIER -117.6 144.76 34.86 Favored Pre-proline 0 C--N 1.327 -0.402 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.288 -177.007 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.462 ' HD3' ' HA ' ' A' ' 33' ' ' PHE . 11.6 Cg_exo -71.11 137.73 32.16 Favored 'Trans proline' 0 C--N 1.351 0.676 0 C-N-CA 122.846 2.364 . . . . 0.0 111.46 175.038 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.585 ' HG2' HG23 ' A' ' 22' ' ' VAL . 12.6 pt20 -87.91 -147.53 0.15 Allowed 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.07 179.261 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 44.5 mm-40 -46.66 -42.73 16.87 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 111.832 0.308 . . . . 0.0 111.832 179.528 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -80.8 68.58 3.37 Favored Glycine 0 CA--C 1.519 0.328 0 C-N-CA 121.184 -0.532 . . . . 0.0 112.544 -179.392 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -77.33 132.07 11.74 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 121.204 -0.522 . . . . 0.0 112.392 179.705 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 85.05 -57.96 4.98 Favored Glycine 0 CA--C 1.518 0.264 0 C-N-CA 121.283 -0.484 . . . . 0.0 112.885 176.653 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.521 HG23 ' HB2' ' A' ' 19' ' ' LYS . 65.5 mt -142.23 140.76 29.12 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 C-N-CA 122.341 0.256 . . . . 0.0 110.458 -177.935 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.454 ' O ' ' HA ' ' A' ' 19' ' ' LYS . 53.0 m -150.71 133.96 16.2 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 174.344 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 55.4 ttp180 -81.47 90.63 6.23 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 109.808 -0.441 . . . . 0.0 109.808 -178.375 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.481 ' HA ' ' HA2' ' A' ' 63' ' ' GLY . 31.4 t -111.96 143.3 22.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.443 -175.721 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -160.96 -177.43 34.06 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.994 -0.622 . . . . 0.0 112.718 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.405 ' O ' HG22 ' A' ' 15' ' ' ILE . 50.5 t -118.04 130.45 72.89 Favored 'Isoleucine or valine' 0 C--O 1.241 0.614 0 CA-C-O 120.721 0.296 . . . . 0.0 110.263 179.859 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' CYS . . . . . 0.684 ' SG ' ' HB3' ' A' ' 60' ' ' LEU . 12.4 p -119.67 122.49 41.6 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.452 173.361 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 33.3 ttpt -78.72 102.03 7.86 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 121.053 0.454 . . . . 0.0 110.145 179.808 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.519 ' O ' ' HB3' ' A' ' 57' ' ' SER . 51.3 t -75.86 110.74 11.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.372 -179.691 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 22.9 ptp -107.7 135.63 48.81 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.288 -0.415 . . . . 0.0 109.979 178.505 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' HIS . . . . . 0.401 ' HA ' ' HD2' ' A' ' 51' ' ' PRO . 19.3 p80 -58.73 127.04 82.03 Favored Pre-proline 0 CA--C 1.532 0.267 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.908 177.984 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.401 ' HD2' ' HA ' ' A' ' 50' ' ' HIS . 18.5 Cg_endo -58.45 -56.94 1.24 Allowed 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 122.351 2.034 . . . . 0.0 110.965 176.23 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 10.4 mp0 -114.41 -60.07 1.93 Allowed 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 170.533 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 176.04 47.78 0.06 OUTLIER Glycine 0 C--N 1.33 0.231 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.314 178.587 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 24.6 p-10 -64.73 -42.8 94.94 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 111.994 0.368 . . . . 0.0 111.994 -174.264 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -168.36 -171.68 34.48 Favored Glycine 0 C--O 1.236 0.248 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.898 -178.056 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -64.84 105.37 0.99 Allowed 'General case' 0 C--O 1.234 0.276 0 CA-C-O 120.859 0.361 . . . . 0.0 111.038 -179.147 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.519 ' HB3' ' O ' ' A' ' 48' ' ' VAL . 22.7 m -68.31 151.91 46.21 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.341 177.214 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -165.37 -147.14 5.04 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.618 -177.828 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -130.32 125.56 35.01 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 -176.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.684 ' HB3' ' SG ' ' A' ' 46' ' ' CYS . 2.3 tt -95.81 118.29 32.18 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 -179.531 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 49.5 mm -84.27 93.95 3.48 Favored 'Isoleucine or valine' 0 C--O 1.235 0.292 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 172.767 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' HIS . . . . . 0.607 ' HB2' HD22 ' A' ' 60' ' ' LEU . 38.5 t-80 -108.48 131.91 54.33 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.941 -171.798 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.481 ' HA2' ' HA ' ' A' ' 43' ' ' VAL . . . -128.24 133.06 7.58 Favored Glycine 0 N--CA 1.449 -0.481 0 N-CA-C 110.89 -0.884 . . . . 0.0 110.89 177.941 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -146.89 178.17 8.55 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.78 0.324 . . . . 0.0 111.329 -172.705 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 5.1 mmt180 68.1 169.37 0.27 Allowed 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 115.303 -0.862 . . . . 0.0 111.868 174.912 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 26.8 mp0 65.33 165.63 0.17 Allowed 'General case' 0 C--O 1.235 0.323 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.297 -173.216 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 24.9 tptp 71.24 -59.82 0.53 Allowed 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 122.946 0.498 . . . . 0.0 109.665 -174.754 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -165.24 -84.97 0.02 OUTLIER 'General case' 0 C--O 1.234 0.28 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.235 173.691 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 4.3 ttmp? -165.85 96.0 0.62 Allowed 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 -179.262 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.4 pp -173.23 178.92 2.32 Favored 'General case' 0 C--O 1.239 0.514 0 CA-C-O 120.633 0.254 . . . . 0.0 110.474 -173.01 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.475 ' O ' HG23 ' A' ' 71' ' ' VAL . 27.4 m -103.41 104.1 16.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.889 177.91 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.438 HG21 ' HB3' ' A' ' 41' ' ' SER . 34.7 m -68.46 -31.37 50.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.41 -178.572 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 40.4 mt -141.06 94.22 2.68 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.362 178.042 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -98.51 94.92 6.96 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 170.793 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' CYS . . . . . 0.469 ' SG ' ' CE2' ' A' ' 100' ' ' PHE . 57.9 m -139.43 89.4 2.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.363 0.601 . . . . 0.0 111.011 -172.386 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.515 ' HA ' ' HA ' ' A' ' 60' ' ' LEU . 29.9 t80 -74.27 116.13 14.57 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.173 178.072 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.605 HG11 HD12 ' A' ' 81' ' ' LEU . 95.8 t -80.19 105.93 10.56 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 CA-C-O 121.144 0.497 . . . . 0.0 109.818 179.719 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.592 ' HD2' ' O ' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -80.79 61.86 4.6 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.276 -179.906 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.58 ' HG3' HD21 ' A' ' 124' ' ' LEU . 45.4 tttp 74.86 124.19 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 115.172 -0.922 . . . . 0.0 111.394 -176.479 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 76.7 m-20 70.6 119.39 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 115.113 -0.949 . . . . 0.0 112.915 174.15 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.605 HD12 HG11 ' A' ' 77' ' ' VAL . 0.0 OUTLIER -143.52 134.26 25.17 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 167.47 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 19.8 t -65.61 -52.02 55.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.888 -169.82 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.465 ' HD2' HG11 ' A' ' 117' ' ' VAL . 0.9 OUTLIER 57.87 51.59 8.93 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 121.292 0.568 . . . . 0.0 109.987 -177.626 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 33.7 m -60.52 114.18 2.83 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.786 -179.74 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.45 ' HB3' ' CD2' ' A' ' 91' ' ' HIS . 0.0 OUTLIER -99.71 102.25 13.66 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.972 0.415 . . . . 0.0 110.334 176.112 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -75.46 -37.15 60.48 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 175.367 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ASN . . . . . 0.458 ' HB2' ' HB3' ' A' ' 90' ' ' PHE . 77.0 m-20 -127.67 151.46 75.33 Favored Pre-proline 0 C--N 1.326 -0.423 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 174.095 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.499 ' O ' ' HB1' ' A' ' 110' ' ' ALA . 88.7 Cg_exo -48.22 -33.82 22.71 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.313 2.009 . . . . 0.0 112.374 178.387 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.448 ' O ' ' HA ' ' A' ' 103' ' ' THR . 14.7 p -97.68 -15.65 20.3 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 115.889 -0.596 . . . . 0.0 112.138 -178.519 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.458 ' HB3' ' HB2' ' A' ' 87' ' ' ASN . 86.8 t80 -107.31 102.47 11.77 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-O 121.087 0.47 . . . . 0.0 110.854 -176.653 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' HIS . . . . . 0.45 ' CD2' ' HB3' ' A' ' 85' ' ' LYS . 56.5 m80 -112.82 147.3 37.24 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.155 177.201 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' HIS . . . . . 0.579 ' HA ' ' HA3' ' A' ' 101' ' ' GLY . 15.4 p80 -153.95 152.84 31.04 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 174.789 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' TRP . . . . . 0.448 ' HD1' HG13 ' A' ' 95' ' ' VAL . 47.8 p90 -137.13 145.28 43.63 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-O 121.283 0.563 . . . . 0.0 111.291 177.867 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 1.1 tmtm? -102.04 119.52 38.93 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.013 -0.994 . . . . 0.0 109.286 176.917 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.448 HG13 ' HD1' ' A' ' 93' ' ' TRP . 19.3 m -125.45 125.64 69.22 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 173.417 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 59.56 -79.4 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.77 -175.518 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 44.1 t30 -142.29 -35.21 0.43 Allowed 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 112.063 0.394 . . . . 0.0 112.063 -177.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.518 ' HD2' ' N ' ' A' ' 98' ' ' ARG . 2.3 mpt_? -84.46 148.29 26.64 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.899 0.381 . . . . 0.0 111.212 -174.659 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.401 ' HB3' ' CH2' ' A' ' 32' ' ' TRP . 3.5 mppt? -119.92 124.49 46.14 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.759 -176.97 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.469 ' CE2' ' SG ' ' A' ' 75' ' ' CYS . 0.7 OUTLIER -144.31 150.44 37.85 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.485 176.095 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.579 ' HA3' ' HA ' ' A' ' 92' ' ' HIS . . . -157.71 -165.61 15.64 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 121.021 -0.609 . . . . 0.0 112.82 -175.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 94.9 mt -128.42 147.32 50.65 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.998 0.428 . . . . 0.0 110.887 -174.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.53 ' HB ' ' HB ' ' A' ' 21' ' ' VAL . 63.2 m -123.79 107.67 11.67 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 172.74 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.451 ' HB3' ' OD2' ' A' ' 109' ' ' ASP . 99.4 m-85 -78.28 167.97 20.54 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.645 -0.707 . . . . 0.0 112.019 -172.122 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 -92.06 -41.76 10.33 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.03 -175.618 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 16.7 m -137.54 156.13 75.01 Favored Pre-proline 0 C--O 1.234 0.285 0 CA-C-N 116.621 -0.263 . . . . 0.0 110.883 -175.606 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -54.2 -32.65 71.61 Favored 'Trans proline' 0 C--N 1.351 0.676 0 C-N-CA 122.656 2.237 . . . . 0.0 112.234 177.392 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -56.43 -66.32 0.46 Allowed 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.401 179.05 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.451 ' OD2' ' HB3' ' A' ' 104' ' ' PHE . 1.6 p-10 -63.63 -35.73 81.47 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.086 -178.415 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.499 ' HB1' ' O ' ' A' ' 88' ' ' PRO . . . -58.64 -61.51 2.55 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 121.174 0.511 . . . . 0.0 111.263 177.444 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 82.5 mtp180 -65.39 -26.32 67.94 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.738 -177.733 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -68.71 -43.06 76.79 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.748 177.873 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -71.98 -37.27 69.91 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 -178.727 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.416 ' O ' HG12 ' A' ' 117' ' ' VAL . 24.0 t70 -55.73 -51.96 65.53 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 121.917 0.865 . . . . 0.0 109.409 172.819 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 35.2 ttt180 -56.16 -37.1 69.07 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 114.347 -1.297 . . . . 0.0 110.676 174.004 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -61.69 -52.57 49.88 Favored Glycine 0 C--N 1.332 0.315 0 CA-C-N 115.853 -0.612 . . . . 0.0 112.446 178.942 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.465 HG11 ' HD2' ' A' ' 83' ' ' TYR . 11.3 p -67.09 -28.72 43.71 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.151 0 CA-C-O 121.001 0.429 . . . . 0.0 109.961 179.233 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.418 HH11 ' HD3' ' A' ' 118' ' ' ARG . 0.0 OUTLIER -58.88 -55.33 36.55 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 176.932 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 59.8 tttm -66.68 -35.29 79.79 Favored 'General case' 0 C--O 1.227 -0.095 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.315 179.356 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -56.6 -58.26 8.84 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 121.132 0.492 . . . . 0.0 110.539 178.441 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.503 HD11 HD13 ' A' ' 81' ' ' LEU . 47.5 mm -63.2 -29.67 47.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.2 178.516 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.824 ' HA ' ' HA ' ' A' ' 126' ' ' GLU . 42.3 tt0 -64.37 -46.31 83.95 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.42 176.912 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -63.19 -34.23 77.18 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 121.197 0.522 . . . . 0.0 109.643 177.628 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.58 HD21 ' HG3' ' A' ' 79' ' ' LYS . 63.0 tp -64.63 -63.52 1.11 Allowed 'General case' 0 C--O 1.235 0.332 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.047 177.95 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.501 ' O ' HG12 ' A' ' 125' ' ' ILE . 12.3 tt -163.5 26.14 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.722 0 CA-C-O 121.128 0.489 . . . . 0.0 110.924 -175.789 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.824 ' HA ' ' HA ' ' A' ' 122' ' ' GLU . 35.4 tt0 . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.413 -0.803 . . . . 0.0 111.151 -178.736 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.731 0 N-CA-C 111.858 -0.497 . . . . 0.0 111.858 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.3 m -72.28 76.27 1.0 Allowed 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 120.909 0.385 . . . . 0.0 110.259 178.916 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 26.3 ptm -127.09 25.46 6.22 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.145 -176.065 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 32.1 p -87.6 17.8 4.39 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-O 120.852 0.358 . . . . 0.0 110.973 179.628 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 30.3 mm-40 -55.4 146.6 19.28 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.949 177.597 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 30.2 mm-40 -61.71 146.78 48.19 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 173.919 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.0 p -151.86 160.05 43.66 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 121.102 0.477 . . . . 0.0 112.0 -169.09 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.433 ' NE2' HG21 ' A' ' 71' ' ' VAL . 84.5 t60 -176.48 -54.07 0.0 OUTLIER Pre-proline 0 CA--C 1.534 0.351 0 CA-C-N 114.666 -1.152 . . . . 0.0 108.468 177.797 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -71.91 -43.12 1.32 Allowed 'Trans proline' 0 C--N 1.36 1.141 0 C-N-CA 121.65 1.567 . . . . 0.0 110.577 168.642 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -85.68 62.61 7.57 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 121.723 0.773 . . . . 0.0 108.972 173.777 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.721 ' HB2' ' HE1' ' A' ' 14' ' ' TYR . 20.9 p-10 -81.76 65.18 6.78 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.038 -0.983 . . . . 0.0 111.683 -173.337 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -106.77 -0.61 23.34 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.686 173.351 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 20.2 m -73.2 5.54 3.44 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.633 175.878 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.721 ' HE1' ' HB2' ' A' ' 11' ' ' ASP . 3.3 m-85 -53.53 135.5 39.98 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.668 176.213 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.756 HD13 ' HB2' ' A' ' 47' ' ' LYS . 38.6 pt -91.84 -27.94 4.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 170.805 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.559 HG23 HG13 ' A' ' 15' ' ' ILE . 67.1 t -137.4 137.92 45.49 Favored 'Isoleucine or valine' 0 C--O 1.232 0.142 0 CA-C-N 114.965 -1.016 . . . . 0.0 108.994 177.682 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 32.2 ptt180 -147.22 134.37 20.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.835 0.35 . . . . 0.0 110.289 178.866 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 29.1 m -133.67 174.31 13.36 Favored 'Isoleucine or valine' 0 C--O 1.237 0.415 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.523 -177.878 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -129.84 121.16 26.19 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 179.207 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -169.84 -174.27 1.78 Allowed 'General case' 0 C--O 1.232 0.182 0 CA-C-O 120.776 0.322 . . . . 0.0 111.249 -176.799 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.449 ' HB ' ' HB ' ' A' ' 103' ' ' THR . 87.6 t -92.25 142.49 13.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.022 178.98 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.442 HG11 HG21 ' A' ' 43' ' ' VAL . 27.4 m -117.42 134.23 61.69 Favored 'Isoleucine or valine' 0 C--O 1.237 0.411 0 CA-C-O 121.308 0.575 . . . . 0.0 111.476 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' MET . . . . . 0.626 ' SD ' ' HG3' ' A' ' 34' ' ' PRO . 24.7 mmt -119.04 169.52 9.83 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.058 -0.974 . . . . 0.0 109.052 178.385 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 8.9 t -153.64 157.25 39.35 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 174.909 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 41.1 ttp180 -128.41 111.17 13.03 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 178.434 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.613 ' H ' ' HE1' ' A' ' 33' ' ' PHE . 38.1 t70 -61.52 97.93 0.08 Allowed 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 179.17 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.543 ' HB3' ' NH1' ' A' ' 98' ' ' ARG . 1.6 p30 46.59 -75.99 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.293 1.037 . . . . 0.0 111.994 -169.208 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.447 ' N ' ' O ' ' A' ' 26' ' ' ASP . 69.3 m -141.13 152.04 44.4 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 110.092 -0.336 . . . . 0.0 110.092 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 21.1 m 67.16 167.8 0.24 Allowed 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.435 -179.147 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 115.07 -6.44 21.72 Favored Glycine 0 N--CA 1.453 -0.212 0 N-CA-C 111.684 -0.566 . . . . 0.0 111.684 -177.197 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 59.07 27.05 61.91 Favored Glycine 0 C--N 1.334 0.432 0 C-N-CA 121.653 -0.308 . . . . 0.0 112.986 179.754 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' TRP . . . . . 0.569 ' CH2' ' HB3' ' A' ' 99' ' ' LYS . 89.2 m95 57.91 98.12 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 121.439 0.638 . . . . 0.0 110.873 -176.516 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.613 ' HE1' ' H ' ' A' ' 26' ' ' ASP . 40.1 p90 -103.16 138.22 19.48 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.906 -175.183 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.626 ' HG3' ' SD ' ' A' ' 23' ' ' MET . 5.1 Cg_exo -79.23 115.43 3.48 Favored 'Trans proline' 0 N--CA 1.457 -0.665 0 C-N-CA 122.452 2.101 . . . . 0.0 110.865 172.593 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -65.88 -162.71 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.836 176.04 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -46.54 -39.14 10.41 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 112.724 0.638 . . . . 0.0 112.724 -176.8 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -72.63 -115.29 0.06 OUTLIER Glycine 0 CA--C 1.519 0.285 0 N-CA-C 111.591 -0.604 . . . . 0.0 111.591 176.347 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.44 ' O ' HG13 ' A' ' 21' ' ' VAL . . . 82.45 -67.09 3.77 Favored Glycine 0 C--N 1.329 0.193 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.104 174.455 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -66.81 80.22 0.13 Allowed Glycine 0 CA--C 1.519 0.291 0 C-N-CA 121.507 -0.378 . . . . 0.0 112.601 -178.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.448 ' O ' ' HG2' ' A' ' 66' ' ' GLN . 50.8 mm 63.64 82.15 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 CA-C-O 121.556 0.693 . . . . 0.0 111.155 178.954 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 49.1 m -99.98 148.33 24.63 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.114 178.201 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.428 HH21 ' CD ' ' A' ' 64' ' ' GLU . 7.4 tmm_? -98.83 99.89 11.02 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 -177.718 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.442 HG21 HG11 ' A' ' 22' ' ' VAL . 50.2 t -120.93 155.16 24.5 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.931 -171.22 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -173.3 -163.5 27.06 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 121.143 -0.551 . . . . 0.0 112.239 176.413 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 61.6 t -130.34 139.73 50.63 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 CA-C-O 120.868 0.366 . . . . 0.0 110.79 -177.119 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 47.2 t -119.96 131.78 55.3 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 173.871 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.756 ' HB2' HD13 ' A' ' 15' ' ' ILE . 84.9 tttt -83.39 118.72 23.91 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.795 0.331 . . . . 0.0 111.021 -174.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 49.1 t -78.85 126.37 38.81 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.227 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 16.0 mmt -84.13 115.91 22.63 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.085 -177.272 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 53.1 m170 -102.36 117.53 60.88 Favored Pre-proline 0 C--N 1.327 -0.382 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 176.869 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_exo -64.39 91.9 0.18 Allowed 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 122.711 2.274 . . . . 0.0 112.087 -178.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 63.01 -177.12 0.15 Allowed 'General case' 0 C--O 1.238 0.458 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.323 177.25 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 98.61 155.52 29.25 Favored Glycine 0 C--O 1.236 0.243 0 CA-C-N 116.072 -0.513 . . . . 0.0 112.428 178.21 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -83.76 2.1 39.61 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.82 0.343 . . . . 0.0 110.543 -179.417 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -72.6 -4.36 61.04 Favored Glycine 0 C--N 1.334 0.433 0 CA-C-N 116.041 -0.527 . . . . 0.0 112.909 179.36 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.598 ' HG3' ' H ' ' A' ' 57' ' ' SER . 11.0 tpt85 68.1 -167.42 0.19 Allowed 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 122.577 0.351 . . . . 0.0 110.15 175.801 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.598 ' H ' ' HG3' ' A' ' 56' ' ' ARG . 16.5 m -105.14 148.29 27.03 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.527 0.203 . . . . 0.0 110.559 -178.4 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -95.52 173.42 31.09 Favored Glycine 0 C--N 1.332 0.355 0 C-N-CA 121.194 -0.527 . . . . 0.0 112.011 -179.705 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -140.18 117.55 11.38 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.986 0.422 . . . . 0.0 110.877 -179.04 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.548 ' HG ' ' HD1' ' A' ' 76' ' ' TYR . 0.5 OUTLIER -87.31 102.85 14.9 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 175.29 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.78 ' HB ' ' HB3' ' A' ' 75' ' ' CYS . 63.5 mt -76.89 116.16 19.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 172.195 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 5.6 t-80 -127.55 141.44 51.64 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 -172.264 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -136.66 115.02 1.22 Allowed Glycine 0 C--N 1.333 0.383 0 C-N-CA 120.914 -0.66 . . . . 0.0 113.335 -174.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.428 ' CD ' HH21 ' A' ' 42' ' ' ARG . 41.7 tt0 -81.02 144.14 32.0 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 122.81 0.444 . . . . 0.0 110.606 178.352 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.486 ' HG2' HG11 ' A' ' 72' ' ' VAL . 0.2 OUTLIER -51.59 -56.07 15.6 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 115.682 -0.69 . . . . 0.0 112.208 -173.875 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.448 ' HG2' ' O ' ' A' ' 40' ' ' ILE . 0.0 OUTLIER -172.52 -77.15 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 -175.526 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 57.6 tttp -117.24 -46.15 2.71 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.39 178.076 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -69.16 132.1 46.01 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.101 174.13 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 23.5 mtpp -74.23 97.12 2.9 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.486 -177.56 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 51.0 tp -146.56 135.56 22.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.936 -179.73 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.433 HG21 ' NE2' ' A' ' 8' ' ' HIS . 26.8 t -81.44 95.18 2.75 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.937 -176.73 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.486 HG11 ' HG2' ' A' ' 65' ' ' ARG . 15.8 m -93.24 -37.72 8.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.058 179.362 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -125.06 143.03 51.12 Favored 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 109.819 -0.438 . . . . 0.0 109.819 176.188 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -159.82 165.12 32.96 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.301 173.154 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' CYS . . . . . 0.78 ' HB3' ' HB ' ' A' ' 61' ' ' ILE . 31.6 t -164.76 103.21 0.8 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.74 -0.663 . . . . 0.0 109.659 -177.153 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.548 ' HD1' ' HG ' ' A' ' 60' ' ' LEU . 57.0 t80 -81.99 99.79 9.32 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.017 -179.142 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.485 HG13 ' O ' ' A' ' 80' ' ' ASP . 95.6 t -90.74 98.16 8.03 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 N-CA-C 109.049 -0.722 . . . . 0.0 109.049 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 16.9 tpt180 -75.37 -42.82 53.16 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 -178.796 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.616 ' HA ' HD11 ' A' ' 124' ' ' LEU . 24.1 ttpp -173.61 29.75 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.226 174.419 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.485 ' O ' HG13 ' A' ' 77' ' ' VAL . 23.1 t70 -144.22 129.69 18.97 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 178.249 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.6 HD21 ' CD1' ' A' ' 83' ' ' TYR . 8.4 tt -156.09 128.39 7.62 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 -173.413 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 61.6 t -132.64 101.27 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.255 -179.248 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.6 ' CD1' HD21 ' A' ' 81' ' ' LEU . 8.1 m-85 -96.34 156.65 16.25 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.023 0.439 . . . . 0.0 110.416 172.531 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 86.0 m -157.82 135.85 10.82 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 176.204 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.458 ' HB3' ' CG ' ' A' ' 91' ' ' HIS . 19.1 ptmt -128.81 141.51 51.28 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.218 0.532 . . . . 0.0 111.397 -179.286 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -100.46 -39.31 8.01 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.581 177.556 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -126.62 151.31 72.97 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 115.415 -0.811 . . . . 0.0 108.919 178.244 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -46.0 -36.81 16.54 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 122.503 2.135 . . . . 0.0 112.173 178.079 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 17.9 p -83.91 -42.01 16.78 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 115.573 -0.739 . . . . 0.0 111.48 178.071 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 68.1 t80 -85.43 92.11 8.4 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-O 120.947 0.403 . . . . 0.0 110.359 -177.615 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' HIS . . . . . 0.543 ' NE2' ' HB3' ' A' ' 83' ' ' TYR . 4.7 t-160 -121.79 118.75 29.78 Favored 'General case' 0 N--CA 1.462 0.17 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 176.897 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 25.4 p80 -120.03 175.47 5.9 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.654 0.264 . . . . 0.0 110.482 -177.008 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' TRP . . . . . 0.485 ' HZ3' ' HB2' ' A' ' 102' ' ' LEU . 36.5 p90 -146.36 155.1 42.37 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.02 175.578 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 28.9 ttpt -120.28 122.34 40.65 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.784 -179.71 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.516 ' O ' ' N ' ' A' ' 97' ' ' ASN . 28.5 m -93.09 142.78 12.68 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 N-CA-C 106.294 -1.743 . . . . 0.0 106.294 160.689 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -60.35 77.66 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.066 0.46 . . . . 0.0 110.692 -177.026 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.566 ' O ' ' HD2' ' A' ' 98' ' ' ARG . 0.2 OUTLIER 169.82 -51.52 0.01 OUTLIER 'General case' 0 C--O 1.234 0.28 0 CA-C-N 115.085 -0.961 . . . . 0.0 109.856 -176.059 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.566 ' HD2' ' O ' ' A' ' 97' ' ' ASN . 0.6 OUTLIER -141.81 155.39 45.58 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.929 -175.304 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.569 ' HB3' ' CH2' ' A' ' 32' ' ' TRP . 89.2 mttt -112.88 116.3 29.81 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.047 173.629 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 27.2 m-85 -103.24 135.46 44.84 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 178.695 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -112.31 146.37 18.13 Favored Glycine 0 N--CA 1.453 -0.218 0 C-N-CA 121.155 -0.545 . . . . 0.0 112.83 -176.785 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.485 ' HB2' ' HZ3' ' A' ' 93' ' ' TRP . 2.8 tt -124.71 116.68 22.73 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 176.674 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.449 ' HB ' ' HB ' ' A' ' 21' ' ' VAL . 35.1 m -104.83 103.07 12.6 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.162 178.337 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.402 ' HB3' ' OD2' ' A' ' 109' ' ' ASP . 74.2 m-85 -65.37 163.28 15.93 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.22 -178.551 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 18.9 pt20 -102.56 -26.59 13.17 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.301 -176.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 19.4 m -147.41 150.17 36.61 Favored Pre-proline 0 CA--C 1.534 0.354 0 CA-C-O 120.439 0.162 . . . . 0.0 110.723 179.374 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -51.56 -27.46 25.41 Favored 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 122.97 2.447 . . . . 0.0 112.732 177.435 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -61.04 -63.0 1.44 Allowed 'General case' 0 C--O 1.237 0.436 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.001 178.718 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.402 ' OD2' ' HB3' ' A' ' 104' ' ' PHE . 1.5 p-10 -64.4 -34.67 78.71 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.86 179.845 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -57.99 -60.74 3.26 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.056 0.455 . . . . 0.0 110.822 176.643 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 61.5 ttt180 -61.22 -36.65 80.51 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.507 -176.615 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -62.63 -45.18 94.05 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-N 115.58 -0.737 . . . . 0.0 110.61 178.896 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 38.9 t80 -76.27 -26.38 55.89 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.469 -178.718 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 46.6 m-20 -59.67 -56.01 27.29 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 173.619 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 90.5 mtt180 -64.62 -27.66 69.09 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.154 174.818 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.477 ' HA2' ' NZ ' ' A' ' 119' ' ' LYS . . . -59.7 -58.8 12.38 Favored Glycine 0 N--CA 1.45 -0.417 0 CA-C-N 115.834 -0.621 . . . . 0.0 112.065 176.589 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.497 ' O ' HG13 ' A' ' 121' ' ' ILE . 9.0 p -65.66 -33.92 66.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 110.404 -0.221 . . . . 0.0 110.404 -179.302 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 43.6 ttm180 -59.78 -54.06 50.66 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.619 -0.264 . . . . 0.0 110.605 177.78 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.477 ' NZ ' ' HA2' ' A' ' 116' ' ' GLY . 25.0 pttm -69.33 -24.11 63.87 Favored 'General case' 0 CA--C 1.528 0.128 0 CA-C-O 120.841 0.353 . . . . 0.0 110.261 -179.739 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -67.2 -43.4 82.18 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.119 174.24 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.497 HG13 ' O ' ' A' ' 117' ' ' VAL . 79.7 mt -62.63 -41.63 92.94 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.168 0 CA-C-N 116.314 -0.403 . . . . 0.0 109.916 177.018 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -58.4 -43.83 88.73 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.132 174.707 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 40.7 t0 -75.51 -19.82 59.12 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.539 -177.76 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.616 HD11 ' HA ' ' A' ' 79' ' ' LYS . 55.2 tp -88.35 -39.1 14.59 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.647 -178.779 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 61.1 mt -112.23 -39.84 3.49 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 N-CA-C 111.801 0.297 . . . . 0.0 111.801 -172.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.323 -0.846 . . . . 0.0 110.226 -174.714 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.656 0 N-CA-C 111.812 -0.515 . . . . 0.0 111.812 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 42.7 t -141.96 170.05 16.43 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 179.442 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 23.8 ptm -144.73 115.25 7.65 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.103 -0.499 . . . . 0.0 109.68 178.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 25.7 m -67.47 133.54 49.7 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.954 -177.932 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -60.95 167.42 2.89 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.374 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -60.82 178.3 0.24 Allowed 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 120.951 0.405 . . . . 0.0 111.753 -179.129 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.471 ' O ' ' HB3' ' A' ' 8' ' ' HIS . 62.7 p 59.86 -172.25 0.12 Allowed 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 123.944 0.898 . . . . 0.0 112.206 178.821 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.471 ' HB3' ' O ' ' A' ' 7' ' ' THR . 20.9 t-80 105.75 -69.56 0.0 OUTLIER Pre-proline 0 N--CA 1.482 1.14 0 C-N-CA 125.813 1.645 . . . . 0.0 112.005 -177.2 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.516 ' HA ' ' HG2' ' A' ' 69' ' ' LYS . 26.5 Cg_endo -60.41 -29.56 89.0 Favored 'Trans proline' 0 C--N 1.365 1.412 0 C-N-CA 121.402 1.402 . . . . 0.0 111.615 -177.376 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -79.04 -32.69 45.04 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.425 176.464 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.433 ' HA ' ' HE2' ' A' ' 14' ' ' TYR . 11.0 t70 53.87 93.92 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.361 -178.823 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -140.3 -66.85 0.44 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.816 178.842 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 16.8 m -79.29 90.89 4.97 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.925 -176.389 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.482 ' HA ' ' HB3' ' A' ' 46' ' ' CYS . 67.5 m-85 -141.85 153.28 44.35 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.704 175.742 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.483 HG22 HG23 ' A' ' 16' ' ' VAL . 52.2 mt -108.35 -63.67 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.714 0.292 . . . . 0.0 110.371 178.106 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.483 HG23 HG22 ' A' ' 15' ' ' ILE . 60.0 t -114.94 113.08 42.6 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.517 -178.604 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 36.8 mtp180 -110.47 99.41 8.41 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.671 175.005 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 16.8 m -128.8 162.27 36.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.759 0.314 . . . . 0.0 110.769 -179.175 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.493 ' HE2' ' HA ' ' A' ' 40' ' ' ILE . 46.3 tttm -97.19 137.74 35.76 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.918 -176.792 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -159.04 -175.74 5.45 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-N 115.958 -0.564 . . . . 0.0 109.768 177.899 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.42 HG22 ' HA2' ' A' ' 39' ' ' GLY . 38.4 t -107.72 100.78 11.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.583 -0.281 . . . . 0.0 110.476 177.452 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.628 HG23 ' NE2' ' A' ' 35' ' ' GLN . 13.6 m -65.39 127.12 25.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.611 177.511 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 19.6 mmt -122.9 149.74 43.83 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.206 -175.131 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.443 HG23 ' CE1' ' A' ' 33' ' ' PHE . 12.7 t -122.31 171.75 8.81 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.051 175.373 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.531 ' HG3' ' H ' ' A' ' 27' ' ' ASP . 14.4 tpt180 -120.1 144.28 47.7 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.656 -178.367 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -79.93 11.91 3.04 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.862 179.64 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.531 ' H ' ' HG3' ' A' ' 25' ' ' ARG . 19.2 t70 63.85 156.73 0.07 Allowed 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.857 -173.779 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 47.8 t 56.58 -116.28 0.97 Allowed 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 -173.774 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 50.8 m -155.3 100.76 2.17 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 118.056 0.389 . . . . 0.0 111.525 177.702 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -131.35 -35.22 0.38 Allowed Glycine 0 C--N 1.329 0.183 0 N-CA-C 111.33 -0.708 . . . . 0.0 111.33 171.864 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.427 ' H ' ' NH1' ' A' ' 25' ' ' ARG . . . 153.72 132.01 1.64 Allowed Glycine 0 CA--C 1.519 0.315 0 N-CA-C 112.117 -0.393 . . . . 0.0 112.117 176.952 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' TRP . . . . . 0.411 ' HZ3' ' HA ' ' A' ' 100' ' ' PHE . 69.1 m95 -67.88 138.18 55.84 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 176.689 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.443 ' CE1' HG23 ' A' ' 24' ' ' THR . 4.6 p90 -145.62 152.55 49.38 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 116.85 -0.159 . . . . 0.0 110.737 -175.375 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -82.67 117.15 2.64 Favored 'Trans proline' 0 N--CA 1.461 -0.424 0 C-N-CA 122.446 2.097 . . . . 0.0 112.042 176.182 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.628 ' NE2' HG23 ' A' ' 22' ' ' VAL . 4.3 pm0 -53.32 -38.7 63.42 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.315 176.397 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -161.96 160.22 27.48 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.069 178.242 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 76.51 -72.53 1.95 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 121.361 -0.447 . . . . 0.0 111.992 178.856 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 69.43 29.6 71.61 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 121.143 -0.551 . . . . 0.0 112.692 179.282 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.42 ' HA2' HG22 ' A' ' 21' ' ' VAL . . . -177.28 -72.09 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.216 179.629 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.546 ' N ' HD12 ' A' ' 40' ' ' ILE . 3.0 mp -92.11 103.72 14.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.694 0.283 . . . . 0.0 110.618 -176.837 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.589 ' HA ' ' O ' ' A' ' 65' ' ' ARG . 30.0 m -146.62 127.41 14.38 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.236 -0.438 . . . . 0.0 109.821 172.894 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.459 ' O ' ' HG3' ' A' ' 42' ' ' ARG . 14.1 ptt180 -92.01 116.67 29.12 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 121.201 0.524 . . . . 0.0 110.092 179.424 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 40.4 t -95.29 128.92 46.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.626 178.417 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -123.25 108.99 1.27 Allowed Glycine 0 N--CA 1.448 -0.562 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.774 -178.402 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 7.6 p -92.14 130.98 40.45 Favored 'Isoleucine or valine' 0 C--O 1.238 0.496 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 175.668 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' CYS . . . . . 0.69 ' SG ' ' HB3' ' A' ' 60' ' ' LEU . 15.3 p -131.97 130.18 41.15 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.839 -178.909 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -92.35 86.54 5.73 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 175.324 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 30.8 m -80.25 159.5 4.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.399 -178.915 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 25.2 ptm -150.68 156.58 41.61 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.778 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' HIS . . . . . 0.44 ' NE2' ' HD2' ' A' ' 56' ' ' ARG . 11.3 m-70 -84.29 140.38 39.22 Favored Pre-proline 0 C--N 1.322 -0.612 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 176.869 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 8.6 Cg_exo -73.14 33.65 0.32 Allowed 'Trans proline' 0 CA--C 1.536 0.61 0 C-N-CA 123.089 2.526 . . . . 0.0 112.531 -179.159 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -109.58 166.25 11.04 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 179.264 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -63.55 -25.54 68.87 Favored Glycine 0 C--N 1.331 0.256 0 N-CA-C 111.295 -0.722 . . . . 0.0 111.295 174.656 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 -59.58 -31.58 69.57 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 115.306 -0.447 . . . . 0.0 110.853 176.586 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 73.43 -79.11 0.81 Allowed Glycine 0 C--N 1.332 0.357 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.817 -176.111 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.44 ' HD2' ' NE2' ' A' ' 50' ' ' HIS . 1.2 tmt_? 57.58 90.13 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 123.037 0.535 . . . . 0.0 110.49 -179.493 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 42.8 p -77.96 143.88 37.24 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.489 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -145.25 135.76 6.17 Favored Glycine 0 N--CA 1.451 -0.331 0 N-CA-C 111.006 -0.838 . . . . 0.0 111.006 175.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.551 ' HB2' ' HB ' ' A' ' 77' ' ' VAL . 83.8 m-85 -107.02 98.41 8.07 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 117.015 0.408 . . . . 0.0 110.353 -177.059 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.718 HD22 ' HB2' ' A' ' 62' ' ' HIS . 0.9 OUTLIER -78.35 106.04 10.01 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 179.633 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.528 HG12 HG23 ' A' ' 77' ' ' VAL . 50.8 mm -84.25 96.26 4.38 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 173.781 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' HIS . . . . . 0.718 ' HB2' HD22 ' A' ' 60' ' ' LEU . 14.8 t60 -119.21 150.87 39.35 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.313 -175.618 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -141.83 123.93 2.35 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 121.297 -0.478 . . . . 0.0 112.099 -178.855 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -99.37 149.89 22.71 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 177.521 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.589 ' O ' ' HA ' ' A' ' 41' ' ' SER . 3.1 tmm_? -58.24 -73.22 0.08 Allowed 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 109.09 -0.708 . . . . 0.0 109.09 176.012 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.507 ' HB2' ' O ' ' A' ' 65' ' ' ARG . 6.6 tp-100 169.38 132.3 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 123.111 0.564 . . . . 0.0 109.564 175.591 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt 68.04 -67.98 0.18 Allowed 'General case' 0 N--CA 1.465 0.302 0 O-C-N 123.794 0.684 . . . . 0.0 110.842 -179.51 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -74.21 128.47 35.61 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 110.109 -0.33 . . . . 0.0 110.109 177.187 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.516 ' HG2' ' HA ' ' A' ' 9' ' ' PRO . 12.5 mptt -67.2 78.21 0.14 Allowed 'General case' 0 C--O 1.236 0.385 0 CA-C-O 121.061 0.458 . . . . 0.0 110.42 -179.535 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 58.0 tp -116.37 116.84 28.44 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.113 -179.051 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 48.8 t -72.59 101.5 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.414 -179.757 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 27.3 m -96.84 -14.43 7.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.782 177.609 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.462 HD23 ' N ' ' A' ' 74' ' ' GLU . 2.2 tt -157.43 130.41 7.63 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 177.664 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.462 ' N ' HD23 ' A' ' 73' ' ' LEU . 4.1 tm-20 -145.59 127.02 14.98 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 177.675 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' CYS . . . . . 0.428 ' HB2' ' HE2' ' A' ' 100' ' ' PHE . 48.5 t -160.72 91.03 0.88 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.463 0.649 . . . . 0.0 109.856 177.468 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.495 ' HD1' ' HG ' ' A' ' 60' ' ' LEU . 82.3 t80 -67.4 118.32 10.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.454 -0.793 . . . . 0.0 110.79 179.638 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.794 HG22 HD13 ' A' ' 81' ' ' LEU . 62.0 t -77.34 94.5 1.35 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.356 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 176.111 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.426 ' HG3' ' HB3' ' A' ' 80' ' ' ASP . 15.1 ptt180 -78.83 35.76 0.25 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.717 179.052 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.695 ' HA ' HD11 ' A' ' 124' ' ' LEU . 59.5 mttp 67.91 13.64 9.21 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 123.16 0.584 . . . . 0.0 110.721 -169.027 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.426 ' HB3' ' HG3' ' A' ' 78' ' ' ARG . 15.0 t70 -135.19 96.73 3.55 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 115.989 -0.55 . . . . 0.0 109.898 178.177 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.794 HD13 HG22 ' A' ' 77' ' ' VAL . 7.1 tt -177.89 137.6 0.19 Allowed 'General case' 0 C--O 1.233 0.212 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 179.697 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.526 ' N ' HD23 ' A' ' 81' ' ' LEU . 40.6 t -126.19 122.52 61.71 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 CA-C-O 120.507 0.194 . . . . 0.0 111.075 -176.482 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.46 ' CG ' HG21 ' A' ' 117' ' ' VAL . 7.4 m-85 -84.52 172.8 11.34 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-O 121.284 0.564 . . . . 0.0 111.231 176.738 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 87.0 m -153.99 101.82 2.45 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.89 177.956 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -79.85 93.53 5.66 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 174.604 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -83.9 -59.22 2.48 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.536 -175.78 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ASN . . . . . 0.468 ' HB2' ' HB3' ' A' ' 90' ' ' PHE . 10.5 m120 -113.11 155.44 44.33 Favored Pre-proline 0 C--N 1.327 -0.385 0 N-CA-C 109.171 -0.678 . . . . 0.0 109.171 -179.196 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_exo -53.59 -19.18 13.31 Favored 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 122.658 2.238 . . . . 0.0 113.034 -179.644 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.44 ' HA ' ' HD2' ' A' ' 104' ' ' PHE . 15.3 t -121.05 -1.31 9.84 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 120.836 0.35 . . . . 0.0 111.448 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.468 ' HB3' ' HB2' ' A' ' 87' ' ' ASN . 78.0 t80 -120.84 114.67 21.94 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-O 121.007 0.432 . . . . 0.0 110.544 -176.254 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 2.0 t-160 -133.0 112.91 12.23 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 -176.066 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' HIS . . . . . 0.601 ' HA ' ' HA3' ' A' ' 101' ' ' GLY . 11.6 p80 -125.73 -178.42 4.26 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 -178.461 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' TRP . . . . . 0.405 ' CZ3' ' HA2' ' A' ' 101' ' ' GLY . 49.4 p90 -146.02 164.83 30.86 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.201 173.468 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 14.4 tmtt? -146.32 130.14 17.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.222 -177.097 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 30.8 m -136.49 147.11 27.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.738 -0.665 . . . . 0.0 109.388 176.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 18.7 t70 59.93 -89.86 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.447 0 O-C-N 123.235 0.334 . . . . 0.0 110.414 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 59.1 t30 -148.21 10.62 0.89 Allowed 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 121.685 0.755 . . . . 0.0 109.415 175.111 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 73.3 mtp180 -109.49 131.87 54.66 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.296 -176.283 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.546 ' HD3' ' N ' ' A' ' 99' ' ' LYS . 0.0 OUTLIER -127.66 127.54 43.93 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.567 -178.062 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.428 ' HE2' ' HB2' ' A' ' 75' ' ' CYS . 4.9 p90 -156.01 164.06 38.93 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.527 -0.761 . . . . 0.0 109.004 177.295 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.601 ' HA3' ' HA ' ' A' ' 92' ' ' HIS . . . -173.94 -135.35 2.01 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.401 -0.904 . . . . 0.0 112.703 -175.611 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 2.2 pp -159.69 175.28 13.36 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 121.339 0.59 . . . . 0.0 111.746 -178.195 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 91.2 m -130.02 140.49 50.87 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.114 176.249 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.44 ' HD2' ' HA ' ' A' ' 89' ' ' THR . 23.7 m-85 -83.18 166.38 18.67 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.324 0.583 . . . . 0.0 111.389 -174.407 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 21.6 tt0 -123.19 -57.31 1.69 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.822 175.34 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 18.8 m -118.66 149.46 46.38 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.345 -176.023 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -53.2 -20.77 15.26 Favored 'Trans proline' 0 C--N 1.352 0.744 0 C-N-CA 122.587 2.191 . . . . 0.0 112.476 179.016 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -62.37 -66.6 0.52 Allowed 'General case' 0 C--O 1.235 0.329 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.523 175.839 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -63.19 -39.23 94.06 Favored 'General case' 0 C--O 1.231 0.101 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.764 -179.604 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.427 ' HA ' ' CD1' ' A' ' 104' ' ' PHE . . . -52.61 -58.99 5.04 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-O 121.387 0.613 . . . . 0.0 111.174 177.008 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 69.7 ttt180 -66.59 -29.26 69.27 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.466 -178.141 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -64.95 -48.34 74.4 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.194 179.685 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.403 ' O ' HG12 ' A' ' 117' ' ' VAL . 58.4 m-85 -67.27 -46.8 72.57 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 116.698 -0.228 . . . . 0.0 110.577 179.072 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -53.18 -64.99 0.64 Allowed 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 121.235 0.54 . . . . 0.0 110.773 178.863 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' ARG . . . . . 0.402 ' O ' ' HB2' ' A' ' 119' ' ' LYS . 41.8 ttm180 -57.3 -38.16 73.57 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 114.938 -1.028 . . . . 0.0 110.799 177.809 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -56.76 -58.2 15.67 Favored Glycine 0 C--N 1.331 0.252 0 CA-C-N 115.955 -0.566 . . . . 0.0 112.484 -177.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.46 HG21 ' CG ' ' A' ' 83' ' ' TYR . 7.6 p -69.03 -36.88 75.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.532 0.206 . . . . 0.0 110.803 -178.938 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 25.1 ttt180 -60.72 -42.77 97.92 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.738 -0.468 . . . . 0.0 109.738 -179.787 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.402 ' HB2' ' O ' ' A' ' 115' ' ' ARG . 7.4 mmtt -74.96 -30.05 61.1 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.659 178.508 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -62.71 -47.92 81.51 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 176.387 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 72.2 mt -66.32 -40.57 87.11 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.037 177.128 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -55.74 -48.31 75.47 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.397 178.64 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -74.94 -35.18 62.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.037 -178.408 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.695 HD11 ' HA ' ' A' ' 79' ' ' LYS . 6.3 tt -62.02 -50.23 72.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.28 -178.164 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 60.8 mt -83.12 -40.32 16.17 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.865 -177.889 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 . . . . . 0 C--O 1.251 1.142 0 CA-C-O 118.311 -0.852 . . . . 0.0 110.544 -177.281 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.747 0 N-CA-C 112.068 -0.413 . . . . 0.0 112.068 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 22.6 p -91.14 51.7 1.99 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.593 0.235 . . . . 0.0 110.886 -178.892 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' MET . . . . . 0.439 ' HB3' ' HG2' ' A' ' 5' ' ' GLU . 3.5 mpp? -54.96 -49.41 71.45 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.971 0.415 . . . . 0.0 109.986 178.251 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 3.5 m 56.38 38.14 29.45 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.665 176.537 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.439 ' HG2' ' HB3' ' A' ' 3' ' ' MET . 20.7 mm-40 -74.36 76.03 1.88 Allowed 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.641 -175.093 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -111.74 -63.33 1.43 Allowed 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 168.366 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.9 t 21.92 78.75 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.607 0 O-C-N 124.726 1.266 . . . . 0.0 113.691 171.21 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 64.4 t60 -73.03 149.13 89.58 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-N 115.661 -0.699 . . . . 0.0 109.857 178.842 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_exo -46.47 102.56 0.04 OUTLIER 'Trans proline' 0 C--N 1.355 0.886 0 C-N-CA 122.283 1.988 . . . . 0.0 111.462 172.843 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 63.33 68.29 0.62 Allowed 'General case' 0 C--O 1.233 0.205 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.48 -171.529 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -52.68 -31.2 36.12 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 114.828 -1.078 . . . . 0.0 111.848 -175.335 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -70.75 -1.38 11.31 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.082 -0.508 . . . . 0.0 112.348 -177.158 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 20.8 m -89.4 -3.22 58.52 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 111.8 0.296 . . . . 0.0 111.8 -174.624 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.436 ' HA ' ' HA ' ' A' ' 46' ' ' CYS . 35.8 m-85 -66.14 135.2 54.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.857 0.36 . . . . 0.0 111.878 -179.564 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 50.3 mm -92.36 -40.94 12.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 171.315 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 7.4 p -155.49 136.74 5.27 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 CA-C-N 115.179 -0.919 . . . . 0.0 109.974 178.356 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 22.4 ptt180 -149.52 114.29 5.35 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.818 0.342 . . . . 0.0 110.232 178.053 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 15.0 m -150.09 -170.82 0.17 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.325 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.057 -178.045 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.544 ' HG2' ' OE1' ' A' ' 105' ' ' GLN . 5.9 ttpm? -87.57 132.69 33.97 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.592 179.343 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.477 ' O ' ' HB2' ' A' ' 41' ' ' SER . . . -157.45 -178.22 7.18 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.178 -0.465 . . . . 0.0 109.846 176.968 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.588 ' HB ' ' HB ' ' A' ' 103' ' ' THR . 38.2 t -112.53 107.77 23.82 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 CA-C-N 116.647 -0.252 . . . . 0.0 110.841 -179.625 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 11.9 m -73.94 96.48 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 CA-C-O 121.368 0.604 . . . . 0.0 110.279 175.817 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 91.9 mmm -82.92 119.41 24.38 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.772 -176.486 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.46 HG23 ' CE1' ' A' ' 33' ' ' PHE . 10.0 t -93.9 171.16 9.04 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.055 176.965 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 14.4 ttp180 -133.46 21.47 3.98 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 178.483 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.426 ' HB3' ' CB ' ' A' ' 29' ' ' SER . 35.6 t70 50.68 36.81 14.98 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 114.778 -1.101 . . . . 0.0 110.536 179.748 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 34.1 t70 61.98 83.21 0.16 Allowed 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.542 -179.528 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 24.2 p 50.1 27.35 2.49 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 115.277 -0.874 . . . . 0.0 112.894 178.009 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.426 ' CB ' ' HB3' ' A' ' 26' ' ' ASP . 32.4 t -70.17 -36.16 74.5 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-O 120.653 0.263 . . . . 0.0 110.981 -178.891 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 150.79 -91.77 0.14 Allowed Glycine 0 C--N 1.332 0.351 0 C-N-CA 120.918 -0.658 . . . . 0.0 112.535 178.813 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -81.99 163.26 43.42 Favored Glycine 0 CA--C 1.518 0.279 0 C-N-CA 121.199 -0.524 . . . . 0.0 112.683 -178.775 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' TRP . . . . . 0.467 ' HH2' ' HB3' ' A' ' 99' ' ' LYS . 74.6 m95 -93.57 147.8 22.67 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-O 120.732 0.301 . . . . 0.0 110.803 -179.337 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.46 ' CE1' HG23 ' A' ' 24' ' ' THR . 6.8 p90 -156.34 150.34 19.58 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.896 176.827 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_exo -63.27 139.8 73.81 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.589 2.193 . . . . 0.0 111.893 176.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -105.64 131.73 52.66 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.604 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 16.0 tp10 64.36 -73.06 0.06 Allowed 'General case' 0 CA--C 1.533 0.312 0 O-C-N 123.851 0.719 . . . . 0.0 111.063 -179.581 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.848 ' HA3' HE21 ' A' ' 66' ' ' GLN . . . -148.65 109.74 0.46 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 121.173 -0.536 . . . . 0.0 111.912 179.726 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.446 ' O ' HG22 ' A' ' 21' ' ' VAL . . . -89.88 5.29 83.42 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 121.393 -0.432 . . . . 0.0 112.539 -178.42 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -81.62 -41.34 9.95 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.945 -0.645 . . . . 0.0 111.802 178.27 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.523 HD12 ' HG3' ' A' ' 19' ' ' LYS . 3.7 tp -143.54 91.95 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 CA-C-O 121.426 0.632 . . . . 0.0 110.756 -179.753 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.477 ' HB2' ' O ' ' A' ' 20' ' ' ALA . 21.4 m -106.32 119.33 38.98 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 173.188 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.611 ' HB3' ' O ' ' A' ' 64' ' ' GLU . 8.2 tpt85 -77.24 90.3 3.72 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 121.453 0.644 . . . . 0.0 109.419 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 38.8 t -94.87 117.88 39.68 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 CA-C-N 115.241 -0.89 . . . . 0.0 110.345 -177.361 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -129.17 118.3 2.65 Favored Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 121.174 -0.536 . . . . 0.0 111.995 179.655 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 61.4 t -96.04 110.22 24.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 176.864 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' CYS . . . . . 0.483 ' SG ' ' HB3' ' A' ' 60' ' ' LEU . 12.3 p -107.96 147.42 31.08 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.583 -179.468 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 10.3 tmtt? -102.03 95.16 6.17 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 176.611 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.574 HG21 ' HE1' ' A' ' 76' ' ' TYR . 35.4 m -71.86 141.94 16.0 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.432 -173.859 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 22.2 mmt -95.89 178.77 5.32 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.403 179.391 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 1.8 p80 -126.81 118.49 22.49 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 120.518 0.199 . . . . 0.0 110.739 -178.628 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_exo -65.37 -39.23 23.14 Favored 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 122.452 2.102 . . . . 0.0 110.703 174.13 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -163.62 139.27 6.51 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 176.228 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 109.27 117.63 4.01 Favored Glycine 0 CA--C 1.517 0.179 0 N-CA-C 111.475 -0.65 . . . . 0.0 111.475 -176.089 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 27.1 p-10 -59.74 -39.2 83.97 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 111.914 0.338 . . . . 0.0 111.914 -174.767 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -96.99 18.83 56.85 Favored Glycine 0 CA--C 1.519 0.316 0 C-N-CA 121.224 -0.512 . . . . 0.0 113.442 -174.835 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 29.5 mmt180 -93.53 -9.8 37.0 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.942 0.371 . . . . 0.0 110.925 179.245 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 14.6 p -98.03 141.83 30.5 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.355 178.145 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 174.13 -145.67 8.25 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 121.058 -0.592 . . . . 0.0 111.945 -179.345 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.446 ' HB2' ' HB ' ' A' ' 77' ' ' VAL . 83.2 m-85 -117.15 161.42 19.47 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.483 ' HB3' ' SG ' ' A' ' 46' ' ' CYS . 2.0 tt -147.07 112.56 5.61 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 176.983 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.499 ' HB ' ' HB2' ' A' ' 75' ' ' CYS . 59.5 mt -84.78 103.69 12.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 174.206 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 12.5 t-80 -117.25 104.51 11.25 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.038 -169.722 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -100.6 121.83 7.38 Favored Glycine 0 C--N 1.333 0.415 0 N-CA-C 111.3 -0.72 . . . . 0.0 111.3 177.493 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.611 ' O ' ' HB3' ' A' ' 42' ' ' ARG . 16.1 pt-20 -150.3 -166.82 2.65 Favored 'General case' 0 C--O 1.24 0.588 0 CA-C-O 121.205 0.526 . . . . 0.0 112.37 -170.707 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.425 ' HB3' ' HB3' ' A' ' 42' ' ' ARG . 29.4 ttt180 74.68 -30.97 0.21 Allowed 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.974 1.31 . . . . 0.0 112.778 170.487 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.848 HE21 ' HA3' ' A' ' 37' ' ' GLY . 7.1 tp60 -59.09 131.69 51.8 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 110.232 -0.284 . . . . 0.0 110.232 177.697 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 85.2 tttt 66.07 76.4 0.31 Allowed 'General case' 0 C--O 1.235 0.332 0 O-C-N 123.7 0.625 . . . . 0.0 109.823 -178.553 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 69.65 -86.78 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.005 -0.998 . . . . 0.0 110.99 -176.397 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 28.9 tptp -175.48 98.47 0.07 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.012 0.434 . . . . 0.0 110.467 -176.806 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -157.89 166.95 31.33 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 172.802 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 6.2 t -99.13 109.31 24.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-O 120.797 0.332 . . . . 0.0 110.523 -176.698 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 33.9 m -94.48 -6.65 10.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.223 -177.41 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -148.51 117.29 6.67 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 -178.241 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -127.92 124.63 37.82 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.094 177.409 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' CYS . . . . . 0.543 ' SG ' ' CD2' ' A' ' 100' ' ' PHE . 24.6 m -145.96 89.15 1.86 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.407 176.915 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.574 ' HE1' HG21 ' A' ' 48' ' ' VAL . 87.1 t80 -71.9 136.75 47.02 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.554 -0.535 . . . . 0.0 109.554 173.478 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.446 ' HB ' ' HB2' ' A' ' 59' ' ' PHE . 58.3 t -125.31 96.0 3.5 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 CA-C-O 120.943 0.401 . . . . 0.0 110.372 -175.772 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 43.4 ttp180 -84.4 69.07 10.46 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.215 0.531 . . . . 0.0 110.023 179.422 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.541 ' HA ' ' HG ' ' A' ' 124' ' ' LEU . 8.2 mtpm? 52.92 21.13 1.88 Allowed 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 115.254 -0.885 . . . . 0.0 112.345 179.17 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -125.19 114.08 18.51 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 172.181 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.478 HD12 HG12 ' A' ' 121' ' ' ILE . 2.8 tm? -152.97 138.23 17.47 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.601 -170.114 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.474 ' HB ' ' HB3' ' A' ' 94' ' ' LYS . 48.6 t -132.45 88.92 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.8 173.618 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.495 ' HD1' ' HD2' ' A' ' 91' ' ' HIS . 0.3 OUTLIER -85.51 146.58 26.85 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 174.829 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.445 ' HB ' ' CE1' ' A' ' 92' ' ' HIS . 38.3 m -140.69 121.74 14.66 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 177.901 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.429 ' HE3' ' HA ' ' A' ' 88' ' ' PRO . 86.5 tttt -83.51 96.0 8.47 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 176.181 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -66.85 -42.63 85.38 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.167 0.508 . . . . 0.0 109.813 179.105 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ASN . . . . . 0.679 ' HB2' ' HD2' ' A' ' 88' ' ' PRO . 9.8 p30 -161.41 164.27 18.67 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-N 115.145 -0.934 . . . . 0.0 108.835 177.442 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.679 ' HD2' ' HB2' ' A' ' 87' ' ' ASN . 9.6 Cg_endo -50.26 -22.55 8.52 Favored 'Trans proline' 0 C--N 1.352 0.75 0 C-N-CA 123.264 2.643 . . . . 0.0 114.091 -175.861 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 10.8 p -116.9 15.23 15.22 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 112.409 0.522 . . . . 0.0 112.409 -176.01 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.435 ' HB3' ' ND2' ' A' ' 87' ' ' ASN . 45.4 t80 -152.1 111.62 3.95 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-O 121.152 0.501 . . . . 0.0 111.383 178.924 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' HIS . . . . . 0.498 ' HD1' ' HE2' ' A' ' 104' ' ' PHE . 2.3 m80 -106.81 155.06 20.12 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 169.409 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' HIS . . . . . 0.445 ' CE1' ' HB ' ' A' ' 84' ' ' THR . 20.6 p80 -146.23 146.98 30.98 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 171.327 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' TRP . . . . . 0.559 ' CE2' ' HB2' ' A' ' 100' ' ' PHE . 28.4 p90 -123.52 146.21 48.27 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.173 0.511 . . . . 0.0 111.072 -178.778 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.474 ' HB3' ' HB ' ' A' ' 82' ' ' VAL . 3.0 tmtm? -110.25 101.18 9.95 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.051 -0.977 . . . . 0.0 108.83 -178.05 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 28.2 m -137.55 145.82 28.64 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 -179.609 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 27.9 t70 55.26 27.86 10.4 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 121.778 0.799 . . . . 0.0 109.978 -177.524 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.47 ' HA ' ' HE3' ' A' ' 94' ' ' LYS . 64.6 t30 74.88 -15.44 0.65 Allowed 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 114.66 -1.155 . . . . 0.0 111.633 -179.116 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 33.7 ttm180 -89.98 156.41 18.44 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.701 0.286 . . . . 0.0 110.462 -177.155 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.467 ' HB3' ' HH2' ' A' ' 32' ' ' TRP . 62.0 mtpt -116.14 133.53 55.92 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.219 -178.62 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.559 ' HB2' ' CE2' ' A' ' 93' ' ' TRP . 31.0 m-85 -128.81 139.51 52.14 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 175.577 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -110.8 163.56 12.28 Favored Glycine 0 N--CA 1.453 -0.183 0 C-N-CA 121.291 -0.48 . . . . 0.0 112.417 -178.315 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.418 ' HB2' ' HZ3' ' A' ' 93' ' ' TRP . 31.3 tp -146.91 112.8 5.74 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 110.145 -0.317 . . . . 0.0 110.145 -178.723 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.588 ' HB ' ' HB ' ' A' ' 21' ' ' VAL . 84.1 m -92.79 134.17 35.32 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 176.312 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.498 ' HE2' ' HD1' ' A' ' 91' ' ' HIS . 46.9 m-85 -90.97 137.98 31.95 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.243 -178.816 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.544 ' OE1' ' HG2' ' A' ' 19' ' ' LYS . 52.7 mt-30 -102.78 -26.39 13.17 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.637 -173.727 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 49.4 m -148.47 159.72 38.16 Favored Pre-proline 0 CA--C 1.536 0.409 0 CA-C-O 120.434 0.159 . . . . 0.0 110.652 -179.667 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.565 ' O ' ' HD3' ' A' ' 111' ' ' ARG . 57.0 Cg_exo -53.48 -34.54 72.44 Favored 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 122.657 2.238 . . . . 0.0 112.413 178.273 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -56.81 -61.27 2.55 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.986 -179.069 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -67.17 -38.41 85.39 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.901 -179.149 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -54.85 -53.05 60.38 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.236 179.231 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.565 ' HD3' ' O ' ' A' ' 107' ' ' PRO . 5.2 mpt_? -71.62 -37.42 70.91 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.555 -178.051 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -59.4 -55.9 28.81 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.638 -179.523 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.461 ' O ' HG23 ' A' ' 117' ' ' VAL . 37.8 m-85 -63.86 -50.24 69.58 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.901 179.718 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.613 ' O ' ' HG2' ' A' ' 118' ' ' ARG . 22.3 t70 -53.01 -67.92 0.21 Allowed 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 121.155 0.502 . . . . 0.0 110.649 -178.934 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 53.1 ttt180 -51.91 -46.31 64.55 Favored 'General case' 0 C--O 1.242 0.691 0 CA-C-N 114.972 -1.013 . . . . 0.0 111.166 -178.107 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -59.52 -42.63 97.75 Favored Glycine 0 C--N 1.334 0.451 0 CA-C-N 115.869 -0.605 . . . . 0.0 112.148 179.133 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.461 HG23 ' O ' ' A' ' 113' ' ' PHE . 41.2 t -66.8 -36.03 76.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 C-N-CA 122.156 0.182 . . . . 0.0 110.698 179.683 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.613 ' HG2' ' O ' ' A' ' 114' ' ' ASP . 8.9 mmm180 -58.53 -56.54 20.8 Favored 'General case' 0 C--O 1.241 0.628 0 CA-C-O 121.277 0.561 . . . . 0.0 109.646 178.164 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 9.8 mmpt? -61.24 -38.97 88.59 Favored 'General case' 0 C--O 1.239 0.507 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.191 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -59.28 -53.93 52.64 Favored 'General case' 0 C--O 1.226 -0.184 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.872 179.654 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.478 HG12 HD12 ' A' ' 81' ' ' LEU . 73.8 mt -55.09 -45.04 76.9 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 O-C-N 123.236 0.335 . . . . 0.0 110.493 -179.097 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.411 ' O ' ' HB2' ' A' ' 126' ' ' GLU . 50.5 mt-10 -55.3 -55.93 25.88 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.07 178.632 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -69.02 -24.8 64.25 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 121.258 0.552 . . . . 0.0 110.971 -179.145 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.541 ' HG ' ' HA ' ' A' ' 79' ' ' LYS . 9.2 tt -74.14 -46.75 40.52 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.54 -0.754 . . . . 0.0 111.956 -174.901 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.448 HG22 ' O ' ' A' ' 121' ' ' ILE . 18.9 tt -106.57 -33.03 2.66 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 N-CA-C 112.38 0.511 . . . . 0.0 112.38 -173.165 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.411 ' HB2' ' O ' ' A' ' 122' ' ' GLU . 44.1 mt-10 . . . . . 0 C--O 1.248 0.988 0 CA-C-O 118.484 -0.769 . . . . 0.0 110.182 -179.157 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.798 0 N-CA-C 112.11 -0.396 . . . . 0.0 112.11 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.5 t -98.68 -25.19 14.77 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 121.187 0.518 . . . . 0.0 110.323 -179.327 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 24.3 mmt -112.88 114.0 26.32 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.789 -178.778 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 15.3 t -92.87 145.41 24.41 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.72 0.295 . . . . 0.0 110.377 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -70.1 99.22 1.44 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.88 0.371 . . . . 0.0 110.647 178.518 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.4 ' OE2' ' HG3' ' A' ' 69' ' ' LYS . 19.0 tt0 -112.6 -69.52 0.86 Allowed 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 175.516 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.549 HG22 ' HB3' ' A' ' 68' ' ' ASP . 82.5 p 47.08 -152.15 0.08 Allowed 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 112.751 0.649 . . . . 0.0 112.751 168.182 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.458 ' HB3' ' HD2' ' A' ' 9' ' ' PRO . 16.6 m80 -130.49 164.54 40.66 Favored Pre-proline 0 CA--C 1.534 0.348 0 O-C-N 122.185 -0.322 . . . . 0.0 110.406 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.458 ' HD2' ' HB3' ' A' ' 8' ' ' HIS . 63.5 Cg_exo -41.72 -53.89 3.1 Favored 'Trans proline' 0 C--N 1.356 0.964 0 C-N-CA 123.567 2.845 . . . . 0.0 114.548 -172.041 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -91.0 22.71 3.53 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 112.108 0.41 . . . . 0.0 112.108 -174.44 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -60.23 -33.17 71.9 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 121.351 0.596 . . . . 0.0 110.409 177.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -62.44 -31.66 72.4 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.507 -0.77 . . . . 0.0 111.173 -177.036 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.72 ' HB2' ' SG ' ' A' ' 46' ' ' CYS . 20.3 m -87.25 14.28 8.1 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.868 -173.394 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.492 ' CE2' ' HA3' ' A' ' 44' ' ' GLY . 4.1 m-30 -66.4 85.1 0.1 Allowed 'General case' 0 C--O 1.234 0.282 0 CA-C-O 120.85 0.357 . . . . 0.0 110.917 175.555 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.489 HD12 ' HB3' ' A' ' 47' ' ' LYS . 55.0 mt -70.16 -59.0 3.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 175.634 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 62.0 t -110.0 113.62 44.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 177.945 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.483 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 0.0 OUTLIER -136.63 130.86 32.88 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.772 0.32 . . . . 0.0 110.177 178.171 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 35.1 m -131.83 171.68 17.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.037 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.477 ' HB2' HD11 ' A' ' 40' ' ' ILE . 57.0 pttt -110.44 109.34 19.68 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 177.495 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -157.01 158.26 36.22 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.724 -177.318 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 50.0 t -81.39 111.85 18.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.642 0.258 . . . . 0.0 110.763 -178.579 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.51 HG23 ' NE2' ' A' ' 35' ' ' GLN . 17.1 m -75.26 128.62 37.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.362 176.126 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 87.1 mmm -122.34 166.66 14.33 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 -177.135 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 9.1 t -143.93 164.51 30.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.445 0.64 . . . . 0.0 111.08 178.477 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.538 ' HB3' ' HB2' ' A' ' 99' ' ' LYS . 73.2 ttt180 -150.04 140.02 21.96 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 -179.846 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.554 ' HA ' ' HG2' ' A' ' 98' ' ' ARG . 26.0 t0 -79.15 37.39 0.32 Allowed 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 121.348 0.594 . . . . 0.0 110.322 -177.869 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.476 ' HA ' ' HG3' ' A' ' 99' ' ' LYS . 22.0 t70 63.49 -63.36 0.13 Allowed 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 123.891 0.876 . . . . 0.0 109.715 -171.018 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 22.3 p -68.93 170.8 9.06 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.861 168.719 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 15.7 m 64.78 96.06 0.05 OUTLIER 'General case' 0 CA--C 1.536 0.431 0 CA-C-O 120.984 0.421 . . . . 0.0 111.142 178.346 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -80.59 22.91 4.43 Favored Glycine 0 CA--C 1.519 0.301 0 C-N-CA 121.494 -0.384 . . . . 0.0 113.557 -175.857 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -80.48 -27.02 53.05 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.949 -0.643 . . . . 0.0 112.458 179.022 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' TRP . . . . . 0.535 ' CH2' ' HB3' ' A' ' 99' ' ' LYS . 83.4 m95 58.15 101.79 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 121.452 0.644 . . . . 0.0 110.841 -176.312 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 31.1 p90 -101.16 135.51 19.9 Favored Pre-proline 0 CA--C 1.532 0.254 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.915 -174.266 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.568 ' HB2' ' HA3' ' A' ' 38' ' ' GLY . 73.7 Cg_endo -79.05 111.41 2.93 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.694 2.262 . . . . 0.0 112.133 178.756 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.51 ' NE2' HG23 ' A' ' 22' ' ' VAL . 4.7 pm0 -75.69 168.3 20.28 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.36 -179.392 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 62.07 -77.84 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 115.395 -0.821 . . . . 0.0 110.794 177.311 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -148.52 -7.72 0.21 Allowed Glycine 0 CA--C 1.518 0.264 0 C-N-CA 121.252 -0.499 . . . . 0.0 112.558 -179.687 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.568 ' HA3' ' HB2' ' A' ' 34' ' ' PRO . . . 58.08 83.07 0.05 OUTLIER Glycine 0 C--N 1.334 0.462 0 C-N-CA 121.38 -0.438 . . . . 0.0 113.113 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -157.35 174.23 34.84 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 121.039 -0.601 . . . . 0.0 112.007 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.477 HD11 ' HB2' ' A' ' 19' ' ' LYS . 9.2 tt -58.55 129.24 20.38 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 CA-C-O 121.074 0.464 . . . . 0.0 110.081 178.66 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 43.7 t -121.61 146.02 47.4 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.317 0.58 . . . . 0.0 111.705 -170.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.649 ' HB3' ' HB2' ' A' ' 64' ' ' GLU . 19.8 ttt180 -77.61 83.23 4.0 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 114.971 -1.013 . . . . 0.0 108.457 171.752 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.483 ' O ' ' HA ' ' A' ' 17' ' ' ARG . 45.7 t -73.1 92.46 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.466 -175.997 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.492 ' HA3' ' CE2' ' A' ' 14' ' ' TYR . . . -93.24 95.67 2.01 Favored Glycine 0 N--CA 1.448 -0.565 0 CA-C-N 115.864 -0.607 . . . . 0.0 112.63 -179.467 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 61.4 t -82.14 93.24 2.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-O 121.407 0.623 . . . . 0.0 109.409 176.625 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' CYS . . . . . 0.72 ' SG ' ' HB2' ' A' ' 13' ' ' SER . 43.0 t -91.45 114.3 26.8 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.547 -177.926 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.489 ' HB3' HD12 ' A' ' 15' ' ' ILE . 40.0 ttmt -75.91 92.6 3.12 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 175.055 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.478 HG21 ' CE1' ' A' ' 76' ' ' TYR . 28.3 m -86.65 170.2 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.571 -174.022 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 26.0 ptm -126.25 -178.13 4.21 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.233 -179.616 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 8.6 p80 -134.22 159.71 71.28 Favored Pre-proline 0 C--N 1.326 -0.442 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 178.384 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.4 ' O ' ' HB2' ' A' ' 52' ' ' GLU . 90.9 Cg_exo -46.1 137.09 13.84 Favored 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 122.797 2.331 . . . . 0.0 112.414 178.596 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.4 ' HB2' ' O ' ' A' ' 51' ' ' PRO . 47.1 mt-10 74.13 -54.52 0.68 Allowed 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 123.575 0.75 . . . . 0.0 110.913 -176.952 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 77.77 95.49 0.23 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 121.255 -0.498 . . . . 0.0 112.392 177.455 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 32.1 p30 -69.45 -27.0 64.86 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.921 0.391 . . . . 0.0 110.763 179.145 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 140.98 -42.15 1.21 Allowed Glycine 0 C--N 1.331 0.286 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.974 177.462 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 7.3 mmm180 -80.64 103.31 10.4 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 120.836 0.35 . . . . 0.0 110.264 -177.9 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 20.9 m -81.09 141.36 34.39 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.616 -177.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -88.68 -174.24 47.02 Favored Glycine 0 C--N 1.331 0.259 0 CA-C-N 116.214 -0.448 . . . . 0.0 112.324 -178.3 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -132.36 139.17 48.02 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.124 0.488 . . . . 0.0 110.583 -179.089 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 3.1 tt -119.82 112.13 18.85 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 176.979 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.472 ' HB ' ' HB3' ' A' ' 75' ' ' CYS . 44.5 mm -75.94 92.73 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 175.842 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 16.9 t-80 -104.19 93.54 4.89 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.469 -175.725 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -102.21 112.71 4.39 Favored Glycine 0 CA--C 1.518 0.277 0 C-N-CA 121.235 -0.507 . . . . 0.0 112.7 -175.622 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.649 ' HB2' ' HB3' ' A' ' 42' ' ' ARG . 43.5 mm-40 -93.43 162.35 14.01 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.708 0.289 . . . . 0.0 110.82 178.043 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.415 HH11 ' HD3' ' A' ' 65' ' ' ARG . 15.1 ttm180 -82.47 151.78 26.38 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 167.77 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 28.4 mm-40 -59.39 88.03 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 120.884 0.373 . . . . 0.0 110.735 -179.586 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 87.1 tttt 173.76 -21.39 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.173 -0.921 . . . . 0.0 108.981 -176.915 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.549 ' HB3' HG22 ' A' ' 7' ' ' THR . 28.1 m-20 71.24 49.59 0.32 Allowed 'General case' 0 C--O 1.237 0.415 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.384 176.064 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.444 ' O ' ' HB2' ' A' ' 70' ' ' LEU . 11.9 tmtt? -176.0 60.19 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.132 -179.155 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.483 ' O ' ' HA ' ' A' ' 64' ' ' GLU . 54.3 tp 174.2 105.29 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.041 177.757 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 4.0 m -70.73 96.0 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 CA-C-O 121.21 0.529 . . . . 0.0 110.593 174.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 28.6 m -86.99 -9.06 11.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.915 179.649 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.463 ' HB2' HG21 ' A' ' 22' ' ' VAL . 1.5 tm? -159.72 121.1 3.21 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 177.793 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -129.09 122.27 29.57 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 179.328 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' CYS . . . . . 0.472 ' HB3' ' HB ' ' A' ' 61' ' ' ILE . 42.6 t -149.21 87.97 1.56 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.204 0.526 . . . . 0.0 110.572 178.877 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.478 ' CE1' HG21 ' A' ' 48' ' ' VAL . 67.0 t80 -77.26 123.04 25.91 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.146 175.065 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.528 HG11 HD12 ' A' ' 81' ' ' LEU . 17.3 m -133.62 111.64 16.05 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 CA-C-O 121.173 0.511 . . . . 0.0 110.092 177.03 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 16.0 ptm180 -81.25 -17.39 49.64 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.796 -178.222 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.438 ' HA ' HD21 ' A' ' 124' ' ' LEU . 85.6 tttt -172.15 152.69 2.9 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.373 -177.429 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 26.8 t70 71.6 105.25 0.07 Allowed 'General case' 0 N--CA 1.468 0.461 0 O-C-N 123.704 0.627 . . . . 0.0 112.235 173.917 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.535 HD23 ' N ' ' A' ' 82' ' ' VAL . 4.7 tt -179.37 129.21 0.1 Allowed 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 177.131 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.535 ' N ' HD23 ' A' ' 81' ' ' LEU . 75.6 t -128.02 129.95 69.7 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 N-CA-C 110.33 -0.248 . . . . 0.0 110.33 177.832 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.439 ' CE2' HG21 ' A' ' 117' ' ' VAL . 6.7 m-85 -83.24 159.56 21.94 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.24 0.543 . . . . 0.0 111.024 178.114 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 87.8 m -150.05 135.79 18.43 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.361 177.674 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.613 ' H ' ' HD2' ' A' ' 85' ' ' LYS . 0.0 OUTLIER -105.59 126.51 52.23 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.795 0.331 . . . . 0.0 110.43 -178.617 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -98.51 -46.08 5.87 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.334 0.588 . . . . 0.0 109.485 175.793 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ASN . . . . . 0.819 ' HB2' ' HB3' ' A' ' 90' ' ' PHE . 5.1 m-20 -125.17 152.03 70.23 Favored Pre-proline 0 C--N 1.327 -0.411 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 174.387 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -54.32 -25.88 41.07 Favored 'Trans proline' 0 CA--C 1.533 0.47 0 C-N-CA 122.44 2.094 . . . . 0.0 112.431 177.552 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.423 ' HA ' ' HD2' ' A' ' 104' ' ' PHE . 14.3 p -112.82 11.99 19.42 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.746 178.919 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.819 ' HB3' ' HB2' ' A' ' 87' ' ' ASN . 35.4 t80 -136.71 96.89 3.41 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-O 121.266 0.555 . . . . 0.0 109.642 178.111 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' HIS . . . . . 0.401 ' NE2' ' HB3' ' A' ' 83' ' ' TYR . 0.4 OUTLIER -97.36 163.08 13.04 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 176.632 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 28.6 p80 -166.63 169.97 13.07 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.909 0.385 . . . . 0.0 111.233 178.031 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' TRP . . . . . 0.54 ' CE2' ' HB2' ' A' ' 100' ' ' PHE . 38.8 p90 -149.69 134.94 18.17 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.36 174.539 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 7.7 tmtm? -102.36 116.68 33.14 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.817 -179.482 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.519 HG23 ' H ' ' A' ' 97' ' ' ASN . 34.9 m -105.72 -170.6 0.32 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.398 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.261 179.596 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -54.62 -25.87 29.33 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 122.877 0.471 . . . . 0.0 111.754 -176.707 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.519 ' H ' HG23 ' A' ' 95' ' ' VAL . 4.9 p-10 -155.11 131.3 10.26 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.179 -0.464 . . . . 0.0 109.972 177.975 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.554 ' HG2' ' HA ' ' A' ' 26' ' ' ASP . 57.7 mtt180 73.04 162.09 0.26 Allowed 'General case' 0 C--O 1.236 0.354 0 CA-C-O 122.071 0.939 . . . . 0.0 112.237 -173.766 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.538 ' HB2' ' HB3' ' A' ' 25' ' ' ARG . 63.5 mttp -122.35 124.54 43.95 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 114.221 -1.354 . . . . 0.0 108.055 174.623 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.54 ' HB2' ' CE2' ' A' ' 93' ' ' TRP . 1.7 m-85 -101.11 128.87 46.98 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 -177.311 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -111.04 164.17 12.18 Favored Glycine 0 N--CA 1.454 -0.114 0 C-N-CA 121.431 -0.414 . . . . 0.0 112.694 -176.743 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 7.0 tt -150.24 104.37 3.25 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 -179.65 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 36.6 m -91.84 115.52 28.13 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.013 178.97 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.423 ' HD2' ' HA ' ' A' ' 89' ' ' THR . 82.1 m-85 -67.35 160.1 27.99 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.616 -175.439 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 60.4 tp60 -92.6 -42.0 9.91 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.382 -178.518 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 49.5 m -143.65 153.95 58.89 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.402 -179.03 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -52.35 -27.96 33.11 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 122.627 2.218 . . . . 0.0 112.344 177.258 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -60.41 -62.18 2.05 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.159 177.952 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 -66.02 -29.22 69.55 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.589 179.573 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.407 ' HA ' ' CD1' ' A' ' 104' ' ' PHE . . . -57.8 -57.51 12.45 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.585 175.767 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 62.0 mtp180 -60.94 -49.28 78.07 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.904 -179.317 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -60.75 -49.68 76.51 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.498 -176.174 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 66.0 t80 -71.62 -38.03 70.83 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.707 -177.191 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -55.87 -61.87 2.08 Favored 'General case' 0 C--O 1.24 0.557 0 CA-C-O 121.847 0.832 . . . . 0.0 110.241 178.843 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 40.7 ttm180 -60.98 -45.88 92.99 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 114.643 -1.162 . . . . 0.0 110.571 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -62.19 -41.45 99.71 Favored Glycine 0 N--CA 1.451 -0.304 0 CA-C-N 115.506 -0.77 . . . . 0.0 112.975 -177.065 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.523 ' O ' HG12 ' A' ' 121' ' ' ILE . 8.1 p -73.98 -33.27 35.9 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-N 116.78 0.29 . . . . 0.0 110.306 -177.228 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 27.5 tpt180 -57.28 -50.32 73.29 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 172.035 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 3.9 tmmm? -57.85 -38.76 76.25 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.725 176.89 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -65.53 -40.93 93.5 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.254 179.562 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.523 HG12 ' O ' ' A' ' 117' ' ' VAL . 46.0 mm -62.9 -40.76 90.1 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 178.216 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -62.42 -43.87 97.79 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.58 174.518 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -65.75 -23.85 66.82 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.006 179.638 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.438 HD21 ' HA ' ' A' ' 79' ' ' LYS . 5.4 tt -77.98 -52.6 8.56 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.452 179.054 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 61.6 mt -94.62 -47.21 13.38 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 -171.209 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 13.5 tp10 . . . . . 0 C--O 1.243 0.746 0 CA-C-O 118.516 -0.754 . . . . 0.0 110.343 -174.966 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.754 0 N-CA-C 111.863 -0.495 . . . . 0.0 111.863 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 25.5 t -73.04 85.2 1.3 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.185 0.516 . . . . 0.0 110.042 179.452 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 66.4 mtt -71.18 81.94 0.72 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.559 177.024 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 10.2 t -90.51 -13.3 34.95 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.36 -0.837 . . . . 0.0 111.644 -174.504 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -88.71 -64.8 1.09 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.394 0.616 . . . . 0.0 109.583 -179.3 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -135.22 153.84 51.8 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 108.617 -0.882 . . . . 0.0 108.617 177.04 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.557 HG21 ' HB2' ' A' ' 64' ' ' GLU . 34.2 p -90.08 -12.18 39.2 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.369 0.604 . . . . 0.0 110.498 178.598 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -130.7 125.63 21.52 Favored Pre-proline 0 C--N 1.328 -0.369 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 170.98 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -54.45 -25.7 41.28 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.381 2.054 . . . . 0.0 111.786 -179.48 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -86.77 -57.86 2.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.331 -0.85 . . . . 0.0 109.927 175.903 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.422 ' HA ' ' CE2' ' A' ' 14' ' ' TYR . 21.7 t70 63.9 0.21 0.9 Allowed 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 115.35 -0.841 . . . . 0.0 112.317 174.933 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -84.32 -32.22 24.43 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.284 0.564 . . . . 0.0 110.653 -177.341 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 28.6 m -74.1 -4.17 34.02 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.139 -0.937 . . . . 0.0 112.65 -171.068 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.422 ' CE2' ' HA ' ' A' ' 11' ' ' ASP . 76.9 m-85 -67.88 110.25 3.76 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-O 120.829 0.347 . . . . 0.0 110.603 178.823 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 48.8 mm -83.6 -55.77 6.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.934 -0.575 . . . . 0.0 109.877 178.459 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 61.8 t -122.91 134.3 66.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.376 -178.869 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 32.8 mtm180 -134.7 94.77 3.23 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 175.04 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 13.6 p -118.02 142.37 32.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.842 0.353 . . . . 0.0 110.882 -177.166 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 64.2 tttm -72.15 131.28 42.58 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.05 -179.42 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -161.7 -164.31 1.09 Allowed 'General case' 0 C--O 1.239 0.52 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.302 179.447 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.403 ' HB ' ' HB ' ' A' ' 103' ' ' THR . 61.7 t -124.21 105.7 15.77 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 CA-C-N 116.741 -0.208 . . . . 0.0 110.525 177.303 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.446 HG21 HG23 ' A' ' 72' ' ' VAL . 28.6 m -72.89 116.78 15.53 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 CA-C-O 121.475 0.655 . . . . 0.0 110.761 178.476 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 25.8 mmt -92.22 110.3 21.68 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.22 178.455 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.652 ' O ' ' HG3' ' A' ' 25' ' ' ARG . 7.4 t -83.23 2.53 35.35 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.578 -179.646 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.775 ' HG3' HH11 ' A' ' 25' ' ' ARG . 0.4 OUTLIER 53.37 172.88 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.956 0 N-CA-C 115.397 1.628 . . . . 0.0 115.397 166.449 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.545 ' HB2' ' CE2' ' A' ' 33' ' ' PHE . 36.6 t70 -143.03 6.76 1.57 Allowed 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 114.047 -1.433 . . . . 0.0 109.91 -178.936 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 65.4 m-20 66.24 -86.23 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.404 -178.219 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 22.9 t -151.1 99.95 2.73 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.334 -174.428 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.468 ' HB3' ' OD2' ' A' ' 26' ' ' ASP . 30.5 t 174.9 -54.46 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 177.983 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -111.26 -41.42 1.16 Allowed Glycine 0 N--CA 1.451 -0.307 0 N-CA-C 110.434 -1.067 . . . . 0.0 110.434 170.575 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 128.07 -109.97 1.09 Allowed Glycine 0 C--N 1.333 0.374 0 C-N-CA 121.578 -0.344 . . . . 0.0 112.675 175.122 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' TRP . . . . . 0.731 ' CE3' ' HB3' ' A' ' 25' ' ' ARG . 65.1 m95 -128.75 114.49 16.65 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 -178.797 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.545 ' CE2' ' HB2' ' A' ' 26' ' ' ASP . 8.5 p90 -120.47 151.41 53.8 Favored Pre-proline 0 C--O 1.239 0.503 0 CA-C-O 120.495 0.188 . . . . 0.0 110.966 178.47 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.475 ' HB2' ' HA3' ' A' ' 38' ' ' GLY . 73.5 Cg_endo -89.44 -154.35 0.05 OUTLIER 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 123.331 2.687 . . . . 0.0 111.739 175.171 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -156.62 147.44 21.82 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-O 120.532 0.206 . . . . 0.0 111.08 -176.779 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.478 ' HB3' ' HD3' ' A' ' 67' ' ' LYS . 12.3 mm-40 54.71 25.77 6.83 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 115.883 -0.598 . . . . 0.0 112.0 175.433 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 115.8 -42.48 1.89 Allowed Glycine 0 N--CA 1.453 -0.207 0 N-CA-C 111.497 -0.641 . . . . 0.0 111.497 -179.057 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.475 ' HA3' ' HB2' ' A' ' 34' ' ' PRO . . . 59.98 67.66 2.05 Favored Glycine 0 C--N 1.331 0.3 0 C-N-CA 121.353 -0.451 . . . . 0.0 112.76 179.198 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -153.78 -46.02 0.02 OUTLIER Glycine 0 N--CA 1.455 -0.1 0 N-CA-C 111.6 -0.6 . . . . 0.0 111.6 177.71 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.563 HG22 ' O ' ' A' ' 40' ' ' ILE . 2.6 mp -97.24 63.45 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 CA-C-O 121.634 0.73 . . . . 0.0 109.379 178.862 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.54 ' HB2' HE22 ' A' ' 66' ' ' GLN . 25.6 t -117.56 109.51 16.8 Favored 'General case' 0 C--N 1.33 -0.242 0 O-C-N 121.978 -0.451 . . . . 0.0 110.23 -178.97 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 60.4 mtp180 -89.62 110.98 21.81 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-O 120.895 0.379 . . . . 0.0 110.206 179.547 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.575 HG21 HD22 ' A' ' 102' ' ' LEU . 46.4 t -72.4 103.04 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.932 177.774 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -92.52 86.02 1.2 Allowed Glycine 0 N--CA 1.449 -0.483 0 CA-C-N 115.793 -0.639 . . . . 0.0 112.389 -178.798 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 51.4 t -71.5 100.72 0.9 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.411 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 176.564 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' CYS . . . . . 0.641 ' SG ' ' HB3' ' A' ' 60' ' ' LEU . 11.5 p -107.97 138.28 44.5 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.627 -178.982 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -95.71 119.37 34.09 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.8 -0.445 . . . . 0.0 109.8 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 33.5 m -92.69 148.38 4.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.802 -177.579 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 85.8 mtp -94.0 159.57 15.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.796 -178.524 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' HIS . . . . . 0.577 ' HB2' ' HA2' ' A' ' 55' ' ' GLY . 21.4 p-80 -75.3 137.37 71.76 Favored Pre-proline 0 CA--C 1.536 0.435 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.296 -177.587 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -82.6 45.19 1.85 Allowed 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 123.626 2.884 . . . . 0.0 112.809 -179.014 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 66.92 -77.79 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 112.935 0.717 . . . . 0.0 112.935 175.13 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -53.99 -91.67 0.01 OUTLIER Glycine 0 C--N 1.339 0.724 0 O-C-N 123.506 0.504 . . . . 0.0 114.056 -169.837 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -69.43 -15.51 63.3 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.821 0.343 . . . . 0.0 110.176 179.855 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.577 ' HA2' ' HB2' ' A' ' 50' ' ' HIS . . . 60.83 -129.26 46.43 Favored Glycine 0 N--CA 1.445 -0.716 0 CA-C-N 115.728 -0.669 . . . . 0.0 112.69 175.951 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 2.5 mpt_? 60.83 85.13 0.12 Allowed 'General case' 0 C--O 1.234 0.261 0 CA-C-O 121.218 0.532 . . . . 0.0 111.16 -178.33 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 33.0 p -79.02 -179.28 6.57 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.694 174.563 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 177.17 -143.1 6.08 Favored Glycine 0 N--CA 1.448 -0.567 0 C-N-CA 120.714 -0.755 . . . . 0.0 111.991 -179.126 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.499 ' HE1' ' HB2' ' A' ' 124' ' ' LEU . 85.7 m-85 -134.03 155.5 49.89 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.995 0.426 . . . . 0.0 110.517 -178.064 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.641 ' HB3' ' SG ' ' A' ' 46' ' ' CYS . 3.8 tt -121.91 107.91 12.82 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 174.364 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.463 ' O ' ' HA ' ' A' ' 74' ' ' GLU . 49.1 mt -70.66 83.86 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 178.643 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' HIS . . . . . 0.577 ' HB2' HD22 ' A' ' 60' ' ' LEU . 11.9 t60 -103.35 93.02 4.75 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.482 -174.624 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -88.3 121.94 6.14 Favored Glycine 0 N--CA 1.447 -0.568 0 N-CA-C 111.057 -0.817 . . . . 0.0 111.057 174.695 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.557 ' HB2' HG21 ' A' ' 7' ' ' THR . 1.7 pp20? -124.63 -175.58 3.31 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 116.857 0.329 . . . . 0.0 110.759 -179.448 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.524 ' O ' ' HB2' ' A' ' 66' ' ' GLN . 0.1 OUTLIER 79.3 147.31 0.09 Allowed 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.064 -0.971 . . . . 0.0 111.409 173.843 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.54 HE22 ' HB2' ' A' ' 41' ' ' SER . 5.4 tp-100 172.31 -57.09 0.01 OUTLIER 'General case' 0 C--O 1.231 0.12 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.612 172.199 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.478 ' HD3' ' HB3' ' A' ' 36' ' ' GLU . 7.2 ptmm? -156.07 -37.43 0.08 Allowed 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.903 -172.958 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -118.41 9.93 12.56 Favored 'General case' 0 N--CA 1.47 0.544 0 O-C-N 122.399 -0.188 . . . . 0.0 111.106 -178.268 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 20.0 ttmm 49.43 90.2 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 121.493 0.663 . . . . 0.0 109.732 -167.165 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.49 ' H ' HD23 ' A' ' 70' ' ' LEU . 2.0 pt? -142.03 160.18 40.73 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 -176.377 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 16.0 t -80.47 93.81 2.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 123.605 0.565 . . . . 0.0 109.567 178.611 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.446 HG23 HG21 ' A' ' 22' ' ' VAL . 30.6 m -79.26 -20.67 12.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.819 -177.575 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.474 HD13 ' N ' ' A' ' 74' ' ' GLU . 2.6 tm? -153.89 133.43 12.86 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 178.86 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.474 ' N ' HD13 ' A' ' 73' ' ' LEU . 13.2 pt-20 -151.49 129.6 11.87 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 176.31 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 61.0 m -146.93 117.7 7.6 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.057 -0.52 . . . . 0.0 109.779 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 42.3 t80 -90.96 144.26 25.86 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 -179.787 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 12.2 p -157.17 145.61 10.76 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 N-CA-C 110.3 -0.259 . . . . 0.0 110.3 179.6 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.404 ' HB3' ' H ' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -86.97 -161.19 0.65 Allowed 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.101 179.663 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.528 ' O ' ' HB2' ' A' ' 80' ' ' ASP . 23.0 ttmm -66.48 77.2 0.11 Allowed 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.934 176.907 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.528 ' HB2' ' O ' ' A' ' 79' ' ' LYS . 25.6 t70 169.13 95.91 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.461 0.705 . . . . 0.0 109.585 174.489 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.478 HD23 ' H ' ' A' ' 82' ' ' VAL . 1.1 tt -137.06 138.83 40.84 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 -178.321 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.478 ' H ' HD23 ' A' ' 81' ' ' LEU . 26.0 m -124.43 127.53 73.12 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 CA-C-O 120.941 0.401 . . . . 0.0 110.933 179.041 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.642 ' HB3' ' NE2' ' A' ' 91' ' ' HIS . 11.7 m-85 -111.53 139.88 46.6 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.909 174.955 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.468 ' HB ' ' CE1' ' A' ' 92' ' ' HIS . 36.6 m -132.84 114.7 14.38 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.505 -179.472 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 2.6 ttmp? -85.34 99.61 11.27 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 177.269 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -83.08 -13.99 54.64 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.283 0.563 . . . . 0.0 110.518 -176.895 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ASN . . . . . 0.766 ' HB3' ' HB3' ' A' ' 90' ' ' PHE . 27.8 t-20 -160.47 140.33 8.29 Favored Pre-proline 0 C--N 1.324 -0.513 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 -178.128 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_endo -46.94 -22.95 2.26 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 122.948 2.432 . . . . 0.0 113.614 178.073 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.471 HG22 ' OD1' ' A' ' 87' ' ' ASN . 12.6 t -116.51 14.7 15.6 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 120.767 0.318 . . . . 0.0 111.62 -179.872 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.766 ' HB3' ' HB3' ' A' ' 87' ' ' ASN . 79.6 t80 -146.39 114.98 6.79 Favored 'General case' 0 C--O 1.239 0.518 0 CA-C-O 121.218 0.532 . . . . 0.0 110.7 -178.262 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' HIS . . . . . 0.642 ' NE2' ' HB3' ' A' ' 83' ' ' TYR . 1.8 t-160 -121.49 123.11 41.25 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 -179.147 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' HIS . . . . . 0.468 ' CE1' ' HB ' ' A' ' 84' ' ' THR . 34.6 p80 -120.4 168.27 11.48 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.686 0.279 . . . . 0.0 110.857 -179.668 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 45.1 p90 -154.22 137.87 16.07 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.112 -177.653 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 56.6 tttp -95.71 107.81 20.06 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 174.466 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 35.5 m -136.41 151.04 27.85 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 CA-C-O 121.032 0.444 . . . . 0.0 111.15 -179.37 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 33.1 t70 59.87 -78.07 0.02 OUTLIER 'General case' 0 C--O 1.236 0.368 0 CA-C-N 114.882 -1.054 . . . . 0.0 112.459 173.291 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -134.96 -22.87 1.57 Allowed 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 112.796 0.665 . . . . 0.0 112.796 -174.373 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 7.9 tpt180 -146.02 175.55 10.37 Favored 'General case' 0 N--CA 1.465 0.316 0 O-C-N 121.884 -0.51 . . . . 0.0 111.026 -172.837 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 38.1 ttmt -101.43 108.42 20.02 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.822 -0.627 . . . . 0.0 109.623 -179.693 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -103.14 166.9 10.16 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 -179.751 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.413 ' HA2' ' HA ' ' A' ' 92' ' ' HIS . . . -159.59 178.57 35.65 Favored Glycine 0 CA--C 1.51 -0.239 0 C-N-CA 119.945 -1.121 . . . . 0.0 112.974 -177.982 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.575 HD22 HG21 ' A' ' 43' ' ' VAL . 3.9 pp -148.94 154.47 39.45 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-O 120.857 0.36 . . . . 0.0 110.771 177.697 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.403 ' HB ' ' HB ' ' A' ' 21' ' ' VAL . 90.0 m -105.42 128.38 53.49 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.755 175.41 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.436 ' CE2' ' HB2' ' A' ' 91' ' ' HIS . 61.2 m-85 -74.19 169.58 17.29 Favored 'General case' 0 C--O 1.238 0.489 0 CA-C-O 121.182 0.515 . . . . 0.0 111.224 -178.264 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 28.2 tt0 -106.94 -38.15 6.13 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.122 -179.363 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 24.8 m -151.83 157.21 34.49 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.94 178.799 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.483 ' HA ' ' HB3' ' A' ' 110' ' ' ALA . 12.2 Cg_endo -56.55 -22.61 43.95 Favored 'Trans proline' 0 C--N 1.352 0.743 0 C-N-CA 122.348 2.032 . . . . 0.0 111.99 177.041 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -60.58 -63.32 1.34 Allowed 'General case' 0 C--O 1.233 0.213 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.716 175.775 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -66.23 -29.08 69.25 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.732 178.656 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.483 ' HB3' ' HA ' ' A' ' 107' ' ' PRO . . . -59.65 -52.5 65.24 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.975 0.416 . . . . 0.0 110.694 175.788 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 60.8 ttp85 -68.39 -44.31 75.39 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.337 -179.488 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -59.18 -42.1 90.02 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.01 -178.681 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 74.9 t80 -73.69 -39.11 64.63 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.424 -179.846 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.419 ' O ' HG12 ' A' ' 117' ' ' VAL . 37.4 t70 -62.69 -65.78 0.64 Allowed 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 121.326 0.584 . . . . 0.0 110.47 179.178 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 1.5 tmt_? -56.69 -39.8 74.47 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.166 -0.925 . . . . 0.0 110.017 177.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -59.19 -51.03 61.61 Favored Glycine 0 C--N 1.333 0.416 0 C-N-CA 121.101 -0.571 . . . . 0.0 112.501 179.62 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.526 ' O ' HG12 ' A' ' 121' ' ' ILE . 8.6 p -68.88 -30.26 46.29 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 N-CA-C 110.209 -0.293 . . . . 0.0 110.209 -178.971 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 3.2 mpt_? -62.53 -46.57 87.78 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.379 177.434 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 53.7 tptt -65.79 -40.92 92.42 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.111 177.889 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -57.49 -45.92 84.34 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.457 177.395 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.526 HG12 ' O ' ' A' ' 117' ' ' VAL . 40.1 mm -64.43 -38.71 83.28 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.337 177.823 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -57.89 -50.65 72.6 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.531 -179.799 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 44.1 m-20 -71.2 -29.42 65.13 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.847 178.697 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.499 ' HB2' ' HE1' ' A' ' 59' ' ' PHE . 65.6 tp -65.71 -54.38 28.13 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.229 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.492 HG22 ' O ' ' A' ' 121' ' ' ILE . 10.7 tp -83.05 -37.18 13.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.19 -174.05 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 . . . . . 0 C--O 1.251 1.163 0 O-C-N 123.59 0.556 . . . . 0.0 109.945 -176.606 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.827 0 N-CA-C 111.867 -0.493 . . . . 0.0 111.867 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 10.9 t -94.36 36.76 1.13 Allowed 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 178.665 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 65.2 mtt 68.52 -168.1 0.19 Allowed 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.34 -176.5 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 63.5 m -146.21 97.41 2.94 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 120.814 0.34 . . . . 0.0 111.145 -178.037 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -139.98 176.9 8.36 Favored 'General case' 0 C--O 1.238 0.453 0 N-CA-C 109.419 -0.585 . . . . 0.0 109.419 173.635 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -82.24 166.92 19.15 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 110.032 -0.359 . . . . 0.0 110.032 177.896 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 4.4 m -116.13 20.85 14.11 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.74 0.781 . . . . 0.0 109.513 -179.702 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.563 ' HB3' ' HD2' ' A' ' 9' ' ' PRO . 25.7 m170 -74.43 170.74 13.61 Favored Pre-proline 0 CA--C 1.535 0.389 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.411 -178.706 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.563 ' HD2' ' HB3' ' A' ' 8' ' ' HIS . 88.3 Cg_exo -43.91 126.23 5.83 Favored 'Trans proline' 0 C--N 1.355 0.873 0 C-N-CA 122.608 2.205 . . . . 0.0 112.677 175.35 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.474 ' HB3' ' HB2' ' A' ' 13' ' ' SER . 3.9 m-20 64.87 38.03 6.81 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 121.348 0.594 . . . . 0.0 110.597 -178.385 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.514 ' HA ' ' CD2' ' A' ' 14' ' ' TYR . 10.2 p-10 -55.69 -28.8 57.57 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.822 176.322 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -76.93 -24.81 52.42 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.231 179.479 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.474 ' HB2' ' HB3' ' A' ' 10' ' ' ASP . 15.8 m -88.96 -8.67 53.7 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 116.041 -0.527 . . . . 0.0 112.278 -171.603 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.622 ' HB3' ' HD2' ' A' ' 17' ' ' ARG . 59.6 m-85 -63.31 93.1 0.06 Allowed 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 120.835 0.35 . . . . 0.0 110.933 179.088 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.4 HG23 HG23 ' A' ' 16' ' ' VAL . 7.5 tp -83.41 -45.66 18.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.308 -178.301 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.4 HG23 HG23 ' A' ' 15' ' ' ILE . 92.1 t -125.3 121.46 60.62 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 CA-C-O 120.848 0.356 . . . . 0.0 110.64 -177.788 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.622 ' HD2' ' HB3' ' A' ' 14' ' ' TYR . 0.0 OUTLIER -125.51 103.8 8.08 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.81 178.94 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 27.2 m -119.89 176.47 3.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 177.547 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 21.5 pttm -128.33 129.97 47.07 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.822 0.344 . . . . 0.0 110.752 -177.888 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.441 ' HB3' HD21 ' A' ' 102' ' ' LEU . . . -159.02 -178.86 7.54 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.833 179.699 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 40.3 t -93.54 99.78 10.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 120.866 0.365 . . . . 0.0 110.707 -176.86 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.488 HG11 ' HG ' ' A' ' 73' ' ' LEU . 57.2 t -81.79 106.42 12.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.626 -179.678 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 23.1 mmt -86.04 150.72 24.26 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.258 177.598 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 5.2 t -123.08 151.49 41.96 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.055 -0.521 . . . . 0.0 109.951 177.539 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 59.1 ttt180 -123.18 104.7 9.34 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.145 -0.48 . . . . 0.0 109.82 -178.61 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -81.2 56.14 2.76 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-O 121.27 0.557 . . . . 0.0 109.681 -179.044 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 65.4 m-20 57.58 22.88 8.65 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.131 -0.94 . . . . 0.0 110.563 -177.374 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.9 m -67.32 156.38 36.58 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 115.179 -0.919 . . . . 0.0 110.782 179.574 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 23.9 m -62.19 -43.73 98.19 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-O 120.961 0.41 . . . . 0.0 110.461 177.903 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -164.01 10.27 0.08 OUTLIER Glycine 0 C--N 1.333 0.371 0 CA-C-N 115.839 -0.619 . . . . 0.0 112.38 177.22 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -83.11 80.22 1.84 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 121.203 -0.522 . . . . 0.0 112.492 -178.96 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 84.9 m95 -72.98 99.64 2.77 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 174.814 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.488 ' HA ' ' HD3' ' A' ' 34' ' ' PRO . 26.0 p90 -98.07 141.04 22.32 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.949 -174.471 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.593 ' HB2' ' HA2' ' A' ' 38' ' ' GLY . 9.1 Cg_exo -72.15 136.34 26.74 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.894 2.396 . . . . 0.0 111.593 178.625 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.434 ' O ' ' N ' ' A' ' 37' ' ' GLY . 2.9 pp0? -93.38 145.13 24.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.208 -179.419 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 44.8 mm-40 41.5 -82.76 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 113.788 1.032 . . . . 0.0 113.788 173.274 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.434 ' N ' ' O ' ' A' ' 35' ' ' GLN . . . -58.8 -30.8 66.6 Favored Glycine 0 C--N 1.333 0.392 0 C-N-CA 121.45 -0.405 . . . . 0.0 112.959 -174.705 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.593 ' HA2' ' HB2' ' A' ' 34' ' ' PRO . . . 67.21 12.06 60.02 Favored Glycine 0 C--N 1.33 0.249 0 C-N-CA 121.046 -0.597 . . . . 0.0 112.261 -179.054 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -167.72 -123.02 0.64 Allowed Glycine 0 N--CA 1.446 -0.67 0 N-CA-C 111.586 -0.606 . . . . 0.0 111.586 -177.831 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 34.0 pt -64.23 135.98 27.12 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 CA-C-O 121.343 0.592 . . . . 0.0 111.815 -177.171 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 39.6 m -144.0 132.84 22.59 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.022 175.284 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.479 ' HD3' ' HB3' ' A' ' 17' ' ' ARG . 5.7 tmm_? -76.3 103.45 6.33 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 -179.017 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.476 HG11 HD11 ' A' ' 102' ' ' LEU . 4.0 p -91.79 110.2 22.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.58 0.705 . . . . 0.0 109.89 177.323 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.451 ' N ' HH11 ' A' ' 42' ' ' ARG . . . -107.43 103.67 1.99 Allowed Glycine 0 N--CA 1.448 -0.536 0 CA-C-N 115.395 -0.821 . . . . 0.0 111.505 -179.495 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 7.5 p -86.13 125.18 40.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 178.899 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' CYS . . . . . 0.789 ' SG ' ' HB3' ' A' ' 60' ' ' LEU . 7.0 p -126.54 128.5 46.97 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.603 -178.063 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 3.2 ttmp? -81.58 98.85 8.53 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 177.162 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 46.0 t -73.87 85.49 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 177.694 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 13.5 tpt -89.58 147.81 23.72 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.499 -178.676 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' HIS . . . . . 0.421 ' CD2' ' HB3' ' A' ' 57' ' ' SER . 0.3 OUTLIER -117.84 159.61 41.91 Favored Pre-proline 0 C--N 1.321 -0.673 0 CA-C-N 115.364 -0.835 . . . . 0.0 109.563 -178.472 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_exo -73.4 43.36 0.75 Allowed 'Trans proline' 0 CA--C 1.537 0.649 0 C-N-CA 122.767 2.311 . . . . 0.0 112.208 176.884 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 57.48 19.99 5.71 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 123.353 0.661 . . . . 0.0 111.811 177.684 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -117.26 -153.17 9.7 Favored Glycine 0 C--N 1.331 0.266 0 C-N-CA 121.278 -0.487 . . . . 0.0 112.697 -178.107 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 63.1 t30 -64.77 -13.0 53.59 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 123.196 0.598 . . . . 0.0 111.42 -175.641 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.447 ' HA2' ' NH1' ' A' ' 56' ' ' ARG . . . -58.29 143.49 43.8 Favored Glycine 0 CA--C 1.521 0.466 0 C-N-CA 121.189 -0.529 . . . . 0.0 112.403 177.782 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.447 ' NH1' ' HA2' ' A' ' 55' ' ' GLY . 0.1 OUTLIER -69.33 140.66 54.34 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 120.712 0.292 . . . . 0.0 110.712 -179.527 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.421 ' HB3' ' CD2' ' A' ' 50' ' ' HIS . 20.2 p -125.28 132.36 52.92 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.452 179.675 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 173.39 -161.61 32.48 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 121.017 -0.611 . . . . 0.0 112.234 179.709 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.474 ' O ' HG22 ' A' ' 77' ' ' VAL . 84.8 m-85 -127.83 125.78 40.41 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 178.963 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.789 ' HB3' ' SG ' ' A' ' 46' ' ' CYS . 1.6 tt -93.99 108.2 20.04 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 179.86 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 48.3 mm -80.65 91.41 1.81 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.261 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 174.418 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' HIS . . . . . 0.672 ' HB2' HD22 ' A' ' 60' ' ' LEU . 28.5 t60 -108.45 106.64 16.85 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.83 -173.908 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.427 ' HA2' ' O ' ' A' ' 42' ' ' ARG . . . -114.8 138.57 14.91 Favored Glycine 0 C--O 1.235 0.209 0 N-CA-C 111.725 -0.55 . . . . 0.0 111.725 178.422 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.419 ' HB2' ' O ' ' A' ' 70' ' ' LEU . 14.4 pt-20 -120.35 160.18 23.55 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 120.881 0.372 . . . . 0.0 110.801 -179.803 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.475 ' HB2' HG11 ' A' ' 72' ' ' VAL . 2.0 tmt_? -82.75 122.66 28.46 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 177.428 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 9.5 mm100 -58.67 97.45 0.03 OUTLIER 'General case' 0 C--O 1.234 0.269 0 CA-C-O 121.105 0.479 . . . . 0.0 112.007 -174.842 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 29.5 mtpp -140.27 -72.05 0.37 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.193 -0.912 . . . . 0.0 108.739 173.152 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -160.25 -46.89 0.05 OUTLIER 'General case' 0 C--O 1.235 0.327 0 CA-C-N 114.67 -1.15 . . . . 0.0 108.93 -178.617 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 56.1 tttm -170.36 99.12 0.26 Allowed 'General case' 0 C--O 1.236 0.39 0 CA-C-N 115.099 -0.955 . . . . 0.0 109.569 177.835 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.419 ' O ' ' HB2' ' A' ' 64' ' ' GLU . 4.1 tt -157.21 107.77 2.28 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 -178.744 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 43.8 t -78.58 125.18 37.9 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.004 -177.377 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.475 HG11 ' HB2' ' A' ' 65' ' ' ARG . 27.7 m -123.02 -28.96 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.584 179.735 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.488 ' HG ' HG11 ' A' ' 22' ' ' VAL . 2.6 tm? -123.66 117.02 24.05 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 -177.446 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -131.78 107.0 8.47 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 176.742 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 52.5 t -135.13 79.5 1.79 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.349 0.595 . . . . 0.0 109.953 179.676 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.549 ' HA ' ' HA ' ' A' ' 60' ' ' LEU . 57.2 t80 -72.74 105.07 4.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.98 175.472 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.474 HG22 ' O ' ' A' ' 59' ' ' PHE . 34.8 m -81.11 114.54 22.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 178.601 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.723 ' HD2' ' H ' ' A' ' 78' ' ' ARG . 0.3 OUTLIER -82.66 61.67 5.89 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 -173.819 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 36.3 mtmm 68.68 -2.87 1.54 Allowed 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.206 -172.385 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -92.36 85.77 5.49 Favored 'General case' 0 N--CA 1.462 0.148 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 174.035 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.721 HD22 HD11 ' A' ' 121' ' ' ILE . 2.4 tt -131.25 106.82 8.56 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.976 -173.854 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 59.5 t -124.05 92.38 2.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.252 176.86 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.407 ' CD1' ' HB3' ' A' ' 93' ' ' TRP . 0.2 OUTLIER -81.49 101.54 9.98 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.04 178.672 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 22.5 m -90.93 127.22 36.31 Favored 'General case' 0 C--N 1.323 -0.543 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 178.602 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 24.7 pttm -93.32 111.25 22.85 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.111 0.481 . . . . 0.0 110.857 -177.844 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -90.07 -44.16 10.01 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.271 0.558 . . . . 0.0 109.503 175.676 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ASN . . . . . 0.612 ' HB2' ' HB3' ' A' ' 90' ' ' PHE . 93.0 m-20 -138.63 153.98 72.81 Favored Pre-proline 0 C--N 1.328 -0.363 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 177.132 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -55.26 -27.41 56.94 Favored 'Trans proline' 0 CA--C 1.533 0.471 0 C-N-CA 122.22 1.947 . . . . 0.0 112.034 176.951 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 10.8 p -105.91 8.47 32.61 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.836 178.842 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.612 ' HB3' ' HB2' ' A' ' 87' ' ' ASN . 25.6 t80 -140.81 102.97 4.4 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-O 121.076 0.465 . . . . 0.0 110.405 -179.784 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 14.2 m80 -107.7 132.51 53.27 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.513 174.321 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' HIS . . . . . 0.424 ' HA ' ' O ' ' A' ' 100' ' ' PHE . 8.2 p80 -126.95 129.56 48.37 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.74 0.305 . . . . 0.0 110.204 178.138 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' TRP . . . . . 0.62 ' HZ3' ' HB2' ' A' ' 102' ' ' LEU . 34.8 p90 -110.01 149.77 29.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.079 179.3 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 14.3 tmtt? -112.57 122.1 46.72 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.059 -178.038 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.439 HG13 ' HD1' ' A' ' 93' ' ' TRP . 21.1 m -124.88 127.33 72.47 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.071 176.863 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 42.3 m-20 59.6 -80.18 0.02 OUTLIER 'General case' 0 C--O 1.235 0.297 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.953 -179.108 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -133.74 -28.48 1.41 Allowed 'General case' 0 C--O 1.234 0.243 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.609 -176.65 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 62.5 mtt180 -103.44 156.46 17.74 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 121.482 0.658 . . . . 0.0 112.495 -171.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.84 137.34 52.83 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 114.64 -1.164 . . . . 0.0 109.846 -179.89 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.424 ' O ' ' HA ' ' A' ' 92' ' ' HIS . 36.6 m-85 -122.98 137.13 55.04 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 176.998 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -115.76 101.59 1.03 Allowed Glycine 0 C--N 1.333 0.409 0 C-N-CA 120.968 -0.634 . . . . 0.0 113.216 -171.116 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.62 ' HB2' ' HZ3' ' A' ' 93' ' ' TRP . 3.7 tt -74.42 104.25 5.09 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.211 -0.662 . . . . 0.0 109.211 177.047 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.401 ' HG1' ' HD2' ' A' ' 90' ' ' PHE . 17.5 m -96.67 114.97 26.66 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.142 179.773 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.422 ' CG ' ' HA ' ' A' ' 110' ' ' ALA . 74.5 m-85 -72.27 167.31 20.67 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.296 -175.368 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -112.71 -31.66 6.67 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.71 -175.89 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 5.7 m -138.51 150.07 64.92 Favored Pre-proline 0 C--N 1.329 -0.31 0 N-CA-C 110.187 -0.301 . . . . 0.0 110.187 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -52.96 -29.02 42.17 Favored 'Trans proline' 0 C--N 1.352 0.718 0 C-N-CA 122.309 2.006 . . . . 0.0 111.86 176.781 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -59.44 -65.59 0.65 Allowed 'General case' 0 C--O 1.236 0.384 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.858 177.227 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -64.92 -31.59 72.9 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.949 -179.344 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.422 ' HA ' ' CG ' ' A' ' 104' ' ' PHE . . . -58.52 -60.85 3.15 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.092 177.395 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 20.0 mtm180 -66.54 -32.54 73.96 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.748 -177.628 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -63.51 -56.67 14.24 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.037 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.405 ' HB3' ' CE1' ' A' ' 104' ' ' PHE . 39.1 t80 -71.03 -28.89 64.72 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.337 -177.214 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -54.84 -63.43 1.16 Allowed 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 121.808 0.813 . . . . 0.0 109.588 173.17 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 52.4 ttt180 -56.51 -37.21 70.1 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.306 -1.315 . . . . 0.0 110.835 177.883 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -63.94 -53.89 34.39 Favored Glycine 0 C--O 1.237 0.304 0 CA-C-N 115.837 -0.62 . . . . 0.0 112.909 -179.164 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.449 ' O ' HG12 ' A' ' 121' ' ' ILE . 11.9 p -67.71 -33.67 63.23 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 -178.292 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.503 ' O ' ' HG3' ' A' ' 122' ' ' GLU . 54.2 ttt180 -55.54 -50.96 68.63 Favored 'General case' 0 C--O 1.231 0.089 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 173.223 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.643 ' HE2' ' HA ' ' A' ' 119' ' ' LYS . 0.6 OUTLIER -56.47 -46.39 80.42 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.065 178.786 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -56.85 -42.5 79.8 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.949 178.769 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.721 HD11 HD22 ' A' ' 81' ' ' LEU . 42.6 mm -61.59 -39.59 83.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.925 176.682 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.53 ' HA ' ' HA ' ' A' ' 126' ' ' GLU . 41.2 mt-10 -66.23 -37.73 86.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.652 179.676 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -65.26 -36.6 84.61 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-O 121.222 0.534 . . . . 0.0 109.988 174.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 59.3 tp -71.46 -55.35 8.07 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.675 -176.714 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.42 ' O ' HG13 ' A' ' 125' ' ' ILE . 11.3 tp -145.47 10.18 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 N-CA-C 111.655 0.243 . . . . 0.0 111.655 -171.937 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.53 ' HA ' ' HA ' ' A' ' 122' ' ' GLU . 34.0 tt0 . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.429 -0.796 . . . . 0.0 110.753 -175.291 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.949 0 N-CA-C 111.722 -0.551 . . . . 0.0 111.722 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 42.1 t -60.47 -40.81 92.57 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 175.915 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 95.7 mmm -100.99 160.85 14.03 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.413 174.256 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 41.7 p -74.37 173.25 10.53 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.538 178.676 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.416 ' HG2' ' H ' ' A' ' 49' ' ' MET . 0.7 OUTLIER -66.37 84.11 0.1 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.39 0.614 . . . . 0.0 110.698 176.697 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -84.62 -44.07 13.83 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 114.941 -1.027 . . . . 0.0 108.561 174.289 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.759 HG22 ' H ' ' A' ' 8' ' ' HIS . 1.7 m 63.54 -162.22 0.28 Allowed 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 114.155 -1.384 . . . . 0.0 110.458 175.283 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.759 ' H ' HG22 ' A' ' 7' ' ' THR . 68.5 t60 94.1 -74.66 0.0 OUTLIER Pre-proline 0 CA--C 1.548 0.883 0 C-N-CA 124.937 1.295 . . . . 0.0 111.008 -173.818 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.54 ' HD3' ' HB3' ' A' ' 8' ' ' HIS . 65.7 Cg_endo -89.66 -4.51 5.53 Favored 'Trans proline' 0 C--N 1.367 1.536 0 CA-C-N 121.483 1.565 . . . . 0.0 111.541 173.957 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.522 ' HB3' ' HA ' ' A' ' 7' ' ' THR . 30.2 t70 -87.55 -51.5 5.87 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.904 178.725 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.442 ' HA ' ' HD1' ' A' ' 14' ' ' TYR . 28.4 t70 75.47 -23.69 0.23 Allowed 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 113.609 0.966 . . . . 0.0 113.609 170.313 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -59.1 -31.96 69.38 Favored 'General case' 0 N--CA 1.469 0.514 0 O-C-N 122.08 -0.387 . . . . 0.0 111.591 -175.285 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 16.5 m -73.84 -15.86 61.15 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 111.857 0.317 . . . . 0.0 111.857 -178.841 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.442 ' HD1' ' HA ' ' A' ' 11' ' ' ASP . 24.7 m-85 -65.14 123.4 19.42 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-O 120.695 0.283 . . . . 0.0 110.561 178.191 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 13.0 tt -102.73 -34.1 3.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 173.411 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.414 ' HB ' ' HB ' ' A' ' 45' ' ' VAL . 97.8 t -139.3 130.12 33.03 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.764 177.808 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 11.6 ptm180 -142.41 91.13 2.29 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.199 0.523 . . . . 0.0 110.277 176.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 35.1 m -107.5 161.08 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.928 -177.629 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 47.3 mtmt -93.83 130.58 39.8 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.392 178.764 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -163.25 158.59 21.72 Favored 'General case' 0 C--N 1.331 -0.223 0 O-C-N 123.254 0.346 . . . . 0.0 110.29 179.219 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 58.4 t -90.77 105.66 16.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 178.939 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.599 HG23 ' NE2' ' A' ' 35' ' ' GLN . 15.8 m -81.23 115.18 23.37 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 CA-C-O 121.406 0.622 . . . . 0.0 111.673 -176.541 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 24.0 mmt -99.66 162.78 12.81 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.973 179.589 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 9.9 t -136.64 158.19 45.02 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.943 0.402 . . . . 0.0 110.854 -179.13 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 20.5 ttt180 -136.36 100.26 4.33 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 -179.651 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.587 ' H ' ' HE1' ' A' ' 33' ' ' PHE . 27.4 t70 -63.03 104.43 0.56 Allowed 'General case' 0 C--O 1.234 0.267 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.541 -172.078 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.639 ' HA ' ' HG2' ' A' ' 98' ' ' ARG . 23.8 t70 60.23 -76.85 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.677 176.862 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 37.4 p -145.01 22.94 1.55 Allowed 'General case' 0 C--O 1.236 0.345 0 N-CA-C 111.484 0.179 . . . . 0.0 111.484 -178.694 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 49.1 m -51.6 143.05 13.1 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.994 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -81.58 61.89 4.57 Favored Glycine 0 CA--C 1.52 0.354 0 C-N-CA 121.431 -0.414 . . . . 0.0 112.629 -177.386 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 158.67 -168.91 34.98 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 121.279 -0.486 . . . . 0.0 111.942 179.195 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' TRP . . . . . 0.571 ' HH2' ' HG2' ' A' ' 99' ' ' LYS . 88.2 m95 -128.26 116.45 19.88 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 177.871 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.587 ' HE1' ' H ' ' A' ' 26' ' ' ASP . 37.7 p90 -110.78 148.29 38.25 Favored Pre-proline 0 C--O 1.235 0.308 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.894 -175.833 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -77.88 157.55 31.14 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.73 2.287 . . . . 0.0 111.549 176.484 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.599 ' NE2' HG23 ' A' ' 22' ' ' VAL . 2.5 pp0? -136.11 -152.89 0.47 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.059 -0.518 . . . . 0.0 109.923 -178.728 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 22.5 tp10 -52.74 -22.15 4.92 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 120.918 0.389 . . . . 0.0 111.49 -177.163 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -112.32 46.13 1.22 Allowed Glycine 0 CA--C 1.518 0.26 0 N-CA-C 111.578 -0.609 . . . . 0.0 111.578 175.304 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -71.95 -19.45 78.3 Favored Glycine 0 C--N 1.331 0.292 0 C-N-CA 121.357 -0.449 . . . . 0.0 112.664 -179.507 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -97.29 -151.04 27.39 Favored Glycine 0 C--O 1.237 0.301 0 C-N-CA 121.35 -0.452 . . . . 0.0 112.097 178.286 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 50.6 mm -65.72 99.18 0.29 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.38 0 CA-C-O 121.154 0.502 . . . . 0.0 110.284 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 36.8 m -105.66 -175.8 2.9 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.475 179.818 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.608 HH22 ' N ' ' A' ' 68' ' ' ASP . 28.3 ttm180 -130.53 134.94 47.44 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.764 -178.022 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.808 HG21 HD22 ' A' ' 102' ' ' LEU . 24.3 t -100.05 94.44 3.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 171.216 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.425 ' HA3' ' HE2' ' A' ' 14' ' ' TYR . . . -98.37 91.94 1.18 Allowed Glycine 0 N--CA 1.449 -0.474 0 CA-C-N 115.827 -0.624 . . . . 0.0 113.098 -173.969 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.414 ' HB ' ' HB ' ' A' ' 16' ' ' VAL . 51.4 t -76.3 109.94 10.94 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 175.236 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' CYS . . . . . 0.699 ' SG ' ' HB3' ' A' ' 60' ' ' LEU . 9.1 p -121.88 137.33 54.82 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.431 -178.446 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.597 ' HB3' ' HB2' ' A' ' 57' ' ' SER . 42.1 mtmt -84.97 118.38 24.52 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.981 0.42 . . . . 0.0 111.033 -179.797 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.429 ' O ' ' HB3' ' A' ' 57' ' ' SER . 42.7 t -90.91 118.24 35.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.185 173.946 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' MET . . . . . 0.416 ' H ' ' HG2' ' A' ' 5' ' ' GLU . 67.1 mtm -87.38 151.01 23.44 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.018 0.437 . . . . 0.0 110.529 -178.597 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 53.7 m-70 -131.38 157.95 76.67 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.127 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -51.75 132.58 42.11 Favored 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 122.342 2.028 . . . . 0.0 111.947 178.191 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 71.97 77.8 0.16 Allowed 'General case' 0 CA--C 1.536 0.427 0 O-C-N 123.719 0.637 . . . . 0.0 110.247 -179.591 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 125.01 119.58 2.39 Favored Glycine 0 C--N 1.333 0.38 0 CA-C-N 116.055 -0.521 . . . . 0.0 112.159 -178.54 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 -126.91 -4.86 6.31 Favored 'General case' 0 N--CA 1.466 0.357 0 O-C-N 122.649 -0.324 . . . . 0.0 111.044 179.875 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -84.6 -76.17 1.2 Allowed Glycine 0 C--N 1.331 0.273 0 C-N-CA 120.997 -0.621 . . . . 0.0 111.91 179.361 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 3.6 tmm_? -80.93 96.89 7.2 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 177.93 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.597 ' HB2' ' HB3' ' A' ' 47' ' ' LYS . 14.7 m -108.81 174.35 5.91 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.805 -176.559 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.574 ' O ' ' HA ' ' A' ' 47' ' ' LYS . . . -73.8 147.19 37.98 Favored Glycine 0 C--N 1.332 0.324 0 C-N-CA 121.366 -0.445 . . . . 0.0 112.079 179.153 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 32.6 m-85 -103.0 97.07 7.24 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.268 0.556 . . . . 0.0 110.5 -177.592 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.719 ' HA ' ' HA ' ' A' ' 76' ' ' TYR . 2.7 tt -81.69 110.0 16.63 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 178.53 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 60.8 mt -75.33 86.4 0.66 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.314 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 174.106 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 12.3 t-80 -90.08 101.19 13.91 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.254 -0.884 . . . . 0.0 109.946 -176.337 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -91.27 114.55 4.52 Favored Glycine 0 N--CA 1.449 -0.435 0 CA-C-N 115.937 -0.574 . . . . 0.0 112.204 -177.853 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -119.51 -170.27 1.91 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.025 0.44 . . . . 0.0 110.934 179.589 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 23.0 mmt85 -83.58 -174.73 5.45 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.451 169.717 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 28.7 pt20 -55.59 -35.17 65.51 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.168 177.127 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -115.51 147.89 40.13 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.278 -178.886 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.608 ' N ' HH22 ' A' ' 42' ' ' ARG . 1.8 m-20 -67.85 105.59 2.02 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.1 -178.424 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -176.17 -39.21 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.348 0 O-C-N 123.168 0.293 . . . . 0.0 111.591 -179.85 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 61.5 tp -122.03 115.54 22.69 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.622 0.249 . . . . 0.0 111.282 -175.839 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 35.4 t -88.82 110.47 21.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.891 176.771 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 35.9 m -91.3 -36.68 8.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.259 -177.696 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -133.42 151.49 51.82 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 122.491 0.317 . . . . 0.0 110.234 178.742 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.542 ' HG2' HD21 ' A' ' 60' ' ' LEU . 2.9 tm-20 -146.94 115.75 6.82 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 175.982 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 50.0 t -141.15 83.7 1.89 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.21 0.529 . . . . 0.0 110.616 -178.364 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.719 ' HA ' ' HA ' ' A' ' 60' ' ' LEU . 78.4 t80 -68.87 122.65 19.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.587 175.768 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.475 HG12 ' HB2' ' A' ' 80' ' ' ASP . 17.2 m -133.21 122.71 45.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.006 0.431 . . . . 0.0 110.281 178.031 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 11.5 ptm180 -110.04 -27.77 9.03 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.2 0.524 . . . . 0.0 110.211 179.164 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -155.05 22.25 0.43 Allowed 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 173.963 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.475 ' HB2' HG12 ' A' ' 77' ' ' VAL . 0.7 OUTLIER -114.7 9.55 16.45 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 114.414 -1.266 . . . . 0.0 109.816 -172.557 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.828 HD22 HD11 ' A' ' 121' ' ' ILE . 3.5 tt -79.17 104.42 9.79 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.171 -172.316 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 48.4 t -127.97 96.78 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 CA-C-N 116.567 -0.288 . . . . 0.0 110.667 177.201 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.506 ' HD2' ' CD2' ' A' ' 91' ' ' HIS . 4.5 m-85 -91.71 172.46 8.47 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-O 121.396 0.617 . . . . 0.0 111.076 178.306 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 50.1 m -154.42 110.75 3.26 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.056 -0.974 . . . . 0.0 109.314 -179.629 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.474 ' NZ ' ' HB3' ' A' ' 85' ' ' LYS . 5.2 ttpm? -77.3 107.05 9.43 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 177.346 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -85.28 -59.65 2.26 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.214 0.53 . . . . 0.0 110.138 -179.614 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 -130.19 158.63 73.59 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.353 -179.177 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -56.13 -13.69 10.05 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 122.6 2.2 . . . . 0.0 113.189 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 12.7 t -125.21 5.8 7.81 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-O 120.452 0.168 . . . . 0.0 111.304 179.509 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 17.8 t80 -135.36 114.28 12.05 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 -179.57 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' HIS . . . . . 0.506 ' CD2' ' HD2' ' A' ' 83' ' ' TYR . 2.3 t-160 -130.24 129.91 43.94 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 -176.897 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 53.6 p-80 -138.78 174.98 9.96 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.527 0.203 . . . . 0.0 111.066 -174.832 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' TRP . . . . . 0.48 ' HB3' ' CD1' ' A' ' 83' ' ' TYR . 34.2 p90 -142.8 171.72 13.67 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 176.427 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -137.24 150.34 47.78 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.037 0.446 . . . . 0.0 110.815 -178.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 24.6 m -122.85 -140.27 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 173.4 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -59.39 83.72 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 118.083 0.401 . . . . 0.0 110.918 176.548 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 52.8 t30 68.99 -63.58 0.36 Allowed 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.232 1.013 . . . . 0.0 112.147 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.639 ' HG2' ' HA ' ' A' ' 27' ' ' ASP . 60.0 mtt-85 -55.03 136.07 48.28 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 121.251 0.548 . . . . 0.0 110.745 -176.611 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.571 ' HG2' ' HH2' ' A' ' 32' ' ' TRP . 4.5 ttmp? -127.18 132.84 50.4 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.472 -0.786 . . . . 0.0 110.308 -169.058 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 1.1 p90 -147.2 158.22 43.87 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 -179.174 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.427 ' HA2' ' CZ3' ' A' ' 93' ' ' TRP . . . -164.23 -153.21 7.29 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.384 -0.912 . . . . 0.0 113.338 -174.572 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.808 HD22 HG21 ' A' ' 43' ' ' VAL . 4.1 pp -144.48 168.21 20.67 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.099 0.476 . . . . 0.0 110.977 -174.63 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 15.3 m -128.59 119.73 25.32 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.533 178.091 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 47.5 m-85 -66.27 160.05 25.27 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.089 178.091 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 29.8 pt20 -129.54 -27.08 2.42 Favored 'General case' 0 C--N 1.328 -0.37 0 N-CA-C 111.535 0.198 . . . . 0.0 111.535 -177.849 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 32.1 m -135.13 150.21 72.29 Favored Pre-proline 0 C--N 1.329 -0.299 0 N-CA-C 110.282 -0.266 . . . . 0.0 110.282 179.449 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.579 ' O ' ' HG2' ' A' ' 111' ' ' ARG . 82.2 Cg_exo -49.59 -35.2 36.79 Favored 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 122.683 2.256 . . . . 0.0 112.254 177.13 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -57.84 -63.52 1.22 Allowed 'General case' 0 C--O 1.235 0.314 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.574 -179.57 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -62.28 -34.37 76.44 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.736 -179.003 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -55.29 -66.59 0.39 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.117 177.151 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.579 ' HG2' ' O ' ' A' ' 107' ' ' PRO . 44.7 ptt85 -59.58 -47.21 86.47 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.237 -176.794 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -63.15 -49.84 72.76 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.74 -172.971 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.493 ' O ' HG23 ' A' ' 117' ' ' VAL . 63.2 t80 -75.6 -43.45 48.05 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.803 -175.655 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -55.47 -59.71 4.43 Favored 'General case' 0 C--O 1.24 0.556 0 CA-C-O 121.566 0.698 . . . . 0.0 109.957 179.688 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 22.8 ttm180 -59.4 -37.23 77.47 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 114.895 -1.048 . . . . 0.0 109.93 177.041 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -58.35 -39.38 92.63 Favored Glycine 0 N--CA 1.45 -0.419 0 CA-C-N 115.861 -0.609 . . . . 0.0 112.362 178.257 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.493 HG23 ' O ' ' A' ' 113' ' ' PHE . 72.6 t -71.3 -49.8 45.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.607 0.241 . . . . 0.0 110.809 -179.727 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.403 HH11 ' HD2' ' A' ' 118' ' ' ARG . 44.2 mtm105 -59.78 -44.87 93.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.875 0.369 . . . . 0.0 110.785 179.503 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 45.3 tptt -65.97 -36.01 82.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.447 177.54 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -62.42 -43.84 97.86 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.309 176.481 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.828 HD11 HD22 ' A' ' 81' ' ' LEU . 32.4 mm -60.68 -42.81 93.34 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.108 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.278 177.617 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.441 ' O ' ' HG3' ' A' ' 126' ' ' GLU . 34.7 tt0 -56.35 -57.32 12.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.165 177.837 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 74.0 m-20 -69.7 -18.91 63.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.601 -177.583 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 6.0 tt -77.27 -45.44 26.34 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 178.057 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 13.9 tt -78.98 -28.05 13.68 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.354 -175.46 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.441 ' HG3' ' O ' ' A' ' 122' ' ' GLU . 50.1 mt-10 . . . . . 0 C--O 1.255 1.39 0 CA-C-O 118.384 -0.817 . . . . 0.0 110.264 178.372 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.708 0 N-CA-C 112.351 -0.3 . . . . 0.0 112.351 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 45.9 t -169.5 -49.54 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 -179.253 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 27.4 ttt -160.58 112.4 1.93 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.215 -0.902 . . . . 0.0 108.848 179.234 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 16.3 p -58.24 -63.95 1.09 Allowed 'General case' 0 C--O 1.236 0.392 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.754 -174.184 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -87.3 135.37 33.34 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 178.069 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -70.03 -53.9 15.54 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.856 0.687 . . . . 0.0 112.856 -166.818 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 91.7 m -137.01 -71.59 0.44 Allowed 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 121.308 -0.157 . . . . 0.0 111.217 -174.194 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 18.3 m80 -158.98 156.84 27.44 Favored Pre-proline 0 CA--C 1.533 0.311 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 -178.048 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_exo -50.87 -31.86 35.29 Favored 'Trans proline' 0 C--N 1.355 0.885 0 C-N-CA 123.301 2.667 . . . . 0.0 113.996 -171.295 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.696 ' HB3' ' HB3' ' A' ' 13' ' ' SER . 29.2 m-20 -109.5 35.86 3.16 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.811 0.338 . . . . 0.0 110.566 -177.138 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.4 ' HA ' ' CD2' ' A' ' 14' ' ' TYR . 6.6 p-10 -53.99 -32.61 54.65 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.824 -177.671 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -85.62 -19.66 30.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.864 0.364 . . . . 0.0 110.984 -179.305 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.696 ' HB3' ' HB3' ' A' ' 10' ' ' ASP . 33.3 t -90.21 -12.58 37.65 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.189 -172.691 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.4 ' CD2' ' HA ' ' A' ' 11' ' ' ASP . 61.8 m-85 -63.36 89.57 0.04 OUTLIER 'General case' 0 C--O 1.233 0.232 0 CA-C-O 121.065 0.46 . . . . 0.0 110.446 177.903 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 62.5 mt -73.96 -32.08 32.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.62 -179.057 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 60.4 t -123.62 100.3 7.63 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.18 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.902 -178.708 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 86.6 mtm180 -112.74 93.58 4.49 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 172.822 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 30.9 m -120.12 174.47 5.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.993 0.425 . . . . 0.0 111.644 -175.69 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.687 ' HD2' HD11 ' A' ' 40' ' ' ILE . 9.4 mtmp? -110.74 114.96 28.72 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.71 -178.1 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -148.54 179.97 7.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.222 179.748 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 42.6 t -109.15 109.89 30.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 110.251 -0.278 . . . . 0.0 110.251 179.69 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 15.8 m -70.46 95.9 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 CA-C-O 121.522 0.677 . . . . 0.0 111.415 -178.728 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' MET . . . . . 0.659 ' H ' ' HA ' ' A' ' 102' ' ' LEU . 21.2 mmt -89.96 115.16 27.04 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.036 -179.781 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.495 HG23 ' CE1' ' A' ' 33' ' ' PHE . 9.6 t -112.67 162.93 15.15 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.341 0.591 . . . . 0.0 110.393 179.67 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.411 ' O ' ' N ' ' A' ' 27' ' ' ASP . 5.4 tpm_? -133.12 98.17 4.2 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 176.557 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.62 ' H ' ' HE1' ' A' ' 33' ' ' PHE . 30.8 t70 -60.7 80.46 0.01 OUTLIER 'General case' 0 C--O 1.233 0.211 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.137 -178.151 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.411 ' N ' ' O ' ' A' ' 25' ' ' ARG . 0.8 OUTLIER 57.04 173.07 0.04 OUTLIER 'General case' 0 C--O 1.235 0.314 0 CA-C-N 115.037 -0.983 . . . . 0.0 111.208 -174.658 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 40.0 m 59.66 -167.83 0.16 Allowed 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 120.873 0.368 . . . . 0.0 110.91 -178.217 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 68.1 m -149.64 132.0 15.61 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 172.274 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 146.95 65.7 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.297 0 N-CA-C 111.601 -0.6 . . . . 0.0 111.601 -178.67 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 118.84 98.84 1.86 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 121.235 -0.507 . . . . 0.0 112.195 -179.525 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' TRP . . . . . 0.539 ' HH2' ' HG2' ' A' ' 99' ' ' LYS . 77.7 m95 -81.9 120.2 24.9 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 176.694 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.62 ' HE1' ' H ' ' A' ' 26' ' ' ASP . 14.2 p90 -115.09 132.5 23.0 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.438 -0.347 . . . . 0.0 110.505 -176.992 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.559 ' HB2' ' HA3' ' A' ' 38' ' ' GLY . 71.4 Cg_endo -74.69 112.86 3.65 Favored 'Trans proline' 0 N--CA 1.458 -0.57 0 C-N-CA 121.939 1.76 . . . . 0.0 110.657 175.158 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -54.81 129.03 35.66 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.455 -175.424 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 63.19 16.0 9.03 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.62 -179.554 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 107.34 -26.27 19.07 Favored Glycine 0 C--N 1.33 0.245 0 C-N-CA 121.494 -0.384 . . . . 0.0 112.643 177.666 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.559 ' HA3' ' HB2' ' A' ' 34' ' ' PRO . . . 72.41 -71.61 1.02 Allowed Glycine 0 CA--C 1.519 0.289 0 C-N-CA 121.221 -0.514 . . . . 0.0 112.572 -179.835 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 62.04 -96.68 0.14 Allowed Glycine 0 C--N 1.333 0.394 0 N-CA-C 112.121 -0.392 . . . . 0.0 112.121 -179.292 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.687 HD11 ' HD2' ' A' ' 19' ' ' LYS . 12.5 tt -141.78 80.53 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 122.056 0.932 . . . . 0.0 109.475 178.23 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 9.3 m -77.09 141.92 40.02 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.67 -173.846 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.755 ' HB3' ' HB2' ' A' ' 64' ' ' GLU . 41.3 ttm180 -92.98 97.53 10.78 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 178.125 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 48.1 t -76.22 107.47 7.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.097 -0.501 . . . . 0.0 109.961 -178.591 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -106.78 112.08 3.7 Favored Glycine 0 N--CA 1.448 -0.511 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.824 179.446 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 62.0 t -106.4 111.52 35.68 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 177.613 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' CYS . . . . . 0.779 ' SG ' ' HB3' ' A' ' 60' ' ' LEU . 8.0 p -104.92 143.1 33.62 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.548 178.352 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 40.9 ttmt -94.89 92.9 7.14 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 121.026 0.441 . . . . 0.0 109.972 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 42.6 t -77.11 88.0 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.769 178.718 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 61.0 mtm -65.3 140.26 58.67 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.256 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 14.7 m-70 -67.13 126.81 93.08 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.405 -179.656 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -59.31 -23.08 68.35 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 122.511 2.14 . . . . 0.0 111.272 175.315 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 7.8 mp0 -59.36 -34.89 72.94 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.418 175.68 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 65.73 11.31 53.53 Favored Glycine 0 CA--C 1.524 0.599 0 CA-C-N 115.954 -0.566 . . . . 0.0 114.374 174.289 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -83.13 -26.26 31.14 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 117.368 0.584 . . . . 0.0 110.776 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 158.47 171.28 24.14 Favored Glycine 0 C--O 1.237 0.287 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.887 -177.725 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 32.6 ttm180 68.1 147.61 0.05 Allowed 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 123.474 0.71 . . . . 0.0 111.301 -177.826 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 23.9 m -134.52 129.64 35.41 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.503 175.756 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -77.84 155.94 43.48 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.999 -0.619 . . . . 0.0 111.662 177.39 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -133.24 119.76 20.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.928 0.394 . . . . 0.0 110.413 -179.54 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.779 ' HB3' ' SG ' ' A' ' 46' ' ' CYS . 1.2 tt -96.2 110.21 22.54 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 179.003 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 57.3 mt -84.85 90.84 2.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 174.54 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -103.46 116.16 31.88 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.082 -175.106 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -91.42 96.05 2.14 Favored Glycine 0 N--CA 1.449 -0.493 0 CA-C-N 115.964 -0.562 . . . . 0.0 112.111 -179.025 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.755 ' HB2' ' HB3' ' A' ' 42' ' ' ARG . 5.2 mm-40 -73.77 145.21 45.24 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 177.365 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.46 ' HD2' HD22 ' A' ' 70' ' ' LEU . 18.6 ttt180 -76.58 8.33 3.66 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.241 -178.591 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.424 ' NE2' ' HB2' ' A' ' 42' ' ' ARG . 6.7 tp-100 71.9 -68.67 0.21 Allowed 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 123.521 0.728 . . . . 0.0 110.263 -178.864 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.409 ' O ' ' HB3' ' A' ' 68' ' ' ASP . 88.0 tttt -88.27 118.19 27.7 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 177.571 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.409 ' HB3' ' O ' ' A' ' 67' ' ' LYS . 32.5 t70 73.61 146.58 0.08 Allowed 'General case' 0 N--CA 1.469 0.518 0 O-C-N 124.003 0.814 . . . . 0.0 111.269 -178.786 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -74.39 79.47 1.89 Allowed 'General case' 0 C--O 1.236 0.369 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.2 -179.33 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.46 HD22 ' HD2' ' A' ' 65' ' ' ARG . 6.2 tt -130.9 131.85 44.76 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 179.762 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.455 ' N ' HD23 ' A' ' 70' ' ' LEU . 23.6 t -89.73 117.67 33.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.042 -175.976 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 32.8 m -98.29 -23.0 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-O 120.713 0.292 . . . . 0.0 110.806 176.792 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.414 HD23 ' N ' ' A' ' 74' ' ' GLU . 9.3 tt -145.54 139.52 26.8 Favored 'General case' 0 N--CA 1.462 0.166 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 -179.179 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.414 ' N ' HD23 ' A' ' 73' ' ' LEU . 1.7 tm-20 -142.5 109.51 5.53 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 -179.129 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' CYS . . . . . 0.424 ' SG ' HG21 ' A' ' 95' ' ' VAL . 35.0 t -140.12 82.56 1.87 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.384 0.611 . . . . 0.0 110.984 -179.288 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.422 ' HA ' ' HA ' ' A' ' 60' ' ' LEU . 82.5 t80 -75.13 121.99 22.91 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.812 174.662 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.511 HG11 ' HB2' ' A' ' 81' ' ' LEU . 92.8 t -124.85 112.02 30.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 -177.218 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.415 ' HD3' ' OH ' ' A' ' 76' ' ' TYR . 46.5 ttp180 -120.4 1.24 10.69 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-O 121.253 0.549 . . . . 0.0 110.58 -179.692 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 19.3 ptmt -141.01 86.86 2.06 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 115.965 -0.562 . . . . 0.0 111.141 -176.002 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.534 ' H ' HD11 ' A' ' 124' ' ' LEU . 18.2 t70 64.5 148.4 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 115.649 -0.705 . . . . 0.0 112.154 178.108 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.511 ' HB2' HG11 ' A' ' 77' ' ' VAL . 51.5 tp -149.46 137.78 20.71 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.846 -0.615 . . . . 0.0 109.961 178.999 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 60.3 t -77.28 -65.13 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.363 178.338 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.438 ' HD2' ' HB ' ' A' ' 117' ' ' VAL . 4.5 t80 37.99 79.89 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 124.111 0.964 . . . . 0.0 111.729 -178.767 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 97.1 m -112.64 136.5 52.13 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.261 -0.881 . . . . 0.0 109.913 179.714 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.464 ' HA ' ' HA ' ' A' ' 91' ' ' HIS . 18.0 ptmt -85.37 108.77 17.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.043 0.449 . . . . 0.0 109.846 176.569 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -74.85 -27.55 60.31 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.446 0.641 . . . . 0.0 109.846 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ASN . . . . . 0.502 ' HB2' ' HB3' ' A' ' 90' ' ' PHE . 16.5 m120 -141.62 156.43 66.4 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-N 115.059 -0.973 . . . . 0.0 108.709 177.923 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -58.56 -13.29 16.72 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.581 2.187 . . . . 0.0 112.561 180.0 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.435 ' HA ' ' HD2' ' A' ' 104' ' ' PHE . 23.6 p -124.55 14.3 8.79 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.608 -178.885 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.502 ' HB3' ' HB2' ' A' ' 87' ' ' ASN . 42.6 t80 -145.19 123.17 12.04 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-O 120.706 0.289 . . . . 0.0 110.833 -177.539 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' HIS . . . . . 0.471 ' HB2' ' CZ ' ' A' ' 104' ' ' PHE . 0.3 OUTLIER -126.01 136.29 52.79 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 -179.134 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 92' ' ' HIS . . . . . 0.569 ' HA ' ' HA3' ' A' ' 101' ' ' GLY . 11.7 p80 -141.53 158.59 43.66 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 120.643 0.259 . . . . 0.0 110.905 -177.148 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' TRP . . . . . 0.517 ' CZ3' ' HA2' ' A' ' 101' ' ' GLY . 39.3 p90 -136.45 158.89 43.36 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.848 0.356 . . . . 0.0 110.375 176.976 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt -122.48 113.96 20.04 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.669 179.577 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.424 HG21 ' SG ' ' A' ' 75' ' ' CYS . 28.0 m -141.34 162.63 21.38 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 N-CA-C 110.021 -0.363 . . . . 0.0 110.021 178.084 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 26.0 t70 63.56 -76.1 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.393 0 O-C-N 123.694 0.621 . . . . 0.0 110.957 179.699 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -155.92 -9.86 0.11 Allowed 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.781 177.269 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 42.0 ttm180 -122.15 155.59 35.43 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.261 0.553 . . . . 0.0 112.032 -165.553 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.539 ' HG2' ' HH2' ' A' ' 32' ' ' TRP . 37.4 ttpt -108.63 107.25 17.66 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.053 -0.976 . . . . 0.0 109.436 178.312 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.456 ' HA ' ' HZ3' ' A' ' 32' ' ' TRP . 3.6 p90 -138.55 155.19 48.59 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.662 -0.245 . . . . 0.0 110.667 -179.419 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.569 ' HA3' ' HA ' ' A' ' 92' ' ' HIS . . . -163.09 -141.5 3.14 Favored Glycine 0 C--N 1.332 0.346 0 C-N-CA 121.116 -0.564 . . . . 0.0 112.702 -177.177 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.659 ' HA ' ' H ' ' A' ' 23' ' ' MET . 0.0 OUTLIER -157.51 156.02 31.3 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 121.032 0.444 . . . . 0.0 111.035 -178.699 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 36.2 m -101.52 132.53 47.1 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.752 175.967 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.471 ' CZ ' ' HB2' ' A' ' 91' ' ' HIS . 19.6 m-85 -67.41 160.27 27.74 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.412 -179.874 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 -117.08 -52.46 2.51 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.205 178.948 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 25.4 m -129.75 153.2 80.79 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.251 -177.868 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_exo -49.11 -31.44 21.3 Favored 'Trans proline' 0 C--N 1.353 0.8 0 C-N-CA 122.669 2.246 . . . . 0.0 112.66 178.569 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -59.47 -62.22 2.04 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.249 179.376 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -65.67 -38.03 88.15 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.591 -179.429 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -52.81 -60.74 2.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.028 0.442 . . . . 0.0 110.781 176.761 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 72.4 mtp180 -64.08 -27.52 69.16 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.634 -179.368 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -65.23 -39.27 92.51 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.547 176.191 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 46.2 m-85 -71.03 -43.84 67.05 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.589 177.667 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.425 ' O ' HG12 ' A' ' 117' ' ' VAL . 49.9 m-20 -61.59 -55.55 29.49 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 120.814 0.34 . . . . 0.0 110.623 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 80.2 mtt-85 -66.39 -28.72 68.86 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-O 121.02 0.438 . . . . 0.0 110.154 176.84 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -59.35 -50.98 61.93 Favored Glycine 0 N--CA 1.447 -0.579 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.86 176.139 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.438 ' HB ' ' HD2' ' A' ' 83' ' ' TYR . 11.9 p -69.27 -32.75 54.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 116.694 0.247 . . . . 0.0 110.584 -179.74 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.454 ' O ' ' HG3' ' A' ' 122' ' ' GLU . 3.4 mmp_? -53.04 -64.63 0.76 Allowed 'General case' 0 C--O 1.238 0.476 0 CA-C-O 121.231 0.539 . . . . 0.0 109.995 174.17 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 81.4 tttt -66.86 -33.63 76.01 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 115.476 -0.783 . . . . 0.0 110.728 -176.107 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -61.03 -50.84 71.72 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.458 178.21 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.552 ' O ' HG22 ' A' ' 125' ' ' ILE . 31.8 mm -60.08 -40.68 84.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.109 178.947 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.484 ' O ' ' HB2' ' A' ' 126' ' ' GLU . 43.5 mt-10 -54.8 -56.46 19.18 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 110.284 -0.265 . . . . 0.0 110.284 176.385 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 49.4 m-20 -65.26 -27.23 68.5 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.668 -0.242 . . . . 0.0 111.425 -178.981 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.534 HD11 ' H ' ' A' ' 80' ' ' ASP . 3.2 tm? -76.51 -56.68 4.4 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.179 -176.126 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.552 HG22 ' O ' ' A' ' 121' ' ' ILE . 11.2 tp -94.12 -34.02 5.43 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 -170.349 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.484 ' HB2' ' O ' ' A' ' 122' ' ' GLU . 32.1 mm-40 . . . . . 0 C--O 1.251 1.142 0 CA-C-O 118.637 -0.697 . . . . 0.0 110.862 -174.535 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.837 0 N-CA-C 112.014 -0.434 . . . . 0.0 112.014 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 13.5 p -69.04 97.29 0.86 Allowed 'General case' 0 CA--C 1.533 0.3 0 CA-C-O 120.769 0.319 . . . . 0.0 111.365 -178.454 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 65.5 mtt -100.6 -8.45 22.96 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.653 179.498 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 7.5 p -72.12 120.78 18.2 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.6 -177.693 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -160.4 106.41 1.51 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.436 -0.802 . . . . 0.0 108.963 176.891 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -164.38 -58.39 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.825 -172.626 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.731 ' HB ' ' HE1' ' A' ' 14' ' ' TYR . 11.3 p 53.67 106.42 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 114.978 -1.01 . . . . 0.0 112.234 179.769 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.608 ' HB3' ' HD3' ' A' ' 9' ' ' PRO . 76.2 t60 178.24 -54.19 0.0 OUTLIER Pre-proline 0 N--CA 1.47 0.534 0 CA-C-N 115.033 -0.985 . . . . 0.0 108.925 -174.558 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.608 ' HD3' ' HB3' ' A' ' 8' ' ' HIS . 98.4 Cg_endo -87.03 5.16 5.89 Favored 'Trans proline' 0 C--N 1.361 1.189 0 C-N-CA 122.273 1.982 . . . . 0.0 110.122 169.445 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -150.84 107.74 3.55 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 114.101 -1.409 . . . . 0.0 107.806 -178.879 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.636 ' HB2' ' HB2' ' A' ' 14' ' ' TYR . 7.7 p-10 -83.6 40.6 0.74 Allowed 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 111.658 0.244 . . . . 0.0 111.658 -171.041 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -43.52 -42.39 4.92 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 112.86 0.689 . . . . 0.0 112.86 -175.391 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 15.6 m -124.4 18.14 8.95 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 -174.108 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.731 ' HE1' ' HB ' ' A' ' 7' ' ' THR . 58.7 m-85 -91.57 106.42 18.47 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 120.806 0.336 . . . . 0.0 111.12 -177.487 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.515 HG22 HG23 ' A' ' 16' ' ' VAL . 52.1 mt -71.66 -57.23 7.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.931 -176.851 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.515 HG23 HG22 ' A' ' 15' ' ' ILE . 61.0 t -129.0 132.05 67.63 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 CA-C-O 120.709 0.29 . . . . 0.0 110.963 -177.06 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.659 ' HD2' ' HB3' ' A' ' 14' ' ' TYR . 0.0 OUTLIER -128.06 115.62 18.75 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 174.949 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 27.6 m -124.11 166.01 19.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.732 0.301 . . . . 0.0 110.804 -179.598 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -87.51 137.08 32.65 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.623 -178.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -169.77 -165.1 0.47 Allowed 'General case' 0 C--O 1.237 0.437 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 178.377 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 7.3 p -140.44 126.97 21.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.031 0.443 . . . . 0.0 110.549 173.934 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.458 HG21 ' HB2' ' A' ' 73' ' ' LEU . 30.9 m -81.25 131.15 34.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.747 175.981 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 89.2 mmm -114.63 130.52 56.8 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.643 -0.502 . . . . 0.0 109.643 -176.471 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.447 HG23 ' HD1' ' A' ' 33' ' ' PHE . 9.5 t -103.16 162.01 13.32 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.086 0.469 . . . . 0.0 111.202 -178.518 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 19.8 ttt180 -120.38 21.26 11.72 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.18 -0.918 . . . . 0.0 108.6 178.239 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.412 ' O ' ' HB3' ' A' ' 27' ' ' ASP . 36.0 t70 49.17 38.39 13.09 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 114.423 -1.262 . . . . 0.0 111.192 177.899 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.412 ' HB3' ' O ' ' A' ' 26' ' ' ASP . 27.6 t70 73.27 -54.86 0.69 Allowed 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 115.242 -0.89 . . . . 0.0 112.758 177.207 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 22.1 m -136.62 18.59 3.09 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 112.611 0.597 . . . . 0.0 112.611 -174.025 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 65.7 m -86.14 -170.69 3.21 Favored 'General case' 0 C--N 1.327 -0.372 0 O-C-N 122.297 -0.252 . . . . 0.0 110.321 177.327 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -111.49 -44.14 0.93 Allowed Glycine 0 C--N 1.334 0.436 0 C-N-CA 121.294 -0.479 . . . . 0.0 112.368 -179.677 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -77.54 170.84 55.12 Favored Glycine 0 C--N 1.33 0.235 0 C-N-CA 121.192 -0.528 . . . . 0.0 112.692 -178.651 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 91.0 m95 -117.41 120.37 37.96 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 179.665 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.447 ' HD1' HG23 ' A' ' 24' ' ' THR . 1.4 m-85 -101.79 156.36 35.29 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.657 -170.896 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.455 ' HB3' ' HA2' ' A' ' 38' ' ' GLY . 51.3 Cg_exo -56.44 -11.82 7.12 Favored 'Trans proline' 0 C--N 1.355 0.918 0 C-N-CA 123.352 2.701 . . . . 0.0 112.992 178.496 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER 72.61 -71.08 0.14 Allowed 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 123.327 0.651 . . . . 0.0 110.554 174.256 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -161.74 -55.1 0.05 OUTLIER 'General case' 0 C--O 1.234 0.24 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 -179.779 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -62.76 -39.66 98.23 Favored Glycine 0 C--N 1.331 0.278 0 CA-C-N 115.596 -0.729 . . . . 0.0 112.553 -179.524 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.455 ' HA2' ' HB3' ' A' ' 34' ' ' PRO . . . 57.57 19.4 34.4 Favored Glycine 0 C--N 1.334 0.431 0 C-N-CA 121.544 -0.36 . . . . 0.0 113.551 177.16 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 140.2 -29.31 2.42 Favored Glycine 0 C--O 1.235 0.187 0 N-CA-C 111.203 -0.759 . . . . 0.0 111.203 -178.189 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.57 ' N ' HD12 ' A' ' 40' ' ' ILE . 2.8 mp -100.63 93.94 3.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 175.842 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 49.1 m -151.75 130.48 12.37 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 174.151 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 34.9 ttp180 -101.31 102.42 13.27 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 177.019 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 4.5 p -81.01 106.84 12.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 121.476 0.655 . . . . 0.0 109.976 179.52 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -102.8 112.37 4.25 Favored Glycine 0 N--CA 1.446 -0.669 0 CA-C-N 115.334 -0.848 . . . . 0.0 112.018 -179.511 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 7.0 p -86.45 109.22 18.6 Favored 'Isoleucine or valine' 0 C--O 1.239 0.5 0 CA-C-O 121.393 0.615 . . . . 0.0 109.967 176.162 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' CYS . . . . . 0.754 ' SG ' ' HB3' ' A' ' 60' ' ' LEU . 12.1 p -105.87 145.43 31.25 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.005 178.358 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 12.0 tmtt? -100.78 105.75 17.1 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 179.335 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.435 HG21 ' HE1' ' A' ' 76' ' ' TYR . 60.8 t -66.87 125.64 24.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.307 -179.129 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 66.1 mtt -87.17 147.38 25.63 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.193 179.253 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' HIS . . . . . 0.456 ' HB3' ' HB3' ' A' ' 57' ' ' SER . 28.8 p80 -85.77 133.97 40.52 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.52 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -79.13 175.06 11.29 Favored 'Trans proline' 0 C--O 1.239 0.547 0 C-N-CA 122.239 1.96 . . . . 0.0 110.608 170.81 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -65.7 135.4 54.91 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-O 120.975 0.417 . . . . 0.0 110.162 178.366 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 129.04 -150.46 18.82 Favored Glycine 0 N--CA 1.453 -0.225 0 N-CA-C 111.098 -0.801 . . . . 0.0 111.098 -176.204 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -58.31 -63.71 1.17 Allowed 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.891 0.377 . . . . 0.0 111.048 -179.641 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 149.34 158.39 8.08 Favored Glycine 0 N--CA 1.45 -0.377 0 CA-C-N 115.921 -0.581 . . . . 0.0 112.04 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 31.3 ttt180 -163.98 29.12 0.08 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.694 0.759 . . . . 0.0 109.028 179.42 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.456 ' HB3' ' HB3' ' A' ' 50' ' ' HIS . 25.3 p -89.29 154.46 20.08 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.318 -0.856 . . . . 0.0 111.261 -176.992 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 166.99 -142.42 7.58 Favored Glycine 0 N--CA 1.45 -0.384 0 N-CA-C 111.261 -0.735 . . . . 0.0 111.261 179.775 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -129.44 154.51 46.89 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 177.956 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.754 ' HB3' ' SG ' ' A' ' 46' ' ' CYS . 3.0 tt -128.42 119.06 24.22 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 178.882 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 57.2 mt -80.23 86.74 1.41 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.371 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 175.442 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' HIS . . . . . 0.444 ' HB3' ' HE2' ' A' ' 14' ' ' TYR . 21.7 t60 -98.84 107.69 20.19 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.981 -176.605 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -97.07 99.16 2.24 Favored Glycine 0 C--O 1.239 0.409 0 CA-C-N 115.81 -0.632 . . . . 0.0 112.488 -178.378 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.438 ' HG2' ' CE1' ' A' ' 8' ' ' HIS . 43.8 mt-10 -73.03 152.13 41.43 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 175.674 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.4 ' O ' HG22 ' A' ' 40' ' ' ILE . 71.0 ttt-85 -67.38 -31.95 72.54 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 174.474 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -168.13 -60.92 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.233 178.377 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 53.7 tttm -173.93 124.12 0.34 Allowed 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 117.804 0.275 . . . . 0.0 111.611 175.883 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 57.69 14.62 2.5 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.636 0.774 . . . . 0.0 112.005 174.002 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -106.77 -69.65 0.83 Allowed 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 111.831 0.308 . . . . 0.0 111.831 -167.322 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 48.5 tp -149.34 138.04 21.05 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.426 -175.078 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 21.4 t -88.52 102.0 12.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 176.075 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 28.3 m -88.17 -20.86 7.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.625 0.25 . . . . 0.0 111.355 -176.04 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.552 HD13 ' N ' ' A' ' 74' ' ' GLU . 2.9 tm? -149.65 140.74 22.99 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 179.373 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.552 ' N ' HD13 ' A' ' 73' ' ' LEU . 34.0 tt0 -159.07 119.86 3.24 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 -177.863 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 66.2 m -142.27 137.86 30.96 Favored 'General case' 0 C--O 1.232 0.161 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 -176.964 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.435 ' HE1' HG21 ' A' ' 48' ' ' VAL . 85.7 t80 -99.82 138.89 36.27 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 110.215 -0.291 . . . . 0.0 110.215 -176.25 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.72 HG12 HG11 ' A' ' 95' ' ' VAL . 20.3 m -135.19 141.16 43.51 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 -178.717 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 36.4 mtm180 -110.32 -73.06 0.7 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.941 0.401 . . . . 0.0 110.068 -178.121 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -152.85 19.63 0.6 Allowed 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 175.675 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -112.61 17.48 19.13 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 114.229 -1.35 . . . . 0.0 110.276 -176.145 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.574 HD22 ' HB2' ' A' ' 83' ' ' TYR . 1.6 tt -73.37 92.54 1.84 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.278 -176.736 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 3.6 p -81.17 85.25 1.52 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 CA-C-O 121.509 0.671 . . . . 0.0 110.009 174.757 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.614 ' HD2' HG21 ' A' ' 117' ' ' VAL . 0.6 OUTLIER -92.23 102.7 15.22 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.003 -177.011 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 99.9 m -114.46 133.12 55.99 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.295 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.534 ' HA ' ' HA ' ' A' ' 91' ' ' HIS . 4.9 ptpp? -94.96 111.8 23.56 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 175.528 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -70.94 -35.04 72.05 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.364 0.602 . . . . 0.0 109.494 175.874 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ASN . . . . . 0.541 ' HB2' ' HB3' ' A' ' 90' ' ' PHE . 92.5 m-20 -134.48 155.18 79.9 Favored Pre-proline 0 C--N 1.332 -0.18 0 CA-C-N 114.99 -1.005 . . . . 0.0 108.529 176.339 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -54.3 -23.23 29.47 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.546 2.164 . . . . 0.0 112.753 178.958 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 14.9 t -112.45 2.31 16.32 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.335 -178.99 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.541 ' HB3' ' HB2' ' A' ' 87' ' ' ASN . 72.1 t80 -131.73 109.74 10.38 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-O 120.929 0.395 . . . . 0.0 110.681 -177.761 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' HIS . . . . . 0.534 ' HA ' ' HA ' ' A' ' 85' ' ' LYS . 0.1 OUTLIER -107.03 159.68 16.11 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 177.65 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 92' ' ' HIS . . . . . 0.413 ' HA ' ' HA2' ' A' ' 101' ' ' GLY . 17.2 p80 -155.73 160.82 40.64 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.612 0.244 . . . . 0.0 110.543 178.311 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 34.6 p90 -149.5 166.29 29.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.741 -178.664 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -131.63 106.08 7.94 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 174.264 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.72 HG11 HG12 ' A' ' 77' ' ' VAL . 29.8 m -136.56 172.54 15.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.139 -0.482 . . . . 0.0 109.822 179.544 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 42.9 m-20 59.09 -77.25 0.02 OUTLIER 'General case' 0 C--O 1.234 0.24 0 O-C-N 123.663 0.602 . . . . 0.0 110.427 -174.135 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 30.4 p-10 -163.26 9.12 0.05 Allowed 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 179.641 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 3.7 tpt180 -149.29 167.28 26.5 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 118.329 0.513 . . . . 0.0 111.627 -175.384 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 58.5 tttm -103.74 118.18 36.1 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.316 -176.882 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 33.8 m-85 -115.37 170.76 8.16 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.152 -0.476 . . . . 0.0 109.935 -178.591 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.413 ' HA2' ' HA ' ' A' ' 92' ' ' HIS . . . -142.39 164.86 26.88 Favored Glycine 0 C--N 1.332 0.35 0 C-N-CA 120.968 -0.634 . . . . 0.0 112.862 -177.657 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 8.3 tt -150.25 132.42 15.39 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 -179.586 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 45.5 m -112.76 134.54 54.23 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.868 0.366 . . . . 0.0 110.316 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 63.8 m-85 -86.78 -178.23 6.29 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.179 -179.003 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 24.6 tt0 -124.54 -70.55 0.75 Allowed 'General case' 0 C--O 1.236 0.346 0 CA-C-O 120.907 0.384 . . . . 0.0 111.122 -178.15 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 48.8 m -108.81 158.49 33.98 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.435 -175.127 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -54.8 -28.72 59.16 Favored 'Trans proline' 0 C--N 1.352 0.731 0 C-N-CA 122.539 2.159 . . . . 0.0 111.96 179.108 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -59.65 -68.39 0.29 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.736 178.513 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -61.62 -44.72 96.47 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.066 -178.475 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -56.23 -63.94 1.02 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.48 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 7.1 tpt180 -61.05 -39.51 90.09 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.635 -175.034 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -65.55 -39.48 91.76 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.075 -179.271 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 21.1 t80 -70.24 -42.87 71.64 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 -178.384 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 45.0 m-20 -58.53 -44.32 89.53 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-O 121.37 0.605 . . . . 0.0 109.991 175.489 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' ARG . . . . . 0.41 HH11 ' HD2' ' A' ' 115' ' ' ARG . 45.2 ttm180 -63.75 -39.67 94.84 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.289 -0.869 . . . . 0.0 109.84 178.265 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -67.55 -44.7 81.91 Favored Glycine 0 N--CA 1.449 -0.468 0 CA-C-N 115.235 -0.893 . . . . 0.0 112.622 -178.063 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.614 HG21 ' HD2' ' A' ' 83' ' ' TYR . 13.0 p -68.5 -35.75 71.78 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.105 0 CA-C-N 116.744 0.272 . . . . 0.0 110.398 -179.237 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 67.1 ttt180 -58.95 -52.53 65.34 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 174.004 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 54.3 tptt -58.08 -32.01 67.64 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.063 178.519 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -68.79 -36.68 78.57 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.476 176.937 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.536 HG13 ' O ' ' A' ' 117' ' ' VAL . 77.5 mt -60.86 -47.98 90.94 Favored 'Isoleucine or valine' 0 C--O 1.232 0.173 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 176.814 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -58.91 -57.83 11.33 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-O 120.907 0.384 . . . . 0.0 110.382 174.167 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -63.03 -29.21 70.64 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.774 -0.648 . . . . 0.0 112.54 -171.658 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 49.6 tp -93.47 -44.41 8.26 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 111.789 0.292 . . . . 0.0 111.789 -177.922 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.523 HD12 HG23 ' A' ' 121' ' ' ILE . 59.3 mt -99.85 -44.52 11.62 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 N-CA-C 112.705 0.631 . . . . 0.0 112.705 -170.457 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 . . . . . 0 C--O 1.249 1.028 0 CA-C-O 119.104 -0.474 . . . . 0.0 111.32 -170.314 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.641 0 N-CA-C 111.709 -0.556 . . . . 0.0 111.709 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 10.9 p -76.15 95.74 3.74 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.708 0.29 . . . . 0.0 110.319 178.545 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 27.1 ttt -62.46 -37.34 85.55 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.465 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 31.0 m -132.31 94.05 3.37 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.364 -179.138 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -114.63 -29.56 6.77 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 108.552 -0.906 . . . . 0.0 108.552 167.934 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -77.21 121.26 23.41 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 114.665 -1.152 . . . . 0.0 110.158 176.244 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 49.0 m -64.35 -31.27 72.41 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.019 0.437 . . . . 0.0 110.975 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.43 ' H ' ' HB2' ' A' ' 11' ' ' ASP . 52.8 m-70 -132.99 150.38 75.47 Favored Pre-proline 0 C--N 1.329 -0.288 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 179.356 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -53.93 -42.82 63.53 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 122.342 2.028 . . . . 0.0 111.716 178.815 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.503 ' HB3' ' HB2' ' A' ' 13' ' ' SER . 5.1 m-20 -105.2 32.61 4.12 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.049 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.439 ' HA ' ' CE1' ' A' ' 14' ' ' TYR . 24.6 t70 -54.96 -36.67 65.58 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.619 -175.721 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -83.44 -19.57 35.65 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.103 -178.548 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.503 ' HB2' ' HB3' ' A' ' 10' ' ' ASP . 19.2 m -92.08 9.59 32.77 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-N 115.993 -0.549 . . . . 0.0 112.056 -172.569 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.581 ' HA ' ' HA ' ' A' ' 46' ' ' CYS . 45.4 m-85 -68.74 125.12 25.56 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 120.623 0.249 . . . . 0.0 110.663 175.696 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 62.4 mt -67.47 -47.66 79.9 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 177.166 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 9.8 p -166.19 139.37 0.92 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.334 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.216 178.494 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.687 HH12 ' NH1' ' A' ' 65' ' ' ARG . 50.0 mtt180 -109.23 100.99 10.05 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 176.317 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 30.1 t -92.52 148.48 4.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.989 -174.702 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -83.75 120.92 26.61 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.445 179.739 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -164.88 -171.04 2.13 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.108 -0.496 . . . . 0.0 109.76 -179.624 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.461 ' HB ' ' HB ' ' A' ' 103' ' ' THR . 84.7 t -121.44 115.88 47.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.651 0.263 . . . . 0.0 110.576 178.774 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.571 HG23 HE22 ' A' ' 35' ' ' GLN . 16.4 m -83.95 125.98 40.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.767 0.318 . . . . 0.0 110.524 177.795 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 22.5 mmt -112.27 150.31 31.13 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.795 -176.658 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 11.9 t -129.61 155.39 45.91 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.112 -0.495 . . . . 0.0 109.932 176.997 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 25.9 tpt180 -140.56 141.02 35.27 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 178.888 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -70.69 111.31 6.06 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 174.435 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 22.7 t70 61.96 -83.19 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.556 0 O-C-N 123.53 0.519 . . . . 0.0 111.887 179.034 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 68.3 m -154.4 -172.06 4.08 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 122.389 0.276 . . . . 0.0 110.882 -176.766 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 12.7 t 85.09 151.73 0.08 Allowed 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.165 0.986 . . . . 0.0 111.47 179.587 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -77.8 80.62 1.32 Allowed Glycine 0 C--N 1.334 0.454 0 CA-C-N 115.605 -0.725 . . . . 0.0 112.581 -176.692 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -152.68 55.51 0.44 Allowed Glycine 0 CA--C 1.51 -0.258 0 N-CA-C 110.595 -1.002 . . . . 0.0 110.595 176.921 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 80.6 m95 -70.79 119.53 15.07 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.158 -0.521 . . . . 0.0 111.219 -173.782 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 46.9 p90 -107.11 126.7 29.52 Favored Pre-proline 0 CA--C 1.534 0.35 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.678 -177.732 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -73.1 99.19 1.07 Allowed 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 122.75 2.3 . . . . 0.0 111.696 178.791 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.571 HE22 HG23 ' A' ' 22' ' ' VAL . 5.0 pm0 -57.2 -48.78 77.93 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 115.648 -0.705 . . . . 0.0 112.703 -175.592 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.587 ' CB ' HG11 ' A' ' 72' ' ' VAL . 16.3 tp10 -134.8 -83.47 0.42 Allowed 'General case' 0 N--CA 1.467 0.406 0 O-C-N 122.254 -0.279 . . . . 0.0 110.919 -174.647 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -72.92 68.02 1.34 Allowed Glycine 0 C--N 1.336 0.568 0 C-N-CA 121.408 -0.425 . . . . 0.0 112.672 179.578 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -80.59 -35.35 25.91 Favored Glycine 0 C--N 1.331 0.267 0 C-N-CA 121.395 -0.431 . . . . 0.0 112.415 -179.085 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -79.45 -29.08 50.62 Favored Glycine 0 C--O 1.236 0.227 0 N-CA-C 111.454 -0.658 . . . . 0.0 111.454 177.741 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.415 HG12 HE22 ' A' ' 66' ' ' GLN . 8.6 tt -174.85 139.16 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 179.037 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 23.3 t -145.11 -178.51 6.09 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 177.628 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 60.1 mtt180 -130.89 106.9 8.73 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.098 0.475 . . . . 0.0 110.211 -177.222 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 40.9 t -81.6 103.39 8.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.127 -179.77 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -90.73 105.06 3.22 Favored Glycine 0 N--CA 1.446 -0.698 0 CA-C-N 115.959 -0.564 . . . . 0.0 112.352 -179.228 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 54.4 t -88.02 103.12 13.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 176.071 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' CYS . . . . . 0.624 ' SG ' ' HB3' ' A' ' 60' ' ' LEU . 5.3 p -108.49 145.55 34.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.258 -179.112 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 35.9 ttmt -98.31 100.96 12.29 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 175.093 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 30.1 m -86.87 128.58 39.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 121.096 0.474 . . . . 0.0 111.602 -172.468 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 25.1 ptm -84.59 140.49 31.35 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.553 178.877 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 23.5 m-70 -101.98 156.74 34.85 Favored Pre-proline 0 C--N 1.331 -0.217 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.115 -177.997 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_exo -71.27 61.85 2.64 Favored 'Trans proline' 0 CA--C 1.535 0.566 0 C-N-CA 122.843 2.362 . . . . 0.0 111.085 171.468 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 68.76 157.45 0.14 Allowed 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.913 -176.31 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 158.06 -26.36 0.43 Allowed Glycine 0 C--N 1.332 0.306 0 C-N-CA 121.331 -0.461 . . . . 0.0 112.235 -179.772 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -162.28 -53.25 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 121.096 0.474 . . . . 0.0 110.332 -178.138 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 140.11 -54.33 0.66 Allowed Glycine 0 CA--C 1.51 -0.24 0 N-CA-C 110.87 -0.892 . . . . 0.0 110.87 -179.183 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 39.0 ttm180 -73.78 139.27 45.08 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.762 0.315 . . . . 0.0 110.172 175.702 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 49.6 m -77.1 152.4 35.01 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.551 179.365 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -85.57 -161.72 35.09 Favored Glycine 0 N--CA 1.45 -0.387 0 N-CA-C 111.505 -0.638 . . . . 0.0 111.505 178.876 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.658 ' HB2' ' HB ' ' A' ' 77' ' ' VAL . 76.9 m-85 -134.96 163.78 29.08 Favored 'General case' 0 C--N 1.327 -0.409 0 O-C-N 122.559 -0.377 . . . . 0.0 110.299 -177.285 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.624 ' HB3' ' SG ' ' A' ' 46' ' ' CYS . 2.8 tt -150.29 118.63 6.41 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 177.843 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.449 ' O ' ' HA ' ' A' ' 74' ' ' GLU . 44.5 mm -82.63 91.53 2.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 175.537 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 12.6 t-80 -102.66 98.07 8.17 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.645 -174.445 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.513 ' O ' ' HB2' ' A' ' 64' ' ' GLU . . . -104.73 116.78 5.42 Favored Glycine 0 CA--C 1.522 0.48 0 CA-C-N 116.096 -0.502 . . . . 0.0 114.319 -171.727 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.681 ' HB2' HG22 ' A' ' 72' ' ' VAL . 7.7 tp10 165.08 -99.23 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 124.799 1.24 . . . . 0.0 109.103 164.228 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.687 ' NH1' HH12 ' A' ' 17' ' ' ARG . 8.6 tpt180 59.35 -1.03 0.15 Allowed 'General case' 0 CA--C 1.545 0.777 0 N-CA-C 113.436 0.902 . . . . 0.0 113.436 171.665 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.415 HE22 HG12 ' A' ' 40' ' ' ILE . 6.6 tp-100 -52.15 -59.04 4.84 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 -171.713 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 51.7 tttp -91.33 5.45 49.19 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-O 120.983 0.421 . . . . 0.0 110.397 -178.692 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 31.8 t0 64.84 149.2 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.568 -175.872 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 4.3 mppt? 55.84 26.23 9.4 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 121.003 0.43 . . . . 0.0 110.7 -169.681 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.574 HD22 ' HG2' ' A' ' 64' ' ' GLU . 0.9 OUTLIER -129.12 128.2 43.0 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.298 -0.631 . . . . 0.0 109.298 -179.056 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.625 ' HA ' ' HB3' ' A' ' 64' ' ' GLU . 51.4 t -137.66 140.67 40.93 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 179.18 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.681 HG22 ' HB2' ' A' ' 64' ' ' GLU . 27.5 m -130.35 -41.17 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 177.529 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.3 tt -124.36 133.79 53.33 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.389 -0.596 . . . . 0.0 109.389 -175.534 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.449 ' HA ' ' O ' ' A' ' 61' ' ' ILE . 11.0 pt-20 -146.98 130.3 16.62 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.067 0.461 . . . . 0.0 109.803 173.444 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' CYS . . . . . 0.54 ' HG ' ' HE1' ' A' ' 93' ' ' TRP . 47.7 t -130.03 109.34 10.78 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 -179.321 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 24.9 t80 -74.7 129.55 37.9 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.046 -0.525 . . . . 0.0 109.914 -177.083 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.658 ' HB ' ' HB2' ' A' ' 59' ' ' PHE . 63.1 t -105.45 85.32 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.496 0.665 . . . . 0.0 109.216 -177.894 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.446 ' O ' ' HB3' ' A' ' 79' ' ' LYS . 6.9 ptm180 -97.29 67.01 2.11 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.195 -0.911 . . . . 0.0 109.631 -179.633 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.49 ' HA ' HD21 ' A' ' 124' ' ' LEU . 7.3 tmtm? 77.39 -49.08 0.52 Allowed 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.478 -175.365 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.43 ' OD1' ' HG3' ' A' ' 78' ' ' ARG . 5.0 p-10 -81.91 128.97 34.6 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-O 121.058 0.456 . . . . 0.0 110.623 -178.595 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.624 HD12 HD11 ' A' ' 121' ' ' ILE . 3.3 tm? -177.48 135.53 0.19 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.269 -0.878 . . . . 0.0 108.684 -178.263 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 3.7 p -145.71 106.09 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 CA-C-O 121.019 0.438 . . . . 0.0 111.3 -179.054 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.706 ' HB3' ' NE2' ' A' ' 91' ' ' HIS . 3.2 m-85 -88.84 150.97 22.64 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.217 176.299 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 81.5 m -150.47 120.23 7.05 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.883 177.566 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.453 ' HA ' ' HA ' ' A' ' 91' ' ' HIS . 8.0 ttpm? -90.64 110.72 21.87 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 177.707 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -78.62 -50.16 11.98 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.069 -179.374 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ASN . . . . . 0.603 ' HB2' ' HB3' ' A' ' 90' ' ' PHE . 91.7 m-20 -120.11 153.41 55.39 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.004 179.706 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_endo -48.39 -33.63 23.24 Favored 'Trans proline' 0 CA--C 1.534 0.518 0 C-N-CA 122.99 2.46 . . . . 0.0 112.881 -176.295 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 15.2 t -112.36 13.87 20.34 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.419 -176.661 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.603 ' HB3' ' HB2' ' A' ' 87' ' ' ASN . 91.3 t80 -139.02 119.85 14.27 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-O 121.187 0.518 . . . . 0.0 111.493 -178.192 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' HIS . . . . . 0.706 ' NE2' ' HB3' ' A' ' 83' ' ' TYR . 1.2 t60 -116.24 157.8 24.34 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.384 -0.825 . . . . 0.0 108.915 178.5 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 25.0 p80 -155.05 157.58 37.8 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 175.304 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' TRP . . . . . 0.54 ' HE1' ' HG ' ' A' ' 75' ' ' CYS . 36.4 p90 -144.03 174.21 11.05 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 176.687 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 61.5 pttt -144.01 155.57 44.06 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 179.559 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.629 HG23 ' H ' ' A' ' 96' ' ' ASP . 7.9 m -133.55 -63.73 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.913 176.977 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.629 ' H ' HG23 ' A' ' 95' ' ' VAL . 20.3 m-20 -115.32 71.8 0.78 Allowed 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 -179.388 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 18.0 m120 74.02 -39.54 0.43 Allowed 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 115.346 -0.843 . . . . 0.0 112.155 178.788 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 63.7 ttt180 -87.18 148.8 25.02 Favored 'General case' 0 C--O 1.242 0.702 0 CA-C-O 121.033 0.444 . . . . 0.0 111.372 -176.083 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 61.9 mttp -100.71 143.57 30.72 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 114.956 -1.02 . . . . 0.0 110.834 178.957 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.408 ' HB2' ' CE2' ' A' ' 93' ' ' TRP . 6.8 m-85 -118.94 143.85 46.78 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 172.061 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -113.09 163.04 12.17 Favored Glycine 0 C--N 1.331 0.285 0 C-N-CA 120.834 -0.698 . . . . 0.0 113.892 -170.722 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.44 ' HB2' ' HZ3' ' A' ' 93' ' ' TRP . 57.3 tp -150.7 106.92 3.46 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 122.793 0.437 . . . . 0.0 110.181 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.461 ' HB ' ' HB ' ' A' ' 21' ' ' VAL . 52.1 m -89.31 125.04 34.95 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.323 178.044 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.55 ' CZ ' ' HB2' ' A' ' 91' ' ' HIS . 23.8 m-85 -78.76 161.04 27.12 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.462 179.465 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 65.3 tt0 -109.17 -42.04 4.51 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.712 179.469 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 13.6 m -140.88 151.63 63.23 Favored Pre-proline 0 CA--C 1.533 0.327 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.254 -179.072 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_exo -50.41 -30.26 26.58 Favored 'Trans proline' 0 C--N 1.352 0.752 0 C-N-CA 122.975 2.45 . . . . 0.0 113.207 -179.289 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -62.87 -64.11 1.01 Allowed 'General case' 0 C--O 1.235 0.291 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.98 179.844 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -62.99 -33.95 76.51 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.354 179.236 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.48 ' HB1' ' NH2' ' A' ' 111' ' ' ARG . . . -54.8 -63.89 1.01 Allowed 'General case' 0 C--O 1.235 0.325 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.092 177.688 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.48 ' NH2' ' HB1' ' A' ' 110' ' ' ALA . 0.0 OUTLIER -65.65 -24.43 67.02 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.788 179.765 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -61.93 -40.51 95.75 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 175.124 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.41 ' O ' HG12 ' A' ' 117' ' ' VAL . 47.4 m-85 -70.89 -48.23 54.84 Favored 'General case' 0 N--CA 1.461 0.1 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.587 176.083 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -53.54 -66.19 0.43 Allowed 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 121.39 0.614 . . . . 0.0 110.441 178.934 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 16.5 mtp180 -63.68 -36.56 84.25 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.889 -178.014 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -60.26 -53.78 42.77 Favored Glycine 0 C--N 1.332 0.344 0 CA-C-N 116.097 -0.501 . . . . 0.0 112.588 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.41 HG12 ' O ' ' A' ' 113' ' ' PHE . 10.7 p -66.27 -36.47 77.46 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.121 0 CA-C-N 116.672 0.236 . . . . 0.0 110.505 -178.071 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 95.8 mtt180 -60.95 -42.59 98.52 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.475 -0.329 . . . . 0.0 111.104 177.777 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 30.8 mmtp -76.29 -27.52 56.66 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 120.68 0.276 . . . . 0.0 110.948 178.223 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -63.35 -48.69 76.91 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 174.732 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.624 HD11 HD12 ' A' ' 81' ' ' LEU . 46.9 mm -66.8 -36.08 76.33 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.187 176.996 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -54.65 -56.67 16.67 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.253 178.265 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 -70.15 -29.5 66.43 Favored 'General case' 0 C--O 1.225 -0.188 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.94 179.386 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.49 HD21 ' HA ' ' A' ' 79' ' ' LYS . 6.7 tt -59.59 -43.76 93.58 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 177.241 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 66.7 mt -77.7 -30.88 16.95 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.495 178.595 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.428 -0.796 . . . . 0.0 109.808 179.101 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.716 0 N-CA-C 112.087 -0.405 . . . . 0.0 112.087 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 26.1 m -67.06 94.36 0.33 Allowed 'General case' 0 CA--C 1.532 0.266 0 CA-C-O 120.968 0.413 . . . . 0.0 110.913 -179.083 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 16.1 tpt -152.83 43.03 0.63 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.791 0.805 . . . . 0.0 109.002 177.758 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 18.2 p -99.61 113.17 25.44 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.538 -176.873 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -121.98 174.07 7.13 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 173.89 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 14.6 tm-20 71.57 -73.88 0.09 Allowed 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 -178.969 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.49 ' CB ' ' HB2' ' A' ' 12' ' ' ASP . 40.1 p 45.99 98.69 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 113.933 1.086 . . . . 0.0 113.933 171.656 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.497 ' H ' ' HD2' ' A' ' 9' ' ' PRO . 25.0 m170 -151.95 -54.85 0.02 OUTLIER Pre-proline 0 CA--C 1.536 0.416 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 -179.047 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.497 ' HD2' ' H ' ' A' ' 8' ' ' HIS . 92.2 Cg_endo -79.7 40.76 1.0 Allowed 'Trans proline' 0 C--N 1.36 1.177 0 C-N-CA 122.215 1.943 . . . . 0.0 110.714 169.855 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -168.75 -30.76 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 -174.133 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 80.21 102.75 0.06 Allowed 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 113.436 -1.711 . . . . 0.0 113.165 165.809 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.49 ' HB2' ' CB ' ' A' ' 7' ' ' THR . 3.7 m-20 -149.42 -23.79 0.28 Allowed 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.8 167.184 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 15.1 m -89.27 -8.12 54.05 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 120.798 0.333 . . . . 0.0 111.538 -176.767 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 67.8 m-85 -88.05 147.9 24.75 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.96 0.41 . . . . 0.0 111.515 -176.649 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 48.9 mm -105.81 -37.88 4.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 168.036 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 59.4 t -136.29 142.98 37.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 114.964 -1.016 . . . . 0.0 108.684 175.327 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.496 HH21 ' CD ' ' A' ' 64' ' ' GLU . 63.1 ttt180 -149.24 84.02 1.44 Allowed 'General case' 0 C--O 1.235 0.304 0 CA-C-O 121.22 0.533 . . . . 0.0 109.931 179.223 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 60.1 t -107.37 141.78 21.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.034 -177.752 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.742 ' HD3' ' H ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -82.83 127.51 33.54 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.943 -0.392 . . . . 0.0 109.943 176.909 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -150.48 171.92 16.29 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.64 178.597 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.56 ' HB ' ' HB ' ' A' ' 103' ' ' THR . 49.0 t -84.99 96.89 5.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.977 0.417 . . . . 0.0 110.783 -176.398 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 57.8 t -79.35 113.67 19.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.562 179.761 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 22.5 mmt -99.34 156.55 16.94 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.024 -0.534 . . . . 0.0 109.923 178.27 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.503 HG23 ' CE1' ' A' ' 33' ' ' PHE . 8.8 t -130.39 142.12 50.53 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.026 0.441 . . . . 0.0 110.536 179.466 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.428 ' HB2' ' CZ3' ' A' ' 32' ' ' TRP . 0.0 OUTLIER -94.06 101.33 13.36 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 173.778 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.487 ' HB2' ' CE1' ' A' ' 33' ' ' PHE . 32.1 t70 -52.4 120.82 5.99 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 178.085 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -39.26 108.68 0.09 Allowed 'General case' 0 N--CA 1.466 0.339 0 O-C-N 124.228 0.955 . . . . 0.0 111.487 -176.231 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 40.6 p 46.02 82.31 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.39 0 O-C-N 123.836 0.71 . . . . 0.0 111.36 -176.377 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 6.9 t -131.15 -69.38 0.63 Allowed 'General case' 0 C--O 1.234 0.27 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.812 -175.535 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 174.12 -62.02 0.12 Allowed Glycine 0 C--N 1.333 0.364 0 C-N-CA 121.177 -0.535 . . . . 0.0 112.005 -179.26 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -128.46 -139.28 4.73 Favored Glycine 0 C--O 1.236 0.245 0 C-N-CA 121.226 -0.511 . . . . 0.0 112.556 -179.213 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' TRP . . . . . 0.496 ' HH2' ' HG2' ' A' ' 99' ' ' LYS . 67.8 m95 -125.1 149.4 47.88 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 179.252 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.503 ' CE1' HG23 ' A' ' 24' ' ' THR . 2.0 p90 -149.07 152.86 37.25 Favored Pre-proline 0 C--O 1.236 0.366 0 N-CA-C 110.318 -0.253 . . . . 0.0 110.318 177.726 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -63.03 125.69 16.41 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 122.297 1.998 . . . . 0.0 111.785 176.008 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.638 ' HG2' HD21 ' A' ' 73' ' ' LEU . 2.0 pp0? -69.06 -168.67 0.15 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.263 174.739 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -55.59 -14.72 2.28 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 -173.871 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -67.59 -40.84 90.57 Favored Glycine 0 CA--C 1.521 0.414 0 N-CA-C 111.599 -0.6 . . . . 0.0 111.599 173.703 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 86.43 -33.95 3.57 Favored Glycine 0 C--N 1.333 0.411 0 N-CA-C 112.17 -0.372 . . . . 0.0 112.17 178.888 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.457 ' O ' ' HA ' ' A' ' 21' ' ' VAL . . . -162.78 -105.06 0.19 Allowed Glycine 0 N--CA 1.443 -0.859 0 N-CA-C 111.195 -0.762 . . . . 0.0 111.195 176.663 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.425 HG23 ' HB2' ' A' ' 19' ' ' LYS . 1.8 mp -60.9 131.88 26.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 120.973 0.416 . . . . 0.0 110.334 -179.904 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 41.6 m -145.82 152.89 40.25 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.333 178.322 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.757 ' HB2' ' HB2' ' A' ' 64' ' ' GLU . 13.1 mmt180 -72.99 105.13 4.34 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 110.379 -0.23 . . . . 0.0 110.379 -179.655 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 56.4 t -83.47 89.89 2.39 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 174.13 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -88.09 104.13 3.0 Favored Glycine 0 N--CA 1.444 -0.794 0 CA-C-N 115.515 -0.766 . . . . 0.0 112.669 -177.79 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 53.5 t -80.58 88.35 1.57 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.522 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 174.774 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' CYS . . . . . 0.683 ' HB3' ' HB3' ' A' ' 60' ' ' LEU . 42.6 t -85.58 146.73 26.75 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.392 179.204 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 79.6 tttt -142.73 96.88 3.01 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 -174.394 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 26.9 m -98.97 132.74 43.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.652 -176.82 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.7 151.83 40.6 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.838 0.351 . . . . 0.0 111.116 -177.065 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 13.6 m170 -93.84 121.61 63.99 Favored Pre-proline 0 C--O 1.233 0.234 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 176.652 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -49.48 -54.19 5.85 Favored 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 123.139 2.559 . . . . 0.0 113.278 -175.145 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -155.99 125.71 6.4 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 121.015 0.436 . . . . 0.0 109.891 -178.527 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 149.63 -159.81 28.22 Favored Glycine 0 C--N 1.329 0.185 0 N-CA-C 110.941 -0.864 . . . . 0.0 110.941 -178.019 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 51.4 t30 -95.71 130.04 42.74 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 117.342 0.571 . . . . 0.0 109.577 175.85 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 121.97 144.58 6.85 Favored Glycine 0 N--CA 1.449 -0.44 0 N-CA-C 111.541 -0.624 . . . . 0.0 111.541 -177.188 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 52.6 ttm-85 -86.92 -56.07 3.56 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.086 0.469 . . . . 0.0 110.265 -178.84 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 24.3 m -156.24 133.87 10.96 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.613 -176.731 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -78.64 147.16 30.71 Favored Glycine 0 N--CA 1.45 -0.422 0 N-CA-C 110.937 -0.865 . . . . 0.0 110.937 174.299 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.446 ' HB2' HG23 ' A' ' 77' ' ' VAL . 69.5 m-85 -104.08 122.31 45.03 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.906 0.384 . . . . 0.0 110.316 -174.65 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.683 ' HB3' ' HB3' ' A' ' 46' ' ' CYS . 3.6 tt -103.9 107.3 18.12 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 179.416 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 61.4 mt -71.49 91.97 0.43 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.327 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 174.707 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 12.4 t-80 -97.3 100.39 11.85 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.074 -173.111 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.437 ' HA3' ' HB2' ' A' ' 73' ' ' LEU . . . -99.35 112.96 4.59 Favored Glycine 0 C--N 1.33 0.22 0 C-N-CA 121.399 -0.429 . . . . 0.0 112.271 -177.373 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.757 ' HB2' ' HB2' ' A' ' 42' ' ' ARG . 22.1 mt-10 -107.05 138.2 43.67 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 122.226 0.21 . . . . 0.0 110.607 -178.545 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 26.6 ttt85 -67.63 130.85 44.3 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 173.768 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 6.8 tp60 -58.56 154.93 13.2 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.368 -176.521 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt 72.86 -69.84 0.18 Allowed 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 123.422 0.689 . . . . 0.0 111.35 177.471 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -69.23 -36.23 77.0 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 120.706 0.289 . . . . 0.0 110.543 -176.541 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 50.4 mtmt 61.93 85.28 0.12 Allowed 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.57 -0.741 . . . . 0.0 112.06 176.285 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -150.26 154.91 38.74 Favored 'General case' 0 C--O 1.24 0.565 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 173.468 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 10.5 t -72.5 92.61 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 CA-C-O 120.958 0.408 . . . . 0.0 111.517 -171.662 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 9.5 m -88.22 -37.47 10.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.452 176.91 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.638 HD21 ' HG2' ' A' ' 35' ' ' GLN . 4.2 mm? -117.35 137.88 52.16 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 176.784 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.584 ' HG3' HD21 ' A' ' 60' ' ' LEU . 35.0 tt0 -150.21 114.56 5.17 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 177.868 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' CYS . . . . . 0.507 ' SG ' ' CE2' ' A' ' 100' ' ' PHE . 36.5 m -138.07 101.4 4.41 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.959 0.409 . . . . 0.0 110.156 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 75.5 t80 -84.62 112.31 20.33 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.12 -0.491 . . . . 0.0 109.924 179.791 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.466 HG21 HD21 ' A' ' 81' ' ' LEU . 16.4 m -97.54 100.33 10.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 121.863 0.84 . . . . 0.0 109.267 177.803 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.452 ' HG2' ' H ' ' A' ' 78' ' ' ARG . 19.5 ptt180 -70.92 -45.68 63.81 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 114.631 -1.168 . . . . 0.0 112.092 -172.117 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 35.8 ttpt -160.99 29.73 0.14 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.569 0.7 . . . . 0.0 109.792 -175.02 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.421 ' O ' ' HB ' ' A' ' 77' ' ' VAL . 7.3 p-10 -149.66 140.98 23.19 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.08 -178.802 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.466 HD21 HG21 ' A' ' 77' ' ' VAL . 12.8 mt -155.36 101.38 2.2 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.967 179.057 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.467 HG23 ' N ' ' A' ' 83' ' ' TYR . 27.6 m -74.3 -53.06 18.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 174.468 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.467 ' N ' HG23 ' A' ' 82' ' ' VAL . 4.5 t80 30.46 82.86 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.431 1.092 . . . . 0.0 112.015 177.992 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 36.0 m -112.41 133.48 54.47 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.998 -179.079 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.525 ' HA ' ' HA ' ' A' ' 91' ' ' HIS . 17.7 ptmt -93.46 101.72 13.93 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.315 0.579 . . . . 0.0 110.224 178.973 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -72.34 -49.49 33.94 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.975 -178.501 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ASN . . . . . 0.572 ' HB2' ' HB3' ' A' ' 90' ' ' PHE . 3.8 m-20 -104.83 153.27 39.44 Favored Pre-proline 0 C--N 1.327 -0.387 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 174.753 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_exo -48.24 -31.91 18.13 Favored 'Trans proline' 0 CA--C 1.534 0.499 0 C-N-CA 122.621 2.214 . . . . 0.0 112.765 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.484 ' HA ' ' HD2' ' A' ' 104' ' ' PHE . 20.5 p -120.09 16.35 12.43 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 112.328 0.492 . . . . 0.0 112.328 -178.321 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.572 ' HB3' ' HB2' ' A' ' 87' ' ' ASN . 5.5 t80 -129.88 105.84 8.27 Favored 'General case' 0 C--O 1.239 0.5 0 CA-C-O 120.93 0.395 . . . . 0.0 110.094 178.665 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' HIS . . . . . 0.525 ' HA ' ' HA ' ' A' ' 85' ' ' LYS . 0.1 OUTLIER -102.73 133.18 48.19 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 177.763 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 30.2 p80 -129.1 155.05 46.07 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.935 0.398 . . . . 0.0 110.812 -178.003 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' TRP . . . . . 0.412 ' CE2' ' HB2' ' A' ' 100' ' ' PHE . 43.8 p90 -144.91 158.49 43.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.174 178.517 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 22.5 ptmt -144.02 148.98 35.98 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 177.784 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.701 HG23 ' H ' ' A' ' 96' ' ' ASP . 4.4 m -127.64 -66.87 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 C-N-CA 121.2 -0.2 . . . . 0.0 111.173 -179.3 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.701 ' H ' HG23 ' A' ' 95' ' ' VAL . 10.9 m-20 -120.87 80.1 1.59 Allowed 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 177.157 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 52.4 t-20 74.35 -52.96 0.68 Allowed 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 114.79 -1.095 . . . . 0.0 111.429 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -68.87 139.42 55.17 Favored 'General case' 0 C--O 1.244 0.806 0 CA-C-O 121.003 0.43 . . . . 0.0 110.239 -175.813 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.496 ' HG2' ' HH2' ' A' ' 32' ' ' TRP . 39.7 ttmt -121.49 135.49 55.03 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.503 -178.711 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.507 ' CE2' ' SG ' ' A' ' 75' ' ' CYS . 20.4 m-85 -124.0 164.31 19.61 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 -178.797 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -139.64 159.74 25.92 Favored Glycine 0 C--N 1.331 0.298 0 C-N-CA 120.764 -0.732 . . . . 0.0 113.461 -174.47 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.41 ' HB2' ' HZ3' ' A' ' 93' ' ' TRP . 5.6 tt -139.54 114.77 9.72 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 -179.496 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.56 ' HB ' ' HB ' ' A' ' 21' ' ' VAL . 48.5 m -93.3 119.65 32.69 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.087 176.873 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.484 ' HD2' ' HA ' ' A' ' 89' ' ' THR . 33.3 m-85 -70.02 158.4 35.74 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.224 179.599 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 50.0 mt-30 -108.13 -46.31 3.77 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.771 -178.924 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 14.7 m -135.07 156.49 78.26 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.408 -176.21 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -51.52 -30.49 35.82 Favored 'Trans proline' 0 C--N 1.35 0.619 0 C-N-CA 122.652 2.235 . . . . 0.0 112.49 177.036 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -60.57 -61.02 2.89 Favored 'General case' 0 C--O 1.239 0.516 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.384 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -65.52 -43.74 89.11 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.433 -0.348 . . . . 0.0 110.599 -178.724 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -51.95 -54.74 26.06 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 121.086 0.47 . . . . 0.0 111.027 177.36 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 34.7 ttt180 -61.59 -39.21 90.4 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.01 -177.633 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -61.99 -43.39 98.94 Favored 'General case' 0 C--O 1.231 0.109 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.304 179.685 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 49.1 m-85 -69.64 -39.86 76.87 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.617 -0.265 . . . . 0.0 110.965 -179.133 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 45.6 m-20 -60.15 -57.88 10.91 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-O 121.31 0.576 . . . . 0.0 110.752 178.45 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 37.3 mmt180 -66.87 -31.27 71.76 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.171 -179.497 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -64.21 -48.86 70.53 Favored Glycine 0 N--CA 1.449 -0.441 0 CA-C-N 115.635 -0.711 . . . . 0.0 112.199 179.195 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.5 ' O ' HG12 ' A' ' 121' ' ' ILE . 11.5 p -66.89 -37.88 80.3 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.086 0 N-CA-C 110.26 -0.274 . . . . 0.0 110.26 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 8.1 tpt180 -56.69 -49.45 75.1 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-O 120.853 0.359 . . . . 0.0 110.169 176.054 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 60.0 tptt -58.61 -44.42 89.9 Favored 'General case' 0 C--O 1.241 0.647 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.382 177.947 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -57.94 -47.23 83.51 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.56 178.946 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.5 HG12 ' O ' ' A' ' 117' ' ' VAL . 43.0 mm -59.21 -46.63 92.05 Favored 'Isoleucine or valine' 0 C--O 1.232 0.14 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.469 179.422 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 62.6 mm-40 -51.7 -58.16 7.16 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.945 179.699 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -73.75 -33.22 64.21 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.569 -174.755 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 60.2 tp -64.98 -41.82 95.08 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.911 0.386 . . . . 0.0 110.449 -179.082 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 47.9 mm -78.99 -55.96 8.4 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.901 -178.106 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 . . . . . 0 C--O 1.253 1.243 0 CA-C-O 119.356 -0.354 . . . . 0.0 111.266 -176.827 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.794 0 N-CA-C 112.031 -0.428 . . . . 0.0 112.031 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 24.2 p -89.31 28.37 1.26 Allowed 'General case' 0 C--O 1.237 0.446 0 CA-C-O 121.336 0.588 . . . . 0.0 110.801 179.365 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 49.1 ttp -92.78 159.15 15.53 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.215 176.404 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 23.5 m 74.0 127.19 0.04 OUTLIER 'General case' 0 C--O 1.235 0.312 0 O-C-N 123.535 0.522 . . . . 0.0 109.935 -177.939 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -110.02 152.53 25.8 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.016 0.436 . . . . 0.0 111.407 -174.971 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.459 ' HB3' ' HB2' ' A' ' 11' ' ' ASP . 1.5 mp0 -108.02 145.57 33.76 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 161.459 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.441 ' O ' ' HG3' ' A' ' 64' ' ' GLU . 0.5 OUTLIER -79.41 -30.19 42.27 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.599 0.714 . . . . 0.0 109.085 -176.003 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.538 ' HD2' ' H ' ' A' ' 10' ' ' ASP . 5.9 t60 -119.35 136.42 24.54 Favored Pre-proline 0 C--N 1.328 -0.362 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 177.301 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -56.13 -6.4 1.31 Allowed 'Trans proline' 0 C--N 1.353 0.787 0 C-N-CA 122.79 2.327 . . . . 0.0 112.775 179.352 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.538 ' H ' ' HD2' ' A' ' 8' ' ' HIS . 27.2 t70 -141.55 46.1 1.7 Allowed 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 173.329 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.459 ' HB2' ' HB3' ' A' ' 6' ' ' GLU . 7.7 t70 -52.38 104.61 0.09 Allowed 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 115.073 -0.967 . . . . 0.0 110.889 -174.953 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -96.66 -54.68 3.15 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.102 -0.499 . . . . 0.0 112.223 -175.783 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 57.8 m -143.55 37.0 1.33 Allowed 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 111.867 0.321 . . . . 0.0 111.867 -175.553 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.442 ' HA ' ' HB3' ' A' ' 46' ' ' CYS . 59.5 m-85 -76.54 93.29 3.54 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 121.111 0.481 . . . . 0.0 110.504 177.922 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.566 HG22 HG23 ' A' ' 16' ' ' VAL . 44.0 mm -69.19 -56.59 11.31 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 CA-C-N 115.437 -0.802 . . . . 0.0 111.465 -173.809 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.566 HG23 HG22 ' A' ' 15' ' ' ILE . 57.8 t -131.84 131.15 61.96 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 CA-C-O 120.574 0.226 . . . . 0.0 111.128 -175.507 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.586 ' HG3' ' HA2' ' A' ' 44' ' ' GLY . 0.5 OUTLIER -110.89 98.27 7.45 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 171.895 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 44.9 t -76.39 154.85 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.464 -177.263 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 58.7 tttp -98.88 131.33 45.06 Favored 'General case' 0 N--CA 1.462 0.129 0 CA-C-O 120.826 0.346 . . . . 0.0 110.374 178.12 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.495 ' O ' ' HB2' ' A' ' 41' ' ' SER . . . -171.19 -166.95 0.5 Allowed 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 175.479 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 61.7 t -117.93 120.19 63.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 167.994 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.528 HG11 ' HG ' ' A' ' 73' ' ' LEU . 49.6 t -71.7 94.15 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 121.148 0.499 . . . . 0.0 109.985 179.65 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' MET . . . . . 0.467 ' HB3' ' HB3' ' A' ' 32' ' ' TRP . 21.4 mmt -86.44 110.7 19.91 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.582 -178.473 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 1.1 m -100.78 120.77 40.6 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.427 -0.806 . . . . 0.0 108.961 172.976 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.79 114.86 11.4 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 179.361 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -58.03 91.18 0.01 OUTLIER 'General case' 0 C--O 1.233 0.222 0 O-C-N 123.345 0.403 . . . . 0.0 110.44 -176.485 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 28.3 t70 55.54 -87.7 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.788 -176.858 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 60.4 m -157.99 26.97 0.26 Allowed 'General case' 0 C--O 1.235 0.315 0 CA-C-O 121.093 0.473 . . . . 0.0 109.993 177.532 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 34.8 t -143.18 159.52 42.14 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.032 -179.358 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 82.38 -53.57 4.8 Favored Glycine 0 C--N 1.329 0.187 0 C-N-CA 121.235 -0.507 . . . . 0.0 112.22 179.207 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 131.29 -161.43 23.59 Favored Glycine 0 C--N 1.331 0.304 0 N-CA-C 111.976 -0.449 . . . . 0.0 111.976 177.457 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' TRP . . . . . 0.467 ' HB3' ' HB3' ' A' ' 23' ' ' MET . 84.2 m95 -84.69 104.83 15.01 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 109.36 -0.608 . . . . 0.0 109.36 176.347 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -103.71 147.84 34.87 Favored Pre-proline 0 C--O 1.237 0.423 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 -175.522 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -59.96 132.21 43.56 Favored 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 122.472 2.114 . . . . 0.0 111.355 179.152 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 50.8 tp60 -39.73 -47.16 2.01 Favored 'General case' 0 N--CA 1.468 0.439 0 O-C-N 123.764 0.665 . . . . 0.0 112.055 -175.782 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -176.07 -34.91 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 178.454 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -108.86 167.9 13.23 Favored Glycine 0 N--CA 1.453 -0.209 0 CA-C-N 115.14 -0.936 . . . . 0.0 110.776 171.466 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -132.49 150.41 19.68 Favored Glycine 0 C--O 1.234 0.151 0 C-N-CA 120.95 -0.643 . . . . 0.0 112.473 -178.194 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 81.06 -58.59 4.82 Favored Glycine 0 C--N 1.331 0.293 0 C-N-CA 121.46 -0.4 . . . . 0.0 112.585 178.407 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.496 ' N ' HD12 ' A' ' 40' ' ' ILE . 3.5 mp -101.85 107.29 21.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.783 0.325 . . . . 0.0 110.599 -178.784 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.495 ' HB2' ' O ' ' A' ' 20' ' ' ALA . 36.6 m -141.9 113.84 8.01 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 171.316 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.502 ' HB2' ' O ' ' A' ' 64' ' ' GLU . 5.7 mpt_? -88.79 133.48 34.23 Favored 'General case' 0 CA--C 1.519 -0.218 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 175.642 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.787 HG21 HD21 ' A' ' 102' ' ' LEU . 75.5 t -106.2 100.01 9.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.006 177.328 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.586 ' HA2' ' HG3' ' A' ' 17' ' ' ARG . . . -71.26 84.63 0.41 Allowed Glycine 0 N--CA 1.448 -0.546 0 CA-C-N 115.673 -0.694 . . . . 0.0 112.693 -179.202 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 54.8 t -75.69 107.96 7.22 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 176.479 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' CYS . . . . . 0.699 ' SG ' ' HB3' ' A' ' 60' ' ' LEU . 6.1 p -125.51 125.71 43.71 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.064 -0.517 . . . . 0.0 111.079 -177.336 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 57.8 tttm -87.6 89.08 7.86 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 175.833 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 31.0 t -77.12 125.57 37.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.23 -174.091 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 97.6 mmm -81.59 109.1 15.71 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 174.763 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 7.5 p80 -68.47 154.33 94.51 Favored Pre-proline 0 C--N 1.325 -0.482 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.424 -179.198 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -54.13 135.45 64.42 Favored 'Trans proline' 0 C--N 1.352 0.724 0 C-N-CA 122.587 2.191 . . . . 0.0 111.569 178.841 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 61.48 40.22 14.07 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.702 -176.026 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -50.16 105.64 0.18 Allowed Glycine 0 C--N 1.333 0.382 0 CA-C-N 115.507 -0.77 . . . . 0.0 112.526 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 30.3 p-10 -79.15 -16.61 56.4 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.914 0.388 . . . . 0.0 111.173 -177.19 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 150.71 -24.65 1.05 Allowed Glycine 0 N--CA 1.453 -0.221 0 N-CA-C 111.546 -0.622 . . . . 0.0 111.546 -178.508 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.551 ' NE ' ' HA ' ' A' ' 56' ' ' ARG . 0.6 OUTLIER -87.05 171.68 10.54 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 177.571 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.482 ' H ' ' HG3' ' A' ' 56' ' ' ARG . 24.9 m -145.13 166.26 25.93 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.749 0.309 . . . . 0.0 110.554 177.849 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -107.09 120.36 6.17 Favored Glycine 0 N--CA 1.448 -0.516 0 N-CA-C 111.29 -0.724 . . . . 0.0 111.29 176.697 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 71.7 m-85 -91.06 104.55 17.12 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.061 0.457 . . . . 0.0 109.813 -176.613 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.699 ' HB3' ' SG ' ' A' ' 46' ' ' CYS . 1.9 tt -93.35 106.71 18.64 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.806 -0.633 . . . . 0.0 109.499 -178.204 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 49.8 mm -78.58 85.91 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 173.853 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' HIS . . . . . 0.409 ' HA ' ' HA ' ' A' ' 74' ' ' GLU . 15.4 t-80 -90.94 168.11 11.92 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.593 -176.548 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -151.09 112.96 0.56 Allowed Glycine 0 C--O 1.236 0.258 0 C-N-CA 120.948 -0.644 . . . . 0.0 112.111 -178.309 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.502 ' O ' ' HB2' ' A' ' 42' ' ' ARG . 0.0 OUTLIER -145.95 -167.29 2.68 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 122.385 0.274 . . . . 0.0 110.739 -176.101 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.43 ' HB3' ' HD3' ' A' ' 42' ' ' ARG . 0.0 OUTLIER 57.41 34.95 25.39 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-O 120.928 0.394 . . . . 0.0 110.205 175.181 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 84.0 mm-40 -63.88 -11.58 28.98 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 115.67 -0.695 . . . . 0.0 112.571 -172.447 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 34.7 ttpt -174.5 -63.28 0.01 OUTLIER 'General case' 0 C--O 1.234 0.261 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 173.311 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -105.43 -85.05 0.49 Allowed 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 170.595 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.484 ' HB3' ' NZ ' ' A' ' 69' ' ' LYS . 6.3 ttpm? -140.72 108.17 5.56 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 178.565 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 48.2 tp -163.73 124.54 2.26 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 110.418 -0.216 . . . . 0.0 110.418 -173.375 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 83.9 t -98.58 135.23 34.28 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 O-C-N 123.697 0.623 . . . . 0.0 109.443 173.052 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 35.4 m -134.92 -41.17 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 N-CA-C 112.127 0.418 . . . . 0.0 112.127 -177.195 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.54 HD13 ' N ' ' A' ' 74' ' ' GLU . 3.0 tm? -119.91 143.3 48.03 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.821 0.343 . . . . 0.0 110.781 -170.847 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.54 ' N ' HD13 ' A' ' 73' ' ' LEU . 9.5 pt-20 -158.45 112.17 2.44 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.915 173.555 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 42.0 t -126.0 97.81 5.26 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 179.512 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.414 ' HB2' ' HG ' ' A' ' 60' ' ' LEU . 69.2 t80 -88.36 134.82 33.72 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.99 -176.336 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 35.1 m -141.42 145.28 24.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 176.31 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 24.5 ttp180 -130.67 -24.44 2.46 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.134 0.493 . . . . 0.0 110.428 177.2 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.521 ' N ' ' HD3' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -160.9 29.21 0.15 Allowed 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 174.948 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -127.92 170.31 12.98 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 115.123 -0.944 . . . . 0.0 110.709 -167.45 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.639 HD11 ' CD1' ' A' ' 93' ' ' TRP . 10.2 tt 72.92 151.8 0.12 Allowed 'General case' 0 N--CA 1.469 0.514 0 O-C-N 123.996 0.81 . . . . 0.0 112.163 167.854 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.511 ' N ' HD23 ' A' ' 81' ' ' LEU . 8.7 p -139.63 141.02 35.74 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.68 177.221 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 14.6 m-85 -94.5 166.35 12.09 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 121.176 0.513 . . . . 0.0 111.079 -177.633 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 88.7 m -152.08 109.81 3.64 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.015 176.548 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.479 ' O ' ' HD2' ' A' ' 85' ' ' LYS . 0.0 OUTLIER -108.81 138.57 44.93 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.941 0.401 . . . . 0.0 110.663 -179.316 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -108.18 -45.72 3.88 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.956 -0.566 . . . . 0.0 109.846 178.92 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 -133.94 158.86 74.42 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.324 -179.749 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -60.43 -19.97 61.36 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.175 1.917 . . . . 0.0 111.917 177.648 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 34.8 p -100.43 2.72 42.49 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.724 -179.84 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 70.6 t80 -147.05 101.39 3.41 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-O 121.128 0.49 . . . . 0.0 109.921 -178.965 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 3.3 t-160 -131.08 110.22 11.04 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 -177.689 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' HIS . . . . . 0.671 ' HA ' ' HA3' ' A' ' 101' ' ' GLY . 16.9 p80 -120.54 -178.19 3.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.744 0.307 . . . . 0.0 110.646 -176.883 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' TRP . . . . . 0.639 ' CD1' HD11 ' A' ' 81' ' ' LEU . 41.4 p90 -148.77 -171.36 3.85 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.57 174.292 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -151.73 147.28 26.5 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.913 0.387 . . . . 0.0 111.029 -177.93 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.451 HG23 ' O ' ' A' ' 95' ' ' VAL . 19.0 m -123.97 107.51 18.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 172.887 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 21.9 t70 67.53 -68.02 0.17 Allowed 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.903 -174.82 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 45.7 t-20 -144.25 -43.04 0.26 Allowed 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 178.766 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 88.2 mtm180 -58.41 124.2 18.74 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.037 -179.538 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.481 ' HD3' ' N ' ' A' ' 99' ' ' LYS . 0.0 OUTLIER -116.42 129.32 56.16 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.245 -175.107 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -148.22 155.3 41.2 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.384 -0.825 . . . . 0.0 109.356 177.421 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.671 ' HA3' ' HA ' ' A' ' 92' ' ' HIS . . . -175.83 -157.57 17.4 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.565 -0.826 . . . . 0.0 113.148 -176.915 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.787 HD21 HG21 ' A' ' 43' ' ' VAL . 9.2 mp -114.56 146.6 40.56 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 121.362 0.601 . . . . 0.0 111.683 -174.354 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 91.4 m -123.69 111.51 16.28 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 166.649 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 48.7 m-85 -89.77 149.42 22.72 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.737 -170.398 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 19.3 mp0 -103.08 -43.14 5.57 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 170.708 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -82.2 141.61 46.59 Favored Pre-proline 0 CA--C 1.535 0.388 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.496 178.7 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -86.38 -38.48 0.09 OUTLIER 'Trans proline' 0 C--N 1.353 0.776 0 C-N-CA 122.676 2.251 . . . . 0.0 114.217 -174.052 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -64.89 -60.08 3.47 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 120.879 0.371 . . . . 0.0 111.639 -172.767 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 22.4 p-10 -66.43 -26.51 67.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.476 -178.696 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -60.68 -52.79 63.62 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 121.217 0.532 . . . . 0.0 110.313 172.706 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 4.2 tmm_? -63.81 -32.72 74.33 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.746 178.242 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -65.68 -39.27 91.11 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.749 177.214 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.484 ' O ' HG23 ' A' ' 117' ' ' VAL . 73.2 t80 -66.91 -52.99 36.48 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.122 179.079 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.452 ' O ' ' HG3' ' A' ' 118' ' ' ARG . 13.7 t70 -54.09 -56.9 13.71 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 121.522 0.677 . . . . 0.0 110.178 179.42 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 15.2 tpt180 -53.27 -47.74 68.87 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-N 114.628 -1.169 . . . . 0.0 110.605 176.825 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -59.76 -38.69 94.29 Favored Glycine 0 N--CA 1.451 -0.327 0 CA-C-N 115.505 -0.77 . . . . 0.0 112.15 -179.695 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.484 HG23 ' O ' ' A' ' 113' ' ' PHE . 48.3 t -62.09 -46.98 95.25 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 CA-C-O 120.736 0.303 . . . . 0.0 110.315 177.406 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.452 ' HG3' ' O ' ' A' ' 114' ' ' ASP . 81.5 mtt180 -54.85 -54.7 39.05 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.125 179.582 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.498 ' HB3' ' HZ2' ' A' ' 119' ' ' LYS . 0.0 OUTLIER -68.2 -29.59 68.47 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.764 -177.258 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -65.19 -58.05 6.96 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.829 0.347 . . . . 0.0 110.342 179.547 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 49.3 mm -59.63 -43.07 90.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.388 179.663 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 13.5 tp10 -58.52 -50.14 74.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.571 -179.303 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -72.7 -29.81 63.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.911 -176.902 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 6.1 tt -69.09 -53.31 20.98 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.753 179.733 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 47.9 mm -72.32 -52.47 23.87 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.547 -174.96 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 . . . . . 0 C--O 1.25 1.107 0 CA-C-O 119.011 -0.519 . . . . 0.0 110.145 -175.288 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 6.4 m . . . . . 0 CA--C 1.536 0.428 0 N-CA-C 112.494 0.553 . . . . 0.0 112.494 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 10.0 m-85 -66.89 112.93 4.56 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 120.685 0.279 . . . . 0.0 110.489 176.009 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.538 HG13 HG23 ' A' ' 16' ' ' VAL . 34.0 pt -92.01 -26.82 4.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.357 178.188 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.538 HG23 HG13 ' A' ' 15' ' ' ILE . 92.1 t -135.35 137.72 49.53 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.194 179.466 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.462 ' NH1' ' HG2' ' A' ' 42' ' ' ARG . 18.9 tpp180 -132.74 123.33 26.03 Favored 'General case' 0 N--CA 1.463 0.21 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 175.508 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 30.2 m -124.09 176.6 5.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 C-N-CA 122.659 0.383 . . . . 0.0 110.375 179.072 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 22.4 pttp -132.48 125.51 30.83 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 179.43 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -165.91 177.71 6.95 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 -179.3 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 60.2 t -100.24 118.14 46.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 110.177 -0.305 . . . . 0.0 110.177 176.059 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 17.8 m -66.71 109.0 1.15 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.354 0 CA-C-O 121.352 0.596 . . . . 0.0 111.237 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 25.1 mmt -106.65 166.52 10.51 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.129 179.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.521 HG23 ' CE1' ' A' ' 33' ' ' PHE . 11.0 t -160.84 150.63 17.39 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.934 -0.575 . . . . 0.0 109.708 177.769 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 20.7 ttt180 -120.31 100.64 7.29 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 174.071 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -69.38 84.31 0.4 Allowed 'General case' 0 C--O 1.235 0.299 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.481 179.449 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 15.4 t70 64.44 -81.63 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.139 -175.673 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 41.2 m -149.43 17.8 0.93 Allowed 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 120.81 0.338 . . . . 0.0 110.432 178.228 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 38.6 t -64.66 89.58 0.07 Allowed 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.829 -179.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 76.32 -63.72 2.91 Favored Glycine 0 C--N 1.332 0.353 0 CA-C-N 116.093 -0.503 . . . . 0.0 112.351 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 158.51 -140.28 6.84 Favored Glycine 0 N--CA 1.449 -0.475 0 N-CA-C 111.027 -0.829 . . . . 0.0 111.027 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . 0.492 ' HH2' ' HG2' ' A' ' 99' ' ' LYS . 97.9 m95 -79.02 93.9 5.2 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 176.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.521 ' CE1' HG23 ' A' ' 24' ' ' THR . 21.3 p90 -103.65 143.17 26.11 Favored Pre-proline 0 C--O 1.236 0.353 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.505 -178.311 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -69.08 103.37 1.04 Allowed 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.286 1.991 . . . . 0.0 111.266 176.19 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.427 ' H ' ' HG2' ' A' ' 35' ' ' GLN . 12.1 pt20 -57.04 -49.44 75.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.476 -179.625 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -157.45 171.2 20.8 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 179.36 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 78.52 -75.41 1.97 Allowed Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 121.053 -0.594 . . . . 0.0 111.777 -179.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 70.91 -73.95 0.64 Allowed Glycine 0 C--N 1.332 0.354 0 C-N-CA 121.562 -0.351 . . . . 0.0 112.25 -179.622 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -70.86 76.96 0.54 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 121.5 -0.381 . . . . 0.0 112.289 178.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 38.1 mm 66.87 142.84 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 C-N-CA 123.442 0.697 . . . . 0.0 111.31 178.455 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 18.2 m -132.96 133.85 43.74 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.057 0.455 . . . . 0.0 110.44 178.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.462 ' HG2' ' NH1' ' A' ' 17' ' ' ARG . 37.8 ttt85 -86.51 83.44 7.64 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.551 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 28.8 t -100.97 155.53 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.567 -172.414 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -162.78 -178.19 36.41 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.623 -0.799 . . . . 0.0 112.702 177.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 59.8 t -128.98 128.63 67.52 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 179.008 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . 0.526 ' SG ' ' HB3' ' A' ' 60' ' ' LEU . 13.7 p -119.45 126.44 51.32 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 176.479 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -82.06 98.39 8.62 Favored 'General case' 0 C--O 1.234 0.237 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 179.392 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.5 HG21 ' HE1' ' A' ' 76' ' ' TYR . 33.0 m -86.53 -168.95 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.21 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 22.1 ptp . . . . . 0 C--N 1.328 -0.351 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 177.497 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.248 0 N-CA-C 110.714 -0.954 . . . . 0.0 110.714 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -135.96 148.7 48.59 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 117.337 0.568 . . . . 0.0 110.518 -177.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.67 HD22 ' HB2' ' A' ' 62' ' ' HIS . 2.3 tt -133.37 113.0 12.07 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 179.171 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.558 ' HB ' ' HB2' ' A' ' 75' ' ' CYS . 46.2 mt -79.96 98.31 3.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 108.396 -0.965 . . . . 0.0 108.396 174.605 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . 0.67 ' HB2' HD22 ' A' ' 60' ' ' LEU . 23.8 t-80 -120.93 141.22 50.86 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 -173.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -156.3 126.93 1.88 Allowed Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.322 -0.942 . . . . 0.0 113.132 -177.439 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -90.5 164.04 14.4 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 172.273 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.576 ' HB3' HG11 ' A' ' 72' ' ' VAL . 16.5 ptm180 -81.41 164.1 22.32 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.176 -0.675 . . . . 0.0 109.176 172.633 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 54.7 tp60 -78.05 68.3 4.07 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-O 121.38 0.61 . . . . 0.0 109.43 179.304 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.817 ' HA ' ' HE3' ' A' ' 67' ' ' LYS . 0.5 OUTLIER -171.58 49.7 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.223 -0.899 . . . . 0.0 109.017 -177.145 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.437 ' HB2' ' O ' ' A' ' 67' ' ' LYS . 4.3 m-20 71.8 -179.05 0.22 Allowed 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 115.257 -0.883 . . . . 0.0 111.149 -177.502 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 5.1 mptp? -65.92 93.62 0.2 Allowed 'General case' 0 C--O 1.233 0.215 0 CA-C-N 115.897 -0.592 . . . . 0.0 112.594 -175.463 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 58.1 tp -136.22 105.14 5.88 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 167.403 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 44.1 t -62.56 108.34 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.673 -177.035 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.576 HG11 ' HB3' ' A' ' 65' ' ' ARG . 33.7 m -107.75 -9.84 10.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.77 179.112 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -144.67 127.11 15.93 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 179.338 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -146.74 115.27 6.74 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 177.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' CYS . . . . . 0.558 ' HB2' ' HB ' ' A' ' 61' ' ' ILE . 39.8 m -137.73 85.42 2.11 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.079 0.466 . . . . 0.0 109.986 177.545 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.5 ' HE1' HG21 ' A' ' 48' ' ' VAL . 86.3 t80 -75.28 135.38 40.94 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.548 176.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.437 HG11 ' HG ' ' A' ' 81' ' ' LEU . 25.6 m -134.19 149.56 30.32 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 177.602 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.444 ' N ' ' HD3' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -108.83 -35.09 6.47 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.183 -174.346 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 59.9 tttm -165.83 23.34 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 121.491 0.663 . . . . 0.0 109.625 -177.591 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -146.63 125.18 12.44 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.227 -170.223 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.437 ' HG ' HG11 ' A' ' 77' ' ' VAL . 5.3 mt -160.81 122.55 3.05 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.014 177.042 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 48.4 t -124.29 98.64 5.52 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 177.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.644 ' HB3' ' NE2' ' A' ' 91' ' ' HIS . 84.1 m-85 -90.58 161.68 15.34 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.407 177.234 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.455 ' HB ' ' CE1' ' A' ' 92' ' ' HIS . 60.7 m -158.89 115.66 2.72 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 174.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.448 ' HA ' ' HA ' ' A' ' 91' ' ' HIS . 36.2 ttpt -89.11 107.54 19.1 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 178.457 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -73.71 -41.68 62.26 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.387 -175.001 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -136.61 153.47 75.97 Favored Pre-proline 0 C--N 1.325 -0.472 0 CA-C-N 115.203 -0.908 . . . . 0.0 108.647 179.017 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_exo -52.89 -23.51 21.26 Favored 'Trans proline' 0 N--CA 1.476 0.449 0 C-N-CA 122.491 2.127 . . . . 0.0 112.695 -179.166 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 14.6 t -107.54 8.93 29.55 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.576 -177.277 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.42 ' HE1' ' HB3' ' A' ' 92' ' ' HIS . 4.6 t80 -148.38 111.68 4.95 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-O 120.975 0.417 . . . . 0.0 110.953 -178.083 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' HIS . . . . . 0.644 ' NE2' ' HB3' ' A' ' 83' ' ' TYR . 3.1 t-160 -111.52 133.28 53.91 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 177.613 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . 0.455 ' CE1' ' HB ' ' A' ' 84' ' ' THR . 33.0 p80 -134.52 165.22 25.69 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.852 0.358 . . . . 0.0 111.346 -177.345 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 47.4 p90 -147.66 143.87 27.97 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.351 -179.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 48.6 tttm -112.99 122.94 49.14 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.153 179.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 27.7 m -110.21 32.88 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.325 0 CA-C-O 121.265 0.555 . . . . 0.0 109.937 -177.538 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 23.8 t70 71.92 -57.42 0.62 Allowed 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 114.859 -1.064 . . . . 0.0 109.81 -173.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -73.9 97.1 2.72 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 172.497 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 12.2 mpt_? 60.56 176.38 0.1 Allowed 'General case' 0 C--O 1.243 0.748 0 CA-C-O 122.186 0.993 . . . . 0.0 112.077 -176.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.492 ' HG2' ' HH2' ' A' ' 32' ' ' TRP . 38.1 ttpt -126.51 106.95 9.81 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 114.34 -1.3 . . . . 0.0 108.2 176.274 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . 0.491 ' CD2' ' SG ' ' A' ' 75' ' ' CYS . 4.7 m-85 -89.76 173.87 8.03 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 -175.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -177.66 -175.44 44.87 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.833 -0.699 . . . . 0.0 111.972 177.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.449 ' O ' HD12 ' A' ' 102' ' ' LEU . 1.3 pp -152.0 150.33 29.87 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.099 0.476 . . . . 0.0 110.898 177.012 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 25.2 m -101.0 116.18 32.24 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.806 176.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 40.5 m-85 -63.59 147.42 51.52 Favored 'General case' 0 C--O 1.237 0.413 0 O-C-N 123.369 0.418 . . . . 0.0 110.422 178.551 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 19.0 pt20 -114.25 -10.8 12.68 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.473 -0.331 . . . . 0.0 110.974 -178.244 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 20.4 m -155.12 151.7 23.5 Favored Pre-proline 0 C--N 1.33 -0.251 0 N-CA-C 110.089 -0.337 . . . . 0.0 110.089 174.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -60.16 -19.2 55.7 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.344 2.029 . . . . 0.0 111.65 176.361 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -66.08 -60.43 2.83 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.519 177.381 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -65.19 -31.98 73.43 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.79 179.035 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -57.61 -61.53 2.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.003 0.43 . . . . 0.0 110.726 175.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . 0.428 ' HD2' ' O ' ' A' ' 111' ' ' ARG . 5.4 tmm_? -62.57 -38.23 89.28 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.235 -177.496 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -63.5 -43.48 97.11 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.095 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.405 ' O ' HG23 ' A' ' 117' ' ' VAL . 75.4 t80 -67.06 -47.33 71.64 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.081 -178.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 59.5 m-20 -57.5 -39.48 76.57 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.526 178.095 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -62.12 -49.86 74.22 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.112 178.359 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -61.25 -42.4 99.77 Favored Glycine 0 C--N 1.333 0.367 0 CA-C-N 115.599 -0.728 . . . . 0.0 112.063 179.631 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.405 HG23 ' O ' ' A' ' 113' ' ' PHE . 55.4 t -60.91 -46.67 96.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.927 0.394 . . . . 0.0 110.699 177.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 25.6 tpt180 -59.88 -49.78 76.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.221 -177.549 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 4.3 mmmp? -64.28 -41.18 97.02 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.942 178.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -58.08 -55.99 27.78 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.538 -179.591 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.457 ' O ' HG22 ' A' ' 125' ' ' ILE . 46.2 mm -58.27 -42.59 84.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.326 178.687 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -53.28 -59.08 5.01 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.472 -179.355 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 50.0 m-20 -74.16 -24.67 59.42 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.271 -176.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 9.9 tt -68.89 -38.83 79.9 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.36 178.511 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.457 HG22 ' O ' ' A' ' 121' ' ' ILE . 13.8 tt -91.17 -37.83 9.77 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 CA-C-N 116.625 -0.261 . . . . 0.0 111.342 -176.496 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 . . . . . 0 C--O 1.25 1.093 0 CA-C-O 118.422 -0.799 . . . . 0.0 110.218 -177.04 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 39.2 t . . . . . 0 C--O 1.238 0.46 0 CA-C-O 120.522 0.201 . . . . 0.0 111.442 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -64.2 140.75 58.9 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 120.912 0.386 . . . . 0.0 111.303 -177.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 61.2 mt -126.71 -64.92 0.98 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.203 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.427 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.566 ' HB ' ' HB ' ' A' ' 45' ' ' VAL . 60.2 t -99.07 106.29 18.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.095 -178.193 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.421 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 62.2 mtm180 -120.42 90.15 3.27 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.044 0.45 . . . . 0.0 110.212 179.421 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.418 HG11 ' HB2' ' A' ' 109' ' ' ASP . 86.6 t -107.89 135.87 45.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.887 -176.545 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -85.46 106.16 16.6 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 174.239 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -144.84 -172.15 3.77 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.114 -177.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.587 ' HB ' ' HB ' ' A' ' 103' ' ' THR . 23.6 t -101.53 121.54 52.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.615 0.245 . . . . 0.0 110.473 -179.193 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.502 HG11 ' HG ' ' A' ' 73' ' ' LEU . 60.8 t -97.71 98.28 7.18 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 CA-C-O 121.035 0.445 . . . . 0.0 110.461 176.134 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . 0.444 ' HB3' ' HB3' ' A' ' 32' ' ' TRP . 24.9 mmt -74.47 106.38 6.04 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 174.06 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.462 HG23 ' CE1' ' A' ' 33' ' ' PHE . 10.0 t -76.69 -46.4 25.72 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 111.583 0.216 . . . . 0.0 111.583 -173.204 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.514 ' HB2' ' CE3' ' A' ' 32' ' ' TRP . 23.4 ttt180 57.84 135.13 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 121.317 0.58 . . . . 0.0 110.396 -172.041 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -81.08 64.85 5.98 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 177.512 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 32.5 t70 58.96 -74.73 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 114.536 -1.211 . . . . 0.0 110.932 -172.5 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 26.4 t -121.76 99.06 6.25 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 177.242 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 10.8 m -126.04 159.71 32.04 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.712 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -69.3 76.55 0.35 Allowed Glycine 0 C--N 1.332 0.34 0 N-CA-C 111.582 -0.607 . . . . 0.0 111.582 176.583 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 106.72 -158.67 15.16 Favored Glycine 0 C--O 1.237 0.334 0 N-CA-C 111.264 -0.735 . . . . 0.0 111.264 -175.035 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . 0.514 ' CE3' ' HB2' ' A' ' 25' ' ' ARG . 53.7 m95 -127.42 126.16 41.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.656 0.265 . . . . 0.0 110.424 -179.593 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.479 ' HA ' ' HD3' ' A' ' 34' ' ' PRO . 6.4 p90 -114.44 137.71 22.75 Favored Pre-proline 0 C--O 1.238 0.45 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.139 -179.851 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.581 ' HB2' ' HA2' ' A' ' 38' ' ' GLY . 7.3 Cg_exo -74.05 154.07 47.18 Favored 'Trans proline' 0 N--CA 1.462 -0.367 0 C-N-CA 122.785 2.323 . . . . 0.0 111.358 175.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.403 ' NE2' ' HB ' ' A' ' 22' ' ' VAL . 0.0 OUTLIER -75.51 -163.39 0.25 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.303 175.166 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -45.99 -34.55 4.09 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 -173.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -66.73 -30.1 75.74 Favored Glycine 0 CA--C 1.519 0.336 0 C-N-CA 121.242 -0.504 . . . . 0.0 113.074 -175.581 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.581 ' HA2' ' HB2' ' A' ' 34' ' ' PRO . . . 58.37 13.53 16.44 Favored Glycine 0 CA--C 1.522 0.476 0 C-N-CA 121.506 -0.378 . . . . 0.0 113.248 179.497 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.482 ' HA2' HG22 ' A' ' 21' ' ' VAL . . . 154.81 -43.12 0.58 Allowed Glycine 0 N--CA 1.449 -0.451 0 N-CA-C 111.612 -0.595 . . . . 0.0 111.612 -176.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.455 ' O ' HG13 ' A' ' 40' ' ' ILE . 32.4 pt -89.88 111.06 22.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 121.221 0.534 . . . . 0.0 110.532 179.263 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 21.1 m -146.41 131.15 17.96 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.73 177.581 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.586 ' HB3' ' HB2' ' A' ' 64' ' ' GLU . 35.4 ttt180 -90.31 103.27 15.97 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 176.304 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.642 HG21 HD21 ' A' ' 102' ' ' LEU . 25.5 t -81.2 94.51 2.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.164 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -90.27 81.89 1.37 Allowed Glycine 0 N--CA 1.452 -0.276 0 CA-C-N 115.978 -0.556 . . . . 0.0 112.639 -177.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.566 ' HB ' ' HB ' ' A' ' 16' ' ' VAL . 61.0 t -76.44 108.72 9.55 Favored 'Isoleucine or valine' 0 C--O 1.24 0.569 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 176.506 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . 0.633 ' SG ' ' HB3' ' A' ' 60' ' ' LEU . 11.8 p -115.65 136.86 52.64 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.997 -177.738 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -91.52 92.31 8.46 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 176.397 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 23.1 m -83.76 111.63 20.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 121.396 0.617 . . . . 0.0 110.667 -176.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 22.7 ptp . . . . . 0 C--O 1.234 0.261 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.392 -179.956 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.387 0 N-CA-C 111.188 -0.765 . . . . 0.0 111.188 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -117.84 106.91 13.49 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.934 0.397 . . . . 0.0 110.286 179.625 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.633 ' HB3' ' SG ' ' A' ' 46' ' ' CYS . 2.5 tt -88.66 105.16 17.5 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 179.7 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.422 ' HB ' ' HB2' ' A' ' 75' ' ' CYS . 58.6 mt -73.41 87.96 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 174.719 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 8.5 t-80 -91.55 100.33 13.09 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.177 -175.318 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.489 ' HA3' ' HB2' ' A' ' 73' ' ' LEU . . . -87.1 95.09 2.04 Favored Glycine 0 N--CA 1.449 -0.496 0 CA-C-N 115.762 -0.654 . . . . 0.0 112.324 -178.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.586 ' HB2' ' HB3' ' A' ' 42' ' ' ARG . 34.6 mt-10 -83.07 137.49 34.08 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 177.007 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.53 ' NH1' ' HB2' ' A' ' 67' ' ' LYS . 6.3 tmm_? -114.04 126.18 54.83 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 178.411 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.433 ' O ' ' HD2' ' A' ' 65' ' ' ARG . 1.0 OUTLIER -67.84 -160.95 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.488 0 O-C-N 123.564 0.54 . . . . 0.0 112.073 -174.262 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.53 ' HB2' ' NH1' ' A' ' 65' ' ' ARG . 34.5 mmtp 65.4 -82.89 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 -173.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.434 ' HB2' HD12 ' A' ' 70' ' ' LEU . 5.9 m-20 -74.22 -30.81 62.35 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.615 176.47 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.44 ' HA ' ' O ' ' A' ' 65' ' ' ARG . 22.8 tptm 60.27 81.89 0.17 Allowed 'General case' 0 C--O 1.233 0.217 0 CA-C-N 115.084 -0.962 . . . . 0.0 110.074 -176.721 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.434 HD12 ' HB2' ' A' ' 68' ' ' ASP . 0.0 OUTLIER -150.1 168.7 23.16 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.472 -177.741 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 21.6 t -83.15 109.69 17.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.893 -176.711 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.435 HG23 HD23 ' A' ' 73' ' ' LEU . 18.0 m -102.05 -35.91 4.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 CA-C-O 120.888 0.375 . . . . 0.0 111.053 177.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.502 ' HG ' HG11 ' A' ' 22' ' ' VAL . 4.5 mm? -116.24 117.11 29.1 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.229 178.741 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -118.96 104.2 10.29 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 176.205 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' CYS . . . . . 0.422 ' HB2' ' HB ' ' A' ' 61' ' ' ILE . 61.1 m -135.22 83.48 2.02 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.346 0.593 . . . . 0.0 110.632 -179.329 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.4 ' HA ' ' HA ' ' A' ' 60' ' ' LEU . 80.0 t80 -69.41 105.98 2.78 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.468 -0.787 . . . . 0.0 108.997 172.477 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 39.6 t -100.69 132.71 45.84 Favored 'Isoleucine or valine' 0 C--O 1.237 0.395 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 -175.053 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 30.4 ttp180 -135.46 100.17 4.43 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.403 -174.33 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.751 ' H ' HD21 ' A' ' 124' ' ' LEU . 66.4 mmtt 72.05 -29.74 0.2 Allowed 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.339 0.655 . . . . 0.0 112.748 178.444 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -88.38 23.01 2.31 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 120.973 0.416 . . . . 0.0 110.753 -177.058 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.604 HD22 HG12 ' A' ' 121' ' ' ILE . 1.0 OUTLIER -71.3 89.85 0.91 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.828 -179.249 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 49.0 t -123.0 99.9 7.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.121 0.486 . . . . 0.0 110.593 179.734 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.716 ' HB3' ' NE2' ' A' ' 91' ' ' HIS . 4.2 m-85 -87.1 115.47 24.51 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.47 175.738 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 31.2 m -98.61 119.71 37.8 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.176 -0.465 . . . . 0.0 109.869 173.387 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 24.2 ttmm -86.6 103.94 15.57 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 176.646 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -82.56 -19.9 37.62 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 121.064 0.459 . . . . 0.0 110.237 -178.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . 0.856 ' HB3' ' HB3' ' A' ' 90' ' ' PHE . 12.3 t-20 -156.58 144.69 14.3 Favored Pre-proline 0 C--N 1.326 -0.453 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 178.761 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.446 ' HD2' ' ND2' ' A' ' 87' ' ' ASN . 33.9 Cg_exo -34.47 -50.8 0.65 Allowed 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 123.374 2.716 . . . . 0.0 113.718 179.309 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.562 ' HA ' ' HD2' ' A' ' 104' ' ' PHE . 19.5 p -102.37 -0.72 32.18 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 112.144 0.424 . . . . 0.0 112.144 -176.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.856 ' HB3' ' HB3' ' A' ' 87' ' ' ASN . 62.0 t80 -115.78 99.3 7.21 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-O 121.402 0.62 . . . . 0.0 110.07 176.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' HIS . . . . . 0.716 ' NE2' ' HB3' ' A' ' 83' ' ' TYR . 0.8 OUTLIER -103.15 149.9 24.18 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 177.493 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 25.5 p80 -149.91 159.56 44.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 118.206 0.457 . . . . 0.0 110.74 176.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . 0.645 ' HZ3' ' HB2' ' A' ' 102' ' ' LEU . 28.5 p90 -137.29 146.72 45.01 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.323 -0.399 . . . . 0.0 109.979 178.632 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.525 ' NZ ' ' HB3' ' A' ' 94' ' ' LYS . 5.7 ttpm? -114.63 99.47 7.55 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.704 -178.708 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.479 HG13 ' HD1' ' A' ' 93' ' ' TRP . 16.7 m -85.18 113.58 23.87 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 176.023 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 57.08 -86.89 0.02 OUTLIER 'General case' 0 C--O 1.235 0.311 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.405 -173.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -126.22 -16.66 5.42 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.457 -177.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.98 134.2 33.51 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.836 0.351 . . . . 0.0 110.86 -177.395 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 3.6 mppt? -109.98 123.24 49.29 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.029 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . 0.401 ' CE2' ' SG ' ' A' ' 75' ' ' CYS . 44.3 m-85 -122.05 141.71 51.1 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 176.211 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -116.73 125.33 6.52 Favored Glycine 0 CA--C 1.516 0.144 0 C-N-CA 121.377 -0.439 . . . . 0.0 113.227 -174.668 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.645 ' HB2' ' HZ3' ' A' ' 93' ' ' TRP . 0.4 OUTLIER -94.4 104.28 16.25 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 175.675 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.587 ' HB ' ' HB ' ' A' ' 21' ' ' VAL . 33.3 m -92.54 119.5 32.07 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 177.161 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.562 ' HD2' ' HA ' ' A' ' 89' ' ' THR . 36.7 m-85 -73.82 148.22 42.64 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.438 -175.04 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -88.81 -52.56 5.05 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.605 -176.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 19.7 m -134.01 159.11 73.67 Favored Pre-proline 0 C--N 1.326 -0.413 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.142 -177.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_endo -55.59 -29.85 71.96 Favored 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 122.526 2.15 . . . . 0.0 112.17 -179.46 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -61.8 -62.04 2.08 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.77 179.371 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.418 ' HB2' HG11 ' A' ' 18' ' ' VAL . 3.3 p-10 -66.83 -29.09 68.92 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.838 -179.455 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -57.82 -60.82 3.12 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.922 0.392 . . . . 0.0 110.697 176.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 69.7 mtp180 -64.12 -42.37 96.89 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.54 -0.754 . . . . 0.0 110.802 -178.431 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -61.54 -41.46 97.38 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.938 -179.359 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 35.4 t80 -75.42 -37.02 60.67 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.213 -177.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 35.3 m-20 -58.82 -53.83 53.92 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 120.884 0.373 . . . . 0.0 110.336 177.29 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? -66.01 -37.92 87.15 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.501 179.05 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -62.77 -49.98 68.07 Favored Glycine 0 C--N 1.331 0.274 0 CA-C-N 116.053 -0.522 . . . . 0.0 112.501 -179.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.515 ' O ' HG13 ' A' ' 121' ' ' ILE . 9.1 p -69.66 -35.45 65.9 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.201 0 N-CA-C 110.123 -0.325 . . . . 0.0 110.123 -178.598 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.52 ' O ' ' HG3' ' A' ' 122' ' ' GLU . 69.8 ttt180 -57.46 -51.16 70.59 Favored 'General case' 0 C--O 1.23 0.073 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 176.091 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 64.3 tttp -56.82 -43.93 81.53 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.422 177.453 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.58 -43.18 97.61 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.154 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.604 HG12 HD22 ' A' ' 81' ' ' LEU . 80.2 mt -62.18 -51.53 71.3 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.195 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.414 179.536 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.52 ' HG3' ' O ' ' A' ' 118' ' ' ARG . 42.8 mt-10 -61.23 -44.52 97.13 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 115.729 -0.668 . . . . 0.0 110.616 -177.363 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -60.67 -42.21 96.62 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.527 178.323 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.751 HD21 ' H ' ' A' ' 79' ' ' LYS . 41.0 tp -66.65 -47.72 71.66 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.134 -177.715 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.481 HG12 ' O ' ' A' ' 121' ' ' ILE . 17.7 pt -74.53 -65.05 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 C-N-CA 120.964 -0.294 . . . . 0.0 111.42 -176.791 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.479 ' H ' HG13 ' A' ' 125' ' ' ILE . 71.7 mm-40 . . . . . 0 C--O 1.25 1.129 0 CA-C-O 119.035 -0.507 . . . . 0.0 110.069 -172.498 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.538 0.503 0 CA-C-O 121.057 0.456 . . . . 0.0 111.277 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -76.89 137.88 39.4 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.046 177.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.715 HD11 ' HB2' ' A' ' 47' ' ' LYS . 1.8 mp -88.35 -53.48 9.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 173.723 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 14.5 p -166.03 146.07 1.66 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.311 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.38 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.541 ' HG2' ' HA3' ' A' ' 44' ' ' GLY . 24.0 mtm180 -118.09 109.06 15.97 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.492 173.04 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 34.8 m -109.23 162.81 6.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.824 -177.058 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.5 ' HE3' HG12 ' A' ' 40' ' ' ILE . 83.9 tttt -84.41 130.13 34.8 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.414 177.172 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -153.92 -167.27 2.61 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 175.378 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.57 ' HB ' ' HB ' ' A' ' 103' ' ' THR . 64.8 t -124.51 114.85 42.63 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 175.15 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.507 HG23 ' HG2' ' A' ' 35' ' ' GLN . 9.3 m -73.08 110.45 6.32 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 CA-C-O 121.367 0.603 . . . . 0.0 111.67 -178.102 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . 0.556 ' SD ' HG12 ' A' ' 21' ' ' VAL . 38.3 mmm -104.42 146.02 29.45 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.628 -0.714 . . . . 0.0 109.554 -178.521 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.497 ' HB ' ' NE2' ' A' ' 35' ' ' GLN . 10.7 t -135.32 -6.12 2.3 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 111.766 0.284 . . . . 0.0 111.766 179.26 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 31.6 ttp180 53.25 46.93 25.46 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 122.891 0.477 . . . . 0.0 111.324 -178.26 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.496 ' O ' ' HB3' ' A' ' 27' ' ' ASP . 4.4 p-10 45.88 26.65 0.4 Allowed 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 124.038 0.935 . . . . 0.0 113.361 174.102 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.496 ' HB3' ' O ' ' A' ' 26' ' ' ASP . 8.3 t70 74.99 -40.23 0.43 Allowed 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 122.785 0.434 . . . . 0.0 111.518 178.633 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 17.2 m -96.91 -91.57 0.24 Allowed 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 116.945 -0.116 . . . . 0.0 111.278 -176.017 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 11.0 p -176.72 27.73 0.0 OUTLIER 'General case' 0 C--O 1.236 0.391 0 N-CA-C 112.253 0.464 . . . . 0.0 112.253 -174.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -76.34 -28.83 59.23 Favored Glycine 0 CA--C 1.519 0.342 0 C-N-CA 120.772 -0.727 . . . . 0.0 111.924 179.066 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 158.34 151.3 6.03 Favored Glycine 0 CA--C 1.519 0.318 0 C-N-CA 121.386 -0.435 . . . . 0.0 112.265 178.593 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 83.9 m95 -76.95 102.04 6.24 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 110.165 -0.309 . . . . 0.0 110.165 179.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.411 ' H ' ' HD1' ' A' ' 33' ' ' PHE . 0.2 OUTLIER -114.83 153.55 46.94 Favored Pre-proline 0 C--O 1.237 0.422 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.145 177.48 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_exo -67.05 130.67 23.39 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.791 2.328 . . . . 0.0 111.473 175.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.507 ' HG2' HG23 ' A' ' 22' ' ' VAL . 7.9 pt20 -92.02 85.92 5.67 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 121.32 0.581 . . . . 0.0 110.837 -178.132 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 71.66 -34.13 0.29 Allowed 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.929 0.892 . . . . 0.0 113.312 176.459 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.446 ' HA2' ' HD2' ' A' ' 65' ' ' ARG . . . -63.77 -50.02 64.3 Favored Glycine 0 C--N 1.333 0.405 0 C-N-CA 121.163 -0.541 . . . . 0.0 112.347 -179.729 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 82.45 -146.0 24.46 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.99 -0.624 . . . . 0.0 111.672 -178.312 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -65.17 -23.6 69.89 Favored Glycine 0 CA--C 1.518 0.243 0 C-N-CA 121.429 -0.415 . . . . 0.0 112.83 -178.601 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.5 HG12 ' HE3' ' A' ' 19' ' ' LYS . 57.8 mt -113.52 104.3 16.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.961 0.41 . . . . 0.0 110.344 179.28 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.454 ' HB3' HG13 ' A' ' 22' ' ' VAL . 19.1 m -131.1 107.71 9.24 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 173.697 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.615 ' HB3' ' HG3' ' A' ' 64' ' ' GLU . 47.0 ttt180 -77.08 91.72 3.7 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.223 0.535 . . . . 0.0 109.901 -177.422 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 78.8 t -79.74 119.89 30.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.197 -179.459 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.541 ' HA3' ' HG2' ' A' ' 17' ' ' ARG . . . -116.91 123.28 5.75 Favored Glycine 0 N--CA 1.445 -0.705 0 CA-C-N 115.897 -0.592 . . . . 0.0 112.76 -177.396 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.456 HG13 ' HB ' ' A' ' 15' ' ' ILE . 7.6 p -99.51 123.29 52.15 Favored 'Isoleucine or valine' 0 C--O 1.24 0.591 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 175.086 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . 0.825 ' SG ' ' HB3' ' A' ' 60' ' ' LEU . 8.8 p -126.37 141.87 51.74 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.507 178.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.715 ' HB2' HD11 ' A' ' 15' ' ' ILE . 83.3 tttt -88.21 102.19 14.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.843 -176.199 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.574 HG11 ' OH ' ' A' ' 76' ' ' TYR . 95.4 t -74.67 96.14 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 121.06 0.457 . . . . 0.0 110.631 -177.139 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.238 0.478 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.286 178.566 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.238 0 N-CA-C 111.827 -0.509 . . . . 0.0 111.827 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -141.09 144.49 34.93 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.751 0.31 . . . . 0.0 110.501 -179.008 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.825 ' HB3' ' SG ' ' A' ' 46' ' ' CYS . 1.6 tt -104.51 109.47 21.36 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 172.559 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.659 ' HB ' ' HB3' ' A' ' 75' ' ' CYS . 44.5 mm -81.66 89.52 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 108.415 -0.958 . . . . 0.0 108.415 174.354 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 12.3 t-80 -93.01 144.35 25.33 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.509 -0.768 . . . . 0.0 110.617 -173.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.513 ' HA3' ' HB3' ' A' ' 73' ' ' LEU . . . -131.43 87.21 0.29 Allowed Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 121.164 -0.541 . . . . 0.0 111.986 179.085 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.615 ' HG3' ' HB3' ' A' ' 42' ' ' ARG . 6.0 pt-20 -88.08 135.13 33.56 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 173.483 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.446 ' HD2' ' HA2' ' A' ' 37' ' ' GLY . 21.7 mtm180 -54.78 -67.05 0.3 Allowed 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 120.868 0.366 . . . . 0.0 111.676 -172.08 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 39.6 mt-30 -118.36 -43.69 2.71 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.054 0.454 . . . . 0.0 110.61 -175.179 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 32.3 ttpt -173.16 94.24 0.11 Allowed 'General case' 0 C--O 1.236 0.352 0 CA-C-N 115.593 -0.73 . . . . 0.0 109.128 -178.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 12.5 t70 52.11 -143.7 0.66 Allowed 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 -175.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 86.0 tttt 71.04 -65.39 0.34 Allowed 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 123.513 0.725 . . . . 0.0 112.028 175.133 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.8 tt -129.01 114.49 16.47 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-O 120.711 0.291 . . . . 0.0 110.279 -175.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 48.3 t -89.18 113.88 26.41 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.623 176.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 18.5 m -105.57 -12.5 9.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 111.762 0.282 . . . . 0.0 111.762 -177.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.513 ' HB3' ' HA3' ' A' ' 63' ' ' GLY . 3.3 tm? -142.98 120.32 11.6 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 -179.617 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -127.71 98.51 5.21 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 178.79 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' CYS . . . . . 0.659 ' HB3' ' HB ' ' A' ' 61' ' ' ILE . 41.9 t -124.08 67.0 1.05 Allowed 'General case' 0 C--O 1.235 0.305 0 CA-C-O 121.668 0.747 . . . . 0.0 110.475 -177.708 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.574 ' OH ' HG11 ' A' ' 48' ' ' VAL . 31.8 t80 -62.64 101.14 0.23 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 114.94 -1.027 . . . . 0.0 109.089 173.64 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.609 HG21 HD12 ' A' ' 81' ' ' LEU . 29.2 m -84.08 111.39 19.92 Favored 'Isoleucine or valine' 0 C--O 1.239 0.539 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 -178.737 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.495 ' NH1' ' O ' ' A' ' 76' ' ' TYR . 9.8 mpt_? -77.56 66.05 3.2 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.98 -177.327 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 50.9 mtpt 72.71 -33.85 0.28 Allowed 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.773 0.829 . . . . 0.0 112.002 -178.476 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -75.92 108.25 8.67 Favored 'General case' 0 C--O 1.233 0.189 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 173.206 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.609 HD12 HG21 ' A' ' 77' ' ' VAL . 6.6 tt -134.58 113.8 12.13 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 -177.519 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 49.2 t -124.28 90.61 1.64 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 CA-C-O 120.701 0.286 . . . . 0.0 110.989 -179.075 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.715 ' HB3' ' NE2' ' A' ' 91' ' ' HIS . 4.1 m-85 -88.26 152.93 21.61 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 120.922 0.392 . . . . 0.0 110.205 174.012 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 61.8 m -155.55 118.2 4.23 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 123.535 0.734 . . . . 0.0 109.097 178.044 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.507 ' HA ' ' HA ' ' A' ' 91' ' ' HIS . 3.1 pptp? -90.81 131.89 36.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.888 0.375 . . . . 0.0 110.249 179.33 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.42 ' HB3' ' HD1' ' A' ' 90' ' ' PHE . . . -96.32 -31.08 13.07 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.249 0.547 . . . . 0.0 109.697 176.437 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . 0.558 ' HB2' ' HB3' ' A' ' 90' ' ' PHE . 43.9 m-80 -143.3 158.93 57.01 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 115.251 -0.886 . . . . 0.0 109.282 179.134 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.422 ' O ' ' HB1' ' A' ' 110' ' ' ALA . 52.3 Cg_exo -55.91 -28.23 67.18 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.227 1.951 . . . . 0.0 111.642 175.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.438 ' HA ' ' HB2' ' A' ' 104' ' ' PHE . 12.6 p -109.3 16.41 22.41 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 115.74 -0.663 . . . . 0.0 111.601 -178.724 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.558 ' HB3' ' HB2' ' A' ' 87' ' ' ASN . 58.7 t80 -150.67 107.11 3.49 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-O 120.803 0.335 . . . . 0.0 110.734 -178.789 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' HIS . . . . . 0.715 ' NE2' ' HB3' ' A' ' 83' ' ' TYR . 2.2 t60 -120.16 141.92 49.43 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 177.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . 0.473 ' HA ' ' HA2' ' A' ' 101' ' ' GLY . 21.5 p80 -138.12 152.62 48.91 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.485 0.183 . . . . 0.0 110.516 -179.275 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . 0.617 ' HZ3' HD22 ' A' ' 102' ' ' LEU . 47.3 p90 -127.13 145.54 50.71 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 121.228 0.537 . . . . 0.0 111.245 -179.214 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 36.3 ttmt -91.59 133.42 35.56 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.285 -176.551 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.402 HG21 ' CE2' ' A' ' 100' ' ' PHE . 9.3 m -134.38 82.04 0.56 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.316 0 CA-C-O 121.558 0.694 . . . . 0.0 110.783 177.138 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 20.0 t70 59.67 -84.73 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 114.861 -1.063 . . . . 0.0 111.846 178.482 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -99.29 -48.39 4.83 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 120.741 0.305 . . . . 0.0 110.826 -176.481 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 9.0 mpt_? -87.76 176.15 7.53 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-O 121.168 0.508 . . . . 0.0 110.878 -178.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.414 ' HE3' ' HB2' ' A' ' 99' ' ' LYS . 39.1 ttmt -154.27 104.21 2.58 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 -178.225 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . 0.432 ' HB2' ' CE2' ' A' ' 93' ' ' TRP . 3.6 m-85 -92.97 179.12 5.54 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 -176.814 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.473 ' HA2' ' HA ' ' A' ' 92' ' ' HIS . . . -168.3 177.57 42.32 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.621 -0.8 . . . . 0.0 112.196 178.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.617 HD22 ' HZ3' ' A' ' 93' ' ' TRP . 2.3 pt? -142.36 133.04 25.41 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 177.163 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.57 ' HB ' ' HB ' ' A' ' 21' ' ' VAL . 24.8 m -93.63 127.4 39.3 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.56 177.081 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.455 ' HE2' ' HB2' ' A' ' 91' ' ' HIS . 73.6 m-85 -86.59 157.3 19.75 Favored 'General case' 0 C--O 1.237 0.41 0 O-C-N 123.305 0.378 . . . . 0.0 110.171 -179.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 21.1 mp0 -102.96 -33.74 9.19 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.327 -177.53 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 8.4 m -137.84 144.77 45.56 Favored Pre-proline 0 CA--C 1.532 0.25 0 CA-C-O 120.437 0.16 . . . . 0.0 110.78 -178.387 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_exo -53.17 -21.9 18.09 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 122.64 2.227 . . . . 0.0 112.491 176.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -64.06 -65.81 0.63 Allowed 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.56 176.362 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -62.48 -36.78 83.58 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.569 179.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.422 ' HB1' ' O ' ' A' ' 88' ' ' PRO . . . -55.84 -67.09 0.32 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.403 177.705 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 83.8 mtm180 -62.29 -34.27 76.25 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.139 -175.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -62.43 -43.35 99.02 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-O 120.949 0.404 . . . . 0.0 110.361 177.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.482 ' O ' HG23 ' A' ' 117' ' ' VAL . 52.8 t80 -69.28 -43.5 73.74 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.02 -179.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -55.78 -46.17 78.01 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 121.015 0.436 . . . . 0.0 110.628 177.411 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 24.2 tpt180 -65.97 -34.79 78.91 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 116.137 -0.483 . . . . 0.0 109.76 178.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -62.28 -38.7 96.66 Favored Glycine 0 C--N 1.333 0.366 0 N-CA-C 111.471 -0.652 . . . . 0.0 111.471 174.451 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.487 ' O ' HG13 ' A' ' 121' ' ' ILE . 96.8 t -62.21 -45.87 97.76 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.142 0 N-CA-C 109.73 -0.471 . . . . 0.0 109.73 176.373 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.539 ' O ' ' HG2' ' A' ' 122' ' ' GLU . 8.5 tpm_? -53.2 -52.44 58.87 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.467 176.621 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 7.4 tmtt? -60.26 -47.72 84.8 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.032 -178.389 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -57.6 -48.17 80.12 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.941 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.487 HG13 ' O ' ' A' ' 117' ' ' VAL . 75.0 mt -56.9 -42.51 78.59 Favored 'Isoleucine or valine' 0 C--O 1.232 0.177 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.44 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.539 ' HG2' ' O ' ' A' ' 118' ' ' ARG . 15.6 mm-40 -57.05 -57.06 14.21 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-O 121.038 0.447 . . . . 0.0 110.621 177.621 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -71.46 -12.74 61.55 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.651 -177.337 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 62.7 tp -87.61 -68.24 0.77 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.761 0.315 . . . . 0.0 110.929 178.679 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.44 HG12 ' O ' ' A' ' 121' ' ' ILE . 34.8 pt -89.79 -18.6 7.66 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 N-CA-C 112.241 0.46 . . . . 0.0 112.241 -172.369 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.43 ' HB3' ' O ' ' A' ' 125' ' ' ILE . 36.5 tt0 . . . . . 0 C--O 1.252 1.192 0 O-C-N 123.441 0.463 . . . . 0.0 110.23 -178.203 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 37.4 t . . . . . 0 C--O 1.231 0.098 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.448 ' CG ' ' HB3' ' A' ' 46' ' ' CYS . 46.5 m-85 64.14 101.73 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 115.8 -0.637 . . . . 0.0 111.803 178.463 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.641 HG23 HG23 ' A' ' 16' ' ' VAL . 11.5 tt -82.14 -31.75 10.46 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 CA-C-N 115.624 -0.717 . . . . 0.0 110.56 -178.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.641 HG23 HG23 ' A' ' 15' ' ' ILE . 76.5 t -117.23 113.98 44.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.249 179.505 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.503 ' NH2' HH12 ' A' ' 42' ' ' ARG . 22.3 mtp180 -136.21 86.54 2.23 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 175.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.411 ' HB ' ' CZ ' ' A' ' 113' ' ' PHE . 44.2 t -130.61 153.89 39.77 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.391 -176.578 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 23.3 pttm -65.28 154.85 37.02 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.466 178.32 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.411 ' HB3' HG23 ' A' ' 43' ' ' VAL . . . -179.61 174.04 1.0 Allowed 'General case' 0 C--O 1.233 0.211 0 O-C-N 123.466 0.479 . . . . 0.0 110.532 175.528 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 61.8 t -123.89 143.98 35.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 171.124 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.415 HG11 HD11 ' A' ' 73' ' ' LEU . 29.6 m -115.02 131.0 68.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-O 121.097 0.475 . . . . 0.0 111.465 -175.401 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 25.2 mmt -100.23 113.42 26.09 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.057 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.407 HG22 ' O ' ' A' ' 33' ' ' PHE . 11.8 t -82.62 152.64 25.81 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 178.005 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.473 ' HD2' ' CZ2' ' A' ' 32' ' ' TRP . 36.1 ttt85 -122.05 114.11 20.48 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 -172.154 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -72.31 93.54 1.51 Allowed 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 107.602 -1.259 . . . . 0.0 107.602 165.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -54.65 149.74 10.46 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 115.603 -0.726 . . . . 0.0 112.879 -169.179 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 51.9 m 72.89 -36.46 0.36 Allowed 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 114.612 -1.176 . . . . 0.0 112.306 179.005 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 29.4 t -78.54 -44.53 24.06 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 175.436 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 149.64 -67.2 0.36 Allowed Glycine 0 N--CA 1.452 -0.291 0 N-CA-C 111.559 -0.616 . . . . 0.0 111.559 178.182 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.453 ' HA3' ' HA ' ' A' ' 25' ' ' ARG . . . 71.34 -126.07 12.65 Favored Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 121.449 -0.405 . . . . 0.0 112.884 178.565 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . 0.53 ' HH2' ' HG2' ' A' ' 99' ' ' LYS . 24.6 m95 58.96 38.03 24.41 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 123.041 0.537 . . . . 0.0 109.957 -175.039 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.407 ' O ' HG22 ' A' ' 24' ' ' THR . 21.1 p90 -112.26 148.93 40.17 Favored Pre-proline 0 CA--C 1.532 0.252 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.574 -177.261 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -68.21 109.58 2.02 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 122.706 2.271 . . . . 0.0 111.85 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 28.9 pt20 -59.4 132.27 53.49 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.375 -177.321 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 60.81 20.9 11.04 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.756 177.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 99.43 -15.62 59.85 Favored Glycine 0 C--N 1.333 0.379 0 CA-C-N 116.023 -0.535 . . . . 0.0 112.33 -179.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 100.18 -115.62 5.35 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 121.577 -0.344 . . . . 0.0 112.398 179.381 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.81 150.0 26.41 Favored Glycine 0 N--CA 1.451 -0.305 0 N-CA-C 111.774 -0.53 . . . . 0.0 111.774 -177.352 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 6.0 tp -55.88 115.73 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 CA-C-O 121.133 0.492 . . . . 0.0 110.689 179.511 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.416 ' HA ' ' HA ' ' A' ' 65' ' ' ARG . 20.0 m -116.95 175.23 5.68 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.361 -177.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.503 HH12 ' NH2' ' A' ' 17' ' ' ARG . 49.6 ttp180 -138.58 137.43 36.98 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.414 -0.588 . . . . 0.0 109.414 177.284 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.632 HG21 HD11 ' A' ' 102' ' ' LEU . 61.7 t -97.49 118.81 44.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 176.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.437 ' HA2' ' O ' ' A' ' 16' ' ' VAL . . . -116.59 94.92 0.66 Allowed Glycine 0 N--CA 1.452 -0.263 0 CA-C-N 116.013 -0.54 . . . . 0.0 112.109 -179.259 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.498 ' HB ' ' HB ' ' A' ' 16' ' ' VAL . 60.8 t -92.04 116.24 32.77 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 N-CA-C 110.235 -0.283 . . . . 0.0 110.235 178.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . 0.537 ' SG ' ' HB3' ' A' ' 60' ' ' LEU . 24.2 p -118.45 131.39 56.27 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.694 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 60.2 tttp -74.33 102.22 4.31 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 175.411 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.442 HG21 ' CE1' ' A' ' 76' ' ' TYR . 26.9 m -73.24 124.95 31.34 Favored 'Isoleucine or valine' 0 C--O 1.24 0.602 0 CA-C-O 121.202 0.525 . . . . 0.0 110.219 179.559 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 25.9 mmt . . . . . 0 C--N 1.328 -0.366 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.599 -176.501 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.227 -0.3 0 CA-C-O 120.847 0.137 . . . . 0.0 113.3 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.412 ' HA ' ' O ' ' A' ' 46' ' ' CYS . 45.1 m-85 -131.76 122.14 25.35 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 122.867 0.467 . . . . 0.0 109.98 177.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.537 ' HB3' ' SG ' ' A' ' 46' ' ' CYS . 0.9 OUTLIER -80.1 112.34 17.31 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 175.582 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.568 ' HB ' ' HB2' ' A' ' 75' ' ' CYS . 50.5 mm -76.27 82.08 0.68 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.322 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 174.303 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . 0.406 ' HB2' HD22 ' A' ' 60' ' ' LEU . 63.1 t-80 -99.59 164.29 12.13 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.198 -0.91 . . . . 0.0 109.751 -176.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 175.48 149.98 7.68 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.816 -0.707 . . . . 0.0 111.651 176.419 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.448 ' CD ' HH21 ' A' ' 42' ' ' ARG . 0.1 OUTLIER -142.06 171.01 14.64 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.96 0.41 . . . . 0.0 110.888 -178.586 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.416 ' HA ' ' HA ' ' A' ' 41' ' ' SER . 38.3 ttm180 -83.98 119.16 24.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.36 177.709 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 -61.77 87.99 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 121.255 0.55 . . . . 0.0 111.518 -173.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 40.0 ttpt 178.2 -30.59 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 114.587 -1.188 . . . . 0.0 108.563 178.343 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -156.65 170.75 21.68 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.021 -0.99 . . . . 0.0 108.875 177.455 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 93.0 mttt -74.64 16.97 0.23 Allowed 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 120.652 0.263 . . . . 0.0 111.175 178.733 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 5.7 tt -58.03 97.94 0.03 OUTLIER 'General case' 0 C--O 1.233 0.219 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 174.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 27.5 m -69.9 130.87 34.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.257 0.551 . . . . 0.0 111.978 -175.352 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 33.1 m -109.69 -14.49 10.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.056 175.211 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.415 HD11 HG11 ' A' ' 22' ' ' VAL . 60.1 mt -132.13 134.39 45.38 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.488 178.593 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -159.39 92.42 1.06 Allowed 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 174.792 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' CYS . . . . . 0.568 ' HB2' ' HB ' ' A' ' 61' ' ' ILE . 66.9 m -136.36 105.67 6.05 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.756 179.102 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.442 ' CE1' HG21 ' A' ' 48' ' ' VAL . 50.9 t80 -76.01 101.22 5.16 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.098 -178.291 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 83.6 t -103.41 99.41 8.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.006 0.431 . . . . 0.0 110.071 -178.186 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.433 ' HD3' ' HE2' ' A' ' 76' ' ' TYR . 18.6 ptt180 -108.38 -20.53 13.09 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.883 -178.397 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 1.8 tmtp? -123.92 79.03 1.68 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.829 -174.33 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 32.7 m-20 62.73 168.34 0.13 Allowed 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 115.124 -0.944 . . . . 0.0 112.102 176.061 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.511 HD23 ' N ' ' A' ' 82' ' ' VAL . 5.6 tt -146.66 135.45 22.27 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 -177.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.511 ' N ' HD23 ' A' ' 81' ' ' LEU . 48.3 t -77.97 -77.25 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 O-C-N 122.978 0.174 . . . . 0.0 111.247 -176.731 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.502 ' CD2' HG21 ' A' ' 117' ' ' VAL . 0.0 OUTLIER 64.66 136.52 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 121.469 0.652 . . . . 0.0 111.399 -177.421 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.516 ' HB ' ' CE1' ' A' ' 92' ' ' HIS . 90.0 m -154.31 117.9 4.62 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.357 -179.399 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.488 ' HB2' ' CE1' ' A' ' 91' ' ' HIS . 36.9 ttpt -95.69 103.99 15.89 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.912 0.387 . . . . 0.0 110.215 -178.111 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -85.15 -29.73 24.54 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.085 178.336 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . 0.609 ' HB2' ' HB3' ' A' ' 90' ' ' PHE . 18.6 m120 -143.93 153.56 57.41 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.264 178.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -63.57 -4.72 7.34 Favored 'Trans proline' 0 N--CA 1.478 0.562 0 C-N-CA 122.735 2.29 . . . . 0.0 112.748 -179.417 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 8.3 t -126.46 16.08 7.66 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 121.355 0.598 . . . . 0.0 110.123 178.267 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.609 ' HB3' ' HB2' ' A' ' 87' ' ' ASN . 64.1 t80 -152.09 101.23 2.7 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.203 -175.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' HIS . . . . . 0.488 ' CE1' ' HB2' ' A' ' 85' ' ' LYS . 2.1 t-160 -125.55 106.81 10.04 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 -179.225 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . 0.553 ' ND1' ' HD2' ' A' ' 99' ' ' LYS . 35.1 p80 -103.49 150.03 24.28 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 120.739 0.304 . . . . 0.0 111.671 -173.769 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . 0.541 ' HZ3' ' HB2' ' A' ' 102' ' ' LEU . 24.9 p90 -132.74 130.98 40.69 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.335 176.199 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.532 ' HA ' ' HA ' ' A' ' 99' ' ' LYS . 65.0 tttp -94.7 139.01 31.81 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.198 -0.455 . . . . 0.0 109.926 172.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.461 HG23 ' H ' ' A' ' 97' ' ' ASN . 29.2 m -117.28 -162.56 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.662 177.288 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -56.35 -24.87 46.99 Favored 'General case' 0 CA--C 1.532 0.27 0 O-C-N 123.094 0.246 . . . . 0.0 111.631 -176.526 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.461 ' H ' HG23 ' A' ' 95' ' ' VAL . 0.9 OUTLIER -114.8 -94.38 0.48 Allowed 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 120.491 0.186 . . . . 0.0 111.457 176.793 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 29.8 mmt180 -93.33 -174.33 3.49 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 121.321 0.581 . . . . 0.0 111.866 -170.637 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.553 ' HD2' ' ND1' ' A' ' 92' ' ' HIS . 38.2 ttpt -125.7 110.22 13.51 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.128 -0.942 . . . . 0.0 109.551 -178.561 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 17.9 m-85 -97.15 162.28 13.43 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 109.819 -0.438 . . . . 0.0 109.819 -176.524 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.503 ' HA2' ' HA ' ' A' ' 92' ' ' HIS . . . -128.78 140.58 11.84 Favored Glycine 0 C--N 1.333 0.415 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.94 -177.592 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.632 HD11 HG21 ' A' ' 43' ' ' VAL . 4.8 tt -109.66 133.84 52.65 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 177.599 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.548 ' N ' HD23 ' A' ' 102' ' ' LEU . 88.1 m -106.66 114.43 28.54 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.808 179.722 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.432 ' CE2' ' HB2' ' A' ' 91' ' ' HIS . 22.5 m-85 -79.76 148.56 31.43 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 175.418 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 59.3 tt0 -105.5 -33.02 8.25 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.876 0.37 . . . . 0.0 110.601 -178.006 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 32.6 t -124.64 147.52 56.1 Favored Pre-proline 0 C--N 1.329 -0.297 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -60.34 -25.62 80.73 Favored 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 121.878 1.719 . . . . 0.0 110.417 172.126 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -69.6 -58.33 4.08 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.786 178.624 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -65.83 -32.89 74.67 Favored 'General case' 0 N--CA 1.463 0.206 0 C-N-CA 121.013 -0.275 . . . . 0.0 110.271 -179.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -55.06 -60.13 3.8 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.745 174.077 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . 0.408 HH11 ' HD3' ' A' ' 111' ' ' ARG . 16.2 ttm180 -61.1 -30.69 70.51 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.469 -178.715 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -62.31 -42.87 99.73 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.434 175.556 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.411 ' CZ ' ' HB ' ' A' ' 18' ' ' VAL . 39.7 m-85 -66.59 -43.27 85.38 Favored 'General case' 0 C--O 1.23 0.079 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.49 177.308 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -55.01 -51.32 66.63 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 120.885 0.374 . . . . 0.0 110.447 178.503 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . 0.414 HH11 ' HD3' ' A' ' 115' ' ' ARG . 3.1 mmp_? -60.48 -46.01 91.65 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.582 178.448 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -60.25 -51.4 59.02 Favored Glycine 0 C--N 1.333 0.367 0 CA-C-N 115.46 -0.791 . . . . 0.0 112.633 -177.519 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.502 HG21 ' CD2' ' A' ' 83' ' ' TYR . 11.4 p -68.53 -32.78 56.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.416 0.15 . . . . 0.0 110.621 -178.281 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 8.1 mmm180 -56.18 -57.05 13.83 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 174.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -63.73 -32.34 73.8 Favored 'General case' 0 C--O 1.224 -0.24 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.388 179.643 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -62.64 -50.32 71.69 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-O 120.564 0.221 . . . . 0.0 111.235 179.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.401 ' O ' ' HB2' ' A' ' 124' ' ' LEU . 69.4 mt -66.47 -39.38 83.86 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 CA-C-O 121.063 0.459 . . . . 0.0 110.338 -179.817 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 -67.32 -34.28 77.03 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.313 177.163 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -79.84 -17.03 54.25 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 121.284 0.564 . . . . 0.0 110.0 178.573 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.407 ' HG ' ' CE1' ' A' ' 59' ' ' PHE . 11.7 mt -71.09 -58.92 3.09 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.581 170.378 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 11.1 tp -68.71 -23.99 28.39 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.054 -176.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 . . . . . 0 C--O 1.251 1.136 0 CA-C-O 118.116 -0.945 . . . . 0.0 110.175 176.691 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 19.9 m . . . . . 0 C--O 1.235 0.305 0 CA-C-O 120.558 0.218 . . . . 0.0 111.062 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 61.9 m-85 -62.63 112.81 2.66 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 120.819 0.343 . . . . 0.0 110.523 177.122 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.526 HG22 HG23 ' A' ' 16' ' ' VAL . 63.0 mt -70.53 -48.78 57.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 174.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.526 HG23 HG22 ' A' ' 15' ' ' ILE . 87.4 t -144.33 104.65 0.82 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.355 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.481 178.718 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.577 ' HA ' ' HA2' ' A' ' 44' ' ' GLY . 27.2 ptt180 -101.6 112.88 25.58 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 169.491 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 7.4 p -143.91 157.37 15.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.14 0.495 . . . . 0.0 111.529 -172.241 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.546 ' NZ ' ' HB3' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -70.01 124.58 24.43 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.326 177.833 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -151.0 -168.6 3.15 Favored 'General case' 0 C--O 1.235 0.33 0 O-C-N 123.243 0.34 . . . . 0.0 110.313 179.394 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.454 ' HB ' ' HB ' ' A' ' 103' ' ' THR . 45.9 t -123.97 138.68 52.83 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 N-CA-C 110.22 -0.289 . . . . 0.0 110.22 176.502 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 17.6 m -106.3 135.4 44.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.532 177.367 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 24.9 mmt -123.47 146.19 48.24 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 178.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.527 HG23 ' H ' ' A' ' 26' ' ' ASP . 6.4 t -129.0 -6.31 4.97 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.597 -0.441 . . . . 0.0 111.616 177.122 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.457 ' HB2' ' CE3' ' A' ' 32' ' ' TRP . 65.2 ttt180 54.07 24.46 4.79 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 121.295 0.569 . . . . 0.0 111.037 178.749 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.527 ' H ' HG23 ' A' ' 24' ' ' THR . 36.4 t70 54.23 45.32 27.58 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.007 -177.228 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 52.8 m-20 73.04 -68.51 0.22 Allowed 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 114.68 -1.145 . . . . 0.0 110.639 -178.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 68.9 m -152.8 87.92 1.31 Allowed 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 176.399 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 53.3 m -140.53 -160.42 1.07 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.774 179.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -61.96 -90.17 0.02 OUTLIER Glycine 0 CA--C 1.52 0.401 0 C-N-CA 121.246 -0.502 . . . . 0.0 113.311 -177.547 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -97.1 176.97 32.23 Favored Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 121.432 -0.413 . . . . 0.0 112.995 -173.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . 0.481 ' CH2' ' HB3' ' A' ' 99' ' ' LYS . 37.3 m95 -97.03 113.82 25.39 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 -179.648 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 2.8 p90 -104.25 145.85 31.45 Favored Pre-proline 0 C--N 1.329 -0.298 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 179.179 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.557 ' HB2' ' HA3' ' A' ' 38' ' ' GLY . 88.9 Cg_endo -84.1 120.46 2.6 Favored 'Trans proline' 0 CA--C 1.534 0.521 0 C-N-CA 122.583 2.189 . . . . 0.0 112.068 178.67 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 5.0 pm0 -107.93 144.61 34.95 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.166 179.312 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 57.94 97.33 0.02 OUTLIER 'General case' 0 C--O 1.238 0.453 0 CA-C-O 121.441 0.638 . . . . 0.0 111.534 179.072 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 76.04 -72.33 1.86 Allowed Glycine 0 N--CA 1.45 -0.404 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.466 -176.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.557 ' HA3' ' HB2' ' A' ' 34' ' ' PRO . . . 58.66 65.8 3.24 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 121.354 -0.45 . . . . 0.0 112.759 177.527 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 156.37 -43.72 0.53 Allowed Glycine 0 N--CA 1.453 -0.176 0 N-CA-C 111.646 -0.581 . . . . 0.0 111.646 -179.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.495 ' O ' HG12 ' A' ' 40' ' ' ILE . 11.9 tt -121.91 22.19 4.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 121.539 0.685 . . . . 0.0 109.696 178.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 21.3 m -60.61 122.36 14.51 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.29 -177.108 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.446 ' HB2' ' HA ' ' A' ' 66' ' ' GLN . 29.0 ttt85 -82.95 92.71 7.39 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.45 -175.562 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 41.1 t -95.47 150.62 4.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.076 -179.322 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.577 ' HA2' ' HA ' ' A' ' 17' ' ' ARG . . . -154.22 116.61 0.74 Allowed Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 121.178 -0.534 . . . . 0.0 112.335 -179.544 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 6.7 p -87.56 117.85 32.29 Favored 'Isoleucine or valine' 0 C--O 1.237 0.415 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 176.356 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . 0.769 ' SG ' ' HB3' ' A' ' 60' ' ' LEU . 13.9 p -113.69 146.54 39.67 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.068 -178.718 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.405 ' HB2' HD11 ' A' ' 15' ' ' ILE . 47.9 tttp -92.48 101.68 14.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.772 179.088 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 22.2 m -85.19 157.05 3.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.689 0.281 . . . . 0.0 110.512 -179.018 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 22.6 ptp . . . . . 0 C--N 1.328 -0.327 0 CA-C-O 120.798 0.333 . . . . 0.0 110.629 -178.85 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.211 0 N-CA-C 111.394 -0.682 . . . . 0.0 111.394 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -141.86 162.49 35.35 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.9 0.35 . . . . 0.0 110.411 -178.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.769 ' HB3' ' SG ' ' A' ' 46' ' ' CYS . 3.3 tt -137.07 121.67 18.45 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.413 ' O ' ' HA ' ' A' ' 74' ' ' GLU . 41.3 mt -83.03 84.29 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 175.066 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . 0.515 ' HB2' HD22 ' A' ' 60' ' ' LEU . 53.9 t60 -96.99 141.89 29.6 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.25 -0.432 . . . . 0.0 109.865 -177.433 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -154.84 127.54 2.11 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 121.036 -0.602 . . . . 0.0 112.043 -179.398 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -115.0 -179.63 3.68 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 176.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.598 ' HD2' HD13 ' A' ' 70' ' ' LEU . 69.8 mtt180 -65.83 -65.41 0.68 Allowed 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 120.549 -0.46 . . . . 0.0 110.274 178.51 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.451 ' HG3' ' HG3' ' A' ' 67' ' ' LYS . 17.1 pt20 175.53 -23.63 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.284 0 O-C-N 123.407 0.442 . . . . 0.0 111.161 -177.817 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.451 ' HG3' ' HG3' ' A' ' 66' ' ' GLN . 98.5 mttt -144.31 129.34 18.54 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.737 -178.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 37.5 t70 71.24 163.33 0.26 Allowed 'General case' 0 CA--C 1.533 0.318 0 O-C-N 123.763 0.665 . . . . 0.0 112.207 169.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 43.6 mtmt -55.47 99.13 0.03 OUTLIER 'General case' 0 C--O 1.234 0.243 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.684 -176.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.598 HD13 ' HD2' ' A' ' 65' ' ' ARG . 3.8 tt -162.51 86.28 0.58 Allowed 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 173.685 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 45.4 t -75.66 117.0 19.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.393 -179.535 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 22.1 m -98.54 -21.89 5.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.335 -177.736 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.409 HD13 ' N ' ' A' ' 74' ' ' GLU . 2.9 tm? -150.51 129.72 12.77 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 -177.236 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.626 ' HG3' HD21 ' A' ' 60' ' ' LEU . 37.0 tt0 -153.81 113.11 3.76 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.986 0.422 . . . . 0.0 110.162 178.606 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' CYS . . . . . 0.548 ' SG ' ' CE2' ' A' ' 100' ' ' PHE . 57.4 m -130.48 118.51 21.24 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 -178.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.416 ' HD1' ' HG ' ' A' ' 60' ' ' LEU . 29.5 t80 -85.32 121.73 28.47 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.01 -173.325 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.521 HG13 ' O ' ' A' ' 80' ' ' ASP . 96.3 t -100.67 97.57 5.9 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 -177.243 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 20.7 ptt-85 -115.92 68.39 0.72 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.226 0.536 . . . . 0.0 110.51 -172.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt 67.53 25.42 8.4 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.011 -177.165 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . 0.521 ' O ' HG13 ' A' ' 77' ' ' VAL . 5.6 p-10 -149.05 -175.26 4.89 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 174.56 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 7.0 tt 66.72 98.22 0.05 Allowed 'General case' 0 CA--C 1.534 0.327 0 CA-C-O 121.193 0.521 . . . . 0.0 110.177 177.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 58.9 t -112.06 133.42 57.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.612 -178.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -68.92 124.38 23.56 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.615 177.388 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 35.9 m -95.86 114.66 26.41 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 174.165 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.413 ' HG2' ' NE2' ' A' ' 91' ' ' HIS . 5.7 tmtp? -75.81 98.9 4.28 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 116.144 -0.48 . . . . 0.0 109.73 178.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -91.21 -46.66 7.95 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.237 0.541 . . . . 0.0 110.183 -179.002 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . 0.773 ' HB2' ' HB3' ' A' ' 90' ' ' PHE . 40.4 m-80 -131.54 153.27 81.51 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.261 178.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -50.62 -31.5 32.18 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.706 2.271 . . . . 0.0 112.683 -179.549 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.546 ' HA ' ' HD2' ' A' ' 104' ' ' PHE . 16.5 p -115.22 18.11 16.32 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.722 -178.182 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.773 ' HB3' ' HB2' ' A' ' 87' ' ' ASN . 74.1 t80 -145.18 115.25 7.44 Favored 'General case' 0 C--O 1.24 0.585 0 CA-C-O 121.366 0.603 . . . . 0.0 111.985 -176.803 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' HIS . . . . . 0.413 ' NE2' ' HG2' ' A' ' 85' ' ' LYS . 31.5 m80 -103.88 157.06 17.35 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.152 -0.931 . . . . 0.0 109.277 171.455 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 19.5 p80 -154.42 149.73 27.13 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 110.191 -0.299 . . . . 0.0 110.191 172.708 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 38.5 p90 -137.66 140.42 40.81 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 110.016 -0.364 . . . . 0.0 110.016 178.417 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -109.85 112.74 24.96 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.101 -173.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 23.4 m -138.9 144.12 30.34 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 174.192 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 58.12 25.9 13.02 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 120.725 0.298 . . . . 0.0 110.712 -178.074 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 68.09 1.47 2.8 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.755 -177.464 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 64.3 mtt-85 -89.31 134.39 34.08 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 109.489 -0.559 . . . . 0.0 109.489 178.131 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.481 ' HB3' ' CH2' ' A' ' 32' ' ' TRP . 12.3 mptt -94.33 97.48 10.24 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.984 0.421 . . . . 0.0 110.491 -178.03 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . 0.548 ' CE2' ' SG ' ' A' ' 75' ' ' CYS . 2.3 m-85 -81.65 141.11 33.95 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 174.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -138.59 157.6 24.68 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 121.224 -0.513 . . . . 0.0 112.103 178.613 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 6.4 tt -143.56 121.31 11.9 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 108.912 -0.774 . . . . 0.0 108.912 178.289 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.454 ' HB ' ' HB ' ' A' ' 21' ' ' VAL . 26.8 m -109.11 136.34 48.78 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.438 -178.519 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.546 ' HD2' ' HA ' ' A' ' 89' ' ' THR . 41.1 m-85 -86.0 139.61 31.03 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.213 -0.448 . . . . 0.0 109.983 178.471 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 8.3 tp-100 -93.44 -42.83 9.05 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.36 -175.487 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -130.49 147.72 67.08 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.518 -176.748 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -53.88 -25.07 33.82 Favored 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 122.299 1.999 . . . . 0.0 111.908 179.039 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -62.26 -57.54 11.05 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.026 176.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -70.35 -29.64 66.38 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.634 -179.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.441 ' O ' ' HB2' ' A' ' 114' ' ' ASP . . . -56.89 -58.16 9.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.251 174.544 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . 0.582 ' HE ' ' HA ' ' A' ' 111' ' ' ARG . 1.3 tpm_? -59.47 -50.49 73.74 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.954 -179.628 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -60.89 -57.19 13.71 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.63 -174.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.512 ' O ' HG23 ' A' ' 117' ' ' VAL . 38.6 t80 -67.4 -36.47 81.37 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.666 -174.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.441 ' HB2' ' O ' ' A' ' 110' ' ' ALA . 8.2 t70 -59.98 -49.25 78.39 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 121.168 0.509 . . . . 0.0 109.753 177.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 41.9 ttt180 -51.74 -45.24 63.59 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 115.117 -0.947 . . . . 0.0 109.923 174.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -60.35 -39.4 96.09 Favored Glycine 0 CA--C 1.519 0.297 0 CA-C-N 115.651 -0.704 . . . . 0.0 112.19 176.12 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.512 HG23 ' O ' ' A' ' 113' ' ' PHE . 75.7 t -66.08 -54.58 25.38 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.163 0 C-N-CA 122.382 0.273 . . . . 0.0 111.112 -179.48 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 19.6 ptp180 -60.3 -38.02 82.33 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 116.578 -0.283 . . . . 0.0 110.606 -177.503 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.403 ' HD2' ' HA ' ' A' ' 119' ' ' LYS . 16.1 mmmt -68.85 -39.22 80.04 Favored 'General case' 0 C--N 1.334 -0.078 0 CA-C-N 116.613 -0.267 . . . . 0.0 110.646 175.151 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.5 -44.26 96.18 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.884 0.373 . . . . 0.0 110.223 177.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.408 HG12 ' O ' ' A' ' 117' ' ' VAL . 48.1 mm -62.9 -45.0 99.97 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.313 178.409 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -57.44 -51.02 71.14 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.661 178.612 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -74.51 -17.31 60.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.247 -178.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 45.1 tp -74.89 -47.7 28.66 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 177.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 75.1 mt -70.18 -40.35 78.04 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.303 178.682 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.249 1.066 0 N-CA-C 109.084 -0.709 . . . . 0.0 109.084 -179.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 19.7 m . . . . . 0 CA--C 1.537 0.478 0 N-CA-C 112.438 0.532 . . . . 0.0 112.438 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.423 ' HD2' ' HB3' ' A' ' 17' ' ' ARG . 3.3 m-85 -70.32 123.63 22.18 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 110.123 -0.325 . . . . 0.0 110.123 176.166 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 7.1 tp -88.45 -41.45 14.18 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 175.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 69.9 t -131.96 128.58 59.74 Favored 'Isoleucine or valine' 0 C--O 1.232 0.178 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 177.074 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.423 ' HB3' ' HD2' ' A' ' 14' ' ' TYR . 6.5 ptm180 -147.12 145.14 29.48 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.055 0.455 . . . . 0.0 111.468 -178.451 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 60.0 t -133.09 154.65 39.91 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 CA-C-N 115.411 -0.813 . . . . 0.0 108.993 177.769 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 2.2 tmmm? -98.41 117.17 32.23 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 175.522 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.499 ' HB1' ' O ' ' A' ' 103' ' ' THR . . . -158.55 -170.39 3.06 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-N 116.678 -0.237 . . . . 0.0 110.929 -178.339 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.733 HG22 ' HA2' ' A' ' 39' ' ' GLY . 60.8 t -99.91 114.2 37.61 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.123 -177.524 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.482 HG21 HG23 ' A' ' 72' ' ' VAL . 19.0 m -80.64 106.87 12.37 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 CA-C-O 121.098 0.475 . . . . 0.0 110.71 176.666 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 45.1 mtt -100.95 167.12 10.46 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.665 179.141 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.487 HG23 ' CE1' ' A' ' 33' ' ' PHE . 10.9 t -141.73 166.9 23.45 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.705 -0.68 . . . . 0.0 109.767 178.531 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.42 ' NH2' ' HA2' ' A' ' 30' ' ' GLY . 19.2 ttt180 -129.98 109.61 11.01 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 177.828 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -56.49 88.36 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.821 -173.578 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.464 ' HA ' ' HG2' ' A' ' 98' ' ' ARG . 34.1 t70 52.0 -84.78 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 123.522 0.729 . . . . 0.0 112.156 -179.403 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 32.9 t -125.02 16.88 8.52 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 120.865 0.364 . . . . 0.0 110.738 -175.553 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 33.1 t -67.96 138.17 55.73 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.304 179.29 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.42 ' HA2' ' NH2' ' A' ' 25' ' ' ARG . . . -83.35 65.1 4.19 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 121.07 -0.586 . . . . 0.0 112.155 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -177.32 167.2 38.2 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.884 -0.674 . . . . 0.0 112.889 179.472 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . 0.511 ' HH2' ' HB3' ' A' ' 99' ' ' LYS . 94.7 m95 -125.85 125.61 43.13 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 122.637 0.375 . . . . 0.0 110.038 178.132 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.487 ' CE1' HG23 ' A' ' 24' ' ' THR . 5.7 p90 -137.47 144.37 44.87 Favored Pre-proline 0 C--O 1.234 0.284 0 CA-C-N 116.631 -0.259 . . . . 0.0 111.244 -176.035 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -60.82 132.35 42.07 Favored 'Trans proline' 0 C--N 1.353 0.803 0 C-N-CA 122.594 2.196 . . . . 0.0 111.271 173.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.419 ' H ' ' HG2' ' A' ' 35' ' ' GLN . 10.1 pt20 -86.91 -36.61 18.27 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.042 -0.526 . . . . 0.0 112.23 -174.442 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 20.1 tp10 -166.16 -55.28 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 120.658 0.266 . . . . 0.0 110.845 -177.312 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -53.97 -41.26 67.76 Favored Glycine 0 C--N 1.332 0.36 0 CA-C-N 116.03 -0.532 . . . . 0.0 113.522 -175.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 67.02 -138.1 34.43 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.994 -0.622 . . . . 0.0 111.954 -177.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.733 ' HA2' HG22 ' A' ' 21' ' ' VAL . . . -62.25 -34.37 88.96 Favored Glycine 0 CA--C 1.521 0.445 0 C-N-CA 121.61 -0.329 . . . . 0.0 113.675 -175.356 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.541 ' N ' HD12 ' A' ' 40' ' ' ILE . 3.1 mp -107.95 108.67 25.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 N-CA-C 110.24 -0.281 . . . . 0.0 110.24 -177.106 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 23.3 m -144.15 118.2 9.45 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.471 0.177 . . . . 0.0 110.551 172.558 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.446 ' CZ ' ' HD3' ' A' ' 65' ' ' ARG . 96.1 mtt180 -71.77 90.82 1.1 Allowed 'General case' 0 CA--C 1.521 -0.157 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 171.563 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.401 ' HA ' ' HA2' ' A' ' 63' ' ' GLY . 7.4 p -104.1 139.53 24.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.893 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -175.99 176.09 47.52 Favored Glycine 0 N--CA 1.443 -0.87 0 C-N-CA 120.463 -0.875 . . . . 0.0 112.703 178.234 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 59.4 t -107.84 129.09 62.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 178.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . 0.761 ' SG ' ' HB3' ' A' ' 60' ' ' LEU . 10.4 p -112.73 117.64 32.77 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.635 176.106 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 36.5 ttmt -76.02 83.21 2.9 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 179.3 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 27.1 m -75.35 135.14 27.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.375 -178.481 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 63.0 mtt . . . . . 0 C--N 1.327 -0.37 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.263 -179.752 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.37 0 N-CA-C 111.064 -0.814 . . . . 0.0 111.064 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 -119.64 112.16 18.96 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.887 0.375 . . . . 0.0 110.499 -178.283 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.761 ' HB3' ' SG ' ' A' ' 46' ' ' CYS . 2.6 tt -101.76 110.88 22.96 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 179.698 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.416 ' O ' ' HA ' ' A' ' 74' ' ' GLU . 62.5 mt -78.26 100.22 3.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 173.634 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 3.2 t-80 -112.22 145.95 39.01 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 -173.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.401 ' HA2' ' HA ' ' A' ' 43' ' ' VAL . . . -146.51 119.59 1.18 Allowed Glycine 0 C--O 1.236 0.242 0 N-CA-C 110.716 -0.954 . . . . 0.0 110.716 -178.578 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -156.69 -175.71 5.58 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.916 0.865 . . . . 0.0 113.235 -167.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.446 ' HD3' ' CZ ' ' A' ' 42' ' ' ARG . 44.4 ttt-85 61.39 89.22 0.08 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 113.395 -1.73 . . . . 0.0 114.219 160.825 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.55 -42.58 0.61 Allowed 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 106.505 -1.665 . . . . 0.0 106.505 162.296 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.58 ' HE2' HD22 ' A' ' 70' ' ' LEU . 37.7 ttpt -90.23 163.19 14.89 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 163.226 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -51.09 94.45 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 -173.299 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 58.3 mtmt 49.77 84.75 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.311 -0.859 . . . . 0.0 112.209 177.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.58 HD22 ' HE2' ' A' ' 67' ' ' LYS . 61.9 tp -136.56 121.04 18.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.866 -179.222 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 54.1 t -79.29 113.37 18.54 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 N-CA-C 109.943 -0.391 . . . . 0.0 109.943 178.059 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.482 HG23 HG21 ' A' ' 22' ' ' VAL . 33.6 m -108.64 -2.5 10.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.602 -175.526 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -169.03 138.64 2.18 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 179.127 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.416 ' HA ' ' O ' ' A' ' 61' ' ' ILE . 0.2 OUTLIER -165.35 145.49 6.9 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 121.082 0.468 . . . . 0.0 111.31 176.752 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' CYS . . . . . 0.597 ' SG ' HG11 ' A' ' 95' ' ' VAL . 50.4 t -166.11 118.83 1.08 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.635 179.542 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 86.5 t80 -94.73 137.83 33.33 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.521 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 35.4 m -132.49 139.11 50.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 109.354 -0.609 . . . . 0.0 109.354 177.066 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 35.0 ttm-85 -107.67 -25.24 11.4 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.007 -175.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 39.4 tptt -170.05 -30.46 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 120.81 0.338 . . . . 0.0 110.496 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -97.03 124.49 41.03 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.993 179.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.473 HD13 ' N ' ' A' ' 82' ' ' VAL . 3.3 tm? -175.85 139.52 0.4 Allowed 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 177.172 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.473 ' N ' HD13 ' A' ' 81' ' ' LEU . 66.0 t -130.48 122.31 52.79 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 CA-C-N 116.602 -0.272 . . . . 0.0 110.554 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.622 ' HB3' ' NE2' ' A' ' 91' ' ' HIS . 96.1 m-85 -91.79 153.83 19.34 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-O 120.968 0.413 . . . . 0.0 110.06 173.8 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 91.4 m -156.0 117.5 3.92 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 174.727 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 20.2 ptmt -101.31 125.13 47.9 Favored 'General case' 0 C--N 1.328 -0.366 0 O-C-N 122.034 -0.416 . . . . 0.0 110.546 178.685 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -80.6 -34.01 35.5 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.63 -0.713 . . . . 0.0 110.363 -178.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -136.99 155.4 76.28 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.084 179.134 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_exo -48.73 -41.91 37.45 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.469 2.113 . . . . 0.0 111.959 176.178 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 13.4 p -97.25 18.16 15.68 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 115.716 -0.675 . . . . 0.0 112.051 -178.485 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 21.5 t80 -147.47 98.32 2.97 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-O 121.148 0.499 . . . . 0.0 110.865 177.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' HIS . . . . . 0.622 ' NE2' ' HB3' ' A' ' 83' ' ' TYR . 3.4 t-160 -109.47 125.15 52.15 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 -179.604 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 25.8 p80 -125.6 167.03 15.64 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.971 0.415 . . . . 0.0 110.926 -178.499 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 26.8 p90 -139.63 177.9 7.61 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.282 176.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 62.6 pttt -154.28 147.29 24.57 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.817 0.341 . . . . 0.0 111.052 -174.435 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.597 HG11 ' SG ' ' A' ' 75' ' ' CYS . 35.7 m -132.72 143.94 38.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 173.737 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 66.01 -72.17 0.08 Allowed 'General case' 0 N--CA 1.465 0.321 0 O-C-N 123.56 0.538 . . . . 0.0 110.719 -176.192 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -165.34 -26.78 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.874 -178.626 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.464 ' HG2' ' HA ' ' A' ' 27' ' ' ASP . 99.8 mtt180 -81.81 149.51 28.32 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 120.832 0.348 . . . . 0.0 111.027 -178.299 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.511 ' HB3' ' HH2' ' A' ' 32' ' ' TRP . 0.0 OUTLIER -114.22 142.66 45.98 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.261 -173.141 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 2.9 p90 -150.05 138.88 20.9 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 173.056 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -142.69 -170.1 12.62 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.205 -0.998 . . . . 0.0 114.605 -169.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.499 HD11 ' HB3' ' A' ' 20' ' ' ALA . 34.3 tp -134.17 124.26 25.74 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 114.995 -0.603 . . . . 0.0 110.868 -173.189 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.556 ' HB ' ' HB ' ' A' ' 21' ' ' VAL . 22.5 m -98.5 124.92 43.51 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 175.563 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 57.0 m-85 -87.76 161.77 17.4 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.863 -175.136 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 23.8 pt20 -96.29 -27.99 14.72 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.655 -177.499 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 49.1 m -149.56 154.43 38.09 Favored Pre-proline 0 CA--C 1.532 0.264 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.544 178.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -58.73 -24.43 71.19 Favored 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 122.555 2.17 . . . . 0.0 112.064 178.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -62.21 -56.09 22.14 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.916 178.542 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -71.73 -28.73 63.87 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.759 179.206 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -58.97 -60.66 3.5 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.127 0.489 . . . . 0.0 110.392 174.456 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 67.5 mtp85 -62.43 -32.62 73.51 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.913 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -62.59 -38.59 90.72 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.311 176.167 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 52.6 t80 -73.68 -34.48 64.91 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.169 179.099 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.4 ' HA ' HG22 ' A' ' 117' ' ' VAL . 63.9 m-20 -61.71 -38.64 88.61 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 121.337 0.589 . . . . 0.0 109.534 173.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 17.0 mmm180 -62.39 -42.05 99.13 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.684 172.071 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -60.17 -46.4 94.3 Favored Glycine 0 N--CA 1.45 -0.412 0 CA-C-N 115.336 -0.847 . . . . 0.0 112.519 178.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.421 ' O ' HG13 ' A' ' 121' ' ' ILE . 21.3 m -70.51 -34.82 59.06 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.366 0 CA-C-N 116.737 0.268 . . . . 0.0 110.634 -178.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -61.88 -48.91 78.38 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 176.839 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 7.9 tmtm? -62.03 -45.9 91.51 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 114.775 -1.102 . . . . 0.0 109.801 -179.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -61.42 -52.11 65.96 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.818 -179.687 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.421 HG13 ' O ' ' A' ' 117' ' ' VAL . 68.4 mt -57.66 -41.12 78.62 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.123 -178.136 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.559 ' O ' ' HG3' ' A' ' 126' ' ' GLU . 37.0 tt0 -63.37 -58.34 7.41 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 121.018 0.437 . . . . 0.0 110.394 177.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -60.76 -22.55 64.18 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.449 -179.506 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 9.4 tt -84.47 -39.82 18.44 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.418 179.346 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.514 HG22 ' O ' ' A' ' 122' ' ' GLU . 10.8 tp -72.11 -25.87 24.25 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 CA-C-N 116.732 -0.213 . . . . 0.0 110.434 -176.04 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.559 ' HG3' ' O ' ' A' ' 122' ' ' GLU . 46.8 mt-10 . . . . . 0 C--O 1.25 1.098 0 CA-C-O 118.728 -0.653 . . . . 0.0 110.336 175.18 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.815 ' HB2' ' SG ' ' A' ' 46' ' ' CYS . 58.3 m . . . . . 0 CA--C 1.532 0.27 0 CA-C-O 119.931 -0.08 . . . . 0.0 110.92 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 31.8 m-85 42.88 91.34 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 122.74 0.416 . . . . 0.0 111.87 -175.263 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.646 HD11 ' HB2' ' A' ' 47' ' ' LYS . 63.0 mt -61.18 -51.15 76.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 121.147 0.499 . . . . 0.0 109.916 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.537 HG23 HG22 ' A' ' 15' ' ' ILE . 92.0 t -140.1 119.33 12.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.882 178.701 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.571 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 27.8 ttp180 -128.05 86.7 2.5 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-O 121.264 0.554 . . . . 0.0 109.776 173.122 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 35.0 m -117.68 173.03 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-N 115.329 -0.85 . . . . 0.0 110.474 -177.205 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 26.1 ttpp -92.06 134.91 34.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.91 0.386 . . . . 0.0 110.914 179.638 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -160.11 -164.21 1.25 Allowed 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 178.304 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 25.0 t -122.44 109.16 23.34 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 177.538 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.703 HG23 ' NE2' ' A' ' 35' ' ' GLN . 19.7 m -84.16 133.18 29.8 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 CA-C-O 120.989 0.423 . . . . 0.0 111.031 -178.233 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 24.5 mmt -117.09 152.42 34.73 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.108 -176.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.432 HG23 ' CE1' ' A' ' 33' ' ' PHE . 9.8 t -132.66 140.26 48.08 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-O 121.134 0.492 . . . . 0.0 110.955 176.427 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.456 ' HE ' ' HA ' ' A' ' 28' ' ' SER . 21.1 tpt180 -90.21 77.78 6.66 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 174.71 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.565 ' HB2' ' HE1' ' A' ' 33' ' ' PHE . 35.7 t70 -56.3 94.74 0.01 OUTLIER 'General case' 0 C--O 1.236 0.371 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 179.478 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 16.0 t70 63.47 -74.78 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.941 -173.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.456 ' HA ' ' HE ' ' A' ' 25' ' ' ARG . 8.0 t -167.27 -44.26 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 175.324 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 18.5 t -61.88 -12.34 17.31 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.53 -178.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -62.1 -26.58 67.68 Favored Glycine 0 CA--C 1.523 0.574 0 C-N-CA 121.153 -0.546 . . . . 0.0 112.478 175.569 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 56.79 28.54 57.34 Favored Glycine 0 C--N 1.338 0.663 0 C-N-CA 121.739 -0.267 . . . . 0.0 113.537 177.298 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . 0.582 ' HH2' ' HG2' ' A' ' 99' ' ' LYS . 62.4 m95 63.03 96.76 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 123.174 0.59 . . . . 0.0 110.678 -177.789 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.565 ' HE1' ' HB2' ' A' ' 26' ' ' ASP . 2.9 p90 -132.04 150.84 77.23 Favored Pre-proline 0 C--O 1.236 0.376 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.928 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.51 ' HB2' ' HA2' ' A' ' 38' ' ' GLY . 77.1 Cg_endo -79.35 109.2 2.46 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.527 2.151 . . . . 0.0 112.084 179.15 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.703 ' NE2' HG23 ' A' ' 22' ' ' VAL . 0.2 OUTLIER -75.57 125.95 30.04 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 176.861 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 65.07 -75.1 0.05 OUTLIER 'General case' 0 C--O 1.236 0.377 0 C-N-CA 123.133 0.573 . . . . 0.0 111.317 -178.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -76.25 74.33 1.69 Allowed Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 121.575 -0.345 . . . . 0.0 112.782 -177.242 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.51 ' HA2' ' HB2' ' A' ' 34' ' ' PRO . . . -75.56 66.74 2.32 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 121.209 -0.52 . . . . 0.0 112.114 177.156 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 129.02 -32.0 3.37 Favored Glycine 0 N--CA 1.453 -0.173 0 C-N-CA 121.415 -0.421 . . . . 0.0 112.07 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 67.4 mt -120.4 100.75 9.76 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 CA-C-O 120.823 0.344 . . . . 0.0 110.501 179.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 16.5 m -132.49 151.42 51.91 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 175.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.407 HH11 ' HD3' ' A' ' 42' ' ' ARG . 6.5 tpt180 -113.9 116.12 28.77 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 174.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.571 ' O ' ' HA ' ' A' ' 17' ' ' ARG . 24.2 t -95.46 103.16 14.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.273 -178.047 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -106.16 89.43 0.61 Allowed Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 121.334 -0.46 . . . . 0.0 112.491 179.787 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 85.0 t -84.86 120.8 36.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 120.856 0.36 . . . . 0.0 110.067 177.015 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . 0.815 ' SG ' ' HB2' ' A' ' 13' ' ' SER . 45.0 t -117.8 165.2 13.93 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.921 -178.666 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.646 ' HB2' HD11 ' A' ' 15' ' ' ILE . 83.8 tttt -118.65 116.05 25.78 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.368 -179.65 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.451 HG21 ' CE2' ' A' ' 76' ' ' TYR . 36.0 m -110.55 150.96 12.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.094 0.473 . . . . 0.0 111.286 -175.414 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 4.0 mpp? . . . . . 0 C--N 1.328 -0.346 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.416 178.36 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.436 0 N-CA-C 111.934 -0.466 . . . . 0.0 111.934 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -133.17 158.09 43.71 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.87 -0.418 . . . . 0.0 109.87 178.574 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.434 HD22 ' HB2' ' A' ' 62' ' ' HIS . 1.9 tt -132.23 113.61 13.47 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 -179.774 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.537 ' HB ' ' HB2' ' A' ' 75' ' ' CYS . 58.0 mt -82.24 97.23 3.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 174.666 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . 0.434 ' HB2' HD22 ' A' ' 60' ' ' LEU . 26.6 t-80 -111.24 91.67 3.75 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.737 -172.446 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -89.98 114.79 4.43 Favored Glycine 0 C--O 1.236 0.275 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.625 177.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -143.49 -161.15 1.21 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.655 0.227 . . . . 0.0 111.526 -174.334 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 1.4 mmp_? 63.98 32.1 13.27 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 115.764 -0.653 . . . . 0.0 112.687 170.547 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.507 HE21 ' N ' ' A' ' 66' ' ' GLN . 0.0 OUTLIER -72.73 -67.51 0.55 Allowed 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.771 -0.372 . . . . 0.0 110.498 176.614 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 64.6 tttm -132.51 130.02 39.87 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 178.396 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 59.71 -80.93 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 -174.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 23.2 pttm -178.66 128.41 0.11 Allowed 'General case' 0 C--O 1.232 0.176 0 C-N-CA 123.149 0.58 . . . . 0.0 109.775 169.114 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -174.46 157.93 2.74 Favored 'General case' 0 C--O 1.24 0.571 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.03 177.634 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 25.0 t -95.41 117.51 39.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 O-C-N 123.297 0.373 . . . . 0.0 110.24 -179.286 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 33.6 m -92.48 -24.9 5.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 120.864 0.364 . . . . 0.0 111.062 -179.101 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -145.85 109.35 4.73 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 -176.287 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -116.9 116.61 27.75 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 178.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' CYS . . . . . 0.537 ' HB2' ' HB ' ' A' ' 61' ' ' ILE . 63.0 m -137.48 90.85 2.55 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 121.151 0.501 . . . . 0.0 110.526 179.448 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.451 ' CE2' HG21 ' A' ' 48' ' ' VAL . 56.6 t80 -70.98 105.26 3.23 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 173.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 15.6 m -103.62 97.55 5.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 121.81 0.814 . . . . 0.0 110.366 -174.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 28.6 ptt180 -83.06 80.37 9.07 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.396 -177.246 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.771 ' HA ' HD11 ' A' ' 124' ' ' LEU . 11.0 tmtt? 76.1 -37.5 0.31 Allowed 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.995 177.735 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -68.82 108.33 3.4 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 122.363 0.265 . . . . 0.0 110.715 -179.425 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.404 HD23 ' HA ' ' A' ' 81' ' ' LEU . 12.2 mt -152.02 163.21 39.77 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.213 0.53 . . . . 0.0 110.832 179.577 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 58.3 t -131.84 -65.7 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.721 176.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.431 ' HB3' ' NE2' ' A' ' 91' ' ' HIS . 21.0 m-85 56.73 103.61 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.431 -176.729 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 53.0 m -134.12 112.52 11.2 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.736 178.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.558 ' HA ' ' HA ' ' A' ' 91' ' ' HIS . 0.2 OUTLIER -82.16 91.1 6.65 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.454 0.645 . . . . 0.0 109.68 177.16 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -66.24 -32.01 73.18 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.046 -178.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . 0.747 ' HB2' ' HB3' ' A' ' 90' ' ' PHE . 15.6 m120 -129.09 155.35 79.96 Favored Pre-proline 0 C--N 1.326 -0.414 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 175.458 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_exo -44.26 -44.01 13.05 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.648 2.232 . . . . 0.0 112.915 179.41 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.548 ' O ' ' HA ' ' A' ' 103' ' ' THR . 37.3 p -108.67 16.98 22.43 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 -177.411 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.747 ' HB3' ' HB2' ' A' ' 87' ' ' ASN . 73.4 t80 -131.0 104.04 6.88 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 120.894 0.378 . . . . 0.0 110.509 -178.543 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' HIS . . . . . 0.558 ' HA ' ' HA ' ' A' ' 85' ' ' LYS . 1.5 t60 -114.9 124.27 51.28 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 -179.121 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . 0.475 ' HA ' ' HA2' ' A' ' 101' ' ' GLY . 23.5 p80 -126.78 159.54 33.5 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 120.953 0.406 . . . . 0.0 111.766 -176.394 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 49.1 p90 -155.39 147.53 23.62 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.282 -179.462 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.42 ' NZ ' ' HB3' ' A' ' 94' ' ' LYS . 5.7 ttpm? -112.85 127.53 56.2 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 177.426 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 19.1 m -146.69 146.94 18.34 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 O-C-N 123.253 0.346 . . . . 0.0 110.473 -179.659 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 33.6 t70 63.82 -73.33 0.05 OUTLIER 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.373 0.669 . . . . 0.0 111.773 178.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -146.43 -57.22 0.28 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.657 0.265 . . . . 0.0 110.65 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -78.8 176.19 9.78 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-O 121.538 0.685 . . . . 0.0 111.249 -178.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.582 ' HG2' ' HH2' ' A' ' 32' ' ' TRP . 37.2 ttpt -128.97 115.33 17.65 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.136 -179.268 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 41.2 m-85 -101.21 168.38 9.6 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.528 -0.306 . . . . 0.0 110.605 -174.037 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.475 ' HA2' ' HA ' ' A' ' 92' ' ' HIS . . . -151.08 170.87 30.79 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 121.136 -0.554 . . . . 0.0 112.161 -177.798 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.436 HD23 ' N ' ' A' ' 103' ' ' THR . 2.5 tt -143.52 128.77 18.8 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 -178.212 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.548 ' HA ' ' O ' ' A' ' 89' ' ' THR . 84.2 m -110.89 122.48 47.96 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.189 176.035 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.423 ' HD2' ' HA ' ' A' ' 89' ' ' THR . 50.9 m-85 -89.28 162.21 15.98 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.699 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 19.0 pt20 -113.5 -48.17 2.96 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 111.396 0.147 . . . . 0.0 111.396 -176.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 17.2 m -117.34 143.93 32.93 Favored Pre-proline 0 C--N 1.328 -0.34 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 -177.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_exo -47.7 -29.98 11.91 Favored 'Trans proline' 0 C--N 1.354 0.829 0 C-N-CA 122.593 2.196 . . . . 0.0 112.314 177.584 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -58.06 -70.75 0.13 Allowed 'General case' 0 C--O 1.233 0.204 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.98 177.024 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -60.45 -37.35 80.69 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.062 -178.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.408 ' HA ' ' CG ' ' A' ' 104' ' ' PHE . . . -54.01 -69.56 0.12 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.261 178.711 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 78.4 mtt180 -70.94 -22.81 62.18 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.536 -173.307 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -65.67 -48.89 70.56 Favored 'General case' 0 C--O 1.238 0.471 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 174.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 57.1 t80 -69.59 -47.16 64.48 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.075 -179.464 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.418 ' O ' ' HG2' ' A' ' 118' ' ' ARG . 4.8 m-20 -51.93 -58.72 5.66 Favored 'General case' 0 N--CA 1.465 0.294 0 O-C-N 123.191 0.307 . . . . 0.0 110.75 178.638 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 27.3 mtp180 -60.71 -38.43 85.04 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-O 120.699 0.285 . . . . 0.0 110.892 -179.007 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . 0.507 ' O ' ' HG3' ' A' ' 119' ' ' LYS . . . -62.04 -56.64 21.22 Favored Glycine 0 CA--C 1.52 0.386 0 C-N-CA 121.183 -0.532 . . . . 0.0 112.575 179.231 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.56 ' O ' HG12 ' A' ' 121' ' ' ILE . 12.1 p -64.59 -30.91 51.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.571 0.224 . . . . 0.0 110.408 -178.529 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.418 ' HG2' ' O ' ' A' ' 114' ' ' ASP . 7.9 mmm180 -62.77 -50.75 69.82 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.653 177.688 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.507 ' HG3' ' O ' ' A' ' 116' ' ' GLY . 0.0 OUTLIER -62.01 -33.98 75.35 Favored 'General case' 0 N--CA 1.462 0.151 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 178.753 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -62.51 -36.53 82.86 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.449 175.423 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.56 HG12 ' O ' ' A' ' 117' ' ' VAL . 40.3 mm -64.09 -44.65 97.71 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.076 0 CA-C-N 116.248 -0.433 . . . . 0.0 109.879 175.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -58.55 -39.19 79.55 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.71 176.175 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 87.9 m-20 -66.05 -37.08 84.95 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 121.252 0.549 . . . . 0.0 110.239 176.439 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.771 HD11 ' HA ' ' A' ' 79' ' ' LYS . 49.4 tp -70.5 -57.73 4.46 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.335 -0.848 . . . . 0.0 111.469 -176.294 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.505 HG13 ' O ' ' A' ' 121' ' ' ILE . 2.9 pp -75.02 -29.47 22.16 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.05 -177.594 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.467 ' N ' HD12 ' A' ' 125' ' ' ILE . 39.5 tt0 . . . . . 0 C--O 1.248 1.008 0 CA-C-O 118.15 -0.929 . . . . 0.0 111.094 176.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 60.5 m . . . . . 0 CA--C 1.533 0.307 0 N-CA-C 111.938 0.347 . . . . 0.0 111.938 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 13.3 m-85 -73.45 123.19 23.4 Favored 'General case' 0 C--O 1.235 0.305 0 O-C-N 122.096 -0.378 . . . . 0.0 110.841 176.591 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.447 HG23 HG12 ' A' ' 16' ' ' VAL . 13.6 tt -85.12 -27.15 6.57 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 174.137 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.447 HG12 HG23 ' A' ' 15' ' ' ILE . 9.2 p -159.15 144.97 6.95 Favored 'Isoleucine or valine' 0 C--O 1.231 0.13 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.906 176.279 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 55.8 ttp180 -160.04 109.35 1.78 Allowed 'General case' 0 C--O 1.235 0.315 0 CA-C-O 121.026 0.441 . . . . 0.0 110.433 176.024 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 34.6 m -113.01 -170.32 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.089 -179.219 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.521 ' HB2' HG23 ' A' ' 40' ' ' ILE . 57.4 pttt -126.26 113.59 17.17 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.069 0.461 . . . . 0.0 110.392 178.511 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -143.52 178.14 7.98 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.351 -177.483 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.53 ' HB ' ' HB ' ' A' ' 103' ' ' THR . 27.5 t -83.37 135.17 25.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.442 0.163 . . . . 0.0 110.564 179.825 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.585 HG23 ' HG2' ' A' ' 35' ' ' GLN . 11.6 m -95.24 95.26 4.87 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 CA-C-O 121.473 0.654 . . . . 0.0 110.847 177.087 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 23.6 mmt -86.77 160.01 18.94 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.699 -178.262 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.431 ' HA ' ' HA ' ' A' ' 100' ' ' PHE . 11.7 t -160.24 150.71 18.53 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.867 174.168 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.407 ' HD2' ' O ' ' A' ' 29' ' ' SER . 47.6 ttp180 -114.1 89.74 3.17 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 107.594 -1.261 . . . . 0.0 107.594 171.835 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -43.47 96.99 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.33 0 O-C-N 124.482 1.114 . . . . 0.0 112.364 -169.357 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 18.7 t70 58.22 -78.92 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 115.15 -0.932 . . . . 0.0 111.088 -179.582 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 21.1 m -141.95 105.7 4.71 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 176.329 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.407 ' O ' ' HD2' ' A' ' 25' ' ' ARG . 36.4 t -141.84 171.1 14.52 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.14 -176.481 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -100.02 38.87 2.93 Favored Glycine 0 CA--C 1.518 0.268 0 C-N-CA 121.293 -0.479 . . . . 0.0 112.93 -176.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 171.92 163.71 26.29 Favored Glycine 0 C--N 1.33 0.243 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.649 177.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . 0.401 ' CH2' ' HB3' ' A' ' 99' ' ' LYS . 86.2 m95 -103.6 113.73 27.47 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 176.646 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.462 ' HA ' ' HD3' ' A' ' 34' ' ' PRO . 0.5 OUTLIER -117.6 144.76 34.86 Favored Pre-proline 0 C--N 1.327 -0.402 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.288 -177.007 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.462 ' HD3' ' HA ' ' A' ' 33' ' ' PHE . 11.6 Cg_exo -71.11 137.73 32.16 Favored 'Trans proline' 0 C--N 1.351 0.676 0 C-N-CA 122.846 2.364 . . . . 0.0 111.46 175.038 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.585 ' HG2' HG23 ' A' ' 22' ' ' VAL . 7.1 pt20 -87.91 -147.53 0.15 Allowed 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.07 179.261 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 44.5 mm-40 -46.66 -42.73 16.87 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 111.832 0.308 . . . . 0.0 111.832 179.528 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -80.8 68.58 3.37 Favored Glycine 0 CA--C 1.519 0.328 0 C-N-CA 121.184 -0.532 . . . . 0.0 112.544 -179.392 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -77.33 132.07 11.74 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 121.204 -0.522 . . . . 0.0 112.392 179.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 85.05 -57.96 4.98 Favored Glycine 0 CA--C 1.518 0.264 0 C-N-CA 121.283 -0.484 . . . . 0.0 112.885 176.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.521 HG23 ' HB2' ' A' ' 19' ' ' LYS . 65.5 mt -142.23 140.76 29.12 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 C-N-CA 122.341 0.256 . . . . 0.0 110.458 -177.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.454 ' O ' ' HA ' ' A' ' 19' ' ' LYS . 53.0 m -150.71 133.96 16.2 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 174.344 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 55.4 ttp180 -81.47 90.63 6.23 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 109.808 -0.441 . . . . 0.0 109.808 -178.375 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.481 ' HA ' ' HA2' ' A' ' 63' ' ' GLY . 31.4 t -111.96 143.3 22.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.443 -175.721 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -160.96 -177.43 34.06 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.994 -0.622 . . . . 0.0 112.718 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.405 ' O ' HG22 ' A' ' 15' ' ' ILE . 50.5 t -118.04 130.45 72.89 Favored 'Isoleucine or valine' 0 C--O 1.241 0.614 0 CA-C-O 120.721 0.296 . . . . 0.0 110.263 179.859 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . 0.684 ' SG ' ' HB3' ' A' ' 60' ' ' LEU . 12.4 p -119.67 122.49 41.6 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.452 173.361 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 33.3 ttpt -78.72 102.03 7.86 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 121.053 0.454 . . . . 0.0 110.145 179.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 51.3 t -75.86 110.74 11.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.372 -179.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 22.9 ptp . . . . . 0 C--N 1.326 -0.415 0 CA-C-N 116.288 -0.415 . . . . 0.0 109.979 178.505 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.594 ' N ' ' HH ' ' A' ' 76' ' ' TYR . . . . . . . . 0 N--CA 1.449 -0.467 0 N-CA-C 112.618 -0.193 . . . . 0.0 112.618 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -130.32 125.56 35.01 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 -176.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.684 ' HB3' ' SG ' ' A' ' 46' ' ' CYS . 2.3 tt -95.81 118.29 32.18 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 -179.531 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 49.5 mm -84.27 93.95 3.48 Favored 'Isoleucine or valine' 0 C--O 1.235 0.292 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 172.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . 0.607 ' HB2' HD22 ' A' ' 60' ' ' LEU . 38.5 t-80 -108.48 131.91 54.33 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.941 -171.798 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.481 ' HA2' ' HA ' ' A' ' 43' ' ' VAL . . . -128.24 133.06 7.58 Favored Glycine 0 N--CA 1.449 -0.481 0 N-CA-C 110.89 -0.884 . . . . 0.0 110.89 177.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -146.89 178.17 8.55 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.78 0.324 . . . . 0.0 111.329 -172.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 5.1 mmt180 68.1 169.37 0.27 Allowed 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 115.303 -0.862 . . . . 0.0 111.868 174.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 65.33 165.63 0.17 Allowed 'General case' 0 C--O 1.235 0.323 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.297 -173.216 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 24.9 tptp 71.24 -59.82 0.53 Allowed 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 122.946 0.498 . . . . 0.0 109.665 -174.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -165.24 -84.97 0.02 OUTLIER 'General case' 0 C--O 1.234 0.28 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.235 173.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 4.3 ttmp? -165.85 96.0 0.62 Allowed 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 -179.262 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.4 pp -173.23 178.92 2.32 Favored 'General case' 0 C--O 1.239 0.514 0 CA-C-O 120.633 0.254 . . . . 0.0 110.474 -173.01 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.475 ' O ' HG23 ' A' ' 71' ' ' VAL . 27.4 m -103.41 104.1 16.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.889 177.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.438 HG21 ' HB3' ' A' ' 41' ' ' SER . 34.7 m -68.46 -31.37 50.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.41 -178.572 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 40.4 mt -141.06 94.22 2.68 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.362 178.042 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -98.51 94.92 6.96 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 170.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' CYS . . . . . 0.469 ' SG ' ' CE2' ' A' ' 100' ' ' PHE . 57.9 m -139.43 89.4 2.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.363 0.601 . . . . 0.0 111.011 -172.386 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.594 ' HH ' ' N ' ' A' ' 58' ' ' GLY . 29.9 t80 -74.27 116.13 14.57 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.173 178.072 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.605 HG11 HD12 ' A' ' 81' ' ' LEU . 95.8 t -80.19 105.93 10.56 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 CA-C-O 121.144 0.497 . . . . 0.0 109.818 179.719 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.592 ' HD2' ' O ' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -80.79 61.86 4.6 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.276 -179.906 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.58 ' HG3' HD21 ' A' ' 124' ' ' LEU . 45.4 tttp 74.86 124.19 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 115.172 -0.922 . . . . 0.0 111.394 -176.479 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 76.7 m-20 70.6 119.39 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 115.113 -0.949 . . . . 0.0 112.915 174.15 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.605 HD12 HG11 ' A' ' 77' ' ' VAL . 0.0 OUTLIER -143.52 134.26 25.17 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 167.47 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 19.8 t -65.61 -52.02 55.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.888 -169.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.465 ' HD2' HG11 ' A' ' 117' ' ' VAL . 0.9 OUTLIER 57.87 51.59 8.93 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 121.292 0.568 . . . . 0.0 109.987 -177.626 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 33.7 m -60.52 114.18 2.83 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.786 -179.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.45 ' HB3' ' CD2' ' A' ' 91' ' ' HIS . 0.0 OUTLIER -99.71 102.25 13.66 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.972 0.415 . . . . 0.0 110.334 176.112 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -75.46 -37.15 60.48 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 175.367 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . 0.458 ' HB2' ' HB3' ' A' ' 90' ' ' PHE . 77.0 m-20 -127.67 151.46 75.33 Favored Pre-proline 0 C--N 1.326 -0.423 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 174.095 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.499 ' O ' ' HB1' ' A' ' 110' ' ' ALA . 88.7 Cg_exo -48.22 -33.82 22.71 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.313 2.009 . . . . 0.0 112.374 178.387 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.448 ' O ' ' HA ' ' A' ' 103' ' ' THR . 14.7 p -97.68 -15.65 20.3 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 115.889 -0.596 . . . . 0.0 112.138 -178.519 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.458 ' HB3' ' HB2' ' A' ' 87' ' ' ASN . 86.8 t80 -107.31 102.47 11.77 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-O 121.087 0.47 . . . . 0.0 110.854 -176.653 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' HIS . . . . . 0.45 ' CD2' ' HB3' ' A' ' 85' ' ' LYS . 56.5 m80 -112.82 147.3 37.24 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.155 177.201 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . 0.579 ' HA ' ' HA3' ' A' ' 101' ' ' GLY . 15.4 p80 -153.95 152.84 31.04 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 174.789 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . 0.448 ' HD1' HG13 ' A' ' 95' ' ' VAL . 47.8 p90 -137.13 145.28 43.63 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-O 121.283 0.563 . . . . 0.0 111.291 177.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 1.1 tmtm? -102.04 119.52 38.93 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.013 -0.994 . . . . 0.0 109.286 176.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.448 HG13 ' HD1' ' A' ' 93' ' ' TRP . 19.3 m -125.45 125.64 69.22 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 173.417 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 59.56 -79.4 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.77 -175.518 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 44.1 t30 -142.29 -35.21 0.43 Allowed 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 112.063 0.394 . . . . 0.0 112.063 -177.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.518 ' HD2' ' N ' ' A' ' 98' ' ' ARG . 2.3 mpt_? -84.46 148.29 26.64 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.899 0.381 . . . . 0.0 111.212 -174.659 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.401 ' HB3' ' CH2' ' A' ' 32' ' ' TRP . 3.5 mppt? -119.92 124.49 46.14 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.759 -176.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . 0.469 ' CE2' ' SG ' ' A' ' 75' ' ' CYS . 0.7 OUTLIER -144.31 150.44 37.85 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.485 176.095 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.579 ' HA3' ' HA ' ' A' ' 92' ' ' HIS . . . -157.71 -165.61 15.64 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 121.021 -0.609 . . . . 0.0 112.82 -175.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 94.9 mt -128.42 147.32 50.65 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.998 0.428 . . . . 0.0 110.887 -174.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.53 ' HB ' ' HB ' ' A' ' 21' ' ' VAL . 63.2 m -123.79 107.67 11.67 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 172.74 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.451 ' HB3' ' OD2' ' A' ' 109' ' ' ASP . 99.4 m-85 -78.28 167.97 20.54 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.645 -0.707 . . . . 0.0 112.019 -172.122 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 -92.06 -41.76 10.33 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.03 -175.618 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 16.7 m -137.54 156.13 75.01 Favored Pre-proline 0 C--O 1.234 0.285 0 CA-C-N 116.621 -0.263 . . . . 0.0 110.883 -175.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -54.2 -32.65 71.61 Favored 'Trans proline' 0 C--N 1.351 0.676 0 C-N-CA 122.656 2.237 . . . . 0.0 112.234 177.392 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -56.43 -66.32 0.46 Allowed 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.401 179.05 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.451 ' OD2' ' HB3' ' A' ' 104' ' ' PHE . 1.6 p-10 -63.63 -35.73 81.47 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.086 -178.415 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.499 ' HB1' ' O ' ' A' ' 88' ' ' PRO . . . -58.64 -61.51 2.55 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 121.174 0.511 . . . . 0.0 111.263 177.444 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 82.5 mtp180 -65.39 -26.32 67.94 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.738 -177.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -68.71 -43.06 76.79 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.748 177.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -71.98 -37.27 69.91 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 -178.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.416 ' O ' HG12 ' A' ' 117' ' ' VAL . 24.0 t70 -55.73 -51.96 65.53 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 121.917 0.865 . . . . 0.0 109.409 172.819 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 35.2 ttt180 -56.16 -37.1 69.07 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 114.347 -1.297 . . . . 0.0 110.676 174.004 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -61.69 -52.57 49.88 Favored Glycine 0 C--N 1.332 0.315 0 CA-C-N 115.853 -0.612 . . . . 0.0 112.446 178.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.465 HG11 ' HD2' ' A' ' 83' ' ' TYR . 11.3 p -67.09 -28.72 43.71 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.151 0 CA-C-O 121.001 0.429 . . . . 0.0 109.961 179.233 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.418 HH11 ' HD3' ' A' ' 118' ' ' ARG . 0.0 OUTLIER -58.88 -55.33 36.55 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 176.932 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 59.8 tttm -66.68 -35.29 79.79 Favored 'General case' 0 C--O 1.227 -0.095 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.315 179.356 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -56.6 -58.26 8.84 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 121.132 0.492 . . . . 0.0 110.539 178.441 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.503 HD11 HD13 ' A' ' 81' ' ' LEU . 47.5 mm -63.2 -29.67 47.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.2 178.516 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.824 ' HA ' ' HA ' ' A' ' 126' ' ' GLU . 42.3 tt0 -64.37 -46.31 83.95 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.42 176.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -63.19 -34.23 77.18 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 121.197 0.522 . . . . 0.0 109.643 177.628 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.58 HD21 ' HG3' ' A' ' 79' ' ' LYS . 63.0 tp -64.63 -63.52 1.11 Allowed 'General case' 0 C--O 1.235 0.332 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.047 177.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.501 ' O ' HG12 ' A' ' 125' ' ' ILE . 12.3 tt -163.5 26.14 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.722 0 CA-C-O 121.128 0.489 . . . . 0.0 110.924 -175.789 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.824 ' HA ' ' HA ' ' A' ' 122' ' ' GLU . 35.4 tt0 . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.413 -0.803 . . . . 0.0 111.151 -178.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 20.2 m . . . . . 0 CA--C 1.534 0.351 0 CA-C-O 121.274 0.559 . . . . 0.0 110.633 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -53.53 135.5 39.98 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.668 176.213 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.756 HD13 ' HB2' ' A' ' 47' ' ' LYS . 38.6 pt -91.84 -27.94 4.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 170.805 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.559 HG23 HG13 ' A' ' 15' ' ' ILE . 67.1 t -137.4 137.92 45.49 Favored 'Isoleucine or valine' 0 C--O 1.232 0.142 0 CA-C-N 114.965 -1.016 . . . . 0.0 108.994 177.682 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 32.2 ptt180 -147.22 134.37 20.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.835 0.35 . . . . 0.0 110.289 178.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 29.1 m -133.67 174.31 13.36 Favored 'Isoleucine or valine' 0 C--O 1.237 0.415 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.523 -177.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -129.84 121.16 26.19 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 179.207 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -169.84 -174.27 1.78 Allowed 'General case' 0 C--O 1.232 0.182 0 CA-C-O 120.776 0.322 . . . . 0.0 111.249 -176.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.449 ' HB ' ' HB ' ' A' ' 103' ' ' THR . 87.6 t -92.25 142.49 13.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.022 178.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.442 HG11 HG21 ' A' ' 43' ' ' VAL . 27.4 m -117.42 134.23 61.69 Favored 'Isoleucine or valine' 0 C--O 1.237 0.411 0 CA-C-O 121.308 0.575 . . . . 0.0 111.476 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . 0.626 ' SD ' ' HG3' ' A' ' 34' ' ' PRO . 24.7 mmt -119.04 169.52 9.83 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.058 -0.974 . . . . 0.0 109.052 178.385 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 8.9 t -153.64 157.25 39.35 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 174.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 41.1 ttp180 -128.41 111.17 13.03 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 178.434 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.613 ' H ' ' HE1' ' A' ' 33' ' ' PHE . 38.1 t70 -61.52 97.93 0.08 Allowed 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 179.17 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.543 ' HB3' ' NH1' ' A' ' 98' ' ' ARG . 1.6 p30 46.59 -75.99 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.293 1.037 . . . . 0.0 111.994 -169.208 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.447 ' N ' ' O ' ' A' ' 26' ' ' ASP . 69.3 m -141.13 152.04 44.4 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 110.092 -0.336 . . . . 0.0 110.092 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 21.1 m 67.16 167.8 0.24 Allowed 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.435 -179.147 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 115.07 -6.44 21.72 Favored Glycine 0 N--CA 1.453 -0.212 0 N-CA-C 111.684 -0.566 . . . . 0.0 111.684 -177.197 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 59.07 27.05 61.91 Favored Glycine 0 C--N 1.334 0.432 0 C-N-CA 121.653 -0.308 . . . . 0.0 112.986 179.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . 0.569 ' CH2' ' HB3' ' A' ' 99' ' ' LYS . 89.2 m95 57.91 98.12 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 121.439 0.638 . . . . 0.0 110.873 -176.516 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.613 ' HE1' ' H ' ' A' ' 26' ' ' ASP . 40.1 p90 -103.16 138.22 19.48 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.906 -175.183 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.626 ' HG3' ' SD ' ' A' ' 23' ' ' MET . 5.1 Cg_exo -79.23 115.43 3.48 Favored 'Trans proline' 0 N--CA 1.457 -0.665 0 C-N-CA 122.452 2.101 . . . . 0.0 110.865 172.593 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -65.88 -162.71 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.836 176.04 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -46.54 -39.14 10.41 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 112.724 0.638 . . . . 0.0 112.724 -176.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -72.63 -115.29 0.06 OUTLIER Glycine 0 CA--C 1.519 0.285 0 N-CA-C 111.591 -0.604 . . . . 0.0 111.591 176.347 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.44 ' O ' HG13 ' A' ' 21' ' ' VAL . . . 82.45 -67.09 3.77 Favored Glycine 0 C--N 1.329 0.193 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.104 174.455 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -66.81 80.22 0.13 Allowed Glycine 0 CA--C 1.519 0.291 0 C-N-CA 121.507 -0.378 . . . . 0.0 112.601 -178.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.448 ' O ' ' HG2' ' A' ' 66' ' ' GLN . 50.8 mm 63.64 82.15 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 CA-C-O 121.556 0.693 . . . . 0.0 111.155 178.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 49.1 m -99.98 148.33 24.63 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.114 178.201 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.428 HH21 ' CD ' ' A' ' 64' ' ' GLU . 7.4 tmm_? -98.83 99.89 11.02 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 -177.718 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.442 HG21 HG11 ' A' ' 22' ' ' VAL . 50.2 t -120.93 155.16 24.5 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.931 -171.22 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -173.3 -163.5 27.06 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 121.143 -0.551 . . . . 0.0 112.239 176.413 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 61.6 t -130.34 139.73 50.63 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 CA-C-O 120.868 0.366 . . . . 0.0 110.79 -177.119 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 47.2 t -119.96 131.78 55.3 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 173.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.756 ' HB2' HD13 ' A' ' 15' ' ' ILE . 84.9 tttt -83.39 118.72 23.91 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.795 0.331 . . . . 0.0 111.021 -174.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 49.1 t -78.85 126.37 38.81 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.227 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 16.0 mmt . . . . . 0 C--N 1.328 -0.363 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.085 -177.272 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.179 0 N-CA-C 112.011 -0.435 . . . . 0.0 112.011 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -140.18 117.55 11.38 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.986 0.422 . . . . 0.0 110.877 -179.04 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.548 ' HG ' ' HD1' ' A' ' 76' ' ' TYR . 0.5 OUTLIER -87.31 102.85 14.9 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 175.29 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.78 ' HB ' ' HB3' ' A' ' 75' ' ' CYS . 63.5 mt -76.89 116.16 19.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 172.195 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 5.6 t-80 -127.55 141.44 51.64 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 -172.264 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -136.66 115.02 1.22 Allowed Glycine 0 C--N 1.333 0.383 0 C-N-CA 120.914 -0.66 . . . . 0.0 113.335 -174.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.428 ' CD ' HH21 ' A' ' 42' ' ' ARG . 41.7 tt0 -81.02 144.14 32.0 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 122.81 0.444 . . . . 0.0 110.606 178.352 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.486 ' HG2' HG11 ' A' ' 72' ' ' VAL . 0.2 OUTLIER -51.59 -56.07 15.6 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 115.682 -0.69 . . . . 0.0 112.208 -173.875 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.448 ' HG2' ' O ' ' A' ' 40' ' ' ILE . 0.0 OUTLIER -172.52 -77.15 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 -175.526 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 57.6 tttp -117.24 -46.15 2.71 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.39 178.076 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -69.16 132.1 46.01 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.101 174.13 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 23.5 mtpp -74.23 97.12 2.9 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.486 -177.56 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 51.0 tp -146.56 135.56 22.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.936 -179.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 26.8 t -81.44 95.18 2.75 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.937 -176.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.486 HG11 ' HG2' ' A' ' 65' ' ' ARG . 15.8 m -93.24 -37.72 8.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.058 179.362 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -125.06 143.03 51.12 Favored 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 109.819 -0.438 . . . . 0.0 109.819 176.188 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -159.82 165.12 32.96 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.301 173.154 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' CYS . . . . . 0.78 ' HB3' ' HB ' ' A' ' 61' ' ' ILE . 31.6 t -164.76 103.21 0.8 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.74 -0.663 . . . . 0.0 109.659 -177.153 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.548 ' HD1' ' HG ' ' A' ' 60' ' ' LEU . 57.0 t80 -81.99 99.79 9.32 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.017 -179.142 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.485 HG13 ' O ' ' A' ' 80' ' ' ASP . 95.6 t -90.74 98.16 8.03 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 N-CA-C 109.049 -0.722 . . . . 0.0 109.049 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 16.9 tpt180 -75.37 -42.82 53.16 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 -178.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.616 ' HA ' HD11 ' A' ' 124' ' ' LEU . 24.1 ttpp -173.61 29.75 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.226 174.419 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . 0.485 ' O ' HG13 ' A' ' 77' ' ' VAL . 23.1 t70 -144.22 129.69 18.97 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 178.249 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.6 HD21 ' CD1' ' A' ' 83' ' ' TYR . 8.4 tt -156.09 128.39 7.62 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 -173.413 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 61.6 t -132.64 101.27 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.255 -179.248 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.6 ' CD1' HD21 ' A' ' 81' ' ' LEU . 8.1 m-85 -96.34 156.65 16.25 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.023 0.439 . . . . 0.0 110.416 172.531 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 86.0 m -157.82 135.85 10.82 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 176.204 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.458 ' HB3' ' CG ' ' A' ' 91' ' ' HIS . 19.1 ptmt -128.81 141.51 51.28 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.218 0.532 . . . . 0.0 111.397 -179.286 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -100.46 -39.31 8.01 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.581 177.556 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -126.62 151.31 72.97 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 115.415 -0.811 . . . . 0.0 108.919 178.244 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -46.0 -36.81 16.54 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 122.503 2.135 . . . . 0.0 112.173 178.079 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 17.9 p -83.91 -42.01 16.78 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 115.573 -0.739 . . . . 0.0 111.48 178.071 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 68.1 t80 -85.43 92.11 8.4 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-O 120.947 0.403 . . . . 0.0 110.359 -177.615 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' HIS . . . . . 0.543 ' NE2' ' HB3' ' A' ' 83' ' ' TYR . 4.7 t-160 -121.79 118.75 29.78 Favored 'General case' 0 N--CA 1.462 0.17 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 176.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 25.4 p80 -120.03 175.47 5.9 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.654 0.264 . . . . 0.0 110.482 -177.008 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . 0.485 ' HZ3' ' HB2' ' A' ' 102' ' ' LEU . 36.5 p90 -146.36 155.1 42.37 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.02 175.578 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 28.9 ttpt -120.28 122.34 40.65 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.784 -179.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.516 ' O ' ' N ' ' A' ' 97' ' ' ASN . 28.5 m -93.09 142.78 12.68 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 N-CA-C 106.294 -1.743 . . . . 0.0 106.294 160.689 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -60.35 77.66 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.066 0.46 . . . . 0.0 110.692 -177.026 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.566 ' O ' ' HD2' ' A' ' 98' ' ' ARG . 0.2 OUTLIER 169.82 -51.52 0.01 OUTLIER 'General case' 0 C--O 1.234 0.28 0 CA-C-N 115.085 -0.961 . . . . 0.0 109.856 -176.059 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.566 ' HD2' ' O ' ' A' ' 97' ' ' ASN . 0.6 OUTLIER -141.81 155.39 45.58 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.929 -175.304 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.569 ' HB3' ' CH2' ' A' ' 32' ' ' TRP . 89.2 mttt -112.88 116.3 29.81 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.047 173.629 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 27.2 m-85 -103.24 135.46 44.84 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 178.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -112.31 146.37 18.13 Favored Glycine 0 N--CA 1.453 -0.218 0 C-N-CA 121.155 -0.545 . . . . 0.0 112.83 -176.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.485 ' HB2' ' HZ3' ' A' ' 93' ' ' TRP . 2.8 tt -124.71 116.68 22.73 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 176.674 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.449 ' HB ' ' HB ' ' A' ' 21' ' ' VAL . 35.1 m -104.83 103.07 12.6 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.162 178.337 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.402 ' HB3' ' OD2' ' A' ' 109' ' ' ASP . 74.2 m-85 -65.37 163.28 15.93 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.22 -178.551 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 18.9 pt20 -102.56 -26.59 13.17 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.301 -176.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 19.4 m -147.41 150.17 36.61 Favored Pre-proline 0 CA--C 1.534 0.354 0 CA-C-O 120.439 0.162 . . . . 0.0 110.723 179.374 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -51.56 -27.46 25.41 Favored 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 122.97 2.447 . . . . 0.0 112.732 177.435 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -61.04 -63.0 1.44 Allowed 'General case' 0 C--O 1.237 0.436 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.001 178.718 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.402 ' OD2' ' HB3' ' A' ' 104' ' ' PHE . 1.5 p-10 -64.4 -34.67 78.71 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.86 179.845 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -57.99 -60.74 3.26 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.056 0.455 . . . . 0.0 110.822 176.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 61.5 ttt180 -61.22 -36.65 80.51 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.507 -176.615 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -62.63 -45.18 94.05 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-N 115.58 -0.737 . . . . 0.0 110.61 178.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 38.9 t80 -76.27 -26.38 55.89 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.469 -178.718 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 46.6 m-20 -59.67 -56.01 27.29 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 173.619 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 90.5 mtt180 -64.62 -27.66 69.09 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.154 174.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . 0.477 ' HA2' ' NZ ' ' A' ' 119' ' ' LYS . . . -59.7 -58.8 12.38 Favored Glycine 0 N--CA 1.45 -0.417 0 CA-C-N 115.834 -0.621 . . . . 0.0 112.065 176.589 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.497 ' O ' HG13 ' A' ' 121' ' ' ILE . 9.0 p -65.66 -33.92 66.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 110.404 -0.221 . . . . 0.0 110.404 -179.302 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 43.6 ttm180 -59.78 -54.06 50.66 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.619 -0.264 . . . . 0.0 110.605 177.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.477 ' NZ ' ' HA2' ' A' ' 116' ' ' GLY . 25.0 pttm -69.33 -24.11 63.87 Favored 'General case' 0 CA--C 1.528 0.128 0 CA-C-O 120.841 0.353 . . . . 0.0 110.261 -179.739 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -67.2 -43.4 82.18 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.119 174.24 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.497 HG13 ' O ' ' A' ' 117' ' ' VAL . 79.7 mt -62.63 -41.63 92.94 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.168 0 CA-C-N 116.314 -0.403 . . . . 0.0 109.916 177.018 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -58.4 -43.83 88.73 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.132 174.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 40.7 t0 -75.51 -19.82 59.12 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.539 -177.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.616 HD11 ' HA ' ' A' ' 79' ' ' LYS . 55.2 tp -88.35 -39.1 14.59 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.647 -178.779 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 61.1 mt -112.23 -39.84 3.49 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 N-CA-C 111.801 0.297 . . . . 0.0 111.801 -172.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.323 -0.846 . . . . 0.0 110.226 -174.714 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 16.8 m . . . . . 0 N--CA 1.453 -0.285 0 CA-C-O 120.926 0.393 . . . . 0.0 110.925 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.482 ' HA ' ' HB3' ' A' ' 46' ' ' CYS . 67.5 m-85 -141.85 153.28 44.35 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.704 175.742 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.483 HG22 HG23 ' A' ' 16' ' ' VAL . 52.2 mt -108.35 -63.67 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.714 0.292 . . . . 0.0 110.371 178.106 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.483 HG23 HG22 ' A' ' 15' ' ' ILE . 60.0 t -114.94 113.08 42.6 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.517 -178.604 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 36.8 mtp180 -110.47 99.41 8.41 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.671 175.005 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 16.8 m -128.8 162.27 36.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.759 0.314 . . . . 0.0 110.769 -179.175 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.493 ' HE2' ' HA ' ' A' ' 40' ' ' ILE . 46.3 tttm -97.19 137.74 35.76 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.918 -176.792 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -159.04 -175.74 5.45 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-N 115.958 -0.564 . . . . 0.0 109.768 177.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.42 HG22 ' HA2' ' A' ' 39' ' ' GLY . 38.4 t -107.72 100.78 11.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.583 -0.281 . . . . 0.0 110.476 177.452 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.628 HG23 ' NE2' ' A' ' 35' ' ' GLN . 13.6 m -65.39 127.12 25.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.611 177.511 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 19.6 mmt -122.9 149.74 43.83 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.206 -175.131 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.443 HG23 ' CE1' ' A' ' 33' ' ' PHE . 12.7 t -122.31 171.75 8.81 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.051 175.373 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.531 ' HG3' ' H ' ' A' ' 27' ' ' ASP . 14.4 tpt180 -120.1 144.28 47.7 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.656 -178.367 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -79.93 11.91 3.04 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.862 179.64 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.531 ' H ' ' HG3' ' A' ' 25' ' ' ARG . 19.2 t70 63.85 156.73 0.07 Allowed 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.857 -173.779 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 47.8 t 56.58 -116.28 0.97 Allowed 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 -173.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 50.8 m -155.3 100.76 2.17 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 118.056 0.389 . . . . 0.0 111.525 177.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -131.35 -35.22 0.38 Allowed Glycine 0 C--N 1.329 0.183 0 N-CA-C 111.33 -0.708 . . . . 0.0 111.33 171.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.427 ' H ' ' NH1' ' A' ' 25' ' ' ARG . . . 153.72 132.01 1.64 Allowed Glycine 0 CA--C 1.519 0.315 0 N-CA-C 112.117 -0.393 . . . . 0.0 112.117 176.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . 0.411 ' HZ3' ' HA ' ' A' ' 100' ' ' PHE . 69.1 m95 -67.88 138.18 55.84 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 176.689 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.443 ' CE1' HG23 ' A' ' 24' ' ' THR . 4.6 p90 -145.62 152.55 49.38 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 116.85 -0.159 . . . . 0.0 110.737 -175.375 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -82.67 117.15 2.64 Favored 'Trans proline' 0 N--CA 1.461 -0.424 0 C-N-CA 122.446 2.097 . . . . 0.0 112.042 176.182 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.628 ' NE2' HG23 ' A' ' 22' ' ' VAL . 4.3 pm0 -53.32 -38.7 63.42 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.315 176.397 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -161.96 160.22 27.48 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.069 178.242 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 76.51 -72.53 1.95 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 121.361 -0.447 . . . . 0.0 111.992 178.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 69.43 29.6 71.61 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 121.143 -0.551 . . . . 0.0 112.692 179.282 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.42 ' HA2' HG22 ' A' ' 21' ' ' VAL . . . -177.28 -72.09 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.216 179.629 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.546 ' N ' HD12 ' A' ' 40' ' ' ILE . 3.0 mp -92.11 103.72 14.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.694 0.283 . . . . 0.0 110.618 -176.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.589 ' HA ' ' O ' ' A' ' 65' ' ' ARG . 30.0 m -146.62 127.41 14.38 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.236 -0.438 . . . . 0.0 109.821 172.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.459 ' O ' ' HG3' ' A' ' 42' ' ' ARG . 14.1 ptt180 -92.01 116.67 29.12 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 121.201 0.524 . . . . 0.0 110.092 179.424 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 40.4 t -95.29 128.92 46.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.626 178.417 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -123.25 108.99 1.27 Allowed Glycine 0 N--CA 1.448 -0.562 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.774 -178.402 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 7.6 p -92.14 130.98 40.45 Favored 'Isoleucine or valine' 0 C--O 1.238 0.496 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 175.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . 0.69 ' SG ' ' HB3' ' A' ' 60' ' ' LEU . 15.3 p -131.97 130.18 41.15 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.839 -178.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -92.35 86.54 5.73 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 175.324 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 30.8 m -80.25 159.5 4.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.399 -178.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 25.2 ptm . . . . . 0 C--N 1.324 -0.508 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.778 179.946 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.331 0 N-CA-C 111.006 -0.838 . . . . 0.0 111.006 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.551 ' HB2' ' HB ' ' A' ' 77' ' ' VAL . 83.8 m-85 -107.02 98.41 8.07 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 117.015 0.408 . . . . 0.0 110.353 -177.059 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.718 HD22 ' HB2' ' A' ' 62' ' ' HIS . 0.9 OUTLIER -78.35 106.04 10.01 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 179.633 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.528 HG12 HG23 ' A' ' 77' ' ' VAL . 50.8 mm -84.25 96.26 4.38 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 173.781 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . 0.718 ' HB2' HD22 ' A' ' 60' ' ' LEU . 21.0 t-80 -119.21 150.87 39.35 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.313 -175.618 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -141.83 123.93 2.35 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 121.297 -0.478 . . . . 0.0 112.099 -178.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -99.37 149.89 22.71 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 177.521 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.589 ' O ' ' HA ' ' A' ' 41' ' ' SER . 3.1 tmm_? -58.24 -73.22 0.08 Allowed 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 109.09 -0.708 . . . . 0.0 109.09 176.012 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.507 ' HB2' ' O ' ' A' ' 65' ' ' ARG . 6.6 tp-100 169.38 132.3 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 123.111 0.564 . . . . 0.0 109.564 175.591 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt 68.04 -67.98 0.18 Allowed 'General case' 0 N--CA 1.465 0.302 0 O-C-N 123.794 0.684 . . . . 0.0 110.842 -179.51 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -74.21 128.47 35.61 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 110.109 -0.33 . . . . 0.0 110.109 177.187 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 12.5 mptt -67.2 78.21 0.14 Allowed 'General case' 0 C--O 1.236 0.385 0 CA-C-O 121.061 0.458 . . . . 0.0 110.42 -179.535 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 58.0 tp -116.37 116.84 28.44 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.113 -179.051 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 48.8 t -72.59 101.5 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.414 -179.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 27.3 m -96.84 -14.43 7.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.782 177.609 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.462 HD23 ' N ' ' A' ' 74' ' ' GLU . 2.2 tt -157.43 130.41 7.63 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 177.664 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.462 ' N ' HD23 ' A' ' 73' ' ' LEU . 4.1 tm-20 -145.59 127.02 14.98 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 177.675 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' CYS . . . . . 0.428 ' HB2' ' HE2' ' A' ' 100' ' ' PHE . 48.5 t -160.72 91.03 0.88 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.463 0.649 . . . . 0.0 109.856 177.468 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.495 ' HD1' ' HG ' ' A' ' 60' ' ' LEU . 82.3 t80 -67.4 118.32 10.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.454 -0.793 . . . . 0.0 110.79 179.638 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.794 HG22 HD13 ' A' ' 81' ' ' LEU . 62.0 t -77.34 94.5 1.35 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.356 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 176.111 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.426 ' HG3' ' HB3' ' A' ' 80' ' ' ASP . 15.1 ptt180 -78.83 35.76 0.25 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.717 179.052 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.695 ' HA ' HD11 ' A' ' 124' ' ' LEU . 59.5 mttp 67.91 13.64 9.21 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 123.16 0.584 . . . . 0.0 110.721 -169.027 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . 0.426 ' HB3' ' HG3' ' A' ' 78' ' ' ARG . 15.0 t70 -135.19 96.73 3.55 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 115.989 -0.55 . . . . 0.0 109.898 178.177 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.794 HD13 HG22 ' A' ' 77' ' ' VAL . 7.1 tt -177.89 137.6 0.19 Allowed 'General case' 0 C--O 1.233 0.212 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 179.697 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.526 ' N ' HD23 ' A' ' 81' ' ' LEU . 40.6 t -126.19 122.52 61.71 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 CA-C-O 120.507 0.194 . . . . 0.0 111.075 -176.482 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.46 ' CG ' HG21 ' A' ' 117' ' ' VAL . 7.4 m-85 -84.52 172.8 11.34 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-O 121.284 0.564 . . . . 0.0 111.231 176.738 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 87.0 m -153.99 101.82 2.45 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.89 177.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -79.85 93.53 5.66 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 174.604 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -83.9 -59.22 2.48 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.536 -175.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . 0.468 ' HB2' ' HB3' ' A' ' 90' ' ' PHE . 10.5 m120 -113.11 155.44 44.33 Favored Pre-proline 0 C--N 1.327 -0.385 0 N-CA-C 109.171 -0.678 . . . . 0.0 109.171 -179.196 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_exo -53.59 -19.18 13.31 Favored 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 122.658 2.238 . . . . 0.0 113.034 -179.644 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.44 ' HA ' ' HD2' ' A' ' 104' ' ' PHE . 15.3 t -121.05 -1.31 9.84 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 120.836 0.35 . . . . 0.0 111.448 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.468 ' HB3' ' HB2' ' A' ' 87' ' ' ASN . 78.0 t80 -120.84 114.67 21.94 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-O 121.007 0.432 . . . . 0.0 110.544 -176.254 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 2.0 t-160 -133.0 112.91 12.23 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 -176.066 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . 0.601 ' HA ' ' HA3' ' A' ' 101' ' ' GLY . 11.6 p80 -125.73 -178.42 4.26 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 -178.461 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . 0.405 ' CZ3' ' HA2' ' A' ' 101' ' ' GLY . 49.4 p90 -146.02 164.83 30.86 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.201 173.468 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 14.4 tmtt? -146.32 130.14 17.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.222 -177.097 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 30.8 m -136.49 147.11 27.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.738 -0.665 . . . . 0.0 109.388 176.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 18.7 t70 59.93 -89.86 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.447 0 O-C-N 123.235 0.334 . . . . 0.0 110.414 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 59.1 t30 -148.21 10.62 0.89 Allowed 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 121.685 0.755 . . . . 0.0 109.415 175.111 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 73.3 mtp180 -109.49 131.87 54.66 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.296 -176.283 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.546 ' HD3' ' N ' ' A' ' 99' ' ' LYS . 0.0 OUTLIER -127.66 127.54 43.93 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.567 -178.062 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . 0.428 ' HE2' ' HB2' ' A' ' 75' ' ' CYS . 4.9 p90 -156.01 164.06 38.93 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.527 -0.761 . . . . 0.0 109.004 177.295 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.601 ' HA3' ' HA ' ' A' ' 92' ' ' HIS . . . -173.94 -135.35 2.01 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.401 -0.904 . . . . 0.0 112.703 -175.611 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 2.2 pp -159.69 175.28 13.36 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 121.339 0.59 . . . . 0.0 111.746 -178.195 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 91.2 m -130.02 140.49 50.87 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.114 176.249 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.44 ' HD2' ' HA ' ' A' ' 89' ' ' THR . 23.7 m-85 -83.18 166.38 18.67 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.324 0.583 . . . . 0.0 111.389 -174.407 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 21.6 tt0 -123.19 -57.31 1.69 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.822 175.34 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 18.8 m -118.66 149.46 46.38 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.345 -176.023 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -53.2 -20.77 15.26 Favored 'Trans proline' 0 C--N 1.352 0.744 0 C-N-CA 122.587 2.191 . . . . 0.0 112.476 179.016 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -62.37 -66.6 0.52 Allowed 'General case' 0 C--O 1.235 0.329 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.523 175.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -63.19 -39.23 94.06 Favored 'General case' 0 C--O 1.231 0.101 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.764 -179.604 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.427 ' HA ' ' CD1' ' A' ' 104' ' ' PHE . . . -52.61 -58.99 5.04 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-O 121.387 0.613 . . . . 0.0 111.174 177.008 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 69.7 ttt180 -66.59 -29.26 69.27 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.466 -178.141 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -64.95 -48.34 74.4 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.194 179.685 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.403 ' O ' HG12 ' A' ' 117' ' ' VAL . 58.4 m-85 -67.27 -46.8 72.57 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 116.698 -0.228 . . . . 0.0 110.577 179.072 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -53.18 -64.99 0.64 Allowed 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 121.235 0.54 . . . . 0.0 110.773 178.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . 0.402 ' O ' ' HB2' ' A' ' 119' ' ' LYS . 41.8 ttm180 -57.3 -38.16 73.57 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 114.938 -1.028 . . . . 0.0 110.799 177.809 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -56.76 -58.2 15.67 Favored Glycine 0 C--N 1.331 0.252 0 CA-C-N 115.955 -0.566 . . . . 0.0 112.484 -177.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.46 HG21 ' CG ' ' A' ' 83' ' ' TYR . 7.6 p -69.03 -36.88 75.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.532 0.206 . . . . 0.0 110.803 -178.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 25.1 ttt180 -60.72 -42.77 97.92 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.738 -0.468 . . . . 0.0 109.738 -179.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.402 ' HB2' ' O ' ' A' ' 115' ' ' ARG . 7.4 mmtt -74.96 -30.05 61.1 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.659 178.508 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -62.71 -47.92 81.51 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 176.387 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 72.2 mt -66.32 -40.57 87.11 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.037 177.128 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -55.74 -48.31 75.47 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.397 178.64 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -74.94 -35.18 62.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.037 -178.408 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.695 HD11 ' HA ' ' A' ' 79' ' ' LYS . 6.3 tt -62.02 -50.23 72.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.28 -178.164 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 60.8 mt -83.12 -40.32 16.17 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.865 -177.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 . . . . . 0 C--O 1.251 1.142 0 CA-C-O 118.311 -0.852 . . . . 0.0 110.544 -177.281 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 20.8 m . . . . . 0 N--CA 1.465 0.316 0 N-CA-C 111.8 0.296 . . . . 0.0 111.8 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.436 ' HA ' ' HA ' ' A' ' 46' ' ' CYS . 35.8 m-85 -66.14 135.2 54.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.857 0.36 . . . . 0.0 111.878 -179.564 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 50.3 mm -92.36 -40.94 12.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 171.315 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 7.4 p -155.49 136.74 5.27 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 CA-C-N 115.179 -0.919 . . . . 0.0 109.974 178.356 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 22.4 ptt180 -149.52 114.29 5.35 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.818 0.342 . . . . 0.0 110.232 178.053 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 15.0 m -150.09 -170.82 0.17 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.325 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.057 -178.045 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.544 ' HG2' ' OE1' ' A' ' 105' ' ' GLN . 5.9 ttpm? -87.57 132.69 33.97 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.592 179.343 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.477 ' O ' ' HB2' ' A' ' 41' ' ' SER . . . -157.45 -178.22 7.18 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.178 -0.465 . . . . 0.0 109.846 176.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.588 ' HB ' ' HB ' ' A' ' 103' ' ' THR . 38.2 t -112.53 107.77 23.82 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 CA-C-N 116.647 -0.252 . . . . 0.0 110.841 -179.625 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 11.9 m -73.94 96.48 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 CA-C-O 121.368 0.604 . . . . 0.0 110.279 175.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 91.9 mmm -82.92 119.41 24.38 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.772 -176.486 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.46 HG23 ' CE1' ' A' ' 33' ' ' PHE . 10.0 t -93.9 171.16 9.04 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.055 176.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 14.4 ttp180 -133.46 21.47 3.98 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 178.483 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.426 ' HB3' ' CB ' ' A' ' 29' ' ' SER . 35.6 t70 50.68 36.81 14.98 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 114.778 -1.101 . . . . 0.0 110.536 179.748 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 34.1 t70 61.98 83.21 0.16 Allowed 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.542 -179.528 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 24.2 p 50.1 27.35 2.49 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 115.277 -0.874 . . . . 0.0 112.894 178.009 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.426 ' CB ' ' HB3' ' A' ' 26' ' ' ASP . 32.4 t -70.17 -36.16 74.5 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-O 120.653 0.263 . . . . 0.0 110.981 -178.891 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 150.79 -91.77 0.14 Allowed Glycine 0 C--N 1.332 0.351 0 C-N-CA 120.918 -0.658 . . . . 0.0 112.535 178.813 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -81.99 163.26 43.42 Favored Glycine 0 CA--C 1.518 0.279 0 C-N-CA 121.199 -0.524 . . . . 0.0 112.683 -178.775 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . 0.467 ' HH2' ' HB3' ' A' ' 99' ' ' LYS . 74.6 m95 -93.57 147.8 22.67 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-O 120.732 0.301 . . . . 0.0 110.803 -179.337 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.46 ' CE1' HG23 ' A' ' 24' ' ' THR . 6.8 p90 -156.34 150.34 19.58 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.896 176.827 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_exo -63.27 139.8 73.81 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.589 2.193 . . . . 0.0 111.893 176.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 22.1 pt20 -105.64 131.73 52.66 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.604 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 16.0 tp10 64.36 -73.06 0.06 Allowed 'General case' 0 CA--C 1.533 0.312 0 O-C-N 123.851 0.719 . . . . 0.0 111.063 -179.581 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.451 ' HA3' ' OE1' ' A' ' 66' ' ' GLN . . . -148.65 109.74 0.46 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 121.173 -0.536 . . . . 0.0 111.912 179.726 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.446 ' O ' HG22 ' A' ' 21' ' ' VAL . . . -89.88 5.29 83.42 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 121.393 -0.432 . . . . 0.0 112.539 -178.42 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -81.62 -41.34 9.95 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.945 -0.645 . . . . 0.0 111.802 178.27 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.523 HD12 ' HG3' ' A' ' 19' ' ' LYS . 3.7 tp -143.54 91.95 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 CA-C-O 121.426 0.632 . . . . 0.0 110.756 -179.753 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.477 ' HB2' ' O ' ' A' ' 20' ' ' ALA . 21.4 m -106.32 119.33 38.98 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 173.188 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.611 ' HB3' ' O ' ' A' ' 64' ' ' GLU . 8.2 tpt85 -77.24 90.3 3.72 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 121.453 0.644 . . . . 0.0 109.419 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 38.8 t -94.87 117.88 39.68 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 CA-C-N 115.241 -0.89 . . . . 0.0 110.345 -177.361 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -129.17 118.3 2.65 Favored Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 121.174 -0.536 . . . . 0.0 111.995 179.655 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 61.4 t -96.04 110.22 24.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 176.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . 0.483 ' SG ' ' HB3' ' A' ' 60' ' ' LEU . 12.3 p -107.96 147.42 31.08 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.583 -179.468 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 10.3 tmtt? -102.03 95.16 6.17 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 176.611 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.574 HG21 ' HE1' ' A' ' 76' ' ' TYR . 35.4 m -71.86 141.94 16.0 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.432 -173.859 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 22.2 mmt . . . . . 0 C--N 1.327 -0.403 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.403 179.391 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.366 0 N-CA-C 111.945 -0.462 . . . . 0.0 111.945 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.446 ' HB2' ' HB ' ' A' ' 77' ' ' VAL . 83.2 m-85 -117.15 161.42 19.47 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.483 ' HB3' ' SG ' ' A' ' 46' ' ' CYS . 2.0 tt -147.07 112.56 5.61 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 176.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.499 ' HB ' ' HB2' ' A' ' 75' ' ' CYS . 59.5 mt -84.78 103.69 12.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 174.206 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 12.5 t-80 -117.25 104.51 11.25 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.038 -169.722 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -100.6 121.83 7.38 Favored Glycine 0 C--N 1.333 0.415 0 N-CA-C 111.3 -0.72 . . . . 0.0 111.3 177.493 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.611 ' O ' ' HB3' ' A' ' 42' ' ' ARG . 16.1 pt-20 -150.3 -166.82 2.65 Favored 'General case' 0 C--O 1.24 0.588 0 CA-C-O 121.205 0.526 . . . . 0.0 112.37 -170.707 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.425 ' HB3' ' HB3' ' A' ' 42' ' ' ARG . 29.4 ttt180 74.68 -30.97 0.21 Allowed 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.974 1.31 . . . . 0.0 112.778 170.487 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.769 HE21 ' HA ' ' A' ' 66' ' ' GLN . 0.0 OUTLIER -59.09 131.69 51.8 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 110.232 -0.284 . . . . 0.0 110.232 177.697 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 85.2 tttt 66.07 76.4 0.31 Allowed 'General case' 0 C--O 1.235 0.332 0 O-C-N 123.7 0.625 . . . . 0.0 109.823 -178.553 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 69.65 -86.78 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.005 -0.998 . . . . 0.0 110.99 -176.397 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 28.9 tptp -175.48 98.47 0.07 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.012 0.434 . . . . 0.0 110.467 -176.806 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -157.89 166.95 31.33 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 172.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 6.2 t -99.13 109.31 24.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-O 120.797 0.332 . . . . 0.0 110.523 -176.698 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 33.9 m -94.48 -6.65 10.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.223 -177.41 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -148.51 117.29 6.67 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 -178.241 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -127.92 124.63 37.82 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.094 177.409 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' CYS . . . . . 0.543 ' SG ' ' CD2' ' A' ' 100' ' ' PHE . 24.6 m -145.96 89.15 1.86 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.407 176.915 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.574 ' HE1' HG21 ' A' ' 48' ' ' VAL . 87.1 t80 -71.9 136.75 47.02 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.554 -0.535 . . . . 0.0 109.554 173.478 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.446 ' HB ' ' HB2' ' A' ' 59' ' ' PHE . 58.3 t -125.31 96.0 3.5 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 CA-C-O 120.943 0.401 . . . . 0.0 110.372 -175.772 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 43.4 ttp180 -84.4 69.07 10.46 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.215 0.531 . . . . 0.0 110.023 179.422 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.541 ' HA ' ' HG ' ' A' ' 124' ' ' LEU . 8.2 mtpm? 52.92 21.13 1.88 Allowed 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 115.254 -0.885 . . . . 0.0 112.345 179.17 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -125.19 114.08 18.51 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 172.181 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.478 HD12 HG12 ' A' ' 121' ' ' ILE . 2.8 tm? -152.97 138.23 17.47 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.601 -170.114 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.474 ' HB ' ' HB3' ' A' ' 94' ' ' LYS . 48.6 t -132.45 88.92 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.8 173.618 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.495 ' HD1' ' HD2' ' A' ' 91' ' ' HIS . 0.3 OUTLIER -85.51 146.58 26.85 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 174.829 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.445 ' HB ' ' CE1' ' A' ' 92' ' ' HIS . 38.3 m -140.69 121.74 14.66 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 177.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.429 ' HE3' ' HA ' ' A' ' 88' ' ' PRO . 86.5 tttt -83.51 96.0 8.47 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 176.181 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -66.85 -42.63 85.38 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.167 0.508 . . . . 0.0 109.813 179.105 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . 0.679 ' HB2' ' HD2' ' A' ' 88' ' ' PRO . 9.8 p30 -161.41 164.27 18.67 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-N 115.145 -0.934 . . . . 0.0 108.835 177.442 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.679 ' HD2' ' HB2' ' A' ' 87' ' ' ASN . 9.6 Cg_endo -50.26 -22.55 8.52 Favored 'Trans proline' 0 C--N 1.352 0.75 0 C-N-CA 123.264 2.643 . . . . 0.0 114.091 -175.861 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 10.8 p -116.9 15.23 15.22 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 112.409 0.522 . . . . 0.0 112.409 -176.01 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.435 ' HB3' ' ND2' ' A' ' 87' ' ' ASN . 45.4 t80 -152.1 111.62 3.95 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-O 121.152 0.501 . . . . 0.0 111.383 178.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' HIS . . . . . 0.498 ' HD1' ' HE2' ' A' ' 104' ' ' PHE . 2.3 m80 -106.81 155.06 20.12 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 169.409 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . 0.445 ' CE1' ' HB ' ' A' ' 84' ' ' THR . 20.6 p80 -146.23 146.98 30.98 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 171.327 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . 0.559 ' CE2' ' HB2' ' A' ' 100' ' ' PHE . 28.4 p90 -123.52 146.21 48.27 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.173 0.511 . . . . 0.0 111.072 -178.778 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.474 ' HB3' ' HB ' ' A' ' 82' ' ' VAL . 3.0 tmtm? -110.25 101.18 9.95 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.051 -0.977 . . . . 0.0 108.83 -178.05 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 28.2 m -137.55 145.82 28.64 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 -179.609 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 27.9 t70 55.26 27.86 10.4 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 121.778 0.799 . . . . 0.0 109.978 -177.524 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.47 ' HA ' ' HE3' ' A' ' 94' ' ' LYS . 64.6 t30 74.88 -15.44 0.65 Allowed 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 114.66 -1.155 . . . . 0.0 111.633 -179.116 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 33.7 ttm180 -89.98 156.41 18.44 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.701 0.286 . . . . 0.0 110.462 -177.155 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.467 ' HB3' ' HH2' ' A' ' 32' ' ' TRP . 62.0 mtpt -116.14 133.53 55.92 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.219 -178.62 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . 0.559 ' HB2' ' CE2' ' A' ' 93' ' ' TRP . 31.0 m-85 -128.81 139.51 52.14 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 175.577 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -110.8 163.56 12.28 Favored Glycine 0 N--CA 1.453 -0.183 0 C-N-CA 121.291 -0.48 . . . . 0.0 112.417 -178.315 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.418 ' HB2' ' HZ3' ' A' ' 93' ' ' TRP . 31.3 tp -146.91 112.8 5.74 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 110.145 -0.317 . . . . 0.0 110.145 -178.723 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.588 ' HB ' ' HB ' ' A' ' 21' ' ' VAL . 84.1 m -92.79 134.17 35.32 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 176.312 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.498 ' HE2' ' HD1' ' A' ' 91' ' ' HIS . 46.9 m-85 -90.97 137.98 31.95 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.243 -178.816 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . 0.544 ' OE1' ' HG2' ' A' ' 19' ' ' LYS . 52.7 mt-30 -102.78 -26.39 13.17 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.637 -173.727 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 49.4 m -148.47 159.72 38.16 Favored Pre-proline 0 CA--C 1.536 0.409 0 CA-C-O 120.434 0.159 . . . . 0.0 110.652 -179.667 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.565 ' O ' ' HD3' ' A' ' 111' ' ' ARG . 57.0 Cg_exo -53.48 -34.54 72.44 Favored 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 122.657 2.238 . . . . 0.0 112.413 178.273 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -56.81 -61.27 2.55 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.986 -179.069 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -67.17 -38.41 85.39 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.901 -179.149 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -54.85 -53.05 60.38 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.236 179.231 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . 0.565 ' HD3' ' O ' ' A' ' 107' ' ' PRO . 5.2 mpt_? -71.62 -37.42 70.91 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.555 -178.051 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -59.4 -55.9 28.81 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.638 -179.523 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.461 ' O ' HG23 ' A' ' 117' ' ' VAL . 37.8 m-85 -63.86 -50.24 69.58 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.901 179.718 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.613 ' O ' ' HG2' ' A' ' 118' ' ' ARG . 22.3 t70 -53.01 -67.92 0.21 Allowed 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 121.155 0.502 . . . . 0.0 110.649 -178.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 53.1 ttt180 -51.91 -46.31 64.55 Favored 'General case' 0 C--O 1.242 0.691 0 CA-C-N 114.972 -1.013 . . . . 0.0 111.166 -178.107 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -59.52 -42.63 97.75 Favored Glycine 0 C--N 1.334 0.451 0 CA-C-N 115.869 -0.605 . . . . 0.0 112.148 179.133 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.461 HG23 ' O ' ' A' ' 113' ' ' PHE . 41.2 t -66.8 -36.03 76.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 C-N-CA 122.156 0.182 . . . . 0.0 110.698 179.683 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.613 ' HG2' ' O ' ' A' ' 114' ' ' ASP . 8.9 mmm180 -58.53 -56.54 20.8 Favored 'General case' 0 C--O 1.241 0.628 0 CA-C-O 121.277 0.561 . . . . 0.0 109.646 178.164 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 9.8 mmpt? -61.24 -38.97 88.59 Favored 'General case' 0 C--O 1.239 0.507 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.191 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -59.28 -53.93 52.64 Favored 'General case' 0 C--O 1.226 -0.184 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.872 179.654 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.478 HG12 HD12 ' A' ' 81' ' ' LEU . 73.8 mt -55.09 -45.04 76.9 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 O-C-N 123.236 0.335 . . . . 0.0 110.493 -179.097 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.411 ' O ' ' HB2' ' A' ' 126' ' ' GLU . 50.5 mt-10 -55.3 -55.93 25.88 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.07 178.632 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -69.02 -24.8 64.25 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 121.258 0.552 . . . . 0.0 110.971 -179.145 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.541 ' HG ' ' HA ' ' A' ' 79' ' ' LYS . 9.2 tt -74.14 -46.75 40.52 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.54 -0.754 . . . . 0.0 111.956 -174.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.448 HG22 ' O ' ' A' ' 121' ' ' ILE . 18.9 tt -106.57 -33.03 2.66 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 N-CA-C 112.38 0.511 . . . . 0.0 112.38 -173.165 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.411 ' HB2' ' O ' ' A' ' 122' ' ' GLU . 44.1 mt-10 . . . . . 0 C--O 1.248 0.988 0 CA-C-O 118.484 -0.769 . . . . 0.0 110.182 -179.157 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.72 ' HB2' ' SG ' ' A' ' 46' ' ' CYS . 20.3 m . . . . . 0 CA--C 1.535 0.369 0 N-CA-C 111.868 0.322 . . . . 0.0 111.868 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.492 ' CE2' ' HA3' ' A' ' 44' ' ' GLY . 4.1 m-30 -66.4 85.1 0.1 Allowed 'General case' 0 C--O 1.234 0.282 0 CA-C-O 120.85 0.357 . . . . 0.0 110.917 175.555 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.489 HD12 ' HB3' ' A' ' 47' ' ' LYS . 55.0 mt -70.16 -59.0 3.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 175.634 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 62.0 t -110.0 113.62 44.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 177.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.483 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 0.0 OUTLIER -136.63 130.86 32.88 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.772 0.32 . . . . 0.0 110.177 178.171 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 35.1 m -131.83 171.68 17.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.037 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.477 ' HB2' HD11 ' A' ' 40' ' ' ILE . 57.0 pttt -110.44 109.34 19.68 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 177.495 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -157.01 158.26 36.22 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.724 -177.318 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 50.0 t -81.39 111.85 18.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.642 0.258 . . . . 0.0 110.763 -178.579 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.51 HG23 ' NE2' ' A' ' 35' ' ' GLN . 17.1 m -75.26 128.62 37.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.362 176.126 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 87.1 mmm -122.34 166.66 14.33 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 -177.135 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 9.1 t -143.93 164.51 30.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.445 0.64 . . . . 0.0 111.08 178.477 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.538 ' HB3' ' HB2' ' A' ' 99' ' ' LYS . 73.2 ttt180 -150.04 140.02 21.96 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 -179.846 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.554 ' HA ' ' HG2' ' A' ' 98' ' ' ARG . 26.0 t0 -79.15 37.39 0.32 Allowed 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 121.348 0.594 . . . . 0.0 110.322 -177.869 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.476 ' HA ' ' HG3' ' A' ' 99' ' ' LYS . 22.0 t70 63.49 -63.36 0.13 Allowed 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 123.891 0.876 . . . . 0.0 109.715 -171.018 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 22.3 p -68.93 170.8 9.06 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.861 168.719 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 15.7 m 64.78 96.06 0.05 OUTLIER 'General case' 0 CA--C 1.536 0.431 0 CA-C-O 120.984 0.421 . . . . 0.0 111.142 178.346 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -80.59 22.91 4.43 Favored Glycine 0 CA--C 1.519 0.301 0 C-N-CA 121.494 -0.384 . . . . 0.0 113.557 -175.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -80.48 -27.02 53.05 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.949 -0.643 . . . . 0.0 112.458 179.022 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . 0.535 ' CH2' ' HB3' ' A' ' 99' ' ' LYS . 83.4 m95 58.15 101.79 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 121.452 0.644 . . . . 0.0 110.841 -176.312 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 31.1 p90 -101.16 135.51 19.9 Favored Pre-proline 0 CA--C 1.532 0.254 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.915 -174.266 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.568 ' HB2' ' HA3' ' A' ' 38' ' ' GLY . 73.7 Cg_endo -79.05 111.41 2.93 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.694 2.262 . . . . 0.0 112.133 178.756 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.51 ' NE2' HG23 ' A' ' 22' ' ' VAL . 4.7 pm0 -75.69 168.3 20.28 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.36 -179.392 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 62.07 -77.84 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 115.395 -0.821 . . . . 0.0 110.794 177.311 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -148.52 -7.72 0.21 Allowed Glycine 0 CA--C 1.518 0.264 0 C-N-CA 121.252 -0.499 . . . . 0.0 112.558 -179.687 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.568 ' HA3' ' HB2' ' A' ' 34' ' ' PRO . . . 58.08 83.07 0.05 OUTLIER Glycine 0 C--N 1.334 0.462 0 C-N-CA 121.38 -0.438 . . . . 0.0 113.113 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -157.35 174.23 34.84 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 121.039 -0.601 . . . . 0.0 112.007 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.477 HD11 ' HB2' ' A' ' 19' ' ' LYS . 9.2 tt -58.55 129.24 20.38 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 CA-C-O 121.074 0.464 . . . . 0.0 110.081 178.66 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 43.7 t -121.61 146.02 47.4 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.317 0.58 . . . . 0.0 111.705 -170.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.649 ' HB3' ' HB2' ' A' ' 64' ' ' GLU . 19.8 ttt180 -77.61 83.23 4.0 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 114.971 -1.013 . . . . 0.0 108.457 171.752 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.483 ' O ' ' HA ' ' A' ' 17' ' ' ARG . 45.7 t -73.1 92.46 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.466 -175.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.492 ' HA3' ' CE2' ' A' ' 14' ' ' TYR . . . -93.24 95.67 2.01 Favored Glycine 0 N--CA 1.448 -0.565 0 CA-C-N 115.864 -0.607 . . . . 0.0 112.63 -179.467 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 61.4 t -82.14 93.24 2.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-O 121.407 0.623 . . . . 0.0 109.409 176.625 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . 0.72 ' SG ' ' HB2' ' A' ' 13' ' ' SER . 43.0 t -91.45 114.3 26.8 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.547 -177.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.489 ' HB3' HD12 ' A' ' 15' ' ' ILE . 40.0 ttmt -75.91 92.6 3.12 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 175.055 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.478 HG21 ' CE1' ' A' ' 76' ' ' TYR . 28.3 m -86.65 170.2 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.571 -174.022 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 26.0 ptm . . . . . 0 C--N 1.326 -0.452 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.233 -179.616 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.193 0 N-CA-C 112.324 -0.31 . . . . 0.0 112.324 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -132.36 139.17 48.02 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.124 0.488 . . . . 0.0 110.583 -179.089 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 3.1 tt -119.82 112.13 18.85 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 176.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.472 ' HB ' ' HB3' ' A' ' 75' ' ' CYS . 44.5 mm -75.94 92.73 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 175.842 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 16.9 t-80 -104.19 93.54 4.89 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.469 -175.725 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -102.21 112.71 4.39 Favored Glycine 0 CA--C 1.518 0.277 0 C-N-CA 121.235 -0.507 . . . . 0.0 112.7 -175.622 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.649 ' HB2' ' HB3' ' A' ' 42' ' ' ARG . 43.5 mm-40 -93.43 162.35 14.01 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.708 0.289 . . . . 0.0 110.82 178.043 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.415 HH11 ' HD3' ' A' ' 65' ' ' ARG . 15.1 ttm180 -82.47 151.78 26.38 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 167.77 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 28.4 mm-40 -59.39 88.03 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 120.884 0.373 . . . . 0.0 110.735 -179.586 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 87.1 tttt 173.76 -21.39 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.173 -0.921 . . . . 0.0 108.981 -176.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 71.24 49.59 0.32 Allowed 'General case' 0 C--O 1.237 0.415 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.384 176.064 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.444 ' O ' ' HB2' ' A' ' 70' ' ' LEU . 11.9 tmtt? -176.0 60.19 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.132 -179.155 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.483 ' O ' ' HA ' ' A' ' 64' ' ' GLU . 54.3 tp 174.2 105.29 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.041 177.757 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 4.0 m -70.73 96.0 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 CA-C-O 121.21 0.529 . . . . 0.0 110.593 174.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 28.6 m -86.99 -9.06 11.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.915 179.649 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.463 ' HB2' HG21 ' A' ' 22' ' ' VAL . 1.5 tm? -159.72 121.1 3.21 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 177.793 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -129.09 122.27 29.57 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 179.328 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' CYS . . . . . 0.472 ' HB3' ' HB ' ' A' ' 61' ' ' ILE . 42.6 t -149.21 87.97 1.56 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.204 0.526 . . . . 0.0 110.572 178.877 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.478 ' CE1' HG21 ' A' ' 48' ' ' VAL . 67.0 t80 -77.26 123.04 25.91 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.146 175.065 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.528 HG11 HD12 ' A' ' 81' ' ' LEU . 17.3 m -133.62 111.64 16.05 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 CA-C-O 121.173 0.511 . . . . 0.0 110.092 177.03 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 16.0 ptm180 -81.25 -17.39 49.64 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.796 -178.222 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.438 ' HA ' HD21 ' A' ' 124' ' ' LEU . 85.6 tttt -172.15 152.69 2.9 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.373 -177.429 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 26.8 t70 71.6 105.25 0.07 Allowed 'General case' 0 N--CA 1.468 0.461 0 O-C-N 123.704 0.627 . . . . 0.0 112.235 173.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.535 HD23 ' N ' ' A' ' 82' ' ' VAL . 4.7 tt -179.37 129.21 0.1 Allowed 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 177.131 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.535 ' N ' HD23 ' A' ' 81' ' ' LEU . 75.6 t -128.02 129.95 69.7 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 N-CA-C 110.33 -0.248 . . . . 0.0 110.33 177.832 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.439 ' CE2' HG21 ' A' ' 117' ' ' VAL . 6.7 m-85 -83.24 159.56 21.94 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.24 0.543 . . . . 0.0 111.024 178.114 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 87.8 m -150.05 135.79 18.43 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.361 177.674 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.613 ' H ' ' HD2' ' A' ' 85' ' ' LYS . 0.0 OUTLIER -105.59 126.51 52.23 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.795 0.331 . . . . 0.0 110.43 -178.617 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.44 ' C ' HD22 ' A' ' 87' ' ' ASN . . . -98.51 -46.08 5.87 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.334 0.588 . . . . 0.0 109.485 175.793 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . 0.819 ' HB2' ' HB3' ' A' ' 90' ' ' PHE . 0.9 OUTLIER -125.17 152.03 70.23 Favored Pre-proline 0 C--N 1.327 -0.411 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 174.387 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -54.32 -25.88 41.07 Favored 'Trans proline' 0 CA--C 1.533 0.47 0 C-N-CA 122.44 2.094 . . . . 0.0 112.431 177.552 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.423 ' HA ' ' HD2' ' A' ' 104' ' ' PHE . 14.3 p -112.82 11.99 19.42 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.746 178.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.819 ' HB3' ' HB2' ' A' ' 87' ' ' ASN . 35.4 t80 -136.71 96.89 3.41 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-O 121.266 0.555 . . . . 0.0 109.642 178.111 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' HIS . . . . . 0.401 ' NE2' ' HB3' ' A' ' 83' ' ' TYR . 0.4 OUTLIER -97.36 163.08 13.04 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 176.632 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 28.6 p80 -166.63 169.97 13.07 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.909 0.385 . . . . 0.0 111.233 178.031 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . 0.54 ' CE2' ' HB2' ' A' ' 100' ' ' PHE . 38.8 p90 -149.69 134.94 18.17 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.36 174.539 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 7.7 tmtm? -102.36 116.68 33.14 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.817 -179.482 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.519 HG23 ' H ' ' A' ' 97' ' ' ASN . 34.9 m -105.72 -170.6 0.32 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.398 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.261 179.596 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -54.62 -25.87 29.33 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 122.877 0.471 . . . . 0.0 111.754 -176.707 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.519 ' H ' HG23 ' A' ' 95' ' ' VAL . 4.9 p-10 -155.11 131.3 10.26 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.179 -0.464 . . . . 0.0 109.972 177.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.554 ' HG2' ' HA ' ' A' ' 26' ' ' ASP . 57.7 mtt180 73.04 162.09 0.26 Allowed 'General case' 0 C--O 1.236 0.354 0 CA-C-O 122.071 0.939 . . . . 0.0 112.237 -173.766 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.538 ' HB2' ' HB3' ' A' ' 25' ' ' ARG . 63.5 mttp -122.35 124.54 43.95 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 114.221 -1.354 . . . . 0.0 108.055 174.623 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . 0.54 ' HB2' ' CE2' ' A' ' 93' ' ' TRP . 1.7 m-85 -101.11 128.87 46.98 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 -177.311 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -111.04 164.17 12.18 Favored Glycine 0 N--CA 1.454 -0.114 0 C-N-CA 121.431 -0.414 . . . . 0.0 112.694 -176.743 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 7.0 tt -150.24 104.37 3.25 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 -179.65 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 36.6 m -91.84 115.52 28.13 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.013 178.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.423 ' HD2' ' HA ' ' A' ' 89' ' ' THR . 82.1 m-85 -67.35 160.1 27.99 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.616 -175.439 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 8.2 tp-100 -92.6 -42.0 9.91 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.382 -178.518 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 49.5 m -143.65 153.95 58.89 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.402 -179.03 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -52.35 -27.96 33.11 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 122.627 2.218 . . . . 0.0 112.344 177.258 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -60.41 -62.18 2.05 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.159 177.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 -66.02 -29.22 69.55 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.589 179.573 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.407 ' HA ' ' CD1' ' A' ' 104' ' ' PHE . . . -57.8 -57.51 12.45 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.585 175.767 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 62.0 mtp180 -60.94 -49.28 78.07 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.904 -179.317 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -60.75 -49.68 76.51 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.498 -176.174 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 66.0 t80 -71.62 -38.03 70.83 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.707 -177.191 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -55.87 -61.87 2.08 Favored 'General case' 0 C--O 1.24 0.557 0 CA-C-O 121.847 0.832 . . . . 0.0 110.241 178.843 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 40.7 ttm180 -60.98 -45.88 92.99 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 114.643 -1.162 . . . . 0.0 110.571 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -62.19 -41.45 99.71 Favored Glycine 0 N--CA 1.451 -0.304 0 CA-C-N 115.506 -0.77 . . . . 0.0 112.975 -177.065 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.523 ' O ' HG12 ' A' ' 121' ' ' ILE . 8.1 p -73.98 -33.27 35.9 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-N 116.78 0.29 . . . . 0.0 110.306 -177.228 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 27.5 tpt180 -57.28 -50.32 73.29 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 172.035 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 3.9 tmmm? -57.85 -38.76 76.25 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.725 176.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -65.53 -40.93 93.5 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.254 179.562 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.523 HG12 ' O ' ' A' ' 117' ' ' VAL . 46.0 mm -62.9 -40.76 90.1 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 178.216 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -62.42 -43.87 97.79 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.58 174.518 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -65.75 -23.85 66.82 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.006 179.638 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.438 HD21 ' HA ' ' A' ' 79' ' ' LYS . 5.4 tt -77.98 -52.6 8.56 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.452 179.054 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 61.6 mt -94.62 -47.21 13.38 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 -171.209 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 13.5 tp10 . . . . . 0 C--O 1.243 0.746 0 CA-C-O 118.516 -0.754 . . . . 0.0 110.343 -174.966 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 28.6 m . . . . . 0 CA--C 1.535 0.369 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 76.9 m-85 -67.88 110.25 3.76 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-O 120.829 0.347 . . . . 0.0 110.603 178.823 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 48.8 mm -83.6 -55.77 6.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.934 -0.575 . . . . 0.0 109.877 178.459 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 61.8 t -122.91 134.3 66.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.376 -178.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 32.8 mtm180 -134.7 94.77 3.23 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 175.04 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 13.6 p -118.02 142.37 32.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.842 0.353 . . . . 0.0 110.882 -177.166 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 64.2 tttm -72.15 131.28 42.58 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.05 -179.42 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -161.7 -164.31 1.09 Allowed 'General case' 0 C--O 1.239 0.52 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.302 179.447 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.403 ' HB ' ' HB ' ' A' ' 103' ' ' THR . 61.7 t -124.21 105.7 15.77 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 CA-C-N 116.741 -0.208 . . . . 0.0 110.525 177.303 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.446 HG21 HG23 ' A' ' 72' ' ' VAL . 28.6 m -72.89 116.78 15.53 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 CA-C-O 121.475 0.655 . . . . 0.0 110.761 178.476 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 25.8 mmt -92.22 110.3 21.68 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.22 178.455 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.652 ' O ' ' HG3' ' A' ' 25' ' ' ARG . 7.4 t -83.23 2.53 35.35 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.578 -179.646 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.775 ' HG3' HH11 ' A' ' 25' ' ' ARG . 0.4 OUTLIER 53.37 172.88 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.956 0 N-CA-C 115.397 1.628 . . . . 0.0 115.397 166.449 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.545 ' HB2' ' CE2' ' A' ' 33' ' ' PHE . 36.6 t70 -143.03 6.76 1.57 Allowed 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 114.047 -1.433 . . . . 0.0 109.91 -178.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 65.4 m-20 66.24 -86.23 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.404 -178.219 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 22.9 t -151.1 99.95 2.73 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.334 -174.428 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.468 ' HB3' ' OD2' ' A' ' 26' ' ' ASP . 30.5 t 174.9 -54.46 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 177.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -111.26 -41.42 1.16 Allowed Glycine 0 N--CA 1.451 -0.307 0 N-CA-C 110.434 -1.067 . . . . 0.0 110.434 170.575 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 128.07 -109.97 1.09 Allowed Glycine 0 C--N 1.333 0.374 0 C-N-CA 121.578 -0.344 . . . . 0.0 112.675 175.122 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . 0.731 ' CE3' ' HB3' ' A' ' 25' ' ' ARG . 65.1 m95 -128.75 114.49 16.65 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 -178.797 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.545 ' CE2' ' HB2' ' A' ' 26' ' ' ASP . 8.5 p90 -120.47 151.41 53.8 Favored Pre-proline 0 C--O 1.239 0.503 0 CA-C-O 120.495 0.188 . . . . 0.0 110.966 178.47 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.475 ' HB2' ' HA3' ' A' ' 38' ' ' GLY . 73.5 Cg_endo -89.44 -154.35 0.05 OUTLIER 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 123.331 2.687 . . . . 0.0 111.739 175.171 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -156.62 147.44 21.82 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-O 120.532 0.206 . . . . 0.0 111.08 -176.779 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.478 ' HB3' ' HD3' ' A' ' 67' ' ' LYS . 12.3 mm-40 54.71 25.77 6.83 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 115.883 -0.598 . . . . 0.0 112.0 175.433 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 115.8 -42.48 1.89 Allowed Glycine 0 N--CA 1.453 -0.207 0 N-CA-C 111.497 -0.641 . . . . 0.0 111.497 -179.057 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.475 ' HA3' ' HB2' ' A' ' 34' ' ' PRO . . . 59.98 67.66 2.05 Favored Glycine 0 C--N 1.331 0.3 0 C-N-CA 121.353 -0.451 . . . . 0.0 112.76 179.198 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -153.78 -46.02 0.02 OUTLIER Glycine 0 N--CA 1.455 -0.1 0 N-CA-C 111.6 -0.6 . . . . 0.0 111.6 177.71 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.563 HG22 ' O ' ' A' ' 40' ' ' ILE . 2.6 mp -97.24 63.45 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 CA-C-O 121.634 0.73 . . . . 0.0 109.379 178.862 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.54 ' HB2' HE22 ' A' ' 66' ' ' GLN . 25.6 t -117.56 109.51 16.8 Favored 'General case' 0 C--N 1.33 -0.242 0 O-C-N 121.978 -0.451 . . . . 0.0 110.23 -178.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 60.4 mtp180 -89.62 110.98 21.81 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-O 120.895 0.379 . . . . 0.0 110.206 179.547 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.575 HG21 HD22 ' A' ' 102' ' ' LEU . 46.4 t -72.4 103.04 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.932 177.774 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -92.52 86.02 1.2 Allowed Glycine 0 N--CA 1.449 -0.483 0 CA-C-N 115.793 -0.639 . . . . 0.0 112.389 -178.798 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 51.4 t -71.5 100.72 0.9 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.411 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 176.564 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . 0.641 ' SG ' ' HB3' ' A' ' 60' ' ' LEU . 11.5 p -107.97 138.28 44.5 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.627 -178.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -95.71 119.37 34.09 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.8 -0.445 . . . . 0.0 109.8 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 33.5 m -92.69 148.38 4.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.802 -177.579 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 85.8 mtp . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.796 -178.524 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.567 0 N-CA-C 111.991 -0.443 . . . . 0.0 111.991 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.499 ' HE1' ' HB2' ' A' ' 124' ' ' LEU . 85.7 m-85 -134.03 155.5 49.89 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.995 0.426 . . . . 0.0 110.517 -178.064 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.641 ' HB3' ' SG ' ' A' ' 46' ' ' CYS . 3.8 tt -121.91 107.91 12.82 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 174.364 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.463 ' O ' ' HA ' ' A' ' 74' ' ' GLU . 49.1 mt -70.66 83.86 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 178.643 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . 0.577 ' HB2' HD22 ' A' ' 60' ' ' LEU . 11.9 t60 -103.35 93.02 4.75 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.482 -174.624 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -88.3 121.94 6.14 Favored Glycine 0 N--CA 1.447 -0.568 0 N-CA-C 111.057 -0.817 . . . . 0.0 111.057 174.695 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.7 pp20? -124.63 -175.58 3.31 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 116.857 0.329 . . . . 0.0 110.759 -179.448 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.524 ' O ' ' HB2' ' A' ' 66' ' ' GLN . 0.1 OUTLIER 79.3 147.31 0.09 Allowed 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.064 -0.971 . . . . 0.0 111.409 173.843 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.54 HE22 ' HB2' ' A' ' 41' ' ' SER . 5.4 tp-100 172.31 -57.09 0.01 OUTLIER 'General case' 0 C--O 1.231 0.12 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.612 172.199 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.478 ' HD3' ' HB3' ' A' ' 36' ' ' GLU . 7.2 ptmm? -156.07 -37.43 0.08 Allowed 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.903 -172.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -118.41 9.93 12.56 Favored 'General case' 0 N--CA 1.47 0.544 0 O-C-N 122.399 -0.188 . . . . 0.0 111.106 -178.268 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 20.0 ttmm 49.43 90.2 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 121.493 0.663 . . . . 0.0 109.732 -167.165 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.49 ' H ' HD23 ' A' ' 70' ' ' LEU . 2.0 pt? -142.03 160.18 40.73 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 -176.377 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 16.0 t -80.47 93.81 2.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 123.605 0.565 . . . . 0.0 109.567 178.611 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.446 HG23 HG21 ' A' ' 22' ' ' VAL . 30.6 m -79.26 -20.67 12.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.819 -177.575 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.474 HD13 ' N ' ' A' ' 74' ' ' GLU . 2.6 tm? -153.89 133.43 12.86 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 178.86 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.474 ' N ' HD13 ' A' ' 73' ' ' LEU . 13.2 pt-20 -151.49 129.6 11.87 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 176.31 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 61.0 m -146.93 117.7 7.6 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.057 -0.52 . . . . 0.0 109.779 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 42.3 t80 -90.96 144.26 25.86 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 -179.787 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 12.2 p -157.17 145.61 10.76 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 N-CA-C 110.3 -0.259 . . . . 0.0 110.3 179.6 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.404 ' HB3' ' H ' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -86.97 -161.19 0.65 Allowed 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.101 179.663 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.528 ' O ' ' HB2' ' A' ' 80' ' ' ASP . 23.0 ttmm -66.48 77.2 0.11 Allowed 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.934 176.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . 0.528 ' HB2' ' O ' ' A' ' 79' ' ' LYS . 25.6 t70 169.13 95.91 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.461 0.705 . . . . 0.0 109.585 174.489 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.478 HD23 ' H ' ' A' ' 82' ' ' VAL . 1.1 tt -137.06 138.83 40.84 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 -178.321 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.478 ' H ' HD23 ' A' ' 81' ' ' LEU . 26.0 m -124.43 127.53 73.12 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 CA-C-O 120.941 0.401 . . . . 0.0 110.933 179.041 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.642 ' HB3' ' NE2' ' A' ' 91' ' ' HIS . 11.7 m-85 -111.53 139.88 46.6 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.909 174.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.468 ' HB ' ' CE1' ' A' ' 92' ' ' HIS . 36.6 m -132.84 114.7 14.38 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.505 -179.472 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 2.6 ttmp? -85.34 99.61 11.27 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 177.269 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -83.08 -13.99 54.64 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.283 0.563 . . . . 0.0 110.518 -176.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . 0.766 ' HB3' ' HB3' ' A' ' 90' ' ' PHE . 27.8 t-20 -160.47 140.33 8.29 Favored Pre-proline 0 C--N 1.324 -0.513 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 -178.128 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_endo -46.94 -22.95 2.26 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 122.948 2.432 . . . . 0.0 113.614 178.073 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.471 HG22 ' OD1' ' A' ' 87' ' ' ASN . 12.6 t -116.51 14.7 15.6 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 120.767 0.318 . . . . 0.0 111.62 -179.872 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.766 ' HB3' ' HB3' ' A' ' 87' ' ' ASN . 79.6 t80 -146.39 114.98 6.79 Favored 'General case' 0 C--O 1.239 0.518 0 CA-C-O 121.218 0.532 . . . . 0.0 110.7 -178.262 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' HIS . . . . . 0.642 ' NE2' ' HB3' ' A' ' 83' ' ' TYR . 1.8 t-160 -121.49 123.11 41.25 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 -179.147 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . 0.468 ' CE1' ' HB ' ' A' ' 84' ' ' THR . 34.6 p80 -120.4 168.27 11.48 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.686 0.279 . . . . 0.0 110.857 -179.668 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 45.1 p90 -154.22 137.87 16.07 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.112 -177.653 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 56.6 tttp -95.71 107.81 20.06 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 174.466 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 35.5 m -136.41 151.04 27.85 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 CA-C-O 121.032 0.444 . . . . 0.0 111.15 -179.37 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 33.1 t70 59.87 -78.07 0.02 OUTLIER 'General case' 0 C--O 1.236 0.368 0 CA-C-N 114.882 -1.054 . . . . 0.0 112.459 173.291 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -134.96 -22.87 1.57 Allowed 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 112.796 0.665 . . . . 0.0 112.796 -174.373 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 7.9 tpt180 -146.02 175.55 10.37 Favored 'General case' 0 N--CA 1.465 0.316 0 O-C-N 121.884 -0.51 . . . . 0.0 111.026 -172.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 38.1 ttmt -101.43 108.42 20.02 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.822 -0.627 . . . . 0.0 109.623 -179.693 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -103.14 166.9 10.16 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 -179.751 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.413 ' HA2' ' HA ' ' A' ' 92' ' ' HIS . . . -159.59 178.57 35.65 Favored Glycine 0 CA--C 1.51 -0.239 0 C-N-CA 119.945 -1.121 . . . . 0.0 112.974 -177.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.575 HD22 HG21 ' A' ' 43' ' ' VAL . 3.9 pp -148.94 154.47 39.45 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-O 120.857 0.36 . . . . 0.0 110.771 177.697 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.403 ' HB ' ' HB ' ' A' ' 21' ' ' VAL . 90.0 m -105.42 128.38 53.49 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.755 175.41 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.436 ' CE2' ' HB2' ' A' ' 91' ' ' HIS . 61.2 m-85 -74.19 169.58 17.29 Favored 'General case' 0 C--O 1.238 0.489 0 CA-C-O 121.182 0.515 . . . . 0.0 111.224 -178.264 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 28.2 tt0 -106.94 -38.15 6.13 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.122 -179.363 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 24.8 m -151.83 157.21 34.49 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.94 178.799 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.483 ' HA ' ' HB3' ' A' ' 110' ' ' ALA . 12.2 Cg_endo -56.55 -22.61 43.95 Favored 'Trans proline' 0 C--N 1.352 0.743 0 C-N-CA 122.348 2.032 . . . . 0.0 111.99 177.041 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -60.58 -63.32 1.34 Allowed 'General case' 0 C--O 1.233 0.213 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.716 175.775 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -66.23 -29.08 69.25 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.732 178.656 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.483 ' HB3' ' HA ' ' A' ' 107' ' ' PRO . . . -59.65 -52.5 65.24 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.975 0.416 . . . . 0.0 110.694 175.788 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 60.8 ttp85 -68.39 -44.31 75.39 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.337 -179.488 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -59.18 -42.1 90.02 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.01 -178.681 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 74.9 t80 -73.69 -39.11 64.63 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.424 -179.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.419 ' O ' HG12 ' A' ' 117' ' ' VAL . 37.4 t70 -62.69 -65.78 0.64 Allowed 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 121.326 0.584 . . . . 0.0 110.47 179.178 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 1.5 tmt_? -56.69 -39.8 74.47 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.166 -0.925 . . . . 0.0 110.017 177.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -59.19 -51.03 61.61 Favored Glycine 0 C--N 1.333 0.416 0 C-N-CA 121.101 -0.571 . . . . 0.0 112.501 179.62 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.526 ' O ' HG12 ' A' ' 121' ' ' ILE . 8.6 p -68.88 -30.26 46.29 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 N-CA-C 110.209 -0.293 . . . . 0.0 110.209 -178.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 3.2 mpt_? -62.53 -46.57 87.78 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.379 177.434 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 53.7 tptt -65.79 -40.92 92.42 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.111 177.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -57.49 -45.92 84.34 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.457 177.395 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.526 HG12 ' O ' ' A' ' 117' ' ' VAL . 40.1 mm -64.43 -38.71 83.28 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.337 177.823 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -57.89 -50.65 72.6 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.531 -179.799 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 44.1 m-20 -71.2 -29.42 65.13 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.847 178.697 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.499 ' HB2' ' HE1' ' A' ' 59' ' ' PHE . 65.6 tp -65.71 -54.38 28.13 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.229 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.492 HG22 ' O ' ' A' ' 121' ' ' ILE . 10.7 tp -83.05 -37.18 13.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.19 -174.05 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 . . . . . 0 C--O 1.251 1.163 0 O-C-N 123.59 0.556 . . . . 0.0 109.945 -176.606 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 15.8 m . . . . . 0 CA--C 1.532 0.283 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.622 ' HB3' ' HD2' ' A' ' 17' ' ' ARG . 59.6 m-85 -63.31 93.1 0.06 Allowed 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 120.835 0.35 . . . . 0.0 110.933 179.088 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.4 HG23 HG23 ' A' ' 16' ' ' VAL . 7.5 tp -83.41 -45.66 18.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.308 -178.301 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.4 HG23 HG23 ' A' ' 15' ' ' ILE . 92.1 t -125.3 121.46 60.62 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 CA-C-O 120.848 0.356 . . . . 0.0 110.64 -177.788 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.622 ' HD2' ' HB3' ' A' ' 14' ' ' TYR . 0.0 OUTLIER -125.51 103.8 8.08 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.81 178.94 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 27.2 m -119.89 176.47 3.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 177.547 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 21.5 pttm -128.33 129.97 47.07 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.822 0.344 . . . . 0.0 110.752 -177.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.441 ' HB3' HD21 ' A' ' 102' ' ' LEU . . . -159.02 -178.86 7.54 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.833 179.699 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 40.3 t -93.54 99.78 10.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 120.866 0.365 . . . . 0.0 110.707 -176.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.488 HG11 ' HG ' ' A' ' 73' ' ' LEU . 57.2 t -81.79 106.42 12.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.626 -179.678 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 23.1 mmt -86.04 150.72 24.26 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.258 177.598 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 5.2 t -123.08 151.49 41.96 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.055 -0.521 . . . . 0.0 109.951 177.539 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 59.1 ttt180 -123.18 104.7 9.34 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.145 -0.48 . . . . 0.0 109.82 -178.61 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -81.2 56.14 2.76 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-O 121.27 0.557 . . . . 0.0 109.681 -179.044 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 65.4 m-20 57.58 22.88 8.65 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.131 -0.94 . . . . 0.0 110.563 -177.374 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.9 m -67.32 156.38 36.58 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 115.179 -0.919 . . . . 0.0 110.782 179.574 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 23.9 m -62.19 -43.73 98.19 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-O 120.961 0.41 . . . . 0.0 110.461 177.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -164.01 10.27 0.08 OUTLIER Glycine 0 C--N 1.333 0.371 0 CA-C-N 115.839 -0.619 . . . . 0.0 112.38 177.22 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -83.11 80.22 1.84 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 121.203 -0.522 . . . . 0.0 112.492 -178.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 84.9 m95 -72.98 99.64 2.77 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 174.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.488 ' HA ' ' HD3' ' A' ' 34' ' ' PRO . 26.0 p90 -98.07 141.04 22.32 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.949 -174.471 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.593 ' HB2' ' HA2' ' A' ' 38' ' ' GLY . 9.1 Cg_exo -72.15 136.34 26.74 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.894 2.396 . . . . 0.0 111.593 178.625 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.434 ' O ' ' N ' ' A' ' 37' ' ' GLY . 2.9 pp0? -93.38 145.13 24.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.208 -179.419 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 44.8 mm-40 41.5 -82.76 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 113.788 1.032 . . . . 0.0 113.788 173.274 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.434 ' N ' ' O ' ' A' ' 35' ' ' GLN . . . -58.8 -30.8 66.6 Favored Glycine 0 C--N 1.333 0.392 0 C-N-CA 121.45 -0.405 . . . . 0.0 112.959 -174.705 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.593 ' HA2' ' HB2' ' A' ' 34' ' ' PRO . . . 67.21 12.06 60.02 Favored Glycine 0 C--N 1.33 0.249 0 C-N-CA 121.046 -0.597 . . . . 0.0 112.261 -179.054 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -167.72 -123.02 0.64 Allowed Glycine 0 N--CA 1.446 -0.67 0 N-CA-C 111.586 -0.606 . . . . 0.0 111.586 -177.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 34.0 pt -64.23 135.98 27.12 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 CA-C-O 121.343 0.592 . . . . 0.0 111.815 -177.171 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 39.6 m -144.0 132.84 22.59 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.022 175.284 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.479 ' HD3' ' HB3' ' A' ' 17' ' ' ARG . 5.7 tmm_? -76.3 103.45 6.33 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 -179.017 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.476 HG11 HD11 ' A' ' 102' ' ' LEU . 4.0 p -91.79 110.2 22.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.58 0.705 . . . . 0.0 109.89 177.323 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.451 ' N ' HH11 ' A' ' 42' ' ' ARG . . . -107.43 103.67 1.99 Allowed Glycine 0 N--CA 1.448 -0.536 0 CA-C-N 115.395 -0.821 . . . . 0.0 111.505 -179.495 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 7.5 p -86.13 125.18 40.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 178.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . 0.789 ' SG ' ' HB3' ' A' ' 60' ' ' LEU . 7.0 p -126.54 128.5 46.97 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.603 -178.063 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 3.2 ttmp? -81.58 98.85 8.53 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 177.162 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 46.0 t -73.87 85.49 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 177.694 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 13.5 tpt . . . . . 0 C--O 1.237 0.431 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.499 -178.676 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.347 0 N-CA-C 112.234 -0.346 . . . . 0.0 112.234 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.474 ' O ' HG22 ' A' ' 77' ' ' VAL . 84.8 m-85 -127.83 125.78 40.41 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 178.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.789 ' HB3' ' SG ' ' A' ' 46' ' ' CYS . 1.6 tt -93.99 108.2 20.04 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 179.86 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 48.3 mm -80.65 91.41 1.81 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.261 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 174.418 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . 0.672 ' HB2' HD22 ' A' ' 60' ' ' LEU . 28.5 t60 -108.45 106.64 16.85 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.83 -173.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.427 ' HA2' ' O ' ' A' ' 42' ' ' ARG . . . -114.8 138.57 14.91 Favored Glycine 0 C--O 1.235 0.209 0 N-CA-C 111.725 -0.55 . . . . 0.0 111.725 178.422 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.419 ' HB2' ' O ' ' A' ' 70' ' ' LEU . 14.4 pt-20 -120.35 160.18 23.55 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 120.881 0.372 . . . . 0.0 110.801 -179.803 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.475 ' HB2' HG11 ' A' ' 72' ' ' VAL . 2.0 tmt_? -82.75 122.66 28.46 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 177.428 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 9.5 mm100 -58.67 97.45 0.03 OUTLIER 'General case' 0 C--O 1.234 0.269 0 CA-C-O 121.105 0.479 . . . . 0.0 112.007 -174.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 29.5 mtpp -140.27 -72.05 0.37 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.193 -0.912 . . . . 0.0 108.739 173.152 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -160.25 -46.89 0.05 OUTLIER 'General case' 0 C--O 1.235 0.327 0 CA-C-N 114.67 -1.15 . . . . 0.0 108.93 -178.617 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 56.1 tttm -170.36 99.12 0.26 Allowed 'General case' 0 C--O 1.236 0.39 0 CA-C-N 115.099 -0.955 . . . . 0.0 109.569 177.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.419 ' O ' ' HB2' ' A' ' 64' ' ' GLU . 4.1 tt -157.21 107.77 2.28 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 -178.744 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 43.8 t -78.58 125.18 37.9 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.004 -177.377 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.475 HG11 ' HB2' ' A' ' 65' ' ' ARG . 27.7 m -123.02 -28.96 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.584 179.735 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.488 ' HG ' HG11 ' A' ' 22' ' ' VAL . 2.6 tm? -123.66 117.02 24.05 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 -177.446 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -131.78 107.0 8.47 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 176.742 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 52.5 t -135.13 79.5 1.79 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.349 0.595 . . . . 0.0 109.953 179.676 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.549 ' HA ' ' HA ' ' A' ' 60' ' ' LEU . 57.2 t80 -72.74 105.07 4.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.98 175.472 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.474 HG22 ' O ' ' A' ' 59' ' ' PHE . 34.8 m -81.11 114.54 22.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 178.601 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.723 ' HD2' ' H ' ' A' ' 78' ' ' ARG . 0.3 OUTLIER -82.66 61.67 5.89 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 -173.819 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 36.3 mtmm 68.68 -2.87 1.54 Allowed 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.206 -172.385 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -92.36 85.77 5.49 Favored 'General case' 0 N--CA 1.462 0.148 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 174.035 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.721 HD22 HD11 ' A' ' 121' ' ' ILE . 2.4 tt -131.25 106.82 8.56 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.976 -173.854 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 59.5 t -124.05 92.38 2.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.252 176.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.407 ' CD1' ' HB3' ' A' ' 93' ' ' TRP . 0.2 OUTLIER -81.49 101.54 9.98 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.04 178.672 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 22.5 m -90.93 127.22 36.31 Favored 'General case' 0 C--N 1.323 -0.543 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 178.602 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 24.7 pttm -93.32 111.25 22.85 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.111 0.481 . . . . 0.0 110.857 -177.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -90.07 -44.16 10.01 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.271 0.558 . . . . 0.0 109.503 175.676 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . 0.612 ' HB2' ' HB3' ' A' ' 90' ' ' PHE . 93.0 m-20 -138.63 153.98 72.81 Favored Pre-proline 0 C--N 1.328 -0.363 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 177.132 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -55.26 -27.41 56.94 Favored 'Trans proline' 0 CA--C 1.533 0.471 0 C-N-CA 122.22 1.947 . . . . 0.0 112.034 176.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 10.8 p -105.91 8.47 32.61 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.836 178.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.612 ' HB3' ' HB2' ' A' ' 87' ' ' ASN . 25.6 t80 -140.81 102.97 4.4 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-O 121.076 0.465 . . . . 0.0 110.405 -179.784 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 14.2 m80 -107.7 132.51 53.27 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.513 174.321 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . 0.424 ' HA ' ' O ' ' A' ' 100' ' ' PHE . 8.2 p80 -126.95 129.56 48.37 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.74 0.305 . . . . 0.0 110.204 178.138 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . 0.62 ' HZ3' ' HB2' ' A' ' 102' ' ' LEU . 34.8 p90 -110.01 149.77 29.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.079 179.3 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 14.3 tmtt? -112.57 122.1 46.72 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.059 -178.038 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.439 HG13 ' HD1' ' A' ' 93' ' ' TRP . 21.1 m -124.88 127.33 72.47 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.071 176.863 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 42.3 m-20 59.6 -80.18 0.02 OUTLIER 'General case' 0 C--O 1.235 0.297 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.953 -179.108 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -133.74 -28.48 1.41 Allowed 'General case' 0 C--O 1.234 0.243 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.609 -176.65 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 62.5 mtt180 -103.44 156.46 17.74 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 121.482 0.658 . . . . 0.0 112.495 -171.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.84 137.34 52.83 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 114.64 -1.164 . . . . 0.0 109.846 -179.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . 0.424 ' O ' ' HA ' ' A' ' 92' ' ' HIS . 36.6 m-85 -122.98 137.13 55.04 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 176.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -115.76 101.59 1.03 Allowed Glycine 0 C--N 1.333 0.409 0 C-N-CA 120.968 -0.634 . . . . 0.0 113.216 -171.116 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.62 ' HB2' ' HZ3' ' A' ' 93' ' ' TRP . 3.7 tt -74.42 104.25 5.09 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.211 -0.662 . . . . 0.0 109.211 177.047 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.401 ' HG1' ' HD2' ' A' ' 90' ' ' PHE . 17.5 m -96.67 114.97 26.66 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.142 179.773 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.422 ' CG ' ' HA ' ' A' ' 110' ' ' ALA . 74.5 m-85 -72.27 167.31 20.67 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.296 -175.368 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -112.71 -31.66 6.67 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.71 -175.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 5.7 m -138.51 150.07 64.92 Favored Pre-proline 0 C--N 1.329 -0.31 0 N-CA-C 110.187 -0.301 . . . . 0.0 110.187 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -52.96 -29.02 42.17 Favored 'Trans proline' 0 C--N 1.352 0.718 0 C-N-CA 122.309 2.006 . . . . 0.0 111.86 176.781 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -59.44 -65.59 0.65 Allowed 'General case' 0 C--O 1.236 0.384 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.858 177.227 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -64.92 -31.59 72.9 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.949 -179.344 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.422 ' HA ' ' CG ' ' A' ' 104' ' ' PHE . . . -58.52 -60.85 3.15 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.092 177.395 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 20.0 mtm180 -66.54 -32.54 73.96 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.748 -177.628 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -63.51 -56.67 14.24 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.037 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.405 ' HB3' ' CE1' ' A' ' 104' ' ' PHE . 39.1 t80 -71.03 -28.89 64.72 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.337 -177.214 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -54.84 -63.43 1.16 Allowed 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 121.808 0.813 . . . . 0.0 109.588 173.17 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 52.4 ttt180 -56.51 -37.21 70.1 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.306 -1.315 . . . . 0.0 110.835 177.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -63.94 -53.89 34.39 Favored Glycine 0 C--O 1.237 0.304 0 CA-C-N 115.837 -0.62 . . . . 0.0 112.909 -179.164 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.449 ' O ' HG12 ' A' ' 121' ' ' ILE . 11.9 p -67.71 -33.67 63.23 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 -178.292 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.503 ' O ' ' HG3' ' A' ' 122' ' ' GLU . 54.2 ttt180 -55.54 -50.96 68.63 Favored 'General case' 0 C--O 1.231 0.089 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 173.223 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.643 ' HE2' ' HA ' ' A' ' 119' ' ' LYS . 0.6 OUTLIER -56.47 -46.39 80.42 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.065 178.786 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -56.85 -42.5 79.8 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.949 178.769 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.721 HD11 HD22 ' A' ' 81' ' ' LEU . 42.6 mm -61.59 -39.59 83.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.925 176.682 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.53 ' HA ' ' HA ' ' A' ' 126' ' ' GLU . 41.2 mt-10 -66.23 -37.73 86.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.652 179.676 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -65.26 -36.6 84.61 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-O 121.222 0.534 . . . . 0.0 109.988 174.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 59.3 tp -71.46 -55.35 8.07 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.675 -176.714 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.42 ' O ' HG13 ' A' ' 125' ' ' ILE . 11.3 tp -145.47 10.18 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 N-CA-C 111.655 0.243 . . . . 0.0 111.655 -171.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.53 ' HA ' ' HA ' ' A' ' 122' ' ' GLU . 34.0 tt0 . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.429 -0.796 . . . . 0.0 110.753 -175.291 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 16.5 m . . . . . 0 CA--C 1.536 0.429 0 N-CA-C 111.857 0.317 . . . . 0.0 111.857 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.425 ' HE2' ' HA3' ' A' ' 44' ' ' GLY . 24.7 m-85 -65.14 123.4 19.42 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-O 120.695 0.283 . . . . 0.0 110.561 178.191 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 13.0 tt -102.73 -34.1 3.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 173.411 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.414 ' HB ' ' HB ' ' A' ' 45' ' ' VAL . 97.8 t -139.3 130.12 33.03 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.764 177.808 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 11.6 ptm180 -142.41 91.13 2.29 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.199 0.523 . . . . 0.0 110.277 176.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 35.1 m -107.5 161.08 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.928 -177.629 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 47.3 mtmt -93.83 130.58 39.8 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.392 178.764 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -163.25 158.59 21.72 Favored 'General case' 0 C--N 1.331 -0.223 0 O-C-N 123.254 0.346 . . . . 0.0 110.29 179.219 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 58.4 t -90.77 105.66 16.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 178.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.599 HG23 ' NE2' ' A' ' 35' ' ' GLN . 15.8 m -81.23 115.18 23.37 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 CA-C-O 121.406 0.622 . . . . 0.0 111.673 -176.541 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 24.0 mmt -99.66 162.78 12.81 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.973 179.589 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 9.9 t -136.64 158.19 45.02 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.943 0.402 . . . . 0.0 110.854 -179.13 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 20.5 ttt180 -136.36 100.26 4.33 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 -179.651 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.587 ' H ' ' HE1' ' A' ' 33' ' ' PHE . 27.4 t70 -63.03 104.43 0.56 Allowed 'General case' 0 C--O 1.234 0.267 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.541 -172.078 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.639 ' HA ' ' HG2' ' A' ' 98' ' ' ARG . 23.8 t70 60.23 -76.85 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.677 176.862 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 37.4 p -145.01 22.94 1.55 Allowed 'General case' 0 C--O 1.236 0.345 0 N-CA-C 111.484 0.179 . . . . 0.0 111.484 -178.694 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 49.1 m -51.6 143.05 13.1 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.994 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -81.58 61.89 4.57 Favored Glycine 0 CA--C 1.52 0.354 0 C-N-CA 121.431 -0.414 . . . . 0.0 112.629 -177.386 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 158.67 -168.91 34.98 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 121.279 -0.486 . . . . 0.0 111.942 179.195 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . 0.571 ' HH2' ' HG2' ' A' ' 99' ' ' LYS . 88.2 m95 -128.26 116.45 19.88 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 177.871 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.587 ' HE1' ' H ' ' A' ' 26' ' ' ASP . 37.7 p90 -110.78 148.29 38.25 Favored Pre-proline 0 C--O 1.235 0.308 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.894 -175.833 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -77.88 157.55 31.14 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.73 2.287 . . . . 0.0 111.549 176.484 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.599 ' NE2' HG23 ' A' ' 22' ' ' VAL . 2.5 pp0? -136.11 -152.89 0.47 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.059 -0.518 . . . . 0.0 109.923 -178.728 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 22.5 tp10 -52.74 -22.15 4.92 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 120.918 0.389 . . . . 0.0 111.49 -177.163 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -112.32 46.13 1.22 Allowed Glycine 0 CA--C 1.518 0.26 0 N-CA-C 111.578 -0.609 . . . . 0.0 111.578 175.304 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -71.95 -19.45 78.3 Favored Glycine 0 C--N 1.331 0.292 0 C-N-CA 121.357 -0.449 . . . . 0.0 112.664 -179.507 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -97.29 -151.04 27.39 Favored Glycine 0 C--O 1.237 0.301 0 C-N-CA 121.35 -0.452 . . . . 0.0 112.097 178.286 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 50.6 mm -65.72 99.18 0.29 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.38 0 CA-C-O 121.154 0.502 . . . . 0.0 110.284 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 36.8 m -105.66 -175.8 2.9 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.475 179.818 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.608 HH22 ' N ' ' A' ' 68' ' ' ASP . 28.3 ttm180 -130.53 134.94 47.44 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.764 -178.022 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.808 HG21 HD22 ' A' ' 102' ' ' LEU . 24.3 t -100.05 94.44 3.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 171.216 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.425 ' HA3' ' HE2' ' A' ' 14' ' ' TYR . . . -98.37 91.94 1.18 Allowed Glycine 0 N--CA 1.449 -0.474 0 CA-C-N 115.827 -0.624 . . . . 0.0 113.098 -173.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.414 ' HB ' ' HB ' ' A' ' 16' ' ' VAL . 51.4 t -76.3 109.94 10.94 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 175.236 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . 0.699 ' SG ' ' HB3' ' A' ' 60' ' ' LEU . 9.1 p -121.88 137.33 54.82 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.431 -178.446 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.574 ' HA ' ' O ' ' A' ' 58' ' ' GLY . 42.1 mtmt -84.97 118.38 24.52 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.981 0.42 . . . . 0.0 111.033 -179.797 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 42.7 t -90.91 118.24 35.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.185 173.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 67.1 mtm . . . . . 0 C--N 1.329 -0.312 0 CA-C-O 121.018 0.437 . . . . 0.0 110.529 -178.597 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.574 ' O ' ' HA ' ' A' ' 47' ' ' LYS . . . . . . . . 0 N--CA 1.452 -0.263 0 N-CA-C 112.079 -0.408 . . . . 0.0 112.079 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 32.6 m-85 -103.0 97.07 7.24 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.268 0.556 . . . . 0.0 110.5 -177.592 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.719 ' HA ' ' HA ' ' A' ' 76' ' ' TYR . 2.7 tt -81.69 110.0 16.63 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 178.53 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 60.8 mt -75.33 86.4 0.66 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.314 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 174.106 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 12.3 t-80 -90.08 101.19 13.91 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.254 -0.884 . . . . 0.0 109.946 -176.337 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -91.27 114.55 4.52 Favored Glycine 0 N--CA 1.449 -0.435 0 CA-C-N 115.937 -0.574 . . . . 0.0 112.204 -177.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -119.51 -170.27 1.91 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.025 0.44 . . . . 0.0 110.934 179.589 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 23.0 mmt85 -83.58 -174.73 5.45 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.451 169.717 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 28.7 pt20 -55.59 -35.17 65.51 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.168 177.127 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -115.51 147.89 40.13 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.278 -178.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.608 ' N ' HH22 ' A' ' 42' ' ' ARG . 1.8 m-20 -67.85 105.59 2.02 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.1 -178.424 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -176.17 -39.21 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.348 0 O-C-N 123.168 0.293 . . . . 0.0 111.591 -179.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 61.5 tp -122.03 115.54 22.69 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.622 0.249 . . . . 0.0 111.282 -175.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 35.4 t -88.82 110.47 21.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.891 176.771 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 35.9 m -91.3 -36.68 8.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.259 -177.696 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -133.42 151.49 51.82 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 122.491 0.317 . . . . 0.0 110.234 178.742 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.542 ' HG2' HD21 ' A' ' 60' ' ' LEU . 2.9 tm-20 -146.94 115.75 6.82 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 175.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 50.0 t -141.15 83.7 1.89 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.21 0.529 . . . . 0.0 110.616 -178.364 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.719 ' HA ' ' HA ' ' A' ' 60' ' ' LEU . 78.4 t80 -68.87 122.65 19.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.587 175.768 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.475 HG12 ' HB2' ' A' ' 80' ' ' ASP . 17.2 m -133.21 122.71 45.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.006 0.431 . . . . 0.0 110.281 178.031 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 11.5 ptm180 -110.04 -27.77 9.03 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.2 0.524 . . . . 0.0 110.211 179.164 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -155.05 22.25 0.43 Allowed 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 173.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . 0.475 ' HB2' HG12 ' A' ' 77' ' ' VAL . 0.7 OUTLIER -114.7 9.55 16.45 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 114.414 -1.266 . . . . 0.0 109.816 -172.557 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.828 HD22 HD11 ' A' ' 121' ' ' ILE . 3.5 tt -79.17 104.42 9.79 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.171 -172.316 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 48.4 t -127.97 96.78 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 CA-C-N 116.567 -0.288 . . . . 0.0 110.667 177.201 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.506 ' HD2' ' CD2' ' A' ' 91' ' ' HIS . 4.5 m-85 -91.71 172.46 8.47 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-O 121.396 0.617 . . . . 0.0 111.076 178.306 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 50.1 m -154.42 110.75 3.26 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.056 -0.974 . . . . 0.0 109.314 -179.629 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.474 ' NZ ' ' HB3' ' A' ' 85' ' ' LYS . 5.2 ttpm? -77.3 107.05 9.43 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 177.346 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -85.28 -59.65 2.26 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.214 0.53 . . . . 0.0 110.138 -179.614 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 -130.19 158.63 73.59 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.353 -179.177 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -56.13 -13.69 10.05 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 122.6 2.2 . . . . 0.0 113.189 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 12.7 t -125.21 5.8 7.81 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-O 120.452 0.168 . . . . 0.0 111.304 179.509 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 17.8 t80 -135.36 114.28 12.05 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 -179.57 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' HIS . . . . . 0.506 ' CD2' ' HD2' ' A' ' 83' ' ' TYR . 2.3 t-160 -130.24 129.91 43.94 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 -176.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . 0.4 ' CE1' ' HD3' ' A' ' 99' ' ' LYS . 20.7 p80 -138.78 174.98 9.96 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.527 0.203 . . . . 0.0 111.066 -174.832 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . 0.48 ' HB3' ' CD1' ' A' ' 83' ' ' TYR . 34.2 p90 -142.8 171.72 13.67 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 176.427 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -137.24 150.34 47.78 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.037 0.446 . . . . 0.0 110.815 -178.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 24.6 m -122.85 -140.27 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 173.4 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -59.39 83.72 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 118.083 0.401 . . . . 0.0 110.918 176.548 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 52.8 t30 68.99 -63.58 0.36 Allowed 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.232 1.013 . . . . 0.0 112.147 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.639 ' HG2' ' HA ' ' A' ' 27' ' ' ASP . 60.0 mtt-85 -55.03 136.07 48.28 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 121.251 0.548 . . . . 0.0 110.745 -176.611 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.571 ' HG2' ' HH2' ' A' ' 32' ' ' TRP . 4.5 ttmp? -127.18 132.84 50.4 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.472 -0.786 . . . . 0.0 110.308 -169.058 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 1.1 p90 -147.2 158.22 43.87 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 -179.174 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.427 ' HA2' ' CZ3' ' A' ' 93' ' ' TRP . . . -164.23 -153.21 7.29 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.384 -0.912 . . . . 0.0 113.338 -174.572 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.808 HD22 HG21 ' A' ' 43' ' ' VAL . 4.1 pp -144.48 168.21 20.67 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.099 0.476 . . . . 0.0 110.977 -174.63 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 15.3 m -128.59 119.73 25.32 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.533 178.091 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 47.5 m-85 -66.27 160.05 25.27 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.089 178.091 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 29.8 pt20 -129.54 -27.08 2.42 Favored 'General case' 0 C--N 1.328 -0.37 0 N-CA-C 111.535 0.198 . . . . 0.0 111.535 -177.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 32.1 m -135.13 150.21 72.29 Favored Pre-proline 0 C--N 1.329 -0.299 0 N-CA-C 110.282 -0.266 . . . . 0.0 110.282 179.449 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.579 ' O ' ' HG2' ' A' ' 111' ' ' ARG . 82.2 Cg_exo -49.59 -35.2 36.79 Favored 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 122.683 2.256 . . . . 0.0 112.254 177.13 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -57.84 -63.52 1.22 Allowed 'General case' 0 C--O 1.235 0.314 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.574 -179.57 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -62.28 -34.37 76.44 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.736 -179.003 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -55.29 -66.59 0.39 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.117 177.151 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . 0.579 ' HG2' ' O ' ' A' ' 107' ' ' PRO . 44.7 ptt85 -59.58 -47.21 86.47 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.237 -176.794 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -63.15 -49.84 72.76 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.74 -172.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.493 ' O ' HG23 ' A' ' 117' ' ' VAL . 63.2 t80 -75.6 -43.45 48.05 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.803 -175.655 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -55.47 -59.71 4.43 Favored 'General case' 0 C--O 1.24 0.556 0 CA-C-O 121.566 0.698 . . . . 0.0 109.957 179.688 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 22.8 ttm180 -59.4 -37.23 77.47 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 114.895 -1.048 . . . . 0.0 109.93 177.041 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -58.35 -39.38 92.63 Favored Glycine 0 N--CA 1.45 -0.419 0 CA-C-N 115.861 -0.609 . . . . 0.0 112.362 178.257 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.493 HG23 ' O ' ' A' ' 113' ' ' PHE . 72.6 t -71.3 -49.8 45.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.607 0.241 . . . . 0.0 110.809 -179.727 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.403 HH11 ' HD2' ' A' ' 118' ' ' ARG . 44.2 mtm105 -59.78 -44.87 93.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.875 0.369 . . . . 0.0 110.785 179.503 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 45.3 tptt -65.97 -36.01 82.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.447 177.54 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -62.42 -43.84 97.86 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.309 176.481 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.828 HD11 HD22 ' A' ' 81' ' ' LEU . 32.4 mm -60.68 -42.81 93.34 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.108 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.278 177.617 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.441 ' O ' ' HG3' ' A' ' 126' ' ' GLU . 34.7 tt0 -56.35 -57.32 12.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.165 177.837 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 74.0 m-20 -69.7 -18.91 63.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.601 -177.583 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 6.0 tt -77.27 -45.44 26.34 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 178.057 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 13.9 tt -78.98 -28.05 13.68 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.354 -175.46 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.441 ' HG3' ' O ' ' A' ' 122' ' ' GLU . 50.1 mt-10 . . . . . 0 C--O 1.255 1.39 0 CA-C-O 118.384 -0.817 . . . . 0.0 110.264 178.372 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 33.3 t . . . . . 0 C--O 1.234 0.254 0 CA-C-O 120.518 0.199 . . . . 0.0 111.189 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 61.8 m-85 -63.36 89.57 0.04 OUTLIER 'General case' 0 C--O 1.233 0.232 0 CA-C-O 121.065 0.46 . . . . 0.0 110.446 177.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 62.5 mt -73.96 -32.08 32.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.62 -179.057 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 60.4 t -123.62 100.3 7.63 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.18 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.902 -178.708 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 86.6 mtm180 -112.74 93.58 4.49 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 172.822 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 30.9 m -120.12 174.47 5.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.993 0.425 . . . . 0.0 111.644 -175.69 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.687 ' HD2' HD11 ' A' ' 40' ' ' ILE . 9.4 mtmp? -110.74 114.96 28.72 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.71 -178.1 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -148.54 179.97 7.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.222 179.748 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 42.6 t -109.15 109.89 30.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 110.251 -0.278 . . . . 0.0 110.251 179.69 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 15.8 m -70.46 95.9 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 CA-C-O 121.522 0.677 . . . . 0.0 111.415 -178.728 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . 0.659 ' H ' ' HA ' ' A' ' 102' ' ' LEU . 21.2 mmt -89.96 115.16 27.04 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.036 -179.781 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.495 HG23 ' CE1' ' A' ' 33' ' ' PHE . 9.6 t -112.67 162.93 15.15 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.341 0.591 . . . . 0.0 110.393 179.67 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.411 ' O ' ' N ' ' A' ' 27' ' ' ASP . 5.4 tpm_? -133.12 98.17 4.2 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 176.557 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.62 ' H ' ' HE1' ' A' ' 33' ' ' PHE . 30.8 t70 -60.7 80.46 0.01 OUTLIER 'General case' 0 C--O 1.233 0.211 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.137 -178.151 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.411 ' N ' ' O ' ' A' ' 25' ' ' ARG . 0.8 OUTLIER 57.04 173.07 0.04 OUTLIER 'General case' 0 C--O 1.235 0.314 0 CA-C-N 115.037 -0.983 . . . . 0.0 111.208 -174.658 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 40.0 m 59.66 -167.83 0.16 Allowed 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 120.873 0.368 . . . . 0.0 110.91 -178.217 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 68.1 m -149.64 132.0 15.61 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 172.274 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 146.95 65.7 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.297 0 N-CA-C 111.601 -0.6 . . . . 0.0 111.601 -178.67 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 118.84 98.84 1.86 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 121.235 -0.507 . . . . 0.0 112.195 -179.525 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . 0.539 ' HH2' ' HG2' ' A' ' 99' ' ' LYS . 77.7 m95 -81.9 120.2 24.9 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 176.694 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.62 ' HE1' ' H ' ' A' ' 26' ' ' ASP . 14.2 p90 -115.09 132.5 23.0 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.438 -0.347 . . . . 0.0 110.505 -176.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.559 ' HB2' ' HA3' ' A' ' 38' ' ' GLY . 71.4 Cg_endo -74.69 112.86 3.65 Favored 'Trans proline' 0 N--CA 1.458 -0.57 0 C-N-CA 121.939 1.76 . . . . 0.0 110.657 175.158 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -54.81 129.03 35.66 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.455 -175.424 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 63.19 16.0 9.03 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.62 -179.554 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 107.34 -26.27 19.07 Favored Glycine 0 C--N 1.33 0.245 0 C-N-CA 121.494 -0.384 . . . . 0.0 112.643 177.666 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.559 ' HA3' ' HB2' ' A' ' 34' ' ' PRO . . . 72.41 -71.61 1.02 Allowed Glycine 0 CA--C 1.519 0.289 0 C-N-CA 121.221 -0.514 . . . . 0.0 112.572 -179.835 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 62.04 -96.68 0.14 Allowed Glycine 0 C--N 1.333 0.394 0 N-CA-C 112.121 -0.392 . . . . 0.0 112.121 -179.292 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.687 HD11 ' HD2' ' A' ' 19' ' ' LYS . 12.5 tt -141.78 80.53 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 122.056 0.932 . . . . 0.0 109.475 178.23 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 9.3 m -77.09 141.92 40.02 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.67 -173.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.755 ' HB3' ' HB2' ' A' ' 64' ' ' GLU . 41.3 ttm180 -92.98 97.53 10.78 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 178.125 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 48.1 t -76.22 107.47 7.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.097 -0.501 . . . . 0.0 109.961 -178.591 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -106.78 112.08 3.7 Favored Glycine 0 N--CA 1.448 -0.511 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.824 179.446 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 62.0 t -106.4 111.52 35.68 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 177.613 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . 0.779 ' SG ' ' HB3' ' A' ' 60' ' ' LEU . 8.0 p -104.92 143.1 33.62 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.548 178.352 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 40.9 ttmt -94.89 92.9 7.14 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 121.026 0.441 . . . . 0.0 109.972 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 42.6 t -77.11 88.0 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.769 178.718 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 61.0 mtm . . . . . 0 C--N 1.328 -0.369 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.256 -179.954 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.366 0 N-CA-C 111.662 -0.575 . . . . 0.0 111.662 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -133.24 119.76 20.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.928 0.394 . . . . 0.0 110.413 -179.54 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.779 ' HB3' ' SG ' ' A' ' 46' ' ' CYS . 1.2 tt -96.2 110.21 22.54 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 179.003 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 57.3 mt -84.85 90.84 2.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 174.54 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -103.46 116.16 31.88 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.082 -175.106 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -91.42 96.05 2.14 Favored Glycine 0 N--CA 1.449 -0.493 0 CA-C-N 115.964 -0.562 . . . . 0.0 112.111 -179.025 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.755 ' HB2' ' HB3' ' A' ' 42' ' ' ARG . 5.2 mm-40 -73.77 145.21 45.24 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 177.365 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.46 ' HD2' HD22 ' A' ' 70' ' ' LEU . 18.6 ttt180 -76.58 8.33 3.66 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.241 -178.591 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.424 ' NE2' ' HB2' ' A' ' 42' ' ' ARG . 6.7 tp-100 71.9 -68.67 0.21 Allowed 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 123.521 0.728 . . . . 0.0 110.263 -178.864 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.409 ' O ' ' HB3' ' A' ' 68' ' ' ASP . 88.0 tttt -88.27 118.19 27.7 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 177.571 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.409 ' HB3' ' O ' ' A' ' 67' ' ' LYS . 32.5 t70 73.61 146.58 0.08 Allowed 'General case' 0 N--CA 1.469 0.518 0 O-C-N 124.003 0.814 . . . . 0.0 111.269 -178.786 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -74.39 79.47 1.89 Allowed 'General case' 0 C--O 1.236 0.369 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.2 -179.33 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.46 HD22 ' HD2' ' A' ' 65' ' ' ARG . 6.2 tt -130.9 131.85 44.76 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 179.762 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.455 ' N ' HD23 ' A' ' 70' ' ' LEU . 23.6 t -89.73 117.67 33.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.042 -175.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 32.8 m -98.29 -23.0 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-O 120.713 0.292 . . . . 0.0 110.806 176.792 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.414 HD23 ' N ' ' A' ' 74' ' ' GLU . 9.3 tt -145.54 139.52 26.8 Favored 'General case' 0 N--CA 1.462 0.166 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 -179.179 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.414 ' N ' HD23 ' A' ' 73' ' ' LEU . 1.7 tm-20 -142.5 109.51 5.53 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 -179.129 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' CYS . . . . . 0.424 ' SG ' HG21 ' A' ' 95' ' ' VAL . 35.0 t -140.12 82.56 1.87 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.384 0.611 . . . . 0.0 110.984 -179.288 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.422 ' HA ' ' HA ' ' A' ' 60' ' ' LEU . 82.5 t80 -75.13 121.99 22.91 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.812 174.662 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.511 HG11 ' HB2' ' A' ' 81' ' ' LEU . 92.8 t -124.85 112.02 30.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 -177.218 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.415 ' HD3' ' OH ' ' A' ' 76' ' ' TYR . 46.5 ttp180 -120.4 1.24 10.69 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-O 121.253 0.549 . . . . 0.0 110.58 -179.692 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 19.3 ptmt -141.01 86.86 2.06 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 115.965 -0.562 . . . . 0.0 111.141 -176.002 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . 0.534 ' H ' HD11 ' A' ' 124' ' ' LEU . 18.2 t70 64.5 148.4 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 115.649 -0.705 . . . . 0.0 112.154 178.108 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.511 ' HB2' HG11 ' A' ' 77' ' ' VAL . 51.5 tp -149.46 137.78 20.71 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.846 -0.615 . . . . 0.0 109.961 178.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 60.3 t -77.28 -65.13 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.363 178.338 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.438 ' HD2' ' HB ' ' A' ' 117' ' ' VAL . 4.5 t80 37.99 79.89 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 124.111 0.964 . . . . 0.0 111.729 -178.767 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 97.1 m -112.64 136.5 52.13 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.261 -0.881 . . . . 0.0 109.913 179.714 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.464 ' HA ' ' HA ' ' A' ' 91' ' ' HIS . 18.0 ptmt -85.37 108.77 17.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.043 0.449 . . . . 0.0 109.846 176.569 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -74.85 -27.55 60.31 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.446 0.641 . . . . 0.0 109.846 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . 0.502 ' HB2' ' HB3' ' A' ' 90' ' ' PHE . 16.5 m120 -141.62 156.43 66.4 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-N 115.059 -0.973 . . . . 0.0 108.709 177.923 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -58.56 -13.29 16.72 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.581 2.187 . . . . 0.0 112.561 180.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.435 ' HA ' ' HD2' ' A' ' 104' ' ' PHE . 23.6 p -124.55 14.3 8.79 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.608 -178.885 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.502 ' HB3' ' HB2' ' A' ' 87' ' ' ASN . 42.6 t80 -145.19 123.17 12.04 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-O 120.706 0.289 . . . . 0.0 110.833 -177.539 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' HIS . . . . . 0.471 ' HB2' ' CZ ' ' A' ' 104' ' ' PHE . 0.3 OUTLIER -126.01 136.29 52.79 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 -179.134 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . 0.569 ' HA ' ' HA3' ' A' ' 101' ' ' GLY . 11.7 p80 -141.53 158.59 43.66 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 120.643 0.259 . . . . 0.0 110.905 -177.148 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . 0.517 ' CZ3' ' HA2' ' A' ' 101' ' ' GLY . 39.3 p90 -136.45 158.89 43.36 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.848 0.356 . . . . 0.0 110.375 176.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt -122.48 113.96 20.04 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.669 179.577 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.424 HG21 ' SG ' ' A' ' 75' ' ' CYS . 28.0 m -141.34 162.63 21.38 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 N-CA-C 110.021 -0.363 . . . . 0.0 110.021 178.084 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 26.0 t70 63.56 -76.1 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.393 0 O-C-N 123.694 0.621 . . . . 0.0 110.957 179.699 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -155.92 -9.86 0.11 Allowed 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.781 177.269 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 42.0 ttm180 -122.15 155.59 35.43 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.261 0.553 . . . . 0.0 112.032 -165.553 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.539 ' HG2' ' HH2' ' A' ' 32' ' ' TRP . 37.4 ttpt -108.63 107.25 17.66 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.053 -0.976 . . . . 0.0 109.436 178.312 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . 0.456 ' HA ' ' HZ3' ' A' ' 32' ' ' TRP . 3.6 p90 -138.55 155.19 48.59 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.662 -0.245 . . . . 0.0 110.667 -179.419 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.569 ' HA3' ' HA ' ' A' ' 92' ' ' HIS . . . -163.09 -141.5 3.14 Favored Glycine 0 C--N 1.332 0.346 0 C-N-CA 121.116 -0.564 . . . . 0.0 112.702 -177.177 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.659 ' HA ' ' H ' ' A' ' 23' ' ' MET . 0.0 OUTLIER -157.51 156.02 31.3 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 121.032 0.444 . . . . 0.0 111.035 -178.699 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 36.2 m -101.52 132.53 47.1 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.752 175.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.471 ' CZ ' ' HB2' ' A' ' 91' ' ' HIS . 19.6 m-85 -67.41 160.27 27.74 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.412 -179.874 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -117.08 -52.46 2.51 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.205 178.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 25.4 m -129.75 153.2 80.79 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.251 -177.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_exo -49.11 -31.44 21.3 Favored 'Trans proline' 0 C--N 1.353 0.8 0 C-N-CA 122.669 2.246 . . . . 0.0 112.66 178.569 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -59.47 -62.22 2.04 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.249 179.376 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -65.67 -38.03 88.15 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.591 -179.429 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -52.81 -60.74 2.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.028 0.442 . . . . 0.0 110.781 176.761 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 72.4 mtp180 -64.08 -27.52 69.16 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.634 -179.368 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -65.23 -39.27 92.51 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.547 176.191 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 46.2 m-85 -71.03 -43.84 67.05 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.589 177.667 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.425 ' O ' HG12 ' A' ' 117' ' ' VAL . 49.9 m-20 -61.59 -55.55 29.49 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 120.814 0.34 . . . . 0.0 110.623 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 80.2 mtt-85 -66.39 -28.72 68.86 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-O 121.02 0.438 . . . . 0.0 110.154 176.84 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -59.35 -50.98 61.93 Favored Glycine 0 N--CA 1.447 -0.579 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.86 176.139 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.438 ' HB ' ' HD2' ' A' ' 83' ' ' TYR . 11.9 p -69.27 -32.75 54.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 116.694 0.247 . . . . 0.0 110.584 -179.74 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.454 ' O ' ' HG3' ' A' ' 122' ' ' GLU . 3.4 mmp_? -53.04 -64.63 0.76 Allowed 'General case' 0 C--O 1.238 0.476 0 CA-C-O 121.231 0.539 . . . . 0.0 109.995 174.17 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 81.4 tttt -66.86 -33.63 76.01 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 115.476 -0.783 . . . . 0.0 110.728 -176.107 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -61.03 -50.84 71.72 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.458 178.21 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.552 ' O ' HG22 ' A' ' 125' ' ' ILE . 31.8 mm -60.08 -40.68 84.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.109 178.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.484 ' O ' ' HB2' ' A' ' 126' ' ' GLU . 43.5 mt-10 -54.8 -56.46 19.18 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 110.284 -0.265 . . . . 0.0 110.284 176.385 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 49.4 m-20 -65.26 -27.23 68.5 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.668 -0.242 . . . . 0.0 111.425 -178.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.534 HD11 ' H ' ' A' ' 80' ' ' ASP . 3.2 tm? -76.51 -56.68 4.4 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.179 -176.126 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.552 HG22 ' O ' ' A' ' 121' ' ' ILE . 11.2 tp -94.12 -34.02 5.43 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 -170.349 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.484 ' HB2' ' O ' ' A' ' 122' ' ' GLU . 32.1 mm-40 . . . . . 0 C--O 1.251 1.142 0 CA-C-O 118.637 -0.697 . . . . 0.0 110.862 -174.535 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 15.6 m . . . . . 0 CA--C 1.535 0.383 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.659 ' HB3' ' HD2' ' A' ' 17' ' ' ARG . 58.7 m-85 -91.57 106.42 18.47 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 120.806 0.336 . . . . 0.0 111.12 -177.487 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.515 HG22 HG23 ' A' ' 16' ' ' VAL . 52.1 mt -71.66 -57.23 7.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.931 -176.851 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.515 HG23 HG22 ' A' ' 15' ' ' ILE . 61.0 t -129.0 132.05 67.63 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 CA-C-O 120.709 0.29 . . . . 0.0 110.963 -177.06 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.659 ' HD2' ' HB3' ' A' ' 14' ' ' TYR . 0.0 OUTLIER -128.06 115.62 18.75 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 174.949 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 27.6 m -124.11 166.01 19.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.732 0.301 . . . . 0.0 110.804 -179.598 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -87.51 137.08 32.65 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.623 -178.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -169.77 -165.1 0.47 Allowed 'General case' 0 C--O 1.237 0.437 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 178.377 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 7.3 p -140.44 126.97 21.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.031 0.443 . . . . 0.0 110.549 173.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.458 HG21 ' HB2' ' A' ' 73' ' ' LEU . 30.9 m -81.25 131.15 34.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.747 175.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 89.2 mmm -114.63 130.52 56.8 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.643 -0.502 . . . . 0.0 109.643 -176.471 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.447 HG23 ' HD1' ' A' ' 33' ' ' PHE . 9.5 t -103.16 162.01 13.32 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.086 0.469 . . . . 0.0 111.202 -178.518 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 19.8 ttt180 -120.38 21.26 11.72 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.18 -0.918 . . . . 0.0 108.6 178.239 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.412 ' O ' ' HB3' ' A' ' 27' ' ' ASP . 36.0 t70 49.17 38.39 13.09 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 114.423 -1.262 . . . . 0.0 111.192 177.899 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.412 ' HB3' ' O ' ' A' ' 26' ' ' ASP . 27.6 t70 73.27 -54.86 0.69 Allowed 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 115.242 -0.89 . . . . 0.0 112.758 177.207 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 22.1 m -136.62 18.59 3.09 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 112.611 0.597 . . . . 0.0 112.611 -174.025 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 65.7 m -86.14 -170.69 3.21 Favored 'General case' 0 C--N 1.327 -0.372 0 O-C-N 122.297 -0.252 . . . . 0.0 110.321 177.327 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -111.49 -44.14 0.93 Allowed Glycine 0 C--N 1.334 0.436 0 C-N-CA 121.294 -0.479 . . . . 0.0 112.368 -179.677 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -77.54 170.84 55.12 Favored Glycine 0 C--N 1.33 0.235 0 C-N-CA 121.192 -0.528 . . . . 0.0 112.692 -178.651 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 91.0 m95 -117.41 120.37 37.96 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 179.665 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.447 ' HD1' HG23 ' A' ' 24' ' ' THR . 1.4 m-85 -101.79 156.36 35.29 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.657 -170.896 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.455 ' HB3' ' HA2' ' A' ' 38' ' ' GLY . 51.3 Cg_exo -56.44 -11.82 7.12 Favored 'Trans proline' 0 C--N 1.355 0.918 0 C-N-CA 123.352 2.701 . . . . 0.0 112.992 178.496 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.607 HE22 ' HB ' ' A' ' 72' ' ' VAL . 0.2 OUTLIER 72.61 -71.08 0.14 Allowed 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 123.327 0.651 . . . . 0.0 110.554 174.256 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -161.74 -55.1 0.05 OUTLIER 'General case' 0 C--O 1.234 0.24 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 -179.779 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -62.76 -39.66 98.23 Favored Glycine 0 C--N 1.331 0.278 0 CA-C-N 115.596 -0.729 . . . . 0.0 112.553 -179.524 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.455 ' HA2' ' HB3' ' A' ' 34' ' ' PRO . . . 57.57 19.4 34.4 Favored Glycine 0 C--N 1.334 0.431 0 C-N-CA 121.544 -0.36 . . . . 0.0 113.551 177.16 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 140.2 -29.31 2.42 Favored Glycine 0 C--O 1.235 0.187 0 N-CA-C 111.203 -0.759 . . . . 0.0 111.203 -178.189 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.57 ' N ' HD12 ' A' ' 40' ' ' ILE . 2.8 mp -100.63 93.94 3.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 175.842 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 49.1 m -151.75 130.48 12.37 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 174.151 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 34.9 ttp180 -101.31 102.42 13.27 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 177.019 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 4.5 p -81.01 106.84 12.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 121.476 0.655 . . . . 0.0 109.976 179.52 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -102.8 112.37 4.25 Favored Glycine 0 N--CA 1.446 -0.669 0 CA-C-N 115.334 -0.848 . . . . 0.0 112.018 -179.511 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 7.0 p -86.45 109.22 18.6 Favored 'Isoleucine or valine' 0 C--O 1.239 0.5 0 CA-C-O 121.393 0.615 . . . . 0.0 109.967 176.162 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . 0.754 ' SG ' ' HB3' ' A' ' 60' ' ' LEU . 12.1 p -105.87 145.43 31.25 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.005 178.358 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 12.0 tmtt? -100.78 105.75 17.1 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 179.335 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.435 HG21 ' HE1' ' A' ' 76' ' ' TYR . 60.8 t -66.87 125.64 24.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.307 -179.129 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 66.1 mtt . . . . . 0 C--N 1.327 -0.4 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.193 179.253 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.384 0 N-CA-C 111.261 -0.735 . . . . 0.0 111.261 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -129.44 154.51 46.89 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 177.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.754 ' HB3' ' SG ' ' A' ' 46' ' ' CYS . 3.0 tt -128.42 119.06 24.22 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 178.882 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 57.2 mt -80.23 86.74 1.41 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.371 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 175.442 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . 0.444 ' HB3' ' HE2' ' A' ' 14' ' ' TYR . 21.7 t60 -98.84 107.69 20.19 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.981 -176.605 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -97.07 99.16 2.24 Favored Glycine 0 C--O 1.239 0.409 0 CA-C-N 115.81 -0.632 . . . . 0.0 112.488 -178.378 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -73.03 152.13 41.43 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 175.674 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.4 ' O ' HG22 ' A' ' 40' ' ' ILE . 71.0 ttt-85 -67.38 -31.95 72.54 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 174.474 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -168.13 -60.92 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.233 178.377 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 53.7 tttm -173.93 124.12 0.34 Allowed 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 117.804 0.275 . . . . 0.0 111.611 175.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 57.69 14.62 2.5 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.636 0.774 . . . . 0.0 112.005 174.002 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -106.77 -69.65 0.83 Allowed 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 111.831 0.308 . . . . 0.0 111.831 -167.322 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 48.5 tp -149.34 138.04 21.05 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.426 -175.078 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 21.4 t -88.52 102.0 12.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 176.075 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.607 ' HB ' HE22 ' A' ' 35' ' ' GLN . 28.3 m -88.17 -20.86 7.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.625 0.25 . . . . 0.0 111.355 -176.04 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.552 HD13 ' N ' ' A' ' 74' ' ' GLU . 2.9 tm? -149.65 140.74 22.99 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 179.373 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.552 ' N ' HD13 ' A' ' 73' ' ' LEU . 34.0 tt0 -159.07 119.86 3.24 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 -177.863 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 66.2 m -142.27 137.86 30.96 Favored 'General case' 0 C--O 1.232 0.161 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 -176.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.435 ' HE1' HG21 ' A' ' 48' ' ' VAL . 85.7 t80 -99.82 138.89 36.27 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 110.215 -0.291 . . . . 0.0 110.215 -176.25 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.72 HG12 HG11 ' A' ' 95' ' ' VAL . 20.3 m -135.19 141.16 43.51 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 -178.717 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 36.4 mtm180 -110.32 -73.06 0.7 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.941 0.401 . . . . 0.0 110.068 -178.121 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -152.85 19.63 0.6 Allowed 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 175.675 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -112.61 17.48 19.13 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 114.229 -1.35 . . . . 0.0 110.276 -176.145 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.574 HD22 ' HB2' ' A' ' 83' ' ' TYR . 1.6 tt -73.37 92.54 1.84 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.278 -176.736 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 3.6 p -81.17 85.25 1.52 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 CA-C-O 121.509 0.671 . . . . 0.0 110.009 174.757 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.614 ' HD2' HG21 ' A' ' 117' ' ' VAL . 0.6 OUTLIER -92.23 102.7 15.22 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.003 -177.011 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 99.9 m -114.46 133.12 55.99 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.295 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.534 ' HA ' ' HA ' ' A' ' 91' ' ' HIS . 4.9 ptpp? -94.96 111.8 23.56 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 175.528 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -70.94 -35.04 72.05 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.364 0.602 . . . . 0.0 109.494 175.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . 0.541 ' HB2' ' HB3' ' A' ' 90' ' ' PHE . 92.5 m-20 -134.48 155.18 79.9 Favored Pre-proline 0 C--N 1.332 -0.18 0 CA-C-N 114.99 -1.005 . . . . 0.0 108.529 176.339 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -54.3 -23.23 29.47 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.546 2.164 . . . . 0.0 112.753 178.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 14.9 t -112.45 2.31 16.32 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.335 -178.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.541 ' HB3' ' HB2' ' A' ' 87' ' ' ASN . 72.1 t80 -131.73 109.74 10.38 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-O 120.929 0.395 . . . . 0.0 110.681 -177.761 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' HIS . . . . . 0.534 ' HA ' ' HA ' ' A' ' 85' ' ' LYS . 0.1 OUTLIER -107.03 159.68 16.11 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 177.65 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . 0.413 ' HA ' ' HA2' ' A' ' 101' ' ' GLY . 17.2 p80 -155.73 160.82 40.64 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.612 0.244 . . . . 0.0 110.543 178.311 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 34.6 p90 -149.5 166.29 29.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.741 -178.664 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -131.63 106.08 7.94 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 174.264 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.72 HG11 HG12 ' A' ' 77' ' ' VAL . 29.8 m -136.56 172.54 15.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.139 -0.482 . . . . 0.0 109.822 179.544 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 42.9 m-20 59.09 -77.25 0.02 OUTLIER 'General case' 0 C--O 1.234 0.24 0 O-C-N 123.663 0.602 . . . . 0.0 110.427 -174.135 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 30.4 p-10 -163.26 9.12 0.05 Allowed 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 179.641 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 3.7 tpt180 -149.29 167.28 26.5 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 118.329 0.513 . . . . 0.0 111.627 -175.384 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 58.5 tttm -103.74 118.18 36.1 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.316 -176.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 33.8 m-85 -115.37 170.76 8.16 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.152 -0.476 . . . . 0.0 109.935 -178.591 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.413 ' HA2' ' HA ' ' A' ' 92' ' ' HIS . . . -142.39 164.86 26.88 Favored Glycine 0 C--N 1.332 0.35 0 C-N-CA 120.968 -0.634 . . . . 0.0 112.862 -177.657 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 8.3 tt -150.25 132.42 15.39 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 -179.586 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 45.5 m -112.76 134.54 54.23 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.868 0.366 . . . . 0.0 110.316 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 63.8 m-85 -86.78 -178.23 6.29 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.179 -179.003 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 24.6 tt0 -124.54 -70.55 0.75 Allowed 'General case' 0 C--O 1.236 0.346 0 CA-C-O 120.907 0.384 . . . . 0.0 111.122 -178.15 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 48.8 m -108.81 158.49 33.98 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.435 -175.127 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -54.8 -28.72 59.16 Favored 'Trans proline' 0 C--N 1.352 0.731 0 C-N-CA 122.539 2.159 . . . . 0.0 111.96 179.108 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -59.65 -68.39 0.29 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.736 178.513 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -61.62 -44.72 96.47 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.066 -178.475 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -56.23 -63.94 1.02 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.48 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 7.1 tpt180 -61.05 -39.51 90.09 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.635 -175.034 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -65.55 -39.48 91.76 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.075 -179.271 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 21.1 t80 -70.24 -42.87 71.64 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 -178.384 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 45.0 m-20 -58.53 -44.32 89.53 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-O 121.37 0.605 . . . . 0.0 109.991 175.489 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . 0.41 HH11 ' HD2' ' A' ' 115' ' ' ARG . 45.2 ttm180 -63.75 -39.67 94.84 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.289 -0.869 . . . . 0.0 109.84 178.265 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -67.55 -44.7 81.91 Favored Glycine 0 N--CA 1.449 -0.468 0 CA-C-N 115.235 -0.893 . . . . 0.0 112.622 -178.063 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.614 HG21 ' HD2' ' A' ' 83' ' ' TYR . 13.0 p -68.5 -35.75 71.78 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.105 0 CA-C-N 116.744 0.272 . . . . 0.0 110.398 -179.237 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 67.1 ttt180 -58.95 -52.53 65.34 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 174.004 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 54.3 tptt -58.08 -32.01 67.64 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.063 178.519 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -68.79 -36.68 78.57 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.476 176.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.536 HG13 ' O ' ' A' ' 117' ' ' VAL . 77.5 mt -60.86 -47.98 90.94 Favored 'Isoleucine or valine' 0 C--O 1.232 0.173 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 176.814 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -58.91 -57.83 11.33 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-O 120.907 0.384 . . . . 0.0 110.382 174.167 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -63.03 -29.21 70.64 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.774 -0.648 . . . . 0.0 112.54 -171.658 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 49.6 tp -93.47 -44.41 8.26 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 111.789 0.292 . . . . 0.0 111.789 -177.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.523 HD12 HG23 ' A' ' 121' ' ' ILE . 59.3 mt -99.85 -44.52 11.62 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 N-CA-C 112.705 0.631 . . . . 0.0 112.705 -170.457 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 . . . . . 0 C--O 1.249 1.028 0 CA-C-O 119.104 -0.474 . . . . 0.0 111.32 -170.314 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 19.2 m . . . . . 0 C--O 1.237 0.42 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.581 ' HA ' ' HA ' ' A' ' 46' ' ' CYS . 45.4 m-85 -68.74 125.12 25.56 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 120.623 0.249 . . . . 0.0 110.663 175.696 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 62.4 mt -67.47 -47.66 79.9 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 177.166 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 9.8 p -166.19 139.37 0.92 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.334 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.216 178.494 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.687 HH12 ' NH1' ' A' ' 65' ' ' ARG . 50.0 mtt180 -109.23 100.99 10.05 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 176.317 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 30.1 t -92.52 148.48 4.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.989 -174.702 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -83.75 120.92 26.61 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.445 179.739 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -164.88 -171.04 2.13 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.108 -0.496 . . . . 0.0 109.76 -179.624 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.461 ' HB ' ' HB ' ' A' ' 103' ' ' THR . 84.7 t -121.44 115.88 47.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.651 0.263 . . . . 0.0 110.576 178.774 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.571 HG23 HE22 ' A' ' 35' ' ' GLN . 16.4 m -83.95 125.98 40.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.767 0.318 . . . . 0.0 110.524 177.795 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 22.5 mmt -112.27 150.31 31.13 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.795 -176.658 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 11.9 t -129.61 155.39 45.91 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.112 -0.495 . . . . 0.0 109.932 176.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 25.9 tpt180 -140.56 141.02 35.27 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 178.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -70.69 111.31 6.06 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 174.435 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 22.7 t70 61.96 -83.19 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.556 0 O-C-N 123.53 0.519 . . . . 0.0 111.887 179.034 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 68.3 m -154.4 -172.06 4.08 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 122.389 0.276 . . . . 0.0 110.882 -176.766 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 12.7 t 85.09 151.73 0.08 Allowed 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.165 0.986 . . . . 0.0 111.47 179.587 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -77.8 80.62 1.32 Allowed Glycine 0 C--N 1.334 0.454 0 CA-C-N 115.605 -0.725 . . . . 0.0 112.581 -176.692 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -152.68 55.51 0.44 Allowed Glycine 0 CA--C 1.51 -0.258 0 N-CA-C 110.595 -1.002 . . . . 0.0 110.595 176.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 80.6 m95 -70.79 119.53 15.07 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.158 -0.521 . . . . 0.0 111.219 -173.782 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 46.9 p90 -107.11 126.7 29.52 Favored Pre-proline 0 CA--C 1.534 0.35 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.678 -177.732 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -73.1 99.19 1.07 Allowed 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 122.75 2.3 . . . . 0.0 111.696 178.791 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.571 HE22 HG23 ' A' ' 22' ' ' VAL . 5.0 pm0 -57.2 -48.78 77.93 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 115.648 -0.705 . . . . 0.0 112.703 -175.592 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.587 ' CB ' HG11 ' A' ' 72' ' ' VAL . 16.3 tp10 -134.8 -83.47 0.42 Allowed 'General case' 0 N--CA 1.467 0.406 0 O-C-N 122.254 -0.279 . . . . 0.0 110.919 -174.647 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -72.92 68.02 1.34 Allowed Glycine 0 C--N 1.336 0.568 0 C-N-CA 121.408 -0.425 . . . . 0.0 112.672 179.578 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -80.59 -35.35 25.91 Favored Glycine 0 C--N 1.331 0.267 0 C-N-CA 121.395 -0.431 . . . . 0.0 112.415 -179.085 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -79.45 -29.08 50.62 Favored Glycine 0 C--O 1.236 0.227 0 N-CA-C 111.454 -0.658 . . . . 0.0 111.454 177.741 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.415 HG12 HE22 ' A' ' 66' ' ' GLN . 8.6 tt -174.85 139.16 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 179.037 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 23.3 t -145.11 -178.51 6.09 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 177.628 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 60.1 mtt180 -130.89 106.9 8.73 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.098 0.475 . . . . 0.0 110.211 -177.222 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 40.9 t -81.6 103.39 8.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.127 -179.77 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -90.73 105.06 3.22 Favored Glycine 0 N--CA 1.446 -0.698 0 CA-C-N 115.959 -0.564 . . . . 0.0 112.352 -179.228 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 54.4 t -88.02 103.12 13.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 176.071 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . 0.624 ' SG ' ' HB3' ' A' ' 60' ' ' LEU . 5.3 p -108.49 145.55 34.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.258 -179.112 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 35.9 ttmt -98.31 100.96 12.29 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 175.093 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 30.1 m -86.87 128.58 39.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 121.096 0.474 . . . . 0.0 111.602 -172.468 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 25.1 ptm . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.553 178.877 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.387 0 N-CA-C 111.505 -0.638 . . . . 0.0 111.505 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.658 ' HB2' ' HB ' ' A' ' 77' ' ' VAL . 76.9 m-85 -134.96 163.78 29.08 Favored 'General case' 0 C--N 1.327 -0.409 0 O-C-N 122.559 -0.377 . . . . 0.0 110.299 -177.285 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.624 ' HB3' ' SG ' ' A' ' 46' ' ' CYS . 2.8 tt -150.29 118.63 6.41 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 177.843 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.449 ' O ' ' HA ' ' A' ' 74' ' ' GLU . 44.5 mm -82.63 91.53 2.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 175.537 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 12.6 t-80 -102.66 98.07 8.17 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.645 -174.445 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.513 ' O ' ' HB2' ' A' ' 64' ' ' GLU . . . -104.73 116.78 5.42 Favored Glycine 0 CA--C 1.522 0.48 0 CA-C-N 116.096 -0.502 . . . . 0.0 114.319 -171.727 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.681 ' HB2' HG22 ' A' ' 72' ' ' VAL . 7.7 tp10 165.08 -99.23 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 124.799 1.24 . . . . 0.0 109.103 164.228 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.687 ' NH1' HH12 ' A' ' 17' ' ' ARG . 8.6 tpt180 59.35 -1.03 0.15 Allowed 'General case' 0 CA--C 1.545 0.777 0 N-CA-C 113.436 0.902 . . . . 0.0 113.436 171.665 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.415 HE22 HG12 ' A' ' 40' ' ' ILE . 6.6 tp-100 -52.15 -59.04 4.84 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 -171.713 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 51.7 tttp -91.33 5.45 49.19 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-O 120.983 0.421 . . . . 0.0 110.397 -178.692 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 31.8 t0 64.84 149.2 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.568 -175.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 4.3 mppt? 55.84 26.23 9.4 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 121.003 0.43 . . . . 0.0 110.7 -169.681 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.574 HD22 ' HG2' ' A' ' 64' ' ' GLU . 0.9 OUTLIER -129.12 128.2 43.0 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.298 -0.631 . . . . 0.0 109.298 -179.056 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.625 ' HA ' ' HB3' ' A' ' 64' ' ' GLU . 51.4 t -137.66 140.67 40.93 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 179.18 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.681 HG22 ' HB2' ' A' ' 64' ' ' GLU . 27.5 m -130.35 -41.17 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 177.529 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.3 tt -124.36 133.79 53.33 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.389 -0.596 . . . . 0.0 109.389 -175.534 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.449 ' HA ' ' O ' ' A' ' 61' ' ' ILE . 11.0 pt-20 -146.98 130.3 16.62 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.067 0.461 . . . . 0.0 109.803 173.444 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' CYS . . . . . 0.54 ' HG ' ' HE1' ' A' ' 93' ' ' TRP . 47.7 t -130.03 109.34 10.78 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 -179.321 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 24.9 t80 -74.7 129.55 37.9 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.046 -0.525 . . . . 0.0 109.914 -177.083 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.658 ' HB ' ' HB2' ' A' ' 59' ' ' PHE . 63.1 t -105.45 85.32 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.496 0.665 . . . . 0.0 109.216 -177.894 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.446 ' O ' ' HB3' ' A' ' 79' ' ' LYS . 6.9 ptm180 -97.29 67.01 2.11 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.195 -0.911 . . . . 0.0 109.631 -179.633 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.49 ' HA ' HD21 ' A' ' 124' ' ' LEU . 7.3 tmtm? 77.39 -49.08 0.52 Allowed 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.478 -175.365 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . 0.43 ' OD1' ' HG3' ' A' ' 78' ' ' ARG . 5.0 p-10 -81.91 128.97 34.6 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-O 121.058 0.456 . . . . 0.0 110.623 -178.595 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.624 HD12 HD11 ' A' ' 121' ' ' ILE . 3.3 tm? -177.48 135.53 0.19 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.269 -0.878 . . . . 0.0 108.684 -178.263 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 3.7 p -145.71 106.09 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 CA-C-O 121.019 0.438 . . . . 0.0 111.3 -179.054 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.706 ' HB3' ' NE2' ' A' ' 91' ' ' HIS . 3.2 m-85 -88.84 150.97 22.64 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.217 176.299 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 81.5 m -150.47 120.23 7.05 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.883 177.566 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.453 ' HA ' ' HA ' ' A' ' 91' ' ' HIS . 8.0 ttpm? -90.64 110.72 21.87 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 177.707 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -78.62 -50.16 11.98 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.069 -179.374 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . 0.603 ' HB2' ' HB3' ' A' ' 90' ' ' PHE . 91.7 m-20 -120.11 153.41 55.39 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.004 179.706 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_endo -48.39 -33.63 23.24 Favored 'Trans proline' 0 CA--C 1.534 0.518 0 C-N-CA 122.99 2.46 . . . . 0.0 112.881 -176.295 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 15.2 t -112.36 13.87 20.34 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.419 -176.661 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.603 ' HB3' ' HB2' ' A' ' 87' ' ' ASN . 91.3 t80 -139.02 119.85 14.27 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-O 121.187 0.518 . . . . 0.0 111.493 -178.192 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' HIS . . . . . 0.706 ' NE2' ' HB3' ' A' ' 83' ' ' TYR . 1.2 t60 -116.24 157.8 24.34 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.384 -0.825 . . . . 0.0 108.915 178.5 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 25.0 p80 -155.05 157.58 37.8 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 175.304 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . 0.54 ' HE1' ' HG ' ' A' ' 75' ' ' CYS . 36.4 p90 -144.03 174.21 11.05 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 176.687 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 61.5 pttt -144.01 155.57 44.06 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 179.559 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.629 HG23 ' H ' ' A' ' 96' ' ' ASP . 7.9 m -133.55 -63.73 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.913 176.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.629 ' H ' HG23 ' A' ' 95' ' ' VAL . 20.3 m-20 -115.32 71.8 0.78 Allowed 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 -179.388 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 18.0 m120 74.02 -39.54 0.43 Allowed 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 115.346 -0.843 . . . . 0.0 112.155 178.788 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 63.7 ttt180 -87.18 148.8 25.02 Favored 'General case' 0 C--O 1.242 0.702 0 CA-C-O 121.033 0.444 . . . . 0.0 111.372 -176.083 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 61.9 mttp -100.71 143.57 30.72 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 114.956 -1.02 . . . . 0.0 110.834 178.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . 0.408 ' HB2' ' CE2' ' A' ' 93' ' ' TRP . 6.8 m-85 -118.94 143.85 46.78 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 172.061 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -113.09 163.04 12.17 Favored Glycine 0 C--N 1.331 0.285 0 C-N-CA 120.834 -0.698 . . . . 0.0 113.892 -170.722 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.44 ' HB2' ' HZ3' ' A' ' 93' ' ' TRP . 57.3 tp -150.7 106.92 3.46 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 122.793 0.437 . . . . 0.0 110.181 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.461 ' HB ' ' HB ' ' A' ' 21' ' ' VAL . 52.1 m -89.31 125.04 34.95 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.323 178.044 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.55 ' CZ ' ' HB2' ' A' ' 91' ' ' HIS . 23.8 m-85 -78.76 161.04 27.12 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.462 179.465 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 65.3 tt0 -109.17 -42.04 4.51 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.712 179.469 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 13.6 m -140.88 151.63 63.23 Favored Pre-proline 0 CA--C 1.533 0.327 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.254 -179.072 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_exo -50.41 -30.26 26.58 Favored 'Trans proline' 0 C--N 1.352 0.752 0 C-N-CA 122.975 2.45 . . . . 0.0 113.207 -179.289 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -62.87 -64.11 1.01 Allowed 'General case' 0 C--O 1.235 0.291 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.98 179.844 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -62.99 -33.95 76.51 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.354 179.236 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.48 ' HB1' ' NH2' ' A' ' 111' ' ' ARG . . . -54.8 -63.89 1.01 Allowed 'General case' 0 C--O 1.235 0.325 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.092 177.688 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . 0.48 ' NH2' ' HB1' ' A' ' 110' ' ' ALA . 0.0 OUTLIER -65.65 -24.43 67.02 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.788 179.765 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -61.93 -40.51 95.75 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 175.124 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.41 ' O ' HG12 ' A' ' 117' ' ' VAL . 47.4 m-85 -70.89 -48.23 54.84 Favored 'General case' 0 N--CA 1.461 0.1 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.587 176.083 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -53.54 -66.19 0.43 Allowed 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 121.39 0.614 . . . . 0.0 110.441 178.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 16.5 mtp180 -63.68 -36.56 84.25 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.889 -178.014 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -60.26 -53.78 42.77 Favored Glycine 0 C--N 1.332 0.344 0 CA-C-N 116.097 -0.501 . . . . 0.0 112.588 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.41 HG12 ' O ' ' A' ' 113' ' ' PHE . 10.7 p -66.27 -36.47 77.46 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.121 0 CA-C-N 116.672 0.236 . . . . 0.0 110.505 -178.071 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 95.8 mtt180 -60.95 -42.59 98.52 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.475 -0.329 . . . . 0.0 111.104 177.777 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 30.8 mmtp -76.29 -27.52 56.66 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 120.68 0.276 . . . . 0.0 110.948 178.223 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -63.35 -48.69 76.91 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 174.732 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.624 HD11 HD12 ' A' ' 81' ' ' LEU . 46.9 mm -66.8 -36.08 76.33 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.187 176.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -54.65 -56.67 16.67 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.253 178.265 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 -70.15 -29.5 66.43 Favored 'General case' 0 C--O 1.225 -0.188 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.94 179.386 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.49 HD21 ' HA ' ' A' ' 79' ' ' LYS . 6.7 tt -59.59 -43.76 93.58 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 177.241 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 66.7 mt -77.7 -30.88 16.95 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.495 178.595 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.428 -0.796 . . . . 0.0 109.808 179.101 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 15.1 m . . . . . 0 N--CA 1.465 0.279 0 CA-C-O 120.798 0.333 . . . . 0.0 111.538 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 67.8 m-85 -88.05 147.9 24.75 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.96 0.41 . . . . 0.0 111.515 -176.649 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 48.9 mm -105.81 -37.88 4.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 168.036 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 59.4 t -136.29 142.98 37.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 114.964 -1.016 . . . . 0.0 108.684 175.327 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.496 HH21 ' CD ' ' A' ' 64' ' ' GLU . 63.1 ttt180 -149.24 84.02 1.44 Allowed 'General case' 0 C--O 1.235 0.304 0 CA-C-O 121.22 0.533 . . . . 0.0 109.931 179.223 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 60.1 t -107.37 141.78 21.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.034 -177.752 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.742 ' HD3' ' H ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -82.83 127.51 33.54 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.943 -0.392 . . . . 0.0 109.943 176.909 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -150.48 171.92 16.29 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.64 178.597 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.56 ' HB ' ' HB ' ' A' ' 103' ' ' THR . 49.0 t -84.99 96.89 5.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.977 0.417 . . . . 0.0 110.783 -176.398 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 57.8 t -79.35 113.67 19.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.562 179.761 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 22.5 mmt -99.34 156.55 16.94 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.024 -0.534 . . . . 0.0 109.923 178.27 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.503 HG23 ' CE1' ' A' ' 33' ' ' PHE . 8.8 t -130.39 142.12 50.53 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.026 0.441 . . . . 0.0 110.536 179.466 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.428 ' HB2' ' CZ3' ' A' ' 32' ' ' TRP . 0.0 OUTLIER -94.06 101.33 13.36 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 173.778 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.487 ' HB2' ' CE1' ' A' ' 33' ' ' PHE . 32.1 t70 -52.4 120.82 5.99 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 178.085 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -39.26 108.68 0.09 Allowed 'General case' 0 N--CA 1.466 0.339 0 O-C-N 124.228 0.955 . . . . 0.0 111.487 -176.231 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 40.6 p 46.02 82.31 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.39 0 O-C-N 123.836 0.71 . . . . 0.0 111.36 -176.377 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 6.9 t -131.15 -69.38 0.63 Allowed 'General case' 0 C--O 1.234 0.27 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.812 -175.535 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 174.12 -62.02 0.12 Allowed Glycine 0 C--N 1.333 0.364 0 C-N-CA 121.177 -0.535 . . . . 0.0 112.005 -179.26 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -128.46 -139.28 4.73 Favored Glycine 0 C--O 1.236 0.245 0 C-N-CA 121.226 -0.511 . . . . 0.0 112.556 -179.213 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . 0.496 ' HH2' ' HG2' ' A' ' 99' ' ' LYS . 67.8 m95 -125.1 149.4 47.88 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 179.252 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.503 ' CE1' HG23 ' A' ' 24' ' ' THR . 2.0 p90 -149.07 152.86 37.25 Favored Pre-proline 0 C--O 1.236 0.366 0 N-CA-C 110.318 -0.253 . . . . 0.0 110.318 177.726 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -63.03 125.69 16.41 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 122.297 1.998 . . . . 0.0 111.785 176.008 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.638 ' HG2' HD21 ' A' ' 73' ' ' LEU . 2.0 pp0? -69.06 -168.67 0.15 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.263 174.739 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -55.59 -14.72 2.28 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 -173.871 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -67.59 -40.84 90.57 Favored Glycine 0 CA--C 1.521 0.414 0 N-CA-C 111.599 -0.6 . . . . 0.0 111.599 173.703 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 86.43 -33.95 3.57 Favored Glycine 0 C--N 1.333 0.411 0 N-CA-C 112.17 -0.372 . . . . 0.0 112.17 178.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.457 ' O ' ' HA ' ' A' ' 21' ' ' VAL . . . -162.78 -105.06 0.19 Allowed Glycine 0 N--CA 1.443 -0.859 0 N-CA-C 111.195 -0.762 . . . . 0.0 111.195 176.663 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.425 HG23 ' HB2' ' A' ' 19' ' ' LYS . 1.8 mp -60.9 131.88 26.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 120.973 0.416 . . . . 0.0 110.334 -179.904 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 41.6 m -145.82 152.89 40.25 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.333 178.322 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.757 ' HB2' ' HB2' ' A' ' 64' ' ' GLU . 13.1 mmt180 -72.99 105.13 4.34 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 110.379 -0.23 . . . . 0.0 110.379 -179.655 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 56.4 t -83.47 89.89 2.39 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 174.13 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -88.09 104.13 3.0 Favored Glycine 0 N--CA 1.444 -0.794 0 CA-C-N 115.515 -0.766 . . . . 0.0 112.669 -177.79 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 53.5 t -80.58 88.35 1.57 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.522 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 174.774 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . 0.683 ' HB3' ' HB3' ' A' ' 60' ' ' LEU . 42.6 t -85.58 146.73 26.75 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.392 179.204 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 79.6 tttt -142.73 96.88 3.01 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 -174.394 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 26.9 m -98.97 132.74 43.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.652 -176.82 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.248 0 CA-C-O 120.838 0.351 . . . . 0.0 111.116 -177.065 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.422 0 N-CA-C 110.937 -0.865 . . . . 0.0 110.937 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.446 ' HB2' HG23 ' A' ' 77' ' ' VAL . 69.5 m-85 -104.08 122.31 45.03 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.906 0.384 . . . . 0.0 110.316 -174.65 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.683 ' HB3' ' HB3' ' A' ' 46' ' ' CYS . 3.6 tt -103.9 107.3 18.12 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 179.416 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 61.4 mt -71.49 91.97 0.43 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.327 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 174.707 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 12.4 t-80 -97.3 100.39 11.85 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.074 -173.111 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.437 ' HA3' ' HB2' ' A' ' 73' ' ' LEU . . . -99.35 112.96 4.59 Favored Glycine 0 C--N 1.33 0.22 0 C-N-CA 121.399 -0.429 . . . . 0.0 112.271 -177.373 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.757 ' HB2' ' HB2' ' A' ' 42' ' ' ARG . 22.1 mt-10 -107.05 138.2 43.67 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 122.226 0.21 . . . . 0.0 110.607 -178.545 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 26.6 ttt85 -67.63 130.85 44.3 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 173.768 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 6.8 tp60 -58.56 154.93 13.2 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.368 -176.521 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt 72.86 -69.84 0.18 Allowed 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 123.422 0.689 . . . . 0.0 111.35 177.471 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -69.23 -36.23 77.0 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 120.706 0.289 . . . . 0.0 110.543 -176.541 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 50.4 mtmt 61.93 85.28 0.12 Allowed 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.57 -0.741 . . . . 0.0 112.06 176.285 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -150.26 154.91 38.74 Favored 'General case' 0 C--O 1.24 0.565 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 173.468 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 10.5 t -72.5 92.61 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 CA-C-O 120.958 0.408 . . . . 0.0 111.517 -171.662 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 9.5 m -88.22 -37.47 10.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.452 176.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.638 HD21 ' HG2' ' A' ' 35' ' ' GLN . 4.2 mm? -117.35 137.88 52.16 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 176.784 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.584 ' HG3' HD21 ' A' ' 60' ' ' LEU . 35.0 tt0 -150.21 114.56 5.17 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 177.868 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' CYS . . . . . 0.507 ' SG ' ' CE2' ' A' ' 100' ' ' PHE . 36.5 m -138.07 101.4 4.41 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.959 0.409 . . . . 0.0 110.156 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 75.5 t80 -84.62 112.31 20.33 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.12 -0.491 . . . . 0.0 109.924 179.791 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.466 HG21 HD21 ' A' ' 81' ' ' LEU . 16.4 m -97.54 100.33 10.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 121.863 0.84 . . . . 0.0 109.267 177.803 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.452 ' HG2' ' H ' ' A' ' 78' ' ' ARG . 19.5 ptt180 -70.92 -45.68 63.81 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 114.631 -1.168 . . . . 0.0 112.092 -172.117 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 35.8 ttpt -160.99 29.73 0.14 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.569 0.7 . . . . 0.0 109.792 -175.02 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . 0.421 ' O ' ' HB ' ' A' ' 77' ' ' VAL . 7.3 p-10 -149.66 140.98 23.19 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.08 -178.802 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.466 HD21 HG21 ' A' ' 77' ' ' VAL . 12.8 mt -155.36 101.38 2.2 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.967 179.057 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.467 HG23 ' N ' ' A' ' 83' ' ' TYR . 27.6 m -74.3 -53.06 18.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 174.468 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.467 ' N ' HG23 ' A' ' 82' ' ' VAL . 4.5 t80 30.46 82.86 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.431 1.092 . . . . 0.0 112.015 177.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 36.0 m -112.41 133.48 54.47 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.998 -179.079 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.525 ' HA ' ' HA ' ' A' ' 91' ' ' HIS . 17.7 ptmt -93.46 101.72 13.93 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.315 0.579 . . . . 0.0 110.224 178.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -72.34 -49.49 33.94 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.975 -178.501 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . 0.572 ' HB2' ' HB3' ' A' ' 90' ' ' PHE . 0.8 OUTLIER -104.83 153.27 39.44 Favored Pre-proline 0 C--N 1.327 -0.387 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 174.753 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_exo -48.24 -31.91 18.13 Favored 'Trans proline' 0 CA--C 1.534 0.499 0 C-N-CA 122.621 2.214 . . . . 0.0 112.765 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.484 ' HA ' ' HD2' ' A' ' 104' ' ' PHE . 20.5 p -120.09 16.35 12.43 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 112.328 0.492 . . . . 0.0 112.328 -178.321 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.572 ' HB3' ' HB2' ' A' ' 87' ' ' ASN . 5.5 t80 -129.88 105.84 8.27 Favored 'General case' 0 C--O 1.239 0.5 0 CA-C-O 120.93 0.395 . . . . 0.0 110.094 178.665 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' HIS . . . . . 0.525 ' HA ' ' HA ' ' A' ' 85' ' ' LYS . 0.1 OUTLIER -102.73 133.18 48.19 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 177.763 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 30.2 p80 -129.1 155.05 46.07 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.935 0.398 . . . . 0.0 110.812 -178.003 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . 0.412 ' CE2' ' HB2' ' A' ' 100' ' ' PHE . 43.8 p90 -144.91 158.49 43.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.174 178.517 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 22.5 ptmt -144.02 148.98 35.98 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 177.784 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.701 HG23 ' H ' ' A' ' 96' ' ' ASP . 4.4 m -127.64 -66.87 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 C-N-CA 121.2 -0.2 . . . . 0.0 111.173 -179.3 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.701 ' H ' HG23 ' A' ' 95' ' ' VAL . 10.9 m-20 -120.87 80.1 1.59 Allowed 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 177.157 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 52.4 t-20 74.35 -52.96 0.68 Allowed 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 114.79 -1.095 . . . . 0.0 111.429 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -68.87 139.42 55.17 Favored 'General case' 0 C--O 1.244 0.806 0 CA-C-O 121.003 0.43 . . . . 0.0 110.239 -175.813 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.496 ' HG2' ' HH2' ' A' ' 32' ' ' TRP . 39.7 ttmt -121.49 135.49 55.03 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.503 -178.711 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . 0.507 ' CE2' ' SG ' ' A' ' 75' ' ' CYS . 20.4 m-85 -124.0 164.31 19.61 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 -178.797 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -139.64 159.74 25.92 Favored Glycine 0 C--N 1.331 0.298 0 C-N-CA 120.764 -0.732 . . . . 0.0 113.461 -174.47 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.41 ' HB2' ' HZ3' ' A' ' 93' ' ' TRP . 5.6 tt -139.54 114.77 9.72 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 -179.496 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.56 ' HB ' ' HB ' ' A' ' 21' ' ' VAL . 48.5 m -93.3 119.65 32.69 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.087 176.873 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.484 ' HD2' ' HA ' ' A' ' 89' ' ' THR . 33.3 m-85 -70.02 158.4 35.74 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.224 179.599 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 45.6 mt-30 -108.13 -46.31 3.77 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.771 -178.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 14.7 m -135.07 156.49 78.26 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.408 -176.21 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -51.52 -30.49 35.82 Favored 'Trans proline' 0 C--N 1.35 0.619 0 C-N-CA 122.652 2.235 . . . . 0.0 112.49 177.036 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -60.57 -61.02 2.89 Favored 'General case' 0 C--O 1.239 0.516 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.384 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -65.52 -43.74 89.11 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.433 -0.348 . . . . 0.0 110.599 -178.724 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -51.95 -54.74 26.06 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 121.086 0.47 . . . . 0.0 111.027 177.36 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 34.7 ttt180 -61.59 -39.21 90.4 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.01 -177.633 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -61.99 -43.39 98.94 Favored 'General case' 0 C--O 1.231 0.109 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.304 179.685 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 49.1 m-85 -69.64 -39.86 76.87 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.617 -0.265 . . . . 0.0 110.965 -179.133 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 45.6 m-20 -60.15 -57.88 10.91 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-O 121.31 0.576 . . . . 0.0 110.752 178.45 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 37.3 mmt180 -66.87 -31.27 71.76 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.171 -179.497 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -64.21 -48.86 70.53 Favored Glycine 0 N--CA 1.449 -0.441 0 CA-C-N 115.635 -0.711 . . . . 0.0 112.199 179.195 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.5 ' O ' HG12 ' A' ' 121' ' ' ILE . 11.5 p -66.89 -37.88 80.3 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.086 0 N-CA-C 110.26 -0.274 . . . . 0.0 110.26 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 8.1 tpt180 -56.69 -49.45 75.1 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-O 120.853 0.359 . . . . 0.0 110.169 176.054 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 60.0 tptt -58.61 -44.42 89.9 Favored 'General case' 0 C--O 1.241 0.647 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.382 177.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -57.94 -47.23 83.51 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.56 178.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.5 HG12 ' O ' ' A' ' 117' ' ' VAL . 43.0 mm -59.21 -46.63 92.05 Favored 'Isoleucine or valine' 0 C--O 1.232 0.14 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.469 179.422 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 62.6 mm-40 -51.7 -58.16 7.16 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.945 179.699 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -73.75 -33.22 64.21 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.569 -174.755 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 60.2 tp -64.98 -41.82 95.08 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.911 0.386 . . . . 0.0 110.449 -179.082 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 47.9 mm -78.99 -55.96 8.4 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.901 -178.106 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 . . . . . 0 C--O 1.253 1.243 0 CA-C-O 119.356 -0.354 . . . . 0.0 111.266 -176.827 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 57.8 m . . . . . 0 N--CA 1.469 0.484 0 N-CA-C 111.867 0.321 . . . . 0.0 111.867 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.442 ' HA ' ' HB3' ' A' ' 46' ' ' CYS . 59.5 m-85 -76.54 93.29 3.54 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 121.111 0.481 . . . . 0.0 110.504 177.922 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.566 HG22 HG23 ' A' ' 16' ' ' VAL . 44.0 mm -69.19 -56.59 11.31 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 CA-C-N 115.437 -0.802 . . . . 0.0 111.465 -173.809 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.566 HG23 HG22 ' A' ' 15' ' ' ILE . 57.8 t -131.84 131.15 61.96 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 CA-C-O 120.574 0.226 . . . . 0.0 111.128 -175.507 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.586 ' HG3' ' HA2' ' A' ' 44' ' ' GLY . 0.5 OUTLIER -110.89 98.27 7.45 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 171.895 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 44.9 t -76.39 154.85 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.464 -177.263 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 58.7 tttp -98.88 131.33 45.06 Favored 'General case' 0 N--CA 1.462 0.129 0 CA-C-O 120.826 0.346 . . . . 0.0 110.374 178.12 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.495 ' O ' ' HB2' ' A' ' 41' ' ' SER . . . -171.19 -166.95 0.5 Allowed 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 175.479 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 61.7 t -117.93 120.19 63.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 167.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.528 HG11 ' HG ' ' A' ' 73' ' ' LEU . 49.6 t -71.7 94.15 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 121.148 0.499 . . . . 0.0 109.985 179.65 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . 0.467 ' HB3' ' HB3' ' A' ' 32' ' ' TRP . 21.4 mmt -86.44 110.7 19.91 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.582 -178.473 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 1.1 m -100.78 120.77 40.6 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.427 -0.806 . . . . 0.0 108.961 172.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.79 114.86 11.4 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 179.361 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -58.03 91.18 0.01 OUTLIER 'General case' 0 C--O 1.233 0.222 0 O-C-N 123.345 0.403 . . . . 0.0 110.44 -176.485 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 28.3 t70 55.54 -87.7 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.788 -176.858 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 60.4 m -157.99 26.97 0.26 Allowed 'General case' 0 C--O 1.235 0.315 0 CA-C-O 121.093 0.473 . . . . 0.0 109.993 177.532 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 34.8 t -143.18 159.52 42.14 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.032 -179.358 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 82.38 -53.57 4.8 Favored Glycine 0 C--N 1.329 0.187 0 C-N-CA 121.235 -0.507 . . . . 0.0 112.22 179.207 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 131.29 -161.43 23.59 Favored Glycine 0 C--N 1.331 0.304 0 N-CA-C 111.976 -0.449 . . . . 0.0 111.976 177.457 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . 0.467 ' HB3' ' HB3' ' A' ' 23' ' ' MET . 84.2 m95 -84.69 104.83 15.01 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 109.36 -0.608 . . . . 0.0 109.36 176.347 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -103.71 147.84 34.87 Favored Pre-proline 0 C--O 1.237 0.423 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 -175.522 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -59.96 132.21 43.56 Favored 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 122.472 2.114 . . . . 0.0 111.355 179.152 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 8.0 tp-100 -39.73 -47.16 2.01 Favored 'General case' 0 N--CA 1.468 0.439 0 O-C-N 123.764 0.665 . . . . 0.0 112.055 -175.782 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -176.07 -34.91 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 178.454 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -108.86 167.9 13.23 Favored Glycine 0 N--CA 1.453 -0.209 0 CA-C-N 115.14 -0.936 . . . . 0.0 110.776 171.466 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -132.49 150.41 19.68 Favored Glycine 0 C--O 1.234 0.151 0 C-N-CA 120.95 -0.643 . . . . 0.0 112.473 -178.194 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 81.06 -58.59 4.82 Favored Glycine 0 C--N 1.331 0.293 0 C-N-CA 121.46 -0.4 . . . . 0.0 112.585 178.407 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.496 ' N ' HD12 ' A' ' 40' ' ' ILE . 3.5 mp -101.85 107.29 21.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.783 0.325 . . . . 0.0 110.599 -178.784 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.495 ' HB2' ' O ' ' A' ' 20' ' ' ALA . 36.6 m -141.9 113.84 8.01 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 171.316 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.502 ' HB2' ' O ' ' A' ' 64' ' ' GLU . 5.7 mpt_? -88.79 133.48 34.23 Favored 'General case' 0 CA--C 1.519 -0.218 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 175.642 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.787 HG21 HD21 ' A' ' 102' ' ' LEU . 75.5 t -106.2 100.01 9.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.006 177.328 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.586 ' HA2' ' HG3' ' A' ' 17' ' ' ARG . . . -71.26 84.63 0.41 Allowed Glycine 0 N--CA 1.448 -0.546 0 CA-C-N 115.673 -0.694 . . . . 0.0 112.693 -179.202 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 54.8 t -75.69 107.96 7.22 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 176.479 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . 0.699 ' SG ' ' HB3' ' A' ' 60' ' ' LEU . 6.1 p -125.51 125.71 43.71 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.064 -0.517 . . . . 0.0 111.079 -177.336 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 57.8 tttm -87.6 89.08 7.86 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 175.833 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 31.0 t -77.12 125.57 37.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.23 -174.091 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 97.6 mmm . . . . . 0 C--N 1.326 -0.45 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 174.763 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.516 0 N-CA-C 111.29 -0.724 . . . . 0.0 111.29 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 71.7 m-85 -91.06 104.55 17.12 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.061 0.457 . . . . 0.0 109.813 -176.613 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.699 ' HB3' ' SG ' ' A' ' 46' ' ' CYS . 1.9 tt -93.35 106.71 18.64 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.806 -0.633 . . . . 0.0 109.499 -178.204 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 49.8 mm -78.58 85.91 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 173.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . 0.409 ' HA ' ' HA ' ' A' ' 74' ' ' GLU . 15.4 t-80 -90.94 168.11 11.92 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.593 -176.548 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -151.09 112.96 0.56 Allowed Glycine 0 C--O 1.236 0.258 0 C-N-CA 120.948 -0.644 . . . . 0.0 112.111 -178.309 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.502 ' O ' ' HB2' ' A' ' 42' ' ' ARG . 0.0 OUTLIER -145.95 -167.29 2.68 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 122.385 0.274 . . . . 0.0 110.739 -176.101 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.43 ' HB3' ' HD3' ' A' ' 42' ' ' ARG . 0.0 OUTLIER 57.41 34.95 25.39 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-O 120.928 0.394 . . . . 0.0 110.205 175.181 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 84.0 mm-40 -63.88 -11.58 28.98 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 115.67 -0.695 . . . . 0.0 112.571 -172.447 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 34.7 ttpt -174.5 -63.28 0.01 OUTLIER 'General case' 0 C--O 1.234 0.261 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 173.311 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -105.43 -85.05 0.49 Allowed 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 170.595 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.484 ' HB3' ' NZ ' ' A' ' 69' ' ' LYS . 6.3 ttpm? -140.72 108.17 5.56 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 178.565 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 48.2 tp -163.73 124.54 2.26 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 110.418 -0.216 . . . . 0.0 110.418 -173.375 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 83.9 t -98.58 135.23 34.28 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 O-C-N 123.697 0.623 . . . . 0.0 109.443 173.052 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 35.4 m -134.92 -41.17 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 N-CA-C 112.127 0.418 . . . . 0.0 112.127 -177.195 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.54 HD13 ' N ' ' A' ' 74' ' ' GLU . 3.0 tm? -119.91 143.3 48.03 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.821 0.343 . . . . 0.0 110.781 -170.847 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.54 ' N ' HD13 ' A' ' 73' ' ' LEU . 9.5 pt-20 -158.45 112.17 2.44 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.915 173.555 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 42.0 t -126.0 97.81 5.26 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 179.512 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.414 ' HB2' ' HG ' ' A' ' 60' ' ' LEU . 69.2 t80 -88.36 134.82 33.72 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.99 -176.336 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 35.1 m -141.42 145.28 24.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 176.31 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 24.5 ttp180 -130.67 -24.44 2.46 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.134 0.493 . . . . 0.0 110.428 177.2 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.521 ' N ' ' HD3' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -160.9 29.21 0.15 Allowed 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 174.948 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -127.92 170.31 12.98 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 115.123 -0.944 . . . . 0.0 110.709 -167.45 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.639 HD11 ' CD1' ' A' ' 93' ' ' TRP . 10.2 tt 72.92 151.8 0.12 Allowed 'General case' 0 N--CA 1.469 0.514 0 O-C-N 123.996 0.81 . . . . 0.0 112.163 167.854 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.511 ' N ' HD23 ' A' ' 81' ' ' LEU . 8.7 p -139.63 141.02 35.74 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.68 177.221 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 14.6 m-85 -94.5 166.35 12.09 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 121.176 0.513 . . . . 0.0 111.079 -177.633 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 88.7 m -152.08 109.81 3.64 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.015 176.548 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.479 ' O ' ' HD2' ' A' ' 85' ' ' LYS . 0.0 OUTLIER -108.81 138.57 44.93 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.941 0.401 . . . . 0.0 110.663 -179.316 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -108.18 -45.72 3.88 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.956 -0.566 . . . . 0.0 109.846 178.92 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 -133.94 158.86 74.42 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.324 -179.749 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -60.43 -19.97 61.36 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.175 1.917 . . . . 0.0 111.917 177.648 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 34.8 p -100.43 2.72 42.49 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.724 -179.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 70.6 t80 -147.05 101.39 3.41 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-O 121.128 0.49 . . . . 0.0 109.921 -178.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 3.3 t-160 -131.08 110.22 11.04 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 -177.689 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . 0.671 ' HA ' ' HA3' ' A' ' 101' ' ' GLY . 16.9 p80 -120.54 -178.19 3.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.744 0.307 . . . . 0.0 110.646 -176.883 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . 0.639 ' CD1' HD11 ' A' ' 81' ' ' LEU . 41.4 p90 -148.77 -171.36 3.85 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.57 174.292 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -151.73 147.28 26.5 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.913 0.387 . . . . 0.0 111.029 -177.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.451 HG23 ' O ' ' A' ' 95' ' ' VAL . 19.0 m -123.97 107.51 18.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 172.887 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 21.9 t70 67.53 -68.02 0.17 Allowed 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.903 -174.82 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 45.7 t-20 -144.25 -43.04 0.26 Allowed 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 178.766 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 88.2 mtm180 -58.41 124.2 18.74 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.037 -179.538 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.481 ' HD3' ' N ' ' A' ' 99' ' ' LYS . 0.0 OUTLIER -116.42 129.32 56.16 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.245 -175.107 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -148.22 155.3 41.2 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.384 -0.825 . . . . 0.0 109.356 177.421 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.671 ' HA3' ' HA ' ' A' ' 92' ' ' HIS . . . -175.83 -157.57 17.4 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.565 -0.826 . . . . 0.0 113.148 -176.915 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.787 HD21 HG21 ' A' ' 43' ' ' VAL . 9.2 mp -114.56 146.6 40.56 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 121.362 0.601 . . . . 0.0 111.683 -174.354 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 91.4 m -123.69 111.51 16.28 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 166.649 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 48.7 m-85 -89.77 149.42 22.72 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.737 -170.398 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 19.3 mp0 -103.08 -43.14 5.57 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 170.708 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -82.2 141.61 46.59 Favored Pre-proline 0 CA--C 1.535 0.388 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.496 178.7 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -86.38 -38.48 0.09 OUTLIER 'Trans proline' 0 C--N 1.353 0.776 0 C-N-CA 122.676 2.251 . . . . 0.0 114.217 -174.052 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -64.89 -60.08 3.47 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 120.879 0.371 . . . . 0.0 111.639 -172.767 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 22.4 p-10 -66.43 -26.51 67.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.476 -178.696 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -60.68 -52.79 63.62 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 121.217 0.532 . . . . 0.0 110.313 172.706 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 4.2 tmm_? -63.81 -32.72 74.33 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.746 178.242 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -65.68 -39.27 91.11 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.749 177.214 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.484 ' O ' HG23 ' A' ' 117' ' ' VAL . 73.2 t80 -66.91 -52.99 36.48 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.122 179.079 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.452 ' O ' ' HG3' ' A' ' 118' ' ' ARG . 13.7 t70 -54.09 -56.9 13.71 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 121.522 0.677 . . . . 0.0 110.178 179.42 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 15.2 tpt180 -53.27 -47.74 68.87 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-N 114.628 -1.169 . . . . 0.0 110.605 176.825 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -59.76 -38.69 94.29 Favored Glycine 0 N--CA 1.451 -0.327 0 CA-C-N 115.505 -0.77 . . . . 0.0 112.15 -179.695 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.484 HG23 ' O ' ' A' ' 113' ' ' PHE . 48.3 t -62.09 -46.98 95.25 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 CA-C-O 120.736 0.303 . . . . 0.0 110.315 177.406 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.452 ' HG3' ' O ' ' A' ' 114' ' ' ASP . 81.5 mtt180 -54.85 -54.7 39.05 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.125 179.582 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.498 ' HB3' ' HZ2' ' A' ' 119' ' ' LYS . 0.0 OUTLIER -68.2 -29.59 68.47 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.764 -177.258 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -65.19 -58.05 6.96 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.829 0.347 . . . . 0.0 110.342 179.547 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 49.3 mm -59.63 -43.07 90.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.388 179.663 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 13.5 tp10 -58.52 -50.14 74.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.571 -179.303 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -72.7 -29.81 63.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.911 -176.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 6.1 tt -69.09 -53.31 20.98 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.753 179.733 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 47.9 mm -72.32 -52.47 23.87 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.547 -174.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 . . . . . 0 C--O 1.25 1.107 0 CA-C-O 119.011 -0.519 . . . . 0.0 110.145 -175.288 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.902 0 N-CA-C 111.447 -0.661 . . . . 0.0 111.447 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.8 t -61.79 -45.82 92.22 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 173.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . 0.435 ' N ' ' SD ' ' A' ' 3' ' ' MET . 1.8 mpt? -99.68 146.27 26.69 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 168.677 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 53.3 m 59.6 93.05 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 O-C-N 123.44 0.463 . . . . 0.0 110.341 -176.245 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -93.8 104.61 16.68 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.049 0.452 . . . . 0.0 111.295 -176.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -94.63 -165.69 1.35 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.692 -0.685 . . . . 0.0 109.25 172.085 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.657 HG23 ' HB2' ' A' ' 13' ' ' SER . 24.7 m 69.66 8.93 6.99 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-O 121.158 0.504 . . . . 0.0 111.419 178.556 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.718 ' HB2' ' HD3' ' A' ' 9' ' ' PRO . 89.3 m-70 -127.94 -63.63 0.02 OUTLIER Pre-proline 0 CA--C 1.541 0.599 0 CA-C-N 116.53 -0.305 . . . . 0.0 111.123 178.575 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.718 ' HD3' ' HB2' ' A' ' 8' ' ' HIS . 84.9 Cg_endo -80.71 -52.34 0.05 OUTLIER 'Trans proline' 0 C--N 1.363 1.325 0 C-N-CA 121.534 1.489 . . . . 0.0 112.272 -177.147 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -79.85 -1.79 40.62 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.461 179.308 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.575 ' O ' ' HA ' ' A' ' 7' ' ' THR . 35.5 m-20 66.24 -79.2 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.74 -179.305 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 12.8 t70 64.33 -74.7 0.05 OUTLIER 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 123.102 0.561 . . . . 0.0 112.344 175.023 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.657 ' HB2' HG23 ' A' ' 7' ' ' THR . 6.4 m -83.85 11.5 7.51 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 112.494 0.553 . . . . 0.0 112.494 -170.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 10.0 m-85 -66.89 112.93 4.56 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 120.685 0.279 . . . . 0.0 110.489 176.009 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.538 HG13 HG23 ' A' ' 16' ' ' VAL . 34.0 pt -92.01 -26.82 4.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.357 178.188 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.538 HG23 HG13 ' A' ' 15' ' ' ILE . 92.1 t -135.35 137.72 49.53 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.194 179.466 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.462 ' NH1' ' HG2' ' A' ' 42' ' ' ARG . 18.9 tpp180 -132.74 123.33 26.03 Favored 'General case' 0 N--CA 1.463 0.21 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 175.508 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 30.2 m -124.09 176.6 5.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 C-N-CA 122.659 0.383 . . . . 0.0 110.375 179.072 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 22.4 pttp -132.48 125.51 30.83 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 179.43 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -165.91 177.71 6.95 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 -179.3 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 60.2 t -100.24 118.14 46.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 110.177 -0.305 . . . . 0.0 110.177 176.059 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 17.8 m -66.71 109.0 1.15 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.354 0 CA-C-O 121.352 0.596 . . . . 0.0 111.237 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 25.1 mmt -106.65 166.52 10.51 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.129 179.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.521 HG23 ' CE1' ' A' ' 33' ' ' PHE . 11.0 t -160.84 150.63 17.39 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.934 -0.575 . . . . 0.0 109.708 177.769 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 20.7 ttt180 -120.31 100.64 7.29 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 174.071 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -69.38 84.31 0.4 Allowed 'General case' 0 C--O 1.235 0.299 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.481 179.449 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 15.4 t70 64.44 -81.63 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.139 -175.673 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 41.2 m -149.43 17.8 0.93 Allowed 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 120.81 0.338 . . . . 0.0 110.432 178.228 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 38.6 t -64.66 89.58 0.07 Allowed 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.829 -179.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 76.32 -63.72 2.91 Favored Glycine 0 C--N 1.332 0.353 0 CA-C-N 116.093 -0.503 . . . . 0.0 112.351 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 158.51 -140.28 6.84 Favored Glycine 0 N--CA 1.449 -0.475 0 N-CA-C 111.027 -0.829 . . . . 0.0 111.027 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . 0.492 ' HH2' ' HG2' ' A' ' 99' ' ' LYS . 97.9 m95 -79.02 93.9 5.2 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 176.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.521 ' CE1' HG23 ' A' ' 24' ' ' THR . 21.3 p90 -103.65 143.17 26.11 Favored Pre-proline 0 C--O 1.236 0.353 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.505 -178.311 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -69.08 103.37 1.04 Allowed 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.286 1.991 . . . . 0.0 111.266 176.19 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.427 ' H ' ' HG2' ' A' ' 35' ' ' GLN . 12.1 pt20 -57.04 -49.44 75.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.476 -179.625 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -157.45 171.2 20.8 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 179.36 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 78.52 -75.41 1.97 Allowed Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 121.053 -0.594 . . . . 0.0 111.777 -179.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 70.91 -73.95 0.64 Allowed Glycine 0 C--N 1.332 0.354 0 C-N-CA 121.562 -0.351 . . . . 0.0 112.25 -179.622 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -70.86 76.96 0.54 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 121.5 -0.381 . . . . 0.0 112.289 178.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 38.1 mm 66.87 142.84 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 C-N-CA 123.442 0.697 . . . . 0.0 111.31 178.455 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 18.2 m -132.96 133.85 43.74 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.057 0.455 . . . . 0.0 110.44 178.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.462 ' HG2' ' NH1' ' A' ' 17' ' ' ARG . 37.8 ttt85 -86.51 83.44 7.64 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.551 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 28.8 t -100.97 155.53 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.567 -172.414 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -162.78 -178.19 36.41 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.623 -0.799 . . . . 0.0 112.702 177.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 59.8 t -128.98 128.63 67.52 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 179.008 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . 0.526 ' SG ' ' HB3' ' A' ' 60' ' ' LEU . 13.7 p -119.45 126.44 51.32 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 176.479 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -82.06 98.39 8.62 Favored 'General case' 0 C--O 1.234 0.237 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 179.392 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.5 HG21 ' HE1' ' A' ' 76' ' ' TYR . 33.0 m -86.53 -168.95 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.21 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 22.1 ptp -169.27 169.68 9.02 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 177.497 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . 0.484 ' H ' ' CD2' ' A' ' 50' ' ' HIS . 0.6 OUTLIER -82.34 131.23 56.45 Favored Pre-proline 0 C--N 1.327 -0.373 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 176.273 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 50' ' ' HIS . 51.5 Cg_exo -56.3 -13.45 9.94 Favored 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 123.306 2.671 . . . . 0.0 113.298 -173.242 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -57.21 -36.79 71.3 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.419 178.208 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 73.44 81.52 0.4 Allowed Glycine 0 C--N 1.333 0.4 0 CA-C-N 115.849 -0.614 . . . . 0.0 112.327 179.043 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 19.5 m120 -134.04 23.04 3.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.891 0.376 . . . . 0.0 110.544 -179.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 84.31 -49.68 4.27 Favored Glycine 0 C--N 1.331 0.284 0 C-N-CA 121.326 -0.464 . . . . 0.0 112.249 179.389 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 30.9 ttp-105 -51.86 128.43 23.94 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 122.616 0.366 . . . . 0.0 110.778 177.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 15.4 m -119.96 161.86 20.18 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.841 -177.101 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -121.83 -173.41 14.45 Favored Glycine 0 N--CA 1.452 -0.248 0 N-CA-C 110.714 -0.954 . . . . 0.0 110.714 176.18 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -135.96 148.7 48.59 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 117.337 0.568 . . . . 0.0 110.518 -177.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.67 HD22 ' HB2' ' A' ' 62' ' ' HIS . 2.3 tt -133.37 113.0 12.07 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 179.171 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.558 ' HB ' ' HB2' ' A' ' 75' ' ' CYS . 46.2 mt -79.96 98.31 3.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 108.396 -0.965 . . . . 0.0 108.396 174.605 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . 0.67 ' HB2' HD22 ' A' ' 60' ' ' LEU . 23.8 t-80 -120.93 141.22 50.86 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 -173.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -156.3 126.93 1.88 Allowed Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.322 -0.942 . . . . 0.0 113.132 -177.439 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -90.5 164.04 14.4 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 172.273 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.576 ' HB3' HG11 ' A' ' 72' ' ' VAL . 16.5 ptm180 -81.41 164.1 22.32 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.176 -0.675 . . . . 0.0 109.176 172.633 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 54.7 tp60 -78.05 68.3 4.07 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-O 121.38 0.61 . . . . 0.0 109.43 179.304 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.817 ' HA ' ' HE3' ' A' ' 67' ' ' LYS . 0.5 OUTLIER -171.58 49.7 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.223 -0.899 . . . . 0.0 109.017 -177.145 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.437 ' HB2' ' O ' ' A' ' 67' ' ' LYS . 4.3 m-20 71.8 -179.05 0.22 Allowed 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 115.257 -0.883 . . . . 0.0 111.149 -177.502 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 5.1 mptp? -65.92 93.62 0.2 Allowed 'General case' 0 C--O 1.233 0.215 0 CA-C-N 115.897 -0.592 . . . . 0.0 112.594 -175.463 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 58.1 tp -136.22 105.14 5.88 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 167.403 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 44.1 t -62.56 108.34 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.673 -177.035 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.576 HG11 ' HB3' ' A' ' 65' ' ' ARG . 33.7 m -107.75 -9.84 10.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.77 179.112 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -144.67 127.11 15.93 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 179.338 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -146.74 115.27 6.74 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 177.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . 0.558 ' HB2' ' HB ' ' A' ' 61' ' ' ILE . 39.8 m -137.73 85.42 2.11 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.079 0.466 . . . . 0.0 109.986 177.545 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.5 ' HE1' HG21 ' A' ' 48' ' ' VAL . 86.3 t80 -75.28 135.38 40.94 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.548 176.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.437 HG11 ' HG ' ' A' ' 81' ' ' LEU . 25.6 m -134.19 149.56 30.32 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 177.602 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.444 ' N ' ' HD3' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -108.83 -35.09 6.47 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.183 -174.346 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 59.9 tttm -165.83 23.34 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 121.491 0.663 . . . . 0.0 109.625 -177.591 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -146.63 125.18 12.44 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.227 -170.223 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.437 ' HG ' HG11 ' A' ' 77' ' ' VAL . 5.3 mt -160.81 122.55 3.05 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.014 177.042 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 48.4 t -124.29 98.64 5.52 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 177.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.644 ' HB3' ' NE2' ' A' ' 91' ' ' HIS . 84.1 m-85 -90.58 161.68 15.34 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.407 177.234 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.455 ' HB ' ' CE1' ' A' ' 92' ' ' HIS . 60.7 m -158.89 115.66 2.72 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 174.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.448 ' HA ' ' HA ' ' A' ' 91' ' ' HIS . 36.2 ttpt -89.11 107.54 19.1 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 178.457 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -73.71 -41.68 62.26 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.387 -175.001 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -136.61 153.47 75.97 Favored Pre-proline 0 C--N 1.325 -0.472 0 CA-C-N 115.203 -0.908 . . . . 0.0 108.647 179.017 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_exo -52.89 -23.51 21.26 Favored 'Trans proline' 0 N--CA 1.476 0.449 0 C-N-CA 122.491 2.127 . . . . 0.0 112.695 -179.166 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 14.6 t -107.54 8.93 29.55 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.576 -177.277 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.42 ' HE1' ' HB3' ' A' ' 92' ' ' HIS . 4.6 t80 -148.38 111.68 4.95 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-O 120.975 0.417 . . . . 0.0 110.953 -178.083 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . 0.644 ' NE2' ' HB3' ' A' ' 83' ' ' TYR . 3.1 t-160 -111.52 133.28 53.91 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 177.613 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . 0.455 ' CE1' ' HB ' ' A' ' 84' ' ' THR . 33.0 p80 -134.52 165.22 25.69 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.852 0.358 . . . . 0.0 111.346 -177.345 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 47.4 p90 -147.66 143.87 27.97 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.351 -179.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 48.6 tttm -112.99 122.94 49.14 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.153 179.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 27.7 m -110.21 32.88 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.325 0 CA-C-O 121.265 0.555 . . . . 0.0 109.937 -177.538 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 23.8 t70 71.92 -57.42 0.62 Allowed 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 114.859 -1.064 . . . . 0.0 109.81 -173.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -73.9 97.1 2.72 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 172.497 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 12.2 mpt_? 60.56 176.38 0.1 Allowed 'General case' 0 C--O 1.243 0.748 0 CA-C-O 122.186 0.993 . . . . 0.0 112.077 -176.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.492 ' HG2' ' HH2' ' A' ' 32' ' ' TRP . 38.1 ttpt -126.51 106.95 9.81 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 114.34 -1.3 . . . . 0.0 108.2 176.274 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.491 ' CD2' ' SG ' ' A' ' 75' ' ' CYS . 4.7 m-85 -89.76 173.87 8.03 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 -175.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -177.66 -175.44 44.87 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.833 -0.699 . . . . 0.0 111.972 177.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.449 ' O ' HD12 ' A' ' 102' ' ' LEU . 1.3 pp -152.0 150.33 29.87 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.099 0.476 . . . . 0.0 110.898 177.012 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 25.2 m -101.0 116.18 32.24 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.806 176.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 40.5 m-85 -63.59 147.42 51.52 Favored 'General case' 0 C--O 1.237 0.413 0 O-C-N 123.369 0.418 . . . . 0.0 110.422 178.551 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 19.0 pt20 -114.25 -10.8 12.68 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.473 -0.331 . . . . 0.0 110.974 -178.244 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 20.4 m -155.12 151.7 23.5 Favored Pre-proline 0 C--N 1.33 -0.251 0 N-CA-C 110.089 -0.337 . . . . 0.0 110.089 174.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -60.16 -19.2 55.7 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.344 2.029 . . . . 0.0 111.65 176.361 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -66.08 -60.43 2.83 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.519 177.381 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -65.19 -31.98 73.43 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.79 179.035 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -57.61 -61.53 2.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.003 0.43 . . . . 0.0 110.726 175.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.428 ' HD2' ' O ' ' A' ' 111' ' ' ARG . 5.4 tmm_? -62.57 -38.23 89.28 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.235 -177.496 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -63.5 -43.48 97.11 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.095 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.405 ' O ' HG23 ' A' ' 117' ' ' VAL . 75.4 t80 -67.06 -47.33 71.64 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.081 -178.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 59.5 m-20 -57.5 -39.48 76.57 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.526 178.095 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -62.12 -49.86 74.22 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.112 178.359 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -61.25 -42.4 99.77 Favored Glycine 0 C--N 1.333 0.367 0 CA-C-N 115.599 -0.728 . . . . 0.0 112.063 179.631 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.405 HG23 ' O ' ' A' ' 113' ' ' PHE . 55.4 t -60.91 -46.67 96.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.927 0.394 . . . . 0.0 110.699 177.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 25.6 tpt180 -59.88 -49.78 76.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.221 -177.549 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 4.3 mmmp? -64.28 -41.18 97.02 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.942 178.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -58.08 -55.99 27.78 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.538 -179.591 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.457 ' O ' HG22 ' A' ' 125' ' ' ILE . 46.2 mm -58.27 -42.59 84.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.326 178.687 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -53.28 -59.08 5.01 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.472 -179.355 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 50.0 m-20 -74.16 -24.67 59.42 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.271 -176.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 9.9 tt -68.89 -38.83 79.9 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.36 178.511 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.457 HG22 ' O ' ' A' ' 121' ' ' ILE . 13.8 tt -91.17 -37.83 9.77 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 CA-C-N 116.625 -0.261 . . . . 0.0 111.342 -176.496 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 . . . . . 0 C--O 1.25 1.093 0 CA-C-O 118.422 -0.799 . . . . 0.0 110.218 -177.04 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.892 0 N-CA-C 112.005 -0.438 . . . . 0.0 112.005 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.403 ' O ' ' HB2' ' A' ' 3' ' ' MET . 20.1 m 66.3 155.31 0.09 Allowed 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 122.875 0.47 . . . . 0.0 111.113 -178.521 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . 0.403 ' HB2' ' O ' ' A' ' 2' ' ' SER . 1.5 mpt? 73.23 -52.08 0.7 Allowed 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.461 0.704 . . . . 0.0 111.225 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 56.4 p -120.47 89.38 3.12 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 110.307 -0.257 . . . . 0.0 110.307 176.006 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 17.8 mp0 -67.42 -57.02 7.32 Favored 'General case' 0 C--O 1.232 0.178 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 175.149 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -90.41 168.99 11.44 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.502 171.587 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.539 HG21 ' HA ' ' A' ' 11' ' ' ASP . 5.2 t -166.04 178.83 6.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.852 0.358 . . . . 0.0 111.368 -176.596 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.448 ' HB3' ' HD3' ' A' ' 9' ' ' PRO . 80.2 t60 176.43 -42.31 0.0 OUTLIER Pre-proline 0 CA--C 1.544 0.714 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.009 -171.192 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.448 ' HD3' ' HB3' ' A' ' 8' ' ' HIS . 45.6 Cg_endo -100.82 15.5 0.39 Allowed 'Trans proline' 0 C--N 1.363 1.296 0 C-N-CA 123.009 2.473 . . . . 0.0 113.698 174.768 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -143.46 -72.41 0.29 Allowed 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 -174.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.539 ' HA ' HG21 ' A' ' 7' ' ' THR . 0.9 OUTLIER 74.1 94.43 0.07 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.135 -0.939 . . . . 0.0 113.384 165.049 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -131.23 21.37 4.83 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.145 -0.934 . . . . 0.0 108.581 171.162 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 39.2 t -128.86 -24.01 3.01 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-N 115.281 -0.872 . . . . 0.0 111.442 -175.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.514 ' HE1' HG23 ' A' ' 7' ' ' THR . 5.2 m-85 -64.2 140.75 58.9 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 120.912 0.386 . . . . 0.0 111.303 -177.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 61.2 mt -126.71 -64.92 0.98 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.203 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.427 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.566 ' HB ' ' HB ' ' A' ' 45' ' ' VAL . 60.2 t -99.07 106.29 18.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.095 -178.193 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.421 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 62.2 mtm180 -120.42 90.15 3.27 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.044 0.45 . . . . 0.0 110.212 179.421 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.418 HG11 ' HB2' ' A' ' 109' ' ' ASP . 86.6 t -107.89 135.87 45.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.887 -176.545 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -85.46 106.16 16.6 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 174.239 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -144.84 -172.15 3.77 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.114 -177.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.587 ' HB ' ' HB ' ' A' ' 103' ' ' THR . 23.6 t -101.53 121.54 52.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.615 0.245 . . . . 0.0 110.473 -179.193 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.502 HG11 ' HG ' ' A' ' 73' ' ' LEU . 60.8 t -97.71 98.28 7.18 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 CA-C-O 121.035 0.445 . . . . 0.0 110.461 176.134 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . 0.444 ' HB3' ' HB3' ' A' ' 32' ' ' TRP . 24.9 mmt -74.47 106.38 6.04 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 174.06 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.462 HG23 ' CE1' ' A' ' 33' ' ' PHE . 10.0 t -76.69 -46.4 25.72 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 111.583 0.216 . . . . 0.0 111.583 -173.204 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.514 ' HB2' ' CE3' ' A' ' 32' ' ' TRP . 23.4 ttt180 57.84 135.13 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 121.317 0.58 . . . . 0.0 110.396 -172.041 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -81.08 64.85 5.98 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 177.512 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 32.5 t70 58.96 -74.73 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 114.536 -1.211 . . . . 0.0 110.932 -172.5 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 26.4 t -121.76 99.06 6.25 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 177.242 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 10.8 m -126.04 159.71 32.04 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.712 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -69.3 76.55 0.35 Allowed Glycine 0 C--N 1.332 0.34 0 N-CA-C 111.582 -0.607 . . . . 0.0 111.582 176.583 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 106.72 -158.67 15.16 Favored Glycine 0 C--O 1.237 0.334 0 N-CA-C 111.264 -0.735 . . . . 0.0 111.264 -175.035 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . 0.514 ' CE3' ' HB2' ' A' ' 25' ' ' ARG . 53.7 m95 -127.42 126.16 41.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.656 0.265 . . . . 0.0 110.424 -179.593 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.479 ' HA ' ' HD3' ' A' ' 34' ' ' PRO . 6.4 p90 -114.44 137.71 22.75 Favored Pre-proline 0 C--O 1.238 0.45 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.139 -179.851 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.581 ' HB2' ' HA2' ' A' ' 38' ' ' GLY . 7.3 Cg_exo -74.05 154.07 47.18 Favored 'Trans proline' 0 N--CA 1.462 -0.367 0 C-N-CA 122.785 2.323 . . . . 0.0 111.358 175.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.403 ' NE2' ' HB ' ' A' ' 22' ' ' VAL . 0.0 OUTLIER -75.51 -163.39 0.25 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.303 175.166 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -45.99 -34.55 4.09 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 -173.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -66.73 -30.1 75.74 Favored Glycine 0 CA--C 1.519 0.336 0 C-N-CA 121.242 -0.504 . . . . 0.0 113.074 -175.581 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.581 ' HA2' ' HB2' ' A' ' 34' ' ' PRO . . . 58.37 13.53 16.44 Favored Glycine 0 CA--C 1.522 0.476 0 C-N-CA 121.506 -0.378 . . . . 0.0 113.248 179.497 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.482 ' HA2' HG22 ' A' ' 21' ' ' VAL . . . 154.81 -43.12 0.58 Allowed Glycine 0 N--CA 1.449 -0.451 0 N-CA-C 111.612 -0.595 . . . . 0.0 111.612 -176.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.455 ' O ' HG13 ' A' ' 40' ' ' ILE . 32.4 pt -89.88 111.06 22.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 121.221 0.534 . . . . 0.0 110.532 179.263 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 21.1 m -146.41 131.15 17.96 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.73 177.581 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.586 ' HB3' ' HB2' ' A' ' 64' ' ' GLU . 35.4 ttt180 -90.31 103.27 15.97 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 176.304 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.642 HG21 HD21 ' A' ' 102' ' ' LEU . 25.5 t -81.2 94.51 2.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.164 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -90.27 81.89 1.37 Allowed Glycine 0 N--CA 1.452 -0.276 0 CA-C-N 115.978 -0.556 . . . . 0.0 112.639 -177.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.566 ' HB ' ' HB ' ' A' ' 16' ' ' VAL . 61.0 t -76.44 108.72 9.55 Favored 'Isoleucine or valine' 0 C--O 1.24 0.569 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 176.506 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . 0.633 ' SG ' ' HB3' ' A' ' 60' ' ' LEU . 11.8 p -115.65 136.86 52.64 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.997 -177.738 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -91.52 92.31 8.46 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 176.397 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 23.1 m -83.76 111.63 20.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 121.396 0.617 . . . . 0.0 110.667 -176.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 22.7 ptp -98.85 124.91 44.06 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.392 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 7.8 p80 -70.23 132.82 87.8 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.09 178.421 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -56.58 138.99 86.84 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 122.859 2.373 . . . . 0.0 112.434 -175.387 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 66.26 16.03 10.29 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 115.736 -0.666 . . . . 0.0 111.172 178.208 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -65.46 148.47 51.26 Favored Glycine 0 C--N 1.333 0.411 0 CA-C-N 115.884 -0.598 . . . . 0.0 112.461 179.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 29.3 p-10 -79.06 -21.04 47.39 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.668 0.27 . . . . 0.0 111.043 -177.426 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 162.66 161.22 11.93 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.291 178.246 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 91.3 mtt-85 67.23 168.77 0.25 Allowed 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 123.513 0.725 . . . . 0.0 111.066 -177.076 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 22.7 m -153.55 161.66 42.0 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.542 -177.525 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -87.11 160.01 31.72 Favored Glycine 0 N--CA 1.45 -0.387 0 N-CA-C 111.188 -0.765 . . . . 0.0 111.188 177.008 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -117.84 106.91 13.49 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.934 0.397 . . . . 0.0 110.286 179.625 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.633 ' HB3' ' SG ' ' A' ' 46' ' ' CYS . 2.5 tt -88.66 105.16 17.5 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 179.7 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.422 ' HB ' ' HB2' ' A' ' 75' ' ' CYS . 58.6 mt -73.41 87.96 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 174.719 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 8.5 t-80 -91.55 100.33 13.09 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.177 -175.318 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.489 ' HA3' ' HB2' ' A' ' 73' ' ' LEU . . . -87.1 95.09 2.04 Favored Glycine 0 N--CA 1.449 -0.496 0 CA-C-N 115.762 -0.654 . . . . 0.0 112.324 -178.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.586 ' HB2' ' HB3' ' A' ' 42' ' ' ARG . 34.6 mt-10 -83.07 137.49 34.08 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 177.007 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.53 ' NH1' ' HB2' ' A' ' 67' ' ' LYS . 6.3 tmm_? -114.04 126.18 54.83 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 178.411 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.433 ' O ' ' HD2' ' A' ' 65' ' ' ARG . 1.0 OUTLIER -67.84 -160.95 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.488 0 O-C-N 123.564 0.54 . . . . 0.0 112.073 -174.262 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.53 ' HB2' ' NH1' ' A' ' 65' ' ' ARG . 34.5 mmtp 65.4 -82.89 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 -173.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.434 ' HB2' HD12 ' A' ' 70' ' ' LEU . 5.9 m-20 -74.22 -30.81 62.35 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.615 176.47 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.44 ' HA ' ' O ' ' A' ' 65' ' ' ARG . 22.8 tptm 60.27 81.89 0.17 Allowed 'General case' 0 C--O 1.233 0.217 0 CA-C-N 115.084 -0.962 . . . . 0.0 110.074 -176.721 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.434 HD12 ' HB2' ' A' ' 68' ' ' ASP . 0.0 OUTLIER -150.1 168.7 23.16 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.472 -177.741 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 21.6 t -83.15 109.69 17.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.893 -176.711 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.435 HG23 HD23 ' A' ' 73' ' ' LEU . 18.0 m -102.05 -35.91 4.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 CA-C-O 120.888 0.375 . . . . 0.0 111.053 177.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.502 ' HG ' HG11 ' A' ' 22' ' ' VAL . 4.5 mm? -116.24 117.11 29.1 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.229 178.741 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -118.96 104.2 10.29 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 176.205 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . 0.422 ' HB2' ' HB ' ' A' ' 61' ' ' ILE . 61.1 m -135.22 83.48 2.02 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.346 0.593 . . . . 0.0 110.632 -179.329 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.4 ' HA ' ' HA ' ' A' ' 60' ' ' LEU . 80.0 t80 -69.41 105.98 2.78 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.468 -0.787 . . . . 0.0 108.997 172.477 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 39.6 t -100.69 132.71 45.84 Favored 'Isoleucine or valine' 0 C--O 1.237 0.395 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 -175.053 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 30.4 ttp180 -135.46 100.17 4.43 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.403 -174.33 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.751 ' H ' HD21 ' A' ' 124' ' ' LEU . 66.4 mmtt 72.05 -29.74 0.2 Allowed 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.339 0.655 . . . . 0.0 112.748 178.444 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -88.38 23.01 2.31 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 120.973 0.416 . . . . 0.0 110.753 -177.058 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.604 HD22 HG12 ' A' ' 121' ' ' ILE . 1.0 OUTLIER -71.3 89.85 0.91 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.828 -179.249 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 49.0 t -123.0 99.9 7.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.121 0.486 . . . . 0.0 110.593 179.734 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.716 ' HB3' ' NE2' ' A' ' 91' ' ' HIS . 4.2 m-85 -87.1 115.47 24.51 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.47 175.738 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 31.2 m -98.61 119.71 37.8 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.176 -0.465 . . . . 0.0 109.869 173.387 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 24.2 ttmm -86.6 103.94 15.57 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 176.646 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -82.56 -19.9 37.62 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 121.064 0.459 . . . . 0.0 110.237 -178.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . 0.856 ' HB3' ' HB3' ' A' ' 90' ' ' PHE . 12.3 t-20 -156.58 144.69 14.3 Favored Pre-proline 0 C--N 1.326 -0.453 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 178.761 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.446 ' HD2' ' ND2' ' A' ' 87' ' ' ASN . 33.9 Cg_exo -34.47 -50.8 0.65 Allowed 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 123.374 2.716 . . . . 0.0 113.718 179.309 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.562 ' HA ' ' HD2' ' A' ' 104' ' ' PHE . 19.5 p -102.37 -0.72 32.18 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 112.144 0.424 . . . . 0.0 112.144 -176.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.856 ' HB3' ' HB3' ' A' ' 87' ' ' ASN . 62.0 t80 -115.78 99.3 7.21 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-O 121.402 0.62 . . . . 0.0 110.07 176.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . 0.716 ' NE2' ' HB3' ' A' ' 83' ' ' TYR . 0.8 OUTLIER -103.15 149.9 24.18 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 177.493 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 25.5 p80 -149.91 159.56 44.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 118.206 0.457 . . . . 0.0 110.74 176.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . 0.645 ' HZ3' ' HB2' ' A' ' 102' ' ' LEU . 28.5 p90 -137.29 146.72 45.01 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.323 -0.399 . . . . 0.0 109.979 178.632 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.525 ' NZ ' ' HB3' ' A' ' 94' ' ' LYS . 5.7 ttpm? -114.63 99.47 7.55 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.704 -178.708 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.479 HG13 ' HD1' ' A' ' 93' ' ' TRP . 16.7 m -85.18 113.58 23.87 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 176.023 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 57.08 -86.89 0.02 OUTLIER 'General case' 0 C--O 1.235 0.311 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.405 -173.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -126.22 -16.66 5.42 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.457 -177.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.98 134.2 33.51 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.836 0.351 . . . . 0.0 110.86 -177.395 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 3.6 mppt? -109.98 123.24 49.29 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.029 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.401 ' CE2' ' SG ' ' A' ' 75' ' ' CYS . 44.3 m-85 -122.05 141.71 51.1 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 176.211 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -116.73 125.33 6.52 Favored Glycine 0 CA--C 1.516 0.144 0 C-N-CA 121.377 -0.439 . . . . 0.0 113.227 -174.668 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.645 ' HB2' ' HZ3' ' A' ' 93' ' ' TRP . 0.4 OUTLIER -94.4 104.28 16.25 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 175.675 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.587 ' HB ' ' HB ' ' A' ' 21' ' ' VAL . 33.3 m -92.54 119.5 32.07 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 177.161 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.562 ' HD2' ' HA ' ' A' ' 89' ' ' THR . 36.7 m-85 -73.82 148.22 42.64 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.438 -175.04 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -88.81 -52.56 5.05 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.605 -176.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 19.7 m -134.01 159.11 73.67 Favored Pre-proline 0 C--N 1.326 -0.413 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.142 -177.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_endo -55.59 -29.85 71.96 Favored 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 122.526 2.15 . . . . 0.0 112.17 -179.46 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -61.8 -62.04 2.08 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.77 179.371 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.418 ' HB2' HG11 ' A' ' 18' ' ' VAL . 3.3 p-10 -66.83 -29.09 68.92 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.838 -179.455 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -57.82 -60.82 3.12 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.922 0.392 . . . . 0.0 110.697 176.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 69.7 mtp180 -64.12 -42.37 96.89 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.54 -0.754 . . . . 0.0 110.802 -178.431 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -61.54 -41.46 97.38 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.938 -179.359 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 35.4 t80 -75.42 -37.02 60.67 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.213 -177.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 35.3 m-20 -58.82 -53.83 53.92 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 120.884 0.373 . . . . 0.0 110.336 177.29 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? -66.01 -37.92 87.15 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.501 179.05 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -62.77 -49.98 68.07 Favored Glycine 0 C--N 1.331 0.274 0 CA-C-N 116.053 -0.522 . . . . 0.0 112.501 -179.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.515 ' O ' HG13 ' A' ' 121' ' ' ILE . 9.1 p -69.66 -35.45 65.9 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.201 0 N-CA-C 110.123 -0.325 . . . . 0.0 110.123 -178.598 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.52 ' O ' ' HG3' ' A' ' 122' ' ' GLU . 69.8 ttt180 -57.46 -51.16 70.59 Favored 'General case' 0 C--O 1.23 0.073 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 176.091 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 64.3 tttp -56.82 -43.93 81.53 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.422 177.453 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.58 -43.18 97.61 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.154 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.604 HG12 HD22 ' A' ' 81' ' ' LEU . 80.2 mt -62.18 -51.53 71.3 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.195 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.414 179.536 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.52 ' HG3' ' O ' ' A' ' 118' ' ' ARG . 42.8 mt-10 -61.23 -44.52 97.13 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 115.729 -0.668 . . . . 0.0 110.616 -177.363 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -60.67 -42.21 96.62 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.527 178.323 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.751 HD21 ' H ' ' A' ' 79' ' ' LYS . 41.0 tp -66.65 -47.72 71.66 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.134 -177.715 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.481 HG12 ' O ' ' A' ' 121' ' ' ILE . 17.7 pt -74.53 -65.05 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 C-N-CA 120.964 -0.294 . . . . 0.0 111.42 -176.791 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.479 ' H ' HG13 ' A' ' 125' ' ' ILE . 71.7 mm-40 . . . . . 0 C--O 1.25 1.129 0 CA-C-O 119.035 -0.507 . . . . 0.0 110.069 -172.498 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.74 0 N-CA-C 112.019 -0.432 . . . . 0.0 112.019 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 49.1 m -83.81 85.2 7.33 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.126 0.489 . . . . 0.0 110.639 179.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 26.1 ptm -71.69 -24.0 61.75 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.131 176.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.441 ' O ' ' HB2' ' A' ' 5' ' ' GLU . 7.7 t -129.12 -174.32 3.24 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 115.452 -0.795 . . . . 0.0 108.938 177.054 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.441 ' HB2' ' O ' ' A' ' 4' ' ' THR . 2.1 mp0 66.51 18.37 10.8 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 110.04 -0.355 . . . . 0.0 110.04 -170.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 59.34 -174.01 0.1 Allowed 'General case' 0 C--O 1.235 0.322 0 CA-C-N 115.399 -0.818 . . . . 0.0 111.365 -177.439 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 57.0 m -152.19 123.57 7.75 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.93 -177.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.694 ' CD2' ' HD2' ' A' ' 9' ' ' PRO . 31.8 t-80 -65.46 149.3 97.34 Favored Pre-proline 0 CA--C 1.539 0.53 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 175.09 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.694 ' HD2' ' CD2' ' A' ' 8' ' ' HIS . 26.8 Cg_exo -36.33 -38.16 0.3 Allowed 'Trans proline' 0 C--N 1.366 1.453 0 C-N-CA 122.967 2.445 . . . . 0.0 112.238 176.094 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -134.94 116.01 14.22 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 163.369 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -116.72 23.01 12.28 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 -177.37 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -106.18 -40.55 5.61 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.292 -175.195 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -92.48 21.31 5.44 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 121.057 0.456 . . . . 0.0 111.277 -173.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -76.89 137.88 39.4 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.046 177.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.715 HD11 ' HB2' ' A' ' 47' ' ' LYS . 1.8 mp -88.35 -53.48 9.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 173.723 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 14.5 p -166.03 146.07 1.66 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.311 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.38 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.541 ' HG2' ' HA3' ' A' ' 44' ' ' GLY . 24.0 mtm180 -118.09 109.06 15.97 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.492 173.04 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 34.8 m -109.23 162.81 6.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.824 -177.058 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.5 ' HE3' HG12 ' A' ' 40' ' ' ILE . 83.9 tttt -84.41 130.13 34.8 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.414 177.172 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -153.92 -167.27 2.61 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 175.378 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.57 ' HB ' ' HB ' ' A' ' 103' ' ' THR . 64.8 t -124.51 114.85 42.63 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 175.15 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.507 HG23 ' HG2' ' A' ' 35' ' ' GLN . 9.3 m -73.08 110.45 6.32 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 CA-C-O 121.367 0.603 . . . . 0.0 111.67 -178.102 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . 0.556 ' SD ' HG12 ' A' ' 21' ' ' VAL . 38.3 mmm -104.42 146.02 29.45 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.628 -0.714 . . . . 0.0 109.554 -178.521 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.497 ' HB ' ' NE2' ' A' ' 35' ' ' GLN . 10.7 t -135.32 -6.12 2.3 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 111.766 0.284 . . . . 0.0 111.766 179.26 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 31.6 ttp180 53.25 46.93 25.46 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 122.891 0.477 . . . . 0.0 111.324 -178.26 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.496 ' O ' ' HB3' ' A' ' 27' ' ' ASP . 4.4 p-10 45.88 26.65 0.4 Allowed 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 124.038 0.935 . . . . 0.0 113.361 174.102 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.496 ' HB3' ' O ' ' A' ' 26' ' ' ASP . 8.3 t70 74.99 -40.23 0.43 Allowed 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 122.785 0.434 . . . . 0.0 111.518 178.633 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 17.2 m -96.91 -91.57 0.24 Allowed 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 116.945 -0.116 . . . . 0.0 111.278 -176.017 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 11.0 p -176.72 27.73 0.0 OUTLIER 'General case' 0 C--O 1.236 0.391 0 N-CA-C 112.253 0.464 . . . . 0.0 112.253 -174.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -76.34 -28.83 59.23 Favored Glycine 0 CA--C 1.519 0.342 0 C-N-CA 120.772 -0.727 . . . . 0.0 111.924 179.066 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 158.34 151.3 6.03 Favored Glycine 0 CA--C 1.519 0.318 0 C-N-CA 121.386 -0.435 . . . . 0.0 112.265 178.593 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 83.9 m95 -76.95 102.04 6.24 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 110.165 -0.309 . . . . 0.0 110.165 179.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.411 ' H ' ' HD1' ' A' ' 33' ' ' PHE . 0.2 OUTLIER -114.83 153.55 46.94 Favored Pre-proline 0 C--O 1.237 0.422 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.145 177.48 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_exo -67.05 130.67 23.39 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.791 2.328 . . . . 0.0 111.473 175.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.507 ' HG2' HG23 ' A' ' 22' ' ' VAL . 7.9 pt20 -92.02 85.92 5.67 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 121.32 0.581 . . . . 0.0 110.837 -178.132 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 71.66 -34.13 0.29 Allowed 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.929 0.892 . . . . 0.0 113.312 176.459 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.446 ' HA2' ' HD2' ' A' ' 65' ' ' ARG . . . -63.77 -50.02 64.3 Favored Glycine 0 C--N 1.333 0.405 0 C-N-CA 121.163 -0.541 . . . . 0.0 112.347 -179.729 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 82.45 -146.0 24.46 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.99 -0.624 . . . . 0.0 111.672 -178.312 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -65.17 -23.6 69.89 Favored Glycine 0 CA--C 1.518 0.243 0 C-N-CA 121.429 -0.415 . . . . 0.0 112.83 -178.601 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.5 HG12 ' HE3' ' A' ' 19' ' ' LYS . 57.8 mt -113.52 104.3 16.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.961 0.41 . . . . 0.0 110.344 179.28 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.454 ' HB3' HG13 ' A' ' 22' ' ' VAL . 19.1 m -131.1 107.71 9.24 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 173.697 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.615 ' HB3' ' HG3' ' A' ' 64' ' ' GLU . 47.0 ttt180 -77.08 91.72 3.7 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.223 0.535 . . . . 0.0 109.901 -177.422 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 78.8 t -79.74 119.89 30.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.197 -179.459 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.541 ' HA3' ' HG2' ' A' ' 17' ' ' ARG . . . -116.91 123.28 5.75 Favored Glycine 0 N--CA 1.445 -0.705 0 CA-C-N 115.897 -0.592 . . . . 0.0 112.76 -177.396 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.456 HG13 ' HB ' ' A' ' 15' ' ' ILE . 7.6 p -99.51 123.29 52.15 Favored 'Isoleucine or valine' 0 C--O 1.24 0.591 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 175.086 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . 0.825 ' SG ' ' HB3' ' A' ' 60' ' ' LEU . 8.8 p -126.37 141.87 51.74 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.507 178.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.715 ' HB2' HD11 ' A' ' 15' ' ' ILE . 83.3 tttt -88.21 102.19 14.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.843 -176.199 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.574 HG11 ' OH ' ' A' ' 76' ' ' TYR . 95.4 t -74.67 96.14 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 121.06 0.457 . . . . 0.0 110.631 -177.139 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -86.44 164.65 16.87 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.286 178.566 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 24.8 p80 -150.68 161.81 29.13 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-N 116.244 -0.435 . . . . 0.0 109.96 -175.246 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -53.94 144.4 56.46 Favored 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 122.438 2.092 . . . . 0.0 111.354 174.135 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -52.17 105.49 0.12 Allowed 'General case' 0 C--O 1.234 0.27 0 CA-C-O 120.847 0.356 . . . . 0.0 110.895 -177.416 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -151.51 -86.29 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.263 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.924 -179.01 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -71.42 -77.22 0.09 Allowed 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.811 0.339 . . . . 0.0 110.999 -179.437 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 132.38 156.59 8.3 Favored Glycine 0 C--N 1.331 0.273 0 N-CA-C 111.572 -0.611 . . . . 0.0 111.572 -178.4 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 31.0 mmt180 60.26 90.01 0.06 Allowed 'General case' 0 C--O 1.234 0.281 0 CA-C-O 121.27 0.557 . . . . 0.0 110.582 -176.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.42 ' OG ' ' HE2' ' A' ' 47' ' ' LYS . 19.3 p -59.89 143.73 50.64 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.215 -0.902 . . . . 0.0 111.472 -178.814 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -81.89 -166.7 37.96 Favored Glycine 0 C--N 1.333 0.369 0 C-N-CA 121.039 -0.601 . . . . 0.0 111.827 179.487 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -141.09 144.49 34.93 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.751 0.31 . . . . 0.0 110.501 -179.008 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.825 ' HB3' ' SG ' ' A' ' 46' ' ' CYS . 1.6 tt -104.51 109.47 21.36 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 172.559 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.659 ' HB ' ' HB3' ' A' ' 75' ' ' CYS . 44.5 mm -81.66 89.52 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 108.415 -0.958 . . . . 0.0 108.415 174.354 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 12.3 t-80 -93.01 144.35 25.33 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.509 -0.768 . . . . 0.0 110.617 -173.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.513 ' HA3' ' HB3' ' A' ' 73' ' ' LEU . . . -131.43 87.21 0.29 Allowed Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 121.164 -0.541 . . . . 0.0 111.986 179.085 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.615 ' HG3' ' HB3' ' A' ' 42' ' ' ARG . 6.0 pt-20 -88.08 135.13 33.56 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 173.483 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.446 ' HD2' ' HA2' ' A' ' 37' ' ' GLY . 21.7 mtm180 -54.78 -67.05 0.3 Allowed 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 120.868 0.366 . . . . 0.0 111.676 -172.08 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 39.6 mt-30 -118.36 -43.69 2.71 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.054 0.454 . . . . 0.0 110.61 -175.179 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 32.3 ttpt -173.16 94.24 0.11 Allowed 'General case' 0 C--O 1.236 0.352 0 CA-C-N 115.593 -0.73 . . . . 0.0 109.128 -178.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 12.5 t70 52.11 -143.7 0.66 Allowed 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 -175.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 86.0 tttt 71.04 -65.39 0.34 Allowed 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 123.513 0.725 . . . . 0.0 112.028 175.133 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.8 tt -129.01 114.49 16.47 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-O 120.711 0.291 . . . . 0.0 110.279 -175.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 48.3 t -89.18 113.88 26.41 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.623 176.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 18.5 m -105.57 -12.5 9.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 111.762 0.282 . . . . 0.0 111.762 -177.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.513 ' HB3' ' HA3' ' A' ' 63' ' ' GLY . 3.3 tm? -142.98 120.32 11.6 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 -179.617 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -127.71 98.51 5.21 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 178.79 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . 0.659 ' HB3' ' HB ' ' A' ' 61' ' ' ILE . 41.9 t -124.08 67.0 1.05 Allowed 'General case' 0 C--O 1.235 0.305 0 CA-C-O 121.668 0.747 . . . . 0.0 110.475 -177.708 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.574 ' OH ' HG11 ' A' ' 48' ' ' VAL . 31.8 t80 -62.64 101.14 0.23 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 114.94 -1.027 . . . . 0.0 109.089 173.64 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.609 HG21 HD12 ' A' ' 81' ' ' LEU . 29.2 m -84.08 111.39 19.92 Favored 'Isoleucine or valine' 0 C--O 1.239 0.539 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 -178.737 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.495 ' NH1' ' O ' ' A' ' 76' ' ' TYR . 9.8 mpt_? -77.56 66.05 3.2 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.98 -177.327 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 50.9 mtpt 72.71 -33.85 0.28 Allowed 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.773 0.829 . . . . 0.0 112.002 -178.476 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -75.92 108.25 8.67 Favored 'General case' 0 C--O 1.233 0.189 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 173.206 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.609 HD12 HG21 ' A' ' 77' ' ' VAL . 6.6 tt -134.58 113.8 12.13 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 -177.519 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 49.2 t -124.28 90.61 1.64 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 CA-C-O 120.701 0.286 . . . . 0.0 110.989 -179.075 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.715 ' HB3' ' NE2' ' A' ' 91' ' ' HIS . 4.1 m-85 -88.26 152.93 21.61 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 120.922 0.392 . . . . 0.0 110.205 174.012 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 61.8 m -155.55 118.2 4.23 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 123.535 0.734 . . . . 0.0 109.097 178.044 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.507 ' HA ' ' HA ' ' A' ' 91' ' ' HIS . 3.1 pptp? -90.81 131.89 36.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.888 0.375 . . . . 0.0 110.249 179.33 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.42 ' HB3' ' HD1' ' A' ' 90' ' ' PHE . . . -96.32 -31.08 13.07 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.249 0.547 . . . . 0.0 109.697 176.437 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . 0.558 ' HB2' ' HB3' ' A' ' 90' ' ' PHE . 43.9 m-80 -143.3 158.93 57.01 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 115.251 -0.886 . . . . 0.0 109.282 179.134 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.422 ' O ' ' HB1' ' A' ' 110' ' ' ALA . 52.3 Cg_exo -55.91 -28.23 67.18 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.227 1.951 . . . . 0.0 111.642 175.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.438 ' HA ' ' HB2' ' A' ' 104' ' ' PHE . 12.6 p -109.3 16.41 22.41 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 115.74 -0.663 . . . . 0.0 111.601 -178.724 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.558 ' HB3' ' HB2' ' A' ' 87' ' ' ASN . 58.7 t80 -150.67 107.11 3.49 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-O 120.803 0.335 . . . . 0.0 110.734 -178.789 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . 0.715 ' NE2' ' HB3' ' A' ' 83' ' ' TYR . 2.2 t60 -120.16 141.92 49.43 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 177.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . 0.473 ' HA ' ' HA2' ' A' ' 101' ' ' GLY . 21.5 p80 -138.12 152.62 48.91 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.485 0.183 . . . . 0.0 110.516 -179.275 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . 0.617 ' HZ3' HD22 ' A' ' 102' ' ' LEU . 47.3 p90 -127.13 145.54 50.71 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 121.228 0.537 . . . . 0.0 111.245 -179.214 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 36.3 ttmt -91.59 133.42 35.56 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.285 -176.551 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.402 HG21 ' CE2' ' A' ' 100' ' ' PHE . 9.3 m -134.38 82.04 0.56 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.316 0 CA-C-O 121.558 0.694 . . . . 0.0 110.783 177.138 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 20.0 t70 59.67 -84.73 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 114.861 -1.063 . . . . 0.0 111.846 178.482 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -99.29 -48.39 4.83 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 120.741 0.305 . . . . 0.0 110.826 -176.481 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 9.0 mpt_? -87.76 176.15 7.53 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-O 121.168 0.508 . . . . 0.0 110.878 -178.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.414 ' HE3' ' HB2' ' A' ' 99' ' ' LYS . 39.1 ttmt -154.27 104.21 2.58 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 -178.225 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.432 ' HB2' ' CE2' ' A' ' 93' ' ' TRP . 3.6 m-85 -92.97 179.12 5.54 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 -176.814 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.473 ' HA2' ' HA ' ' A' ' 92' ' ' HIS . . . -168.3 177.57 42.32 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.621 -0.8 . . . . 0.0 112.196 178.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.617 HD22 ' HZ3' ' A' ' 93' ' ' TRP . 2.3 pt? -142.36 133.04 25.41 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 177.163 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.57 ' HB ' ' HB ' ' A' ' 21' ' ' VAL . 24.8 m -93.63 127.4 39.3 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.56 177.081 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.455 ' HE2' ' HB2' ' A' ' 91' ' ' HIS . 73.6 m-85 -86.59 157.3 19.75 Favored 'General case' 0 C--O 1.237 0.41 0 O-C-N 123.305 0.378 . . . . 0.0 110.171 -179.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 21.1 mp0 -102.96 -33.74 9.19 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.327 -177.53 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 8.4 m -137.84 144.77 45.56 Favored Pre-proline 0 CA--C 1.532 0.25 0 CA-C-O 120.437 0.16 . . . . 0.0 110.78 -178.387 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_exo -53.17 -21.9 18.09 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 122.64 2.227 . . . . 0.0 112.491 176.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -64.06 -65.81 0.63 Allowed 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.56 176.362 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -62.48 -36.78 83.58 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.569 179.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.422 ' HB1' ' O ' ' A' ' 88' ' ' PRO . . . -55.84 -67.09 0.32 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.403 177.705 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 83.8 mtm180 -62.29 -34.27 76.25 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.139 -175.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -62.43 -43.35 99.02 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-O 120.949 0.404 . . . . 0.0 110.361 177.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.482 ' O ' HG23 ' A' ' 117' ' ' VAL . 52.8 t80 -69.28 -43.5 73.74 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.02 -179.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -55.78 -46.17 78.01 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 121.015 0.436 . . . . 0.0 110.628 177.411 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 24.2 tpt180 -65.97 -34.79 78.91 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 116.137 -0.483 . . . . 0.0 109.76 178.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -62.28 -38.7 96.66 Favored Glycine 0 C--N 1.333 0.366 0 N-CA-C 111.471 -0.652 . . . . 0.0 111.471 174.451 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.487 ' O ' HG13 ' A' ' 121' ' ' ILE . 96.8 t -62.21 -45.87 97.76 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.142 0 N-CA-C 109.73 -0.471 . . . . 0.0 109.73 176.373 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.539 ' O ' ' HG2' ' A' ' 122' ' ' GLU . 8.5 tpm_? -53.2 -52.44 58.87 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.467 176.621 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 7.4 tmtt? -60.26 -47.72 84.8 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.032 -178.389 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -57.6 -48.17 80.12 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.941 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.487 HG13 ' O ' ' A' ' 117' ' ' VAL . 75.0 mt -56.9 -42.51 78.59 Favored 'Isoleucine or valine' 0 C--O 1.232 0.177 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.44 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.539 ' HG2' ' O ' ' A' ' 118' ' ' ARG . 15.6 mm-40 -57.05 -57.06 14.21 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-O 121.038 0.447 . . . . 0.0 110.621 177.621 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -71.46 -12.74 61.55 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.651 -177.337 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 62.7 tp -87.61 -68.24 0.77 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.761 0.315 . . . . 0.0 110.929 178.679 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.44 HG12 ' O ' ' A' ' 121' ' ' ILE . 34.8 pt -89.79 -18.6 7.66 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 N-CA-C 112.241 0.46 . . . . 0.0 112.241 -172.369 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.43 ' HB3' ' O ' ' A' ' 125' ' ' ILE . 36.5 tt0 . . . . . 0 C--O 1.252 1.192 0 O-C-N 123.441 0.463 . . . . 0.0 110.23 -178.203 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.741 0 N-CA-C 112.102 -0.399 . . . . 0.0 112.102 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 17.5 m -70.09 -7.43 41.33 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 122.547 0.339 . . . . 0.0 111.751 -177.592 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . 0.514 ' O ' HG23 ' A' ' 4' ' ' THR . 25.2 ttt -62.46 -70.01 0.23 Allowed 'General case' 0 CA--C 1.529 0.166 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 175.037 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.514 HG23 ' O ' ' A' ' 3' ' ' MET . 0.8 OUTLIER -167.98 88.51 0.26 Allowed 'General case' 0 C--O 1.236 0.379 0 CA-C-N 114.996 -1.002 . . . . 0.0 108.383 175.97 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -72.29 122.82 21.77 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.023 0.44 . . . . 0.0 111.016 -174.375 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -157.92 143.15 16.8 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-N 115.45 -0.795 . . . . 0.0 109.452 178.244 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.465 ' O ' ' HE2' ' A' ' 69' ' ' LYS . 35.5 p -108.7 -173.45 2.28 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.731 -176.007 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 85.9 m-70 -62.48 157.09 58.69 Favored Pre-proline 0 N--CA 1.464 0.257 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 175.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_exo -43.36 -44.44 10.39 Favored 'Trans proline' 0 C--N 1.357 1.015 0 C-N-CA 122.561 2.174 . . . . 0.0 111.202 175.328 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -132.77 109.28 9.55 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 169.305 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -104.26 82.15 1.91 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.836 0.35 . . . . 0.0 110.665 -173.523 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -64.34 -55.54 20.51 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.995 178.447 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 37.4 t -164.6 -58.3 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.914 -176.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.448 ' CG ' ' HB3' ' A' ' 46' ' ' CYS . 46.5 m-85 64.14 101.73 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 115.8 -0.637 . . . . 0.0 111.803 178.463 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.641 HG23 HG23 ' A' ' 16' ' ' VAL . 11.5 tt -82.14 -31.75 10.46 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 CA-C-N 115.624 -0.717 . . . . 0.0 110.56 -178.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.641 HG23 HG23 ' A' ' 15' ' ' ILE . 76.5 t -117.23 113.98 44.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.249 179.505 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.503 ' NH2' HH12 ' A' ' 42' ' ' ARG . 22.3 mtp180 -136.21 86.54 2.23 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 175.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.411 ' HB ' ' CZ ' ' A' ' 113' ' ' PHE . 44.2 t -130.61 153.89 39.77 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.391 -176.578 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 23.3 pttm -65.28 154.85 37.02 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.466 178.32 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.411 ' HB3' HG23 ' A' ' 43' ' ' VAL . . . -179.61 174.04 1.0 Allowed 'General case' 0 C--O 1.233 0.211 0 O-C-N 123.466 0.479 . . . . 0.0 110.532 175.528 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 61.8 t -123.89 143.98 35.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 171.124 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.415 HG11 HD11 ' A' ' 73' ' ' LEU . 29.6 m -115.02 131.0 68.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-O 121.097 0.475 . . . . 0.0 111.465 -175.401 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 25.2 mmt -100.23 113.42 26.09 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.057 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.407 HG22 ' O ' ' A' ' 33' ' ' PHE . 11.8 t -82.62 152.64 25.81 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 178.005 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.473 ' HD2' ' CZ2' ' A' ' 32' ' ' TRP . 36.1 ttt85 -122.05 114.11 20.48 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 -172.154 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -72.31 93.54 1.51 Allowed 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 107.602 -1.259 . . . . 0.0 107.602 165.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -54.65 149.74 10.46 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 115.603 -0.726 . . . . 0.0 112.879 -169.179 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 51.9 m 72.89 -36.46 0.36 Allowed 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 114.612 -1.176 . . . . 0.0 112.306 179.005 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 29.4 t -78.54 -44.53 24.06 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 175.436 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 149.64 -67.2 0.36 Allowed Glycine 0 N--CA 1.452 -0.291 0 N-CA-C 111.559 -0.616 . . . . 0.0 111.559 178.182 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.453 ' HA3' ' HA ' ' A' ' 25' ' ' ARG . . . 71.34 -126.07 12.65 Favored Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 121.449 -0.405 . . . . 0.0 112.884 178.565 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . 0.53 ' HH2' ' HG2' ' A' ' 99' ' ' LYS . 24.6 m95 58.96 38.03 24.41 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 123.041 0.537 . . . . 0.0 109.957 -175.039 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.407 ' O ' HG22 ' A' ' 24' ' ' THR . 21.1 p90 -112.26 148.93 40.17 Favored Pre-proline 0 CA--C 1.532 0.252 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.574 -177.261 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -68.21 109.58 2.02 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 122.706 2.271 . . . . 0.0 111.85 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 28.9 pt20 -59.4 132.27 53.49 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.375 -177.321 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 60.81 20.9 11.04 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.756 177.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 99.43 -15.62 59.85 Favored Glycine 0 C--N 1.333 0.379 0 CA-C-N 116.023 -0.535 . . . . 0.0 112.33 -179.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 100.18 -115.62 5.35 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 121.577 -0.344 . . . . 0.0 112.398 179.381 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.81 150.0 26.41 Favored Glycine 0 N--CA 1.451 -0.305 0 N-CA-C 111.774 -0.53 . . . . 0.0 111.774 -177.352 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 6.0 tp -55.88 115.73 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 CA-C-O 121.133 0.492 . . . . 0.0 110.689 179.511 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.416 ' HA ' ' HA ' ' A' ' 65' ' ' ARG . 20.0 m -116.95 175.23 5.68 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.361 -177.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.503 HH12 ' NH2' ' A' ' 17' ' ' ARG . 49.6 ttp180 -138.58 137.43 36.98 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.414 -0.588 . . . . 0.0 109.414 177.284 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.632 HG21 HD11 ' A' ' 102' ' ' LEU . 61.7 t -97.49 118.81 44.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 176.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.437 ' HA2' ' O ' ' A' ' 16' ' ' VAL . . . -116.59 94.92 0.66 Allowed Glycine 0 N--CA 1.452 -0.263 0 CA-C-N 116.013 -0.54 . . . . 0.0 112.109 -179.259 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.498 ' HB ' ' HB ' ' A' ' 16' ' ' VAL . 60.8 t -92.04 116.24 32.77 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 N-CA-C 110.235 -0.283 . . . . 0.0 110.235 178.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . 0.537 ' SG ' ' HB3' ' A' ' 60' ' ' LEU . 24.2 p -118.45 131.39 56.27 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.694 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.677 ' HE3' ' HB2' ' A' ' 57' ' ' SER . 60.2 tttp -74.33 102.22 4.31 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 175.411 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.442 HG21 ' CE1' ' A' ' 76' ' ' TYR . 26.9 m -73.24 124.95 31.34 Favored 'Isoleucine or valine' 0 C--O 1.24 0.602 0 CA-C-O 121.202 0.525 . . . . 0.0 110.219 179.559 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 25.9 mmt -88.09 -179.4 6.18 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.599 -176.501 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 1.8 p80 -129.11 125.95 22.92 Favored Pre-proline 0 C--N 1.323 -0.578 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.766 -177.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_endo -57.3 -47.28 23.0 Favored 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 122.564 2.176 . . . . 0.0 111.335 179.543 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -162.2 138.65 7.85 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.388 173.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 132.83 96.8 0.63 Allowed Glycine 0 N--CA 1.448 -0.533 0 N-CA-C 110.953 -0.859 . . . . 0.0 110.953 -177.633 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -53.62 146.46 13.13 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-O 120.711 0.291 . . . . 0.0 110.916 -178.012 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 152.76 -153.47 24.89 Favored Glycine 0 N--CA 1.448 -0.54 0 N-CA-C 111.629 -0.588 . . . . 0.0 111.629 -178.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.517 HH11 ' HA ' ' A' ' 125' ' ' ILE . 67.6 mtm180 -105.54 125.95 51.57 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 110.348 -0.242 . . . . 0.0 110.348 -178.333 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.677 ' HB2' ' HE3' ' A' ' 47' ' ' LYS . 14.8 m -80.23 132.21 35.82 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 178.541 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -92.44 -173.24 41.61 Favored Glycine 0 C--O 1.227 -0.3 0 C-N-CA 121.06 -0.591 . . . . 0.0 113.3 -168.261 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.412 ' HA ' ' O ' ' A' ' 46' ' ' CYS . 45.1 m-85 -131.76 122.14 25.35 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 122.867 0.467 . . . . 0.0 109.98 177.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.537 ' HB3' ' SG ' ' A' ' 46' ' ' CYS . 0.9 OUTLIER -80.1 112.34 17.31 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 175.582 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.568 ' HB ' ' HB2' ' A' ' 75' ' ' CYS . 50.5 mm -76.27 82.08 0.68 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.322 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 174.303 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . 0.406 ' HB2' HD22 ' A' ' 60' ' ' LEU . 63.1 t-80 -99.59 164.29 12.13 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.198 -0.91 . . . . 0.0 109.751 -176.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 175.48 149.98 7.68 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.816 -0.707 . . . . 0.0 111.651 176.419 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.448 ' CD ' HH21 ' A' ' 42' ' ' ARG . 0.1 OUTLIER -142.06 171.01 14.64 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.96 0.41 . . . . 0.0 110.888 -178.586 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.416 ' HA ' ' HA ' ' A' ' 41' ' ' SER . 38.3 ttm180 -83.98 119.16 24.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.36 177.709 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 -61.77 87.99 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 121.255 0.55 . . . . 0.0 111.518 -173.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 40.0 ttpt 178.2 -30.59 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 114.587 -1.188 . . . . 0.0 108.563 178.343 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -156.65 170.75 21.68 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.021 -0.99 . . . . 0.0 108.875 177.455 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.465 ' HE2' ' O ' ' A' ' 7' ' ' THR . 93.0 mttt -74.64 16.97 0.23 Allowed 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 120.652 0.263 . . . . 0.0 111.175 178.733 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 5.7 tt -58.03 97.94 0.03 OUTLIER 'General case' 0 C--O 1.233 0.219 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 174.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 27.5 m -69.9 130.87 34.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.257 0.551 . . . . 0.0 111.978 -175.352 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 33.1 m -109.69 -14.49 10.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.056 175.211 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.415 HD11 HG11 ' A' ' 22' ' ' VAL . 60.1 mt -132.13 134.39 45.38 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.488 178.593 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -159.39 92.42 1.06 Allowed 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 174.792 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . 0.568 ' HB2' ' HB ' ' A' ' 61' ' ' ILE . 66.9 m -136.36 105.67 6.05 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.756 179.102 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.442 ' CE1' HG21 ' A' ' 48' ' ' VAL . 50.9 t80 -76.01 101.22 5.16 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.098 -178.291 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 83.6 t -103.41 99.41 8.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.006 0.431 . . . . 0.0 110.071 -178.186 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.433 ' HD3' ' HE2' ' A' ' 76' ' ' TYR . 18.6 ptt180 -108.38 -20.53 13.09 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.883 -178.397 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 1.8 tmtp? -123.92 79.03 1.68 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.829 -174.33 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 32.7 m-20 62.73 168.34 0.13 Allowed 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 115.124 -0.944 . . . . 0.0 112.102 176.061 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.511 HD23 ' N ' ' A' ' 82' ' ' VAL . 5.6 tt -146.66 135.45 22.27 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 -177.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.511 ' N ' HD23 ' A' ' 81' ' ' LEU . 48.3 t -77.97 -77.25 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 O-C-N 122.978 0.174 . . . . 0.0 111.247 -176.731 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.502 ' CD2' HG21 ' A' ' 117' ' ' VAL . 0.0 OUTLIER 64.66 136.52 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 121.469 0.652 . . . . 0.0 111.399 -177.421 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.516 ' HB ' ' CE1' ' A' ' 92' ' ' HIS . 90.0 m -154.31 117.9 4.62 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.357 -179.399 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.488 ' HB2' ' CE1' ' A' ' 91' ' ' HIS . 36.9 ttpt -95.69 103.99 15.89 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.912 0.387 . . . . 0.0 110.215 -178.111 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -85.15 -29.73 24.54 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.085 178.336 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . 0.609 ' HB2' ' HB3' ' A' ' 90' ' ' PHE . 18.6 m120 -143.93 153.56 57.41 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.264 178.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -63.57 -4.72 7.34 Favored 'Trans proline' 0 N--CA 1.478 0.562 0 C-N-CA 122.735 2.29 . . . . 0.0 112.748 -179.417 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 8.3 t -126.46 16.08 7.66 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 121.355 0.598 . . . . 0.0 110.123 178.267 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.609 ' HB3' ' HB2' ' A' ' 87' ' ' ASN . 64.1 t80 -152.09 101.23 2.7 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.203 -175.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . 0.488 ' CE1' ' HB2' ' A' ' 85' ' ' LYS . 2.1 t-160 -125.55 106.81 10.04 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 -179.225 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . 0.553 ' ND1' ' HD2' ' A' ' 99' ' ' LYS . 35.1 p80 -103.49 150.03 24.28 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 120.739 0.304 . . . . 0.0 111.671 -173.769 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . 0.541 ' HZ3' ' HB2' ' A' ' 102' ' ' LEU . 24.9 p90 -132.74 130.98 40.69 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.335 176.199 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.532 ' HA ' ' HA ' ' A' ' 99' ' ' LYS . 65.0 tttp -94.7 139.01 31.81 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.198 -0.455 . . . . 0.0 109.926 172.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.461 HG23 ' H ' ' A' ' 97' ' ' ASN . 29.2 m -117.28 -162.56 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.662 177.288 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -56.35 -24.87 46.99 Favored 'General case' 0 CA--C 1.532 0.27 0 O-C-N 123.094 0.246 . . . . 0.0 111.631 -176.526 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.461 ' H ' HG23 ' A' ' 95' ' ' VAL . 0.9 OUTLIER -114.8 -94.38 0.48 Allowed 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 120.491 0.186 . . . . 0.0 111.457 176.793 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 29.8 mmt180 -93.33 -174.33 3.49 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 121.321 0.581 . . . . 0.0 111.866 -170.637 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.553 ' HD2' ' ND1' ' A' ' 92' ' ' HIS . 38.2 ttpt -125.7 110.22 13.51 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.128 -0.942 . . . . 0.0 109.551 -178.561 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 17.9 m-85 -97.15 162.28 13.43 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 109.819 -0.438 . . . . 0.0 109.819 -176.524 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.503 ' HA2' ' HA ' ' A' ' 92' ' ' HIS . . . -128.78 140.58 11.84 Favored Glycine 0 C--N 1.333 0.415 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.94 -177.592 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.632 HD11 HG21 ' A' ' 43' ' ' VAL . 4.8 tt -109.66 133.84 52.65 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 177.599 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.548 ' N ' HD23 ' A' ' 102' ' ' LEU . 88.1 m -106.66 114.43 28.54 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.808 179.722 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.432 ' CE2' ' HB2' ' A' ' 91' ' ' HIS . 22.5 m-85 -79.76 148.56 31.43 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 175.418 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 59.3 tt0 -105.5 -33.02 8.25 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.876 0.37 . . . . 0.0 110.601 -178.006 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 32.6 t -124.64 147.52 56.1 Favored Pre-proline 0 C--N 1.329 -0.297 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -60.34 -25.62 80.73 Favored 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 121.878 1.719 . . . . 0.0 110.417 172.126 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -69.6 -58.33 4.08 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.786 178.624 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -65.83 -32.89 74.67 Favored 'General case' 0 N--CA 1.463 0.206 0 C-N-CA 121.013 -0.275 . . . . 0.0 110.271 -179.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -55.06 -60.13 3.8 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.745 174.077 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.408 HH11 ' HD3' ' A' ' 111' ' ' ARG . 16.2 ttm180 -61.1 -30.69 70.51 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.469 -178.715 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -62.31 -42.87 99.73 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.434 175.556 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.411 ' CZ ' ' HB ' ' A' ' 18' ' ' VAL . 39.7 m-85 -66.59 -43.27 85.38 Favored 'General case' 0 C--O 1.23 0.079 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.49 177.308 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -55.01 -51.32 66.63 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 120.885 0.374 . . . . 0.0 110.447 178.503 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . 0.414 HH11 ' HD3' ' A' ' 115' ' ' ARG . 3.1 mmp_? -60.48 -46.01 91.65 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.582 178.448 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -60.25 -51.4 59.02 Favored Glycine 0 C--N 1.333 0.367 0 CA-C-N 115.46 -0.791 . . . . 0.0 112.633 -177.519 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.502 HG21 ' CD2' ' A' ' 83' ' ' TYR . 11.4 p -68.53 -32.78 56.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.416 0.15 . . . . 0.0 110.621 -178.281 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 8.1 mmm180 -56.18 -57.05 13.83 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 174.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -63.73 -32.34 73.8 Favored 'General case' 0 C--O 1.224 -0.24 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.388 179.643 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -62.64 -50.32 71.69 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-O 120.564 0.221 . . . . 0.0 111.235 179.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.401 ' O ' ' HB2' ' A' ' 124' ' ' LEU . 69.4 mt -66.47 -39.38 83.86 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 CA-C-O 121.063 0.459 . . . . 0.0 110.338 -179.817 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 -67.32 -34.28 77.03 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.313 177.163 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -79.84 -17.03 54.25 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 121.284 0.564 . . . . 0.0 110.0 178.573 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.435 ' O ' ' HD2' ' A' ' 56' ' ' ARG . 11.7 mt -71.09 -58.92 3.09 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.581 170.378 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.517 ' HA ' HH11 ' A' ' 56' ' ' ARG . 11.1 tp -68.71 -23.99 28.39 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.054 -176.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 . . . . . 0 C--O 1.251 1.136 0 CA-C-O 118.116 -0.945 . . . . 0.0 110.175 176.691 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.935 0 N-CA-C 112.344 -0.302 . . . . 0.0 112.344 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 56.6 m -151.87 173.57 14.63 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 110.102 -0.333 . . . . 0.0 110.102 -179.459 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 69.3 mtm -92.42 146.26 23.82 Favored 'General case' 0 C--O 1.238 0.474 0 N-CA-C 109.651 -0.499 . . . . 0.0 109.651 174.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 77.6 p -73.39 165.74 24.49 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.454 -176.216 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.411 ' O ' ' HG3' ' A' ' 5' ' ' GLU . 7.5 pt-20 -150.09 96.61 2.45 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-O 121.359 0.6 . . . . 0.0 110.147 175.841 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -87.57 171.47 10.47 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.304 179.538 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 25.3 p -81.35 175.55 10.48 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.772 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 31.0 m-70 -62.4 146.29 93.46 Favored Pre-proline 0 C--O 1.235 0.297 0 N-CA-C 110.043 -0.354 . . . . 0.0 110.043 178.572 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -53.83 -28.99 50.69 Favored 'Trans proline' 0 C--N 1.354 0.842 0 C-N-CA 122.797 2.331 . . . . 0.0 112.128 -176.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.804 ' HB3' ' HB2' ' A' ' 13' ' ' SER . 13.4 m-20 -130.26 44.22 3.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.555 178.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -51.57 -39.13 57.24 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 114.857 -1.065 . . . . 0.0 112.26 -175.377 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -100.2 -3.21 32.08 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 111.486 0.18 . . . . 0.0 111.486 -178.433 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.804 ' HB2' ' HB3' ' A' ' 10' ' ' ASP . 19.9 m -92.74 -0.36 57.29 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 120.558 0.218 . . . . 0.0 111.062 -178.424 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 61.9 m-85 -62.63 112.81 2.66 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 120.819 0.343 . . . . 0.0 110.523 177.122 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.526 HG22 HG23 ' A' ' 16' ' ' VAL . 63.0 mt -70.53 -48.78 57.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 174.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.526 HG23 HG22 ' A' ' 15' ' ' ILE . 87.4 t -144.33 104.65 0.82 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.355 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.481 178.718 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.577 ' HA ' ' HA2' ' A' ' 44' ' ' GLY . 27.2 ptt180 -101.6 112.88 25.58 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 169.491 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 7.4 p -143.91 157.37 15.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.14 0.495 . . . . 0.0 111.529 -172.241 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.546 ' NZ ' ' HB3' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -70.01 124.58 24.43 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.326 177.833 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -151.0 -168.6 3.15 Favored 'General case' 0 C--O 1.235 0.33 0 O-C-N 123.243 0.34 . . . . 0.0 110.313 179.394 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.454 ' HB ' ' HB ' ' A' ' 103' ' ' THR . 45.9 t -123.97 138.68 52.83 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 N-CA-C 110.22 -0.289 . . . . 0.0 110.22 176.502 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 17.6 m -106.3 135.4 44.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.532 177.367 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 24.9 mmt -123.47 146.19 48.24 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 178.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.527 HG23 ' H ' ' A' ' 26' ' ' ASP . 6.4 t -129.0 -6.31 4.97 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.597 -0.441 . . . . 0.0 111.616 177.122 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.457 ' HB2' ' CE3' ' A' ' 32' ' ' TRP . 65.2 ttt180 54.07 24.46 4.79 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 121.295 0.569 . . . . 0.0 111.037 178.749 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.527 ' H ' HG23 ' A' ' 24' ' ' THR . 36.4 t70 54.23 45.32 27.58 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.007 -177.228 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 52.8 m-20 73.04 -68.51 0.22 Allowed 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 114.68 -1.145 . . . . 0.0 110.639 -178.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 68.9 m -152.8 87.92 1.31 Allowed 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 176.399 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 53.3 m -140.53 -160.42 1.07 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.774 179.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -61.96 -90.17 0.02 OUTLIER Glycine 0 CA--C 1.52 0.401 0 C-N-CA 121.246 -0.502 . . . . 0.0 113.311 -177.547 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -97.1 176.97 32.23 Favored Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 121.432 -0.413 . . . . 0.0 112.995 -173.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . 0.481 ' CH2' ' HB3' ' A' ' 99' ' ' LYS . 37.3 m95 -97.03 113.82 25.39 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 -179.648 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 2.8 p90 -104.25 145.85 31.45 Favored Pre-proline 0 C--N 1.329 -0.298 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 179.179 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.557 ' HB2' ' HA3' ' A' ' 38' ' ' GLY . 88.9 Cg_endo -84.1 120.46 2.6 Favored 'Trans proline' 0 CA--C 1.534 0.521 0 C-N-CA 122.583 2.189 . . . . 0.0 112.068 178.67 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 5.0 pm0 -107.93 144.61 34.95 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.166 179.312 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 57.94 97.33 0.02 OUTLIER 'General case' 0 C--O 1.238 0.453 0 CA-C-O 121.441 0.638 . . . . 0.0 111.534 179.072 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 76.04 -72.33 1.86 Allowed Glycine 0 N--CA 1.45 -0.404 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.466 -176.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.557 ' HA3' ' HB2' ' A' ' 34' ' ' PRO . . . 58.66 65.8 3.24 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 121.354 -0.45 . . . . 0.0 112.759 177.527 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 156.37 -43.72 0.53 Allowed Glycine 0 N--CA 1.453 -0.176 0 N-CA-C 111.646 -0.581 . . . . 0.0 111.646 -179.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.495 ' O ' HG12 ' A' ' 40' ' ' ILE . 11.9 tt -121.91 22.19 4.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 121.539 0.685 . . . . 0.0 109.696 178.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 21.3 m -60.61 122.36 14.51 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.29 -177.108 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.446 ' HB2' ' HA ' ' A' ' 66' ' ' GLN . 29.0 ttt85 -82.95 92.71 7.39 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.45 -175.562 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 41.1 t -95.47 150.62 4.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.076 -179.322 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.577 ' HA2' ' HA ' ' A' ' 17' ' ' ARG . . . -154.22 116.61 0.74 Allowed Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 121.178 -0.534 . . . . 0.0 112.335 -179.544 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 6.7 p -87.56 117.85 32.29 Favored 'Isoleucine or valine' 0 C--O 1.237 0.415 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 176.356 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . 0.769 ' SG ' ' HB3' ' A' ' 60' ' ' LEU . 13.9 p -113.69 146.54 39.67 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.068 -178.718 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.405 ' HB2' HD11 ' A' ' 15' ' ' ILE . 47.9 tttp -92.48 101.68 14.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.772 179.088 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 22.2 m -85.19 157.05 3.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.689 0.281 . . . . 0.0 110.512 -179.018 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 22.6 ptp -151.24 153.39 34.79 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.798 0.333 . . . . 0.0 110.629 -178.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . 0.428 ' NE2' ' HA3' ' A' ' 53' ' ' GLY . 0.4 OUTLIER -70.2 143.52 91.22 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.076 179.152 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -69.64 -15.38 37.49 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 122.598 2.199 . . . . 0.0 111.958 179.545 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 15.0 tp10 -131.11 93.74 3.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.748 179.527 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.428 ' HA3' ' NE2' ' A' ' 50' ' ' HIS . . . 165.56 -175.96 41.18 Favored Glycine 0 N--CA 1.452 -0.258 0 N-CA-C 111.801 -0.519 . . . . 0.0 111.801 -179.341 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 -136.62 -74.03 0.43 Allowed 'General case' 0 C--O 1.236 0.365 0 CA-C-O 120.787 0.327 . . . . 0.0 111.666 -175.176 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.41 ' O ' ' HG3' ' A' ' 56' ' ' ARG . . . -100.49 52.49 0.95 Allowed Glycine 0 C--N 1.33 0.2 0 CA-C-N 116.289 -0.414 . . . . 0.0 113.844 -170.342 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.41 ' HG3' ' O ' ' A' ' 55' ' ' GLY . 53.4 mtt180 -160.85 136.07 7.77 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 122.678 0.391 . . . . 0.0 110.024 172.244 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 49.8 m -156.21 161.49 40.27 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 116.466 -0.333 . . . . 0.0 110.639 -177.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -121.52 -158.88 10.51 Favored Glycine 0 C--N 1.33 0.242 0 N-CA-C 111.394 -0.682 . . . . 0.0 111.394 179.428 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -141.86 162.49 35.35 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.9 0.35 . . . . 0.0 110.411 -178.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.769 ' HB3' ' SG ' ' A' ' 46' ' ' CYS . 3.3 tt -137.07 121.67 18.45 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.413 ' O ' ' HA ' ' A' ' 74' ' ' GLU . 41.3 mt -83.03 84.29 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 175.066 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . 0.515 ' HB2' HD22 ' A' ' 60' ' ' LEU . 53.9 t60 -96.99 141.89 29.6 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.25 -0.432 . . . . 0.0 109.865 -177.433 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -154.84 127.54 2.11 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 121.036 -0.602 . . . . 0.0 112.043 -179.398 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -115.0 -179.63 3.68 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 176.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.598 ' HD2' HD13 ' A' ' 70' ' ' LEU . 69.8 mtt180 -65.83 -65.41 0.68 Allowed 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 120.549 -0.46 . . . . 0.0 110.274 178.51 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.451 ' HG3' ' HG3' ' A' ' 67' ' ' LYS . 17.1 pt20 175.53 -23.63 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.284 0 O-C-N 123.407 0.442 . . . . 0.0 111.161 -177.817 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.451 ' HG3' ' HG3' ' A' ' 66' ' ' GLN . 98.5 mttt -144.31 129.34 18.54 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.737 -178.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 37.5 t70 71.24 163.33 0.26 Allowed 'General case' 0 CA--C 1.533 0.318 0 O-C-N 123.763 0.665 . . . . 0.0 112.207 169.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 43.6 mtmt -55.47 99.13 0.03 OUTLIER 'General case' 0 C--O 1.234 0.243 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.684 -176.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.598 HD13 ' HD2' ' A' ' 65' ' ' ARG . 3.8 tt -162.51 86.28 0.58 Allowed 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 173.685 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 45.4 t -75.66 117.0 19.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.393 -179.535 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 22.1 m -98.54 -21.89 5.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.335 -177.736 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.409 HD13 ' N ' ' A' ' 74' ' ' GLU . 2.9 tm? -150.51 129.72 12.77 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 -177.236 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.626 ' HG3' HD21 ' A' ' 60' ' ' LEU . 37.0 tt0 -153.81 113.11 3.76 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.986 0.422 . . . . 0.0 110.162 178.606 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . 0.548 ' SG ' ' CE2' ' A' ' 100' ' ' PHE . 57.4 m -130.48 118.51 21.24 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 -178.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.416 ' HD1' ' HG ' ' A' ' 60' ' ' LEU . 29.5 t80 -85.32 121.73 28.47 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.01 -173.325 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.521 HG13 ' O ' ' A' ' 80' ' ' ASP . 96.3 t -100.67 97.57 5.9 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 -177.243 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 20.7 ptt-85 -115.92 68.39 0.72 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.226 0.536 . . . . 0.0 110.51 -172.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt 67.53 25.42 8.4 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.011 -177.165 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.521 ' O ' HG13 ' A' ' 77' ' ' VAL . 5.6 p-10 -149.05 -175.26 4.89 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 174.56 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 7.0 tt 66.72 98.22 0.05 Allowed 'General case' 0 CA--C 1.534 0.327 0 CA-C-O 121.193 0.521 . . . . 0.0 110.177 177.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 58.9 t -112.06 133.42 57.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.612 -178.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -68.92 124.38 23.56 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.615 177.388 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 35.9 m -95.86 114.66 26.41 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 174.165 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.413 ' HG2' ' NE2' ' A' ' 91' ' ' HIS . 5.7 tmtp? -75.81 98.9 4.28 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 116.144 -0.48 . . . . 0.0 109.73 178.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -91.21 -46.66 7.95 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.237 0.541 . . . . 0.0 110.183 -179.002 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . 0.773 ' HB2' ' HB3' ' A' ' 90' ' ' PHE . 40.4 m-80 -131.54 153.27 81.51 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.261 178.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -50.62 -31.5 32.18 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.706 2.271 . . . . 0.0 112.683 -179.549 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.546 ' HA ' ' HD2' ' A' ' 104' ' ' PHE . 16.5 p -115.22 18.11 16.32 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.722 -178.182 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.773 ' HB3' ' HB2' ' A' ' 87' ' ' ASN . 74.1 t80 -145.18 115.25 7.44 Favored 'General case' 0 C--O 1.24 0.585 0 CA-C-O 121.366 0.603 . . . . 0.0 111.985 -176.803 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . 0.413 ' NE2' ' HG2' ' A' ' 85' ' ' LYS . 31.5 m80 -103.88 157.06 17.35 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.152 -0.931 . . . . 0.0 109.277 171.455 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 19.5 p80 -154.42 149.73 27.13 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 110.191 -0.299 . . . . 0.0 110.191 172.708 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 38.5 p90 -137.66 140.42 40.81 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 110.016 -0.364 . . . . 0.0 110.016 178.417 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -109.85 112.74 24.96 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.101 -173.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 23.4 m -138.9 144.12 30.34 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 174.192 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 58.12 25.9 13.02 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 120.725 0.298 . . . . 0.0 110.712 -178.074 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 68.09 1.47 2.8 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.755 -177.464 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 64.3 mtt-85 -89.31 134.39 34.08 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 109.489 -0.559 . . . . 0.0 109.489 178.131 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.481 ' HB3' ' CH2' ' A' ' 32' ' ' TRP . 12.3 mptt -94.33 97.48 10.24 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.984 0.421 . . . . 0.0 110.491 -178.03 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.548 ' CE2' ' SG ' ' A' ' 75' ' ' CYS . 2.3 m-85 -81.65 141.11 33.95 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 174.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -138.59 157.6 24.68 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 121.224 -0.513 . . . . 0.0 112.103 178.613 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 6.4 tt -143.56 121.31 11.9 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 108.912 -0.774 . . . . 0.0 108.912 178.289 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.454 ' HB ' ' HB ' ' A' ' 21' ' ' VAL . 26.8 m -109.11 136.34 48.78 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.438 -178.519 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.546 ' HD2' ' HA ' ' A' ' 89' ' ' THR . 41.1 m-85 -86.0 139.61 31.03 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.213 -0.448 . . . . 0.0 109.983 178.471 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 8.3 tp-100 -93.44 -42.83 9.05 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.36 -175.487 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -130.49 147.72 67.08 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.518 -176.748 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -53.88 -25.07 33.82 Favored 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 122.299 1.999 . . . . 0.0 111.908 179.039 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -62.26 -57.54 11.05 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.026 176.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -70.35 -29.64 66.38 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.634 -179.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.441 ' O ' ' HB2' ' A' ' 114' ' ' ASP . . . -56.89 -58.16 9.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.251 174.544 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.582 ' HE ' ' HA ' ' A' ' 111' ' ' ARG . 1.3 tpm_? -59.47 -50.49 73.74 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.954 -179.628 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -60.89 -57.19 13.71 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.63 -174.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.512 ' O ' HG23 ' A' ' 117' ' ' VAL . 38.6 t80 -67.4 -36.47 81.37 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.666 -174.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.441 ' HB2' ' O ' ' A' ' 110' ' ' ALA . 8.2 t70 -59.98 -49.25 78.39 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 121.168 0.509 . . . . 0.0 109.753 177.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 41.9 ttt180 -51.74 -45.24 63.59 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 115.117 -0.947 . . . . 0.0 109.923 174.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -60.35 -39.4 96.09 Favored Glycine 0 CA--C 1.519 0.297 0 CA-C-N 115.651 -0.704 . . . . 0.0 112.19 176.12 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.512 HG23 ' O ' ' A' ' 113' ' ' PHE . 75.7 t -66.08 -54.58 25.38 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.163 0 C-N-CA 122.382 0.273 . . . . 0.0 111.112 -179.48 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 19.6 ptp180 -60.3 -38.02 82.33 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 116.578 -0.283 . . . . 0.0 110.606 -177.503 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.403 ' HD2' ' HA ' ' A' ' 119' ' ' LYS . 16.1 mmmt -68.85 -39.22 80.04 Favored 'General case' 0 C--N 1.334 -0.078 0 CA-C-N 116.613 -0.267 . . . . 0.0 110.646 175.151 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.5 -44.26 96.18 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.884 0.373 . . . . 0.0 110.223 177.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.408 HG12 ' O ' ' A' ' 117' ' ' VAL . 48.1 mm -62.9 -45.0 99.97 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.313 178.409 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -57.44 -51.02 71.14 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.661 178.612 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -74.51 -17.31 60.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.247 -178.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 45.1 tp -74.89 -47.7 28.66 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 177.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 75.1 mt -70.18 -40.35 78.04 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.303 178.682 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.249 1.066 0 N-CA-C 109.084 -0.709 . . . . 0.0 109.084 -179.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.728 0 N-CA-C 112.18 -0.368 . . . . 0.0 112.18 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.9 p -75.51 -13.83 60.39 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.217 0.532 . . . . 0.0 110.662 178.216 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 21.2 ptp -152.54 174.58 13.74 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 115.463 -0.79 . . . . 0.0 109.851 -178.535 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 6.2 t -135.24 136.83 42.02 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.048 0.451 . . . . 0.0 110.667 179.071 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -120.69 21.2 11.58 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 176.56 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -75.3 -84.09 0.05 Allowed 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 115.062 -0.972 . . . . 0.0 111.231 -175.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.6 m 55.5 66.54 1.19 Allowed 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.609 -178.57 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 1.2 t60 171.36 -65.54 0.0 OUTLIER Pre-proline 0 CA--C 1.542 0.65 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.265 -175.315 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -59.02 104.95 0.21 Allowed 'Trans proline' 0 C--N 1.356 0.941 0 C-N-CA 121.747 1.631 . . . . 0.0 112.119 -174.086 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 36.3 t70 62.69 41.96 8.7 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.03 -178.45 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 63.67 -88.0 0.03 OUTLIER 'General case' 0 C--O 1.235 0.328 0 CA-C-N 114.755 -1.111 . . . . 0.0 111.665 173.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 17.9 t70 69.25 -63.44 0.37 Allowed 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 123.574 0.749 . . . . 0.0 112.222 -175.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 19.7 m -87.29 1.24 53.82 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 112.438 0.532 . . . . 0.0 112.438 -172.603 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.423 ' HD2' ' HB3' ' A' ' 17' ' ' ARG . 3.3 m-85 -70.32 123.63 22.18 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 110.123 -0.325 . . . . 0.0 110.123 176.166 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 7.1 tp -88.45 -41.45 14.18 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 175.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 69.9 t -131.96 128.58 59.74 Favored 'Isoleucine or valine' 0 C--O 1.232 0.178 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 177.074 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.423 ' HB3' ' HD2' ' A' ' 14' ' ' TYR . 6.5 ptm180 -147.12 145.14 29.48 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.055 0.455 . . . . 0.0 111.468 -178.451 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 60.0 t -133.09 154.65 39.91 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 CA-C-N 115.411 -0.813 . . . . 0.0 108.993 177.769 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 2.2 tmmm? -98.41 117.17 32.23 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 175.522 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.499 ' HB1' ' O ' ' A' ' 103' ' ' THR . . . -158.55 -170.39 3.06 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-N 116.678 -0.237 . . . . 0.0 110.929 -178.339 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.733 HG22 ' HA2' ' A' ' 39' ' ' GLY . 60.8 t -99.91 114.2 37.61 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.123 -177.524 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.482 HG21 HG23 ' A' ' 72' ' ' VAL . 19.0 m -80.64 106.87 12.37 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 CA-C-O 121.098 0.475 . . . . 0.0 110.71 176.666 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 45.1 mtt -100.95 167.12 10.46 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.665 179.141 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.487 HG23 ' CE1' ' A' ' 33' ' ' PHE . 10.9 t -141.73 166.9 23.45 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.705 -0.68 . . . . 0.0 109.767 178.531 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.42 ' NH2' ' HA2' ' A' ' 30' ' ' GLY . 19.2 ttt180 -129.98 109.61 11.01 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 177.828 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -56.49 88.36 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.821 -173.578 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.464 ' HA ' ' HG2' ' A' ' 98' ' ' ARG . 34.1 t70 52.0 -84.78 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 123.522 0.729 . . . . 0.0 112.156 -179.403 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 32.9 t -125.02 16.88 8.52 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 120.865 0.364 . . . . 0.0 110.738 -175.553 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 33.1 t -67.96 138.17 55.73 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.304 179.29 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.42 ' HA2' ' NH2' ' A' ' 25' ' ' ARG . . . -83.35 65.1 4.19 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 121.07 -0.586 . . . . 0.0 112.155 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -177.32 167.2 38.2 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.884 -0.674 . . . . 0.0 112.889 179.472 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . 0.511 ' HH2' ' HB3' ' A' ' 99' ' ' LYS . 94.7 m95 -125.85 125.61 43.13 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 122.637 0.375 . . . . 0.0 110.038 178.132 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.487 ' CE1' HG23 ' A' ' 24' ' ' THR . 5.7 p90 -137.47 144.37 44.87 Favored Pre-proline 0 C--O 1.234 0.284 0 CA-C-N 116.631 -0.259 . . . . 0.0 111.244 -176.035 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -60.82 132.35 42.07 Favored 'Trans proline' 0 C--N 1.353 0.803 0 C-N-CA 122.594 2.196 . . . . 0.0 111.271 173.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.419 ' H ' ' HG2' ' A' ' 35' ' ' GLN . 10.1 pt20 -86.91 -36.61 18.27 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.042 -0.526 . . . . 0.0 112.23 -174.442 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 20.1 tp10 -166.16 -55.28 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 120.658 0.266 . . . . 0.0 110.845 -177.312 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -53.97 -41.26 67.76 Favored Glycine 0 C--N 1.332 0.36 0 CA-C-N 116.03 -0.532 . . . . 0.0 113.522 -175.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 67.02 -138.1 34.43 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.994 -0.622 . . . . 0.0 111.954 -177.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.733 ' HA2' HG22 ' A' ' 21' ' ' VAL . . . -62.25 -34.37 88.96 Favored Glycine 0 CA--C 1.521 0.445 0 C-N-CA 121.61 -0.329 . . . . 0.0 113.675 -175.356 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.541 ' N ' HD12 ' A' ' 40' ' ' ILE . 3.1 mp -107.95 108.67 25.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 N-CA-C 110.24 -0.281 . . . . 0.0 110.24 -177.106 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 23.3 m -144.15 118.2 9.45 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.471 0.177 . . . . 0.0 110.551 172.558 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.446 ' CZ ' ' HD3' ' A' ' 65' ' ' ARG . 96.1 mtt180 -71.77 90.82 1.1 Allowed 'General case' 0 CA--C 1.521 -0.157 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 171.563 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.401 ' HA ' ' HA2' ' A' ' 63' ' ' GLY . 7.4 p -104.1 139.53 24.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.893 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -175.99 176.09 47.52 Favored Glycine 0 N--CA 1.443 -0.87 0 C-N-CA 120.463 -0.875 . . . . 0.0 112.703 178.234 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 59.4 t -107.84 129.09 62.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 178.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . 0.761 ' SG ' ' HB3' ' A' ' 60' ' ' LEU . 10.4 p -112.73 117.64 32.77 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.635 176.106 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 36.5 ttmt -76.02 83.21 2.9 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 179.3 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 27.1 m -75.35 135.14 27.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.375 -178.481 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 63.0 mtt -92.05 173.48 7.82 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.263 -179.752 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 26.2 p80 -142.58 149.91 52.33 Favored Pre-proline 0 C--N 1.325 -0.473 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.174 -176.33 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_endo -61.93 149.4 90.35 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 122.167 1.911 . . . . 0.0 110.644 173.6 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 11.8 mm-40 61.33 94.22 0.04 OUTLIER 'General case' 0 C--O 1.233 0.229 0 N-CA-C 109.935 -0.395 . . . . 0.0 109.935 -175.1 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -76.06 35.05 1.27 Allowed Glycine 0 CA--C 1.519 0.341 0 CA-C-N 116.251 -0.432 . . . . 0.0 113.464 -175.071 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 77.8 m-20 -86.37 76.7 9.61 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 177.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 162.83 -96.52 0.14 Allowed Glycine 0 N--CA 1.451 -0.348 0 CA-C-N 114.833 -1.076 . . . . 0.0 110.77 -177.532 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 22.5 ttm-85 -173.09 -86.99 0.01 OUTLIER 'General case' 0 C--O 1.233 0.206 0 N-CA-C 110.497 -0.186 . . . . 0.0 110.497 175.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 58.3 m -164.27 172.58 13.38 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 122.545 0.338 . . . . 0.0 110.189 -177.525 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -118.34 153.66 16.94 Favored Glycine 0 N--CA 1.45 -0.37 0 N-CA-C 111.064 -0.814 . . . . 0.0 111.064 175.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 -119.64 112.16 18.96 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.887 0.375 . . . . 0.0 110.499 -178.283 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.761 ' HB3' ' SG ' ' A' ' 46' ' ' CYS . 2.6 tt -101.76 110.88 22.96 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 179.698 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.416 ' O ' ' HA ' ' A' ' 74' ' ' GLU . 62.5 mt -78.26 100.22 3.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 173.634 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 3.2 t-80 -112.22 145.95 39.01 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 -173.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.401 ' HA2' ' HA ' ' A' ' 43' ' ' VAL . . . -146.51 119.59 1.18 Allowed Glycine 0 C--O 1.236 0.242 0 N-CA-C 110.716 -0.954 . . . . 0.0 110.716 -178.578 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -156.69 -175.71 5.58 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.916 0.865 . . . . 0.0 113.235 -167.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.446 ' HD3' ' CZ ' ' A' ' 42' ' ' ARG . 44.4 ttt-85 61.39 89.22 0.08 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 113.395 -1.73 . . . . 0.0 114.219 160.825 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.55 -42.58 0.61 Allowed 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 106.505 -1.665 . . . . 0.0 106.505 162.296 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.58 ' HE2' HD22 ' A' ' 70' ' ' LEU . 37.7 ttpt -90.23 163.19 14.89 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 163.226 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -51.09 94.45 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 -173.299 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 58.3 mtmt 49.77 84.75 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.311 -0.859 . . . . 0.0 112.209 177.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.58 HD22 ' HE2' ' A' ' 67' ' ' LYS . 61.9 tp -136.56 121.04 18.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.866 -179.222 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 54.1 t -79.29 113.37 18.54 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 N-CA-C 109.943 -0.391 . . . . 0.0 109.943 178.059 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.482 HG23 HG21 ' A' ' 22' ' ' VAL . 33.6 m -108.64 -2.5 10.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.602 -175.526 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -169.03 138.64 2.18 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 179.127 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.416 ' HA ' ' O ' ' A' ' 61' ' ' ILE . 0.2 OUTLIER -165.35 145.49 6.9 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 121.082 0.468 . . . . 0.0 111.31 176.752 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . 0.597 ' SG ' HG11 ' A' ' 95' ' ' VAL . 50.4 t -166.11 118.83 1.08 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.635 179.542 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 86.5 t80 -94.73 137.83 33.33 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.521 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 35.4 m -132.49 139.11 50.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 109.354 -0.609 . . . . 0.0 109.354 177.066 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 35.0 ttm-85 -107.67 -25.24 11.4 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.007 -175.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 39.4 tptt -170.05 -30.46 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 120.81 0.338 . . . . 0.0 110.496 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -97.03 124.49 41.03 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.993 179.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.473 HD13 ' N ' ' A' ' 82' ' ' VAL . 3.3 tm? -175.85 139.52 0.4 Allowed 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 177.172 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.473 ' N ' HD13 ' A' ' 81' ' ' LEU . 66.0 t -130.48 122.31 52.79 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 CA-C-N 116.602 -0.272 . . . . 0.0 110.554 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.622 ' HB3' ' NE2' ' A' ' 91' ' ' HIS . 96.1 m-85 -91.79 153.83 19.34 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-O 120.968 0.413 . . . . 0.0 110.06 173.8 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 91.4 m -156.0 117.5 3.92 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 174.727 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 20.2 ptmt -101.31 125.13 47.9 Favored 'General case' 0 C--N 1.328 -0.366 0 O-C-N 122.034 -0.416 . . . . 0.0 110.546 178.685 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -80.6 -34.01 35.5 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.63 -0.713 . . . . 0.0 110.363 -178.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -136.99 155.4 76.28 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.084 179.134 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_exo -48.73 -41.91 37.45 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.469 2.113 . . . . 0.0 111.959 176.178 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 13.4 p -97.25 18.16 15.68 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 115.716 -0.675 . . . . 0.0 112.051 -178.485 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 21.5 t80 -147.47 98.32 2.97 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-O 121.148 0.499 . . . . 0.0 110.865 177.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . 0.622 ' NE2' ' HB3' ' A' ' 83' ' ' TYR . 3.4 t-160 -109.47 125.15 52.15 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 -179.604 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 25.8 p80 -125.6 167.03 15.64 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.971 0.415 . . . . 0.0 110.926 -178.499 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 26.8 p90 -139.63 177.9 7.61 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.282 176.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 62.6 pttt -154.28 147.29 24.57 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.817 0.341 . . . . 0.0 111.052 -174.435 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.597 HG11 ' SG ' ' A' ' 75' ' ' CYS . 35.7 m -132.72 143.94 38.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 173.737 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 66.01 -72.17 0.08 Allowed 'General case' 0 N--CA 1.465 0.321 0 O-C-N 123.56 0.538 . . . . 0.0 110.719 -176.192 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -165.34 -26.78 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.874 -178.626 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.464 ' HG2' ' HA ' ' A' ' 27' ' ' ASP . 99.8 mtt180 -81.81 149.51 28.32 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 120.832 0.348 . . . . 0.0 111.027 -178.299 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.511 ' HB3' ' HH2' ' A' ' 32' ' ' TRP . 0.0 OUTLIER -114.22 142.66 45.98 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.261 -173.141 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 2.9 p90 -150.05 138.88 20.9 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 173.056 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -142.69 -170.1 12.62 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.205 -0.998 . . . . 0.0 114.605 -169.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.499 HD11 ' HB3' ' A' ' 20' ' ' ALA . 34.3 tp -134.17 124.26 25.74 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 114.995 -0.603 . . . . 0.0 110.868 -173.189 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.556 ' HB ' ' HB ' ' A' ' 21' ' ' VAL . 22.5 m -98.5 124.92 43.51 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 175.563 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 57.0 m-85 -87.76 161.77 17.4 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.863 -175.136 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 23.8 pt20 -96.29 -27.99 14.72 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.655 -177.499 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 49.1 m -149.56 154.43 38.09 Favored Pre-proline 0 CA--C 1.532 0.264 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.544 178.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -58.73 -24.43 71.19 Favored 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 122.555 2.17 . . . . 0.0 112.064 178.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -62.21 -56.09 22.14 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.916 178.542 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -71.73 -28.73 63.87 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.759 179.206 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -58.97 -60.66 3.5 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.127 0.489 . . . . 0.0 110.392 174.456 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 67.5 mtp85 -62.43 -32.62 73.51 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.913 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -62.59 -38.59 90.72 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.311 176.167 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 52.6 t80 -73.68 -34.48 64.91 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.169 179.099 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.4 ' HA ' HG22 ' A' ' 117' ' ' VAL . 63.9 m-20 -61.71 -38.64 88.61 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 121.337 0.589 . . . . 0.0 109.534 173.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 17.0 mmm180 -62.39 -42.05 99.13 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.684 172.071 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -60.17 -46.4 94.3 Favored Glycine 0 N--CA 1.45 -0.412 0 CA-C-N 115.336 -0.847 . . . . 0.0 112.519 178.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.421 ' O ' HG13 ' A' ' 121' ' ' ILE . 21.3 m -70.51 -34.82 59.06 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.366 0 CA-C-N 116.737 0.268 . . . . 0.0 110.634 -178.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -61.88 -48.91 78.38 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 176.839 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 7.9 tmtm? -62.03 -45.9 91.51 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 114.775 -1.102 . . . . 0.0 109.801 -179.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -61.42 -52.11 65.96 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.818 -179.687 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.421 HG13 ' O ' ' A' ' 117' ' ' VAL . 68.4 mt -57.66 -41.12 78.62 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.123 -178.136 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.559 ' O ' ' HG3' ' A' ' 126' ' ' GLU . 37.0 tt0 -63.37 -58.34 7.41 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 121.018 0.437 . . . . 0.0 110.394 177.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -60.76 -22.55 64.18 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.449 -179.506 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 9.4 tt -84.47 -39.82 18.44 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.418 179.346 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.514 HG22 ' O ' ' A' ' 122' ' ' GLU . 10.8 tp -72.11 -25.87 24.25 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 CA-C-N 116.732 -0.213 . . . . 0.0 110.434 -176.04 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.559 ' HG3' ' O ' ' A' ' 122' ' ' GLU . 46.8 mt-10 . . . . . 0 C--O 1.25 1.098 0 CA-C-O 118.728 -0.653 . . . . 0.0 110.336 175.18 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.767 0 N-CA-C 111.929 -0.469 . . . . 0.0 111.929 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 32.2 t -69.03 126.94 31.38 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-O 120.727 0.299 . . . . 0.0 110.742 -179.641 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 34.7 tpp -71.82 112.68 8.13 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.474 178.342 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 43.5 m 69.64 92.06 0.09 Allowed 'General case' 0 CA--C 1.531 0.248 0 O-C-N 123.686 0.616 . . . . 0.0 111.565 178.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -100.1 -52.15 3.49 Favored 'General case' 0 C--O 1.233 0.229 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 173.336 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 19.3 mm-40 -87.08 -161.26 0.67 Allowed 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 115.232 -0.894 . . . . 0.0 108.902 174.407 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 21.5 m 72.78 76.12 0.15 Allowed 'General case' 0 C--O 1.234 0.27 0 CA-C-O 121.369 0.604 . . . . 0.0 111.349 177.029 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.613 ' HB3' ' HD2' ' A' ' 9' ' ' PRO . 33.4 m170 -89.79 170.16 11.08 Favored Pre-proline 0 CA--C 1.535 0.386 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.488 173.356 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.613 ' HD2' ' HB3' ' A' ' 8' ' ' HIS . 35.7 Cg_exo -37.29 -48.14 1.71 Allowed 'Trans proline' 0 C--N 1.364 1.346 0 C-N-CA 123.215 2.61 . . . . 0.0 113.068 179.179 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -124.66 89.94 3.16 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 172.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.462 ' HB2' ' H ' ' A' ' 8' ' ' HIS . 14.2 t70 -106.52 -14.17 15.13 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.227 -175.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -75.28 -20.36 59.18 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.29 -174.438 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.815 ' HB2' ' SG ' ' A' ' 46' ' ' CYS . 58.3 m -93.97 -90.03 0.21 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.729 -0.214 . . . . 0.0 110.92 178.772 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.46 ' CE2' ' HA ' ' A' ' 11' ' ' ASP . 31.8 m-85 42.88 91.34 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 122.74 0.416 . . . . 0.0 111.87 -175.263 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.646 HD11 ' HB2' ' A' ' 47' ' ' LYS . 63.0 mt -61.18 -51.15 76.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 121.147 0.499 . . . . 0.0 109.916 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.537 HG23 HG22 ' A' ' 15' ' ' ILE . 92.0 t -140.1 119.33 12.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.882 178.701 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.571 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 27.8 ttp180 -128.05 86.7 2.5 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-O 121.264 0.554 . . . . 0.0 109.776 173.122 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 35.0 m -117.68 173.03 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-N 115.329 -0.85 . . . . 0.0 110.474 -177.205 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 26.1 ttpp -92.06 134.91 34.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.91 0.386 . . . . 0.0 110.914 179.638 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -160.11 -164.21 1.25 Allowed 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 178.304 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 25.0 t -122.44 109.16 23.34 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 177.538 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.703 HG23 ' NE2' ' A' ' 35' ' ' GLN . 19.7 m -84.16 133.18 29.8 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 CA-C-O 120.989 0.423 . . . . 0.0 111.031 -178.233 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 24.5 mmt -117.09 152.42 34.73 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.108 -176.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.432 HG23 ' CE1' ' A' ' 33' ' ' PHE . 9.8 t -132.66 140.26 48.08 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-O 121.134 0.492 . . . . 0.0 110.955 176.427 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.456 ' HE ' ' HA ' ' A' ' 28' ' ' SER . 21.1 tpt180 -90.21 77.78 6.66 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 174.71 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.565 ' HB2' ' HE1' ' A' ' 33' ' ' PHE . 35.7 t70 -56.3 94.74 0.01 OUTLIER 'General case' 0 C--O 1.236 0.371 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 179.478 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 16.0 t70 63.47 -74.78 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.941 -173.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.456 ' HA ' ' HE ' ' A' ' 25' ' ' ARG . 8.0 t -167.27 -44.26 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 175.324 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 18.5 t -61.88 -12.34 17.31 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.53 -178.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -62.1 -26.58 67.68 Favored Glycine 0 CA--C 1.523 0.574 0 C-N-CA 121.153 -0.546 . . . . 0.0 112.478 175.569 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 56.79 28.54 57.34 Favored Glycine 0 C--N 1.338 0.663 0 C-N-CA 121.739 -0.267 . . . . 0.0 113.537 177.298 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . 0.582 ' HH2' ' HG2' ' A' ' 99' ' ' LYS . 62.4 m95 63.03 96.76 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 123.174 0.59 . . . . 0.0 110.678 -177.789 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.565 ' HE1' ' HB2' ' A' ' 26' ' ' ASP . 2.9 p90 -132.04 150.84 77.23 Favored Pre-proline 0 C--O 1.236 0.376 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.928 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.51 ' HB2' ' HA2' ' A' ' 38' ' ' GLY . 77.1 Cg_endo -79.35 109.2 2.46 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.527 2.151 . . . . 0.0 112.084 179.15 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.703 ' NE2' HG23 ' A' ' 22' ' ' VAL . 0.2 OUTLIER -75.57 125.95 30.04 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 176.861 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 65.07 -75.1 0.05 OUTLIER 'General case' 0 C--O 1.236 0.377 0 C-N-CA 123.133 0.573 . . . . 0.0 111.317 -178.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -76.25 74.33 1.69 Allowed Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 121.575 -0.345 . . . . 0.0 112.782 -177.242 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.51 ' HA2' ' HB2' ' A' ' 34' ' ' PRO . . . -75.56 66.74 2.32 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 121.209 -0.52 . . . . 0.0 112.114 177.156 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 129.02 -32.0 3.37 Favored Glycine 0 N--CA 1.453 -0.173 0 C-N-CA 121.415 -0.421 . . . . 0.0 112.07 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 67.4 mt -120.4 100.75 9.76 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 CA-C-O 120.823 0.344 . . . . 0.0 110.501 179.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 16.5 m -132.49 151.42 51.91 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 175.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.407 HH11 ' HD3' ' A' ' 42' ' ' ARG . 6.5 tpt180 -113.9 116.12 28.77 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 174.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.571 ' O ' ' HA ' ' A' ' 17' ' ' ARG . 24.2 t -95.46 103.16 14.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.273 -178.047 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -106.16 89.43 0.61 Allowed Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 121.334 -0.46 . . . . 0.0 112.491 179.787 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 85.0 t -84.86 120.8 36.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 120.856 0.36 . . . . 0.0 110.067 177.015 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . 0.815 ' SG ' ' HB2' ' A' ' 13' ' ' SER . 45.0 t -117.8 165.2 13.93 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.921 -178.666 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.646 ' HB2' HD11 ' A' ' 15' ' ' ILE . 83.8 tttt -118.65 116.05 25.78 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.368 -179.65 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.451 HG21 ' CE2' ' A' ' 76' ' ' TYR . 36.0 m -110.55 150.96 12.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.094 0.473 . . . . 0.0 111.286 -175.414 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 4.0 mpp? -93.51 -171.44 2.63 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.416 178.36 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 28.8 p80 -137.1 157.66 74.09 Favored Pre-proline 0 C--O 1.237 0.41 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.725 -177.249 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -64.86 -153.06 0.02 OUTLIER 'Trans proline' 0 C--N 1.353 0.787 0 C-N-CA 122.925 2.417 . . . . 0.0 111.285 172.558 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 67.8 mm-40 -56.58 118.76 5.15 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 120.651 0.262 . . . . 0.0 110.435 178.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -170.17 -179.91 42.0 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 121.211 -0.519 . . . . 0.0 111.932 -177.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -83.89 -40.76 18.2 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.695 0.283 . . . . 0.0 110.838 -177.662 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.402 ' O ' ' HB2' ' A' ' 56' ' ' ARG . . . 167.13 -140.93 6.57 Favored Glycine 0 N--CA 1.453 -0.221 0 C-N-CA 121.078 -0.582 . . . . 0.0 111.89 -178.552 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.402 ' HB2' ' O ' ' A' ' 55' ' ' GLY . 3.6 mpt_? 69.32 100.32 0.06 Allowed 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 121.206 0.527 . . . . 0.0 111.016 -177.631 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 23.4 p -75.58 124.76 27.75 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.48 179.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -86.46 161.31 33.82 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.893 -0.67 . . . . 0.0 111.934 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -133.17 158.09 43.71 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.87 -0.418 . . . . 0.0 109.87 178.574 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.434 HD22 ' HB2' ' A' ' 62' ' ' HIS . 1.9 tt -132.23 113.61 13.47 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 -179.774 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.537 ' HB ' ' HB2' ' A' ' 75' ' ' CYS . 58.0 mt -82.24 97.23 3.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 174.666 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . 0.434 ' HB2' HD22 ' A' ' 60' ' ' LEU . 26.6 t-80 -111.24 91.67 3.75 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.737 -172.446 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -89.98 114.79 4.43 Favored Glycine 0 C--O 1.236 0.275 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.625 177.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -143.49 -161.15 1.21 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.655 0.227 . . . . 0.0 111.526 -174.334 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 1.4 mmp_? 63.98 32.1 13.27 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 115.764 -0.653 . . . . 0.0 112.687 170.547 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.507 HE21 ' N ' ' A' ' 66' ' ' GLN . 0.0 OUTLIER -72.73 -67.51 0.55 Allowed 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.771 -0.372 . . . . 0.0 110.498 176.614 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 64.6 tttm -132.51 130.02 39.87 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 178.396 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 59.71 -80.93 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 -174.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 23.2 pttm -178.66 128.41 0.11 Allowed 'General case' 0 C--O 1.232 0.176 0 C-N-CA 123.149 0.58 . . . . 0.0 109.775 169.114 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -174.46 157.93 2.74 Favored 'General case' 0 C--O 1.24 0.571 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.03 177.634 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 25.0 t -95.41 117.51 39.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 O-C-N 123.297 0.373 . . . . 0.0 110.24 -179.286 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 33.6 m -92.48 -24.9 5.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 120.864 0.364 . . . . 0.0 111.062 -179.101 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -145.85 109.35 4.73 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 -176.287 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -116.9 116.61 27.75 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 178.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . 0.537 ' HB2' ' HB ' ' A' ' 61' ' ' ILE . 63.0 m -137.48 90.85 2.55 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 121.151 0.501 . . . . 0.0 110.526 179.448 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.451 ' CE2' HG21 ' A' ' 48' ' ' VAL . 56.6 t80 -70.98 105.26 3.23 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 173.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 15.6 m -103.62 97.55 5.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 121.81 0.814 . . . . 0.0 110.366 -174.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 28.6 ptt180 -83.06 80.37 9.07 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.396 -177.246 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.771 ' HA ' HD11 ' A' ' 124' ' ' LEU . 11.0 tmtt? 76.1 -37.5 0.31 Allowed 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.995 177.735 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -68.82 108.33 3.4 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 122.363 0.265 . . . . 0.0 110.715 -179.425 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.404 HD23 ' HA ' ' A' ' 81' ' ' LEU . 12.2 mt -152.02 163.21 39.77 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.213 0.53 . . . . 0.0 110.832 179.577 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 58.3 t -131.84 -65.7 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.721 176.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.431 ' HB3' ' NE2' ' A' ' 91' ' ' HIS . 21.0 m-85 56.73 103.61 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.431 -176.729 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 53.0 m -134.12 112.52 11.2 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.736 178.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.558 ' HA ' ' HA ' ' A' ' 91' ' ' HIS . 0.2 OUTLIER -82.16 91.1 6.65 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.454 0.645 . . . . 0.0 109.68 177.16 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -66.24 -32.01 73.18 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.046 -178.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . 0.747 ' HB2' ' HB3' ' A' ' 90' ' ' PHE . 15.6 m120 -129.09 155.35 79.96 Favored Pre-proline 0 C--N 1.326 -0.414 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 175.458 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_exo -44.26 -44.01 13.05 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.648 2.232 . . . . 0.0 112.915 179.41 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.548 ' O ' ' HA ' ' A' ' 103' ' ' THR . 37.3 p -108.67 16.98 22.43 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 -177.411 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.747 ' HB3' ' HB2' ' A' ' 87' ' ' ASN . 73.4 t80 -131.0 104.04 6.88 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 120.894 0.378 . . . . 0.0 110.509 -178.543 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . 0.558 ' HA ' ' HA ' ' A' ' 85' ' ' LYS . 1.5 t60 -114.9 124.27 51.28 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 -179.121 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . 0.475 ' HA ' ' HA2' ' A' ' 101' ' ' GLY . 23.5 p80 -126.78 159.54 33.5 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 120.953 0.406 . . . . 0.0 111.766 -176.394 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 49.1 p90 -155.39 147.53 23.62 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.282 -179.462 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.42 ' NZ ' ' HB3' ' A' ' 94' ' ' LYS . 5.7 ttpm? -112.85 127.53 56.2 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 177.426 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 19.1 m -146.69 146.94 18.34 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 O-C-N 123.253 0.346 . . . . 0.0 110.473 -179.659 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 33.6 t70 63.82 -73.33 0.05 OUTLIER 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.373 0.669 . . . . 0.0 111.773 178.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -146.43 -57.22 0.28 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.657 0.265 . . . . 0.0 110.65 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -78.8 176.19 9.78 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-O 121.538 0.685 . . . . 0.0 111.249 -178.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.582 ' HG2' ' HH2' ' A' ' 32' ' ' TRP . 37.2 ttpt -128.97 115.33 17.65 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.136 -179.268 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 41.2 m-85 -101.21 168.38 9.6 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.528 -0.306 . . . . 0.0 110.605 -174.037 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.475 ' HA2' ' HA ' ' A' ' 92' ' ' HIS . . . -151.08 170.87 30.79 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 121.136 -0.554 . . . . 0.0 112.161 -177.798 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.436 HD23 ' N ' ' A' ' 103' ' ' THR . 2.5 tt -143.52 128.77 18.8 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 -178.212 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.548 ' HA ' ' O ' ' A' ' 89' ' ' THR . 84.2 m -110.89 122.48 47.96 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.189 176.035 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.423 ' HD2' ' HA ' ' A' ' 89' ' ' THR . 50.9 m-85 -89.28 162.21 15.98 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.699 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 19.0 pt20 -113.5 -48.17 2.96 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 111.396 0.147 . . . . 0.0 111.396 -176.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 17.2 m -117.34 143.93 32.93 Favored Pre-proline 0 C--N 1.328 -0.34 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 -177.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_exo -47.7 -29.98 11.91 Favored 'Trans proline' 0 C--N 1.354 0.829 0 C-N-CA 122.593 2.196 . . . . 0.0 112.314 177.584 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -58.06 -70.75 0.13 Allowed 'General case' 0 C--O 1.233 0.204 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.98 177.024 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -60.45 -37.35 80.69 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.062 -178.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.408 ' HA ' ' CG ' ' A' ' 104' ' ' PHE . . . -54.01 -69.56 0.12 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.261 178.711 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 78.4 mtt180 -70.94 -22.81 62.18 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.536 -173.307 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -65.67 -48.89 70.56 Favored 'General case' 0 C--O 1.238 0.471 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 174.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 57.1 t80 -69.59 -47.16 64.48 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.075 -179.464 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.418 ' O ' ' HG2' ' A' ' 118' ' ' ARG . 4.8 m-20 -51.93 -58.72 5.66 Favored 'General case' 0 N--CA 1.465 0.294 0 O-C-N 123.191 0.307 . . . . 0.0 110.75 178.638 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 27.3 mtp180 -60.71 -38.43 85.04 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-O 120.699 0.285 . . . . 0.0 110.892 -179.007 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.507 ' O ' ' HG3' ' A' ' 119' ' ' LYS . . . -62.04 -56.64 21.22 Favored Glycine 0 CA--C 1.52 0.386 0 C-N-CA 121.183 -0.532 . . . . 0.0 112.575 179.231 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.56 ' O ' HG12 ' A' ' 121' ' ' ILE . 12.1 p -64.59 -30.91 51.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.571 0.224 . . . . 0.0 110.408 -178.529 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.418 ' HG2' ' O ' ' A' ' 114' ' ' ASP . 7.9 mmm180 -62.77 -50.75 69.82 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.653 177.688 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.507 ' HG3' ' O ' ' A' ' 116' ' ' GLY . 0.0 OUTLIER -62.01 -33.98 75.35 Favored 'General case' 0 N--CA 1.462 0.151 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 178.753 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -62.51 -36.53 82.86 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.449 175.423 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.56 HG12 ' O ' ' A' ' 117' ' ' VAL . 40.3 mm -64.09 -44.65 97.71 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.076 0 CA-C-N 116.248 -0.433 . . . . 0.0 109.879 175.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -58.55 -39.19 79.55 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.71 176.175 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 87.9 m-20 -66.05 -37.08 84.95 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 121.252 0.549 . . . . 0.0 110.239 176.439 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.771 HD11 ' HA ' ' A' ' 79' ' ' LYS . 49.4 tp -70.5 -57.73 4.46 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.335 -0.848 . . . . 0.0 111.469 -176.294 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.505 HG13 ' O ' ' A' ' 121' ' ' ILE . 2.9 pp -75.02 -29.47 22.16 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.05 -177.594 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.467 ' N ' HD12 ' A' ' 125' ' ' ILE . 39.5 tt0 . . . . . 0 C--O 1.248 1.008 0 CA-C-O 118.15 -0.929 . . . . 0.0 111.094 176.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.729 0 N-CA-C 112.185 -0.366 . . . . 0.0 112.185 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 23.8 p -66.19 113.44 4.55 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 177.303 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 52.2 ttp -144.99 128.26 16.79 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.976 0.417 . . . . 0.0 111.554 -173.583 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 12.0 t -166.52 137.42 3.4 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 176.006 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -158.32 -85.89 0.04 OUTLIER 'General case' 0 C--O 1.234 0.237 0 CA-C-O 120.613 0.244 . . . . 0.0 111.056 -174.107 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -90.01 -50.25 6.13 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 121.101 0.477 . . . . 0.0 109.974 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 15.2 t -63.08 157.64 21.66 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.774 178.171 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.686 ' HB2' ' HD3' ' A' ' 9' ' ' PRO . 32.1 m170 103.09 -68.74 0.0 OUTLIER Pre-proline 0 N--CA 1.482 1.145 0 C-N-CA 125.391 1.476 . . . . 0.0 113.235 176.726 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.686 ' HD3' ' HB2' ' A' ' 8' ' ' HIS . 80.7 Cg_exo -48.96 -44.59 31.89 Favored 'Trans proline' 0 C--N 1.37 1.693 0 C-N-CA 121.867 1.711 . . . . 0.0 112.066 -177.217 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -83.29 -85.8 0.12 Allowed 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 172.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -175.12 -50.02 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 168.196 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 33.1 t70 65.15 -71.16 0.08 Allowed 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 112.959 0.725 . . . . 0.0 112.959 172.568 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 60.5 m -130.53 26.86 5.04 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 111.938 0.347 . . . . 0.0 111.938 -175.703 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.648 ' HE2' ' HA ' ' A' ' 8' ' ' HIS . 13.3 m-85 -73.45 123.19 23.4 Favored 'General case' 0 C--O 1.235 0.305 0 O-C-N 122.096 -0.378 . . . . 0.0 110.841 176.591 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.447 HG23 HG12 ' A' ' 16' ' ' VAL . 13.6 tt -85.12 -27.15 6.57 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 174.137 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.447 HG12 HG23 ' A' ' 15' ' ' ILE . 9.2 p -159.15 144.97 6.95 Favored 'Isoleucine or valine' 0 C--O 1.231 0.13 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.906 176.279 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 55.8 ttp180 -160.04 109.35 1.78 Allowed 'General case' 0 C--O 1.235 0.315 0 CA-C-O 121.026 0.441 . . . . 0.0 110.433 176.024 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 34.6 m -113.01 -170.32 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.089 -179.219 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.521 ' HB2' HG23 ' A' ' 40' ' ' ILE . 57.4 pttt -126.26 113.59 17.17 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.069 0.461 . . . . 0.0 110.392 178.511 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -143.52 178.14 7.98 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.351 -177.483 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.53 ' HB ' ' HB ' ' A' ' 103' ' ' THR . 27.5 t -83.37 135.17 25.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.442 0.163 . . . . 0.0 110.564 179.825 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.585 HG23 ' HG2' ' A' ' 35' ' ' GLN . 11.6 m -95.24 95.26 4.87 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 CA-C-O 121.473 0.654 . . . . 0.0 110.847 177.087 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 23.6 mmt -86.77 160.01 18.94 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.699 -178.262 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.431 ' HA ' ' HA ' ' A' ' 100' ' ' PHE . 11.7 t -160.24 150.71 18.53 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.867 174.168 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.407 ' HD2' ' O ' ' A' ' 29' ' ' SER . 47.6 ttp180 -114.1 89.74 3.17 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 107.594 -1.261 . . . . 0.0 107.594 171.835 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -43.47 96.99 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.33 0 O-C-N 124.482 1.114 . . . . 0.0 112.364 -169.357 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 18.7 t70 58.22 -78.92 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 115.15 -0.932 . . . . 0.0 111.088 -179.582 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 21.1 m -141.95 105.7 4.71 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 176.329 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.407 ' O ' ' HD2' ' A' ' 25' ' ' ARG . 36.4 t -141.84 171.1 14.52 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.14 -176.481 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -100.02 38.87 2.93 Favored Glycine 0 CA--C 1.518 0.268 0 C-N-CA 121.293 -0.479 . . . . 0.0 112.93 -176.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 171.92 163.71 26.29 Favored Glycine 0 C--N 1.33 0.243 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.649 177.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . 0.401 ' CH2' ' HB3' ' A' ' 99' ' ' LYS . 86.2 m95 -103.6 113.73 27.47 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 176.646 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.462 ' HA ' ' HD3' ' A' ' 34' ' ' PRO . 0.5 OUTLIER -117.6 144.76 34.86 Favored Pre-proline 0 C--N 1.327 -0.402 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.288 -177.007 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.462 ' HD3' ' HA ' ' A' ' 33' ' ' PHE . 11.6 Cg_exo -71.11 137.73 32.16 Favored 'Trans proline' 0 C--N 1.351 0.676 0 C-N-CA 122.846 2.364 . . . . 0.0 111.46 175.038 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.585 ' HG2' HG23 ' A' ' 22' ' ' VAL . 7.1 pt20 -87.91 -147.53 0.15 Allowed 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.07 179.261 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 44.5 mm-40 -46.66 -42.73 16.87 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 111.832 0.308 . . . . 0.0 111.832 179.528 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -80.8 68.58 3.37 Favored Glycine 0 CA--C 1.519 0.328 0 C-N-CA 121.184 -0.532 . . . . 0.0 112.544 -179.392 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -77.33 132.07 11.74 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 121.204 -0.522 . . . . 0.0 112.392 179.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 85.05 -57.96 4.98 Favored Glycine 0 CA--C 1.518 0.264 0 C-N-CA 121.283 -0.484 . . . . 0.0 112.885 176.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.521 HG23 ' HB2' ' A' ' 19' ' ' LYS . 65.5 mt -142.23 140.76 29.12 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 C-N-CA 122.341 0.256 . . . . 0.0 110.458 -177.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.454 ' O ' ' HA ' ' A' ' 19' ' ' LYS . 53.0 m -150.71 133.96 16.2 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 174.344 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 55.4 ttp180 -81.47 90.63 6.23 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 109.808 -0.441 . . . . 0.0 109.808 -178.375 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.481 ' HA ' ' HA2' ' A' ' 63' ' ' GLY . 31.4 t -111.96 143.3 22.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.443 -175.721 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -160.96 -177.43 34.06 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.994 -0.622 . . . . 0.0 112.718 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.405 ' O ' HG22 ' A' ' 15' ' ' ILE . 50.5 t -118.04 130.45 72.89 Favored 'Isoleucine or valine' 0 C--O 1.241 0.614 0 CA-C-O 120.721 0.296 . . . . 0.0 110.263 179.859 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . 0.684 ' SG ' ' HB3' ' A' ' 60' ' ' LEU . 12.4 p -119.67 122.49 41.6 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.452 173.361 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 33.3 ttpt -78.72 102.03 7.86 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 121.053 0.454 . . . . 0.0 110.145 179.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.519 ' O ' ' HB3' ' A' ' 57' ' ' SER . 51.3 t -75.86 110.74 11.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.372 -179.691 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 22.9 ptp -107.7 135.63 48.81 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.288 -0.415 . . . . 0.0 109.979 178.505 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . 0.401 ' HA ' ' HD2' ' A' ' 51' ' ' PRO . 19.3 p80 -58.73 127.04 82.03 Favored Pre-proline 0 CA--C 1.532 0.267 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.908 177.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.401 ' HD2' ' HA ' ' A' ' 50' ' ' HIS . 18.5 Cg_endo -58.45 -56.94 1.24 Allowed 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 122.351 2.034 . . . . 0.0 110.965 176.23 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 10.4 mp0 -114.41 -60.07 1.93 Allowed 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 170.533 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 176.04 47.78 0.06 OUTLIER Glycine 0 C--N 1.33 0.231 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.314 178.587 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 24.6 p-10 -64.73 -42.8 94.94 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 111.994 0.368 . . . . 0.0 111.994 -174.264 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -168.36 -171.68 34.48 Favored Glycine 0 C--O 1.236 0.248 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.898 -178.056 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -64.84 105.37 0.99 Allowed 'General case' 0 C--O 1.234 0.276 0 CA-C-O 120.859 0.361 . . . . 0.0 111.038 -179.147 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.519 ' HB3' ' O ' ' A' ' 48' ' ' VAL . 22.7 m -68.31 151.91 46.21 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.341 177.214 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -165.37 -147.14 5.04 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.618 -177.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -130.32 125.56 35.01 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 -176.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.684 ' HB3' ' SG ' ' A' ' 46' ' ' CYS . 2.3 tt -95.81 118.29 32.18 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 -179.531 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 49.5 mm -84.27 93.95 3.48 Favored 'Isoleucine or valine' 0 C--O 1.235 0.292 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 172.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . 0.607 ' HB2' HD22 ' A' ' 60' ' ' LEU . 38.5 t-80 -108.48 131.91 54.33 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.941 -171.798 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.481 ' HA2' ' HA ' ' A' ' 43' ' ' VAL . . . -128.24 133.06 7.58 Favored Glycine 0 N--CA 1.449 -0.481 0 N-CA-C 110.89 -0.884 . . . . 0.0 110.89 177.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -146.89 178.17 8.55 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.78 0.324 . . . . 0.0 111.329 -172.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 5.1 mmt180 68.1 169.37 0.27 Allowed 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 115.303 -0.862 . . . . 0.0 111.868 174.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 65.33 165.63 0.17 Allowed 'General case' 0 C--O 1.235 0.323 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.297 -173.216 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 24.9 tptp 71.24 -59.82 0.53 Allowed 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 122.946 0.498 . . . . 0.0 109.665 -174.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -165.24 -84.97 0.02 OUTLIER 'General case' 0 C--O 1.234 0.28 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.235 173.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 4.3 ttmp? -165.85 96.0 0.62 Allowed 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 -179.262 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.4 pp -173.23 178.92 2.32 Favored 'General case' 0 C--O 1.239 0.514 0 CA-C-O 120.633 0.254 . . . . 0.0 110.474 -173.01 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.475 ' O ' HG23 ' A' ' 71' ' ' VAL . 27.4 m -103.41 104.1 16.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.889 177.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.438 HG21 ' HB3' ' A' ' 41' ' ' SER . 34.7 m -68.46 -31.37 50.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.41 -178.572 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 40.4 mt -141.06 94.22 2.68 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.362 178.042 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -98.51 94.92 6.96 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 170.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . 0.469 ' SG ' ' CE2' ' A' ' 100' ' ' PHE . 57.9 m -139.43 89.4 2.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.363 0.601 . . . . 0.0 111.011 -172.386 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.515 ' HA ' ' HA ' ' A' ' 60' ' ' LEU . 29.9 t80 -74.27 116.13 14.57 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.173 178.072 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.605 HG11 HD12 ' A' ' 81' ' ' LEU . 95.8 t -80.19 105.93 10.56 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 CA-C-O 121.144 0.497 . . . . 0.0 109.818 179.719 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.592 ' HD2' ' O ' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -80.79 61.86 4.6 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.276 -179.906 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.58 ' HG3' HD21 ' A' ' 124' ' ' LEU . 45.4 tttp 74.86 124.19 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 115.172 -0.922 . . . . 0.0 111.394 -176.479 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 76.7 m-20 70.6 119.39 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 115.113 -0.949 . . . . 0.0 112.915 174.15 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.605 HD12 HG11 ' A' ' 77' ' ' VAL . 0.0 OUTLIER -143.52 134.26 25.17 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 167.47 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 19.8 t -65.61 -52.02 55.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.888 -169.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.465 ' HD2' HG11 ' A' ' 117' ' ' VAL . 0.9 OUTLIER 57.87 51.59 8.93 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 121.292 0.568 . . . . 0.0 109.987 -177.626 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 33.7 m -60.52 114.18 2.83 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.786 -179.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.45 ' HB3' ' CD2' ' A' ' 91' ' ' HIS . 0.0 OUTLIER -99.71 102.25 13.66 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.972 0.415 . . . . 0.0 110.334 176.112 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -75.46 -37.15 60.48 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 175.367 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . 0.458 ' HB2' ' HB3' ' A' ' 90' ' ' PHE . 77.0 m-20 -127.67 151.46 75.33 Favored Pre-proline 0 C--N 1.326 -0.423 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 174.095 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.499 ' O ' ' HB1' ' A' ' 110' ' ' ALA . 88.7 Cg_exo -48.22 -33.82 22.71 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.313 2.009 . . . . 0.0 112.374 178.387 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.448 ' O ' ' HA ' ' A' ' 103' ' ' THR . 14.7 p -97.68 -15.65 20.3 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 115.889 -0.596 . . . . 0.0 112.138 -178.519 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.458 ' HB3' ' HB2' ' A' ' 87' ' ' ASN . 86.8 t80 -107.31 102.47 11.77 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-O 121.087 0.47 . . . . 0.0 110.854 -176.653 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . 0.45 ' CD2' ' HB3' ' A' ' 85' ' ' LYS . 56.5 m80 -112.82 147.3 37.24 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.155 177.201 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . 0.579 ' HA ' ' HA3' ' A' ' 101' ' ' GLY . 15.4 p80 -153.95 152.84 31.04 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 174.789 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . 0.448 ' HD1' HG13 ' A' ' 95' ' ' VAL . 47.8 p90 -137.13 145.28 43.63 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-O 121.283 0.563 . . . . 0.0 111.291 177.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 1.1 tmtm? -102.04 119.52 38.93 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.013 -0.994 . . . . 0.0 109.286 176.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.448 HG13 ' HD1' ' A' ' 93' ' ' TRP . 19.3 m -125.45 125.64 69.22 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 173.417 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 59.56 -79.4 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.77 -175.518 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 44.1 t30 -142.29 -35.21 0.43 Allowed 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 112.063 0.394 . . . . 0.0 112.063 -177.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.518 ' HD2' ' N ' ' A' ' 98' ' ' ARG . 2.3 mpt_? -84.46 148.29 26.64 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.899 0.381 . . . . 0.0 111.212 -174.659 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.401 ' HB3' ' CH2' ' A' ' 32' ' ' TRP . 3.5 mppt? -119.92 124.49 46.14 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.759 -176.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.469 ' CE2' ' SG ' ' A' ' 75' ' ' CYS . 0.7 OUTLIER -144.31 150.44 37.85 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.485 176.095 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.579 ' HA3' ' HA ' ' A' ' 92' ' ' HIS . . . -157.71 -165.61 15.64 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 121.021 -0.609 . . . . 0.0 112.82 -175.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 94.9 mt -128.42 147.32 50.65 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.998 0.428 . . . . 0.0 110.887 -174.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.53 ' HB ' ' HB ' ' A' ' 21' ' ' VAL . 63.2 m -123.79 107.67 11.67 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 172.74 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.451 ' HB3' ' OD2' ' A' ' 109' ' ' ASP . 99.4 m-85 -78.28 167.97 20.54 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.645 -0.707 . . . . 0.0 112.019 -172.122 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 -92.06 -41.76 10.33 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.03 -175.618 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 16.7 m -137.54 156.13 75.01 Favored Pre-proline 0 C--O 1.234 0.285 0 CA-C-N 116.621 -0.263 . . . . 0.0 110.883 -175.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -54.2 -32.65 71.61 Favored 'Trans proline' 0 C--N 1.351 0.676 0 C-N-CA 122.656 2.237 . . . . 0.0 112.234 177.392 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -56.43 -66.32 0.46 Allowed 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.401 179.05 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.451 ' OD2' ' HB3' ' A' ' 104' ' ' PHE . 1.6 p-10 -63.63 -35.73 81.47 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.086 -178.415 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.499 ' HB1' ' O ' ' A' ' 88' ' ' PRO . . . -58.64 -61.51 2.55 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 121.174 0.511 . . . . 0.0 111.263 177.444 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 82.5 mtp180 -65.39 -26.32 67.94 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.738 -177.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -68.71 -43.06 76.79 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.748 177.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -71.98 -37.27 69.91 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 -178.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.416 ' O ' HG12 ' A' ' 117' ' ' VAL . 24.0 t70 -55.73 -51.96 65.53 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 121.917 0.865 . . . . 0.0 109.409 172.819 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 35.2 ttt180 -56.16 -37.1 69.07 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 114.347 -1.297 . . . . 0.0 110.676 174.004 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -61.69 -52.57 49.88 Favored Glycine 0 C--N 1.332 0.315 0 CA-C-N 115.853 -0.612 . . . . 0.0 112.446 178.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.465 HG11 ' HD2' ' A' ' 83' ' ' TYR . 11.3 p -67.09 -28.72 43.71 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.151 0 CA-C-O 121.001 0.429 . . . . 0.0 109.961 179.233 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.418 HH11 ' HD3' ' A' ' 118' ' ' ARG . 0.0 OUTLIER -58.88 -55.33 36.55 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 176.932 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 59.8 tttm -66.68 -35.29 79.79 Favored 'General case' 0 C--O 1.227 -0.095 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.315 179.356 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -56.6 -58.26 8.84 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 121.132 0.492 . . . . 0.0 110.539 178.441 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.503 HD11 HD13 ' A' ' 81' ' ' LEU . 47.5 mm -63.2 -29.67 47.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.2 178.516 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.824 ' HA ' ' HA ' ' A' ' 126' ' ' GLU . 42.3 tt0 -64.37 -46.31 83.95 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.42 176.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -63.19 -34.23 77.18 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 121.197 0.522 . . . . 0.0 109.643 177.628 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.58 HD21 ' HG3' ' A' ' 79' ' ' LYS . 63.0 tp -64.63 -63.52 1.11 Allowed 'General case' 0 C--O 1.235 0.332 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.047 177.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.501 ' O ' HG12 ' A' ' 125' ' ' ILE . 12.3 tt -163.5 26.14 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.722 0 CA-C-O 121.128 0.489 . . . . 0.0 110.924 -175.789 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.824 ' HA ' ' HA ' ' A' ' 122' ' ' GLU . 35.4 tt0 . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.413 -0.803 . . . . 0.0 111.151 -178.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.731 0 N-CA-C 111.858 -0.497 . . . . 0.0 111.858 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.3 m -72.28 76.27 1.0 Allowed 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 120.909 0.385 . . . . 0.0 110.259 178.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 26.3 ptm -127.09 25.46 6.22 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.145 -176.065 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 32.1 p -87.6 17.8 4.39 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-O 120.852 0.358 . . . . 0.0 110.973 179.628 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 30.3 mm-40 -55.4 146.6 19.28 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.949 177.597 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 30.2 mm-40 -61.71 146.78 48.19 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 173.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.0 p -151.86 160.05 43.66 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 121.102 0.477 . . . . 0.0 112.0 -169.09 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.433 ' NE2' HG21 ' A' ' 71' ' ' VAL . 84.5 t60 -176.48 -54.07 0.0 OUTLIER Pre-proline 0 CA--C 1.534 0.351 0 CA-C-N 114.666 -1.152 . . . . 0.0 108.468 177.797 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -71.91 -43.12 1.32 Allowed 'Trans proline' 0 C--N 1.36 1.141 0 C-N-CA 121.65 1.567 . . . . 0.0 110.577 168.642 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -85.68 62.61 7.57 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 121.723 0.773 . . . . 0.0 108.972 173.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.721 ' HB2' ' HE1' ' A' ' 14' ' ' TYR . 20.9 p-10 -81.76 65.18 6.78 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.038 -0.983 . . . . 0.0 111.683 -173.337 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -106.77 -0.61 23.34 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.686 173.351 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 20.2 m -73.2 5.54 3.44 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.633 175.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.721 ' HE1' ' HB2' ' A' ' 11' ' ' ASP . 3.3 m-85 -53.53 135.5 39.98 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.668 176.213 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.756 HD13 ' HB2' ' A' ' 47' ' ' LYS . 38.6 pt -91.84 -27.94 4.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 170.805 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.559 HG23 HG13 ' A' ' 15' ' ' ILE . 67.1 t -137.4 137.92 45.49 Favored 'Isoleucine or valine' 0 C--O 1.232 0.142 0 CA-C-N 114.965 -1.016 . . . . 0.0 108.994 177.682 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 32.2 ptt180 -147.22 134.37 20.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.835 0.35 . . . . 0.0 110.289 178.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 29.1 m -133.67 174.31 13.36 Favored 'Isoleucine or valine' 0 C--O 1.237 0.415 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.523 -177.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -129.84 121.16 26.19 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 179.207 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -169.84 -174.27 1.78 Allowed 'General case' 0 C--O 1.232 0.182 0 CA-C-O 120.776 0.322 . . . . 0.0 111.249 -176.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.449 ' HB ' ' HB ' ' A' ' 103' ' ' THR . 87.6 t -92.25 142.49 13.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.022 178.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.442 HG11 HG21 ' A' ' 43' ' ' VAL . 27.4 m -117.42 134.23 61.69 Favored 'Isoleucine or valine' 0 C--O 1.237 0.411 0 CA-C-O 121.308 0.575 . . . . 0.0 111.476 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . 0.626 ' SD ' ' HG3' ' A' ' 34' ' ' PRO . 24.7 mmt -119.04 169.52 9.83 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.058 -0.974 . . . . 0.0 109.052 178.385 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 8.9 t -153.64 157.25 39.35 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 174.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 41.1 ttp180 -128.41 111.17 13.03 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 178.434 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.613 ' H ' ' HE1' ' A' ' 33' ' ' PHE . 38.1 t70 -61.52 97.93 0.08 Allowed 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 179.17 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.543 ' HB3' ' NH1' ' A' ' 98' ' ' ARG . 1.6 p30 46.59 -75.99 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.293 1.037 . . . . 0.0 111.994 -169.208 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.447 ' N ' ' O ' ' A' ' 26' ' ' ASP . 69.3 m -141.13 152.04 44.4 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 110.092 -0.336 . . . . 0.0 110.092 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 21.1 m 67.16 167.8 0.24 Allowed 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.435 -179.147 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 115.07 -6.44 21.72 Favored Glycine 0 N--CA 1.453 -0.212 0 N-CA-C 111.684 -0.566 . . . . 0.0 111.684 -177.197 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 59.07 27.05 61.91 Favored Glycine 0 C--N 1.334 0.432 0 C-N-CA 121.653 -0.308 . . . . 0.0 112.986 179.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . 0.569 ' CH2' ' HB3' ' A' ' 99' ' ' LYS . 89.2 m95 57.91 98.12 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 121.439 0.638 . . . . 0.0 110.873 -176.516 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.613 ' HE1' ' H ' ' A' ' 26' ' ' ASP . 40.1 p90 -103.16 138.22 19.48 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.906 -175.183 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.626 ' HG3' ' SD ' ' A' ' 23' ' ' MET . 5.1 Cg_exo -79.23 115.43 3.48 Favored 'Trans proline' 0 N--CA 1.457 -0.665 0 C-N-CA 122.452 2.101 . . . . 0.0 110.865 172.593 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -65.88 -162.71 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.836 176.04 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -46.54 -39.14 10.41 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 112.724 0.638 . . . . 0.0 112.724 -176.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -72.63 -115.29 0.06 OUTLIER Glycine 0 CA--C 1.519 0.285 0 N-CA-C 111.591 -0.604 . . . . 0.0 111.591 176.347 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.44 ' O ' HG13 ' A' ' 21' ' ' VAL . . . 82.45 -67.09 3.77 Favored Glycine 0 C--N 1.329 0.193 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.104 174.455 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -66.81 80.22 0.13 Allowed Glycine 0 CA--C 1.519 0.291 0 C-N-CA 121.507 -0.378 . . . . 0.0 112.601 -178.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.448 ' O ' ' HG2' ' A' ' 66' ' ' GLN . 50.8 mm 63.64 82.15 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 CA-C-O 121.556 0.693 . . . . 0.0 111.155 178.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 49.1 m -99.98 148.33 24.63 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.114 178.201 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.428 HH21 ' CD ' ' A' ' 64' ' ' GLU . 7.4 tmm_? -98.83 99.89 11.02 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 -177.718 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.442 HG21 HG11 ' A' ' 22' ' ' VAL . 50.2 t -120.93 155.16 24.5 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.931 -171.22 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -173.3 -163.5 27.06 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 121.143 -0.551 . . . . 0.0 112.239 176.413 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 61.6 t -130.34 139.73 50.63 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 CA-C-O 120.868 0.366 . . . . 0.0 110.79 -177.119 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 47.2 t -119.96 131.78 55.3 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 173.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.756 ' HB2' HD13 ' A' ' 15' ' ' ILE . 84.9 tttt -83.39 118.72 23.91 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.795 0.331 . . . . 0.0 111.021 -174.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 49.1 t -78.85 126.37 38.81 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.227 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 16.0 mmt -84.13 115.91 22.63 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.085 -177.272 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 53.1 m170 -102.36 117.53 60.88 Favored Pre-proline 0 C--N 1.327 -0.382 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 176.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_exo -64.39 91.9 0.18 Allowed 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 122.711 2.274 . . . . 0.0 112.087 -178.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 63.01 -177.12 0.15 Allowed 'General case' 0 C--O 1.238 0.458 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.323 177.25 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 98.61 155.52 29.25 Favored Glycine 0 C--O 1.236 0.243 0 CA-C-N 116.072 -0.513 . . . . 0.0 112.428 178.21 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -83.76 2.1 39.61 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.82 0.343 . . . . 0.0 110.543 -179.417 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -72.6 -4.36 61.04 Favored Glycine 0 C--N 1.334 0.433 0 CA-C-N 116.041 -0.527 . . . . 0.0 112.909 179.36 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.598 ' HG3' ' H ' ' A' ' 57' ' ' SER . 11.0 tpt85 68.1 -167.42 0.19 Allowed 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 122.577 0.351 . . . . 0.0 110.15 175.801 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.598 ' H ' ' HG3' ' A' ' 56' ' ' ARG . 16.5 m -105.14 148.29 27.03 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.527 0.203 . . . . 0.0 110.559 -178.4 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -95.52 173.42 31.09 Favored Glycine 0 C--N 1.332 0.355 0 C-N-CA 121.194 -0.527 . . . . 0.0 112.011 -179.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -140.18 117.55 11.38 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.986 0.422 . . . . 0.0 110.877 -179.04 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.548 ' HG ' ' HD1' ' A' ' 76' ' ' TYR . 0.5 OUTLIER -87.31 102.85 14.9 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 175.29 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.78 ' HB ' ' HB3' ' A' ' 75' ' ' CYS . 63.5 mt -76.89 116.16 19.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 172.195 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 5.6 t-80 -127.55 141.44 51.64 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 -172.264 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -136.66 115.02 1.22 Allowed Glycine 0 C--N 1.333 0.383 0 C-N-CA 120.914 -0.66 . . . . 0.0 113.335 -174.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.428 ' CD ' HH21 ' A' ' 42' ' ' ARG . 41.7 tt0 -81.02 144.14 32.0 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 122.81 0.444 . . . . 0.0 110.606 178.352 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.486 ' HG2' HG11 ' A' ' 72' ' ' VAL . 0.2 OUTLIER -51.59 -56.07 15.6 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 115.682 -0.69 . . . . 0.0 112.208 -173.875 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.448 ' HG2' ' O ' ' A' ' 40' ' ' ILE . 0.0 OUTLIER -172.52 -77.15 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 -175.526 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 57.6 tttp -117.24 -46.15 2.71 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.39 178.076 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -69.16 132.1 46.01 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.101 174.13 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 23.5 mtpp -74.23 97.12 2.9 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.486 -177.56 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 51.0 tp -146.56 135.56 22.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.936 -179.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.433 HG21 ' NE2' ' A' ' 8' ' ' HIS . 26.8 t -81.44 95.18 2.75 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.937 -176.73 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.486 HG11 ' HG2' ' A' ' 65' ' ' ARG . 15.8 m -93.24 -37.72 8.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.058 179.362 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -125.06 143.03 51.12 Favored 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 109.819 -0.438 . . . . 0.0 109.819 176.188 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -159.82 165.12 32.96 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.301 173.154 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . 0.78 ' HB3' ' HB ' ' A' ' 61' ' ' ILE . 31.6 t -164.76 103.21 0.8 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.74 -0.663 . . . . 0.0 109.659 -177.153 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.548 ' HD1' ' HG ' ' A' ' 60' ' ' LEU . 57.0 t80 -81.99 99.79 9.32 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.017 -179.142 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.485 HG13 ' O ' ' A' ' 80' ' ' ASP . 95.6 t -90.74 98.16 8.03 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 N-CA-C 109.049 -0.722 . . . . 0.0 109.049 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 16.9 tpt180 -75.37 -42.82 53.16 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 -178.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.616 ' HA ' HD11 ' A' ' 124' ' ' LEU . 24.1 ttpp -173.61 29.75 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.226 174.419 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.485 ' O ' HG13 ' A' ' 77' ' ' VAL . 23.1 t70 -144.22 129.69 18.97 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 178.249 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.6 HD21 ' CD1' ' A' ' 83' ' ' TYR . 8.4 tt -156.09 128.39 7.62 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 -173.413 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 61.6 t -132.64 101.27 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.255 -179.248 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.6 ' CD1' HD21 ' A' ' 81' ' ' LEU . 8.1 m-85 -96.34 156.65 16.25 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.023 0.439 . . . . 0.0 110.416 172.531 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 86.0 m -157.82 135.85 10.82 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 176.204 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.458 ' HB3' ' CG ' ' A' ' 91' ' ' HIS . 19.1 ptmt -128.81 141.51 51.28 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.218 0.532 . . . . 0.0 111.397 -179.286 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -100.46 -39.31 8.01 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.581 177.556 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -126.62 151.31 72.97 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 115.415 -0.811 . . . . 0.0 108.919 178.244 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -46.0 -36.81 16.54 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 122.503 2.135 . . . . 0.0 112.173 178.079 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 17.9 p -83.91 -42.01 16.78 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 115.573 -0.739 . . . . 0.0 111.48 178.071 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 68.1 t80 -85.43 92.11 8.4 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-O 120.947 0.403 . . . . 0.0 110.359 -177.615 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . 0.543 ' NE2' ' HB3' ' A' ' 83' ' ' TYR . 4.7 t-160 -121.79 118.75 29.78 Favored 'General case' 0 N--CA 1.462 0.17 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 176.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 25.4 p80 -120.03 175.47 5.9 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.654 0.264 . . . . 0.0 110.482 -177.008 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . 0.485 ' HZ3' ' HB2' ' A' ' 102' ' ' LEU . 36.5 p90 -146.36 155.1 42.37 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.02 175.578 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 28.9 ttpt -120.28 122.34 40.65 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.784 -179.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.516 ' O ' ' N ' ' A' ' 97' ' ' ASN . 28.5 m -93.09 142.78 12.68 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 N-CA-C 106.294 -1.743 . . . . 0.0 106.294 160.689 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -60.35 77.66 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.066 0.46 . . . . 0.0 110.692 -177.026 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.566 ' O ' ' HD2' ' A' ' 98' ' ' ARG . 0.2 OUTLIER 169.82 -51.52 0.01 OUTLIER 'General case' 0 C--O 1.234 0.28 0 CA-C-N 115.085 -0.961 . . . . 0.0 109.856 -176.059 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.566 ' HD2' ' O ' ' A' ' 97' ' ' ASN . 0.6 OUTLIER -141.81 155.39 45.58 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.929 -175.304 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.569 ' HB3' ' CH2' ' A' ' 32' ' ' TRP . 89.2 mttt -112.88 116.3 29.81 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.047 173.629 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 27.2 m-85 -103.24 135.46 44.84 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 178.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -112.31 146.37 18.13 Favored Glycine 0 N--CA 1.453 -0.218 0 C-N-CA 121.155 -0.545 . . . . 0.0 112.83 -176.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.485 ' HB2' ' HZ3' ' A' ' 93' ' ' TRP . 2.8 tt -124.71 116.68 22.73 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 176.674 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.449 ' HB ' ' HB ' ' A' ' 21' ' ' VAL . 35.1 m -104.83 103.07 12.6 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.162 178.337 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.402 ' HB3' ' OD2' ' A' ' 109' ' ' ASP . 74.2 m-85 -65.37 163.28 15.93 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.22 -178.551 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 18.9 pt20 -102.56 -26.59 13.17 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.301 -176.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 19.4 m -147.41 150.17 36.61 Favored Pre-proline 0 CA--C 1.534 0.354 0 CA-C-O 120.439 0.162 . . . . 0.0 110.723 179.374 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -51.56 -27.46 25.41 Favored 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 122.97 2.447 . . . . 0.0 112.732 177.435 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -61.04 -63.0 1.44 Allowed 'General case' 0 C--O 1.237 0.436 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.001 178.718 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.402 ' OD2' ' HB3' ' A' ' 104' ' ' PHE . 1.5 p-10 -64.4 -34.67 78.71 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.86 179.845 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -57.99 -60.74 3.26 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.056 0.455 . . . . 0.0 110.822 176.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 61.5 ttt180 -61.22 -36.65 80.51 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.507 -176.615 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -62.63 -45.18 94.05 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-N 115.58 -0.737 . . . . 0.0 110.61 178.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 38.9 t80 -76.27 -26.38 55.89 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.469 -178.718 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 46.6 m-20 -59.67 -56.01 27.29 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 173.619 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 90.5 mtt180 -64.62 -27.66 69.09 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.154 174.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.477 ' HA2' ' NZ ' ' A' ' 119' ' ' LYS . . . -59.7 -58.8 12.38 Favored Glycine 0 N--CA 1.45 -0.417 0 CA-C-N 115.834 -0.621 . . . . 0.0 112.065 176.589 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.497 ' O ' HG13 ' A' ' 121' ' ' ILE . 9.0 p -65.66 -33.92 66.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 110.404 -0.221 . . . . 0.0 110.404 -179.302 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 43.6 ttm180 -59.78 -54.06 50.66 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.619 -0.264 . . . . 0.0 110.605 177.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.477 ' NZ ' ' HA2' ' A' ' 116' ' ' GLY . 25.0 pttm -69.33 -24.11 63.87 Favored 'General case' 0 CA--C 1.528 0.128 0 CA-C-O 120.841 0.353 . . . . 0.0 110.261 -179.739 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -67.2 -43.4 82.18 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.119 174.24 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.497 HG13 ' O ' ' A' ' 117' ' ' VAL . 79.7 mt -62.63 -41.63 92.94 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.168 0 CA-C-N 116.314 -0.403 . . . . 0.0 109.916 177.018 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -58.4 -43.83 88.73 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.132 174.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 40.7 t0 -75.51 -19.82 59.12 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.539 -177.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.616 HD11 ' HA ' ' A' ' 79' ' ' LYS . 55.2 tp -88.35 -39.1 14.59 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.647 -178.779 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 61.1 mt -112.23 -39.84 3.49 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 N-CA-C 111.801 0.297 . . . . 0.0 111.801 -172.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.323 -0.846 . . . . 0.0 110.226 -174.714 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.656 0 N-CA-C 111.812 -0.515 . . . . 0.0 111.812 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 42.7 t -141.96 170.05 16.43 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 179.442 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 23.8 ptm -144.73 115.25 7.65 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.103 -0.499 . . . . 0.0 109.68 178.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 25.7 m -67.47 133.54 49.7 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.954 -177.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -60.95 167.42 2.89 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.374 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -60.82 178.3 0.24 Allowed 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 120.951 0.405 . . . . 0.0 111.753 -179.129 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.471 ' O ' ' HB3' ' A' ' 8' ' ' HIS . 62.7 p 59.86 -172.25 0.12 Allowed 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 123.944 0.898 . . . . 0.0 112.206 178.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.471 ' HB3' ' O ' ' A' ' 7' ' ' THR . 20.9 t-80 105.75 -69.56 0.0 OUTLIER Pre-proline 0 N--CA 1.482 1.14 0 C-N-CA 125.813 1.645 . . . . 0.0 112.005 -177.2 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.516 ' HA ' ' HG2' ' A' ' 69' ' ' LYS . 26.5 Cg_endo -60.41 -29.56 89.0 Favored 'Trans proline' 0 C--N 1.365 1.412 0 C-N-CA 121.402 1.402 . . . . 0.0 111.615 -177.376 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -79.04 -32.69 45.04 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.425 176.464 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.433 ' HA ' ' HE2' ' A' ' 14' ' ' TYR . 11.0 t70 53.87 93.92 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.361 -178.823 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -140.3 -66.85 0.44 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.816 178.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 16.8 m -79.29 90.89 4.97 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.925 -176.389 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.482 ' HA ' ' HB3' ' A' ' 46' ' ' CYS . 67.5 m-85 -141.85 153.28 44.35 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.704 175.742 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.483 HG22 HG23 ' A' ' 16' ' ' VAL . 52.2 mt -108.35 -63.67 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.714 0.292 . . . . 0.0 110.371 178.106 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.483 HG23 HG22 ' A' ' 15' ' ' ILE . 60.0 t -114.94 113.08 42.6 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.517 -178.604 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 36.8 mtp180 -110.47 99.41 8.41 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.671 175.005 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 16.8 m -128.8 162.27 36.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.759 0.314 . . . . 0.0 110.769 -179.175 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.493 ' HE2' ' HA ' ' A' ' 40' ' ' ILE . 46.3 tttm -97.19 137.74 35.76 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.918 -176.792 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -159.04 -175.74 5.45 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-N 115.958 -0.564 . . . . 0.0 109.768 177.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.42 HG22 ' HA2' ' A' ' 39' ' ' GLY . 38.4 t -107.72 100.78 11.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.583 -0.281 . . . . 0.0 110.476 177.452 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.628 HG23 ' NE2' ' A' ' 35' ' ' GLN . 13.6 m -65.39 127.12 25.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.611 177.511 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 19.6 mmt -122.9 149.74 43.83 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.206 -175.131 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.443 HG23 ' CE1' ' A' ' 33' ' ' PHE . 12.7 t -122.31 171.75 8.81 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.051 175.373 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.531 ' HG3' ' H ' ' A' ' 27' ' ' ASP . 14.4 tpt180 -120.1 144.28 47.7 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.656 -178.367 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -79.93 11.91 3.04 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.862 179.64 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.531 ' H ' ' HG3' ' A' ' 25' ' ' ARG . 19.2 t70 63.85 156.73 0.07 Allowed 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.857 -173.779 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 47.8 t 56.58 -116.28 0.97 Allowed 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 -173.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 50.8 m -155.3 100.76 2.17 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 118.056 0.389 . . . . 0.0 111.525 177.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -131.35 -35.22 0.38 Allowed Glycine 0 C--N 1.329 0.183 0 N-CA-C 111.33 -0.708 . . . . 0.0 111.33 171.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.427 ' H ' ' NH1' ' A' ' 25' ' ' ARG . . . 153.72 132.01 1.64 Allowed Glycine 0 CA--C 1.519 0.315 0 N-CA-C 112.117 -0.393 . . . . 0.0 112.117 176.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . 0.411 ' HZ3' ' HA ' ' A' ' 100' ' ' PHE . 69.1 m95 -67.88 138.18 55.84 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 176.689 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.443 ' CE1' HG23 ' A' ' 24' ' ' THR . 4.6 p90 -145.62 152.55 49.38 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 116.85 -0.159 . . . . 0.0 110.737 -175.375 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -82.67 117.15 2.64 Favored 'Trans proline' 0 N--CA 1.461 -0.424 0 C-N-CA 122.446 2.097 . . . . 0.0 112.042 176.182 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.628 ' NE2' HG23 ' A' ' 22' ' ' VAL . 4.3 pm0 -53.32 -38.7 63.42 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.315 176.397 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -161.96 160.22 27.48 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.069 178.242 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 76.51 -72.53 1.95 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 121.361 -0.447 . . . . 0.0 111.992 178.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 69.43 29.6 71.61 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 121.143 -0.551 . . . . 0.0 112.692 179.282 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.42 ' HA2' HG22 ' A' ' 21' ' ' VAL . . . -177.28 -72.09 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.216 179.629 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.546 ' N ' HD12 ' A' ' 40' ' ' ILE . 3.0 mp -92.11 103.72 14.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.694 0.283 . . . . 0.0 110.618 -176.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.589 ' HA ' ' O ' ' A' ' 65' ' ' ARG . 30.0 m -146.62 127.41 14.38 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.236 -0.438 . . . . 0.0 109.821 172.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.459 ' O ' ' HG3' ' A' ' 42' ' ' ARG . 14.1 ptt180 -92.01 116.67 29.12 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 121.201 0.524 . . . . 0.0 110.092 179.424 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 40.4 t -95.29 128.92 46.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.626 178.417 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -123.25 108.99 1.27 Allowed Glycine 0 N--CA 1.448 -0.562 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.774 -178.402 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 7.6 p -92.14 130.98 40.45 Favored 'Isoleucine or valine' 0 C--O 1.238 0.496 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 175.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . 0.69 ' SG ' ' HB3' ' A' ' 60' ' ' LEU . 15.3 p -131.97 130.18 41.15 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.839 -178.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -92.35 86.54 5.73 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 175.324 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 30.8 m -80.25 159.5 4.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.399 -178.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 25.2 ptm -150.68 156.58 41.61 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.778 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . 0.44 ' NE2' ' HD2' ' A' ' 56' ' ' ARG . 11.3 m-70 -84.29 140.38 39.22 Favored Pre-proline 0 C--N 1.322 -0.612 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 176.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 8.6 Cg_exo -73.14 33.65 0.32 Allowed 'Trans proline' 0 CA--C 1.536 0.61 0 C-N-CA 123.089 2.526 . . . . 0.0 112.531 -179.159 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -109.58 166.25 11.04 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 179.264 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -63.55 -25.54 68.87 Favored Glycine 0 C--N 1.331 0.256 0 N-CA-C 111.295 -0.722 . . . . 0.0 111.295 174.656 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 -59.58 -31.58 69.57 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 115.306 -0.447 . . . . 0.0 110.853 176.586 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 73.43 -79.11 0.81 Allowed Glycine 0 C--N 1.332 0.357 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.817 -176.111 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.44 ' HD2' ' NE2' ' A' ' 50' ' ' HIS . 1.2 tmt_? 57.58 90.13 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 123.037 0.535 . . . . 0.0 110.49 -179.493 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 42.8 p -77.96 143.88 37.24 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.489 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -145.25 135.76 6.17 Favored Glycine 0 N--CA 1.451 -0.331 0 N-CA-C 111.006 -0.838 . . . . 0.0 111.006 175.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.551 ' HB2' ' HB ' ' A' ' 77' ' ' VAL . 83.8 m-85 -107.02 98.41 8.07 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 117.015 0.408 . . . . 0.0 110.353 -177.059 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.718 HD22 ' HB2' ' A' ' 62' ' ' HIS . 0.9 OUTLIER -78.35 106.04 10.01 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 179.633 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.528 HG12 HG23 ' A' ' 77' ' ' VAL . 50.8 mm -84.25 96.26 4.38 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 173.781 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . 0.718 ' HB2' HD22 ' A' ' 60' ' ' LEU . 21.0 t-80 -119.21 150.87 39.35 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.313 -175.618 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -141.83 123.93 2.35 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 121.297 -0.478 . . . . 0.0 112.099 -178.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -99.37 149.89 22.71 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 177.521 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.589 ' O ' ' HA ' ' A' ' 41' ' ' SER . 3.1 tmm_? -58.24 -73.22 0.08 Allowed 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 109.09 -0.708 . . . . 0.0 109.09 176.012 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.507 ' HB2' ' O ' ' A' ' 65' ' ' ARG . 6.6 tp-100 169.38 132.3 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 123.111 0.564 . . . . 0.0 109.564 175.591 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt 68.04 -67.98 0.18 Allowed 'General case' 0 N--CA 1.465 0.302 0 O-C-N 123.794 0.684 . . . . 0.0 110.842 -179.51 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -74.21 128.47 35.61 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 110.109 -0.33 . . . . 0.0 110.109 177.187 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.516 ' HG2' ' HA ' ' A' ' 9' ' ' PRO . 12.5 mptt -67.2 78.21 0.14 Allowed 'General case' 0 C--O 1.236 0.385 0 CA-C-O 121.061 0.458 . . . . 0.0 110.42 -179.535 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 58.0 tp -116.37 116.84 28.44 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.113 -179.051 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 48.8 t -72.59 101.5 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.414 -179.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 27.3 m -96.84 -14.43 7.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.782 177.609 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.462 HD23 ' N ' ' A' ' 74' ' ' GLU . 2.2 tt -157.43 130.41 7.63 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 177.664 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.462 ' N ' HD23 ' A' ' 73' ' ' LEU . 4.1 tm-20 -145.59 127.02 14.98 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 177.675 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . 0.428 ' HB2' ' HE2' ' A' ' 100' ' ' PHE . 48.5 t -160.72 91.03 0.88 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.463 0.649 . . . . 0.0 109.856 177.468 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.495 ' HD1' ' HG ' ' A' ' 60' ' ' LEU . 82.3 t80 -67.4 118.32 10.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.454 -0.793 . . . . 0.0 110.79 179.638 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.794 HG22 HD13 ' A' ' 81' ' ' LEU . 62.0 t -77.34 94.5 1.35 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.356 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 176.111 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.426 ' HG3' ' HB3' ' A' ' 80' ' ' ASP . 15.1 ptt180 -78.83 35.76 0.25 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.717 179.052 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.695 ' HA ' HD11 ' A' ' 124' ' ' LEU . 59.5 mttp 67.91 13.64 9.21 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 123.16 0.584 . . . . 0.0 110.721 -169.027 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.426 ' HB3' ' HG3' ' A' ' 78' ' ' ARG . 15.0 t70 -135.19 96.73 3.55 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 115.989 -0.55 . . . . 0.0 109.898 178.177 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.794 HD13 HG22 ' A' ' 77' ' ' VAL . 7.1 tt -177.89 137.6 0.19 Allowed 'General case' 0 C--O 1.233 0.212 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 179.697 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.526 ' N ' HD23 ' A' ' 81' ' ' LEU . 40.6 t -126.19 122.52 61.71 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 CA-C-O 120.507 0.194 . . . . 0.0 111.075 -176.482 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.46 ' CG ' HG21 ' A' ' 117' ' ' VAL . 7.4 m-85 -84.52 172.8 11.34 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-O 121.284 0.564 . . . . 0.0 111.231 176.738 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 87.0 m -153.99 101.82 2.45 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.89 177.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -79.85 93.53 5.66 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 174.604 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -83.9 -59.22 2.48 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.536 -175.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . 0.468 ' HB2' ' HB3' ' A' ' 90' ' ' PHE . 10.5 m120 -113.11 155.44 44.33 Favored Pre-proline 0 C--N 1.327 -0.385 0 N-CA-C 109.171 -0.678 . . . . 0.0 109.171 -179.196 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_exo -53.59 -19.18 13.31 Favored 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 122.658 2.238 . . . . 0.0 113.034 -179.644 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.44 ' HA ' ' HD2' ' A' ' 104' ' ' PHE . 15.3 t -121.05 -1.31 9.84 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 120.836 0.35 . . . . 0.0 111.448 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.468 ' HB3' ' HB2' ' A' ' 87' ' ' ASN . 78.0 t80 -120.84 114.67 21.94 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-O 121.007 0.432 . . . . 0.0 110.544 -176.254 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 2.0 t-160 -133.0 112.91 12.23 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 -176.066 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . 0.601 ' HA ' ' HA3' ' A' ' 101' ' ' GLY . 11.6 p80 -125.73 -178.42 4.26 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 -178.461 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . 0.405 ' CZ3' ' HA2' ' A' ' 101' ' ' GLY . 49.4 p90 -146.02 164.83 30.86 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.201 173.468 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 14.4 tmtt? -146.32 130.14 17.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.222 -177.097 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 30.8 m -136.49 147.11 27.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.738 -0.665 . . . . 0.0 109.388 176.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 18.7 t70 59.93 -89.86 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.447 0 O-C-N 123.235 0.334 . . . . 0.0 110.414 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 59.1 t30 -148.21 10.62 0.89 Allowed 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 121.685 0.755 . . . . 0.0 109.415 175.111 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 73.3 mtp180 -109.49 131.87 54.66 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.296 -176.283 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.546 ' HD3' ' N ' ' A' ' 99' ' ' LYS . 0.0 OUTLIER -127.66 127.54 43.93 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.567 -178.062 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.428 ' HE2' ' HB2' ' A' ' 75' ' ' CYS . 4.9 p90 -156.01 164.06 38.93 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.527 -0.761 . . . . 0.0 109.004 177.295 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.601 ' HA3' ' HA ' ' A' ' 92' ' ' HIS . . . -173.94 -135.35 2.01 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.401 -0.904 . . . . 0.0 112.703 -175.611 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 2.2 pp -159.69 175.28 13.36 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 121.339 0.59 . . . . 0.0 111.746 -178.195 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 91.2 m -130.02 140.49 50.87 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.114 176.249 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.44 ' HD2' ' HA ' ' A' ' 89' ' ' THR . 23.7 m-85 -83.18 166.38 18.67 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.324 0.583 . . . . 0.0 111.389 -174.407 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 21.6 tt0 -123.19 -57.31 1.69 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.822 175.34 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 18.8 m -118.66 149.46 46.38 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.345 -176.023 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -53.2 -20.77 15.26 Favored 'Trans proline' 0 C--N 1.352 0.744 0 C-N-CA 122.587 2.191 . . . . 0.0 112.476 179.016 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -62.37 -66.6 0.52 Allowed 'General case' 0 C--O 1.235 0.329 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.523 175.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -63.19 -39.23 94.06 Favored 'General case' 0 C--O 1.231 0.101 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.764 -179.604 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.427 ' HA ' ' CD1' ' A' ' 104' ' ' PHE . . . -52.61 -58.99 5.04 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-O 121.387 0.613 . . . . 0.0 111.174 177.008 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 69.7 ttt180 -66.59 -29.26 69.27 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.466 -178.141 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -64.95 -48.34 74.4 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.194 179.685 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.403 ' O ' HG12 ' A' ' 117' ' ' VAL . 58.4 m-85 -67.27 -46.8 72.57 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 116.698 -0.228 . . . . 0.0 110.577 179.072 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -53.18 -64.99 0.64 Allowed 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 121.235 0.54 . . . . 0.0 110.773 178.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . 0.402 ' O ' ' HB2' ' A' ' 119' ' ' LYS . 41.8 ttm180 -57.3 -38.16 73.57 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 114.938 -1.028 . . . . 0.0 110.799 177.809 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -56.76 -58.2 15.67 Favored Glycine 0 C--N 1.331 0.252 0 CA-C-N 115.955 -0.566 . . . . 0.0 112.484 -177.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.46 HG21 ' CG ' ' A' ' 83' ' ' TYR . 7.6 p -69.03 -36.88 75.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.532 0.206 . . . . 0.0 110.803 -178.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 25.1 ttt180 -60.72 -42.77 97.92 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.738 -0.468 . . . . 0.0 109.738 -179.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.402 ' HB2' ' O ' ' A' ' 115' ' ' ARG . 7.4 mmtt -74.96 -30.05 61.1 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.659 178.508 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -62.71 -47.92 81.51 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 176.387 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 72.2 mt -66.32 -40.57 87.11 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.037 177.128 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -55.74 -48.31 75.47 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.397 178.64 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -74.94 -35.18 62.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.037 -178.408 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.695 HD11 ' HA ' ' A' ' 79' ' ' LYS . 6.3 tt -62.02 -50.23 72.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.28 -178.164 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 60.8 mt -83.12 -40.32 16.17 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.865 -177.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 . . . . . 0 C--O 1.251 1.142 0 CA-C-O 118.311 -0.852 . . . . 0.0 110.544 -177.281 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.747 0 N-CA-C 112.068 -0.413 . . . . 0.0 112.068 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 22.6 p -91.14 51.7 1.99 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.593 0.235 . . . . 0.0 110.886 -178.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . 0.439 ' HB3' ' HG2' ' A' ' 5' ' ' GLU . 3.5 mpp? -54.96 -49.41 71.45 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.971 0.415 . . . . 0.0 109.986 178.251 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 3.5 m 56.38 38.14 29.45 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.665 176.537 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.439 ' HG2' ' HB3' ' A' ' 3' ' ' MET . 20.7 mm-40 -74.36 76.03 1.88 Allowed 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.641 -175.093 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -111.74 -63.33 1.43 Allowed 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 168.366 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.9 t 21.92 78.75 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.607 0 O-C-N 124.726 1.266 . . . . 0.0 113.691 171.21 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 64.4 t60 -73.03 149.13 89.58 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-N 115.661 -0.699 . . . . 0.0 109.857 178.842 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_exo -46.47 102.56 0.04 OUTLIER 'Trans proline' 0 C--N 1.355 0.886 0 C-N-CA 122.283 1.988 . . . . 0.0 111.462 172.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 63.33 68.29 0.62 Allowed 'General case' 0 C--O 1.233 0.205 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.48 -171.529 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -52.68 -31.2 36.12 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 114.828 -1.078 . . . . 0.0 111.848 -175.335 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -70.75 -1.38 11.31 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.082 -0.508 . . . . 0.0 112.348 -177.158 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 20.8 m -89.4 -3.22 58.52 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 111.8 0.296 . . . . 0.0 111.8 -174.624 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.436 ' HA ' ' HA ' ' A' ' 46' ' ' CYS . 35.8 m-85 -66.14 135.2 54.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.857 0.36 . . . . 0.0 111.878 -179.564 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 50.3 mm -92.36 -40.94 12.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 171.315 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 7.4 p -155.49 136.74 5.27 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 CA-C-N 115.179 -0.919 . . . . 0.0 109.974 178.356 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 22.4 ptt180 -149.52 114.29 5.35 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.818 0.342 . . . . 0.0 110.232 178.053 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 15.0 m -150.09 -170.82 0.17 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.325 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.057 -178.045 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.544 ' HG2' ' OE1' ' A' ' 105' ' ' GLN . 5.9 ttpm? -87.57 132.69 33.97 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.592 179.343 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.477 ' O ' ' HB2' ' A' ' 41' ' ' SER . . . -157.45 -178.22 7.18 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.178 -0.465 . . . . 0.0 109.846 176.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.588 ' HB ' ' HB ' ' A' ' 103' ' ' THR . 38.2 t -112.53 107.77 23.82 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 CA-C-N 116.647 -0.252 . . . . 0.0 110.841 -179.625 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 11.9 m -73.94 96.48 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 CA-C-O 121.368 0.604 . . . . 0.0 110.279 175.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 91.9 mmm -82.92 119.41 24.38 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.772 -176.486 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.46 HG23 ' CE1' ' A' ' 33' ' ' PHE . 10.0 t -93.9 171.16 9.04 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.055 176.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 14.4 ttp180 -133.46 21.47 3.98 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 178.483 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.426 ' HB3' ' CB ' ' A' ' 29' ' ' SER . 35.6 t70 50.68 36.81 14.98 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 114.778 -1.101 . . . . 0.0 110.536 179.748 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 34.1 t70 61.98 83.21 0.16 Allowed 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.542 -179.528 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 24.2 p 50.1 27.35 2.49 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 115.277 -0.874 . . . . 0.0 112.894 178.009 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.426 ' CB ' ' HB3' ' A' ' 26' ' ' ASP . 32.4 t -70.17 -36.16 74.5 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-O 120.653 0.263 . . . . 0.0 110.981 -178.891 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 150.79 -91.77 0.14 Allowed Glycine 0 C--N 1.332 0.351 0 C-N-CA 120.918 -0.658 . . . . 0.0 112.535 178.813 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -81.99 163.26 43.42 Favored Glycine 0 CA--C 1.518 0.279 0 C-N-CA 121.199 -0.524 . . . . 0.0 112.683 -178.775 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . 0.467 ' HH2' ' HB3' ' A' ' 99' ' ' LYS . 74.6 m95 -93.57 147.8 22.67 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-O 120.732 0.301 . . . . 0.0 110.803 -179.337 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.46 ' CE1' HG23 ' A' ' 24' ' ' THR . 6.8 p90 -156.34 150.34 19.58 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.896 176.827 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_exo -63.27 139.8 73.81 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.589 2.193 . . . . 0.0 111.893 176.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 22.1 pt20 -105.64 131.73 52.66 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.604 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 16.0 tp10 64.36 -73.06 0.06 Allowed 'General case' 0 CA--C 1.533 0.312 0 O-C-N 123.851 0.719 . . . . 0.0 111.063 -179.581 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.451 ' HA3' ' OE1' ' A' ' 66' ' ' GLN . . . -148.65 109.74 0.46 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 121.173 -0.536 . . . . 0.0 111.912 179.726 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.446 ' O ' HG22 ' A' ' 21' ' ' VAL . . . -89.88 5.29 83.42 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 121.393 -0.432 . . . . 0.0 112.539 -178.42 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -81.62 -41.34 9.95 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.945 -0.645 . . . . 0.0 111.802 178.27 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.523 HD12 ' HG3' ' A' ' 19' ' ' LYS . 3.7 tp -143.54 91.95 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 CA-C-O 121.426 0.632 . . . . 0.0 110.756 -179.753 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.477 ' HB2' ' O ' ' A' ' 20' ' ' ALA . 21.4 m -106.32 119.33 38.98 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 173.188 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.611 ' HB3' ' O ' ' A' ' 64' ' ' GLU . 8.2 tpt85 -77.24 90.3 3.72 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 121.453 0.644 . . . . 0.0 109.419 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 38.8 t -94.87 117.88 39.68 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 CA-C-N 115.241 -0.89 . . . . 0.0 110.345 -177.361 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -129.17 118.3 2.65 Favored Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 121.174 -0.536 . . . . 0.0 111.995 179.655 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 61.4 t -96.04 110.22 24.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 176.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . 0.483 ' SG ' ' HB3' ' A' ' 60' ' ' LEU . 12.3 p -107.96 147.42 31.08 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.583 -179.468 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 10.3 tmtt? -102.03 95.16 6.17 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 176.611 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.574 HG21 ' HE1' ' A' ' 76' ' ' TYR . 35.4 m -71.86 141.94 16.0 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.432 -173.859 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 22.2 mmt -95.89 178.77 5.32 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.403 179.391 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 1.8 p80 -126.81 118.49 22.49 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 120.518 0.199 . . . . 0.0 110.739 -178.628 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_exo -65.37 -39.23 23.14 Favored 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 122.452 2.102 . . . . 0.0 110.703 174.13 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -163.62 139.27 6.51 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 176.228 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 109.27 117.63 4.01 Favored Glycine 0 CA--C 1.517 0.179 0 N-CA-C 111.475 -0.65 . . . . 0.0 111.475 -176.089 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 27.1 p-10 -59.74 -39.2 83.97 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 111.914 0.338 . . . . 0.0 111.914 -174.767 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -96.99 18.83 56.85 Favored Glycine 0 CA--C 1.519 0.316 0 C-N-CA 121.224 -0.512 . . . . 0.0 113.442 -174.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 29.5 mmt180 -93.53 -9.8 37.0 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.942 0.371 . . . . 0.0 110.925 179.245 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 14.6 p -98.03 141.83 30.5 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.355 178.145 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 174.13 -145.67 8.25 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 121.058 -0.592 . . . . 0.0 111.945 -179.345 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.446 ' HB2' ' HB ' ' A' ' 77' ' ' VAL . 83.2 m-85 -117.15 161.42 19.47 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.483 ' HB3' ' SG ' ' A' ' 46' ' ' CYS . 2.0 tt -147.07 112.56 5.61 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 176.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.499 ' HB ' ' HB2' ' A' ' 75' ' ' CYS . 59.5 mt -84.78 103.69 12.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 174.206 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 12.5 t-80 -117.25 104.51 11.25 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.038 -169.722 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -100.6 121.83 7.38 Favored Glycine 0 C--N 1.333 0.415 0 N-CA-C 111.3 -0.72 . . . . 0.0 111.3 177.493 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.611 ' O ' ' HB3' ' A' ' 42' ' ' ARG . 16.1 pt-20 -150.3 -166.82 2.65 Favored 'General case' 0 C--O 1.24 0.588 0 CA-C-O 121.205 0.526 . . . . 0.0 112.37 -170.707 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.425 ' HB3' ' HB3' ' A' ' 42' ' ' ARG . 29.4 ttt180 74.68 -30.97 0.21 Allowed 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.974 1.31 . . . . 0.0 112.778 170.487 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.769 HE21 ' HA ' ' A' ' 66' ' ' GLN . 0.0 OUTLIER -59.09 131.69 51.8 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 110.232 -0.284 . . . . 0.0 110.232 177.697 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 85.2 tttt 66.07 76.4 0.31 Allowed 'General case' 0 C--O 1.235 0.332 0 O-C-N 123.7 0.625 . . . . 0.0 109.823 -178.553 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 69.65 -86.78 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.005 -0.998 . . . . 0.0 110.99 -176.397 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 28.9 tptp -175.48 98.47 0.07 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.012 0.434 . . . . 0.0 110.467 -176.806 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -157.89 166.95 31.33 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 172.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 6.2 t -99.13 109.31 24.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-O 120.797 0.332 . . . . 0.0 110.523 -176.698 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 33.9 m -94.48 -6.65 10.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.223 -177.41 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -148.51 117.29 6.67 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 -178.241 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -127.92 124.63 37.82 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.094 177.409 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . 0.543 ' SG ' ' CD2' ' A' ' 100' ' ' PHE . 24.6 m -145.96 89.15 1.86 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.407 176.915 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.574 ' HE1' HG21 ' A' ' 48' ' ' VAL . 87.1 t80 -71.9 136.75 47.02 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.554 -0.535 . . . . 0.0 109.554 173.478 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.446 ' HB ' ' HB2' ' A' ' 59' ' ' PHE . 58.3 t -125.31 96.0 3.5 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 CA-C-O 120.943 0.401 . . . . 0.0 110.372 -175.772 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 43.4 ttp180 -84.4 69.07 10.46 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.215 0.531 . . . . 0.0 110.023 179.422 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.541 ' HA ' ' HG ' ' A' ' 124' ' ' LEU . 8.2 mtpm? 52.92 21.13 1.88 Allowed 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 115.254 -0.885 . . . . 0.0 112.345 179.17 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -125.19 114.08 18.51 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 172.181 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.478 HD12 HG12 ' A' ' 121' ' ' ILE . 2.8 tm? -152.97 138.23 17.47 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.601 -170.114 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.474 ' HB ' ' HB3' ' A' ' 94' ' ' LYS . 48.6 t -132.45 88.92 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.8 173.618 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.495 ' HD1' ' HD2' ' A' ' 91' ' ' HIS . 0.3 OUTLIER -85.51 146.58 26.85 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 174.829 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.445 ' HB ' ' CE1' ' A' ' 92' ' ' HIS . 38.3 m -140.69 121.74 14.66 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 177.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.429 ' HE3' ' HA ' ' A' ' 88' ' ' PRO . 86.5 tttt -83.51 96.0 8.47 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 176.181 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -66.85 -42.63 85.38 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.167 0.508 . . . . 0.0 109.813 179.105 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . 0.679 ' HB2' ' HD2' ' A' ' 88' ' ' PRO . 9.8 p30 -161.41 164.27 18.67 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-N 115.145 -0.934 . . . . 0.0 108.835 177.442 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.679 ' HD2' ' HB2' ' A' ' 87' ' ' ASN . 9.6 Cg_endo -50.26 -22.55 8.52 Favored 'Trans proline' 0 C--N 1.352 0.75 0 C-N-CA 123.264 2.643 . . . . 0.0 114.091 -175.861 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 10.8 p -116.9 15.23 15.22 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 112.409 0.522 . . . . 0.0 112.409 -176.01 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.435 ' HB3' ' ND2' ' A' ' 87' ' ' ASN . 45.4 t80 -152.1 111.62 3.95 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-O 121.152 0.501 . . . . 0.0 111.383 178.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . 0.498 ' HD1' ' HE2' ' A' ' 104' ' ' PHE . 2.3 m80 -106.81 155.06 20.12 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 169.409 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . 0.445 ' CE1' ' HB ' ' A' ' 84' ' ' THR . 20.6 p80 -146.23 146.98 30.98 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 171.327 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . 0.559 ' CE2' ' HB2' ' A' ' 100' ' ' PHE . 28.4 p90 -123.52 146.21 48.27 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.173 0.511 . . . . 0.0 111.072 -178.778 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.474 ' HB3' ' HB ' ' A' ' 82' ' ' VAL . 3.0 tmtm? -110.25 101.18 9.95 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.051 -0.977 . . . . 0.0 108.83 -178.05 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 28.2 m -137.55 145.82 28.64 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 -179.609 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 27.9 t70 55.26 27.86 10.4 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 121.778 0.799 . . . . 0.0 109.978 -177.524 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.47 ' HA ' ' HE3' ' A' ' 94' ' ' LYS . 64.6 t30 74.88 -15.44 0.65 Allowed 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 114.66 -1.155 . . . . 0.0 111.633 -179.116 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 33.7 ttm180 -89.98 156.41 18.44 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.701 0.286 . . . . 0.0 110.462 -177.155 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.467 ' HB3' ' HH2' ' A' ' 32' ' ' TRP . 62.0 mtpt -116.14 133.53 55.92 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.219 -178.62 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.559 ' HB2' ' CE2' ' A' ' 93' ' ' TRP . 31.0 m-85 -128.81 139.51 52.14 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 175.577 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -110.8 163.56 12.28 Favored Glycine 0 N--CA 1.453 -0.183 0 C-N-CA 121.291 -0.48 . . . . 0.0 112.417 -178.315 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.418 ' HB2' ' HZ3' ' A' ' 93' ' ' TRP . 31.3 tp -146.91 112.8 5.74 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 110.145 -0.317 . . . . 0.0 110.145 -178.723 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.588 ' HB ' ' HB ' ' A' ' 21' ' ' VAL . 84.1 m -92.79 134.17 35.32 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 176.312 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.498 ' HE2' ' HD1' ' A' ' 91' ' ' HIS . 46.9 m-85 -90.97 137.98 31.95 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.243 -178.816 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.544 ' OE1' ' HG2' ' A' ' 19' ' ' LYS . 52.7 mt-30 -102.78 -26.39 13.17 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.637 -173.727 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 49.4 m -148.47 159.72 38.16 Favored Pre-proline 0 CA--C 1.536 0.409 0 CA-C-O 120.434 0.159 . . . . 0.0 110.652 -179.667 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.565 ' O ' ' HD3' ' A' ' 111' ' ' ARG . 57.0 Cg_exo -53.48 -34.54 72.44 Favored 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 122.657 2.238 . . . . 0.0 112.413 178.273 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -56.81 -61.27 2.55 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.986 -179.069 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -67.17 -38.41 85.39 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.901 -179.149 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -54.85 -53.05 60.38 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.236 179.231 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.565 ' HD3' ' O ' ' A' ' 107' ' ' PRO . 5.2 mpt_? -71.62 -37.42 70.91 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.555 -178.051 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -59.4 -55.9 28.81 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.638 -179.523 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.461 ' O ' HG23 ' A' ' 117' ' ' VAL . 37.8 m-85 -63.86 -50.24 69.58 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.901 179.718 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.613 ' O ' ' HG2' ' A' ' 118' ' ' ARG . 22.3 t70 -53.01 -67.92 0.21 Allowed 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 121.155 0.502 . . . . 0.0 110.649 -178.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 53.1 ttt180 -51.91 -46.31 64.55 Favored 'General case' 0 C--O 1.242 0.691 0 CA-C-N 114.972 -1.013 . . . . 0.0 111.166 -178.107 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -59.52 -42.63 97.75 Favored Glycine 0 C--N 1.334 0.451 0 CA-C-N 115.869 -0.605 . . . . 0.0 112.148 179.133 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.461 HG23 ' O ' ' A' ' 113' ' ' PHE . 41.2 t -66.8 -36.03 76.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 C-N-CA 122.156 0.182 . . . . 0.0 110.698 179.683 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.613 ' HG2' ' O ' ' A' ' 114' ' ' ASP . 8.9 mmm180 -58.53 -56.54 20.8 Favored 'General case' 0 C--O 1.241 0.628 0 CA-C-O 121.277 0.561 . . . . 0.0 109.646 178.164 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 9.8 mmpt? -61.24 -38.97 88.59 Favored 'General case' 0 C--O 1.239 0.507 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.191 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -59.28 -53.93 52.64 Favored 'General case' 0 C--O 1.226 -0.184 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.872 179.654 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.478 HG12 HD12 ' A' ' 81' ' ' LEU . 73.8 mt -55.09 -45.04 76.9 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 O-C-N 123.236 0.335 . . . . 0.0 110.493 -179.097 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.411 ' O ' ' HB2' ' A' ' 126' ' ' GLU . 50.5 mt-10 -55.3 -55.93 25.88 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.07 178.632 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -69.02 -24.8 64.25 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 121.258 0.552 . . . . 0.0 110.971 -179.145 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.541 ' HG ' ' HA ' ' A' ' 79' ' ' LYS . 9.2 tt -74.14 -46.75 40.52 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.54 -0.754 . . . . 0.0 111.956 -174.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.448 HG22 ' O ' ' A' ' 121' ' ' ILE . 18.9 tt -106.57 -33.03 2.66 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 N-CA-C 112.38 0.511 . . . . 0.0 112.38 -173.165 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.411 ' HB2' ' O ' ' A' ' 122' ' ' GLU . 44.1 mt-10 . . . . . 0 C--O 1.248 0.988 0 CA-C-O 118.484 -0.769 . . . . 0.0 110.182 -179.157 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.798 0 N-CA-C 112.11 -0.396 . . . . 0.0 112.11 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.5 t -98.68 -25.19 14.77 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 121.187 0.518 . . . . 0.0 110.323 -179.327 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 24.3 mmt -112.88 114.0 26.32 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.789 -178.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 15.3 t -92.87 145.41 24.41 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.72 0.295 . . . . 0.0 110.377 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -70.1 99.22 1.44 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.88 0.371 . . . . 0.0 110.647 178.518 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.4 ' OE2' ' HG3' ' A' ' 69' ' ' LYS . 19.0 tt0 -112.6 -69.52 0.86 Allowed 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 175.516 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.549 HG22 ' HB3' ' A' ' 68' ' ' ASP . 82.5 p 47.08 -152.15 0.08 Allowed 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 112.751 0.649 . . . . 0.0 112.751 168.182 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.458 ' HB3' ' HD2' ' A' ' 9' ' ' PRO . 16.6 m80 -130.49 164.54 40.66 Favored Pre-proline 0 CA--C 1.534 0.348 0 O-C-N 122.185 -0.322 . . . . 0.0 110.406 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.458 ' HD2' ' HB3' ' A' ' 8' ' ' HIS . 63.5 Cg_exo -41.72 -53.89 3.1 Favored 'Trans proline' 0 C--N 1.356 0.964 0 C-N-CA 123.567 2.845 . . . . 0.0 114.548 -172.041 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -91.0 22.71 3.53 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 112.108 0.41 . . . . 0.0 112.108 -174.44 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -60.23 -33.17 71.9 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 121.351 0.596 . . . . 0.0 110.409 177.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -62.44 -31.66 72.4 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.507 -0.77 . . . . 0.0 111.173 -177.036 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.72 ' HB2' ' SG ' ' A' ' 46' ' ' CYS . 20.3 m -87.25 14.28 8.1 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.868 -173.394 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.492 ' CE2' ' HA3' ' A' ' 44' ' ' GLY . 4.1 m-30 -66.4 85.1 0.1 Allowed 'General case' 0 C--O 1.234 0.282 0 CA-C-O 120.85 0.357 . . . . 0.0 110.917 175.555 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.489 HD12 ' HB3' ' A' ' 47' ' ' LYS . 55.0 mt -70.16 -59.0 3.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 175.634 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 62.0 t -110.0 113.62 44.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 177.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.483 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 0.0 OUTLIER -136.63 130.86 32.88 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.772 0.32 . . . . 0.0 110.177 178.171 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 35.1 m -131.83 171.68 17.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.037 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.477 ' HB2' HD11 ' A' ' 40' ' ' ILE . 57.0 pttt -110.44 109.34 19.68 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 177.495 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -157.01 158.26 36.22 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.724 -177.318 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 50.0 t -81.39 111.85 18.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.642 0.258 . . . . 0.0 110.763 -178.579 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.51 HG23 ' NE2' ' A' ' 35' ' ' GLN . 17.1 m -75.26 128.62 37.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.362 176.126 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 87.1 mmm -122.34 166.66 14.33 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 -177.135 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 9.1 t -143.93 164.51 30.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.445 0.64 . . . . 0.0 111.08 178.477 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.538 ' HB3' ' HB2' ' A' ' 99' ' ' LYS . 73.2 ttt180 -150.04 140.02 21.96 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 -179.846 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.554 ' HA ' ' HG2' ' A' ' 98' ' ' ARG . 26.0 t0 -79.15 37.39 0.32 Allowed 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 121.348 0.594 . . . . 0.0 110.322 -177.869 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.476 ' HA ' ' HG3' ' A' ' 99' ' ' LYS . 22.0 t70 63.49 -63.36 0.13 Allowed 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 123.891 0.876 . . . . 0.0 109.715 -171.018 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 22.3 p -68.93 170.8 9.06 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.861 168.719 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 15.7 m 64.78 96.06 0.05 OUTLIER 'General case' 0 CA--C 1.536 0.431 0 CA-C-O 120.984 0.421 . . . . 0.0 111.142 178.346 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -80.59 22.91 4.43 Favored Glycine 0 CA--C 1.519 0.301 0 C-N-CA 121.494 -0.384 . . . . 0.0 113.557 -175.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -80.48 -27.02 53.05 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.949 -0.643 . . . . 0.0 112.458 179.022 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . 0.535 ' CH2' ' HB3' ' A' ' 99' ' ' LYS . 83.4 m95 58.15 101.79 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 121.452 0.644 . . . . 0.0 110.841 -176.312 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 31.1 p90 -101.16 135.51 19.9 Favored Pre-proline 0 CA--C 1.532 0.254 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.915 -174.266 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.568 ' HB2' ' HA3' ' A' ' 38' ' ' GLY . 73.7 Cg_endo -79.05 111.41 2.93 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.694 2.262 . . . . 0.0 112.133 178.756 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.51 ' NE2' HG23 ' A' ' 22' ' ' VAL . 4.7 pm0 -75.69 168.3 20.28 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.36 -179.392 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 62.07 -77.84 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 115.395 -0.821 . . . . 0.0 110.794 177.311 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -148.52 -7.72 0.21 Allowed Glycine 0 CA--C 1.518 0.264 0 C-N-CA 121.252 -0.499 . . . . 0.0 112.558 -179.687 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.568 ' HA3' ' HB2' ' A' ' 34' ' ' PRO . . . 58.08 83.07 0.05 OUTLIER Glycine 0 C--N 1.334 0.462 0 C-N-CA 121.38 -0.438 . . . . 0.0 113.113 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -157.35 174.23 34.84 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 121.039 -0.601 . . . . 0.0 112.007 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.477 HD11 ' HB2' ' A' ' 19' ' ' LYS . 9.2 tt -58.55 129.24 20.38 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 CA-C-O 121.074 0.464 . . . . 0.0 110.081 178.66 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 43.7 t -121.61 146.02 47.4 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.317 0.58 . . . . 0.0 111.705 -170.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.649 ' HB3' ' HB2' ' A' ' 64' ' ' GLU . 19.8 ttt180 -77.61 83.23 4.0 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 114.971 -1.013 . . . . 0.0 108.457 171.752 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.483 ' O ' ' HA ' ' A' ' 17' ' ' ARG . 45.7 t -73.1 92.46 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.466 -175.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.492 ' HA3' ' CE2' ' A' ' 14' ' ' TYR . . . -93.24 95.67 2.01 Favored Glycine 0 N--CA 1.448 -0.565 0 CA-C-N 115.864 -0.607 . . . . 0.0 112.63 -179.467 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 61.4 t -82.14 93.24 2.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-O 121.407 0.623 . . . . 0.0 109.409 176.625 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . 0.72 ' SG ' ' HB2' ' A' ' 13' ' ' SER . 43.0 t -91.45 114.3 26.8 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.547 -177.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.489 ' HB3' HD12 ' A' ' 15' ' ' ILE . 40.0 ttmt -75.91 92.6 3.12 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 175.055 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.478 HG21 ' CE1' ' A' ' 76' ' ' TYR . 28.3 m -86.65 170.2 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.571 -174.022 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 26.0 ptm -126.25 -178.13 4.21 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.233 -179.616 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 8.6 p80 -134.22 159.71 71.28 Favored Pre-proline 0 C--N 1.326 -0.442 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 178.384 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.4 ' O ' ' HB2' ' A' ' 52' ' ' GLU . 90.9 Cg_exo -46.1 137.09 13.84 Favored 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 122.797 2.331 . . . . 0.0 112.414 178.596 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.4 ' HB2' ' O ' ' A' ' 51' ' ' PRO . 47.1 mt-10 74.13 -54.52 0.68 Allowed 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 123.575 0.75 . . . . 0.0 110.913 -176.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 77.77 95.49 0.23 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 121.255 -0.498 . . . . 0.0 112.392 177.455 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 32.1 p30 -69.45 -27.0 64.86 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.921 0.391 . . . . 0.0 110.763 179.145 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 140.98 -42.15 1.21 Allowed Glycine 0 C--N 1.331 0.286 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.974 177.462 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 7.3 mmm180 -80.64 103.31 10.4 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 120.836 0.35 . . . . 0.0 110.264 -177.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 20.9 m -81.09 141.36 34.39 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.616 -177.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -88.68 -174.24 47.02 Favored Glycine 0 C--N 1.331 0.259 0 CA-C-N 116.214 -0.448 . . . . 0.0 112.324 -178.3 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -132.36 139.17 48.02 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.124 0.488 . . . . 0.0 110.583 -179.089 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 3.1 tt -119.82 112.13 18.85 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 176.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.472 ' HB ' ' HB3' ' A' ' 75' ' ' CYS . 44.5 mm -75.94 92.73 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 175.842 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 16.9 t-80 -104.19 93.54 4.89 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.469 -175.725 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -102.21 112.71 4.39 Favored Glycine 0 CA--C 1.518 0.277 0 C-N-CA 121.235 -0.507 . . . . 0.0 112.7 -175.622 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.649 ' HB2' ' HB3' ' A' ' 42' ' ' ARG . 43.5 mm-40 -93.43 162.35 14.01 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.708 0.289 . . . . 0.0 110.82 178.043 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.415 HH11 ' HD3' ' A' ' 65' ' ' ARG . 15.1 ttm180 -82.47 151.78 26.38 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 167.77 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 28.4 mm-40 -59.39 88.03 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 120.884 0.373 . . . . 0.0 110.735 -179.586 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 87.1 tttt 173.76 -21.39 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.173 -0.921 . . . . 0.0 108.981 -176.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.549 ' HB3' HG22 ' A' ' 7' ' ' THR . 28.1 m-20 71.24 49.59 0.32 Allowed 'General case' 0 C--O 1.237 0.415 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.384 176.064 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.444 ' O ' ' HB2' ' A' ' 70' ' ' LEU . 11.9 tmtt? -176.0 60.19 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.132 -179.155 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.483 ' O ' ' HA ' ' A' ' 64' ' ' GLU . 54.3 tp 174.2 105.29 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.041 177.757 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 4.0 m -70.73 96.0 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 CA-C-O 121.21 0.529 . . . . 0.0 110.593 174.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 28.6 m -86.99 -9.06 11.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.915 179.649 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.463 ' HB2' HG21 ' A' ' 22' ' ' VAL . 1.5 tm? -159.72 121.1 3.21 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 177.793 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -129.09 122.27 29.57 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 179.328 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . 0.472 ' HB3' ' HB ' ' A' ' 61' ' ' ILE . 42.6 t -149.21 87.97 1.56 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.204 0.526 . . . . 0.0 110.572 178.877 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.478 ' CE1' HG21 ' A' ' 48' ' ' VAL . 67.0 t80 -77.26 123.04 25.91 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.146 175.065 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.528 HG11 HD12 ' A' ' 81' ' ' LEU . 17.3 m -133.62 111.64 16.05 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 CA-C-O 121.173 0.511 . . . . 0.0 110.092 177.03 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 16.0 ptm180 -81.25 -17.39 49.64 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.796 -178.222 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.438 ' HA ' HD21 ' A' ' 124' ' ' LEU . 85.6 tttt -172.15 152.69 2.9 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.373 -177.429 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 26.8 t70 71.6 105.25 0.07 Allowed 'General case' 0 N--CA 1.468 0.461 0 O-C-N 123.704 0.627 . . . . 0.0 112.235 173.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.535 HD23 ' N ' ' A' ' 82' ' ' VAL . 4.7 tt -179.37 129.21 0.1 Allowed 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 177.131 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.535 ' N ' HD23 ' A' ' 81' ' ' LEU . 75.6 t -128.02 129.95 69.7 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 N-CA-C 110.33 -0.248 . . . . 0.0 110.33 177.832 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.439 ' CE2' HG21 ' A' ' 117' ' ' VAL . 6.7 m-85 -83.24 159.56 21.94 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.24 0.543 . . . . 0.0 111.024 178.114 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 87.8 m -150.05 135.79 18.43 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.361 177.674 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.613 ' H ' ' HD2' ' A' ' 85' ' ' LYS . 0.0 OUTLIER -105.59 126.51 52.23 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.795 0.331 . . . . 0.0 110.43 -178.617 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.44 ' C ' HD22 ' A' ' 87' ' ' ASN . . . -98.51 -46.08 5.87 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.334 0.588 . . . . 0.0 109.485 175.793 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . 0.819 ' HB2' ' HB3' ' A' ' 90' ' ' PHE . 0.9 OUTLIER -125.17 152.03 70.23 Favored Pre-proline 0 C--N 1.327 -0.411 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 174.387 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -54.32 -25.88 41.07 Favored 'Trans proline' 0 CA--C 1.533 0.47 0 C-N-CA 122.44 2.094 . . . . 0.0 112.431 177.552 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.423 ' HA ' ' HD2' ' A' ' 104' ' ' PHE . 14.3 p -112.82 11.99 19.42 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.746 178.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.819 ' HB3' ' HB2' ' A' ' 87' ' ' ASN . 35.4 t80 -136.71 96.89 3.41 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-O 121.266 0.555 . . . . 0.0 109.642 178.111 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . 0.401 ' NE2' ' HB3' ' A' ' 83' ' ' TYR . 0.4 OUTLIER -97.36 163.08 13.04 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 176.632 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 28.6 p80 -166.63 169.97 13.07 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.909 0.385 . . . . 0.0 111.233 178.031 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . 0.54 ' CE2' ' HB2' ' A' ' 100' ' ' PHE . 38.8 p90 -149.69 134.94 18.17 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.36 174.539 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 7.7 tmtm? -102.36 116.68 33.14 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.817 -179.482 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.519 HG23 ' H ' ' A' ' 97' ' ' ASN . 34.9 m -105.72 -170.6 0.32 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.398 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.261 179.596 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -54.62 -25.87 29.33 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 122.877 0.471 . . . . 0.0 111.754 -176.707 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.519 ' H ' HG23 ' A' ' 95' ' ' VAL . 4.9 p-10 -155.11 131.3 10.26 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.179 -0.464 . . . . 0.0 109.972 177.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.554 ' HG2' ' HA ' ' A' ' 26' ' ' ASP . 57.7 mtt180 73.04 162.09 0.26 Allowed 'General case' 0 C--O 1.236 0.354 0 CA-C-O 122.071 0.939 . . . . 0.0 112.237 -173.766 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.538 ' HB2' ' HB3' ' A' ' 25' ' ' ARG . 63.5 mttp -122.35 124.54 43.95 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 114.221 -1.354 . . . . 0.0 108.055 174.623 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.54 ' HB2' ' CE2' ' A' ' 93' ' ' TRP . 1.7 m-85 -101.11 128.87 46.98 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 -177.311 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -111.04 164.17 12.18 Favored Glycine 0 N--CA 1.454 -0.114 0 C-N-CA 121.431 -0.414 . . . . 0.0 112.694 -176.743 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 7.0 tt -150.24 104.37 3.25 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 -179.65 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 36.6 m -91.84 115.52 28.13 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.013 178.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.423 ' HD2' ' HA ' ' A' ' 89' ' ' THR . 82.1 m-85 -67.35 160.1 27.99 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.616 -175.439 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 8.2 tp-100 -92.6 -42.0 9.91 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.382 -178.518 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 49.5 m -143.65 153.95 58.89 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.402 -179.03 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -52.35 -27.96 33.11 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 122.627 2.218 . . . . 0.0 112.344 177.258 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -60.41 -62.18 2.05 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.159 177.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 -66.02 -29.22 69.55 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.589 179.573 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.407 ' HA ' ' CD1' ' A' ' 104' ' ' PHE . . . -57.8 -57.51 12.45 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.585 175.767 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 62.0 mtp180 -60.94 -49.28 78.07 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.904 -179.317 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -60.75 -49.68 76.51 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.498 -176.174 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 66.0 t80 -71.62 -38.03 70.83 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.707 -177.191 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -55.87 -61.87 2.08 Favored 'General case' 0 C--O 1.24 0.557 0 CA-C-O 121.847 0.832 . . . . 0.0 110.241 178.843 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 40.7 ttm180 -60.98 -45.88 92.99 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 114.643 -1.162 . . . . 0.0 110.571 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -62.19 -41.45 99.71 Favored Glycine 0 N--CA 1.451 -0.304 0 CA-C-N 115.506 -0.77 . . . . 0.0 112.975 -177.065 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.523 ' O ' HG12 ' A' ' 121' ' ' ILE . 8.1 p -73.98 -33.27 35.9 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-N 116.78 0.29 . . . . 0.0 110.306 -177.228 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 27.5 tpt180 -57.28 -50.32 73.29 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 172.035 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 3.9 tmmm? -57.85 -38.76 76.25 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.725 176.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -65.53 -40.93 93.5 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.254 179.562 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.523 HG12 ' O ' ' A' ' 117' ' ' VAL . 46.0 mm -62.9 -40.76 90.1 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 178.216 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -62.42 -43.87 97.79 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.58 174.518 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -65.75 -23.85 66.82 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.006 179.638 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.438 HD21 ' HA ' ' A' ' 79' ' ' LYS . 5.4 tt -77.98 -52.6 8.56 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.452 179.054 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 61.6 mt -94.62 -47.21 13.38 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 -171.209 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 13.5 tp10 . . . . . 0 C--O 1.243 0.746 0 CA-C-O 118.516 -0.754 . . . . 0.0 110.343 -174.966 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.754 0 N-CA-C 111.863 -0.495 . . . . 0.0 111.863 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 25.5 t -73.04 85.2 1.3 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.185 0.516 . . . . 0.0 110.042 179.452 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 66.4 mtt -71.18 81.94 0.72 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.559 177.024 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 10.2 t -90.51 -13.3 34.95 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.36 -0.837 . . . . 0.0 111.644 -174.504 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -88.71 -64.8 1.09 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.394 0.616 . . . . 0.0 109.583 -179.3 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -135.22 153.84 51.8 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 108.617 -0.882 . . . . 0.0 108.617 177.04 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.557 HG21 ' HB2' ' A' ' 64' ' ' GLU . 34.2 p -90.08 -12.18 39.2 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.369 0.604 . . . . 0.0 110.498 178.598 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -130.7 125.63 21.52 Favored Pre-proline 0 C--N 1.328 -0.369 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 170.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -54.45 -25.7 41.28 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.381 2.054 . . . . 0.0 111.786 -179.48 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -86.77 -57.86 2.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.331 -0.85 . . . . 0.0 109.927 175.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.422 ' HA ' ' CE2' ' A' ' 14' ' ' TYR . 21.7 t70 63.9 0.21 0.9 Allowed 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 115.35 -0.841 . . . . 0.0 112.317 174.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -84.32 -32.22 24.43 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.284 0.564 . . . . 0.0 110.653 -177.341 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 28.6 m -74.1 -4.17 34.02 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.139 -0.937 . . . . 0.0 112.65 -171.068 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.422 ' CE2' ' HA ' ' A' ' 11' ' ' ASP . 76.9 m-85 -67.88 110.25 3.76 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-O 120.829 0.347 . . . . 0.0 110.603 178.823 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 48.8 mm -83.6 -55.77 6.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.934 -0.575 . . . . 0.0 109.877 178.459 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 61.8 t -122.91 134.3 66.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.376 -178.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 32.8 mtm180 -134.7 94.77 3.23 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 175.04 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 13.6 p -118.02 142.37 32.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.842 0.353 . . . . 0.0 110.882 -177.166 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 64.2 tttm -72.15 131.28 42.58 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.05 -179.42 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -161.7 -164.31 1.09 Allowed 'General case' 0 C--O 1.239 0.52 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.302 179.447 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.403 ' HB ' ' HB ' ' A' ' 103' ' ' THR . 61.7 t -124.21 105.7 15.77 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 CA-C-N 116.741 -0.208 . . . . 0.0 110.525 177.303 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.446 HG21 HG23 ' A' ' 72' ' ' VAL . 28.6 m -72.89 116.78 15.53 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 CA-C-O 121.475 0.655 . . . . 0.0 110.761 178.476 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 25.8 mmt -92.22 110.3 21.68 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.22 178.455 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.652 ' O ' ' HG3' ' A' ' 25' ' ' ARG . 7.4 t -83.23 2.53 35.35 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.578 -179.646 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.775 ' HG3' HH11 ' A' ' 25' ' ' ARG . 0.4 OUTLIER 53.37 172.88 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.956 0 N-CA-C 115.397 1.628 . . . . 0.0 115.397 166.449 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.545 ' HB2' ' CE2' ' A' ' 33' ' ' PHE . 36.6 t70 -143.03 6.76 1.57 Allowed 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 114.047 -1.433 . . . . 0.0 109.91 -178.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 65.4 m-20 66.24 -86.23 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.404 -178.219 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 22.9 t -151.1 99.95 2.73 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.334 -174.428 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.468 ' HB3' ' OD2' ' A' ' 26' ' ' ASP . 30.5 t 174.9 -54.46 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 177.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -111.26 -41.42 1.16 Allowed Glycine 0 N--CA 1.451 -0.307 0 N-CA-C 110.434 -1.067 . . . . 0.0 110.434 170.575 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 128.07 -109.97 1.09 Allowed Glycine 0 C--N 1.333 0.374 0 C-N-CA 121.578 -0.344 . . . . 0.0 112.675 175.122 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . 0.731 ' CE3' ' HB3' ' A' ' 25' ' ' ARG . 65.1 m95 -128.75 114.49 16.65 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 -178.797 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.545 ' CE2' ' HB2' ' A' ' 26' ' ' ASP . 8.5 p90 -120.47 151.41 53.8 Favored Pre-proline 0 C--O 1.239 0.503 0 CA-C-O 120.495 0.188 . . . . 0.0 110.966 178.47 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.475 ' HB2' ' HA3' ' A' ' 38' ' ' GLY . 73.5 Cg_endo -89.44 -154.35 0.05 OUTLIER 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 123.331 2.687 . . . . 0.0 111.739 175.171 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -156.62 147.44 21.82 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-O 120.532 0.206 . . . . 0.0 111.08 -176.779 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.478 ' HB3' ' HD3' ' A' ' 67' ' ' LYS . 12.3 mm-40 54.71 25.77 6.83 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 115.883 -0.598 . . . . 0.0 112.0 175.433 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 115.8 -42.48 1.89 Allowed Glycine 0 N--CA 1.453 -0.207 0 N-CA-C 111.497 -0.641 . . . . 0.0 111.497 -179.057 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.475 ' HA3' ' HB2' ' A' ' 34' ' ' PRO . . . 59.98 67.66 2.05 Favored Glycine 0 C--N 1.331 0.3 0 C-N-CA 121.353 -0.451 . . . . 0.0 112.76 179.198 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -153.78 -46.02 0.02 OUTLIER Glycine 0 N--CA 1.455 -0.1 0 N-CA-C 111.6 -0.6 . . . . 0.0 111.6 177.71 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.563 HG22 ' O ' ' A' ' 40' ' ' ILE . 2.6 mp -97.24 63.45 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 CA-C-O 121.634 0.73 . . . . 0.0 109.379 178.862 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.54 ' HB2' HE22 ' A' ' 66' ' ' GLN . 25.6 t -117.56 109.51 16.8 Favored 'General case' 0 C--N 1.33 -0.242 0 O-C-N 121.978 -0.451 . . . . 0.0 110.23 -178.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 60.4 mtp180 -89.62 110.98 21.81 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-O 120.895 0.379 . . . . 0.0 110.206 179.547 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.575 HG21 HD22 ' A' ' 102' ' ' LEU . 46.4 t -72.4 103.04 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.932 177.774 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -92.52 86.02 1.2 Allowed Glycine 0 N--CA 1.449 -0.483 0 CA-C-N 115.793 -0.639 . . . . 0.0 112.389 -178.798 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 51.4 t -71.5 100.72 0.9 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.411 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 176.564 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . 0.641 ' SG ' ' HB3' ' A' ' 60' ' ' LEU . 11.5 p -107.97 138.28 44.5 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.627 -178.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -95.71 119.37 34.09 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.8 -0.445 . . . . 0.0 109.8 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 33.5 m -92.69 148.38 4.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.802 -177.579 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 85.8 mtp -94.0 159.57 15.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.796 -178.524 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . 0.577 ' HB2' ' HA2' ' A' ' 55' ' ' GLY . 5.0 p80 -75.3 137.37 71.76 Favored Pre-proline 0 CA--C 1.536 0.435 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.296 -177.587 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -82.6 45.19 1.85 Allowed 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 123.626 2.884 . . . . 0.0 112.809 -179.014 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 66.92 -77.79 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 112.935 0.717 . . . . 0.0 112.935 175.13 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -53.99 -91.67 0.01 OUTLIER Glycine 0 C--N 1.339 0.724 0 O-C-N 123.506 0.504 . . . . 0.0 114.056 -169.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -69.43 -15.51 63.3 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.821 0.343 . . . . 0.0 110.176 179.855 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.577 ' HA2' ' HB2' ' A' ' 50' ' ' HIS . . . 60.83 -129.26 46.43 Favored Glycine 0 N--CA 1.445 -0.716 0 CA-C-N 115.728 -0.669 . . . . 0.0 112.69 175.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 2.5 mpt_? 60.83 85.13 0.12 Allowed 'General case' 0 C--O 1.234 0.261 0 CA-C-O 121.218 0.532 . . . . 0.0 111.16 -178.33 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 33.0 p -79.02 -179.28 6.57 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.694 174.563 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 177.17 -143.1 6.08 Favored Glycine 0 N--CA 1.448 -0.567 0 C-N-CA 120.714 -0.755 . . . . 0.0 111.991 -179.126 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.499 ' HE1' ' HB2' ' A' ' 124' ' ' LEU . 85.7 m-85 -134.03 155.5 49.89 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.995 0.426 . . . . 0.0 110.517 -178.064 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.641 ' HB3' ' SG ' ' A' ' 46' ' ' CYS . 3.8 tt -121.91 107.91 12.82 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 174.364 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.463 ' O ' ' HA ' ' A' ' 74' ' ' GLU . 49.1 mt -70.66 83.86 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 178.643 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . 0.577 ' HB2' HD22 ' A' ' 60' ' ' LEU . 11.9 t60 -103.35 93.02 4.75 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.482 -174.624 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -88.3 121.94 6.14 Favored Glycine 0 N--CA 1.447 -0.568 0 N-CA-C 111.057 -0.817 . . . . 0.0 111.057 174.695 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.557 ' HB2' HG21 ' A' ' 7' ' ' THR . 1.7 pp20? -124.63 -175.58 3.31 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 116.857 0.329 . . . . 0.0 110.759 -179.448 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.524 ' O ' ' HB2' ' A' ' 66' ' ' GLN . 0.1 OUTLIER 79.3 147.31 0.09 Allowed 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.064 -0.971 . . . . 0.0 111.409 173.843 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.54 HE22 ' HB2' ' A' ' 41' ' ' SER . 5.4 tp-100 172.31 -57.09 0.01 OUTLIER 'General case' 0 C--O 1.231 0.12 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.612 172.199 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.478 ' HD3' ' HB3' ' A' ' 36' ' ' GLU . 7.2 ptmm? -156.07 -37.43 0.08 Allowed 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.903 -172.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -118.41 9.93 12.56 Favored 'General case' 0 N--CA 1.47 0.544 0 O-C-N 122.399 -0.188 . . . . 0.0 111.106 -178.268 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 20.0 ttmm 49.43 90.2 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 121.493 0.663 . . . . 0.0 109.732 -167.165 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.49 ' H ' HD23 ' A' ' 70' ' ' LEU . 2.0 pt? -142.03 160.18 40.73 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 -176.377 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 16.0 t -80.47 93.81 2.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 123.605 0.565 . . . . 0.0 109.567 178.611 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.446 HG23 HG21 ' A' ' 22' ' ' VAL . 30.6 m -79.26 -20.67 12.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.819 -177.575 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.474 HD13 ' N ' ' A' ' 74' ' ' GLU . 2.6 tm? -153.89 133.43 12.86 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 178.86 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.474 ' N ' HD13 ' A' ' 73' ' ' LEU . 13.2 pt-20 -151.49 129.6 11.87 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 176.31 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 61.0 m -146.93 117.7 7.6 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.057 -0.52 . . . . 0.0 109.779 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 42.3 t80 -90.96 144.26 25.86 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 -179.787 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 12.2 p -157.17 145.61 10.76 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 N-CA-C 110.3 -0.259 . . . . 0.0 110.3 179.6 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.404 ' HB3' ' H ' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -86.97 -161.19 0.65 Allowed 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.101 179.663 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.528 ' O ' ' HB2' ' A' ' 80' ' ' ASP . 23.0 ttmm -66.48 77.2 0.11 Allowed 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.934 176.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.528 ' HB2' ' O ' ' A' ' 79' ' ' LYS . 25.6 t70 169.13 95.91 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.461 0.705 . . . . 0.0 109.585 174.489 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.478 HD23 ' H ' ' A' ' 82' ' ' VAL . 1.1 tt -137.06 138.83 40.84 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 -178.321 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.478 ' H ' HD23 ' A' ' 81' ' ' LEU . 26.0 m -124.43 127.53 73.12 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 CA-C-O 120.941 0.401 . . . . 0.0 110.933 179.041 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.642 ' HB3' ' NE2' ' A' ' 91' ' ' HIS . 11.7 m-85 -111.53 139.88 46.6 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.909 174.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.468 ' HB ' ' CE1' ' A' ' 92' ' ' HIS . 36.6 m -132.84 114.7 14.38 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.505 -179.472 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 2.6 ttmp? -85.34 99.61 11.27 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 177.269 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -83.08 -13.99 54.64 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.283 0.563 . . . . 0.0 110.518 -176.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . 0.766 ' HB3' ' HB3' ' A' ' 90' ' ' PHE . 27.8 t-20 -160.47 140.33 8.29 Favored Pre-proline 0 C--N 1.324 -0.513 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 -178.128 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_endo -46.94 -22.95 2.26 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 122.948 2.432 . . . . 0.0 113.614 178.073 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.471 HG22 ' OD1' ' A' ' 87' ' ' ASN . 12.6 t -116.51 14.7 15.6 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 120.767 0.318 . . . . 0.0 111.62 -179.872 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.766 ' HB3' ' HB3' ' A' ' 87' ' ' ASN . 79.6 t80 -146.39 114.98 6.79 Favored 'General case' 0 C--O 1.239 0.518 0 CA-C-O 121.218 0.532 . . . . 0.0 110.7 -178.262 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . 0.642 ' NE2' ' HB3' ' A' ' 83' ' ' TYR . 1.8 t-160 -121.49 123.11 41.25 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 -179.147 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . 0.468 ' CE1' ' HB ' ' A' ' 84' ' ' THR . 34.6 p80 -120.4 168.27 11.48 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.686 0.279 . . . . 0.0 110.857 -179.668 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 45.1 p90 -154.22 137.87 16.07 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.112 -177.653 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 56.6 tttp -95.71 107.81 20.06 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 174.466 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 35.5 m -136.41 151.04 27.85 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 CA-C-O 121.032 0.444 . . . . 0.0 111.15 -179.37 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 33.1 t70 59.87 -78.07 0.02 OUTLIER 'General case' 0 C--O 1.236 0.368 0 CA-C-N 114.882 -1.054 . . . . 0.0 112.459 173.291 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -134.96 -22.87 1.57 Allowed 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 112.796 0.665 . . . . 0.0 112.796 -174.373 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 7.9 tpt180 -146.02 175.55 10.37 Favored 'General case' 0 N--CA 1.465 0.316 0 O-C-N 121.884 -0.51 . . . . 0.0 111.026 -172.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 38.1 ttmt -101.43 108.42 20.02 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.822 -0.627 . . . . 0.0 109.623 -179.693 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -103.14 166.9 10.16 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 -179.751 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.413 ' HA2' ' HA ' ' A' ' 92' ' ' HIS . . . -159.59 178.57 35.65 Favored Glycine 0 CA--C 1.51 -0.239 0 C-N-CA 119.945 -1.121 . . . . 0.0 112.974 -177.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.575 HD22 HG21 ' A' ' 43' ' ' VAL . 3.9 pp -148.94 154.47 39.45 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-O 120.857 0.36 . . . . 0.0 110.771 177.697 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.403 ' HB ' ' HB ' ' A' ' 21' ' ' VAL . 90.0 m -105.42 128.38 53.49 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.755 175.41 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.436 ' CE2' ' HB2' ' A' ' 91' ' ' HIS . 61.2 m-85 -74.19 169.58 17.29 Favored 'General case' 0 C--O 1.238 0.489 0 CA-C-O 121.182 0.515 . . . . 0.0 111.224 -178.264 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 28.2 tt0 -106.94 -38.15 6.13 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.122 -179.363 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 24.8 m -151.83 157.21 34.49 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.94 178.799 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.483 ' HA ' ' HB3' ' A' ' 110' ' ' ALA . 12.2 Cg_endo -56.55 -22.61 43.95 Favored 'Trans proline' 0 C--N 1.352 0.743 0 C-N-CA 122.348 2.032 . . . . 0.0 111.99 177.041 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -60.58 -63.32 1.34 Allowed 'General case' 0 C--O 1.233 0.213 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.716 175.775 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -66.23 -29.08 69.25 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.732 178.656 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.483 ' HB3' ' HA ' ' A' ' 107' ' ' PRO . . . -59.65 -52.5 65.24 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.975 0.416 . . . . 0.0 110.694 175.788 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 60.8 ttp85 -68.39 -44.31 75.39 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.337 -179.488 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -59.18 -42.1 90.02 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.01 -178.681 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 74.9 t80 -73.69 -39.11 64.63 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.424 -179.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.419 ' O ' HG12 ' A' ' 117' ' ' VAL . 37.4 t70 -62.69 -65.78 0.64 Allowed 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 121.326 0.584 . . . . 0.0 110.47 179.178 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 1.5 tmt_? -56.69 -39.8 74.47 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.166 -0.925 . . . . 0.0 110.017 177.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -59.19 -51.03 61.61 Favored Glycine 0 C--N 1.333 0.416 0 C-N-CA 121.101 -0.571 . . . . 0.0 112.501 179.62 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.526 ' O ' HG12 ' A' ' 121' ' ' ILE . 8.6 p -68.88 -30.26 46.29 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 N-CA-C 110.209 -0.293 . . . . 0.0 110.209 -178.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 3.2 mpt_? -62.53 -46.57 87.78 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.379 177.434 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 53.7 tptt -65.79 -40.92 92.42 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.111 177.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -57.49 -45.92 84.34 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.457 177.395 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.526 HG12 ' O ' ' A' ' 117' ' ' VAL . 40.1 mm -64.43 -38.71 83.28 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.337 177.823 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -57.89 -50.65 72.6 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.531 -179.799 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 44.1 m-20 -71.2 -29.42 65.13 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.847 178.697 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.499 ' HB2' ' HE1' ' A' ' 59' ' ' PHE . 65.6 tp -65.71 -54.38 28.13 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.229 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.492 HG22 ' O ' ' A' ' 121' ' ' ILE . 10.7 tp -83.05 -37.18 13.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.19 -174.05 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 . . . . . 0 C--O 1.251 1.163 0 O-C-N 123.59 0.556 . . . . 0.0 109.945 -176.606 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.827 0 N-CA-C 111.867 -0.493 . . . . 0.0 111.867 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 10.9 t -94.36 36.76 1.13 Allowed 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 178.665 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 65.2 mtt 68.52 -168.1 0.19 Allowed 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.34 -176.5 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 63.5 m -146.21 97.41 2.94 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 120.814 0.34 . . . . 0.0 111.145 -178.037 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -139.98 176.9 8.36 Favored 'General case' 0 C--O 1.238 0.453 0 N-CA-C 109.419 -0.585 . . . . 0.0 109.419 173.635 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -82.24 166.92 19.15 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 110.032 -0.359 . . . . 0.0 110.032 177.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 4.4 m -116.13 20.85 14.11 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.74 0.781 . . . . 0.0 109.513 -179.702 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.563 ' HB3' ' HD2' ' A' ' 9' ' ' PRO . 25.7 m170 -74.43 170.74 13.61 Favored Pre-proline 0 CA--C 1.535 0.389 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.411 -178.706 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.563 ' HD2' ' HB3' ' A' ' 8' ' ' HIS . 88.3 Cg_exo -43.91 126.23 5.83 Favored 'Trans proline' 0 C--N 1.355 0.873 0 C-N-CA 122.608 2.205 . . . . 0.0 112.677 175.35 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.474 ' HB3' ' HB2' ' A' ' 13' ' ' SER . 3.9 m-20 64.87 38.03 6.81 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 121.348 0.594 . . . . 0.0 110.597 -178.385 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.514 ' HA ' ' CD2' ' A' ' 14' ' ' TYR . 10.2 p-10 -55.69 -28.8 57.57 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.822 176.322 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -76.93 -24.81 52.42 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.231 179.479 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.474 ' HB2' ' HB3' ' A' ' 10' ' ' ASP . 15.8 m -88.96 -8.67 53.7 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 116.041 -0.527 . . . . 0.0 112.278 -171.603 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.622 ' HB3' ' HD2' ' A' ' 17' ' ' ARG . 59.6 m-85 -63.31 93.1 0.06 Allowed 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 120.835 0.35 . . . . 0.0 110.933 179.088 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.4 HG23 HG23 ' A' ' 16' ' ' VAL . 7.5 tp -83.41 -45.66 18.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.308 -178.301 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.4 HG23 HG23 ' A' ' 15' ' ' ILE . 92.1 t -125.3 121.46 60.62 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 CA-C-O 120.848 0.356 . . . . 0.0 110.64 -177.788 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.622 ' HD2' ' HB3' ' A' ' 14' ' ' TYR . 0.0 OUTLIER -125.51 103.8 8.08 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.81 178.94 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 27.2 m -119.89 176.47 3.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 177.547 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 21.5 pttm -128.33 129.97 47.07 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.822 0.344 . . . . 0.0 110.752 -177.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.441 ' HB3' HD21 ' A' ' 102' ' ' LEU . . . -159.02 -178.86 7.54 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.833 179.699 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 40.3 t -93.54 99.78 10.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 120.866 0.365 . . . . 0.0 110.707 -176.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.488 HG11 ' HG ' ' A' ' 73' ' ' LEU . 57.2 t -81.79 106.42 12.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.626 -179.678 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 23.1 mmt -86.04 150.72 24.26 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.258 177.598 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 5.2 t -123.08 151.49 41.96 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.055 -0.521 . . . . 0.0 109.951 177.539 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 59.1 ttt180 -123.18 104.7 9.34 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.145 -0.48 . . . . 0.0 109.82 -178.61 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -81.2 56.14 2.76 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-O 121.27 0.557 . . . . 0.0 109.681 -179.044 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 65.4 m-20 57.58 22.88 8.65 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.131 -0.94 . . . . 0.0 110.563 -177.374 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.9 m -67.32 156.38 36.58 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 115.179 -0.919 . . . . 0.0 110.782 179.574 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 23.9 m -62.19 -43.73 98.19 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-O 120.961 0.41 . . . . 0.0 110.461 177.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -164.01 10.27 0.08 OUTLIER Glycine 0 C--N 1.333 0.371 0 CA-C-N 115.839 -0.619 . . . . 0.0 112.38 177.22 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -83.11 80.22 1.84 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 121.203 -0.522 . . . . 0.0 112.492 -178.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 84.9 m95 -72.98 99.64 2.77 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 174.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.488 ' HA ' ' HD3' ' A' ' 34' ' ' PRO . 26.0 p90 -98.07 141.04 22.32 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.949 -174.471 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.593 ' HB2' ' HA2' ' A' ' 38' ' ' GLY . 9.1 Cg_exo -72.15 136.34 26.74 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.894 2.396 . . . . 0.0 111.593 178.625 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.434 ' O ' ' N ' ' A' ' 37' ' ' GLY . 2.9 pp0? -93.38 145.13 24.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.208 -179.419 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 44.8 mm-40 41.5 -82.76 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 113.788 1.032 . . . . 0.0 113.788 173.274 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.434 ' N ' ' O ' ' A' ' 35' ' ' GLN . . . -58.8 -30.8 66.6 Favored Glycine 0 C--N 1.333 0.392 0 C-N-CA 121.45 -0.405 . . . . 0.0 112.959 -174.705 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.593 ' HA2' ' HB2' ' A' ' 34' ' ' PRO . . . 67.21 12.06 60.02 Favored Glycine 0 C--N 1.33 0.249 0 C-N-CA 121.046 -0.597 . . . . 0.0 112.261 -179.054 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -167.72 -123.02 0.64 Allowed Glycine 0 N--CA 1.446 -0.67 0 N-CA-C 111.586 -0.606 . . . . 0.0 111.586 -177.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 34.0 pt -64.23 135.98 27.12 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 CA-C-O 121.343 0.592 . . . . 0.0 111.815 -177.171 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 39.6 m -144.0 132.84 22.59 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.022 175.284 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.479 ' HD3' ' HB3' ' A' ' 17' ' ' ARG . 5.7 tmm_? -76.3 103.45 6.33 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 -179.017 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.476 HG11 HD11 ' A' ' 102' ' ' LEU . 4.0 p -91.79 110.2 22.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.58 0.705 . . . . 0.0 109.89 177.323 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.451 ' N ' HH11 ' A' ' 42' ' ' ARG . . . -107.43 103.67 1.99 Allowed Glycine 0 N--CA 1.448 -0.536 0 CA-C-N 115.395 -0.821 . . . . 0.0 111.505 -179.495 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 7.5 p -86.13 125.18 40.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 178.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . 0.789 ' SG ' ' HB3' ' A' ' 60' ' ' LEU . 7.0 p -126.54 128.5 46.97 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.603 -178.063 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 3.2 ttmp? -81.58 98.85 8.53 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 177.162 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 46.0 t -73.87 85.49 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 177.694 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 13.5 tpt -89.58 147.81 23.72 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.499 -178.676 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . 0.421 ' CD2' ' HB3' ' A' ' 57' ' ' SER . 0.3 OUTLIER -117.84 159.61 41.91 Favored Pre-proline 0 C--N 1.321 -0.673 0 CA-C-N 115.364 -0.835 . . . . 0.0 109.563 -178.472 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_exo -73.4 43.36 0.75 Allowed 'Trans proline' 0 CA--C 1.537 0.649 0 C-N-CA 122.767 2.311 . . . . 0.0 112.208 176.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 57.48 19.99 5.71 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 123.353 0.661 . . . . 0.0 111.811 177.684 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -117.26 -153.17 9.7 Favored Glycine 0 C--N 1.331 0.266 0 C-N-CA 121.278 -0.487 . . . . 0.0 112.697 -178.107 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 63.1 t30 -64.77 -13.0 53.59 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 123.196 0.598 . . . . 0.0 111.42 -175.641 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.447 ' HA2' ' NH1' ' A' ' 56' ' ' ARG . . . -58.29 143.49 43.8 Favored Glycine 0 CA--C 1.521 0.466 0 C-N-CA 121.189 -0.529 . . . . 0.0 112.403 177.782 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.447 ' NH1' ' HA2' ' A' ' 55' ' ' GLY . 0.1 OUTLIER -69.33 140.66 54.34 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 120.712 0.292 . . . . 0.0 110.712 -179.527 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.421 ' HB3' ' CD2' ' A' ' 50' ' ' HIS . 20.2 p -125.28 132.36 52.92 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.452 179.675 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 173.39 -161.61 32.48 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 121.017 -0.611 . . . . 0.0 112.234 179.709 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.474 ' O ' HG22 ' A' ' 77' ' ' VAL . 84.8 m-85 -127.83 125.78 40.41 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 178.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.789 ' HB3' ' SG ' ' A' ' 46' ' ' CYS . 1.6 tt -93.99 108.2 20.04 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 179.86 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 48.3 mm -80.65 91.41 1.81 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.261 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 174.418 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . 0.672 ' HB2' HD22 ' A' ' 60' ' ' LEU . 28.5 t60 -108.45 106.64 16.85 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.83 -173.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.427 ' HA2' ' O ' ' A' ' 42' ' ' ARG . . . -114.8 138.57 14.91 Favored Glycine 0 C--O 1.235 0.209 0 N-CA-C 111.725 -0.55 . . . . 0.0 111.725 178.422 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.419 ' HB2' ' O ' ' A' ' 70' ' ' LEU . 14.4 pt-20 -120.35 160.18 23.55 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 120.881 0.372 . . . . 0.0 110.801 -179.803 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.475 ' HB2' HG11 ' A' ' 72' ' ' VAL . 2.0 tmt_? -82.75 122.66 28.46 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 177.428 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 9.5 mm100 -58.67 97.45 0.03 OUTLIER 'General case' 0 C--O 1.234 0.269 0 CA-C-O 121.105 0.479 . . . . 0.0 112.007 -174.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 29.5 mtpp -140.27 -72.05 0.37 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.193 -0.912 . . . . 0.0 108.739 173.152 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -160.25 -46.89 0.05 OUTLIER 'General case' 0 C--O 1.235 0.327 0 CA-C-N 114.67 -1.15 . . . . 0.0 108.93 -178.617 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 56.1 tttm -170.36 99.12 0.26 Allowed 'General case' 0 C--O 1.236 0.39 0 CA-C-N 115.099 -0.955 . . . . 0.0 109.569 177.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.419 ' O ' ' HB2' ' A' ' 64' ' ' GLU . 4.1 tt -157.21 107.77 2.28 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 -178.744 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 43.8 t -78.58 125.18 37.9 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.004 -177.377 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.475 HG11 ' HB2' ' A' ' 65' ' ' ARG . 27.7 m -123.02 -28.96 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.584 179.735 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.488 ' HG ' HG11 ' A' ' 22' ' ' VAL . 2.6 tm? -123.66 117.02 24.05 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 -177.446 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -131.78 107.0 8.47 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 176.742 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 52.5 t -135.13 79.5 1.79 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.349 0.595 . . . . 0.0 109.953 179.676 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.549 ' HA ' ' HA ' ' A' ' 60' ' ' LEU . 57.2 t80 -72.74 105.07 4.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.98 175.472 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.474 HG22 ' O ' ' A' ' 59' ' ' PHE . 34.8 m -81.11 114.54 22.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 178.601 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.723 ' HD2' ' H ' ' A' ' 78' ' ' ARG . 0.3 OUTLIER -82.66 61.67 5.89 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 -173.819 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 36.3 mtmm 68.68 -2.87 1.54 Allowed 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.206 -172.385 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -92.36 85.77 5.49 Favored 'General case' 0 N--CA 1.462 0.148 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 174.035 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.721 HD22 HD11 ' A' ' 121' ' ' ILE . 2.4 tt -131.25 106.82 8.56 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.976 -173.854 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 59.5 t -124.05 92.38 2.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.252 176.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.407 ' CD1' ' HB3' ' A' ' 93' ' ' TRP . 0.2 OUTLIER -81.49 101.54 9.98 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.04 178.672 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 22.5 m -90.93 127.22 36.31 Favored 'General case' 0 C--N 1.323 -0.543 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 178.602 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 24.7 pttm -93.32 111.25 22.85 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.111 0.481 . . . . 0.0 110.857 -177.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -90.07 -44.16 10.01 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.271 0.558 . . . . 0.0 109.503 175.676 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . 0.612 ' HB2' ' HB3' ' A' ' 90' ' ' PHE . 93.0 m-20 -138.63 153.98 72.81 Favored Pre-proline 0 C--N 1.328 -0.363 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 177.132 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -55.26 -27.41 56.94 Favored 'Trans proline' 0 CA--C 1.533 0.471 0 C-N-CA 122.22 1.947 . . . . 0.0 112.034 176.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 10.8 p -105.91 8.47 32.61 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.836 178.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.612 ' HB3' ' HB2' ' A' ' 87' ' ' ASN . 25.6 t80 -140.81 102.97 4.4 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-O 121.076 0.465 . . . . 0.0 110.405 -179.784 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 14.2 m80 -107.7 132.51 53.27 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.513 174.321 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . 0.424 ' HA ' ' O ' ' A' ' 100' ' ' PHE . 8.2 p80 -126.95 129.56 48.37 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.74 0.305 . . . . 0.0 110.204 178.138 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . 0.62 ' HZ3' ' HB2' ' A' ' 102' ' ' LEU . 34.8 p90 -110.01 149.77 29.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.079 179.3 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 14.3 tmtt? -112.57 122.1 46.72 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.059 -178.038 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.439 HG13 ' HD1' ' A' ' 93' ' ' TRP . 21.1 m -124.88 127.33 72.47 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.071 176.863 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 42.3 m-20 59.6 -80.18 0.02 OUTLIER 'General case' 0 C--O 1.235 0.297 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.953 -179.108 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -133.74 -28.48 1.41 Allowed 'General case' 0 C--O 1.234 0.243 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.609 -176.65 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 62.5 mtt180 -103.44 156.46 17.74 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 121.482 0.658 . . . . 0.0 112.495 -171.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.84 137.34 52.83 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 114.64 -1.164 . . . . 0.0 109.846 -179.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.424 ' O ' ' HA ' ' A' ' 92' ' ' HIS . 36.6 m-85 -122.98 137.13 55.04 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 176.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -115.76 101.59 1.03 Allowed Glycine 0 C--N 1.333 0.409 0 C-N-CA 120.968 -0.634 . . . . 0.0 113.216 -171.116 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.62 ' HB2' ' HZ3' ' A' ' 93' ' ' TRP . 3.7 tt -74.42 104.25 5.09 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.211 -0.662 . . . . 0.0 109.211 177.047 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.401 ' HG1' ' HD2' ' A' ' 90' ' ' PHE . 17.5 m -96.67 114.97 26.66 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.142 179.773 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.422 ' CG ' ' HA ' ' A' ' 110' ' ' ALA . 74.5 m-85 -72.27 167.31 20.67 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.296 -175.368 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -112.71 -31.66 6.67 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.71 -175.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 5.7 m -138.51 150.07 64.92 Favored Pre-proline 0 C--N 1.329 -0.31 0 N-CA-C 110.187 -0.301 . . . . 0.0 110.187 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -52.96 -29.02 42.17 Favored 'Trans proline' 0 C--N 1.352 0.718 0 C-N-CA 122.309 2.006 . . . . 0.0 111.86 176.781 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -59.44 -65.59 0.65 Allowed 'General case' 0 C--O 1.236 0.384 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.858 177.227 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -64.92 -31.59 72.9 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.949 -179.344 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.422 ' HA ' ' CG ' ' A' ' 104' ' ' PHE . . . -58.52 -60.85 3.15 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.092 177.395 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 20.0 mtm180 -66.54 -32.54 73.96 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.748 -177.628 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -63.51 -56.67 14.24 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.037 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.405 ' HB3' ' CE1' ' A' ' 104' ' ' PHE . 39.1 t80 -71.03 -28.89 64.72 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.337 -177.214 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -54.84 -63.43 1.16 Allowed 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 121.808 0.813 . . . . 0.0 109.588 173.17 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 52.4 ttt180 -56.51 -37.21 70.1 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.306 -1.315 . . . . 0.0 110.835 177.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -63.94 -53.89 34.39 Favored Glycine 0 C--O 1.237 0.304 0 CA-C-N 115.837 -0.62 . . . . 0.0 112.909 -179.164 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.449 ' O ' HG12 ' A' ' 121' ' ' ILE . 11.9 p -67.71 -33.67 63.23 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 -178.292 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.503 ' O ' ' HG3' ' A' ' 122' ' ' GLU . 54.2 ttt180 -55.54 -50.96 68.63 Favored 'General case' 0 C--O 1.231 0.089 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 173.223 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.643 ' HE2' ' HA ' ' A' ' 119' ' ' LYS . 0.6 OUTLIER -56.47 -46.39 80.42 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.065 178.786 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -56.85 -42.5 79.8 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.949 178.769 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.721 HD11 HD22 ' A' ' 81' ' ' LEU . 42.6 mm -61.59 -39.59 83.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.925 176.682 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.53 ' HA ' ' HA ' ' A' ' 126' ' ' GLU . 41.2 mt-10 -66.23 -37.73 86.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.652 179.676 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -65.26 -36.6 84.61 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-O 121.222 0.534 . . . . 0.0 109.988 174.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 59.3 tp -71.46 -55.35 8.07 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.675 -176.714 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.42 ' O ' HG13 ' A' ' 125' ' ' ILE . 11.3 tp -145.47 10.18 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 N-CA-C 111.655 0.243 . . . . 0.0 111.655 -171.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.53 ' HA ' ' HA ' ' A' ' 122' ' ' GLU . 34.0 tt0 . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.429 -0.796 . . . . 0.0 110.753 -175.291 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.949 0 N-CA-C 111.722 -0.551 . . . . 0.0 111.722 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 42.1 t -60.47 -40.81 92.57 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 175.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 95.7 mmm -100.99 160.85 14.03 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.413 174.256 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 41.7 p -74.37 173.25 10.53 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.538 178.676 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.416 ' HG2' ' H ' ' A' ' 49' ' ' MET . 0.7 OUTLIER -66.37 84.11 0.1 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.39 0.614 . . . . 0.0 110.698 176.697 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -84.62 -44.07 13.83 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 114.941 -1.027 . . . . 0.0 108.561 174.289 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.759 HG22 ' H ' ' A' ' 8' ' ' HIS . 1.7 m 63.54 -162.22 0.28 Allowed 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 114.155 -1.384 . . . . 0.0 110.458 175.283 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.759 ' H ' HG22 ' A' ' 7' ' ' THR . 68.5 t60 94.1 -74.66 0.0 OUTLIER Pre-proline 0 CA--C 1.548 0.883 0 C-N-CA 124.937 1.295 . . . . 0.0 111.008 -173.818 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.54 ' HD3' ' HB3' ' A' ' 8' ' ' HIS . 65.7 Cg_endo -89.66 -4.51 5.53 Favored 'Trans proline' 0 C--N 1.367 1.536 0 CA-C-N 121.483 1.565 . . . . 0.0 111.541 173.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.522 ' HB3' ' HA ' ' A' ' 7' ' ' THR . 30.2 t70 -87.55 -51.5 5.87 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.904 178.725 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.442 ' HA ' ' HD1' ' A' ' 14' ' ' TYR . 28.4 t70 75.47 -23.69 0.23 Allowed 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 113.609 0.966 . . . . 0.0 113.609 170.313 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -59.1 -31.96 69.38 Favored 'General case' 0 N--CA 1.469 0.514 0 O-C-N 122.08 -0.387 . . . . 0.0 111.591 -175.285 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 16.5 m -73.84 -15.86 61.15 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 111.857 0.317 . . . . 0.0 111.857 -178.841 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.442 ' HD1' ' HA ' ' A' ' 11' ' ' ASP . 24.7 m-85 -65.14 123.4 19.42 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-O 120.695 0.283 . . . . 0.0 110.561 178.191 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 13.0 tt -102.73 -34.1 3.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 173.411 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.414 ' HB ' ' HB ' ' A' ' 45' ' ' VAL . 97.8 t -139.3 130.12 33.03 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.764 177.808 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 11.6 ptm180 -142.41 91.13 2.29 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.199 0.523 . . . . 0.0 110.277 176.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 35.1 m -107.5 161.08 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.928 -177.629 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 47.3 mtmt -93.83 130.58 39.8 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.392 178.764 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -163.25 158.59 21.72 Favored 'General case' 0 C--N 1.331 -0.223 0 O-C-N 123.254 0.346 . . . . 0.0 110.29 179.219 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 58.4 t -90.77 105.66 16.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 178.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.599 HG23 ' NE2' ' A' ' 35' ' ' GLN . 15.8 m -81.23 115.18 23.37 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 CA-C-O 121.406 0.622 . . . . 0.0 111.673 -176.541 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 24.0 mmt -99.66 162.78 12.81 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.973 179.589 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 9.9 t -136.64 158.19 45.02 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.943 0.402 . . . . 0.0 110.854 -179.13 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 20.5 ttt180 -136.36 100.26 4.33 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 -179.651 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.587 ' H ' ' HE1' ' A' ' 33' ' ' PHE . 27.4 t70 -63.03 104.43 0.56 Allowed 'General case' 0 C--O 1.234 0.267 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.541 -172.078 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.639 ' HA ' ' HG2' ' A' ' 98' ' ' ARG . 23.8 t70 60.23 -76.85 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.677 176.862 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 37.4 p -145.01 22.94 1.55 Allowed 'General case' 0 C--O 1.236 0.345 0 N-CA-C 111.484 0.179 . . . . 0.0 111.484 -178.694 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 49.1 m -51.6 143.05 13.1 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.994 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -81.58 61.89 4.57 Favored Glycine 0 CA--C 1.52 0.354 0 C-N-CA 121.431 -0.414 . . . . 0.0 112.629 -177.386 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 158.67 -168.91 34.98 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 121.279 -0.486 . . . . 0.0 111.942 179.195 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . 0.571 ' HH2' ' HG2' ' A' ' 99' ' ' LYS . 88.2 m95 -128.26 116.45 19.88 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 177.871 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.587 ' HE1' ' H ' ' A' ' 26' ' ' ASP . 37.7 p90 -110.78 148.29 38.25 Favored Pre-proline 0 C--O 1.235 0.308 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.894 -175.833 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -77.88 157.55 31.14 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.73 2.287 . . . . 0.0 111.549 176.484 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.599 ' NE2' HG23 ' A' ' 22' ' ' VAL . 2.5 pp0? -136.11 -152.89 0.47 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.059 -0.518 . . . . 0.0 109.923 -178.728 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 22.5 tp10 -52.74 -22.15 4.92 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 120.918 0.389 . . . . 0.0 111.49 -177.163 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -112.32 46.13 1.22 Allowed Glycine 0 CA--C 1.518 0.26 0 N-CA-C 111.578 -0.609 . . . . 0.0 111.578 175.304 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -71.95 -19.45 78.3 Favored Glycine 0 C--N 1.331 0.292 0 C-N-CA 121.357 -0.449 . . . . 0.0 112.664 -179.507 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -97.29 -151.04 27.39 Favored Glycine 0 C--O 1.237 0.301 0 C-N-CA 121.35 -0.452 . . . . 0.0 112.097 178.286 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 50.6 mm -65.72 99.18 0.29 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.38 0 CA-C-O 121.154 0.502 . . . . 0.0 110.284 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 36.8 m -105.66 -175.8 2.9 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.475 179.818 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.608 HH22 ' N ' ' A' ' 68' ' ' ASP . 28.3 ttm180 -130.53 134.94 47.44 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.764 -178.022 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.808 HG21 HD22 ' A' ' 102' ' ' LEU . 24.3 t -100.05 94.44 3.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 171.216 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.425 ' HA3' ' HE2' ' A' ' 14' ' ' TYR . . . -98.37 91.94 1.18 Allowed Glycine 0 N--CA 1.449 -0.474 0 CA-C-N 115.827 -0.624 . . . . 0.0 113.098 -173.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.414 ' HB ' ' HB ' ' A' ' 16' ' ' VAL . 51.4 t -76.3 109.94 10.94 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 175.236 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . 0.699 ' SG ' ' HB3' ' A' ' 60' ' ' LEU . 9.1 p -121.88 137.33 54.82 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.431 -178.446 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.597 ' HB3' ' HB2' ' A' ' 57' ' ' SER . 42.1 mtmt -84.97 118.38 24.52 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.981 0.42 . . . . 0.0 111.033 -179.797 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.429 ' O ' ' HB3' ' A' ' 57' ' ' SER . 42.7 t -90.91 118.24 35.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.185 173.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . 0.416 ' H ' ' HG2' ' A' ' 5' ' ' GLU . 67.1 mtm -87.38 151.01 23.44 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.018 0.437 . . . . 0.0 110.529 -178.597 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 53.7 m-70 -131.38 157.95 76.67 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.127 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -51.75 132.58 42.11 Favored 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 122.342 2.028 . . . . 0.0 111.947 178.191 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 71.97 77.8 0.16 Allowed 'General case' 0 CA--C 1.536 0.427 0 O-C-N 123.719 0.637 . . . . 0.0 110.247 -179.591 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 125.01 119.58 2.39 Favored Glycine 0 C--N 1.333 0.38 0 CA-C-N 116.055 -0.521 . . . . 0.0 112.159 -178.54 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -126.91 -4.86 6.31 Favored 'General case' 0 N--CA 1.466 0.357 0 O-C-N 122.649 -0.324 . . . . 0.0 111.044 179.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -84.6 -76.17 1.2 Allowed Glycine 0 C--N 1.331 0.273 0 C-N-CA 120.997 -0.621 . . . . 0.0 111.91 179.361 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 3.6 tmm_? -80.93 96.89 7.2 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 177.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.597 ' HB2' ' HB3' ' A' ' 47' ' ' LYS . 14.7 m -108.81 174.35 5.91 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.805 -176.559 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.574 ' O ' ' HA ' ' A' ' 47' ' ' LYS . . . -73.8 147.19 37.98 Favored Glycine 0 C--N 1.332 0.324 0 C-N-CA 121.366 -0.445 . . . . 0.0 112.079 179.153 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 32.6 m-85 -103.0 97.07 7.24 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.268 0.556 . . . . 0.0 110.5 -177.592 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.719 ' HA ' ' HA ' ' A' ' 76' ' ' TYR . 2.7 tt -81.69 110.0 16.63 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 178.53 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 60.8 mt -75.33 86.4 0.66 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.314 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 174.106 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 12.3 t-80 -90.08 101.19 13.91 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.254 -0.884 . . . . 0.0 109.946 -176.337 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -91.27 114.55 4.52 Favored Glycine 0 N--CA 1.449 -0.435 0 CA-C-N 115.937 -0.574 . . . . 0.0 112.204 -177.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -119.51 -170.27 1.91 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.025 0.44 . . . . 0.0 110.934 179.589 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 23.0 mmt85 -83.58 -174.73 5.45 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.451 169.717 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 28.7 pt20 -55.59 -35.17 65.51 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.168 177.127 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -115.51 147.89 40.13 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.278 -178.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.608 ' N ' HH22 ' A' ' 42' ' ' ARG . 1.8 m-20 -67.85 105.59 2.02 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.1 -178.424 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -176.17 -39.21 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.348 0 O-C-N 123.168 0.293 . . . . 0.0 111.591 -179.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 61.5 tp -122.03 115.54 22.69 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.622 0.249 . . . . 0.0 111.282 -175.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 35.4 t -88.82 110.47 21.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.891 176.771 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 35.9 m -91.3 -36.68 8.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.259 -177.696 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -133.42 151.49 51.82 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 122.491 0.317 . . . . 0.0 110.234 178.742 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.542 ' HG2' HD21 ' A' ' 60' ' ' LEU . 2.9 tm-20 -146.94 115.75 6.82 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 175.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 50.0 t -141.15 83.7 1.89 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.21 0.529 . . . . 0.0 110.616 -178.364 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.719 ' HA ' ' HA ' ' A' ' 60' ' ' LEU . 78.4 t80 -68.87 122.65 19.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.587 175.768 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.475 HG12 ' HB2' ' A' ' 80' ' ' ASP . 17.2 m -133.21 122.71 45.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.006 0.431 . . . . 0.0 110.281 178.031 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 11.5 ptm180 -110.04 -27.77 9.03 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.2 0.524 . . . . 0.0 110.211 179.164 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -155.05 22.25 0.43 Allowed 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 173.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.475 ' HB2' HG12 ' A' ' 77' ' ' VAL . 0.7 OUTLIER -114.7 9.55 16.45 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 114.414 -1.266 . . . . 0.0 109.816 -172.557 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.828 HD22 HD11 ' A' ' 121' ' ' ILE . 3.5 tt -79.17 104.42 9.79 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.171 -172.316 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 48.4 t -127.97 96.78 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 CA-C-N 116.567 -0.288 . . . . 0.0 110.667 177.201 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.506 ' HD2' ' CD2' ' A' ' 91' ' ' HIS . 4.5 m-85 -91.71 172.46 8.47 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-O 121.396 0.617 . . . . 0.0 111.076 178.306 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 50.1 m -154.42 110.75 3.26 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.056 -0.974 . . . . 0.0 109.314 -179.629 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.474 ' NZ ' ' HB3' ' A' ' 85' ' ' LYS . 5.2 ttpm? -77.3 107.05 9.43 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 177.346 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -85.28 -59.65 2.26 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.214 0.53 . . . . 0.0 110.138 -179.614 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 -130.19 158.63 73.59 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.353 -179.177 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -56.13 -13.69 10.05 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 122.6 2.2 . . . . 0.0 113.189 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 12.7 t -125.21 5.8 7.81 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-O 120.452 0.168 . . . . 0.0 111.304 179.509 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 17.8 t80 -135.36 114.28 12.05 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 -179.57 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . 0.506 ' CD2' ' HD2' ' A' ' 83' ' ' TYR . 2.3 t-160 -130.24 129.91 43.94 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 -176.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . 0.4 ' CE1' ' HD3' ' A' ' 99' ' ' LYS . 20.7 p80 -138.78 174.98 9.96 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.527 0.203 . . . . 0.0 111.066 -174.832 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . 0.48 ' HB3' ' CD1' ' A' ' 83' ' ' TYR . 34.2 p90 -142.8 171.72 13.67 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 176.427 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -137.24 150.34 47.78 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.037 0.446 . . . . 0.0 110.815 -178.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 24.6 m -122.85 -140.27 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 173.4 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -59.39 83.72 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 118.083 0.401 . . . . 0.0 110.918 176.548 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 52.8 t30 68.99 -63.58 0.36 Allowed 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.232 1.013 . . . . 0.0 112.147 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.639 ' HG2' ' HA ' ' A' ' 27' ' ' ASP . 60.0 mtt-85 -55.03 136.07 48.28 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 121.251 0.548 . . . . 0.0 110.745 -176.611 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.571 ' HG2' ' HH2' ' A' ' 32' ' ' TRP . 4.5 ttmp? -127.18 132.84 50.4 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.472 -0.786 . . . . 0.0 110.308 -169.058 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 1.1 p90 -147.2 158.22 43.87 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 -179.174 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.427 ' HA2' ' CZ3' ' A' ' 93' ' ' TRP . . . -164.23 -153.21 7.29 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.384 -0.912 . . . . 0.0 113.338 -174.572 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.808 HD22 HG21 ' A' ' 43' ' ' VAL . 4.1 pp -144.48 168.21 20.67 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.099 0.476 . . . . 0.0 110.977 -174.63 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 15.3 m -128.59 119.73 25.32 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.533 178.091 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 47.5 m-85 -66.27 160.05 25.27 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.089 178.091 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 29.8 pt20 -129.54 -27.08 2.42 Favored 'General case' 0 C--N 1.328 -0.37 0 N-CA-C 111.535 0.198 . . . . 0.0 111.535 -177.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 32.1 m -135.13 150.21 72.29 Favored Pre-proline 0 C--N 1.329 -0.299 0 N-CA-C 110.282 -0.266 . . . . 0.0 110.282 179.449 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.579 ' O ' ' HG2' ' A' ' 111' ' ' ARG . 82.2 Cg_exo -49.59 -35.2 36.79 Favored 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 122.683 2.256 . . . . 0.0 112.254 177.13 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -57.84 -63.52 1.22 Allowed 'General case' 0 C--O 1.235 0.314 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.574 -179.57 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -62.28 -34.37 76.44 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.736 -179.003 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -55.29 -66.59 0.39 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.117 177.151 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.579 ' HG2' ' O ' ' A' ' 107' ' ' PRO . 44.7 ptt85 -59.58 -47.21 86.47 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.237 -176.794 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -63.15 -49.84 72.76 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.74 -172.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.493 ' O ' HG23 ' A' ' 117' ' ' VAL . 63.2 t80 -75.6 -43.45 48.05 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.803 -175.655 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -55.47 -59.71 4.43 Favored 'General case' 0 C--O 1.24 0.556 0 CA-C-O 121.566 0.698 . . . . 0.0 109.957 179.688 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 22.8 ttm180 -59.4 -37.23 77.47 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 114.895 -1.048 . . . . 0.0 109.93 177.041 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -58.35 -39.38 92.63 Favored Glycine 0 N--CA 1.45 -0.419 0 CA-C-N 115.861 -0.609 . . . . 0.0 112.362 178.257 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.493 HG23 ' O ' ' A' ' 113' ' ' PHE . 72.6 t -71.3 -49.8 45.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.607 0.241 . . . . 0.0 110.809 -179.727 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.403 HH11 ' HD2' ' A' ' 118' ' ' ARG . 44.2 mtm105 -59.78 -44.87 93.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.875 0.369 . . . . 0.0 110.785 179.503 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 45.3 tptt -65.97 -36.01 82.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.447 177.54 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -62.42 -43.84 97.86 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.309 176.481 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.828 HD11 HD22 ' A' ' 81' ' ' LEU . 32.4 mm -60.68 -42.81 93.34 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.108 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.278 177.617 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.441 ' O ' ' HG3' ' A' ' 126' ' ' GLU . 34.7 tt0 -56.35 -57.32 12.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.165 177.837 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 74.0 m-20 -69.7 -18.91 63.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.601 -177.583 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 6.0 tt -77.27 -45.44 26.34 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 178.057 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 13.9 tt -78.98 -28.05 13.68 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.354 -175.46 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.441 ' HG3' ' O ' ' A' ' 122' ' ' GLU . 50.1 mt-10 . . . . . 0 C--O 1.255 1.39 0 CA-C-O 118.384 -0.817 . . . . 0.0 110.264 178.372 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.708 0 N-CA-C 112.351 -0.3 . . . . 0.0 112.351 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 45.9 t -169.5 -49.54 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 -179.253 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 27.4 ttt -160.58 112.4 1.93 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.215 -0.902 . . . . 0.0 108.848 179.234 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 16.3 p -58.24 -63.95 1.09 Allowed 'General case' 0 C--O 1.236 0.392 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.754 -174.184 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -87.3 135.37 33.34 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 178.069 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -70.03 -53.9 15.54 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.856 0.687 . . . . 0.0 112.856 -166.818 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 91.7 m -137.01 -71.59 0.44 Allowed 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 121.308 -0.157 . . . . 0.0 111.217 -174.194 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 18.3 m80 -158.98 156.84 27.44 Favored Pre-proline 0 CA--C 1.533 0.311 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 -178.048 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_exo -50.87 -31.86 35.29 Favored 'Trans proline' 0 C--N 1.355 0.885 0 C-N-CA 123.301 2.667 . . . . 0.0 113.996 -171.295 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.696 ' HB3' ' HB3' ' A' ' 13' ' ' SER . 29.2 m-20 -109.5 35.86 3.16 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.811 0.338 . . . . 0.0 110.566 -177.138 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.4 ' HA ' ' CD2' ' A' ' 14' ' ' TYR . 6.6 p-10 -53.99 -32.61 54.65 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.824 -177.671 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -85.62 -19.66 30.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.864 0.364 . . . . 0.0 110.984 -179.305 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.696 ' HB3' ' HB3' ' A' ' 10' ' ' ASP . 33.3 t -90.21 -12.58 37.65 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.189 -172.691 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.4 ' CD2' ' HA ' ' A' ' 11' ' ' ASP . 61.8 m-85 -63.36 89.57 0.04 OUTLIER 'General case' 0 C--O 1.233 0.232 0 CA-C-O 121.065 0.46 . . . . 0.0 110.446 177.903 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 62.5 mt -73.96 -32.08 32.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.62 -179.057 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 60.4 t -123.62 100.3 7.63 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.18 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.902 -178.708 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 86.6 mtm180 -112.74 93.58 4.49 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 172.822 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 30.9 m -120.12 174.47 5.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.993 0.425 . . . . 0.0 111.644 -175.69 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.687 ' HD2' HD11 ' A' ' 40' ' ' ILE . 9.4 mtmp? -110.74 114.96 28.72 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.71 -178.1 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -148.54 179.97 7.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.222 179.748 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 42.6 t -109.15 109.89 30.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 110.251 -0.278 . . . . 0.0 110.251 179.69 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 15.8 m -70.46 95.9 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 CA-C-O 121.522 0.677 . . . . 0.0 111.415 -178.728 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . 0.659 ' H ' ' HA ' ' A' ' 102' ' ' LEU . 21.2 mmt -89.96 115.16 27.04 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.036 -179.781 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.495 HG23 ' CE1' ' A' ' 33' ' ' PHE . 9.6 t -112.67 162.93 15.15 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.341 0.591 . . . . 0.0 110.393 179.67 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.411 ' O ' ' N ' ' A' ' 27' ' ' ASP . 5.4 tpm_? -133.12 98.17 4.2 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 176.557 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.62 ' H ' ' HE1' ' A' ' 33' ' ' PHE . 30.8 t70 -60.7 80.46 0.01 OUTLIER 'General case' 0 C--O 1.233 0.211 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.137 -178.151 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.411 ' N ' ' O ' ' A' ' 25' ' ' ARG . 0.8 OUTLIER 57.04 173.07 0.04 OUTLIER 'General case' 0 C--O 1.235 0.314 0 CA-C-N 115.037 -0.983 . . . . 0.0 111.208 -174.658 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 40.0 m 59.66 -167.83 0.16 Allowed 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 120.873 0.368 . . . . 0.0 110.91 -178.217 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 68.1 m -149.64 132.0 15.61 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 172.274 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 146.95 65.7 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.297 0 N-CA-C 111.601 -0.6 . . . . 0.0 111.601 -178.67 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 118.84 98.84 1.86 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 121.235 -0.507 . . . . 0.0 112.195 -179.525 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . 0.539 ' HH2' ' HG2' ' A' ' 99' ' ' LYS . 77.7 m95 -81.9 120.2 24.9 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 176.694 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.62 ' HE1' ' H ' ' A' ' 26' ' ' ASP . 14.2 p90 -115.09 132.5 23.0 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.438 -0.347 . . . . 0.0 110.505 -176.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.559 ' HB2' ' HA3' ' A' ' 38' ' ' GLY . 71.4 Cg_endo -74.69 112.86 3.65 Favored 'Trans proline' 0 N--CA 1.458 -0.57 0 C-N-CA 121.939 1.76 . . . . 0.0 110.657 175.158 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -54.81 129.03 35.66 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.455 -175.424 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 63.19 16.0 9.03 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.62 -179.554 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 107.34 -26.27 19.07 Favored Glycine 0 C--N 1.33 0.245 0 C-N-CA 121.494 -0.384 . . . . 0.0 112.643 177.666 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.559 ' HA3' ' HB2' ' A' ' 34' ' ' PRO . . . 72.41 -71.61 1.02 Allowed Glycine 0 CA--C 1.519 0.289 0 C-N-CA 121.221 -0.514 . . . . 0.0 112.572 -179.835 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 62.04 -96.68 0.14 Allowed Glycine 0 C--N 1.333 0.394 0 N-CA-C 112.121 -0.392 . . . . 0.0 112.121 -179.292 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.687 HD11 ' HD2' ' A' ' 19' ' ' LYS . 12.5 tt -141.78 80.53 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 122.056 0.932 . . . . 0.0 109.475 178.23 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 9.3 m -77.09 141.92 40.02 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.67 -173.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.755 ' HB3' ' HB2' ' A' ' 64' ' ' GLU . 41.3 ttm180 -92.98 97.53 10.78 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 178.125 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 48.1 t -76.22 107.47 7.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.097 -0.501 . . . . 0.0 109.961 -178.591 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -106.78 112.08 3.7 Favored Glycine 0 N--CA 1.448 -0.511 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.824 179.446 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 62.0 t -106.4 111.52 35.68 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 177.613 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . 0.779 ' SG ' ' HB3' ' A' ' 60' ' ' LEU . 8.0 p -104.92 143.1 33.62 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.548 178.352 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 40.9 ttmt -94.89 92.9 7.14 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 121.026 0.441 . . . . 0.0 109.972 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 42.6 t -77.11 88.0 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.769 178.718 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 61.0 mtm -65.3 140.26 58.67 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.256 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 14.7 m-70 -67.13 126.81 93.08 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.405 -179.656 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -59.31 -23.08 68.35 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 122.511 2.14 . . . . 0.0 111.272 175.315 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.574 ' HB3' HD22 ' A' ' 54' ' ' ASN . 7.8 mp0 -59.36 -34.89 72.94 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.418 175.68 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 65.73 11.31 53.53 Favored Glycine 0 CA--C 1.524 0.599 0 CA-C-N 115.954 -0.566 . . . . 0.0 114.374 174.289 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.574 HD22 ' HB3' ' A' ' 52' ' ' GLU . 11.5 p30 -83.13 -26.26 31.14 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 117.368 0.584 . . . . 0.0 110.776 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 158.47 171.28 24.14 Favored Glycine 0 C--O 1.237 0.287 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.887 -177.725 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 32.6 ttm180 68.1 147.61 0.05 Allowed 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 123.474 0.71 . . . . 0.0 111.301 -177.826 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 23.9 m -134.52 129.64 35.41 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.503 175.756 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -77.84 155.94 43.48 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.999 -0.619 . . . . 0.0 111.662 177.39 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -133.24 119.76 20.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.928 0.394 . . . . 0.0 110.413 -179.54 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.779 ' HB3' ' SG ' ' A' ' 46' ' ' CYS . 1.2 tt -96.2 110.21 22.54 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 179.003 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 57.3 mt -84.85 90.84 2.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 174.54 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -103.46 116.16 31.88 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.082 -175.106 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -91.42 96.05 2.14 Favored Glycine 0 N--CA 1.449 -0.493 0 CA-C-N 115.964 -0.562 . . . . 0.0 112.111 -179.025 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.755 ' HB2' ' HB3' ' A' ' 42' ' ' ARG . 5.2 mm-40 -73.77 145.21 45.24 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 177.365 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.46 ' HD2' HD22 ' A' ' 70' ' ' LEU . 18.6 ttt180 -76.58 8.33 3.66 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.241 -178.591 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.424 ' NE2' ' HB2' ' A' ' 42' ' ' ARG . 6.7 tp-100 71.9 -68.67 0.21 Allowed 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 123.521 0.728 . . . . 0.0 110.263 -178.864 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.409 ' O ' ' HB3' ' A' ' 68' ' ' ASP . 88.0 tttt -88.27 118.19 27.7 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 177.571 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.409 ' HB3' ' O ' ' A' ' 67' ' ' LYS . 32.5 t70 73.61 146.58 0.08 Allowed 'General case' 0 N--CA 1.469 0.518 0 O-C-N 124.003 0.814 . . . . 0.0 111.269 -178.786 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -74.39 79.47 1.89 Allowed 'General case' 0 C--O 1.236 0.369 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.2 -179.33 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.46 HD22 ' HD2' ' A' ' 65' ' ' ARG . 6.2 tt -130.9 131.85 44.76 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 179.762 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.455 ' N ' HD23 ' A' ' 70' ' ' LEU . 23.6 t -89.73 117.67 33.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.042 -175.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 32.8 m -98.29 -23.0 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-O 120.713 0.292 . . . . 0.0 110.806 176.792 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.414 HD23 ' N ' ' A' ' 74' ' ' GLU . 9.3 tt -145.54 139.52 26.8 Favored 'General case' 0 N--CA 1.462 0.166 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 -179.179 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.414 ' N ' HD23 ' A' ' 73' ' ' LEU . 1.7 tm-20 -142.5 109.51 5.53 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 -179.129 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . 0.424 ' SG ' HG21 ' A' ' 95' ' ' VAL . 35.0 t -140.12 82.56 1.87 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.384 0.611 . . . . 0.0 110.984 -179.288 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.422 ' HA ' ' HA ' ' A' ' 60' ' ' LEU . 82.5 t80 -75.13 121.99 22.91 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.812 174.662 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.511 HG11 ' HB2' ' A' ' 81' ' ' LEU . 92.8 t -124.85 112.02 30.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 -177.218 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.415 ' HD3' ' OH ' ' A' ' 76' ' ' TYR . 46.5 ttp180 -120.4 1.24 10.69 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-O 121.253 0.549 . . . . 0.0 110.58 -179.692 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 19.3 ptmt -141.01 86.86 2.06 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 115.965 -0.562 . . . . 0.0 111.141 -176.002 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.534 ' H ' HD11 ' A' ' 124' ' ' LEU . 18.2 t70 64.5 148.4 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 115.649 -0.705 . . . . 0.0 112.154 178.108 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.511 ' HB2' HG11 ' A' ' 77' ' ' VAL . 51.5 tp -149.46 137.78 20.71 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.846 -0.615 . . . . 0.0 109.961 178.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 60.3 t -77.28 -65.13 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.363 178.338 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.438 ' HD2' ' HB ' ' A' ' 117' ' ' VAL . 4.5 t80 37.99 79.89 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 124.111 0.964 . . . . 0.0 111.729 -178.767 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 97.1 m -112.64 136.5 52.13 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.261 -0.881 . . . . 0.0 109.913 179.714 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.464 ' HA ' ' HA ' ' A' ' 91' ' ' HIS . 18.0 ptmt -85.37 108.77 17.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.043 0.449 . . . . 0.0 109.846 176.569 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -74.85 -27.55 60.31 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.446 0.641 . . . . 0.0 109.846 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . 0.502 ' HB2' ' HB3' ' A' ' 90' ' ' PHE . 16.5 m120 -141.62 156.43 66.4 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-N 115.059 -0.973 . . . . 0.0 108.709 177.923 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -58.56 -13.29 16.72 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.581 2.187 . . . . 0.0 112.561 180.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.435 ' HA ' ' HD2' ' A' ' 104' ' ' PHE . 23.6 p -124.55 14.3 8.79 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.608 -178.885 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.502 ' HB3' ' HB2' ' A' ' 87' ' ' ASN . 42.6 t80 -145.19 123.17 12.04 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-O 120.706 0.289 . . . . 0.0 110.833 -177.539 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . 0.471 ' HB2' ' CZ ' ' A' ' 104' ' ' PHE . 0.3 OUTLIER -126.01 136.29 52.79 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 -179.134 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . 0.569 ' HA ' ' HA3' ' A' ' 101' ' ' GLY . 11.7 p80 -141.53 158.59 43.66 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 120.643 0.259 . . . . 0.0 110.905 -177.148 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . 0.517 ' CZ3' ' HA2' ' A' ' 101' ' ' GLY . 39.3 p90 -136.45 158.89 43.36 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.848 0.356 . . . . 0.0 110.375 176.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt -122.48 113.96 20.04 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.669 179.577 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.424 HG21 ' SG ' ' A' ' 75' ' ' CYS . 28.0 m -141.34 162.63 21.38 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 N-CA-C 110.021 -0.363 . . . . 0.0 110.021 178.084 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 26.0 t70 63.56 -76.1 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.393 0 O-C-N 123.694 0.621 . . . . 0.0 110.957 179.699 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -155.92 -9.86 0.11 Allowed 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.781 177.269 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 42.0 ttm180 -122.15 155.59 35.43 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.261 0.553 . . . . 0.0 112.032 -165.553 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.539 ' HG2' ' HH2' ' A' ' 32' ' ' TRP . 37.4 ttpt -108.63 107.25 17.66 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.053 -0.976 . . . . 0.0 109.436 178.312 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.456 ' HA ' ' HZ3' ' A' ' 32' ' ' TRP . 3.6 p90 -138.55 155.19 48.59 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.662 -0.245 . . . . 0.0 110.667 -179.419 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.569 ' HA3' ' HA ' ' A' ' 92' ' ' HIS . . . -163.09 -141.5 3.14 Favored Glycine 0 C--N 1.332 0.346 0 C-N-CA 121.116 -0.564 . . . . 0.0 112.702 -177.177 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.659 ' HA ' ' H ' ' A' ' 23' ' ' MET . 0.0 OUTLIER -157.51 156.02 31.3 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 121.032 0.444 . . . . 0.0 111.035 -178.699 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 36.2 m -101.52 132.53 47.1 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.752 175.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.471 ' CZ ' ' HB2' ' A' ' 91' ' ' HIS . 19.6 m-85 -67.41 160.27 27.74 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.412 -179.874 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -117.08 -52.46 2.51 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.205 178.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 25.4 m -129.75 153.2 80.79 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.251 -177.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_exo -49.11 -31.44 21.3 Favored 'Trans proline' 0 C--N 1.353 0.8 0 C-N-CA 122.669 2.246 . . . . 0.0 112.66 178.569 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -59.47 -62.22 2.04 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.249 179.376 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -65.67 -38.03 88.15 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.591 -179.429 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -52.81 -60.74 2.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.028 0.442 . . . . 0.0 110.781 176.761 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 72.4 mtp180 -64.08 -27.52 69.16 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.634 -179.368 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -65.23 -39.27 92.51 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.547 176.191 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 46.2 m-85 -71.03 -43.84 67.05 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.589 177.667 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.425 ' O ' HG12 ' A' ' 117' ' ' VAL . 49.9 m-20 -61.59 -55.55 29.49 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 120.814 0.34 . . . . 0.0 110.623 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 80.2 mtt-85 -66.39 -28.72 68.86 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-O 121.02 0.438 . . . . 0.0 110.154 176.84 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -59.35 -50.98 61.93 Favored Glycine 0 N--CA 1.447 -0.579 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.86 176.139 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.438 ' HB ' ' HD2' ' A' ' 83' ' ' TYR . 11.9 p -69.27 -32.75 54.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 116.694 0.247 . . . . 0.0 110.584 -179.74 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.454 ' O ' ' HG3' ' A' ' 122' ' ' GLU . 3.4 mmp_? -53.04 -64.63 0.76 Allowed 'General case' 0 C--O 1.238 0.476 0 CA-C-O 121.231 0.539 . . . . 0.0 109.995 174.17 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 81.4 tttt -66.86 -33.63 76.01 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 115.476 -0.783 . . . . 0.0 110.728 -176.107 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -61.03 -50.84 71.72 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.458 178.21 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.552 ' O ' HG22 ' A' ' 125' ' ' ILE . 31.8 mm -60.08 -40.68 84.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.109 178.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.484 ' O ' ' HB2' ' A' ' 126' ' ' GLU . 43.5 mt-10 -54.8 -56.46 19.18 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 110.284 -0.265 . . . . 0.0 110.284 176.385 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 49.4 m-20 -65.26 -27.23 68.5 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.668 -0.242 . . . . 0.0 111.425 -178.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.534 HD11 ' H ' ' A' ' 80' ' ' ASP . 3.2 tm? -76.51 -56.68 4.4 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.179 -176.126 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.552 HG22 ' O ' ' A' ' 121' ' ' ILE . 11.2 tp -94.12 -34.02 5.43 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 -170.349 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.484 ' HB2' ' O ' ' A' ' 122' ' ' GLU . 32.1 mm-40 . . . . . 0 C--O 1.251 1.142 0 CA-C-O 118.637 -0.697 . . . . 0.0 110.862 -174.535 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.837 0 N-CA-C 112.014 -0.434 . . . . 0.0 112.014 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 13.5 p -69.04 97.29 0.86 Allowed 'General case' 0 CA--C 1.533 0.3 0 CA-C-O 120.769 0.319 . . . . 0.0 111.365 -178.454 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 65.5 mtt -100.6 -8.45 22.96 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.653 179.498 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 7.5 p -72.12 120.78 18.2 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.6 -177.693 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -160.4 106.41 1.51 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.436 -0.802 . . . . 0.0 108.963 176.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -164.38 -58.39 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.825 -172.626 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.731 ' HB ' ' HE1' ' A' ' 14' ' ' TYR . 11.3 p 53.67 106.42 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 114.978 -1.01 . . . . 0.0 112.234 179.769 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.608 ' HB3' ' HD3' ' A' ' 9' ' ' PRO . 76.2 t60 178.24 -54.19 0.0 OUTLIER Pre-proline 0 N--CA 1.47 0.534 0 CA-C-N 115.033 -0.985 . . . . 0.0 108.925 -174.558 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.608 ' HD3' ' HB3' ' A' ' 8' ' ' HIS . 98.4 Cg_endo -87.03 5.16 5.89 Favored 'Trans proline' 0 C--N 1.361 1.189 0 C-N-CA 122.273 1.982 . . . . 0.0 110.122 169.445 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -150.84 107.74 3.55 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 114.101 -1.409 . . . . 0.0 107.806 -178.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.636 ' HB2' ' HB2' ' A' ' 14' ' ' TYR . 7.7 p-10 -83.6 40.6 0.74 Allowed 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 111.658 0.244 . . . . 0.0 111.658 -171.041 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -43.52 -42.39 4.92 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 112.86 0.689 . . . . 0.0 112.86 -175.391 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 15.6 m -124.4 18.14 8.95 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 -174.108 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.731 ' HE1' ' HB ' ' A' ' 7' ' ' THR . 58.7 m-85 -91.57 106.42 18.47 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 120.806 0.336 . . . . 0.0 111.12 -177.487 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.515 HG22 HG23 ' A' ' 16' ' ' VAL . 52.1 mt -71.66 -57.23 7.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.931 -176.851 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.515 HG23 HG22 ' A' ' 15' ' ' ILE . 61.0 t -129.0 132.05 67.63 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 CA-C-O 120.709 0.29 . . . . 0.0 110.963 -177.06 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.659 ' HD2' ' HB3' ' A' ' 14' ' ' TYR . 0.0 OUTLIER -128.06 115.62 18.75 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 174.949 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 27.6 m -124.11 166.01 19.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.732 0.301 . . . . 0.0 110.804 -179.598 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -87.51 137.08 32.65 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.623 -178.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -169.77 -165.1 0.47 Allowed 'General case' 0 C--O 1.237 0.437 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 178.377 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 7.3 p -140.44 126.97 21.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.031 0.443 . . . . 0.0 110.549 173.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.458 HG21 ' HB2' ' A' ' 73' ' ' LEU . 30.9 m -81.25 131.15 34.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.747 175.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 89.2 mmm -114.63 130.52 56.8 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.643 -0.502 . . . . 0.0 109.643 -176.471 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.447 HG23 ' HD1' ' A' ' 33' ' ' PHE . 9.5 t -103.16 162.01 13.32 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.086 0.469 . . . . 0.0 111.202 -178.518 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 19.8 ttt180 -120.38 21.26 11.72 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.18 -0.918 . . . . 0.0 108.6 178.239 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.412 ' O ' ' HB3' ' A' ' 27' ' ' ASP . 36.0 t70 49.17 38.39 13.09 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 114.423 -1.262 . . . . 0.0 111.192 177.899 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.412 ' HB3' ' O ' ' A' ' 26' ' ' ASP . 27.6 t70 73.27 -54.86 0.69 Allowed 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 115.242 -0.89 . . . . 0.0 112.758 177.207 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 22.1 m -136.62 18.59 3.09 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 112.611 0.597 . . . . 0.0 112.611 -174.025 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 65.7 m -86.14 -170.69 3.21 Favored 'General case' 0 C--N 1.327 -0.372 0 O-C-N 122.297 -0.252 . . . . 0.0 110.321 177.327 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -111.49 -44.14 0.93 Allowed Glycine 0 C--N 1.334 0.436 0 C-N-CA 121.294 -0.479 . . . . 0.0 112.368 -179.677 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -77.54 170.84 55.12 Favored Glycine 0 C--N 1.33 0.235 0 C-N-CA 121.192 -0.528 . . . . 0.0 112.692 -178.651 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 91.0 m95 -117.41 120.37 37.96 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 179.665 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.447 ' HD1' HG23 ' A' ' 24' ' ' THR . 1.4 m-85 -101.79 156.36 35.29 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.657 -170.896 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.455 ' HB3' ' HA2' ' A' ' 38' ' ' GLY . 51.3 Cg_exo -56.44 -11.82 7.12 Favored 'Trans proline' 0 C--N 1.355 0.918 0 C-N-CA 123.352 2.701 . . . . 0.0 112.992 178.496 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.607 HE22 ' HB ' ' A' ' 72' ' ' VAL . 0.2 OUTLIER 72.61 -71.08 0.14 Allowed 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 123.327 0.651 . . . . 0.0 110.554 174.256 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -161.74 -55.1 0.05 OUTLIER 'General case' 0 C--O 1.234 0.24 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 -179.779 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -62.76 -39.66 98.23 Favored Glycine 0 C--N 1.331 0.278 0 CA-C-N 115.596 -0.729 . . . . 0.0 112.553 -179.524 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.455 ' HA2' ' HB3' ' A' ' 34' ' ' PRO . . . 57.57 19.4 34.4 Favored Glycine 0 C--N 1.334 0.431 0 C-N-CA 121.544 -0.36 . . . . 0.0 113.551 177.16 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 140.2 -29.31 2.42 Favored Glycine 0 C--O 1.235 0.187 0 N-CA-C 111.203 -0.759 . . . . 0.0 111.203 -178.189 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.57 ' N ' HD12 ' A' ' 40' ' ' ILE . 2.8 mp -100.63 93.94 3.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 175.842 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 49.1 m -151.75 130.48 12.37 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 174.151 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 34.9 ttp180 -101.31 102.42 13.27 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 177.019 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 4.5 p -81.01 106.84 12.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 121.476 0.655 . . . . 0.0 109.976 179.52 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -102.8 112.37 4.25 Favored Glycine 0 N--CA 1.446 -0.669 0 CA-C-N 115.334 -0.848 . . . . 0.0 112.018 -179.511 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 7.0 p -86.45 109.22 18.6 Favored 'Isoleucine or valine' 0 C--O 1.239 0.5 0 CA-C-O 121.393 0.615 . . . . 0.0 109.967 176.162 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . 0.754 ' SG ' ' HB3' ' A' ' 60' ' ' LEU . 12.1 p -105.87 145.43 31.25 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.005 178.358 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 12.0 tmtt? -100.78 105.75 17.1 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 179.335 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.435 HG21 ' HE1' ' A' ' 76' ' ' TYR . 60.8 t -66.87 125.64 24.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.307 -179.129 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 66.1 mtt -87.17 147.38 25.63 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.193 179.253 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . 0.456 ' HB3' ' HB3' ' A' ' 57' ' ' SER . 28.8 p80 -85.77 133.97 40.52 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.52 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -79.13 175.06 11.29 Favored 'Trans proline' 0 C--O 1.239 0.547 0 C-N-CA 122.239 1.96 . . . . 0.0 110.608 170.81 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -65.7 135.4 54.91 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-O 120.975 0.417 . . . . 0.0 110.162 178.366 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 129.04 -150.46 18.82 Favored Glycine 0 N--CA 1.453 -0.225 0 N-CA-C 111.098 -0.801 . . . . 0.0 111.098 -176.204 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -58.31 -63.71 1.17 Allowed 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.891 0.377 . . . . 0.0 111.048 -179.641 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 149.34 158.39 8.08 Favored Glycine 0 N--CA 1.45 -0.377 0 CA-C-N 115.921 -0.581 . . . . 0.0 112.04 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 31.3 ttt180 -163.98 29.12 0.08 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.694 0.759 . . . . 0.0 109.028 179.42 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.456 ' HB3' ' HB3' ' A' ' 50' ' ' HIS . 25.3 p -89.29 154.46 20.08 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.318 -0.856 . . . . 0.0 111.261 -176.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 166.99 -142.42 7.58 Favored Glycine 0 N--CA 1.45 -0.384 0 N-CA-C 111.261 -0.735 . . . . 0.0 111.261 179.775 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -129.44 154.51 46.89 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 177.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.754 ' HB3' ' SG ' ' A' ' 46' ' ' CYS . 3.0 tt -128.42 119.06 24.22 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 178.882 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 57.2 mt -80.23 86.74 1.41 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.371 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 175.442 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . 0.444 ' HB3' ' HE2' ' A' ' 14' ' ' TYR . 21.7 t60 -98.84 107.69 20.19 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.981 -176.605 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -97.07 99.16 2.24 Favored Glycine 0 C--O 1.239 0.409 0 CA-C-N 115.81 -0.632 . . . . 0.0 112.488 -178.378 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.438 ' HG2' ' CE1' ' A' ' 8' ' ' HIS . 43.8 mt-10 -73.03 152.13 41.43 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 175.674 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.4 ' O ' HG22 ' A' ' 40' ' ' ILE . 71.0 ttt-85 -67.38 -31.95 72.54 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 174.474 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -168.13 -60.92 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.233 178.377 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 53.7 tttm -173.93 124.12 0.34 Allowed 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 117.804 0.275 . . . . 0.0 111.611 175.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 57.69 14.62 2.5 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.636 0.774 . . . . 0.0 112.005 174.002 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -106.77 -69.65 0.83 Allowed 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 111.831 0.308 . . . . 0.0 111.831 -167.322 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 48.5 tp -149.34 138.04 21.05 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.426 -175.078 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 21.4 t -88.52 102.0 12.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 176.075 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.607 ' HB ' HE22 ' A' ' 35' ' ' GLN . 28.3 m -88.17 -20.86 7.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.625 0.25 . . . . 0.0 111.355 -176.04 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.552 HD13 ' N ' ' A' ' 74' ' ' GLU . 2.9 tm? -149.65 140.74 22.99 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 179.373 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.552 ' N ' HD13 ' A' ' 73' ' ' LEU . 34.0 tt0 -159.07 119.86 3.24 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 -177.863 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 66.2 m -142.27 137.86 30.96 Favored 'General case' 0 C--O 1.232 0.161 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 -176.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.435 ' HE1' HG21 ' A' ' 48' ' ' VAL . 85.7 t80 -99.82 138.89 36.27 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 110.215 -0.291 . . . . 0.0 110.215 -176.25 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.72 HG12 HG11 ' A' ' 95' ' ' VAL . 20.3 m -135.19 141.16 43.51 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 -178.717 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 36.4 mtm180 -110.32 -73.06 0.7 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.941 0.401 . . . . 0.0 110.068 -178.121 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -152.85 19.63 0.6 Allowed 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 175.675 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -112.61 17.48 19.13 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 114.229 -1.35 . . . . 0.0 110.276 -176.145 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.574 HD22 ' HB2' ' A' ' 83' ' ' TYR . 1.6 tt -73.37 92.54 1.84 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.278 -176.736 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 3.6 p -81.17 85.25 1.52 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 CA-C-O 121.509 0.671 . . . . 0.0 110.009 174.757 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.614 ' HD2' HG21 ' A' ' 117' ' ' VAL . 0.6 OUTLIER -92.23 102.7 15.22 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.003 -177.011 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 99.9 m -114.46 133.12 55.99 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.295 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.534 ' HA ' ' HA ' ' A' ' 91' ' ' HIS . 4.9 ptpp? -94.96 111.8 23.56 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 175.528 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -70.94 -35.04 72.05 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.364 0.602 . . . . 0.0 109.494 175.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . 0.541 ' HB2' ' HB3' ' A' ' 90' ' ' PHE . 92.5 m-20 -134.48 155.18 79.9 Favored Pre-proline 0 C--N 1.332 -0.18 0 CA-C-N 114.99 -1.005 . . . . 0.0 108.529 176.339 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -54.3 -23.23 29.47 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.546 2.164 . . . . 0.0 112.753 178.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 14.9 t -112.45 2.31 16.32 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.335 -178.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.541 ' HB3' ' HB2' ' A' ' 87' ' ' ASN . 72.1 t80 -131.73 109.74 10.38 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-O 120.929 0.395 . . . . 0.0 110.681 -177.761 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . 0.534 ' HA ' ' HA ' ' A' ' 85' ' ' LYS . 0.1 OUTLIER -107.03 159.68 16.11 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 177.65 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . 0.413 ' HA ' ' HA2' ' A' ' 101' ' ' GLY . 17.2 p80 -155.73 160.82 40.64 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.612 0.244 . . . . 0.0 110.543 178.311 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 34.6 p90 -149.5 166.29 29.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.741 -178.664 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -131.63 106.08 7.94 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 174.264 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.72 HG11 HG12 ' A' ' 77' ' ' VAL . 29.8 m -136.56 172.54 15.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.139 -0.482 . . . . 0.0 109.822 179.544 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 42.9 m-20 59.09 -77.25 0.02 OUTLIER 'General case' 0 C--O 1.234 0.24 0 O-C-N 123.663 0.602 . . . . 0.0 110.427 -174.135 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 30.4 p-10 -163.26 9.12 0.05 Allowed 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 179.641 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 3.7 tpt180 -149.29 167.28 26.5 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 118.329 0.513 . . . . 0.0 111.627 -175.384 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 58.5 tttm -103.74 118.18 36.1 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.316 -176.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 33.8 m-85 -115.37 170.76 8.16 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.152 -0.476 . . . . 0.0 109.935 -178.591 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.413 ' HA2' ' HA ' ' A' ' 92' ' ' HIS . . . -142.39 164.86 26.88 Favored Glycine 0 C--N 1.332 0.35 0 C-N-CA 120.968 -0.634 . . . . 0.0 112.862 -177.657 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 8.3 tt -150.25 132.42 15.39 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 -179.586 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 45.5 m -112.76 134.54 54.23 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.868 0.366 . . . . 0.0 110.316 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 63.8 m-85 -86.78 -178.23 6.29 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.179 -179.003 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 24.6 tt0 -124.54 -70.55 0.75 Allowed 'General case' 0 C--O 1.236 0.346 0 CA-C-O 120.907 0.384 . . . . 0.0 111.122 -178.15 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 48.8 m -108.81 158.49 33.98 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.435 -175.127 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -54.8 -28.72 59.16 Favored 'Trans proline' 0 C--N 1.352 0.731 0 C-N-CA 122.539 2.159 . . . . 0.0 111.96 179.108 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -59.65 -68.39 0.29 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.736 178.513 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -61.62 -44.72 96.47 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.066 -178.475 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -56.23 -63.94 1.02 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.48 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 7.1 tpt180 -61.05 -39.51 90.09 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.635 -175.034 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -65.55 -39.48 91.76 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.075 -179.271 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 21.1 t80 -70.24 -42.87 71.64 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 -178.384 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 45.0 m-20 -58.53 -44.32 89.53 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-O 121.37 0.605 . . . . 0.0 109.991 175.489 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . 0.41 HH11 ' HD2' ' A' ' 115' ' ' ARG . 45.2 ttm180 -63.75 -39.67 94.84 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.289 -0.869 . . . . 0.0 109.84 178.265 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -67.55 -44.7 81.91 Favored Glycine 0 N--CA 1.449 -0.468 0 CA-C-N 115.235 -0.893 . . . . 0.0 112.622 -178.063 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.614 HG21 ' HD2' ' A' ' 83' ' ' TYR . 13.0 p -68.5 -35.75 71.78 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.105 0 CA-C-N 116.744 0.272 . . . . 0.0 110.398 -179.237 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 67.1 ttt180 -58.95 -52.53 65.34 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 174.004 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 54.3 tptt -58.08 -32.01 67.64 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.063 178.519 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -68.79 -36.68 78.57 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.476 176.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.536 HG13 ' O ' ' A' ' 117' ' ' VAL . 77.5 mt -60.86 -47.98 90.94 Favored 'Isoleucine or valine' 0 C--O 1.232 0.173 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 176.814 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -58.91 -57.83 11.33 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-O 120.907 0.384 . . . . 0.0 110.382 174.167 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -63.03 -29.21 70.64 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.774 -0.648 . . . . 0.0 112.54 -171.658 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 49.6 tp -93.47 -44.41 8.26 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 111.789 0.292 . . . . 0.0 111.789 -177.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.523 HD12 HG23 ' A' ' 121' ' ' ILE . 59.3 mt -99.85 -44.52 11.62 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 N-CA-C 112.705 0.631 . . . . 0.0 112.705 -170.457 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 . . . . . 0 C--O 1.249 1.028 0 CA-C-O 119.104 -0.474 . . . . 0.0 111.32 -170.314 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.641 0 N-CA-C 111.709 -0.556 . . . . 0.0 111.709 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 10.9 p -76.15 95.74 3.74 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.708 0.29 . . . . 0.0 110.319 178.545 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 27.1 ttt -62.46 -37.34 85.55 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.465 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 31.0 m -132.31 94.05 3.37 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.364 -179.138 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -114.63 -29.56 6.77 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 108.552 -0.906 . . . . 0.0 108.552 167.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -77.21 121.26 23.41 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 114.665 -1.152 . . . . 0.0 110.158 176.244 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 49.0 m -64.35 -31.27 72.41 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.019 0.437 . . . . 0.0 110.975 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.43 ' H ' ' HB2' ' A' ' 11' ' ' ASP . 52.8 m-70 -132.99 150.38 75.47 Favored Pre-proline 0 C--N 1.329 -0.288 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 179.356 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -53.93 -42.82 63.53 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 122.342 2.028 . . . . 0.0 111.716 178.815 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.503 ' HB3' ' HB2' ' A' ' 13' ' ' SER . 5.1 m-20 -105.2 32.61 4.12 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.049 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.439 ' HA ' ' CE1' ' A' ' 14' ' ' TYR . 24.6 t70 -54.96 -36.67 65.58 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.619 -175.721 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -83.44 -19.57 35.65 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.103 -178.548 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.503 ' HB2' ' HB3' ' A' ' 10' ' ' ASP . 19.2 m -92.08 9.59 32.77 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-N 115.993 -0.549 . . . . 0.0 112.056 -172.569 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.581 ' HA ' ' HA ' ' A' ' 46' ' ' CYS . 45.4 m-85 -68.74 125.12 25.56 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 120.623 0.249 . . . . 0.0 110.663 175.696 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 62.4 mt -67.47 -47.66 79.9 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 177.166 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 9.8 p -166.19 139.37 0.92 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.334 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.216 178.494 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.687 HH12 ' NH1' ' A' ' 65' ' ' ARG . 50.0 mtt180 -109.23 100.99 10.05 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 176.317 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 30.1 t -92.52 148.48 4.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.989 -174.702 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -83.75 120.92 26.61 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.445 179.739 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -164.88 -171.04 2.13 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.108 -0.496 . . . . 0.0 109.76 -179.624 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.461 ' HB ' ' HB ' ' A' ' 103' ' ' THR . 84.7 t -121.44 115.88 47.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.651 0.263 . . . . 0.0 110.576 178.774 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.571 HG23 HE22 ' A' ' 35' ' ' GLN . 16.4 m -83.95 125.98 40.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.767 0.318 . . . . 0.0 110.524 177.795 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 22.5 mmt -112.27 150.31 31.13 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.795 -176.658 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 11.9 t -129.61 155.39 45.91 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.112 -0.495 . . . . 0.0 109.932 176.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 25.9 tpt180 -140.56 141.02 35.27 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 178.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -70.69 111.31 6.06 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 174.435 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 22.7 t70 61.96 -83.19 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.556 0 O-C-N 123.53 0.519 . . . . 0.0 111.887 179.034 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 68.3 m -154.4 -172.06 4.08 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 122.389 0.276 . . . . 0.0 110.882 -176.766 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 12.7 t 85.09 151.73 0.08 Allowed 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.165 0.986 . . . . 0.0 111.47 179.587 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -77.8 80.62 1.32 Allowed Glycine 0 C--N 1.334 0.454 0 CA-C-N 115.605 -0.725 . . . . 0.0 112.581 -176.692 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -152.68 55.51 0.44 Allowed Glycine 0 CA--C 1.51 -0.258 0 N-CA-C 110.595 -1.002 . . . . 0.0 110.595 176.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 80.6 m95 -70.79 119.53 15.07 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.158 -0.521 . . . . 0.0 111.219 -173.782 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 46.9 p90 -107.11 126.7 29.52 Favored Pre-proline 0 CA--C 1.534 0.35 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.678 -177.732 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -73.1 99.19 1.07 Allowed 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 122.75 2.3 . . . . 0.0 111.696 178.791 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.571 HE22 HG23 ' A' ' 22' ' ' VAL . 5.0 pm0 -57.2 -48.78 77.93 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 115.648 -0.705 . . . . 0.0 112.703 -175.592 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.587 ' CB ' HG11 ' A' ' 72' ' ' VAL . 16.3 tp10 -134.8 -83.47 0.42 Allowed 'General case' 0 N--CA 1.467 0.406 0 O-C-N 122.254 -0.279 . . . . 0.0 110.919 -174.647 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -72.92 68.02 1.34 Allowed Glycine 0 C--N 1.336 0.568 0 C-N-CA 121.408 -0.425 . . . . 0.0 112.672 179.578 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -80.59 -35.35 25.91 Favored Glycine 0 C--N 1.331 0.267 0 C-N-CA 121.395 -0.431 . . . . 0.0 112.415 -179.085 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -79.45 -29.08 50.62 Favored Glycine 0 C--O 1.236 0.227 0 N-CA-C 111.454 -0.658 . . . . 0.0 111.454 177.741 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.415 HG12 HE22 ' A' ' 66' ' ' GLN . 8.6 tt -174.85 139.16 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 179.037 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 23.3 t -145.11 -178.51 6.09 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 177.628 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 60.1 mtt180 -130.89 106.9 8.73 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.098 0.475 . . . . 0.0 110.211 -177.222 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 40.9 t -81.6 103.39 8.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.127 -179.77 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -90.73 105.06 3.22 Favored Glycine 0 N--CA 1.446 -0.698 0 CA-C-N 115.959 -0.564 . . . . 0.0 112.352 -179.228 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 54.4 t -88.02 103.12 13.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 176.071 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . 0.624 ' SG ' ' HB3' ' A' ' 60' ' ' LEU . 5.3 p -108.49 145.55 34.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.258 -179.112 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 35.9 ttmt -98.31 100.96 12.29 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 175.093 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 30.1 m -86.87 128.58 39.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 121.096 0.474 . . . . 0.0 111.602 -172.468 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 25.1 ptm -84.59 140.49 31.35 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.553 178.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 23.5 m-70 -101.98 156.74 34.85 Favored Pre-proline 0 C--N 1.331 -0.217 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.115 -177.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_exo -71.27 61.85 2.64 Favored 'Trans proline' 0 CA--C 1.535 0.566 0 C-N-CA 122.843 2.362 . . . . 0.0 111.085 171.468 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 68.76 157.45 0.14 Allowed 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.913 -176.31 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 158.06 -26.36 0.43 Allowed Glycine 0 C--N 1.332 0.306 0 C-N-CA 121.331 -0.461 . . . . 0.0 112.235 -179.772 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -162.28 -53.25 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 121.096 0.474 . . . . 0.0 110.332 -178.138 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 140.11 -54.33 0.66 Allowed Glycine 0 CA--C 1.51 -0.24 0 N-CA-C 110.87 -0.892 . . . . 0.0 110.87 -179.183 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 39.0 ttm180 -73.78 139.27 45.08 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.762 0.315 . . . . 0.0 110.172 175.702 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 49.6 m -77.1 152.4 35.01 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.551 179.365 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -85.57 -161.72 35.09 Favored Glycine 0 N--CA 1.45 -0.387 0 N-CA-C 111.505 -0.638 . . . . 0.0 111.505 178.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.658 ' HB2' ' HB ' ' A' ' 77' ' ' VAL . 76.9 m-85 -134.96 163.78 29.08 Favored 'General case' 0 C--N 1.327 -0.409 0 O-C-N 122.559 -0.377 . . . . 0.0 110.299 -177.285 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.624 ' HB3' ' SG ' ' A' ' 46' ' ' CYS . 2.8 tt -150.29 118.63 6.41 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 177.843 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.449 ' O ' ' HA ' ' A' ' 74' ' ' GLU . 44.5 mm -82.63 91.53 2.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 175.537 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 12.6 t-80 -102.66 98.07 8.17 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.645 -174.445 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.513 ' O ' ' HB2' ' A' ' 64' ' ' GLU . . . -104.73 116.78 5.42 Favored Glycine 0 CA--C 1.522 0.48 0 CA-C-N 116.096 -0.502 . . . . 0.0 114.319 -171.727 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.681 ' HB2' HG22 ' A' ' 72' ' ' VAL . 7.7 tp10 165.08 -99.23 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 124.799 1.24 . . . . 0.0 109.103 164.228 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.687 ' NH1' HH12 ' A' ' 17' ' ' ARG . 8.6 tpt180 59.35 -1.03 0.15 Allowed 'General case' 0 CA--C 1.545 0.777 0 N-CA-C 113.436 0.902 . . . . 0.0 113.436 171.665 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.415 HE22 HG12 ' A' ' 40' ' ' ILE . 6.6 tp-100 -52.15 -59.04 4.84 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 -171.713 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 51.7 tttp -91.33 5.45 49.19 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-O 120.983 0.421 . . . . 0.0 110.397 -178.692 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 31.8 t0 64.84 149.2 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.568 -175.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 4.3 mppt? 55.84 26.23 9.4 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 121.003 0.43 . . . . 0.0 110.7 -169.681 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.574 HD22 ' HG2' ' A' ' 64' ' ' GLU . 0.9 OUTLIER -129.12 128.2 43.0 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.298 -0.631 . . . . 0.0 109.298 -179.056 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.625 ' HA ' ' HB3' ' A' ' 64' ' ' GLU . 51.4 t -137.66 140.67 40.93 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 179.18 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.681 HG22 ' HB2' ' A' ' 64' ' ' GLU . 27.5 m -130.35 -41.17 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 177.529 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.3 tt -124.36 133.79 53.33 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.389 -0.596 . . . . 0.0 109.389 -175.534 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.449 ' HA ' ' O ' ' A' ' 61' ' ' ILE . 11.0 pt-20 -146.98 130.3 16.62 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.067 0.461 . . . . 0.0 109.803 173.444 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . 0.54 ' HG ' ' HE1' ' A' ' 93' ' ' TRP . 47.7 t -130.03 109.34 10.78 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 -179.321 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 24.9 t80 -74.7 129.55 37.9 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.046 -0.525 . . . . 0.0 109.914 -177.083 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.658 ' HB ' ' HB2' ' A' ' 59' ' ' PHE . 63.1 t -105.45 85.32 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.496 0.665 . . . . 0.0 109.216 -177.894 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.446 ' O ' ' HB3' ' A' ' 79' ' ' LYS . 6.9 ptm180 -97.29 67.01 2.11 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.195 -0.911 . . . . 0.0 109.631 -179.633 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.49 ' HA ' HD21 ' A' ' 124' ' ' LEU . 7.3 tmtm? 77.39 -49.08 0.52 Allowed 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.478 -175.365 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.43 ' OD1' ' HG3' ' A' ' 78' ' ' ARG . 5.0 p-10 -81.91 128.97 34.6 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-O 121.058 0.456 . . . . 0.0 110.623 -178.595 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.624 HD12 HD11 ' A' ' 121' ' ' ILE . 3.3 tm? -177.48 135.53 0.19 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.269 -0.878 . . . . 0.0 108.684 -178.263 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 3.7 p -145.71 106.09 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 CA-C-O 121.019 0.438 . . . . 0.0 111.3 -179.054 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.706 ' HB3' ' NE2' ' A' ' 91' ' ' HIS . 3.2 m-85 -88.84 150.97 22.64 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.217 176.299 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 81.5 m -150.47 120.23 7.05 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.883 177.566 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.453 ' HA ' ' HA ' ' A' ' 91' ' ' HIS . 8.0 ttpm? -90.64 110.72 21.87 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 177.707 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -78.62 -50.16 11.98 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.069 -179.374 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . 0.603 ' HB2' ' HB3' ' A' ' 90' ' ' PHE . 91.7 m-20 -120.11 153.41 55.39 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.004 179.706 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_endo -48.39 -33.63 23.24 Favored 'Trans proline' 0 CA--C 1.534 0.518 0 C-N-CA 122.99 2.46 . . . . 0.0 112.881 -176.295 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 15.2 t -112.36 13.87 20.34 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.419 -176.661 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.603 ' HB3' ' HB2' ' A' ' 87' ' ' ASN . 91.3 t80 -139.02 119.85 14.27 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-O 121.187 0.518 . . . . 0.0 111.493 -178.192 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . 0.706 ' NE2' ' HB3' ' A' ' 83' ' ' TYR . 1.2 t60 -116.24 157.8 24.34 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.384 -0.825 . . . . 0.0 108.915 178.5 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 25.0 p80 -155.05 157.58 37.8 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 175.304 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . 0.54 ' HE1' ' HG ' ' A' ' 75' ' ' CYS . 36.4 p90 -144.03 174.21 11.05 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 176.687 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 61.5 pttt -144.01 155.57 44.06 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 179.559 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.629 HG23 ' H ' ' A' ' 96' ' ' ASP . 7.9 m -133.55 -63.73 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.913 176.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.629 ' H ' HG23 ' A' ' 95' ' ' VAL . 20.3 m-20 -115.32 71.8 0.78 Allowed 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 -179.388 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 18.0 m120 74.02 -39.54 0.43 Allowed 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 115.346 -0.843 . . . . 0.0 112.155 178.788 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 63.7 ttt180 -87.18 148.8 25.02 Favored 'General case' 0 C--O 1.242 0.702 0 CA-C-O 121.033 0.444 . . . . 0.0 111.372 -176.083 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 61.9 mttp -100.71 143.57 30.72 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 114.956 -1.02 . . . . 0.0 110.834 178.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.408 ' HB2' ' CE2' ' A' ' 93' ' ' TRP . 6.8 m-85 -118.94 143.85 46.78 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 172.061 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -113.09 163.04 12.17 Favored Glycine 0 C--N 1.331 0.285 0 C-N-CA 120.834 -0.698 . . . . 0.0 113.892 -170.722 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.44 ' HB2' ' HZ3' ' A' ' 93' ' ' TRP . 57.3 tp -150.7 106.92 3.46 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 122.793 0.437 . . . . 0.0 110.181 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.461 ' HB ' ' HB ' ' A' ' 21' ' ' VAL . 52.1 m -89.31 125.04 34.95 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.323 178.044 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.55 ' CZ ' ' HB2' ' A' ' 91' ' ' HIS . 23.8 m-85 -78.76 161.04 27.12 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.462 179.465 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 65.3 tt0 -109.17 -42.04 4.51 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.712 179.469 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 13.6 m -140.88 151.63 63.23 Favored Pre-proline 0 CA--C 1.533 0.327 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.254 -179.072 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_exo -50.41 -30.26 26.58 Favored 'Trans proline' 0 C--N 1.352 0.752 0 C-N-CA 122.975 2.45 . . . . 0.0 113.207 -179.289 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -62.87 -64.11 1.01 Allowed 'General case' 0 C--O 1.235 0.291 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.98 179.844 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -62.99 -33.95 76.51 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.354 179.236 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.48 ' HB1' ' NH2' ' A' ' 111' ' ' ARG . . . -54.8 -63.89 1.01 Allowed 'General case' 0 C--O 1.235 0.325 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.092 177.688 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.48 ' NH2' ' HB1' ' A' ' 110' ' ' ALA . 0.0 OUTLIER -65.65 -24.43 67.02 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.788 179.765 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -61.93 -40.51 95.75 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 175.124 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.41 ' O ' HG12 ' A' ' 117' ' ' VAL . 47.4 m-85 -70.89 -48.23 54.84 Favored 'General case' 0 N--CA 1.461 0.1 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.587 176.083 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -53.54 -66.19 0.43 Allowed 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 121.39 0.614 . . . . 0.0 110.441 178.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 16.5 mtp180 -63.68 -36.56 84.25 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.889 -178.014 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -60.26 -53.78 42.77 Favored Glycine 0 C--N 1.332 0.344 0 CA-C-N 116.097 -0.501 . . . . 0.0 112.588 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.41 HG12 ' O ' ' A' ' 113' ' ' PHE . 10.7 p -66.27 -36.47 77.46 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.121 0 CA-C-N 116.672 0.236 . . . . 0.0 110.505 -178.071 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 95.8 mtt180 -60.95 -42.59 98.52 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.475 -0.329 . . . . 0.0 111.104 177.777 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 30.8 mmtp -76.29 -27.52 56.66 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 120.68 0.276 . . . . 0.0 110.948 178.223 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -63.35 -48.69 76.91 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 174.732 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.624 HD11 HD12 ' A' ' 81' ' ' LEU . 46.9 mm -66.8 -36.08 76.33 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.187 176.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -54.65 -56.67 16.67 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.253 178.265 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 -70.15 -29.5 66.43 Favored 'General case' 0 C--O 1.225 -0.188 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.94 179.386 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.49 HD21 ' HA ' ' A' ' 79' ' ' LYS . 6.7 tt -59.59 -43.76 93.58 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 177.241 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 66.7 mt -77.7 -30.88 16.95 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.495 178.595 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.428 -0.796 . . . . 0.0 109.808 179.101 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.716 0 N-CA-C 112.087 -0.405 . . . . 0.0 112.087 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 26.1 m -67.06 94.36 0.33 Allowed 'General case' 0 CA--C 1.532 0.266 0 CA-C-O 120.968 0.413 . . . . 0.0 110.913 -179.083 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 16.1 tpt -152.83 43.03 0.63 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.791 0.805 . . . . 0.0 109.002 177.758 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 18.2 p -99.61 113.17 25.44 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.538 -176.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -121.98 174.07 7.13 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 173.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 14.6 tm-20 71.57 -73.88 0.09 Allowed 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 -178.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.49 ' CB ' ' HB2' ' A' ' 12' ' ' ASP . 40.1 p 45.99 98.69 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 113.933 1.086 . . . . 0.0 113.933 171.656 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.497 ' H ' ' HD2' ' A' ' 9' ' ' PRO . 25.0 m170 -151.95 -54.85 0.02 OUTLIER Pre-proline 0 CA--C 1.536 0.416 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 -179.047 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.497 ' HD2' ' H ' ' A' ' 8' ' ' HIS . 92.2 Cg_endo -79.7 40.76 1.0 Allowed 'Trans proline' 0 C--N 1.36 1.177 0 C-N-CA 122.215 1.943 . . . . 0.0 110.714 169.855 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -168.75 -30.76 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 -174.133 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 80.21 102.75 0.06 Allowed 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 113.436 -1.711 . . . . 0.0 113.165 165.809 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.49 ' HB2' ' CB ' ' A' ' 7' ' ' THR . 3.7 m-20 -149.42 -23.79 0.28 Allowed 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.8 167.184 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 15.1 m -89.27 -8.12 54.05 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 120.798 0.333 . . . . 0.0 111.538 -176.767 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 67.8 m-85 -88.05 147.9 24.75 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.96 0.41 . . . . 0.0 111.515 -176.649 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 48.9 mm -105.81 -37.88 4.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 168.036 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 59.4 t -136.29 142.98 37.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 114.964 -1.016 . . . . 0.0 108.684 175.327 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.496 HH21 ' CD ' ' A' ' 64' ' ' GLU . 63.1 ttt180 -149.24 84.02 1.44 Allowed 'General case' 0 C--O 1.235 0.304 0 CA-C-O 121.22 0.533 . . . . 0.0 109.931 179.223 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 60.1 t -107.37 141.78 21.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.034 -177.752 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.742 ' HD3' ' H ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -82.83 127.51 33.54 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.943 -0.392 . . . . 0.0 109.943 176.909 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -150.48 171.92 16.29 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.64 178.597 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.56 ' HB ' ' HB ' ' A' ' 103' ' ' THR . 49.0 t -84.99 96.89 5.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.977 0.417 . . . . 0.0 110.783 -176.398 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 57.8 t -79.35 113.67 19.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.562 179.761 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 22.5 mmt -99.34 156.55 16.94 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.024 -0.534 . . . . 0.0 109.923 178.27 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.503 HG23 ' CE1' ' A' ' 33' ' ' PHE . 8.8 t -130.39 142.12 50.53 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.026 0.441 . . . . 0.0 110.536 179.466 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.428 ' HB2' ' CZ3' ' A' ' 32' ' ' TRP . 0.0 OUTLIER -94.06 101.33 13.36 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 173.778 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.487 ' HB2' ' CE1' ' A' ' 33' ' ' PHE . 32.1 t70 -52.4 120.82 5.99 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 178.085 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -39.26 108.68 0.09 Allowed 'General case' 0 N--CA 1.466 0.339 0 O-C-N 124.228 0.955 . . . . 0.0 111.487 -176.231 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 40.6 p 46.02 82.31 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.39 0 O-C-N 123.836 0.71 . . . . 0.0 111.36 -176.377 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 6.9 t -131.15 -69.38 0.63 Allowed 'General case' 0 C--O 1.234 0.27 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.812 -175.535 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 174.12 -62.02 0.12 Allowed Glycine 0 C--N 1.333 0.364 0 C-N-CA 121.177 -0.535 . . . . 0.0 112.005 -179.26 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -128.46 -139.28 4.73 Favored Glycine 0 C--O 1.236 0.245 0 C-N-CA 121.226 -0.511 . . . . 0.0 112.556 -179.213 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . 0.496 ' HH2' ' HG2' ' A' ' 99' ' ' LYS . 67.8 m95 -125.1 149.4 47.88 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 179.252 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.503 ' CE1' HG23 ' A' ' 24' ' ' THR . 2.0 p90 -149.07 152.86 37.25 Favored Pre-proline 0 C--O 1.236 0.366 0 N-CA-C 110.318 -0.253 . . . . 0.0 110.318 177.726 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -63.03 125.69 16.41 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 122.297 1.998 . . . . 0.0 111.785 176.008 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.638 ' HG2' HD21 ' A' ' 73' ' ' LEU . 2.0 pp0? -69.06 -168.67 0.15 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.263 174.739 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -55.59 -14.72 2.28 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 -173.871 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -67.59 -40.84 90.57 Favored Glycine 0 CA--C 1.521 0.414 0 N-CA-C 111.599 -0.6 . . . . 0.0 111.599 173.703 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 86.43 -33.95 3.57 Favored Glycine 0 C--N 1.333 0.411 0 N-CA-C 112.17 -0.372 . . . . 0.0 112.17 178.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.457 ' O ' ' HA ' ' A' ' 21' ' ' VAL . . . -162.78 -105.06 0.19 Allowed Glycine 0 N--CA 1.443 -0.859 0 N-CA-C 111.195 -0.762 . . . . 0.0 111.195 176.663 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.425 HG23 ' HB2' ' A' ' 19' ' ' LYS . 1.8 mp -60.9 131.88 26.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 120.973 0.416 . . . . 0.0 110.334 -179.904 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 41.6 m -145.82 152.89 40.25 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.333 178.322 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.757 ' HB2' ' HB2' ' A' ' 64' ' ' GLU . 13.1 mmt180 -72.99 105.13 4.34 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 110.379 -0.23 . . . . 0.0 110.379 -179.655 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 56.4 t -83.47 89.89 2.39 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 174.13 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -88.09 104.13 3.0 Favored Glycine 0 N--CA 1.444 -0.794 0 CA-C-N 115.515 -0.766 . . . . 0.0 112.669 -177.79 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 53.5 t -80.58 88.35 1.57 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.522 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 174.774 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . 0.683 ' HB3' ' HB3' ' A' ' 60' ' ' LEU . 42.6 t -85.58 146.73 26.75 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.392 179.204 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 79.6 tttt -142.73 96.88 3.01 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 -174.394 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 26.9 m -98.97 132.74 43.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.652 -176.82 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.7 151.83 40.6 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.838 0.351 . . . . 0.0 111.116 -177.065 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 13.6 m170 -93.84 121.61 63.99 Favored Pre-proline 0 C--O 1.233 0.234 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 176.652 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -49.48 -54.19 5.85 Favored 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 123.139 2.559 . . . . 0.0 113.278 -175.145 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -155.99 125.71 6.4 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 121.015 0.436 . . . . 0.0 109.891 -178.527 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 149.63 -159.81 28.22 Favored Glycine 0 C--N 1.329 0.185 0 N-CA-C 110.941 -0.864 . . . . 0.0 110.941 -178.019 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 51.4 t30 -95.71 130.04 42.74 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 117.342 0.571 . . . . 0.0 109.577 175.85 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 121.97 144.58 6.85 Favored Glycine 0 N--CA 1.449 -0.44 0 N-CA-C 111.541 -0.624 . . . . 0.0 111.541 -177.188 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 52.6 ttm-85 -86.92 -56.07 3.56 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.086 0.469 . . . . 0.0 110.265 -178.84 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 24.3 m -156.24 133.87 10.96 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.613 -176.731 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -78.64 147.16 30.71 Favored Glycine 0 N--CA 1.45 -0.422 0 N-CA-C 110.937 -0.865 . . . . 0.0 110.937 174.299 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.446 ' HB2' HG23 ' A' ' 77' ' ' VAL . 69.5 m-85 -104.08 122.31 45.03 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.906 0.384 . . . . 0.0 110.316 -174.65 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.683 ' HB3' ' HB3' ' A' ' 46' ' ' CYS . 3.6 tt -103.9 107.3 18.12 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 179.416 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 61.4 mt -71.49 91.97 0.43 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.327 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 174.707 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 12.4 t-80 -97.3 100.39 11.85 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.074 -173.111 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.437 ' HA3' ' HB2' ' A' ' 73' ' ' LEU . . . -99.35 112.96 4.59 Favored Glycine 0 C--N 1.33 0.22 0 C-N-CA 121.399 -0.429 . . . . 0.0 112.271 -177.373 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.757 ' HB2' ' HB2' ' A' ' 42' ' ' ARG . 22.1 mt-10 -107.05 138.2 43.67 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 122.226 0.21 . . . . 0.0 110.607 -178.545 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 26.6 ttt85 -67.63 130.85 44.3 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 173.768 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 6.8 tp60 -58.56 154.93 13.2 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.368 -176.521 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt 72.86 -69.84 0.18 Allowed 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 123.422 0.689 . . . . 0.0 111.35 177.471 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -69.23 -36.23 77.0 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 120.706 0.289 . . . . 0.0 110.543 -176.541 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 50.4 mtmt 61.93 85.28 0.12 Allowed 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.57 -0.741 . . . . 0.0 112.06 176.285 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -150.26 154.91 38.74 Favored 'General case' 0 C--O 1.24 0.565 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 173.468 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 10.5 t -72.5 92.61 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 CA-C-O 120.958 0.408 . . . . 0.0 111.517 -171.662 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 9.5 m -88.22 -37.47 10.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.452 176.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.638 HD21 ' HG2' ' A' ' 35' ' ' GLN . 4.2 mm? -117.35 137.88 52.16 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 176.784 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.584 ' HG3' HD21 ' A' ' 60' ' ' LEU . 35.0 tt0 -150.21 114.56 5.17 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 177.868 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . 0.507 ' SG ' ' CE2' ' A' ' 100' ' ' PHE . 36.5 m -138.07 101.4 4.41 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.959 0.409 . . . . 0.0 110.156 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 75.5 t80 -84.62 112.31 20.33 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.12 -0.491 . . . . 0.0 109.924 179.791 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.466 HG21 HD21 ' A' ' 81' ' ' LEU . 16.4 m -97.54 100.33 10.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 121.863 0.84 . . . . 0.0 109.267 177.803 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.452 ' HG2' ' H ' ' A' ' 78' ' ' ARG . 19.5 ptt180 -70.92 -45.68 63.81 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 114.631 -1.168 . . . . 0.0 112.092 -172.117 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 35.8 ttpt -160.99 29.73 0.14 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.569 0.7 . . . . 0.0 109.792 -175.02 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.421 ' O ' ' HB ' ' A' ' 77' ' ' VAL . 7.3 p-10 -149.66 140.98 23.19 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.08 -178.802 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.466 HD21 HG21 ' A' ' 77' ' ' VAL . 12.8 mt -155.36 101.38 2.2 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.967 179.057 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.467 HG23 ' N ' ' A' ' 83' ' ' TYR . 27.6 m -74.3 -53.06 18.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 174.468 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.467 ' N ' HG23 ' A' ' 82' ' ' VAL . 4.5 t80 30.46 82.86 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.431 1.092 . . . . 0.0 112.015 177.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 36.0 m -112.41 133.48 54.47 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.998 -179.079 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.525 ' HA ' ' HA ' ' A' ' 91' ' ' HIS . 17.7 ptmt -93.46 101.72 13.93 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.315 0.579 . . . . 0.0 110.224 178.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -72.34 -49.49 33.94 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.975 -178.501 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . 0.572 ' HB2' ' HB3' ' A' ' 90' ' ' PHE . 0.8 OUTLIER -104.83 153.27 39.44 Favored Pre-proline 0 C--N 1.327 -0.387 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 174.753 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_exo -48.24 -31.91 18.13 Favored 'Trans proline' 0 CA--C 1.534 0.499 0 C-N-CA 122.621 2.214 . . . . 0.0 112.765 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.484 ' HA ' ' HD2' ' A' ' 104' ' ' PHE . 20.5 p -120.09 16.35 12.43 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 112.328 0.492 . . . . 0.0 112.328 -178.321 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.572 ' HB3' ' HB2' ' A' ' 87' ' ' ASN . 5.5 t80 -129.88 105.84 8.27 Favored 'General case' 0 C--O 1.239 0.5 0 CA-C-O 120.93 0.395 . . . . 0.0 110.094 178.665 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . 0.525 ' HA ' ' HA ' ' A' ' 85' ' ' LYS . 0.1 OUTLIER -102.73 133.18 48.19 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 177.763 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 30.2 p80 -129.1 155.05 46.07 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.935 0.398 . . . . 0.0 110.812 -178.003 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . 0.412 ' CE2' ' HB2' ' A' ' 100' ' ' PHE . 43.8 p90 -144.91 158.49 43.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.174 178.517 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 22.5 ptmt -144.02 148.98 35.98 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 177.784 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.701 HG23 ' H ' ' A' ' 96' ' ' ASP . 4.4 m -127.64 -66.87 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 C-N-CA 121.2 -0.2 . . . . 0.0 111.173 -179.3 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.701 ' H ' HG23 ' A' ' 95' ' ' VAL . 10.9 m-20 -120.87 80.1 1.59 Allowed 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 177.157 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 52.4 t-20 74.35 -52.96 0.68 Allowed 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 114.79 -1.095 . . . . 0.0 111.429 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -68.87 139.42 55.17 Favored 'General case' 0 C--O 1.244 0.806 0 CA-C-O 121.003 0.43 . . . . 0.0 110.239 -175.813 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.496 ' HG2' ' HH2' ' A' ' 32' ' ' TRP . 39.7 ttmt -121.49 135.49 55.03 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.503 -178.711 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.507 ' CE2' ' SG ' ' A' ' 75' ' ' CYS . 20.4 m-85 -124.0 164.31 19.61 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 -178.797 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -139.64 159.74 25.92 Favored Glycine 0 C--N 1.331 0.298 0 C-N-CA 120.764 -0.732 . . . . 0.0 113.461 -174.47 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.41 ' HB2' ' HZ3' ' A' ' 93' ' ' TRP . 5.6 tt -139.54 114.77 9.72 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 -179.496 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.56 ' HB ' ' HB ' ' A' ' 21' ' ' VAL . 48.5 m -93.3 119.65 32.69 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.087 176.873 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.484 ' HD2' ' HA ' ' A' ' 89' ' ' THR . 33.3 m-85 -70.02 158.4 35.74 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.224 179.599 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 45.6 mt-30 -108.13 -46.31 3.77 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.771 -178.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 14.7 m -135.07 156.49 78.26 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.408 -176.21 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -51.52 -30.49 35.82 Favored 'Trans proline' 0 C--N 1.35 0.619 0 C-N-CA 122.652 2.235 . . . . 0.0 112.49 177.036 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -60.57 -61.02 2.89 Favored 'General case' 0 C--O 1.239 0.516 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.384 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -65.52 -43.74 89.11 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.433 -0.348 . . . . 0.0 110.599 -178.724 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -51.95 -54.74 26.06 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 121.086 0.47 . . . . 0.0 111.027 177.36 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 34.7 ttt180 -61.59 -39.21 90.4 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.01 -177.633 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -61.99 -43.39 98.94 Favored 'General case' 0 C--O 1.231 0.109 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.304 179.685 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 49.1 m-85 -69.64 -39.86 76.87 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.617 -0.265 . . . . 0.0 110.965 -179.133 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 45.6 m-20 -60.15 -57.88 10.91 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-O 121.31 0.576 . . . . 0.0 110.752 178.45 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 37.3 mmt180 -66.87 -31.27 71.76 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.171 -179.497 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -64.21 -48.86 70.53 Favored Glycine 0 N--CA 1.449 -0.441 0 CA-C-N 115.635 -0.711 . . . . 0.0 112.199 179.195 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.5 ' O ' HG12 ' A' ' 121' ' ' ILE . 11.5 p -66.89 -37.88 80.3 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.086 0 N-CA-C 110.26 -0.274 . . . . 0.0 110.26 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 8.1 tpt180 -56.69 -49.45 75.1 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-O 120.853 0.359 . . . . 0.0 110.169 176.054 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 60.0 tptt -58.61 -44.42 89.9 Favored 'General case' 0 C--O 1.241 0.647 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.382 177.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -57.94 -47.23 83.51 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.56 178.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.5 HG12 ' O ' ' A' ' 117' ' ' VAL . 43.0 mm -59.21 -46.63 92.05 Favored 'Isoleucine or valine' 0 C--O 1.232 0.14 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.469 179.422 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 62.6 mm-40 -51.7 -58.16 7.16 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.945 179.699 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -73.75 -33.22 64.21 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.569 -174.755 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 60.2 tp -64.98 -41.82 95.08 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.911 0.386 . . . . 0.0 110.449 -179.082 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 47.9 mm -78.99 -55.96 8.4 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.901 -178.106 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 . . . . . 0 C--O 1.253 1.243 0 CA-C-O 119.356 -0.354 . . . . 0.0 111.266 -176.827 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.794 0 N-CA-C 112.031 -0.428 . . . . 0.0 112.031 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 24.2 p -89.31 28.37 1.26 Allowed 'General case' 0 C--O 1.237 0.446 0 CA-C-O 121.336 0.588 . . . . 0.0 110.801 179.365 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 49.1 ttp -92.78 159.15 15.53 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.215 176.404 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 23.5 m 74.0 127.19 0.04 OUTLIER 'General case' 0 C--O 1.235 0.312 0 O-C-N 123.535 0.522 . . . . 0.0 109.935 -177.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -110.02 152.53 25.8 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.016 0.436 . . . . 0.0 111.407 -174.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.459 ' HB3' ' HB2' ' A' ' 11' ' ' ASP . 1.5 mp0 -108.02 145.57 33.76 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 161.459 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.441 ' O ' ' HG3' ' A' ' 64' ' ' GLU . 0.5 OUTLIER -79.41 -30.19 42.27 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.599 0.714 . . . . 0.0 109.085 -176.003 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.538 ' HD2' ' H ' ' A' ' 10' ' ' ASP . 5.9 t60 -119.35 136.42 24.54 Favored Pre-proline 0 C--N 1.328 -0.362 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 177.301 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -56.13 -6.4 1.31 Allowed 'Trans proline' 0 C--N 1.353 0.787 0 C-N-CA 122.79 2.327 . . . . 0.0 112.775 179.352 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.538 ' H ' ' HD2' ' A' ' 8' ' ' HIS . 27.2 t70 -141.55 46.1 1.7 Allowed 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 173.329 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.459 ' HB2' ' HB3' ' A' ' 6' ' ' GLU . 7.7 t70 -52.38 104.61 0.09 Allowed 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 115.073 -0.967 . . . . 0.0 110.889 -174.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -96.66 -54.68 3.15 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.102 -0.499 . . . . 0.0 112.223 -175.783 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 57.8 m -143.55 37.0 1.33 Allowed 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 111.867 0.321 . . . . 0.0 111.867 -175.553 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.442 ' HA ' ' HB3' ' A' ' 46' ' ' CYS . 59.5 m-85 -76.54 93.29 3.54 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 121.111 0.481 . . . . 0.0 110.504 177.922 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.566 HG22 HG23 ' A' ' 16' ' ' VAL . 44.0 mm -69.19 -56.59 11.31 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 CA-C-N 115.437 -0.802 . . . . 0.0 111.465 -173.809 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.566 HG23 HG22 ' A' ' 15' ' ' ILE . 57.8 t -131.84 131.15 61.96 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 CA-C-O 120.574 0.226 . . . . 0.0 111.128 -175.507 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.586 ' HG3' ' HA2' ' A' ' 44' ' ' GLY . 0.5 OUTLIER -110.89 98.27 7.45 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 171.895 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 44.9 t -76.39 154.85 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.464 -177.263 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 58.7 tttp -98.88 131.33 45.06 Favored 'General case' 0 N--CA 1.462 0.129 0 CA-C-O 120.826 0.346 . . . . 0.0 110.374 178.12 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.495 ' O ' ' HB2' ' A' ' 41' ' ' SER . . . -171.19 -166.95 0.5 Allowed 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 175.479 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 61.7 t -117.93 120.19 63.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 167.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.528 HG11 ' HG ' ' A' ' 73' ' ' LEU . 49.6 t -71.7 94.15 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 121.148 0.499 . . . . 0.0 109.985 179.65 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . 0.467 ' HB3' ' HB3' ' A' ' 32' ' ' TRP . 21.4 mmt -86.44 110.7 19.91 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.582 -178.473 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 1.1 m -100.78 120.77 40.6 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.427 -0.806 . . . . 0.0 108.961 172.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.79 114.86 11.4 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 179.361 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -58.03 91.18 0.01 OUTLIER 'General case' 0 C--O 1.233 0.222 0 O-C-N 123.345 0.403 . . . . 0.0 110.44 -176.485 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 28.3 t70 55.54 -87.7 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.788 -176.858 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 60.4 m -157.99 26.97 0.26 Allowed 'General case' 0 C--O 1.235 0.315 0 CA-C-O 121.093 0.473 . . . . 0.0 109.993 177.532 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 34.8 t -143.18 159.52 42.14 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.032 -179.358 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 82.38 -53.57 4.8 Favored Glycine 0 C--N 1.329 0.187 0 C-N-CA 121.235 -0.507 . . . . 0.0 112.22 179.207 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 131.29 -161.43 23.59 Favored Glycine 0 C--N 1.331 0.304 0 N-CA-C 111.976 -0.449 . . . . 0.0 111.976 177.457 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . 0.467 ' HB3' ' HB3' ' A' ' 23' ' ' MET . 84.2 m95 -84.69 104.83 15.01 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 109.36 -0.608 . . . . 0.0 109.36 176.347 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -103.71 147.84 34.87 Favored Pre-proline 0 C--O 1.237 0.423 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 -175.522 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -59.96 132.21 43.56 Favored 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 122.472 2.114 . . . . 0.0 111.355 179.152 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 8.0 tp-100 -39.73 -47.16 2.01 Favored 'General case' 0 N--CA 1.468 0.439 0 O-C-N 123.764 0.665 . . . . 0.0 112.055 -175.782 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -176.07 -34.91 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 178.454 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -108.86 167.9 13.23 Favored Glycine 0 N--CA 1.453 -0.209 0 CA-C-N 115.14 -0.936 . . . . 0.0 110.776 171.466 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -132.49 150.41 19.68 Favored Glycine 0 C--O 1.234 0.151 0 C-N-CA 120.95 -0.643 . . . . 0.0 112.473 -178.194 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 81.06 -58.59 4.82 Favored Glycine 0 C--N 1.331 0.293 0 C-N-CA 121.46 -0.4 . . . . 0.0 112.585 178.407 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.496 ' N ' HD12 ' A' ' 40' ' ' ILE . 3.5 mp -101.85 107.29 21.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.783 0.325 . . . . 0.0 110.599 -178.784 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.495 ' HB2' ' O ' ' A' ' 20' ' ' ALA . 36.6 m -141.9 113.84 8.01 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 171.316 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.502 ' HB2' ' O ' ' A' ' 64' ' ' GLU . 5.7 mpt_? -88.79 133.48 34.23 Favored 'General case' 0 CA--C 1.519 -0.218 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 175.642 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.787 HG21 HD21 ' A' ' 102' ' ' LEU . 75.5 t -106.2 100.01 9.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.006 177.328 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.586 ' HA2' ' HG3' ' A' ' 17' ' ' ARG . . . -71.26 84.63 0.41 Allowed Glycine 0 N--CA 1.448 -0.546 0 CA-C-N 115.673 -0.694 . . . . 0.0 112.693 -179.202 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 54.8 t -75.69 107.96 7.22 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 176.479 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . 0.699 ' SG ' ' HB3' ' A' ' 60' ' ' LEU . 6.1 p -125.51 125.71 43.71 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.064 -0.517 . . . . 0.0 111.079 -177.336 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 57.8 tttm -87.6 89.08 7.86 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 175.833 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 31.0 t -77.12 125.57 37.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.23 -174.091 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 97.6 mmm -81.59 109.1 15.71 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 174.763 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 7.5 p80 -68.47 154.33 94.51 Favored Pre-proline 0 C--N 1.325 -0.482 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.424 -179.198 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -54.13 135.45 64.42 Favored 'Trans proline' 0 C--N 1.352 0.724 0 C-N-CA 122.587 2.191 . . . . 0.0 111.569 178.841 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 61.48 40.22 14.07 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.702 -176.026 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -50.16 105.64 0.18 Allowed Glycine 0 C--N 1.333 0.382 0 CA-C-N 115.507 -0.77 . . . . 0.0 112.526 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 30.3 p-10 -79.15 -16.61 56.4 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.914 0.388 . . . . 0.0 111.173 -177.19 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 150.71 -24.65 1.05 Allowed Glycine 0 N--CA 1.453 -0.221 0 N-CA-C 111.546 -0.622 . . . . 0.0 111.546 -178.508 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.551 ' NE ' ' HA ' ' A' ' 56' ' ' ARG . 0.6 OUTLIER -87.05 171.68 10.54 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 177.571 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.482 ' H ' ' HG3' ' A' ' 56' ' ' ARG . 24.9 m -145.13 166.26 25.93 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.749 0.309 . . . . 0.0 110.554 177.849 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -107.09 120.36 6.17 Favored Glycine 0 N--CA 1.448 -0.516 0 N-CA-C 111.29 -0.724 . . . . 0.0 111.29 176.697 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 71.7 m-85 -91.06 104.55 17.12 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.061 0.457 . . . . 0.0 109.813 -176.613 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.699 ' HB3' ' SG ' ' A' ' 46' ' ' CYS . 1.9 tt -93.35 106.71 18.64 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.806 -0.633 . . . . 0.0 109.499 -178.204 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 49.8 mm -78.58 85.91 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 173.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . 0.409 ' HA ' ' HA ' ' A' ' 74' ' ' GLU . 15.4 t-80 -90.94 168.11 11.92 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.593 -176.548 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -151.09 112.96 0.56 Allowed Glycine 0 C--O 1.236 0.258 0 C-N-CA 120.948 -0.644 . . . . 0.0 112.111 -178.309 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.502 ' O ' ' HB2' ' A' ' 42' ' ' ARG . 0.0 OUTLIER -145.95 -167.29 2.68 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 122.385 0.274 . . . . 0.0 110.739 -176.101 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.43 ' HB3' ' HD3' ' A' ' 42' ' ' ARG . 0.0 OUTLIER 57.41 34.95 25.39 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-O 120.928 0.394 . . . . 0.0 110.205 175.181 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 84.0 mm-40 -63.88 -11.58 28.98 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 115.67 -0.695 . . . . 0.0 112.571 -172.447 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 34.7 ttpt -174.5 -63.28 0.01 OUTLIER 'General case' 0 C--O 1.234 0.261 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 173.311 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -105.43 -85.05 0.49 Allowed 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 170.595 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.484 ' HB3' ' NZ ' ' A' ' 69' ' ' LYS . 6.3 ttpm? -140.72 108.17 5.56 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 178.565 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 48.2 tp -163.73 124.54 2.26 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 110.418 -0.216 . . . . 0.0 110.418 -173.375 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 83.9 t -98.58 135.23 34.28 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 O-C-N 123.697 0.623 . . . . 0.0 109.443 173.052 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 35.4 m -134.92 -41.17 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 N-CA-C 112.127 0.418 . . . . 0.0 112.127 -177.195 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.54 HD13 ' N ' ' A' ' 74' ' ' GLU . 3.0 tm? -119.91 143.3 48.03 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.821 0.343 . . . . 0.0 110.781 -170.847 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.54 ' N ' HD13 ' A' ' 73' ' ' LEU . 9.5 pt-20 -158.45 112.17 2.44 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.915 173.555 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 42.0 t -126.0 97.81 5.26 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 179.512 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.414 ' HB2' ' HG ' ' A' ' 60' ' ' LEU . 69.2 t80 -88.36 134.82 33.72 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.99 -176.336 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 35.1 m -141.42 145.28 24.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 176.31 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 24.5 ttp180 -130.67 -24.44 2.46 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.134 0.493 . . . . 0.0 110.428 177.2 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.521 ' N ' ' HD3' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -160.9 29.21 0.15 Allowed 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 174.948 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -127.92 170.31 12.98 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 115.123 -0.944 . . . . 0.0 110.709 -167.45 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.639 HD11 ' CD1' ' A' ' 93' ' ' TRP . 10.2 tt 72.92 151.8 0.12 Allowed 'General case' 0 N--CA 1.469 0.514 0 O-C-N 123.996 0.81 . . . . 0.0 112.163 167.854 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.511 ' N ' HD23 ' A' ' 81' ' ' LEU . 8.7 p -139.63 141.02 35.74 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.68 177.221 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 14.6 m-85 -94.5 166.35 12.09 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 121.176 0.513 . . . . 0.0 111.079 -177.633 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 88.7 m -152.08 109.81 3.64 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.015 176.548 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.479 ' O ' ' HD2' ' A' ' 85' ' ' LYS . 0.0 OUTLIER -108.81 138.57 44.93 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.941 0.401 . . . . 0.0 110.663 -179.316 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -108.18 -45.72 3.88 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.956 -0.566 . . . . 0.0 109.846 178.92 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 -133.94 158.86 74.42 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.324 -179.749 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -60.43 -19.97 61.36 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.175 1.917 . . . . 0.0 111.917 177.648 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 34.8 p -100.43 2.72 42.49 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.724 -179.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 70.6 t80 -147.05 101.39 3.41 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-O 121.128 0.49 . . . . 0.0 109.921 -178.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 3.3 t-160 -131.08 110.22 11.04 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 -177.689 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . 0.671 ' HA ' ' HA3' ' A' ' 101' ' ' GLY . 16.9 p80 -120.54 -178.19 3.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.744 0.307 . . . . 0.0 110.646 -176.883 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . 0.639 ' CD1' HD11 ' A' ' 81' ' ' LEU . 41.4 p90 -148.77 -171.36 3.85 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.57 174.292 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -151.73 147.28 26.5 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.913 0.387 . . . . 0.0 111.029 -177.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.451 HG23 ' O ' ' A' ' 95' ' ' VAL . 19.0 m -123.97 107.51 18.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 172.887 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 21.9 t70 67.53 -68.02 0.17 Allowed 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.903 -174.82 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 45.7 t-20 -144.25 -43.04 0.26 Allowed 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 178.766 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 88.2 mtm180 -58.41 124.2 18.74 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.037 -179.538 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.481 ' HD3' ' N ' ' A' ' 99' ' ' LYS . 0.0 OUTLIER -116.42 129.32 56.16 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.245 -175.107 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -148.22 155.3 41.2 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.384 -0.825 . . . . 0.0 109.356 177.421 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.671 ' HA3' ' HA ' ' A' ' 92' ' ' HIS . . . -175.83 -157.57 17.4 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.565 -0.826 . . . . 0.0 113.148 -176.915 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.787 HD21 HG21 ' A' ' 43' ' ' VAL . 9.2 mp -114.56 146.6 40.56 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 121.362 0.601 . . . . 0.0 111.683 -174.354 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 91.4 m -123.69 111.51 16.28 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 166.649 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 48.7 m-85 -89.77 149.42 22.72 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.737 -170.398 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 19.3 mp0 -103.08 -43.14 5.57 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 170.708 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -82.2 141.61 46.59 Favored Pre-proline 0 CA--C 1.535 0.388 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.496 178.7 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -86.38 -38.48 0.09 OUTLIER 'Trans proline' 0 C--N 1.353 0.776 0 C-N-CA 122.676 2.251 . . . . 0.0 114.217 -174.052 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -64.89 -60.08 3.47 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 120.879 0.371 . . . . 0.0 111.639 -172.767 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 22.4 p-10 -66.43 -26.51 67.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.476 -178.696 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -60.68 -52.79 63.62 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 121.217 0.532 . . . . 0.0 110.313 172.706 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 4.2 tmm_? -63.81 -32.72 74.33 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.746 178.242 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -65.68 -39.27 91.11 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.749 177.214 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.484 ' O ' HG23 ' A' ' 117' ' ' VAL . 73.2 t80 -66.91 -52.99 36.48 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.122 179.079 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.452 ' O ' ' HG3' ' A' ' 118' ' ' ARG . 13.7 t70 -54.09 -56.9 13.71 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 121.522 0.677 . . . . 0.0 110.178 179.42 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 15.2 tpt180 -53.27 -47.74 68.87 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-N 114.628 -1.169 . . . . 0.0 110.605 176.825 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -59.76 -38.69 94.29 Favored Glycine 0 N--CA 1.451 -0.327 0 CA-C-N 115.505 -0.77 . . . . 0.0 112.15 -179.695 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.484 HG23 ' O ' ' A' ' 113' ' ' PHE . 48.3 t -62.09 -46.98 95.25 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 CA-C-O 120.736 0.303 . . . . 0.0 110.315 177.406 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.452 ' HG3' ' O ' ' A' ' 114' ' ' ASP . 81.5 mtt180 -54.85 -54.7 39.05 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.125 179.582 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.498 ' HB3' ' HZ2' ' A' ' 119' ' ' LYS . 0.0 OUTLIER -68.2 -29.59 68.47 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.764 -177.258 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -65.19 -58.05 6.96 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.829 0.347 . . . . 0.0 110.342 179.547 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 49.3 mm -59.63 -43.07 90.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.388 179.663 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 13.5 tp10 -58.52 -50.14 74.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.571 -179.303 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -72.7 -29.81 63.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.911 -176.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 6.1 tt -69.09 -53.31 20.98 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.753 179.733 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 47.9 mm -72.32 -52.47 23.87 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.547 -174.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 . . . . . 0 C--O 1.25 1.107 0 CA-C-O 119.011 -0.519 . . . . 0.0 110.145 -175.288 . . . . . . . . 0 0 . 1 stop_ save_